PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Ueda, Y; Walker, SA; Povlishock, JT				Ueda, Yuji; Walker, Susan A.; Povlishock, John T.			Perivascular nerve damage in the cerebral circulation following traumatic brain injury	ACTA NEUROPATHOLOGICA			English	Article						traumatic brain injury; perivascular nerve fibers; PGP-9.5; Fluoro-Jade; serotonin	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; CEREBROVASCULAR NERVES; NEURONAL DEGENERATION; FLUORO-JADE; RATS; IMMUNOREACTIVITY; ARTERIES; FIBERS; LOCALIZATION; SEROTONIN	Traumatic brain injury (TBI) causes cerebral vascular dysfunction. Most have assumed that it was the result of endothelial and/or smooth muscle alteration. No consideration, however, has been given to the possibility that the forces of injury may also damage the perivascular nerve network, thereby contributing to the observed abnormalities. To test this premise, we subjected rats to impact acceleration. At 6 h, 24 h and 7 days post-TBI, cerebral basal arteries were removed and processed with antibody targeting protein gene product 9.5 (PGP-9.5), with parallel assessments of 5-hydroxytryptamine (5-HT) accumulation in the perivascular nerves. Additionally, Fluoro-Jade was also used as a marker of axonal degeneration. The perivascular nerve network revealed no abnormality in sham animals. However, by 6 h post injury, Fluoro-Jade reactivity appeared in the perivascular regions, with the number of fibers increasing with time. By 24 h post injury, a significant reduction in the perivascular 5-HT accumulation occurred, together with a reduction in PGP-9.5 fiber staining. At 7 days, a recovery of the PGP-9.5 immunoreactivity occurred, however, it did not reach a control-like distribution. These studies suggest that neurogenic damage occurs following TBI and may be a contributor to some of the associated vascular abnormalities.	Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi 7558505, Japan	Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Med Coll Virginia Campus,Box 980709, Richmond, VA 23298 USA.	jtpovlis@vcu.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 20193] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS020193] Funding Source: NIH RePORTER		ALABADI JA, 1994, NEUROSURGERY, V34, P1027, DOI 10.1227/00006123-199406000-00011; Armstead WM, 1997, STROKE, V28, P2273, DOI 10.1161/01.STR.28.11.2273; Bleys RLAW, 2001, MICROSC RES TECHNIQ, V53, P106, DOI 10.1002/jemt.1075; BOUMA GJ, 1992, J NEUROTRAUMA S1, V9, P333; Busto R, 1997, J NEUROTRAUM, V14, P35, DOI 10.1089/neu.1997.14.35; CHANG JY, 1989, BRAIN RES, V492, P79, DOI 10.1016/0006-8993(89)90891-3; COWEN T, 1990, BRAIN RES, V513, P237, DOI 10.1016/0006-8993(90)90461-J; EDVINSSON L, 1991, NEUROSCI LETT, V121, P151, DOI 10.1016/0304-3940(91)90672-G; EDVINSSON L, 1994, ACTA NEUROL SCAND, V90, P324; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Goda M, 2002, J NEUROTRAUM, V19, P1445, DOI 10.1089/089771502320914679; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; HARA H, 1988, ACTA NEUROPATHOL, V75, P538, DOI 10.1007/BF00687145; HARA H, 1986, J NEUROSURG, V65, P531, DOI 10.3171/jns.1986.65.4.0531; JACKOWSKI A, 1989, NEUROSCIENCE, V29, P453, DOI 10.1016/0306-4522(89)90072-9; JACKOWSKI A, 1989, J CEREBR BLOOD F MET, V9, P271, DOI 10.1038/jcbfm.1989.45; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1981, AM J PHYSIOL, V240, P511; Lin WM, 1997, NEUROREPORT, V8, P2999, DOI 10.1097/00001756-199709290-00002; LOBATO RD, 1980, J NEUROSURG, V53, P477, DOI 10.3171/jns.1980.53.4.0477; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Navarro X, 1997, J COMP NEUROL, V380, P164, DOI 10.1002/(SICI)1096-9861(19970407)380:2<164::AID-CNE2>3.0.CO;2-1; Pluta RM, 1996, J NEUROSURG, V84, P648, DOI 10.3171/jns.1996.84.4.0648; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Sandor P, 1999, NEUROCHEM INT, V35, P237, DOI 10.1016/S0197-0186(99)00067-4; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; THOMPSON RJ, 1983, BRAIN RES, V278, P224, DOI 10.1016/0006-8993(83)90241-X; UEMURA Y, 1987, J NEUROSURG, V66, P741, DOI 10.3171/jns.1987.66.5.0741; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; YOSHIOKA J, 1984, STROKE, V15, P288, DOI 10.1161/01.STR.15.2.288; Youn SH, 1997, BRAIN RES, V752, P161, DOI 10.1016/S0006-8993(96)01451-5	39	14	14	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0001-6322	1432-0533		ACTA NEUROPATHOL	Acta Neuropathol.	JUL	2006	112	1					85	94		10.1007/s00401-005-0029-5			10	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	057YJ	WOS:000238630800010	16718445				2021-06-18	
J	Lange, RT; Chelune, GJ; Taylor, MJ; Woodward, TS; Heaton, RK				Lange, Rael T.; Chelune, Gordon J.; Taylor, Michael J.; Woodward, Todd. S.; Heaton, Robert K.			Development of demographic norms for four new WAIS-III/WMS-III indexes	PSYCHOLOGICAL ASSESSMENT			English	Article; Proceedings Paper	24th Annual Meeting of the National-Academy-of-Neuropsychology	NOV 17-20, 2004	Seattle, WA	Natl Acad Neuropsychol		WAIS-III; WMS-III; demographic norms; standardization sample	CONFIRMATORY FACTOR-ANALYSIS; R STANDARDIZATION SAMPLE; TRAUMATIC BRAIN INJURY; GENERAL ABILITY INDEX; MEMORY SCALE-III; WMS-III; EDUCATION; SCORES; INTELLIGENCE; UTILITY	Following the publication of the third edition Wechsler scales (i.e., WAIS-III and WMS-III), demographically corrected norms were made available in the form of a computerized scoring program (i.e., WAIS-III/WMS-III/WIAT-II Scoring Assistant). These norms correct for age, gender, ethnicity, and education. Since then, four new indexes have been developed: the WAIS-III General Ability Index, the WMS-III Delayed Memory Index, and the two alternate Immediate and Delayed Memory Indexes. The purpose of this study was to develop demographically corrected norms for the four new indexes using the standardization sample and education oversample from the WAIS-III and WMS-III. These norms were developed using the same methodology as the demographically corrected norms made available in the WAIS-III/WMS-III/WIAT-II Scoring Assistant.	Riverview Hosp, Res Dept, Coquitlam, BC V3C 4J2, Canada; Cleveland Clin Fdn, Cleveland, OH 44106 USA; Univ Calif San Diego, San Diego, CA 92103 USA	Lange, RT (corresponding author), Riverview Hosp, Res Dept, Room 124,ADMIN Bldg,2601 Lougheed Highway, Coquitlam, BC V3C 4J2, Canada.	rlange@bcmhs.bc.ca		Woodward, Todd/0000-0001-8083-0079			Axelrod BN, 1996, CLIN NEUROPSYCHOL, V10, P159, DOI 10.1080/13854049608406677; Chiaravalloti ND, 2004, J CLIN EXP NEUROPSYC, V26, P484, DOI 10.1080/13803390490496623; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Fastenau PS, 1996, J CLIN EXP NEUROPSYC, V18, P444; Fisher D C, 2000, Appl Neuropsychol, V7, P126, DOI 10.1207/S15324826AN0703_2; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton R., 1992, COMPREHENSIVE NORMS; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heaton R K., 2004, COMPREHENSIVE NORMS; Heaton R. K., 2003, CLIN INTERPRETATION, P181, DOI [DOI 10.1016/B978-012703570-3/50010-9, 10.1016/B978-012703570-3/50010-9]; HEATON RK, 2000, HDB NEUROPSYCHOLOGY; Heaton RK., 1996, NEUROPSYCHOL ASSESS, V2, P141; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P77, DOI 10.1016/j.acn.2005.07.007; KAUFMAN AS, 1988, J CLIN PSYCHOL, V44, P231, DOI 10.1002/1097-4679(198803)44:2<231::AID-JCLP2270440224>3.0.CO;2-J; Kurland, 1992, CLIN NEUROPSYCHOL, V6, P1, DOI DOI 10.1080/13854049208401877; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Mitchell AJ, 2008, CLIN NEUROPSYCHOL, V79, P1386, DOI DOI 10.1080/13854049208401878; MITRUSHINA MN, 1998, HDB NORMATIVE DATA N; Price LR, 2002, J CLIN EXP NEUROPSYC, V24, P574, DOI 10.1076/jcen.24.5.574.1013; *PSYCH CORP, 2001, WAIS 3 WMS 3 WIAT 2; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHN M; REYNOLDS CR, 1987, J SCHOOL PSYCHOL, V25, P323, DOI 10.1016/0022-4405(87)90035-5; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; RYAN JJ, 1991, J CLIN PSYCHOL, V47, P104, DOI 10.1002/1097-4679(199101)47:1<104::AID-JCLP2270470117>3.0.CO;2-2; Shores EA, 2000, AUST PSYCHOL, V35, P41, DOI 10.1080/00050060008257467; Spreen O., 1998, COMPENDIUM NEUROPSYC; Taylor MJ, 2001, J INT NEUROPSYCH SOC, V7, P867, DOI 10.1017/S1355617701777107; Tulsky D.S., 2003, CLIN INTERPRETATION, P147; Tulsky DS, 2004, J CLIN EXP NEUROPSYC, V26, P563, DOI 10.1080/13803390490490782; Tulsky DS, 2001, PSYCHOL ASSESSMENT, V13, P566, DOI 10.1037/1040-3590.13.4.566; Tulsky DS., 2003, CLIN INTERPRETATION, P93, DOI [10.1016/B978-012703570-3/50007-9, DOI 10.1016/B978-012703570-3/50007-9]; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wilde NJ, 2003, PSYCHOL ASSESSMENT, V15, P56, DOI 10.1037/1040-3590.15.1.56; YEUDALL LT, 1987, J CLIN PSYCHOL, V43, P346, DOI 10.1002/1097-4679(198705)43:3<346::AID-JCLP2270430308>3.0.CO;2-Q	41	14	14	0	6	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	JUN	2006	18	2					174	181		10.1037/1040-3590.18.2.174			8	Psychology, Clinical	Psychology	053QV	WOS:000238320900005	16768593				2021-06-18	
J	Ardila, A; Surloff, C				Ardila, Alfredo; Surloff, Cheri			Dysexecutive agraphia: A major executive dysfunction sign	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						agraphia; dysexecutive syndrome; executive functions; frontal syndrome	ALZHEIMERS-DISEASE; EVOLUTION; DEMENTIA; LANGUAGE; DAMAGE	Different types of writing disorders associated with brain pathology have been described. Limited mention the writing disturbances associated with prefrontal pathology, however, is found. Clinical observations of patients not only with focal prefrontal pathology but also with other conditions affecting the frontal system ( e. g., traumatic head injury, dementia) confirm the assumption that these patients present an overt decrease in the ability to express ideas in writing. It is proposed that complex aspects of writing, such as planning, narrative coherence, and maintained attention, are significantly disturbed in cases of impairments of executive functions. Frontal lobe patients not only have difficulties in keeping the effort required for writing, but also to organize the ideas in the written texts. The term dysexecutive agraphia is proposed to refer to this writing disorder. Three illustrative cases are presented. It is finally suggested that questions regarding the ability to write should be included in dementia questionnaires and executive functioning testing.	Florida Int Univ, Dept Commun Sci & Disorders, Miami, FL 33199 USA; Mem Reg Hosp, Hollywood, FL USA	Ardila, A (corresponding author), Florida Int Univ, Dept Commun Sci & Disorders, NLS144, Miami, FL 33199 USA.	ardilaa@fiu.edu					ANDERSON SW, 1993, ACTA PSYCHOL, V82, P193, DOI 10.1016/0001-6918(93)90012-G; ANDERSON SW, 1990, BRAIN, V113, P749, DOI 10.1093/brain/113.3.749; ARDILA A, 1993, BRAIN COGNITION, V22, P137, DOI 10.1006/brcg.1993.1029; ARDILA A, 2004, MEDLINK NEUROLOGY; ARDILA A, 2000, MEDLINK NEUROLOGY; Baddeley A. D., 1986, WORKING MEMORY; Benson D. F., 1985, HDB CLIN NEUROLOGY, V45, P457; Benson DF., 1996, APHASIA CLIN PERSPEC; Berthier M. L., 1999, TRANSCORTICAL APHASI; Chedru F, 1972, Cortex, V8, P395; Croisile B, 1999, DEMENT GERIATR COGN, V10, P226, DOI 10.1159/000017124; Denckla M.B., 1994, FRAMES REFERENCE ASS, P117; Denckla M.B., 1996, ATTENTION MEMORY EXE, P263; DUBOIS J, 1969, NEUROPSYCHOLOGIA, V7, P271, DOI 10.1016/0028-3932(69)90008-6; Exner S., 1881, UNERSUCHUNGEN LOKALI; Forbes KE, 2004, BRAIN RES BULL, V63, P19, DOI 10.1016/j.brainresbull.2003.11.005; Goldberg E., 2001, EXECUTIVE BRAIN; Goldstein K., 1948, LANGUAGE LANGUAGE DI; Groves-Wright K, 2004, J COMMUN DISORD, V37, P109, DOI 10.1016/j.jcomdis.2003.08.004; Hecaen H., 1978, HUMAN NEUROPSYCHOLOG; HENDERSON VW, 1992, NEUROLOGY, V42, P776, DOI 10.1212/WNL.42.4.776; Hooper SR, 2002, J LEARN DISABIL-US, V35, P57, DOI 10.1177/002221940203500105; HORNER J, 1988, ARCH NEUROL-CHICAGO, V45, P760; Katanoda K, 2001, HUM BRAIN MAPP, V13, P34, DOI 10.1002/hbm.1023; LABARGE E, 1992, ARCH NEUROL-CHICAGO, V49, P1151, DOI 10.1001/archneur.1992.00530350065021; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; Luria A. R., 1976, BASIC PROBLEMS NEURO; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2nd; Luria A. R., 1969, HDB CLINICAL NEUROLO, V2, P725; Luzzatti C, 2003, NEUROPSYCHOLOGIA, V41, P759, DOI 10.1016/S0028-3932(02)00328-7; Matsuo K, 2003, NEUROSCI LETT, V340, P13, DOI 10.1016/S0304-3940(03)00050-8; NEILS J, 1989, J CLIN EXP NEUROPSYC, V11, P692, DOI 10.1080/01688638908400925; Omura K, 2004, NEUROREPORT, V15, P949, DOI 10.1097/00001756-200404290-00004; PLATEL H, 1993, NEUROPSYCHOLOGIA, V31, P1147, DOI 10.1016/0028-3932(93)90064-7; Roeltgen DP, 2003, CLIN NEUROPSYCHOLOGY, P127; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; TOMOEDA CK, 1993, ALZ DIS ASSOC DIS, V7, P223	38	14	15	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0020-7454	1563-5279		INT J NEUROSCI	Int. J. Neurosci.	MAY	2006	116	5					653	663		10.1080/00207450600592206			11	Neurosciences	Neurosciences & Neurology	041XL	WOS:000237489900010	16644524				2021-06-18	
J	Bartle, CJ; Goozee, JV; Scott, D; Murdoch, BE; Kuruvilla, M				Bartle, Carly J.; Goozee, Justine V.; Scott, Dion; Murdoch, Bruce E.; Kuruvilla, Mili			EMA assessment of tongue-jaw co-ordination during speech in dysarthria following traumatic brain injury	BRAIN INJURY			English	Article						dysarthria; traumatic brain injury; EMA assessment; tongue; jaw; co-ordination; articulation	KINEMATIC ANALYSIS; MOTOR CONTROL; MOVEMENTS; CHILDREN	Primary objective: To investigate the spatio-timing aspects of tongue-jaw co-ordination during speech in individuals with traumatic brain injury (TBI). It was hypothesized that both timing and spatial co-ordination would be affected by TBI. Research design: A group comparison design wherein Mann-Whitney U-tests were used to compare non-neurologically impaired individuals with individuals with TBI. Methods and procedures: Nine non-neurologically impaired adults and nine adults with TBI were involved in the study. Electromagnetic articulography (EMA) was used to track tongue and jaw movement during /t/ and /k/, embedded in sentence and syllable stimuli. Main outcomes and results: Analysis of group data did not reveal a significant difference in spatio-timing tongue-jaw co-ordination between the control group and TBI group. On an individual basis, a proportion of individuals with TBI differed from non- neurologically impaired participants with regard to articulatory order and percentage of jaw contribution to /t/. Conclusions: EMA assessment results supported perceptual data; those adults who presented with severe articulatory disturbances exhibited the most deviant spatio-timing tongue-jaw co-ordination patterns. This finding could provide a new and specific direction for treatment, directed at combined movement patterns.	Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia	Bartle, CJ (corresponding author), Univ Queensland, Div Speech Pathol, Motor Speech Res Unit, Brisbane, Qld 4072, Australia.	c.bartle@uq.edu.au	Murdoch, Bruce E/C-1397-2012; Meyer, Carly/L-7240-2019; Meyer, Carly/E-4519-2010	Meyer, Carly/0000-0002-2268-3055; Meyer, Carly/0000-0002-2268-3055; Kuruvilla-Dugdale, Mili/0000-0001-7900-2364			ABBS JH, 1984, J MOTOR BEHAV, V16, P195; Alfonso PJ, 1997, INT CONGR SER, V1146, P151; BARLOW SM, 1988, ASS RES OT ABSTR, V11, P218; Bernstein N., 1967, COORDINATION REGULAT; COELHO CA, 1994, MOTOR SPEECH DISORDE, P103; Cotert HS, 1999, J ORAL REHABIL, V26, P75, DOI 10.1046/j.1365-2842.1999.00340.x; Darley F., 1975, MOTOR SPEECH DISORDE; Duffy J. R., 2020, MOTOR SPEECH DISORDE; FLETCHER SG, 1992, ARTICULATION PHYSL A; FOWLER CA, 1993, LANG SPEECH, V36, P171, DOI 10.1177/002383099303600304; Goozee J V, 2001, Logoped Phoniatr Vocol, V26, P51; Goozee JV, 2002, FOLIA PHONIATR LOGO, V54, P177, DOI 10.1159/000063191; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; GRACCO VL, 1986, EXP BRAIN RES, V65, P156; GRACCO VL, 1988, J NEUROSCI, V8, P4628; Green JR, 2003, J ACOUST SOC AM, V113, P2820, DOI 10.1121/1.1562646; Green JR, 2000, J SPEECH LANG HEAR R, V43, P239, DOI 10.1044/jslhr.4301.239; HUGHES OM, 1976, PHONETICA, V33, P199; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; KELSO JAS, 1986, J PHONETICS, V14, P29, DOI 10.1016/S0095-4470(19)30608-4; Kent R. D., 1977, J PHONETICS, V5, P115, DOI DOI 10.1016/S0095-4470(19)31123-4; KENT RD, 1987, J SPEECH HEAR DISORD, V52, P367, DOI 10.1044/jshd.5204.367; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; LEE WA, 1984, J MOTOR BEHAV, V16, P135; LEVIN HS, 1981, ACQUIRED APHASIA, P427; Loh EWL, 2005, BRAIN INJURY, V19, P529, DOI 10.1080/02699050400025083; MCHENRY MA, 1984, J MED SPEECH-LANG PA, V2, P59; MOOSHAMMER C, 2003, 15 INT C PHON SCI AU, P81; Muller E. M., 1985, Mathematics and computers in biomedical applications, P363; Murdoch B. E., 1987, AUSTR J HUMAN COMMUN, V15, P15; Murdoch BE, 2003, BRAIN INJURY, V17, P79, DOI 10.1080/0269905021000010203; Murdoch BE, 2001, TRAUMATIC BRAIN INJU, P1; MURDOCH BE, 1997, ACQUIRED SPEECH LANG, P120; NETSELL R, 1976, J SPEECH HEAR DISORD, V41, P93, DOI 10.1044/jshd.4101.93; NETSELL R, 1984, DYSARTHRIAS PHYSL AC, P1; Perkell J. S., 1997, HDB PHONETIC SCI, P333; PERKELL JS, 1995, J PHONETICS, V23, P23, DOI 10.1016/S0095-4470(95)80030-1; ROBIN DA, 1991, DYSARTHRIA AND APRAXIA OF SPEECH, P173; ROSENBEK JC, 1978, CLIN MANAGEMENT NEUR, P251; RUSK H, 1969, LATE EFFECTS HEAD IN, P327; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SCHONLE PW, 1987, BRAIN LANG, V31, P26, DOI 10.1016/0093-934X(87)90058-7; STEVENS KN, 1998, ACOUSTIC PHONETICS, P323; Stierwalt JAG, 1996, DISORDERS MOTOR SPEE, P241; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU, p[53, 75]; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1995, BRAIN INJURY, V9, P237, DOI 10.3109/02699059509008196; THEODOROS DG, 1998, DYSARTHRIA PHYSL APP, P337; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vatikiotis-Bateson E., 1999, IEEE SMC'99 Conference Proceedings. 1999 IEEE International Conference on Systems, Man, and Cybernetics (Cat. No.99CH37028), P442, DOI 10.1109/ICSMC.1999.825301; Weismer G, 2003, J SPEECH LANG HEAR R, V46, P1247, DOI 10.1044/1092-4388(2003/097); ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; ZIEGLER W, 1983, PHONETICA, V40, P63	53	14	16	0	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2006	20	5					529	545		10.1080/02699050500487613			17	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	045GO	WOS:000237730800009	16716999				2021-06-18	
J	Garcia, R; Ponsky, T; Brody, F; Long, J				Garcia, Ryan; Ponsky, Todd; Brody, Fredrick; Long, Joy			Bilateral luxatio erecta complicated by venous thrombosis	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							UPPER EXTREMITY	Inferior shoulder dislocation or luxatio erecta is an exceedingly rare form of shoulder dislocation and compromises less than 0.5% of all shoulder dislocations. Furthermore, bilateral luxatio erecta is reported only nine times in the English literature. This paper documents the tenth case of bilateral luxatio erecta. This tenth patient suffered an axial load injury to his outstretched arms and displaced both humeral heads inferiorly. After closed reduction, the patient was discharged home on hospital day two. However, he developed an axillary vein thrombosis 3 days later and required anticoagulation therapy. This report reviews the mechanisms of injury associated with inferior shoulder dislocations as well as the presentation and treatment of luxatio erecta. The complication of axillary vein thrombosis and its treatment in this patient are discussed also.	Univ Texas, Hlth Sci Ctr, Dept Surg, San Antonio, TX 78284 USA	Brody, F (corresponding author), George Washington Univ, Med Ctr, Dept Surg, 2150 Penn Ave NW,Suite 6B, Washington, DC 20037 USA.	fbrody@mfa.gwu.edu	Ponsky, Todd/J-1214-2014	Ponsky, Todd/0000-0001-7195-1493			Brady William J., 1995, Journal of Emergency Medicine, V13, P37, DOI 10.1016/0736-4679(94)00110-3; FREUNDLICH BD, 1983, J TRAUMA, V23, P434, DOI 10.1097/00005373-198305000-00015; Gelczer RK, 1996, J TRAUMA, V40, P825, DOI 10.1097/00005373-199605000-00025; Karaoglu S, 2003, ARCH ORTHOP TRAUM SU, V123, P308, DOI 10.1007/s00402-003-0517-9; LASKIN RS, 1971, CLIN ORTHOP RELAT R, P126, DOI 10.1097/00003086-197110000-00017; Mallon W J, 1990, J Orthop Trauma, V4, P19; MARX J, 2002, ROSENS EMERGENCY MED, P597; Middeldorpf M, 1859, CLIN EUROPENNE, V2, P12; Mills LD, 2003, J EMERG MED, V24, P61, DOI 10.1016/S0736-4679(02)00668-6; NEWMAN KJH, 1993, INJURY, V24, P684, DOI 10.1016/0020-1383(93)90323-X; Stephens MB, 1997, AM FAM PHYSICIAN, V55, P533; TILNEY NL, 1970, ARCH SURG-CHICAGO, V101, P792	12	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAY	2006	60	5					1132	1134		10.1097/01.ta.0000217246.64718.02			3	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	044NB	WOS:000237678100046	16688085				2021-06-18	
J	Feleppa, M; Di Iorio, W; Saracino, DMT				Feleppa, M; Di Iorio, W; Saracino, DMT			Early poststroke seizures	CLINICAL AND EXPERIMENTAL HYPERTENSION			English	Article; Proceedings Paper	1st Chieti Stroke Meeting	SEP   06, 2004	Chieti, ITALY				EPILEPTIC SEIZURES; ACUTE STROKE; INTRACEREBRAL HEMORRHAGE; POPULATION; PROGNOSIS; PREDICTORS; INFARCTION; FREQUENCY; MORTALITY; ISCHEMIA	We define as early seizure (ES) those occurring within 7 days alter stroke and late seizures those developing beyond I week after stroke. Seizures are well known to occur at the onset of intracerebral hemorrhage and serve as a clinical marker. Onset seizures may be focal or generalized, are usually brief and are associated with loss of consciousness in the setting of hemorrhage. A similar concept of immediate seizure occurs in traumatic brain injury. Predictive factors of ES can be classified of general and neurologic origin. An important question is whether ES per se worsen prognosis and outcome. The viability of the penumbral region in animal models of focal ischemia is influenced by the peri-infarct depolarization waves. If this also is trite in humans, seizures in the immediate poststroke period might worsen outcome. Recently, hypercholesterolemia has been associated with better functional outcome at 1 month after a first-ever stroke, and multivariate analysis studies have shown that mean cholesterol values were lower in patients with ES compared with controls.	Dipartimento Neurosci, Unita Operat Neurol, Benevento, Italy; Direz Sanit Azienda Osped G Rummo, Benevento, Italy	Feleppa, M (corresponding author), Azienda Osped G Rummo Benevento, Direttore Dipartimento Neurosci, UO Neurol, Via Angelo, I-82100 Benevento, Italy.	Michele.feleppa@ao-rummo.it					Afsar N, 2003, SEIZURE-EUR J EPILEP, V12, P23, DOI 10.1016/S1059131102001437; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Arboix A, 1997, STROKE, V28, P1590, DOI 10.1161/01.STR.28.8.1590; Arboix A, 2003, EUR NEUROL, V50, P78, DOI 10.1159/000072503; Berges S, 2000, EUR NEUROL, V43, P3, DOI 10.1159/000008120; Bladin CF, 2000, ARCH NEUROL-CHICAGO, V57, P1617, DOI 10.1001/archneur.57.11.1617; Burn J, 1997, BRIT MED J, V315, P1582, DOI 10.1136/bmj.315.7122.1582; DAVALOS A, 1988, J NEUROL NEUROSUR PS, V51, P1464, DOI 10.1136/jnnp.51.11.1464; Devuyst G, 2003, NEUROLOGY, V61, P249, DOI 10.1212/01.WNL.0000070410.68541.7E; GIROUD M, 1994, EPILEPSIA, V35, P959, DOI 10.1111/j.1528-1157.1994.tb02540.x; GOODRIDGE DMG, 1983, BMJ-BRIT MED J, V287, P641, DOI 10.1136/bmj.287.6393.641; KILPATRICK CJ, 1990, ARCH NEUROL-CHICAGO, P47; Labovitz DL, 2001, NEUROLOGY, V57, P200, DOI 10.1212/WNL.57.2.200; Lamy C, 2003, NEUROLOGY, V60, P400, DOI 10.1212/WNL.60.3.400; LANCMAN ME, 1993, EPILEPSIA, V34, P141, DOI 10.1111/j.1528-1157.1993.tb02386.x; LEPPIK IE, 2002, SEMINARS NEUROLOGY, V22, P310; MILANDRE L, 1992, REV NEUROL, V148, P767; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; OLSSON T, 1992, STROKE, V23, P1573, DOI 10.1161/01.STR.23.11.1573; Reith J, 1997, STROKE, V28, P1585, DOI 10.1161/01.STR.28.8.1585; REITH J, 1996, EUR J N EUROL S2, V3, P93; Rumbach L, 2000, NEUROLOGY, V54, P350, DOI 10.1212/WNL.54.2.350; SCHOLTES FB, 1994, EPILEPSIA, V35, P1104, DOI 10.1111/j.1528-1157.1994.tb02562.x; SHINTON RA, 1988, J NEUROL NEUROSUR PS, V51, P273, DOI 10.1136/jnnp.51.2.273; Silverman IE, 2002, ARCH NEUROL-CHICAGO, V59, P195, DOI 10.1001/archneur.59.2.195; Sitajayalakshmi S, 2002, NEUOROL INDIA, V50, P78; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; SUNG CY, 1989, J NEUROL NEUROSUR PS, V52, P1273, DOI 10.1136/jnnp.52.11.1273; Takano K, 1996, ANN NEUROL, V39, P308, DOI 10.1002/ana.410390307; TOWNE AR, 1994, EPILEPSIA, V35, P27, DOI 10.1111/j.1528-1157.1994.tb02908.x; Vauthey C, 2000, NEUROLOGY, V54, P1944, DOI 10.1212/WNL.54.10.1944; Velioglu SK, 2001, STROKE, V32, P1169, DOI 10.1161/01.STR.32.5.1169; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4	34	14	16	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1064-1963			CLIN EXP HYPERTENS	Clin. Exp. Hypertens.	APR-MAY	2006	28	3-4					265	270		10.1080/10641960600549215			6	Pharmacology & Pharmacy; Peripheral Vascular Disease	Pharmacology & Pharmacy; Cardiovascular System & Cardiology	038MM	WOS:000237225900011	16833033				2021-06-18	
J	Johnston, MV; Shawaryn, MA; Malec, J; Kreutzer, J; Hammond, FM				Johnston, Mark V.; Shawaryn, Marla A.; Malec, James; Kreutzer, Jeffrey; Hammond, Flora M.			The structure of functional and community outcomes following traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; measurement; outcomes; community participation; psychometrics	DISABILITY RATING-SCALE; REHABILITATION; VALIDITY; INVENTORY; INDIVIDUALS; RELIABILITY; INSTRUMENT	Objectives: To investigate the dimensionality of functional and community outcomes following serious TBI. To identify items that fit, misfit or are redundant, as well as to assess person misfit. Methods: Rating-scale (Rasch) analysis was applied to 1-year follow-up data from 231 cases in the US National TBI Model Systems database. Items selected for analysis included all items indicative of global outcomes, disability, activity or participation. Results: A powerful singular measurement dimension was identified. Item reliability was very high (0.98), as was person reliability (0.97). The dimension fit over 90% of cases; that is similar to 10% of cases displayed anomalous patterns of functioning that indicated that their functioning was not measurable in terms of the general dimension identified. There was tension within the dimension between ratings of dependency (FIM) and cognitive functioning in everyday life (NFI). Most-but not all-neuropsychological test scores misfit the outcome dimension. Conclusions: Actual dimensionality was distinct from the named scales employed. A unidimensional measure model fit the data much better than expected. This outcome dimension might be called 'general community functioning'. In the future, it should be possible to develop more valid and parsimonious measures of community outcomes following TBI.	Kessler Med Rehabil Res & Educ Corp, W Orange, NJ 07052 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, W Orange, NJ 07052 USA; Mayo Med Ctr, Dept Phys Med & Rehabil, Rochester, MN USA; Virginia Commonwealth Univ, Med Coll Virginia, Dept Phys Med & Rehabil, Richmond, VA 23298 USA; Charlotte Inst Rehabil, Dept Phys Med & Rehabil, Charlotte, NC USA	Johnston, MV (corresponding author), Kessler Med Rehabil Res & Educ Corp, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	mjohnston@kmrrec.org					Allen MJ, 1979, INTRO MEASUREMENT TH; Anderson Shirley I., 1993, Brain Injury, V7, P309, DOI 10.3109/02699059309034957; Boake C, 1996, AM J PHYS MED REHAB, V75, P105, DOI 10.1097/00002060-199603000-00005; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Bond T.G., 2001, APPL RASCH MODEL FUN; Bowling A, 2001, MEASURING DIS REV DI; Brown SA, 2001, AM J PHYS MED REHAB, V80, P196, DOI 10.1097/00002060-200103000-00009; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; CONZEN M, 1992, Brain Injury, V6, P45, DOI 10.3109/02699059209008121; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; DODWELL D, 1988, J NEUROL NEUROSUR PS, V51, P833, DOI 10.1136/jnnp.51.6.833; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; FISHER AG, 1999, ASSESSMENT MOTOR PRO; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; GRAHAM DI, 1999, REHABILITATION ADULT, P19; GROHER ME, 1999, REHABILITATION ADULT, P183; Haffey W. J., 1990, NEUROPSYCHOLOGY EVER, P99; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; JOHNSTON M V, 1991, Brain Injury, V5, P141, DOI 10.3109/02699059109008085; JOHNSTON MV, 1992, ARCH PHYS MED REHAB, V73, pS3; JOHNSTON MV, 1996, MED REHABILITATION T, P197; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; LINACRE JM, 2001, WINSTEPS 3 30; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; Palav A, 2001, J HEAD TRAUMA REHAB, V16, P275, DOI 10.1097/00001199-200106000-00006; Powell JH, 1998, ARCH PHYS MED REHAB, V79, P1213, DOI 10.1016/S0003-9993(98)90265-9; Putnam S, 1999, REHABILITATION ADULT, P147; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Riemsma R P, 2001, Health Technol Assess, V5, P1; Rizzo Matthew, 1996, P1; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Streiner D., 1995, HLTH MEASUREMENT SCA, V2; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; *TRAUM BRAIN INJ N, 2006, TRAUM BRAIN INJ MOD; Turner-Stokes L, 1999, CLIN REHABIL, V13, P273, DOI 10.1191/026921599670005973; Wade DT, 2001, CLIN REHABIL, V15, P229, DOI 10.1191/026921501677354949; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Witol A., 1999, REHABILITATION ADULT, P167; World Health Organization, 2001, INT CLASS FUNCT DIS; WRIGHT BD, 1996, JMRASCH MEASUREMEN 2, P385	43	14	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2006	20	4					391	407		10.1080/02699050500487795			17	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	045GN	WOS:000237730700004	16716985				2021-06-18	
J	Moran, CA; Nippold, MA; Gillon, GT				Moran, CA; Nippold, MA; Gillon, GT			Working memory and proverb comprehension in adolescents with traumatic brain injury: A preliminary investigation	BRAIN INJURY			English	Article						traumatic brain injury; language comprehension; adolescents	CLOSED-HEAD INJURY; INDIVIDUAL-DIFFERENCES; ADULTS; FAMILIARITY; LANGUAGE; CHILDREN; PREADOLESCENTS; TRANSPARENCY; EXPLANATION; INFERENCE	Primary objective: This study investigated the relationship between working memory and comprehension of low-familiarity proverbs in adolescents with traumatic brain injury (TBI). Methods and procedures: Ten adolescents, aged 12 - 21 years who had suffered a TBI prior to the age of 10 years and 10 individually age-matched peers with typical development participated in the study. The participants listened to short paragraphs containing a proverb and interpreted the meaning of the proverb using a forced-choice task. In addition, participants engaged in a task that evaluated working memory ability. Main outcomes and results: Analysis revealed that individuals with TBI differed from their non-injured peers in their understanding of proverbs. In addition, working memory capacity influenced performance for all participants. Conclusions: The importance of considering working memory when evaluating figurative language comprehension in adolescents with TBI is highlighted. Implications for future research, particularly with regard to varying working memory and task demands, are considered.	Univ Canterbury, Coll Sci, Dept Commun Disorders, Christchurch 1, New Zealand	Moran, CA (corresponding author), Univ Canterbury, Coll Sci, Dept Commun Disorders, Private Bag 4800, Christchurch 1, New Zealand.	catherine.moran@canterbury.ac.nz		Gillon, Gail/0000-0001-9501-8147			Brundage SB, 1995, CLIN APHASIOL, V23, P165; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dennis M., 1989, CLIN NEUROPSYCHOLOGY, P89; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; GIBBS RW, 1995, PSYCHOL BULL, V118, P113; Granier JP, 2000, APHASIOLOGY, V14, P501, DOI 10.1080/026870300401270; Hartley L. L., 1995, COGNITIVE COMMUNICAT; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Jordan FM, 1996, BRAIN INJURY, V10, P729, DOI 10.1080/026990596123990; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kerbel D, 1997, CHILD LANG TEACH THE, V13, P113, DOI [10.1177/026565909701300201, DOI 10.1177/026565909701300201]; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Lehman MT, 2000, APHASIOLOGY, V14, P485, DOI 10.1080/026870300401261; Lehman-Blake MT, 2001, J SPEECH LANG HEAR R, V44, P639, DOI 10.1044/1092-4388(2001/052); LEVORATO MC, 1992, J CHILD LANG, V19, P415, DOI 10.1017/S0305000900011478; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; MORAN C, 2002, LANGUAGE COMPREHENSI; Nippold M., 1998, LATER LANGUAGE DEV S; Nippold M. A, 2001, NZ J SPEECH LANGUAGE, P14; NIPPOLD MA, 1993, J SPEECH HEAR RES, V36, P728, DOI 10.1044/jshr.3604.728; Nippold MA, 2001, AM J SPEECH-LANG PAT, V10, P169, DOI 10.1044/1058-0360(2001/016); NIPPOLD MA, 1988, J SPEECH HEAR RES, V31, P19, DOI 10.1044/jshr.3101.19; Nippold MA, 2000, J SPEECH LANG HEAR R, V43, P621, DOI 10.1044/jslhr.4303.621; NIPPOLD MA, 1995, J SPEECH HEAR RES, V38, P426, DOI 10.1044/jshr.3802.426; Nippold MA, 1996, J SPEECH HEAR RES, V39, P166, DOI 10.1044/jshr.3901.166; Nippold MA, 1997, J SPEECH LANG HEAR R, V40, P245, DOI 10.1044/jslhr.4002.245; Nippold MA, 2001, LANG SPEECH HEAR SER, V32, P90, DOI 10.1044/0161-1461(2001/009); Nippold Marilyn A., 1998, J CHILDRENS COMMUNIC, V19, P49; Qualls CD, 2003, AM J SPEECH-LANG PAT, V12, P92, DOI 10.1044/1058-0360(2003/055); Secord, 1989, TEST LANGUAGE COMPET; SWINNEY DA, 1979, J VERB LEARN VERB BE, V18, P523, DOI 10.1016/S0022-5371(79)90284-6; TOMPKINS CA, 1994, J SPEECH HEAR RES, V37, P896, DOI 10.1044/jshr.3704.896; TOWNE RL, 1993, LANG SPEECH HEAR SER, V24, P100; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Warr-Leeper G.A., 1989, LANGUAGE, V20, P420, DOI [10.1044/0161-1461.2004.420, DOI 10.1044/0161-1461.2004.420]	36	14	15	0	9	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	2006	20	4					417	423		10.1080/02699050500488223			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	045GN	WOS:000237730700006	16716987				2021-06-18	
J	Schneider, HJ; Stalla, GK; Buchfelder, M				Schneider, HJ; Stalla, GK; Buchfelder, M			Expert meeting: hypopituitarism after traumatic brain injury and subarachnoid haemorrhage	ACTA NEUROCHIRURGICA			English	Article						endocrine dysfunction; head injury; hormonal deficiencies; hypopituitarism; traumatic brain injury; subarachnoid haemorrhage	HUMAN GROWTH-HORMONE; ADULTS		Univ Erlangen Nurnberg, Dept Neurosurg, Sch Med, D-91054 Erlangen, Germany; Max Planck Inst Psychiat, Dept Endocrinol & Clin Chem, Munich, Germany	Buchfelder, M (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Sch Med, Schwabachanlage 6, D-91054 Erlangen, Germany.	buchfelder@hotmail.com					ADAMS JH, 1962, J PHYSIOL, V165, pP22; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Ceballos R, 1966, Ala J Med Sci, V3, P185; EDWARDS OM, 1986, MEDICINE, V65, P281; Frieboes RM, 1999, J NEUROPSYCH CLIN N, V11, P354, DOI 10.1176/jnp.11.3.354; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; HERNDON DN, 1990, ANN SURG, V212, P424, DOI 10.1097/00000658-199010000-00005; Hoffmann B, 2002, ACT NEUR S, V79, P33; JEEVANANDAM M, 1995, JPEN-PARENTER ENTER, V19, P137, DOI 10.1177/0148607195019002137; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KNOX J, 1995, J TRAUMA, V39, P526; KREITSCHMANNAND.I, 2003, J NEUROL NEUROSUR PS, V74, P1127; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Schneider HJ, 2004, DTSCH ARZTEBL, V101, pA712; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; TEASDALE G, 1974, LANCET, V2, P81; Van den Berghe G, 2000, EUR J ENDOCRINOL, V143, P1, DOI 10.1530/eje.0.1430001	19	14	16	1	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	APR	2006	148	4					449	456		10.1007/s00701-005-0724-y			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	023GN	WOS:000236114600023	16421764				2021-06-18	
J	Gujral, IB; Stallones, L; Gabella, BA; Keefe, TJ; Chen, P				Gujral, IB; Stallones, L; Gabella, BA; Keefe, TJ; Chen, P			Sex differences in mortality after traumatic brain injury, Colorado 1994-1998	BRAIN INJURY			English	Article						traumatic brain injury; mortality; blunt; penetrating	GLASGOW COMA SCALE; HEAD-INJURIES; GENDER; ESTROGEN; SCORE	Primary objective: The purpose of this study was to assess the relationship between sex and traumatic brain injury (TBI) mortality. Methods and procedures: A total of 20 465 persons with TBI were identified from a Colorado population-based surveillance system for 1994 - 1998. Case fatality ratios were calculated to identify sex differences for selected risk factors. Unconditional logistic regression was used to determine the relationship between TBI mortality and sex controlling for risk factors. Main outcomes and results: Adjusting for age, race, metropolitan residence and penetrating injury, the estimated odds of TBI mortality for males compared to females was 1.21 ( 95% CI 1.10, 1.34) for pre-hospital fatalities and 1.19 ( 95% CI 1.05, 1.37) for hospital fatalities. Conclusion: Results indicate differences in TBI mortality comparing males and females. Future studies are warranted to identify if behaviour and physiological responses are associated with TBI outcomes among males and females.	Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; Colorado Dept Publ Hlth & Environm, Colorado Traumat Brain Injury Surveillance, Denver, CO USA	Gujral, IB (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	indiragujral0214@msn.com	Stallones, Lorann/AAC-6248-2021	Stallones, Lorann/0000-0001-7616-582X	PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [R49/CCR811509, U17/CCU811909] Funding Source: Medline		Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; *COL DEP PUBL HLTH, 2002, INJ COL, P10; *COL DEP PUBL HLTH, 2005, INJ COL; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Hosmer D. W., 2000, APPL LOGISTIC REGRES; LANGLOIS JA, 2004, TRAUMATIC BRAIN INJU, P1; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA; THURMAN DJ, 2001, HEAD TRAUMA BASIC PR, P1	19	14	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAR	2006	20	3					283	291		10.1080/02699050500488058			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	021GT	WOS:000235972400008	16537270				2021-06-18	
J	Singh, R; Sharma, SC; Goel, TL				Singh, R; Sharma, SC; Goel, TL			Traumatic inferior hip dislocation in an adult with ipsilateral trochanteric fracture	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						dislocation; hip; inferior; trochanteric fracture	FEMORAL-HEAD FRACTURES; TERM-FOLLOW-UP; ANTERIOR DISLOCATION; LUXATIO-ERECTA; GREATER TROCHANTER; MECHANISM	Traumatic Inferior dislocation of]lip in adult is an extremely rare Occurrence. We report a case of an inferior]lip dislocation associated with an intertrochanteric fracture. Treatment consisted of an initial closed manipulative reduction of the dislocation with the aid of a Schanz screw inserted in a T handle universal chuck and using C-arm, imaging. A dynamic hip screw was then used to fix the intertrochanteric fracture. At 2.5 years after the injury, the patient has symmetrical range of motion versus his contra lateral normal hip. Radiographs of the hip show normal anatomy without signs of avascular necrosis of the femoral head. To our knowledge, this is the first reported case of an adult with an inferior hip dislocation with a trochanteric fracture.	Post Grad Inst Med Sci, Dept Orthopaed Surg Phys Med Paraplegia & Rehabil, Rohtak 124001, Haryana, India	Singh, R (corresponding author), 8J-3,Med Enclave, Rohtak 124001, Haryana, India.	drroopsingh@rediffmail.com					Bartley RE, 1995, ORTHOPEDICS, V18, P1173; BEAUCHESNE R, 1994, ORTHOPEDICS, V17, P72; Brogdon BG, 1997, SKELETAL RADIOL, V26, P548, DOI 10.1007/s002560050284; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; DUSSAULT RG, 1980, RADIOLOGY, V135, P627, DOI 10.1148/radiology.135.3.7384446; Epstein HC, 1985, ORTHOPEDICS, V8, P132; ERB RE, 1995, AM J ROENTGENOL, V165, P1215, DOI 10.2214/ajr.165.5.7572506; Ferguson KL, 2000, AM J EMERG MED, V18, P117, DOI 10.1016/S0735-6757(00)90067-6; JACOB JR, 1987, CLIN ORTHOP RELAT R, P249; KOROVESSIS P, 1990, CLIN ORTHOP RELAT R, P164; Lamberti PM, 2003, J ORTHOP TRAUMA, V17, P65, DOI 10.1097/00005131-200301000-00011; LAVELLE DG, 2003, CAMPBELLS OPERATIVE, P2931; MARUOKA A, 1993, ARCH ORTHOP TRAUM SU, V112, P299, DOI 10.1007/BF00452970; MAUCK H, 1935, J BONE JOINT SURG, V5, P1011; Phillips AM, 2000, CLIN ORTHOP RELAT R, P7; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; SCHLICKEWEI W, 1993, INJURY, V24, P27, DOI 10.1016/0020-1383(93)90078-K; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Toms AD, 2001, J BONE JOINT SURG BR, V83B, P113, DOI 10.1302/0301-620X.83B1.10289	19	14	16	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0890-5339			J ORTHOP TRAUMA	J. Orthop. Trauma	MAR	2006	20	3					220	222		10.1097/00005131-200603000-00010			3	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	030UZ	WOS:000236661800013	16648705				2021-06-18	
J	Trabold, R; Schueler, OG; Eriskat, J; Plesnila, N; Baethmann, A; Back, T				Trabold, R; Schueler, OG; Eriskat, J; Plesnila, N; Baethmann, A; Back, T			Arterial hypotension triggers perifocal depolarizations and aggravates secondary damage in focal brain injury	BRAIN RESEARCH			English	Article						brain injury; cerebral blood flow; cold lesion; depolarization; spreading depression	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; SPREADING DEPRESSION; CORTICAL DEPOLARIZATIONS; GENE-EXPRESSION; TISSUE NECROSIS; AUTO-REGULATION; RAT; ISCHEMIA; OCCLUSION	Perifocal depolarizations (PFD) have been observed after traumatic brain injury, are known to disturb cerebrovascular reactivity and thus may contribute to the morphological consequences of brain injury. In this investigation, the role of PFD was studied in focal brain lesions with/without induction of delayed hypotension. Cerebral freeze lesions were induced in anesthetized normotensive rats that underwent perfusion fixation of brains S min, 4 h or 24 h after lesioning, respectively, to obtain quantitative histopathology. In additional groups, a 45-min period of moderate hypobaric hypotension was applied 15 min post-trauma and brains were perfusion fixed after 4 h or 24 h. In a second series, the direct current (DC) potential and cortical laser-Doppler flow (LDF) were measured adjacent to lesions under normotensive or hypotensive conditions. Sham procedures were carried out in rats that underwent hypotension alone. Lesioning resulted in a significant LDF decrease to 50% of baseline, further decreased during hypotension to less than 40% of control (P < 0.05). Sham animals had LDF values between 60 and 70% of control when subjected to hypotension. Focal brain injury always induced a negative DC shift shortly after lesioning. In 6 of 8 rats that under-went cold lesion plus hypotension, a second PFD was observed approximately 2.5 min after onset of hypotension accompanied by a relative LDF increase by 25 +/- 12%. Lesion expansion was significantly worsened by hypotension (8.19 +/- 0.56 mm(3) at 24 h) compared with normotensive rats (7.01 +/- 0.3 mm(3) at 24 h, P < 0.01). We conclude that hypotension triggers depolarizations by an ischemic mechanism that contributes to final tissue damage. (C) 2005 Elsevier B.V. All rights reserved.	Heidelberg Univ, Klinikum Mannheim, Dept Neurol, D-68167 Mannheim, Germany; Univ Wurzburg, Dept Neurosurg, D-97070 Wurzburg, Germany; Municipal Hosp Munich Bogenhausen, Dept Neurol, Munich, Germany; Univ Munich, Grosshadern Med Ctr, Inst Surg Res, Munich, Germany	Back, T (corresponding author), Heidelberg Univ, Klinikum Mannheim, Dept Neurol, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	back@neuro.ma.uni-heidelberg.de	Plesnila, Nikolaus/T-7522-2019				Armstead WM, 1998, J NEUROTRAUM, V15, P721, DOI 10.1089/neu.1998.15.721; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; Back T, 1996, J CEREBR BLOOD F MET, V16, P202, DOI 10.1097/00004647-199603000-00004; BACK T, 1994, J CEREBR BLOOD F MET, V14, P12, DOI 10.1038/jcbfm.1994.3; BACK T, 1998, CEREBROVASC DIS, V1, P276; BOLANDER HG, 1989, STROKE, V20, P930, DOI 10.1161/01.STR.20.7.930; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Bramlett HM, 1999, J NEUROSURG, V91, P653, DOI 10.3171/jns.1999.91.4.0653; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIRNAGL U, 1993, NEUROL RES, V15, P128; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; ERISKAT J, 1994, ACTA NEUROCHIR, P425; Giri BK, 2000, STROKE, V31, P961, DOI 10.1161/01.STR.31.4.961; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Gorlach C, 1998, J NEUROTRAUM, V15, P1067, DOI 10.1089/neu.1998.15.1067; Hermann DM, 1998, NEUROREPORT, V9, P1249, DOI 10.1097/00001756-199804200-00053; Hermann DM, 1999, RESTOR NEUROL NEUROS, V14, P103; Hermeren G, 1999, ACTA PAEDIATR, V88, P99, DOI 10.1080/080352599750029501; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; LAURITZEN M, 1982, ANN NEUROL, V12, P469, DOI 10.1002/ana.410120510; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LIJIMA T, 1992, J CEREB BLOOD FLOW M, V12, P727; Matsushita Y, 2001, J CEREBR BLOOD F MET, V21, P847, DOI 10.1097/00004647-200107000-00010; Mies G, 1997, NEUROSCI LETT, V221, P165, DOI 10.1016/S0304-3940(96)13317-6; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; NEDERGAARD M, 1986, J CEREBR BLOOD F MET, V6, P607, DOI 10.1038/jcbfm.1986.108; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OZAWA Y, 1991, Neurologia Medico-Chirurgica, V31, P685, DOI 10.2176/nmc.31.685; Plesnila N, 2003, NEUROSCI LETT, V345, P85, DOI 10.1016/S0304-3940(03)00396-3; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Stoffel M, 2004, J NEUROTRAUM, V21, P733, DOI 10.1089/0897715041269678; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; TYSON GW, 1984, ANN NEUROL, V15, P559, DOI 10.1002/ana.410150608; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P19, DOI 10.1016/0165-0270(86)90111-1; Windmuller O, 2005, BRAIN, V128, P2042, DOI 10.1093/brain/awh545; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117	46	14	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	FEB 3	2006	1071	1					237	244		10.1016/j.brainres.2005.11.095			8	Neurosciences	Neurosciences & Neurology	021VS	WOS:000236014600025	16412395				2021-06-18	
J	Li, SH; Kuroiwa, T; Katsumata, N; Ishibashi, S; Sun, LY; Endo, S; Ohno, K				Li, SH; Kuroiwa, T; Katsumata, N; Ishibashi, S; Sun, LY; Endo, S; Ohno, K			Transient versus prolonged hyperlocomotion following lateral fluid percussion injury in Mongolian gerbils	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						cognitive dysfunction; traumatic brain injury; white matter rarefaction	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; VASCULAR COGNITIVE IMPAIRMENT; CONTROLLED CORTICAL IMPACT; WHITE-MATTER LESIONS; LOCOMOTOR-ACTIVITY; COMPUTED-TOMOGRAPHY; FOREBRAIN ISCHEMIA; CEREBRAL-ISCHEMIA; CONFUSIONAL STATE	Posttraumatic hyperactivity is a neurobehavioral symptom commonly seen in patients after traumatic brain injury (TB1). No useful animal model has yet been established for evaluation of this important symptom. We induced either mild (MILD, 0.7-0.9 atm) or moderate (MOD, 1.3-1.6 atm) lateral fluid percussion injury (LFPI) in Mongolian gerbils. Open-field and T-maze tests were used during a 7-day period after the trauma. All animals were perfusion fixed for histopathological examinations. Transient locomotor hyperactivity was found with a peak at 6 hr after injury in the MILD animals, whereas MOD animals showed prolonged and severe hyperlocomotion throughout the 7-day posttrauma period (P < 0.0001). Interestingly, the temporal profile of the posttraumatic hyperactivity was similar to that of the working memory deficit in both injury groups. Histological examination revealed significant neural tissue damages, including cortical necrosis, white matter rarefaction, and neuronal loss in the hippocampus in the ipsilateral hemisphere of the MOD animals, vs. only negligible changes in the MILD animals. Correlation analysis revealed that the volume of white matter lesions was significantly correlated with both posttraumatic hyperactivity (r = 0.591, P < 0.01) and working memory deficit (r = -0.859, P < 0.0001). Taken together, our findings confirm the successful reproduction of posttraumatic hyperactivity following experimental TBI. The posttraumatic hyperlocomotion probably shared pathomechanisms common to those of cognitive dysfunction caused by LFPI, supporting the speculation from previous studies that some neurobehavioral abnormities intimately correlate with TBI-induced cognitive dysfunction. Histopathologically, significant involvement of white matter damage in the posttraumatic functional deficits was indicated. (C) 2006 Wiley-Liss, Inc.	Tokyo Med & Dent Univ, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Tokyo 1138510, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; Tokyo Med & Dent Univ, Grad Sch Med, Anim Res Ctr, Tokyo, Japan	Kuroiwa, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Neuropathol, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138510, Japan.	t.kuroiwa.npat@mri.tmed.ac.jp					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BABCOCK AM, 1993, BRAIN RES, V625, P351, DOI 10.1016/0006-8993(93)91081-3; Bishop C, 2003, SYNAPSE, V50, P164, DOI 10.1002/syn.10253; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bogner JA, 2001, AM J PHYS MED REHAB, V80, P636, DOI 10.1097/00002060-200109000-00002; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Englund E, 2002, CEREBROVASC DIS, V13, P11, DOI 10.1159/000049144; Floyd CL, 2002, J NEUROTRAUM, V19, P303, DOI 10.1089/089771502753594873; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; GROSWASSER Z, 1987, SURG NEUROL, V27, P331, DOI 10.1016/0090-3019(87)90007-3; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Ishibashi S, 2003, STROKE, V34, P1501, DOI 10.1161/01.STR.0000074034.32371.13; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; KUROIWA T, 1991, NEUROSCI LETT, V122, P141, DOI 10.1016/0304-3940(91)90842-H; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; LEVINE S, 1969, ARCH PATHOL, V87, P315; LINDGREN S, 1969, ACTA PHYSIOL SCAND, V76, P340, DOI 10.1111/j.1748-1716.1969.tb04477.x; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MILESON BE, 1991, NEUROSCI LETT, V128, P71, DOI 10.1016/0304-3940(91)90762-I; MILLEN JE, 1985, J NEUROSURG, V62, P587, DOI 10.3171/jns.1985.62.4.0587; MORI E, 1987, ARCH NEUROL-CHICAGO, V44, P1139, DOI 10.1001/archneur.1987.00520230029009; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NOUEL D, 1994, EUR J PHARMACOL, V254, P263, DOI 10.1016/0014-2999(94)90463-4; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P316; Onaya M, 2002, NEUROPATHOLOGY, V22, P243, DOI 10.1046/j.1440-1789.2002.00456.x; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; Qian L, 1996, ACTA NEUROCHIR, V138, P90, DOI 10.1007/BF01411731; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Silver BV, 1996, BRAIN INJURY, V10, P609; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; STARKSTEIN SE, 1988, BRAIN RES, V473, P74, DOI 10.1016/0006-8993(88)90317-4; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; van der Naalt J, 2000, BRAIN INJURY, V14, P781; WANG D, 1990, BRAIN RES, V533, P78, DOI 10.1016/0006-8993(90)91798-L	51	14	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB 1	2006	83	2					292	300		10.1002/jnr.20720			9	Neurosciences	Neurosciences & Neurology	013UC	WOS:000235434300013	16397904				2021-06-18	
J	Schaller, C; Kessler, M				Schaller, C; Kessler, M			On the difficulty of neurosurgical end of life decisions	JOURNAL OF MEDICAL ETHICS			English	Article							WITHDRAWAL	Objective: To analyse the process of end of life decisions in a neurosurgical environment. Methods: All 113 neurosurgical patients, who were subject to so called end of life decisions within a one year period were prospectively enrolled in a computerised data bank. Decision pathways according to patient and physician related parameters were assessed. Results: Leading primary diagnoses of the patients were traumatic brain injury and intracranial haemorrhage. Forty-five patients had undergone an emergency neurosurgical operation prior to end of life decision, N = 69 were conservatively treated, which included intracranial pressure recording, or they were not offered neurosurgical care because of futile prognosis. N = 111 died after a median of two ( zero to nine) days. Two, in whom the end of life decisions were revised, survived. Clear decisions to terminate further treatment were made by a senior staff member on call being informed by the senior resident on call (27.4%), difficult decisions on the basis of extensive round discussions (71.7%), and very difficult decision by an interdisciplinary ethical consult (0.9%). Decisions were further substantiated by electrophysiological examinations in N = 59. Conclusion: End of life decisions are to be considered standard situations for neurosurgeons. These decisions may reach a high rate of "positive'' prediction, if substantiated by electrophysiological examinations as well as on the grounds of clinical experience and respect for the assumed will of the patient. The fact that patients may survive following revision of an end of life decision underlines the necessity for repeated reassessment of these decisions. Ethical training for neurosurgeons is to be encouraged.	Univ Bonn, Med Ctr, Dept Neurosurg, D-53127 Bonn, Germany	Schaller, C (corresponding author), Univ Bonn, Med Ctr, Dept Neurosurg, Siegmund Freud Str 25, D-53127 Bonn, Germany.	carlo.schaller@ukb.uni-bonn.de					Agich GJ, 2000, CLEV CLIN J MED, V67, P392; Ashkan K, 2001, BRIT J NEUROSURG, V15, P342; BARLOW P, 1991, SCOT MED J, V36, P109, DOI 10.1177/003693309103600404; Christophis P, 2004, ZBL NEUROCHIR, V65, P25, DOI 10.1055/s-2004-44885; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Fitzpatrick MO, 1999, SCOT MED J, V44, P47, DOI 10.1177/003693309904400206; Kelly PJ, 2003, NEUROSURGERY, V52, P927, DOI 10.1227/01.NEU.0000053179.51319.D0; Levy MM, 2001, CRIT CARE MED, V29, pN56, DOI 10.1097/00003246-200102001-00011; Nyman DJ, 2000, INTENS CARE MED, V26, P1414, DOI 10.1007/s001340000641; Prendergast TJ, 2002, JAMA-J AM MED ASSOC, V288, P2732, DOI 10.1001/jama.288.21.2732; Sittisombut S, 2001, INT J EPIDEMIOL, V30, P896, DOI 10.1093/ije/30.4.896; Tschann JM, 2003, J AM GERIATR SOC, V51, P835, DOI 10.1046/j.1365-2389.2003.51266.x; Vincent JL, 2001, CRIT CARE MED, V29, pN52, DOI 10.1097/00003246-200102001-00010; ZENTNER J, 1994, NEUROL RES, V16, P89	15	14	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	FEB 1	2006	32	2					65	69		10.1136/jme.2005.011767			5	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	007XF	WOS:000235004000002	16446408	Green Published			2021-06-18	
J	Brown, S				Brown, Stephen			Deterioration	EPILEPSIA			English	Article; Proceedings Paper	Meeting on Cognitive and Behavioral Outcomes of Epileptic Syndromes	OCT, 2004	Bologna, ITALY			epilepsy; cognition; developmental disabilities; dementia	TRANSITORY COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN INJURY; ANTIEPILEPTIC DRUGS; EPILEPTIC CHILDREN; ACADEMIC-ACHIEVEMENT; CLINICAL-TRIALS; EEG DISCHARGES; DEMENTIA; SEIZURE; UNDERACHIEVEMENT	Intellectual deterioration in epilepsy may be real or apparent. The latter refers to delay in cognitive development such that performance against age-related norms appears to drop. The former, real deterioration can occur due to concomitant degenerative neurological disease of which epilepsy is also a symptom, or it may happen as a consequence of one or more of a number of other factors. These include (1) direct effects of seizures and abnormal electroencephalogram activity on brain function, (2) traumatic brain injury secondary to seizures, including status epilepticus, (3) the influence of antiepileptic therapy, both drugs and surgery, on cognitive function, (4) psychosocial sequelae of diagnosis. Some epilepsy syndromes include intellectual deterioration as a frequent feature, with various causes. Developmental factors may also play a part. Cognitive functioning may be impaired by the presence of an epileptogenic lesion, and also in different ways and at different times by other brain areas involved with partial seizures, including irritative and functional deficit zones. Abnormal activity in these areas at critical periods in development may interact and disrupt pathways necessary for maturation of frontal lobe and limbic system functioning, leading to long-term neurological deficits. Increased understanding of the mechanisms by which this may happen raises intriguing possibilities for prevention and remediation.	Peninsula Med Sch, Dev Disabil Res & Educ Grp, Unit 10, Bodmin Business Ctr, Bodmin PL31 1AH, Cornwall, England	Brown, S (corresponding author), Peninsula Med Sch, Dev Disabil Res & Educ Grp, Unit 10, Bodmin Business Ctr, Harleigh Rd, Bodmin PL31 1AH, Cornwall, England.	stephen.brown@cpt.cornwall.nhs.uk					AARTS JHP, 1984, BRAIN, V107, P293, DOI 10.1093/brain/107.1.293; Adab N, 2004, J NEUROL NEUROSUR PS, V75, P1575, DOI 10.1136/jnnp.2003.029132; ALDENKAMP AP, 1992, ACTA NEUROL SCAND, V86, P111, DOI 10.1111/j.1600-0404.1992.tb04479.x; Aldenkamp AP, 2001, EPILEPSY RES, V45, P155, DOI 10.1016/S0920-1211(01)00244-3; Aldenkamp AP, 2005, J CHILD NEUROL, V20, P175, DOI 10.1177/08830738050200030101; Aldenkamp AP, 1997, EPILEPSIA, V38, pS52, DOI 10.1111/j.1528-1157.1997.tb04520.x; ALDENKAMP AP, 1995, EPILEPSY CHILDREN AD, P225; Austin JK, 1998, DEV MED CHILD NEUROL, V40, P248, DOI 10.1111/j.1469-8749.1998.tb15457.x; Austin JK, 1999, DEV MED CHILD NEUROL, V41, P473, DOI 10.1017/S0012162299001024; Bailet LL, 2000, EPILEPSIA, V41, P426, DOI 10.1111/j.1528-1157.2000.tb00184.x; BAIRD HW, 1980, ELECTROEN CLIN NEURO, V48, P683, DOI 10.1016/0013-4694(80)90425-3; Baker GA, 2001, EPILEPSY RES, V45, P163, DOI 10.1016/S0920-1211(01)00246-7; Besag F M, 1995, Semin Pediatr Neurol, V2, P261, DOI 10.1016/S1071-9091(95)80005-0; BINNIE CD, 1992, EPILEPSIA, V33, pS11; BINNIE CD, 1993, BRAIN DEV-JPN, V15, P23, DOI 10.1016/0387-7604(93)90003-Q; BOTEZ MI, 1993, EPILEPSY RES, V16, P157, DOI 10.1016/0920-1211(93)90030-B; BOURGEOIS BFD, 1983, ANN NEUROL, V14, P438, DOI 10.1002/ana.410140407; BROWN CW, 1992, ADV NEAR INFRARED ME, V1, P1; Brown S, 1996, EUR J NEUROL, V3, P35; BROWN SW, 1984, ACTA NEUROL SCAND, V70, P233; BROWN SW, 2002, NEUROPSYCHIATRY EPIL, P135; BROWN SW, 1990, ACTA NEUROL SCAND  S, V82, P13; BROWN SW, 1988, EPILEPSY BEHAV COGNI, P177; BROWN SW, 1989, ED CHILD PSYCHOL, V6, P25; BROWN SW, 1999, EPILEPSY MENTAL RETA, P115; Butlin A T, 1984, Clin Exp Neurol, V20, P57; Chen YJ, 1996, EPILEPSIA, V37, P81, DOI 10.1111/j.1528-1157.1996.tb00516.x; Chen YJ, 2001, EPILEPSY RES, V44, P65, DOI 10.1016/S0920-1211(00)00204-7; Dawson S, 1929, Arch Dis Child, V4, P142; DODRILL CB, 1986, EPILEPSIA, V27, P399, DOI 10.1111/j.1528-1157.1986.tb03559.x; DODRILL CB, 1991, NEUROLOGY, V41, P141, DOI 10.1212/WNL.41.1.141; Enoki H, 1996, EPILEPSY RES, V25, P59, DOI 10.1016/0920-1211(96)00025-3; Fastenau PS, 2004, EPILEPSIA, V45, P1261, DOI 10.1111/j.0013-9580.2004.15204.x; Fritz N, 2005, EPILEPSY BEHAV, V6, P373, DOI 10.1016/j.yebeh.2005.01.002; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Helmstaedter C, 1999, LANCET, V354, P2133, DOI 10.1016/S0140-6736(99)03542-4; Hoffmann AF, 2004, EPILEPSY BEHAV, V5, P873, DOI 10.1016/j.yebeh.2004.09.005; Hogh P, 2002, NEUROLOGY, V58, P298, DOI 10.1212/WNL.58.2.298; INGVAR DH, 1984, ACTA PSYCHIAT SCAND, V69, P21; Jambaque I, 2000, EPILEPSY RES, V38, P151, DOI 10.1016/S0920-1211(99)00082-0; Jellinger KA, 2001, EUR J NEUROL, V8, P707, DOI 10.1046/j.1468-1331.2001.00322.x; KUBOTA F, 1995, CLIN ELECTROENCEPHAL, V26, P120, DOI 10.1177/155005949502600210; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MARSTON D, 1993, DEV MED CHILD NEUROL, V35, P574; Metz-Lutz MN, 1999, DEV NEUROSCI-BASEL, V21, P182, DOI 10.1159/000017397; Neyens LGJ, 1999, EPILEPSY RES, V34, P85, DOI 10.1016/S0920-1211(98)00118-1; Rasalam AD, 2005, DEV MED CHILD NEUROL, V47, P551, DOI 10.1017/S0012162205001076; Rosen J A, 1968, Trans Am Neurol Assoc, V93, P273; Rutter M, 1970, NEUROPSYCHIATRIC STU; Scholtes FBJ, 2005, EPILEPSY BEHAV, V6, P167, DOI 10.1016/j.yebeh.2004.11.001; SIEBELINK BM, 1988, EPILEPSY RES, V2, P117, DOI 10.1016/0920-1211(88)90028-9; TINDALL RSA, 1978, ARCH INTERN MED, V138, P1168, DOI 10.1001/archinte.138.7.1168; Tomka-Hoffmeister M, 2004, FORTSCHR NEUROL PSYC, V72, P160, DOI 10.1055/s-2004-818360; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X	55	14	14	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0013-9580	1528-1167		EPILEPSIA	Epilepsia		2006	47			2			19	23		10.1111/j.1528-1167.2006.00682.x			5	Clinical Neurology	Neurosciences & Neurology	109LU	WOS:000242310400005	17105454				2021-06-18	
J	Dockree, PM; O'Keeffe, FM; Moloney, P; Bishara, AJ; Carton, S; Jacoby, LL; Robertson, IH				Dockree, PM; O'Keeffe, FM; Moloney, P; Bishara, AJ; Carton, S; Jacoby, LL; Robertson, IH			Capture by misleading information and its false acceptance in patients with traumatic brain injury	BRAIN			English	Article						misinformation; capture; false memory; traumatic brain injury; prefrontal cortices	CLOSED-HEAD-INJURY; PROSPECTIVE MEMORY; PREFRONTAL CORTEX; EPISODIC MEMORY; FRONTAL-CORTEX; PERFORMANCE; RETRIEVAL; ADULTS; TASK; DISSOCIATION	Exposure to misleading information, presented after a critical episode, can alter or impair memory reports about that episode. Here, we examine vulnerability to misleading information in patients with traumatic brain injury (TBI). The ability to initiate an effective retrieval strategy and inhibit irrelevant or interfering information requires participation from the prefrontal cortices, which are susceptible to damage following brain injury. We report that TBI patients are more prone to interference effects produced by misleading information during a cued-recall task and are more likely to accept this information as the product of 'remembering' compared with healthy controls. The results are consistent with a model proposing that patients are captured by highly accessible responses eliminating their opportunity to engage in recollection. Correlations between the cued-recall interference task and other executive measures helped elucidate the processes underlying 'capture'. In TBI patients, reduced recollection produced by a misleading prime was associated with impaired prospective remembering when engaged in a background task. A common functional deficit that may underlie poor performance on both tasks is the failure to inhibit previously relevant but currently irrelevant information. Subjective reports pertaining to the subject's cued-recall response were indexed by electrodermal activity. In control subjects, larger skin conductance responses (SCRs) were associated with a greater frequency of guess reports, suggesting that SCRs provide a marker for uncertainty regarding the candidacy of a selected response. TBI patients did not show this relationship, suggesting that impairments of post-retrieval evaluation might also underlie greater false acceptance of misinformation. Discussion focuses on the role of the prefrontal cortex and cognitive processes that mediate the selection and evaluation of memories.	Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland; Natl Rehabil Hosp, Dept Neuropsychol, Dun Laoghaire, Co Dublin, Ireland; Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Dockree, PM (corresponding author), Univ Dublin Trinity Coll, Trinity Coll Inst Neurosci, Dublin 2, Ireland.	dockreep@tcd.ie		Robertson, Ian H/0000-0001-8637-561X			Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Burgess PW, 1996, MEMORY, V4, P359, DOI 10.1080/096582196388906; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; DELBECQDEROUESNE J, 1990, BRAIN, V113, P1045, DOI 10.1093/brain/113.4.1045; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; Duncan John, 1995, P721; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Einstein GO, 1997, PSYCHOL AGING, V12, P479, DOI 10.1037/0882-7974.12.3.479; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; FUSTER JM, 1989, PREFRONTAL CORTEX AN; Gardiner John M., 1993, P163; Goldman-Rakic P. S., 1987, NERVOUS SYSTEM, P373, DOI DOI 10.1002/CPHY.CP010509; Hasher L., 1988, PSYCHOL LEARNING MOT, V22, P193, DOI DOI 10.1016/S0079-7421(08)60041-9; Jacoby LL, 2005, J EXP PSYCHOL GEN, V134, P131, DOI 10.1037/0096-3445.134.2.131; Jacoby LL, 1999, COGNITIVE NEUROPSYCH, V16, P417, DOI 10.1080/026432999380861; Jacoby LL, 1996, BASIC APPL MEMORY RE, P161; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; MANDLER G, 1989, MEMORY INTERDISCIPLI, P84; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McDaniel M A, 1993, Memory, V1, P23, DOI 10.1080/09658219308258223; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; Norman K. A., 1996, IMPLICIT MEMORY META, P229; O'Connell RG, 2004, NEUROREPORT, V15, P2535, DOI 10.1097/00001756-200411150-00021; O'Keeffe FM, 2004, COGNITIVE BRAIN RES, V22, P101, DOI 10.1016/j.cogbrainres.2004.07.012; Parkin AJ, 1996, BRAIN COGNITION, V32, P14, DOI 10.1006/brcg.1996.0055; RICHARDSON JTE, 2000, CLIN NEUROPSYCHOLOGI; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Shimamura Arthur P., 1995, P803; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stern R.M., 2001, PSYCHOPHYSIOLOGICAL; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Thorndike EL., 1944, TEACHERS WORD BOOK 3; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; WALKER D, 2003, REMEMBRANCE THINGS F; Wallace JC, 2002, J GEN PSYCHOL, V129, P238, DOI 10.1080/00221300209602098; Wechsler D, 1998, WECHSLER MEMORY SCAL; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; Zahn TP, 1999, INT J PSYCHOPHYSIOL, V33, P113, DOI 10.1016/S0167-8760(99)00030-6; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmer H, 2000, Z EXP PSYCHOL, V47, P129; ZOCCOLOTTI P, 1982, Journal of Clinical Neuropsychology, V4, P143, DOI 10.1080/01688638208401124	52	14	14	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JAN	2006	129		1				128	140		10.1093/brain/awh664			13	Clinical Neurology; Neurosciences	Neurosciences & Neurology	000AL	WOS:000234433200013	16280354	Bronze			2021-06-18	
J	Ivins, BJ; Schwab, KA; Baker, G; Warden, DL				Ivins, Brian J.; Schwab, Karen A.; Baker, Gayle; Warden, Deborah L.			Hospital admissions associated with traumatic brain injury in the US army during peacetime: 1990s Trends	NEUROEPIDEMIOLOGY			English	Article						traumatic brain injury; US Army; injury prevention; hospital admission practices	UNITED-STATES-ARMY; HEAD-INJURY; MILITARY; MANAGEMENT; SYSTEM; CARE; QUALITY; COSTS; SCANS; RISK	Introduction: This paper examines 10-year trends in traumatic brain injury (TBI)-related hospitalization rates for active duty US Army personnel in the 1990s. It does this within the context of various factors, including enhanced injury prevention policies and changed hospital admission practices, that may have affected TBI hospitalization rates. It also compares TBI hospitalization rates in the Army to those from an age-comparable segment of the US civilian population over this time period. Methods: Crude (unadjusted) incidence rates for all active duty US Army personnel hospitalized with a TBI diagnosis from fiscal years (FY) 1990 to 1999 were calculated. Once the trends were identified, the percentage change in the overall rate, as well as the rates for different TBI severity levels, and in-hospital deaths from FY1990 and FY1999 were analyzed. Changes in age- and gender-specific rates as well as crude rates for cases with and without other injuries and cases treated in military and civilian hospitals were also analyzed. Rate ratios were used to compare aggregated 5-year TBI hospitalization rates in the Army to rates for civilians 17 - 49 years of age during the following time periods: 1990 - 1994 and 1995 - 1999. The rates used in the comparison were adjusted to control for differences in age and gender. Results: The overall incidence of TBI-related hospitalization in the Army decreased 75% from FY1990 to FY1999. The rates for all TBI severity levels decreased, but the rate for mild TBI decreased more than the rates for moderate and severe TBI. The rate of in-hospital deaths from TBI also decreased. Rates decreased similarly for males and females, across all age groups, as well as for cases with and without other injuries. TBI rates decreased for Army personnel treated in military hospitals but changed minimally for Army personnel treated in civilian hospitals. The Army's TBI hospitalization rates were generally higher than civilian rates in the early 1990s but by the late 1990s, most of the Army's rates were lower than or equal to the civilian rates. Conclusions: The incidence of TBI-related hospitalization in the active duty US Army decreased markedly (75%) during the 1990s. As a result, most of the Army's TBI hospitalization rates were lower than civilian rates by the late 1990s. Effective injury prevention and changes in the Army population were two of the factors that likely contributed to the decrease in rates for all TBI severity levels, while changes in hospital admission practices likely contributed to the disproportionate decrease in the Army's rates for mild TBI. Copyright (c) 2006 S. Karger AG, Basel.	Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20012 USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD USA	Ivins, BJ (corresponding author), Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, POB 59181, Washington, DC 20012 USA.	brian.ivins@na.amedd.army.mil					*ARM PUBL AFF, 1997, US ARM ACH SAF YEAR; *ARM SAF PROG, 1988, 38510 DEP ARM; Brundage JF, 1998, MIL MED, V163, P272; Carey ME, 1998, MIL MED, V163, P581; *CDC, 2004, TRAUM BRAIN IN US EM; *CDC MIL HIST US A, 1997, FISC YEAR 1990 1991, pCH4; *CONG BUDG OFF, 2003, GROWTH MED SPEND DEP; Corn R F, 1981, Inquiry, V18, P351; *CTR MILL HIST US, 2001, FISC YEAR 1992, pCH9; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; *DEP ARM, 1995, 67274 DEP ARM; *DEP ARM, 1987, 38540 DEP ARM; *DEP ARM, 1987, 38555 DEP ARM; *DEP DEF INSP GEN, 1998, JO AUD REP MIL HE SY; DOREMUS HD, 1983, MED CARE, V21, P1001, DOI 10.1097/00005650-198310000-00006; Hamm CK, 1999, MIL MED, V164, P867; HOSEK H, 2003, US ARMY NEW NATL SEC, pCH10; HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604; *J HOPK U T INC, 1998, ICDMAP90; Jackson JL, 1999, MIL MED, V164, P701; Kahn H. A., 1989, STAT METHODS EPIDEMI; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LIVINGSTON DH, 1991, AM SURGEON, V57, P14; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V8, P48, DOI 10.1159/000110165; MCCARROLL JE, 1989, NEUROEPIDEMIOLOGY, V9, P296; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; Meyer GS, 1998, MIL MED, V163, P461; Miller T. R., 1994, HEAD NECK INJURY, P211; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; *OFF SEC DEF WASH, 2004, GULF WAR CAS SUMM; *OFF SEC DEV, 2006, US CAS STAT; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; ROTHBERG JM, 1990, JAMA-J AM MED ASSOC, V264, P2241, DOI 10.1001/jama.264.17.2241; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; Smith GS, 2000, AM J PREV MED, V18, P41, DOI 10.1016/S0749-3797(99)00171-3; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Taylor AJ, 1997, J AM COLL CARDIOL, V30, P901, DOI 10.1016/S0735-1097(97)00271-4; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 2001, HEAD TRAUMA, P327; TOTTEN J, 1979, LANCET, V1, P369; WEED DL, 1986, J OCCUP ENVIRON MED, V28, P343	46	14	14	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350			NEUROEPIDEMIOLOGY	Neuroepidemiology		2006	27	3					154	163		10.1159/000096127			10	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	101XF	WOS:000241773900006	17035692				2021-06-18	
J	Ripley, DL				Ripley, DL			Atomoxetine for individuals with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							DEFICIT-HYPERACTIVITY DISORDER; ADOLESCENTS; CHILDREN; ADHD; TOMOXETINE; ADULTS; MANIA		Craig Hosp, Denver, CO 80113 USA	Ripley, DL (corresponding author), Craig Hosp, Denver, CO 80113 USA.	dripley@craighospital.org		Ripley, David/0000-0002-5349-1830			BERIGAN TR, 2004, J CLIN PSYCHIAT, V6, P93; Buitelaar JK, 2004, EUR CHILD ADOLES PSY, V13, P249, DOI 10.1007/s00787-004-0401-3; CHOUINARD G, 1984, PSYCHOPHARMACOLOGY, V83, P126, DOI 10.1007/BF00427436; Christman AK, 2004, PHARMACOTHERAPY, V24, P1020, DOI 10.1592/phco.24.11.1020.36146; Henderson TA, 2004, PEDIATRICS, V114, P895, DOI 10.1542/peds.2004-1140; Henderson TA, 2004, J CLIN PSYCHOPHARM, V24, P567, DOI 10.1097/01.jcp.0000139760.11458.aa; Hwang BH, 1999, NEUROSCI LETT, V265, P151, DOI 10.1016/S0304-3940(99)00241-4; Lee TSW, 2004, J AM ACAD CHILD PSY, V43, P1068, DOI 10.1097/01.chi.0000132833.12842.4e; Sauer JM, 2004, J PHARMACOL EXP THER, V308, P410, DOI 10.1124/jpet.103.058727; Sawant S, 2004, AM J PSYCHIAT, V161, P757, DOI 10.1176/appi.ajp.161.4.757; Simpson D, 2004, CNS DRUGS, V18, P397, DOI 10.2165/00023210-200418060-00011; Spencer T, 2004, PSYCHIAT CLIN N AM, V27, P373, DOI 10.1016/j.psc.2003.12.001; *US FDA, 2004, NEW WARN AT; Velcea G, 2004, AM J PSYCHIAT, V161, P1718, DOI 10.1176/appi.ajp.161.9.1718-a; Wernicke JF, 2002, J CLIN PSYCHIAT, V63, P50; Wernicke JF, 2003, DRUG SAFETY, V26, P729, DOI 10.2165/00002018-200326100-00006; ZERBE RL, 1985, J PHARMACOL EXP THER, V232, P139; 2004, ATOMOXETINE PACKAGE	18	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2006	21	1					85	88		10.1097/00001199-200601000-00010			4	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	004WW	WOS:000234784300010	16456396				2021-06-18	
J	Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA				Casarett, D; Fishman, JM; MacMoran, HJ; Pickard, A; Asch, DA			Epidemiology and prognosis of coma in daytime television dramas	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SOAP-OPERA; VEGETATIVE STATE; HEAD-INJURY; BREAST-CANCER; BRAIN-INJURY; EDUCATION; ATTITUDES; BEHAVIOR; PROGRAM; AIDS	Objective To determine how soap operas Portray, and possibly misrepresent, the likelihood of recovery for patients in coma. Design Retrospective cohort study Setting Nine soap operas in the United States reviewed between 1 January 1995 and 15 May 2005. Subjects 64 characters who experienced a period of unconsciousness lasting at least 24 hours. Their final status at the end of the follow-up period was compared with pooled data from a meta-analysis. Results Comas lasted a median of 13 days (interquartile range 7-25 days). Fifty seven (89%) patients recovered fully, five (8%) died, and two (3%) remained in a vegetative state. Mortality for non-traumatic and traumatic coma was significantly lower than would be predicted from the meta-analysis data (non-traumatic 4% v 53%; traumatic 6% v 67%; Fisher's exact test both P < 0.001). On the day that patients regained consciousness, most (49/57; 86%) had no evidence of limited function, cognitive deficit, or residual disability needing rehabilitation. Compared with meta-analysis data, patients in this sample had a much better than expected chance of returning to normal function (non-traumatic 91% v 1%; traumatic 89% 7%; both P < 0.001). Conclusions The portrayal of coma in soap operas is overly optimistic. Although these programmes are presented as fiction, they may contribute to unrealistic expectations of recovery.	Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Div Geriatr Med, Philadelphia, PA 19104 USA	Casarett, D (corresponding author), Philadelphia VA Med Ctr, Ctr Hlth Equity Res & Promot, 9 E,3900 Woodland Ave, Philadelphia, PA 19104 USA.	casarett@mail.med.upenn.edu		Asch, David/0000-0002-7970-286X			Ang I., 1991, DESPERATELY SEEKING; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BANJA JD, 1990, PHYS MED REHABIL, V4, P579; BATES D, 1991, J NEUROL NEUROSUR PS, V54, P569, DOI 10.1136/jnnp.54.7.569; Borrayo EA, 2004, PREV MED, V39, P99, DOI 10.1016/j.ypmed.2004.03.024; BRAAKMAN R, 1988, ACTA NEUROCHIR, V95, P49, DOI 10.1007/BF01793082; Brodie M, 2001, HEALTH AFFAIR, V20, P192, DOI 10.1377/hlthaff.20.1.192; Campbell MK, 2004, J NUTR EDUC BEHAV, V36, P58, DOI 10.1016/S1499-4046(06)60134-6; *COUNC SCI AFF COU, 1990, JAMA-J AM MED ASSOC, P426; Cranford R E, 1991, Law Med Health Care, V19, P13; Crayford T, 1997, BRIT MED J, V315, P1649, DOI 10.1136/bmj.315.7123.1649; Diem SJ, 1996, NEW ENGL J MED, V334, P1578, DOI 10.1056/NEJM199606133342406; Dresser R, 2004, HASTINGS CENT REP, V34, P8, DOI 10.2307/3528413; Gostin LO, 2005, JAMA-J AM MED ASSOC, V293, P2403, DOI 10.1001/jama.293.19.2403; Grubb A, 1996, LANCET, V348, P35, DOI 10.1016/S0140-6736(96)02030-2; Hamel Mary Beth, 1995, JAMA (Journal of the American Medical Association), V273, P1842, DOI 10.1001/jama.273.23.1842; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; HODGES MO, 1994, ARCH INTERN MED, V154, P1013, DOI 10.1001/archinte.154.9.1013; Howe A, 2002, J PUBLIC HEALTH MED, V24, P299, DOI 10.1093/pubmed/24.4.299; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; Jibaja ML, 2000, J CANCER EDUC, V15, P237; JUDSON JA, 1990, CRIT CARE MED, V18, P363, DOI 10.1097/00003246-199004000-00003; KALICHMAN SC, 1994, AIDS EDUC PREV, V6, P542; Kennedy MG, 2004, J COMMUN, V54, P287, DOI 10.1093/joc/54.2.287; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVY DE, 1985, JAMA-J AM MED ASSOC, V253, P1420, DOI 10.1001/jama.253.10.1420; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Masson F, 2003, BRAIN INJURY, V17, P279, DOI 10.1080/0269905021000030805; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; *MULT SOC TASK FOR, 1995, NEW ENGL J MED, V330, P1572; *NIELS MED RES, 2000, REP TEL; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; SAZBON L, 1993, J NEUROL NEUROSUR PS, V56, P407, DOI 10.1136/jnnp.56.4.407; Shapiro D, 2003, AIDS CARE, V15, P303, DOI 10.1080/0954012031000105360; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Walker WC, 1996, BRAIN INJURY, V10, P65	38	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 24	2005	331	7531					1537	1539		10.1136/bmj.331.7531.1537			5	Medicine, General & Internal	General & Internal Medicine	998WT	WOS:000234351300025	16373744	Bronze, Green Published			2021-06-18	
J	Chan, RCK				Chan, RCK			How severe should symptoms be before someone is said to be suffering from post-concussion syndrome? An exploratory study with self-reported checklist using Rasch analysis	BRAIN INJURY			English	Article						post-concussion; Rasch analysis	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; BASE RATES; PATIENT COMPLAINTS; MILD; DEFICITS; PROSPECTS	Primary objective: This study aimed to examine the diagnosis of post-concussive symptoms among a group of people with subjective post-concussive symptoms (PCS) complaints using a self-reported checklist. Research design: A cross-sectional design was adopted with a total of 92 patients with PCS and 123 normal controls. Methods and procedures: The Rivermead Post-concussion Symptoms Questionnaire was administered to all participants. Analysis using the Rasch Model was undertaken. Main outcomes and results: The common matrix of symptom profiles indicated significant effects of gender ( p < 0.005) and litigation ( p < 0.0004). The patient group reported significantly higher symptoms than the healthy group ( p < 0.0001) with differential symptom endorsement along the logits unit continuum. Conclusions: The application of Rasch model analysis successfully set up a common matrix to discriminate patients with post-concussive symptoms from healthy people along the logits unit continuum.	Sun Yat Sen Univ, Dept Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Guangzhou 510275, Peoples R China; Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China	Chan, RCK (corresponding author), Sun Yat Sen Univ, Dept Psychol, Neuropsychol & Appl Cognit Neurosci Lab, Guangzhou 510275, Peoples R China.	edschchq@zsu.edu.cn	Chan, Raymond CK/B-6717-2009	Chan, Raymond CK/0000-0002-3414-450X			Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BOHNEN N, 1992, NEUROSURGERY, V30, P692; Bond T.G., 2001, APPL RASCH MODEL FUN; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; CHAN RKC, 2001, INT C OUTC MEAS ICOM; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FOX DD, 1995, CLIN NEUROPSYCHOL, V9, P89, DOI 10.1080/13854049508402064; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; King NS, 1996, J NEUROL NEUROSUR PS, V61, P75, DOI 10.1136/jnnp.61.1.75; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEESHALEY PR, 1993, ARCH CLIN NEUROPSYCH, V8, P203, DOI 10.1016/0887-6177(93)90036-Z; Linacre J. M., 1998, RASCH MEASUREMENT T, V12, P636; LINACRE JM, 2000, USERS GUIDE WINSTEPS; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; MANDEL S, 1989, POSTGRAD MED, V85, P213; MELENDEZ F, 1994, ADULT NEUROPSYCHOLOG; Miller W., 1992, PHYSICAL MED REHABIL, V6, P547; OHARA C, 1994, COGNITIVE SYMPTOMS C; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Rasch G., 1960, PROBABILISTIC MODELS; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RUFF RM, 1993, J HEAD TRAUMA REHAB, V8, P60, DOI DOI 10.1097/00001199-199309000-00008; Stone MH., 1979, BEST TEST DESIGN; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wright B. D., 1982, RATING SCALE ANAL RA; WRIGHTSON P, 1981, INJURY, V12, P445, DOI 10.1016/0020-1383(81)90161-3	35	14	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2005	19	13					1117	1124		10.1080/026990500150088			8	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	983ZD	WOS:000233270000006	16286325				2021-06-18	
J	Kunz, T; Marklund, N; Hillered, L; Oliw, EH				Kunz, T; Marklund, N; Hillered, L; Oliw, EH			Assessment of the effects of the cyclooxygenase-2 inhibitor rofecoxib on visuospatial learning and hippocampal cell death following kainate-induced seizures in the rat	COGNITIVE BRAIN RESEARCH			English	Article						cell death; limbic seizure; Morris water maze; non-steroidal anti-inflammatory drug; TUNEL staining; visuospatial learning	TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; KAINIC ACID; GENE-EXPRESSION; MEMORY; DAMAGE; LESIONS; DEFICITS; NEURODEGENERATION; POSTTREATMENT	Kainate-induced seizures result in hippocampal neurodegeneration and spatial learning deficits in rodents. Previous studies show that rofecoxib, a selective cyclooxygenase-2 inhibitor, protects against kainate-induced hippocampal cell death 3 days after seizures. Our aim was to determine whether rofecoxib attenuates visuospatial learning deficits and late neuronal death after kainate-induced seizures. Seizures were induced in Sprague-Dawley rats with kainic acid (10 mg/kg, i.p.). Eight hours later, animals received rofecoxib (10 mg/kg; n = 15) or vehicle (dimethylsulfoxide, n = 11). Animals were then treated daily for additional 2 or 9 days. Visuospatial learning was assessed in the Morris water maze (MWM) on days 5-9 after seizures. Seizure animals teamed the MWM task significantly slower than non-seizure controls, but seizure animals showed higher swim speed (P < 0.05). Seizure animals receiving rofecoxib for 2 days showed no significant improvement in acquisition of the task compared to the vehicle group, even though mean latencies in the rofecoxib group were shorter from the third trial day onwards. This tendency was lost when rofecoxib was given for 9 days. TdT-mediated dUTP nick end labelling showed cell death in limbic structures 9 days after seizures. The time course of kainate-induced hippocampal cell death might be delayed by rofecoxib treatment, as the attenuation of cell death observed 3 days after seizures was no longer present after 9 days. We conclude that even though increasing evidence points to an injurious role of cyclooxygenase-2 products in acute brain injury processes, rofecoxib treatment failed to attenuate seizure-induced visuospatial learning deficits and the late phase of hippocampal neurodegeneration. (c) 2005 Elsevier B.V. All rights reserved.	Uppsala Univ, Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden	Kunz, T (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Inst Neurosci, Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	t.kunz@dundee.ac.uk		Marklund, Niklas/0000-0002-9797-5626; Oliw, Ernst/0000-0002-7986-8130			BARAN H, 1994, BRAIN RES, V646, P201, DOI 10.1016/0006-8993(94)90078-7; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; BENARI Y, 1985, NEUROSCIENCE, V14, P375, DOI 10.1016/0306-4522(85)90299-4; BREDER CD, 1992, J COMP NEUROL, V322, P409, DOI 10.1002/cne.903220309; Brzozowski T, 1999, EUR J PHARMACOL, V385, P47, DOI 10.1016/S0014-2999(99)00681-0; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; CHEN J, 1995, NEUROREPORT, V6, P245; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dembo G, 2005, ANESTHESIOLOGY, V102, P409, DOI 10.1097/00000542-200502000-00026; Desjardins P, 2003, NEUROCHEM INT, V42, P299, DOI 10.1016/S0197-0186(02)00101-8; Faherty CJ, 1999, MOL BRAIN RES, V70, P159, DOI 10.1016/S0169-328X(99)00143-6; GAYOSO MJ, 1994, BRAIN RES, V653, P92, DOI 10.1016/0006-8993(94)90376-X; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; Goodenough S, 1997, EXP NEUROL, V145, P451, DOI 10.1006/exnr.1997.6471; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Kemppainen S, 2004, NEUROSCIENCE, V126, P485, DOI 10.1016/j.neuroscience.2004.03.015; Klivenyi P, 2003, J MOL NEUROSCI, V21, P191, DOI 10.1385/JMN:21:3:191; Korhonen L, 2001, MOL CELL NEUROSCI, V17, P364, DOI 10.1006/mcne.2000.0935; Kunz T, 2001, EUR J NEUROSCI, V13, P569, DOI 10.1046/j.1460-9568.2001.01420.x; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Marklund N, 2005, RESTOR NEUROL NEUROS, V23, P31; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Matsuoka Y, 1999, EXP BRAIN RES, V124, P215, DOI 10.1007/s002210050616; Mikati MA, 2001, EPILEPSY RES, V43, P97, DOI 10.1016/S0920-1211(00)00187-X; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; PAXINOS G, 1996, RAT BRAIN STEREOTAXI; Rall JM, 2003, BRAIN RES, V968, P273, DOI 10.1016/S0006-8993(03)02248-0; Sandrini M, 2002, INFLAMM RES, V51, P154, DOI 10.1007/PL00000287; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sibbald B, 2004, CAN MED ASSOC J, V171, P1027, DOI 10.1503/cmaj.1041606; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Tacconelli S, 2004, CURR PHARM DESIGN, V10, P589, DOI 10.2174/1381612043453108; Takadera T, 2002, NEUROSCI LETT, V317, P61, DOI 10.1016/S0304-3940(01)02449-1; Teather LA, 2002, LEARN MEMORY, V9, P41, DOI 10.1101/lm.43602; TEITELBAUM JS, 1990, NEW ENGL J MED, V322, P1781, DOI 10.1056/NEJM199006213222505; Weiss S, 1996, NEUROSCIENCE, V74, P541, DOI 10.1016/0306-4522(96)00148-0	46	14	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0926-6410			COGNITIVE BRAIN RES	Cognit. Brain Res.	DEC	2005	25	3					826	832		10.1016/j.cogbrainres.2005.09.017			7	Computer Science, Artificial Intelligence; Neurosciences; Neuroimaging	Computer Science; Neurosciences & Neurology	997HQ	WOS:000234236500022	16263251				2021-06-18	
J	Hawkins, ML; Lewis, FD; Medeiros, RS				Hawkins, ML; Lewis, FD; Medeiros, RS			Impact of length of stay on functional outcomes of TBI patients	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southeastern-Surgical-Congress	FEB 11-15, 2005	New Orleans, LA	SE Surg Congress			TRAUMATIC BRAIN-INJURY; UNITED-STATES; REHABILITATION; VARIABLES; SEVERITY; PREDICTORS; RECOVERY; QUALITY; CHARGES; LIFE	The purpose of this study was to compare the functional outcomes of two groups of patients with traumatic brain injury (TBI) with attention to the impact of reduced length of stay (LOS) in the trauma center (TC) and rehabilitation hospital (RH). From 1991 to 1994, 55 patients, Group 1, with serious TBI (Abbreviated Injury Scale score >= 3) were admitted to a level 1 TC and subsequently transferred to a comprehensive inpatient RH. These results have been previously published. From 1996 to 2002,64 similarly injured patients, Group 2, received inpatient care at the same TC and RH. These patients had a marked decrease in length of stay. Functional Independence Measures (FIM) were obtained at admission (Adm), discharge (D/C), and at 1 year follow-up for both groups. The average length of stay at the TC dropped from 36 days in Group 1 to 26 days in Group 2. In addition, the average length of stay at the RH dropped from 46 days (Group 1) to 25 days (Group 2); overall, an average reduction of 31 days of inpatient care. Group 2 had significantly lower FIM scores at the time of RH discharge for self-care, locomotion, and mobility compared to Group 1. At the 1 year follow-up, however, there were no significant differences between Groups 1 and 2 in these FIM scores. FIM scores at I year were higher in Group 2 for communication (90% vs 71%) and social cognition (77% vs 49%) compared to Group 1. Over one-fourth of each group returned to work by the I year follow-up. Socially disruptive behavior occurred at least weekly in 28 per cent (Group 1) and 23 per cent (Group 2) of patients. The outcome for serious TBI is better than generally perceived. Reduction of inpatient LOS did not adversely affect the ultimate functional outcome. The decreased LOS placed a greater demand on outpatient rehabilitative services as well as a greater burden on the family of the brain-injured patient	Med Coll Georgia, Dept Surg, Augusta, GA 30912 USA; Walton Rehabil Hosp, Augusta, GA USA	Hawkins, ML (corresponding author), Med Coll Georgia, Dept Surg, Augusta, GA 30912 USA.						*AG HLTH CAR POL R, 1999, 5 NIS AG HLTH CAR PO; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; COOK L, 1994, ARCH PHYS MED REHAB, V75, P390, DOI 10.1016/0003-9993(94)90160-0; COPE D N, 1991, Brain Injury, V5, P111, DOI 10.3109/02699059109008083; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Di Donato B A, 1994, Rehabil Nurs, V19, P219; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Haffey W. J., 1990, NEUROPSYCHOLOGY EVER, P99; Hagen C., 1972, LEVELS COGNITIVE FUN; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hawkins ML, 1996, J TRAUMA, V41, P257, DOI 10.1097/00005373-199608000-00010; JACOBS HE, 1987, J HEAD TRAUMA REHAB, V2, P37; Johnson J, 2001, INT J PSYCHIAT CLIN, V5, P141, DOI 10.1080/136515001300374894; JOHNSTON MV, 1994, ARCH PHYSICAL MED RE, V75, P2; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LEWIN ICF, 1992, COST DISORDERS BRAIN; LONG WB, 1994, ARCH PHYS MED REHAB, V75, P144; MacKenzie E., 1991, J HEAD TRAUMA REHAB, V6, P76, DOI [10.1097/00001199-199106000-00010, DOI 10.1097/00001199-199106000-00010]; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; MALKMUS D, 1974, RANCHO LEVELS COGNIT; *NIH CONS STAT, 1998, REH PERS TRAUM BRAIN, P1041; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Phillips VL, 2004, J HEAD TRAUMA REHAB, V19, P217, DOI 10.1097/00001199-200405000-00003; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PRIGATANO GP, 1987, BNI Q, V3, P10; RHODES M, 1988, J TRAUMA, V28, P931, DOI 10.1097/00005373-198807000-00005; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; Schootman M, 2003, BRAIN INJURY, V17, P983, DOI 10.1080/0269905031000110427; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; STRAX TE, 1994, ARCH PHYS MED REHAB, V75, pSC1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005	37	14	14	0	4	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	NOV	2005	71	11					920	929					10	Surgery	Surgery	985SH	WOS:000233398200009	16372610				2021-06-18	
J	Kumar, A; Schmidt, EA; Hiler, M; Smielewski, P; Pickard, JD; Czosnyka, M				Kumar, A; Schmidt, EA; Hiler, M; Smielewski, P; Pickard, JD; Czosnyka, M			Asymmetry of critical closing pressure following head injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							CEREBRAL-CIRCULATION; TRANSCRANIAL DOPPLER; AUTOREGULATION; HEMODYNAMICS; TONE	Objective: Critical closing pressure (CCP) is the arterial pressure below which the vessels collapse. Hypothetically it is the sum of intracranial pressure (ICP) and vessel wall tension in the cerebral circulation. This study investigated transhemispherical asymmetry of CCP by studying its correlation with radiological findings on computed tomography (CT) scans in head injury patients. Method: ICP, arterial blood pressure, and middle cerebral artery blood flow velocity were recorded daily in 119 ventilated patients. Waveforms were processed to calculate CCP. CT scans were analysed according to a system based on the Marshall classification. Results: Left-right differences in CCP correlated with midline shift on the CT scan (r = 0.48; p < 0.02). Asymmetry of CCP also corresponded with the side of the head lesion (p < 0.007) and the side of the craniotomy where it was performed (p < 0.006). Absolute CCP weakly correlated with brain swelling (r = -0.23; p < 0.03) and arterial pressure (r = 0.21; p < 0.02) but did not correlate with ICP. Cerebral perfusion pressure calculated as the difference between mean arterial pressure and CCP did not correlate with outcome, but ''traditional'' cerebral perfusion pressure (mean arterial pressure minus intracranial pressure) did. Conclusions: Critical closing pressure is disturbed by localised brain lesions. Its asymmetry corresponds to asymmetrical findings on CT scans. CCP seems to describe vascular resistance better than ICP.	Addenbrookes Hosp, Acad Neurosurg Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Sch Clin, Addenbrookes Hosp, Cambridge, England	Czosnyka, M (corresponding author), Addenbrookes Hosp, Acad Neurosurg Unit, Hills Rd,Box 167, Cambridge CB2 2QQ, England.	mc141@medschl.cam.ac.uk		Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390] Funding Source: Medline		Aaslid R, 2003, STROKE, V34, P1645, DOI 10.1161/01.STR.0000077927.63758.B6; Aaslid R, 1992, TRANSCRANIAL DOPPLER, P49; BURTON AC, 1951, AM J PHYSIOL, V164, P319; Carey BJ, 2001, CLIN SCI, V101, P351, DOI 10.1042/CS20010021; Czosnyka M, 1999, J NEUROL NEUROSUR PS, V66, P606, DOI 10.1136/jnnp.66.5.606; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Gooskens I, 2003, ACTA NEUROCHIR, V145, P527, DOI 10.1007/s00701-003-0045-y; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Panerai RB, 2003, MED ENG PHYS, V25, P621, DOI 10.1016/S1350-4533(03)00027-4; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Schmidt EA, 2003, J NEUROIMAGING, V13, P248, DOI 10.1177/1051228403013003008; Schmidt EA, 2003, J NEUROSURG, V99, P991, DOI 10.3171/jns.2003.99.6.0991; Soehle M, 2004, STROKE, V35, P1393, DOI 10.1161/01.STR.0000128411.07036.a9; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002	15	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	NOV	2005	76	11					1570	1573		10.1136/jnnp.2004.059493			4	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	974HF	WOS:000232581400025	16227554	Green Published, Bronze			2021-06-18	
J	McNaughton, HK; Weatherall, M; McPherson, KM				McNaughton, HK; Weatherall, M; McPherson, KM			Functional measures across neurologic disease states: Analysis of factors in common	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						factor analysis; statistical; outcome assessment (health care); rehabilitation	HEALTH SURVEY; SHORT FORM-36; STROKE; RELIABILITY; VALIDITY; QUESTIONNAIRES; PARTICIPATION; INDIVIDUALS; POPULATION; HANDICAP	Objective: To describe the underlying dimensions for a range of functional measures across 3 neurologic diseases at different time points. Design: Multiple cohort study. Setting: Combination of public hospital wards and community. Participants: Patients (N = 308) from 3 cohorts: paralytic poliomyelitis (n = 38), mean of 25 years previously, assessed once; acute stroke admitted to hospital and followed up for 12 months postdischarge (n = 181); and traumatic brain injury (TBI), admitted to hospital and followed up for 12 months postdischarge (n = 89). Interventions: Not applicable. Main Outcome Measures: The Barthel Index, FIM instrument, Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) physical component score (PCS) and mental component score (MCS), Community Integration Questionnaire (CIQ), and the London Handicap Score (LHS). Measures were compared at 2 time points: pre-event status for stroke, TBI and the polio cohort, and 12-month postdischarge status for stroke and TBI. Results: The different measures generally correlated highly within disease states at each time point. Principal components analysis revealed 2 underlying dimensions, a physical dimension onto which loaded the Barthel Index, FIM, PCS, and LHS and a cognitive/emotional dimension onto which loaded the MCS and, for subjects with polio, the CIQ. These 2 dimensions accounted for 69% of the variance in measures at the pre-event time point and 85% of the variance at the 12-month time point. Conclusions: These data Suggest 2 basic underlying dimensions across a wide range of measures in 3 different neurologic conditions even at different time points. Most of the variation in the measures can be captured using the 2 component summary scores (PCS, MCS) of the SF-36.	Med Res Inst New Zealand, Wellington, New Zealand; Univ Otago, Wellington Sch Med & Hlth Sci, Rehabil Teaching & Res Unit, Otago, New Zealand; Auckland Univ Technol, Natl Inst Rehabil Res, Auckland, New Zealand	McNaughton, HK (corresponding author), Med Res Inst New Zealand, POB 10055, Wellington, New Zealand.	harry.mcnaughton@mrinz.ac.nz	Weatherall, Mark/Y-6824-2019; McNaughton, Harry/AAC-6556-2020	Weatherall, Mark/0000-0002-0051-9107; McPherson, Kath/0000-0003-0487-8497; McPherson, Kathryn/0000-0003-1240-8882			BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P824, DOI 10.1136/jnnp.53.10.824; BONITA R, 1994, STROKE, V25, P552, DOI 10.1161/01.STR.25.3.552; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Dorman P, 1998, STROKE, V29, P63, DOI 10.1161/01.STR.29.1.63; Dorman PJ, 1997, BRIT MED J, V315, P461, DOI 10.1136/bmj.315.7106.461; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; HARWOOD RH, 1994, J NEUROL NEUROSUR PS, V57, P825, DOI 10.1136/jnnp.57.7.825; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Hsueh IP, 2003, STROKE, V34, P1741, DOI 10.1161/01.STR.0000075295.45185.D4; Khattree R., 2000, MULTIVARIATE DATA RE; MAHONEY F I, 1965, Md State Med J, V14, P61; Mayo NE, 2002, ARCH PHYS MED REHAB, V83, P1035, DOI 10.1053/apmr.2002.33984; McNaughton H, 2001, INT J REHABIL RES, V24, P133; McPherson K, 2004, MED CARE, V42, P1143, DOI 10.1097/00005650-200411000-00014; McPherson KM, 2004, DISABIL REHABIL, V26, P988, DOI 10.1080/09638280410001702414; Paniak C, 1999, J HEAD TRAUMA REHAB, V14, P211, DOI 10.1097/00001199-199906000-00002; Scott KM, 1999, AUST NZ J PUBL HEAL, V23, P401, DOI 10.1111/j.1467-842X.1999.tb01282.x; Stadnyk K, 1998, J CLIN EPIDEMIOL, V51, P827, DOI 10.1016/S0895-4356(98)00061-4; Wade DT, 1992, MEASUREMENT NEUROLOG; WARE JE, 1995, SF 36 SCORE SF 36 PH; Willer B, 1993, J HEAD TRAUMA REHAB, V3, P75, DOI DOI 10.1097/00001199-199308020-00009	23	14	15	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2005	86	11					2184	2188		10.1016/j.apmr.2005.06.010			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	983TB	WOS:000233253900018	16271568				2021-06-18	
J	Karabiyikoglu, M; Keep, R; Hua, Y; Xi, GH				Karabiyikoglu, M; Keep, R; Hua, Y; Xi, GH			Acute subdural hematoma: New model delineation and effects of coagulation inhibitors	NEUROSURGERY			English	Article						ischemia; rat; subdural hematoma; thrombin; thrombosis	CEREBRAL-BLOOD-FLOW; PLATELET-ACTIVATING-FACTOR; TRAUMATIC BRAIN-INJURY; ISCHEMIC DAMAGE; INTRACEREBRAL HEMORRHAGE; COMPUTERIZED-TOMOGRAPHY; RAT; THROMBIN; NEUROPROTECTION; ARGATROBAN	OBJECTIVE: To develop a highly reproducible rat model and behavioral tests for acute subdural hematoma (ASDH) and to investigate the role of intravascular coagulation and thrombin in the pathogenesis of brain injury in this model. METHODS: A new method was implemented to inject 200 mu l of autologous blood subdurally in rats. Immunohistochemistry was used to investigate intravascular fibrin deposition and thrombin levels in the cortex underlying the ASDH. Effectiveness of systemic heparin, argatroban, or ginkgolide B treatment was determined by histological lesion volume, number of occluded microvessels, and neurological deficits. Neurological deficits were monitored for 7 days after ASDH by use of forelimb placing, forelimb use asymmetry, and corner turn tests. RESULTS: Consistent brain damage and sensorimotor deficits were observed in all animals with ASDH. Histological analysis demonstrated occluded microvessels and enlarged perivascular spaces in the underlying cortex starting 1 hour after hematoma induction. Fibrin and thrombin immunoreactivity were increased in the lesioned cortical parenchyma at 4 and 24 hours. However, no intravascular fibrin deposition was detected. Heparin induced hemorrhagic transformation in the cortical lesion and did not attenuate microvessel occlusion. Argatroban and ginkgolide B did not induce hemorrhage but failed to improve microvessel occlusion, lesion volume, and neurological deficits. CONCLUSION: Intravascular coagulation and thrombin are not the major mediators of brain damage after ASDH. The model and behavioral tests presented in this study can be used to investigate other putative mechanisms of injury and to test future therapeutic interventions in ASDH.	Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Physiol, Ann Arbor, MI 48109 USA	Karabiyikoglu, M (corresponding author), Univ Michigan, Dept Neurosurg, 5550 Kresge 1, Ann Arbor, MI 48109 USA.	karabiyikoglu@yahoo.com	Karabiyikoglu, Murat/AAB-9443-2021	Keep, Richard/0000-0001-6441-5334	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039866] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-39866] Funding Source: Medline		Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Berry CN, 2000, THROMB HAEMOSTASIS, V84, P278; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Daneyemez M, 1999, NEUROSCIENCE, V92, P783, DOI 10.1016/S0306-4522(99)00035-4; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Donovan FM, 1997, J NEUROSCI, V17, P5316; FUJISAWA H, 1994, ACT NEUR S, V60, P193; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HARA T, 1994, HAEMOSTASIS, V24, P351; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Jiang YJ, 2002, J CEREBR BLOOD F MET, V22, P404, DOI 10.1097/00004647-200204000-00004; Karabiyikoglu M, 2004, J CEREBR BLOOD F MET, V24, P159, DOI 10.1097/01.WCB.0000100062.36077.84; Kawai H, 1996, J PHARMACOL EXP THER, V278, P780; KURODA Y, 1992, NEUROSURGERY, V30, P687; KURODA Y, 1992, J NEUROSURG, V76, P471, DOI 10.3171/jns.1992.76.3.0471; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Li SQ, 1999, CLIN EXP PHARMACOL P, V26, P824, DOI 10.1046/j.1440-1681.1999.03146.x; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Maeda T, 1997, ACT NEUR S, V70, P102; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; Mary V, 2001, STROKE, V32, P993, DOI 10.1161/01.STR.32.4.993; MILLER JD, 1990, NEUROSURGERY, V27, P433, DOI 10.1227/00006123-199009000-00016; Mori M, 1996, J NEUROSCI, V16, P3590; Ninomia T, 2000, J CEREBR BLOOD F MET, V20, P998, DOI 10.1097/00004647-200006000-00012; Nishida K, 1996, J NEUROCHEM, V66, P433; Patel TR, 1999, BRAIN RES, V829, P125, DOI 10.1016/S0006-8993(99)01378-5; RADEN AI, 1992, AM J PHYSIOL, V263, pR909; Riek-Burchardt M, 2002, NEUROSCI LETT, V329, P181, DOI 10.1016/S0304-3940(02)00645-6; SALVANT JB, 1993, NEUROSURGERY, V33, P387; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SPINNEWYN B, 1987, PROSTAGLANDINS, V34, P337, DOI 10.1016/0090-6980(87)90079-7; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Striggow F, 2001, EUR J NEUROSCI, V14, P595, DOI 10.1046/j.0953-816x.2001.01676.x; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; Uchida K, 2001, EUR J ANAESTH, V18, P295, DOI 10.1046/j.0265-0215.2000.00825.x; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Yilmazlar S, 1997, J Neurosurg Sci, V41, P379; Zhang ZG, 2001, BRAIN RES, V912, P181, DOI 10.1016/S0006-8993(01)02735-4	44	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA	0148-396X			NEUROSURGERY	Neurosurgery	SEP	2005	57	3					565	571		10.1227/01.NEU.0000170435.47739.AE			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	963DB	WOS:000231782400031	16145537				2021-06-18	
J	Moochhala, SM; Lu, J; Xing, MCK; Ng, KC; Ycing, KLS; Whiteman, M; Atan, S				Moochhala, SM; Lu, J; Xing, MCK; Ng, KC; Ycing, KLS; Whiteman, M; Atan, S			Mercaptoethylguanidine inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expressions induced in rats after fluid-percussion brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						fluid-percussion injury; inducible nitric oxide synthase; mercaptoethylguanidine; cyclo-oxygenase-2; neuronal survival; rat	BLOOD-PRESSURE; PEROXYNITRITE; TRAUMA; MODEL; MOTOR; NEUROPROTECTION; AMINOGUANIDINE; INFLAMMATION; DYSFUNCTION; SCAVENGER	The present study examined the temporal expression of inducible nitric oxide synthase (iNOS) and cyclo-oxygenase (COX)-2 in rat brains after traumatic brain injury (TBI). We studied the effects of mercaptoethylguanidine (MEG), a dual inhibitor of the inducible iNOS and COX with scavenging effect on peroxynitrite, on physiologic variables, brain pathogenesis, and neurologic performance in rats after a lateral fluid percussive-induced TBI. Mean arterial blood pressure and percentage cerebral tissue perfusion in MEG-treated TBI rats showed significant improvement when compared with TBI rats. Immunohistochemical analysis showed a marked number of iNOS and COX-2 immunopositive cells in the cerebral cortex ipsilateral to the injury in TBI rats when compared with MEG-treated TBI rats. MEG also significantly decreased the number of hyperchromatic and shrunken cortical neurons when compared with TBI rats' brain nitrate/nitrite, and prostaglandin E-2 levels were attenuated in MEG-treated TBI rats when compared with TBI rats. It is therefore suggested that treatment of MEG via inhibition of iNOS and COX-2 might contribute to improved physiologic variables, neuronal cell survival, and neurologic outcome after TBI.	DSO, Def Med & Environm Res Inst, Ctr Head Biomed Sci, Singapore 117510, Singapore; Natl Univ Singapore, Dept Pharmacol, Singapore 117548, Singapore; Natl Univ Singapore, Dept Biochem, Singapore, Singapore	Moochhala, SM (corresponding author), DSO, Def Med & Environm Res Inst, Ctr Head Biomed Sci, 27 Med Dr,Level 12 Gen Off, Singapore 117510, Singapore.	nmiv19@nus.edu.sg	Whiteman, Matthew/C-6079-2009	Whiteman, Matthew/0000-0002-6583-6779; MOOCHHALA, SHABBIR/0000-0003-4521-3192			Acarin L, 2002, J NEUROSCI RES, V68, P745, DOI 10.1002/jnr.10261; Bedell EA, 1998, J NEUROTRAUM, V15, P985, DOI 10.1089/neu.1998.15.985; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buccellati C, 1998, NEUROSCI LETT, V257, P123, DOI 10.1016/S0304-3940(98)00745-9; Buluc M, 2002, PROSTAG OTH LIPID M, V70, P227, DOI 10.1016/S0090-6980(02)00112-0; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Dawson VL, 1996, J CHEM NEUROANAT, V10, P179, DOI 10.1016/0891-0618(96)00148-2; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; Fink MP, 1999, CRIT CARE MED, V27, P2019, DOI 10.1097/00003246-199909000-00050; Frishman WH, 2002, AM J CARDIOL, V89, p18D; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gong C, 2001, BRAIN RES, V901, P38, DOI 10.1016/S0006-8993(01)02186-2; Hooper DC, 2000, FASEB J, V14, P691; Hurley SD, 2002, J NEUROTRAUM, V19, P1, DOI 10.1089/089771502753460196; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286; Irazuzta JE, 2000, LIFE SCI, V67, P365, DOI 10.1016/S0024-3205(00)00637-8; Knoferl MW, 2001, SHOCK, V16, P479, DOI 10.1097/00024382-200116060-00013; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu J, 2003, NEUROSCI LETT, V339, P147, DOI 10.1016/S0304-3940(03)00003-X; MARKLUND NP, 2001, ABSTR SOC NEUROSCI, V27, P573; Marnett LJ, 2002, PROSTAG OTH LIPID M, V68-9, P153, DOI 10.1016/S0090-6980(02)00027-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Park CO, 2001, YONSEI MED J, V42, P518, DOI 10.3349/ymj.2001.42.5.518; Paya M, 1997, BRIT J PHARMACOL, V120, P1445, DOI 10.1038/sj.bjp.0701073; Petrov T, 2001, J NEUROTRAUM, V18, P799, DOI 10.1089/089771501316919166; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/0165-3806(96)00098-3; SALVEMINI D, 1994, J CLIN INVEST, V93, P1940, DOI 10.1172/JCI117185; Schade S, 2002, BIOCHEM PHARMACOL, V64, P1227, DOI 10.1016/S0006-2952(02)01290-X; SHAPIRO Y, 1997, CRIT CARE MED, V16, P258; SINSON G, 1995, J NEUROCHEM, V65, P2209; Stoffel M, 2000, ACTA NEUROCHIR SUPPL, V76, P357; Sunose Y, 2001, J AM COLL SURGEONS, V192, P54, DOI 10.1016/S1072-7515(00)00773-0; Szabo A, 1999, CRIT CARE MED, V27, P1343, DOI 10.1097/00003246-199907000-00027; Szabo C, 1996, BRAIN RES BULL, V41, P131, DOI 10.1016/S0361-9230(96)00159-1; Szabo C, 1997, J BIOL CHEM, V272, P9030; TOMLINSON A, 1994, BRIT J PHARMACOL, V113, P693, DOI 10.1111/j.1476-5381.1994.tb17048.x; VANE JR, 1994, P NATL ACAD SCI USA, V91, P2046, DOI 10.1073/pnas.91.6.2046; VANLERSBERGHE C, 1993, ACTA ANAESTH BELG, V43, P211; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wolff DJ, 1997, J PHARMACOL EXP THER, V283, P265; Zingarelli B, 1997, EUR J PHARMACOL, V338, P55, DOI 10.1016/S0014-2999(97)01325-3; Zingarelli B, 1997, BRIT J PHARMACOL, V120, P357, DOI 10.1038/sj.bjp.0700892	48	14	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	AUG	2005	59	2					448	455		10.1097/01.ta.0000174858.79847.6d			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	014BX	WOS:000235454800040	16294091				2021-06-18	
J	Portella, G; Cormio, M; Citerio, G; Contant, C; Kiening, K; Enblad, P; Piper, I				Portella, G; Cormio, M; Citerio, G; Contant, C; Kiening, K; Enblad, P; Piper, I			Continuous cerebral compliance monitoring in severe head injury: its relationship with intracranial pressure and cerebral perfusion pressure	ACTA NEUROCHIRURGICA			English	Article						traumatic brain injury; ICP; compliance; CPP; Spiegelberg	VOLUME INDEX; BLOOD-FLOW; DYNAMICS; CSF	Background. Cerebral compliance expresses the capability to buffer an intracranial volume increase while avoiding a rise in intracranial pressure (ICP). The autoregulatory response to Cerebral Perfusion Pressure (CPP) variation influences cerebral blood volume which is an important determinant of compliance. The direction of compliance change in relation to CPP variation is still under debate. The aim of the study was to investigate the relationship between CPP and compliance in traumatic brain injured (TBI) patients by a new method for continuous monitoring of intracranial compliance as used in neuro-intensive care (NICU). Method. Three European NICU's standardised collection of CPP, compliance and ICP data to a joint database. Data were analyzed using an unpaired student t-test and a multi-level statistical model. Results. For each variable 108,263 minutes of data were recorded from 21 TBI patients ( 19 patients GCS <= 8; 90% male; age 10 - 77 y). The average value for the following parameters were: ICP 15.1 +/- 8.9 mmHg, mmHg, CPP 74.3 +/- 14 mmHg and compliance 0.68 +/- 0.3 ml/mmHg. ICP was >= 20 mmHg in 20% and CPP < 60 mmHg for 10.7% of the time. Compliance was lower (0.51 +/- 0.34 ml/mmHg) at ICP >= 20 than at ICP < 20mmHg (0.73 +/- 0.37 ml/mmHg) (p < 0.0001). Compliance was significantly lower at CPP < 60 than at CPP >= 60mmHg: 0.56 +/- 0.36 and 0.70 +/- 0.37ml/mmHg respectively (p < 0.0001). The CPP compliance relationship was different when ICP was above 20mmHg compared with below 20mmHg. At ICP < 20mmHg compliance rose as CPP rose. At ICP >= 20mmHg, the relation curve was convexly shaped. At low CPP, the compliance was between 0.20 and 0.30 ml/mmHg. As the CPP reach 80 mmHg average compliance was 0.55 ml/mmHg., but compliance fell to 0.40 ml/mmHg when CPP was 100 mmHg. Conclusions. Low CPP levels are confirmed to be detrimental for intracranial compliance. Moreover, when ICP was pathological, indicating unstable intracranial equilibrium, a high CPP level was also associated with a low volume-buffering capacity.	Osped San Gerardo, Dept Intens Care, Monza, MI, Italy; Baylor Coll Med, Houston, TX 77030 USA; Univ Heidelberg, Heidelberg, Germany; Univ Uppsala Hosp, Uppsala, Sweden; So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland	Portella, G (corresponding author), Osped San Gerardo, Dept Intens Care, Monza, MI, Italy.	portella.gina@libero.it		Citerio, Giuseppe/0000-0002-5374-3161			AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Avezaat CJJ, 1984, THESIS ERASMUS U ROT; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, INTRACRANIAL PRESSUR, V8, P529; Czosnyka M, 1997, J NEUROL NEUROSUR PS, V63, P732, DOI 10.1136/jnnp.63.6.732; Goldstein H, 2002, STAT MED, V21, P3291, DOI 10.1002/sim.1264; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; HERMANN HD, 1993, NEUROSURGERY, V33, P1111; Howells T. P., 1995, Journal of Neurotrauma, V12, P471; KONTOS HA, 1978, AM J PHYSIOL, V234, P371; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; MARMAROU A, 1973, THESIS DREXEL U; MARMAROU A, 1993, INTRACRANIAL PRESSUR, pCH10; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Miller J D, 1972, Prog Brain Res, V35, P411; MILLER JD, 1973, ARCH NEUROL-CHICAGO, V28, P265, DOI 10.1001/archneur.1973.00490220073011; Miller JD, 1972, INTRACRANIAL PRESSUR, P270; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MUIZELAAR JP, 1989, INTRACRANIAL PRESSUR, V7, P825; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Piper I, 1999, BRIT J NEUROSURG, V13, P581, DOI 10.1080/02688699943097; PIPER IR, 1990, ACT NEUR S, V51, P387; Raabe A, 1999, ACTA NEUROCHIR, V141, P31, DOI 10.1007/s007010050263; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHAPIRO K, 1980, ANN NEUROL, V7, P508, DOI 10.1002/ana.410070603; SPIEGELBERG A, 1996, WORK C INT GROUP INT; TANS JTJ, 1983, J NEUROSURG, V59, P810, DOI 10.3171/jns.1983.59.5.0810; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P597, DOI [10.1089/neu.2000.17.597, DOI 10.1089/NEU.2000.17.597]; Yau YH, 2000, J NEUROSURG, V93, P1072, DOI 10.3171/jns.2000.93.6.1072	32	14	14	0	2	SPRINGER WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUL	2005	147	7					707	713		10.1007/s00701-005-0537-z			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	938AK	WOS:000229972100004	15900402				2021-06-18	
J	Rigg, JL; Elovic, EP; Greenwald, BD				Rigg, JL; Elovic, EP; Greenwald, BD			A review of the effectiveness of antioxidant therapy to reduce neuronal damage in acute traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							HEAD-INJURY; OXIDATIVE STRESS; MELATONIN; MULTICENTER; EFFICACY; TRIAL; RAT		Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07103 USA; Kessler Med Rehabil Res & Educ Corp, W Orange, NJ USA; Mt Sinai Sch Med, Dept Phys Med & Rehabil, New York, NY 10029 USA; Mt Sinai Med Ctr, New York, NY 10029 USA	Rigg, JL (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Kaufman Med Bldg,3471 5th Ave,Ste 201, Pittsburgh, PA 15213 USA.	jackrigg@yaboo.com					Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Beni SM, 2004, FASEB J, V18, P149, DOI 10.1096/fj.03-0323fje; Cirak B, 1999, PEDIATR NEUROSURG, V31, P298, DOI 10.1159/000028879; CLIFTON G L, 1989, Journal of Neurotrauma, V6, P71, DOI 10.1089/neu.1989.6.71; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Guidetti C, 2001, J PHARM PHARMACOL, V53, P387, DOI 10.1211/0022357011775442; Inci S, 1998, NEUROSURGERY, V43, P330, DOI 10.1097/00006123-199808000-00095; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mesenge C, 1998, J PINEAL RES, V25, P41, DOI 10.1111/j.1600-079X.1998.tb00384.x; Sarrafzadeh AS, 2000, ACTA NEUROCHIR, V142, P1293, DOI 10.1007/s007010070028; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; YOSHIDA S, 1985, NEUROLOGY, V35, P126, DOI 10.1212/WNL.35.1.126; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	15	14	16	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2005	20	4					389	391		10.1097/00001199-200507000-00010			3	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	941MV	WOS:000230219800010	16030445				2021-06-18	
J	Foster, DR; Rhoney, DH				Foster, DR; Rhoney, DH			Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes	SURGICAL NEUROLOGY			English	Article						Enterobacter; gram-negative bacillary meningitis; meningitis; postneurosurgery	TRIMETHOPRIM-SULFAMETHOXAZOLE; CEFOTAXIME; AEROGENES; EMERGENCE	Background: Meningitis due to Enterobacter species is an uncommon infection in adults; however, when present, treatment is frequently complicated by resistance of many Enterobacter isolates to third-generation cephalosporins and poor central nervous system penetration of other antibiotics. The aim of this study was to retrospectively review cases of meningitis caused by Enterobacter species at our institution, to better characterize patient factors, pathogen characteristics, and treatment options for this infection. Methods: We reviewed all cases of Enterobacter meningitis in a 12-year period at a tertiary care center. Data collected included patient demographics, antibiotic sensitivities of Enterobacter isolates, antimicrobial therapy, and patient outcomes. Results: Nineteen cases were identified, primarily in patients with neurotrauma and in neurosurgical patients. Enterobacter cloacae was the most frequent Enterobacter species isolated followed by Enterobacter aerogenes and Enterobacter agglomerans (50%, 34%, and 16% of cultures, respectively). Overall, clinical cure/improvement was achieved in 47% of patients, and the mortality rate was 21%. Antibiotic treatment varied substantially and included third-generation cephalosporins, intravenous and intrathecal aminoglycosides, trimethoprim-sulfamethoxazole (TMP-SMX), piperacillin, ciprofloxacm, and other miscellaneous antibiotics. Treatment with TMP-SMX was associated with a high rate of clinical cure/improvernent, whereas third-generation cephalosporins were less efficacious. Conclusions: Enterobacter meningitis is an infrequent complication of neurological insult. Treatment is often complicated by resistance of Enterobacter species to third-generation cephalosporins. Our results indicate that while third-generation cephalosporins are not the most appropriate choice of agents to treat Enterobacter meningitis, TMP-SMX may yield satisfactory results. (c) 2005 Elsevier Inc. All rights reserved.	Wayne State Univ, Coll Pharm & Allied Hlth Profess, Dept Pharm Practice, Detroit, MI 48201 USA; Wayne State Univ, Coll Med, Dept Neurol, Detroit, MI 48201 USA; Purdue Univ, Sch Pharm & Pharm Sci, Dept Pharm Practice, W Lafayette, IN 47907 USA	Rhoney, DH (corresponding author), Wayne State Univ, Coll Pharm & Allied Hlth Profess, Dept Pharm Practice, Detroit, MI 48201 USA.	drhoney@wayne.edu					D'Antuono VS, 1998, CLIN INFECT DIS, V26, P206, DOI 10.1086/517020; DECHAMPS C, 1991, INFECTION, V19, P181, DOI 10.1007/BF01643247; HEUSSER MF, 1990, PEDIATR INFECT DIS J, V9, P509, DOI 10.1097/00006454-199007000-00011; Huang CR, 2001, INFECTION, V29, P75, DOI 10.1007/s15010-001-0087-0; LEVITZ RE, 1984, ANN INTERN MED, V100, P881, DOI 10.7326/0003-4819-100-6-881; RALPH ED, 1987, SCAND J INFECT DIS, V19, P577, DOI 10.3109/00365548709032425; Rousseau JM, 2001, J TRAUMA, V50, P971, DOI 10.1097/00005373-200105000-00041; SAAD AF, 1974, ARCH INTERN MED, V134, P738, DOI 10.1001/archinte.134.4.738; SALTER AJ, 1982, REV INFECT DIS, V4, P196; WOLFF MA, 1993, CLIN INFECT DIS, V16, P772, DOI 10.1093/clind/16.6.772	10	14	15	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	JUN	2005	63	6					533	537		10.1016/j.surneu.2004.06.018			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	938JU	WOS:000229996700008	15936376				2021-06-18	
J	Wu, TS; Garmel, GM				Wu, TS; Garmel, GM			Improved neurological function after amantadine treatment in two patients with brain injury	JOURNAL OF EMERGENCY MEDICINE			English	Article						amantadine; brain injury; dopaminergic agonists	RECOVERY	This article presents two cases of functional recovery in patients with brain injury after treatment with Amantadine, a dopaminergic stimulant. Also presented is a review of current data available concerning dopaminergic therapy after traumatic brain injury. (c) 2005 Elsevier Inc.	Stanford Kaiser Emergency Med Residency Program, Stanford, CA USA; Kaiser Permanente Med Ctr, Santa Clara, CA USA	Wu, TS (corresponding author), 701 Welch Rd,Bldg C, Palo Alto, CA 94304 USA.						ALLEN RM, 1983, CLIN NEUROPHARMACOL, V6, pS64; BOTEZ MI, 1989, NEUROLOGY, V39, P749, DOI 10.1212/WNL.39.5.749-b; CHANDLER M, 1988, BRAIN INJURY, V4, P309; CHIERICHETTI SM, 1977, CURR THER RES CLIN E, V22, P158; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; CROSBY NJ, 2003, COCHRANE LIB; Debette S, 2002, J NEUROL, V249, P1678, DOI 10.1007/s00415-002-0903-1; DIXON CE, IN PRESS COMMUNICATI; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GIANUTSOS G, 1985, EUR J PHARMACOL, V110, P357, DOI 10.1016/0014-2999(85)90564-3; GUALTIERI T, 1989, CLIN NEUROPHARMACOL, V12, P258, DOI 10.1097/00002826-198908000-00003; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Meythaler JM, 2003, J HEAD TRAUMA REHAB, V18, P5, DOI 10.1097/00001199-200301000-00004; ROSENBERG GA, 1985, CAN J NEUROL SCI, V12, P251; STEVENS JR, 1973, ARCH GEN PSYCHIAT, V29, P177; Zink Brian J., 1996, Emergency Medicine Clinics of North America, V14, P115	17	14	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	APR	2005	28	3					289	292		10.1016/j.jemermed.2004.11.016			4	Emergency Medicine	Emergency Medicine	908LT	WOS:000227789200007	15769570				2021-06-18	
J	Imberti, R; Fuardo, M; Bellinzona, G; Pagani, M; Langer, M				Imberti, R; Fuardo, M; Bellinzona, G; Pagani, M; Langer, M			The use of indomethacin in the treatment of plateau waves: effects on cerebral perfusion and oxygenation	JOURNAL OF NEUROSURGERY			English	Article						plateau wave; intracranial pressure; cerebral oxygenation; transcranial Doppler ultrasonography; venoarterial difference in partial pressure of carbon dioxide	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; BLOOD-FLOW; HYPERTENSION; METABOLISM; VOLUME; RISES; MODEL	Object. Plateau waves are sudden and steep increases in intracranial pressure (ICP) that can develop in patients with cerebral injuries, reduced pressure-volume compensatory reserve, and preserved autoregulation. They are caused by cerebral vasodilation in response to a reduction in cerebral perfusion and are associated with increased cerebral blood volume and reduced cerebral blood flow. The authors evaluated the hypothesis that administration of indomethacin, a potent cerebral arteriolar vasoconstrictor, could interrupt the vicious cycle that occurs during plateau waves, extinguishing these waves and, ultimately, restoring cerebral perfusion and oxygenation. Methods. Plateau waves developed in nine patients, seven with severe traumatic brain injury and two with intraparenchymal hemorrhage. One to four episodes of plateau waves per patient were treated with indomethacin (15-20 mg), which was delivered by an intravenous bolus injection. Each patient's mean arterial blood flow (MABP), lCP, cerebral perfusion pressure (CPP), and cerebral tissue PO2 were continuously monitored and the data obtained were stored in a personal computer. Each patient's jugular venous 0, saturation (SjvO(2),) and venoarterial difference in PCO2 were evaluated by intermittent blood sampling. During five episodes of plateau waves, middle cerebral artery flow velocities were evaluated by transcranial Doppler ultrasonography. Indomethacin extinguished all plateau waves. On average, the ICP decreased from an initial value of 58.9 +/- 11.6 mm Hg to 21.2 +/- 8.6 and 25.8 +/- 13.7 mm Hg after 5 and 10 minutes, respectively (p < 0.01). The MABP did not change significantly. As a consequence the CPP increased by 98 and 81% after 5 and 10 minutes, respectively (p < 0.01). Five and 10 minutes after indomethacin was administered, SjvO(2), increased from an initial value of 50 +/- 10.5% to 62 +/- 7.6 and 59.9 +/- 9.3%, respectively (p < 0.01); the cerebral tissue PO, increased from an initial value of 13.4 +/- 10.6 mm Hg to 23.6 +/- 9.58 and 21.9 +/- 9.2 mm Hg, respectively (p < 0.05); and the venous-arterial PCO2 decreased significantly. The mean and diastolic flow velocities increased significantly, whereas the pulsatility index decreased from 1.39 +/- 0.56 to 1.09 +/- 0.4 at 5 minutes and 1.06 +/- 0.36 at 10 minutes (p < 0.05). Conclusions. The findings confirm that plateau waves are caused by vasodilation and show that indomethacin, by constricting the cerebral arteries, is effective in extinguishing plateau waves, ultimately restoring cerebral perfusion and oxygenation.	IRCCS, Policlin San Matteo, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy	Imberti, R (corresponding author), IRCCS, Policlin San Matteo, Serv Anestesia & Rianimaz 2, I-27100 Pavia, Italy.	r.imberti@smatteo.pv.it					BIESTRO AA, 1995, J NEUROSURG, V83, P627, DOI 10.3171/jns.1995.83.4.0627; Bundgaard H, 1996, J NEUROSURG ANESTH, V8, P273, DOI 10.1097/00008506-199610000-00003; CRUZ J, 1992, J TRAUMA, V32, P401, DOI 10.1097/00005373-199203000-00020; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; DEDEYNE C, 1995, INTENSIVE CARE ME S1, V21, pS153; HANSEN PA, 1995, J NEUROSURG ANESTH, V7, P117, DOI 10.1097/00008506-199504000-00007; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; Imberti R, 1997, ACTA ANAESTH SCAND, V41, P536, DOI 10.1111/j.1399-6576.1997.tb04738.x; Imberti R, 2000, J NEUROSURG ANESTH, V12, P124, DOI 10.1097/00008506-200004000-00011; JENSEN K, 1993, ACTA NEUROCHIR, V124, P114, DOI 10.1007/BF01401132; JENSEN K, 1991, ACTA NEUROCHIR, V108, P116, DOI 10.1007/BF01418518; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; NILSSON F, 1995, ANESTHESIOLOGY, V83, P1283, DOI 10.1097/00000542-199512000-00019; RISBERG J, 1969, J NEUROSURG, V31, P303, DOI 10.3171/jns.1969.31.3.0303; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Rossi S, 2002, ACT NEUR S, V81, P201; Slavik RS, 1999, NEUROL RES, V21, P491; Ursino M, 1997, J APPL PHYSIOL, V82, P1256; WENNMALM A, 1981, CLIN PHYSIOL, V1, P227, DOI 10.1111/j.1475-097X.1981.tb00891.x	21	14	14	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2005	102	3					455	459		10.3171/jns.2005.102.3.0455			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	911PR	WOS:000228017200009	15796379				2021-06-18	
J	Haranishi, Y; Kawata, R; Fukuda, S; Kiyoshima, T; Morimoto, Y; Matsumoto, M; Sakabe, T				Haranishi, Y; Kawata, R; Fukuda, S; Kiyoshima, T; Morimoto, Y; Matsumoto, M; Sakabe, T			Moderate hypothermia, but not calpain inhibitor 2, attenuates the proteolysis of microtubule-associated protein 2 in the hippocampus following traumatic brain injury in rats	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article						brain injuries, traumatic, acute, neuroprotection; calpain inhibitors; hypothermia	CONTROLLED CORTICAL IMPACT; POSTTRAUMATIC HYPOTHERMIA; SPECTRIN; MECHANISMS; DEFICITS	Background and objective: The degradation of the cytoskeletal protein microtubule-associated protein 2 (MAP2), by calpain has been known to occur following traumatic brain injury. We examined the therapeutic potential of calpain inhibitor 2, compared with that of moderate hypothermia in traumatic brain injury produced by weight drop in rats. Methods: An inhibitor treated group (n = 8) received calpain inhibitor 2 intravenously (i.v.) for 5 min before and for 6 h after injury (total 2 mu mol); a hypothermic (HT) group (n = 8) was maintained at 30 degrees C (temporalis muscle temperature) for 45 min prior to and 60 min after injury; an untreated (UT) group (n = 8) received an infusion of inactive vehicle. Eight rats (sham group) underwent surgery without brain injury. Histopathological (haematoxylin and eosin staining) and MAP2 (immunohistchemistry and western blotting) evaluations were performed at 6 h after injury. Results: Ipsilateral cortical damage was marked in the injured groups. In the hippocampus, marked pyramidal neuronal damage was observed in the UT and calpain inhibitor treated (CI) groups, while these neurons were better preserved in the HT group. The hippocampal MAP2 levels in the UT, CI and HT groups were significantly decreased to 13 +/- 9%, 28 +/- 33% and 62 +/- 25% of the sham control, respectively. MAP2 concentration in the HT group was significantly higher than in UT and CI groups (P < 0.05). Conclusion: The results suggest that moderate hypothermia, but not calpain inhibitor 2 with the tested regime, attenuates cytoskeletal damage in the ipsilateral hippocampus at 6 h after traumatic brain injury.	Yamaguchi Univ, Sch Med, Dept Anesthesiol Resuscitol, Yamaguchi 7558505, Japan	Sakabe, T (corresponding author), Yamaguchi Univ, Sch Med, Dept Anesthesiol Resuscitol, 1-1-1 Minami Kogushi, Yamaguchi 7558505, Japan.	sakabe@po.cc.yamaguchi-u.ac.jp					Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fukuda S, 1998, J NEUROCHEM, V70, P2526; Germano A, 2002, J NEUROTRAUM, V19, P887, DOI 10.1089/08977150260190474; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; JOHNSON GVW, 1991, J NEUROCHEM, V56, P1630, DOI 10.1111/j.1471-4159.1991.tb02061.x; Kampfl A, 1997, J NEUROTRAUM, V14, P121, DOI 10.1089/neu.1997.14.121; Katoh H, 1997, BRAIN RES, V758, P153, DOI 10.1016/S0006-8993(97)00213-8; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Posmantur RM, 1996, J NEUROPATH EXP NEUR, V55, P68, DOI 10.1097/00005072-199601000-00007; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; TUCKER RP, 1990, BRAIN RES REV, V15, P101, DOI 10.1016/0165-0173(90)90013-E; Zhao XR, 1998, J CEREBR BLOOD F MET, V18, P161, DOI 10.1097/00004647-199802000-00006	28	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	FEB	2005	22	2					140	147		10.1017/S0265021505000268			8	Anesthesiology	Anesthesiology	932DV	WOS:000229535300011	15816594				2021-06-18	
J	Ashton, VL; Donders, J; Hoffman, NM				Ashton, VL; Donders, J; Hoffman, NM			Rey Complex Figure Test performance after traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; CONFIRMATORY FACTOR-ANALYSIS; CLOSED-HEAD INJURY; MEMORY; PATTERNS; DEFICITS; MODERATE; EPILEPSY	The influence of factors such as cerebral injury characteristics, education, perceptual organization skills, and speed of information processing on performance on the Rey Complex Figure Test & Recognition Trial (RCF) was examined by means of hierarchical regression analyses in 100 consecutively referred persons with traumatic brain injury at a median of 2.5 months post-injury. Patients with premorbid (e.g., psychiatric history) or comorbid (e.g., financial compensation-seeking) complicating factors were excluded. Perceptual organization skills and the presence of a diffuse intracranial lesion but not education or speed of processing were statistically significant predictors of the variance in RCF variables. A large proportion of the sample improved by at least a standard deviation from independent delayed recall to multiple-choice recognition, and this was mediated by perceptual organization skills but not by injury parameters. It is concluded that Performance on the RCF after traumatic brain injury is affected relatively more by perceptual organization skills than by injury severity characteristics.	Mary Free Bed Rehabil Hosp, Dept Psychol, Grand Rapids, MI 49503 USA; Adler Sch Profess Psychol, Chicago, IL USA	Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Dept Psychol, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					Barr WB, 1997, J INT NEUROPSYCH SOC, V3, P435, DOI 10.1017/S1355617797004359; Benton A., 1994, MULTILINGUAL APHASIA; Berry D.T., 1991, CLIN NEUROPSYCHOL, V5, P143, DOI [10.1080/13854049108403298, DOI 10.1080/13854049108403298, https://doi.org/10.1080/13854049108403298]; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; BOONE KB, 1993, CLIN NEUROPSYCHOL, V7, P22, DOI 10.1080/13854049308401884; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Feeman RQ, 2000, NEUROPSYCHOLOGY, V14, P415, DOI 10.1037//0894-4105.14.3.415; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Giovagnoli AR, 1999, EPILEPSIA, V40, P904, DOI 10.1111/j.1528-1157.1999.tb00797.x; Hartman M, 1998, CLIN NEUROPSYCHOL, V12, P513, DOI 10.1076/clin.12.4.513.7233; Heaton R.K., 1991, COMPREHENSIVE NORMS; HEILBRONNER RL, 1992, CLIN NEUROPSYCHOL, V6, P105; Kixmiller JS, 2000, J CLIN EXP NEUROPSYC, V22, P198, DOI 10.1076/1380-3395(200004)22:2;1-1;FT198; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; Meyers J., 1995, REY COMPLEX FIGURE T; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Millis SR, 1999, J CLIN EXP NEUROPSYC, V21, P87, DOI 10.1076/jcen.21.1.87.937; Novack TA, 2000, BRAIN INJURY, V14, P987; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Rosselli M., 1991, CLIN NEUROPSYCHOL, V5, P370, DOI [DOI 10.1080/13854049108404104, 10.1080/13854049108404104]; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Sherer M, 2000, J HEAD TRAUMA REHAB, V15, P767, DOI 10.1097/00001199-200004000-00002; Sherrill-Pattison S, 2000, CLIN NEUROPSYCHOL, V14, P496, DOI 10.1076/clin.14.4.496.7196; Shum DHK, 2000, J CLIN EXP NEUROPSYC, V22, P25, DOI 10.1076/1380-3395(200002)22:1;1-8;FT025; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; STERN RA, 1999, BOSTON QUALITATIVE S; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Tombaugh TN, 1996, TEST MEMORY MALINGER; Trahan D, 1988, CONTINUOUS VISUAL ME; Vanderploeg RD, 1997, CLIN NEUROPSYCHOL, V11, P210, DOI 10.1080/13854049708407054; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; Wechsler D, 1997, WAIS 3 ADM SCORING M; Wiegner S, 1999, J CLIN EXP NEUROPSYC, V21, P159, DOI 10.1076/jcen.21.2.159.925; Wilde NJ, 2003, PSYCHOL ASSESSMENT, V15, P56, DOI 10.1037/1040-3590.15.1.56; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Wolfson D., 1993, HALSTEAD REITAN NEUR	43	14	14	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JAN	2005	27	1					55	64		10.1080/138033990513636			10	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	908NM	WOS:000227793700004	15814442				2021-06-18	
J	McGrath, J				McGrath, J			Beyond restoration to transformation: positive outcomes in the rehabilitation of acquired brain injury	CLINICAL REHABILITATION			English	Article							SENSE; SELF	Objectives: This paper compares the situation of the person with acquired brain injury to that of the people of Israel in the sixth century BCE (before the current era) during the period of exile in Babylon. Both situations are characterized by traumatic multiple losses, and a struggle to regain a sense of identity: personal, national or spiritual. Evidence from the literature on both brain injury rehabilitation and from the Hebrew Scriptures indicates that models of restoration of function and transformation of suffering have been applied to both situations. The relative strengths and weaknesses of these models are considered, and it is argued that models of transformation of suffering have much to offer, especially in the longer term psychotherapeutic rehabilitation of people with acquired brain injury, when restoration of function has reached its limits.	Rivermead Rehabil Ctr, Oxford OX1 4XD, England; Univ Oxford, Oxford, England	McGrath, J (corresponding author), Wycliffe Hall,54 Banbury Rd, Oxford OX2 6PW, England.	Joanna.McGrath@wycliffe.ox.ac.uk					ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; DIRENFELD G, 1991, COGNIT REHABIL, V9, P20; FRANK RG, 1987, CLIN PSYCHOL REV, V7, P611, DOI 10.1016/0272-7358(87)90009-2; Frankl V.E, 1963, MANS SEARCH MEANING; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; Jung C. G, 1955, INTERPRETATION NATUR; KAY T, 1986, MINOR HEAD INJURY IN; Lazarus R.S., 1984, STRESS APPRAISAL COP; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; MCGRATH J, 1998, THESIS OXFORD BROOKE; MOHL PC, 1982, GEN HOSP PSYCHIAT, V4, P113, DOI 10.1016/0163-8343(82)90040-8; Nadell J., 1991, COGNITIVE REHABILITA, V9, P8; PERSINGER MA, 1993, PSYCHOL REP, V72, P1059, DOI 10.2466/pr0.1993.72.3c.1059; PRIGATANO G, 1994, BRAIN INJURY NEUROPS; PRIGATANO G, 1986, NEUROPSYCHOL REHABIL, P216; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Smith Daniel, 1989, RELIG LANDLESS, P198; STILLWELL J, 1997, NATL TRAUMATIC BRAIN; Whitehouse A. M., 1994, J COGN PSYCHOTHER, V8, P141	23	14	14	0	3	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.	NOV	2004	18	7					767	775		10.1191/0269215504cr802oa			9	Rehabilitation	Rehabilitation	871VM	WOS:000225164700007	15573833				2021-06-18	
J	Read, D; Ashford, B				Read, D; Ashford, B			Surgical aspects of operation Bali assist: Initial wound surgery on the tarmac and in flight	ANZ JOURNAL OF SURGERY			English	Article						disaster; injury; military medicine; surgery; terrorism; wound		Background: The explosion of three bombs on 12 October 2002 in Kuta, Bali resulted in mass casualties akin to those seen in war. The aim of the present report is to describe the sequence of events of Operation Bali Assist including triage, resuscitation and initial wound surgery in Bali at Sanglah Hospital in the aeromedical staging facility (ASF), Denpasar airport and the evacuation to Darwin. Methods: A descriptive report is provided of the event and includes; resuscitation, anaesthesia, initial burns surgery management including escharotomy and fasciotomy, head injury management and importance of supplies and medical records with a description of the evacuation to Darwin. Results: Operation Bali Assist involved five C130 Hercules aircraft and aeromedical evacuation medical and nursing teams managing 66 casualties in the Denpasar area and their evacuation to Royal Darwin Hospital with ketamine the most useful anaesthetic agent and cling film the most useful burns dressing. Twelve procedures were performed at the ASF including seven escharotomies, three fasciotomies and two closed reductions. One escharotomy was performed in flight. Discussion: The important lessons learnt from the exercise is the inclusion of a surgeon in the aeromedical evacuation team, the importance of debridement and delayed primary closure, the usefulness of cling film as a burns dressing and the importance of continuous assessment. Future disaster planning exercises need to consider a patient age mix that might be expected in a shopping mall, rather than the young adult encountered in Bali, a more familiar age mix for Australian Defence Force medical staff.	Royal Darwin Hosp, Dept Surg, Darwin, NT 0810, Australia; RAAMC, Hlth Support Battal 3, Canberra, ACT, Australia; Royal Australian AF Specialist Reserve, Canberra, ACT, Australia	Read, D (corresponding author), Royal Darwin Hosp, Dept Surg, Rocklands Dr, Darwin, NT 0810, Australia.	DavidJ.Read@nt.gov.au					*AUSTR DEF FORC, 1996, AUSTR DEF FORC PUBL, V708, pCH9; Hampson GV, 2002, MED J AUSTRALIA, V177, P620, DOI 10.5694/j.1326-5377.2002.tb04986.x; HULL JB, 1994, BRIT J SURG, V81, P1132, DOI 10.1002/bjs.1800810815; MELLOR SG, 1989, BRIT J SURG, V76, P1006, DOI 10.1002/bjs.1800761006; MELLOR SG, 1997, BALLISTIC TRAUMA CLI	5	14	15	0	4	BLACKWELL PUBLISHING ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1445-1433			ANZ J SURG	ANZ J. Surg.	NOV	2004	74	11					986	991		10.1111/j.1445-1433.2004.03246.x			6	Surgery	Surgery	869ZN	WOS:000225023900014	15550089				2021-06-18	
J	Caldicott, DGE; Pearce, A; Price, R; Croser, D; Brophy, B				Caldicott, DGE; Pearce, A; Price, R; Croser, D; Brophy, B			Not just another 'head lac'... low-velocity, penetrating intra-cranial injuries: a case report and review of the literature	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article							TRANSCRANIAL STAB WOUNDS; CRANIOCEREBRAL INJURIES; TRAUMATIC ANEURYSM; SKULL; BRAIN; MANAGEMENT; WOOD; COMPLICATIONS; CHOPSTICK; FEATURES		Royal Adelaide Hosp, Emergency Dept, Adelaide, SA 5000, Australia	Caldicott, DGE (corresponding author), Royal Adelaide Hosp, Emergency Dept, N Terrace, Adelaide, SA 5000, Australia.	dcaldico@mail.rah.sa.gov.au	Caldicott, David/N-2840-2013	Caldicott, David/0000-0002-7040-6861			AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; ABBASSIOUN K, 1979, J NEUROL NEUROSUR PS, V42, P1046, DOI 10.1136/jnnp.42.11.1046; Adams RF, 2001, CLIN RADIOL, V56, P676, DOI 10.1053/crad.1999.0461; Amirjamshidi A, 1997, SURG NEUROL, V47, P331, DOI 10.1016/S0090-3019(96)00357-6; Amirjamshidi A, 1996, J NEUROSURG, V84, P769, DOI 10.3171/jns.1996.84.5.0769; ASARI S, 1977, J NEUROSURG, V46, P795, DOI 10.3171/jns.1977.46.6.0795; BARD LA, 1964, ARCH OPHTHALMOL-CHIC, V71, P332; Barlas O, 1983, Neurosurgery, V13, P105; Bauer M, 2002, FORENSIC SCI INT, V129, P122, DOI 10.1016/S0379-0738(02)00271-2; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BHOOTRA BK, 1985, J FORENSIC SCI, V30, P567; BRAUN J, 1987, J COMPUT ASSIST TOMO, V11, P525, DOI 10.1097/00004728-198705000-00030; Chadwick EKJ, 1999, FORENSIC SCI INT, V105, P35, DOI 10.1016/S0379-0738(99)00117-6; DABEZIES OH, 1982, ANN OPHTHALMOL, V14, P780; Deb S, 2000, J TRAUMA, V48, P1159, DOI 10.1097/00005373-200006000-00026; DIMAIO VJM, 1972, MIL MED, V137, P434; DOMINGO Z, 1994, PEDIATR NEUROSURG, V21, P45, DOI 10.1159/000120813; DOOLING JA, 1967, J NEUROSURG, V26, P636, DOI 10.3171/jns.1967.26.6.0636; DUFFY GP, 1969, BRIT J SURG, V56, P685, DOI 10.1002/bjs.1800560912; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; Franklin GA, 2002, J TRAUMA, V52, P1009, DOI 10.1097/00005373-200205000-00034; Hanigan W C, 1986, Pediatr Emerg Care, V2, P247, DOI 10.1097/00006565-198612000-00011; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; Joly LM, 2002, ANESTH ANALG, V94, P231, DOI 10.1097/00000539-200201000-00045; KHALIL N, 1991, SURG NEUROL, V35, P294, DOI 10.1016/0090-3019(91)90008-W; Khosla D, 2002, J TRAUMA, V52, P1192, DOI 10.1097/00005373-200206000-00029; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; KIRKBY GR, 1986, BRIT MED J, V293, P1646, DOI 10.1136/bmj.293.6562.1646; Koestler J, 2001, J EMERG MED, V21, P145, DOI 10.1016/S0736-4679(01)00363-8; LAWSON D, 1990, AUST NZ J OPHTHALMOL, V18, P221; Levin LA, 1996, J TRAUMA, V41, P926, DOI 10.1097/00005373-199611000-00035; Liliang PC, 2001, INJURY, V32, P497, DOI 10.1016/S0020-1383(01)00042-0; MARKHAM JW, 1964, J NEUROSURG, V21, P1095, DOI 10.3171/jns.1964.21.12.1095; Maroun FB, 2002, J TRAUMA, V52, P1008, DOI 10.1097/00005373-200205000-00033; MCKECHNIE J, 1986, BRIT J ORAL MAX SURG, V24, P258, DOI 10.1016/0266-4356(86)90090-2; MILLER CF, 1977, SURG NEUROL, V7, P95; Mitra K, 2002, INJURY, V33, P374, DOI 10.1016/S0020-1383(02)00024-4; Nathoo N, 2000, NEUROSURGERY, V47, P1117, DOI 10.1097/00006123-200011000-00018; O'Callaghan PT, 1999, FORENSIC SCI INT, V104, P173, DOI 10.1016/S0379-0738(99)00115-2; Olumide A A, 1976, Surg Neurol, V6, P306; RAHIMIZADEH A, 1987, NEUROSURGERY, V21, P427; Rao GP, 1998, BRIT J NEUROSURG, V12, P569; RITTER C, 1986, Z RECHTSMED, V96, P229; RITTER C, 2001, MED REHABIL, V82, P306; SEBAG J, 1986, OPHTHALMIC SURG LAS, V17, P631; Sharif S, 2000, BRIT J NEUROSURG, V14, P159; SPETZLER RF, 1979, NEUROSURGERY, V4, P334, DOI 10.1227/00006123-197904000-00011; Suzuki H, 2002, PAEDIATR ANAESTH, V12, P88, DOI 10.1046/j.1460-9592.2002.0787g.x; Taylor AG, 1997, J NEUROSURG, V87, P512, DOI 10.3171/jns.1997.87.4.0512; TIWARI SM, 1978, SURG NEUROL, V9, P267; TRIBOLET ND, 1979, SURG NEUROL, V11, P187; Tutton MG, 2000, J ACCID EMERG MED, V17, P225; VANDELLEN JR, 1978, SURG NEUROL, V10, P110; VILLIERS JCD, 1975, BRIT J OPHTHALMOL, V59, P52; WEBER W, 1974, Z RECHTSMED, V74, P111, DOI 10.1007/BF02114697; YAMAMOTO I, 1985, SURG NEUROL, V23, P396, DOI 10.1016/0090-3019(85)90215-0	57	14	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	OCT	2004	35	10					1044	1054		10.1016/j.injury.2003.10.026			11	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	858BC	WOS:000224164100020	15351675				2021-06-18	
J	Milosavljevic, S; Carman, AB; Milburn, PD; Wilson, BD; Davidson, PL				Milosavljevic, S; Carman, AB; Milburn, PD; Wilson, BD; Davidson, PL			The influence of a back support harness on spinal forces during sheep shearing	ERGONOMICS			English	Article						sheep shearing; occupation force; back harness	DISORDER	Previous research has classified the occupation of sheep shearing as heavy work where shearers. ex their spine and hips for long periods of time, handle awkward loads and expend high amounts of energy. The aim of this research was to investigate the magnitude of spinal forces produced during the shearing phase of the work and to determine whether the use of a commercially available back support harness would reduce these forces. Following discussion on task complexity and risk of back injury with senior shearing instructors, three component tasks of the shearing phase were identified as posing high risk of injury and were prioritized for primary analysis. Although the dragging out of a sheep in preparation for shearing and an unexpected loss of animal control were also identified as being of high risk, technological and instrumentation difficulties precluded their analysis. Twelve experienced shearers were videotaped while shearing with and without the use of a back harness. Surface mounted retro-reflective markers placed on the trunk defined three linked segments: Pelvis, Lumbar and Head, Arms, and Upper Trunk (HAUT). A 3D, link segment, top down, inverse dynamics approach was used to describe the motion and to estimate forces involved during the identified tasks of shearing. The spinal force/time profiles of this sample of shearers demonstrated large compressive and shear forces for all three tasks that are close to the NIOSH and University of Waterloo action limits for compressive and shear forces respectively ( McGill 1997, Yingling and McGill 1999, Marras 2000). The use of the back support harness reduced these forces by substantial and statistically significant amounts. This effect was consistent across all three tasks. The results of this study demonstrate the production of high levels of compressive and shear forces within the spine of shearers during the three shearing tasks studied and that the use of a back support harness can substantially reduce these forces. Therefore the use of a back harness may reduce the cumulative load on the spine during shearing thereby moderating damage to the articular structures. However it is not known whether the harness would protect the spine from a sudden or unexpected force.	Univ Otago, Sch Physiotherapy, Dunedin, New Zealand; Univ Otago, Sch Phys Educ, Dunedin, New Zealand; Univ Otago, Injury Prevent Res Unit, Dunedin, New Zealand	Milosavljevic, S (corresponding author), Univ Otago, Sch Physiotherapy, Dunedin, New Zealand.	smilosavljevic@gandalf.otago.ac.nz	Milosavljevic, Stephan/AAR-6127-2021	Milosavljevic, Stephan/0000-0001-8938-5290			*ACC, 2001, UNPUB STAT DAT BACK; Adams MA, 1996, SPINE, V21, P434, DOI 10.1097/00007632-199602150-00006; Adams MA, 1996, CLIN BIOMECH, V11, P194, DOI 10.1016/0268-0033(96)00002-2; ADAMS MA, 1995, CLIN BIOMECH, V10, P3, DOI 10.1016/0268-0033(95)90432-9; Allard P., 1995, 3 DIMENSIONAL ANAL H; BERNARD P, 1997, MUSCULOSKELETAL DISO; Bogduk N., 1997, CLIN ANATOMY LUMBAR, V3rd ed; CULVENOR J, 1993, THESIS LA TROBE U ME; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Dempsey PG, 1998, ERGONOMICS, V41, P73, DOI 10.1080/001401398187332; Firth H, 2002, J OCCUP HLTH SAF AUS, V18, P167; Granata KP, 1999, ERGONOMICS, V42, P1187, DOI 10.1080/001401399185072; HARLICK J, 2000, P 7 SCI C INT FED OR, P201; Harvey JT, 2002, APPL ERGON, V33, P523, DOI 10.1016/S0003-6870(02)00071-6; Lavender SA, 2003, INT J IND ERGONOM, V31, P51, DOI 10.1016/S0169-8141(02)00174-9; Lower T., 2000, J OCCUP HEALTH, V16, P117; MARRAS WS, 1995, ERGONOMICS, V38, P377, DOI 10.1080/00140139508925111; Marras WS, 2000, ERGONOMICS, V43, P880, DOI 10.1080/001401300409080; MARSHALL RN, 1995, UNPUB BIOMECHANICAL; McGill SM, 1997, J BIOMECH, V30, P465, DOI 10.1016/S0021-9290(96)00172-8; McGill SM, 1993, CURRENT ISSUES BIOME, P69; MILOSAVLJEVIC S, 2000, P 7 SCI C INT FED OR, P323; MILOSAVLJEVIC S, 2000, P 7 SCI C INT FED OR, P319; MILOSAVLJEVIC S, 1998, THESIS U OTAGO DUNED; PAYNE W, 1998, ERGONOMICS SHEEP SHE; PAYNE W, 2002, J OCCUP HEALTH, V18, P173; POOLE PM, 1983, SEARCH, V14, P103; ROSS BH, 1988, P U OT MED SCH, P17; ROWLAND G, 2002, COMMUNICATION; SANKEY K, 1997, UNPUB TABLES NZ RESI; Shadbolt N. R., 1995, EVALUATION HUMAN WOR, P406; Singer KP, 2000, CLINICAL ANATOMY AND MANAGEMENT OF THORACIC SPINE PAIN, VOL 2, P100; Twomey L, 1994, Aust J Physiother, V40S, P19, DOI 10.1016/S0004-9514(14)60620-6; WILSON NC, 1991, BODY SIZE SHAPE NZ; Winter D.A., 1990, BIOMECHANICS MOTOR C, V2nd; Yingling VR, 1999, SPINE, V24, P1882, DOI 10.1097/00007632-199909150-00004	36	14	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0014-0139			ERGONOMICS	Ergonomics	SEP 15	2004	47	11					1208	1225		10.1080/00140130410001699155			18	Engineering, Industrial; Ergonomics; Psychology, Applied; Psychology	Engineering; Psychology	846XA	WOS:000223351600005	15370857				2021-06-18	
J	Soustiel, JF; Shik, V; Findlay, JM				Soustiel, JF; Shik, V; Findlay, JM			Posttraumatic basilar artery vasospasm	SURGICAL NEUROLOGY			English	Article						head injury; subarachnoid hemorrhage; vasospasm; transcranial Doppler	TRAUMATIC SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER ULTRASOUND; CEREBRAL BLOOD-FLOW; HEAD-INJURY; VERTEBROBASILAR VASOSPASM; VELOCITY-MEASUREMENTS; PRACTICAL SCALE; BRAIN-DAMAGE; SPASM; ULTRASONOGRAPHY	BACKGROUND During the past decade, vasospasm following posttraumatic subarachnoid hemorrhage (tSAH) has drawn increasing attention. However, despite accumulating evidence linking this phenomenon with poorer outcome, the clinical significance of posttraumatic vasospasm is still debated and often disputed, so that no definite therapeutic attitude has yet been adopted. Recent attention has been drawn to basilar vasospasm, suggesting a negative influence on neurologic outcome. The aim of the present study was the evaluation of basilar vasospasm as an independent factor of secondary brain damage following posttraumatic hemorrhage. METHODS Daily transcranial Doppler (TCD) evaluations were conducted in 93 consecutive patients with tSAH. Basilar artery (BA) vasospasm was defined by blood flow velocity (FV) higher than 85 cm/s for at least 2 consecutive days. RESULTS Thirty-two patients (34.4%) had BA FVs higher than 85 cm/s. In those patients, the ratio between BA FV and mean vertebral artery FV was higher than 2.5 and below 2 and those without TCD signs of vasospasm. Using multivariate logistic regression analysis, BA vasospasm proved to independently influence neurologic outcome. CONCLUSIONS BA vasospasm severe enough to compromise cerebral blood flow to the brainstem, although uncommon, may nevertheless have a potential deleterious effect on neural tissue sensitized by trauma. The present results suggest that specific imaging procedures and eventually therapeutic measures should be conducted in the presence of significant BA vasospasm. (C) 2004 Elsevier Inc. All rights reserved.	Technion Israel Inst Technol, Fac Med, Rambam Med Ctr, Dept Neurosurg, IL-31096 Haifa, Israel	Soustiel, JF (corresponding author), Technion Israel Inst Technol, Fac Med, Rambam Med Ctr, Dept Neurosurg, POB 9602, IL-31096 Haifa, Israel.						AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; ADAMS JH, 1982, RECENT ADV NEUROPATH, V2, P165; ALEXANDER MJ, 1994, ACTA NEUROCHIR, P479; ECHLIN FA, 1965, J NEUROSURG, V23, P1, DOI 10.3171/jns.1965.23.1.0001; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fujioka KA., 1992, TRANSCRANIAL DOPPLER, P9; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; GAETANI P, 1994, J NEUROL NEUROSUR PS, V57, P66, DOI 10.1136/jnnp.57.1.66; HUTCHISON KJ, 1995, ULTRASOUND MED BIOL, V21, P447, DOI 10.1016/0301-5629(94)00144-3; JENNETT B, 1975, LANCET, V1, P480; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LAUMER R, 1993, NEUROSURGERY, V33, P1, DOI 10.1227/00006123-199307000-00001; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; MARSHALL LF, 1978, J NEUROSURG, V48, P560, DOI 10.3171/jns.1978.48.4.0560; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SANDER D, 1993, J NEUROL SCI, V119, P1, DOI 10.1016/0022-510X(93)90185-2; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Sloan M. A., 1997, NEW TRENDS CEREBRAL, P221; SLOAN MA, 1994, STROKE, V25, P2187, DOI 10.1161/01.STR.25.11.2187; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Soustiel JF, 2002, STROKE, V33, P72, DOI 10.1161/hs0102.100484; Soustiel JF, 1998, NEUROSURGERY, V43, P282, DOI 10.1097/00006123-199808000-00061; Soustiel JF, 2001, STROKE, V32, P629, DOI 10.1161/01.STR.32.3.629; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; TEASDALE G, 1974, LANCET, V2, P81; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	33	14	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	SEP	2004	62	3					201	206		10.1016/j.surneu.2003.10.037			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	850PM	WOS:000223624900008	15336858				2021-06-18	
J	Bushnik, T; Englander, J; Duong, T				Bushnik, T; Englander, J; Duong, T			Medical and social issues related to posttraumatic seizures in persons with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						epilepsy; late posttraumatic seizures; outcomes; traumatic brain injury	QUALITY-OF-LIFE; TEMPORAL-LOBE EPILEPSY; PSYCHOSOCIAL CONSEQUENCES; DRIVING RESTRICTIONS; ANTIEPILEPTIC DRUGS; RISK-FACTORS; HEAD TRAUMA; PEOPLE; CARBAMAZEPINE; EMPLOYMENT	Background: The incidence of late posttraumatic seizures (LPTS) in individuals with traumatic brain injury (FBI) ranges anywhere from 5% to 18.9% in civilian populations up to 32% to 50% in military personnel. Objective: This article reviews the current knowledge about the incidence and prevalence of LPTS following a TBI, the risk factors for developing LPTS, and the options available for preventing the development of LPTS. Methods: The psychosocial ramifications of LPTS following a TBI have not been well explored. As a result, the psychosocial findings from the current literature on epilepsy will be reviewed with the hope that the need for future TBI outcomes research to investigate the impact of LPTS following a TBI or, at least, to include LPTS as a potential contributing. factor will be recognized.	Santa Clara Valley Med Ctr, No Calif TBI Model Syst Car, San Jose, CA 95128 USA	Bushnik, T (corresponding author), Santa Clara Valley Med Ctr, No Calif TBI Model Syst Car, 751 S Bascom Ave, San Jose, CA 95128 USA.	tamara@tbi-sci.org		Bushnik, Tamara/0000-0003-3328-257X			Andermann L, 1992, Seizure, V1, P173, DOI 10.1016/1059-1311(92)90021-R; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; ARMSTRONG KK, 1990, ARCH PHYS MED REHAB, V71, P156; Ascroft PB, 1941, BMJ-BRIT MED J, V1941, P739, DOI 10.1136/bmj.1.4193.739; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Beghi E, 2000, EPILEPSIA, V41, P998; Berto P, 2002, PHARMACOECONOMICS, V20, P1039, DOI 10.2165/00019053-200220150-00002; *BRAIN TRAUM FDN I, 2000, MAN PROGN SEV TRAUM, P159; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Breier JI, 1998, ARCH NEUROL-CHICAGO, V55, P660, DOI 10.1001/archneur.55.5.660; BULLOCK R, 1995, GUIDELINES MANAGEMEN; CALLAGHAN N, 1992, IRISH MED J, V85, P17; Carroll D, 1992, Seizure, V1, P127, DOI 10.1016/1059-1311(92)90010-X; CAVENESS WF, 1961, EPILEPSIA, V2, P123; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Chadwick DW, 2001, NEUROLOGY, V57, P1749, DOI 10.1212/WNL.57.10.1749; Collings J A, 1994, Seizure, V3, P255, DOI 10.1016/S1059-1311(05)80172-4; Couldridge L, 2001, SEIZURE-EUR J EPILEP, V10, P605, DOI 10.1053/seiz.2001.0652; COURJON J, 1970, EPILEPSIA, V11, P29, DOI 10.1111/j.1528-1157.1970.tb03863.x; DASILVA AM, 1990, ACT NEUR S, V50, P48; De Santis A, 1979, J Neurosurg Sci, V23, P207; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Engelberts NHJ, 2002, J NEUROL, V249, P294, DOI 10.1007/s004150200008; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Fisher RS, 2000, EPILEPSY RES, V41, P39, DOI 10.1016/S0920-1211(00)00126-1; Gilliam F, 1997, EPILEPSIA, V38, P233, DOI 10.1111/j.1528-1157.1997.tb01102.x; GLOTZNER FL, 1983, NEUROCHIRURGIA, V26, P66; Grafman J, 1992, Adv Neurol, V57, P369; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; Haltiner A M, 1996, J Int Neuropsychol Soc, V2, P494; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; Hartshorn J C, 1994, J Neurosci Nurs, V26, P288; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; HERMANN BP, 1990, BRIT J PSYCHIAT, V156, P98, DOI 10.1192/bjp.156.1.98; HERMANN BP, 1992, J EPILEPSY, V5, P153, DOI 10.1016/S0896-6974(05)80134-3; ISOJARVI JIT, 1990, ARCH NEUROL-CHICAGO, V47, P670, DOI 10.1001/archneur.1990.00530060082023; JENNETT B, 1973, SCOT MED J, V18, P8, DOI 10.1177/003693307301800103; Jennett B, 1975, EPILEPSY NONMISSILE; Jokeit H, 1999, J NEUROL NEUROSUR PS, V67, P44, DOI 10.1136/jnnp.67.1.44; JONES KL, 1989, NEW ENGL J MED, V320, P1661, DOI 10.1056/NEJM198906223202505; KANEKO S, 1988, EPILEPSIA, V29, P459, DOI 10.1111/j.1528-1157.1988.tb03746.x; KOLLEVOLD T, 1978, J OSLO CITY HOSP, V2, P78; Krauss GL, 2001, NEUROLOGY, V57, P1780, DOI 10.1212/WNL.57.10.1780; Krauss GL, 1999, NEUROLOGY, V52, P1324, DOI 10.1212/WNL.52.7.1324; Lehrner J, 1999, SEIZURE-EUR J EPILEP, V8, P88, DOI 10.1053/seiz.1999.0272; Leidy NK, 1999, NEUROLOGY, V53, P162, DOI 10.1212/WNL.53.1.162; LIPMAN LJ, 1994, EPILEPSIA, V35, P696; MOORE PM, 1994, EPILEPSY RES, V18, P75, DOI 10.1016/0920-1211(94)90035-3; Moore PM, 2002, SEIZURE-EUR J EPILEP, V11, P224, DOI 10.1053/seiz.2001.0668; O'Donoghue MF, 1999, BRIT J GEN PRACT, V49, P211; PAILLAS JE, 1970, EPILEPSIA, V11, P5, DOI 10.1111/j.1528-1157.1970.tb03860.x; RAMSAY RE, 1991, EPILEPSIA, V32, pS60, DOI 10.1111/j.1528-1157.1991.tb05894.x; REYNOLDS EH, 1985, DRUGS, V29, P570, DOI 10.2165/00003495-198529060-00004; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SALAZAR AM, 1987, ADV EPILEPTOL, V16, P627; SALINSKY MC, 1992, EPILEPSIA, V33, P469, DOI 10.1111/j.1528-1157.1992.tb01693.x; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; SMITH DF, 1991, EPILEPSY RES, V9, P231, DOI 10.1016/0920-1211(91)90057-M; STANDAGE KF, 1975, PSYCHOL MED, V5, P152, DOI 10.1017/S0033291700056403; Strauss E, 1995, J CLIN EXP NEUROPSYC, V17, P909, DOI 10.1080/01688639508402439; Suurmeijer TPBM, 2001, EPILEPSIA, V42, P1160, DOI 10.1046/j.1528-1157.2001.37000.x; TEDMAN S, 1995, SEIZURE, V4, P221, DOI 10.1016/S1059-1311(05)80065-2; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WALKER AE, 1959, J NEUROSURG, V16, P600, DOI 10.3171/jns.1959.16.6.0600; WALKER AE, 1970, EPILEPSIA, V11, P17, DOI 10.1111/j.1528-1157.1970.tb03861.x; WALKER AE, 1961, FOLLOW UP STUDY HEAD; Wiebe S, 1999, CAN J NEUROL SCI, V26, P263, DOI 10.1017/S0317167100000354; Yablon SA, 1998, ARCH PHYS MED REHAB, V79, P594; 2001, MORB MORTAL WKLY REP, V50, P24	74	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2004	19	4					296	304		10.1097/00001199-200407000-00004			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	839CB	WOS:000222759800004	15263857				2021-06-18	
J	Chotel, F; Vallese, P; Parot, R; Laville, JM; Hodgkinson, I; Muller, C; Berard, J				Chotel, F; Vallese, P; Parot, R; Laville, JM; Hodgkinson, I; Muller, C; Berard, J			Complete dislocation of the radial head following fracture of the radial neck in children: the Jeffery type II lesion	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						radial neck fracture; dislocation; child; Jeffery type 2; mechanism; complication	REDUCTION; EPIPHYSIS	The authors report four cases of Jeffery type 2 lesions in children. Despite the probable mechanism of such lesions, none of the cases reported here displayed a dislocation of the elbow. In the first observation the diagnosis was suspected only 15 days after injury. Two other cases were initially treated by closed external manipulations, one with percutaneous Kirschner wire leverage and the other with closed intramedullary pinning, but both cases displayed a 180 degrees reversal of the radial head, suspected only secondarily. The first exhaustive review of the literature on the subject, shows that this complication is classical in Jeffery type 2 fractures. In fact none of the 22 cases described in the literature had successfully been reduced by external manipulations. Interposition of the lateral condyle, pathognomonic of the Jeffery type 2 fracture, hampers reduction. Attempts at reduction by external manipulation in nine cases therefore led to two non-reduction and seven reversal of the radial head. Knowledge of this particular fracture will allow an early diagnosis and an immediate surgical treatment. (c) 2004 Lippincott Williams & Wilkins.	Hop Debrousse, Praticien Hosp, Dept Paediat Orthopaed, 29 Rue Soeurs Bouvier, F-69322 Lyon, France; Bellepierre Univ Hosp, Dept Paediat Surg, St Denis Messageries, Reunion, France; S Lyon Hosp, Ctr Paediat Funct Rehabil, Pierre Benite, France; Bois Abbaya Hosp, Seraing, Belgium	Chotel, F (corresponding author), Hop Debrousse, Praticien Hosp, Dept Paediat Orthopaed, 29 Rue Soeurs Bouvier, F-69322 Lyon, France.						ACHDJIAN M, 1972, PAEDIAT ORTHOPEDICS, V2; BAHER FH, 1932, NEW ENGL J MED, V206, P1263; CHAMBERS HG, 1996, FRACTURES CHILDREN, V3, P586; DORMANS JP, 1990, ORTHOP CLIN N AM, V21, P257; FRASER KE, 1995, J BONE JOINT SURG AM, V77A, P782, DOI 10.2106/00004623-199505000-00016; Jeffery C C, 1972, J Bone Joint Surg Br, V54, P717; JEFFERY CC, 1950, J BONE JOINT SURG BR, V32, P314; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; NEWMAN JH, 1977, INJURY, V9, P114, DOI 10.1016/0020-1383(77)90004-3; O'Brien P I, 1965, Clin Orthop Relat Res, V41, P51; RANG M, 1974, CHILDRENS FRACTURE, P112; REIDY JA, 1963, J BONE JOINT SURG AM, V45, P1355, DOI 10.2106/00004623-196345070-00002; Schwartz RP, 1933, SURG GYNECOL OBSTET, V57, P528; Shtarker H, 2001, J PEDIATR ORTHOP B, V10, P331; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; WARD WT, 1991, J TRAUMA, V31, P1686, DOI 10.1097/00005373-199112000-00020; WATSONJONES R, 1996, FRACTURE JOINT INJUR; WILKINS KE, 1994, OPERATIVE MANGEMENT; Wong-Chung J, 1997, INJURY, V28, P559, DOI 10.1016/S0020-1383(97)00096-X; WOOD S K, 1969, Journal of Bone and Joint Surgery British Volume, V51, P707; WRAY CC, 1989, INJURY, V20, P241, DOI 10.1016/0020-1383(89)90126-5	21	14	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2004	13	4					268	274		10.1097/01.bpb.0000111050.85604.f1			7	Orthopedics; Pediatrics	Orthopedics; Pediatrics	916WX	WOS:000228418400009	15199284				2021-06-18	
J	Lundblad, C; Grande, PO; Bentzer, P				Lundblad, C; Grande, PO; Bentzer, P			A mouse model for evaluation of capillary perfusion, microvascular permeability, cortical blood flow, and cortical edema in the traumatized brain	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; capillary perfuison; cerebral blood flow; edema; microvascular permeability; secondary injury and ischemia	CEREBRAL-ARTERY OCCLUSION; LOW-DOSE PROSTACYCLIN; HEAD-INJURY; IMPACT INJURY; RAT; TRANSPORT; CONTUSION; ISCHEMIA; DEXTRAN; BARRIER	Genetically engineered mice have successfully been used to investigate molecular and cellular mechanisms associated with cell dysfunction following brain trauma. Such animals may also offer a possibility to investigate mechanisms involved in posttraumatic hemodynamic alterations. The objective of the study was to establish a mouse model in which important hemodynamic alterations following trauma could be analyzed. C57/BL6 male mice were subjected to controlled cortical impact injury (CCI) or sham-injury. Distribution of blood flow was estimated by determining number of perfused capillaries using FITC-dextran as an intravascular marker. Cortical blood flow was measured using [C-14]-iodoantipyrine, brain water content (BWC) was measured using a wet vs. dry weight method, and permeability surface area product (PS) was estimated by the transfer constant for [Cr-51]-EDTA. Number of perfused capillaries in the contusion area was progressively reduced during the first 24 h following trauma by at most 60% relative to a value of 329 +/- 61/mm(2) in sham-injured animals. Blood flow in the contusion area decreased simultaneously by at most 50% relative to a control value of 1.8 +/- 0.4 mL (.) min(-1) (.) g(-1), and was reduced further in subregions within the contusion area. BWC in the injured hemisphere increased from 79.3 +/- 0.5% at control to at most 79.9 +/- 0.6% at 24 h post trauma. PS in the injured hemisphere increased by 71% at 3 h post trauma relative to a control value of 0.45 +/- 0.1 muL (.) min(-1.) g(-1), and was close to control at 24 h. The present study demonstrates that brain trauma in addition to a reduction in cortical blood flow, reduces number of perfused capillaries, which most likely affects exchange of nutrients and fluid. The CCI in mouse is likely to be a useful tool to elucidate mechanisms involved in hemodynamic alterations following brain trauma.	Lund Univ, Dept Psychol Sci, SE-22184 Lund, Sweden; Lund Univ, Dept Anesthesia & Intens Care, SE-22184 Lund, Sweden; Univ Lund Hosp, S-22185 Lund, Sweden	Lundblad, C (corresponding author), Lund Univ, Dept Psychol Sci, BMC F11, SE-22184 Lund, Sweden.	Cornelia.Lundblad@mphy.lu.se		Lundblad, Cornelia/0000-0001-9686-2112			ARAKAWA M, 1990, CIRC RES, V67, P852, DOI 10.1161/01.RES.67.4.852; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bentzer P, 2003, J NEUROTRAUM, V20, P447, DOI 10.1089/089771503765355522; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BLASBERG RG, 1983, J CEREBR BLOOD F MET, V3, P8, DOI 10.1038/jcbfm.1983.2; BRYAN RM, 1995, ANESTH ANALG, V80, P687, DOI 10.1097/00000539-199504000-00007; BULLOCK R, 1990, ACT NEUR S, V51, P286; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; FENSTERMACHER JD, 1981, PHARMACOL THERAPEUT, V14, P217, DOI 10.1016/0163-7258(81)90062-0; FENSTERMACHER JD, 1984, EDEMA, P383; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859; GOBEL U, 1989, J CEREBR BLOOD F MET, V9, P491; GOBEL U, 1990, CIRC RES, V66, P271, DOI 10.1161/01.RES.66.2.271; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; Grande PO, 1997, J TRAUMA, V42, pS23, DOI 10.1097/00005373-199705001-00005; Gueniau C, 1997, J PHARMACOL EXP THER, V282, P1; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Holbeck S, 2001, CRIT CARE MED, V29, P123, DOI 10.1097/00003246-200101000-00025; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; Kochanek OM, 1995, J NEUROTRAUM, V12, P1015, DOI 10.1089/neu.1995.12.1015; LARSSON M, 1980, ACTA PHYSIOL SCAND, V110, P53, DOI 10.1111/j.1748-1716.1980.tb06629.x; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Maeda K, 2000, J CEREBR BLOOD F MET, V20, P10, DOI 10.1097/00004647-200001000-00003; Maeda T, 1997, ACT NEUR S, V70, P102; MIES G, 1991, J CEREBR BLOOD F MET, V11, P753, DOI 10.1038/jcbfm.1991.132; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Naredi S, 2001, ACTA ANAESTH SCAND, V45, P402, DOI 10.1034/j.1399-6576.2001.045004402.x; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petrov T, 2001, NEUROL RES, V23, P139, DOI 10.1179/016164101101198479; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Renkin E. M., 1984, HDB PHYSL 2, VIV, P627; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59; SARNA GS, 1977, BRAIN RES, V138, P550, DOI 10.1016/0006-8993(77)90692-8; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Steinbauer M, 1998, SHOCK, V9, P345, DOI 10.1097/00024382-199805000-00006; VILLRINGER A, 1994, CIRC RES, V75, P55, DOI 10.1161/01.RES.75.1.55; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; WANIEWSKI J, 1992, NEPHROL DIAL TRANSPL, V7, P50; WEISS HR, 1988, MICROVASC RES, V36, P172, DOI 10.1016/0026-2862(88)90017-9; Wellons JC, 2000, BRAIN RES, V868, P14, DOI 10.1016/S0006-8993(00)02216-2; Whalen MJ, 2000, J LEUKOCYTE BIOL, V67, P160; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yang GY, 1997, BRAIN RES, V751, P181, DOI 10.1016/S0006-8993(96)01277-2; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; Zoccoli G, 2000, EXP BRAIN RES, V130, P73	52	14	14	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2004	21	6					741	753		10.1089/0897715041269614			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	836EG	WOS:000222537600010	15253802				2021-06-18	
J	McCrory, P; Turner, M; Murray, J				McCrory, P; Turner, M; Murray, J			A punch drunk jockey?	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							APOLIPOPROTEIN-E EPSILON-4; TRAUMATIC BRAIN-INJURY; DAMAGE; AFTERMATH	The case is reported of a retired professional jockey with progressive memory loss. The concern is that he may be suffering from chronic traumatic encephalopathy or the "punch drunk syndrome''.	Jockey Club, London W1H 6EN, England; British Journal Sports Med, Melbourne, Vic, Australia	Turner, M (corresponding author), Jockey Club, 42 Portman Sq, London W1H 6EN, England.	mturner@thejockeyclub.co.uk	McCrory, Paul/Q-8688-2019				CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; FOSTER JB, 1976, LANCET, V1, P981; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Jordan B. D., 1998, SPORTS NEUROLOGY, P351; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; JORDAN BD, 1995, ANN NEUROL, V38, P698, DOI 10.1002/ana.410380429; JORDAN BD, 1993, MED ASPECTS BOXING; LEVIN HS, 1993, MED ASPECTS BOXING, P197; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2002, BRIT J SPORT MED, V36, P157, DOI 10.1136/bjsm.36.3.157; Moseley IF, 2000, NEURORADIOLOGY, V42, P1, DOI 10.1007/s002340050001; NICHOLL JAR, 1995, NAT MED, V1, P135; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Turner M, 2002, BRIT J SPORT MED, V36, P403, DOI 10.1136/bjsm.36.6.403	21	14	14	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JUN 1	2004	38	3							e3	10.1136/bjsm.2003.006338			3	Sport Sciences	Sport Sciences	823CD	WOS:000221586400039	15155454	Bronze, Green Published			2021-06-18	
J	Chapman, HR; Curran, ALM				Chapman, HR; Curran, ALM			Bicycle helmets - does the dental profession have a role in promoting their use?	BRITISH DENTAL JOURNAL			English	Article							MILD HEAD-INJURY; SAFETY HELMETS; EARLY ADULTHOOD; FACIAL INJURY; CYCLISTS; PREVENTION; CHILDREN; LEGISLATION; ADOLESCENTS; TRAUMA	Objectives To review the available literature regarding the: epidemiology of bicycle related head injuries; consequences of head injuries; rates of cycle helmet use; impact of educational campaigns and legislation on usage rates; effectiveness of cycle helmets in protecting against head and facial injuries; arguments against the compulsory use of bicycle helmets Data sources A computerised Medline search was conducted using the keywords: head injury, facial injury, bicycle helmets, accidents. Data selection All available information was considered. Data synthesis Data was collated manually. Conclusions The wearing of bicycle helmets contributes significantly to the prevention of head injuries (HI) and traumatic brain injury (TBI), particularly in children and adolescents. There is evidence to support the role of cycle helmets in the prevention of injuries to the middle third of the face and some dental injuries. There is a case for the implementation of legislation accompanied by educational campaigns to increase significantly the use of cycle helmets. The dental profession could: play an active role in promoting cycle helmet use; support calls for the compulsory wearing of cycling helmets, particularly for children; press for modification of helmet design and standards to increase protection of the face.	Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England	Chapman, HR (corresponding author), 8 Millais Court,Manor Fields, Horsham RH13 6SJ, W Sussex, England.	helen.chapman@tesco.net	Chapman, Helen/AAM-4204-2021	Chapman, Helen/0000-0001-7699-9832			Acton C H, 1995, Inj Prev, V1, P86, DOI 10.1136/ip.1.2.86; Acton CHC, 1996, MED J AUSTRALIA, V165, P249, DOI 10.5694/j.1326-5377.1996.tb124957.x; Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; *BMA BOARD SCI ED, 1999, CYCL HELM; Bogan AM, 1997, BRAIN INJURY, V11, P431; Caplow MP, 1995, AM J PREV MED, V11, P371; Cook A, 2000, BRIT MED J, V321, P1055, DOI 10.1136/bmj.321.7268.1055; Deb S, 1998, J NEUROL NEUROSUR PS, V65, P899, DOI 10.1136/jnnp.65.6.899; *DEP TRANSP LOC GO, 2003, ROAD ACC GREAT BRIT; *DEP TRANSP LOC GO, 2001, ROAD ACC GREAT BRIT; Harrison MG, 1999, J ROY COLL SURG EDIN, V44, P82; Hillman M, 1997, BRIT MED J, V315, P490, DOI 10.1136/bmj.315.7106.490; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jennett B, 1989, MILD HEAD INJURY, P23; Lee A J, 2000, Inj Prev, V6, P151, DOI 10.1136/ip.6.2.151; LEE AJ, 1120 BHIT; LI GH, 1995, J TRAUMA, V38, P871, DOI 10.1097/00005373-199506000-00007; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; Mann N.P., 1999, CURR PAEDIAT, V9, P173; MARSDEN CD, 1998, CLIN NEUROLOGY, P272; MCDERMOTT FT, 1995, ANN ROY COLL SURG, V77, P38; MCDERMOTT FT, 1993, J TRAUMA, V34, P834, DOI 10.1097/00005373-199306000-00015; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, P28; Moss NEG, 1996, INJURY, V27, P159, DOI 10.1016/0020-1383(95)00217-0; Ni HY, 1997, ARCH PEDIAT ADOL MED, V151, P59, DOI 10.1001/archpedi.1997.02170380063010; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Quine L, 2001, BRIT J HEALTH PSYCH, V6, P327, DOI 10.1348/135910701169241; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293; RIVARA FP, 1994, PEDIATRICS, V93, P567; ROBINSON DL, 1996, ACCIDENT ANAL PREV, V28, P473; ROURKE LL, 1994, CAN FAM PHYSICIAN, V40, P1116; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Scuffham PA, 1997, ACCIDENT ANAL PREV, V29, P1, DOI 10.1016/S0001-4575(96)00054-1; SHARPLES PM, 1990, BRIT MED J, V301, P1193, DOI 10.1136/bmj.301.6762.1193; Sosin DM, 1996, PEDIATRICS, V98, P868; SPAITE DW, 1991, J TRAUMA, V31, P1510, DOI 10.1097/00005373-199111000-00008; TAKRITI R, 2000, 1125 BHIT; TAKRITI R, 1999, INITIATING BICYCLE H; Talamonti G, 1995, ACTA NEUROCHIR, V137, P164, DOI 10.1007/BF02187189; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1471, DOI 10.2105/AJPH.80.12.1471; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1968, DOI 10.1001/jama.276.24.1968; THOMPSON DC, 2001, COCHRANE LIB; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; WIEDERHOLT WC, 2000, NEUROLOGY NONNEUROLO, P297; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	48	14	16	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0007-0610			BRIT DENT J	Br. Dent. J.	MAY 8	2004	196	9					555	560		10.1038/sj.bdj.4811227			6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	818OU	WOS:000221255200019	15131627	Bronze			2021-06-18	
J	Prigatano, GP				Prigatano, GP			Challenging dogma in neuropsychology and related disciplines	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article; Proceedings Paper	21st Annual Conference of the National-Academy-of-Neuropsychology	OCT 31-NOV 03, 2001	SAN FRANCISCO, CALIFORNIA	Natl Acad Neuropsychol		neuropsychology; psychotherapy; self-awareness; rehabilitation; dogma	TRAUMATIC BRAIN-INJURY; REHABILITATION; AWARENESS	Challenging "dogmas" in neuropsychology and related fields is important for the advancement of our professional development. Five dogmas that I have found worth challenging are reviewed in this article. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA	Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.						Bowlby J., 1973, ATTACHMENT LOSS, VII; BRODAL A, 1973, BRAIN, V96, P675, DOI 10.1093/brain/96.4.675; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Damasio A, 2000, PRINCIPLES BEHAV COG, P294; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; Johnson S. C., 2000, BNI Q, V16, P37; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Klonoff PS, 2000, ARCH PHYS MED REHAB, V81, P1535, DOI 10.1053/apmr.2000.9177; Kuhn TS., 1970, STRUCTURE SCI REVOLU; LURIA AR, 1966, HIGHER CEREBRAL FUNC; MAUSEAU C, 1995, SEVERE TRAUMATIC BRA; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Mesulam MM, 2000, PRINCIPLES BEHAV COG, P1; MOORE JC, 1986, RECOVERY FUNCTION TH, P9; Ogden R, 1917, PSYCHOBIOLOGY, V1, P33, DOI [10.1037/h0074814, DOI 10.1037/H0074814]; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; Prigatano GP, 2000, JAMA-J AM MED ASSOC, V284, P1783, DOI 10.1001/jama.284.14.1783; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Prigatano GP, 1999, J HEAD TRAUMA REHAB, V14, P308, DOI 10.1097/00001199-199906000-00009; PRIGATANO GP, 1982, J NEUROL NEUROSUR PS, V45, P78, DOI 10.1136/jnnp.45.1.78; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P847, DOI 10.1016/S0003-9993(97)90198-2; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; PRIGATANO GP, 2001, BNI Q, V17, P21; Prigatano GP, 1994, BRAIN INJURY NEUROPS, P173; PRIGATANO GP, 1991, BARROW NEUROLOGICAL, V7, P17; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schacter DL., 1991, AWARENESS DEFICIT BR, P17; WINTER R, 1991, STAR TREK 6	34	14	14	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2003	18	8					811	825	PII S0887-6177(02)00205-6	10.1016/S0887-6177(02)00205-6			15	Psychology, Clinical; Psychology	Psychology	747WZ	WOS:000186830200001	14609578				2021-06-18	
J	Ross, SR; Putnam, SH; Gass, CS; Bailey, DE; Adams, KM				Ross, SR; Putnam, SH; Gass, CS; Bailey, DE; Adams, KM			MMPI-2 indices of psychological disturbance and attention and memory test performance in head injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						MMPI-2; litigation; head injury; attention; memory	NEUROPSYCHOLOGICAL DEFICITS; SYMPTOMS; CONCUSSION; LITIGATION; IMPAIRMENT; TRAUMA	A number of studies have investigated the relationship between psychological disturbance and neuropsychological (NP) test performance. The current study is a replication and extension of Gass (1996) who found that MMPI-2 indices of psychological disturbance are related to performance on NP tests of attention and memory in psychiatric and head-injured patients. In a large sample (N = 381) referred for evaluation after sustaining presumed head injury, we examined the relationship between MMPI-2 indices of psychological disturbance and measures of attention and memory from the Wechsler Memory Scale-Revised (WMS-R; Wechsler, 1987), Wechsler Adult Intelligence Scale-Revised (WAIS-R; Wechsler, 1981), California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987), and the Memory Assessment Scales (MAS; Williams, 1991). Although related to other domains, MMPI-2 variables were most consistently related to measures of attention and List Learning. Even when demographic variables, injury severity, and litigation status were controlled, MMPI-2 indices significantly predicted performance on six out of eight tests. However, the correspondence between similar indices on the WMS-R and MAS were relatively low, especially for Verbal Memory and Visual Reproduction. Further, litigation was significant in predicting only 2 of 8 attention and memory indices. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved.	Depauw Univ, Dept Psychol, Greencastle, IN 46135 USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA; Vet Adm Med Ctr, Miami, FL 33125 USA; Wayne State Univ, Med Ctr, Detroit, MI 48202 USA	Ross, SR (corresponding author), Depauw Univ, Dept Psychol, 7 Larabee St, Greencastle, IN 46135 USA.	srross@depauw.edu	Gass, Carlton/AAO-5906-2020				Berry DTR, 1995, PSYCHOL ASSESSMENT, V7, P517; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Binder LM, 1996, AM J PSYCHIAT, V153, P7; BURT DB, 1995, PSYCHOL BULL, V117, P285, DOI 10.1037/0033-2909.117.2.285; Delis DC, 1987, CALIFORNIA VERBAL LE; FEE CRA, 1988, ARCH EMERG MED, V5, P12; GASS CS, 1994, J CLIN PSYCHOL, V50, P586, DOI 10.1002/1097-4679(199407)50:4<586::AID-JCLP2270500414>3.0.CO;2-Z; Gass CS, 1996, PSYCHOL ASSESSMENT, V8, P135, DOI 10.1037/1040-3590.8.2.135; Golden CJ, 1999, ARCH CLIN NEUROPSYCH, V14, P265, DOI 10.1016/S0887-6177(98)00017-1; HILSABECK RC, 1996, ASSESSMENT, V3, P417; LEININGER B, 1992, REHABILITATION POST, P169; LEININGER B E, 1991, Brain Injury, V5, P199, DOI 10.3109/02699059109008090; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; MILLIS SR, 1994, J CLIN PSYCHOL, V50, P601, DOI 10.1002/1097-4679(199407)50:4<601::AID-JCLP2270500417>3.0.CO;2-9; MILLIS SR, 1994, PERCEPT MOTOR SKILL, V79, P384, DOI 10.2466/pms.1994.79.1.384; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; Putnam S. H., 1996, NEUROPSYCHOLOGICAL A, P529; Putzke JD, 1997, ASSESSMENT, V4, P365, DOI 10.1177/107319119700400407; Reitan RM, 1997, NEUROPSYCHOL REV, V7, P3, DOI 10.1007/BF02876970; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Tabachnik BG, 1996, USING MULTIVARIATE S; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WILLIAMS MJ, 1991, MEMORY ASSESSMENT SC; Wrobel NH, 1996, ARCH CLIN NEUROPSYCH, V11, P625; Youngjohn JR, 1997, PSYCHOL ASSESSMENT, V9, P177, DOI 10.1037/1040-3590.9.3.177	29	14	14	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2003	18	8					905	916	PII S0887-6177(02)00169-5	10.1016/S0887-6177(02)00169-5			12	Psychology, Clinical; Psychology	Psychology	747WZ	WOS:000186830200007	14609584	Bronze			2021-06-18	
J	Gottesman, RF; Komotar, R; Hillis, AE				Gottesman, RF; Komotar, R; Hillis, AE			Neurologic aspects of traumatic brain injury	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							DIFFUSE AXONAL INJURY; SUBARACHNOID HEMORRHAGE; CONSORTIUM SURVEY; HEAD-INJURY; MANAGEMENT; HYPOTHERMIA; HEMATOMA; IMPACT; VOLUME; DAMAGE	Traumatic brain injury is a common neurologic condition that can have a significant emotional and financial burden. Neurologic injury is classified on the basis of initial clinical status by the Glasgow Coma Scale, and also by the type and location of head injury. Complications in the management of these patients are reviewed, ranging from intracranial pressure management and stroke to post-traumatic epilepsy. In addition, predictive prognostic variables that can be used to predict outcome based on a patient's presentation at the time of a head trauma are discussed. Finally, interventions such as induced hypothermia that can be undertaken to try to optimize outcome, are discussed along with current data in support of or against such techniques.	Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Hillis, AE (corresponding author), Johns Hopkins Univ Hosp, Dept Neurol, Meyer 5-185,600 N Wolfe St, Baltimore, MD 21287 USA.	argye@jhmi.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Dolinak D, 2000, ACTA NEUROPATHOL, V100, P553, DOI 10.1007/s004010000218; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Fukuda T, 1998, NEUROSURGERY, V43, P1040, DOI 10.1097/00006123-199811000-00022; Greene KA, 1996, J TRAUMA, V41, P964, DOI 10.1097/00005373-199612000-00004; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; JENNETT B, 1975, LANCET, V1, P480; Jennett B, 2001, NEUROLOGY, V56, P486, DOI 10.1212/WNL.56.4.486; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kinoshita K, 2002, J NEUROTRAUM, V19, P681, DOI 10.1089/08977150260139075; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MEDINA JL, 1992, HEADACHE, V32, P180, DOI 10.1111/j.1526-4610.1992.hed3204180.x; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Muszynski CA, 1999, NEURORADIOLOGY, V41, P875, DOI 10.1007/s002340050859; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Paterniti S, 1998, ACTA NEUROCHIR, V140, P953, DOI 10.1007/s007010050198; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; SCHIERHOUT G, 2002, COCHRANE LIB; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Server A, 2001, ACTA RADIOL, V42, P254; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; van den Brink WA, 1999, ACTA NEUROCHIR, V141, P509, DOI 10.1007/s007010050332; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188	41	14	16	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	NOV	2003	15	4					302	309		10.1080/09540260310001606683			8	Psychiatry	Psychiatry	739UD	WOS:000186364100002	15276951				2021-06-18	
J	Moseley, AM; Yap, MC				Moseley, AM; Yap, MC			Interrater reliability of the TEMPA for the measurement of upper limb function in adults with traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adult; arm; brain injuries; functional assessment; interrater reliability; physical therapy	UPPER EXTREMITY PERFORMANCE; VALIDITY	Objective: To investigate the interrater reliability of the TEMPA in adults with traumatic brain injury (TBI). Participants: Twenty adults with upper limb dysfunction after TBI who were participating in inpatient rehabilitation. Design: The TEMPA assessment was videotaped for each participant and 5 physical therapists independently rated these video recordings. Main outcome measure: Functional rating and speed of execution for each item of the TEMPA. Results: Intra-class correlation coefficients (ICC) for the speed of execution and functional rating components of the TEMPA ranged from 0, 898 to 1.000. Conclusion: The excellent interrater reliability supports the use of the TEMPA in adults with TBI.	Univ Sydney, Fac Med, Rehabil Studies Unit, Dept Med, Ryde, NSW 1680, Australia	Moseley, AM (corresponding author), Univ Sydney, Fac Med, Rehabil Studies Unit, Dept Med, POB 6, Ryde, NSW 1680, Australia.						DESROSIERS J, 1995, ARCH PHYS MED REHAB, V76, P1125, DOI 10.1016/S0003-9993(95)80120-0; DESROSIERS J, 1994, OCCUP THER J RES, V14, P267, DOI 10.1177/153944929401400405; Desrosiers J, 1993, CAN J OCCUP THER, V60, P9, DOI DOI 10.1177/000841749306000104; DESROSIERS J, 1991, TEMPA ADM MANUAL; Feys P, 2002, CLIN REHABIL, V16, P166, DOI 10.1191/0269215502cr471oa; Fleiss J., 1986, DESIGN ANAL CLIN EXP; MAYERSON NH, 1984, ARCH PHYS MED REHAB, V65, P92; PINKOWSKI C, 2000, P REH K WURZB GERM, P188; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Richards L, 2001, OCCUP THER J RES, V21, P201, DOI 10.1177/153944920102100304; van Loo M, 2003, CLIN REHABIL, V17, P775, DOI 10.1191/0269215503cr677oa	11	14	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2003	18	6					526	531		10.1097/00001199-200311000-00006			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	747MX	WOS:000186809200006	14707882				2021-06-18	
J	Ko, K; Conforti, A				Ko, K; Conforti, A			Training protocol for intracranial pressure monitor placement by nonneurosurgeons: 5-year experience	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						ventricular catheter; ventriculostomy; intracranial pressure; monitoring; brain injury; neurosurgeon; neurosurgery house officer	GUIDE; CARE	Background: This report evaluates a protocol for training nonneurosurgeon medical staff to perform ventricular catheter placement for ICP monitoring in traumatic brain injury and other appropriate patients under the guidance of neurosurgeons. Methods. Eleven neurosurgery house officers were enrolled in the program to be certified for ventricular catheter placement. The training program using the Ghajar Guide is described as well as the preprocedural checklist. The results of these certified house officers were tracked over a 5-year period. Results: Ten house officers successfully completed the certification process for ventricular catheter placement in a total of 106 patients. The majority of ventricular catheters were placed at the bedside. The reported results and the complication rates of catheter-related infections and intracranial hemorrhage are similar to that of neurosurgeons or neurosurgeons in training. Conclusion:. House officers under the guidance of neurosurgeons can be trained to successfully and safely place ventricular catheters for ICP monitoring in patients needing ICP monitoring.	Cornell Univ, Dept Neurol Surg, New York, NY USA; Jamaica Hosp, Med Ctr, Queens, NY USA	Ko, K (corresponding author), Cherokee Stn, POB 20398, New York, NY 10021 USA.	kgyrus@attglobal.net					Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; Bullock RM, 2000, J NEUROTRAUM, V17, P449; GHAJAR JBG, 1985, J NEUROSURG, V63, P985, DOI 10.3171/jns.1985.63.6.0985; HERSDORFFER DC, 2002, J TRAUMA, V52, P1202; Kaups KL, 1998, J TRAUMA, V45, P884, DOI 10.1097/00005373-199811000-00007; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; O'Leary ST, 2000, J NEUROSURG, V92, P801, DOI 10.3171/jns.2000.92.5.0801; Picard P, 1997, ANN FR ANESTH, V16, P420, DOI 10.1016/S0750-7658(97)81474-8; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004	9	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	2003	55	3					480	483		10.1097/01.TA.0000074111.04885.28			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	721DZ	WOS:000185302900018	14501890				2021-06-18	
J	McGruder, J; Cors, D; Tiernan, AM; Tomlin, G				McGruder, J; Cors, D; Tiernan, AM; Tomlin, G			Weighted wrist cuffs for tremor reduction during eating in adults with static brain lesions	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						intention tremor; rehabilitation; traumatic brain injury	ENERGY-DISSIPATION ORTHOSIS; SUPPRESSION	OBJECTIVE. This study examined whether weighting the forearm during feeding decreased tremors and increased functional feeding in adults with intention tremor caused by static brain lesions. METHOD. Five individuals with various diagnoses, ages 30-81, were videotaped during 8 or 16 meal sessions, alternating treatment and control conditions within each meal. In this single-case design, treatment consisted of application of a weighted fabric wrist cuff and the baseline (control) condition employed an identical cuff with the weights removed. Dependent variables studied were time to acquire and deliver a bite, grams of food eaten, number of times food was spilled, number of times a compensatory technique was used, participant self-rating, and investigator rating of the severity of the tremor. RESULTS. All five participants demonstrated improvement during treatment in one or more of the dependent variables. t Tests of the means of baseline and treatment half-sessions incorporating conservative control of Type I error revealed the following statistically significant improvements under the weighted condition: Participants 3, 4, and 5 took less time to acquire a bite, Participants 4 and 5 made fewer spills; Participants 3 and 5 showed a diminished tremor. There were no statistically significant decreases in function on any variable for any participants during the weighted condition. CONCLUSION. The application of weight to the wrist of a person with upper-extremity tremor is accompanied by some functional improvement in self-feeding for some individuals. The size of benefit seems to be sensitive to the amount of weight used.	Univ Puget Sound, Sch Occupat Therapy & Phys Therapy, Tacoma, WA 98416 USA; Univ Puget Sound, Sch Occupat Therapy & Phys Therapy, Occupat Therapy Program, Tacoma, WA 98416 USA	McGruder, J (corresponding author), Univ Puget Sound, Sch Occupat Therapy & Phys Therapy, Tacoma, WA 98416 USA.						AISEN ML, 1993, NEUROLOGY, V43, P1346, DOI 10.1212/WNL.43.7.1346; ARNOLD AS, 1993, J ELECTROMYOGR KINES, V3, P131, DOI 10.1016/S1050-6411(05)80001-X; BROADHURST M, 1990, J BIOMED ENG, V5, P156; COOKE D M, 1958, Am J Occup Ther, V12, P89; DAHLINWEBB SR, 1986, AM J OCCUP THER, V40, P363, DOI 10.5014/ajot.40.5.363; ERICKSON RP, 1989, MAYO CLIN PROC, V64, P818; FICKE RC, 1992, US DEP ED; FINLAYSON M, 1994, BRAIN INJURY REHAB C; Franklin R. D., 1996, DESIGN ANAL SINGLE C; Gapsis K, 1990, TOPICS NEUROLOGY, P7; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Holm MB, 2000, AM J OCCUP THER, V54, P575, DOI 10.5014/ajot.54.6.575; Kotovsky J, 1998, J REHABIL RES DEV, V35, P373; Kovich K., 1988, HEAD INJURY GUIDE FU; Michaelis J., 1988, ACTION RES-LONDON, V6, P2; Portney GP, 2000, FDN CLIN RES APPL PR; ROSEN MJ, 1995, J REHABIL RES DEV, V32, P1; *S S WORLDW, 2001, WEIGHT UT CAT DESCR; SHARPE PA, 1990, AM J OCCUP THER, V44, P328, DOI 10.5014/ajot.44.4.328; TROMBLY CA, 2002, OCCUPATIONAL THERAPY; UMPHRED D, 1995, NEUROLOGICAL REHAB; WOOD R, 1989, MODELS BRAIN INFURY; YUEN H, 1998, AUSTR OCCUPATIONAL T, V45, P43; 2001, TUMBLE FORMS	24	14	15	0	2	AMER OCCUPATIONAL THERAPY ASSOC, INC	BETHESDA	4720 MONTGOMERY LANE, BETHESDA, MD 20814-3425 USA	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	SEP-OCT	2003	57	5					507	516		10.5014/ajot.57.5.507			10	Rehabilitation	Rehabilitation	721TL	WOS:000185333400004	14527112				2021-06-18	
J	Carey, ME				Carey, ME			The treatment of wartime brain wounds: Traditional versus minimal debridement	SURGICAL NEUROLOGY			English	Article						war wounds; gunshot wounds; penetrating brain; debridement	PENETRATING CRANIOCEREBRAL INJURIES; VIETNAM HEAD-INJURY; LEBANESE CONFLICT; MISSILE WOUNDS; INFECTIONS	BACKGROUND Since World War 11, surgeons in Western armies dealing with brain wounds have generally advocated thorough missile track debridement, and many have urged meticulous dural closure to prevent cerebral spinal fluid (CSF) leakage and subsequent infection. For the last decade some reports have appeared wherein wartime brain wounds have been treated by minimal brain debridement with little or no attention to tight dural closure. This report compares and contrasts postdebridement complications reported with each method. METHODS I reviewed the pertinent neurosurgical papers from Vietnam, the Israeli war in Lebanon, and the Iran-Iraq war and compared the results of traditional debridement and water-tight dural closure to those following minimal debridement without close attention to dural closure. RESULTS Minimal brain debridements without tight dural closure were up to 20 to 30 times more likely to require additional debridement, had a 10-15 times higher incidence of life-threatening CSF leakage, a fivefold increase in postdebridement meningitis, and a 2.5 times greater risk of fatal meningitis. CONCLUSIONS Compared to thorough brain debridement and watertight dural closure, minimal debridements and nonwatertight dural closure give inferior results. (C) 2003 Elsevier Inc. All rights reserved.	Louisiana State Univ, Ctr Hlth Sci, New Orleans, LA 70112 USA	Carey, ME (corresponding author), Louisiana State Univ, Ctr Hlth Sci, 1542 Tulane Ave, New Orleans, LA 70112 USA.						Aarabi B, 1998, NEUROSURGERY, V42, P500, DOI 10.1097/00006123-199803000-00014; AARABI B, 1987, NEUROSURGERY, V20, P610, DOI 10.1227/00006123-198704000-00018; AARABI B, 1989, NEUROSURGERY, V25, P923, DOI 10.1227/00006123-198912000-00011; Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; ASCROFT PB, 1947, BR J SURG S, V1, P183; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; CAMPBELL EH, 1945, ANN SURG, V122, P375, DOI 10.1097/00000658-194509000-00004; CAREY ME, 1972, SURG GYNECOL OBSTETR, V135, P386; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; CAREY ME, 1974, J NEUROSURG, V41, P542, DOI 10.3171/jns.1974.41.5.0542; DRESSER AC, 1973, ARCH NEUROL-CHICAGO, V29, P111, DOI 10.1001/archneur.1973.00490260055011; Gray HMW, 1916, BRIT MED J, V1916, P261, DOI 10.1136/bmj.1.2877.261; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; HARSH GR, 1965, NEUROLOGICAL SURGERY, P135; Horsley V, 1915, LANCET, V1, P359; MARTIN J, 1946, J NEUROSURG, V3, P58, DOI 10.3171/jns.1946.3.1.0058; MATSON DD, 1958, SURGERY WORLD WAR 2, V1, P123; Meirowsky A., 1965, NEUROLOGICAL SURGERY, P103; MEIROWSKY AM, 1981, J NEUROSURG, V54, P44, DOI 10.3171/jns.1981.54.1.0044; MEIROWSKY AM, 1968, MIL MED, V133, P887; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; Roberts JEH, 1915, BRIT MED J, V1915, P498, DOI 10.1136/bmj.2.2857.498; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Sargent P, 1916, BRIT J SURG, V3, P475; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; SMALL J M, 1947, Br J Surg, V55, P62; TAHA JM, 1991, NEUROSURGERY, V29, P380, DOI 10.1227/00006123-199109000-00007; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010; WEBSTER JE, 1946, J NEUROSURG, V3, P7, DOI 10.3171/jns.1946.3.1.0007	30	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0090-3019			SURG NEUROL	Surg. Neurol.	AUG	2003	60	2					112	119		10.1016/S0090-3019(03)00352-5			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	707WB	WOS:000184531900004	12900112				2021-06-18	
J	Merrick, EE; Donders, J; Wiersum, M				Merrick, EE; Donders, J; Wiersum, M			Validity of the WCST-64 after traumatic brain injury	CLINICAL NEUROPSYCHOLOGIST			English	Article							CARD-SORTING-TEST; CLINICAL-SAMPLES; SCORES	The Wisconsin Card Sorting Test-64 (WCST-64) is a recent modification of the Wisconsin Card Sorting Test (WCST) that utilizes only one deck of cards. The present study investigated the validity of the WCST-64 in a sample of 100 patients with traumatic brain injury (TBI). Mean T scores for Perseverative Responses were more than half a standard deviation lower for the WCST-64 than for the full-length version, even though the respective variables shared almost two thirds of common variance. Moreover, about a quarter of the sample had a T score discrepancy between the respective Perseverative Responses indexes that was greater than one standard deviation. The findings indicate that the WCST-64 cannot be used interchangeably with the original WCST, at least not in patients with TBI.	Mary Free Bed Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; Calvin Coll, Grand Rapids, MI 49506 USA	Donders, J (corresponding author), Mary Free Bed Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.						Axelrod BN, 2002, CLIN NEUROPSYCHOL, V16, P7, DOI 10.1076/clin.16.1.7.8331; Bell MD, 1997, J CLIN EXP NEUROPSYC, V19, P933, DOI 10.1080/01688639708403774; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Donders J, 2002, PSYCHOL ASSESSMENT, V14, P360, DOI 10.1037//1040-3590.14.3.360; GOLDMAN RS, 1996, ASSESSMENT, V3, P73, DOI DOI 10.1177/107319119600300108; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton R.K., 1991, COMPREHENSIVE NORMS; Heaton RK., 1999, WISCONSIN CARD SORTI; HEATON RK, 2000, WCST 64 COMPUTER VER; Jones R. D., 1996, P395; Kongs S.K., 2000, WCST 64 WISCONSIN CA; Martin TA, 2000, REHABIL PSYCHOL, V45, P402, DOI 10.1037/0090-5550.45.4.402; PAOLO AM, 1995, ARCH CLIN NEUROPSYCH, V10, P463, DOI 10.1016/0887-6177(95)00052-6; Reitan R.M., 1993, HALSTEADREITAN NEURO; Robinson L J, 1991, Arch Clin Neuropsychol, V6, P27, DOI 10.1016/0887-6177(91)90019-6; SCHERZER BP, 1993, BRAIN INJURY, V7, P411, DOI 10.3109/02699059309029684; Sherer M, 2003, J CLIN EXP NEUROPSYC, V25, P512, DOI 10.1076/jcen.25.4.512.13877; Smith-Seemiller L, 1997, CLIN NEUROPSYCHOL, V11, P421, DOI 10.1080/13854049708400472; TEASDALE G, 1974, LANCET, V2, P81; VILKKI J, 1992, NEUROPSYCHOLOGIA, V30, P807, DOI 10.1016/0028-3932(92)90084-Y; Wiegner S, 1999, ASSESSMENT, V6, P179, DOI 10.1177/107319119900600205; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williamson D. J. G., 1996, NEUROPSYCHOLOGY CLIN, P9, DOI [10.1037/10198-001, DOI 10.1037/10198-001]	25	14	15	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	MAY	2003	17	2					153	158		10.1076/clin.17.2.153.16512			6	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	734PF	WOS:000186065200004	13680422				2021-06-18	
J	Dave, JR; Williams, AJ; Moffett, JR; Koenig, ML; Tortella, FC				Dave, JR; Williams, AJ; Moffett, JR; Koenig, ML; Tortella, FC			Studies on neuronal apoptosis in primary forebrain cultures: Neuroprotective/anti-apoptotic action of NR2B NMDA antagonists	NEUROTOXICITY RESEARCH			English	Article						primary neuronal cultures; apoptosis; staurosporine; ifenprodil; CGX-1007; conantokin-G	METHYL-D-ASPARTATE; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C RELEASE; RAT-BRAIN; RECEPTOR ANTAGONIST; CONANTOKIN-G; ALLOSTERIC INTERACTION; CASPASE ACTIVATION; THERAPEUTIC WINDOW	While the role of apoptosis in neuronal injury is continually being re-defined, approaches to intervene in the progression of apoptotic injury have been documented to provide neuroprotection against a variety of insults. The present studies were undertaken to systematically study the effects of certain neuroprotective agents against neuronal apoptosis mediated by staurosporine (ST). ST (0.01-5 muM) produced a dose-related apoptotic injury (as characterized by cellular morphology, `Comet' assay analysis [single cell gel electrophoresis] and caspase-3 activation) in primary cultures of fore-brain neurons. ST significantly increased caspase-3 activity. The NMDA receptor subtype non-selective antagonist dizocilpine [(+) MK-801; 0.1-50 muM] and a novel sodium channel blocker RS100642 (1.0-250 muM) had no significant effects against ST induced neurotoxicity. Conversely, NR2B-selective NMDA receptor antagonists CGX-1007 (0.01-50 muM) and ifenprodil (0.01-50 muM) provided dose-dependent neuroprotection against ST induced neurotoxicity (as measured by neuronal viability and comet assay analysis). CGX-1007 had no significant effect on ST induced caspase-3 activity; however, ifenprodil did block activation of caspase-3. These studies demonstrate that NR2B NMDA receptor antagonists are anti-apoptotic and may mediate their action via mechanism(s) that are dependent or independent of caspase-3 activation.	Walter Reed Army Inst Res, Dept Neuropharmacol, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Dept Biol Mol, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Dept Neuroendocrinol Neurochem, Div Neurosci, Silver Spring, MD 20910 USA	Dave, JR (corresponding author), Walter Reed Army Inst Res, Dept Neuropharmacol, Silver Spring, MD 20910 USA.						Ahlemeyer B, 2002, BRAIN RES, V934, P107, DOI 10.1016/S0006-8993(02)02365-X; Badolo L, 1998, EUR J PHARMACOL, V342, pR1, DOI 10.1016/S0014-2999(97)01601-4; Bialer M, 2002, EPILEPSY RES, V51, P31, DOI 10.1016/S0920-1211(02)00106-7; Bredesen DE, 1995, ANN NEUROL, V38, P839, DOI 10.1002/ana.410380604; Bresink I, 1996, BRIT J PHARMACOL, V119, P195, DOI 10.1111/j.1476-5381.1996.tb15971.x; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chang SH, 2000, AM J PATHOL, V156, P637, DOI 10.1016/S0002-9440(10)64768-2; Chazot PL, 1997, J NEUROCHEM, V69, P2138; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Clark RSB, 1997, J NEUROSCI, V17, P9172; COHEN GM, 1992, BIOCHEM J, V286, P331, DOI 10.1042/bj2860331; CONTRERAS PC, 1990, NEUROSCI LETT, V116, P190, DOI 10.1016/0304-3940(90)90408-2; Dave JR, 2001, NEUROTOX RES, V3, P381, DOI 10.1007/BF03033199; Dave JR, 1997, MOL CHEM NEUROPATHOL, V30, P1, DOI 10.1007/BF02815146; DECOSTER MA, 1992, NEUROREPORT, V3, P773, DOI 10.1097/00001756-199209000-00013; Dempsey RJ, 2000, NEUROSURGERY, V47, P399, DOI 10.1097/00006123-200008000-00024; Deshmukh M, 2002, J NEUROSCI, V22, P8018; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dogan A, 1997, J NEUROSURG, V87, P921, DOI 10.3171/jns.1997.87.6.0921; Donevan SD, 2000, MOL PHARMACOL, V58, P614; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Isenmann S, 1998, BRAIN PATHOL, V8, P49; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kew JNC, 1998, J PHYSIOL-LONDON, V512, P17, DOI 10.1111/j.1469-7793.1998.017bf.x; Khan AM, 2000, J COMP NEUROL, V428, P428; KOH JY, 1995, EXP NEUROL, V135, P153, DOI 10.1006/exnr.1995.1074; Kruidering M, 2001, J BIOL CHEM, V276, P38417, DOI 10.1074/jbc.M103471200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li Y, 1997, BRAIN RES, V765, P301, DOI 10.1016/S0006-8993(97)00524-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Menniti F, 1997, EUR J PHARMACOL, V331, P117, DOI 10.1016/S0014-2999(97)10092-9; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; PorteraCailliau C, 1997, J COMP NEUROL, V378, P88, DOI 10.1002/(SICI)1096-9861(19970203)378:1<88::AID-CNE5>3.0.CO;2-G; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; SKOLNICK P, 1992, J NEUROCHEM, V59, P1516, DOI 10.1111/j.1471-4159.1992.tb08468.x; Sloviter RS, 1996, J COMP NEUROL, V366, P516, DOI 10.1002/(SICI)1096-9861(19960311)366:3<516::AID-CNE10>3.0.CO;2-N; STEINBERG GK, 1995, NEUROBIOL DIS, V2, P109, DOI 10.1006/nbdi.1995.0011; TAMOKI T, 1986, BIOCHEM BIOPH RES CO, V135, P397; Thompson CL, 2000, NEUROSCI LETT, V283, P85, DOI 10.1016/S0304-3940(00)00930-7; TOMEI LD, 1993, P NATL ACAD SCI USA, V90, P853, DOI 10.1073/pnas.90.3.853; VED HS, 1991, J NEUROSCI RES, V30, P353, DOI 10.1002/jnr.490300211; Wenzel A, 1995, NEUROREPORT, V7, P45, DOI 10.1097/00001756-199512000-00010; Williams AJ, 2002, EUR J PHARMACOL, V452, P135, DOI 10.1016/S0014-2999(02)02327-0; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Zhou LM, 1996, J NEUROCHEM, V66, P620; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	52	14	14	0	2	F P GRAHAM PUBLISHING CO	MOUNTAIN HOME	PO BOX 370, MOUNTAIN HOME, TN 37684 USA	1029-8428			NEUROTOX RES	Neurotox. Res.		2003	5	4					255	+		10.1007/BF03033383			9	Neurosciences	Neurosciences & Neurology	715RR	WOS:000184986500003	12835117				2021-06-18	
J	Prigatano, GP; Borgaro, SR				Prigatano, GP; Borgaro, SR			Qualitative features of finger movement during the Halstead finger oscillation test following traumatic brain injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						finger tapping; speed; abnormal patterns; TBI	HEAD-INJURY; 1-YEAR	Qualitative and quantitative performance on the Halstead Finger Tapping test may help differentiate brain dysfunctional patients from normal controls. "Normal" and "abnormal" finger tapping patterns during this task have been characterized and illustrated pictorially. Data from 65 patients with traumatic brain injury (TBI) and 15 normal controls support the dual proposition that (1) abnormal finger tapping patterns are more commonly observed in TBI patients than in controls and (2) the frequency of abnormal finger movements may relate to the severity of TBI during the acute stages after trauma. Future prospective studies are needed to replicate these findings.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Sect Neuropsychol, Phoenix, AZ USA	Prigatano, GP (corresponding author), Barrow Neurol Inst, Dept Clin Neuropsychol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.						DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; FUSTER JM, 1997, PREFRONTAL CORTEX; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead WC, 1947, BRAIN INTELLIGENCE; Heilman K. M., 1993, INT J CLIN NEUROPSYC, P141; JENNETT B, 1974, MANAGEMENT HEAD INJU; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; JOHNSON SC, 2000, BNI Q, V16, P155; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; PRIGATANO GP, 1976, J CONSULT CLIN PSYCH, V44, P527, DOI 10.1037/0022-006X.44.4.527; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P847, DOI 10.1016/S0003-9993(97)90198-2; Prigatano GP., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1995, MANUAL BNI SCREEN HI; Prigatano GP, 1997, BNI Q, V13, P14; REITAN RM, 1994, CLIN NEUROPSYCHOL, V8, P193, DOI 10.1080/13854049408401557; Reitan RM, 1955, MANUAL ADM NEUROPSYC; VEGA A, 1967, J CONSULT PSYCHOL, V31, P619, DOI 10.1037/h0025112	18	14	14	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	40 WEST 20TH ST, NEW YORK, NY 10011-4221 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2003	9	1					128	133		10.1017/S1355617703000134			6	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	661HL	WOS:000181885100013	12570365				2021-06-18	
J	Rhodes, JKJ; Andrews, PJD; Holmes, MC; Seckl, JR				Rhodes, JKJ; Andrews, PJD; Holmes, MC; Seckl, JR			Expression of interleukin-6 messenger RNA in a rat model of diffuse axonal injury	NEUROSCIENCE LETTERS			English	Article						brain injury; in situ hybridisation; interleukin-6; rodent model	NECROSIS-FACTOR-ALPHA; ACUTE BRAIN INJURY; CHOLINERGIC NEURONS; HUMAN ASTROCYTES; CYTOKINES; IL-1-BETA; SURVIVAL; IL-6	Having demonstrated a transcranial gradient of the cytokine interleukin-6 (IL-6) in patients with either traumatic brain injury or spontaneous subarachnoid haemorrhage we have employed in situ hybridisation for IL-6 messenger RNA (mRNA) to determine the site of this IL-6 production within the central nervous system (CNS). A rodent weight drop model of traumatic brain injury was used. IL-6 mRNA levels in brains were determined 6 h after injury. Sham animals had normal constitutive expression for IL6 mRNA. In traumatised animals an intense area of IL-6 mRNA labelling was found below the hippocampus. Cells strongly expressing IL-6 mRNA were also seen in the dentate gyrus. This inflammatory cytokine is clearly implicated in the response to CNS injury, but whether this response is neuroprotective or pathological is uncertain. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.	Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Dept Mol Endocrinol, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Intens Care Unit, Edinburgh EH4 2XU, Midlothian, Scotland	Rhodes, JKJ (corresponding author), Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Dept Mol Endocrinol, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.		Seckl, Jonathan R/C-3555-2013				ALOISI F, 1992, J IMMUNOL, V149, P2358; CHUNG IY, 1990, J IMMUNOL, V144, P2999; CSUKA E, 1997, SHOCK, P8; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; HAMA T, 1991, NEUROSCIENCE, V40, P445, DOI 10.1016/0306-4522(91)90132-8; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McKeating EG, 1998, BRIT J ANAESTH, V80, P572; McKeating EG, 1998, BRIT J ANAESTH, V80, P77; McKeating EG, 1997, BRIT J ANAESTH, V78, P520; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; MORGANTIKOSSMANN MC, 1992, TRENDS PHARMACOL SCI, V13, P286, DOI 10.1016/0165-6147(92)90087-M; ROTHWELL NJ, 1993, NEUROSCI BIOBEHAV R, V17, P217, DOI 10.1016/S0149-7634(05)80152-6; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SECKL JR, 1990, J NEUROENDOCRINOL, V2, P911, DOI 10.1111/j.1365-2826.1990.tb00659.x; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S	19	14	16	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	DEC 19	2002	335	1					1	4	PII S0304-3940(02)00811-X	10.1016/S0304-3940(02)00811-X			4	Neurosciences	Neurosciences & Neurology	625AY	WOS:000179795700001	12457728				2021-06-18	
J	Sekiya, T; Yagihashi, A; Asano, K; Suzuki, S				Sekiya, T; Yagihashi, A; Asano, K; Suzuki, S			Nimodipine ameliorates trauma-induced cochlear neuronal death	NEUROLOGICAL RESEARCH			English	Article						calcium channel; cochlear nerve; hearing; nerve degeneration; nimodipine; spiral ganglion cell	SPIRAL GANGLION-CELLS; GUINEA-PIG; CALCIUM CHANNELS; FACIAL-NERVE; RAT; ISCHEMIA; INJURY; BRAIN; METHYLPREDNISOLONE; DAMAGE	Excessive entry of Ca2+ into injured cochlear neurons activates various Ca2+-activated enzymes and subsequent spiral ganglion cell death. Therefore, preventing intracellular calcium overload by using Ca2+ channel antagonists may become an important countermeasure to spiral ganglion cell death. We experimentally investigated whether an L-type Ca2+ channel blocker (nimodipine) can rescue traumatized cochlear neurons from degeneration. A group of rats (n = 6) was pre-operatively treated with nimodipine for one week and compression injury was applied to the cerebellopontine angle portion of the cochlear nerve in a highly quantitative fashion. The rats from the compression with nimodipine treatment groups were post-operatively treated with nimodipine for 10 days and killed for histological examination. The histological analysis of the temporal bones revealed that the spiral ganglion cells in the basal turn of the cochlea where the magnitude of traumatic impact had been the least in our experimental condition were rescued in a statistically significant fashion in the compression with nimodipine treatment group. The results of the present study indicate that nimodipine may become an intra- and post-operative important adjunct to raise the rate of hearing preservation in vestibular schwannoma excision or other cerebellopontine angle surgical interventions.	Hirosaki Univ, Sch Med, Dept Neurosurg, Hirosaki, Aomori 0368216, Japan	Sekiya, T (corresponding author), Hirosaki Univ, Sch Med, Dept Neurosurg, 5 Zaifu Cho, Hirosaki, Aomori 0368216, Japan.	seky@cc.hirosaki-u.ac.jp					Angelov DN, 1996, J NEUROSCI, V16, P1041; Asai Y, 1996, ANN OTO RHINOL LARYN, V105, P472, DOI 10.1177/000348949610500610; BAR PR, 1990, J NEUR TR S, V31, P55; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; DINGLEDINE R, 1998, BASIC NEUROCHEMISTRY, P315; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fechter LD, 1995, HEARING RES, V91, P101, DOI 10.1016/0378-5955(95)00176-X; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; HAN DY, 1993, ACTA OTO-LARYNGOL, P26; Hille B., 2001, ION CHANNELS EXCITAB, P95; Hisashi K, 1995, HEARING RES, V91, P196, DOI 10.1016/0378-5955(95)00191-3; Horn J, 2001, STROKE, V32, P2433, DOI 10.1161/hs1001.096009; Kusakari J, 1981, Auris Nasus Larynx, V8, P55; LANGLEY MS, 1989, DRUGS, V37, P669, DOI 10.2165/00003495-198937050-00004; LUITEN PGM, 1994, ANN NY ACAD SCI, V747, P431; Mattson P, 1999, J NEUROSURG, V90, P760, DOI 10.3171/jns.1999.90.4.0760; NYAKAS C, 1994, NEUROSCIENCE, V59, P541, DOI 10.1016/0306-4522(94)90176-7; Ogawa K, 1996, ACTA OTO-LARYNGOL, V116, P253, DOI 10.3109/00016489609137835; Olney JW, 1999, CELL DEATH AND DISEASES OF THE NERVOUS SYSTEM, P197; PERLMAN HB, 1959, LAYNGOSCOPE, V9, P591; PUTNEY JW, 1998, BASIC NEUROCHEMISTRY, P453; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; SCHUURMAN T, 1987, NEUROSCI RES COMMUN, V1, P9; Sekiya T, 2001, HEARING RES, V151, P125, DOI 10.1016/S0378-5955(00)00219-7; Sekiya T, 2001, BRAIN RES, V905, P152, DOI 10.1016/S0006-8993(01)02523-9; Sekiya T, 2000, J NEUROSURG, V93, P90, DOI 10.3171/jns.2000.93.1.0090; Sekiya T, 2000, EXP NEUROL, V161, P490, DOI 10.1006/exnr.1999.7280; Sekiya T, 2000, ACTA OTO-LARYNGOL, V120, P473, DOI 10.1080/000164800750045956; SHIMOZONO M, 1995, NEUROREPORT, V6, P421, DOI 10.1097/00001756-199502000-00004; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Strauss C, 2001, J NEUROSURG, V95, P771, DOI 10.3171/jns.2001.95.5.0771; TETTENBORN D, 1993, DRUG DEV, V2, P473; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; VANDERZEE CEEM, 1987, NEUROSCI LETT, V83, P143, DOI 10.1016/0304-3940(87)90231-X; Zornow M H, 1996, New Horiz, V4, P107	36	14	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	DEC	2002	24	8					775	780		10.1179/016164102101200889			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	622PR	WOS:000179655900006	12500700				2021-06-18	
J	Powell, EC; Jovtis, E; Tanz, RR				Powell, EC; Jovtis, E; Tanz, RR			Incidence and description of stroller-related injuries to children	PEDIATRICS			English	Article						injury; infant; stroller; falls	SAFETY	Objective. To describe the incidence, circumstances, and types of stroller-related injuries among US children. Design. Retrospective review of data for children 3 years old and younger from the National Electronic Injury Surveillance System of the United States Consumer Product Safety Commission for 1994-1998. Results. There were an estimated 64 373 stroller-related injuries (95% confidence interval [CI]: 49 223-79514) to children 3 years old and younger treated in hospital emergency departments in the United States during the 5-year study period. The median age at the time of the injury was 11 months; 51% were males. The annual rate of injury among children <1 year old was 184.4 per 100 000. Seventy-six percent of injuries resulted from a fall from the stroller. A motor vehicle was involved in <1% of cases. Most injuries involved the head (44%) or face (43%). Injury diagnoses included contusions or abrasions (38%), lacerations (24%), closed head injury (22%), and extremity fractures (3%). Two percent of injured children, an estimated 992 (95% CI: 428-1556), were admitted to the hospital during the study period, an annual admission rate of 1.3 per 100 000. Seventy percent of admissions were for head trauma. Conclusions. Injuries related to strollers are common, particularly among children in the first year of life. They often result from falls from the stroller. The data suggest that restraint use would prevent many stroller-related injuries.	Childrens Mem Hosp, Div Pediat Emergency Med, Chicago, IL 60614 USA; Childrens Mem Hosp, Div Gen Acad Pediat, Chicago, IL 60614 USA; Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA	Powell, EC (corresponding author), Childrens Mem Hosp, Div Pediat Emergency Med, Box 62,2300 Childrens Plaza, Chicago, IL 60614 USA.			Powell, Elizabeth/0000-0003-3147-9889			COUPER RTL, 1994, MED J AUSTRALIA, V160, P335, DOI 10.5694/j.1326-5377.1994.tb138233.x; Lee ACW, 1997, J PAEDIATR CHILD H, V33, P446; Powell EC, 2002, AMBUL PEDIATR, V2, P276, DOI 10.1367/1539-4409(2002)002<0276:IADOHC>2.0.CO;2; United States Consumer Product Safety Commission, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1994, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1993, EXPL SHEET NEISS EST; *US CONS PROD SAF, 1996, CONSUMER PROD SAFETY, V1, P4; *US CONS PROD SAF, 2000, NURS PROD REP; *US CONS PROD SAF, 1986, US CONS PROD SAF COM; *US DEP HHS, US POP EST; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	11	14	16	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	NOV	2002	110	5							e62	10.1542/peds.110.5.e62			3	Pediatrics	Pediatrics	610QK	WOS:000178971800012	12415068				2021-06-18	
J	Powell, EC; Jovtis, E; Tanz, RR				Powell, EC; Jovtis, E; Tanz, RR			Incidence and description of high chair-related injuries to children	AMBULATORY PEDIATRICS			English	Article; Proceedings Paper	41st Annual Meeting of the Ambulatory-Pediatrics-Association	MAY   02, 2001	BALTIMORE, MARYLAND	Ambulatory Pediat Assoc		falls; high chair; infant; injury		Study Objective.-To describe the incidence, circumstances. and types (of high chair-related injuries among, US children. Design.-Retrospective review of data for children 3 bears old and younger iron) the National Electronic Injury Surveillance System of the US Consumer Product Safety Commission for 1994-98. Results.-There were an estimated 40650 hi,, h chair-related injuries (951,1 confidence interval [Cl]. 32657-48643) to children 3 years old and younger treated in hospital emergency department,, in the LIS during the 5-year study period, An estimated 5231 injuries (13%) were related to use of an attachable high chair (including booster,eats). and an estimated 4067 10%) were related to the use of a youth chair. The annual rate Of injury among, children less than or equal to3 years old was 5.3 per 10000. The mean age was 10 months (median. 1 year): 56% were boys. Nienty-four percent of injuries resulted from a fall from the chair. Most injuries involved the head (44%) or face (39%). Injury diagnoses included contusions or abrasions (36%), lacerations (25%). closed head injury (21%) and fractures (8%). Two percent of injured children, an estimated 941 (95% Cl. 399-1487). were admitted to the hospital during the study period, an annual admission rate of 0.1 per 10000. There were no significant differences between attachable high chairs, youth chairs, and high chairs in anatomic sites of injury. injury diagnosis, or frequency I of hospital admission. Conclusions.-Injuries related to high chairs are common. particularly anion, children in the first year of life. They often result front falls from the chair. The data suggest that restraint use would prevent most of these injuries.	Childrens Mem Hosp, Div Pediat Emergency Med, Chicago, IL 60614 USA; Childrens Mem Hosp, Div Gen Acad Pediat, Chicago, IL 60614 USA; Northwestern Univ, Sch Med, Dept Pediat, Chicago, IL 60611 USA	Powell, EC (corresponding author), Childrens Mem Hosp, Div Pediat Emergency Med, Box 62,2300 Childrens Plaza, Chicago, IL 60614 USA.			Powell, Elizabeth/0000-0003-3147-9889			*CPSC, 2000, COSC ANN REC REP HIG; Mayr JM, 1999, ACTA PAEDIATR, V88, P319, DOI 10.1080/08035259950170105; Smith GA, 1996, PEDIATRICS, V97, P161; TINSWORTH DK, 2001, COMMUNICATION   0504; *US CONS PROD SAF, 1994, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1993, EXPL SHEET NEISS EST; *US CONS PROD SAF, 1998, NAT EL INJ SURV SYST; *US CONS PROD SAF, 1996, CONSUMER PROD SAFETY, V1, P4; *US CONS PROD SAF, 2000, NURS PROD REP; *US CONS PROD SAF, 1986, US CONS PROD SAF COM; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	11	14	16	0	4	AMBULATORY PEDIATRIC ASSOC	MCLEAN	6728 OLD MCLEAN VILLAGE DR, MCLEAN, VA 22101-3906 USA	1530-1567			AMBUL PEDIATR	Ambul. Pediatr.	JUL-AUG	2002	2	4					276	278		10.1367/1539-4409(2002)002<0276:IADOHC>2.0.CO;2			3	Pediatrics	Pediatrics	577LP	WOS:000177062600007	12135401				2021-06-18	
J	Alderson, AL; Novack, TA				Alderson, AL; Novack, TA			Measuring recovery of orientation during acute rehabilitation for traumatic brain injury: Value and expectations of recovery	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							POSTTRAUMATIC AMNESIA; GALVESTON ORIENTATION; COGNITIVE ORIENTATION; HEAD-INJURY; SCALE; LOG	Objectives: To further evaluate the use of the orientation log (O-Log) in an acute rehabilitation program for adults with traumatic brain injury (TBI), specifically focusing on prediction of rehabilitation outcome, possible use of the O-Log to promote recovery, and development of templates of orientation recovery. Design: Stepwise discriminant function analysis was used in one study and ANOVA based on between-groups comparisons in another. Confidence intervals were established in the third study. Setting: Acute rehabilitation hospital. Patients: Samples were taken from an overall pool of 389 subjects with predominantly severe TBI based on Glasgow Coma Scale score. Results: A combination of initial O-Log performance, time since injury; and number of O-Log assessments correctly predicted resolution of disorientation for 76% of the sample. Individuals attaining orientation before discharge achieved higher discharge scores on functional measures. Administration of the O-Log 3 versus 5 times a week did not result in more rapid resolution of disorientation. A similar pattern of steady improvement in orientation was evident for mild-moderate and severe injury cases across 10 administrations. Conclusions: Recovery of orientation provides important information about recovery following TBI and is predictive of rehabilitation outcome. More frequent administration of a formal orientation measure does not seem to expedite the recovery of orientation, which on average seems to progress at a steady pace in a rehabilitation setting regardless of the time since injury or severity of injury:	Shepherd Ctr, Inpatient Neuropsychol Acquired Brain Injury Prog, Atlanta, GA 30309 USA; Univ Alabama, Dept Phys Med & Rehabil, Birmingham, AL USA	Alderson, AL (corresponding author), Shepherd Ctr, Inpatient Neuropsychol Acquired Brain Injury Prog, 2020 Peachtree Rd NW, Atlanta, GA 30309 USA.				NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD07420] Funding Source: Medline		Ahmed S, 2000, BRAIN INJURY, V14, P765; BODE RK, 2000, J HEAD TRAUMA REHAB, V15, P1; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Dowler RN, 2000, BRAIN INJURY, V14, P117, DOI 10.1080/026990500120781; Gronwall D, 1989, MILD HEAD INJURY, P153; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jain N, 2000, CLIN NEUROPSYCHOL, V14, P13, DOI 10.1076/1385-4046(200002)14:1;1-8;FT013; Keith R A, 1987, Adv Clin Rehabil, V1, P6; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Wilson BA, 1999, BRAIN INJURY, V13, P505, DOI 10.1080/026990599121412; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	14	14	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	2002	17	3					210	219		10.1097/00001199-200206000-00003			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	552WE	WOS:000175642400003	12086575				2021-06-18	
J	Elgafy, H; Ebraheim, NA; Shaheen, PE; Yeasting, RA				Elgafy, H; Ebraheim, NA; Shaheen, PE; Yeasting, RA			Extensor hallucis longus innervation - An anatomic study	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article								Thirty legs from skeletally mature embalmed cadavers were dissected to define the most common pattern and the variants of innervation of the extensor hallucis longus muscle and its clinical significance. Twenty-seven muscles had only one innervating branch (90%). Only three muscles had two innervating branches (10%). Twenty-one of the branches entered the muscles from the fibular side (63.6%), six entered the muscles from the tibial side (18.2%), and six entered the muscles from the anterior edge (18.2%). The branches innervating the extensor hallucis longus from the fibular side had a closer relation with the fibular periosteum than those entering the muscle from the tibial side or the anterior edge. The mean length of these branches between their points of origin and entry in the extensor hallucis longus was 5.0 +/- 1.5 cm. The high risk zone for the iatrogenic injury to the muscular branch of the extensor hallucis longus was located between 5.9 +/- 1.7 and 10.9 +/- 1.7 cm inferior to the most distal palpable point of the fibular head. The current study confirmed that the extensor hallucis longus was supplied mostly by one nerve that usually entered the muscle from the fibular side and had a close relation to the fibular periosteum in the dangerous zone.	Med Coll Ohio, Dept Orthopaed Surg, Toledo, OH 43614 USA; Med Coll Ohio, Dept Anat, Toledo, OH 43614 USA	Ebraheim, NA (corresponding author), Med Coll Ohio, Dept Orthopaed Surg, Dowling Hall 3065 Arlington Ave, Toledo, OH 43614 USA.						Aydogdu S, 1996, Acta Orthop Belg, V62, P156; GARLAND DE, 1979, CLIN ORTHOP RELAT R, P169; GIBSON MJ, 1986, J BONE JOINT SURG BR, V68, P471; KIRGIS A, 1992, J BONE JOINT SURG AM, V74A, P1180, DOI 10.2106/00004623-199274080-00007; Loredo R, 1998, J COMPUT ASSIST TOMO, V22, P925, DOI 10.1097/00004728-199811000-00017; NAUMANN T, 1987, ORTHOP PRAX, V23, P466; PIGOTT T J D, 1991, British Journal of Neurosurgery, V5, P7, DOI 10.3109/02688699108998440; ROMANES GJ, 1972, PERIPHERAL NERVOUS S, P766; Satku K, 1992, Ann Acad Med Singap, V21, P222; STITGEN SH, 1992, CLIN ORTHOP RELAT R, P134; WILLIAMS PL, 1989, COMMON PERONEAL NERV, P1148	11	14	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-921X			CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	MAY	2002		398					245	251					7	Orthopedics; Surgery	Orthopedics; Surgery	549FJ	WOS:000175433600035	11964657				2021-06-18	
J	Beers, SR; De Bellis, MD				Beers, SR; De Bellis, MD			Outcomes of child abuse	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NONACCIDENTAL HEAD-INJURY; SEXUAL-ABUSE; INFANTS; DIAGNOSIS	The rate of intentional injury to younger children has increased over the past decade. This article discusses the outcomes of inflicted traumatic brain injury during infancy and early childhood. We discuss both the short and long term effects of injury. A post-traumatic stress disorder model is proposed as a way of integrating both physical and psychological effects of trauma occurring in younger children, We discuss results of studies that suggest that there may be a synergistic interaction between sequelae of inflicted traumatic brain injury and physiological changes associated with chronic stress.	Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dev Traumatol Neuroimaging Lab, Pittsburgh, PA 15213 USA	Beers, SR (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.	beerssr@msx.upmc.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001324] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [5 K08 MHO 1324-02] Funding Source: Medline		American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1999, BIOL PSYCHIAT, V45, P806, DOI 10.1016/S0006-3223(98)00297-2; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; *COMM CHILD AB NEG, 1993, AM ACAD PEDIAT, V92, P872; Conway EE, 1998, PEDIATR ANN, V27, P677, DOI 10.3928/0090-4481-19981001-11; De Bellis MD, 2000, AM J PSYCHIAT, V157, P1175, DOI 10.1176/appi.ajp.157.7.1175; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; DEBELLIS MD, 1997, HDB PREVENTION TREAT, P455; DiScala C, 2000, ARCH PEDIAT ADOL MED, V154, P16; Dubner AE, 1999, J CONSULT CLIN PSYCH, V67, P367, DOI 10.1037/0022-006X.67.3.367; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; FAMULARO R, 1994, CHILD ABUSE NEGLECT, V18, P27, DOI 10.1016/0145-2134(94)90093-0; Fulton D R, 2000, Crit Care Nurs Q, V23, P43; GREEN A, 1985, CHILDREN TRAUMATIZED; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; *NAT RES OCUNC, 1993, UND AB NEGL; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; PRICHARD JW, 1996, MR SPECTROSCOPY CLIN, P1; PYNOOS RS, 1985, WITNESSING ACTS PERS; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; SBALCHIERO J, 2000, ANN EMERG MED, V36, pS48; SCHEERINGA MS, 1995, J AM ACAD CHILD PSY, V34, P191, DOI 10.1097/00004583-199502000-00014; Sedlak AJ., 1996, 3 NATL INCIDENCE STU; Shin LM, 1999, AM J PSYCHIAT, V156, P575; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; *US DEP HHS, 1999, CHLD MALTR 1997 REP; *US DEP HHS, 1998, CHILD MALTR 1996 REP	38	14	14	3	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2002	13	2					235	+	PII S1042-3680(01)00003-1	10.1016/S1042-3680(01)00003-1			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	573HM	WOS:000176823500009	12391707				2021-06-18	
J	Eng, JJ; Rowe, SJ; McLaren, LM				Eng, JJ; Rowe, SJ; McLaren, LM			Mobility status during inpatient rehabilitation: A comparison of patients with stroke and traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						brain injuries; outcome assessment (health care); rehabilitation	OUTCOMES; LENGTH; STAY; POSTSTROKE; AGE; DISABILITY; PREDICTION; RECOVERY; CHARGES; MOTOR	Objectives: To compare the mobility status (admission and discharge status, change in status) between patients with stroke and traumatic brain injury (TBI) during inpatient rehabilitation and to determine the relationship between mobility status and outcome variables including length of stay (LOS). Design: Prospective study. Setting: Free-standing tertiary rehabilitation center. Participants: A total of 210 patients with stroke (n = 136) and TBI (n = 74) consecutively admitted for inpatient rehabilitation. Interventions: Not applicable. Main Outcome Measures: Clinical Outcome Variable Scale (COVS), a 13-item scale of mobility status (measured on admission and discharge from inpatient rehabilitation), and rehabilitation LOS. Results: With age and time since injury controlled in the model, the TBI group showed a significantly higher mobility status on admission and discharge over the stroke group, but the change (improvement) in mobility status did not differ. The admission mobility status accounted for 61% and 60% of variability of the discharge mobility status for the stroke and TBI groups, respectively. The admission mobility status accounted for 40% and 50% of the variability in rehabilitation LOS for the stroke and TBI groups, respectively. Either the admission mobility status or the physical therapist's prediction of the discharge status could be used to determine the actual discharge mobility status, although the physical therapist's predictions were more accurate than using a statistical model. Conclusions: The TBI group showed a higher mobility status at admission and discharge from inpatient rehabilitation than the stroke group; however, the rate of improvement (improvement in mobility status per day) did not differ between groups. Admission mobility status using the COVS was an excellent predictor of discharge mobility status and rehabilitation LOS in stroke and TBI patients.	Univ British Columbia, Sch Rehabil Sci, Vancouver, BC VT6 2B5, Canada; Gf Strong Rehab Ctr, Rehabil Res Lab, Vancouver, BC, Canada; Gf Strong Rehab Ctr, Acquired Brain Injury Program, Vancouver, BC, Canada	Eng, JJ (corresponding author), Univ British Columbia, Sch Rehabil Sci, T325-2211 Wesbrook Mall, Vancouver, BC VT6 2B5, Canada.			Eng, Janice/0000-0002-2093-0788	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [57862] Funding Source: Medline		Brock K, 1997, J Qual Clin Pract, V17, P37; Brosseau L, 1996, AM J PHYS MED REHAB, V75, P422, DOI 10.1097/00002060-199611000-00005; Brosseau L, 1996, AM J PHYS MED REHAB, V75, P431, DOI 10.1097/00002060-199611000-00006; CAREY RG, 1988, ARCH PHYS MED REHAB, V69, P337; CHAE J, 1995, AM J PHYS MED REHAB, V74, P218, DOI 10.1097/00002060-199505000-00007; CHANG WC, 1995, ARCH PHYS MED REHAB, V76, P934, DOI 10.1016/S0003-9993(95)80070-0; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Duncan P, 1989, DUKE MOBILITY SKILLS; Franchignoni F, 1998, Ann Ist Super Sanita, V34, P463; Freeman JA, 1996, DISABIL REHABIL, V18, P106, DOI 10.3109/09638289609166025; GRANGER CV, 1992, STROKE, V23, P978, DOI 10.1161/01.STR.23.7.978; Harvey RL, 1998, ARCH PHYS MED REHAB, V79, P1349, DOI 10.1016/S0003-9993(98)90226-X; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; HEINEMANN AW, 1987, ARCH NEUROL-CHICAGO, V44, P167; Heinemann AW, 1990, J NEUROL REHABIL, V4, P27; HERTANU JS, 1984, ARCH PHYS MED REHAB, V65, P505; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; *I REH RES DEV, 1999, COVS PHYS CLIN OUTC; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; JONGBLOED L, 1988, CAN J REHABIL, V2, P87; Juneja G, 1998, AM J PHYS MED REHAB, V77, P388, DOI 10.1097/00002060-199809000-00005; KALRA L, 1994, STROKE, V25, P346, DOI 10.1161/01.STR.25.2.346; Kleinbaum D., 1998, APPL REGRESSION ANAL; KORNERBITENSKY N, 1989, ARCH PHYS MED REHAB, V70, P95; MAYO NE, 1991, AM J PHYS MED REHAB, V70, P5, DOI 10.1097/00002060-199102000-00003; MERBITZ C, 1989, ARCH PHYS MED REHAB, V70, P308; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Prudham D, 1981, Age Ageing, V10, P141; Reeder KP, 1996, J HEAD TRAUMA REHAB, V11, P22, DOI 10.1097/00001199-199606000-00006; Sakari-Rantala R, 1998, SCAND J REHABIL MED, V30, P121; SEABY L, 1989, Physiotherapy Canada, V41, P264; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; STINEMAN MG, 1994, MED CARE, V32, P366, DOI 10.1097/00005650-199404000-00005; STINEMAN MG, 1990, ARCH PHYS MED REHAB, V71, P881; TAPPING C, 1981, ASSESSMENT QUALITY C, V2; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; Wade D T, 1987, Int Rehabil Med, V8, P129; WRIGHT BD, 1989, ARCH PHYS MED REHAB, V70, P857	39	14	14	1	3	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2002	83	4					483	490		10.1053/apmr.2002.31203			8	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	538DF	WOS:000174798300007	11932849	Green Accepted			2021-06-18	
J	Ruppel, RA; Clark, RSB; Bayir, H; Satchell, MA; Kochanek, PM				Ruppel, RA; Clark, RSB; Bayir, H; Satchell, MA; Kochanek, PM			Critical mechanisms of secondary damage after inflicted head injury in infants and children	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article							TRAUMATIC BRAIN INJURY; METHYL-D-ASPARTATE; CEREBRAL BLOOD-FLOW; CENTRAL NERVOUS-SYSTEM; PROGRAMMED CELL-DEATH; TUMOR-NECROSIS-FACTOR; SHAKEN BABY SYNDROME; NEONATAL RAT-BRAIN; CEREBROSPINAL-FLUID; QUINOLINIC ACID	A number of critical mechanisms are involved in the pathophysiology of inflicted head injury. Excitotoxicity, oxidative stress, inflammation, programmed cell death, and mediators of blood flow and metabolism all contribute to secondary injury after abusive head trauma. These mechanisms are reviewed and the implications for clinical practice discussed.	Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Ctr Injury Control & Res, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15213 USA	Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol & Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@anes.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32-NS07485-01, NS30318] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER		Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bayir H, 2000, CRIT CARE MED, V28, pA52; BAYIR H, 2001, SOC NEUR ABSTR, V27; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bergeron M, 2000, ANN NEUROL, V48, P285, DOI 10.1002/1531-8249(200009)48:3<285::AID-ANA2>3.3.CO;2-#; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Biagas KV, 1996, J NEUROTRAUM, V13, P189, DOI 10.1089/neu.1996.13.189; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown JIM, 1998, J NEUROTRAUM, V15, P253, DOI 10.1089/neu.1998.15.253; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Cheema ZF, 1999, J NEUROSCI, V19, P1754; Chen J, 1997, NEUROLOGY, V48, P306, DOI 10.1212/WNL.48.2.306; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Clark RSB, 1997, NEUROSURGERY, V41, P1284, DOI 10.1097/00006123-199712000-00010; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Currie RW, 2000, BRAIN RES, V863, P169, DOI 10.1016/S0006-8993(00)02133-8; Duhaime A.C., 1993, J NEUROTRAUMA S1, V10, pS59; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; GIDDAY JM, 1994, NEUROSCI LETT, V168, P221, DOI 10.1016/0304-3940(94)90455-3; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Gorgias N, 1996, BRAIN RES, V714, P215, DOI 10.1016/0006-8993(95)01548-5; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Han YY, 1999, CRIT CARE MED, V27, pA75, DOI 10.1097/00003246-199912001-00184; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; HEYES MP, 1993, BIOCHEM SOC T, V21, P83, DOI 10.1042/bst0210083; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Janesko K. L., 2000, Journal of Neurotrauma, V17, P956; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; KATO H, 1992, NEUROSCI LETT, V139, P118, DOI 10.1016/0304-3940(92)90871-4; KATO N, 1993, P NATL ACAD SCI USA, V90, P7114, DOI 10.1073/pnas.90.15.7114; KITAGAWA K, 1990, BRAIN RES, V528, P21, DOI 10.1016/0006-8993(90)90189-I; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; KOCHANEK PM, 2001, TRAUMATIC CNS INJURY, P251; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; MARINI AM, 1992, P NATL ACAD SCI USA, V89, P6555, DOI 10.1073/pnas.89.14.6555; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; Perez-Pinzon MA, 1999, NEUROREPORT, V10, P2951, DOI 10.1097/00001756-199909290-00014; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; PorteraCailliau C, 1997, J COMP NEUROL, V378, P70; Raghupathi R, 1998, J CEREBR BLOOD F MET, V18, P1259, DOI 10.1097/00004647-199811000-00013; ROBERTSON CL, 1999, J NEUROTRAUM, V16, P975; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; ROSENBERG PA, 1989, NEUROSCI LETT, V103, P162, DOI 10.1016/0304-3940(89)90569-7; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Ruppel RA, 1999, CRIT CARE MED, V27, pA76, DOI 10.1097/00003246-199912001-00188; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; SANCHEZRODRIGUEZ VF, 1995, AM J FOREN MED PATH, V16, P210, DOI 10.1097/00000433-199509000-00004; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Smith SL, 1998, J NEUROTRAUM, V15, P707, DOI 10.1089/neu.1998.15.707; SPECTOR R, 1984, FED PROC, V43, P196; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Whalen MJ, 1998, J NEUROTRAUM, V15, P777, DOI 10.1089/neu.1998.15.777; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029; Xiao F, 2000, NEUROSCI LETT, V285, P5, DOI 10.1016/S0304-3940(00)00997-6; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Zhong J, 1996, MOL PHARMACOL, V50, P631	86	14	14	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2002	13	2					169	+	PII S1042-3680(01)00005-5	10.1016/S1042-3680(01)00005-5			19	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	573HM	WOS:000176823500004	12391702				2021-06-18	
J	Stoffel, M; Plesnila, N; Eriskat, J; Furst, M; Baethmann, A				Stoffel, M; Plesnila, N; Eriskat, J; Furst, M; Baethmann, A			Release of excitatory amino acids in the penumbra of a focal cortical necrosis	JOURNAL OF NEUROTRAUMA			English	Article						aspartate; glutamate; microdialysis; penumbra; rats; secondary necrosis growth; traumatic brain injury	TRAUMATIC BRAIN INJURY; RAT HIPPOCAMPUS; INTRACEREBRAL MICRODIALYSIS; GLUTAMATE RELEASE; IMPACT INJURY; L-ARGININE; EDEMA; ISCHEMIA; DAMAGE; INVIVO	A cortical tissue necrosis from focal trauma expands between 30% and 300% from its initial size within 24 h, depending on the species studied. To shed light on the pathophysiological processes in the penumbra 1 zone after a focal cortical lesion, the release of excitatory amino acids into the traumatic penumbra zone 1 was measured throughout the entire period of necrosis expansion. A microdialysis probe was inserted at an oblique angle into the cortex of Sprague-Dawley rats 2 mm below the brain surface. One day later, a highly standardized cortical freezing lesion was induced at the brain cortex above the microdialysis probe. Dialysate was continuously collected prior to, during, and up to 24 h after trauma and analyzed for primary amino acids. In each animal, it was confirmed histologically that the tip of the microdialysis probe was localized in the gray matter in close proximity to the primary lesion. Following induction of the trauma, a statistically significant sharp increase of the dialysate level of aspartate, glutamate, glycine, and serine was observed. Thereafter, the dialysate levels of these amino acids returned to baseline levels without any further increase throughout the remaining observation period. This process ranged in time from a few minutes to a few hours. The level of alanine in the dialysate was essentially not altered throughout the experiment. Although the early post-traumatic increase of the excitatory neurotransmitters aspartate and glutamate may well contribute to the secondary lesion growth of a cortical necrosis after trauma, glutamate receptor targeted therapeutic intervention may be in view of these findings of limited use when initiated post trauma.	Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany; Univ Munich, Klinikum Grosshadern, Inst Surg Res, D-8000 Munich, Germany	Stoffel, M (corresponding author), Univ Bonn, Dept Neurosurg, Sigmund Freud Str 25, D-53105 Bonn, Germany.	michael.stoffel@ukb.uni-bonn.de	Plesnila, Nikolaus/T-7522-2019				Attwell D, 2000, J NUTR, V130, p1023S, DOI 10.1093/jn/130.4.1023S; BAETHMANN A, 1988, CRIT CARE MED, V16, P972, DOI 10.1097/00003246-198810000-00008; BAETHMANN A, 1989, J NEUROSURG, V70, P578, DOI 10.3171/jns.1989.70.4.0578; BAETHMANN A, 1990, ACT NEUR S, V50, P14; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; BENVENISTE H, 1989, J NEUROCHEM, V52, P1667, DOI 10.1111/j.1471-4159.1989.tb07243.x; BENVENISTE H, 1987, ACTA NEUROPATHOL, V74, P234, DOI 10.1007/BF00688186; BONDOLI A, 1981, RESUSCITATION, V9, P119, DOI 10.1016/0300-9572(81)90021-6; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; DALKARA T, 1992, BRAIN RES, V576, P197, DOI 10.1016/0006-8993(92)90680-8; DANBOLT NC, 1993, GLUTAMATE TRANSMITTE, P12; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; EGGERT HR, 1985, NEUROSURGERY, V16, P443, DOI 10.1227/00006123-198504000-00001; ERISKAT J, 1994, ACTA NEUROCHIR, P425; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Gagliardi RJ, 2000, ARQ NEURO-PSIQUIAT, V58, P583, DOI 10.1590/S0004-282X2000000300030; GAUCHY C, 1980, BRAIN RES, V193, P129, DOI 10.1016/0006-8993(80)90950-6; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; HALL ED, 1993, RES P ARNMD, V71, P81; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KEHR J, 1993, J NEUROSCI METH, V48, P251, DOI 10.1016/0165-0270(93)90096-A; KEMPSKI OS, 1994, ANAESTHESIST, V43, pS25; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; Koura SS, 1998, ACT NEUR S, V71, P244; LANGE KW, 1993, GLUTAMATE TRANSMITTE, P30; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; LINDSBERG PJ, 1991, J CEREBR BLOOD F MET, V11, P88, DOI 10.1038/jcbfm.1991.10; MAIERHAUFF K, 1984, RECENT PROGR STUDY T, P183; MARCOUX FW, 1993, GLUTAMATE TRANSMITTE, P76; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MCBRIDE WJ, 1973, J NEUROBIOL, V4, P557, DOI 10.1002/neu.480040608; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; MURDOCH J, 1990, CAN J ANAESTH, V37, P663, DOI 10.1007/BF03006487; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; OLNEY JW, 1993, GLUTAMATE TRANSMITTE, P3; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PLESNILA N, 1997, J CEREB BLOOD FLOW M, V17, pS73; POLITI LE, 1985, NEUROCHEM PATHOL, V3, P249; PUMAIN R, 1985, J NEUROPHYSIOL, V53, P1; ROTHMAN SM, 1985, J NEUROSCI, V5, P1483; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SMITH SE, 1995, STROKE, V26, P117, DOI 10.1161/01.STR.26.1.117; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Stover JF, 2000, BRAIN RES, V875, P51, DOI 10.1016/S0006-8993(00)02597-X; Unterberg AW, 1997, ACT NEUR S, V70, P106; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; VONHOF S, 1997, THESIS L MAXIMILIANS; WIELOCH T, 1985, PROG BRAIN RES, V63, P69; WYRWICH W, 1997, THESIS L MAXIMILIANS; XUE D, 1994, J CEREBR BLOOD F MET, V14, P251, DOI 10.1038/jcbfm.1994.32; YOUNG AMJ, 1986, J NEUROCHEM, V47, P1399, DOI 10.1111/j.1471-4159.1986.tb00771.x	61	14	17	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2002	19	4					467	477		10.1089/08977150252932415			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	542XP	WOS:000175071200007	11990352				2021-06-18	
J	Hausmann, ON; Hu, WH; Keren-Raifman, T; Witherow, DS; Wang, Q; Levay, K; Frydel, B; Slepak, VZ; Bethea, JR				Hausmann, ON; Hu, WH; Keren-Raifman, T; Witherow, DS; Wang, Q; Levay, K; Frydel, B; Slepak, VZ; Bethea, JR			Spinal cord injury induces expression of RGS7 in microglia/macrophages in rats	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						RGS protein; Gbeta5; CNS; inflammation; TNF-alpha; trauma	PROTEIN BETA-SUBUNIT; GTPASE-ACTIVATING PROTEINS; ALPHA-SUBUNITS; INFLAMMATORY RESPONSE; MESSENGER-RNA; MICE LACKING; G-BETA-5; DOMAIN; BRAIN; REGULATORS	RGS proteins regulate G protein-mediated signalling pathways through direct interaction with the Galpha subunits and facilitation of GTP hydrolysis. An RGS subfamily consisting of RGS 6, 7, 9, and 11 also interacts with the G protein beta subunit Gbeta5 via a characteristic Ggamma-like domain. Thus far, these complexes were found only in neurons, with RGS7 being the most widely distributed in the brain. Here we confirm the expression of RGS7 in spinal neurons and show as a novel finding that following an experimental spinal cord injury in rats, expression of RGS7 is induced in a subpopulation of other cells. Immunofluorescent confocal microscopy using a series of cell specific antibodies identified these RGS7 positive cells as activated microglia and/or invading peripheral macrophages. To rule out interference from the adjacent neurons and confirm the presence of RGS7-Gbeta5 complex in inflammatory cells, we performed immunocytochemistry, RT-PCR, Western blot, and immunoprecipitation using microglial (BV2) and peripheral macrophage (RAW) cell lines. Expression of RGS7 mRNA and protein are nearly undetectable in non-stimulated BV2 and RAW cells, but remarkably increased after stimulation with LPS or TNF-alpha In addition, RGS7-positive cells were also found in the perinodular rim in the rat spleen. Our findings show that RGS7-Gbeta5 complex is expressed in immunocompetent cells such as resident microglia and peripheral macrophages following spinal cord injury. This expression might contribute to the post-traumatic inflammatory responses in the central nervous system.	Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA; Univ Miami, Sch Med, Dept Neurol Surg, Miami, FL 33101 USA; Univ Clin, Dept Neurosurg, Basel, Switzerland	Bethea, JR (corresponding author), Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL 33101 USA.		Kumar, Rishabh/P-4667-2017	Witherow, D. Scott/0000-0002-7344-1574	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM060019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS037130] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM60019] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS37130] Funding Source: Medline		Acarin L, 2000, EUR J NEUROSCI, V12, P3505, DOI 10.1046/j.1460-9568.2000.00226.x; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bethea JR, 1999, J NEUROTRAUM, V16, P851, DOI 10.1089/neu.1999.16.851; Bethea JR, 1998, J NEUROSCI, V18, P3251; BIRNBAUMER L, 1992, CELL, V71, P1069, DOI 10.1016/S0092-8674(05)80056-X; Bruce AJ, 1996, NAT MED, V2, P788, DOI 10.1038/nm0796-788; Cabrera JL, 1998, BIOCHEM BIOPH RES CO, V249, P898, DOI 10.1006/bbrc.1998.9218; Carlson SL, 1998, EXP NEUROL, V151, P77, DOI 10.1006/exnr.1998.6785; Chase DL, 2001, CURR BIOL, V11, P222, DOI 10.1016/S0960-9822(01)00071-9; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; Hunt TW, 1996, NATURE, V383, P175, DOI 10.1038/383175a0; Jones PG, 1998, BBA-MOL CELL RES, V1402, P288, DOI 10.1016/S0167-4889(98)00017-2; Keren-Raifman T, 2001, FEBS LETT, V492, P20, DOI 10.1016/S0014-5793(01)02220-7; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8; Kovoor A, 2000, J BIOL CHEM, V275, P3397, DOI 10.1074/jbc.275.5.3397; Levay K, 1999, P NATL ACAD SCI USA, V96, P2503, DOI 10.1073/pnas.96.5.2503; Liang JJ, 2000, J NEUROSCI RES, V60, P58, DOI 10.1002/(SICI)1097-4547(20000401)60:1<58::AID-JNR6>3.0.CO;2-L; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2000, PROG BRAIN RES, V128, P43; Posner BA, 1999, J BIOL CHEM, V274, P31087, DOI 10.1074/jbc.274.43.31087; Schwab ME, 1996, PHYSIOL REV, V76, P319; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; Taoka Y, 2000, J NEUROTRAUM, V17, P219, DOI 10.1089/neu.2000.17.219; Watanabe T, 1999, J NEUROTRAUM, V16, P255, DOI 10.1089/neu.1999.16.255; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; Zhang JH, 2001, J BIOL CHEM, V276, P10284, DOI 10.1074/jbc.M009247200; Zhang SL, 2000, ACTA MATH SCI, V20, P1	40	14	15	0	1	BLACKWELL PUBLISHING LTD	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DG, OXON, ENGLAND	0953-816X			EUR J NEUROSCI	Eur. J. Neurosci.	FEB	2002	15	4					602	612		10.1046/j.1460-9568.2002.01916.x			11	Neurosciences	Neurosciences & Neurology	536HB	WOS:000174693700002	11886441				2021-06-18	
J	Rosati, DL				Rosati, DL			Early polyneuropharmacologic rehabilitation, a division of UB intervention in brain injury agitation	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						brain injury; agitation; treatment	PATIENT	Objective: To evaluate clinical outcomes observed in the treatment of posttraumatic brain injury agitation with multiple medications. Design: Longitudinal evaluation of effect of treatment intervention on patients admitted to a level 1 trauma center with traumatic brain injury. Eleven adult patients referred for physiatry consultation to manage posttraumatic brain injury agitation were treated with a combination of medications and other agents (antipsychotics and sedatives) were discontinued. The Rancho Los Amigos scale was rated on initial consultation and follow-up, ranging from 1 to 3 wk. Results: All 11 patients demonstrated an average improvement of three Rancho Los Amigos levels within an average treatment duration of 10 days. Simultaneously, 9 of 11 patients were discontinued from treatment and prescribed antipsychotic and sedative agents. Conclusions: The findings suggest that administration of multiple neuropharmacologic agents used early in the treatment of posttraumatic brain injury agitation may be an effective therapeutic intervention in which behavioral and, possibly, cognitive benefits occur. These results were noted as patients were discontinued from other agents more commonly employed in the acute care setting for the treatment of posttraumatic brain injury agitation. Further research is needed to determine the most effective medication combinations and the best time to initiate treatment.	Hosp Special Care, Dept Phys Med & Rehabil, New Britain, CT 06053 USA; Hartford Hosp, Dept Emergency Med Traumatol & Rehabil, Hartford, CT 06115 USA	Rosati, DL (corresponding author), Hosp Special Care, Dept Phys Med & Rehabil, 2150 Corbin Ave, New Britain, CT 06053 USA.						CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Sandel ME, 1996, ARCH PHYS MED REHAB, V77, P617, DOI 10.1016/S0003-9993(96)90306-8; WIERCISIEWSKI DR, 1997, PHYS MED REHABIL CLI, V8, P763	6	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2002	81	2					90	93		10.1097/00002060-200202000-00003			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	515GJ	WOS:000173486800003	11807342				2021-06-18	
J	Smith, CP; Somogyi, GT; Bird, ET; Chancellor, MB; Boone, TB				Smith, CP; Somogyi, GT; Bird, ET; Chancellor, MB; Boone, TB			Neurogenic bladder model for spinal cord injury: spinal cord microdialysis and chronic urodynamics	BRAIN RESEARCH PROTOCOLS			English	Article						microdialysis; amino acid; spinal cord injury; bladder	EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN INJURY; MICTURITION REFLEX; NMDA RECEPTORS; IMPACT INJURY; RAT; GLUTAMATE; NEUROTOXICITY; ANTAGONIST; ELEVATION	We describe an animal model to study neurotransmitter changes in parallel with urodynamic testing following Spinal Cord Injury (SCI). Urodynamic access was achieved using a subcutaneously placed 7 French dual lumen portacatheter. Spinal cord injury was induced by weight drop technique onto exposed dura at T8. The L6-S1 detrusor nuclei were localized stereotactically and microdialysis probe placement was confirmed through histologic methods. Chronic urodynamics revealed detrusor hyper-reflexia (DH) 14 days following SCI. In vivo microdialysis of spinal cord amino acids was performed using CMA 11 (240 muM) probes in halothane-anesthetized rats at baseline and intervals of 20-30 min following spinal cord injury. Significant increases in the excitatory amino acid glutamate, and the inhibitory amino acids, glycine and taurine, were seen following spinal cord injury. Amino acid levels peaked at approximately 40 min following contusion injury with glycine demonstrating the highest levels of all amino acids measured. This neurogenic rat model provides a useful means of examining the effects of spinal cord injury on bladder function. By utilizing spinal cord microdialysis, one could intervene at the level of the detrusor nuclei to modulate bladder function. (C) 2002 Elsevier Science B.V. All rights reserved.	Baylor Coll Med, Dept Urol, Houston, TX 77030 USA; Vet Affairs Spinal Cord Injury Unit, Houston, TX USA; Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Urol, Pittsburgh, PA USA	Smith, CP (corresponding author), LS Kaufmann Bldg 700,3471 5th Ave, Pittsburgh, PA 15213 USA.						BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BUTCHER SP, 1987, J NEUROCHEM, V48, P722, DOI 10.1111/j.1471-4159.1987.tb05576.x; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Liu D, 1999, NEUROSCIENCE, V93, P1383, DOI 10.1016/S0306-4522(99)00278-X; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; MATSUMOTO G, 1995, NEUROSCI LETT, V183, P58, DOI 10.1016/0304-3940(94)11114-X; McAdoo DJ, 1999, EXP NEUROL, V159, P538, DOI 10.1006/exnr.1999.7166; NOBLE LJ, 1987, EXP NEUROL, V95, P530, DOI 10.1016/0014-4886(87)90162-2; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pikov V, 1998, J NEUROTRAUM, V15, P375, DOI 10.1089/neu.1998.15.375; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; SIMPSON RK, 1993, NEUROCHEM RES, V18, P887, DOI 10.1007/BF00998273; SLUKA KA, 1994, J PHARMACOL EXP THER, V271, P76; STEERS WD, 1991, J COMP NEUROL, V310, P401, DOI 10.1002/cne.903100309; SVED AF, 1993, J NEUROCHEM, V61, P2089, DOI 10.1111/j.1471-4159.1993.tb07446.x; WAHL P, 1989, J NEUROCHEM, V53, P1316, DOI 10.1111/j.1471-4159.1989.tb07430.x; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; YOSHIYAMA M, 1993, J PHARMACOL EXP THER, V265, P844; ZANOTTO L, 1983, NEUROSCI LETT, V35, P79, DOI 10.1016/0304-3940(83)90530-X	23	14	16	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1385-299X			BRAIN RES PROTOC	Brain Res. Protoc.	FEB	2002	9	1					57	64	PII S1385-299X(01)00137-4	10.1016/S1385-299X(01)00137-4			8	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	536VL	WOS:000174722500008	11852271				2021-06-18	
J	Cihangiroglu, M; Ramsey, RG; Dohrmann, GJ				Cihangiroglu, M; Ramsey, RG; Dohrmann, GJ			Brain injury: Analysis of imaging modalities	NEUROLOGICAL RESEARCH			English	Article						brain injuries; brain CT; brain MR; brain SPECT; brain PET; imaging of brain trauma	MAGNETIC-RESONANCE-SPECTROSCOPY; DIFFUSE AXONAL INJURY; INTERMEDIATE-FIELD MR; COMPUTED-TOMOGRAPHY; HEAD TRAUMA; SUBDURAL HEMATOMAS; CT; CHILDREN; LOCALIZATION; PREDICTORS	Advances in imaging have had a significant impact not only on the diagnosis of but also on the management of patients with brain injury. Various modalities are available to image the brain; however, it is not always clear which imaging modality (CT, MRI, SPECT, PET, etc.) is optimal for a specific aspect of traumatized brain. The purpose of this paper is to analyze the over 20,000 imaging studies clone in brain injury and to compare the results with the experience in the literature. A detailed comparison has been clone relative to CT, MRI, SPECT and PET in traumatic brain injury.	Univ Chicago, Med Ctr, Neurosurg Sect, Chicago, IL 60637 USA; Univ Chicago, Med Ctr, Neuroradiol Sect, Chicago, IL 60637 USA	Dohrmann, GJ (corresponding author), Univ Chicago, Med Ctr, Neurosurg Sect, MC 3026,5841 S Maryland Ave, Chicago, IL 60637 USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 1991, NEUROIMAG CLIN N AM, V1, P397; AHMADI J, 1983, AM J NEURORADIOL, V4, P131; Balcer LJ, 1996, AM J OPHTHALMOL, V122, P437, DOI 10.1016/S0002-9394(14)72078-1; BAYKANER K, 1988, SURG NEUROL, V30, P339, DOI 10.1016/0090-3019(88)90195-4; BORZCUK P, 1997, EMERG MED CLIN N AM, V15, P563; BOYKO OB, 1991, AM J NEURORADIOL, V12, P341; CARON MH, 1996, NEUROTRAUMA, P163; COMELIUS RS, 1991, NEUROIMAG CLIN N AM, V1, P433; Diaz-Marchan P.G., 1996, NEUROTRAUMA, P137; EDELMAN RR, 1986, AM J NEURORADIOL, V7, P751; EVANS RW, 1992, NEUROL CLIN, V10, P815; Fatouros PP, 1999, J NEUROSURG, V90, P109, DOI 10.3171/jns.1999.90.1.0109; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Gean A, 1994, IMAGING HEAD TRAUMA; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gentry LR, 1991, NEUROIMAG CLIN N AM, V1, P411; Gomori J M, 1988, Radiographics, V8, P427; GOMORI JM, 1985, RADIOLOGY, V157, P87, DOI 10.1148/radiology.157.1.4034983; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HANKINS L, 1996, NEUROTRAUMA, P151; Haseler LJ, 1997, PEDIATRICS, V99, P4, DOI 10.1542/peds.99.1.4; Holbourn AHS, 1943, LANCET, V2, P438; Howard-Lech VL, 1999, PHYSIOL MEAS, V20, P75, DOI 10.1088/0967-3334/20/1/006; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KLEINMAN PK, 1990, AM J ROENTGENOL, V155, P703, DOI 10.2214/ajr.155.4.2119097; LESOIN F, 1984, NEURORADIOLOGY, V26, P515, DOI 10.1007/BF00342691; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Miller EC, 1996, ANN EMERG MED, V27, P290, DOI 10.1016/S0196-0644(96)70261-5; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mogbo KI, 1998, RADIOLOGY, V208, P521, DOI 10.1148/radiology.208.2.9680586; Mullan BP, 1996, NEUROSURG CLIN N AM, V7, P617; Newmark J, 1999, MIL MED, V164, P59; OSBORN AG, 1994, DIAGNOSTIC NEURORADI, P199; OZGEN T, 1990, NEURORADIOLOGY, V32, P481; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Petitti N, 1998, ACAD RADIOL, V5, P215, DOI 10.1016/S1076-6332(98)80287-0; PHELPS ME, 1992, CLIN BRAIN IMAGING P, P71; REED D, 1986, AM J NEURORADIOL, V7, P417; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; SEIDENWURM D, 1989, RADIOLOGY, V172, P189, DOI 10.1148/radiology.172.1.2740502; SMITH WP, 1981, AM J ROENTGENOL, V136, P543, DOI 10.2214/ajr.136.3.543; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Varney NR, 1998, J HEAD TRAUMA REHAB, V13, P63; Yano Koh, 1997, Neurologia Medico-Chirurgica, V37, P838; Zee CS, 1998, NEUROIMAG CLIN N AM, V8, P525; ZIMMERMAN RA, 1991, NEUROIMAG CLIN N AM, V1, P443; ZYED A, 1991, AM J NEURORADIOL, V12, P469	56	14	14	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JAN	2002	24	1					7	18		10.1179/016164102101199440			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	519WJ	WOS:000173748200003	11783756				2021-06-18	
J	Johnson, PD; Hertel, J; Olmsted, LC; Denegar, CR; Putukian, M				Johnson, PD; Hertel, J; Olmsted, LC; Denegar, CR; Putukian, M			Effect of mild brain injury on an instrumented agility task	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						cerebral concussion; Postconcussion syndrome; functional assessment	MINOR HEAD-INJURIES; CEREBRAL CONCUSSION; CONTACT-SPORTS; PREVENTION; SEQUELAE; GUIDELINES; MANAGEMENT; RETURN	Objective: To identify an objective evaluation technique to guide return-to-play decisions following mild brain injury (MBI) using an agility task that incorporates cognitive and motor performance. Design: Prospective, controlled, repeated measures study. Setting: Collegiate athletic training facility. Participants: 84 athletes (25 male rugby players, 34 female rugby players, 25 male ice hockey players) from 3 intercollegiate club teams participated. 9 athletes who suffered MBI during their competitive seasons and 9 matched controls completed the entire study protocol. Main Outcome Measures: Time to complete an agility task on the Cybex Reactor and a postconcussive symptoms scale score were assessed in all subjects during the preseason. Injured subjects and matched controls were also assessed 1, 3. 5. and 10 days postinjury. Results: Repeated measures analyses of variance revealed significant differences between injured Subjects and controls in postconcussion symptoms, but not agility performance. Post hoc testing revealed that injured Subjects reported significantly more postconcussion symptoms on Day I after injury. Conclusion: The methods of agility assessment used in this study appear to not be sensitive enough to detect functional impairment following MBI.	Penn State Univ, Dept Kinesiol, Athlet Training Res Lab, University Pk, PA 16802 USA; Penn State Univ, Ctr Orthoped & Sports Med, University Pk, PA 16802 USA	Hertel, J (corresponding author), Penn State Univ, Dept Kinesiol, Athlet Training Res Lab, 269 Recreat Bldg, University Pk, PA 16802 USA.		denegar, craig/AAX-7373-2020				[Anonymous], 1991, COL MED SOC REP SPOR; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Bleiberg J, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199804000-00006; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1988, SPORTS MED DIGEST, V10, P1; CARLSSON GS, 1987, J NEUROSURG, V67, P197, DOI 10.3171/jns.1987.67.2.0197; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; GUSKIEWICZ KM, 1997, MED SCI SPORTS EXERC, V29, P213; Hertel J, 1999, J SPORT REHABIL, V8, P24, DOI 10.1123/jsr.8.1.24; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LOVELL MR, 1998, SPORTS RELATED CONCU; Macciocchi SN, 1998, CLIN SPORT MED, V17, P27, DOI 10.1016/S0278-5919(05)70058-2; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1997, MED SCI SPORT EXER, V29, pS207; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; NELSON W, 1984, ATHL TRAIN JNATA, V19, P95; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; Putukian M, 1996, PHYSICIAN SPORTSMED, V24, P25, DOI 10.3810/psm.1996.11.1283; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; TORG JS, 1987, CLIN SPORTS MED, V6, P17; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3429; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005	27	14	15	2	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1050-642X			CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2002	12	1					12	17		10.1097/00042752-200201000-00006			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	521CA	WOS:000173820100005	11854583				2021-06-18	
J	Ravens-Sieberer, U; Patrick, PD				Ravens-Sieberer, U; Patrick, PD		CHI Consensus Grp	Quality of life in children with traumatic brain injury - basic issues, assessment, and recommendations - Results of a consensus meeting	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article; Proceedings Paper	Consensus Conference on Quality of Life after Multiple Trauma	SEP 29-OCT 02, 1999	WERMELSKIRCHEN, GERMANY	German Minist Educ & Res		children; quality of life; traumatic brain injury; consensus conference	OF-LIFE; CHILDHOOD; ADOLESCENTS; ASTHMA	An international Task Force was convened under the guidance of BMBF Conference so as to review the "State of the art" for measuring quality of life (QoL) in children who have suffered traumatic brain injury (TBI). After expert review of instruments and evaluation of two independent literature reviews this work group established "inclusion criteria" for the review of current tools that could contribute to the measurement of QoL in children with TBI. Six instruments were determined to meet all or most of the criteria required to be used in current clinical practice and research for children with TBI.	Robert Koch Inst, D-13353 Berlin, Germany; Univ Virginia, Kluge Childrens Rehabil Ctr, Childrens Med Ctr, Charlottesville, VA 22903 USA	Ravens-Sieberer, U (corresponding author), Robert Koch Inst, Seestr 10, D-13353 Berlin, Germany.						BARR RD, 1994, INT J ONCOL, V4, P639; BIRD JE, 1990, PSYCHOL HEALTH, V4, P175; Bruil J, 1996, QUALITY LIFE NEWSLET, V13, P9; BULLINGER M, 1991, THEOR SURG, V6, P143; Bullinger M, 1995, PRAX KINDERPSYCHOL K, V44, P391; Bullinger M, 1994, Z GESUNDHEITSPSYCHOL, V2, P64; BULLINGER M, 1991, CONTROLLED CLIN TRIA, V12, P915; CARNEY N, 1999, EVIDENCE REPORT RE S; Christie MJ, 1991, CHILDHOOD ASTHMA QUE; EDELBROCK C, 1986, J CHILD PSYCHOL PSYC, V27, P181, DOI 10.1111/j.1469-7610.1986.tb02329.x; Eiser C, 1996, BRIT J CANCER, V73, P1313, DOI 10.1038/bjc.1996.251; Eiser C, 1997, ARCH DIS CHILD, V77, P350, DOI 10.1136/adc.77.4.350; Guyatt GH, 1997, PEDIATRICS, V99, P165, DOI 10.1542/peds.99.2.165; GUYER B, 1990, AM J DIS CHILD, V144, P649, DOI 10.1001/archpedi.1990.02150300047016; HALEY SM, 1991, PHYS MED REH CLIN N, V2, P689; Harter S., 1989, CAMBRIDGE STUDIES SO, P81; HERJANIC B, 1975, J ABNORM CHILD PSYCH, V3, P41, DOI 10.1007/BF00916029; Juniper EF, 1996, QUAL LIFE RES, V5, P27, DOI 10.1007/BF00435966; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KRAUS JF, 1987, HEAD INJURY, P1; Landgraf I, 1997, CHILD HLTH QUESTIONN; Landgraf J. M., 1997, DIALOGUES PEDIAT URO, V20, P5; LANDGRAF JM, 1993, 10 AN M HLTH SERV RE; LEWIS CC, 1989, MED CARE S3, V27, P54; Marra CA, 1996, PHARMACOTHERAPY, V16, P879; Mulhern RK, 1990, PSYCHOL ASSESSMENT, V2, P149; MURGIO A, 1999, 3 WORLD C BRAIN INJ; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; RAVENSSIEBERER U, 1998, MED PSYCHOL EINEM SI; RAVENSSIEBERER U, 1998, QUALITY LIFE CHILDRE; Rosenbaum LP, 1996, QUALITY LIFE PHARMAE, P793; Sartorius N, 1987, QUALITY LIFE CANC PA, P1075; Seiffge-Krenke I., 1990, KRANKHEITSVERARBEITU; SIMEONI MC, 1998, 5 ANN C INT SOC QUAL; SIMMONS RG, 1987, MOVING ADOLESCENCE I; Spieth LE, 1996, J PEDIATR PSYCHOL, V21, P175, DOI 10.1093/jpepsy/21.2.175; Spilker B., 1990, QUALITY LIFE ASSESSM; STARFIELD B, 1998, MEASURING HLTH RELAT; STEWART AL, 1981, MED CARE, V19, P473, DOI 10.1097/00005650-198105000-00001; STEWART AL, 1992, MEASURING FUNCTION W; Verrips GH, 1997, J APPL THER RES, V1, P357	41	14	14	0	0	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2002	20	3-4					151	159					9	Neurosciences	Neurosciences & Neurology	633MR	WOS:000180287500009	12454363				2021-06-18	
J	van Dijk, KRA; Scherder, EJA; Scheltens, P; Sergeant, JA				van Dijk, KRA; Scherder, EJA; Scheltens, P; Sergeant, JA			Effects of Transcutaneous Electrical Nerve Stimulation (TENS) on non-pain related cognitive and behavioural functioning	REVIEWS IN THE NEUROSCIENCES			English	Article						transcutaneous electrical nerve stimulation; neglect; stroke; Alzheimer's disease; coma	PROBABLE ALZHEIMERS-DISEASE; RANDOMIZED CONTROLLED TRIALS; ANTERIOR CINGULATE CORTEX; LOCUS-COERULEUS; NEGLECT PATIENTS; CEREBRAL ATROPHY; SPINAL PATHWAYS; SENILE DEMENTIA; RAPHE NUCLEUS; NECK MUSCLES	An extensive search through nine electronic bibliographic databases (PubMed, Cochrane Library, Web of Science, ERIC, PsychINFO, Psyndex, Cinahl, Biological Abstracts, Rehab-data) was performed in order to review the effects of Transcutaneous Electrical Nerve Stimulation (TENS) on non-pain related cognitive and behavioural functioning. Eight studies were identified on neglect due to stroke, six studies on Alzheimer's disease (AD), one study on aging, and two studies on coma due to traumatic brain injury. The results of the various studies revealed that TENS has a variety of effects. These consist of enhancement of. somatosensory functioning, visuo-spatial abilities and postural control in neglect, improved memory, affective behaviour and rest-activity rhythm in AD and acceleration of awakening in coma. Effectiveness of TENS is discussed in relation to various stimulation parameters: duration, frequency, pulse width and intensity. It is argued that arousal may underlie the beneficial influence of TENS in various conditions. Finally, suggestions are offered for future research.	Vrije Univ Amsterdam, Dept Clin Neurophysiol, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Med, Dept Neurol, Amsterdam, Netherlands		kra.van.dijk@psy.vu.nl	Van Dijk, Koene/G-3317-2012; Scheltens, Philip/AAL-9631-2020	Van Dijk, Koene/0000-0001-6137-4282; Scheltens, Philip/0000-0002-1046-6408			Arendt T, 1997, J NEUROSCI, V17, P516; ASHBY P, 1976, NEUROLOGY, V26, P1145, DOI 10.1212/WNL.26.12.1145; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Blin J, 1997, NEUROIMAGE, V6, P335, DOI 10.1006/nimg.1997.0296; BOBILLIER P, 1976, BRAIN RES, V113, P449, DOI 10.1016/0006-8993(76)90050-0; Braak H, 1996, ACTA NEUROPATHOL, V92, P197, DOI 10.1007/s004010050508; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; BRODY H, 1992, ACTA NEUROL SCAND, V85, P40, DOI 10.1111/j.1600-0404.1992.tb05037.x; BURSTEIN R, 1989, BRAIN RES, V497, P149, DOI 10.1016/0006-8993(89)90981-5; CARPENTER GA, 1993, TRENDS NEUROSCI, V16, P131, DOI 10.1016/0166-2236(93)90118-6; Carrol EN, 2001, ARCH PHYS MED REHAB, V82, P262, DOI 10.1053/apmr.2001.9176; CHENG RSS, 1981, BRAIN RES, V215, P77; COFFEY CE, 1992, NEUROLOGY, V42, P527, DOI 10.1212/WNL.42.3.527; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; COLEMAN PD, 1987, NEUROBIOL AGING, V8, P512; Collette F, 1997, HUM BRAIN MAPP, V5, P110, DOI 10.1002/(SICI)1097-0193(1997)5:2<110::AID-HBM4>3.0.CO;2-6; Cooper JB, 1999, BRAIN INJURY, V13, P261, DOI 10.1080/026990599121638; Cummings JL, 1998, AM J GERIAT PSYCHIAT, V6, pS64, DOI 10.1097/00019442-199821001-00009; CUSUMANO S, 1992, ELECTROEN CLIN NEURO, V84, P499, DOI 10.1016/0168-5597(92)90039-E; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370; DECARLI C, 1994, AM J NEURORADIOL, V15, P689; DELAMONTE SM, 1989, ANN NEUROL, V25, P450, DOI 10.1002/ana.410250506; DURANTI R, 1988, BRAIN RES, V452, P66, DOI 10.1016/0006-8993(88)90009-1; Facco E., 1993, Neurophysiologie Clinique, V23, P237, DOI 10.1016/S0987-7053(05)80233-3; GIESLER GJ, 1994, TRENDS NEUROSCI, V17, P244, DOI 10.1016/0166-2236(94)90007-8; Glanz M, 1996, ARCH PHYS MED REHAB, V77, P549, DOI 10.1016/S0003-9993(96)90293-2; GOUDSMIT E, 1990, NEUROBIOL AGING, V11, P529, DOI 10.1016/0197-4580(90)90114-F; Guariglia C, 1998, CORTEX, V34, P233, DOI 10.1016/S0010-9452(08)70750-0; Guariglia C, 2000, NEUROREPORT, V11, P1945, DOI 10.1097/00001756-200006260-00027; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Hitoto T, 1998, NEUROCHEM RES, V23, P1461, DOI 10.1007/BF03177488; HOWSON DC, 1978, PHYS THER, V58, P1467; Hozumi S, 1996, INT J NEUROSCI, V88, P1; HUBBARD BM, 1981, J NEUROL SCI, V50, P135, DOI 10.1016/0022-510X(81)90048-4; INGVAR DH, 1975, CIBA F S, V34, P97; Johansson BB, 2001, STROKE, V32, P707, DOI 10.1161/01.STR.32.3.707; KARNATH HO, 1995, EXP BRAIN RES, V105, P321; Kayama Y, 1998, EUR UROL, V33, P12, DOI 10.1159/000052235; KLAWANSKY S, 1995, J NERV MENT DIS, V183, P478, DOI 10.1097/00005053-199507000-00010; Kwan CL, 2000, PAIN, V85, P359, DOI 10.1016/S0304-3959(99)00287-0; LEGORATTISANCHEZ MO, 1989, BRAIN RES BULL, V23, P283, DOI 10.1016/0361-9230(89)90210-4; Levy CE, 2001, AM J PHYS MED REHAB, V80, P4, DOI 10.1097/00002060-200101000-00003; LEWINN EB, 1980, ROY SOC HEALTH J, V100, P19, DOI 10.1177/146642408010000107; Limoge A, 1999, NEUROSCI BIOBEHAV R, V23, P529, DOI 10.1016/S0149-7634(98)00048-7; MANN DMA, 1983, MECH AGEING DEV, V23, P73, DOI 10.1016/0047-6374(83)90100-8; MILNE S, 2001, COCHRANE DATABASE SY, V2; MITCHELL S, 1990, Brain Injury, V4, P273, DOI 10.3109/02699059009026177; MOKHA SS, 1985, EXP BRAIN RES, V58, P213; MOORE RY, 1992, PROG BRAIN RES, V93, P101; Mouton PR, 1998, NEUROBIOL AGING, V19, P371, DOI 10.1016/S0197-4580(98)00080-3; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; OMAHONY D, 1994, NEUROLOGY, V44, P2089, DOI 10.1212/WNL.44.11.2089; OMURA Y, 1983, ACUPUNCTURE ELECTRO, V8, P177; Pan CX, 2000, J PAIN SYMPTOM MANAG, V20, P374, DOI 10.1016/S0885-3924(00)00190-1; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Perennou DA, 2001, ARCH PHYS MED REHAB, V82, P440, DOI 10.1053/apmr.2001.21986; PETROV T, 1992, J COMP NEUROL, V318, P18, DOI 10.1002/cne.903180103; PIERCE J P, 1990, Brain Injury, V4, P191, DOI 10.3109/02699059009026165; Pizzamiglio L, 1996, RESTOR NEUROL NEUROS, V10, P197, DOI 10.3233/RNN-1996-10402; Pollak C P, 1991, J Geriatr Psychiatry Neurol, V4, P204, DOI 10.1177/089198879100400405; REGEUR L, 1994, NEUROBIOL AGING, V15, P347, DOI 10.1016/0197-4580(94)90030-2; Richard C, 2001, NEUROSCI LETT, V301, P64, DOI 10.1016/S0304-3940(01)01598-1; Robbins Trevor W., 1995, P703; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; ROCHE P A, 1990, Physiotherapy Theory and Practice, V6, P25, DOI 10.3109/09593989009087753; ROSSOR M, 1988, HDB PSYCHOPHARMACOLO, P107; RUSAK B, 1979, PHYSIOL REV, V59, P449; SALZMANN E, 1992, FORTSCHR NEUROL PSYC, V60, P163, DOI 10.1055/s-2007-999137; Samuelsson H, 1998, J CLIN EXP NEUROPSYC, V20, P73, DOI 10.1076/jcen.20.1.73.1481; SAPER CB, 1988, HDB PSYCHOPHARMACOLO, P131; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Scherder E, 1999, J PAIN SYMPTOM MANAG, V17, P152; SCHERDER EJA, 1995, BEHAV BRAIN RES, V67, P211, DOI 10.1016/0166-4328(94)00115-V; Scherder EJA, 1999, BEHAV BRAIN RES, V101, P105, DOI 10.1016/S0166-4328(98)00150-8; SCHERDER EJA, 1992, J CLIN EXP NEUROPSYC, V14, P951, DOI 10.1080/01688639208402546; Scherder EJA, 1998, BIOL PSYCHIAT, V43, P417, DOI 10.1016/S0006-3223(97)00208-4; Scherder EJA, 1999, BIOL PSYCHIAT, V45, P743, DOI 10.1016/S0006-3223(98)00072-9; Scherder EJA, 2000, BEHAV BRAIN RES, V111, P223, DOI 10.1016/S0166-4328(00)00170-4; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Sonde L, 2000, CLIN REHABIL, V14, P14, DOI 10.1191/026921500673534278; SWAAB DF, 1991, NEUROBIOL AGING, V12, P317, DOI 10.1016/0197-4580(91)90008-8; SWAAB DF, 1994, NEUROBIOL AGING, V15, P369, DOI 10.1016/0197-4580(94)90037-X; SWAAB DF, 1997, HDB CHEM NEUROANATOM; TAYLOR DN, 1989, ACUPUNCTURE ELECTRO, V14, P29, DOI 10.3727/036012989816358551; VALLAR G, 1995, NEUROPSYCHOLOGIA, V33, P73, DOI 10.1016/0028-3932(94)00088-7; Vallar G, 1996, J Int Neuropsychol Soc, V2, P452; Van Someren EJW, 1998, ALZ DIS ASSOC DIS, V12, P114, DOI 10.1097/00002093-199806000-00010; VANSOMEREN EJW, 1993, BEHAV BRAIN RES, V57, P235, DOI 10.1016/0166-4328(93)90140-L; VERTES RP, 1991, J COMP NEUROL, V313, P643, DOI 10.1002/cne.903130409; WEBER PL, 1984, ARCH PHYS MED REHAB, V65, P457; White PF, 2001, ANESTH ANALG, V92, P505, DOI 10.1213/00000539-200102000-00042; Wright A, 2001, CLIN J PAIN, V17, P33, DOI 10.1097/00002508-200103000-00006	93	14	15	0	7	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-1763	1607-8470		REV NEUROSCIENCE	Rev. Neurosci.		2002	13	3					257	270					14	Neurosciences	Neurosciences & Neurology	606LG	WOS:000178735000005	12405228				2021-06-18	
J	Elovic, EP; Zafonte, RD				Elovic, EP; Zafonte, RD			Ginkgo biloba: Applications in traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							EXTRACT EGB-761; CONSTITUENTS; MECHANISMS; VOLUNTEERS; TINNITUS; DEMENTIA; MEMORY; CELLS		Univ Med & Dent New Jersey, New Jersey Med Sch, W Orange, NJ 07052 USA	Elovic, EP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.						Bastianetto S, 2000, J NEUROCHEM, V74, P2268, DOI 10.1046/j.1471-4159.2000.0742268.x; Blumenthal M, 2000, HERBAL MED EXPANDED; Diamond BJ, 2000, ARCH PHYS MED REHAB, V81, P668, DOI 10.1016/S0003-9993(00)90052-2; Ernst E, 1999, CLIN OTOLARYNGOL, V24, P164, DOI 10.1046/j.1365-2273.1999.00243.x; FOURTILLAN JB, 1995, THERAPIE, V50, P137; Galluzzi S, 2000, J NEUROL NEUROSUR PS, V68, P679; *GOLD STAND MED, 2001, CLIN PHARM 2000 PHYS; HOLGERS KM, 1994, AUDIOLOGY, V33, P85; Kanowski S, 1996, PHARMACOPSYCHIATRY, V29, P47, DOI 10.1055/s-2007-979544; Kaye AD, 2000, J CLIN ANESTH, V12, P468, DOI 10.1016/S0952-8180(00)00195-1; LeBars PL, 1997, JAMA-J AM MED ASSOC, V278, P1327, DOI 10.1001/jama.278.16.1327; Lyon MR, 2001, J PSYCHIATR NEUROSCI, V26, P221; Ondrizek RR, 1999, FERTIL STERIL, V71, P517, DOI 10.1016/S0015-0282(98)00476-2; Rigney U, 1999, PHYTOTHER RES, V13, P408, DOI 10.1002/(SICI)1099-1573(199908/09)13:5&lt;408::AID-PTR530&gt;3.0.CO;2-C; Shih JC, 2000, ANTIOXID REDOX SIGN, V2, P467, DOI 10.1089/15230860050192242; Soholm B, 1998, ADV THER, V15, P54; Weiss SJ, 2001, ACAD EMERG MED, V8, P41, DOI 10.1111/j.1553-2712.2001.tb00548.x; Xin WJ, 2000, TOXICOLOGY, V148, P103, DOI 10.1016/S0300-483X(00)00200-6; Zhang XY, 2001, J CLIN PSYCHOPHARM, V21, P85, DOI 10.1097/00004714-200102000-00015	19	14	14	0	0	ASPEN PUBL INC	GAITHERSBURG	200 ORCHARD RIDGE DR, STE 200, GAITHERSBURG, MD 20878 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	2001	16	6					603	607		10.1097/00001199-200112000-00008			5	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	501AL	WOS:000172660800008	11732975				2021-06-18	
J	Groger, A				Groger, A			Ten years of ice hockey-related-injuries in the German Ice Hockey Federation - A ten year prospective study/523 international games	SPORTVERLETZUNG-SPORTSCHADEN			English	Article						hockey; national team; juniors; seniors; injuries; statistics; prospektiv 10-year follow up		Since January 1986 all injuries in players of the German national hockey teams (juniors A/B and seniors A/B), which have occurred during international competitions, have been registrated and evaluated by using a strict definition of injury, standardized reporting strategies and diagnosis by the team physician. Patterns of injury have been identified and correlations between position, zone and cause of injury could be analysed and, as a consequence, measures were taken to prevent them. A total of 147 injuries forcing a consecutive absence from the game during 523 international games of the German national teams were reported. During the 10 year period there was a marked decrease of the total number and incidence of injuries. In addition, injury rate and average absence from game time improved. There were more frequent concussions of the brain but the total number of facial injuries dropped after the introduction of a visor and the full face mask especially in junior hockey. The forward was the position most at risk to be injured and most injuries were caused by players contact.	Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopadie & Sportorthopadie, D-8000 Munich, Germany	Groger, A (corresponding author), Tech Univ Munich, Klin Orthopadie & Sportorthopadie, Ismaninger Str 22, D-81675 Munich, Germany.	sportmedag@web.de					BIASCA N, 1993, UNFALLCHIRURG, V96, P259; BJORKENHEIM JM, 1993, ACTA ORTHOP SCAND, V64, P459; GROGER A, 1995, SPORTORTH SPORTTRAUM, V114, P285; HASTINGS DE, 1974, CAN ACAD SPORTS MED, V4, P1; PASHBY TJ, 1975, CAN MED ASSOC J, V113, P663; PASHBY TJ, 1986, CAN FAM PHYSICIAN, P32; PASHBY TJ, 1977, CMA J, V117, P462; PATTERSSON M, 1993, BRIT J SPORT MED, V27, P251, DOI 10.1136/bjsm.27.4.251; PAULOS LE, 1991, AM J SPORT MED, V19, P337, DOI 10.1177/036354659101900403; RECHL H, 1995, SPORTORTHO SPORTTRAU, V11, P32; RECHL H, 1995, SPORTORTHO SPORTTRAU, V11, P42; REYNEN PD, 1994, AM J SPORT MED, V22, P167, DOI 10.1177/036354659402200203; Tegner Y, 1991, Br J Sports Med, V25, P159; Tegner Y, 1991, Br J Sports Med, V25, P87	14	14	14	0	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0932-0555	1439-1236		SPORTVERLETZ SPORTSC	Sportverletz. Sportschaden	DEC	2001	15	4					82	86		10.1055/s-2001-19047			5	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	509HB	WOS:000173140000003	11753779				2021-06-18	
J	Sekharan, J; Dennis, JW; Miranda, FE; Hertz, JA; Veldenz, HC; Dovgan, PS; Frykberg, ER				Sekharan, J; Dennis, JW; Miranda, FE; Hertz, JA; Veldenz, HC; Dovgan, PS; Frykberg, ER			Long-term follow-up of prophylactic Greenfield filters in multisystem trauma patients	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	60th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma	OCT 11-15, 2000	SAN ANTONIO, TEXAS	Amer Assoc Surg Trauma			VENA-CAVAL FILTERS; HIGH-RISK; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; MAJOR TRAUMA; THROMBOSIS; PLACEMENT	Purpose. The efficacy of prophylactic Greenfield filter (PGF) placement in multisystem trauma patients at high risk for venous thromboembolism has been established. The objective of this study is to demonstrate the long-term safety and durability of PGFs placed in young, active trauma patients. Methods. Starting January 1992, all trauma patients at high risk for development of venous thromboembolism were identified for placement of PGFs. These included patients with ISS > 9 and severe closed head injury, spinal injury, pelvic fracture, multiple long bone fracture, or direct iliofemoral venous injury. Four patients with PGFs placed before the study protocol in 1992 were also included. Follow-up was attempted in all patients with at least 5 years' duration since placement of PGF using physical examination, duplex ultrasound (US), and plain abdominal radiograph. Results: There were 108 patients who had a PGF placement during the period of January 1992 to June 1994 that were eligible for the study. Eighteen of these 108 (17%) patients died. Twelve of them (67%) had autopsies and medical records available to determine the cause of death, none from a pulmonary embolism. The average time of death was 2.7 months after injury. The remaining 90 patients and the 4 patients with PGFs placed before 1992 were sought for follow-up, but only 36 patients could be contacted, 33 of which returned for evaluation (35%). The mean time of follow-up from the time of injury to the time of examination was 67.7 months, and the mean age at follow-up was 38.1 years. Although six patients had mild to moderate lower extremity edema on physical examination, none of them had a deep venous thrombosis by US. Radiographs obtained in 19 of the 33 patients showed no migration or breakdown of the Greenfield filters in place. Conclusion: Prophylactic Greenfield filters in high-risk trauma patients are safe and durable. There appears to be no significant consequence in over 5 years of follow-up.	Univ Florida, Hlth Sci Ctr, Dept Surg, Jacksonville, FL 32209 USA	Dennis, JW (corresponding author), Univ Florida, Hlth Sci Ctr, Dept Surg, 653-2 W 8th St, Jacksonville, FL 32209 USA.						BERNSTEIN MJ, 1986, JAMA-J AM MED ASSOC, V256, P744; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; ENDERSON BL, 1991, J TRAUMA, V31, P1240, DOI 10.1097/00005373-199109000-00007; FREEARK RJ, 1967, ARCH SURG-CHICAGO, V95, P567; Geerts WH, 1996, NEW ENGL J MED, V335, P701, DOI 10.1056/NEJM199609053351003; Greenfield L J, 1995, Cardiovasc Surg, V3, P199, DOI 10.1016/0967-2109(95)90895-C; GREENFIELD LJ, 1973, SURGERY, V73, P599; Greenfield LJ, 2000, J VASC SURG, V32, P490, DOI 10.1067/mva.2000.108636; JOFFE SN, 1975, J NEUROSURG, V42, P201, DOI 10.3171/jns.1975.42.2.0201; KAKKAR V V, 1975, Lancet, V2, P45; KHANSARINIA S, 1995, J VASC SURG, V22, P231, DOI 10.1016/S0741-5214(95)70135-4; KNUDSON MM, 1994, J TRAUMA, V37, P480, DOI 10.1097/00005373-199409000-00025; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Langan EM, 1999, J VASC SURG, V30, P484, DOI 10.1016/S0741-5214(99)70075-3; LEACH TA, 1994, AM SURGEON, V60, P292; MATOUS SK, 1994, 24 ANN SCI M W TRAUM; McCartney JS, 1934, AM J PATHOL, V10, P709; Patton JH, 1996, J TRAUMA, V41, P231, DOI 10.1097/00005373-199608000-00006; RICHARDSON JD, 1987, ARCH SURG-CHICAGO, V122, P678; Rodriguez JL, 1996, J TRAUMA, V40, P797, DOI 10.1097/00005373-199605000-00020; ROGERS FB, 1993, J TRAUMA, V35, P637, DOI 10.1097/00005373-199310000-00021; Rogers FB, 1998, ARCH SURG-CHICAGO, V133, P406, DOI 10.1001/archsurg.133.4.406; SEVITT S, 1961, BRIT J SURG, V48, P475, DOI 10.1002/bjs.18004821103; SHACKFORD SR, 1990, AM J SURG, V159, P365, DOI 10.1016/S0002-9610(05)81272-3; Todd J W, 1976, Paraplegia, V14, P50; Walsh JJ, 1965, PARAPLEGIA, V3, P209; Watson N, 1968, Paraplegia, V6, P113; Webb L X, 1992, J Orthop Trauma, V6, P139, DOI 10.1097/00005131-199206000-00002	28	14	14	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0022-5282			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2001	51	6					1087	1090		10.1097/00005373-200112000-00012			4	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	504CV	WOS:000172840500012	11740258				2021-06-18	
J	Jacobs, U; Iacopino, V				Jacobs, U; Iacopino, V			Torture and its consequences: A challenge to clinical neuropsychology	PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN INJURY	The high incidence of head trauma and other causes of brain damage during political torture challenges psychologists and other health professionals to consider the need for thorough neurological and neuropsychological evaluations of the survivors they may treat. In this article, the authors argue for contributions to the assessment, documentation, and rehabilitation of the consequences of torture from the perspective of clinical neuropsychology on the basis of ethical, humanitarian, and epidemiological considerations. Traumatic brain injury and posttraumatic stress disorder are among the most common sequelae of torture. Neuropsychologists are uniquely qualified to make significant contributions in this area. Indications and limitations of the utility of neuropsychological assessment in the documentation of torture are discussed, and a brief clinical case study is provided.	Survivors Int, San Francisco, CA 94108 USA	Jacobs, U (corresponding author), Survivors Int, 447 Sutter St,Suite 811, San Francisco, CA 94108 USA.						Basoglu M, 1992, TORTURE ITS CONSEQUE; DALTON JE, 1989, INT J CLIN NEUROPSYC, V11, P121; Fastenau PS, 1996, J CLIN EXP NEUROPSYC, V18, P444; Fletcher-Janzen E., 2000, HDB CROSS CULTURAL N; Fuld P. A., 1977, FULD OBJECT MEMORY E; GIANUTSOS R, 1991, Brain Injury, V5, P353, DOI 10.3109/02699059109008108; Gill T., 1990, J TRAUMA STRESS, V3, P29, DOI DOI 10.1002/JTS.2490030104; Gorman W, 2001, PROF PSYCHOL-RES PR, V32, P443; HORTON AM, 1993, PERCEPT MOTOR SKILL, V76, P243, DOI 10.2466/pms.1993.76.1.243; Iacopino V, 1996, JAMA-J AM MED ASSOC, V276, P396, DOI 10.1001/jama.276.5.396; IACOPINO V, IN PRESS MANUAL EFFE; IFORTUNY LA, 1998, CLIN NEUROPSYCHOL, V12, P113; IVNIK RJ, 1978, AM PSYCHOL, V33, P766; Jacobs DM, 1997, J CLIN EXP NEUROPSYC, V19, P331, DOI 10.1080/01688639708403862; Jacobs Uwe, 2000, TORTURE, V10, P68; Jaranson JM, 1998, CARING FOR VICTIMS OF TORTURE, P15; JARANSON JM, 1995, TRANSCULT PSYCHIATRY, V32, P253; Joseph S, 1999, J TRAUMA STRESS, V12, P437, DOI 10.1023/A:1024762919372; KAPLAN E, 1988, CLIN NEUROPSYCHOLOGY, P127; Knight J, 1997, ASSESSING PSYCHOL TR; LAYTON BS, 1995, CLIN NEUROPSYCHOL, V9, P2, DOI 10.1080/13854049508402050; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LURIA AR, 1977, AM PSYCHOL, V32, P959, DOI 10.1037/0003-066X.32.11.959; McAllister Thomas W., 1994, P357; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P1567; Nell V., 2000, CROSS CULTURAL NEURO; PEEL M, 2000, TORTURE, V1, P12; Price K. P., 1994, DEF LAW J, V43, P113; RASMUSSEN OV, 1990, DAN MED B, V1, P1; Resnick PJ, 1997, CLIN ASSESSMENT MALI, P130; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Suedfeld Peter, 1990, PSYCHOL TORTURE; TRAUE HC, 1997, VERHALTENSTHERAPIE V, V1, P41; VANDERKOLK BA, 1994, HARVARD REV PSYCHIAT, V1, P253, DOI 10.3109/10673229409017088	34	14	14	0	5	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0735-7028			PROF PSYCHOL-RES PR	Prof. Psychol.-Res. Pract.	OCT	2001	32	5					458	464		10.1037/0735-7028.32.5.458			7	Psychology, Multidisciplinary	Psychology	478DB	WOS:000171326700003					2021-06-18	
J	Vavilala, MS; Roberts, JS; Moore, AE; Newell, DW; Lam, AM				Vavilala, MS; Roberts, JS; Moore, AE; Newell, DW; Lam, AM			The influence of inhaled nitric oxide on cerebral blood flow and metabolism in a child with traumatic brain injury	ANESTHESIA AND ANALGESIA			English	Article							SYNTHASE INHIBITION; HEMODYNAMICS; CIRCULATION; INHALATION		Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	Vavilala, MS (corresponding author), Harborview Med Ctr, Dept Anesthesiol, 325 9th Ave,Box 359724, Seattle, WA 98104 USA.						Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Berger C, 1998, ACTA NEUROL SCAND, V97, P118; Cardozo RHL, 1996, BIOL NEONATE, V69, P284; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; FARACI FM, 1993, NEUROSURGERY, V33, P648, DOI 10.1227/00006123-199310000-00014; GREENBERG RS, 1994, CRIT CARE MED, V22, P384, DOI 10.1097/00003246-199403000-00006; Hudetz AG, 1998, AM J PHYSIOL-HEART C, V274, pH982; IADECOLA C, 1994, AM J PHYSIOL, V267, pR228; Jones SC, 1999, AM J PHYSIOL-HEART C, V276, pH1253; Kusuda S, 1999, ARCH DIS CHILD-FETAL, V80, pF30, DOI 10.1136/fn.80.1.F30; LADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913; Richards HK, 1997, ACTA NEUROCHIR, V139, P63, DOI 10.1007/BF01850870; ROSENBERG AA, 1995, CRIT CARE MED, V23, P1391, DOI 10.1097/00003246-199508000-00013; Todd MM, 1997, J CEREBR BLOOD F MET, V17, P1319, DOI 10.1097/00004647-199712000-00007; WEI HM, 1993, ANESTH ANALG, V77, P880; White RP, 1998, STROKE, V29, P467, DOI 10.1161/01.STR.29.2.467	16	14	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	AUG	2001	93	2					351	353		10.1097/00000539-200108000-00023			3	Anesthesiology	Anesthesiology	456YU	WOS:000170111000023	11473859				2021-06-18	
J	Iwase, H; Kobayashi, M; Kurata, A; Inoue, S				Iwase, H; Kobayashi, M; Kurata, A; Inoue, S			Clinically unidentified dissection of vertebral artery as a cause of cerebellar infarction	STROKE			English	Article						cerebellar infarction; dissection; trauma; vertebral artery	INJURY	Background and Purpose-Dissection of vertebral arteries has been reported in association with minor neck movements without signs of trauma on the surface of the neck. In addition, injury of a vertebral artery can cause brain infarctions. However, few cases have been reported in which fatal brain infarction was due to nonocclusive, clinically undetected, traumatic thrombus formation in a vertebral artery. Case Description-A 62-year-old man was hit by a car, and a right cerebellar infarction was found the day after the accident. The cause of the infarction could not be detected by angiography. Although the patient recovered favorably after surgical removal of the right lateral hemisphere of the cerebellum, he died suddenly 2 weeks after the accident. An autopsy and a microscopic study revealed pulmonary thromboembolism and organizing traumatic lesions of the right vertebral artery without occlusion or noteworthy stenosis of the artery. Conclusions-We concluded that the patient sustained traumatic lesions of the right vertebral artery during the traffic accident 2 weeks before death and that his cerebellar infarction was due to a thrombus resulting from these traumatic lesions.	Univ Tokyo, Dept Forens Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Human Pathol, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Vasc Surg, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan	Iwase, H (corresponding author), Univ Tokyo, Dept Forens Med, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ALEXANDER JJ, 1986, J NEUROSURG, V64, P662, DOI 10.3171/jns.1986.64.4.0662; BROMILOW A, 1985, J CLIN PATHOL, V38, P1400, DOI 10.1136/jcp.38.12.1400; CHARLES N, 1992, J NEUROL NEUROSUR PS, V55, P188, DOI 10.1136/jnnp.55.3.188; HEROS RC, 1979, J NEUROSURG, V51, P111, DOI 10.3171/jns.1979.51.1.0111; Hutchinson PJ, 2000, J NEUROL NEUROSUR PS, V68, P98, DOI 10.1136/jnnp.68.1.98; Johnson CP, 2000, FORENSIC SCI INT, V109, P169, DOI 10.1016/S0379-0738(99)00198-X; POTSCH L, 1994, INT J LEGAL MED, V107, P99, DOI 10.1007/BF01225496; SHERMAN DG, 1981, STROKE, V12, P2, DOI 10.1161/01.STR.12.1.2; SPETZLER RF, 1987, J NEUROSURG, V66, P648, DOI 10.3171/jns.1987.66.5.0648; TETTENBORN B, 1993, NEUROLOGY, V43, P471, DOI 10.1212/WNL.43.3_Part_1.471; TRAMO MJ, 1985, STROKE, V16, P1039, DOI 10.1161/01.STR.16.6.1039; VANEZIS P, 1986, J FORENSIC SCI SOC, V26, P281, DOI 10.1016/S0015-7368(86)72496-1; VIKTRUP L, 1995, STROKE, V26, P2194, DOI 10.1161/01.STR.26.11.2194; YOUNG CA, 1991, J NEUROL NEUROSUR PS, V54, P365, DOI 10.1136/jnnp.54.4.365	14	14	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0039-2499			STROKE	Stroke	JUN	2001	32	6					1422	1424		10.1161/01.STR.32.6.1422			3	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	440PZ	WOS:000169184600036	11387508	Bronze			2021-06-18	
J	Vath, A; Meixensberger, J; Dings, J; Roosen, K				Vath, A; Meixensberger, J; Dings, J; Roosen, K			Advanced neuromonitoring including cerebral tissue oxygenation and outcome after traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						head injury; prognosis; intracranial pressure; brain tissue oxygenation; cerebral perfusion pressure	SEVERE HEAD-INJURY; EVOKED-POTENTIALS; PRESSURE; EXPERIENCE; COMA; MANAGEMENT; PREDICTION; PROGNOSIS; SCALE	For 51 patients suffering from traumatic brain injury (GCS < 9), we compared the prognostic value of critical parameters derived from neuromonitoring of intracranial pressure (ICP) cerebral perfusion pressure (CPP) and brain tissue oxygenation (PtiO2) during different time periods after trauma (less than or equal to 12, less than or equal to 24, less than or equal to 48, less than or equal to 72 and less than or equal to 96 h). For patients with good outcome (GOS = 4-5, n = 30) the proportion of critical ICP values (> 40 mmHg) was about 0.2% during all time periods. The corresponding proportions for patients with bad outcome (GOS = 1-3, n = 21) rose from 0.2% to 4.7% during increasing time periods. The frequency of critical ICP values was significantly related to outcome (p < 0.001) for time periods > 48 h after trauma. Differences of critical CPP (less than or equal to 50 mmHg) and hypoxic PtiO2 (less than or equal to 5 mmHg) between both outcome groups were less pronounced and for both parameters significant relations to outcome were only obtained for the longest time period (less than or equal to 96 h, p less than or equal to 0.05). Higher thresholds for CPP (less than or equal to 60 mmHg, less than or equal to 70 mmHg) did not reveal any relation to outcome. For all neuromonitoring parameters significant relations between the frequency of critical values and outcome could be determined. Critical ICP values provide the earliest and highest prognostic power, while critical CPP and hypoxic PtiO2 only showed prognostic power in later time periods.	Univ Leipzig, Dept Neurosurg, D-04103 Leipzig, Germany	Meixensberger, J (corresponding author), Univ Leipzig, Dept Neurosurg, Johannisallee 34, D-04103 Leipzig, Germany.	meix@nch.uni-leipzig.de					Bardt TF, 1998, ACT NEUR S, V71, P153; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CHOI SC, 1996, NEUROTRAUMA, P779; Dings J, 1998, NEUROL RES, V20, pS71; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Facco E, 1998, NEUROL RES, V20, pS40; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lang EW, 1997, NEUROL RES, V19, P274, DOI 10.1080/01616412.1997.11740813; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Meixensberger J, 1998, ACT NEUR S, V71, P260; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 1998, ACT NEUR S, V71, P190	20	14	14	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUN	2001	23	4					315	320		10.1179/016164101101198677			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	443RX	WOS:000169355100004	11428507				2021-06-18	
J	Chesser, TJS; Langdon, IJ; Ogilvie, C; Sarangi, PP; Clarke, AM				Chesser, TJS; Langdon, IJ; Ogilvie, C; Sarangi, PP; Clarke, AM			Fractures involving splitting of the humeral head	JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME			English	Article							SHOULDER; DISLOCATIONS	Splitting fractures of the humeral head are rare; part of the humeral head dislocates and the unfractured part remains attached to the shaft. We report eight cases in young patients. In five the diagnosis was made at presentation: three had minimal internal fixation using a superior subacromial approach, one had a closed reduction and one a primary prosthetic replacement. All five patients regained excellent function with no avascular necrosis at two years, In three the injury was initially unrecognised; two developed a painless bony ankylosis and one is awaiting hemiarthroplasty. It is important to obtain the three trauma radiographic views to diagnose these unusual fractures reliably. CT delineates the configuration of the fracture. In young patients open reduction and internal fixation seems preferable to replacement of the humeral head, since we have shown that the head is potentially viable.	Southmead Gen Hosp, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England; Bristol Royal Infirm, Bristol BS2 8HW, Avon, England; Musgrave Pk Hosp, Taunton, Somerset, England	Langdon, IJ (corresponding author), Southmead Gen Hosp, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England.						Bigliani LU, 1990, SHOULDER, P278; CISTERNINO SJ, 1978, AM J ROENTGENOL, V130, P951, DOI 10.2214/ajr.130.5.951; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, V214, P161; HAWKINS RJ, 1987, J BONE JOINT SURG AM, V69A, P9, DOI 10.2106/00004623-198769010-00003; Jakob RP, 1984, SURG SHOULDER, P330; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; RANDELLI M, 1988, 2 C SOC EUR CHIR EP; RICHARDS RH, 1989, INJURY, V20, P297, DOI 10.1016/0020-1383(89)90174-5; ROCKWOOD CA, 1996, ROCKWOOD GREENS FRAC, P1221; ROWE CR, 1982, J BONE JOINT SURG AM, V64, P494, DOI 10.2106/00004623-198264040-00004; Sperling JW, 1998, J BONE JOINT SURG AM, V80A, P464, DOI 10.2106/00004623-199804000-00002; STABLEFORTH PG, 1992, J BONE JOINT SURG BR, V74, P579; WADLINGTON VR, 1992, J TRAUMA, V32, P113, DOI 10.1097/00005373-199201000-00024; WALCH G, 1990, REV CHIR ORTHOP, V76, P546	14	14	20	0	1	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	0301-620X			J BONE JOINT SURG BR	J. Bone Joint Surg.-Br. Vol.	APR	2001	83B	3					423	426		10.1302/0301-620X.83B3.11218			4	Orthopedics; Surgery	Orthopedics; Surgery	426KK	WOS:000168348200023	11341432				2021-06-18	
J	Barami, K; Zhao, J; Diaz, FG; Lyman, WD				Barami, K; Zhao, J; Diaz, FG; Lyman, WD			Comparison of neural precursor cell fate in second trimester human brain and spinal cord	NEUROLOGICAL RESEARCH			English	Article						brain; fetal human; glia; neurons; spinal cord; stem cells	FIBROBLAST GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; FIBRILLARY ACIDIC PROTEIN; PROGENITOR CELLS; STEM-CELLS; FACTOR PROMOTES; FETAL BRAIN; RAT; TRANSPLANTATION	Neural transplantation holds promise for the treatment of traumatic brain and spinal cord injury by replacing lost cellular elements as well as repairing neural damage. Fetal human stem cells derived from central nervous system (CNS) tissue are potential transplantable sources for all cell types found in the mature human nervous system including neurons, astrocytes and oligodendroglia. Although nearly all areas of the fetal human neuraxis contain undifferentiated neural precursor cells, the phenotypic fate of the daughter cells might vary from one region to another during a specific developmental period. The purpose of this study was to compare the various cell types derived from neural precursors cultured from second trimester fetal human brain and spinal cord. To this end, brains (n = 8) and spinal cords (n = 8) of 15-24 week fetuses were dissociated and grown in culture medium supplemented with epidermal growth factor (EGF) basic fibroblast growth factor (FGF) and leukemia inhibitory factor (LIF). The proliferating precursor cells from both brain and spinal cord grew as spherical masses that were plated on laminin-coated dishes after seven days in culture. During the next 5-7 days, the cells that emerged from these spheres were fixed and processed for immunocytochemistry. Brain derived spheres gave rise to cells expressing antigens specific for neurons (MAP-2ab and neuron specific-intermediate filaments), astrocytes (GFAP) and oligodendrocytes (A007). in contrast, cells that emerged from spinal cord derived spheres were only immunoreactive for GFAP. These data suggest that neuroepithelial precursor cells from different CNS regions, although similar in their responsiveness to proliferative growth factors, might differ in their ability to generate different cell types in the adult CNS.	Wayne State Univ, Dept Neurosurg, Detroit, MI 48201 USA; Childrens Hosp Michigan, Childrens Res Ctr Michigan, Detroit, MI USA; Wayne State Univ, Detroit Med Ctr, Dept Pediat, Detroit, MI USA	Barami, K (corresponding author), Wayne State Univ, Dept Neurosurg, 4201 St Antoine Blvd,UHC-6E, Detroit, MI 48201 USA.	Barami@neurosurgery.wayne.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763			AHMED S, 1995, J NEUROSCI, V15, P5765; ALOISI F, 1992, GLIA, V5, P171, DOI 10.1002/glia.440050303; Aquino DA, 1996, DEV BRAIN RES, V91, P1, DOI 10.1016/0165-3806(95)00146-8; BANSAL R, 1992, J NEUROCHEM, V58, P2221, DOI 10.1111/j.1471-4159.1992.tb10967.x; Barami K, 2000, NEUROSURGERY, V47, P691; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; BOYER KL, 1995, NEUROSURG CLIN N AM, V6, P113; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; CHOI BH, 1981, DEV BRAIN RES, V1, P249, DOI 10.1016/0165-3806(81)90112-7; CHOI BH, 1984, SCIENCE, V223, P407, DOI 10.1126/science.6197755; CULICAN SM, 1990, J NEUROSCI, V10, P684; DELOULME JC, 1991, J NEUROSCI RES, V29, P499, DOI 10.1002/jnr.490290410; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GONZALEZ MF, 1988, EXP NEUROL, V99, P154, DOI 10.1016/0014-4886(88)90135-5; Gritti A, 1996, J NEUROSCI, V16, P1091; Hajihosseini M, 1996, J NEUROSCI, V16, P7981; Horner PJ, 2000, J NEUROSCI, V20, P2218; Kalyani AJ, 1998, BIOCHEM CELL BIOL, V76, P1051, DOI 10.1139/bcb-76-6-1051; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Kuhn HG, 1997, J NEUROSCI, V17, P5820; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; Lee JC, 2000, GLIA, V30, P105, DOI 10.1002/(SICI)1098-1136(200004)30:2<105::AID-GLIA1>3.0.CO;2-H; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; Murray K, 1997, J NEUROSCI RES, V50, P146; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Quinn SM, 1999, J NEUROSCI RES, V57, P590, DOI 10.1002/(SICI)1097-4547(19990901)57:5<590::AID-JNR2>3.3.CO;2-O; RAY J, 1994, J NEUROSCI, V14, P3548; REIER PJ, 1992, J NEUROTRAUM, V9, pS223; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, J NEUROSCI RES, V33, P476, DOI 10.1002/jnr.490330314; Richards LJ, 1996, EUR J NEUROSCI, V8, P291, DOI 10.1111/j.1460-9568.1996.tb01213.x; RIVKIN MJ, 1995, ANN NEUROL, V38, P92, DOI 10.1002/ana.410380116; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Roy NS, 2000, NAT MED, V6, P271; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; TOHYAMA T, 1991, J COMP NEUROL, V310, P285, DOI 10.1002/cne.903100302; Weidenheim KM, 1996, J NEUROPATH EXP NEUR, V55, P734, DOI 10.1097/00005072-199606000-00008; Weiss S, 1996, J NEUROSCI, V16, P7599; White MG, 1999, CELL TRANSPLANT, V8, P59, DOI 10.1177/096368979900800115	43	14	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	MAR-APR	2001	23	2-3					260	266		10.1179/016164101101198406			7	Clinical Neurology; Neurosciences	Neurosciences & Neurology	422DX	WOS:000168104200019	11320606				2021-06-18	
J	Viguier, D; Dellatolas, G; Gasquet, I; Martin, C; Choquet, M				Viguier, D; Dellatolas, G; Gasquet, I; Martin, C; Choquet, M			A psychological assessment of adolescent and young adult inpatients after traumatic brain injury	BRAIN INJURY			English	Article							PSYCHIATRIC-DISORDERS; HEAD-INJURY; DEPRESSION; ANXIETY; MOOD	The purpose of this study was to evaluate the cognitive, behavioural, depressive and self- awareness disorders, and their relationships, after severe traumatic brain injury (TBI) in adolescent and young adult inpatients. Two groups of patients with (n = 83) and without (n = 103) TBI, aged 14-25 years, hospitalized after severe traumatic pathology, were compared using the clinician' s report and self-report. A higher frequency of depressive tendencies in TBI patients than in controls was shown in the clinician' s therapeutic attitude (i. e. prescription of antidepressant drugs), the clinician's report and the self- report. The same difference between the two groups was observed for behavioural and schooling problems in the clinician' s report, but not in the self- report. Discrepancies between self- and clinician's evaluation were in favour of a lack of self- awareness of behavioural and cognitive disorders among TBI patients. Correlations of depressive mood with anxiety and cognitive complaints were stronger in TBI than in non- TBI patients. Depression in TBI patients seems compatible with some degree of lack of self- awareness of cognitive and behavioural difficulties.	INSERM, U472, F-94807 Villejuif, France; Hop Paul Brousse, Villejuif, France	Viguier, D (corresponding author), INSERM, U472, 16 Av Paul Vaillant Couturier, F-94807 Villejuif, France.	dellatolas@vjf.inserm.fr					Brooks N., 1987, J HEAD TRAUMA REHABI, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Choquet M, 1994, ADOLESCENTS ENQUETE; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; GAINOTTI G, 1993, NEUROPSYCHOL REHABIL, V3, P259, DOI 10.1080/09602019308401440; GASQUET I, 1995, NEUROPSYCHIAT ENFAN, V43, P366; Gualtari CT, 1991, BRAIN INJURY, V5, P219; GURNS S, 1994, BRAIN INJURY, V8, P413, DOI 10.3109/02699059409150993; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P369; KANDEL DB, 1982, ARCH GEN PSYCHIAT, V39, P1205; Levin H. S., 1991, FRONTAL LOBE FUNCTIO; Lezak M. D., 1987, J HEAD TRAUMA REHAB, V2, P57, DOI [10.1097/00001199-198703000-00009, DOI 10.1097/00001199-198703000-00009]; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lisspers J, 1997, ACTA PSYCHIAT SCAND, V96, P281, DOI 10.1111/j.1600-0447.1997.tb10164.x; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Olsson GI, 1999, ACTA PSYCHIAT SCAND, V99, P324, DOI 10.1111/j.1600-0447.1999.tb07237.x; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P231; Prigatano G. P., 1991, AWARENESS DEFICIT BR; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Silver J. M., 1991, NEUROPSY NEUROPSY BE, V4, P12; Silver JM., 1994, NEUROPSYCHIATRY TRAU; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Varney NR, 1987, NEUROPSYCHOLOGY, V1, P7, DOI 10.1037//0894-4105.1.1.7; Winston FK, 1998, BIOM HLTH R, V21, P101	28	14	14	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2001	15	3					263	271					9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	407ZM	WOS:000167302100006	11260774				2021-06-18	
J	Lehnung, M; Leplow, B; Herzog, A; Benz, B; Ritz, A; Stolze, H; Mehdorn, M; Ferstl, R				Lehnung, M; Leplow, B; Herzog, A; Benz, B; Ritz, A; Stolze, H; Mehdorn, M; Ferstl, R			Children's spatial behavior is differentially affected after traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article							PEDIATRIC HEAD-INJURY; PRESCHOOL-CHILDREN; MEMORY; CHILDHOOD; MAZE; IMPAIRMENT; DEFICITS; RATS; CONSEQUENCES; LOCALIZATION	Spatial behavior in 20 children with severe traumatic brain injury (TBI) and 20 healthy controls was investigated using the Kiel Locomotor Maze. Children had to remember defined locations in an experimental chamber with completely controlled intra- and extra-maze cues until learning criterion was reached. In a second experiment, spatial orientation strategies were assessed. Children with TBI were shown to be impaired in spatial learning and spatial memory. Spatial orientation was found to be deficient even in cases where spatial learning and memory proved to be unimpaired, especially in tasks that demanded the use of relational place strategies. Children who suffered a TBI at an early age proved to be more severely impaired in spatial learning and orientation than older children.	Univ Kiel, Dept Psychol, D-24098 Kiel, Germany; Univ Halle Wittenberg, Dept Psychol, D-4010 Halle An Der Saale, Germany; Childrens Rehabil Ctr, Bremen, Germany; Univ Kiel, Dept Physiol, D-24098 Kiel, Germany; Univ Kiel, Clin Neurosurg, D-24098 Kiel, Germany	Lehnung, M (corresponding author), Univ Kiel, Dept Psychol, Olshausenstr 62, D-24098 Kiel, Germany.	lehnung@psychologie.uni-kiel.de	Mehdorn, Maximilian/D-2495-2010				AADLAND J, 1985, DEV PSYCHOBIOL, V18, P163, DOI 10.1002/dev.420180208; ACREDOLO LP, 1980, DEV PSYCHOL, V16, P312, DOI 10.1037/0012-1649.16.4.312; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BENZ B, 1996, KINDH ENTWICK, V5, P201; Bowen JM, 1997, DEV MED CHILD NEUROL, V39, P17; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Cornell EH, 1996, APPL COGNITIVE PSYCH, V10, P301, DOI 10.1002/(SICI)1099-0720(199608)10:4<301::AID-ACP383>3.3.CO;2-1; CORNELL EH, 1983, J EXP CHILD PSYCHOL, V35, P93, DOI 10.1016/0022-0965(83)90072-3; DENNIS M, 1994, HDB PERCEPTION COGNI, V15, P219; Dennis M., 1995, TRAUMATIC HEAD INJUR, P165; ESLINGER PJ, 1992, ARCH NEUROL-CHICAGO, V49, P764, DOI 10.1001/archneur.1992.00530310112021; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; EWINGCOBBS L, 1997, J INT NEUROPSYCH SOC, V3, P568; FOREMAN N, 1984, DEV PSYCHOBIOL, V17, P129, DOI 10.1002/dev.420170204; FOREMAN N, 1994, BRIT J PSYCHOL, V85, P17, DOI 10.1111/j.2044-8295.1994.tb02505.x; FOREMAN N, 1990, J GEN PSYCHOL, V117, P267; FOREMAN N, 1990, J GEN PSYCHOL, V117, P215, DOI 10.1080/00221309.1990.9921139; Hallett T L, 1997, Pediatr Rehabil, V1, P219; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HUTTENLOCHER J, 1994, COGNITIVE PSYCHOL, V27, P115, DOI 10.1006/cogp.1994.1014; JORDAN FM, 1993, APHASIOLOGY, V7, P503, DOI 10.1080/02687039308248626; Lehnung M, 1998, BRIT J PSYCHOL, V89, P463, DOI 10.1111/j.2044-8295.1998.tb02697.x; LEHNUNG MM, 2000, ENTWICKLUNG RAUMLICH; LEPLOW B, 1994, NEUROPSYCHOLOGIE RAU; LEPLOW B, 1998, LECT NOTES ARTIFICAL; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; LordMaes J, 1996, J LEARN DISABIL, V29, P609, DOI 10.1177/002221949602900605; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Massagli TL, 1996, ARCH PHYS MED REHAB, V77, P223, DOI 10.1016/S0003-9993(96)90102-1; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Overman WH, 1996, BEHAV NEUROSCI, V110, P1205, DOI 10.1037/0735-7044.110.6.1205; OVERMAN WH, 1990, ANN NY ACAD SCI, V608, P365, DOI 10.1111/j.1749-6632.1990.tb48903.x; PIAGET J, 1975, NATURLICHE GEOMETRIE; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Roman MJ, 1998, J CLIN EXP NEUROPSYC, V20, P245, DOI 10.1076/jcen.20.2.245.1168; Sandberg EH, 1996, CHILD DEV, V67, P721, DOI 10.2307/1131858; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; SIEGEL AW, 1977, CHILD DEV, V48, P388; Soblosky JS, 1996, BEHAV BRAIN RES, V80, P185, DOI 10.1016/0166-4328(96)00034-4; Stolze H, 1997, ELECTROMYOGR MOTOR C, V105, P490, DOI 10.1016/S0924-980X(97)00055-6; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Yeates KO, 2000, PEDIAT NEUROPSYCHOLO	52	14	14	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.		2001	7	2					59	71		10.1076/chin.7.2.59.3129			13	Clinical Neurology	Neurosciences & Neurology	535QU	WOS:000174656400001	11935414				2021-06-18	
J	Kerr, ME; Marion, D; Sereika, SM; Weber, BB; Orndoff, PA; Henker, R; Wilberger, J				Kerr, ME; Marion, D; Sereika, SM; Weber, BB; Orndoff, PA; Henker, R; Wilberger, J			The effect of cerebrospinal fluid drainage on cerebral perfusion in traumatic brain injured adults	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						cerebral spinal fluid; cerebral perfusion; traumatic brain injury	SEVERE HEAD-INJURY; INTRACRANIAL HYPERTENSION; CARE MANAGEMENT; PRESSURE; BLOOD; EDEMA; SYSTEM; WATER; ICP	Cerebrospinal fluid drainage is a first line treatment used to manage severely elevated intracranial pressure (greater than or equal to 20 mm Pig) and improve outcomes in patients with acute head injury. There is no consensus regarding the optimal method of cerebrospinal fluid removal. The purpose of this investigation was to determine whether cerebrospinal fluid drainage decreases intracranial pressure and improves cerebral perfusion and to identify factors that impact treatment effectiveness. This study involved 31 severely head injured patients. Intracranial pressure and other indices of cerebral perfusion (cerebral perfusion pressure, cerebral blood now velocity, and regional cerebral oximetry) were measured before, during, and after cerebrospinal fluid drainage. Arterial and jugular venous oxygen content was measured before and after cerebrospinal fluid drainage. Patients underwent three randomly ordered cerebrospinal fluid drainage protocols that varied in the volume of cerebrospinal fluid removed (1 mL, 2 mL, and 3 mL) for a total of 6 mL of cerebrospinal fluid removed. There was a significant change in the intracranial pressure from a mean at baseline of 26.1 mm Pig (SD = 4.4) to 22.1 mm Pig immediately after drainage. One third of patients experienced a decrease in the intracranial pressure below 20 mm Pig; in two patients the intracranial pressure dropped less than 1 mm Pig. The following factors predicted 61.5% of the variance in the responsiveness of intracranial pressure to drainage: vecuronium hypothermia, baseline cerebral perfusion pressure and acuity of illness. Cerebrospinal fluid drainage provides a transient decrease in intracranial pressure without a measurable improvement in other indices of cerebral perfusion.	Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; Allegheny Gen Hosp, Pittsburgh, PA 15212 USA	Kerr, ME (corresponding author), Univ Pittsburgh, Sch Nursing, 4200 5th Ave, Pittsburgh, PA 15213 USA.				NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [NR03451] Funding Source: Medline; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR003451] Funding Source: NIH RePORTER		ARTRU AA, 1988, J CEREBR BLOOD F MET, V8, P750, DOI 10.1038/jcbfm.1988.123; ARTRU AA, 1987, J CEREBR BLOOD F MET, V7, P471, DOI 10.1038/jcbfm.1987.90; BORN JD, 1984, NEUROCHIRURGIE, V30, P329; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1993, ACTA NEUROCHIR, P86; Czosnyka M, 1996, CEREBROVAS BRAIN MET, V8, P273; DURWARD QJ, 1983, J NEUROSURG, V59, P803, DOI 10.3171/jns.1983.59.5.0803; EARLY CB, 1974, J NEUROSURG, V41, P590, DOI 10.3171/jns.1974.41.5.0590; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; GHAJAR JB, 1993, ADV NEUROSURG, P173; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; GREGORY IC, 1974, J PHYSIOL-LONDON, V236, P625, DOI 10.1113/jphysiol.1974.sp010456; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JAMES HE, 1976, J TRAUMA, V16, P437, DOI 10.1097/00005373-197606000-00002; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LANGFITT TW, 1971, CLIN DEV MED, P118; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Miller J D, 1979, Acta Neurochir Suppl (Wien), V28, P86; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; PAPO I, 1981, ACTA NEUROCHIR, V56, P191, DOI 10.1007/BF01407230; REULEN HJ, 1976, BRIT J ANAESTH, V48, P741, DOI 10.1093/bja/48.8.741; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729	29	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	OCT	2000	12	4					324	333		10.1097/00008506-200010000-00005			10	Anesthesiology; Clinical Neurology; Surgery	Anesthesiology; Neurosciences & Neurology; Surgery	360PL	WOS:000089676400005	11147381				2021-06-18	
J	Geldmacher, DS; Fritsch, T; Riedel, TM				Geldmacher, DS; Fritsch, T; Riedel, TM			Effects of stimulus properties and age on random-array letter cancellation tasks	AGING NEUROPSYCHOLOGY AND COGNITION			English	Article							TRAUMATIC BRAIN INJURY; TO-DISTRACTOR RATIO; VISUAL NEGLECT; FEATURE-INTEGRATION; ATTENTION; SEARCH; PERFORMANCE; NUMBER	Random-array letter cancellation tasks are commonly used in the clinical assessment of visuospatial function. How stimulus properties and aging affect cancellation performance is not well understood. This study evaluated the effects of stimulus factors and age on 3 measures of cancellation performance. Thirty younger and 30 older adults each completed 12 cancellation forms that varied in paper size, stimulus density, and target-to-distractor (T/D) ratio. Interactions between stimulus factors were identified for a calculated composite measure of speed and accuracy (effectiveness), a standardized measure of the time required for completion of forms, and a standardized measure of the number of omission errors. The results showed complex interactions between stimulus factors that were different for each dependent variable. These interactions were generally similar for both age groups. The findings indicate that both stimulus properties and dependent variables must be carefully considered in the design and interpretation of cancellation paradigms.	Case Western Reserve Univ, Alzheimer Ctr, Cleveland, OH 44120 USA	Geldmacher, DS (corresponding author), Case Western Reserve Univ, Alzheimer Ctr, 12200 Fairhill Rd, Cleveland, OH 44120 USA.						ALBERT ML, 1973, NEUROLOGY, V23, P658, DOI 10.1212/WNL.23.6.658; CHATTERJEE A, 1992, NEUROPSYCHOLOGIA, V30, P1101, DOI 10.1016/0028-3932(92)90101-Q; FOLDI NS, 1992, J GERONTOL B-PSYCHOL, V47, P146; FOLK CL, 1992, PSYCHOL AGING, V7, P453, DOI 10.1037/0882-7974.7.3.453; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; GELDMACHER D, 1997, J INT NEUROPSYCH SOC, V3, P16; Geldmacher DS, 1996, BRAIN COGNITION, V32, P405, DOI 10.1006/brcg.1996.0073; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; Geldmacher DS, 1999, NEUROPSY NEUROPSY BE, V12, P28; GELDMACHER DS, 1995, J INT NEUROPSYCH SOC, V1, P129; GELDMACHER DS, 1998, ANN M AM SOC NEUR MI; Hills EC, 1998, BRAIN INJURY, V12, P69, DOI 10.1080/026990598122872; JACOBS AM, 1987, ACTA PSYCHOL, V65, P133, DOI 10.1016/0001-6918(87)90023-0; KAPLAN RF, 1991, ARCH NEUROL-CHICAGO, V48, P1263, DOI 10.1001/archneur.1991.00530240067023; Keppel, 1991, DESIGN ANAL RES HDB; MARSHALL JC, 1989, COGNITIVE NEUROPSYCH, V6, P403, DOI 10.1080/02643298908253290; OKEN BS, 1994, J GERIATR PSYCH NEUR, V7, P163, DOI 10.1177/089198879400700307; PLUDE DJ, 1989, PSYCHOL AGING, V4, P98, DOI 10.1037/0882-7974.4.1.98; RAPCSACK SZ, 1989, ARCH NEUROL-CHICAGO, V46, P172; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Spreen O., 1991, COMPENDIUM NEUROPSYC; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VILLARDITA C, 1983, ARCH NEUROL-CHICAGO, V40, P737, DOI 10.1001/archneur.1983.04050110055008	24	14	14	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1382-5585			AGING NEUROPSYCHOL C	Aging Neuropsychol. Cogn.	SEP	2000	7	3					194	204		10.1076/1382-5585(200009)7:3;1-Q;FT194			11	Psychology, Developmental; Psychology, Experimental	Psychology	369ZD	WOS:000165096900005					2021-06-18	
J	Satoh, H; Kumano, K; Ogami, R; Nishi, T; Onda, J; Nishimura, S; Kurisu, K				Satoh, H; Kumano, K; Ogami, R; Nishi, T; Onda, J; Nishimura, S; Kurisu, K			Sigmoid sinus thrombosis after mild closed head injury in an infant: Diagnosis by magnetic resonance imaging in the acute phase - Case Report	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						sinus thrombosis; sigmoid sinus; closed head injury; magnetic resonance imaging	CEREBRAL VENOUS THROMBOSIS; DURAL SINUS; HIGH-FIELD; BLOOD	Intracranial sinus thrombosis following a mild closed head injury without a skull fracture or intracranial hematoma is extremely rare. A 23-month-old girl presented with vomiting and gait ataxia 1 day after occipital trauma. Computed tomography revealed a slightly increased density area in the region of the left sigmoid sinus. T-1-weighted magnetic resonance (MR) imaging demonstrated an isointense area in the left sigmoid sinus and T-2-weighted imaging showed a hyperintense area reflecting the characteristics of oxyhemoglobin. MR angiography and cerebral angiography indicated occlusion of the left sigmoid sinus. After 4 days of conservative treatment, her symptoms subsided completely. Follow-up MR angiography and cerebral angiography showed recanalization of the sigmoid sinus. The MR images and MR angiograms were useful for both early diagnosis and follow-up. Treatment should reflect the severity of individual cases, and early diagnosis will help achieve a good outcome.	Kitakyushu Gen Hosp, Dept Neurosurg, Fukuoka, Japan; Hiroshima Univ, Sch Med, Dept Neurosurg, Hiroshima, Japan	Satoh, H (corresponding author), Hiroshima Prefectural Hosp, Dept Neurosurg, Minami Ku, 1-5-54 Ujina Kanda, Hiroshima 7348530, Japan.						AMERI A, 1992, NEUROL CLIN, V10, P87; BJORNEBRINK J, 1976, ANGIOLOGY, V27, P688, DOI 10.1177/000331977602701203; BOUSSER MG, 1985, STROKE, V16, P199, DOI 10.1161/01.STR.16.2.199; BUOANNO F, 1978, J COMPUT ASSIST TOMO, V2, P281; CARRIE AW, 1954, J NEUROSURG, V11, P173, DOI 10.3171/jns.1954.11.2.0173; CRIMMINS TJ, 1984, J NEUROSURG, V60, P179, DOI 10.3171/jns.1984.60.1.0179; D'Alise MD, 1998, SURG NEUROL, V49, P430, DOI 10.1016/S0090-3019(97)00182-1; EINHAUPL KM, 1991, LANCET, V338, P597, DOI 10.1016/0140-6736(91)90607-Q; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; GOLDBERG AL, 1986, J COMPUT ASSIST TOMO, V10, P16, DOI 10.1097/00004728-198601000-00003; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; ISENSEE C, 1994, STROKE, V25, P29, DOI 10.1161/01.STR.25.1.29; Kannuki S, 1990, No To Shinkei, V42, P781; KINAL ME, 1967, J NEUROSURG, V27, P142, DOI 10.3171/jns.1967.27.2.0142; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; MACCHI PJ, 1986, J COMPUT ASSIST TOMO, V10, P10, DOI 10.1097/00004728-198601000-00002; MCLEAN BN, 1991, BRIT J HOSP MED, V45, P226; MCMURDO SK, 1986, RADIOLOGY, V161, P83, DOI 10.1148/radiology.161.1.3763888; PROVENZALE JM, 1994, J COMPUT ASSIST TOMO, V18, P719, DOI 10.1097/00004728-199409000-00007; RIPPE DJ, 1990, AM J NEURORADIOL, V11, P199; Satoh Hideki, 1993, Neurological Surgery, V21, P953; STRINGER WL, 1983, NEUROSURGERY, V12, P95; SUEISHI K, 1989, THROMBOSIS, P85; SUZUKI M, 1994, THROMB HAEMOSTASIS, V71, P155; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008; THULBORN KR, 1982, BIOCHIM BIOPHYS ACTA, V714, P265, DOI 10.1016/0304-4165(82)90333-6; TSAI FY, 1992, AM J NEURORADIOL, V13, P1137; VIRAPONGSE C, 1987, RADIOLOGY, V162, P779, DOI 10.1148/radiology.162.3.3809494	29	14	15	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	C/O AKAMON-MAE IWATA BLDG, 5-27-8 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0387-2572			NEUROL MED-CHIR	Neurol. Med.-Chir.	JUL	2000	40	7					361	365		10.2176/nmc.40.361			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	337JN	WOS:000088354200011	10927903	Bronze			2021-06-18	
J	Mamelak, M				Mamelak, M			The motor vehicle collision injury syndrome	NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY			English	Article							TRAUMATIC BRAIN INJURY; EMISSION COMPUTED-TOMOGRAPHY; CEREBRAL BLOOD-FLOW; MILD HEAD-INJURY; CHRONIC FATIGUE SYNDROME; TECHNETIUM-99M-HMPAO SPECT; WHIPLASH INJURY; FOLLOW-UP; MAJOR DEPRESSION; MITOCHONDRIAL DYSFUNCTION	Objective: The objective of this study was to examine the central nervous system changes that may occur after acceleration/deceleration injuries in motor vehicle accidents. Background: Occupants of motor vehicles involved in a collision often develop a disabling syndrome consisting of head, neck, and back pain, impaired short-term memory and concentration; fatigue and a loss of stamina, poor balance; and a change in personality. Injury victims experience a loss of motivation, emotional lability, and a decrease in libido. The major features of this injury syndrome are subjective, and there usually are few objective findings on physical examination. The pathogenesis of this syndrome is poorly understood. but it is hypothesized that the collision impact produces an inertial strain injury to the anterior regions of the brain which depresses the functions of the frontotemporal lobes, at the same time, sensitizing somatosensory neural afferent systems. Damage to the orbital surfaces of the frontotemporal lobes, in particular, impairs the gating mechanisms that normally limit sensory input to the brain and further promotes central sensitization. The psychiatric disorders that emerge in the wake of these injuries are likely grounded in these pathologic events. Method: The current literature on the biomechanics of head injury and the associated brain imaging findings in minor head injury are reviewed. A summary of some of the biochemical sequelae of strain injury to the brain is also provided, with an emphasis on the changes in energy metabolism and excitatory amino acid release. Results and Conclusions: Early intervention to arrest the injury-induced metabolic cascade, and treatment with agents that activate cerebral metabolism may mitigate the symptoms of this injury syndrome.	Baycrest Ctr Geriatr Care, Toronto, ON M6A 2E1, Canada; Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Mamelak, M (corresponding author), Baycrest Ctr Geriatr Care, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.						Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Armstead WM, 1997, P SOC EXP BIOL MED, V214, P210; Bendtsen L, 1997, ARTHRITIS RHEUM, V40, P98, DOI 10.1002/art.1780400114; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bicik I, 1998, NEUROLOGY, V51, P345, DOI 10.1212/WNL.51.2.345; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blanchard EB, 1998, J TRAUMA STRESS, V11, P337, DOI 10.1023/A:1024407321677; Bryant B, 1997, MED SCI LAW, V37, P326, DOI 10.1177/002580249703700408; Buskila D, 1997, ARTHRITIS RHEUM, V40, P446, DOI 10.1002/art.1780400310; Castejon OJ, 1998, J SUBMICR CYTOL PATH, V30, P145; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; DEROO M, 1989, EUR J NUCL MED, V15, P9, DOI 10.1007/BF00253592; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Elsasser A, 1997, CIRCULATION, V96, P2920, DOI 10.1161/01.CIR.96.9.2920; FEE CRA, 1988, ARCH EMERG MED, V5, P12; Ferrari MD, 1998, LANCET, V351, P1043, DOI 10.1016/S0140-6736(97)11370-8; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fischer AJEM, 1997, CLIN OTOLARYNGOL, V22, P192, DOI 10.1046/j.1365-2273.1997.00031.x; Fischler B, 1996, NEUROPSYCHOBIOLOGY, V34, P175, DOI 10.1159/000119307; FRERICHS KU, 1995, AM J PHYSIOL-REG I, V268, pR445; FUSTER JM, 1997, PREFRONTAL CORTEX AN; Galynker II, 1998, J NUCL MED, V39, P608; Gennarelli T, 1996, NEUROSURGERY, V2, P2611; Goodwin GM, 1997, BRIT J PSYCHIAT, V170, P426, DOI 10.1192/bjp.170.5.426; Goodwin GM, 1997, J PSYCHOPHARMACOL, V11, P115, DOI 10.1177/026988119701100204; GRAY BG, 1992, J NUCL MED, V33, P52; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Ho AP, 1996, ARCH GEN PSYCHIAT, V53, P645; HOFFMAN WE, 1986, ANESTH ANALG, V65, P639; Holmin S, 1998, NEUROSURGERY, V42, P291, DOI 10.1097/00006123-199802000-00047; ICHISE M, 1994, J NUCL MED, V35, P217; ICHISE M, 1992, NUCL MED COMMUN, V13, P767, DOI 10.1097/00006231-199213100-00011; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; JENKINS A, 1986, LANCET, V2, P445; Kant R, 1997, BRAIN INJURY, V11, P115, DOI 10.1080/026990597123700; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Klemm E, 1996, PSYCHIAT RES-NEUROIM, V68, P1, DOI 10.1016/S0925-4927(96)02837-5; LANCE JW, 1973, MECH MANAGEMENT HEAD; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231; Liddle PF, 1996, BRIT MED BULL, V52, P486; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Mamelak M, 1997, J GERIATR PSYCH NEUR, V10, P29, DOI 10.1177/089198879701000106; MCCANDLESS DW, 1981, BRAIN RES, V215, P225, DOI 10.1016/0006-8993(81)90504-7; MENDELSON G, 1984, INT J LAW PSYCHIAT, V7, P179, DOI 10.1016/0160-2527(84)90031-1; MICHAEL GM, 1992, AM J EMERG MED, V10, P24; MIGLIORELLI R, 1993, J NEUROPSYCH CLIN N, V5, P379; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Moller AR, 1997, AM J OTOL, V18, P577; MORRIS JH, 1989, ROBBINS PATHOLOGIC B, P1385; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; NORDHOFF LS, 1996, MOTOR VEHICLE COLLIS; OCONNELL RA, 1995, J NEUROIMAGING, V5, P101, DOI 10.1111/jon199552101; OLESEN J, 1991, CEREBROVAS BRAIN MET, V3, P1; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; PAKHOTIN PI, 1993, PROG NEUROBIOL, V40, P123, DOI 10.1016/0301-0082(93)90021-J; PAZDERNIK T, 1994, NEUROCHEM RES, V19, P1393, DOI 10.1007/BF00972468; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; RADANOV BP, 1995, MEDICINE, V74, P281, DOI 10.1097/00005792-199509000-00005; Rao VLR, 1998, J NEUROCHEM, V70, P2020; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Russo CM, 1998, ANNU REV MED, V49, P123; Sabri O, 1997, LANCET, V349, P1735, DOI 10.1016/S0140-6736(96)08380-8; Sataloff RT, 1996, AM J OTOL, V17, P909; Schlaepfer TE, 1998, AM J PSYCHIAT, V155, P470, DOI 10.1176/ajp.155.4.470; SCHWARTZ RB, 1994, AM J ROENTGENOL, V162, P943, DOI 10.2214/ajr.162.4.8141022; SETO H, 1994, CLIN NUCL MED, V19, P215, DOI 10.1097/00003072-199403000-00010; SKINNER J E, 1973, P185; Sorensen J, 1998, J RHEUMATOL, V25, P152; Standaert D. G., 1996, PHARMACOL BASIS THER, P503; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; Stoffel M, 1997, ACT NEUR S, V70, P91; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TENJIN H, 1994, NEUROSURGERY, V35, P971; TIIHONEN J, 1995, BIOL PSYCHIAT, V37, P134, DOI 10.1016/0006-3223(94)00230-Z; Vanoverschelde JLJ, 1997, CIRCULATION, V95, P1961; VARNEY NR, 1995, J HEAD TRAUMA REHAB, V10, P18; Venneri A, 1998, NEUROLOGY, V50, P186, DOI 10.1212/WNL.50.1.186; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; VIANO DC, 1998, P 32 STRAPP CAR CRAS, P1; Vink R, 1996, J NEUROCHEM, V66, P2477; Wallis BJ, 1996, PAIN, V66, P223, DOI 10.1016/0304-3959(96)03044-8; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; 1962, LORD BRAIN DIS NERVO	100	14	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-878X			NEUROPSY NEUROPSY BE	Neuropsychiatr. Neuropsychol. Behav. Neurol.	APR	2000	13	2					125	135					11	Clinical Neurology; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	408AL	WOS:000167304300007	10780631				2021-06-18	
J	Cummings, TJ; Johnson, RR; Diaz, FG; Michael, DB				Cummings, TJ; Johnson, RR; Diaz, FG; Michael, DB			The relationship of blunt head trauma, subarachnoid hemorrhage, and rupture of pre-existing intracranial saccular aneurysms	NEUROLOGICAL RESEARCH			English	Article						head injury; subarachnoid hemorrhage; aneurysm; angiography	CAROTID-ARTERY; INJURY	Patients with a history of closed head trauma and subarachnoid hemorrhage are uncommonly diagnosed with an intracranial saccular aneurysm. This study presents a group of patients in whom a pre-existing aneurysm was discovered during work-up for traumatic subarachnoid hemorrhage. Without an accurate pre-trauma clinical history, it is difficult to define the relationship between trauma and the rupture of a preexisting intracranial saccular aneurysm. We retrospectively reviewed 130 patients who presented to Detroit Receiving Hospital between 1993 and 1997 with a diagnosis of subarachnoid hemorrhage (SAH). Of these 130 patients, 70 were spontaneous, and 60 had a history of trauma. Mechanisms of trauma include motor vehicle accident, assault, or fall from a height Of the 60 patients with subarachnoid hemorrhage and a history of trauma, 51 (86%) did not undergo conventional four-vessel angiography, and had no further neurological sequelae. Nine patients (14%) had a suspicious quantity of blood within the basal cisterns or Sylvian fissure and had a four-vessel angiogram. Five patients (8%) were diagnosed with a saccular intracranial aneurysm, and all underwent surgical clipping of the aneurysm. We conclude that the majority of patients (92%), with post-traumatic SAH do not harbor intracranial aneurysms. However, during initial evaluation, a high level of suspicion must be entertained when post-traumatic subarachnoid hemorrhage is encountered in the basal cisterns or Sylvian fissure, as 8% of our population were diagnosed with aneurysms.	Wayne State Univ, Sch Med, Dept Neurol Surg, Detroit, MI 48201 USA	Michael, DB (corresponding author), Wayne State Univ, Sch Med, Dept Neurol Surg, 4201 St Antoine 6E, Detroit, MI 48201 USA.						DOWLING G, 1988, AM J FOREN MED PATH, V9, P23, DOI 10.1097/00000433-198803000-00007; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; FREYTAG E, 1966, ARCH PATHOL, V81, P418; GROSS A, 1990, FORENSIC SCI INT, V45, P53, DOI 10.1016/0379-0738(90)90221-J; HARLAND WA, 1983, J CLIN PATHOL, V36, P1335, DOI 10.1136/jcp.36.12.1335; HILLBOM M, 1981, J NEUROL NEUROSUR PS, V44, P523, DOI 10.1136/jnnp.44.6.523; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; JENNETT B, 1975, LANCET, V1, P480; JUNGMICHEL G, 1932, DTSCH Z GES GERICHTL, V19, P197; KAKARIEKA A, 1997, TRAUMATIC SUBARACHNO, P5; LEVY ML, 1993, NEUROSURGERY, V32, P532, DOI 10.1227/00006123-199304000-00007; LOCKSLEY HB, 1966, J NEUROSURG, V25, P219, DOI 10.3171/jns.1966.25.2.0219; MAREK Z, 1981, AM J FOREN MED PATH, V2, P19, DOI 10.1097/00000433-198103000-00004; MCCORMICK WF, 1980, AM J FOREN MED PATH, V1, P223, DOI 10.1097/00000433-198009000-00006; NEWBARR FD, 1958, J FORENSIC SCI, V3, P174; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; Simonsen J, 1967, J Forensic Med, V14, P146; STEINMETZ H, 1988, SURG NEUROL, V30, P305, DOI 10.1016/0090-3019(88)90304-7; TAKAKURA K, 1990, NEUROLOGICAL SURG, V3, P1864; TATSUNO Y, 1974, ARCH PATHOL, V97, P211; YAZBAK PA, 1995, PEDIATR NEUROSURG, V22, P15, DOI 10.1159/000121294; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016	22	14	16	0	7	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	MAR	2000	22	2					165	170		10.1080/01616412.2000.11741055			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	302VD	WOS:000086385600006	10763504				2021-06-18	
J	Ludwig, HC; Klingler, M; Timmermann, A; Weyland, W; Mursch, K; Reparon, C; Markakis, E				Ludwig, HC; Klingler, M; Timmermann, A; Weyland, W; Mursch, K; Reparon, C; Markakis, E			The influence of airway pressure changes on intracranial pressure (ICP) and the blood flow velocity in the middle cerebral artery (V-MCA)	ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE			English	Article						traumatic brain injury; intracranial pressure monitoring; ventilation; compliance	SEVERE HEAD-INJURY; PERFUSION-PRESSURE; RESISTANCE; MANAGEMENT; BIPAP	Objective: Due to the exponential shape of the intracranial volume-pressure relation, simple measurement of epidural, parenchymal or intraventricular intracranial pressure (ICP) in traumatic brain injury (TBI) often fails to early recognize patients with a fulminant development of intracranial hypertension even during recently available methods of tissue PO2 and microdialysis measurements. One approach to this problem could be repetitive intracranial volume provocations to evaluate a trend of the intracranial elastance. Several previously published methods use invasive volume challenge through access to the cerebrospinal fluid (CSF). This pilot study describes changes in intracranial pressure due to variations of airway pressure with BIPAP ventilation maneuvers. Patients and methods: Ten patients with severe TBI were enrolled and completed the study. The inclusion was based on radiologic signs due to TBI in the first CT-scan and the clinical indication for insertion of an ICP monitoring device. Patients with elevated ICP above 20 mm Hg were excluded. The epidural ICP response together with haemodynamic parameters in relation to defined airway pressure changes (Delta P-AW) was detected. The influence of the duration of Delta P-AW was evaluated additionally. Data of central venous pressure (CVP), ICP, mean arterial pressure (MAP), cerebral perfusion pressure (CPP), airway pressure (P-AW) and blood flow velocity of the middle cerebral artery (V-MCA) were analyzed on the basis of differences between the maximum (inspiration) and minimum P-AW values (expiration). Results: Elevations of P-AW in the range of 20 to 35 cm H2O resulted in changes of the ICPmean from 4.1 to 6.0 mm Hg (r = 0.9, p < 0.05). A correlation was estimated for the changes of systolic arterial pressure (P-art) and CPPmean due to P-AW variations which ranged between 4.5 and 11.6 mm Hg (r = 0.99, p < 0.05). Concerning the transcranial doppler measurements the data of changes of the blood flow velocity of the middle cerebral artery (V-MCA) revealed a positive correlation to P-AW with a r = 0.99, p < 0.05. Conclusions: Elevation of the venous outflow resistance and a transient increase in cardiac output have to be considered as mechanisms for transduction of transthoracic pressure changes to intracranial pressure variations. We conclude, that trends of changes in elastance can be derived from intermittent airway pressure variations. This can be useful in easy and on line dynamic monitoring of ICP in traumatic brain injury.	Univ Gottingen, Dept Neurosurg, D-37075 Gottingen, Germany; Univ Gottingen, Dept Anaesthesiol Ernergency & Intens Care Med, D-37075 Gottingen, Germany	Ludwig, HC (corresponding author), Univ Gottingen, Dept Neurosurg, Robert Koch Str 40, D-37075 Gottingen, Germany.						BAUM M, 1989, ANAESTHESIST, V38, P452; BRINKER T, 1984, ANASTH INTENSIVMED, V1, P19; Chesnut R M, 1995, New Horiz, V3, P581; CUYPERS J, 1976, J NEUROSURG, V45, P89, DOI 10.3171/jns.1976.45.1.0089; HORMANN C, 1994, EUR J ANAESTH, V11, P37; LAKIN W D, 1992, Neurological Research, V14, P219; Lang E W, 1995, New Horiz, V3, P400; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; Marmarou A, 1992, J NEURORAUMA, V9, P327; MURR R, 1995, NEUROL RES, V17, P329, DOI 10.1080/01616412.1995.11740338; MURSCH K, 1995, ACTA NEUROCHIR, V137, P19, DOI 10.1007/BF02188774; NARAYAN RK, 1995, J NEUROTRAUM, V12, P907, DOI 10.1089/neu.1995.12.907; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; Pollard C, 1995, Aust Fam Physician, V24, P2230; Raabe A, 1999, ACTA NEUROCHIR, V141, P31, DOI 10.1007/s007010050263; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SCHEDL R, 1985, ANAESTHESIST, V34, P578; STOCHAJ U, 1993, EUR J CELL BIOL, V59, P1	19	14	15	0	3	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0939-2661			ANASTH INTENSIV NOTF	Anasthesiol. Intensivmed. NotfMed. Schmerzther.	MAR	2000	35	3					141	145		10.1055/s-2000-13008			5	Anesthesiology; Critical Care Medicine	Anesthesiology; General & Internal Medicine	296JT	WOS:000086021800004	10768051				2021-06-18	
J	Hu, WH; Qiang, WA; Li, F; Liu, N; Wang, GQ; Wang, HY; Wan, XCST; Liao, WH; Liu, JS; Jen, MF				Hu, WH; Qiang, WA; Li, F; Liu, N; Wang, GQ; Wang, HY; Wan, XCST; Liao, WH; Liu, JS; Jen, MF			Constitutive and inducible nitric oxide synthases after dynorphin-induced spinal cord injury	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						nitric oxide; nitric oxide synthase; dynorphin; spinal cord injury; neurotoxicity	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; CENTRAL-NERVOUS-SYSTEM; DORSAL HORN NEURONS; NADPH-DIAPHORASE; MESSENGER-RNA; OPIOID RECEPTORS; NEONATAL RAT; GLIAL-CELLS; EXPRESSION	It has recently been demonstrated that selective inhibition of both neuronal constitutive and inducible nitric oxide synthases (ncNOS and iNOS) is neuroprotective in a model of dynorphin (Dyn) A(1-17)-induced spinal cord injury. In the present study, various methods including the conversion of H-3-L-arginine to H-3-citrulline, immunohistochemistry and in situ hybridization are employed to determine the temporal profiles of the enzymatic activities, immunoreactivities, and mRNA expression for both ncNOS and iNOS after intrathecal injection of a neurotoxic dose (20 nmol) of Dyn A(1-17). The expression of ncNOS immunoreactivity and mRNA increased as early as 30 min after injection and persisted for 1-4 h. At 24-48 h, the number of ncNOS positive cells remained elevated while most neurons died. The cNOS enzymatic activity in the ventral spinal cord also significantly increased at 30 min-48 h, but no significant changes in the dorsal spinal cord were observed. However, iNOS mRNA expression increased later at 2 h, iNOS immunoreactivity and enzymatic activity increased later at 4 h and persisted for 24-48 h after injection of 20 nmol Dyn A(1-17). These results indicate that both ncNOS and iNOS are associated with Dyn-induced spinal cord injury, with ncNOS predominantly involved at an early stags and iNOS at a later stage: (C) 2000 Elsevier Science B.V. All rights reserved.	Third Mil Med Univ, Inst Surg Res, Dept Spinal Cord Injury, Chongqing 400042, Peoples R China; Third Mil Med Univ, Daping Hosp, Chongqing 400042, Peoples R China; Peking Union Med Coll, Inst Basic Med Sci, Dept Pharmacol, Beijing 100005, Peoples R China; Peking Union Med Coll, Inst Basic Med Sci, Dept Neurobiol, Beijing 100005, Peoples R China; Chinese Acad Med Sci, Beijing 100005, Peoples R China	Hu, WH (corresponding author), Third Mil Med Univ, Inst Surg Res, Dept Spinal Cord Injury, Chongqing 400042, Peoples R China.	huwenhui98@hotmail.com	Qiang, Wenan/AAA-7633-2021	Qiang, Wenan/0000-0001-5068-7128			Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Behrens MI, 1996, NEUROBIOL DIS, V3, P72, DOI 10.1006/nbdi.1996.0007; BEHRMANN DL, 1993, EXP NEUROL, V119, P258, DOI 10.1006/exnr.1993.1028; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bishop A, 1999, FREE RADICAL BIO MED, V26, P978, DOI 10.1016/S0891-5849(98)00284-6; Bolanos JP, 1999, BBA-BIOENERGETICS, V1411, P415, DOI 10.1016/S0005-2728(99)00030-4; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Callsen-Cencic P, 1999, CELL TISSUE RES, V295, P183, DOI 10.1007/s004410051224; Catalan RE, 1996, NEUROSCI RES, V25, P195; CHEN B, 1995, CHIN J PHARM TOXICOL, V9, P36; Coeroli L, 1998, J NEUROCHEM, V70, P2516; DALKARA T, 1994, BRAIN PATHOL, V4, P49; DUBNER R, 1992, TRENDS NEUROSCI, V15, P96, DOI 10.1016/0166-2236(92)90019-5; DUMONT M, 1994, EUR J PHARMACOL, V271, P241, DOI 10.1016/0014-2999(94)90288-7; DUN NJ, 1993, NEUROSCIENCE, V54, P845, DOI 10.1016/0306-4522(93)90579-5; ENDOH M, 1993, NEUROSCI LETT, V154, P125, DOI 10.1016/0304-3940(93)90187-P; Faden A I, 1987, Cent Nerv Syst Trauma, V4, P227; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; Grossman SD, 1999, J NEUROSCI, V19, P5711, DOI 10.1523/JNEUROSCI.19-14-05711.1999; Guizar-Sahagun G, 1998, NEUROREPORT, V9, P2899, DOI 10.1097/00001756-199808240-00040; Haas J, 1999, NEUROSCI LETT, V264, P129, DOI 10.1016/S0304-3940(99)00191-3; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hammarberg H, 1998, J COMP NEUROL, V400, P57; HANEMANN CO, 1993, J HISTOCHEM CYTOCHEM, V41, P1383, DOI 10.1177/41.9.8354878; HASSAN AHS, 1992, NEUROSCI LETT, V140, P85, DOI 10.1016/0304-3940(92)90688-4; Herz A, 1996, PROG BRAIN RES, V110, P95; Higuchi Y, 1996, BRAIN DEV-JPN, V18, P369, DOI 10.1016/0387-7604(96)00019-8; Hu WH, 1996, NEUROSCI LETT, V203, P13, DOI 10.1016/0304-3940(95)12246-X; Hu WH, 1998, EUR J PHARMACOL, V342, P325, DOI 10.1016/S0014-2999(97)01492-1; Hu WH, 1999, J NEUROTRAUM, V16, P85, DOI 10.1089/neu.1999.16.85; HYLDEN JLK, 1991, PAIN, V44, P187, DOI 10.1016/0304-3959(91)90136-L; HYMAN BT, 1992, ANN NEUROL, V32, P818, DOI 10.1002/ana.410320618; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; IKESHIMA H, 1993, J NEUROSCI RES, V36, P111, DOI 10.1002/jnr.490360112; Jacobsson G, 1998, EUR J NEUROSCI, V10, P301, DOI 10.1046/j.1460-9568.1998.00050.x; Kaur C, 1999, HISTOL HISTOPATHOL, V14, P417, DOI 10.14670/HH-14.417; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; Laughlin TM, 1997, PAIN, V72, P253, DOI 10.1016/S0304-3959(97)00046-8; Lecanu L, 1998, BRIT J PHARMACOL, V125, P584, DOI 10.1038/sj.bjp.0702119; LI FC, 1997, CHIN J REHABIL THEOR, V3, P6; Li QS, 1999, J HUMAN VIROL, V2, P139; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; LIU SF, 1993, BIOCHEM BIOPH RES CO, V196, P1208, DOI 10.1006/bbrc.1993.2380; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; MacLennan AJ, 1999, NEUROSCIENCE, V91, P1401, DOI 10.1016/S0306-4522(98)00717-9; Marsala J, 1997, EXP NEUROL, V145, P165, DOI 10.1006/exnr.1997.6455; MAYER B, 1990, FEBS LETT, V277, P215, DOI 10.1016/0014-5793(90)80848-D; McCann SM, 1998, EXP GERONTOL, V33, P813, DOI 10.1016/S0531-5565(98)00050-3; Meyding-Lamade U, 1998, NEUROSCI LETT, V244, P9, DOI 10.1016/S0304-3940(98)00115-3; MOLANDER C, 1984, J COMP NEUROL, V230, P133, DOI 10.1002/cne.902300112; MUFSON EJ, 1994, NEUROREPORT, V5, P705, DOI 10.1097/00001756-199402000-00011; MURPHY S, 1993, TRENDS NEUROSCI, V16, P323, DOI 10.1016/0166-2236(93)90109-Y; Nakagomi S, 1999, EUR J NEUROSCI, V11, P2160, DOI 10.1046/j.1460-9568.1999.00634.x; Parkinson JF, 1997, J MOL MED, V75, P174, DOI 10.1007/s001090050102; Perez-Severiano F, 1998, NEUROCHEM RES, V23, P1297, DOI 10.1023/A:1020700401678; QIANG WA, 1996, CHIN J MED, V76, P567; Rao AM, 1998, BRAIN RES, V793, P265, DOI 10.1016/S0006-8993(98)00183-8; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; SCHMIDT W, 1995, NEUROSCIENCE, V67, P345, DOI 10.1016/0306-4522(95)00027-G; Seidel B, 1997, NEUROSCI LETT, V239, P109, DOI 10.1016/S0304-3940(97)00912-9; Sheng Wen S., 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P359; Shibata T, 1999, J COMP NEUROL, V404, P172, DOI 10.1002/(SICI)1096-9861(19990208)404:2<172::AID-CNE3>3.0.CO;2-U; SHUKLA VK, 1994, TRENDS PHARMACOL SCI, V15, P420, DOI 10.1016/0165-6147(94)90091-4; SKILLING SR, 1992, BRAIN RES, V575, P272, DOI 10.1016/0006-8993(92)90090-V; Stojkovic T, 1998, GLIA, V22, P329, DOI 10.1002/(SICI)1098-1136(199804)22:4<329::AID-GLIA2>3.0.CO;2-Z; Strijbos PJLM, 1998, CRIT REV NEUROBIOL, V12, P223, DOI 10.1615/CritRevNeurobiol.v12.i3.40; Tachibana T, 1998, J NEUROTRAUM, V15, P485, DOI 10.1089/neu.1998.15.485; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; TIAN XF, 1994, CHIN J PHYSL SCI, V10, P289; VANDAM AM, 1995, J NEUROSCI RES, V40, P251, DOI 10.1002/jnr.490400214; VIZZARD MA, 1994, J COMP NEUROL, V339, P62, DOI 10.1002/cne.903390107; Vizzard MA, 1997, DEV NEUROSCI-BASEL, V19, P232, DOI 10.1159/000111212; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; WALLACE MN, 1992, NEUROREPORT, V3, P953, DOI 10.1097/00001756-199211000-00001; Winkler T, 1998, AMINO ACIDS, V14, P131, DOI 10.1007/BF01345253; WU W, 1994, NEUROSCIENCE, V61, P719, DOI 10.1016/0306-4522(94)90394-8; Xu M, 1998, BRAIN RES, V808, P23, DOI 10.1016/S0006-8993(98)00787-2; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yamanaka K, 1998, NEUROSCI RES, V31, P347, DOI 10.1016/S0168-0102(98)00052-2; Zhang FY, 1996, STROKE, V27, P317, DOI 10.1161/01.STR.27.2.317; ZHANG ZG, 1994, BRAIN RES, V654, P85	84	14	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	JAN	2000	17	4					183	197		10.1016/S0891-0618(99)00039-3			15	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	285FX	WOS:000085380000001	10697245				2021-06-18	
J	Wallace, JJ; Caroselli, JS; Scheibel, RS; High, WM				Wallace, JJ; Caroselli, JS; Scheibel, RS; High, WM			Predictive validity of the Neurobehavioural Cognitive Status Examination (NCSE) in a post-acute rehabilitation setting	BRAIN INJURY			English	Article							STROKE PATIENTS; POPULATION; RELIABILITY; IMPAIRMENT	Within the context of a post-acute rehabilitation setting, association and agreement between results from the Neurobehavioural Cognitive Status Examination (NCSE) and from the neuropsychological (NP) evaluation are examined. AU participants (n = 48) had sustained a severe traumatic brain injury and NCSE testing preceded NP testing by an average of 1 month. A significant relationship and fair classification agreement (i.e. presence or absence of cognitive impairment) was found between dir overall results from NCSE and NP evaluation. Significant relationships were also observed between most NCSE subtests and paired NP tests thought to be assessing the same cognitive domains. However, the classification agreement (i.e. the presence or absence of deficient performance) between most NCSE subtests and paired NP tests was poor. The findings are discussed from the standpoint of individual treatment planning.	Transit Learning Ctr Galveston, Galveston, TX 77553 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA	Caroselli, JS (corresponding author), Transit Learning Ctr Galveston, POB 1228,1528 PO, Galveston, TX 77553 USA.						BENTON AL, 1978, MANUAL MULTILINGUAL; BENTON AL, 1983, MANUAL JUDGEMENT LIN; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Drane DL, 1997, ARCH CLIN NEUROPSYCH, V12, P139, DOI 10.1016/S0887-6177(96)00057-1; ENGLEHART C, 1994, CLIN NEUROPSYCHOL, V8, P405; Fleiss JL, 1981, STAT METHODS RATES P, V2nd; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GRUNSEIT AC, 1994, J CLIN EXP NEUROPSYC, V16, P898, DOI 10.1080/01688639408402701; JENNET B, 1981, MANAGEMENT HEAD INJU; Kaplan E., 1987, MANUAL CALIFORNIA VE; Karzmark P, 1997, ASSESSMENT, V4, P1; KAUFMAN DM, 1979, GEN HOSP PSYCHIAT, V1, P247, DOI 10.1016/0163-8343(79)90026-4; KEWMAN DG, 1991, INT J PSYCHIAT MED, V21, P253, DOI 10.2190/FRYK-TMGA-AULW-BM5G; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; LAMARRE CJ, 1994, J PSYCHIATR NEUROSCI, V19, P103; LOGUE PE, 1993, J CLIN PSYCHOL, V49, P80, DOI 10.1002/1097-4679(199301)49:1<80::AID-JCLP2270490111>3.0.CO;2-Z; Marcotte TD, 1997, J CLIN EXP NEUROPSYC, V19, P386, DOI 10.1080/01688639708403867; MEEK PS, 1989, J PSYCHOACTIVE DRUGS, V21, P153, DOI 10.1080/02791072.1989.10472155; Mitrushina M, 1996, J CLIN PSYCHOL, V52, P177, DOI 10.1002/(SICI)1097-4679(199603)52:2<177::AID-JCLP9>3.0.CO;2-R; MITRUSHINA M, 1994, J PSYCHIATR RES, V28, P85, DOI 10.1016/0022-3956(94)90037-X; MYSIW WJ, 1989, AM J PHYS MED REHAB, V68, P168, DOI 10.1097/00002060-198908000-00003; Nabors NA, 1997, J HEAD TRAUMA REHAB, V12, P79, DOI 10.1097/00001199-199706000-00008; NELSON A, 1986, J NERV MENT DIS, V174, P73, DOI 10.1097/00005053-198602000-00002; OSATO SS, 1993, NEUROPSY NEUROPSY BE, V6, P98; OSMON DC, 1992, ARCH PHYS MED REHAB, V73, P414; Roper BL, 1996, NEUROPSY NEUROPSY BE, V9, P54; SCHWAMM LH, 1987, ANN INTERN MED, V107, P486, DOI 10.7326/0003-4819-107-4-486; Spreen O., 1991, COMPENDIUM NEUROPSYC; Veltman R H, 1993, J Neurosci Nurs, V25, P367; WEBSTER JS, 1984, J CLIN PSYCHOL, V40, P237, DOI 10.1002/1097-4679(198401)40:1<237::AID-JCLP2270400146>3.0.CO;2-T; Wechsler D., 1987, MANUAL WECHSLER MEMO; Wechsler D., 1981, WAIS R MANUAL WECHSL; Whiteside DM, 1996, CLIN NEUROPSYCHOL, V10, P459, DOI 10.1080/13854049608406707; Wiederman Michael W., 1995, Clinical Gerontologist, V15, P35, DOI 10.1300/J018v15n04_04; 1988, MANUAL NEUROBEHAVIOR	36	14	15	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2000	14	1					63	69		10.1080/026990500120934			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	274CY	WOS:000084747200007	10670662				2021-06-18	
J	Heath, DL; Vink, R				Heath, DL; Vink, R			Concentration of brain free magnesium following severe brain injury correlates with neurologic motor outcome	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						diffuse axonal injury; trauma; rat; NMR	NUCLEAR-MAGNETIC-RESONANCE; AXONAL INJURY; RATS; MG2+; METABOLISM; PHOSPHORYLATION; DECLINE; DAMAGE; TRAUMA; MG-2+	Recent studies have shown that brain intracellular free magnesium concentration significantly declines following mild to severe, focal and diffuse traumatic brain injury. However, little is known about how this decline or its attenuation by magnesium salts relates to neurologic outcome. This study uses phosphorus magnetic resonance spectroscopy and rotarod tests to characterise the relationship between brain free magnesium concentration and neurologic motor scores following severe, diffuse traumatic brain injury in rats. An intravenous bolus of MgSO4 or MgCl2 (100 mu moles/kg) at 30 min following brain injury significantly attenuated the postinjury brain free magnesium decline. This improved magnesium homeostasis was sustained for the entire postinjury monitoring period (1 week). There was an associated significant improvement in neurologic motor function in magnesium treated rats. Moreover, the brain free magnesium concentration over the one week period was linearly correlated with the neurologic motor function (r=0.70; P < 0.001) as assessed on a daily basis. We propose that brain free magnesium concentration may be used as a prognostic indicator of neurologic motor function after traumatic brain injury. (C) 1999 Harcourt Publishers Ltd.	James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia	Vink, R (corresponding author), James Cook Univ N Queensland, Dept Physiol & Pharmacol, Townsville, Qld 4811, Australia.		AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			Bara M, 1984, MAGNESIUM, V3, P212; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; BRAUGHLER JM, 1992, CENTRAL NERVOUS SYST, P1; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAGIAN MM, 1986, BIOCHIM BIOPHYS ACTA, V852, P262, DOI 10.1016/0005-2728(86)90231-8; GARFINKEL L, 1985, Magnesium, V4, P60; GRUBBS RD, 1987, MAGNESIUM, V6, P113; GUPTA RK, 1978, J BIOL CHEM, V253, P6172; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HAYES RL, 1992, CENTRAL NERVOUS SYST, P173; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1995, J NEUROTRAUM, V12, P1027, DOI 10.1089/neu.1995.12.1027; Heath DL, 1996, NEUROSCI RES COMMUN, V18, P163; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; HOVDA DA, 1992, CENTRAL NERVOUS SYST, P47; KWACK H, 1992, CURR TOP CELL REGUL, V33, P185; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCDONALD JW, 1990, NEUROSCI LETT, V109, P234, DOI 10.1016/0304-3940(90)90569-U; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; PETROFF OAC, 1985, NEUROLOGY, V35, P1681, DOI 10.1212/WNL.35.12.1681; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; RAMADAN NM, 1989, HEADACHE, V29, P416, DOI 10.1111/j.1526-4610.1989.hed2907416.x; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; TERASAKI M, 1985, P NATL ACAD SCI USA, V82, P7324, DOI 10.1073/pnas.82.21.7324; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; VINK R, 1988, J NEUROTRAUMA, V5, P365; Zhang AM, 1996, BRAIN RES, V728, P204, DOI 10.1016/0006-8993(96)00401-5; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	41	14	14	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	1999	6	6					505	509		10.1016/S0967-5868(99)90011-5			5	Clinical Neurology; Neurosciences	Neurosciences & Neurology	265FE	WOS:000084230800012	18639191				2021-06-18	
J	Mignani, S; Aloup, JC; Barreau, M; Blanchard, JC; Bohme, GA; Boireau, A; Damour, D; Debono, MW; Dubroeucq, MC; Genevois-Borella, A; Imperato, A; Jimonet, P; Pratt, J; Randle, JCR; Reibaud, M; Ribeill, Y; Stutzmann, JM				Mignani, S; Aloup, JC; Barreau, M; Blanchard, JC; Bohme, GA; Boireau, A; Damour, D; Debono, MW; Dubroeucq, MC; Genevois-Borella, A; Imperato, A; Jimonet, P; Pratt, J; Randle, JCR; Reibaud, M; Ribeill, Y; Stutzmann, JM			Synthesis and pharmacological properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, a new competitive AMPA/KA receptor antagonist	DRUG DEVELOPMENT RESEARCH			English	Article						AMPA/KA antagonists; anticonvulsant agent; neuroprotective agent	AMINO-ACID PHARMACOLOGY; FOCAL CEREBRAL-ISCHEMIA; RAT CORTICAL MEMBRANES; SPINAL-CORD INJURY; NON-NMDA RECEPTOR; ANTICONVULSANT ACTION; NERVOUS-SYSTEM; RILUZOLE; SITE	The excessive release of glutamate, a potent excitatory neurotransmitter, is thought to play an important role in a variety of acute and chronic neurological disorders. Consequently, excitatory amino acid antagonists may have an important therapeutic potential in the treatment of these diseases. Glutamate interacts with at least three types of receptor: 1) NMDA (N-methyl-D-aspartic acid) receptors; 2) AMPA [2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionic acid]/kainic acid (KA) receptors; and 3) metabotropic receptors. Blockade of ionotropic AMPA/KA receptors has been shown to prevent cerebral ischemia insult in experimental models. This article describes the synthesis, pharmacological activity, and neuroprotective properties of 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one (1), a novel AMPA/KA antagonist which showed micromolar affinity at AMPA/KA receptors and competitively inhibited functional responses mediated by these receptors. In mice, 1 had significant anticonvulsive properties and conferred protection against hypobaric hypoxia and KCN intoxication. In rats and gerbils, 1 possesses significant activity in models of global or focal cerebral ischemia, as well as in a model of neurotrauma. Compound 1 was prepared from 2-bromo-indanone using two synthetic pathways in two or three steps with moderate (30%) or good (70%) yields, respectively. (C) 1999 Wiley-Liss, Inc.	Rhone Poulenc Rorer SA, Ctr Rech Vitry Alfortville, F-94403 Vitry, France	Stutzmann, JM (corresponding author), Rhone Poulenc Rorer SA, Ctr Rech Vitry Alfortville, 13 Quai Jules Guesde,BP 14, F-94403 Vitry, France.			Mignani, Serge/0000-0002-1383-5256			ALOUP JC, 1993, Patent No. 9407893; Auberson YP, 1998, BIOORG MED CHEM LETT, V8, P65, DOI 10.1016/S0960-894X(97)10186-X; BENZEL EC, 1990, J SPINAL DISORD, V3, P334; Bigge CF, 1997, EXPERT OPIN THER PAT, V7, P1099, DOI 10.1517/13543776.7.10.1099; BUCHAN AM, 1991, NEUROSCI LETT, V132, P255, DOI 10.1016/0304-3940(91)90314-J; CANTON T, 1992, J PHARM PHARMACOL, V44, P812, DOI 10.1111/j.2042-7158.1992.tb03211.x; Chapman A., 1991, EXCITATORY AMINO ACI, P265; CHAPMAN AG, 1987, EUR J PHARMACOL, V139, P91, DOI 10.1016/0014-2999(87)90501-2; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; CROUCHER MJ, 1982, SCIENCE, V216, P899, DOI 10.1126/science.7079744; Damour D, 1999, HETEROCYCLES, V50, P259; DAVEY DD, 1987, J ORG CHEM, V52, P4379, DOI 10.1021/jo00228a042; DEBONO MW, 1993, EUR J PHARMACOL, V235, P283, DOI 10.1016/0014-2999(93)90147-A; EPPERSON JR, 1993, BIOORG MED CHEM LETT, V3, P2801, DOI 10.1016/S0960-894X(01)80768-X; GALEAZZI E, 1995, J ORG CHEM, V60, P1090, DOI 10.1021/jo00109a052; HONORE T, 1988, J NEUROCHEM, V51, P457, DOI 10.1111/j.1471-4159.1988.tb01060.x; JACKSON PF, 1991, BIOORG MED CHEM LETT, V1, P751, DOI 10.1016/S0960-894X(01)81062-3; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; MALGOURIS C, 1989, J NEUROSCI, V9, P3720; MCQUAID LA, 1992, J MED CHEM, V35, P3319, DOI 10.1021/jm00096a002; MELDRUM BS, 1991, EXCITATORY AMINO ACI, P1; MONAGHAN DT, 1989, ANNU REV PHARMACOL, V29, P365, DOI 10.1146/annurev.pa.29.040189.002053; OHMORI J, 1994, J MED CHEM, V37, P467, DOI 10.1021/jm00030a006; Ohmori J, 1997, J MED CHEM, V40, P2053, DOI 10.1021/jm960664c; OLNEY JW, 1989, BIOL PSYCHIAT, V26, P505, DOI 10.1016/0006-3223(89)90072-3; PRATT J, 1992, NEUROSCI LETT, V140, P225, DOI 10.1016/0304-3940(92)90108-J; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SNELL LD, 1988, EUR J PHARMACOL, V156, P105, DOI 10.1016/0014-2999(88)90152-5; SWINYARD EA, 1952, J PHARMACOL EXP THER, V106, P319; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; YOUNG AB, 1988, SCIENCE, V241, P981, DOI 10.1126/science.2841762	33	14	14	0	2	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0272-4391			DRUG DEVELOP RES	Drug Dev. Res.	NOV	1999	48	3					121	129		10.1002/(SICI)1098-2299(199911)48:3<121::AID-DDR4>3.0.CO;2-E			9	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	269TW	WOS:000084494500004					2021-06-18	
J	Levy, O; Pritsch, M; Rath, E				Levy, O; Pritsch, M; Rath, E			An operative technique for recurrent shoulder dislocations in older patients	JOURNAL OF SHOULDER AND ELBOW SURGERY			English	Article								Recurrent anterior shoulder dislocation in the elderly is not as exceptional as if was once thought to be. That anterior shoulder dislocation in older patients is caused by a rotator cuff fear through the posterior mechanism is well accepted. However, in the subset of patients who have multiple recurrent or intractable dislocations develop, there may be combined pathologic conditions at work: large or massive rotator cuff fears together with anterior capsulolabral injuries such as a Bankart lesion or fracture of the glenoid rim. These patients have multiple recurrences because of disruption of both the anterior and the posterior stability mechanisms. We suggest a procedure that provides anterior stabilization with the capsular shift technique and that is supplemented by Bankart repair as necessary. The capsule transfer is performed superiorly and posteriorly to close the defect in the cuff. In this way a capsulodesis effect can be achieved that displaces the humeral head downward and produces active centering of the head in the course of abduction. Use of only the anterior capsule for the shift, and not the subscapularis tendon, does not compromise subscapularis function. Between 1990 and 1996, we used this technique to treat 16 patients older than 55 years of age with multiple recurrent anterior shoulder dislocation and massive rotator cuff fear. We report the results for the first 10 patients with a minimum follow-up of 2 years (range 2 to 7 years) and an average follow-up of 52 months. There were 7 excellent results, 2 good results, and 1 fair result according to the Rowe criteria. None of the patients had a recurrence of the dislocation. All the patients regained full or functional range of motion with stable shoulders, and most of them could perform activities of daily living without limitation. The average Constant score was 83%. This procedure appears to be successful in treating older patients with recurrent shoulder dislocation.	Ben Gurion Univ Negev, Soroka Med Ctr, Dept Orthopaed, Shoulder Surg Serv, Beer Sheva, Israel; Chaim Sheba Med Ctr, Dept Orthopaed, Shoulder Surg Serv, IL-52621 Tel Hashomer, Israel	Levy, O (corresponding author), Royal Berkshire Hosp, Dept Shoulder Surg, London Rd, Reading RG1 5AN, Berks, England.						CADMAN EA, 1934, SHOULDER, P262; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; COPELAND SA, 1995, OPERATIVE SHOULDER S, P102; CRAIG EV, 1984, CLIN ORTHOP RELAT R, P212; GERBER C, 1991, J BONE JOINT SURG BR, V73, P389; GONZALEZ D, 1991, J BONE JOINT SURG AM, V73A, P620, DOI 10.2106/00004623-199173040-00024; HAWKINS RJ, 1986, CLIN ORTHOP RELAT R, P192; HOVELIUS L, 1983, J BONE JOINT SURG AM, V65, P343, DOI 10.2106/00004623-198365030-00008; LEVY O, 1996, J SHOULDER ELBOW S S, V5, pS22; LEVY O, 1993, J SHOULDER ELBOW S S, V2, pS17; MCLAUGHL.HL, 1967, J TRAUM, V7, P191, DOI 10.1097/00005373-196703000-00002; NEER CS, 1972, J BONE JOINT SURG AM, VA 54, P41, DOI 10.2106/00004623-197254010-00003; NEVIASER J S, 1956, Instr Course Lect, V13, P187; Neviaser R J, 1995, J Shoulder Elbow Surg, V4, P416, DOI 10.1016/S1058-2746(05)80032-1; NEVIASER RJ, 1993, CLIN ORTHOP RELAT R, P103; NEVIASER RJ, 1988, J BONE JOINT SURG AM, V70A, P1308, DOI 10.2106/00004623-198870090-00005; NEVIASER RJ, 1980, ORTHOP CLIN N AM, V11, P295; PATTE D, 1986, ENCY MED CHIR TECHNI, P1; PRITSCH M, 1995, P 6 INT C SURG SHOUL; ROWE C R, 1961, Clin Orthop, V20, P40; ROWE CR, 1978, J BONE JOINT SURG AM, V60, P1; SONNABEND DH, 1994, CLIN ORTHOP RELAT R, P74; Stevens JH, 1926, ANN SURG, V83, P84; WALCH G, 1988, FRENCH J ORTHOP SURG, V2, P19	24	14	14	0	1	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	1058-2746			J SHOULDER ELB SURG	J. Shoulder Elbow Surg.	SEP-OCT	1999	8	5					452	457		10.1016/S1058-2746(99)90075-7			6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	250HK	WOS:000083382800010	10543598				2021-06-18	
J	Alexander, BH; Franklin, GM; Fulton-Kehoe, D				Alexander, BH; Franklin, GM; Fulton-Kehoe, D			Comparison of fatal and severe nonfatal traumatic work-related injuries in Washington State	AMERICAN JOURNAL OF INDUSTRIAL MEDICINE			English	Article						occupational accidents; fatalities; injury severity score; workers' compensation; surveillance	OCCUPATIONAL INJURIES; UNITED-STATES; CONSTRUCTION-INDUSTRY; HIGH-RISK; EMERGENCY; HOMICIDE	Objective To compare fatal and hospitalized nonfatal work-related traumatic injuries by occupation and cause. Methods Fatal and hospitalized nonfatal injuries occurring from 1991-1995 were identified from Washington State workers' compensation claims data. Nonfatal injuries were classified as severe if they harl at least one of the following criteria: a brain or spinal cord injury, an Injury Severity Score of greater than or equal to 16 or were hospitalized for more than 7 days. The frequency and rate of fatal and severe nonfatal injuries were then described by industrial risk class and cause. Results The study identified 335 fatal injuries and 4,405 hospitalized nonfatal injuries, of which 1,105 were classified as severe. Tree topping and pruning, carnival work, roofing, and metal siding and gutters risk classes had several severe nonfatal injuries, but few, if any, fatalities. Causes of fatal and severe nonfatal injuries were notably different for the roofing, restaurant, and orchard workers risk classes. Conclusions: The inclusion of severe hospitalized injuries in occupational injury surveillance systems will provide a broader view of high-risk occupations and profile of injury causation with which to direct occupational injury prevention efforts. Am. J. Ind. Med. 36:317-325, 1999. (C) 1999 Wiley-Liss, Inc.	Univ Washington, Sch Publ Hlth & Community Med, Dept Environm Hlth, Occupat Epidemiol & Hlth Outcomes Program, Seattle, WA 98195 USA; Washington State Dept Labor & Ind, Olympia, WA 98504 USA	Alexander, BH (corresponding author), Univ Minnesota, Div Environm & Occupat Hlth, Box 807,Mayo Bldg,420 Delaware St, Minneapolis, MN 55455 USA.						BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BELL CA, 1991, AM J PUBLIC HEALTH, V81, P729, DOI 10.2105/AJPH.81.6.729; BELL CA, 1990, JAMA-J AM MED ASSOC, V263, P3047, DOI 10.1001/jama.263.22.3047; CASTILLO DN, 1994, J OCCUP ENVIRON MED, V36, P125, DOI 10.1097/00043764-199402000-00006; CHEADLE A, 1994, AM J PUBLIC HEALTH, V84, P190, DOI 10.2105/AJPH.84.2.190; *COMM INJ SCAL, 1985, ABBR INJ SCAL 1985 R; DAVIS H, 1987, AM J PUBLIC HEALTH, V77, P1524, DOI 10.2105/AJPH.77.12.1524; Fosbroke DE, 1997, AM J IND MED, V31, P459, DOI 10.1002/(SICI)1097-0274(199704)31:4<459::AID-AJIM13>3.3.CO;2-E; FRANKLIN GM, 1991, AM J PUBLIC HEALTH, V81, P741, DOI 10.2105/AJPH.81.6.741; HEINRICH HW, 1980, IND ACC PREV; HEYER NJ, 1994, AM J PUBLIC HEALTH, V84, P1106, DOI 10.2105/AJPH.84.7.1106; INANCSI W, 1987, J OCCUP ENVIRON MED, V29, P730; Jenkins E. Lynn, 1994, Annals of Epidemiology, V4, P146, DOI 10.1016/1047-2797(94)90061-2; KISNER SM, 1994, J OCCUP ENVIRON MED, V36, P137, DOI 10.1097/00043764-199402000-00008; KRAUS JF, 1987, AM J PUBLIC HEALTH, V77, P1285, DOI 10.2105/AJPH.77.10.1285; LOZADALARSEN S, 1987, P HUM FACT SOC 31 AN, V1, P200; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Pollack ES, 1996, AM J IND MED, V30, P325; ROSSIGNOL AM, 1986, J TRAUMA, V26, P1097, DOI 10.1097/00005373-198612000-00007; Ruser JW, 1998, AM J IND MED, V33, P151, DOI 10.1002/(SICI)1097-0274(199802)33:2<151::AID-AJIM6>3.0.CO;2-0; SALMINEN S, 1992, SAFETY SCI, V15, P109, DOI 10.1016/0925-7535(92)90011-N; STOUT N, 1991, AM J PUBLIC HEALTH, V81, P725, DOI 10.2105/AJPH.81.6.725; Toscano G, 1996, Stat Bull Metrop Insur Co, V77, P12; *US DEP LAB BLS, 1995, CENS FAT OCC INJ; VEAZIE MA, 1994, ANNU REV PUBL HEALTH, V15, P203, DOI 10.1146/annurev.pu.15.050194.001223; *WA STAT DEP LAB I, 1993, OCC INJ ILLN SURV RE; Zwerling C, 1996, J OCCUP ENVIRON MED, V38, P698, DOI 10.1097/00043764-199607000-00013	27	14	15	0	1	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0271-3586			AM J IND MED	Am. J. Ind. Med.	AUG	1999	36	2					317	325		10.1002/(SICI)1097-0274(199908)36:2<317::AID-AJIM11>3.3.CO;2-I			9	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	214GD	WOS:000081319500011	10398940				2021-06-18	
J	Connolly, JF; Major, A; Allen, S; D'Arcy, RC				Connolly, JF; Major, A; Allen, S; D'Arcy, RC			Performance on WISC-III and WAIS-R NI vocabulary subtests assessed with event-related brain potentials: An innovative method of assessment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							RECEPTIVE VOCABULARY; APHASIA; DETERMINANTS; SENTENCES; LANGUAGE; STROKE; WORDS; P300	Assessment of intellectual functions is essential for rehabilitative interventions with traumatic brain injury and stroke patients. However, many of these patients are difficult or impossible to assess because of aphasia and physical disabilities that prevent their performance on traditionally administered tests of mental functioning. We present normative evidence obtained from healthy individuals for the efficacy of a new method of assessing such patients using standardized and validated tests formatted for computer presentation and using direct measures of brain activity (event-related brain potentials, ERP) as the measurable response instead of verbal or motor behavior.	Dalhousie Univ, Dept Psychol, Life Sci Ctr, Cognit Clin Neurosci Unit, Halifax, NS B3H 4J1, Canada; Dalhousie Univ, Dept Med, Div Psychiat, Halifax, NS, Canada	Connolly, JF (corresponding author), Dalhousie Univ, Dept Psychol, Life Sci Ctr, Cognit Clin Neurosci Unit, Halifax, NS B3H 4J1, Canada.			Connolly, John/0000-0001-8869-5369			Byrne JM, 1995, CHILD NEUROPSYCHOL, V1, P211, DOI 10.1080/09297049508400226; BYRNE JM, 1995, J CLIN EXP NEUROPSYC, V17, P9, DOI 10.1080/13803399508406576; CHIAPPA K, 1997, EVOKED POTENTIALS CL; CONNOLLY J, 1999, UNPUB SPATIOTEMPORAL; CONNOLLY JF, 1992, BRAIN LANG, V43, P1, DOI 10.1016/0093-934X(92)90018-A; CONNOLLY JF, 1995, J CLIN EXP NEUROPSYC, V17, P548, DOI 10.1080/01688639508405145; CONNOLLY JF, 1990, BRAIN LANG, V39, P302, DOI 10.1016/0093-934X(90)90016-A; CONNOLLY JF, 1995, ELECTROEN CLIN NEURO, V94, P276, DOI 10.1016/0013-4694(95)98479-R; CONNOLLY JF, IN PRESS ARCH PHYSIC; CONNOLLY JF, IN PRESS INT J PSYCH; DARCY RCN, 1998, THESIS DALHOUSIE U H; DARCY RCN, IN PRESS NEUROPSYCHO; DARCY RCN, IN PRESS J INT NEURO; Dunn L., 1981, PEABODY PICTURE VOCA; Enderby P, 1987, Int Rehabil Med, V8, P162; ENDERBY P, 1986, BRIT J DISORD COMMUN, V21, P151; Goodglass H., 1972, ASSESSMENT APHASIA R; Helenius P, 1998, BRAIN, V121, P1133, DOI 10.1093/brain/121.6.1133; Hulley S. B., 1988, DESIGNING CLIN RES; Ingles JL, 1996, CORTEX, V32, P199, DOI 10.1016/S0010-9452(96)80047-5; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Kaplan E., 1991, WAIS R NEUROPSYCHOLO; Kay J, 1996, APHASIOLOGY, V10, P159, DOI 10.1080/02687039608248403; Kay J., 1992, PALPA PSYCHOLINGUIST; KERTESZ A, 1982, NEUROPSYCHOLOGIA, V20, P275, DOI 10.1016/0028-3932(82)90102-6; KUTAS M, 1994, HDB PSYCHOLINGUISTIC, P83, DOI DOI 10.1016/8978-012369374-7/50018-3; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEVIN HS, 1981, ACQUIRED APHASIA, P427; LEZAK M, 1995, AM PSYCHOL, V47, P1007; MARQUARDSEN J, 1969, ACTA NEUROL SCAND  S, V38, P67; NAATANEN R, 1995, EAR HEARING, V16, P6; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P210; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PEDERSEN PM, 1995, ANN NEUROL, V38, P659, DOI 10.1002/ana.410380416; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Rugg Michael D., 1995, P789; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; Wechsler D., 1991, WECHSLER INTELLIGENC	41	14	15	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	AUG	1999	21	4					444	464		10.1076/jcen.21.4.444.879			21	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	258LX	WOS:000083841600003	10550805				2021-06-18	
J	Dias, MS; Carnevale, F; Li, V				Dias, MS; Carnevale, F; Li, V			Immediate posttraumatic seizures: Is routine hospitalization necessary?	PEDIATRIC NEUROSURGERY			English	Article						posttraumatic seizure; posttraumatic epilepsy; closed head injury; minor brain injury	MILD HEAD-INJURY; CHILDREN; TRAUMA	Objective: A recent Internet survey of pediatric neurosurgeons showed that 86% routinely admitted children with immediate posttraumatic seizures (PTS) for a brief period of observation. We wished to determine whether certain children meeting predefined criteria could instead be safely discharged from the emergency room. Methods: We reviewed the records of children admitted during the past 5 years with a diagnosis of seizure and head injury. Children with a minor head injury, a PTS occurring within 24 h of injury and no intracranial abnormalities on admission CT scan were included. Children with previous neurological conditions, a history of prior seizures (other than PTS or febrile seizures), a prior history of anticonvulsant use, or intracranial abnormalities on the admission CT scan were excluded. Records were abstracted for child's age, gender, length of admission, previous history of PTS or febrile seizures, mechanism of injury, location of impact, time between impact and PTS, the number, length and type of PTS, Glasgow Coma Score (GCS) on admission, subsequent complications and hospital costs. Results: Seventy-one children met the inclusion criteria. Eleven children presented to the emergency room with prolonged seizures, transient apnea or persistently low GCS and required admission to the intensive care unit (ICU). Among the 60 remaining children with simple PTS, none had further seizures during the follow-up period, and none had significant complications. The average cost of hospitalization was known for 58 children; after excluding the costs for 5 patients who were admitted to the ICU, the average hospital cost amounted to USD 1,615 per patient. Conclusions: Our data suggest that children with isolated minor head injuries and simple PTS who recover fully in the emergency room, whose CT scans show no intracranial abnormalities and who have no prior history of neurological disease, epilepsy or anticonvulsant use are at low risk for recurrent seizures or neurological complications, and could potentially be sent home to a reliable caretaker and a stable home situation. However, because of the limited sample size in this study, the statistical risk of a bad outcome may be as high as 9%; we therefore suggest that much larger studies are potentially needed before this becomes a standard policy.	SUNY Buffalo, Childrens Hosp, Dept Neurosurg, Buffalo, NY 14260 USA; SUNY Buffalo, Childrens Hosp, Dept Pediat, Buffalo, NY 14260 USA	Dias, MS (corresponding author), Childrens Hosp, Dept Pediat Neurosurg, 219 Bryant St, Buffalo, NY 14222 USA.						Aldrich EF, 1996, NEUROLOGICAL SURG, P1719; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Bergman DA, 1996, PEDIATRICS, V97, P769; Black P, 1972, T AM NEUROL ASSOC, V97, P247; DASILVA AM, 1990, ACT NEUR S, V50, P48; DAVIES RL, 1995, PEDIATRICS, V95, P345; DESAI BT, 1983, EPILEPSIA, V24, P289, DOI 10.1111/j.1528-1157.1983.tb04892.x; ELDRIDGE AR, 1939, T AM NEURAL ASS, V65, P125; FOULON M, 1977, ACTA NEUROL BELG, V77, P276; GLANTZ GA, 1987, PRIMER BIOSTATISTICS; GRAND W, 1974, J NEUROL NEUROSUR PS, V37, P178, DOI 10.1136/jnnp.37.2.178; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HAHN YS, 1988, NEUROSURGERY, V22, P864, DOI 10.1227/00006123-198805000-00008; HENDRICK EB, 1968, J TRAUM, V8, P547; Huang MC, 1998, PEDIATR NEUROL, V18, P150, DOI 10.1016/S0887-8994(97)00171-9; JAMISON DL, 1974, ARCH DIS CHILD, V49, P376, DOI 10.1136/adc.49.5.376; Jennet B, 1976, HDB CLIN NEUROLOGY, V24, P445; JENNETT B, 1973, DEV MED CHILD NEUROL, V15, P56; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kollevold T, 1976, J Oslo City Hosp, V26, P99; MISES J, 1970, EPILEPSIA, V11, P37, DOI 10.1111/j.1528-1157.1970.tb03864.x; MITCHELL KA, 1994, J PEDIATR SURG, V29, P851, DOI 10.1016/0022-3468(94)90001-9; Roddy SP, 1998, PEDIATRICS, V101, P575, DOI 10.1542/peds.101.4.575; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; SHAKELFORD SR, 1992, J TRAUMA, V33, P385; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003	29	14	14	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	MAY	1999	30	5					232	238		10.1159/000028803			7	Clinical Neurology; Pediatrics; Surgery	Neurosciences & Neurology; Pediatrics; Surgery	227RF	WOS:000082092900002	10461069				2021-06-18	
J	Cantagallo, A; Grassi, L; Della Sala, S				Cantagallo, A; Grassi, L; Della Sala, S			Dissociative disorder after traumatic brain injury	BRAIN INJURY			English	Article							MULTIPLE PERSONALITY-DISORDER; HEAD-INJURY; CAPGRAS SYNDROME; REDUPLICATIVE PARAMNESIA; AUTOBIOGRAPHICAL MEMORY; PSYCHIATRIC-DISORDERS; RETROGRADE-AMNESIA; PSYCHOSIS; EPILEPSY; MMPI	Several episodes of dissociative disorder, including depersonalization and multiple personality, have been observed in a 32-year old man during a period of a few months following a mild traumatic brain injury. The psychogenic or organic aetiology of these psychiatric disorders remains undetermined. This case highlights the need to consider dissociative disorder among the possible (temporary) outcomes of a brain injury.	Univ Aberdeen, Dept Psychol, Kings Coll, Neuropsychol Res Grp, Aberdeen AB24 2UB, Scotland; Ferrara Hosp, Unita Operat Med Riabilitat, Ferrara, Italy; Univ Ferrara, Dept Psychiat, I-44100 Ferrara, Italy	Della Sala, S (corresponding author), Univ Aberdeen, Dept Psychol, Kings Coll, Neuropsychol Res Grp, Aberdeen AB24 2UB, Scotland.			GRASSI, Luigi/0000-0002-1050-4494			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ALEXANDER MP, 1979, NEUROLOGY, V29, P334, DOI 10.1212/WNL.29.3.334; ALLAMANNO N, 1987, ITAL J NEUROL SCI, V8, P111, DOI 10.1007/BF02337583; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; BARNHILL LJ, 1989, NEUROPSY NEUROPSY BE, V2, P211; BENSON DF, 1976, NEUROLOGY, V26, P147, DOI 10.1212/WNL.26.2.147; BENTON A L, 1978, Archives of Neurology, V35, P364; BIENENFELD D, 1989, J CLIN PSYCHIAT, V50, P68; BLISS EL, 1984, J NERV MENT DIS, V172, P197, DOI 10.1097/00005053-198404000-00002; BORRINI G, 1989, PSYCHOL MED, V19, P215, DOI 10.1017/S0033291700011181; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BRUTON CJ, 1994, NEUROLOGY, V44, P34, DOI 10.1212/WNL.44.1.34; COONS PM, 1988, J NERV MENT DIS, V176, P519, DOI 10.1097/00005053-198809000-00001; COONS PM, 1990, PSYCHOL REP, V66, P831, DOI 10.2466/PR0.66.3.831-834; Della Sala S., 1996, METHOD MADNESS CASE, P209; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; EAMES P, 1992, J NEUROL NEUROSUR PS, V55, P1046, DOI 10.1136/jnnp.55.11.1046; EAMES P, 1990, NEUROBEHAVIORAL SEQU, P133; Fann JR, 1997, J PSYCHOSOM RES, V43, P335, DOI 10.1016/S0022-3999(97)00130-X; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; FILLEY CM, 1987, NEUROLOGY, V37, P701, DOI 10.1212/WNL.37.4.701; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; GRISBY J, 1986, INT J CLIN NEUROPSYC, V8, P65; GRISBY J, 1993, BRAIN INJURY, V7, P507; GRONWALL D, 1980, Journal of Clinical Neuropsychology, V2, P51, DOI 10.1080/01688638008403780; Gualtari CT, 1991, BRAIN INJURY, V5, P219; HATHAWAY SR, 1951, MANUAL MINNESOTA MUL; HODGES JR, 1991, TRANSIENT AMNESIA CL; JORGE RE, 1993, AM J PSYCHIAT, V150, P916; KIHLSTROM JF, 1995, HDB MEMORY DISORDERS, P337; LEVINE DN, 1982, NEUROLOGY, V32, P267, DOI 10.1212/WNL.32.3.267; LISHMAN WA, 1998, ORGANIC PSYCHOL PSYC; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LUCCHELLI F, 1995, BRAIN, V118, P167, DOI 10.1093/brain/118.1.167; LUKIANOWICZ N, 1960, J MENT SCI, V106, P979; Markowitsch HJ, 1998, NEUROPSYCHOLOGIA, V36, P77, DOI 10.1016/S0028-3932(97)00093-6; MARKOWITSCH HJ, 1990, TRANSIENT GLOBAL AMN; MASDEU JC, 1994, NEUROLOGY, V44, P1970, DOI 10.1212/WNL.44.10.1970; Mayer-Gross W, 1935, BRIT J MED PSYCHOL, V15, P103, DOI 10.1111/j.2044-8341.1935.tb01140.x; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; MERSKEY H, 1992, NEUROL CLIN, V10, P895; Meyer A, 1904, AM J INSANITY, V60, P373, DOI 10.1176/ajp.60.3.373; Minsky Marvin, 1987, SOC MIND; OHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; PARKER R, 1990, TRAUMATIC BRAIN INJU; RICHARDSON JTE, 1990, CLIN NEUROPSYCHOLOGI; SANDEL ME, 1990, ARCH PHYS MED REHAB, V71, P523; SEDMAN G, 1970, BRIT J PSYCHIAT, V117, P1; Silver JM., 1994, NEUROPSYCHIATRY TRAU; SIMS A, 1995, SYMPTOMS MIND; Smeltzer Donald J., 1994, P251; Spanos N.P., 1996, MULTIPLE IDENTITIES; SPINNLER H, 1987, ITALIAN J NEUROLOG S, V6; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; Syz H, 1937, J GEN PSYCHOL, V17, P355, DOI 10.1080/00221309.1937.9918005; TOMSEN I, 1984, J NEUROL NEUROSUR PS, V47, P260; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Venneri A, 1998, BRAIN INJURY, V12, P605, DOI 10.1080/026990598122368; WATSON CG, 1979, J NERV MENT DIS, V167, P243, DOI 10.1097/00005053-197904000-00008; WESTON MJ, 1971, BRIT J PSYCHIAT, V119, P25, DOI 10.1192/bjp.119.548.25; WILL RG, 1988, BRIT J PSYCHIAT, V152, P410, DOI 10.1192/bjp.152.3.410; Wood RLL, 1990, NEUROBEHAVIORAL SEQU; ZIMMERMAN P, 1992, TESTBATTERIE AUFMERK	66	14	14	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	APR	1999	13	4					219	228		10.1080/026990599121593			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	186RH	WOS:000079742400001	10230523				2021-06-18	
J	Halonen, T; Nissinen, J; Pitkanen, A				Halonen, T; Nissinen, J; Pitkanen, A			Neuroprotective effect of remacemide hydrochloride in a perforant pathway stimulation model of status epilepticus in the rat	EPILEPSY RESEARCH			English	Article						amygdala; antiepileptic drug; electroencephalogram; entorhinal cortex; epilepsy; hippocampus; neuronal damage; piriform cortex	TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL-LESIONS; ELECTRICAL-STIMULATION; NEURONAL DAMAGE; BRAIN; METABOLITE; MEMORY; IMPAIRMENT; INHIBITION; ISCHEMIA	Previous studies have demonstrated that remacemide and its desglycinyl metabolite, AR-R12495AA, reduce neuronal damage in animal models of ischemia, subarachnoid hemorrhage, and traumatic brain injury. The aim of the present study was to investigate whether remacemide hydrochloride also alleviates seizure-induced neuronal damage in a model of status epilepticus induced by the stimulation of the perforant pathway (PP) in the rat. Chronic oral remacemide treatment (3 x 25 mg/kg/day) was started either 2 days before or 2 h after the beginning of PP stimulation (2 mA, 20 Hz, 0.1 ms pulse duration for 60 min). The effects of remacemide treatment on the severity of seizures, electroencephalogram (EEG) parameters, seizure-induced neuronal damage in the temporal lobe regions, and memory impairment were compared to unstimulated and stimulated vehicle-treated controls, and carbamazepine-pretreated (3 x 40 mg/kg/day) rats. Both remacemide and carbamazepine pretreatments, but not remacemide posttreatment, decreased pyramidal cell damage in the CA3 and CA1 subregions of the hippocampus (P < 0.05). In addition, overall neuronal damage in the extrahippocampal temporal lobe regions (the piriform cortex, entorhinal cortex, and the amygdaloid complex) was milder in remacemide-pretreated rats compared to stimulated control rats (P < 0.01). The neuroprotective effect was most evident on the side contralateral to stimulation. Remacemide or carbamazepine pretreatment had no evident effect on the number or duration of behavioral seizures during PP stimulation. Neither drug altered the spectral parameters of the baseline EEG or prevented status epilepticus-induced EEG slowing observed 2 weeks after PP stimulation. Nor did remacemide or carbamazepine treatment alleviate spatial memory impairment determined in a Morris water-maze task 2 weeks after PP stimulation. Our data provide evidence that pretreatment with remacemide has a moderate neuroprotective effect against status epilepticus-induced neuronal damage. (C) 1999 Elsevier Science B.V. All rights reserved.	Univ Kuopio, AI Virtanen Inst Mol Sci, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Neurol, FIN-70211 Kuopio, Finland	Halonen, T (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, POB 1627, FIN-70211 Kuopio, Finland.						BANNAN PE, 1994, BRAIN RES, V664, P271, DOI 10.1016/0006-8993(94)91984-4; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Black MA, 1996, J NEUROCHEM, V66, P989; BORNSTEIN RA, 1988, ARCH NEUROL-CHICAGO, V45, P884, DOI 10.1001/archneur.1988.00520320074019; Cereghino J J, 1975, Adv Neurol, V11, P309; CHEUNG H, 1992, FASEB J, V6, pA1879; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; Clark Bruce, 1995, P1035; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; FISH BJ, 1991, SPEHLMANNS EEG PRIME; Halonen T, 1996, EUR J PHARMACOL, V299, P69, DOI 10.1016/0014-2999(95)00835-7; HARRIS E, 1992, MULTIPLE SIGMA PCP R, P643; Insausti R, 1997, HIPPOCAMPUS, V7, P146, DOI 10.1002/(SICI)1098-1063(1997)7:2<146::AID-HIPO4>3.0.CO;2-L; LENCZ T, 1992, ANN NEUROL, V31, P629, DOI 10.1002/ana.410310610; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Palmer GC, 1995, ANN NY ACAD SCI, V765, P236, DOI 10.1111/j.1749-6632.1995.tb16580.x; Palmer Gene C., 1993, Drugs of the Future, V18, P1021; Paxinos G, 1986, RAT BRAIN STEREOTAXI; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Pitkanen A, 1996, EPILEPSY RES, V24, P29, DOI 10.1016/0920-1211(95)00093-3; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; SCHWARZER C, 1995, NEUROSCIENCE, V69, P831, DOI 10.1016/0306-4522(95)00268-N; SECHI GP, 1987, EPILEPSY RES, V1, P173, DOI 10.1016/0920-1211(87)90038-6; SIMON RP, 1985, J PHARMACOL EXP THER, V234, P830; SLOVITER RS, 1983, BRAIN RES BULL, V10, P675, DOI 10.1016/0361-9230(83)90037-0; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; Subramaniam S, 1996, J PHARMACOL EXP THER, V276, P161; Subramaniam S., 1993, Society for Neuroscience Abstracts, V19, P717; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; SWANSSON LW, 1992, BRAINMAPS STRUCTURE; VANLUIJTELAAR ELJM, 1995, NEUROPHARMACOLOGY, V34, P419, DOI 10.1016/0028-3908(95)00008-T; Wamil AW, 1996, EPILEPSY RES, V23, P1, DOI 10.1016/0920-1211(95)00053-4; WIESER HG, 1992, TEMPORAL LOBES LIMBI, P169; YLINEN AMA, 1991, P NATL ACAD SCI USA, V88, P7650, DOI 10.1073/pnas.88.17.7650	39	14	14	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	APR	1999	34	2-3					251	269		10.1016/S0920-1211(98)00122-3			19	Clinical Neurology	Neurosciences & Neurology	194MC	WOS:000080196600019	10210040				2021-06-18	
J	Mayr, JM; Seebacher, U; Schimpl, G; Fiala, F				Mayr, JM; Seebacher, U; Schimpl, G; Fiala, F			Highchair accidents	ACTA PAEDIATRICA			English	Article						accident prevention; child; head injury; highchair; restraint	CHILDREN	In order to establish guidelines for highchair accident prevention we investigated causes, mode and complications of highchair accidents by the following methods: The charts of 103 children attending our Accident & Emergency department for highchair related injuries were studied retrospectively. Questionnaires were sent to the parents to obtain detailed information about the mode of accident. They were also asked to suggest preventive measures. In addition, a random sample survey was performed with 163 families inquiring about the rate of highchair use and the incidence of highchair related accidents. Of the 103 infants, 15.5% had sustained a skull fracture, 13.6% a brain concussion, 2.0% limb fractures and 68.9% a simple contusion of the head or lacerations to the scalp or face. The questionnaires were fully completed by 61.2% of parents. Every second family reported that their infant had tried to stand up in the highchair before falling off (only one child had been wearing a restraint). In a further 14.3% of accidents the highchair tipped over. Eighty-seven percent of parents would appreciate a pre-installation of restraints, 54.0% requested more informative instructions for users, and 33.3% asked for products with better stability. The random sample survey revealed a highchair use rate of 92%; 18% of families used highchairs equipped with restraints, and 6% reported highchair accidents sustained by their children. We conclude that most highchair accidents occur when unrestrained infants try to stand up. Pre-installed child restraints, better manuals for users and increased highchair stability should be recommended as promising accident prevention strategies.	Graz Univ, Dept Paediat Surg, A-8036 Graz, Austria; Austrian Stand Inst, Vienna, Austria; Consumer Council, Vienna, Austria	Mayr, JM (corresponding author), Graz Univ, Dept Paediat Surg, Auenbruggerplatz 34, A-8036 Graz, Austria.						FINISON K, 1983, SCIPP REPORTS, V4, P1; GARRETTSON LK, 1985, PEDIATR CLIN N AM, V32, P153; JAFFE D, 1991, NEW ENGL J MED, V324, P1477; JONES S, 1991, CONSUMER REPORTS BOO, P194; WATSON WL, 1993, J PAEDIATR CHILD H, V29, P228, DOI 10.1111/j.1440-1754.1993.tb00493.x	5	14	15	0	4	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0803-5253			ACTA PAEDIATR	Acta Paediatr.	MAR	1999	88	3					319	322		10.1080/08035259950170105			4	Pediatrics	Pediatrics	179PR	WOS:000079338200016	10229045				2021-06-18	
J	Watts, R; Perlesz, A				Watts, R; Perlesz, A			Psychosocial outcome risk indicator: predicting psychosocial outcome following traumatic brain injury	BRAIN INJURY			English	Article							FAMILY ASSESSMENT DEVICE; CLOSED-HEAD INJURY; SOCIAL SUPPORT; CAREGIVERS; RELIABILITY; VALIDITY; DISTRESS; HEALTH; IMPACT; LIFE	This study examines the outcome of 29 individuals with traumatic brain injury (TBI) and 23 of their respective significant others, 12 months after discharge from inpatient rehabilitation services, as a means of determining the validity of a measure developed to predict psychosocial outcome. This measure consists of 18 questions that examine 12 factors and requires the rater re make a judgement about the likely impact each factor would have on the individual with TBI and significant other. Results indicate that the serial work raters accurately predicted outcome according to the factors contained in the measure. Scores on the measure at discharge were also found to be associated with general psychological distress, anxiety and insomnia, depression, family functioning, and the problems related to emotion and behaviour. Although the sample size was small, there is an indication that the devised measure is useful in predicting outcome and so has clinical value in identifying adults at greatest risk of pool psychosocial outcome after a traumatic brain injury.	Rehab Plus, Auckland 1002, New Zealand	Watts, R (corresponding author), Rehab Plus, 54 Carrington Rd,POB 44037, Auckland 1002, New Zealand.						ADAMS N, 1996, AUSTR NZ J FAMILY TH, V17, P75; Bishop DS, 1988, J HEAD TRAUMA REHAB, V3, P16; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; CAMPLAIR PS, 1990, COMMUNITY INTEGRATIO, P207; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; GLASS TA, 1993, STROKE, V24, P64, DOI 10.1161/01.STR.24.1.64; Godfrey HPD, 1996, J HEAD TRAUMA REHAB, V11, P29, DOI 10.1097/00001199-199612000-00006; Goldberg D., 1978, MANUAL GEN HLTH QUES; GRAY JM, 1994, CLIN REHABIL, V8, P188, DOI DOI 10.1080/09602010902949207; HINKELDEY N S, 1990, Brain Injury, V4, P115, DOI 10.3109/02699059009026157; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Johnson L H, 1996, J Neurosci Nurs, V28, P259; Kabacoff R.I., 1990, J FAMILY PSYCHOL, V3, P431, DOI [10.1037/h0080547, DOI 10.1037/H0080547]; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; KAY T, 1992, HEAD INJURY FAMILY I; KINSELLA G, 1988, PSYCHOL MED, V18, P57, DOI 10.1017/S0033291700001884; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kinsella G, 1989, Int Disabil Stud, V11, P9; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; KOSCIULEK JF, 1994, REHABIL COUNS BULL, V37, P244; KOSCIULEK JF, 1993, J REHABILITATION JUL, P40; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LAMONT M, 1993, THESIS TROBE U MELBO; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1995, J NEUROL NEUROSUR PS, V48, P876; Maitz E.A., 1991, HEAD INJURY FAMILY M, P65; MAITZ EA, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199504000-00003; MAYER NH, 1993, J HEAD TRAUMA REHAB, V8, pR6; McCubin M. A., 1991, FAMILY ASSESSMENT IN, P3; MCGORRY PD, 1992, AUST NZ J PSYCHIAT, V26, P3, DOI 10.3109/00048679209068305; McMordie W R, 1988, Brain Inj, V2, P357, DOI 10.3109/02699058809150908; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; MOORE A, 1993, BRAIN INJURY, V7, P247, DOI 10.3109/02699059309029677; PARRY A, 1985, THESIS TROBE U MELBO; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; PERLESZ A, 1992, AUSTR NZ J FAMILY TH, V13, P145, DOI DOI 10.1002/J.1467-8438.1992.TB00910.X; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; SACHS PR, 1991, TREATING FAMILIES BR; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; Tarter S B, 1990, Arch Clin Neuropsychol, V5, P15; THOMPSON K, 1988, WHY CANT S KOWALSKI; THOMSEN IV, 1992, SCAND J REHABIL MED, P142; VANZOMEREN AH, J NEUROLOGY NEUROSUR, V48, P21; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009	52	14	14	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB	1999	13	2					113	124		10.1080/026990599121773			12	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	167HQ	WOS:000078626800004	10079956				2021-06-18	
J	Regan, RF; Guo, YP				Regan, RF; Guo, YP			Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione	NEUROSCIENCE			English	Article						brain injury; calcium; cell culture; excitotoxicity; glutamate; ischemia	CORTICAL CELL-CULTURE; CEREBELLAR GRANULE CELLS; SPINAL-CORD NEURONS; NMDA RECEPTOR; AMINO-ACIDS; OXIDIZED GLUTATHIONE; GLUTAMATE TOXICITY; FOREBRAIN NEURONS; BINDING-SITES; RAT	Glutathione is present in the central nervous system in millimolar concentrations, and is a predominant intracellular antioxidant and detoxicant. In addition, glutathione is released into the extracellular space via a depolarization-enhanced process. Although the role of extracellular glutathione has not been precisely defined, a growing body of experimental evidence suggests that it has multifaceted electrophysiological effects. At low micromolar concentrations, glutathione depolarizes neurons by binding to its own receptors and modulates glutamatergic excitatory neurotransmission by displacing glutamate from its ionotropic receptors, At higher concentrations, reduced glutathione may increase N-methyl-D-aspartate receptor responses by interacting with its redox sites. In this study, the effect of extracellular glutathione on excitotoxic neuronal injury was quantitatively assessed in murine cortical cell cultures. Neuronal death due to 20-25 h exposure to 6-9 mu M N-methyl-D-aspartate was not altered by 10-100 mu M reduced glutathione bur was markedly enhanced by 300-1000 mu M reduced glutathione; kainate neurotoxicity was unaffected. Two related compounds that lack a sulfhydryl group, oxidized glutathione and S-hexylglutathione, had no significant effect on N-methyl-D-aspartate neurotoxicity alone but completely blocked the effect of reduced glutathione. Mercaptoethanol, a sulfhydryl reducing agent that increases N-methyl-D-aspartare receptor responses by interacting with redox sites, increased N-methyl-D-aspartate neurotoxicity to a degree comparable to that of reduced glutathione; this effect was also blocked by equimolar S-hexylglutathione or oxidized glutathione. Addition of reduced glutathione to mercaptoethanol did not further increase N-methyl-D-aspartate-induced neuronal death. These results suggest that release of reduced glutathione from central nervous system cells that are subjected to traumatic or ischemic insults may enhance excitotoxic neuronal loss. Although multiple mechanisms may account for this phenomenon, the high concentrations required suggest that it is at least partly mediated by reduction of N-methyl-D-aspartare receptor redox sires. (C) 1999 IBRO. Published by Elsevier Science Ltd.	Thomas Jefferson Univ, Div Emergency Med, Philadelphia, PA 19107 USA	Regan, RF (corresponding author), Thomas Jefferson Univ, Div Emergency Med, 1020 Sanson St,239 Thompson Bldg, Philadelphia, PA 19107 USA.						AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; CHOI DW, 1987, J NEUROSCI, V7, P357; COYLE JT, 1991, EPILEPSY RES, V10, P41, DOI 10.1016/0920-1211(91)90093-U; Dringen R, 1997, J NEUROCHEM, V69, P868; GILBERT KR, 1991, NEUROSCI LETT, V133, P11, DOI 10.1016/0304-3940(91)90045-U; GUO N, 1992, MOL BRAIN RES, V15, P207, DOI 10.1016/0169-328X(92)90110-W; GUO N, 1992, NEUROSCIENCE, V51, P835, DOI 10.1016/0306-4522(92)90524-6; HALLIWELL B, 1989, FREE RADICAL BIO MED, P80; HELD KD, 1994, RADIAT RES, V139, P15, DOI 10.2307/3578727; JANAKY R, 1993, NEUROSCI LETT, V156, P153, DOI 10.1016/0304-3940(93)90461-S; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; LANDOLT H, 1992, J CEREBR BLOOD F MET, V12, P96, DOI 10.1038/jcbfm.1992.12; LANIUS RA, 1994, J NEUROCHEM, V63, P155; LEVY DI, 1991, NEUROREPORT, V2, P345, DOI 10.1097/00001756-199106000-00011; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MAJEWSKA MD, 1990, BRAIN RES, V537, P328, DOI 10.1016/0006-8993(90)90379-P; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; MURPHY TH, 1990, FASEB J, V4, P1624; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; OGITA K, 1988, BRAIN RES, V463, P37, DOI 10.1016/0006-8993(88)90524-0; Orlowski M, 1976, Int Rev Neurobiol, V19, P75, DOI 10.1016/S0074-7742(08)60702-3; Pasqualotto BA, 1998, GLUTATHIONE NERVOUS, P197; PUTTFARCKEN PS, 1993, BRAIN RES, V624, P223, DOI 10.1016/0006-8993(93)90081-W; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; Regan RF, 1998, J NEUROTRAUM, V15, P645, DOI 10.1089/neu.1998.15.645; REGAN RF, 1993, NEUROSCI LETT, V153, P219, DOI 10.1016/0304-3940(93)90326-G; REGAN RF, 1995, BRAIN RES, V682, P144, DOI 10.1016/0006-8993(95)00330-S; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; Rose Kamala, 1993, P46; Shaw CA, 1996, NEUROREPORT, V7, P1149, DOI 10.1097/00001756-199604260-00010; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; TATE SS, 1974, J BIOL CHEM, V249, P7593; VANDEPUTTE C, 1994, CELL BIOL TOXICOL, V10, P415, DOI 10.1007/BF00755791; VARGA V, 1989, NEUROCHEM RES, V14, P1223, DOI 10.1007/BF00965513; Varga V, 1997, NEUROCHEM RES, V22, P1165, DOI 10.1023/A:1027377605054; YUDKOFF M, 1990, J NEUROCHEM, V55, P137, DOI 10.1111/j.1471-4159.1990.tb08831.x; ZANGERLE L, 1992, J NEUROCHEM, V59, P181, DOI 10.1111/j.1471-4159.1992.tb08889.x	40	14	16	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		1999	91	2					463	470		10.1016/S0306-4522(98)00597-1			8	Neurosciences	Neurosciences & Neurology	190RA	WOS:000079977200006	10366003				2021-06-18	
J	Stamatakis, EA; Wilson, JTL; Wyper, DJ				Stamatakis, EA; Wilson, JTL; Wyper, DJ			Analysis of HMPAO SPECT scans in head injury using statistical parametric mapping	BEHAVIOURAL NEUROLOGY			English	Article							CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; HM-PAO-SPECT; ALZHEIMERS-DISEASE; TECHNETIUM-99M-HMPAO SPECT; COMPUTED-TOMOGRAPHY; TC-99M-HMPAO SPECT; CT; MRI; MILD	The paper examines the ability of Statistical Parametric Mapping (SPM) to contribute towards the quantitative analysis of HMPAO SPECT images containing lesions. A validation study is described in which SPECT images were created that contained synthetic lesions and were analysed with SPM. The study established a set of guidelines concerning the alignment, smoothing, and statistical analysis of images. These were then applied to analysis of SPECT scans from head injured patients. A demonstration is given of the use of SPM to identify localised blood flow abnormalities associated with cognitive deficits after head injury. Correlations between blood flow abnormalities and a test of visual memory are illustrated.	Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; Univ Glasgow, Dept Clin Phys, Glasgow G12 8QQ, Lanark, Scotland		easl@stir.ac.uk	Wilson, Lindsay/O-8883-2019; Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Acton PD, 1998, EUR J NUCL MED, V25, P663; Bartenstein P, 1997, J NUCL MED, V38, P1095; BAVETTA S, 1994, NUCL MED COMMUN, V15, P961, DOI 10.1097/00006231-199412000-00007; BULLOCK R, 1990, ACT NEUR S, V51, P286; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P6, DOI 10.1136/jnnp.54.1.6; COSTA DC, 1988, J CEREBR BLOOD F MET, V8, pS109, DOI 10.1038/jcbfm.1988.40; Friston K., 1995, HUM BRAIN MAPP, V2, P189, DOI [10.1002/hbm.460020402, DOI 10.1002/HBM.460020402]; Friston K.J., 1994, FUNCTIONAL NEUROIMAG, P79; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; GRAY BG, 1992, J NUCL MED, V33, P52; HOUSTON AS, 1994, J NUCL MED, V35, P239; Houston AS, 1998, J NUCL MED, V39, P425; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; Jacobs A, 1996, J NUCL MED, V37, P1605; JOHNSON KA, 1993, J NUCL MED, V34, P2044; Johnson LS, 1999, J NUCL MED, V40, p270P; KARBE H, 1994, NEURORADIOLOGY, V36, P1, DOI 10.1007/BF00599183; Lee JS, 1999, J NUCL MED, V40, p276P; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Mitchener A, 1997, J NEUROL NEUROSUR PS, V62, P633, DOI 10.1136/jnnp.62.6.633; MONTALDI D, 1990, J NEUROL NEUROSUR PS, V53, P33, DOI 10.1136/jnnp.53.1.33; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; NEWTON MR, 1992, J NEUROL NEUROSUR PS, V55, P92, DOI 10.1136/jnnp.55.2.92; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; PEARLSON GD, 1992, ARCH GEN PSYCHIAT, V49, P402; PIPER I, 1998, INT J INTENSIVE CARE, V5, P140; ROPER SN, 1991, J NUCL MED, V32, P1684; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Stamatakis EA, 1999, NEUROIMAGE, V10, P397, DOI 10.1006/nimg.1999.0477; STAMATAKIS EA, 1999, P MED IMAGE UNDERSTA, V99, P21; SYED GMS, 1992, NUCL MED COMMUN, V13, P811, DOI 10.1097/00006231-199211000-00007; Tikofsky RS, 1999, J NUCL MED, V40, p272P; Wiedmann KD, 1989, NEUROPSYCHOLOGY, V3, P267, DOI 10.1037//0894-4105.3.4.267; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29; WILSON JTL, 1996, RECOVERY TRAUMATIC B	38	14	14	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		1999	12	1-2					29	37		10.1155/2000/681916			9	Clinical Neurology	Neurosciences & Neurology	367RM	WOS:000090075300004	11455040	DOAJ Gold			2021-06-18	
J	Bedell, EA; DeWitt, DS; Prough, DS				Bedell, EA; DeWitt, DS; Prough, DS			Fentanyl infusion preserves cerebral blood flow during decreased arterial blood pressure after traumatic brain injury in cats	JOURNAL OF NEUROTRAUMA			English	Article						brain blood flow; cerebral blood flow; fentanyl; fluid-percussion injury; traumatic brain injury	HEAD-INJURY; ENDOGENOUS OPIOIDS; PERFUSION-PRESSURE; OXYGEN DELIVERY; MILD HEMORRHAGE; SHOCK; HYPOTENSION; RESPONSES; NALOXONE	Hypotension after traumatic brain injury (TBI) has been associated with significant reductions in cerebral blood flow (CBF) in experimental animals. In humans, posttraumatic hypotension is associated with significantly worsened outcome, possibly because of cerebral hypoperfusion. The existence of opioid receptor-mediated cerebrovascular dilatory effects in humans has been theorized. We studied the systemic and cerebral vascular effects of fentanyl after fluid-percussion injury (FPI) TBI in isoflurane-anesthetized cats. In an approved protocol, 17 fasted cats were anesthetized, mechanically ventilated with 1-1.5% isoflurane in 70% N2O/30% O-2, and prepared for FPI. Electroencephalogram (EEG) and intracranial pressure (ICP) were monitored. Cerebral blood flow and cardiac output were measured with radiolabelled microspheres. Animals received moderate FPI (2.2 atm) followed by 15 min of stabilization. Cats were then randomized to control (isoflurane anesthesia plus saline placebo) or fentanyl (isoflurane anesthesia plus fentanyl 50 mu g.kg(-1) h(-1)) groups. CBF, EEG, and ICP were recorded at baseline (Baseline), 15 min post-FPI (post-FPI), and at 15, 75, and 135 min after beginning fentanyl or saline placebo infusions (INF 15, INF 75, INF 135). EEG, ICP, PaCO2, PaO2, pH, and temperature were similar between groups. Mean arterial pressure was signifciantly lower than in the control group after fentanyl administration, while total CBF was not significantly different from control values. In a previous study, decreasing MAP to 80 mm Hg after TBI in isoflurane-anesthetzied cats resulted in a 30% decrease in CBF. In this study, fentanyl after TBI significantly decreased MAP but not CBF. Fentanyl administration was associated with preservation of CBF despite hypotension. Further research is necessary to evaluate the effects of fentanyl on cerebral autoregulation after TBI.	Univ Texas, Med Branch, Dept Anesthesiol 0591, Galveston, TX 77555 USA	Bedell, EA (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol 0591, Galveston, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X			BERNTON EW, 1985, FED PROC, V44, P290; Bouma G J, 1995, New Horiz, V3, P384; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUMA S1, V9, P333; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeWitt DS, 1997, J NEUROTRAUM, V14, P931, DOI 10.1089/neu.1997.14.931; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; FADEN AI, 1979, SCIENCE, V205, P317, DOI 10.1126/science.451606; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HOFFBRAND BI, 1969, CARDIOVASC RES, V3, P426, DOI 10.1093/cvr/3.4.426; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kofke WA, 1997, J NEUROSURG ANESTH, V9, P349, DOI 10.1097/00008506-199710000-00011; KOMJATI K, 1997, SHOCK, V4, P288; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; LANG RE, 1982, REGUL PEPTIDES, P363; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609010-00010; MARMAROU A, 1991, J NEUROSURG S, V75, P59; MASTRIANNI JA, 1989, NEUROSCIENCE, V33, P559, DOI 10.1016/0306-4522(89)90408-9; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MILDE LN, 1990, ANESTH ANALG, V70, P138; MUIZELAAR JP, 1985, CENTRAL NERVOUS SYST, P123; PERRY DC, 1995, MOL CHEM NEUROPATHOL, V16, P49; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PRIOR PF, 1978, BRIT J ANAESTH, V50, P993, DOI 10.1093/bja/50.10.993; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; Smith D H, 1995, New Horiz, V3, P562; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; Stene Johan K., 1994, ANESTHESIA, P2157; VINK R, 1990, J NEUROSCI, V10, P3524; Wang BG, 1997, J NEUROSURG ANESTH, V9, P335, DOI 10.1097/00008506-199710000-00008; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	39	14	14	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	1998	15	11					985	992		10.1089/neu.1998.15.985			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	139RN	WOS:000077043400007	9840771				2021-06-18	
J	Ralph, MAL				Ralph, MAL			Distributed versus localist representations: Evidence from a study of item consistency in a case of classical anemia	BRAIN AND LANGUAGE			English	Article							LEXICAL ACCESS; RETRIEVAL; ACTIVATION	Models of word production and comprehension can be split into two broad classes: localist and distributed. In localist architectures each word within the lexicon is represented by a single unit. The distributed approach, on the other hand, encodes each lexical item as a pattern of activation across a set of shared units. If we assume that the localist representations are more than a convenient shorthand for distributed representations at the neuroanatomical level, it should be possible to find patients who, after brain injury, have lost specific words from their premorbid vocabulary. Following a closed head injury, JS had severe word-finding difficulties with no measurable semantic impairment nor did he make phonological errors in naming. Cueing with an initial phoneme proved relatively ineffective. JS showed a high degree of item consistency across three administrations of two tests of naming to confrontation. This consistency could not be predicted from a linear combination of psycholinguistic variables but the distribution fitted a stochastic model in which it is assumed that a proportion of items have become consistently unavailable. Further evidence is presented which suggests that these items are not, in fact, lost but rather have a very low probability of retrieval. Given phonemic cueing of sufficient length, or delayed repetition priming from a written word, the consistently unnamed items were produced by JS. Additional data is reported which seems to support a distributed model of speech production. JS's naming accuracy for one set of pictures was found to predict his performance on a second set of items only when the names of the pictures were both semantically and phonologically related (e.g., eat-rat). There was no association for pairs of pictures if they were only semantically (e.g., cat-dog) or phonologically related (e.g., cat-cap). It is argued that JS's data are best described in terms of a graded, non-linear, distributed model of speech production. (C) 1998 Academic Press.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England	Ralph, MAL (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.		Lambon Ralph, Matthew/A-1695-2009	Lambon Ralph, Matthew/0000-0001-5907-2488			Allport DA, 1985, CURRENT PERSPECTIVES; Butterworth B., 1989, LEXICAL REPRESENTATI, pI08; CARAMAZZA A, 1990, CORTEX, V26, P95, DOI 10.1016/S0010-9452(13)80077-9; *CTR LEX INF, 1993, CEL LEX DAT; DELL GS, 1992, COGNITION, V42, P287, DOI 10.1016/0010-0277(92)90046-K; Dell GS, 1997, PSYCHOL REV, V104, P801, DOI 10.1037/0033-295X.104.4.801; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DUNN A, 1965, PEABODY PICTURE VOCA; FAGLIONI P, 1993, CORTEX, V29, P501, DOI 10.1016/S0010-9452(13)80256-0; FRANKLIN S, 1992, ADA COMPREHENSION BA; Graham K, 1995, NEUROCASE, V1, P25; HOWARD D, 1995, Q J EXP PSYCHOL-A, V48, P999, DOI 10.1080/14640749508401426; HOWARD D, 1988, MISSING MEANING; Howard D., 1992, PYRAMIDS PALM TREES; HOWARD D, 1987, LANGUAGE PERCEPTION; KAPLAN E, 1976, BOSTON NAMING TEST; KAY J, 1987, BRAIN, V110, P613, DOI 10.1093/brain/110.3.613; Kucera H, 1967, COMPUTATIONAL ANAL P; LAMBON RMA, UNPUB COGNITIVE NEUR; LEVELT WJM, 1992, COGNITION, V42, P1, DOI 10.1016/0010-0277(92)90038-J; LEVELT WJM, 1989, SPEAKING INTENTION A; McClelland J. L., 1986, PARALLEL DISTRIBUTED; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P170; MORTON J, 1985, CURRENT PERSPECTVES; PAGE MPA, UNPUB BEHAV BRAIN SC; PLAUT DC, 1993, COGNITIVE NEUROPSYCH, V10, P377, DOI 10.1080/02643299308253469; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; QUINLAN PT, 1992, MRC PSYCHOLINGUISTIC; SEIDENBERG MS, 1989, PSYCHOL REV, V96, P523, DOI 10.1037/0033-295X.96.4.523; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Tyler L. K., 1992, SPOKEN LANGUAGE COMP; WARRINGTON EK, GRADED NAMING TEST; WINGFIELD A, 1990, BRAIN LANG, V39, P373, DOI 10.1016/0093-934X(90)90146-8	33	14	14	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X			BRAIN LANG	Brain Lang.	OCT 1	1998	64	3					339	360					22	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	122EE	WOS:000076058300006	9743547				2021-06-18	
J	Lazorthes, Y; Sallerin, B; Verdie, JC; Casaux, J; Caraoue, F; Sol, JC				Lazorthes, Y; Sallerin, B; Verdie, JC; Casaux, J; Caraoue, F; Sol, JC			Treatment of the spasticity by intrathecal administration of baclofen.	NEUROCHIRURGIE			French	Article							ACQUIRED BRAIN INJURY; CEREBRAL-PALSY; SPINAL ORIGIN; INFUSION	Direct intrathecal administration of baclofen in the treatment of severe spasticity was proposed in 1984 by Richard Penn with the objective to carry out a selective spinal distribution of the active principle thus avoiding supraspinal side effects. We presented our first results at the French Language Association of Neurosurgery in 1985 within the framework of a report on << Functional neurosurgery of cerebral palsy >> (Neurochirurgie, 1985, 31 (suppl 1) : 1-118). This study aims to specify the selection criteria and current indications of this method for the treatment of severe chronic diffused spasticity of spinal and cerebral origin in adults and in children. This report relates to our experience concerning 60 patients (10 children) that benefit from the use of a totally implantable system for chronic administration, The total follow-up of all patients was 48 months (from 3 to 140 months). The initial effective daily amount of baclofen was 156 mu g/24 hours and progressed in time to reach in the long run 280 mu g/24 hours, with a very broad interindividual variability from 36 to 1050 mu g/24 hours. All the patients benefited from a reduction in muscular hypertonicity as well as painful muscular spasms. On the other hand, the functional improvement was very variable from one patient to another and depended primarily on the initial clinical stale and the etiology of the spasticity. The results observed were more significant in post-traumatic paraplegia than those secondary to demyelination disease even if they were stabilized with regard to spasticity of spinal origin. This mode of administration currently plays a significant role in the treatment of spasticity of cerebral origin, in particular in children presenting a motor disorder of cerebral origin with spastic prevalence. The current limitations of this type of treatment are technical because of the frequent catheter malfunctions, but are due essentially to the importance and constraint of the multi-disciplinary organization needed for the out-patient follow-up.	CHU Rangueil, Hop Rangueil, Serv Neurochirurg, F-31054 Toulouse, France	Lazorthes, Y (corresponding author), CHU Rangueil, Hop Rangueil, Serv Neurochirurg, F-31054 Toulouse, France.						ALBRIGHT AL, 1991, JAMA-J AM MED ASSOC, V265, P1418, DOI 10.1001/jama.265.11.1418; ALBRIGHT AL, 1993, JAMA-J AM MED ASSOC, V270, P2475, DOI 10.1001/jama.270.20.2475; Armstrong RW, 1997, J NEUROSURG, V87, P409, DOI 10.3171/jns.1997.87.3.0409; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; COFFEY RJ, 1993, J NEUROSURG, V78, P226, DOI 10.3171/jns.1993.78.2.0226; LAZORTHES Y, 1990, J NEUROSURG, V72, P393, DOI 10.3171/jns.1990.72.3.0393; LAZORTHES Y, 1988, LOCAL SPINAL THERAPY, P215; Meythaler JM, 1997, J NEUROSURG, V87, P415, DOI 10.3171/jns.1997.87.3.0415; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; MULLER H, 1987, J NEUROL, V234, P348, DOI 10.1007/BF00314294; MULLER H, 1988, LOCAL SPINAL THERAPY, P155; OCHS G, 1989, J NEUROL NEUROSUR PS, V52, P933, DOI 10.1136/jnnp.52.8.933; PENN RD, 1985, LANCET, V2, P125; PENN RD, 1987, J NEUROSURG, V66, P181, DOI 10.3171/jns.1987.66.2.0181; PENN RD, 1992, J NEUROSURG, V77, P236, DOI 10.3171/jns.1992.77.2.0236; PENN RD, 1984, LANCET, V1, P1078; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; SIEGFRIED J, 1985, NEUROCHIRURGIE, V31, P1; STEINBOK P, 1995, PEDIATR NEUROSURG, V22, P155	19	14	15	0	0	MASSON EDITEUR	PARIS 06	120 BLVD SAINT-GERMAIN, 75280 PARIS 06, FRANCE	0028-3770			NEUROCHIRURGIE	Neurochirurgie	SEP	1998	44	3					201	208					8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	129MT	WOS:000076468100008	9827437				2021-06-18	
J	Talmor, D; Roytblat, L; Artru, AA; Yuri, O; Koyfman, L; Katchko, L; Shapira, Y				Talmor, D; Roytblat, L; Artru, AA; Yuri, O; Koyfman, L; Katchko, L; Shapira, Y			Phenylephrine-induced hypertension does not improve outcome after closed head trauma in rats	ANESTHESIA AND ANALGESIA			English	Article							CEREBRAL BLOOD-FLOW; BRAIN EDEMA; 5-PERCENT DEXTROSE; RAPID INFUSION; NEUROLOGICAL STATUS; 0.9-PERCENT SALINE; INFARCT VOLUME; INJURY; MAGNESIUM; ISCHEMIA	Phenylephrine-induced hypertension (increase of 30-35 mm Hg for 15 min) is reported to increase cerebral perfusion pressure and collateral flow to ischemic areas of the brain in a rat model of focal cerebral ischemia. In the present study, we examined whether phenylephrine-induced hypertension of similar magnitude and duration was beneficial in a rat model of closed head trauma (CHT). Forty-eight rats were randomized into four experimental conditions: CHT at time 0 min (yes/no), plus phenylephrine-induced hypertension (increase of 30-35 mm Hg for 15 min) at 65 min (yes/no). CHT was delivered using a weight-drop device (0.5 J). Outcome measures were neurological severity score (NSS) at 1, 4, and 24 h, and brain tissue specific gravity (microgravimetry) and injury volume (2,3,5-triphenyltetrazoium chloride) at 24h. After CHT, NSS at 24h (median +/- range) and brain tissue specific gravity (mean +/- so, injured hemisphere) were 7 +/- 2 and 1.033 +/- 0.007 without phenylephrine and 8 +/- 2 and 1.035 +/- 0.005 with phenylephrine (P = 0.43), respectively. Tissue injury volume (mean +/- so) was 335 +/- 92 mm(3) without phenylephrine and 357 +/- 154 mm(3) with phenylephrine (P > 0.62). The results of our study indicate that postinjury treatment with 15 min of phenylephrine-induced hypertension does not attenuate brain edema, reduce tissue injury volume, or improve neurological outcome after CHT in rats. Implications: Phenylephrine-induced hypertension is reported to increase cerebral perfusion pressure and blood flow in a rat model of focal cerebral ischemia. In our study, phenylephrine-induced hypertension did not decrease brain edema or tissue injury volume or improve neurological outcome in a rat model of closed head trauma.	Univ Washington, Sch Med, Dept Anesthesiol, Seattle, WA 98195 USA; Ben Gurion Univ Negev, Div Anesthesiol, Soroka Med Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; Kaplan Hosp, Dept Anesthesiol, IL-76100 Rehovot, Israel	Artru, AA (corresponding author), Univ Washington, Sch Med, Dept Anesthesiol, Box 356540, Seattle, WA 98195 USA.	artruaa@u.washington.edu					BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; DRUMMOND JC, 1989, STROKE, V20, P1538, DOI 10.1161/01.STR.20.11.1538; EDVINSSON L, 1993, CEREBRAL BLOOD FLOW, P183; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Forbes ML, 1997, J CEREBR BLOOD F MET, V17, P865, DOI 10.1097/00004647-199708000-00005; Gurevich B, 1997, ANESTH ANALG, V84, P554, DOI 10.1097/00000539-199703000-00016; Gurevich B, 1998, J NEUROSURG, V88, P1066, DOI 10.3171/jns.1998.88.6.1066; MARMAROU A, 1978, J NEUROSURG, V49, P503; MICHENFELDER JD, 1977, STROKE, V8, P87, DOI 10.1161/01.STR.8.1.87; Narayan RK, 1996, NEUROTRAUMA; NELSON SR, 1971, J APPL PHYSIOL, V30, P268; Pittman JE, 1997, ANESTHESIOLOGY, V87, P1139, DOI 10.1097/00000542-199711000-00018; ROGERS AT, 1988, ANESTHESIOLOGY, V69, P547, DOI 10.1097/00000542-198810000-00015; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; SHAPIRA Y, 1995, J NEUROSURG ANESTH, V7, P17, DOI 10.1097/00008506-199501000-00004; SHAPIRA Y, 1993, J CEREBR BLOOD F MET, V13, P962, DOI 10.1038/jcbfm.1993.120; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P51, DOI 10.1097/00008506-199701000-00012; SHAPIRA Y, 1992, ANESTH ANALG, V75, P238; SHAPIRA Y, 1995, ANESTHETIC MANAGEMEN, P285; ULRICH K, 1985, STROKE, V16, P880, DOI 10.1161/01.STR.16.5.880	25	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	SEP	1998	87	3					574	578		10.1097/00000539-199809000-00014			5	Anesthesiology	Anesthesiology	114QW	WOS:000075621200014	9728831				2021-06-18	
J	Wogar, MA; van den Broek, MD; Bradshaw, CM; Szabadi, E				Wogar, MA; van den Broek, MD; Bradshaw, CM; Szabadi, E			A new performance-curve method for the detection of simulated cognitive impairment	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							MEMORY; INTELLIGENCE; MATRICES; FAKING; INJURY; AGE	Objectives. To evaluate a new performance-curve method for detecting simulated cognitive impairment. Design. The method was based on quantitative analysis of choice reaction times in a series of eight matching-to-sample tasks of graded complexity, in which participants were required to identify which of two comparison stimuli was identical to a simultaneously presented sample stimulus. The stimuli consisted of arrays of letters, the number of letters ranging from 1 to 10 in the eight tasks. Methods. Mean reaction times of a standardization group of 20 healthy young adults were used to construct regression equations to describe the behaviour of three test groups: 20 healthy individuals instructed to perform to the best of their ability (non-simulators), 20 healthy individuals instructed to simulate cognitive impairment incurred as a result of a head injury (simulators), and 25 patients with a history of closed head injury (patients). Results. There was a linear relationship between individual participants' latencies and the mean latencies of the standardization sample; the patient group showed steeper slopes, and the simulators higher intercepts, than the non-simulator group. A univariate measure of performance, based on the proportionate increase in latency corresponding to a standard increase in the standardization group's latency was able to identify 14/20 simulators while misclassifying 2/20 non-simulators and 2/25 patients. Other measures, including the number of errors made in the choice reaction time task and in recognition memory tasks, and a performance-curve measure based on Raven's Standard Progressive Matrices, were less successful in identifying simulators. Conclusions. This new performance-curve method may prove to be a useful addition to tests currently used to diagnose simulated cognitive impairment in clinical and medicolegal settings.	Univ Nottingham, Queens Med Ctr, Dept Psychiat, Nottingham NG7 2UH, England; Camden & Islington Community Hlth Serv Trust, London, England; Rathbone Hosp, Liverpool, Merseyside, England	Bradshaw, CM (corresponding author), Univ Nottingham, Queens Med Ctr, Dept Psychiat, Nottingham NG7 2UH, England.						BAKER GA, 1993, J CLIN EXP NEUROPSYC, V15, P668, DOI 10.1080/01688639308402588; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; BERNARD LC, 1993, J CLIN PSYCHOL, V49, P45, DOI 10.1002/1097-4679(199301)49:1<45::AID-JCLP2270490107>3.0.CO;2-7; CERELLA J, 1985, PSYCHOL BULL, V98, P67, DOI 10.1037/0033-2909.98.1.67; Cerella J., 1980, AGING 1980S PSYCHOL, P332, DOI DOI 10.1037/10050-024; GUDJONSSON GH, 1986, BRIT J CLIN PSYCHOL, V25, P35, DOI 10.1111/j.2044-8260.1986.tb00668.x; HALE S, 1987, J GERONTOL, V42, P131, DOI 10.1093/geronj/42.2.131; IVERSON GL, 1994, ARCH CLIN NEUROPSYCH, V9, P437, DOI 10.1016/0887-6177(94)90006-X; LORRABEE GJ, 1990, NEUROPSYCHOLOGIA, V4, P239; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MARTIN RC, 1993, J CLIN EXP NEUROPSYC, V15, P867, DOI 10.1080/01688639308402604; MYERSON J, 1989, J EXP ANAL BEHAV, V52, P353, DOI 10.1901/jeab.1989.52-353; NELSON HE, 1975, BRIT J SOC CLIN PSYC, V14, P259, DOI 10.1111/j.2044-8260.1975.tb00178.x; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; RABBITT P, 1994, Q J EXP PSYCHOL-A, V47, P741, DOI 10.1080/14640749408401135; Raven J., 1960, GUIDE STANDARD PROGR; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; RUDDLE HV, 1982, BRIT J CLIN PSYCHOL, V21, P159, DOI 10.1111/j.2044-8260.1982.tb00548.x; Salthouse T. A., 1985, THEORY COGNITIVE AGI; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Siegel S., 1956, NONPARAMETRIC STAT B; SLICK D, 1994, J CLIN EXP NEUROPSYC, V16, P472, DOI 10.1080/01688639408402657; TRUEBLOOD W, 1993, J CLIN EXPT NEUROPSY, V15, P278; VANDENBROEK MD, 1994, BRIT J CLIN PSYCHOL, V33, P509; Warrington EK., 1984, RECOGNITION MEMORY T; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]	27	14	15	0	1	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER, LEICS, ENGLAND LE1 7DR	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	SEP	1998	37		3				327	339		10.1111/j.2044-8260.1998.tb01389.x			13	Psychology, Clinical	Psychology	121FU	WOS:000076003300007	9784887				2021-06-18	
J	Alagarsamy, S; DeWitt, DS; Johnson, KM				Alagarsamy, S; DeWitt, DS; Johnson, KM			Effects of moderate, central fluid percussion traumatic brain injury on nitric oxide synthase activity in rats	JOURNAL OF NEUROTRAUMA			English	Article						arginine; calcium; cerebral blood flow; cortex; fluid percussion; glutamate	CEREBRAL BLOOD-FLOW; SUPEROXIDE; INHIBITION; ISCHEMIA; SLICES	Experimental traumatic brain injury (TBI) damages cerebral vascular endothelium and reduces cerebral blood flow (CBF), The nitric oxide synthase (NOS) substrate, L-arginine, prevents CBF reductions after TBI, but the mechanism is not known. This study examined the possibility that posttraumatic hypoperfusion is due to reductions in the substrate sensitivity of NOS which are overcome by L-arginine, Isoflurane-anesthetized rats were prepared for TBI (midline fluid-percussion, 2.2 atm), sham-TBI, or no surgery (control), and were decapitated 30 min after injury or sham injury. The brains were removed and homogenized or minced for measurements of crude soluble or cell-dependent stimulated NOS activity, respectively, Baseline arterial oxygen, carbon dioxide, pH, or hemoglobin levels did not differ among control, sham, or TBI groups. Total cortical soluble NOS activity in TBI-treated rats was not significantly different from either untreated or sham groups when 0.45 mu M or 1.5 mu M L-arginine was added. Also, there were no differences in cell-dependent NOS activity among the three groups stimulated by 300 mu M N-methyl-D-aspartate, 50 mM K+, or 10 mu M ionomycin, These data suggest that TBI reduces CBF by a mechanism other than altering the substrate specificity or activation of nNOS.	Univ Texas, Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77550 USA; Univ Texas, Med Branch, Dept Anesthesiol, Charles R Allen Res Labs, Galveston, TX 77550 USA	Alagarsamy, S (corresponding author), Emory Univ, Dept Pharmacol, 5068 Rollins Res Bldg,1510 Clifton Rd, Atlanta, GA 30322 USA.		Johnson, Kenneth/E-7944-2014		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19355] Funding Source: Medline		ALAGARSAMY S, 1994, J NEUROSCI RES, V38, P648, DOI 10.1002/jnr.490380607; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BECKMAN JS, 1994, PROG BRAIN RES, V103, P371; BECKMAN JS, 1991, J DEV PHYSIOL, V15, P53; BECKMAN JS, 1991, J CEREB BLOOD FLO S2, V11, pS629; BERGJOHNSEN J, 1987, ACTA PHYSIOL SCAND, V130, P679, DOI 10.1111/j.1748-1716.1987.tb08192.x; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Crow J P, 1995, Adv Pharmacol, V34, P17; DEWITT D S, 1992, Anesthesiology (Hagerstown), V77, pA689, DOI 10.1097/00000542-199209001-00689; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DEWITT DS, 1997, J NEUROTRAUM, V14, P219; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; FABRICIUS M, 1995, AM J PHYSIOL-HEART C, V269, pH23; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KOBAYASHI H, 1991, J NEUROSURG, V75, P906, DOI 10.3171/jns.1991.75.6.0906; KOVACH AGB, 1994, ANN NY ACAD SCI, V738, P348; KUMURA E, 1994, J CEREBR BLOOD F MET, V14, P487, DOI 10.1038/jcbfm.1994.60; MORIKAWA E, 1994, STROKE, V25, P429, DOI 10.1161/01.STR.25.2.429; MUIR JK, 1992, J NEUROTRAUM, V9, P355, DOI 10.1089/neu.1992.9.355; PELLIGRINO DA, 1993, J CEREBR BLOOD F MET, V13, P80, DOI 10.1038/jcbfm.1993.10; RUBANYI GM, 1986, AM J PHYSIOL, V250, P822; TANAKA K, 1991, NEUROSCI LETT, V127, P129, DOI 10.1016/0304-3940(91)90911-C; TERASAKO K, 1994, ANESTH ANALG, V79, P921; TOBIN JR, 1994, ANESTHESIOLOGY, V81, P1264, DOI 10.1097/00000542-199411000-00021; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	35	14	14	0	1	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1998	15	8					627	633		10.1089/neu.1998.15.627			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	111KP	WOS:000075436500006	9726261				2021-06-18	
J	Taher, AAY				Taher, AAY			Management of weapon injuries to the craniofacial skeleton	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						firearms; craniofacial injuries; classification; management; complications	FRACTURES	One thousand one hundred thirty-five patients suffering from different types of facial injuries caused by various weapons were treated in two university hospitals in Tehran, Iran from 1984 to 1990. The referred patients suffered from one of three types of facial injuries: soft-tissues injuries, 9.16% (N = 104); bone fractures, 18.15% (N = 206); and soft-tissue injuries and bone fractures (mixed injuries), 72.69% (N = 825). The number of male patients was greater than females (1,123 males and 12 females). Anatomically the facial injuries were classified into seven groups (lower third; middle third; upper third; lower and middle third; lower and upper third; middle and upper third; and lower, middle, and upper third). Lower-third facial injuries were the most common injuries, 72.60% (N = 824); followed by the middle-third injuries, 36.30% (N = 412); and the upper-third injuries, 20% (N = 227). The mandible was the most common site of injury in the lower-third injuries, zygomatico-orbital fractures were the most common site in the middle-third injuries, and the frontal bone was the most common site in the upper-third injuries. Of the total number of patients, 3.17% were children (N = 36) with different types of maxillofacial injuries. The majority of the injuries (52.42%; N = 595) were from bullets. The most common injuries not associated with maxillofacial injuries were head and ocular injuries. The least common were abdominal injuries. The head injuries were classified into five grades according to clinical and computed tomographic findings. Treatment of facial injuries ranged from minor repair and/or closed reduction to major soft-tissue and/or bone reconstruction. Postinjury complications were very high. The follow-up period ranged from 3 months to 3 years. The aim of this study is to add our experience in the management of facial injuries to the literature.	Baqiet Ulla Univ Hosp, Head Oral & Maxillofacial Surg Dept, Tehran, Iran	Taher, AAY (corresponding author), 147 Park Lane, Wembley HA9 7SD, Middx, England.		TAHER, ABBAS/O-5098-2017	TAHER, ABBAS/0000-0003-2417-6687			ABIOSE BO, 1986, BRIT J ORAL MAX SURG, V24, P31, DOI 10.1016/0266-4356(86)90037-9; AJAGB HA, 1980, E AFR MED J, V80, P227; ALABOSSI K, 1970, INT J ORAL SURG, V5, P8; AMOTO JJ, 1972, J CARDIOVASC SURG, V13, P147; BAKER SP, 1967, J TRAUMA, V6, P510; BANKS P, 1985, MAXILLOFACIAL INJURI, V2, P563; BARTKOWSKI SB, 1982, J MAXILLOFAC SURG, V10, P155, DOI 10.1016/S0301-0503(82)80033-7; CARTER E, 1982, AUST DENT J, V27, P227, DOI 10.1111/j.1834-7819.1982.tb04102.x; CONVERS JM, 1957, BR J PLASTIC SURG, V9, P264; CONVERSE JM, 1967, PLAST RECONSTR SURG, V39, P20, DOI 10.1097/00006534-196701000-00002; CULBERTSON WW, 1983, OTOLARYNG CLIN N AM, V16, P563; DAWSON TLG, 1953, BRIT J SURG, V41, P354; Dortzbach R K, 1987, Adv Ophthalmic Plast Reconstr Surg, V6, P287; ELLIS E, 1985, ORAL SURG ORAL MED O, V59, P120, DOI 10.1016/0030-4220(85)90002-7; GRINKLER RR, 1966, CEREBRUM CEREBRAL HE, P63; KEER NW, 1966, BR J ORAL SURG, V4, P132; MATRAS H, 1980, J CRANIOMAXILLOFAC S, V8, P25; MORGAN WC, 1971, ORAL SURG ORAL MED O, V9, P231; SHEPHERD JP, 1987, BRIT J PLAST SURG, V40, P614, DOI 10.1016/0007-1226(87)90157-3; SHUKER S, 1986, J ORAL MAXIL SURG, V44, P152, DOI 10.1016/0278-2391(86)90202-8; STYLOGIANNI L, 1991, BRIT J ORAL MAX SURG, V29, P9, DOI 10.1016/0266-4356(91)90164-Z; Taher A A, 1993, J Craniofac Surg, V4, P21; Taher A A, 1992, J Craniofac Surg, V3, P90, DOI 10.1097/00001665-199209000-00008; TAHER AAY, 1990, J CRANIO MAXILL SURG, V18, P310, DOI 10.1016/S1010-5182(05)80538-4; TAHER AAY, 1994, PLAST RECONSTR SURG, V93, P441, DOI 10.1097/00006534-199402000-00046; TAHER AAY, 1986, BRIT J ORAL MAX SURG, V24, P44, DOI 10.1016/0266-4356(86)90039-2; TAHER AAY, 1993, ORAL SURG ORAL MED O, V75, P433, DOI 10.1016/0030-4220(93)90165-Z; TAHER AAY, 1993, J CRANIO MAXILL SURG, V21, P360, DOI 10.1016/S1010-5182(05)80499-8; TAHER AAY, 1993, MED J IRAN, V7, P17; TAHER AAY, 1992, MED J ISLAMIC REPUBL, V6, P201; TAHER AAY, 1993, J CRANIOFAC SURG, V4, P53; THORESBY FP, 1967, BRIT J SURG, V54, P359, DOI 10.1002/bjs.1800540509	32	14	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1049-2275			J CRANIOFAC SURG	J. Craniofac. Surg.	JUL	1998	9	4					371	382		10.1097/00001665-199807000-00015			12	Surgery	Surgery	101PA	WOS:000074876300015	9780933				2021-06-18	
J	Gfeller, JD; Cradock, MM				Gfeller, JD; Cradock, MM			Detecting feigned neuropsychological impairment with the Seashore Rhythm Test	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article; Proceedings Paper	1994 Annual Meeting of the National-Academy-of-Neuropsychology	NOV, 1994	ORLANDO, FLORIDA	Natl Acad Neuropsychol			RECOGNITION MEMORY TEST; FORCED-CHOICE METHOD; MILD HEAD-INJURY; VALIDITY; DEFICITS	Sixty undergraduate subjects were randomly assigned to one of three groups and completed the Seashore Rhythm Test (SRT) as part of an investigation regarding simulated neuropsychological impairment. A sophisticated simulator group was instructed to feign impairment and was provided information regarding traumatic brain injury (TBI) sequelae. A naive simulator group was instructed to feign impairment, but was given no such information. A control group was instructed to perform optimally. Additionally, SRT scores for 20 TBI subjects who completed neuropsychological evaluations were analyzed. Mean SRT scores for the sophisticated and naive simulators did not differ but were significantly lower when compared to control subjects and TB subjects. A discriminate function analysis cutting score correctly classified 79% of subjects, while classification rates obtained with two previously investigated cutting scores were 64% and 72%. Implications of using these curling scores are discussed. The findings indicate the SRT is a useful indicator of feigned neurological impairment. (C) 1998 John Wiley & Sons, Inc.	St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; Univ Arkansas Med Sci, Little Rock, AR 72205 USA	Gfeller, JD (corresponding author), St Louis Univ, Dept Psychol, 221 N Grand Blvd, St Louis, MO 63103 USA.						AUBREY JB, 1989, J NEUROL NEUROSUR PS, V52, P842, DOI 10.1136/jnnp.52.7.842; BEETAR JT, 1995, ARCH CLIN NEUROPSYCH, V10, P57, DOI 10.1016/0887-6177(94)E0005-A; Bernard L C, 1991, Arch Clin Neuropsychol, V6, P81, DOI 10.1016/0887-6177(91)90024-4; BERNARD LC, 1990, J CLIN PSYCHOL, V46, P432, DOI 10.1002/1097-4679(199007)46:4<432::AID-JCLP2270460410>3.0.CO;2-0; BINDER LM, 1990, CLIN NEUROPSYCHOLOGI, V4, P36; CRADOCK MM, 1995, THESIS LOUIS U ST LO; Dunn E J, 1990, Arch Clin Neuropsychol, V5, P103, DOI 10.1016/0887-6177(90)90032-K; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FINN SE, 1995, OXF TEXT CLIN PSY, V2, P224; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; Golden C. J., 1981, INTERPRETATION HALST; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOL, V7, P59, DOI 10.1080/13854049308401888; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R.K., 1986, NEUROPSYCHOLOGICAL A, P100; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; IVERSON GL, 1993, ARCH CLIN NEUROPSYCH, V8, P234; JARVIS P, 1994, HALSTEADREITAN NEURO; LEESHALEY PR, 1994, J CLIN PSYCHOL, V50, P252, DOI 10.1002/1097-4679(199403)50:2<252::AID-JCLP2270500217>3.0.CO;2-T; MARTIN RC, 1992, ARCH CLIN NEUROPSYCH, V7, P347; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; MEEHL PE, 1955, PSYCHOL BULL, V52, P194, DOI 10.1037/h0048070; Miller W., 1992, PHYSICAL MED REHABIL, V6, P547; MILLIS S, 1994, ARCH CLIN NEUROPSYCH, V9, P163; MILLIS SR, 1992, CLIN NEUROPSYCHOL, V6, P406; NIES KJ, 1994, ARCH CLIN NEUROPSYCH, V9, P501, DOI 10.1016/0887-6177(94)90041-8; Reitan R.M., 1993, HALSTEADREITAN NEURO; REITAN RM, 1989, CLIN NEUROPSYCHOL, V3, P70; SHERER M, 1991, J CLIN EXP NEUROPSYC, V13, P741, DOI 10.1080/01688639108401087; SPECTOR J, 1994, 14 ANN C NAT AC NEUR; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Warrington EK., 1984, RECOGNITION MEMORY T; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]	32	14	14	0	2	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	JUN	1998	54	4					431	438		10.1002/(SICI)1097-4679(199806)54:4<431::AID-JCLP5>3.0.CO;2-Q			8	Psychology, Clinical	Psychology	ZN929	WOS:000073697700005	9623748				2021-06-18	
J	Hinchliffe, FJ; Murdoch, BE; Chenery, HJ; Baglioni, AJ; Harding-Clark, J				Hinchliffe, FJ; Murdoch, BE; Chenery, HJ; Baglioni, AJ; Harding-Clark, J			Cognitive-linguistic subgroups in closed-head injury	BRAIN INJURY			English	Article							PRAGMATIC LANGUAGE-SKILLS; TOMOGRAPHY; DISORDERS; ABILITY; MEMORY	This study examined variability in the interrelationship between language skill and neuropsychological function within a group of 25 severe closed head injury (CHI) subjects and 23 matched controls. All subjects underwent a battery of standardized language and neuropsychological tests. Cluster analyses were conducted to determine whether the CHI sample was universally or differentially impaired. Further subgroup analysis using a Q-type factor analysis outlined the differences in performance profiles within the group of CHI subjects. Results support the hypothesis that while some deficits were common to all CHI subjects, impairments delinated by whole group analysis do not necessarily represent universal impairments. In particular, ability to perform tasks involving auditory comprehension, naming, verbal memory, visual memory and visuospatial skills appeared to be important components in group differentiation. The cognitive-linguistic impairments which were common to all CHI subjects and considered to be the 'cardinal' cognitive-linguistic deficits following severe CHI were deficits in lexical-semantic and sentential semantic skills, Verbal fluency, complex auditory comprehension, and attentional operations. Profile analysis revealed the existence of a double dissociation between performances on naming and verbal memory tasks and performances on visually related cognitive tasks. Results are discussed with reference to findings on previous studies of subgroups in the CHI population.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia; Princess Alexandra Hosp, Dept Psychol, Brisbane, Qld 4102, Australia	Hinchliffe, FJ (corresponding author), Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.		Murdoch, Bruce E/C-1397-2012; Chenery, Helen J/F-5194-2010				ADAMOVICH BB, 1990, FOLIA PHONIATR, V42, P11, DOI 10.1159/000266015; AU R, 1988, APHASIOLOGY, V2, P161, DOI 10.1080/02687038808248901; BADDELEY A, 1987, NEUROBEHAVIORAL RECO, P295; BASSO A, 1985, BRAIN LANG, V26, P201, DOI 10.1016/0093-934X(85)90039-2; BAYLES KA, 1989, J SPEECH HEAR DISORD, V54, P74, DOI 10.1044/jshd.5401.74; BRYAN KL, 1989, RIGHT HEMISPHERE LAN; CHAPMAN S, 1992, BRAIN LANG, V43, P4; CHAPMAN SB, 1995, HDB NEUROLOGICAL SPE, P387; Coelho CA, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; DAVIS GA, 1989, APHASIOLOGY, V3, P723, DOI 10.1080/02687038908249040; DAVIS GA, 1989, APHASIOLOGY, V3, P759, DOI 10.1080/02687038908249046; DELDOTTO JE, 1985, NEUROPSYCHOLOGY LEAR, P89; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; Ehrlich J, 1989, Brain Inj, V3, P193, DOI 10.3109/02699058909004552; Fisher NJ, 1996, J CLIN EXP NEUROPSYC, V18, P349, DOI 10.1080/01688639608408993; Gardner HowardE., 1983, FRAMES MIND THEORY M; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; HINCHLIFFE F, 1997, IN PRESS CONCEPTUALI; HOLLAND AL, 1982, CLIN APHASIOLOGY, V12, P345; HOLM S, 1979, SCAND J STAT, V6, P65; HUISINGH R, 1990, WORLD TEST REVISED; Irvine L, 1986, S Afr J Commun Disord, V33, P49; JOANETTE Y, 1992, RES PER ALZ, P33; Kaplan E., 1983, BOSTON NAMING TEST; Kertesz A., 1982, W APHASIA BATTERY; LEVIN H, 1992, J NEUROL NEUROSUR PS, V55, P225; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; LEZAK M, 1996, NEUROPSYCHOLOGICAL A; MARTIN A, 1990, MODULAR DEFICITS ALZ, P143; MCDONALD S, 1992, Brain Injury, V6, P283, DOI 10.3109/02699059209029670; MCDONALD S, 1993, COGNITIVE NEUROPSYCH, V10, P297, DOI 10.1080/02643299308253466; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MCDONALD S, 1995, BRAIN INJURY, V9, P255, DOI 10.3109/02699059509008197; McNeil M. R., 1978, REVISED TOKEN TEST; Morse P, 1992, CLIN SYNDROMES ADULT, P85; NORUSIS MJ, 1990, SPSS PC PLUS 4 0; PAYNEJOHNSON JC, 1986, J COMMUN DISORD, V19, P237, DOI 10.1016/0021-9924(86)90030-4; PEACH RK, 1992, J SPEECH HEAR RES, V35, P810, DOI 10.1044/jshr.3504.810; RICE ML, 1983, J SPEECH HEAR DISORD, V48, P347, DOI 10.1044/jshd.4804.347; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Secord, 1989, TEST LANGUAGE COMPET; Spreen O, 1969, NEUROSENSORY CTR COM; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; ULATOWSKA HK, 1988, NEUROPSYCHOLOGICAL S, P108; VILKKI J, 1992, J CLIN EXP NEUROPSYC, V14, P518, DOI 10.1080/01688639208402841; Wechsler, 1981, WAIS R MANUAL; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wiig E, 1992, TEST WORD KNOWLEDGE; WIIG EH, 1974, PERCEPT MOTOR SKILL, V38, P171, DOI 10.2466/pms.1974.38.1.171; WILG E, 1988, NEUROPSYCHOLOGICAL S, P188; WILSON JTL, 1992, J HEAD TRAUMA REHAB, V7, P29	59	14	14	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1998	12	5					369	398		10.1080/026990598122502			30	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ZL444	WOS:000073433500002	9591142				2021-06-18	
J	Zhao, YJ; Yang, GY; Ben-Joseph, O; Ross, BD; Chenevert, TL; Domino, EF				Zhao, YJ; Yang, GY; Ben-Joseph, O; Ross, BD; Chenevert, TL; Domino, EF			Acute ethanol effects on focal cerebral ischemia in fasted rats	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						ethanol; ethyl alcohol; hyperglycemia; insulin; ischemia	TRAUMATIC BRAIN INJURY; ZINC PROTOPORPHYRIN; RISK FACTOR; ALCOHOL; STROKE; EDEMA; INTOXICATION	The effects of acute ethanol intoxication were investigated in a rat model of unilateral middle cerebral artery occlusion. Groups of 5 to 8 male Sprague-Dawley rats were subjected to 4 hr of left middle cerebral artery occlusion. All groups were deprived of food overnight and were pretreated intraperitoneally with 5% dextrose solution (10 ml/kg), 20% ethyl alcohol in 5% dextrose solution (2 g/kg), or 30% ethyl alcohol in a 5% dextrose solution (3 g/kg) 1 hr before middle cerebral artery occlusion. Regional cerebral blood flow during ipsilateral occlusion was similar to 9.1 to 10% of baseline in all groups. The mean % brain water content in control, 2 g/kg ethanol-treated groups, and 3 g/kg ethanol-treated groups were: in the ischemic core-81.6, 81.2, and 82.4; intermediate zone-80.5, 80.6, and 81.7; and outer zone-79.7, 79.7, and 80.8, respectively. Brain Na+ and K+ content in the three groups was related to water content, but much greater with ethanol pretreatment. The water content of the intermediate zones in the 3 g/kg ethanol-treated animals was significantly greater than in the control (p < 0.01 and 0.001) and the 2 g/kg ethanol-treated groups. One-way analysis of variance indicated a significant dose-effect relationship in which the lower dose of ethanol tended to reduce ischemic core water content, and the larger dose increased ischemic core water, compared with the control. None of the overnight fasted groups had any significant hyperglycemia. The group given 3 g/kg ip ethanol 1 hr before had exacerbated edema formation with a mean whole blood level of ethanol of similar to 230 mg/dl. The neurotoxic effects of high concentrations of ethanol were unrelated to any change in plasma glucose concentrations.	Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Surg Neurosurg, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA	Domino, EF (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.						ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ALTURA BM, 1983, SCIENCE, V220, P331, DOI 10.1126/science.6836278; Barlow OW, 1936, J PHARMACOL EXP THER, V56, P117; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BETZ AL, 1990, STROKE, V21, P1199, DOI 10.1161/01.STR.21.8.1199; BUNEGIN L, 1986, CRIT CARE MED, V14, P387, DOI 10.1097/00003246-198604000-00151; CAMARGO CA, 1989, STROKE, V20, P1611, DOI 10.1161/01.STR.20.12.1611; ELLENHORN MJ, 1988, MED TOXICOLOGY DIAGN, P792; Ema M, 1991, Magnes Trace Elem, V10, P269; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GORELICK P B, 1987, Stroke, V18, P268; GORELICK PB, 1987, STROKE, V18, P359, DOI 10.1161/01.STR.18.2.359; GORELICK PB, 1989, STROKE, V20, P1607, DOI 10.1161/01.STR.20.12.1607; JEHLE D, 1988, ANN EMERG MED, V17, P953, DOI 10.1016/S0196-0644(88)80678-4; KADOYA C, 1995, STROKE, V26, P1035, DOI 10.1161/01.STR.26.6.1035; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KIRN TF, 1988, JAMA-J AM MED ASSOC, V260, P2480, DOI 10.1001/jama.1988.03410170018005; Koroshetz WJ, 1996, TRENDS PHARMACOL SCI, V17, P227, DOI 10.1016/0165-6147(96)10020-1; MARTZ D, 1990, J CEREBR BLOOD F MET, V10, P352, DOI 10.1038/jcbfm.1990.64; MAYHAN WG, 1995, STROKE, V26, P2097, DOI 10.1161/01.STR.26.11.2097; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; POLLACK CV, 1990, J TRAUMA, V30, P888, DOI 10.1097/00005373-199007000-00021; Sorensen AG, 1996, RADIOLOGY, V199, P391, DOI 10.1148/radiology.199.2.8668784; WAGNER JG, 1972, RES COMMUN CHEM PATH, V4, P61; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; ZHANG A, 1993, EUR J PHARM-ENVIRON, V248, P229, DOI 10.1016/0926-6917(93)90049-V; Zhao YJ, 1997, ALCOHOL CLIN EXP RES, V21, P745, DOI 10.1111/j.1530-0277.1997.tb03832.x; Zhao YJ, 1996, STROKE, V27, P2299, DOI 10.1161/01.STR.27.12.2299; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275	31	14	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0145-6008			ALCOHOL CLIN EXP RES	Alcoholism (NY)	MAY	1998	22	3					717	722		10.1111/j.1530-0277.1998.tb04316.x			6	Substance Abuse	Substance Abuse	ZP311	WOS:000073739600025	9622455				2021-06-18	
J	Max, JE; Lindgren, SD; Knutson, C; Pearson, CS; Ihrig, D; Welborn, A				Max, JE; Lindgren, SD; Knutson, C; Pearson, CS; Ihrig, D; Welborn, A			Child and adolescent traumatic brain injury: correlates of injury severity	BRAIN INJURY			English	Article							COMA	A record review focused on children and adolescents, with a history of traumatic brain injury, who were consecutively admitted to a brain injury clinic in which all new patients are psychiatrically evaluated. Significant correlates of severity of injury in the cognitive, education and communication domains of functioning included Performance IQ but not Verbal IQ nor standardized ratings of language or learning disability. Current organic personality syndrome (OPS) but not attention deficit hyperactivity disorder or oppositional defiant disorder/conduct disorder diagnostic status was significantly related to severity. In conclusion, the findings in this referred sample are similar to prospective studies indicating that Performance IQ appears sensitive in reflecting brain damage. The finding linking OPS to severity of injury is not surprising. This is because OPS is a diagnosis which is dependent on the clinician's judgment of the likelihood that the organic factor is etiologically related to a defined behavioural syndrome. The diagnosis therefore requires a clinical judgment that the threshold of severity of a presumed organic etiological factor has been reached.	Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	Max, JE (corresponding author), Univ Iowa Hosp & Clin, Dept Psychiat, 200 Hawkins Dr,1876 JPP, Iowa City, IA 52242 USA.			Ihrig, Damien/0000-0002-5083-5853	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MHCRC 43271, MH 40856, MH 31593] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P50MH043271, R01MH040856, P30MH043271, R37MH031593, R01MH031593] Funding Source: NIH RePORTER		American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Jastak S, 1984, WIDE RANGE ACHIEVEME; JEFFREY R, 1986, IOWAS SEVERITY RATIN; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEMKUHL G, 1991, BRAIN BEHAV CHILD PS, P267; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1997, J NERV MENT DIS, V185, P394, DOI 10.1097/00005053-199706000-00006; MAX JE, IN PRESS BRAIN INJUR; MAX JE, 1992, THESIS U IOWA IOWA C; MAX JE, IN PRESS J AM ACAD C; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Wechsler, 1949, WECHSLER INTELLIGENC; Wechsler D., 1974, MANUAL WECHSLER INTE; Wechsler D., 1991, WECHSLER INTELLIGENC	25	14	14	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1998	12	1					31	40					10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	YT347	WOS:000071592500003	9483335				2021-06-18	
J	Semlyen, JK; Summers, SJ; Barnes, MP				Semlyen, JK; Summers, SJ; Barnes, MP			Aspects of caregiver distress after severe head injury	JOURNAL OF NEUROLOGIC REHABILITATION			English	Article						caregivers; head injury; psychological distress; functional outcome; Newcastle Independence Assessment Form (NIAF); GHQ-28	TRAUMATIC BRAIN INJURY; RELATIVES VIEW; FAMILY NEEDS	The caregivers of 22 severely head-injured individuals were interviewed at 6 and 12 months post injury to obtain information about the extent of their distress and to investigate the relationship between their distress and two aspects of burden: caregivers perceptions of the head-injured person's problems and an objective assessment of functional independence. Caregivers reported high levels of distress. The Factors associated with caregiver distress included the number of perceived problems at 6 months post injury, the overall level of disability, and certain aspects of functional independence at both 6 and 12 months, particularly ii the person required assistance with self-care and home-based tasks. Implications for rehabilitation of both the head-injured individual and his or her caregivers are examined, especially with reference to issues surrounding return to the community.	Hunters Moor Reg Neurol Rehabil Ctr, Acad Unit Neurol Rehabil, Newcastle Upon Tyne NE2 4NR, Tyne & Wear, England		j.k.semlyen@ncl.ac.uk		SEMLYEN, JOANNA/0000-0001-5372-1344			BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1984, CLOSED HEAD INJURY P; Gervasio AH, 1988, NEUROPSYCHOLOGY, V2, P161; Goldberg D., 1978, MANUAL GEN HLTH QUES; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; GRAY JM, 1994, CLIN REHABIL, V8, P188, DOI DOI 10.1080/09602010902949207; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HART T, 1986, CLIN NEUROPSYCHOLOGY; KAUSAR R, 1996, CLIN REHABIL, V10, P159; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; KOETER MWJ, 1992, J AFFECT DISORDERS, V24, P271, DOI 10.1016/0165-0327(92)90112-J; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON M, 1988, J HEAD TRAUMA REHAB, V3, P6, DOI DOI 10.1097/00001199-198812000-00004; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LIVINGSTON MG, 1985, BMJ-BRIT MED J, V291, P919, DOI 10.1136/bmj.291.6500.919; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Panting A., 1972, REHABILITATION, V38, P33; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P681; Semlyen JK, 1997, J NEUROL REHABIL, V11, P213; Semlyen JK, 1998, BRAIN INJURY, V12, P155, DOI 10.1080/026990598122782; Semlyen JK, 1996, J NEUROL REHABIL, V10, P251; SERIO CD, 1995, J HEAD TRAUMA REHAB, V10, P32, DOI 10.1097/00001199-199504000-00005; Walker A E, 1972, Scand J Rehabil Med, V4, P5	33	14	14	0	3	DEMOS PUBLICATIONS	NEW YORK	386 PARK AVE S STE 201, NEW YORK, NY 10016-8804 USA	0888-4390			J NEUROL REHABIL	J. Neurol. Rehabil.		1998	12	2					53	59					7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	123RB	WOS:000076137200002					2021-06-18	
J	Andary, MT; Crewe, N; Ganzel, SK; HainesPepi, C; Kulkarni, MR; Stanton, DF; Thompson, A; Yosef, M				Andary, MT; Crewe, N; Ganzel, SK; HainesPepi, C; Kulkarni, MR; Stanton, DF; Thompson, A; Yosef, M			Traumatic brain injury chronic pain syndrome: A case comparison study	CLINICAL JOURNAL OF PAIN			English	Article						chronic pain; traumatic brain injury; vocational rehabilitation	MINOR HEAD-INJURY	Objective: To identify the pretreatment characteristics and progress in treatment and outcomes of chronic pain patients, with and without concomitant traumatic brain injury (TBI). Design and Patients: Retrospective cohort study of 12 consecutive patients in a chronic pain treatment program who were discovered to have previously untreated brain injury and a cohort of 12 chronic pain patients from the same program matched for age and sex who did not have brain injury. Setting: Interdisciplinary university-based outpatient rehabilitation medicine clinic. Main Outcome Measures: Length of time in treatment and vocational outcomes. Results: A surprising number of patients referred for treatment of chronic pain were found to have history and symptoms indicative of previously untreated or undiagnosed mild traumatic brain injury (n = 21 of 65). Of these, 12 received therapy for both their brain injury and chronic pain. The 12 treated, dual diagnosed patients did not differ in terms of education, employment status, or marital status from the chronic pain patients. Those with TBI were more likely to have sustained an automobile injury and less likely to have a work-related injury. On admission, 25% of each group were working, and at discharge, that proportion reached 75% for each group. Those with TBI required significantly longer treatment (459 consecutive days) from intake to discharge compared with the control group (295 days). Conclusion: Patients who exhibit memory or concentration problems, who express confusion about their diagnosis, who were injured in an automobile accident, or who complain of pain in the head, neck, or arms should be questioned about the possibility of concurrent TBI. Most of these patients can achieve successful employment outcomes, however, the TBI group may require a longer treatment time.		Andary, MT (corresponding author), MICHIGAN STATE UNIV,COLL OSTEOPATH MED,B-401 W FEE HALL,E LANSING,MI 48823, USA.		Andary, Michael/O-9975-2019	Andary, Michael/0000-0003-3897-6327			ANDARY MT, 1993, PHYS MED REHABIL CLI, V4, P141; ANDERSON JM, 1990, ARCH PHYS MED REHAB, V71, P703; BRAAF MM, 1955, NY STATE J MED, V5, P237; COPE DN, 1990, HDB PHYSICAL MED REH, P1217; ELKIND AH, 1989, OTOLARYNG CLIN N AM, V22, P1251; HOHL M, 1983, CERVICAL SPINE, P282; HORN LJ, 1972, PHYS MED REHABIL STA, V6, P69; JANE JA, 1985, J NEUROSURG, V62, P96, DOI 10.3171/jns.1985.62.1.0096; KEWMAN DG, 1989, ARCH PHYS MED REHAB, V70, pA19; KULKARNI MR, 1987, MICH OSTEOPATH J, P13; Luria A. R, 1973, WORKING BRAIN; MILLER L, 1990, COGNITIVE REHABILITA, V8, P12; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; RADANOV BP, 1992, SPINE, V17, P127, DOI 10.1097/00007632-199202000-00001; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; WADSWORTH BJ, 1971, PIAGETS THEORY COGNI; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	18	14	14	0	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0749-8047			CLIN J PAIN	Clin. J. Pain	SEP	1997	13	3					244	250		10.1097/00002508-199709000-00010			7	Anesthesiology; Clinical Neurology	Anesthesiology; Neurosciences & Neurology	YF456	WOS:A1997YF45600010	9303257				2021-06-18	
J	Jacobson, S; Henriksen, SJ; ProsperoGarcia, O; Phillips, TR; Elder, JH; Young, WG; Bloom, FE; Fox, HS				Jacobson, S; Henriksen, SJ; ProsperoGarcia, O; Phillips, TR; Elder, JH; Young, WG; Bloom, FE; Fox, HS			Cortical neuronal cytoskeletal changes associated with FIV infection	JOURNAL OF NEUROVIROLOGY			English	Article						FIV; brain; neuron; neurofilament; AIDS	FELINE IMMUNODEFICIENCY VIRUS; CENTRAL-NERVOUS-SYSTEM; SENSORY-MOTOR CORTEX; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; CEREBRAL-CORTEX; COLUMNAR DISTRIBUTION; NEOCORTICAL DAMAGE; RHESUS-MONKEY; AIDS BRAINS	HIV-1 infection is often complicated by central nervous system (CNS) dysfunction. Degenerative neuronal changes as well as neuronal lass have been documented in individuals with AIDS. Feline immunodeficiency virus (FIV) infection of cats provides a model for both the immune and the central nervous system manifestations of HIV infection of humans. In this study we have examined neurons in the frontal cortex of feline immunodeficiency virus-infected cats and controls for immunoreactivity with SMI 32, an antibody recognizing a non-phosphorylated epitope on neurofilaments. We noted a significant increase in the number of immunoreactive pyramidal cells in infected animals compared to controls. The changes seen in the neuronal cytoskeleton as a consequence of the inoculation with FIV were similar to those seen in humans undergoing the normal aging process as well as those suffering from neurological diseases, including Alzheimer's and dementia pugilistica. The changes we noted in the feline brain were also similar to that reported in animals with traumatic injuries or with spontaneously occurring or induced motor neuron diseases, suggesting that the increase in reactivity represents a deleterious effect of FIV on the central nervous system.	Scripps Res Inst, DEPT NEUROPHARMACOL, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, DEPT BIOL MOL, LA JOLLA, CA 92037 USA; TUFTS UNIV, SCH MED, DEPT ANAT & CELLULAR BIOL, BOSTON, MA 02111 USA				Fox, Howard/0000-0003-2032-374X	NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 47680, MH/DA 52154] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P01MH052154, P20MH052154, P50MH047680] Funding Source: NIH RePORTER		BERSHADSKY AD, 1988, CYTOSKELETON; Boche D, 1996, J NEUROVIROL, V2, P377, DOI 10.3109/13550289609146903; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; CORK LC, 1982, LAB INVEST, V46, P89; CORK LC, 1988, J NEUROPATH EXP NEUR, V47, P420, DOI 10.1097/00005072-198807000-00003; GOLDMAN PS, 1977, BRAIN RES, V122, P393, DOI 10.1016/0006-8993(77)90453-X; HARLOW HJF, 1965, BIOL BIOCH BASIS BEH, P63; Henriksen SJ, 1995, CURR TOP MICROBIOL, V202, P167; HIGGINS RJ, 1983, ACTA NEUROPATHOL, V59, P288, DOI 10.1007/BF00691495; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; HURTREL M, 1992, AIDS, V6, P399, DOI 10.1097/00002030-199204000-00007; JONES EG, 1977, J COMP NEUROL, V175, P391, DOI 10.1002/cne.901750403; JONES EG, 1979, J COMP NEUROL, V188, P113, DOI 10.1002/cne.901880110; KETZLER S, 1990, ACTA NEUROPATHOL, V80, P92, DOI 10.1007/BF00294228; LAFRADO LJ, 1993, AIDS RES REV, V3, P115; LEWIS DA, 1987, J NEUROSCI, V7, P1799; MASLIAH E, 1993, AM J PATHOL, V142, P871; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; MASLIAH E, 1992, LAB INVEST, V66, P285; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MONTALI RJ, 1974, VET PATHOL, V11, P68, DOI 10.1177/030098587401100108; OSTER S, 1995, APMIS, V103, P525, DOI 10.1111/j.1699-0463.1995.tb01401.x; Phillips TR, 1996, J NEUROVIROL, V2, P388, DOI 10.3109/13550289609146904; PHILLIPS TR, 1994, J GEN VIROL, V75, P979, DOI 10.1099/0022-1317-75-5-979; PRICE RW, 1994, RES P ARNMD, V72, P1; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; ROUSSEAUX CG, 1985, VET PATHOL, V22, P104, DOI 10.1177/030098588502200202; SCHLAEPFER WW, 1987, J NEUROPATH EXP NEUR, V46, P117, DOI 10.1097/00005072-198703000-00001; SEILHEAN D, 1993, NEUROLOGY, V43, P1492, DOI 10.1212/WNL.43.8.1492; SHIELDS RP, 1983, ACTA NEUROPATH BERL, V59, P288; SIEGEL SJ, 1993, BRAIN RES, V619, P299, DOI 10.1016/0006-8993(93)91624-2; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; TROJANOWSKI JQ, 1993, BRAIN PATHOL, V3, P45, DOI 10.1111/j.1750-3639.1993.tb00725.x; TROJANOWSKI JQ, 1976, J COMP NEUROL, V169, P371, DOI 10.1002/cne.901690307; TROJANOWSKI JQ, 1991, ANNU REV GERONTOL, V10, P167; TRONCOSO JC, 1986, BRAIN RES, V364, P295, DOI 10.1016/0006-8993(86)90842-5; TRONCOSO JC, 1985, BRAIN RES, V342, P172, DOI 10.1016/0006-8993(85)91369-1; VICKERS JC, 1992, BRAIN RES, V594, P273, DOI 10.1016/0006-8993(92)91134-Z; WEIS S, 1993, ACTA NEUROPATHOL, V85, P185; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613; Winkler C, 1914, ANATOMICAL GUIDE EXP	41	14	14	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1355-0284			J NEUROVIROL	J. Neurovirol.	AUG	1997	3	4					283	289		10.3109/13550289709029469			7	Neurosciences; Virology	Neurosciences & Neurology; Virology	XT808	WOS:A1997XT80800005	9291236				2021-06-18	
J	Primus, EA; Bigler, ED; Anderson, CV; Johnson, SC; Mueller, RM; Blatter, D				Primus, EA; Bigler, ED; Anderson, CV; Johnson, SC; Mueller, RM; Blatter, D			Corpus striatum and traumatic brain injury	BRAIN INJURY			English	Article							HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; DEMENTIA; MEMORY	The possibility of a 'subcortical' syndrome differentially affecting memory in traumatic brian injury (TBI) subjects was examined. Magnetic resonance imaging scans of 46 traumatic brain injured male patients were compared with those of 34 male control subjects. Surface area measurements of the corpus striatum were calculated for both groups. Results demonstrated no significant differences in corpus striatum surface area measurements. Additionally, TBI patients were grouped according to severity of injury, as well as degree of corpus striatum atrophy, and neuropsychological outcome was examined. There were modest (r = 0.35) but significant correlations between corpus striatum degeneration and the delayed recall trial and total score of the Rey Auditory Verbal Learning Test, but no other correlations between neuropsychological and corpus striatal surface area were significant. Because subcortical pathology may have a differential effect on memory, recognition and recall memory were further analysed, but no significant differences were found. TBI subjects with the smallest corpus striatum values did not test significantly different from TBI patients with normal corpus striatum values or differences in cortical atrophy, as determined by a ventricle-to-brain ratio. These findings suggest that there is not a unique pattern of subcortical pathology involving the corpus striatum in TBI.	LDS HOSP,SALT LAKE CITY,UT	Primus, EA (corresponding author), BRIGHAM YOUNG UNIV,DEPT PSYCHOL,POB 25543,PROVO,UT 84602, USA.			Mueller, Reed/0000-0002-9881-7734			ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; Anderson CV, 1996, J NEUROTRAUM, V13, P35, DOI 10.1089/neu.1996.13.35; AYLWARD EH, 1994, NEUROLOGY, V44, P823, DOI 10.1212/WNL.44.5.823; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; Bigler ED, 1996, NEUROPSYCHOLOGY, V10, P333, DOI 10.1037/0894-4105.10.3.333; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; BIGLER ED, 1997, NEUROIMAGING INTERAC, P163; BIGLER ED, 1996, TRAUMATIC BRAIN INJU, V2; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; BLATTER DD, 1995, AM J NEURORADIOL, V16, P241; COTE L, 1991, BASAL GANGLIA, P647; CUMMINGS JL, 1990, SUBCORTICAL DEMENTIA, P3; Gabrieli JDE, 1996, NEUROPSYCHOLOGY, V10, P322, DOI 10.1037/0894-4105.10.3.321; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gean A, 1994, IMAGING HEAD TRAUMA; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; Heaton R.K., 1991, COMPREHENSIVE NORMS; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; MAHURIN RK, 1993, COGNITION PARKINSONS, P308; MASSMAN PJ, 1990, J CLIN EXP NEUROPSYC, V12, P729, DOI 10.1080/01688639008401015; *MAYO FDN, 1986, BIOM IM RES ANALYZE; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Osterrieth P. A, 1944, ARCH PSYCHOL, V30, P286; PARKER R, 1990, TRAUMATIC BRAIN INJU; Rey A, 1964, EXAMEN CLIN PSYCHOL; RIFAI Z, 1994, ARCH NEUROL-CHICAGO, V51, P90, DOI 10.1001/archneur.1994.00540130124021; ROSENTHAL M, 1993, TRAUMATIC BRAIN INJU; SALMON DP, 1989, ARCH NEUROL-CHICAGO, V46, P1204, DOI 10.1001/archneur.1989.00520470060028; SPREEN O, 1991, COMPENDIUM NEUROPSYC, P1800; TROSTER AI, 1993, J CLIN EXP NEUROPSYC, V15, P773, DOI 10.1080/01688639308402595; TROSTER AI, 1989, BRAIN LANG, V37, P500, DOI 10.1016/0093-934X(89)90032-1; Warrington EK., 1984, RECOGNITION MEMORY T; Wechsler D., 1987, WECHSLER MEMORY SCAL; Wechsler D, 2008, WECHSLER ADULT INTEL, V4th; WOOD DMG, 1995, BRAIN RES BULL, V38, P545, DOI 10.1016/0361-9230(95)02026-0	36	14	14	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	AUG	1997	11	8					577	586					10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	XL930	WOS:A1997XL93000003	9251866				2021-06-18	
J	Scott, JS; Ockey, RR; Holmes, GE; Varghese, G				Scott, JS; Ockey, RR; Holmes, GE; Varghese, G			Autonomic dysfunction associated with locked-in syndrome in a child	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						autonomic dysfunction; hypothalamic storming; locked-in syndrome; dopamine agonist	TRAUMATIC BRAIN INJURY; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; PROPRANOLOL; HYPERTENSION; HYPERTHERMIA; EPILEPSY; BLOCKADE; ATENOLOL; PLACEBO	This is a report of a young boy with the unusual combination of autonomic dysfunction with locked-in syndrome following multiple shunt revisions for hydrocephalus. A review of the literature on autonomic dysfunction syndrome and the complex clinical picture of the combined syndromes in a pediatric patient are discussed. The marked effectiveness of treatment with carbidopa/levodopa over bromocriptine for both syndromes is noted.	UNIV KANSAS,MED CTR,DEPT PEDIAT,KANSAS CITY,KS 66160; TULSA DEV PEDIAT,TULSA,OK; CTR FAMILY PSYCHOL,TULSA,OK; WILFORD HALL USAF MED CTR,SAN ANTONIO,TX 78236; UNIV KANSAS,MED CTR,DEPT REHABIL MED,KANSAS CITY,KS 66160							ARING CD, 1945, ARCH NEURO PSYCHIATR, V54, P44, DOI 10.1001/archneurpsyc.1945.02300070054005; BALDESSARINI RJ, 1996, PHARM BASIS THERAPEU; BAUER G, 1979, J NEUROL, V221, P77, DOI 10.1007/BF00313105; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; CARMEL PW, 1985, ACTA NEUROCHIR, V75, P113, DOI 10.1007/BF01406331; CHERINGTON M, 1976, NEUROLOGY, V26, P180, DOI 10.1212/WNL.26.2.180; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; CORBETT SW, 1983, AM J PHYSIOL, V245, pE535; ENGEL GL, 1945, ARCH NEURO PSYCHIATR, V54, P37, DOI 10.1001/archneurpsyc.1945.02300070047004; FOX RH, 1973, BRIT MED J, V2, P693, DOI 10.1136/bmj.2.5868.693; GREENBLATT DJ, 1993, CLIN PHARMACOL THER, V53, P577, DOI 10.1038/clpt.1993.73; HACKENBERRY LE, 1982, CRIT CARE MED, V10, P641; JACOME DE, 1990, CLIN ELECTROENCEPHAL, V21, P31, DOI 10.1177/155005949002100112; KATZ RT, 1981, NEUROSURGERY, V73, P403; KHURANA RK, 1980, ANN NEUROL, V8, P439, DOI 10.1002/ana.410080418; LASSER NL, 1989, AM J MED, V86, P98, DOI 10.1016/0002-9343(89)90142-3; LOW PA, 1993, CLIN AUTONOMIC DISOR, P466; MELVILLE KI, 1963, AM J CARDIOL, V12, P781, DOI 10.1016/0002-9149(63)90281-9; MEYTHALER JM, 1994, ARCH PHYS MED REHAB, V75, P816; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; OCKEY RR, 1995, ARCH PHYS MED REHAB, V76, P868, DOI 10.1016/S0003-9993(95)80554-0; OHRY A, 1981, PARAPLEGIA, V28, P73; PALAC DM, 1990, J GEN INTERN MED, V5, P310, DOI 10.1007/BF02600398; PATTERSON JR, 1986, STROKE, V17, P758, DOI 10.1161/01.STR.17.4.758; Penfield W, 1929, ARCH NEURO PSYCHIATR, V22, P358, DOI 10.1001/archneurpsyc.1929.02220020174010; Penfield W, 1954, EPILEPSY FUNCTIONAL; PLUM F, 1996, DIAGNOSIS STUPOR COM; PRANZATELLI MR, 1991, J CHILD NEUROL, V6, P115, DOI 10.1177/088307389100600204; Rao N, 1989, Brain Inj, V3, P207, DOI 10.3109/02699058909004554; RATEY JJ, 1983, AM J PSYCHIAT, V140, P1356; REICHENBACH DD, 1970, HUM PATHOL, V1, P125; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; ROGERS TK, 1990, POSTGRAD MED J, V66, P1050, DOI 10.1136/pgmj.66.782.1050; Rossitch E Jr, 1988, Br J Neurosurg, V2, P471, DOI 10.3109/02688698809029601; SIMPSON RK, 1989, SOUTHERN MED J, V82, P1577, DOI 10.1097/00007611-198912000-00031; SOLOMON GE, 1973, J PEDIATR-US, V83, P277, DOI 10.1016/S0022-3476(73)80492-5; TALMAN WT, 1988, ARCH NEUROL-CHICAGO, V45, P1037, DOI 10.1001/archneur.1988.00520330129022; Wurzelmann J, 1987, Cardiol Clin, V5, P689; YUDOFSKY S, 1981, AM J PSYCHIAT, V138, P218	40	14	15	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY-JUN	1997	76	3					200	203		10.1097/00002060-199705000-00007			4	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	XG430	WOS:A1997XG43000007	9207704				2021-06-18	
J	Noel, F; Ijichi, A; Chen, JJ; Gumin, GJ; Tofilon, PJ				Noel, F; Ijichi, A; Chen, JJ; Gumin, GJ; Tofilon, PJ			X-ray-mediated reduction in basic fibroblast growth factor expression in primary rat astrocyte cultures	RADIATION RESEARCH			English	Article							CILIARY NEUROTROPHIC FACTOR; CENTRAL-NERVOUS-SYSTEM; FACTOR MESSENGER-RNA; GENE-EXPRESSION; CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; PROGENITOR CELLS; BRAIN; RADIATION; INJURY	Injury of the normal central nervous system is a major concern in the radiotherapy of brain tumors, but the pathogenesis of injury remains poorly understood, Modulation of the production of growth factors is associated with ischemia and traumatic injury in the central nervous system. Ionizing radiation has been shown to induce basic fibroblast growth factor in endothelial cells and in cells of a human breast carcinoma cell line, The inducibility of basic fibroblast growth factor after irradiation and its potential role in the recovery response of the central nervous system led us to investigate the effects of radiation on the expression of this growth factor in primary cultures of normal rat type 1 astrocytes. Astrocyte monolayers were exposed to ionizing radiation (1 to 10 Gy), Northern blot analysis revealed that doses of 2 to 10 Gy markedly reduced the expression of basic fibroblast growth factor as early as 1 h after irradiation, and that it remained below levels in unirradiated cells for at least 24 h. The effect was not associated with astrocyte cytotoxicity, and it appears to have some specificity for basic fibroblast growth factor since the levels of mRNA coding for ciliary neurotrophic factor and glial fibrillary acidic protein were not affected. (C) 1997 by Radiation Research Society.	UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT EXPT RADIAT ONCOL,HOUSTON,TX 77030					NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [CA1672, CA72156] Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA072156] Funding Source: NIH RePORTER		BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; DANIELSON PE, 1988, DNA-J MOLEC CELL BIO, V7, P261, DOI 10.1089/dna.1988.7.261; ECCLESTON PA, 1985, DEV BRAIN RES, V21, P315, DOI 10.1016/0165-3806(85)90221-4; ECKENSTEIN FP, 1994, J NEUROBIOL, V25, P1467; Fan Lei, 1995, Molecular Brain Research, V30, P125, DOI 10.1016/0169-328X(94)00287-O; FINKLESTEIN SP, 1988, BRAIN RES, V460, P253, DOI 10.1016/0006-8993(88)90370-8; FORNACE AJ, 1992, ANNU REV GENET, V26, P507; FUKS Z, 1994, CANCER RES, V54, P2582; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; IJICHI A, 1995, GLIA, V14, P87, DOI 10.1002/glia.440140203; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; KIMELMAN D, 1989, CELL, V59, P687, DOI 10.1016/0092-8674(89)90015-9; KOKETSU N, 1994, ANN NEUROL, V35, P451, DOI 10.1002/ana.410350413; LEE YJ, 1995, J BIOL CHEM, V270, P28790, DOI 10.1074/jbc.270.48.28790; LEHRMANN E, 1995, EXP NEUROL, V131, P114, DOI 10.1016/0014-4886(95)90013-6; LOGAN A, 1993, TRENDS PHARMACOL SCI, V14, P337, DOI 10.1016/0165-6147(93)90007-7; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; MEYERS R, 1986, BR J CANC S7, V53, P221; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLER HW, 1995, PHARMACOL THERAPEUT, V65, P1, DOI 10.1016/0163-7258(94)00047-7; MURPHY PR, 1994, MOL ENDOCRINOL, V8, P852, DOI 10.1210/me.8.7.852; POWELL PP, 1993, EXP CELL RES, V209, P224, DOI 10.1006/excr.1993.1305; SCHULTHEISS TE, 1992, BRIT J RADIOL, V65, P737, DOI 10.1259/0007-1285-65-777-737; Shibata F, 1991, GROWTH FACTORS, V4, P277, DOI 10.3109/08977199109043913; SHIMASAKI S, 1988, BIOCHEM BIOPH RES CO, V157, P256, DOI 10.1016/S0006-291X(88)80041-X; Speliotes EK, 1996, MOL BRAIN RES, V39, P31, DOI 10.1016/0169-328X(95)00351-R; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; TAKAMI K, 1992, EXP BRAIN RES, V90, P1; UEBA T, 1994, P NATL ACAD SCI USA, V91, P9009, DOI 10.1073/pnas.91.19.9009; VANDERKOGEL AJ, 1986, BRIT J CANCER, V53, P207; VRDOLJAK E, 1994, INT J RADIAT BIOL, V66, P739; WITTE L, 1989, CANCER RES, V49, P5066; WOLSWIJK G, 1992, J CELL BIOL, V118, P889, DOI 10.1083/jcb.118.4.889; WOODWARD WR, 1992, J NEUROSCI, V12, P142; YAKOVLEV AG, 1995, J NEUROTRAUM, V12, P767, DOI 10.1089/neu.1995.12.767	37	14	15	0	0	RADIATION RESEARCH SOC	OAK BROOK	2021 SPRING RD, STE 600, OAK BROOK, IL 60521	0033-7587			RADIAT RES	Radiat. Res.	APR	1997	147	4					484	489		10.2307/3579506			6	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	WQ559	WOS:A1997WQ55900012	9092929				2021-06-18	
J	Savage, RC				Savage, RC			Integrating rehabilitation and education services for school-age children with brain injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						education; managed care; rehabilitation; special education; traumatic brain injury	REENTRY; PREDICTION; MILD	This article explores the development of service delivery systems in rehabilitation and education for school-age children with TBI. Historical relationships between rehabilitation services and special education services are examined in terms of what the future map hold for these systems within a changing health care world. Examples of critical changes in these delivery systems and the development of program models that merge rehabilitation and special education services for children are profiled.		Savage, RC (corresponding author), MAY INST INC,220 NORWOOD PK S,SUITE 204,NORWOOD,MA 02062, USA.						Begali V., 1987, HEAD INJURY CHILDREN; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; BLOSSER JL, 1994, PED TRAUM BRAIN INJ; BRYAN MR, 1995, ED MANUAL WHAT ED NE; CARNEY J, 1990, Pediatrician, V17, P222; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Cook J., 1987, ABI HDB SERVING STUD; COSTER WJ, 1996, SCH FUNCTION ASSESSM; CURRAN C, 1995, MANAGED CARE Q, V3, P14; DEJONG G, 1995, BRAIN INJ ASS ANN S; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DEPOMPEI R, 1986, LANGUAGE SPEECH HEAR, V18, P292; *EM MED SERV CHILD, 1996, HOSP HOM TRANS CHILD; Grant P H, 1995, J Healthc Qual, V17, P10; HANSON SL, 1992, PHYSICAL MED REHABIL, V6, P483; KAUFMAN J, 1996, J CARE MANAGEMENT, V2, P46; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; LASH M, 1996, MANUAL FAMILIES CHIL; LAZAR MF, 1995, J HEAD TRAUMA REHAB, V10, P55, DOI 10.1097/00001199-199510000-00007; LEHR E, 1991, PSYCHOL MANAGEMENT H; Lehr E, 1990, PSYCHOL MANAGEMENT T; MACLAREN E, 1994, NURSE WEEK, V7, P10; MIRA M, 1988, TRAUMATIC HEAD INJUR; *RES TRAIN CTR REH, 1995, NAT PED TRAUM REG; ROSEN CD, 1992, HEAD TRAUMA ED REINT; SAVAGE RC, 1996, CHILDREN ACQUIRED BR; SAVAGE RC, 1991, HEAD INJURY FAMILY M; SAVAGE RC, 1995, ED DIMENSIONS ACQUIR; SEIDEL JS, 1991, EM MED SERV CHILDR R; SHURTLEFF HA, 1995, J HEAD TRAUMA REHAB, V10, P64, DOI 10.1097/00001199-199510000-00008; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Turnbull A. P., 1995, EXCEPTIONAL LIVES SP; TYLER J, 1990, TRAUMATIC HEAD INJUR; Wolcott G., 1995, SIGNS STRATEGIES ED; Wolcott G. F, 1995, ED MANUAL WHAT ED NE; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P42, DOI 10.1097/00001199-199512000-00007; YLVISAKER M, 1995, J HEAD TRAUMA REHAB, V10, P25, DOI 10.1097/00001199-199512000-00006; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006	39	14	14	2	6	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1997	12	2					11	20		10.1097/00001199-199704000-00003			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	WT782	WOS:A1997WT78200004					2021-06-18	
J	Webster, JB; Bell, KR				Webster, JB; Bell, KR			Primary adrenal insufficiency following traumatic brain injury: A case report and review of the literature	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							ADDISONS-DISEASE; HEMORRHAGE; DIAGNOSIS	Primary adrenal insufficiency (PAI) is a relatively rare but serious condition that can lead to signs and symptoms ranging from mild generalized weakness and fatigue to fulminant shock and death. We present the case of a previously healthy 31-year-old man who developed PAI while undergoing rehabilitation after a severe traumatic brain injury (TBI). The patient suffered a TBI with comminuted skull fractures, bifrontal contusions, and bilateral epidural hematomas in a jet-ski accident. Acute hospitalization was prolonged by several medical complications, and the patient was admitted for subacute rehabilitation 1 month after his injury with cognitive deficits, persistent agitation, confusion, generalized weakness, and poor endurance for therapy. His weakness, fatigue, and orthostasis did not improve with attempts at gradual remobilization. The patient also had persistent anorexia, nausea, and hyponatremia despite various treatment regimens. Endocrinology workup showed normal anterior pituitary function but an abnormal response to adrenocorticotropic hormone (ACTH) stimulation, leading to the diagnosis of PAI. The patient was treated with prednisone and fludrocortisone, which resulted in improvement in clinical symptoms followed by rapid gains in all functional areas. No previous descriptions of PAI following head injury were found in the medical literature. It is important for physiatrists to be aware of this entity because symptoms of adrenal insufficiency can be similar to those commonly seen with TBI alone. PAI may also be confused with other endocrine disorders more frequently seen after TBI such as the syndrome of inappropriate antidiuretic hormone secretion. Recognition and appropriate management of adrenal insufficiency can lead to significant clinical and functional gains. (C) 1997 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation.	UNIV WASHINGTON,DEPT REHABIL MED,SEATTLE,WA 98195				Bell, Kathleen/0000-0002-0928-2046			Atchison James W., 1993, Brain Injury, V7, P347, DOI 10.3109/02699059309034961; BONTKE CF, 1989, PHYS MED REHABIL STA, V3, P43; BURKE CW, 1985, CLIN ENDOCRINOL META, V14, P947, DOI 10.1016/S0300-595X(85)80084-0; BURKS DW, 1992, AM J ROENTGENOL, V158, P503, DOI 10.2214/ajr.158.3.1738984; CLAUSSEN MS, 1992, J TRAUMA, V32, P94, DOI 10.1097/00005373-199201000-00020; DEROSA G, 1987, EXP CLIN ENDOCRINOL, V90, P232, DOI 10.1055/s-0029-1210695; FEUERSTEIN B, 1991, ANN INTERN MED, V115, P785, DOI 10.7326/0003-4819-115-10-785; GOMEZ RG, 1993, J TRAUMA, V35, P870, DOI 10.1097/00005373-199312000-00012; Hansen J. R., 1993, PHYS MED REHABIL STA, V7, P569; HARDWICKE MB, 1992, ARCH INTERN MED, V152, P845, DOI 10.1001/archinte.152.4.845; HORN LJ, 1988, J HEAD TRAUMA REHABI, V3, P86; HORN LJ, 1990, REHABILITATION ADULT, P114; JOHNSTONE PAS, 1990, PSYCHOSOMATICS, V31, P103, DOI 10.1016/S0033-3182(90)72226-8; LEWIS JV, 1994, SOUTHERN MED J, V87, P1269, DOI 10.1097/00007611-199412000-00012; Murphy Joseph F., 1993, Journal of Burn Care and Rehabilitation, V14, P155, DOI 10.1097/00004630-199303000-00005; NERUP J, 1974, ACTA ENDOCRINOL-COP, V76, P127, DOI 10.1530/acta.0.0760127; Orth DN, 1992, WILLIAMS TXB ENDOCRI, P489; STEINBOK P, 1978, NEUROSURGERY, V3, P9, DOI 10.1227/00006123-197807000-00002; SZALADOS JE, 1994, INTENS CARE MED, V20, P216, DOI 10.1007/BF01704704; VALENZUELA G, 1990, AM J GASTROENTEROL, V85, P1626; VALENZUELA GA, 1987, AM J GASTROENTEROL, V82, P1066; WERBEL SS, 1993, ENDOCRIN METAB CLIN, V22, P303, DOI 10.1016/S0889-8529(18)30168-3	22	14	15	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAR	1997	78	3					314	318		10.1016/S0003-9993(97)90040-X			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	WM783	WOS:A1997WM78300015	9084356				2021-06-18	
J	Gerberich, SG; Gibson, RW; Fife, D; Mandel, JS; Aeppli, D; Le, CT; Maxwell, R; Rolnick, SJ; Renier, C; Burlew, M; Matross, R				Gerberich, SG; Gibson, RW; Fife, D; Mandel, JS; Aeppli, D; Le, CT; Maxwell, R; Rolnick, SJ; Renier, C; Burlew, M; Matross, R			Effects of brain injury on college academic performance	NEUROEPIDEMIOLOGY			English	Article						brain injury, effects; effects on academic performance; mild brain injury	SEVERE HEAD-INJURY; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; RECOVERY; TRAUMA; CONCUSSION; DISABILITY; SEQUELAE; DEFICITS	Brain injury, a leading cause of mortality, morbidity and disability in the United States, has serious consequences and substantial costs. Although previous studies have assessed a variety of outcomes subsequent to brain injury, documentation of performance prior to brain injury using a case-control approach has not been included; preinjury performance differences may confound the estimate of the effects of brain injury on performance. The primary objective of this study was to compare academic performance before and after brain injury in a population of university undergraduate students to determine the extent to which the academic career of the brain-injured person was altered from what would have been expected in the absence of such an injury. Cases included all undergraduate students in a major university, between the ages of 17 and 27, who incurred a brain injury requiring hospitalization between 1980 and 1984 (n = 99). Two comparison groups were used to determine whether changes in academic performance were specifically related to brain injuries or injuries in general: (1) injured controls, i.e. 121 students between the ages of 17 and 27 years, hospitalized for injuries other than to the central nervous system, and (2) uninjured academic controls, i.e. 198 students without injuries requiring hospitalization during the study period, matched 2:1 to the brain-injured students by age, gender, and completed course credits categorized as <90, greater than or equal to 90. Although there were no differences when the total groups, including both males and females, were compared, there was a significant pre- to postinjury decrease in the grade point average for female cases when compared to their uninjured academic controls (p < 0.02). This difference was related to the effects of brain injury, and not to the effects of injury in general. No such difference was observed for the males. There were also no differences when the total groups, including males and females, were compared relevant to return to school. However, a significantly higher proportion of the female cases, compared with their uninjured academic controls, did not return to school after their injury; similar findings were identified for the injured controls as well. Thus, these differences were not specific to brain injury but rather to injury in general. In spite of this observation, the difference be tween female cases who returned and those who did not return was associated with neurological deficits, especially upper left limb motor deficits, at the time of hospital discharge. The findings from this effort are suggestive of gender differences in the consequences of brain injury and serve as a basis for further studies to evaluate the magnitude of this problem.	UNIV MINNESOTA,SCH PUBL HLTH,DIV EPIDEMIOL & ENVIRONM HLTH,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH PUBL HLTH,DIV BIOSTAT,MINNEAPOLIS,MN 55455; UNIV MINNESOTA,SCH MED,DEPT NEUROSURG,MINNEAPOLIS,MN 55455; GRP HLTH FDN,MINNEAPOLIS,MN; UNIV MINNESOTA,DEPT BEHAV SCI,DULUTH,MN 55812; RW JOHNSON PHARMACEUT RES INST,SPRING HOUSE,PA 19477	Gerberich, SG (corresponding author), UNIV MINNESOTA,REG INJURY PREVENT RES CTR,DIV EOH,SPH,POB 807 UMHC,420 DELAWARE ST SE,MINNEAPOLIS,MN 55455, USA.		Gerberich, Susan G/K-9956-2019	Gerberich, Susan G/0000-0001-6424-7131; Renier, Colleen/0000-0001-5083-5282			BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BENNETT DR, 1980, AM J SPORT MED, V8, P202, DOI 10.1177/036354658000800312; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BRESLOW NE, 1980, STATISTICAL METHODS; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROWNELL HH, 1986, BRAIN LANG, V27, P310, DOI 10.1016/0093-934X(86)90022-2; *COMM INJ SCAL, 1980, ABBR INJ SCAL 1980; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CRAWFORD C, 1983, NEW ZEAL MED J, V96, P972; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; DIXON WJ, 1985, PLR STEPWISE LOG REG; ESON ME, 1978, J NEUROL NEUROSUR PS, V41, P1036, DOI 10.1136/jnnp.41.11.1036; Fleiss JL, 1981, STATISTICAL METHODS; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRENCH LR, 1985, AM J EPIDEMIOL, V121, P414, DOI 10.1093/oxfordjournals.aje.a114013; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; GERBERICH SG, 1980, THESIS U MINNESOTA M; GILCHRIST E, 1979, ARCH NEUROL-CHICAGO, V36, P355, DOI 10.1001/archneur.1979.00500420065008; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; GRAYBOW JD, 1984, AM J PUBLIC HEALTH, V74, P710; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; GUSTAFSON T, 1987, EPISTAT 3 3; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; *INT CLASS DIS, 1980, CLIN MOD, V3; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; JENNETT B, 1976, LANCET, V1, P1031; Jennett B, 1981, MANAGEMENT HEAD INJU; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KIMURA D, 1992, SCI AM, V267, P119; KIMURA D, 1984, PROG BRAIN RES, V61, P423; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1991, NEUROEPIDEMIOLOGY TR; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LANSDELL H, 1962, NATURE, V194, P852, DOI 10.1038/194852a0; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1979, CORTEX, V15, P63, DOI 10.1016/S0010-9452(79)80007-6; LUNDHOLM J, 1975, J REHABIL MED, V7, P97; MacKenzie E J, 1989, Md Med J, V38, P725; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MANTEL N, 1959, J NATL CANCER I, V22, P719; MAY PRA, 1979, ARCH NEUROL-CHICAGO, V36, P370, DOI 10.1001/archneur.1979.00500420080011; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; NETER J, 1974, APPL LINEAR STAT MOD, P615; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NEWCOMBE F, 1982, INJURY, V14, P111, DOI 10.1016/0020-1383(82)90046-8; NIE NH, 1975, ANOVA STAT PACKAGE S; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PRIGATANO GP, 1982, J PERCEPTUAL MOTOR S, V54, P859; Rice DP, 1989, COST INJURY US REPOR; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; SNOEK JJ, 1981, J NEUROL NEUROSUR PS, V44, P285; SPRINGER SP, 1981, LEFT BRAIN RIGHT BRA, P121; STATON RD, 1982, CORTEX, V18, P23, DOI 10.1016/S0010-9452(82)80016-6; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; SYMONDS C, 1962, LANCET, V1, P1; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019	70	14	14	0	13	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350			NEUROEPIDEMIOLOGY	Neuroepidemiology	JAN-FEB	1997	16	1					1	14		10.1159/000109665			14	Public, Environmental & Occupational Health; Clinical Neurology	Public, Environmental & Occupational Health; Neurosciences & Neurology	WB536	WOS:A1997WB53600001	8994935				2021-06-18	
J	Lawler, KA; Terregino, CA				Lawler, KA; Terregino, CA			Guidelines for evaluation and education of adult patients with mild traumatic brain injuries in an acute care hospital setting	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive assessment; patient education; postconcussion syndrome; traumatic brain injury	MINOR HEAD-INJURY; NEUROPSYCHOLOGICAL DEFICITS; POST-CONCUSSION; SYMPTOMS; SEQUELAE; RECOVERY; AMNESIA; MEMORY	The purpose of this article is to provide practice guidelines that outline a systematic approach to be followed in an acute care setting with patients who have sustained a mild traumatic brain injury (TBI). Most patients are seen briefly in an emergency department and then released, with little or no information concerning the sequelae of mild TBI. This article reviews the literature supporting the importance of early education of patients concerning the possible effects of mild TBI and proposes a specific protocol to be followed in providing patients with medical assessment, a brief cognitive screening evaluation, educational information, and follow-up treatment.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,NEWARK,NJ 07103; COOPER HOSP UNIV MED CTR,DEPT EMERGENCY MED,CAMDEN,NJ 08103	Lawler, KA (corresponding author), COOPER HOSP UNIV MED CTR,DEPT MED,DIV NEUROL,NEUROPSYCHOL LAB,3 COOPER PLAZA,SUITE 320,CAMDEN,NJ 08103, USA.						ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ALVES W, 1986, J HEAD TRAUMA REHABI, V2, P1; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BOHNEN N, 1992, NEUROSURGERY, V30, P692; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; CICERONE KD, 1995, BRAIN INJURY, V9, P865; Committee on Mild Traumatic Brain Injury American Congress of Rehabilitation Medicine (ACRM), 1993, J HEAD TRAUMA REHAB, V8, P86; DENCKER SJ, 1958, ACTA PSYCHIAT N S122, V33, P1; DICKER BG, 1992, J HEAD TRAUMA REHAB, V7, P83; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1989, MILD HEAD INJURY; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; ELKIND AH, 1989, CLIN J PAIN, V5, P77, DOI 10.1097/00002508-198903000-00014; EVANS RW, 1994, HEADACHE, V34, P268, DOI 10.1111/j.1526-4610.1994.hed3405268.x; GRONWALL D, 1975, LANCET, V2, P995; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; GUILMETTE TJ, 1995, NEUROPSYCHOLOGY, V9, P338, DOI 10.1037/0894-4105.9.3.338; HALL S, 1991, J NEUROSURG, V75, P378, DOI 10.3171/jns.1991.75.3.0378; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; KAY T, 1986, MINOR HEAD INJURY IN; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN H, 1989, MODERATE HEAD INJURY; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MILLER H, 1969, BRIT MED J, V1, P9; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NEWCOMBE F, 1994, J NEUROL NEUROSUR PS, V57, P709, DOI 10.1136/jnnp.57.6.709; OMMAYA A, 1974, BRAIN, V95, P633; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Stewart DP, 1996, ACAD EMERG MED, V3, P21, DOI 10.1111/j.1553-2712.1996.tb03297.x; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Wechsler D., 1987, WECHSLER MEMORY SCAL; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; WILSON G, 1985, RIVERMEAD BEHAV MEMO; WILSON JTL, 1994, J NEUROL NEUROSUR PS, V57, P198, DOI 10.1136/jnnp.57.2.198; Yarnell P R, 1988, Brain Inj, V2, P255, DOI 10.3109/02699058809150950	44	14	14	0	5	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	DEC	1996	11	6					18	28		10.1097/00001199-199612000-00005			11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	VW427	WOS:A1996VW42700004					2021-06-18	
J	Leybaert, L; deHemptinne, A				Leybaert, L; deHemptinne, A			Changes of intracellular free calcium following mechanical injury in a spinal cord slice preparation	EXPERIMENTAL BRAIN RESEARCH			English	Article						intracellular free calcium; traumatic injury; spinal cord; intercellular communication; rat	RAT SENSORY NEURONS; SPREADING DEPRESSION; GAP-JUNCTIONS; INTERCELLULAR COMMUNICATION; MAMMALIAN BRAIN; GLIAL-CELLS; STORES; GLUTAMATE; CHANNELS; WAVES	Intracellular calcium ions are, in addition to free radicals, an important mediator of tissue destruction following traumatic injury to the spinal cord. In vivo measurements of calcium in the interstitial space and in the tissue suggest the occurrence of a posttraumatic shift of calcium from the extracellular to the intracellular compartment at the injury site. No information is, however, available on the posttraumatic changes of calcium in the intracellular compartment, where the ion exerts its crucial messenger function. We developed an in vitro model of local traumatic spinal injury, using a spinal cord slice preparation, allowing us to investigate injury-related changes of intracellular free calcium. The injury consisted of the impact of a small needle, and intracellular free calcium was measured with fura-2. Application of the injury at different places within the gray matter caused a transient and reproducible increase in the fura-2 fluorescence ratio. This injury-induced ratio increase was largely, but not completely, suppressed under zero extracellular calcium conditions. It was also largely depressed in the presence of high extracellular potassium and in the absence of extracellular sodium. It was modestly depressed by the calcium channel blocker nifedipin, by the calcium release channel blocker dantrolene, and by the gap junction blockers halothane and octanol. The calcium channel blocker flunarizine, the N-methyl D-aspartate (NMDA)-receptor-channel blocker MK-801 and the endoplasmic reticulum calcium-ATPase blocker thapsigargin had no effect. The experiments suggest that injury is associated with an increase in intracellular free calcium that is mediated by calcium influx, in part via L-type calcium channels. They furthermore give evidence that sodium influx and gap junctions are involved in these injury-associated changes of intracellular free calcium.		Leybaert, L (corresponding author), STATE UNIV GHENT,LAB NORMALE & PATHOL FYSIOL,DE PINTELAAN 185,B-9000 GHENT,BELGIUM.		Leybaert, Luc/F-4079-2015	Leybaert, Luc/0000-0001-6452-6982			AHLIJANIAN MK, 1990, NEURON, V4, P819, DOI 10.1016/0896-6273(90)90135-3; AKAIKE N, 1989, J PHYSIOL-LONDON, V412, P181, DOI 10.1113/jphysiol.1989.sp017610; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BRAUGHLER JM, 1992, J NEUROTRAUM, V9, pS1; BURT JM, 1993, PROG CELL R, V3, P113; BURT JM, 1989, CIRC RES, V65, P829, DOI 10.1161/01.RES.65.3.829; CARBONE E, 1987, J PHYSIOL-LONDON, V386, P547, DOI 10.1113/jphysiol.1987.sp016551; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHARLES AC, 1993, GLIA, V7, P134, DOI 10.1002/glia.440070203; CHARLES AC, 1992, J CELL BIOL, V118, P195, DOI 10.1083/jcb.118.1.195; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; DELEY G, 1993, J NEUROTRAUM, V10, P25, DOI 10.1089/neu.1993.10.25; DUCHEN MR, 1990, J PHYSIOL-LONDON, V424, P411, DOI 10.1113/jphysiol.1990.sp018074; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; FURUYAMA T, 1993, MOL BRAIN RES, V18, P141, DOI 10.1016/0169-328X(93)90183-P; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; HANSEN AJ, 1985, PHYSIOL REV, V65, P101; HENZI V, 1992, NEUROSCIENCE, V46, P251, DOI 10.1016/0306-4522(92)90049-8; KWO S, 1989, Journal of Neurotrauma, V6, P13, DOI 10.1089/neu.1989.6.13; LEIBOWITZ DH, 1992, P ROY SOC B-BIOL SCI, V250, P287, DOI 10.1098/rspb.1992.0161; LEYBAERT L, 1993, N-S ARCH PHARMACOL, V348, P269, DOI 10.1007/BF00169155; LEYBAERT L, 1994, EXP BRAIN RES, V100, P369, DOI 10.1007/BF02738397; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MARCOTTE GV, 1990, J CELL PHYSIOL, V142, P78, DOI 10.1002/jcp.1041420111; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; PEREZARMENDARIZ M, 1991, BIOPHYS J, V59, P76, DOI 10.1016/S0006-3495(91)82200-7; Press W.H., 1989, NUMERICAL RECIPES PA; PURO DG, 1991, GLIA, V4, P456, DOI 10.1002/glia.440040505; REGAN RF, 1994, BRAIN RES, V633, P236, DOI 10.1016/0006-8993(94)91544-X; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; SANDERSON MJ, 1990, CELL REGUL, V1, P585; SANDERSON MJ, 1994, MOL CELL ENDOCRINOL, V98, P173, DOI 10.1016/0303-7207(94)90136-8; SCHURR A, 1992, HIPPOCAMPUS, V2, P221, DOI 10.1002/hipo.450020303; Shi RY, 1989, J NEUROTRAUM, V6, P261, DOI 10.1089/neu.1989.6.261; SIESJO BK, 1994, ANN NY ACAD SCI, V747, P140; SILVER IA, 1990, J GEN PHYSIOL, V95, P837, DOI 10.1085/jgp.95.5.837; SOMJEN GG, 1992, CAN J PHYSIOL PHARM, V70, pS248, DOI 10.1139/y92-268; SOMJEN GG, 1989, J NEUROSCI METH, V28, P35, DOI 10.1016/0165-0270(89)90007-1; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TYRGER J, 1991, BRAIN RES, V549, P112; USACHEV Y, 1993, NEUROSCIENCE, V57, P845, DOI 10.1016/0306-4522(93)90029-F; VANHEEL B, 1989, AM J PHYSIOL, V257, pC365; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	47	14	15	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0014-4819			EXP BRAIN RES	Exp. Brain Res.	DEC	1996	112	3					392	402		10.1007/BF00227945			11	Neurosciences	Neurosciences & Neurology	WF376	WOS:A1996WF37600006	9007541				2021-06-18	
J	Piper, IR; Thomson, D; Miller, JD				Piper, IR; Thomson, D; Miller, JD			Monitoring weight drop velocity and foam stiffness as an aid to quality control of a rodent model of impact acceleration neurotrauma	JOURNAL OF NEUROSCIENCE METHODS			English	Article						neurotrauma; rodent; methodology; weight drop		Since the publication by Marmarou of a new rodent model of head injury, an increasing number of centres are adopting the model for use in a variety of paradigms. We report on two simple methods we have applied which allows us to monitor weight drop velocity and foam stiffness, both of which are critical factors for producing repeatable closed head injury with this model. We hope the application of these methods will assist in the standardisation of this model between centres.		Piper, IR (corresponding author), WESTERN GEN HOSP,DEPT CLIN NEUROSCI,CREWE RD S,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.						FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291	2	14	14	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270			J NEUROSCI METH	J. Neurosci. Methods	NOV	1996	69	2					171	174		10.1016/S0165-0270(96)00046-5			4	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	VV820	WOS:A1996VV82000006	8946320				2021-06-18	
J	Donders, J; Ballard, E				Donders, J; Ballard, E			Psychological adjustment characteristics of children before and after moderate to severe traumatic brain injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED HEAD-INJURY; ADOLESCENTS; BEHAVIOR	Objective: To examine the pre- and postinjury patterns of behavioral and psychosocial adjustment in children with moderate to severe traumatic brain injury, and to identify variables that predict adjustment outcome. Design: Premorbid and follow-up parental ratings of children's adjustment were compared. Outcome predictor variables were identified through stepwise regression analysis. Setting: Pediatric program at a regional comprehensive rehabilitation center. Patients: 50 children with moderate to severe traumatic brain injury, selected from a SG-month series of consecutive clinical inpatient referrals. Measure: Achenbach Child Behavior Checklist. Results: Premorbid behavioral or psychosocial deficits were no more common than in the general population. Level of psychosocial adjustment deteriorated significantly after traumatic brain injury (P < .0001). Significant predictors of psychosocial adjustment at follow-up included premorbid psychosocial adjustment (P < .01), diffuse lesion on computed tomography/magnetic resonance imaging scan (P < .001), and length of coma (P < .10). Conclusions: Postinjury psychosocial impairments are common in children with moderate to severe traumatic brain injury and are related to injury severity. In the majority of the cases, such problems cannot be attributed exclusively to premorbid dysfunction.		Donders, J (corresponding author), MARY FREE BED HOSP,235 WEALTHY SE,GRAND RAPIDS,MI 49503, USA.						Achenbach T.M., 1991, MANUAL TEACHERS REPO; ACHENBACH TM, 1983, MANUAL CHILD BEHAVIO; ACHENBACH TM, 1991, MANUAL CHILD BEHAVIO; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DEATON AV, 1994, ED DIMENSIONS ACQUIR; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; FLETCHER JM, 1988, HDB PEDIAT PSYCHOL; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Lehr E, 1990, PSYCHOL MANAGEMENT T; ODDY M, 1993, NEUROPSYCHOL REHABIL, V3, P301, DOI 10.1080/09602019308401444; Parmelee D X, 1989, Psychiatr Med, V7, P11; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/pms.1991.73.3f.1139; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; TEASDALE G, 1974, LANCET, V2, P81	18	14	14	0	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1996	11	3					67	73		10.1097/00001199-199606000-00010			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UP774	WOS:A1996UP77400010					2021-06-18	
J	Araujo, M; Wandosell, F				Araujo, M; Wandosell, F			Differential cellular response after glutamate analog hippocampal damage	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						reactive astrocyte; activated microglia; neuronal APP overexpression	AMYLOID PRECURSOR PROTEIN; CENTRAL NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; GENE-RELATED PEPTIDE; REACTIVE ASTROCYTES; ALZHEIMERS-DISEASE; RAT-BRAIN; WALLERIAN DEGENERATION; MOLECULAR PATHOLOGY; EXCITOTOXIC LESION	The tissue response after brain damage implicates the cellular ''activation'' of astrocytes and microglia, This glial response is referred as reactive gliosis. Using immunohistochemical markers, we have analyzed the neuronal and glial response to some neurotoxic-induced lesions. We have compared the effects of two glutamate analogs, AMPA and kainic acid, with those of traumatic injury. Our data showed that the time-course of appearance, the relative contribution of and the behavior of reactive astrocytes and microglial cells were clearly different after AMPA or kainic acid administration. The immunoreactivity associated with microglia response, with respect to the immunoreactivity associated with reactive astrocytes, was higher after AMPA damage than after kainic acid treatment. In both cases, however, glial cells were more abundant than after traumatic lesions. Interestingly, the CA1 pyramidal neurons affected by AMPA and some cortical neurons affected by traumatic injury responded with an overexpression of amyloid precursor protein, whereas no neuronal response was detected after the kainic acid treatment. Our data suggest that the gliotic response is highly specific to the type of insult and heterogeneous depending on the brain area affected. (C) 1996 Wiley-Liss, Inc.	UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC SEVERO OCHOA, E-28049 MADRID, SPAIN			Wandosell, Francisco/AAV-6391-2020; Wandosell, Francisco/G-6105-2015	Wandosell, Francisco/0000-0001-6537-2321			BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BOVOLENTA P, 1984, DEV BIOL, V102, P248, DOI 10.1016/0012-1606(84)90189-1; BOVOLENTA P, 1991, NERVE GROWTH CONE, P477; BOYA J, 1986, ACTA ANAT, V127, P142; CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L; CARD JP, 1988, NEURON, V1, P835, DOI 10.1016/0896-6273(88)90131-6; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P263, DOI 10.1016/0166-2236(87)90170-6; DAHL D, 1982, DIFFERENTIATION, V22, P185, DOI 10.1111/j.1432-0436.1982.tb01248.x; DRAGUNOW M, 1990, BRAIN RES, V527, P41, DOI 10.1016/0006-8993(90)91058-O; DUMOULIN FL, 1992, ANN NY ACAD SCI, V657, P351, DOI 10.1111/j.1749-6632.1992.tb22782.x; DUSART I, 1991, NEUROSCIENCE, V45, P541, DOI 10.1016/0306-4522(91)90269-T; ENG LF, 1992, PROG BRAIN RES, V94, P353; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; FERRARA N, 1988, BRAIN RES, V462, P223, DOI 10.1016/0006-8993(88)90550-1; GARTHWAITE G, 1989, NEUROSCI LETT, V99, P113, DOI 10.1016/0304-3940(89)90274-7; GEISERT EE, 1990, P NATL ACAD SCI USA, V87, P3967, DOI 10.1073/pnas.87.10.3967; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; GIULIAN D, 1987, J NEUROSCI RES, V18, P155, DOI 10.1002/jnr.490180123; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GRAEBER MB, 1989, NEUROSCI LETT, V103, P241, DOI 10.1016/0304-3940(89)90106-7; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; GUNN AJ, 1990, BRAIN RES, V531, P105, DOI 10.1016/0006-8993(90)90763-2; HAAS CA, 1990, J NEUROSCI RES, V27, P270, DOI 10.1002/jnr.490270305; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HEURTEAUX C, 1993, P NATL ACAD SCI USA, V90, P9431, DOI 10.1073/pnas.90.20.9431; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x; MANSOUR H, 1990, J NEUROSCI RES, V25, P300, DOI 10.1002/jnr.490250306; MANTHORPE M, 1986, ASTROCYTES CELL BIOL, V2, P315; MARTY S, 1991, NEUROSCIENCE, V45, P529, DOI 10.1016/0306-4522(91)90268-S; MCGEER PL, 1991, ALZHEIMERS DISEASE : BASIC MECHANISMS, DIAGNOSIS AND THERAPEUTIC STRATEGIES, P587; MORENOFLORES MT, 1993, GLIA, V7, P146, DOI 10.1002/glia.440070204; MURABE Y, 1981, CELL TISSUE RES, V218, P75; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; OLNEY JW, 1978, KAINIC ACID TOOL NEU, P201; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; POTTER H, 1992, PROG BRAIN RES, V94, P447; Reier P J, 1988, Adv Neurol, V47, P87; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; SCHOEPP D, 1990, TRENDS PHARMACOL SCI, V11, P508, DOI 10.1016/0165-6147(90)90052-A; SELKOE DJ, 1989, NEUROBIOL AGING, V10, P387, DOI 10.1016/0197-4580(89)90072-9; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHAW G, 1981, EUR J CELL BIOL, V26, P68; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SINHA S, 1992, NEURODEGENERATION, V1, P169; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; SOLA C, 1993, NEUROSCIENCE, V53, P267, DOI 10.1016/0306-4522(93)90304-X; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; STREIT WJ, 1993, J CHEM NEUROANAT, V6, P261, DOI 10.1016/0891-0618(93)90047-8; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; STREIT WJ, 1988, J COMP NEUROL, V268, P248, DOI 10.1002/cne.902680209; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; THOMAS WE, 1992, BRAIN RES REV, V17, P61; WANDOSELL F, 1993, J NEUROPATH EXP NEUR, V52, P205, DOI 10.1097/00005072-199305000-00004; WATKINS JC, 1990, TRENDS PHARMACOL SCI, V11, P25, DOI 10.1016/0165-6147(90)90038-A	64	14	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	MAY 15	1996	44	4					397	409					13	Neurosciences	Neurosciences & Neurology	UL385	WOS:A1996UL38500011	8739159				2021-06-18	
J	Markowsky, SJ; Skaar, DJ; Christie, JM; Eyer, SD; Ehresman, DJ				Markowsky, SJ; Skaar, DJ; Christie, JM; Eyer, SD; Ehresman, DJ			Phenytoin protein binding and dosage requirements during acute and convalescent phases following brain injury	ANNALS OF PHARMACOTHERAPY			English	Article							HEPATIC DRUG CLEARANCE; MODEL TRAUMATIC INJURY; POSTTRAUMATIC SEIZURES; DISEASE; DIPHENYLHYDANTOIN; SERUM	OBJECTIVE: To longitudinally evaluate unbound and total serum phenytoin concentrations during intravenous phenytoin maintenance dosage and to determine the relationship among phenytoin protein binding, serum albumin, and unbound fatty acid concentrations in patients with head injuries during intensive care unit (ICU) and convalescent care. DESIGN: Serum albumin and phenytoin unbound fraction were determined twice weekly during ICU and convalescent care in 10 patients receiving phenytoin following acute brain injury. Phenytoin protein binding was also determined in 10 healthy control subjects. MAIN OUTCOME MEASURES: Longitudinal serum phenytoin concentrations associated with dosage adjustments targeted to achieve unbound phenytoin serum concentrations between 1.0 and 2.0 mg/L were documented during ICU and convalescent care. Longitudinal phenytoin protein binding was correlated with serum albumin and unbound fatty acid concentrations in neurotrauma patients. RESULTS: ICU patients received intravenous therapy for a mean of 15.0 days. The mean +/- SD initial phenytoin intravenous dosage regimen of 6.0 +/- 0.7 mg/kg/d resulted in mean +/- SD total and unbound phenytoin concentrations of 3.2 +/- 2.3 and 0.3 +/- 0.2 mg/L. Two patients had seizures associated with low phenytoin concentrations. Four patients continued to receive oral phenytoin therapy during convalescent care; phenytoin dosage requirements decreased over time in these patients. During acute and convalescent care, the phenytoin unbound fraction ranged from 6.0% to 18.3% and correlated with albumin (r(2) = 0.61, p < 0.0001) but did not correlate with unbound fatty acid concentrations. The mean phenytoin unbound fraction was 10.1% and 8.9% for the ICU and convalescent patients with brain injuries, respectively, and was 7.0% for the healthy volunteers. CONCLUSIONS: Phenytoin protein binding was significantly correlated with albumin and was more variable in ICU and convalescent patients with brain injuries than in healthy volunteers. The high dosage requirements and subtherapeutic unbound phenytoin concentrations observed during acute care are best explained by increased metabolism. Phenytoin dosage requirements decreased during convalescence.	UNIV S FLORIDA,DEPT ANESTHESIA,TAMPA,FL; MERCK & CO INC,TAMPA,FL; UNIV FLORIDA,COLL PHARM,GAINESVILLE,FL; PHILADELPHIA COLL PHARM & SCI,PHILADELPHIA,PA 19104; ST PAUL RAMSEY MED CTR,DEPT SURG,SURG INTENS CARE UNIT,ST PAUL,MN 55101; ST PAUL RAMSEY MED CTR,DEPT PATHOL,ST PAUL,MN 55101							BAUER LA, 1982, NEUROLOGY, V32, P570, DOI 10.1212/WNL.32.5.570; BAUER LA, 1983, J TRAUMA, V23, P1058, DOI 10.1097/00005373-198312000-00007; BOUCHER BA, 1988, CLIN PHARMACOL THER, V44, P675, DOI 10.1038/clpt.1988.211; BOUCHER BA, 1991, CLIN PHARMACOL THER, V50, P487, DOI 10.1038/clpt.1991.173; GLASKO AJ, 1969, CLIN PHARMACOL THER, V10, P498; GODOLPHIN W, 1978, CLIN CHEM, V24, P483; GRIFFETH LK, 1983, DRUG METAB DISPOS, V11, P517; HOOPER WD, 1974, CLIN PHARMACOL THER, V15, P276; KABRA PM, 1983, CLIN CHEM, V29, P473; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; KUTT H, 1989, ANTIEPILEPTIC DRUGS, P215; LEPPIK IE, 1986, NEUROLOGY, V36, P1367, DOI 10.1212/WNL.36.10.1367; LEVY RH, 1984, CLIN PHARMACOKINET, V9, P1, DOI 10.2165/00003088-198400091-00001; LUND L, 1974, ARCH NEUROL-CHICAGO, V31, P289, DOI 10.1001/archneur.1974.00490410037002; MARKOWSKY SJ, 1996, INTENS CARE MED, P2338; PERUCCA E, 1981, DRUGS, V21, P120, DOI 10.2165/00003495-198121020-00003; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; RAUCKMAN EJ, 1980, J TRAUMA, V20, P884, DOI 10.1097/00005373-198010000-00012; RICHENS A, 1979, CLIN PHARMACOKINET, V4, P153, DOI 10.2165/00003088-197904030-00001; SHERWIN AL, 1976, NEUROLOGY, V26, P874, DOI 10.1212/WNL.26.9.874; SLAUGHTER RL, 1985, DRUG INTEL CLIN PHAR, V19, P799, DOI 10.1177/106002808501901101; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WILDER BJ, 1973, CLIN PHARMACOL THER, V14, P798; WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377	25	14	15	0	1	HARVEY WHITNEY BOOKS CO	CINCINNATI	PO BOX 42696, CINCINNATI, OH 45242	1060-0280			ANN PHARMACOTHER	Ann. Pharmacother.	MAY	1996	30	5					443	448		10.1177/106002809603000501			6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	UJ215	WOS:A1996UJ21500001	8740320				2021-06-18	
J	Richardson, JTE				Richardson, JTE			Memory impairment in multiple sclerosis: Reports of patients and relatives	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							SEVERE HEAD-INJURY; EVERYDAY MEMORY; COGNITIVE DYSFUNCTION	This paper reports the results of a questionnaire survey on problems in everyday memory that involved 115 community-based patients with multiple sclerosis (MS) and their carers or close relatives. Cluster analyses of their responses enabled the patients to be classified as either 'impaired' or 'unimpaired', though the salient items differed between the reports of the patients and the relatives. Both the self-reports and the relatives' reports indicated that roughly 10 per cent of the patients were impaired, a much lower estimate than that which was previously suggested based upon psychometric testing. It is concluded that neuropsychological assessment may underestimate the capacity of MS patients in their daily activities.		Richardson, JTE (corresponding author), BRUNEL UNIV, DEPT HUMAN SCI, UXBRIDGE UB8 3PH, MIDDX, ENGLAND.			Richardson, John/0000-0002-6267-0603			Babbie ER, 1973, SURVEY RES METHODS; BADDELEY A, 1982, ALZHEIMERS DISEASE R, P141; Baltes P. B., 1990, SUCCESSFUL AGING PER, P1, DOI [DOI 10.1017/CBO9780511665684, 10.1017/CBO9780511665684.003, DOI 10.1017/CBO9780511665684.003]; BRADLEY DR, 1979, PSYCHOL BULL, V86, P1290, DOI 10.1037/0033-2909.86.6.1290; CAVANAUGH JC, 1987, INT J AGING HUM DEV, V24, P271, DOI 10.2190/8WTA-P1WP-EJYJ-Q33D; COLVILLE PL, 1983, MULTIPLE SCLEROSIS P, P631; COMPSTON A, 1993, BRAINS DIS NERVOUS S, P351; Corcoran R, 1992, Seizure, V1, P37, DOI 10.1016/1059-1311(92)90053-4; COTTRELL SS, 1929, J NEUROL PSYCHOPATH, V7, P1; CRAWFORD M, 1989, BRIT J PSYCHOL, V80, P391, DOI 10.1111/j.2044-8295.1989.tb02329.x; Everitt B.S., 1993, CLUSTER ANAL; FEINSTEIN A, 1992, J NEUROL NEUROSUR PS, V55, P869, DOI 10.1136/jnnp.55.10.869; FISCHER JS, 1989, CURR PROB N, V10, P39; GERVASIO AH, 1988, B PSYCHONOMIC SOC, V26, P339, DOI 10.3758/BF03337675; GILBERT JJ, 1983, ARCH NEUROL-CHICAGO, V40, P533, DOI 10.1001/archneur.1983.04050080033003; GILEWSKI MJ, 1986, HDB CLIN MEMORY ASSE, P93, DOI DOI 10.1037/10057-008; GRANT I, 1984, J NEUROL NEUROSUR PS, V47, P250, DOI 10.1136/jnnp.47.3.250; GUDEX C, 1988, 38 U YORK CTR HLTH E; Harabasz, 1974, COMMUN STAT, V3, P1, DOI DOI 10.1080/03610927408827101; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; HERRMANN DJ, 1990, SELF DIRECTEDNESS CA, P199; HICKOX A, 1992, HDB NEUROPSYCHOLOGIC, P103; KIDEER LH, 1981, RES METHODS SOCIAL R; KURTZKE JF, 1972, ACTA NEUROL SCAND, V48, P19, DOI 10.1111/j.1600-0404.1972.tb07525.x; LINCOLN NB, 1989, BRIT J CLIN PSYCHOL, V28, P61, DOI 10.1111/j.2044-8260.1989.tb00812.x; MACKAY RP, 1967, ARCH NEUROL-CHICAGO, V17, P588, DOI 10.1001/archneur.1967.00470300030007; MCALPINE D, 1972, MULTIPLE SCLEROSIS; MCINTOSHMICHAELIS SA, 1991, BRIT J CLIN PSYCHOL, V30, P333, DOI 10.1111/j.2044-8260.1991.tb00954.x; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Morris P. E, 1984, EVERYDAY MEMORY ACTI, P153; NELSON LM, 1988, J CLIN EPIDEMIOL, V41, P187, DOI 10.1016/0895-4356(88)90093-5; Newcombe F, 1979, Int Rehabil Med, V1, P182; OVERALL JE, 1993, J CLIN PSYCHOL, V49, P459, DOI 10.1002/1097-4679(199307)49:4<459::AID-JCLP2270490402>3.0.CO;2-P; PEYSER JM, 1990, ARCH NEUROL-CHICAGO, V47, P94, DOI 10.1001/archneur.1990.00530010120030; PEYSER JM, 1980, ARCH NEUROL-CHICAGO, V37, P577, DOI 10.1001/archneur.1980.00500580073013; PEYSER JM, 1980, ARCH NEUROL-CHICAGO, V37, P437, DOI 10.1001/archneur.1980.00500560067009; POLLARD P, 1987, PSYCHOL BULL, V102, P159, DOI 10.1037/0033-2909.102.1.159; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1986, J CLIN EXP NEUROPSYC, V8, P503, DOI 10.1080/01688638608405173; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; RAO SM, 1989, NEUROLOGY, V39, P161, DOI 10.1212/WNL.39.2.161; SCHWARTZ AF, 1989, CORTEX, V25, P665, DOI 10.1016/S0010-9452(89)80026-7; SHEPHERD DI, 1979, ACTA NEUROL SCAND, V60, P218; STENAGER E, 1990, SEMIN NEUROL, V10, P254, DOI 10.1055/s-2008-1041276; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Tabachnick B.G., 1989, USING MULTIVARIATE S; TRUELLE JL, 1987, REV NEUROL, V143, P595; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wilson B.A., 1991, NEUROPSYCHOL REHABIL, V1, P117, DOI [https://doi.org/10.1080/09602019108401386, DOI 10.1080/09602019108401386]; Zelinski EM, 1980, NEW DIRECTIONS MEMOR, P519	53	14	14	0	1	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	MAY	1996	35		2				205	219		10.1111/j.2044-8260.1996.tb01177.x			15	Psychology, Clinical	Psychology	UM867	WOS:A1996UM86700004	8773798				2021-06-18	
J	Vitale, AE; Sullivan, SJ; Jankowski, LW; Fleury, J; Lefrancois, C; Lebouthillier, E				Vitale, AE; Sullivan, SJ; Jankowski, LW; Fleury, J; Lefrancois, C; Lebouthillier, E			Screening of health risk factors prior to exercise or a fitness evaluation of adults with traumatic brain injury: A consensus by rehabilitation professionals	BRAIN INJURY			English	Article							DELPHI	A modified Delphi technique was used to obtain group consensus among 31 rehabilitation professionals (RPs) from nine rehabilitation centres throughout the province of Quebec (Canada) to ascertain their expert opinion on the health risk factors (HRF) to be verified prior to beginning an exercise programme or evaluation for patients with traumatic brain injury (TBI). From the initial survey 87 items were generated, which were later regrouped into 27 HRFs. The relative importance of each HRF in regard to being screened before exercise in a population with TBI was then assessed by each RP using a five-point ordinal scale (1 = not important to 5 = extremely important). HRFs that were considered extremely important by at least 50% of HPs include: angina pectoris, aortic stenosis, exertional syncope, musculoskeletal sequelae which are exacerbated by exercise, outward aggressivity, pulmonary embolism, uncontrolled epilepsy (seizures), and ventricular arrhythmias. Professionals involved in exercising patients with TBI may and these factors useful to the efficient conduct of their rehabilitation programme.	INST READAPTAT MONTREAL,CTR RECH,MONTREAL,PQ H3S 2J4,CANADA; UNIV MONTREAL,FAC MED,ECOLE READAPTAT,MONTREAL,PQ H3C 3J7,CANADA; CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL,PQ,CANADA; INST READAPTAT MONTREAL,DEPT PSYCHIAT,MONTREAL,PQ,CANADA; CTR READAPTAT LUCIE BRUNEA,MONTREAL,PQ,CANADA							*AM COLL SPORTS ME, 1991, GUID EX TEST PRESCR, P6; Couper M R, 1984, ANS Adv Nurs Sci, V7, P72; FROST EAM, 1989, NEUROTRAUMA TREATMEN, V1, P29; GOODMAN CM, 1987, J ADV NURS, V12, P729, DOI 10.1111/j.1365-2648.1987.tb01376.x; GREEN CG, 1993, J AM DIET ASSOC, V93, P1307, DOI 10.1016/0002-8223(93)91962-P; Green LW., 1980, HLTH ED PLANNING DIA; HARRINGTON JM, 1994, OCCUP ENVIRON MED, V51, P289, DOI 10.1136/oem.51.5.289; HUNTER M, 1990, PHYS THER, V70, P363, DOI 10.1093/ptj/70.6.363; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; LINESTONE HA, 1975, DELPHI METHOD TECHNI, P3; McMurray A R, 1994, J Nurs Staff Dev, V10, P62; MILESTAPPING C, 1990, PHYS THER, V70, P448, DOI 10.1093/ptj/70.7.448; PILON M, 1995, BRAIN INJURY, V9, P365, DOI 10.3109/02699059509005776; Prigatano G. P., 1990, CLIN NEUROPSYCHOL, V4, P163, DOI [10.1080/13854049008401509, DOI 10.1080/13854049008401509]; RAINHORN JD, 1994, B WORLD HEALTH ORGAN, V72, P257; ROBERG AL, 1992, CANADIAN J PROGRAM E, V7, P27; ROSENTHAL M, 1990, REHABILITATION ADULT; SHEPHARD RJ, 1988, SPORTS MED, V5, P185, DOI 10.2165/00007256-198805030-00005; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; SWAINE BR, 1994, BRAIN INJURY, V8, P323, DOI 10.3109/02699059409150983; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; VITALE AE, 1995, PERCEPT MOTOR SKILL, V80, P57, DOI 10.2466/pms.1995.80.1.57; Whiting S A, 1994, Issues Ment Health Nurs, V15, P37, DOI 10.3109/01612849409074932; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; Wolman RL, 1994, CLIN REHABIL, V8, P253	25	14	14	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY	1996	10	5					367	375		10.1080/026990596124377			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UL742	WOS:A1996UL74200004	8735666				2021-06-18	
J	SchmitterEdgecombe, M				SchmitterEdgecombe, M			Effects of traumatic brain injury on cognitive performance: An attentional resource hypothesis in search of data	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						attention; attention deficit; attentional resources; automaticity; automatic processes; divided attention; effortful processes; traumatic brain injury; treatment	CLOSED-HEAD-INJURY; DIVIDING ATTENTION; MULTIPLE RESOURCES; REACTION-TIME; MEMORY; TASK; FREQUENCY; AUTOMATICITY; DIFFICULTY; DISORDERS	Individuals who sustain severe traumatic brain injuries (TBI) typically exhibit residual performance deficits across a wide range of cognitive tasks. It is therefore possible that the performance deficits of persons with TBI may be at least partially the result of deficiencies in some fundamental cognitive abilities that are involved in the performance of many different activities. This article explores the possibility that attentional processes may be such a fundamental cognitive ability. According to the attentional resource hypothesis, some of the cognitive deficits that follow a TBI may occur because these people have less attentional resources available to allocate to task performances. To evaluate the merits of an attentional resource hypothesis, the TBI literature is reviewed in terms of three explicit predictions of this hypothesis. Several important questions raised by the reviewed research are then addressed. Implications of the attentional resource hypothesis for treatment and intervention strategies are also discussed.		SchmitterEdgecombe, M (corresponding author), WASHINGTON STATE UNIV,DEPT PSYCHOL,PULLMAN,WA 99164, USA.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; BORCHERDING B, 1988, J ABNORM CHILD PSYCH, V16, P333, DOI 10.1007/BF00913804; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; BROOKS D N, 1975, Cortex, V11, P329; CHA KH, 1990, INT REV RES MENT RET, V16, P51; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; DYWAN J, 1993, BRAIN COGNITION, V21, P20, DOI 10.1006/brcg.1993.1002; FAHY JF, UNPUB DISSOCIATIONS; FRIEDMAN A, 1982, J EXP PSYCHOL HUMAN, V8, P625, DOI 10.1037/0096-1523.8.5.625; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gentilini M., 1989, MILD HEAD INJURY; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; GLISKY EL, 1988, J LEARN DISABIL-US, V21, P333, DOI 10.1177/002221948802100604; GLISKY EL, 1986, J HEAD TRAUMA REHAB, V1, P54, DOI DOI 10.1097/00001199-198609000-00009; GREENE RL, 1984, MEM COGNITION, V12, P90, DOI 10.3758/BF03197001; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; ISREAL JB, 1980, PSYCHOPHYSIOLOGY, V17, P259, DOI 10.1111/j.1469-8986.1980.tb00146.x; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JACOBY LL, 1989, J EXP PSYCHOL GEN, V118, P115, DOI 10.1037/0096-3445.118.2.115; Kahneman D, 1984, VARIETIES ATTENTION; KAHNEMAN D, 1973, ATTENTION MEMORY; KINCHLA RA, 1980, ATTENTION PERFORMANC, V8; KLENSCH H, 1981, EVACTION TIME ATTENT; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; LIGHT LL, 1991, ANNU REV PSYCHOL, V42, P333, DOI 10.1146/annurev.ps.42.020191.002001; Mateer C.A., 1988, NEUROPSYCHOLOGICAL S; MCDOWD JM, 1988, J EXP PSYCHOL HUMAN, V14, P267, DOI 10.1037/0096-1523.14.2.267; Miller E, 1970, Cortex, V6, P121; MUTTER SA, 1990, COGNITIVE NEUROPSYCH, V7, P329, DOI 10.1080/02643299008253447; NAVEHBENJAMIN M, 1986, J EXP PSYCHOL LEARN, V12, P378, DOI 10.1037/0278-7393.12.3.378; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Parasuraman R., 1984, VARIETIES ATTENTION; PARKIN AJ, 1990, EUROPEAN J COGNITIVE, V2, P71, DOI DOI 10.1080/09541449008406198; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; POSNER MI, 1987, TRENDS NEUROSCI, V10, P13, DOI 10.1016/0166-2236(87)90116-0; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; ROGERS WA, 1994, PSYCHOL AGING, V9, P398, DOI 10.1037/0882-7974.9.3.398; Ruff RM, 1986, J HEAD TRAUMA REHAB, V1, P43; SALTHOUSE TA, 1984, MEM COGNITION, V12, P613, DOI 10.3758/BF03213350; SALTHOUSE TA, 1990, DEV REV, V10, P101, DOI 10.1016/0273-2297(90)90006-P; Schmitter-Edgecombe M., 1993, NEUROPSYCHOLOGY, V7, P136, DOI DOI 10.1037/0894-4105.7.2.136; SCHMITTEREDGECO.M, UNPUB AUTOMATIC PROC; SCHMITTEREDGECO.M, IN PRESS NEUROPSYCHO; SCHMITTEREDGECO.M, IN PRESS J INT NEURO; SCHMITTEREDGECO.M, UNPUB VISUAL SELECTI; SCHMITTEREDGECO.ME, 1992, J CLIN EXP NEUROPSYC, V14, P728; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHNEIDER W, 1982, PERCEPT PSYCHOPHYS, V31, P160, DOI 10.3758/BF03206216; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SHIFFRIN RM, 1981, ATTENTION PERFORMANC, V9; SHUM DHK, 1990, J CLIN EXP NEUROPSYC, V12, P247, DOI 10.1080/01688639008400971; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SOMBERG BL, 1982, J EXP PSYCHOL HUMAN, V8, P651, DOI 10.1037/0096-1523.8.5.651; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; SPIKMAN JM, 1995, J CLIN EXP NEUROPSYC, V17, P29, DOI 10.1080/13803399508406578; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; TOTH JP, 1992, NEUROPSYCHOLOGY MEMO; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; VAKIL E, 1991, J CLIN EXP NEUROPSYC, V13, P291, DOI 10.1080/01688639108401044; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; WICKENS CD, 1984, VARIEITES ATTENTION	72	14	15	1	3	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	APR	1996	11	2					17	30		10.1097/00001199-199604000-00003			14	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	UD674	WOS:A1996UD67400003					2021-06-18	
J	Pileggi, R; Dumsha, TC; Myslinksi, NR				Pileggi, R; Dumsha, TC; Myslinksi, NR			The reliability of electrical pulp test after concussion injury	ENDODONTICS & DENTAL TRAUMATOLOGY			English	Article						dental trauma; dental concussion; electric pulp test; pulpal vasculature		Traumatic injuries to teeth present a difficult diagnostic problem with respect to determining the vitality of the affected teeth. Conventionally, a latency period of 4 to 6 weeks is proposed as the amount of time required for the return of a positive electric pulp test (EPT) response; however, this has been based on empirical data. The purpose of this study was to 1) determine a time frame during which a return of a reliable response to EPT may be measured, and 2) correlate this time frame with pulpal vascular changes that occur after traumatic injuries. Four canines from each of nine ferrets were used for this experiment (18 traumatized and 18 control teeth). A reproducible concussion injury was devised by releasing a known weight at a constant height above the facial surface of the experimental teeth. The EPT response was confirmed by the use of an ER IG muscle recorder. Animals were killed at 24, 18 and 72 h and 6, 12 and 28 days after the injury and the teeth analyzed histologically. The histological sections showed an absence of inflammatory cells in both groups; however, according to the NIH image system; an increase in the number of vessels Tvas detected in the experimental group when compared to the controls. In a majority of the cases, a positive response to the EPT returned within 12 days post concussion injury and as early as 10 days. In addition, a significant vascular change was accompanied with the loss of the EPT response. This study provided a reliable method by which concussion injuries may be studied using an animal model.	UNIV MARYLAND,SCH DENT,DEPT ENDODONT,BALTIMORE,MD; UNIV MARYLAND,SCH DENT,DEPT CRANIOFACIAL BIOL SCI,BALTIMORE,MD	Pileggi, R (corresponding author), UNIV MICHIGAN,SCH DENT,DEPT CARIOL RESTORAT SCI & ENDODONT,1011 N UNIV,ANN ARBOR,MI 48109, USA.						ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P9; ANDREASEN F M, 1985, Endodontics and Dental Traumatology, V1, P207; ANDREASEN F M, 1986, Endodontics and Dental Traumatology, V2, P90; ANDREASEN F M, 1987, Endodontics and Dental Traumatology, V3, P103; ANDREASEN JO, 1981, TAUMATIC INJURIES TE; Andreasen JO., 1994, TXB COLOR ATLAS TRAU, V3; CRONALARSSON G, 1991, ENDOD DENT TRAUMATOL, V7, P199; DUMSHA T, 1995, INT ENDOD J, V28, P7, DOI 10.1111/j.1365-2591.1995.tb00149.x; DUMSHA T, 1992, J ENDODONT, V8, P410; Dumsha T C, 1995, Dent Clin North Am, V39, P79; DUMSHA T C, 1992, Dental Clinics of North America, V36, P425; GAMSON EG, 1992, J ENDOD, V18; MYSLINSKI N, 1987, J NEUROSCI METH, V22, P73, DOI 10.1016/0165-0270(87)90092-6; OHMAN A, 1965, ONDONTOL TIDSKR, V4, P165; PATIL S, 1994, INT ENDOD J, V27, P1, DOI 10.1111/j.1365-2591.1994.tb00220.x; POGREL MA, 1989, ORAL SURG ORAL MED O, V67, P583, DOI 10.1016/0030-4220(89)90277-6; ROWE AHR, 1990, INT ENDOD J, V23, P77, DOI 10.1111/j.1365-2591.1990.tb00843.x; Skieller V., 1960, ACTA ODONTOL SCAND, V18, P171; WILDERSMITH PEEB, 1988, INT ENDOD J, V21, P307, DOI 10.1111/j.1365-2591.1988.tb01140.x	19	14	15	0	2	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0109-2502			ENDOD DENT TRAUMATOL	Endod. Dent. Traumatol.	FEB	1996	12	1					16	19					4	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	UB572	WOS:A1996UB57200003	8631284				2021-06-18	
J	Dauch, WA; Schutze, M; Guttinger, M; Bauer, BL				Dauch, WA; Schutze, M; Guttinger, M; Bauer, BL			Posttraumatic prophylaxis for seizures - The results of a survey among 127 neurosurgical departments	ZENTRALBLATT FUR NEUROCHIRURGIE			English	Article						epilepsy; intracranial haemorrhage; risk factors; skull fracture; brain injury	POST-TRAUMATIC SEIZURES; PROPHYLACTICALLY ADMINISTERED PHENYTOIN; HEAD-INJURY; EPILEPSY; RISK; FAILURE	Starting in November, 1993, until January, 1994, we performed a survey among 127 Neurosurgical Departments in Austria, Germany, and Switzerland concerning the practice of antiepileptic prophylaxis in head injured patients. Seventy seven percent of the 12-item multiple choice questionnaires were completed and returned. They indicate a variety of attitudes towards prophylaxis for seizures: in 12% of the responding institutions, antiepileptic prophylaxis is given to every brain trauma patient, in 36%, no prophylaxis is carried out, and in 52% some patients receive prophylaxis while others do not. Penetrating injuries, intracranial haemorrhages and electroencephalographic abnormalities were the most frequent reasons why prophylaxis was initiated. Phenytoin is by far the most popular drug, given usually for at least three months, and in most cases monitored by routine serum level observations. Nevertheless, about three out of four neurosurgeons conceded that a general renunciation of antiepileptic prophylaxis after brain trauma might be justified. There is no uniform way in which patients are informed about a possible risk of seizures, as it may be relevant, for instance, in respect of driving abilities.	ZENTRUM SCHWERST SCHADEL HIROVERLETZTE FREIN & HA,D-22081 HAMBURG,GERMANY; UNIV MARBURG,NEUROCHIRURG KLIN,MARBURG,GERMANY							BAUER J, 1992, NERVENHEILKUNDE, V11, P74; BIRKMAYER W, 1951, Wien Klin Wochenschr, V63, P606; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; GLOTZNER FL, 1979, AKTUEL NEUROL, V6, P241; HAINES SJ, 1983, J NEUROSURG, V59, P730; HEIKKINEN ER, 1990, STEREOT FUNCT NEUROS, V54-5, P25, DOI 10.1159/000100186; Janz D, 1994, Zentralbl Neurochir, V55, P1; JANZ D, 1982, NERVENARZT, V53, P238; KELLY DF, 1989, NEUROSURGERY, V25, P976, DOI 10.1227/00006123-198912000-00022; KUHL DA, 1990, DICP ANN PHARMAC, V24, P277, DOI 10.1177/106002809002400314; MANAKA S, 1992, JPN J PSYCHIAT NEUR, V46, P311; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MCQUEEN JK, 1983, J NEUROL NEUROSUR PS, V46, P899, DOI 10.1136/jnnp.46.10.899; MURRI L, 1992, ITAL J NEUROL SCI, V13, P755, DOI 10.1007/BF02229161; RAPPORT RL, 1972, EPILEPSIA, V13, P295; RAPPORT RL, 1973, J NEUROSURG, V38, P159, DOI 10.3171/jns.1973.38.2.0159; RISH BL, 1973, J NEUROSURG, V38, P155, DOI 10.3171/jns.1973.38.2.0155; SERVIT Z, 1981, EPILEPSIA, V22, P315, DOI 10.1111/j.1528-1157.1981.tb04115.x; Temkin N R, 1991, Neurosurg Clin N Am, V2, P425; WEISS GH, 1986, ARCH NEUROL-CHICAGO, V43, P771, DOI 10.1001/archneur.1986.00520080019013; YOUNG B, 1983, J NEUROSURG, V58, P236, DOI 10.3171/jns.1983.58.2.0236; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231	23	14	14	0	0	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-4251			ZBL NEUROCHIR	Zent.bl. Neurochir.		1996	57	4					190	195					6	Neurosciences; Surgery	Neurosciences & Neurology; Surgery	WG715	WOS:A1996WG71500003	9133148				2021-06-18	
J	Schupp, W				Schupp, W			A concept for treatment, rehabilitation and care of neurological and neurosurgical patients in Germany	NERVENARZT			German	Article						neurological rehabilitation; concept of phases; neurorehabilitational; needs; delivery and chain of services		The German medical service and social support network for patients with neurological diseases and disabilities are publicly criticized as inadequate. However, the German social laws give everybody the legal right to be admitted not only for acute medical treatment but also for rehabilitation measures if they are going to be disabled and at risk of becoming dependent on care or of losing the ability to work. Rehabilitation beginning in the early stage of illness is required. Institutions are now being built up to close the gap between acute medical treatment and the beginning of comprehensive rehabilitation, especially in those neurologically severely disabled patients who need ''rehabilitation before care''. As a basis for planning to improve the situation, a study group set up by the German Pension Insurance Association (Verband Deutscher Rentenversicherer) has developed the following concept of phases in neurological and neurosurgical treatment, rehabilitation and care. The aims and tasks of each phase are defined by the patient's functional status and requirements for recovery: 1. Acute medical treatment and care in intensive care units or normal clinical wards; 2. Early rehabilitation of patients who are not really conscious or cooperative and need intermediate care services should complications arise (''early rehabilitation''); 3. Rehabilitation of patients who are conscious and able to cooperate but depend upon care for functions in activities of daily living (ADL) (''comprehensive'' or ''post-primary rehabilitation''); 4. Rehabilitation of patients who are independent in ADL functions but need comprehensive treatment for further recovery (''medical rehabilitation'' in a traditional sense); 5. Institutional or outpatient rehabilitational aftercare for vocational and/or social reintegration (''aftercare''); 6. Private or institutional care aimed at maintaining the patients' functional status (''permanent care''). Patients with severe traumatic brain injury or cerebral hypoxia often require phase B care, while those who have had a stroke and those with some other neurological diseases (e.g. multiple sclerosis) often require institutions offering phase C rehabilitation. Acute treatment, rehabilitation, care and aftercare must be connected as a chain of services. Problems of sharing the costs among the different parts of the German social insurance system has hitherto led to gaps in that chain.		Schupp, W (corresponding author), FACHKLIN ENZENSBERG,NEUROL & NEUROPSYCHOL ABT,HOHENSTR 56,D-87629 HOPFEN AM SEE,GERMANY.						BAHR E, 1994, HIRNVERLETZTER 2, P20; BAHR E, 1994, HIRNVERLETZER 1, P26; BULAU P, 1994, NERVENARZT, V65, P836; FRIES W, 1993, GESUNDHEITSWESEN, V55, pR27; GARNER C, 1994, NERVENARZT, V65, P361; GARNER C, 1995, NERVENARZT, V66, P462; GARNER C, 1994, PHYS MED REHAB KUROR, V4, P220; GRASSEL E, 1994, DEUT MED WOCHENSCHR, V119, P501, DOI 10.1055/s-2008-1058722; HAUSSLER B, 1995, IN PRESS SCHLAGANFAL; JANZIK HH, 1993, SPEKTRUM NEUROREHABI, P121; JANZIK HH, 1992, STANDARDS NEUROLOGIS; JORK K, 1993, AKTUELLE TRENDS REHA, V2, P50; KAPPOS L, 1992, NERVENARZT, V63, P581; KIRCHBERGER S, 1993, SPEKTRUM NEUROREHABI, P91; KUGELGEN B, 1993, NOT, V3, P22; LEGNER R, 1993, GESUNDHEITSWESEN, V55, pR27; MAASSEN HJ, 1990, GESETZLICHE KRANKENV; MAYER K, 1993, SPEKTRUM NEUROREHABI, P87; MUFFELMANN B, 1995, NERVENARZT, V66, P111; OSTERMANN K, 1993, DTSCH RENTENVERS, V4, P284; SCHLENCK KJ, 1993, DRV SCHRIFTEN, V2, P57; SCHONLE PW, 1995, IN PRESS REHABILITAT; SCHONLE PW, 1993, SPEKTRUM NEUROREHABI, P125; SCHONLE PW, 1993, SPEKTRUM NEUROREHABI, P133; Schupp W, 1991, Rehabilitation (Stuttg), V30, P23; SCHUPP W, 1995, IN PRESS NERVENHEILK; SCHUPP W, 1992, VERHANDLUNGEN DTSCH, V7, P867; SCHUPP W, 1994, DTSCH RENTENVERS, V11, P797; SCHUPP W, 1994, BAYER ARZTEBL, V9, P322; SCHUPP W, 1995, IN PRESS REHABILITAT; SCHUPP W, 1994, KRANKENGYMNASTIK, V46, P1310; Voss A, 1993, SPECTRUM NEUROREHABI, P112; 1993, EMPFEHLUNGEN ARBEITS; 1992, VDR STATISTIK REHABI, V101; 1995, INFORMATIONSSCHRIFT; 1994, DTSCH RENTENVERS, V2, P111; 1994, REHABILITATION BE 3B, P264	37	14	14	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-2804			NERVENARZT	Nervenarzt	DEC	1995	66	12					907	914					10	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	TM475	WOS:A1995TM47500007	8584075				2021-06-18	
J	THEODOROS, DG; MURDOCH, BE; STOKES, PD				THEODOROS, DG; MURDOCH, BE; STOKES, PD			VARIABILITY IN THE PERCEPTUAL AND PHYSIOLOGICAL FEATURES OF DYSARTHRIA FOLLOWING SEVERE CLOSED-HEAD INJURY - AN EXAMINATION OF 5 CASES	BRAIN INJURY			English	Article							VERBAL IMPAIRMENT; PARKINSONIAN DYSARTHRIA; TRAUMATIC MUTISM; SPEECH DISORDERS; SPEAKERS; RECOVERY	The perceptual and physiological features of the dysarthric speech of five severely closed-head-injured (CHI) subjects were examined in a case-by-case analysis. The five male CHI subjects included in the study were selected to reflect the range of severity and types of dysarthria evident in the CHI population. The perceptual profiles of each subject consisted of the findings of a perceptual speech analysis, the Frenchay Dysarthria Assessment (FDA) and the Assessment of the Intelligibility of Dysarthric Speakers (ASSIDS). The subjects' physiological profiles included the results of instrumental assessments of the respiratory, laryngeal, velopharyngeal and articulatory subsystems of the speech-production mechanism. The case studies highlighted the variability among the individual subjects with respect to the location, physiological nature, and severity of the impairment in their speech-production mechanisms. In addition, the interdependence of the various speech subsystems in determining speech outcome, the presence of differential subsystem impairment in dysarthria following CHI, and the varied therapeutic requirements ofthe individual subjects were identified. Clinically, the case studies highlighted the importance of developing individual treatment programmes based on comprehensive perceptual and physiological evaluations of the speech mechanism in each CHI subject with dysarthric speech.	UNIV QUEENSLAND,DEPT SPEECH & HEARING,MOTOR SPEECH RES UNIT,BRISBANE,QLD 4072,AUSTRALIA			Theodoros, Deborah/F-1362-2010; Murdoch, Bruce E/C-1397-2012				ARONSON AE, 1968, J SPEECH HEAR DISORD, V33, P203, DOI 10.1044/jshd.3303.203; ARONSON AE, 1986, J SPEECH HEAR DISORD, V33, P219; BASSICH CJ, 1986, J SPEECH HEAR DISORD, V51, P125, DOI 10.1044/jshd.5102.125; BELLAIRE K, 1986, J COMMUN DISORD, V19, P271, DOI 10.1016/0021-9924(86)90033-X; BLAUSTEIN S, 1983, J COMMUN DISORD, V16, P157, DOI 10.1016/0021-9924(83)90046-1; BRANCEWICZ TM, 1989, J SPEECH HEAR RES, V32, P837, DOI 10.1044/jshr.3204.837; BZOCH KR, 1989, COMMUNICATIVE DISORD, P137; Darley F., 1975, MOTOR SPEECH DISORDE; FEX S, 1992, J VOICE, V6, P155, DOI 10.1016/S0892-1997(05)80130-4; FROKJAERJENSEN B, C INT ASS LOGOPEDICS; HANSON DG, 1983, ANN OTO RHINOL LARYN, V92, P413, DOI 10.1177/000348948309200501; HARDCASTLE WJ, 1991, BRIT J DISORD COMMUN, V26, P41; HARTMAN DE, 1984, ANN OTO RHINOL LARYN, V93, P57, DOI 10.1177/000348948409300114; HIROSE H, 1986, FOLIA PHONIATR, V38, P61, DOI 10.1159/000265824; HIROSE H, 1982, FOLIA PHONIATR, V34, P210, DOI 10.1159/000265651; HOODIN RB, 1989, FOLIA PHONIATR, V41, P249, DOI 10.1159/000265976; KENT R, 1978, J SPEECH HEAR DISORD, V42, P353; KENT RD, 1982, BRAIN LANG, V15, P259, DOI 10.1016/0093-934X(82)90060-8; LABLANCE G R, 1991, Ear Nose and Throat Journal, V70, P691; LEVIN HS, 1981, ACQUIRED APHASIA, P427; Ludlow C., 1983, CLIN DYSARTHRIA, P121; MCCLEAN MD, 1987, J SPEECH HEAR RES, V30, P276, DOI 10.1044/jshr.3002.276; Moncur JP, 1974, MODIFYING VOCAL BEHA; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; Murdoch B. E., 1987, AUSTR J HUMAN COMMUN, V15, P15; MURDOCH BE, 1993, BRAIN INJURY, V7, P295, DOI 10.3109/02699059309034956; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; NETSELL R, 1975, J SPEECH HEAR DISORD, V40, P170, DOI 10.1044/jshd.4002.170; NETSELL R, 1969, J SPEECH HEAR DISORD, V34, P113, DOI 10.1044/jshd.3402.113; NETSELL R, 1979, ARCH PHYS MED REHAB, V60, P502; NETSELL R, 1989, RECENT ADV CLIN DYSA, P4; NETSELL R, 1984, SEMINARS SPEECH LANG, V5, P279; RUSK H, 1969, LATE EFFECTS HEAD IN, P327; Sarno M, 1985, SPEECH LANGUAGE EVAL, P323; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; Sherman D, 1954, J SPEECH HEAR DISORD, V19, P312, DOI 10.1044/jshd.1903.312; THEODOROS D, 1993, BRAIN INJURY, V7, P59, DOI 10.3109/02699059309008157; THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; THEODOROS DG, 1994, BRAIN INJURY, V8, P667, DOI 10.3109/02699059409151021; THEODOROS DG, IN PRESS BRAIN INJUR, V9; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; VOGEL M, 1983, FOLIA PHONIATR, V35, P294, DOI 10.1159/000265705; VONCRAMON D, 1981, NEUROPSYCHOLOGIA, V19, P801, DOI 10.1016/0028-3932(81)90092-0; Weismer G., 1984, SEMINARS SPEECH LANG, V5, P293; ZIEGLER W, 1988, BRIT J DISORD COMMUN, V23, P215	48	14	14	0	4	TAYLOR & FRANCIS LTD LONDON	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	OCT	1995	9	7					671	696		10.3109/02699059509008225			26	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	RZ814	WOS:A1995RZ81400002	8680396				2021-06-18	
J	HAMM, RJ; PIKE, BR; PHILLIPS, LL; ODELL, DM; TEMPLE, MD; LYETH, BG				HAMM, RJ; PIKE, BR; PHILLIPS, LL; ODELL, DM; TEMPLE, MD; LYETH, BG			IMPAIRED GUSTATORY NEOPHOBIA FOLLOWING TRAUMATIC BRAIN INJURY IN RATS	JOURNAL OF NEUROTRAUMA			English	Article						AMYGDALA; GUSTATORY NEOPHOBIA; HIPPOCAMPUS; RATS; TRAUMATIC BRAIN INJURY	HEAD-INJURY; AMYGDALA; MEMORY; HIPPOCAMPUS; DEFICITS; LESIONS; SITES	To investigate the function of the amygdala following traumatic brain injury (TBI), rats were tested on a gustatory neophobia task that is sensitive to amygdala and hippocampaI damage. Rats were either injured at a moderate level of fluid percussion injury (2.1 atm) or surgically prepared but not injured (sham-injury). Seven days after injury (n = 8) or sham injury (n = 9), rats were habituated to the testing chamber without food items present for 30 min. All rats were then food deprived. Twenty-four hours later, rats were placed in the testing chamber for 30 min and allowed to eat freely from four dishes of different foods: rat chow, raisins, potatoes, and cookies. Results showed that injured and sham-injured rats did not differ in their ability to find hidden food, suggesting that TBI does not produce an enduring impairment of olfaction. There was also no difference in the total amount of food eaten between injured and sham groups (p > 0.05). The percentage of each type of food consumed did differ between the two groups with sham controls consuming more familiar food (rat chow) compared to the unfamiliar foods (p < 0.01). The injured animals distributed their eating evenly among the four foods with no particular preference for any one food (p > 0.05). This pattern of eating behavior in injured animals is similar to animals that have lesions to both the hippocampus and amygdala (Sutherland and McDonald, 1990). Therefore, the results of this experiment suggest that, in addition to the hippocampus, the amygdala may also contribute to the behavioral changes observed following TBI.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DIV NEUROSURG,RICHMOND,VA 23284	HAMM, RJ (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PSYCHOL,POB 842018,RICHMOND,VA 23284, USA.			Lyeth, Bruce/0000-0003-4811-1474	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-12857] Funding Source: Medline		Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Delahunty T. M., 1993, Society for Neuroscience Abstracts, V19, P1879; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; GREENAMYRE JT, 1985, J PHARMACOL EXP THER, V233, P254; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, BEHAV BRAIN RES, V59, P169; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KESNER RP, 1988, NEUROBIOL AGING, V9, P609, DOI 10.1016/S0197-4580(88)80122-2; KESNER RP, 1991, ACTIVATION ACQUISITI, P263; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; NACHMAN M, 1974, J COMP PHYSIOL PSYCH, V80, P622; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OLTON DS, 1978, BRAIN RES, V233, P241; RAY M H, 1991, Society for Neuroscience Abstracts, V17, P167; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROLLS ET, 1973, J COMP PHYSIOL PSYCH, V83, P248, DOI 10.1037/h0034414; ROSEN JB, 1988, PHYSIOL BEHAV, V44, P117, DOI 10.1016/0031-9384(88)90354-X; SARTER M, 1985, BEHAV NEUROSCI, V99, P342, DOI 10.1037/0735-7044.99.2.342; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Wenk G. L., 1987, ANIMAL MODELS DEMENT, P81, DOI [10.1016/j.expneurol.2005.06.020, DOI 10.1016/J.EXPNEUROL.2005.06.020]	31	14	15	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	1995	12	3					307	314		10.1089/neu.1995.12.307			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	RM331	WOS:A1995RM33100008	7473805				2021-06-18	
J	PRIGATANO, GP				PRIGATANO, GP			1994 BERROL,SHELDON, MD, SENIOR LECTURESHIP - THE PROBLEM OF LOST NORMALITY AFTER BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	13th Annual National Head-Injury-Foundation Conference	NOV   06, 1994	CHICAGO, IL	Head Injury Fdn		PSYCHOLOGICAL JUDGMENT; REHABILITATION; BRAIN INJURY	CLOSED HEAD-INJURY	The significant losses in higher cerebral functioning caused by moderate to severe traumatic brain injury (TBI) can leave patients frustrated and confused. A central issue in working with these individuals is to help them deal with the problem of lost normality. Impaired self-awareness, as well as denial of disability, can contribute to this problem. Helping individuals establish meaning in their life in the face of (not despite) their impairments has benefited some individuals. A brief conceptualization of the problem of lost normality is presented, and the role of neuropsychological rehabilitation in dealing with this problem is outlined.		PRIGATANO, GP (corresponding author), ST JOSEPHS HOSP,BARROW NEUROL INST,NEUROPSYCHOL SECT,PHOENIX,AZ 85013, USA.						Ben-Yishay Y, 1990, REHABILITATION ADULT; Berg I. J., 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI [DOI 10.1080/09602019108401384, 10.1080/09602019108401384]; CAMPBELL J, 1989, HERO WITH 1000 FACES; COEN CW, 1985, FUNCTIONS BRAIN; FRANZEN EA, 1973, NEUROPSYCHOLOGIA, V11, P141, DOI 10.1016/0028-3932(73)90002-X; GINSBURG SW, 1955, COMMUNICATION PROGRA; Goldstein K., 1942, AFTEREFFECTS BRAIN I; JAHODA M, 1955, COMMUNITY PROGRAMS M; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; JUNG CG, 1957, BOLLINGER SERIES, V20, P16; Keppel G., 1989, DATA ANAL RES DESIGN; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KLONOFF P, IN PRESS J HEAD TRAU; Kozloff R, 1987, J HEAD TRAUMA REHAB, V2, P14, DOI DOI 10.1097/00001199-198709000-00004; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Peck MS., 1978, ROAD LESS TRAVELED; PRIGATANO G, 1994, BRAIN INJURY NEUROPS; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G. P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 1991, J HEAD TRAUMA REHAB, V6, P1; Prigatano G. P., 1994, J HEAD TRAUMA REHAB, V9, P91, DOI [DOI 10.1097/00001199-199403000-00011, 10.1097/00001199-199403000-00011]; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; PRIGATANO GP, 1992, AUG AM PSYCH ASS CEN; PRIGATANO GP, 1991, FRONTAL LOBE FUNCTIO; PRIGATANO GP, IN PRESS BEHAVIORAL; PRIGATANO GP, IN PRESS NEUROPSYCHO; Watzlawick P., 1983, REAL IS REAL; ZIMMERMAN RA, 1989, NEUROPSYCHOLOGY, V3, P189; 1994, PARADE MAGAZINE 0911	32	14	14	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1995	10	3					87	95					9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	RC717	WOS:A1995RC71700008					2021-06-18	
J	DELAHUNTY, TM; JIANG, JY; BLACK, RT; LYETH, BG				DELAHUNTY, TM; JIANG, JY; BLACK, RT; LYETH, BG			DIFFERENTIAL MODULATION OF CARBACHOL AND TRANS-ACPD-STIMULATED PHOSPHOINOSITIDE TURNOVER FOLLOWING TRAUMATIC BRAIN INJURY	NEUROCHEMICAL RESEARCH			English	Article						MUSCARINIC RECEPTOR; METABOTROPIC GLUTAMATE RECEPTOR; INOSITOL PHOSPHATES; HIPPOCAMPUS; TRAUMATIC BRAIN INJURY	METABOTROPIC GLUTAMATE-RECEPTOR; INOSITOL PHOSPHOLIPID HYDROLYSIS; EXCITATORY AMINO-ACIDS; LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; KINDLED RATS; RELEASE; SLICES; ENHANCEMENT; POTASSIUM	In the fluid percussion model of traumatic brain injury (TBI), we examined muscarinic and metabotropic glutamate receptor-stimulated polyphosphoinositide (PPI) turnover in rat hippocampus. Moderate injury was obtained by displacement and deformation of the brain within the closed cranial cavity using a fluid percussion device. Carbachol and(+/-)-1-Aminocyclopentane-trans-1,3-dicarboxylic acid (trans-ACPD)-stimulated PPI hydrolysis was assayed in hippocampus from injured and sham-injured controls at both 1 hour and 15 days following injury. At 1 hour after TBI, the response to carbachol was enhanced in injured rats by up to 200% but the response to trans-ACPD was diminished by as much as 28%. By contrast, at 15 days after TBI, the response to carbachol was enhanced by 25% and the response to trans-ACPD was enhanced by 73%. The ionotropic glutamate agonists N-methyl-D-aspartate (NMDA), and alpha-amino-3 hydroxy-5-methyl-4-isoxazolepropionate (AMPA), did not increase PPI hydrolysis in either sham or injured rats and injury did not alter basal hydrolysis. Thus, hippocampal muscarinic and metabotropic receptors linked to phospholipase C are differentially altered by TBI.		DELAHUNTY, TM (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,BOX 693,MCV STN RICHMOND,RICHMOND,VA 23298, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029995, P01NS012587, P50NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 07288, NS 29995, NS 12587] Funding Source: Medline		AKIYAMA K, 1992, BRAIN RES, V569, P71, DOI 10.1016/0006-8993(92)90370-O; ARONICA E, 1991, J NEUROCHEM, V57, P376, DOI 10.1111/j.1471-4159.1991.tb03763.x; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; BIRELL GJ, 1993, NEUROPHARMACOLOGY, V32, P1351; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; CHEN CK, 1988, J NEUROCHEM, V51, P353, DOI 10.1111/j.1471-4159.1988.tb01046.x; CHOU C-L, 1991, Society for Neuroscience Abstracts, V17, P722; DELAHUNTY TM, 1988, BIOCHEM J, V255, P69, DOI 10.1042/bj2550069; DELAHUNTY TM, 1992, BRAIN RES, V594, P307, DOI 10.1016/0006-8993(92)91140-A; DEWITT DS, 1988, ANESTHESIOLOGY REV, V15, P31; DIAMANT S, 1990, NEUROSCI LETT, V109, P140, DOI 10.1016/0304-3940(90)90552-K; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1992, ROLE OF NEUROTRANSMITTERS IN BRAIN INJURY, P213; DIXON CE, 1993, J NEUROTRAUM, V10, pS209; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAROOQUI AA, 1991, BRAIN RES REV, V16, P171, DOI 10.1016/0165-0173(91)90004-R; GORMAN LK, 1989, J NEUROTRAUM, V6, P203; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HERRERO I, 1994, EUR J NEUROSCI, V6, P115, DOI 10.1111/j.1460-9568.1994.tb00253.x; HERRERO I, 1994, NATURE, V360, P163; Jenkins LW, 1988, J NEUROTRAUM, V5, P275, DOI 10.1089/neu.1988.5.275; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOH JY, 1991, P NATL ACAD SCI USA, V88, P9431, DOI 10.1073/pnas.88.21.9431; LIPARTITI M, 1993, LIFE SCI, V52, P85; LITTMAN L, 1993, J NEUROCHEM, V61, P586; LOMBARDI G, 1993, BRIT J PHARMACOL, V110, P1407, DOI 10.1111/j.1476-5381.1993.tb13977.x; LOVINGER DM, 1993, J NEUROPHYSIOL, V69, P1236; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYETH BG, 1992, J NEUROTRAUMA S2, V9, P463; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MOUNT HTJ, 1993, J NEUROSCI, V13, P3173; NICOLETTI F, 1988, J NEUROCHEM, V51, P725, DOI 10.1111/j.1471-4159.1988.tb01804.x; PEARCE B, 1986, EUR J PHARMACOL, V121, P231, DOI 10.1016/0014-2999(86)90494-2; PIZZI M, 1993, J NEUROCHEM, V61, P683; PRASAD RM, 1994, J NEUROCHEM, V63, P773; ROBINSON SE, 1990, BRAIN RES, V509, P41, DOI 10.1016/0006-8993(90)90306-V; SCHOEPP DD, 1991, J NEUROCHEM, V56, P1789, DOI 10.1111/j.1471-4159.1991.tb02082.x; SCHOEPP DD, 1994, NEUROCHEM INT, V24, P439, DOI 10.1016/0197-0186(94)90092-2; SEREN MS, 1989, J NEUROCHEM, V53, P1700, DOI 10.1111/j.1471-4159.1989.tb09233.x; TIGER G, 1990, NEUROSCI LETT, V115, P243, DOI 10.1016/0304-3940(90)90462-I; ZHANG WQ, 1990, NEUROSCI LETT, V118, P57, DOI 10.1016/0304-3940(90)90248-8	47	14	14	0	0	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0364-3190			NEUROCHEM RES	Neurochem. Res.	APR	1995	20	4					405	411					7	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	QY040	WOS:A1995QY04000006	7651577				2021-06-18	
J	ASGEIRSSON, B; GRANDE, PO; NORDSTROM, CH				ASGEIRSSON, B; GRANDE, PO; NORDSTROM, CH			THE LUND CONCEPT OF POSTTRAUMATIC BRAIN EDEMA THERAPY	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article; Proceedings Paper	23rd Congress of the Scandinavian-Society-of-Anaesthesiologists	JUN 12-16, 1995	REYKJAVIK, ICELAND	Scandinavian Soc Anaesthesiologists			INTRACRANIAL-PRESSURE; HEAD-INJURY	A new therapy of post-traumatic brain oedema has recently been introduced into clinical practice at the University Hospital of Lund, Sweden (1). This therapy is based on basal physiological principles, presuming that an important part of post-traumatic brain swelling is due to extracellular oedema, in turn caused by disturbance of the normal volume regulation of the brain. Thus, the aim of therapy is to prevent brain herniation by keeping intracranial pressure (ICP) at a safe level until the normal volume regulating mechanisms of the brain, namely the semi-permeable blood-brain barrier (BBB) and cerebrovascular autoregulation, have been restored. Tn clinical practice, this concept has dramatically improved outcome in severely head injured patients, when compared to historical control groups.	LUND UNIV,DEPT NEUROSURG,LUND,SWEDEN; LUND UNIV,DEPT ANAESTHESIA & INTENS CARE,LUND,SWEDEN	ASGEIRSSON, B (corresponding author), UNIV LUND HOSP,DEPT ANAESTHESIA & INTENS CARE,S-22185 LUND,SWEDEN.						ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P567, DOI 10.1007/BF01705723; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; ASGEIRSSON B, 1995, IN PRESS ACTA ANAEST; BOUMA GJ, 1990, J NEUROSURG, V73, P368, DOI 10.3171/jns.1990.73.3.0368; CANCIO LC, 1994, RESUSCITATION, V28, P9, DOI 10.1016/0300-9572(94)90049-3; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; Guyton AC, 1991, TXB MED PHYSL; HARIRI RJ, 1993, J NEUROSURG, V79, P421, DOI 10.3171/jns.1993.79.3.0421; HAYASHI Y, 1993, BRIT J ANAESTH, V71, P108, DOI 10.1093/bja/71.1.108; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; PAPPIUS HM, 1989, IMPLICATIONS BLOOD B, P293; ROTH B, 1993, INTENS CARE MED, V19, P111, DOI 10.1007/BF01708372; SCHALEN W, 1992, ACTA ANAESTH SCAND, V36, P369, DOI 10.1111/j.1399-6576.1992.tb03483.x; SCHALEN W, 1991, ACTA ANAESTH SCAND, P113; SIMARD JM, 1989, AM J CARDIOL, V63, pC32, DOI 10.1016/0002-9149(89)90403-7; TODD NV, 1990, ACT NEUR S, V51, P296; TRANMER BI, 1989, NEUROSURGERY, V25, P173, DOI 10.1227/00006123-198908000-00004	20	14	15	0	1	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.		1995	39			105			103	106		10.1111/j.1399-6576.1995.tb04285.x			4	Anesthesiology	Anesthesiology	RN486	WOS:A1995RN48600028					2021-06-18	
J	CRONQVIST, AKA; KALLMAN, P; TURESSON, I; BRAHME, A				CRONQVIST, AKA; KALLMAN, P; TURESSON, I; BRAHME, A			VOLUME AND HETEROGENEITY DEPENDENCE OF THE DOSE-RESPONSE RELATIONSHIP FOR HEAD AND NECK TUMORS	ACTA ONCOLOGICA			English	Article							RADIATION-THERAPY; NASOPHARYNGEAL CARCINOMA; EPIDERMOID CARCINOMA; TIME; OPTIMIZATION; RADIOTHERAPY; MANAGEMENT; INJURY; TUMORS; CORD	Based on the Poisson statistics of cell kill a model for the response of heterogeneous tumours to non-uniform dose delivery have been developed. The five parameters required to characterize the response are the 50% response dose, D-50, the normalized dose-response gradient, gamma, the tumour heterogeneity factor, h, the relative volume, upsilon and the extra daily dose required to counteract the tumour cell proliferation, delta. The model has been fitted to data from a number of clinical investigations to allow the derivation of clinically relevant radiation response parameters for head and neck tumours. The D-50 value for T2 larynx cancers is 59.9 Gy in 41 days with a relative standard deviation of 2.1 Gy and the gamma value is 2.9 with a relative standard deviation of 0.3. The value of delta, which is most consistent with the clinical data for laryngeal tumours, is 0.35 Gy/day and this value should be used if the treatment time is changed from the 41 days normalization. The heterogeneity factor, h, is close to zero for laryngeal tumours which indicates that their response is basically governed by Poisson statistics. Nasopharyngeal tumours, on the other hand, exhibit h values around 0.2 which indicates that these tumours are more heterogeneous in their internal organization and so are their responses to radiation.	KAROLINSKA INST,DEPT MED RADIAT PHYS,STOCKHOLM,SWEDEN; UNIV STOCKHOLM,STOCKHOLM,SWEDEN; GOTHENBURG UNIV,SAHLGRENS HOSP,DEPT ONCOL,S-41345 GOTHENBURG,SWEDEN							AGREN A, 1990, INT J RADIAT ONCOL, V19, P1077, DOI 10.1016/0360-3016(90)90037-K; AGREN AK, 1994, IN PRESS MODELLING C; ARISTIZABAL SA, 1972, RADIOLOGY, V130, P419; BEDWINEK JM, 1980, CANCER, V45, P2725, DOI 10.1002/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO;2-1; BRAHME A, 1987, ACTA ONCOL, V26, P377, DOI 10.3109/02841868709104364; BRAHME A, 1984, ACTA RADIOL ONCOL, V23, P379, DOI 10.3109/02841868409136037; BRAHME A, 1995, RAD THERAPY PHYSICS; BRAHME A, 1994, ION BEAM THERAPY; Brahme A, 1988, ACTA ONCOL S, V1, P5; COHEN L, 1960, AMER J ROENTGENOL RA, V84, P741; COHEN L, 1982, INT J RADIAT ONCOL, V8, P2173, DOI 10.1016/0360-3016(82)90565-X; DUTREIX J, 1988, RADIOTHER ONCOL, V11, P239, DOI 10.1016/0167-8140(88)90006-0; HARWOOD AR, 1983, INT J RADIAT ONCOL, V9, P311, DOI 10.1016/0360-3016(83)90289-4; HENDRY JH, 1992, RADIOTHER ONCOL, V25, P308, DOI 10.1016/0167-8140(92)90252-P; HENDRY JH, 1994, RADIOTHER ONCOL, V31, P14, DOI 10.1016/0167-8140(94)90409-X; HJELMHANSEN M, 1979, ACTA RADIOL ONCOL, V18, P385, DOI 10.3109/02841867909128225; JENKIN RDT, 1981, CANCER, V47, P360, DOI 10.1002/1097-0142(19810115)47:2<360::AID-CNCR2820470225>3.0.CO;2-3; KALLMAN P, 1992, INT J RADIAT BIOL, V62, P249, DOI 10.1080/09553009214552071; KIM JC, 1978, CANCER, V42, P1114, DOI 10.1002/1097-0142(197809)42:3<1114::AID-CNCR2820420312>3.0.CO;2-3; LINDBORG L, 1990, RADIAT RES, V124, P23; METZ CE, 1982, INT J RADIAT ONCOL, V8, P1185, DOI 10.1016/0360-3016(82)90066-9; ROBERTSON AG, 1993, EUR J CANCER, V29A, P501, DOI 10.1016/S0959-8049(05)80139-X; SHUKOVSKY LJ, 1970, AMER J ROENTGENOL RA, V108, P27, DOI 10.2214/ajr.108.1.27; SLEVIN NJ, 1992, RADIOTHER ONCOL, V24, P215, DOI 10.1016/0167-8140(92)90226-K; SODERSTROM S, 1995, INT J RADIAT ONCOL B; STEWART JG, 1975, LARYNGOSCOPE, V85, P1107, DOI 10.1288/00005537-197507000-00001; THAMES HD, 1980, BRIT J CANCER, V41, P35; THAMES HD, 1992, INT J RADIAT ONCOL, V22, P241, DOI 10.1016/0360-3016(92)90039-K; TILIKIDIS A, 1994, ACTA ONCOL, V33, P457, DOI 10.3109/02841869409098443; TOKARS RP, 1979, INT J RADIAT ONCOL, V5, P1741, DOI 10.1016/0360-3016(79)90555-8; TRAVIS EL, 1987, INT J RADIAT ONCOL, V13, P283, DOI 10.1016/0360-3016(87)90141-6; TURESSON I, 1992, CLIN RATIONALE HIGH; WITHERS HR, 1988, ACTA ONCOL, V27, P131, DOI 10.3109/02841868809090333; WITHERS HR, 1992, PRINCIPLES PRACTICE, P67; WOLBARST AB, 1984, INT J RADIAT ONCOL, V10, P741, DOI 10.1016/0360-3016(84)90305-5; YAN JH, 1989, INT J RADIAT ONCOL, V16, P1465, DOI 10.1016/0360-3016(89)90950-4	36	14	14	0	0	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0284-186X			ACTA ONCOL	Acta Oncol.		1995	34	6					851	860		10.3109/02841869509127196			10	Oncology	Oncology	RZ612	WOS:A1995RZ61200022		Bronze			2021-06-18	
J	YAKUBU, A; MABOGUNJE, OA				YAKUBU, A; MABOGUNJE, OA			SKIN-CANCER IN ZARIA, NIGERIA	TROPICAL DOCTOR			English	Article								Skin cancer from 775 patients in the savannah showed a preponderance of squamous cell carcinoma (SCC) of the leg related to neglected, poorly managed and chronic ulcers or scars from burns or injuries. SCC of the head and neck had no predisposing factor. Malignant melanoma overwhelmingly affected the feet, dermatofibrosarcoma affected the trunk and Kaposi sarcoma affected the limbs. Basal cell carcinoma (BCC) comprised only 2% of all skin cancers. The 18 albino patients had a higher frequency of both SCC and BCC mostly on the head and neck. Excisional surgery was generally effective, the wounds being closed primarily or by means of flaps and skin grafts. However, 98 patients required amputation below the knee for tibial involvement by SCC. The prognosis and health care costs of skin cancer will only be improved if burns and injuries are adequately treated.	AHMADU BELLO UNIV HOSP,DEPT SURG,ZARIA,NIGERIA								0	14	14	0	3	ROYAL SOC MEDICINE SERVICES LTD	LONDON	1 WIMPOLE STREET, LONDON, ENGLAND W1M 8AE	0049-4755			TROP DOCT	Trop. Dr.		1995	25			1			63	67		10.1177/00494755950250S120			5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	QH900	WOS:A1995QH90000020	7879275				2021-06-18	
J	DONALD, PJ				DONALD, PJ			FRONTOBASAL APPROACH FOR TRAUMA AND TUMOR	MINIMALLY INVASIVE NEUROSURGERY			English	Article						FRONTOBASAL SURGERY; FRONTAL SINUS TRAUMA; SINUS MALIGNANCY		The potential for remediation of a host of varied disease processes afflicting the skull base has been increasingly realized over the past two decades, Advances in medical technology, the development of new approaches, and most importantly the close cooperation of the head and neck surgeon and the neurological surgeon have made this possible, Surgeons are attempting to diminish the injury to normal uninvolved structures while at the same time maximizing exposure and enabling rectification of the disease or disorder, This is especially pertinent in a number of frontobasal approaches used in anterior craniofacial surgery, The osteoplastic flap approach to the posterior wall of the frontal sinus to repair small cerebrospinal fluid leaks and manage posterior wall fractures saves the patient a larger anterior craniotomy and brain retraction. Cranialization of the frontal sinus in comminuted through-and-through fractures allows for removal of devitalized brain, dural repair, and safe management of the frontal sinus, The lateral rhinotomy medial maxillectomy-ethmosphenoidectomy approach coupled with either an osteoplastic flap of the frontal sinus or a low limited craniotomy is an excellent approach for resection of tumors encroaching on the anterior skull base. Even malignancies of this region can be completely excised with adequate margins, yet produce minimal to no facial aesthetic distortion, Moreover, larger tumors requiring a more extensive lip-splitting incision and total maxillectomy with orbital exenteration can often anticipate minimal deformity, especially with good prosthetic rehabilitation. In the resection of aggressive malignancies, techniques of ocular preservation and facial bone sparing have been developed with encouraging cosmetic results.	UNIV CALIF DAVIS,DEPT OTOLARYNGOL HEAD & NECK SURG,DAVIS,CA 95616; UNIV CALIF DAVIS,CTR SKULL BASE SURG,DAVIS,CA 95616							ALLIS A, 1979, LARYNGOSCOPE, V98, P557; DONALD PJ, 1979, OTOLARYNG HEAD NECK, V87, P557, DOI 10.1177/019459987908700502; DONALD PJ, 1978, LARYNGOSCOPE, V88, P225, DOI 10.1288/00005537-197802000-00002; GANDOUREDWARDS RF, 1993, HEAD NECK-J SCI SPEC, V15, P373, DOI 10.1002/hed.2880150502	4	14	16	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0942-6027			MINIM INVAS NEUROSUR	Minim. Invasive Neurosurg.	DEC	1994	37	2					37	41		10.1055/s-2008-1053446			5	Clinical Neurology; Neuroimaging; Surgery	Neurosciences & Neurology; Surgery	RU576	WOS:A1994RU57600001	7882073				2021-06-18	
J	RICHARDSON, ED; SPRINGER, JA; VARNEY, NR; STRUCHEN, MA; ROBERTS, RJ				RICHARDSON, ED; SPRINGER, JA; VARNEY, NR; STRUCHEN, MA; ROBERTS, RJ			DICHOTIC-LISTENING IN THE CLINIC - NEW NEUROPSYCHOLOGICAL APPLICATIONS	CLINICAL NEUROPSYCHOLOGIST			English	Article							EAR EXTINCTION; MULTIPLE-SCLEROSIS; CEREBRAL MALARIA; CORPUS-CALLOSUM; PERFORMANCE	In the first part of this study, a simple dichotic word listening task was administered to 275 normal control subjects. Normative data demonstrated that age and gender both had significant effects on dichotic listening performance (i.e., females outperformed males, and younger adults did better than older adults). In the second part of this study, clinical observations on three patient populations (status--post closed-head injury, cerebral malaria survivors, and Parkinson Disease) demonstrated significantly poorer dichotic listening performance relative to controls. Overall, the results suggest that, when normative observations are systematically collected, dichotic listening tasks may become useful adjuncts to traditional neuropsychological assessments. Dichotic listening may be particularly useful in demonstrating cerebral dysfunction in a wider variety of neurologically impaired patients than has commonly been assumed.	UNIV CINCINNATI,CINCINNATI,OH 45221; YALE UNIV,SCH MED,NEW HAVEN,CT 06510; UNIV HOUSTON,HOUSTON,TX 77004; VET ADM MED CTR,IOWA CITY,IA 52240							ARBOIX A, 1990, ACTA NEUROL SCAND, V81, P507; BARTLETT EJ, 1987, BRAIN LANG, V32, P1, DOI 10.1016/0093-934X(87)90115-5; BLONDER LX, 1987, J CLIN EXP NEUROPSYC, V9, P20; BOUMA A, 1988, J CLIN EXP NEUROPSYC, V10, P709, DOI 10.1080/01688638808402809; DAMASIO H, 1979, NEUROLOGY, V29, P644, DOI 10.1212/WNL.29.5.644; Forrester ATW, 1920, LANCET, V1, P16; Hugdahl K, 1988, HDB DICHOTIC LISTENI; JACOBSON JT, 1983, EAR HEARING, V4, P311, DOI 10.1097/00003446-198311000-00009; JERGER J, 1975, SCAND AUDIOL, V4, P147, DOI DOI 10.3109/01050397509043077; KIMURA D, 1961, CAN J PSYCHOLOGY, V15, P156, DOI 10.1037/h0083218; KREMEN WS, 1992, J NERV MENT DIS, V180, P89, DOI 10.1097/00005053-199202000-00004; LEVIN HS, 1989, J NEUROL NEUROSUR PS, V52, P1162, DOI 10.1136/jnnp.52.10.1162; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MOHR E, 1990, J CLIN EXP NEUROPSYC, V12, P235, DOI 10.1080/01688639008400970; MUSIEK F, 1983, MONOGRAPHS CONT AUDI, V4, P1; PUJOL J, 1991, NEUROPSYCHOLOGIA, V29, P177, DOI 10.1016/0028-3932(91)90019-5; RAO SM, 1989, ARCH NEUROL-CHICAGO, V46, P918, DOI 10.1001/archneur.1989.00520440114028; RISSE GL, 1989, ARCH NEUROL-CHICAGO, V46, P437, DOI 10.1001/archneur.1989.00520400097026; Roberts RJ, 1990, NEUROPSYCHOLOGY, V4, P65; ROBERTS RJ, 1990, J CLIN EXP NEUROPSYC, V12, P448, DOI 10.1080/01688639008400992; Sparks R, 1970, Cortex, V6, P249; Sparks R., 1968, CORTEX, V4, P3, DOI DOI 10.1016/S0010-9452(68)80009-7; SPICER KB, 1988, ARCH NEUROL-CHICAGO, V45, P429, DOI 10.1001/archneur.1988.00520280079019; SPRINGER JA, 1991, J NERV MENT DIS, V179, P459, DOI 10.1097/00005053-199108000-00002; SPRINGER SP, 1975, NEUROPSYCHOLOGIA, V13, P341, DOI 10.1016/0028-3932(75)90011-1; TORO G, 1978, ARCH NEUROL-CHICAGO, V35, P271, DOI 10.1001/archneur.1978.00500290017004; VERDUYN W H, 1992, Brain Injury, V6, P245, DOI 10.3109/02699059209029666; WILLIAMS SM, 1989, CORTEX, V25, P523, DOI 10.1016/S0010-9452(89)80067-X	28	14	14	0	2	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0920-1637			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	DEC	1994	8	4					416	428		10.1080/13854049408402044			13	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	PX792	WOS:A1994PX79200005					2021-06-18	
J	ZIELINSKI, JJ				ZIELINSKI, JJ			MALINGERING AND DEFENSIVENESS IN THE NEUROPSYCHOLOGICAL ASSESSMENT OF MILD TRAUMATIC BRAIN INJURY	CLINICAL PSYCHOLOGY-SCIENCE AND PRACTICE			English	Article						MALINGERING; DEFENSIVENESS; NEUROPSYCHOLOGICAL ASSESSMENT; TRAUMATIC BRAIN INJURY	MINOR HEAD-INJURY; FAKING; MMPI; DEFICITS; SYMPTOMS; PROSPECTS; DISORDERS; SEQUELAE	A balanced approach to the detection of malingering and defensiveness in the neuropsychological assessment of mild traumatic brain injury (MTBI) is suggested, while genuine neurobehavioral and psychopathological sequelae are documented. The absence of neuroradiological evidence and heavy reliance on patient report and neuropsychological test data make malingering and defensiveness issues that are critical in forensic contexts and for the credibility of neuropsychology. Deficiencies in interview data collection and the relative strengths and weaknesses of the MMPI (Minnesota Multiphasic Personality Inventory) are reviewed. The potential independence of malingering and defensiveness and of MMPI and neuropsychological data are noted. The equivocal research on malingering is reviewed, with particular emphasis on assessment of memory deficits as one of the most common complaints in MTBI. Arguably, malingering is more similar to than different from other diagnoses, but it has not been so treated in clinical practice. The need for developing sophisticated malingering probes is acknowledged, but the quest for a single malingering test is criticized and preference given to approaches that rely on evaluating data patterns indicating malingering.								ADAMS KB, 1992, 27TH WORKSH COND ANN; Alfano Dennis P, 1990, Clin Neuropsychol, V4, P69, DOI 10.1080/13854049008401498; Alfano Dennis P, 1992, Clin Neuropsychol, V6, P134, DOI 10.1080/13854049208401850; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ARKES HR, 1990, PROFESSIONAL PSYCHOL, V21, P3; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BERNARD LC, 1990, J CLIN EXP NEUROPSYC, V12, P715, DOI 10.1080/01688639008401014; BERRY DTR, 1991, CLIN PSYCHOL REV, V11, P585, DOI 10.1016/0272-7358(91)90005-F; BIGLER ED, 1990, J CONSULT CLIN PSYCH, V58, P244, DOI 10.1037/0022-006X.58.2.244; Binder Laurence M, 1990, Clin Neuropsychol, V4, P25, DOI 10.1080/13854049008401494; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BINDER LM, 1987, J CLIN EXP NEUROPSYC, V9, P167, DOI 10.1080/01688638708405357; BOHNEN N, 1992, J NERV MENT DIS, V180, P683, DOI 10.1097/00005053-199211000-00002; BOHNEN N, 1993, NEUROPSY NEUROPSY BE, V6, P193; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BORNSTEIN RA, 1988, NEUROSURGERY, V23, P622, DOI 10.1227/00006123-198811000-00013; CICERONE KD, 1992, PHYSICAL MED REHABIL, V6, P129; Cullum C, 1991, FORENSIC NEUROPSYCHO, P141; Dahlstrom W. G., 1972, MMPI HDB, V1; DAHLSTROM WG, 1980, BASIC READINGS MMPI; DELIS D, 1987, CALIFORNIA VERBAL LE; DIAMOND R, 1988, INT J CLIN NEUROPSYC, V10, P35; DIKMEN S, 1977, ANN NEUROL, V2, P492, DOI 10.1002/ana.410020608; DIKMEN S, 1974, PERCEPT MOTOR SKILL, V39, P831, DOI 10.2466/pms.1974.39.2.831; DIKMEN S, 1977, J NERV MENT DIS, V165, P247, DOI 10.1097/00005053-197710000-00004; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; DIKMEN S, 1974, J ABNORM PSYCHOL, V83, P675, DOI 10.1037/h0037473; DOERR HO, 1991, FORENSIC NEUROPSYCHO; EKMAN P, 1989, KIDS LIE PARENTS CAN; Evans RW., 1992, PROGNOSIS NEUROLOGIC, P97; FAUST D, 1990, J CONSULT CLIN PSYCH, V58, P248, DOI 10.1037/0022-006X.58.2.248; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FAUST D, 1991, BRAIN DAMAGE CLAIMS; FINLAYSON MAJ, 1991, FORENSIC NEUROPSYCHO, P123; FRANZEN M D, 1990, Neuropsychology Review, V1, P247, DOI 10.1007/BF01112573; GASS CS, 1991, PSYCHOL ASSESSMENT J, V3, P27; GASS CS, 1990, PSYCHOL ASSESSMENT J, V2, P175, DOI DOI 10.1037//1040-3590.2.2.175; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; GRAHAM JR, 1991, J PERS ASSESS, V57, P264, DOI 10.1207/s15327752jpa5702_6; Gronwall D, 1991, NEUROPSYCHOLOGY, V5, P253, DOI DOI 10.1037/0894-4105.5.4.253; GUILMETTE TJ, 1993, CLIN NEUROPSYCHOLOGI, V1, P59; GUILMETTE TJ, 1991, CLIN NEUROPSYCHOL, V5, P197; Hathaway S.R., 1943, MINNESOTA MULTIPHASI; Hathaway S. R., 1943, MANUAL ADM SCORING M; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R. K, 1981, WISCONSIN CARD SORTI; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; HISCOCK M, 1989, J CLIN EXP NEUROPSYC, V11, P967, DOI 10.1080/01688638908400949; JONES JC, 1990, CLIN PSYCHOL REV, V10, P299, DOI 10.1016/0272-7358(90)90064-H; KAY T, 1992, NEUROPSYCHOLOGY, V4, P371; KOLB LC, 1987, AM J PSYCHIAT, V144, P989; KROPP PR, 1991, UNPUB CAPACITY PSYCH; Langs R., 1982, PSYCHOTHERAPY BASIC; Lee G.P., 1992, PSYCHOL ASSESSMENT, V4, P43, DOI [10.1037/1040-3590.4.1.43, DOI 10.1037/1040-3590.4.1.43]; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin HS, 1989, MILD HEAD INJURY; Lewis M., 1993, LYING DECEPTION EVER; Loftus E. F., 1982, GS HALL LECTURES, P119; MACCIOCCHI SN, 1990, J CLIN PSYCHOL, V46, P628, DOI 10.1002/1097-4679(199009)46:5<628::AID-JCLP2270460514>3.0.CO;2-V; MACNIVEN E, 1993, BRAIN INJURY, V1, P241; MATARAZZO JD, 1986, AM PSYCHOL, V41, P14, DOI 10.1037/0003-066X.41.1.14; MATARAZZO JD, 1990, AM PSYCHOL, V45, P999, DOI 10.1037/0003-066X.45.9.999; MATARAZZO JD, 1986, AM PSYCHOL, V41, P94; MENSCH AJ, 1986, INT J CLIN NEUROPSYC, V8, P59; Miller L., 1993, PSYCHOTHERAPY BRAIN; PANKRATZ L, 1983, PERCEPT MOTOR SKILL, V57, P367, DOI 10.2466/pms.1983.57.2.367; Pankratz L., 1990, CLIN NEUROPSYCHOL, V4, P379; PARKER N, 1979, MED J AUSTRALIA, V1, P568, DOI 10.5694/j.1326-5377.1979.tb127072.x; PILOWSKY I, 1992, STRESS MEDICINE, V8, P77, DOI 10.1002/smi.2460080204; PILOWSKY I, 1985, BRIT J PSYCHIAT, V147, P310, DOI 10.1192/bjp.147.3.310; POPE HS, 1993, MMPI MMPI 2 MMPI A C; Prigatano G. P., 1990, CLIN NEUROPSYCHOL, V4, P163, DOI [10.1080/13854049008401509, DOI 10.1080/13854049008401509]; Reitan R. M., 1986, TRAUMATIC BRAIN INJU, VI; Resnick P. J., 1988, CLIN ASSESSMENT MALI, P84; Rey A, 1964, EXAMEN CLIN PSYCHOL; ROGERS R, 1993, CLIN PSYCHOL REV, V13, P255, DOI 10.1016/0272-7358(93)90023-F; Rogers R., 1984, BEHAV SCI LAW, V2, P93, DOI [10.1002/bsl.2370020109, DOI 10.1002/BSL.2370020109]; Rogers R., 1988, CLIN ASSESSMENT MALI, P250; ROGERS R, 1988, CLIN ASSESSMENT MALI; Rogers R., 1992, SIRS STRUCTURED INTE; SCHMIDT JP, 1989, PROF PSYCHOL-RES PR, V20, P140, DOI 10.1037/h0092792; SCHRETLEN D, 1990, J CLIN PSYCHOL, V46, P782, DOI 10.1002/1097-4679(199011)46:6<782::AID-JCLP2270460614>3.0.CO;2-2; SCHRETLEN D, 1992, PSYCHOL ASSESSMENT, V4, P77; Schretlen D., 1991, PSYCHOL ASSESSMENT J, V3, P667, DOI [10.1037/1040-3590.3.4.667, DOI 10.1037/1040-3590.3.4.667]; Spence, 1982, NARRATIVE TRUTH HIST; Spitzer R.L., 1978, SCHEDULE AFFECTIVE D; TAYLOR S, 1991, J ANXIETY DISORD, V5, P293, DOI 10.1016/0887-6185(91)90030-W; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; WALTERS GD, 1988, J CONSULT CLIN PSYCH, V56, P111, DOI 10.1037/0022-006X.56.1.111; Weed N, 1990, PSYCHOL ASSESSMENT J, V2, P281, DOI DOI 10.1037/1040-3590.2.3.281; Wetter M. W., 1992, PSYCHOL ASSESSMENT, V4, P369, DOI 10.1037/1040-3590.4.3.369; WIGGINS EC, 1988, LAW HUMAN BEHAV, V12, P57, DOI 10.1007/BF01064274; Williams JM, 1991, MEMORY ASSESSMENT SC; Willis SC., 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI [10.1037/1040-3590.3.2.175, DOI 10.1037/1040-3590.3.2.175]; WILSON RS, 1991, FORENSIC NEUROPSYCHO, P89; Zasler N., 1993, J HEAD TRAUMA REHAB, V8, P13	96	14	14	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513	0969-5893			CLIN PSYCHOL-SCI PR	Clin. Psychol.-Sci. Pract.	WIN	1994	1	2					169	184		10.1111/j.1468-2850.1994.tb00018.x			16	Psychology, Clinical	Psychology	PY450	WOS:A1994PY45000005					2021-06-18	
J	DEPOMPEI, R; WILLIAMS, J				DEPOMPEI, R; WILLIAMS, J			WORKING WITH FAMILIES AFTER TBI - A FAMILY-CENTERED APPROACH	TOPICS IN LANGUAGE DISORDERS			English	Article						COLLABORATION; FAMILY-CENTERED COUNSELING; FAMILY SYSTEMS; TRAUMATIC BRAIN INJURY	HEAD-INJURY	This article focuses on family involvement as critical to successful rehabilitation of individuals with cognitive-communicative impairments following traumatic brain injury (TBI). A family-centered perspective is embraced within which capacity rather than dysfunction in families is sought. Family members are actively included as collaborators in rehabilitation and reintegration to home, school, work, and community life. This family-centered perspective can help develop capability within the family system throughout its life cycle. Suggestions for understanding family responses to TBI and for involving families more fully are presented.	UNIV KANSAS,RES & TRAINING CTR INDEPENDENT LIVING,LAWRENCE,KS 66045	DEPOMPEI, R (corresponding author), UNIV AKRON,SCH COMMUN DISORDERS,AKRON,OH 44325, USA.						ANDREWS J R, 1986, Seminars in Speech and Language, V7, P359, DOI 10.1055/s-0028-1085234; ANDREWS JR, 1993, FAMILY BASED TREATME; BANJA JD, 1992, J HEAD TRAUMA REHAB, V7, P112; Blosser J L, 1992, Clin Commun Disord, V2, P52; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N., 1984, CLOSED HEAD INJURY P; Carter B., 1988, CHANGING FAMILY LIFE; CAVALLO M, 1992, DEC NAT HEAD INJ F A; Crais ER., 1991, AM J SPEECH LANG PAT, V1, P5; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; DEPOMPEI R, 1988, J HEAD TRAUMA REHAB, V3, P13; DEPOMPEI R, 1993, STAFF DEV CLIN INTER; DEPOMPEI R, 1991, COGNITIVE REHABILITA; DUNST CJ, 1989, NATIONAL STUDENT SPE, V17, P39; GILLETTE Y, CHILDHOOD LANGUAGE D; GILLETTE Y, 1992, CATCH GUIDE PLANNING; Goldenberg H., 1985, FAMILY THERAPY OVERV; HOCK RA, 1984, REHABILITATION CHILD; HOSACK K, 1992, J VOCATIONAL REHABIL, V2, P1; KLONFF P, 1987, COMMUNITY REENTRY HE; Kreutzer J, 1988, J HEAD TRAUMA REHAB, V3, P51, DOI DOI 10.1097/00001199-198812000-00008; KREUTZER J, 1993, MAR OH SPEECH LANG H; Kubler-Ross E., 1969, DEATH DYING; Lehr E, 1990, PSYCHOL MANAGEMENT T; MACDONALD J, 1988, PARENT CHILD INTERAC; MACDONALD JD, 1986, J ASSOC PERS SEVERE, V11, P255; MAITZ E, 1991, HEAD INJURY FAMILY M; MCGOLDRICK M, 1982, ETHNICITY FAMILY THE; MCKINALY WW, 1987, J NEUROL NEUROSUR PS, V44, P527; Minuchin S., 1967, FAMILIES SLUMS; PENN P, 1988, CHANGING FAMILY LIFE; ROLLAND JS, 1988, CHRONIC ILLNESS DISA; ROLLAND JS, 1988, CHANGING FAMILY LIFE; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Satir V., 1975, HELPING FAMILIES CHA; SAVAGE R, 1991, NEURODEVELOPMENTS NE, V1, P3; SCHROEDER H, 1993, HEADLINES; SENELICK R, 1991, LIVING HEAD INJURY G; Waaland PK, 1990, COMMUNITY REINTEGRAT; WILLER B, 1989, RRTC892 U BUFF TECH; WILLER B, 1989, RRTC895 U BUFF TECH; WILLIAMS J, 1991, HEAD INJURY FAMILY M; Williams Janet M., 1993, Seminars in Speech and Language, V14, P44, DOI 10.1055/s-2008-1064158; YLVISAKER M, 1993, STAFF DEV CLIN INTER; YLVISAKER M, 1987, COMMUNITY REENTRY HE; ZARSKI JJ, 1989, J HEAD TRAUMA REHABI, V3, P31	47	14	14	0	0	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0271-8294			TOP LANG DISORD	Top. Lang. Disord.	NOV	1994	15	1					68	81		10.1097/00011363-199411000-00007			14	Linguistics; Rehabilitation	Linguistics; Rehabilitation	PL838	WOS:A1994PL83800007					2021-06-18	
J	OSTERMANN, PAW; HENRY, SL				OSTERMANN, PAW; HENRY, SL			RUSSEL-TAYLOR RECONSTRUCTION NAIL IN THE TREATMENT OF IPSILATERAL NECK AND SHAFT FRACTURES	CHIRURG			German	Article						IPSILATERAL FEMORAL NECK AND SHAFT FRACTURES; RECONSTRUCTION NAIL; FEMORAL HEAD NECROSIS	FEMORAL-SHAFT; HIP-FRACTURES; FEMUR	Eleven ipsilateral neck and shaft fractures of the femur in 11 patients (4 females, 7 males) were treated between May 1987 and December 1990 at the Department of Orthopedic Surgery, University of Louisville, Trauma center level one. The mean age was 34.5 (16-60) years. All patients sustained their injuries from high energy trauma (8 traffic accidents, 3 falls). All neck fractures were closed and there were 8 closed and 3 open (grade I, grade II, grade IIIA = one each) shaft fractures. All fractures were operated on the fracture table and all were stabilized with the Russell-Taylor reconstruction nail. Thus, antegrade reamed nailing of the shaft fracture was followed by internal fixation of the neck fracture with 8.0 mm and 6.4 mm lag screws. Those were placed with a targeting device through the proximal locking holes of the nail. Then, the distal locking bolts were implanted by free hand technique. The mean follow-up was 36.2 (18-71) months. All fractures of the neck and shaft healed. There was no necrosis of the femoral head. No infection was observed. The mean healing time for the neck fractures was 13.4 weeks and 16.8 weeks for the shaft fractures. In one case autogenous cancellous bone grafting was performed in delayed healing of a shaft fracture. There were no varus or valgus malangulations. Five patients had a minor limited ROM of the hip joint, another 6 patients an average shortening of 1.3 cm of he involved leg. In one case a locking bolt had to be removed due to loosening. The Russell-Taylor reconstruction nail is a favourable device for the stabilization of ipsilateral fractures of the femoral neck and shaft and provides excellent results for these complex injuries.	UNIV LOUISVILLE,HLTH SCI CTR,SCH MED,DEPT ORTHOPED SURG,FRACTURE SERV,LOUISVILLE,KY 40202	OSTERMANN, PAW (corresponding author), UNIV BOCHUM,CHIRURG KLIN & POLIKLIN,BERUFSGENOSSENSCHAFTLICHE KLINIKEN BERGMANNSHEIL,D-44789 BOCHUM,GERMANY.						ASHBY ME, 1977, CLIN ORTHOPAEDICS, V127, P156; BENNETT FS, 1993, CLIN ORTHOP RELAT R, V296, P168; BOSE WJ, 1992, J TRAUMA, V32, P1; BUCHOLZ RW, 1985, ORTHOPEDICS, V8, P1402; CASEY MJ, 1979, J BONE JOINT SURG AM, V61, P503, DOI 10.2106/00004623-197961040-00003; EISKJAER S, 1989, ORTHOPEDICS, V12, P397; FRIEDMAN RJ, 1986, CLIN ORTHOP RELAT R, V208, P188; Geissler W B, 1988, J Orthop Trauma, V2, P297, DOI 10.1097/00005131-198802040-00005; HARRYMAN DT, 1986, CLIN ORTHOPAEDICS, V213, P183; LEUNG KS, 1993, INJURY, V24, P41, DOI 10.1016/0020-1383(93)90082-H; SCHATZKER J, 1968, CAN J SURG, V11, P297; SWIONTKOWSKI MF, 1987, ORTHOP CLIN N AM, V18, P73; SWIONTKOWSKI MF, 1984, J BONE JOINT SURG AM, V66A, P260, DOI 10.2106/00004623-198466020-00013; Wiss D A, 1992, J Orthop Trauma, V6, P159, DOI 10.1097/00005131-199206000-00005; WU CC, 1993, J TRAUMA, V34, P70, DOI 10.1097/00005373-199301000-00013; ZETTAS JP, 1981, CLIN ORTHOP RELAT R, V160, P63	16	14	14	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0009-4722			CHIRURG	Chirurg	NOV	1994	65	11					1042	1045					4	Surgery	Surgery	PV069	WOS:A1994PV06900021	7821064				2021-06-18	
J	LEBLANC, KE				LEBLANC, KE			CONCUSSIONS IN SPORTS - GUIDELINES FOR RETURN TO COMPETITION	AMERICAN FAMILY PHYSICIAN			English	Article								Concussion is the most common head injury in sports. The injury ranges from a simple ''ding'' to prolonged loss of consciousness with amnesia. Proper grading of the severity of the injury is necessary to establish a protocol for deciding when to allow an athlete to return to his or her sport. This approach to concussions will minimize the risk of further, even fatal, complications.		LEBLANC, KE (corresponding author), UNIV SW LOUISIANA,MED CTR,LAFAYETTE,LA 70504, USA.							0	14	14	0	1	AMER ACAD FAMILY PHYSICIANS	KANSAS CITY	8880 WARD PARKWAY, KANSAS CITY, MO 64114-2797	0002-838X			AM FAM PHYSICIAN	Am. Fam. Physician	SEP 15	1994	50	4					801	806					6	Primary Health Care; Medicine, General & Internal	General & Internal Medicine	PH353	WOS:A1994PH35300013	8079910				2021-06-18	
J	KEREN, O; SAZBON, L; GROSWASSER, Z; SHMUEL, M				KEREN, O; SAZBON, L; GROSWASSER, Z; SHMUEL, M			FOLLOW-UP-STUDIES OF SOMATOSENSORY-EVOKED POTENTIALS AND AUDITORY BRAIN-STEM EVOKED-POTENTIALS IN PATIENTS WITH POST-COMA UNAWARENESS (PCU) OF TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; PROGNOSIS	Some patients who suffer severe traumatic brain injury (TBI) fail to recover higher brain functions in spite of giving the appearance of sleep-wake cycles. Such a state is called post-coma unawareness (PCU) and varies in type and degree. Patients may remain in this state for months or even years. This study focused on the follow-up of upper-limb somatosensory evoked potential (USEP) measurements and auditory brainstem responses (ABR), with an emphasis on dynamic changes, in 10 patients with PCU resulting from TBI. The prognostic value of USEP and ABR was evaluated. Results showed that the presence of ABR in PCU patients had no prognostic value, because ABRs were found both in patients who recovered and those who did not, even a year after the trauma. The presence of normal ABR in PCU patients may suggest that the brainstem has been spared in the pathoanatomy of the PCU condition, with the significant damage occurring above this level, in cortical and subcortical (that is, hemispheral) areas. USEP was graded using the new system of Houlden [1] for 'acute' comatose patients. It was found that USEP measurements had some prognostic value in PCU patients. Most of the patients who remained in the PCU state had grade 2 or less initially, whereas most of the patients who later recovered or achieved at least a 'reduced life' state were grade 4 or more. On initial testing (when all patients were still in the PCU state), defined cortical potential (mainly in the slope of the building NI potential) was seen in only some of the patients who later recovered. No dynamic changes or signs of improvement were seen in any of the patients who did not recover (that is, who remained in the PCU state). On the other hand, dynamic changes in evoked potential (amplitude, latency and shortened latency) were found in all patients who got well and, although not homogeneous, the changes involved all the elements of normal patterns and showed a trend towards improvement. Patients who remained comatose showed no change or reduction in Houlden's grade, whereas all patients who recovered showed no change or elevation. (In one of the latter patients, the grade increased from 2 to 5.) In some patients who recovered, morphological changes in cortical potentials were seen, mainly in NI slopes.	LOEWENSTEIN HOSP REHABIL,CTR REHABIL,EVOKED POTENTIALS LAB,RAANANA,ISRAEL; TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL							AMINOFF MJ, 1990, ANN NEUROL, V28, P706, DOI 10.1002/ana.410280517; BUCHNER H, 1988, ELECTROEN CLIN NEURO, V69, P14, DOI 10.1016/0013-4694(88)90031-4; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CHATRIAN GE, 1990, CURRENT PRACTICE CLI, P425; DELATORRE JC, 1978, EXP NEUROL, V60, P304, DOI 10.1016/0014-4886(78)90085-7; GANES T, 1988, ELECTROEN CLIN NEURO, V69, P6, DOI 10.1016/0013-4694(88)90030-2; Goldberg G, 1987, Electromyogr Clin Neurophysiol, V27, P455; HOULDEN DA, 1990, NEUROSURGERY, V27, P701, DOI 10.1227/00006123-199011000-00006; HUME AL, 1979, ANN NEUROL, V5, P379, DOI 10.1002/ana.410050412; KAJIMA Y, 1991, ELECTROENCEPHALOGRAP, V80, P26; KEREN O, 1991, Brain Injury, V5, P233, DOI 10.3109/02699059109008094; KRESCH EN, 1992, ARCH PHYS MED REHAB, V73, P829; LARSON SJ, 1973, SURGERY, V74, P34; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; LUTSCHG J, 1983, AM J DIS CHILD, V137, P421; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; SAZBON L, 1991, J NEUROL NEUROSUR PS, V54, P149, DOI 10.1136/jnnp.54.2.149; Sazbon L, 1991, Brain Inj, V5, P1, DOI 10.3109/02699059108998504; UZIEL A, 1982, CLIN APPLICATIONS EV, P195; VIGOUROUX PR, 1972, NEUROCHIRURGIE S2, V18, P25	20	14	14	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	APR	1994	8	3					239	247		10.3109/02699059409150976			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ND714	WOS:A1994ND71400005	8004082				2021-06-18	
J	SEN, S; GOLDMAN, H; MOREHEAD, M; MURPHY, S; PHILLIS, JW				SEN, S; GOLDMAN, H; MOREHEAD, M; MURPHY, S; PHILLIS, JW			OXYPURINOL INHIBITS FREE-RADICAL RELEASE FROM THE CEREBRAL-CORTEX OF CLOSED-HEAD INJURED RATS	NEUROSCIENCE LETTERS			English	Article						CLOSE HEAD INJURY; HEAD TRAUMA; ESR; POBN; HYDROXYL RADICAL; OXYPURINOL	BRAIN INJURY; BLOOD-FLOW; ISCHEMIA	Traumatic brain injury (TBI) is a significant cause of mortality and morbidity. Although the sequence of events underlying the resultant neuronal loss is still poorly understood, there are indications that oxygen-free radical generation is critically involved. Free radical generation in the cerebral cortex of closed head injury rats was monitored by measuring free radical release into cortical superfusates containing the spin trap agent 4-pyridyl-1-oxide-N-tert-butylnitrone (POBN, 100 mM). ESR analysis of the superfusates revealed six line spectra (alpha(N) = 15.4 G and alpha(H)beta = 2.5 G) characteristic of POBN-OH adducts. Administration of oxypurinol (40 mg/kg) 15 min prior to TBI prevented the formation of these radical adducts.	WAYNE STATE UNIV,SCH MED,DEPT PHYSIOL,540 E CANFIELD,DETROIT,MI 48201; WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201					NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS26912-05] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [H133A20016, G0087C002] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026912] Funding Source: NIH RePORTER		Goldman H, 1991, J NEUROTRAUM, V8, P129, DOI 10.1089/neu.1991.8.129; GRAMMAS P, 1993, FREE RADICAL BIO MED, V14, P553, DOI 10.1016/0891-5849(93)90113-9; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LANGE D G, 1990, Free Radical Biology and Medicine, V9, P97; LIN Y, 1992, BRAIN RES, V571, P272, DOI 10.1016/0006-8993(92)90665-V; OZAWA T, 1990, BIOCH INT, V26, P477; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; PHILLIS JW, 1989, BRAIN RES BULL, V23, P467, DOI 10.1016/0361-9230(89)90191-3; PHILLIS JW, 1987, J CEREBR BLOOD F MET, V7, P679, DOI 10.1038/jcbfm.1987.122; PHILLIS JW, 1993, DRUG DEVELOP RES, V28, P390, DOI 10.1002/ddr.430280337; PHILLIS JW, 1990, INT J PURINE PYRIMID, V1, P31; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; ZINI I, 1992, NEUROSCI LETT, V138, P279, DOI 10.1016/0304-3940(92)90933-X	14	14	14	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	NOV 12	1993	162	1-2					117	120		10.1016/0304-3940(93)90574-5			4	Neurosciences	Neurosciences & Neurology	MH359	WOS:A1993MH35900030	8121612				2021-06-18	
J	DEWEY, CW; DOWNS, MO; ARON, DN; MAHAFFEY, EA				DEWEY, CW; DOWNS, MO; ARON, DN; MAHAFFEY, EA			ACUTE TRAUMATIC INTRACRANIAL HEMORRHAGE IN DOGS AND CATS - A RETROSPECTIVE EVALUATION OF 23 CASES	VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY			English	Article						ACUTE TRAUMATIC INTRACRANIAL HEMORRHAGE; BRAIN INJURY; DOGS; CATS		Twenty-three records of dogs and cats having experienced severe craniocerebral trauma were reviewed. Case selection was restricted to those patients whose brains were examined at necropsy and/or surgery. Records of 14 dogs and nine cats were evaluated for the presence or absence of intracranial haemorrhage. The majority of patients were victims of automobile trauma (n = 16), the remainder being victims of household accidents (n = 4), malicious human behavior (n = 2), and injury inflicted by another animal (n = 1). Six of the 23 (27%) were conscious upon admission. One patient was unconscious upon admission, but regained consciousness following medical therapy. Evidence of intracranial haemorrhage was found in 100% (14/14) of the canine and 89% (8/9) of the feline cases. Four dogs and four cats exhibited two forms of intracranial haemorrhage. One cat exhibited three forms of intracranial haemorrhage. The distribution of intracranial haemorrhage was as follows: two epidural, 10 subdural, 10 subarachnoid and 10 intraparenchymal. Histopathology was available for 10 of the 23 cases. Surgical confirmation of the subdural haematomas, as typical subdural haematomas (focal intradural mass lesions), was available for four cases. Gross pathology of one other of the 10 subdural hematomas described a focal, 2 x 3 cm mass lesion. The remaining five subdural haematomas were of a more diffuse nature (more typical of subarachnoid haemorrhage), but three of these five were described as massive accumulations of blood. Four patients underwent emergency craniotomy/craniectomy; two of these patients made rapid and full recoveries, one died on the operating table, and one was euthanatized at the operation because of uncontrollable brain swelling. Ninety-three percent of the canine and 75% of the feline cases had haemorrhagic lesions that would have been potentially accessible via a lateral craniotomy/craniectomy. The results of this investigation suggest that acute intracranial haemorrhage may be a relatively frequent occurrence, following severe brain injury in dogs and cats. Prospective studies are needed to better define the incidence, anatomical distribution, and potential clinical significance of acute traumatic intracranial haemorrhage in dogs and cats. Comparative aspects of acute traumatic intracranial haemorrhage in people and small animals (dogs and cats) are discussed.		DEWEY, CW (corresponding author), UNIV CALIF DAVIS,SCH VET MED,DEPT VET SURG,DAVIS,CA 95616, USA.							0	14	14	0	8	F K SCHATTAUER VERLAG GMBH	STUTTGART	P O BOX 10 45 45, LENZHALDE 3, D-70040 STUTTGART, GERMANY	0932-0814			VET COMP ORTHOPAED	Vet. Comp. Orthop. Traumatol.	AUG	1993	6	3					153	159					7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	LT023	WOS:A1993LT02300005					2021-06-18	
J	CHOUINARD, MJ; BRAUN, CMJ				CHOUINARD, MJ; BRAUN, CMJ			A METAANALYSIS OF THE RELATIVE SENSITIVITY OF NEUROPSYCHOLOGICAL SCREENING-TESTS	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC HEAD-INJURY; MULTIPLE-SCLEROSIS; PARKINSONS-DISEASE; COGNITIVE DISTURBANCES; ALZHEIMERS-DISEASE; FEMALE ALCOHOLICS; HALSTEAD-REITAN; DEFICITS; PERFORMANCE; IMPAIRMENT	The National Institute of Mental Health recently formed a committee of experts which published a proposal for a lengthy neuropsychological test battery judged most apt to detect diffuse brain damage while covering a wide range of cognitive abilities. The purposes of the present study were (1) to assemble empirical evidence of the existence of statistically significantly sensitive screening tests across an equivalently wide range of functional domains, and (2) to present this evidence systematically, in such a manner as to help clinicians select subsets of screening tests manifesting greatest sensitivity to diffuse brain damage. It was found that in certain functional domains (speed of processing, problem solving, executive functions), marked differences in sensitivity occured. Brief tests just as sensitive as time-consuming tests were also identified. The reader is cautioned about possible extraneous sources of the differences obtained (test and group selection bias, test reliability, test difficulty, procedural effects, Type I error). Nevertheless, it was concluded that a brief highly sensitive and functionally wide-ranging neuropsychological test battery for screening cases of putative diffuse brain dysfunction can be assembled.	UNIV QUEBEC, DEPT PSYCHOL, CP 8888, SUCC A, MONTREAL H3C 3P8, QUEBEC, CANADA; UNIV QUEBEC, NEUROSCI COGNIT LAB, MONTREAL H3C 3P8, QUEBEC, CANADA							ACKER C, 1985, ALCOHOL ALCOHOLISM, V20, P379; ADAMS KM, 1990, J CLIN EXP NEUROPSYC, V12, P960, DOI 10.1080/01688639008401034; ARDILA A, 1989, DEV NEUROPSYCHOL, V5, P307, DOI 10.1080/87565648909540441; BAK JS, 1980, J CONSULT CLIN PSYCH, V48, P395, DOI 10.1037/0022-006X.48.3.395; BEATTY PA, 1977, J NERV MENT DIS, V164, P42, DOI 10.1097/00005053-197701000-00008; BEATTY WW, 1989, ARCH NEUROL-CHICAGO, V46, P1113, DOI 10.1001/archneur.1989.00520460103020; BENTON AL, 1957, J ABNORM SOC PSYCH, V54, P109, DOI 10.1037/h0047176; BIGLER E D, 1981, Clinical Neuropsychology, V3, P5; BIGLER E D, 1981, Clinical Neuropsychology, V3, P13; BIRD M, 1991, J CLIN EXP NEUROPSYC, V13, P508, DOI 10.1080/01688639108401067; BIRREN JE, 1980, AGING 1980S; BLACKBURN H L, 1955, Confin Neurol, V15, P327; BLUSEWICZ MJ, 1977, J NERV MENT DIS, V165, P348, DOI 10.1097/00005053-197711000-00006; BOLL TJ, 1974, J NERV MENT DIS, V158, P61, DOI 10.1097/00005053-197401000-00008; BORNSTEIN RA, 1990, PSYCHIAT RES, V31, P15, DOI 10.1016/0165-1781(90)90104-D; BRAUN CMJ, 1989, INT J CLIN NEUROPSYC, V11, P167; Bruhn P, 1971, Cortex, V7, P278; BUTTERS N, 1990, J CLIN EXPT NEUROPSY, V12, P953; CHAPMAN JP, 1983, J NERV MENT DIS, V171, P658, DOI 10.1097/00005053-198311000-00003; CULLUM CM, 1990, ARCH CLIN NEUROPSYCH, V5, P23, DOI DOI 10.1093/ARCLIN/5.1.23; DAIGNEAULT S, 1992, DEV NEUROPSYCHOL, V8, P99, DOI 10.1080/87565649209540518; DEE HL, 1971, ACTA PSYCHIAT SCAND, V47, P315, DOI 10.1111/j.1600-0447.1971.tb02217.x; DENBURG SD, 1987, J CLIN EXP NEUROPSYC, V9, P323, DOI 10.1080/01688638708405054; DERENZI E, 1965, CORTEX, V1, P410; DODRILL CB, 1978, EPILEPSIA, V19, P611, DOI 10.1111/j.1528-1157.1978.tb05041.x; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; DUBOIS B, 1990, NEUROLOGY, V40, P38, DOI 10.1212/WNL.40.1.38; DYE OA, 1979, ACTA NEUROL SCAND, V59, P10; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; ESTRIN WJ, 1990, J TOXICOL-CLIN TOXIC, V28, P1; FITZHUGH KB, 1961, J CONSULT PSYCHOL, V25, P61, DOI 10.1037/h0043344; GOULETFISHER D, 1986, INT J CLIN NEUROPSYC, V8, P14; GRANT I, 1984, J NEUROL NEUROSUR PS, V47, P250, DOI 10.1136/jnnp.47.3.250; HAXBY JV, 1990, ARCH NEUROL-CHICAGO, V47, P753, DOI 10.1001/archneur.1990.00530070043010; HEAD D, 1989, BIOL PSYCHIAT, V25, P929, DOI 10.1016/0006-3223(89)90272-2; Heaton R.K., 1986, NEUROPSYCHOLOGICAL A, P100; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; HEILMAN KM, 1985, CLIN NEUROPSYCHOLOGY; HILLBOM M, 1986, J NEUROL NEUROSUR PS, V49, P1348, DOI 10.1136/jnnp.49.12.1348; HOM J, 1990, J CLIN EXP NEUROPSYC, V12, P644, DOI 10.1080/01688639008401008; HUA MS, 1991, J CLIN EXP NEUROPSYC, V13, P495, DOI 10.1080/01688639108401066; JANSSEN RS, 1989, ANN NEUROL, V26, P592, DOI 10.1002/ana.410260503; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KANE RL, 1985, J CLIN EXP NEUROPSYC, V7, P211, DOI 10.1080/01688638508401254; LEE GP, 1988, J CLIN EXP NEUROPSYC, V10, P769, DOI 10.1080/01688638808402813; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN BE, 1989, NEUROLOGY, V39, P557, DOI 10.1212/WNL.39.4.557; LEVINE J, 1972, J CONSULT CLIN PSYCH, V39, P508, DOI 10.1037/h0034017; Lezak M.D., 1983, NEUROPSYCHOLOGICAL A; LIBON DJ, 1990, 18TH ANN M INT NEURO; MATTHEWS CG, 1979, NEUROLOGY, V29, P951, DOI 10.1212/WNL.29.7.951; Matthews CG, 1966, CORTEX, V2, P244; Miller E, 1970, Cortex, V6, P121; MILLER EN, 1990, NEUROLOGY, V40, P197, DOI 10.1212/WNL.40.2.197; MINDEN SL, 1990, J CLIN EXP NEUROPSYC, V12, P566, DOI 10.1080/01688639008401002; MITTENBERG W, 1989, J CLIN EXP NEUROPSYC, V11, P918, DOI 10.1080/01688638908400945; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; MORROW LA, 1990, J OCCUP ENVIRON MED, V32, P444, DOI 10.1097/00043764-199005000-00010; OLEARY MR, 1979, J CLIN PSYCHOL, V35, P204, DOI 10.1002/1097-4679(197901)35:1<204::AID-JCLP2270350133>3.0.CO;2-L; PATTERSON BW, 1989, INT J NEUROSCI, V49, P319, DOI 10.3109/00207458909084830; PETERSON JB, 1990, J STUD ALCOHOL, V51, P114, DOI 10.15288/jsa.1990.51.114; REID WGJ, 1989, INT J NEUROSCI, V48, P205, DOI 10.3109/00207458909002162; RUMSEY JM, 1988, J CLIN EXP NEUROPSYC, V10, P201, DOI 10.1080/01688638808408236; SILBERSTEIN JA, 1981, J ABNORM PSYCHOL, V90, P179, DOI 10.1037/0021-843X.90.2.179; SKENAZY JA, 1984, J CLIN PSYCHOL, V40, P246, DOI 10.1002/1097-4679(198401)40:1<246::AID-JCLP2270400148>3.0.CO;2-P; SKORASZEWSKI MJ, 1991, J CLIN EXP NEUROPSYC, V13, P278, DOI 10.1080/01688639108401043; TARTER RE, 1988, ALCOHOL CLIN EXP RES, V12, P619, DOI 10.1111/j.1530-0277.1988.tb00252.x; Van Zomeren A. H., 1981, REACTION TIME ATTENT; VILLARDITA C, 1985, ARCH GERONTOL GERIAT, V4, P311, DOI 10.1016/0167-4943(85)90038-X; WHEELER L, 1963, PERCEPT MOTOR SKILL, V16, P417, DOI 10.2466/pms.1963.16.2.417; WILKIE FL, 1990, ARCH NEUROL-CHICAGO, V47, P433, DOI 10.1001/archneur.1990.00530040085022; WILSON B, 1987, PSYCHOBIOLOGY, V15, P300; WOLFE N, 1990, ARCH NEUROL-CHICAGO, V47, P129, DOI 10.1001/archneur.1990.00530020025010; YOHMAN JR, 1985, ALCOHOL CLIN EXP RES, V9, P114, DOI 10.1111/j.1530-0277.1985.tb05530.x	74	14	14	0	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL	1993	15	4					591	607		10.1080/01688639308402581			17	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	LJ168	WOS:A1993LJ16800012	8354711				2021-06-18	
J	STAMBROOK, M; MOORE, AD; LUBUSKO, AA; PETERS, LC; BLUMENSCHEIN, S				STAMBROOK, M; MOORE, AD; LUBUSKO, AA; PETERS, LC; BLUMENSCHEIN, S			ALTERNATIVES TO THE GLASGOW COMA SCALE AS A QUALITY-OF-LIFE PREDICTOR FOLLOWING TRAUMATIC BRAIN INJURY	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; SEVERITY; UNCONSCIOUSNESS; ADULT; AGE	Conventional ''staging'' of traumatic brain injury (TBI) typically uses depth of coma assessed by the Glasgow Coma Scale (GCS) score near admission as a severity marker Frequently, early GCS scores are contaminated by alcohol or drug ingestion and other, nonneurological organ system trauma. As well, this measure's usefulness is limited due to its restricted range in survivors. Here we explore the utility of using length of posttraumatic amnesia, coma duration, and age as indirect markers of severity. Cluster analytic techniques were used to examine the relationship of severity so defined to long-term outcome in 106 mild, moderate, and severe TBI patients. Results indicate complex relationships between cluster groups with the influence of age of patient being highlighted as an important moderator in determining severity of injury and later psychosocial outcome.	UNIV MANITOBA,DEPT PSYCHIAT,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT PSYCHOL,WINNIPEG R3T 2N2,MANITOBA,CANADA; UNIV MANITOBA,DEPT MED,WINNIPEG R3T 2N2,MANITOBA,CANADA; HLTH SCI CLIN RES CTR,SOC MANITOBANS DISABIL,WINNIPEG R3A 1R9,MB,CANADA	STAMBROOK, M (corresponding author), HLTH SCI CLIN RES CTR,NEUROPSYCHOL RES UNIT,MS-779A THORLAKSON BLDG,820 SHERBROOK ST,WINNIPEG R3A 1R9,MB,CANADA.						ABEL EL, 1985, J STUD ALCOHOL, V46, P228, DOI 10.15288/jsa.1985.46.228; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; BERGNER M, 1976, COPING ADAPTATION, P127; BERROL S, 1989, MILD MODERATE HEAD I, P135; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; CLARK WC, 1986, J NEUROSURG, V65, P9, DOI 10.3171/jns.1986.65.1.0009; COREY MR, 1987, COGNITIVE REHABILITA, V5, P28; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; EWING CL, 1983, IMPACT INJURY HEAD S; GENSEMER IB, 1989, ANN EMERG MED, V18, P9, DOI 10.1016/S0196-0644(89)80303-8; GILL D, 1988, AUG ANN CONV AM PSYC; Gurdjian ES, 1975, IMPACT HEAD INJURY M; HAIR JF, 1987, MULTIVARIATE DATA AN; HANS P, 1987, BRIT J HOSP MED, V23, P535; HOGARTY GE, 1971, ARCH GEN PSYCHIAT, V25, P470; Jennett B, 1981, MANAGEMENT HEAD INJU; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LYLE DM, 1986, J NEUROSURG, V65, P15, DOI 10.3171/jns.1986.65.1.0015; MARSHALL LF, 1989, MILD MODERATE HEAD I, P29; McNair DM, 1971, EITS MANUAL PROFILE; Moore A. D., 1991, J HEAD TRAUMA REHAB, V6, P83; NOCKLEBY DM, 1987, INT J CLIN NEUROPSYC, V9, P145; OHNO K, 1987, NO SHINKEI GEKA, V16, P607; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PRUNETI CA, 1988, RES COMMUN PSYCH PSY, V13, P193; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SELECKI BR, 1982, AUST NZ J SURG, V52, P93, DOI 10.1111/j.1445-2197.1982.tb05297.x; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; *SPSS INC, 1986, SPSSX US GUID; STAMBROOK M, 1990, CAN J SURG, V33, P115; STARMARK JE, 1988, J NEUROSURG, V69, P692, DOI 10.3171/jns.1988.69.5.0692; TEASDALE G, 1974, LANCET, V2, P81; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; VAPALAHTI M, 1986, ANN CLIN RES, V18, P37	39	14	14	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR-APR	1993	8	2					95	103					9	Psychology, Clinical; Psychology	Psychology	KK429	WOS:A1993KK42900001	14589667				2021-06-18	
J	EMERSON, CS; VINK, R				EMERSON, CS; VINK, R			INCREASED MORTALITY IN FEMALE RATS AFTER BRAIN TRAUMA IS ASSOCIATED WITH LOWER FREE MG-2+	NEUROREPORT			English	Article						MAGNESIUM; NUCLEAR MAGNETIC RESONANCE; BIOENERGETICS; BRAIN INJURY	MAGNETIC-RESONANCE SPECTROSCOPY; FREE MAGNESIUM; INJURY; PH; METABOLISM	MALE and female Sprague-Dawley rat siblings (200-350 g) were monitored by phosphorus magnetic resonance spectroscopy for 4 h after moderate (2.8 atmospheres) fluid-percussion-induced traumatic brain injury. Following injury, two of nine male animals died whereas 1 00 % of all female rats (n = 16) died (p < 0.01). Prior to injury, brain free magnesium concentration in males was 0.58 +/- 0.05 mM and in females 0.41 +/- 0.09. After injury, mean brain free magnesium concentration in males declined to 0.32 +/- 0.06 whereas mean brain free magnesium concentration in ventilated females (n = 6) after injury declined to 0.17 +/- 0.03 (p < 0.05). There were no significant differences between groups with respect to any other measured variables. We conclude that female rats are more susceptible to irreversible injury afterbrain trauma, and that this increased susceptibility to injury may be related to brain free magnesium levels.	JAMES COOK UNIV N QUEENSLAND,DEPT CHEM & BIOCHEM,TOWNSVILLE,QLD 4811,AUSTRALIA			AM, Robert Vink/S-5616-2019; Vink, Robert/J-7351-2012	AM, Robert Vink/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667			Aikawa J., 1981, MAGNESIUM ITS BIOL S; BOCK JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P8, DOI 10.1016/0167-4889(87)90079-6; DEGANI H, 1984, BIOCHEMISTRY-US, V23, P2572, DOI 10.1021/bi00307a006; EBEL H, 1980, J CLIN CHEM CLIN BIO, V18, P257; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GARFINKEL L, 1984, BIOCHEMISTRY-US, V23, P3547, DOI 10.1021/bi00310a025; GUPTA RK, 1983, PHYSIOL CHEM PHYS, V15, P265; JANE JA, 1991, 1991 CENTR NERV SYST; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; MAGUIRE ME, 1984, TRENDS PHARMACOL SCI, V5, P73, DOI 10.1016/0165-6147(84)90372-9; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; RUBIN H, 1976, J CELL PHYSL, V89, P61; SIESJO BK, 1985, 1985 CENTR NERV SYST, P5132; SMITH SS, 1989, BRAIN RES, V503, P354, DOI 10.1016/0006-8993(89)91691-0; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1990, Magnes Res, V3, P163; VINK R, 1988, J BIOL CHEM, V263, P757; VINK R, 1988, MAGNET RESON MED, V6, P37, DOI 10.1002/mrm.1910060105; VINK R, 1988, J NEUROTRAUMA, V5, P365; VINK R, 1991, MAGNESIUM EXCITABLE, P695	23	14	14	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	NOV	1992	3	11					957	960		10.1097/00001756-199211000-00002			4	Neurosciences	Neurosciences & Neurology	KA083	WOS:A1992KA08300002	1482764				2021-06-18	
J	HEARY, RF; HUNT, CD; KRIEGER, AJ; ANTONIO, C; LIVINGSTON, DH				HEARY, RF; HUNT, CD; KRIEGER, AJ; ANTONIO, C; LIVINGSTON, DH			ACUTE STABILIZATION OF THE CERVICAL-SPINE BY HALO VEST APPLICATION FACILITATES EVALUATION AND TREATMENT OF MULTIPLE TRAUMA PATIENTS	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	22ND ANNUAL MEETING OF THE WESTERN TRAUMA ASSOC	FEB 29-MAR 07, 1992	STEAMBOAT SPRINGS, CO	W TRAUMA ASSOC			CORD INJURY; FRACTURES; IMMOBILIZATION; FUSION	The management of acute cervical spine injuries has traditionally used bed-based skeletal traction until all non-neurologic injuries have been evaluated. This treatment method substantially hinders the ability to transport patients and to perform imaging studies and surgical procedures. In contrast, early application of a halo/vest apparatus provides immediate cervical stabilization and facilitates the diagnostic work-up and treatment of the patients with multiple injuries. The records of all 78 patients admitted from February 1988 through June 1991 who had acute cervical spine fractures, subluxations, or both with a risk of instability were reviewed. All patients were treated with halo/vests and no patient deteriorated neurologically following halo/vest application. Twenty-nine patients (37%) had a total of 55 associated injuries including long bone/pelvic fractures in 17, thoracic injuries in 13, closed head injuries in 11, facial fractures in 6, noncontiguous spinal fractures in 5, and abdominal injuries in 3. The mean Injury Severity Score (ISS) was 18 (range, 9-54). While in the halo/vest, 43 patients (55%) had a total of 99 diagnostic studies completed and 46 patients (59%) had a total of 76 surgical procedures performed. There were 35 neurosurgical procedures on 32 patients and 41 non-neurosurgical surgical procedures on 24 patients. Over the past year, 20 of 21 patients (95%) had their halo/vests placed in the emergency department. The data demonstrate that many diagnostic and surgical procedures need to be performed on patients with unstable cervical spine injuries. While we recognize that application of the halo/vest is not the definitive treatment in a number of patients with multiple injuries (41% in this series), acute placement of the halo/vest both stabilized the patients' neurologic status and facilitated the expeditious diagnosis and treatment of potentially life-threatening associated injuries.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT NURSING,NEWARK,NJ 07103; UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,TRAUMA SECT,NEWARK,NJ 07103	HEARY, RF (corresponding author), UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,CTR NEUROL SURGEONS,DEPT SURG,NEUROL SURG SECT,NEWARK,NJ 07103, USA.						BEHRMAN SW, 1990, J TRAUMA, V30, P792, DOI 10.1097/00005373-199007000-00005; BONE LB, 1989, J BONE JOINT SURG AM, V71A, P336, DOI 10.2106/00004623-198971030-00004; BORDER JR, 1987, ANN SURG, V206, P427, DOI 10.1097/00000658-198710000-00004; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BUCCI MN, 1988, J TRAUMA, V28, P1001, DOI 10.1097/00005373-198807000-00015; BUCHOLZ RD, 1989, J NEUROSURG, V70, P884, DOI 10.3171/jns.1989.70.6.0884; BURNEY RE, 1989, J TRAUMA, V29, P1497, DOI 10.1097/00005373-198911000-00008; CHAN RC, 1983, J NEUROSURG, V58, P508, DOI 10.3171/jns.1983.58.4.0508; COOPER PR, 1979, J NEUROSURG, V50, P603, DOI 10.3171/jns.1979.50.5.0603; COTLER HB, 1990, SPINE, V15, P448, DOI 10.1097/00007632-199006000-00003; Crutchfield WG, 1933, STH SURG, V2, P156; GARFIN SR, 1986, J BONE JOINT SURG AM, V68A, P320, DOI 10.2106/00004623-198668030-00002; GARFIN SR, 1989, CLIN ORTHOP RELAT R, V239, P19; GLASER JA, 1986, J NEUROSURG, V65, P762, DOI 10.3171/jns.1986.65.6.0762; JAMES J I, 1960, J R Coll Surg Edinb, V5, P232; JOHNSON KD, 1985, J TRAUMA, V25, P375, DOI 10.1097/00005373-198505000-00001; KEENEN TL, 1990, J TRAUMA, V30, P489, DOI 10.1097/00005373-199030040-00022; KESTERSON L, 1991, J NEUROSURG, V75, P213, DOI 10.3171/jns.1991.75.2.0213; KOSTUIK JP, 1981, CLIN ORTHOP RELAT R, V154, P46; LETTS M, 1988, J BONE JOINT SURG BR, V70, P277; LIND B, 1988, SPINE, V13, P425, DOI 10.1097/00007632-198804000-00010; LIND B, 1987, SPINE, V12, P173, DOI 10.1097/00007632-198703000-00014; MARSHALL LF, 1987, J NEUROSURG, V66, P400, DOI 10.3171/jns.1987.66.3.0400; PERRY J, 1959, J BONE JOINT SURG AM, V41, P37, DOI 10.2106/00004623-195941010-00006; POWELL JN, 1989, J TRAUMA, V29, P1146, DOI 10.1097/00005373-198908000-00013; REISS SJ, 1986, NEUROSURGERY, V18, P327, DOI 10.1227/00006123-198603000-00012; ROCKSWOLD GL, 1990, J TRAUMA, V30, P893, DOI 10.1097/00005373-199007000-00022; SABOE LA, 1991, J TRAUMA, V31, P43, DOI 10.1097/00005373-199101000-00010; SCHWEIGEL JF, 1987, SPINE, V12, P838, DOI 10.1097/00007632-198711000-00002; SEARS W, 1990, J NEUROSURG, V72, P426, DOI 10.3171/jns.1990.72.3.0426; SEIBEL R, 1985, ANN SURG, V202, P283, DOI 10.1097/00000658-198509000-00003; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; WATERS JM, 1973, J TRAUMA, V13, P645, DOI 10.1097/00005373-197307000-00009; WOLF A, 1991, J NEUROSURG, V75, P883, DOI 10.3171/jns.1991.75.6.0883	34	14	15	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1992	33	3					445	451		10.1097/00005373-199209000-00019			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	JR171	WOS:A1992JR17100019	1404517				2021-06-18	
J	VONBIERBRAUER, A; WEISSENBORN, K; HINRICHS, H; SCHOLZ, M; KUNKEL, H				VONBIERBRAUER, A; WEISSENBORN, K; HINRICHS, H; SCHOLZ, M; KUNKEL, H			COMPUTER-ASSISTED VERSUS VISUAL EEG-ANALYSIS IN PATIENTS WITH MINOR HEAD-INJURY (A FOLLOW-UP EXAMINATION)	EEG-EMG-ZEITSCHRIFT FUR ELEKTROENZEPHALOGRAPHIE ELEKTROMYOGRAPHIE UND VERWANDTE GEBIETE			German	Article						HEAD INJURIES; BRAIN CONCUSSION; FOLLOW-UP STUDIES; ELECTROENCEPHALOGRAPHY		The study was designed to examine the clinical applicability and use of computer-assisted EEG-analysis in comparsion to visual EEG-analysis in patients with minor head injuries. For this in 31 patients the following examinations were performed within the first 24 hours, one, three and eight weeks after traumatization: EEG, neurological examination and standardized evaluation of subjective complaints. The EEG was analysed visually as well as computer-assisted. The results were compared to the neurological findings and subjective complaints. Reversible posttraumatic EEG-changes were observed in 50% of all patients. The results of computer-analysis and visual analysis were equivalent in respect to baseline-activity (as one of the main characteristic EEG-features). Furthermore, based on computer-assisted analysis a discriminant function is provided, which is of diagnostic and prognostic value in the single patient. We conclude that the computer-assisted EEG-analysis can be a useful alternative in EEG-routine diagnosis after minor head injuries.	HANNOVER MED SCH,ZENTRUMS NEUROL MED,NEUROPHYSIOL KLIN,NEUROL KLIN,W-3000 HANNOVER 61,GERMANY							BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BUCY PC, 1970, JOM-J OCCUP MED, V12, P318; CHRISTIAN W, 1982, KLINISCHE ELEKTROENZ; COONLEYHOGANSON R, 1984, NEUROSURGERY, V14, P315, DOI 10.1227/00006123-198403000-00009; DOLCE G, 1975, CEAN COMPUTERIZED EE; FERBER G, 1983, THESIS HANNOVER; FUNFGELD E W, 1957, Zentralbl Neurochir, V17, P326; GRONWALL D, 1974, LANCET, V2, P605; GULBRANDSEN GB, 1984, J CLIN EXP NEUROPSYC, V3, P257; HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4; JACOME DE, 1984, CLIN ENCEPHALOGR, V4, P214; JENNETT B, 1976, NEW ZEAL MED J, V84, P144; JONKMAN EJ, 1986, HDB ELECTROENCEPHALO, V2, P205; KOUFEN H, 1978, FORTSCHR NEUROL PSYC, V46, P165; KOUFEN H, 1975, THESIS U FREIBURG; KUTZNER M, 1982, UNFALLHEILKUNDE, V85, P179; RIMEL RW, 1982, NEUROSURGERY, V11, P334; RUSSEL WR, 1971, TRAUMATIC AMNESIAS; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; SYMONDS C, 1961, LANCET, V1, P1; VANHUFFELEN AC, 1980, ELECTROEN CLIN NEURO, P125; VONBIERBRAUER A, 1989, THESIS HANNOVER	22	14	14	0	0	GEORG THIEME VERLAG	STUTTGART	P O BOX 30 11 20, D-70451 STUTTGART, GERMANY	0941-3790			EEG-EMG-Z ELEK ELEKT	EEG-EMG-Z. Elektroenz. Elektron. Geb.	SEP	1992	23	3					151	157					7	Engineering, Biomedical; Clinical Neurology	Engineering; Neurosciences & Neurology	JU618	WOS:A1992JU61800008	1425393				2021-06-18	
J	PERRY, DC; LYETH, BG; MILLER, LP; GETZ, RL; JENKINS, LW; HAYES, RL				PERRY, DC; LYETH, BG; MILLER, LP; GETZ, RL; JENKINS, LW; HAYES, RL			EFFECTS OF TRAUMATIC BRAIN INJURY IN RATS ON BINDING TO FOREBRAIN OPIATE RECEPTOR SUBTYPES	MOLECULAR AND CHEMICAL NEUROPATHOLOGY			English	Article						TRAUMATIC BRAIN INJURY; MU OPIATE RECEPTORS; KAPPA OPIATE RECEPTORS; HIPPOCAMPUS; DENTATE GYRUS; ENDOGENOUS OPIOIDS; EXCITOTOXICITY	FLUID-PERCUSSION MODEL; KAPPA-OPIOID RECEPTORS; SPINAL-CORD INJURY; ENDOGENOUS OPIOIDS; GERBIL HIPPOCAMPUS; ISCHEMIA; VULNERABILITY; RESPONSES; DEATH; CAT	Sprague-Dawley rats were subjected to a moderate level (2.2 atm) of traumatic brain injury (TBI) using fluid percussion. Injured animals were allowed to survive posttrauma for periods of 5 min, 3 h, and 24 h. The effect of TBI on binding to forebrain opiate receptors was assessed using quantitative receptor autoradiography, and compared to a sham control group. Binding of [H-3]DAGO to mu receptors in neocortex and the CA1 pyramidal layer of the hippocampus was significantly decreased in the 24-h group (p < 0.05). [H-3]Bremazocine binding to kappa receptors was unchanged at 5 min and 24 h, but showed large decreases 3 h after TBI in the CA1 pyramidal layer (65%, p < 0.05) and dentate gyrus (43%, p < 0.05). Levels of delta binding (measured with [H-3]DSLET) and lambda binding (measured with [H-3]naloxone) were unaffected by TBI. These data support previous suggestions of a role for endogenous opioids in TBI, and provide further evidence that mu and kappa opioid receptor subtypes in neocortex and hippocampus may have different functions in TBI.	VET ADM MED CTR,NEUROSCI LAB 151S,WASHINGTON,DC 20422; GEORGETOWN UNIV,SCH MED,DEPT PHARMACOL,WASHINGTON,DC 20007; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT SURG,DIV NEUROSURG,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT ANAT,RICHMOND,VA 23298	PERRY, DC (corresponding author), GEORGE WASHINGTON UNIV,MED CTR,DEPT PHARMACOL,WASHINGTON,DC 20037, USA.			Lyeth, Bruce/0000-0003-4811-1474	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, R01NS021458, P01NS012587] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21458, NS 12587] Funding Source: Medline; PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [D 04191] Funding Source: Medline		DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FADEN AI, 1987, CLIN NEUROPHARMACOL, V10, P193, DOI 10.1097/00002826-198706000-00001; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FADEN AI, 1988, J PHARMACOL EXP THER, V245, P742; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HOLADAY JW, 1985, ENDOGENOUS OPIOIDS T; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; JENKINS LW, 1988, J NEUROTRAUM, V5, P303; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MANSOUR A, 1987, J NEUROSCI, V7, P2445; MCGINTY JF, 1983, P NATL ACAD SCI-BIOL, V80, P589, DOI 10.1073/pnas.80.2.589; MCINTOSH T K, 1988, Society for Neuroscience Abstracts, V14, P1152; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; MCLEAN S, 1987, J COMP NEUROL, V255, P497, DOI 10.1002/cne.902550403; MIAZAKI S, 1989, INTRACRANIAL PRESSUR, V7, P651; MILLER LP, 1989, BRAIN RES, V495, P367, DOI 10.1016/0006-8993(89)90230-8; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; NORTH RA, 1979, LIFE SCI, V24, P1527, DOI 10.1016/0024-3205(79)90014-6; ORI C, 1989, ANESTHESIOLOGY, V70, P541, DOI 10.1097/00000542-198903000-00027; PATERSON SJ, 1983, BRIT MED BULL, V39, P31, DOI 10.1093/oxfordjournals.bmb.a071787; Paxinos G, 1986, RAT BRAIN STEREOTAXI; PERRY DC, 1986, EUR J PHARMACOL, V129, P147, DOI 10.1016/0014-2999(86)90346-8; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; TEJWANI GA, 1991, NEUROPHARMACOLOGY, V30, P643, DOI 10.1016/0028-3908(91)90085-P; VINK R, 1990, J NEUROSCI, V10, P3524; ZIMMERMAN RS, 1990, NEUROSURGERY, V26, P764, DOI 10.1227/00006123-199005000-00005	32	14	14	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512	1044-7393			MOL CHEM NEUROPATHOL	Mol. Chem. Neuropathol.	FEB-APR	1992	16	1-2					95	107		10.1007/BF03159963			13	Neurosciences; Pathology	Neurosciences & Neurology; Pathology	HQ515	WOS:A1992HQ51500008	1325802				2021-06-18	
J	MARK, AS; PHISTER, SH; JACKSON, DE; KOLSKY, MP				MARK, AS; PHISTER, SH; JACKSON, DE; KOLSKY, MP			TRAUMATIC LESIONS OF THE SUPRASELLAR REGION - MR IMAGING	RADIOLOGY			English	Article						BRAIN, HEMORRHAGE; BRAIN, INJURIES; BRAIN, MR; NERVES, OPTIC	PITUITARY-STALK RUPTURE; DIABETES-INSIPIDUS; CHIASMAL SYNDROME; HEAD-INJURY	The authors studied nine patients with injuries to the suprasellar region with 1.5-T magnetic resonance (MR) imaging. Five patients had chiasmal injuries diagnosed by means of clinical examination. MR imaging demonstrated complete transection in two of these five patients, contusion of the chiasm by inferior herniation of the gyrus rectus in one, and a normal chiasm in two. Two patients had large tears of the floor of the third ventricle resulting in wide communication between the third ventricle and the prepontine cistern. One of these patients also had an avulsed third nerve. Transection of the pituitary stalk was seen in two patients. MR imaging can demonstrate injuries to the suprasellar structures. The MR imaging appearance of optic chiasm correlates with different types of injury to the chiasm described in the clinical literature and may alleviate the need for additional diagnostic studies to help explain the patient's symptoms.	UNIV CALIF SAN FRANCISCO,DEPT RADIOL,SAN FRANCISCO,CA 94143; GEORGE WASHINGTON UNIV,DEPT RADIOL,WASHINGTON,DC 20052; WASHINGTON HOSP CTR,DEPT OPHTHALMOL,WASHINGTON,DC 20010	MARK, AS (corresponding author), WASHINGTON HOSP CTR,DEPT RADIOL,110 IRVING ST NW,WASHINGTON,DC 20010, USA.						CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; FISHER NF, 1968, AM J OPHTHALMOL, V65, P237, DOI 10.1016/0002-9394(68)93594-0; FUJISAWA I, 1987, RADIOLOGY, V165, P487, DOI 10.1148/radiology.165.2.3659371; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GUY J, 1990, OPHTHALMOLOGY, V97, P592; HALIMI P, 1988, J COMPUT ASSIST TOMO, V12, P135, DOI 10.1097/00004728-198801000-00026; KELLY WM, 1988, AM J NEURORADIOL, V9, P453; MASSOL J, 1987, NEURORADIOLOGY, V29, P299, DOI 10.1007/BF00451773; OSTERBERG G, 1928, ACTA OPHTHALMOL, V16, P466; RAND CW, 1937, B LOS ANGELES NEUROL, V2, P91; RESNECK JD, 1981, AM J OPHTHALMOL, V92, P233, DOI 10.1016/0002-9394(81)90778-9; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; Traquair HM, 1935, BRAIN, V58, P398, DOI 10.1093/brain/58.3.398; WALSH FB, 1960, AM J OPHTHALMOL, V50, P1031, DOI 10.1016/0002-9394(60)90990-9; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215	16	14	16	0	0	RADIOLOGICAL SOC NORTH AMER	EASTON	20TH AND NORTHAMPTON STS, EASTON, PA 18042	0033-8419			RADIOLOGY	Radiology	JAN	1992	182	1					49	52		10.1148/radiology.182.1.1727308			4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	GW054	WOS:A1992GW05400012	1727308				2021-06-18	
J	SJOGREN, A; THELESTAM, M; BLOMQVIST, L; LINDA, H; REMAHL, S; RISLING, M				SJOGREN, A; THELESTAM, M; BLOMQVIST, L; LINDA, H; REMAHL, S; RISLING, M			EXTRAVASATION OF STAPHYLOCOCCAL ALPHA-TOXIN IN NORMAL AND INJURED CNS REGIONS LACKING BLOOD-BRAIN-BARRIER FUNCTION - OBSERVATIONS AFTER VENTRAL ROOT REPLANTATION	BRAIN RESEARCH			English	Article						BLOOD BRAIN BARRIER; INFECTION; BACTERIAL TOXIN; SPINAL CORD LESION; CENTRAL NERVOUS SYSTEM REGENERATION	NERVE GROWTH-FACTOR; SPINAL-CORD; ULTRASTRUCTURAL-LOCALIZATION; AXONAL REGENERATION; OPTIC-NERVE; ADULT CATS; RAT; NEURONS; SYSTEM; REINNERVATION	Staphylococcus aureus plays an important role as a bacterial pathogen after traumatic injury. The majority of isolated strains produces alpha-toxin, a 33-kDa protein, with membrane-damaging and lethal effects. The central nervous system (CNS) has been considered as the possible target for the lethal action of this toxin. A transfer of alpha-toxin across an intact blood-brain barrier (BBB) is however unlikely. The aim of the present study was to determine if alpha-toxin is accumulated in CNS regions which lack the BBB function. The distribution of alpha-toxin after intravascular injections, in normal mice and rats as well as in rats subjected to ventral root replantation, was assessed using immunogold technique. The results show that, although alpha-toxin does not cross the BBB, alpha-toxin-like immunoreactivity could be detected in the area postrema and at the optic nerve-retinal junction. Extravasation of alpha-toxin was also shown to occur in the spinal cord even 22 months after ventral root replantation. This finding suggests that axon regeneration after ventral root replantation takes place in a macromolecular environment which is totally different from the normal CNS. The implications of vascular spread of alpha-toxin to regions devoid of BBB function are discussed in relation to the bacterial infections which might complicate severe spinal injuries.	KAROLINSKA INST,DEPT ANAT,POB 60400,S-10401 STOCKHOLM 60,SWEDEN; KAROLINSKA INST,DEPT BACTERIOL,S-10401 STOCKHOLM 60,SWEDEN							ADAMO P, 1989, CAN J CARDIOL, V5, P395; BASBAUM AI, 1989, J HISTOCHEM CYTOCHEM, V37, P1811, DOI 10.1177/37.12.2479673; BHAKDI S, 1988, PROG ALLERGY, V40, P1; BHAKDI S, 1988, J EXP MED, V168, P527, DOI 10.1084/jem.168.2.527; BLOMQVIST L, 1987, INFECT IMMUN, V55, P1906, DOI 10.1128/IAI.55.8.1906-1913.1987; BLOMQVIST L, 1988, TOXICON, V26, P265, DOI 10.1016/0041-0101(88)90217-6; BORISON HL, 1989, TOXICOL APPL PHARM, V101, P399, DOI 10.1016/0041-008X(89)90190-7; BROMAN T, 1964, ACTA NEUROL SCAND, V40, P21, DOI 10.1111/j.1600-0404.1964.tb04718.x; CARLSTEDT T, 1986, ACTA PHYSIOL SCAND, V128, P645, DOI 10.1111/j.1748-1716.1986.tb08024.x; Carlstedt T, 1977, Acta Physiol Scand Suppl, V446, P5; CARPENTER DO, 1990, CAN J PHYSIOL PHARM, V68, P230, DOI 10.1139/y90-036; CHEN KF, 1987, TOXICON, V25, P631; CULLHEIM S, 1989, NEUROSCIENCE, V29, P725, DOI 10.1016/0306-4522(89)90144-9; DEWAELE M, 1988, J HISTOCHEM CYTOCHEM, V36, P679, DOI 10.1177/36.6.3259250; DUMOULIN GC, 1985, BRAIN RES, V340, P261, DOI 10.1016/0006-8993(85)90922-9; EDELWEJN Z, 1973, TOXICOL APPL PHARM, V25, P1, DOI 10.1016/0041-008X(73)90156-7; GATTI PJ, 1988, BRAIN RES, V448, P313, DOI 10.1016/0006-8993(88)91269-3; HARSHMAN S, 1985, TOXICON, V23, P801, DOI 10.1016/0041-0101(85)90011-X; HILDEBRAND C, 1985, J NEUROCYTOL, V14, P597, DOI 10.1007/BF01200800; HILDEBRAND C, 1976, J COMP NEUROL, V170, P191, DOI 10.1002/cne.901700205; KIERNAN JA, 1979, BIOL REV, V54, P155, DOI 10.1111/j.1469-185X.1979.tb00871.x; KIERNAN JA, 1980, ACTA NEUROPATHOL, V51, P39, DOI 10.1007/BF00688848; KIERNAN JA, 1985, J ANAT, V141, P139; LIPMAN JJ, 1985, TOXICON, V23, P325, DOI 10.1016/0041-0101(85)90155-2; LOHLER J, 1988, J NEUROIMMUNOL, V20, P181, DOI 10.1016/0165-5728(88)90159-2; MELLICK RS, 1968, BRAIN, V91, P141, DOI 10.1093/brain/91.1.141; PERSSON L, 1976, ACTA NEUROPATHOL, V34, P125, DOI 10.1007/BF00684663; PERSSON MAA, 1989, J NEUROIMMUNOL, V22, P135, DOI 10.1016/0165-5728(89)90044-1; Priestley JV, 1984, IMMUNOLABELLING ELEC, P37; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; RISLING M, 1983, BRAIN RES, V280, P15, DOI 10.1016/0006-8993(83)91169-1; RISLING M, 1989, BRAIN RES, V494, P13, DOI 10.1016/0006-8993(89)90138-8; RISLING M, 1990, PATHOPHYSIOLOGY BLOO, P555; ROSENSTEIN JM, 1987, SCIENCE, V235, P772, DOI 10.1126/science.2433767; ROTH J, 1978, J HISTOCHEM CYTOCHEM, V26, P1074, DOI 10.1177/26.12.366014; SASAKI T, 1986, NEUROSURGERY, V19, P177, DOI 10.1227/00006123-198608000-00002; SCHULTZBERG M, 1988, J NEUROSCI RES, V21, P56, DOI 10.1002/jnr.490210109; STEINWALL O, 1965, ACTA NEUROL SCAND, V4113, P591; STEPHANI U, 1987, J NEUROSCI RES, V17, P25, DOI 10.1002/jnr.490170105; STEWART PA, 1987, J NEUROSURG, V67, P697, DOI 10.3171/jns.1987.67.5.0697; STOECKEL K, 1977, BRAIN RES, V132, P273, DOI 10.1016/0006-8993(77)90421-8; THELESTAM M, 1988, TOXICON, V26, P51, DOI 10.1016/0041-0101(88)90137-7; VARNDELL IM, 1986, MODERN METHODS APPLI, P147; WADSTROM T, 1968, BIOCHIM BIOPHYS ACTA, V168, P228, DOI 10.1016/0005-2795(68)90146-3; ZAMBONI L, 1967, J CELL BIOL, V35, pA148	45	14	14	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	SEP 20	1991	559	2					276	282		10.1016/0006-8993(91)90012-K			7	Neurosciences	Neurosciences & Neurology	GK827	WOS:A1991GK82700012	1794101				2021-06-18	
J	DEACON, D; CAMPBELL, KB				DEACON, D; CAMPBELL, KB			DECISION-MAKING FOLLOWING CLOSED-HEAD INJURY - CAN RESPONSE SPEED BE RETRAINED	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							REACTION-TIME; P300	The present study was designed to assess the extent to which the effects of feedback (FB) and time windows, on the RTs of closed-head-injured outpatients, might carry-over when these external cues were removed. RT and evoked potentials were recorded while 12 closed-head-injured outpatients and 12 matched controls performed an auditory discrimination task. The FB and time windows were provided on three trials, then gradually removed. Following the removal of the FB and windows, patient RTs remained significantly faster and were approximately equal to the RTs of controls prior to the presentation of the cues. As in controls, the RTs of patients following removal of the cues occurred at approximately the same time as their P300s (the latency of this event-related potential component is thought to index stimulus evaluation time). To this extent, patient RTs did not appear to be exaggerated beyond the time needed for stimulus evaluation. The results obtained, therefore, provided tentative evidence that the experimental manipulation might have a lasting effect on CHI patient RTs.	UNIV OTTAWA,OTTAWA K1N 6N5,ONTARIO,CANADA							ANNETT J, 1966, Q J EXP PSYCHOL, V18, P179, DOI 10.1080/14640746608400027; BROOKHUIS KA, 1983, BIOL PSYCHOL, V17, P277, DOI 10.1016/0301-0511(83)90004-2; CAMPBELL K, 1986, STUDIES EVENT RELATE, V38, P486; Damasio A., 1979, CLIN NEUROPSYCHOLOGY, P360; DEACON D, 1991, ELECTROEN CLIN NEURO, V78, P133, DOI 10.1016/0013-4694(91)90113-I; DEACON D, 1990, UNPUB SPEED DECISION; DENCKER SJ, 1958, ACTA PSYCHIAT NEUROL, V33, P122; DUNCANJOHNSON CC, 1981, SCIENCE, V214, P938, DOI 10.1126/science.7302571; GREEN DM, 1966, SIGNAL DETECTION THE; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gronwall D.M., 1974, PSYCHOL EFFECTS CONC; JENNETT B, 1975, LANCET, V1, P480; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P169; MAZZIOTTA J C, 1986, P493; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Miller E, 1970, Cortex, V6, P121; MULDER G, 1984, PSYCHOL RES-PSYCH FO, V46, P15, DOI 10.1007/BF00308590; NORRMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236, DOI 10.1111/j.1600-0447.1961.tb07359.x; Pachella R. G., 1974, HUMAN INFORM PROCESS, P41; Rabbit P.M.A., 1981, HUMAN SKILLS, P153; RABBITT P, 1979, BRIT J PSYCHOL, V70, P305, DOI 10.1111/j.2044-8295.1979.tb01687.x; RAGOT R, 1981, BIOL PSYCHOL, V13, P289, DOI 10.1016/0301-0511(81)90044-2; RAGOT R, 1984, PSYCHOPHYSIOLOGY, V21, P159, DOI 10.1111/j.1469-8986.1984.tb00199.x; RIMEL RW, 1983, REHABILITATION HEAD, P9; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; RUSSELL WR, 1971, TRAUMATIC AMNESIAS; SHALLICE T, 1982, NEUROPSYCHOLOGY COGN, P199; Van Zomeren A. H., 1981, REACTION TIME ATTENT	31	14	14	0	0	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	SEP	1991	13	5					639	651		10.1080/01688639108401079			13	Psychology, Clinical; Clinical Neurology; Psychology	Psychology; Neurosciences & Neurology	GK476	WOS:A1991GK47600001	1955521				2021-06-18	
J	ENDO, M; ICHIKAWA, F; MIYASAKA, Y; YADA, K; OHWADA, T				ENDO, M; ICHIKAWA, F; MIYASAKA, Y; YADA, K; OHWADA, T			CAPSULAR AND THALAMIC INFARCTION CAUSED BY TENTORIAL HERNIATION SUBSEQUENT TO HEAD TRAUMA	NEURORADIOLOGY			English	Article						DESCENDING TRANSTENTORIAL HERNIATION; CAPSULAR INFARCTION; THALAMIC INFARCTION; CT SCAN	COMPUTED TOMOGRAPHY	Five patients (4 male and 1 female) were observed to have capsular and thalamic infarction ascribed to descending transtentorial herniation (DTH) caused by head injury. A lucid interval immediately after the trauma and the presence of an epidural hematoma (EDH) characterized all five cases. At the time of hospitalization consciousness was seriously impaired and signs of cerebral herniation were apparent. Two to four days after the trauma, low attenuation in the computed tomography (CT) images pinpointed intracerebral damage in the anterolateral part of the thalamus and in the internal capsule on the same side as that of the EDH in three patients, and in the other two patients bilateral thalamic and capsular damage was noted. The low attenuation implicated the perforating arteries, that is the anterior thalamoperforating and anterior choroidal arteries, suggesting infarcted regions caused by occlusion of these arteries. Findings in the present study suggest that arterial occlusion in closed head injury may result from DTH. Moreover, infarction may be attributed to the delayed effects of injury.	KITASATO UNIV,SCH MED,DEPT CRIT CARE & EMERGENCY MED,SAGAMIHARA,KANAGAWA 228,JAPAN; KITASATO UNIV,SCH MED,DEPT NEUROSURG,SAGAMIHARA,KANAGAWA 228,JAPAN	ENDO, M (corresponding author), INT GOODWILL GEN HOSP,DEPT NEUROSURG,1-28-1 NISHIGAOKA,IZUMI KU,YOKOHAMA 245,JAPAN.						Evans JP, 1943, ARCH NEURO PSYCHIATR, V50, P258, DOI 10.1001/archneurpsyc.1943.02290210036002; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; LAZORTHES G, 1971, J NEUROSURG, V34, P23, DOI 10.3171/jns.1971.34.1.0023; LINDENBERG R, 1955, J NEUROPATH EXP NEUR, V14, P223, DOI 10.1097/00005072-195507000-00001; NAGASHIMA C, 1985, PROGR COMPUT TOMOGR, V7, P65; NIIKAWA S, 1988, Brain and Nerve (Tokyo), V40, P1151; OSBORN AG, 1977, RADIOLOGY, V123, P93, DOI 10.1148/123.1.93; Plets C, 1970, Acta Neurol Belg, V70, P687; STOVRING J, 1977, NEURORADIOLOGY, V14, P101, DOI 10.1007/BF00333050	10	14	14	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0028-3940			NEURORADIOLOGY	Neuroradiology		1991	33	4					296	299		10.1007/BF00587809			4	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GA826	WOS:A1991GA82600002	1922742				2021-06-18	
J	Marsh, NV; Knight, RG; Godfrey, HPD				Marsh, Nigel V.; Knight, Robert G.; Godfrey, Hamish P. D.			Long-Term Psychosocial Adjustment Following Very Severe Closed Head Injury	NEUROPSYCHOLOGY			English	Article						Psychosocial adjustment; very severe closed head injury; chronic, community-dwelling, poor-outcome patients		This study examined the cognitive, psychological, and social functioning of 18 community-dwelling patients who had experienced a very severe closed head injury at least 18 months previously and still required contact with rehabilitation services. Results from the patients were compared to those obtained by a group of normal control subjects matched on age, sex, years of education, and an estimate of premorbid IQ. Information on the subjects' behavior was also obtained from their significant others. Results showed that the closed head injury patients exhibited deficits in their cognitive and social functioning but showed no signs of emotional or psychiatric disturbance. Attempts to find a relationship between the patients' cognitive impairment and their social functioning were only partially successful.	[Marsh, Nigel V.] Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand; [Knight, Robert G.; Godfrey, Hamish P. D.] Univ Otago, Dept Psychol, Dunedin, New Zealand	Marsh, NV (corresponding author), Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand.		Marsh, Nigel V./F-5433-2019	Marsh, Nigel V./0000-0002-4060-6432	Accident Compensation Corporation of New Zealand	This study was funded in part by the Accident Compensation Corporation of New Zealand.	BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS DN, 1984, CLOSED HEAD INJURY P; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Buschke H., 1973, J VERB LEARN VERB BE, V12, P72; DEROGATIS L R, 1973, Psychopharmacology Bulletin, V9, P13; ELSASS L, 1987, PSYCHOL MED, V17, P67, DOI 10.1017/S003329170001299X; GODFREY HPD, 1987, NEW ZEAL J PSYCHOL, V16, P49; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Grove W. M., 1982, J NERV MENT DIS, V170, P2; HOLM S, 1979, SCAND J STAT, V6, P65; KNIGHT RG, 1984, J CONSULT CLIN PSYCH, V52, P769; KNIGHT RG, 1984, J CLIN PSYCHOL, V40, P751, DOI 10.1002/1097-4679(198405)40:3<751::AID-JCLP2270400320>3.0.CO;2-Y; KORIAT A, 1985, J EXP PSYCHOL HUMAN, V11, P490, DOI 10.1037/0096-1523.11.4.490; KRAEMER HC, 1983, PSYCHOL BULL, V94, P367, DOI 10.1037/0033-2909.94.2.367; LARZELERE RE, 1977, PSYCHOL BULL, V84, P557, DOI 10.1037/0033-2909.84.3.557; LEVIN HS, 1982, NEUROBEHAVIOURAL CON; MCCORMICK IA, 1985, BEHAV ASSESS, V7, P95; McGill C.W., 1984, FAMILY CARE SCHIZOPH; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1984, NEUROSURGERY, V14, P393, DOI 10.1227/00006123-198404000-00001; Nelson HE, 1982, NATL ADULT READING T; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PASHLER H, 1985, J EXP PSYCHOL HUMAN, V11, P105, DOI 10.1037/0096-1523.11.2.105; PECK DF, 1970, J CLIN PSYCHOL, V26, P67, DOI 10.1002/1097-4679(197001)26:1<67::AID-JCLP2270260117>3.0.CO;2-T; POWELL GE, 1980, BRIT J SOC CLIN PSYC, V19, P189, DOI 10.1111/j.2044-8260.1980.tb00947.x; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RATHUS SA, 1973, BEHAV THER, V4, P398, DOI 10.1016/S0005-7894(73)80120-0; Raven J.C.C.J., 1977, MANUAL RAVENS PROGR; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1126/science.148.3671.804; ROSENTHAL M, 1983, REHABILITATION HEAD; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Snedecor G.W., 1980, STAT METHODS, V7th; Spielberger C.D., 1985, ANGER HOSTILITY CARD; SPIELBERGER CD, 1979, PRELIMINARY MA UNPUB; Wechsler D., 1955, MANUAL WECHSLER ADUL; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111	41	14	14	0	7	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JAN	1990	4	1					13	27		10.1037/0894-4105.4.1.13			15	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	V44JX	WOS:000209746400002					2021-06-18	
J	LANSER, JBK; JENNEKENSSCHINKEL, A; PETERS, ACB				LANSER, JBK; JENNEKENSSCHINKEL, A; PETERS, ACB			HEADACHE AFTER CLOSED HEAD-INJURY IN CHILDREN	HEADACHE			English	Article									STATE UNIV HOSP LEIDEN,DEPT CHILD NEUROL,2300 RC LEIDEN,NETHERLANDS	LANSER, JBK (corresponding author), STATE UNIV HOSP LEIDEN,DEPT NEUROPSYCHOL,POB 9600,2300 RC LEIDEN,NETHERLANDS.						BARLOW CF, 1984, CLIN DEV MED, V91; BEEKMAN F, 1928, ANN SURG, V3, P355; BILLE B, 1962, ACTA PAEDIATR, V51, P33; BILLE B, 1968, HDB CLINICAL NEUROLO, V5, P239; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BLACK P, 1971, HEAD INJURIES, P131; Black P, 1972, T AM NEUROL ASSOC, V97, P247; BLACK P, 1969, LATE EFFECTS HEAD IN, P142; Black P, 1975, CIBA F S, V34, P215; BLACK P, 1970, PHYSICAL TRAUMA ETIO, P287; Black P, 1981, BRAIN DYSFUNCTION CH, P171; BURKINSHAW J, 1960, ARCH DIS CHILD, V35, P205, DOI 10.1136/adc.35.181.205; HJERN B, 1964, ACTA PAEDIAT SCAND S, V152; JAY GW, 1981, HEADACHE, V21, P5, DOI 10.1111/j.1526-4610.1981.hed2101005.x; KIENE S, 1968, SCHADELHIRNTRAUMA KI; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KOCH C, 1969, DAN MED BULL, V16, P109; LANGECOSACK H, 1973, HIRNTRAUMA KINDES JU; LAUX W, 1960, MED KLIN, V51, P2273; Paris R., 1974, CLIN NEUROPSYCHOLOGY, P179; ROTHNER AD, 1978, HEADACHE, V18, P169, DOI 10.1111/j.1526-4610.1978.hed1803169.x; ROWBOTHAM GF, 1954, BRIT MED J, V1, P726, DOI 10.1136/bmj.1.4864.726; SILANPAA M, 1976, HEADACHE, V16, P288; SSOUHAREVA G, 1935, Z KINDERPSYCHIAT, V1, P165	24	14	15	0	1	AMER ASSOC STUDY HEADACHE	WOODBURY	875 KINGS HIGHWAY, STE 200, WOODBURY, NJ 08096	0017-8748			HEADACHE	Headache	APR	1988	28	3					176	179		10.1111/j.1526-4610.1988.hed2803176.x			4	Clinical Neurology	Neurosciences & Neurology	M8942	WOS:A1988M894200001	3384643				2021-06-18	
J	DAVIS, CS; ACTON, P				DAVIS, CS; ACTON, P			TREATMENT OF THE ELDERLY BRAIN-INJURED PATIENT - EXPERIENCE IN A TRAUMATIC BRAIN INJURY UNIT	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article									GAYLORD HOSP,WALLINGFORD,CT							CARLSSON CA, 1968, J NEUROSURG, V29, P242, DOI 10.3171/jns.1968.29.3.0242; CARTLIDGE NEF, 1981, MAJOR PROBLEMS NEURO, V10, P13; CAVENESS WF, 1979, ADV NEUROL, V22, P1; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P67, DOI 10.1007/BF01809175; JENNETT B, 1976, LANCET, V1, P1031; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; MALKMUS D, 1980, REHABILITATION HEAD; ROSENTHAL M, 1983, REHABILITATION HEAD; TEASDALE G, 1982, HEAD INJURY BASIC CL, P213	9	14	14	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0002-8614			J AM GERIATR SOC	J. Am. Geriatr. Soc.	MAR	1988	36	3					225	229		10.1111/j.1532-5415.1988.tb01805.x			5	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	M4419	WOS:A1988M441900007	3339231				2021-06-18	
J	FISHER, JM				FISHER, JM			COGNITIVE AND BEHAVIORAL CONSEQUENCES OF CLOSED HEAD-INJURY	SEMINARS IN NEUROLOGY			English	Article										FISHER, JM (corresponding author), NEW MEDICO ASSOC INC, CTR NEUROL, 28 KELLOGG RD, CORTLAND, NY 13045 USA.						ADAMOVICH BB, 1985, COGNITIVE REHABILITA; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BECKER B, 1977, J CLIN PSYCHOL, V47, P307; BENNA P, 1982, ITAL J NEUROL SCI, V3, P281, DOI 10.1007/BF02043575; BENTON A, 1979, CENTRAL NERVOUS SYST, P220; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; BOND MR, 1975, OUTCOME SEVERE DAMAG, P141; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS N, 1985, COMMUNICATION   0429; BROOKS N, 1983, REHABILITATION HEAD, P185; COPE D, 1982, INCIDENCE PREVALENCE, P1; COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; DRUDGE OW, 1984, J CLIN PSYCHOL, V40, P259, DOI 10.1002/1097-4679(198401)40:1<259::AID-JCLP2270400149>3.0.CO;2-C; DYE OA, 1981, J CLIN PSYCHOL, V37, P472, DOI 10.1002/1097-4679(198107)37:3<472::AID-JCLP2270370304>3.0.CO;2-Q; FISHER J, 1981, THESIS U ROCHESTER; GAROUTTE B, 1984, PSYCHIAT ANN, V14, P507, DOI 10.3928/0048-5713-19840701-08; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; Hagen C, 1981, TOP LANG DIS, V1, P73; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; JARVIE H, 1963, Curr Med Drugs, V3, P15; Jennett B, 1981, MANAGEMENT HEAD INJU; KALSBEEK WD, 1980, J NEUROSURG, V53, P519; KURTZKE JF, 1982, NEUROLOGY, V32, P1207, DOI 10.1212/WNL.32.11.1207; KWENTUS JA, 1985, PSYCHOSOMATICS, V26, P8, DOI 10.1016/S0033-3182(85)72900-3; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LIPOWSKI ZJ, 1978, COMPR PSYCHIAT, V19, P309, DOI 10.1016/0010-440X(78)90013-5; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; LISHMAN WA, 1978, J IRISH MED ASSOC, V71, P306; Luria A.R., 1980, HIGHER CORTICAL FUNC, V2nd; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MACKWORTH N, 1982, COGNITIVE VISUAL ASS, P1; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; MCLEAN A, 1983, J CLIN NEUROPSYCHOL, V5, P361, DOI 10.1080/01688638308401185; MERSKEY H, 1972, BRAIN, V95, P521, DOI 10.1093/brain/95.3.521; MILLER E, 1979, BRIT J SOC CLIN PSYC, V18, P87, DOI 10.1111/j.2044-8260.1979.tb00310.x; Miller E, 1970, Cortex, V6, P121; MILLER E, 1984, RECOVERY MANAGEMENT; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MUIR CA, 1983, REHABILITATION HEAD, P381; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; ROBINSON RG, 1981, ANN NEUROL, V9, P447, DOI 10.1002/ana.410090506; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenthal M., 1983, REHABILITATION HEAD, P197; ROSENTHAL M, 1983, REHABILITATION HEAD, P407; ROWE MJ, 1980, ARCH NEUROL-CHICAGO, V37, P679, DOI 10.1001/archneur.1980.00500600027002; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; RUTHERFORD WH, 1977, LANCET, V1, P1; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SMITH E, 1974, J NEUROL NEUROSUR PS, V37, P719, DOI 10.1136/jnnp.37.6.719; Strub R. L., 1981, ORGANIC BRAIN SYNDRO; STUSS D, NEUROSURGERY; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; SYMONDS C, 1962, LANCET, V1, P1; TAYLOR AR, 1966, LANCET, V2, P178; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; TRIMBLE M, 1983, POST TRAUMATIC NEURO; TSUANG MT, 1985, AM J PSYCHIAT, V142, P538; Van Zomeren A. H., 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Whishaw W. H., 1980, FUNDAMENTALS HUMAN N; Wood R., 1984, CLOSED HEAD INJURY P, P195	81	14	14	0	3	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.		1985	5	3					197	204		10.1055/s-2008-1041516			8	Clinical Neurology	Neurosciences & Neurology	APU75	WOS:A1985APU7500002					2021-06-18	
J	LEVIN, HS; KALISKY, Z; HANDEL, SF; GOLDMAN, AM; EISENBERG, HM; MORRISON, D; VONLAUFEN, A				LEVIN, HS; KALISKY, Z; HANDEL, SF; GOLDMAN, AM; EISENBERG, HM; MORRISON, D; VONLAUFEN, A			MAGNETIC-RESONANCE IMAGING IN RELATION TO THE SEQUELAE AND REHABILITATION OF DIFFUSE CLOSED HEAD-INJURY - PRELIMINARY FINDINGS	SEMINARS IN NEUROLOGY			English	Article										LEVIN, HS (corresponding author), UNIV TEXAS, MED BRANCH, DIV NEUROSURG, GALVESTON, TX 77550 USA.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; BYDDER GM, 1982, AM J ROENTGENOL, V139, P215, DOI 10.2214/ajr.139.2.215; CROOKS LE, 1982, RADIOLOGY, V144, P843, DOI 10.1148/radiology.144.4.7111736; GANDY SE, 1984, ANN NEUROL, V16, P254, DOI 10.1002/ana.410160217; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; HANNAY H J, 1982, Journal of Clinical Neuropsychology, V4, P117; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Holbourn AHS, 1943, LANCET, V2, P438; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; KIMURA D, 1963, ARCH NEUROL-CHICAGO, V8, P264, DOI 10.1001/archneur.1963.00460030048004; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1981, ARCH NEUROL-CHICAGO, V38, P623, DOI 10.1001/archneur.1981.00510100051007; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1977, CORTEX, V13, P119, DOI 10.1016/S0010-9452(77)80003-8; LEVIN HS, 1981, BRAIN LANG, V12, P360, DOI 10.1016/0093-934X(81)90025-0; LEVIN HS, 1982, NEUROBEHAVIORAL CONS; LEVIN HS, BRAIN; LEVIN HS, ARCH NEUROL; MANDLEBERG IA, 1976, J NEUROL NEUROSUR PS, V39, P1001, DOI 10.1136/jnnp.39.10.1001; MEYERS CA, 1983, J NEUROL NEUROSUR PS, V46, P1092, DOI 10.1136/jnnp.46.12.1092; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; RUBENS AB, 1977, ARCH NEUROL-CHICAGO, V34, P750, DOI 10.1001/archneur.1977.00500240038006; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; TEASDALE G, 1974, LANCET, V2, P81; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452	38	14	14	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.		1985	5	3					221	232		10.1055/s-2008-1041519			12	Clinical Neurology	Neurosciences & Neurology	APU75	WOS:A1985APU7500005					2021-06-18	
J	BECKER, B				BECKER, B			INTELLECTUAL CHANGES AFTER CLOSED HEAD-INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article									USN,MED CTR,PSYCHOL DEPT,BETHESDA,MD 20014							HOTELLING H, 1951, 2 P BERK S MATH STAT, V23; Matarazzo JD, 1972, WECHSLERS MEASUREMEN	2	14	14	0	0	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.		1975	31	2					307	309		10.1002/1097-4679(197504)31:2<307::AID-JCLP2270310231>3.0.CO;2-Y			3	Psychology, Clinical	Psychology	AA380	WOS:A1975AA38000030	1133197				2021-06-18	
J	GRUBB, RL; NAUMANN, RA; OMMAYA, AK				GRUBB, RL; NAUMANN, RA; OMMAYA, AK			RESPIRATION AND CEREBROSPINAL FLUID IN EXPERIMENTAL CEREBRAL CONCUSSION	JOURNAL OF NEUROSURGERY			English	Article																COOK AW, 1961, J NEUROSURG, V18, P366, DOI 10.3171/jns.1961.18.3.0366; DUCKER TB, 1968, J NEUROSURG, V28, P118, DOI 10.3171/jns.1968.28.2.0118; DUCKER TB, 1968, J NEUROSURG, V28, P112, DOI 10.3171/jns.1968.28.2.0112; DUCKER TB, 1968, J NEUROSURG, V29, P475, DOI 10.3171/jns.1968.29.5.0475; FAAS FH, 1968, J NEUROSURG, V28, P137, DOI 10.3171/jns.1968.28.2.0137; Flamm E S, 1966, Surg Forum, V17, P414; FORMAN C, 1968, BR J ANAESTH, V40, P354; HUANG CT, 1963, ARCH NEUROL-CHICAGO, V9, P545, DOI 10.1001/archneur.1963.00460110113012; INGVAR DM, 1968, SCAND J CLIN LA S102, V22; LUNDBERG N, 1959, Acta Psychiatr Scand Suppl, V34, P1; MACIVER IN, 1968, LANCET, V1, P390; MOODY RA, 1969, J NEUROSURG, V30, P482, DOI 10.3171/jns.1969.30.4.0482; NAERAA N, 1963, ACTA ANAESTH SCAND, V7, P191, DOI 10.1111/j.1399-6576.1963.tb00219.x; NAUMANN RA, IN PRESS; Ommaya A K, 1966, Ann R Coll Surg Engl, V39, P317; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1966, HEAD INJURY C P; OMMAYA AK, 1968 P INT C ACC PAT; PLUM F, 1959, ARCH NEURO PSYCHIATR, V81, P535, DOI 10.1001/archneurpsyc.1959.02340170001001; SCHNEDORF JG, 1940, SURG GYNECOL OBSTET, V70, P628; SIMMONS RL, 1968, J TRAUM, V8, P800, DOI 10.1097/00005373-196809000-00023; SIRIS JH, 1962, NEW YORK STATE J MED, V62, P1440; SWANN HE, 1960, ARCH PATHOL, V69, P557; YARNELL P, 1967, J NEUROSURG, V27, P515, DOI 10.3171/jns.1967.27.6.0515	24	14	14	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.		1970	32	3					320	&		10.3171/jns.1970.32.3.0320			0	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	F3720	WOS:A1970F372000008	4984664				2021-06-18	
J	Allison, TA; Lin, PJ; Gass, JA; Chong, K; Prater, SJ; Escobar, MA; Hartman, HD				Allison, Teresa A.; Lin, Pei Jen; Gass, Jennifer A.; Chong, Kenneth; Prater, Samuel J.; Escobar, Miguel A.; Hartman, Heather D.			Evaluation of the Use of Low-Dose 4-Factor Prothrombin Complex Concentrate in the Reversal of Direct Oral Anticoagulants in Bleeding Patients	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						anticoagulants; blood coagulation; hemostatics; therapeutic use; hemorrhage; prevention and control; hemorrhage; drug therapy; prothrombin complex concentrates	RIVAROXABAN; WARFARIN; EDOXABAN; DABIGATRAN; APIXABAN; MANAGEMENT	Objective: This study investigated the percentage of patients who achieved hemostasis with 4-factor prothrombin complex concentrate (4-factor PCC) 35 U/kg. The primary end point was to determine the effect of 4-factor PCC 35 U/kg on bleeding progression, assessed using computed tomography. Methods: This was a retrospective, observational, single-center study conducted in patients with a major bleed admitted to a level 1 trauma center from May 1, 2013, to June 15, 2015, who received 4-factor PCC 35 U/kg for reversal of a direct factor Xa inhibitor taken prior to admission. Results: Thirty-three patients were included in the study, with 31 patients in the final analysis. The mean (standard deviation) age was 73 (14.8) years; 54.5% of patients were female. Of the 33 patients, 13 presented with a traumatic brain injury, 9 with an aneurysmal subarachnoid hemorrhage, 8 with an intracerebral hemorrhage, 1 with a gastrointestinal bleed, 1 with a hematoma with active extravasation, and 1 with an intra-abdominal bleed. The most frequently used direct factor Xa inhibitor was rivaroxaban (81.8%). Overall, 83.8% of patients achieved hemostasis with 4-factor PCC 35 U/kg. Progression of hemorrhage was observed in 4 patients on repeat computed tomography scan and 1 patient had continued surgical bleeding. No thromboembolic events were reported. Conclusions: Low-dose, 4-factor PCC 35 U/kg appeared to produce hemostasis in a majority of the patients. This may be an effective dosing regimen for anticoagulant reversal of factor Xa inhibitors in clinically bleeding patients.	[Allison, Teresa A.; Lin, Pei Jen; Gass, Jennifer A.; Chong, Kenneth; Hartman, Heather D.] Mem Hermann Texas Med Ctr, Dept Pharm, Houston, TX 77030 USA; [Prater, Samuel J.; Escobar, Miguel A.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, McGovern Med Sch, Houston, TX 77030 USA	Hartman, HD (corresponding author), Mem Hermann Texas Med Ctr, Dept Pharm Serv, 6411 Fannin St, Houston, TX 77030 USA.	heather.hartman@memorialhermann.org	Gass, Jennifer/X-9446-2019	Gass, Jennifer/0000-0002-9113-4033			Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; [Anonymous], 2015, ELIQUIS; [Anonymous], 2014, XAR PACK INS; [Anonymous], 2015, PRAD PACK INS; [Anonymous], 2018, AND PACK INS; [Anonymous], 2014, KCENTR PACK INS; [Anonymous], 2015, SAVAYSA; [Anonymous], 2015, COUM PACK INS; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eerenberg ES, 2011, CIRCULATION, V124, P1573, DOI 10.1161/CIRCULATIONAHA.111.029017; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Herzog E, 2015, ANESTHESIOLOGY, V122, P387, DOI 10.1097/ALN.0000000000000520; Kalina U, 2008, INT J CLIN PRACT, V62, P1614, DOI 10.1111/j.1742-1241.2008.01859.x; Khorsand N, 2016, J THROMB HAEMOST, V14, P211, DOI 10.1111/jth.13148; Levi M, 2014, J THROMB HAEMOST, V12, P1428, DOI 10.1111/jth.12599; Majeed A, 2017, BLOOD, V130, P1706, DOI 10.1182/blood-2017-05-782060; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Perzborn E, 2010, PATHOPHYSIOL HAEMO T, V37; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schulman S, 2018, THROMB HAEMOSTASIS, V118, P842, DOI 10.1055/s-0038-1636541; Siegal DM, 2015, NEW ENGL J MED, V373, P2413, DOI 10.1056/NEJMoa1510991; Siegal DM, 2015, J THROMB THROMBOLYS, V39, P395, DOI 10.1007/s11239-015-1167-9; Zahir H, 2015, CIRCULATION, V131, P82, DOI 10.1161/CIRCULATIONAHA.114.013445	27	13	13	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	SEP	2020	35	9					903	908		10.1177/0885066618800657			6	Critical Care Medicine	General & Internal Medicine	MT2PL	WOS:000554807700011	30244638				2021-06-18	
J	Hawryluk, GWJ; Rubiano, AM; Totten, AM; O'Reilly, C; Ullman, JS; Bratton, SL; Chesnut, R; Harris, OA; Kissoon, N; Shutter, L; Tasker, RC; Vavilala, MS; Wilberger, J; Wright, DW; Lumba-Brown, A; Ghajar, J				Hawryluk, Gregory W. J.; Rubiano, Andres M.; Totten, Annette M.; O'Reilly, Cindy; Ullman, Jamie S.; Bratton, Susan L.; Chesnut, Randall; Harris, Odette A.; Kissoon, Niranjan; Shutter, Lori; Tasker, Robert C.; Vavilala, Monica S.; Wilberger, Jack; Wright, David W.; Lumba-Brown, Angela; Ghajar, Jamshid			Guidelines for the Management of Severe Traumatic Brain Injury: 2020 Update of the Decompressive Craniectomy Recommendations	NEUROSURGERY			English	Article						Traumatic brain injury; Head injury; Guideline; Fourth edition; Brain Trauma Foundation; Severe; Decompressive craniectomy; Craniectomy; Decompression; Surgery	INTRACRANIAL HYPERTENSION; TRIAL	When the fourth edition of the Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury were finalized in late 2016, it was known that the results of the RESCUEicp (Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension) randomized controlled trial of decompressive craniectomy would be public after the guidelines were released. The guideline authors decided to proceed with publication but to update the decompressive craniectomy recommendations later in the spirit of "living guidelines," whereby topics are updated more frequently, and between new editions, when important new evidence is published. The update to the decompressive craniectomy chapter presented here integrates the findings of the RESCUEicp study as well as the recently published 12-mo outcome data from the DECRA (Decompressive Craniectomy in Patients With Severe Traumatic Brain Injury) trial. Incorporation of these publications into the body of evidence led to the generation of 3 new level-IIA recommendations; a fourth previously presented level-IIA recommendation remains valid and has been restated. To increase the utility of the recommendations, we added a new section entitled incorporating the Evidence into Practice. This summary of expert opinion provides important context and addresses key issues for practitioners, which are intended to help the clinician utilize the available evidence and these recommendations. The full guideline can be found at: https://braintraurna.org/guidelines/guidelines-for-the-management-of-severe-tbi-4th-ed#/.	[Hawryluk, Gregory W. J.] Univ Manitoba, GB1 Hlth Sci Ctr, Sect Neurosurg, 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada; [Rubiano, Andres M.] Univ El Bosque, INUB MEDITECH Res Grp, Bogota, Colombia; [Rubiano, Andres M.] Valle Salud Clin, Cali, Colombia; [Totten, Annette M.; O'Reilly, Cindy] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Ullman, Jamie S.] Zucker Sch Med Hofstra Northwell, Hempstead, NY USA; [Bratton, Susan L.] Univ Utah, Salt Lake City, UT USA; [Chesnut, Randall; Vavilala, Monica S.] Univ Washington, Seattle, WA 98195 USA; [Harris, Odette A.; Lumba-Brown, Angela; Ghajar, Jamshid] Stanford Univ, Stanford, CA 94305 USA; [Kissoon, Niranjan] Univ British Columbia, Vancouver, BC, Canada; [Shutter, Lori] Univ Pittsburgh, Pittsburgh, PA USA; [Tasker, Robert C.] Harvard Med Sch, Boston, MA 02115 USA; [Tasker, Robert C.] Boston Childrens Hosp, Boston, MA USA; [Wilberger, Jack] Drexel Univ, Pittsburgh, PA USA; [Wright, David W.] Emory Univ, Atlanta, GA 30322 USA	Hawryluk, GWJ (corresponding author), Univ Manitoba, GB1 Hlth Sci Ctr, Sect Neurosurg, 820 Sherbrook St, Winnipeg, MB R3A 1R9, Canada.	ghawryluk@hsc.mb.ca		Tasker, Robert/0000-0003-3647-8113; Kissoon, Niranjan/0000-0001-8847-9973; Hawryluk, Gregory/0000-0002-5604-7057	US Army Contracting Command, Aberdeen ProvingGround, Natick ContractingDivision [W911 QY-14-C-0086]	This material is based upon work supported by (1) the US Army Contracting Command, Aberdeen ProvingGround, Natick ContractingDivision, through a contract awarded to Stanford University (W911 QY-14-C-0086). Any opinions, findings, and conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, or Stanford University. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. This material is based upon work supported by (1) the US Army Contracting Command, Aberdeen ProvingGround, Natick ContractingDivision, through a contract awarded to Stanford University (W911 QY-14-C-0086). Any opinions, findings, and conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, or Stanford University. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2020, INTENS CARE MED, V46, P919, DOI 10.1007/s00134-019-05900-x; Clark DJ, 2013, ACTA NEUROCHIR, V155, P1329, DOI 10.1007/s00701-013-1748-3; Cooper DJ, 2020, J NEUROTRAUM, V37, P810, DOI 10.1089/neu.2019.6869; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Dunn LT, 2002, J NEUROL NEUROSUR PS, V73, pI23; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Hawryluk GWJ, 2019, INTENS CARE MED, V45, DOI 10.1007/s00134-019-05805-9; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2019, ACTA NEUROCHIR, V161, P1261, DOI 10.1007/s00701-019-03936-y; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Marion DW, 2006, NEUROSURGERY, V58, P655; Monro Alexander, 1783, OBSERVATIONS STRUCTU; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Tsoucalas G, 2017, WORLD NEUROSURG, V103, P501, DOI 10.1016/j.wneu.2017.04.022; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	20	13	13	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	SEP	2020	87	3					427	434		10.1093/neuros/nyaa278			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	OW8HM	WOS:000593120600044	32761068	Green Published, Other Gold			2021-06-18	
J	Liu, S; Gao, JG; Zhu, MQ; Liu, KD; Zhang, HL				Liu, Shan; Gao, Jiguo; Zhu, Mingqin; Liu, Kangding; Zhang, Hong-Liang			Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment	MOLECULAR NEUROBIOLOGY			English	Article						Alzheimer's disease; Gut microbiota; Microbiota-gut-brain axis; Gut dysbiosis	TRANSGENIC MICE CORRELATE; TRAUMATIC BRAIN-INJURY; INTESTINAL MICROBIOTA; MEDITERRANEAN DIET; MOUSE MODEL; BILE-ACIDS; IMMUNE; HEALTH; EXPRESSION; BEHAVIOR	Understanding how gut flora influences gut-brain communications has been the subject of significant research over the past decade. The broadening of the term "microbiota-gut-brain axis" from "gut-brain axis" underscores a bidirectional communication system between the gut and the brain. The microbiota-gut-brain axis involves metabolic, endocrine, neural, and immune pathways which are crucial for the maintenance of brain homeostasis. Alterations in the composition of gut microbiota are associated with multiple neuropsychiatric disorders. Although a causal relationship between gut dysbiosis and neural dysfunction remains elusive, emerging evidence indicates that gut dysbiosis may promote amyloid-beta aggregation, neuroinflammation, oxidative stress, and insulin resistance in the pathogenesis of Alzheimer's disease (AD). Illustration of the mechanisms underlying the regulation by gut microbiota may pave the way for developing novel therapeutic strategies for AD. In this narrative review, we provide an overview of gut microbiota and their dysregulation in the pathogenesis of AD. Novel insights into the modification of gut microbiota composition as a preventive or therapeutic approach for AD are highlighted.	[Liu, Shan; Gao, Jiguo; Zhu, Mingqin; Liu, Kangding] Jilin Univ, Dept Neurol, First Hosp Jilin Univ, Xinmin St 71, Changchun 130021, Peoples R China; [Zhu, Mingqin] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Zhu, Mingqin] Mayo Clin, Dept Neurol, Rochester, MN USA; [Zhu, Mingqin] Mayo Clin, Dept Immunol, Rochester, MN USA; [Zhang, Hong-Liang] Natl Nat Sci Fdn China, Dept Life Sci, Shuangqing Rd 83, Beijing 100085, Peoples R China	Liu, KD (corresponding author), Jilin Univ, Dept Neurol, First Hosp Jilin Univ, Xinmin St 71, Changchun 130021, Peoples R China.; Zhang, HL (corresponding author), Natl Nat Sci Fdn China, Dept Life Sci, Shuangqing Rd 83, Beijing 100085, Peoples R China.	kangdingliu@163.com; drzhl@hotmail.com	Zhang, Hongliang/AAN-3077-2020	Zhang, Hongliang/0000-0001-9205-5559	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771299]	The work was supported by a grant from the National Natural Science Foundation of China (No. 81771299) to KL.	Abraham D, 2019, EXP GERONTOL, V115, P122, DOI 10.1016/j.exger.2018.12.005; Alexandrov PN, 2019, FOLIA NEUROPATHOL, V57, P211, DOI 10.5114/fn.2019.88449; Allegretti JR, 2019, LANCET, V394, P420, DOI 10.1016/S0140-6736(19)31266-8; Allegretti JR, 2018, GASTROINTEST ENDOSC, V87, P18, DOI 10.1016/j.gie.2017.05.036; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Arioz BI, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01511; Ashraf GM, 2019, MOL NEUROBIOL, V56, P4479, DOI 10.1007/s12035-018-1388-y; Asl ZR, 2019, BEHAV BRAIN RES, V376, DOI 10.1016/j.bbr.2019.112183; Bauerl C, 2018, LETT APPL MICROBIOL, V66, P464, DOI 10.1111/lam.12882; Bagarolli RA, 2017, J NUTR BIOCHEM, V50, P16, DOI 10.1016/j.jnutbio.2017.08.006; Baglietto-Vargas D, 2016, NEUROSCI BIOBEHAV R, V64, P272, DOI 10.1016/j.neubiorev.2016.03.005; Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x; Basu M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006240; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Bendiks ZA, 2020, NUTR RES, V77, P12, DOI 10.1016/j.nutres.2020.02.009; Berti V, 2018, NEUROLOGY, V90, pE1789, DOI 10.1212/WNL.0000000000005527; Boccardi V, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100936; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Bonfili L, 2020, NEUROBIOL AGING, V87, P35, DOI 10.1016/j.neurobiolaging.2019.11.004; Brandscheid C, 2017, J ALZHEIMERS DIS, V56, P775, DOI 10.3233/JAD-160926; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Catania C, 2009, MOL PSYCHIATR, V14, P95, DOI 10.1038/sj.mp.4002101; Cattaneo A, 2017, NEUROBIOL AGING, V49, P60, DOI 10.1016/j.neurobiolaging.2016.08.019; Chen DL, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00403; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clarke G, 2014, MOL ENDOCRINOL, V28, P1221, DOI 10.1210/me.2014-1108; Cobley JN, 2018, REDOX BIOL, V15, P490, DOI 10.1016/j.redox.2018.01.008; Colciaghi F, 2004, NEUROLOGY, V62, P498, DOI 10.1212/01.WNL.0000106953.49802.9C; Condello C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7176; Crumeyrolle-Arias M, 2014, PSYCHONEUROENDOCRINO, V42, P207, DOI 10.1016/j.psyneuen.2014.01.014; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Cummings J, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0529-5; Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3; De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Del Chierico F, 2014, INT J MOL SCI, V15, P11678, DOI 10.3390/ijms150711678; Del Tredici K, 2016, NEUROPATH APPL NEURO, V42, P33, DOI 10.1111/nan.12298; DeMartino P, 2020, CURR OPIN BIOTECH, V61, P66, DOI 10.1016/j.copbio.2019.10.008; Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106; Dobra I, 2018, CURR NEUROL NEUROSCI, V18, DOI 10.1007/s11910-018-0914-7; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Du LL, 2017, MOL NEUROBIOL, V54, P1992, DOI 10.1007/s12035-016-9758-9; Dumitrescu L, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2406594; Durack J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03157-4; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Emery DC, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00195; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Evin G, 2012, WORLD J PSYCHIATR, V2, P102, DOI 10.5498/wjp.v2.i6.102; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Fulling C, 2019, NEURON, V101, P998, DOI 10.1016/j.neuron.2019.02.008; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Gao Q, 2019, AGING-US, V11, P8642, DOI 10.18632/aging.102352; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hansen DV, 2018, J CELL BIOL, V217, P459, DOI 10.1083/jcb.201709069; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hayward JA, 2018, MICROBIOL MOL BIOL R, V82, DOI 10.1128/MMBR.00015-18; Heck AL, 2019, NEUROPSYCHOPHARMACOL, V44, P45, DOI 10.1038/s41386-018-0167-9; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Ho L, 2018, EXPERT REV NEUROTHER, V18, P83, DOI 10.1080/14737175.2018.1400909; Hodson R, 2018, NATURE, V559, pS1, DOI 10.1038/d41586-018-05717-6; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Holzer P, 2014, ADV EXP MED BIOL, V817, P195, DOI 10.1007/978-1-4939-0897-4_9; Honarpisheh P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051711; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hoyles L, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0439-y; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Jia W, 2020, MED RES REV, V40, P1496, DOI 10.1002/med.21653; Jucker M, 2018, NAT NEUROSCI, V21, P1341, DOI 10.1038/s41593-018-0238-6; Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236; Kandimalla R, 2017, J ALZHEIMERS DIS, V57, P1049, DOI 10.3233/JAD-161118; Kawashima K, 2007, LIFE SCI, V80, P2206, DOI 10.1016/j.lfs.2007.01.059; Kim MS, 2020, GUT, V69, P283, DOI 10.1136/gutjnl-2018-317431; Kiriyama Y, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9060232; Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Leblhuber F, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00054; Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156; Liu C, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00114; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Long-Smith C, 2020, ANNU REV PHARMACOL, V60, P477, DOI 10.1146/annurev-pharmtox-010919-023628; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Lukiw WJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01544; Luo J, 2020, AGEING RES REV, V57, DOI 10.1016/j.arr.2019.100982; Landete JM, 2008, CRIT REV FOOD SCI, V48, P697, DOI 10.1080/10408390701639041; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Miguez B, 2018, J AGR FOOD CHEM, V66, P9426, DOI 10.1021/acs.jafc.8b02940; Mittal R, 2017, J CELL PHYSIOL, V232, P2359, DOI 10.1002/jcp.25518; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Mullish BH, 2018, GUT, V67, P1920, DOI 10.1136/gutjnl-2018-316818; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Nguyen TT, 2020, NEUROCHEM RES, V45, P1481, DOI 10.1007/s11064-020-03031-0; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Niraula A, 2017, NEUROPSYCHOPHARMACOL, V42, P318, DOI 10.1038/npp.2016.185; O'Leary OF, 2018, EUR NEUROPSYCHOPHARM, V28, P307, DOI 10.1016/j.euroneuro.2017.12.004; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Osadchiy V, 2020, COMPR PHYSIOL, V10, P57, DOI 10.1002/cphy.c180031; Ostojic SM, 2018, TRENDS ENDOCRIN MET, V29, P286, DOI 10.1016/j.tem.2018.02.006; Paley EL, 2018, J ALZHEIMERS DIS, V61, P1531, DOI 10.3233/JAD-170764; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Pellegrini C, 2018, ACTA NEUROPATHOL, V136, P345, DOI 10.1007/s00401-018-1856-5; Perez-Munoz ME, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0268-4; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Quinn M, 2014, DIGEST LIVER DIS, V46, P527, DOI 10.1016/j.dld.2014.01.159; Reese AT, 2018, ELIFE, V7, DOI 10.7554/eLife.35987; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Schirmer M, 2019, NAT REV MICROBIOL, V17, P497, DOI 10.1038/s41579-019-0213-6; Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044; Schokker D, 2018, J ANIM SCI, V96, P2139, DOI 10.1093/jas/sky110; Schwartz K, 2013, CURR OPIN MICROBIOL, V16, P93, DOI 10.1016/j.mib.2012.12.001; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Semar S, 2013, J ALZHEIMERS DIS, V36, P7, DOI 10.3233/JAD-120511; Shen L, 2017, J ALZHEIMERS DIS, V56, P385, DOI 10.3233/JAD-160884; Shi HL, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01760-1; Shokryazdan P, 2017, MED MICROBIOL IMMUN, V206, P1, DOI 10.1007/s00430-016-0481-y; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Sochocka M, 2019, MOL NEUROBIOL, V56, P1841, DOI 10.1007/s12035-018-1188-4; Soliman ML, 2011, MOL CELL BIOCHEM, V352, P173, DOI 10.1007/s11010-011-0751-3; Sonnenburg JL, 2019, SCIENCE, V366, P444, DOI 10.1126/science.aaw9255; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; Soto M, 2018, MOL PSYCHIATR, V23, P2287, DOI 10.1038/s41380-018-0086-5; Sotoudegan F, 2019, FOOD CHEM TOXICOL, V129, P22, DOI 10.1016/j.fct.2019.04.032; Spielman LJ, 2018, NEUROCHEM INT, V120, P149, DOI 10.1016/j.neuint.2018.08.005; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Suez J, 2019, NAT MED, V25, P716, DOI 10.1038/s41591-019-0439-x; Sun J, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0525-3; Sun J, 2019, J AGR FOOD CHEM, V67, P3006, DOI 10.1021/acs.jafc.8b07313; Sundman MH, 2017, BRAIN BEHAV IMMUN, V66, P31, DOI 10.1016/j.bbi.2017.05.009; Swerdlow RH, 2018, J ALZHEIMERS DIS, V62, P1403, DOI 10.3233/JAD-170585; Tang WHW, 2019, J AM COLL CARDIOL, V73, P2089, DOI 10.1016/j.jacc.2019.03.024; Tapia-Rojas C, 2019, PROG NEUROBIOL, V175, P54, DOI 10.1016/j.pneurobio.2018.12.005; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Ticinesi A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071633; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179; Vanderweyde T, 2016, CELL REP, V15, P1455, DOI 10.1016/j.celrep.2016.04.045; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Wang A, 2014, AM J PATHOL, V184, P2516, DOI 10.1016/j.ajpath.2014.05.019; Wang XF, 2020, GUT, V69, P2131, DOI [10.1136/gutjnl-2019-319766, 10.1136/gutjnl-2020-322526]; Wang XY, 2019, CELL RES, V29, P787, DOI 10.1038/s41422-019-0216-x; Wolozin B, 2019, NAT REV NEUROSCI, V20, P649, DOI 10.1038/s41583-019-0222-5; Yang XQ, 2020, ACTA PHARMACOL SIN B, V10, P475, DOI 10.1016/j.apsb.2019.07.001; Zarrinpar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05336-9; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; Zhang L, 2017, J ALZHEIMERS DIS, V60, P1241, DOI 10.3233/JAD-170020; Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774; Zhao Y, 2015, CELL MOL NEUROBIOL, V35, P101, DOI 10.1007/s10571-014-0127-9; Zhao YH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00318; Zhou YZ, 2012, J BIOL CHEM, V287, P35092, DOI 10.1074/jbc.M112.383737; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011; Zhuang ZQ, 2018, J ALZHEIMERS DIS, V63, P1337, DOI 10.3233/JAD-180176; Zlomuzica A, 2016, NEUROPHARMACOLOGY, V106, P135, DOI 10.1016/j.neuropharm.2015.05.007	172	13	13	5	18	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2020	57	12					5026	5043		10.1007/s12035-020-02073-3		AUG 2020	18	Neurosciences	Neurosciences & Neurology	NX8NH	WOS:000562049400001	32829453	Green Published, Other Gold			2021-06-18	
J	Giromini, L; Viglione, DJ; Pignolo, C; Zennaro, A				Giromini, Luciano; Viglione, Donald J.; Pignolo, Claudia; Zennaro, Alessandro			An Inventory of Problems-29 Sensitivity Study Investigating Feigning of Four Different Symptom Presentations Via Malingering Experimental Paradigm	JOURNAL OF PERSONALITY ASSESSMENT			English	Article							DETECTING RANDOM; MMPI-2; VALIDITY; PATTERNS; SIMS	The Inventory of Problems-29 (IOP-29) is a newly developed, self-administered test designed to assist practitioners evaluating the credibility of various symptom presentations. In a recent simulation study comparing real patients against experimental feigners, its classification accuracy compared favorably with that of the Structured Inventory of Malingered Symptomatology and generalized better to different types of symptom reports (i.e., mood- or trauma-related vs. psychosis-related). Extending on these findings, this sensitivity study tested whether the IOP-29 would be similarly accurate in detecting feigning of conditions related to depression, mild traumatic brain injury, posttraumatic stress disorder (PTSD), and schizophrenia. Additionally, it also evaluated the susceptibility of the IOP-29 to uncooperative or random-like responding. Examination of 1,200 IOP-29 records from 400 nonclinical Italian volunteers who took the Italian version of the IOP-29 3 times, in 3 different conditions (i.e., standard instructions, feigned disorder, and random-like responding), confirmed that the IOP-29 might be similarly valid across a wide variety of mental health and cognitive complaints. Indeed, using the standard a priori cutoff of the IOP-29 (i.e., >= .50), sensitivity estimates ranged from .86 (for feigned PTSD) to .95 (for feigned depression) and did not significantly differ from one symptom presentation to another. These findings were obtained despite the fact that participants were coached to respond in a believable manner. Interestingly, the random-like responding generated extremely variable IOP-29 scores.	[Giromini, Luciano; Pignolo, Claudia; Zennaro, Alessandro] Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy; [Viglione, Donald J.] Alliant Int Univ, Calif Sch Profess Psychol, San Diego, CA USA	Giromini, L (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy.	luciano.giromini@unito.it	Pignolo, Claudia/AAK-5032-2020; Giromini, Luciano/AAF-9386-2019	Pignolo, Claudia/0000-0002-6977-224X; Giromini, Luciano/0000-0002-9540-4803; ZENNARO, Alessandro/0000-0002-2774-307X			American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; Archer RP, 1999, J PERS ASSESS, V73, P407, DOI 10.1207/S15327752JPA7303_8; Baer RA, 1999, J PERS ASSESS, V72, P308, DOI 10.1207/S15327752JP720213; BAGBY RM, 1991, PSYCHOL ASSESSMENT J, V3, P496, DOI DOI 10.1037/1040-3590.3.3.496; BEACH DA, 1989, J PSYCHOL, V123, P101, DOI 10.1080/00223980.1989.10542966; Burchett D, 2016, PSYCHOL ASSESSMENT, V28, P458, DOI 10.1037/pas0000205; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Butcher JN., 2001, MINNESOTA MULTIPHASI; Cattell R.B., 1970, HDB 16 PERSONALITY F; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Charter RA, 2003, J CLIN PSYCHOL, V59, P985, DOI 10.1002/jclp.10183; Fronczyk K., 2014, ROCZNIKI PSYCHOL, V17, P459; Giromini L, 2018, PSYCHOL INJ LAW, V11, P340, DOI 10.1007/s12207-018-9314-1; Greene R. L., 2011, MMPI 2 MMPI 2 RF INT; Keeley JW, 2016, J PERS ASSESS, V98, P351, DOI 10.1080/00223891.2016.1158719; Kelley SE, 2019, ASSESSMENT, V26, P465, DOI 10.1177/1073191117738048; LePage JP, 2009, DEPRESS ANXIETY, V26, P592, DOI 10.1002/da.20397; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey L. C., 1991, PERSONALITY ASSESSME; Morey LC., 2007, PERSONALITY ASSESSME; NICHOLS DS, 1989, J CLIN PSYCHOL, V45, P239, DOI 10.1002/1097-4679(198903)45:2<239::AID-JCLP2270450210>3.0.CO;2-1; Osborne JW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00220; Pinsoneault TB, 2007, PSYCHOL ASSESSMENT, V19, P159, DOI 10.1037/1040-3590.19.1.159; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R., 2011, RES METHODS FORENSIC, P174; Rogers R., 2018, CLIN ASSESSMENT MALI; Rogers R., 2013, HDB PSYCHOL, V11, P517; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Viglione D. J., 2018, J PERS ASSESS, P1; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882; Widows MR., 2005, SIMS STRUCTURED INVE	33	13	13	4	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3891	1532-7752		J PERS ASSESS	J. Pers. Assess.	JUL 3	2020	102	4					563	572		10.1080/00223891.2019.1566914			10	Psychology, Clinical; Psychology, Social	Psychology	ME8LY	WOS:000544906000001	30714835				2021-06-18	
J	Zewdie, E; Ciechanski, P; Kuo, HC; Giuffre, A; Kahl, C; King, R; Cole, L; Godfrey, H; Seeger, T; Swansburg, R; Damji, O; Rajapakse, T; Hodge, J; Nelson, S; Selby, B; Gan, L; Jadavji, Z; Larson, JR; MacMaster, F; Yang, JF; Barlow, K; Gorassini, M; Brunton, K; Kirton, A				Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Seeger, T.; Swansburg, R.; Damji, O.; Rajapakse, T.; Hodge, J.; Nelson, S.; Selby, B.; Gan, L.; Jadavji, Z.; Larson, J. R.; MacMaster, F.; Yang, J. F.; Barlow, K.; Gorassini, M.; Brunton, K.; Kirton, A.			Safety and tolerability of transcranial magnetic and direct current stimulation in children: Prospective single center evidence from 3.5 million stimulations	BRAIN STIMULATION			English	Article						TMS; tDCS; Children; HD-tDCS; Safety; Tolerability	HUMAN MOTOR CORTEX; NONINVASIVE BRAIN-STIMULATION; PERINATAL STROKE; CORTICAL EXCITABILITY; MAJOR DEPRESSION; ENHANCE WALKING; PLASTICITY; PRINCIPLES; IMPACT; RTMS	Background: Non-invasive brain stimulation is being increasingly used to interrogate neurophysiology and modulate brain function. Despite the high scientific and therapeutic potential of non-invasive brain stimulation, experience in the developing brain has been limited. Objective: To determine the safety and tolerability of non-invasive neurostimulation in children across diverse modalities of stimulation and pediatric populations. Methods: A non-invasive brain stimulation program was established in 2008 at our pediatric, academic institution. Multi-disciplinary neurophysiological studies included single- and paired-pulse Transcranial Magnetic Stimulation (TMS) methods. Motor mapping employed robotic TMS. Interventional trials included repetitive TMS (rTMS) and transcranial direct current stimulation (tDCS). Standardized safety and tolerability measures were completed prospectively by all participants. Results: Over 10 years, 384 children underwent brain stimulation (median 13 years, range 0.8-18.0). Populations included typical development (n = 118), perinatal stroke/cerebral palsy (n = 101), mild traumatic brain injury (n = 121) neuropsychiatric disorders (n = 37), and other (n = 7). No serious adverse events occurred. Drop-outs were rare (<1%). No seizures were reported despite >100 participants having brain injuries and/or epilepsy. Tolerability between single and paired-pulse TMS (542340 stimulations) and rTMS (3.0 million stimulations) was comparable and favourable. TMS-related headache was more common in perinatal stroke (40%) than healthy participants (13%) but was mild and self-limiting. Tolerability improved over time with side-effect frequency decreasing by >50%. Robotic TMS motor mapping was well-tolerated though neck pain was more common than with manual TMS (33% vs 3%). Across 612 tDCS sessions including 92 children, tolerability was favourable with mild itching/tingling reported in 37%. Conclusions: Standard non-invasive brain stimulation paradigms are safe and well-tolerated in children and should be considered minimal risk. Advancement of applications in the developing brain are warranted. A new and improved pediatric NIBS safety and tolerability form is included. (C) 2020 The Authors. Published by Elsevier Inc.	[Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Cole, L.; Seeger, T.; Damji, O.; Hodge, J.; Jadavji, Z.; Larson, J. R.; Kirton, A.] Univ Calgary, Calgary Pediat Stroke Program, Calgary, AB, Canada; [Zewdie, E.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Zewdie, E.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Zewdie, E.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Brunton, K.; Kirton, A.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Swansburg, R.; Damji, O.; Rajapakse, T.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Dept Neurosci, Calgary, AB, Canada; [Zewdie, E.; Ciechanski, P.; Kuo, H. C.; Giuffre, A.; Kahl, C.; King, R.; Cole, L.; Godfrey, H.; Seeger, T.; Swansburg, R.; Damji, O.; Rajapakse, T.; Hodge, J.; Nelson, S.; Selby, B.; Gan, L.; Jadavji, Z.; Larson, J. R.; MacMaster, F.; Barlow, K.; Kirton, A.] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Yang, J. F.] Univ Alberta, Dept Phys Therapy, Edmonton, AB, Canada; [Gorassini, M.] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada	Zewdie, E (corresponding author), Alberta Childrens Prov Gen Hosp, Oki Dr, Calgary, AB T3B 6A8, Canada.	ephrem.zewdie@ucalgary.ca	; Barlow, Karen/C-1323-2014	Swansburg, Rose/0000-0003-0679-6380; Barlow, Karen/0000-0003-2612-8507; Giuffre, Adrianna/0000-0001-9632-0612	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Alberta Children's Hospital Foundation; Hotchkiss Brain Institute of University of Calgary	We would like to thank all the participants of the studies and their families. We also would like to thank the several funding agencies that funded the 27 studies included in this paper. We would like to thank Alberto NettelAguirre for his contribution to build the brain stimulation laboratories. We also would like to thank the Canadian Institutes of Health Research, Alberta Children's Hospital Foundation and Hotchkiss Brain Institute of University of Calgary that funded the Pediatric NIBS laboratory.	Allen CH, 2017, PEDIATR NEUROL, V68, P3, DOI 10.1016/j.pediatrneurol.2016.12.009; Andre-Obadia N, 2006, CLIN NEUROPHYSIOL, V117, P1536, DOI 10.1016/j.clinph.2006.03.025; Bae EH, 2007, EPILEPSY BEHAV, V10, P521, DOI 10.1016/j.yebeh.2007.03.004; Bikson M, 2016, BRAIN STIMUL, V9, P641, DOI 10.1016/j.brs.2016.06.004; Chae Jeong-Ho, 2004, Cogn Behav Neurol, V17, P109, DOI 10.1097/01.wnn.0000116253.78804.3a; Chen R, 2003, J NEUROPHYSIOL, V89, P1256, DOI 10.1152/jn.00950.2002; Chhatbar PY, 2016, BRAIN STIMUL, V9, P16, DOI 10.1016/j.brs.2015.09.002; Ciechanski P, 2016, PEDIAT BRAIN STIMULA, P475; Ciechanski P, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00268; Ciechanski P, 2017, CEREB CORTEX, V27, P2758, DOI 10.1093/cercor/bhw114; Cole L, EFFECTS HIGH DEFINIT; Croarkin PE, 2010, J ECT, V26, P323, DOI 10.1097/YCT.0b013e3181dd17eb; Damji O, 2015, DEV MED CHILD NEUROL, V57, P548, DOI 10.1111/dmcn.12704; Durmaz O, 2017, PSYCHIAT CLIN PSYCH, V27, P14, DOI 10.1080/24750573.2017.1293239; Eng D, CLIN NEUROPHYS; Garvey MA, 2004, EUR J PAEDIATR NEURO, V8, P7, DOI 10.1016/j.ejpn.2003.11.002; Garvey MA, 2003, CLIN NEUROPHYSIOL, V114, P1662, DOI 10.1016/S1388-2457(03)00130-5; George MS, 1996, J NEUROPSYCH CLIN N, V8, P172; Grab JG, 2018, J NEUROSCI METH, V309, P41, DOI 10.1016/j.jneumeth.2018.08.007; Hameed MQ, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0719-0; Hong YJH, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00029; Hosomi K, 2016, J STROKE CEREBROVASC, V25, P1655, DOI 10.1016/j.jstrokecerebrovasdis.2016.02.024; Hurd C, 2017, PHYS THER, V97, P818, DOI 10.1093/ptj/pzx045; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jamil A, 2017, J PHYSIOL-LONDON, V595, P1273, DOI 10.1113/JP272738; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kessler SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076112; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Kirton A, 2017, NEUROLOGY, V88, P259, DOI 10.1212/WNL.0000000000003518; Kirton JA A., 2015, EUR J PAEDIAT NEU S1, V19, pS10, DOI [10.1016/S1090-3798(15)30030-1, DOI 10.1016/S1090-3798(15)30030-1]; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Krishnan C, 2015, BRAIN STIMUL, V8, P76, DOI 10.1016/j.brs.2014.10.012; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Kuo MF, 2014, NEUROIMAGE, V85, P948, DOI 10.1016/j.neuroimage.2013.05.117; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Lisanby SH, 2009, NEUROPSYCHOPHARMACOL, V34, P522, DOI 10.1038/npp.2008.118; Machii K, 2006, CLIN NEUROPHYSIOL, V117, P455, DOI 10.1016/j.clinph.2005.10.014; Moliadze V, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/837141; Pell GS, 2011, PROG NEUROBIOL, V93, P59, DOI 10.1016/j.pneurobio.2010.10.003; Quintana H, 2005, J ECT, V21, P88, DOI 10.1097/01.yct.0000162556.02720.58; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schrader LM, 2004, CLIN NEUROPHYSIOL, V115, P2728, DOI 10.1016/j.clinph.2004.06.018; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Tarapore PE, 2016, CLIN NEUROPHYSIOL, V127, P1916, DOI 10.1016/j.clinph.2015.11.043; Tokimura H, 1996, ELECTROMYOGR MOTOR C, V101, P263, DOI 10.1016/0924-980X(96)95664-7; Valero-Cabre A, 2017, NEUROSCI BIOBEHAV R, V83, P381, DOI 10.1016/j.neubiorev.2017.10.006; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wu SW, 2012, DEV MED CHILD NEUROL, V54, P636, DOI 10.1111/j.1469-8749.2012.04300.x; Yang JF, 2013, SEMIN PEDIATR NEUROL, V20, P106, DOI 10.1016/j.spen.2013.06.011; Zewdie E., 2016, PEDIAT BRAIN STIMULA, P475; Zewdie E, 2017, NEUROREHAB NEURAL RE, V31, P261, DOI 10.1177/1545968316680485; Ziemann U, 1998, J PHYSIOL-LONDON, V511, P181, DOI 10.1111/j.1469-7793.1998.181bi.x	56	13	13	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	MAY-JUN	2020	13	3					565	575		10.1016/j.brs.2019.12.025			11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	LO3IP	WOS:000533522600011	32289678	Other Gold			2021-06-18	
J	Hsieh, TH; Kuo, CW; Hsieh, KH; Shieh, MJ; Peng, CW; Chen, YC; Chang, YL; Huang, YZ; Chen, CC; Chang, PK; Chen, KY; Chen, HY				Hsieh, Tsung-Hsun; Kuo, Chi-Wei; Hsieh, Kai-Hsuan; Shieh, Meng-Jyh; Peng, Chih-Wei; Chen, Yen-Chien; Chang, Ying-Ling; Huang, Ying-Zu; Chen, Chih-Chung; Chang, Pi-Kai; Chen, Kai-Yun; Chen, Hsin-Yung			Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson's Disease	BRAIN SCIENCES			English	Article						probiotics; Parkinson's disease; neuroprotection; motor function; MitoPark; mice	TRAUMATIC BRAIN-INJURY; CERULEIN-INDUCED PANCREATITIS; GUT-MICROBIOTA; GASTROINTESTINAL SYMPTOMS; SENSORY NEURONS; NITRIC-OXIDE; IN-VITRO; SEROTONIN; AXIS; MODULATION	Parkinson's disease (PD) is one of the common long-term degenerative disorders that primarily affect motor systems. Gastrointestinal (GI) symptoms are common in individuals with PD and often present before motor symptoms. It has been found that gut dysbiosis to PD pathology is related to the severity of motor and non-motor symptoms in PD. Probiotics have been reported to have the ability to improve the symptoms related to constipation in PD patients. However, the evidence from preclinical or clinical research to verify the beneficial effects of probiotics for the motor functions in PD is still limited. An experimental PD animal model could be helpful in exploring the potential therapeutic strategy using probiotics. In the current study, we examined whether daily and long-term administration of probiotics has neuroprotective effects on nigrostriatal dopamine neurons and whether it can further alleviate the motor dysfunctions in PD mice. Transgenic MitoPark PD mice were chosen for this study and the effects of daily probiotic treatment on gait, beam balance, motor coordination, and the degeneration levels of dopaminergic neurons were identified. From the results, compared with the sham treatment group, we found that the daily administration of probiotics significantly reduced the motor impairments in gait pattern, balance function, and motor coordination. Immunohistochemically, a tyrosine hydroxylase (TH)-positive cell in the substantia nigra was significantly preserved in the probiotic-treated PD mice. These results showed that long-term administration of probiotics has neuroprotective effects on dopamine neurons and further attenuates the deterioration of motor dysfunctions in MitoPark PD mice. Our data further highlighted the promising possibility of the potential use of probiotics, which could be the relevant approach for further application on human PD subjects.	[Hsieh, Tsung-Hsun; Kuo, Chi-Wei; Hsieh, Kai-Hsuan; Chen, Chih-Chung] Chang Gung Univ, Sch Phys Therapy, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun; Kuo, Chi-Wei; Hsieh, Kai-Hsuan; Chen, Chih-Chung] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan 33302, Taiwan; [Hsieh, Tsung-Hsun; Huang, Ying-Zu] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan 33305, Taiwan; [Hsieh, Tsung-Hsun; Huang, Ying-Zu; Chen, Chih-Chung] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan 33302, Taiwan; [Kuo, Chi-Wei] Natl Taiwan Univ, Dept Life Sci, Taipei 10617, Taiwan; [Shieh, Meng-Jyh] Tajen Inst Technol, Dept Biotechnol, Pingtung 90741, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Sch Biomed Engn, Coll Biomed Engn, Taipei 11031, Taiwan; [Chen, Yen-Chien] Taichung Gen Veteran Hosp, Dept Food & Nutr, Taichung 40705, Taiwan; [Chang, Ying-Ling] Chang Gung Univ, Sch & Grad Inst Tradit Chinese Med, Coll Med, Taoyuan 33302, Taiwan; [Chang, Ying-Ling] Chang Gung Mem Hosp, Div Chinese Internal Med, Ctr Tradit Chinese Med, Taoyuan 33305, Taiwan; [Huang, Ying-Zu; Chang, Pi-Kai] Gung Mem Hosp, Dept Neurol, Taoyuan 33305, Taiwan; [Huang, Ying-Zu; Chang, Pi-Kai] Chang Gung Univ, Coll Med, Taoyuan 33305, Taiwan; [Chen, Kai-Yun] Taipei Med Univ, Grad Inst Neural Regenerat Med, Coll Med Sci & Technol, Taipei 11031, Taiwan; [Chen, Hsin-Yung] Chang Gung Univ, Coll Med, Dept Occupat Therapy, Taoyuan 33302, Taiwan; [Chen, Hsin-Yung] Chang Gung Univ, Coll Med, Grad Inst Behav Sci, Taoyuan 33302, Taiwan; [Chen, Hsin-Yung] Chang Gung Mem Hosp, Dept Neurol, Taoyuan 33378, Taiwan; [Chen, Hsin-Yung] Chang Gung Mem Hosp, Dementia Ctr, Taoyuan 33378, Taiwan	Chen, HY (corresponding author), Chang Gung Univ, Coll Med, Dept Occupat Therapy, Taoyuan 33302, Taiwan.; Chen, HY (corresponding author), Chang Gung Univ, Coll Med, Grad Inst Behav Sci, Taoyuan 33302, Taiwan.; Chen, HY (corresponding author), Chang Gung Mem Hosp, Dept Neurol, Taoyuan 33378, Taiwan.; Chen, HY (corresponding author), Chang Gung Mem Hosp, Dementia Ctr, Taoyuan 33378, Taiwan.	hsiehth@mail.cgu.edu.tw; kiwi725@gmail.com; katie911734@yahoo.com.tw; shieh@tajen.eduu.tw; cwpeng@tmu.edu.tw; cychien@vghtc.gov.tw; c1220@mail.cgu.edu.tw; yzhuang@cgmh.org.tw; jackccchen@mail.cgu.edu.tw; tyrant001dx@gmail.com; kychen08@tmu.edu.tw; hychen@mail.cgu.edu.tw	Hsieh, Tung-Hsun/AAZ-5010-2020	Hsieh, Tung-Hsun/0000-0002-1794-7941; Peng, Chih-Wei/0000-0001-9744-4094; Chen, Hsin-Yung/0000-0002-5165-3840	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [106-2410-H-182-008-MY2, 108-2314-B-182-011, 106-2221-E-182-001, 108-2314-B-182-015-MY3, MOST 107-2314-B-038-063]; Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPD1H0461 CMRPD1H0462, BMRPE30, CMRPD1H0671, CMRPD3H0021, BMRPA70]	This study was supported by grants from the Ministry of Science and Technology, Taiwan (106-2410-H-182-008-MY2 and 108-2314-B-182-011 to T.H. Hsieh, 106-2221-E-182-001 to K.Y. Chen and 108-2314-B-182-015-MY3 to Y.Z. Huang and MOST 107-2314-B-038-063) and Chang Gung Memorial Hospital, Taiwan (CMRPD1H0461 CMRPD1H0462 and BMRPE30 to T.H. Hsieh and CMRPD1H0671, CMRPD3H0021, and BMRPA70 to H.Y. Chen).	Banks WA, 2010, NEUROBIOL DIS, V37, P26, DOI 10.1016/j.nbd.2009.07.031; Barichella M, 2016, NEUROLOGY, V87, P1274, DOI 10.1212/WNL.0000000000003127; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Caputi V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061689; Cassani E, 2011, Minerva Gastroenterol Dietol, V57, P117; Cersosimo MG, 2012, J NEUROL SCI, V313, P57, DOI 10.1016/j.jns.2011.09.030; Chapelet G, 2019, PARKINSONISM RELAT D, V59, P26, DOI 10.1016/j.parkreldis.2018.11.014; DEMBINSKI A, 1995, J PHYSIOL PHARMACOL, V46, P351; Dembinski A, 2004, J PHYSIOL PHARMACOL, V55, P223; Dembinski A, 1996, INT J PANCREATOL, V19, P179; Dembinski Artur, 2003, Med Sci Monit, V9, pBR418; Dembinski A, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/3126280; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Erickson JT, 2001, J NEUROSCI, V21, P581, DOI 10.1523/JNEUROSCI.21-02-00581.2001; Fang X, 2019, NEUROL SCI, V40, P51, DOI 10.1007/s10072-018-3641-6; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Gazerani P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174121; Georgescu D, 2016, CLIN INTERV AGING, V11, P1601, DOI 10.2147/CIA.S106284; Ghaisas S, 2019, NEUROTOXICOLOGY, V75, P186, DOI 10.1016/j.neuro.2019.09.004; Gonzalez-Arancibia C, 2019, PSYCHOPHARMACOLOGY, V236, P1611, DOI 10.1007/s00213-019-05265-5; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942; Hsieh TH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178186; Hsieh TH, 2011, BEHAV BRAIN RES, V222, P1, DOI 10.1016/j.bbr.2011.03.031; Jaworek J, 2018, GASTROENT RES PRACT, V2018, DOI 10.1155/2018/6915059; Jiang PZ, 2018, ACTA NEUROPATHOL, V135, P13, DOI 10.1007/s00401-017-1788-5; Jones JD, 2020, PARKINSONISM RELAT D, V72, P7, DOI 10.1016/j.parkreldis.2020.01.009; KELLER F, 1988, CLIN CHEM, V34, P2486; Kim DY, 2000, AM J GASTROENTEROL, V95, P2698, DOI 10.1016/S0002-9270(00)01970-5; Kim N, 2018, J MICROBIOL, V56, P172, DOI 10.1007/s12275-018-8032-4; Konturek SJ, 2003, J PHYSIOL PHARMACOL, V54, P293; Lai JH, 2019, BRAIN RES, V1720, DOI 10.1016/j.brainres.2019.146301; Lee HY, 2012, MED BIOL ENG COMPUT, V50, P937, DOI 10.1007/s11517-012-0933-5; Leopold NA, 1996, DYSPHAGIA, V11, P14, DOI 10.1007/BF00385794; Li HW, 2019, NEUROGASTROENT MOTIL, V31, DOI 10.1111/nmo.13677; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Liang JI, 2014, J MATER SCI-MATER M, V25, P217, DOI 10.1007/s10856-013-5036-9; Liang S, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00033; Liu NK, 2014, BRAIN RES, V1576, P18, DOI 10.1016/j.brainres.2014.05.042; Magistrelli L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00969; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Minato T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187307; Mulak A, 2015, WORLD J GASTROENTERO, V21, P10609, DOI 10.3748/wjg.v21.i37.10609; Musa NH, 2017, J DAIRY RES, V84, P488, DOI 10.1017/S0022029917000620; Nagpal R, 2017, ANN NUTR METAB, V71, P11, DOI 10.1159/000479918; Nirmalkar K, 2018, NUTRIENTS, V10, DOI 10.3390/nu10122009; O'Brien R, 2020, NEUROGASTROENT MOTIL, V32, DOI 10.1111/nmo.13738; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Parashar A, 2017, PARKINSONISM RELAT D, V38, P1, DOI 10.1016/j.parkreldis.2017.02.002; Pendharkar SA, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2016.63; Pietrucci D, 2019, PARKINSONISM RELAT D, V65, P124, DOI 10.1016/j.parkreldis.2019.06.003; Poirier AA, 2016, PARKINSONS DIS-US, V2016, DOI 10.1155/2016/6762528; Polotis M, 2015, BEHAV BRAIN RES, V277, P136, DOI 10.1016/j.bbr.2014.07.037; Rial D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114216; Rodes L, 2013, J MICROBIOL BIOTECHN, V23, P518, DOI 10.4014/jmb.1205.05018; Salari M, 2016, J RES MED SCI, V21, DOI 10.4103/1735-1995.196608; Santos SF, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00574; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Spohn SN, 2017, NAT REV GASTRO HEPAT, V14, P412, DOI 10.1038/nrgastro.2017.51; Srivastav S, 2019, J NUTR BIOCHEM, V69, P73, DOI 10.1016/j.jnutbio.2019.03.021; Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015; Sun MF, 2018, BRAIN BEHAV IMMUN, V70, P48, DOI 10.1016/j.bbi.2018.02.005; Tamtaji OR, 2019, CLIN NUTR, V38, P1031, DOI 10.1016/j.clnu.2018.05.018; Tsai WL, 2019, BEHAV NEUROL, V2019, DOI 10.1155/2019/4829572; Tsai YL, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-018-0493-6; Uyar GO, 2019, BIOSCI MICROB FOOD H, V38, P115, DOI [10.12938/bmfh.19-002, https://doi.org/10.12938/bmfh.19-002]; Warzecha Z, 2001, J PHYSIOL PHARMACOL, V52, P679; Warzecha Z, 1997, J PHYSIOL PHARMACOL, V48, P43; Woitalla D, 2015, PARKINSONISM RELAT D, V21, P199, DOI 10.1016/j.parkreldis.2014.11.024	72	13	13	2	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	APR	2020	10	4							206	10.3390/brainsci10040206			13	Neurosciences	Neurosciences & Neurology	LP4EO	WOS:000534271500044	32244769	DOAJ Gold, Green Published			2021-06-18	
J	Withiel, TD; Sharp, VL; Wong, DN; Ponsford, JL; Warren, N; Stolwyk, RJ				Withiel, Toni D.; Sharp, Vanessa L.; Wong, Dana; Ponsford, Jennie L.; Warren, Narelle; Stolwyk, Renerus J.			Understanding the experience of compensatory and restorative memory rehabilitation: A qualitative study of stroke survivors	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Memory rehabilitation; Cognitive training; Memory skills group; Compensatory strategies; Stroke rehabilitation; Qualitative analysis	TRAUMATIC BRAIN-INJURY; COGNITIVE DEFICITS; WORKING-MEMORY; PAGING SYSTEM; STRATEGIES; FREQUENCY; EFFICACY; ADULTS	Memory impairment is common following stroke. Memory skills groups (MSGs) utilising compensatory strategies and computerised cognitive training (CCT) are two rehabilitation approaches available to improve memory function; however, there is no consensus as to which is more effective following stroke. This study aimed to explore and contrast the qualitative experiences of 20 stroke survivors (M-age = 61.90,SD = 10.48, range: 34-77 years) who received six weeks' training in MSG (manualised memory skills group,n = 10) or individual-CCT (Lumosity(TM),n = 10). Using semi-structured interviews, data were collected and analysed thematically, adopting a critical realist approach. Six themes were identified: (1)Facilitators and barriers to intervention engagement, (2)Improving knowledge and understanding, (3)Connecting with others, (4)Perception of the intervention, (5)Impact on everyday memoryand (6)Impact on emotions and sense of purpose. Encouragingly, most participants valued and enjoyed participating in the memory interventions, irrespective of rehabilitation approach. MSG participants reported learning and sharing with similar others as important to the experience and described everyday memory improvements. CCT participants described enjoyment of its game-like nature, yet reported frustration associated with game-specific characteristics, and did not report everyday memory improvements.	[Withiel, Toni D.; Sharp, Vanessa L.; Wong, Dana; Ponsford, Jennie L.; Stolwyk, Renerus J.] Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [Withiel, Toni D.; Wong, Dana; Ponsford, Jennie L.; Stolwyk, Renerus J.] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Withiel, Toni D.] Royal Melbourne Hosp, Allied Hlth, Melbourne, Vic, Australia; [Wong, Dana] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Warren, Narelle] Monash Univ, Sch Social Sci, Melbourne, Vic, Australia	Stolwyk, RJ (corresponding author), Monash Univ, Sch Psychol Sci, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia.; Stolwyk, RJ (corresponding author), Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia.	rene.stolwyk@monash.edu	Warren, Narelle/H-9318-2019; Wong, Dana/AAD-3410-2020; Ponsford, Jennie/H-8341-2014; Cadilhac, Dominique/I-1912-2014	Warren, Narelle/0000-0003-2623-4078; Ponsford, Jennie/0000-0003-0430-125X; Withiel, Toni/0000-0001-8075-2760; Stolwyk, Renerus/0000-0002-4975-3332; Wong, Dana/0000-0001-9619-1929; Sharp, Vanessa/0000-0002-2481-1030; Cadilhac, Dominique/0000-0001-8162-682X			Arenth PM, 2006, BRAIN INJURY, V20, P253, DOI 10.1080/02699050500487662; Braun V, 2013, SUCCESSFUL QUALITATI; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]; Cadilhac DA, 2010, INT J STROKE, V5, P217, DOI 10.1111/j.1747-4949.2010.00430.x; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Connor B. B., 2012, 9 INT C DIS VIR REAL; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; das Nair R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002293.pub3; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; de Joode E, 2010, CLIN REHABIL, V24, P701, DOI 10.1177/0269215510367551; Dowswell G., 2003, EVALUATION, V9, P30, DOI DOI 10.1177/1356389003009001003; Dunning DL, 2014, MEM COGNITION, V42, P854, DOI 10.3758/s13421-014-0410-5; Elliott M, 2014, BRAIN INJURY, V28, P1610, DOI 10.3109/02699052.2014.934921; Evans J, 1992, CLIN REHABIL, V6, P75, DOI DOI 10.1177/026921559200600110; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Grosdemange A, 2015, J NEUROL NEUROSUR PS, V86, P513, DOI 10.1136/jnnp-2014-308232; Guest G., 2008, HDB TEAM BASED QUALI, P3; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hux K, 2000, BRAIN INJURY, V14, P907; Lampit A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001756; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Livescribe, 2015, ECH SMART AUTH; Miller L., 2010, MAKING MOST YOUR MEM; Mowszowski L, 2016, NEUROPSYCHOL REV, V26, P252, DOI 10.1007/s11065-016-9329-x; Nilsson C, 2011, DISABIL REHABIL, V33, P969, DOI 10.3109/09638288.2010.528141; O'Neil-Pirozzi TM, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000181; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Polit DF, 2010, INT J NURS STUD, V47, P1451, DOI 10.1016/j.ijnurstu.2010.06.004; Pollock A, 2014, INT J STROKE, V9, P313, DOI 10.1111/j.1747-4949.2012.00942.x; QSR International, 2014, NIV QUAL DAT AN SOFT; Quemada JI, 2003, J HEAD TRAUMA REHAB, V18, P532, DOI 10.1097/00001199-200311000-00007; Sigmundsdottir L, 2016, NEUROPSYCHOL REHABIL, V26, P673, DOI 10.1080/09602011.2016.1140657; Simons DJ, 2016, PSYCHOL SCI PUBL INT, V17, P103, DOI 10.1177/1529100616661983; Spreij LA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00993; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; van Rijsbergen MWA, 2014, J STROKE CEREBROVASC, V23, P408, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.003; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Viera AJ, 2005, FAM MED, V37, P360; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477	41	13	13	8	19	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 15	2020	30	3					503	522		10.1080/09602011.2018.1479275			20	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	MB2FW	WOS:000542421300007	30058468				2021-06-18	
J	Sigurdardottir, S; Andelic, N; Wehling, E; Anke, A; Skandsen, T; Holthe, OO; Manskow, US; Roe, C				Sigurdardottir, Solrun; Andelic, Nada; Wehling, Eike; Anke, Audny; Skandsen, Toril; Holthe, Oyvor Oistensen; Manskow, Unn Sollid; Roe, Cecilie			Return to work after severe traumatic brain injury: a national study with a one-year follow-up of neurocognitive and behavioural outcomes	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						TBI; Employment; Outcome assessment; Behaviour; Neuropsychological; Executive functions	QUALITY-OF-LIFE; EXECUTIVE FUNCTION; POSTTRAUMATIC AMNESIA; DEPRESSION SCALE; RATING INVENTORY; HOSPITAL ANXIETY; SELF-AWARENESS; HEAD-INJURY; EMPLOYMENT; REHABILITATION	The objectives were to investigate the frequency of return-to-work (RTW) one year after severe traumatic brain injury (sTBI: Glasgow Coma Scale, GCS 3-8) and to identify which demographic and injury-related characteristics and neurocognitive factors are associated with RTW. This study is part of a prospective national study on sTBI conducted in all four Norwegian Trauma Referral Centres, including patients aged >15 years over a period of three years (n = 378). For the purpose of this study, only pre-employed individuals of working age (16 to 67 years) were investigated for RTW (n = 143), and of these, 104 participants underwent neuropsychological testing. Measures of acute injury severity, neuropsychological composite scores (Memory, Processing Speed, Executive Functions) at the one-year follow-up, and the Behaviour Rating Inventory of Executive Functions (patient- and relative reports) were explored as predictors of RTW. The frequency of RTW was 54.5%. Multivariate logistic regression analyses identified younger age, shorter length of stay in intensive care, better Processing Speed scores, and lower levels of metacognitive difficulties as rated by relatives as significant predictors of RTW. Findings support the importance of neuropsychological measures in predicting long-term RTW and highlight the need to address neurocognitive and behavioural difficulties to improve RTW after sTBI.	[Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway; [Sigurdardottir, Solrun; Andelic, Nada; Roe, Cecilie] Univ Oslo, Fac Med, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, POB 1130 Blindern, N-0318 Oslo, Norway; [Andelic, Nada; Holthe, Oyvor Oistensen; Roe, Cecilie] Oslo Univ Hosp, Div Clin Neurosci, Dept Phys Med & Rehabil, Oslo, Norway; [Wehling, Eike] Haukeland Hosp, Dept Phys Med & Rehabil, Bergen, Norway; [Anke, Audny; Manskow, Unn Sollid] Univ Hosp North Norway, Dept Rehabil, Tromso, Norway; [Anke, Audny] Univ Tromso, Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Skandsen, Toril] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Skandsen, Toril] Norwegian Univ Sci & Technol NTNU, Dept Neuromed & Movement Sci, Fac Med & Heath Sci, Trondheim, Norway; [Manskow, Unn Sollid] Univ Tromso, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway	Sigurdardottir, S (corresponding author), Sunnaas Rehabil Hosp, Dept Res, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.; Sigurdardottir, S (corresponding author), Univ Oslo, Fac Med, Inst Hlth & Soc, Res Ctr Habilitat & Rehabil Models & Serv CHARM, POB 1130 Blindern, N-0318 Oslo, Norway.	solrun.sigurdardottir@sunnaas.no		Andelic, Nada/0000-0002-3719-4406; Anke, Audny/0000-0002-2491-2560	Research Council of NorwayResearch Council of Norway [209748]	This study was supported by The Research Council of Norway, Grant number 185267, and The Research Council of Norway, Project number 209748.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL REV 19; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Avesani R, 2005, BRAIN INJURY, V19, P933, DOI 10.1080/02699050400002371; Azouvi P, 2016, J HEAD TRAUMA REHAB, V31, pE10, DOI 10.1097/HTR.0000000000000169; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Boake C, 2001, ARCH PHYS MED REHAB, V82, P761, DOI 10.1053/apmr.2001.23753; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cattran CJ, 2011, BRAIN INJURY, V25, P1035, DOI 10.3109/02699052.2011.607787; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Donders J, 2015, J HEAD TRAUMA REHAB, V30, pE30, DOI 10.1097/HTR.0000000000000120; Duggan MC, 2017, J CRIT CARE, V37, P72, DOI 10.1016/j.jcrc.2016.08.023; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Hanks RA, 2016, CLIN NEUROPSYCHOL, V30, P1074, DOI 10.1080/13854046.2016.1194479; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Kalechstein AD, 2003, J CLIN EXP NEUROPSYC, V25, P1186, DOI 10.1076/jcen.25.8.1186.16723; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Kompier MAJ, 2006, SCAND J WORK ENV HEA, V32, P421, DOI 10.5271/sjweh.1048; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lovstad M, 2016, J INT NEUROPSYCH SOC, V22, P682, DOI 10.1017/S135561771600031X; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; Meyers J., 1995, REY COMPLEX FIGURE T; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Rao V, 2008, J NEUROPSYCH CLIN N, V20, P118, DOI 10.1176/jnp.2008.20.1.118; Roe C, 2013, J REHABIL MED, V45, P734, DOI 10.2340/16501977-1198; Roth R.M., 2005, BEHAV RATING INVENTO; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; Skandsen T, 2008, CLIN REHABIL, V22, P653, DOI 10.1177/0269215508089067; Spitz G, 2012, NEUROPSYCHOLOGY, V26, P604, DOI 10.1037/a0029239; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sveen U, 2016, EUR J PHYS REHAB MED, V52, P650; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waid-Ebbs JK, 2012, BRAIN INJURY, V26, P1646, DOI 10.3109/02699052.2012.700087; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Wechsler D, 1997, WAIS 3 ADM SCORING M; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2008, J REHABIL MED, V40, P850, DOI 10.2340/16501977-0271; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507	77	13	13	1	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	FEB 7	2020	30	2					281	297		10.1080/09602011.2018.1462719			17	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	KQ4EM	WOS:000516877900008	29667477				2021-06-18	
J	Rickard, JJS; Di-Pietro, V; Smith, DJ; Davies, DJ; Belli, A; Oppenheimer, PG				Rickard, Jonathan J. S.; Di-Pietro, Valentina; Smith, David J.; Davies, David J.; Belli, Antonio; Oppenheimer, Pola Goldberg			Rapid optofluidic detection of biomarkers for traumatic brain injury via surface-enhanced Raman spectroscopy	NATURE BIOMEDICAL ENGINEERING			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; EXTRACELLULAR N-ACETYLASPARTATE; IN-VIVO; SCATTERING DETECTION; SURROGATE MARKER; TEMPORAL WINDOW; CANAVAN DISEASE; SERS DETECTION; MILD; CARE	An optofluidic device rapidly detects, via surface-enhanced Raman scattering, picomolar concentrations of biomarkers for traumatic brain injury in finger-prick blood samples from patients. Current technologies for the point-of-care diagnosis of traumatic brain injury (TBI) lack sensitivity, require specialist handling or involve complicated and costly procedures. Here, we report the development and testing of an optofluidic device for the rapid and label-free detection, via surface-enhanced Raman scattering (SERS), of picomolar concentrations of biomarkers for TBI in biofluids. The SERS-active substrate of the device consists of electrohydrodynamically fabricated submicrometre pillars covered with a plasmon-active nanometric gold layer, integrated in an optofluidic chip. We show that the device can detect N-acetylasparate in finger-prick blood samples from patients with TBI, and that the biomarker is released immediately from the central nervous system after TBI. The simplicity, sensitivity and robustness of SERS-integrated optofluidic technology might eventually help the triaging of TBI patients and assist clinical decision making at point-of-care settings.	[Rickard, Jonathan J. S.; Oppenheimer, Pola Goldberg] Univ Birmingham, Coll Engn & Phys Sci, Sch Chem Engn, Birmingham, W Midlands, England; [Rickard, Jonathan J. S.] Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England; [Di-Pietro, Valentina; Belli, Antonio] Univ Birmingham, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Di-Pietro, Valentina; Davies, David J.; Belli, Antonio] Univ Birmingham, Inst Inflammat & Ageing, Natl Inst Hlth Res, Dept Neurosci & Ophthalmol, Birmingham, W Midlands, England; [Smith, David J.] Univ Birmingham, Coll Engn & Phys Sci, Sch Math, Edgbaston, England; [Oppenheimer, Pola Goldberg] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Trauma Management Healthcare Technol Cooperat, Healthcare Technol Inst, Birmingham, W Midlands, England	Rickard, JJS; Oppenheimer, PG (corresponding author), Univ Birmingham, Coll Engn & Phys Sci, Sch Chem Engn, Birmingham, W Midlands, England.; Rickard, JJS (corresponding author), Univ Cambridge, Dept Phys, Cavendish Lab, Cambridge, England.; Oppenheimer, PG (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Trauma Management Healthcare Technol Cooperat, Healthcare Technol Inst, Birmingham, W Midlands, England.	jjr1001@cam.ac.uk; GoldberP@bham.ac.uk	Belli, Antonio/I-3799-2015; Smith, David/G-5775-2011	Belli, Antonio/0000-0002-3211-9933; Goldberg Oppenheimer, Pola/0000-0002-1014-4724; Smith, David/0000-0002-3427-0936	Wellcome TrustWellcome TrustEuropean Commission [174ISSFPP]; Royal Academy of EngineeringRoyal Academy of Engineering - UK [RF1415\14\28]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [DTAARGCQ19497]; Royal Academy of Engineering Research FellowshipRoyal Academy of Engineering - UK	We acknowledge funding from the Wellcome Trust (grant no. 174ISSFPP), the Royal Academy of Engineering (grant no. RF1415\14\28) and the National Institute for Health Research (grant no. DTAARGCQ19497). P.G.O. is a Royal Academy of Engineering Research Fellowship holder. The authors also thank M. J. Rowney and F. M. Colacino for helpful discussions about the technology and insights into classification analyses. Components of the developed device were fabricated using the facilities at the Cavendish Laboratory at the Department of Physics and the Nanoscience Centre for Fabrication, University of Cambridge.	Ackermann L, 2006, ANGEW CHEM INT EDIT, V45, P2619, DOI 10.1002/anie.200504450; [Anonymous], 2016, NEUROTRAUMA; Aquino C, 2015, EMERG RADIOL, V22, P65, DOI 10.1007/s10140-014-1226-0; Azouvi P, 2017, REV NEUROL-FRANCE, V173, P461, DOI 10.1016/j.neurol.2017.07.006; Banbury C, 2019, ACS APPL MATER INTER, V11, P14437, DOI 10.1021/acsami.9b00420; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Belli A, 2006, J NEUROCHEM, V96, P861, DOI 10.1111/j.1471-4159.2005.03602.x; Benarroch EE, 2008, NEUROLOGY, V70, P1353, DOI 10.1212/01.wnl.0000311267.63292.6c; Brown M, 2018, J NEURORADIOLOGY, V45, P123, DOI 10.1016/j.neurad.2017.09.004; Carney N, 2016, GUIDELINES MANAGEMEN; Chang J., 2017, NANO BIOMED ENG, V9, P49, DOI DOI 10.5101/nbe.v9i1.p49-56; Chen G, 2014, RSC ADV, V4, P54434, DOI 10.1039/c4ra09251a; Chen LX, 2008, ELECTROPHORESIS, V29, P1815, DOI 10.1002/elps.200700554; Coon AL, 2006, AM J NEURORADIOL, V27, P1053; Croall Iain, 2015, Top Magn Reson Imaging, V24, P267, DOI 10.1097/RMR.0000000000000063; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Dadas A, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0045-y; Danielson E. R., 1999, MAGNETIC RESONANCE S; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Dennis EL, 2018, HUM BRAIN MAPP, V39, P3759, DOI 10.1002/hbm.24209; Di Costanzo A, 2003, EUR J RADIOL, V48, P146, DOI 10.1016/j.ejrad.2003.08.009; Di Pietro V, 2013, CLIN BIOCHEM, V46, P1902, DOI 10.1016/j.clinbiochem.2013.09.004; Dimov IK, 2011, LAB CHIP, V11, P845, DOI [10.1039/c0lc00403k, 10.1039/c01c00403k]; Dinish US, 2014, J BIOPHOTONICS, V7, P956, DOI 10.1002/jbio.201300084; Dinish US, 2014, SCI REP-UK, V4, DOI 10.1038/srep04075; Dinish US, 2012, BIOSENS BIOELECTRON, V33, P293, DOI 10.1016/j.bios.2011.12.056; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Duda R. O., 2007, PATTERN CLASSIFICATI; Durucan O., 2015, 19 INT C MIN SYST CH, P1831; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Gauglitz G, 2014, HDB SPECTROSCOPY, V2; Goldberg Oppenheimer P., 2017, International patent, Patent No. [PCT/GB2018/050193, 2018050193]; Goldberg-Oppenheimer P, 2012, J PHYS CHEM LETT, V3, P3486, DOI 10.1021/jz301333r; Goldberg-Oppenheimer P, 2012, ADV MATER, V24, pOP175, DOI 10.1002/adma.201104159; Granger JH, 2016, CHEM SOC REV, V45, P3865, DOI 10.1039/c5cs00828j; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Han XX, 2009, ANAL BIOANAL CHEM, V394, P1719, DOI 10.1007/s00216-009-2702-3; Han XX, 2012, TRAC-TREND ANAL CHEM, V38, P67, DOI 10.1016/j.trac.2012.05.006; Tran HN, 2015, ADV NAT SCI-NANOSCI, V6, DOI 10.1088/2043-6262/6/2/023002; Hoonejani MR, 2015, NANOSCALE, V7, P16834, DOI 10.1039/c5nr04147c; Hoshino H, 2014, PEDIATR INT, V56, P477, DOI 10.1111/ped.12422; Huang SX, 2015, NANO LETT, V15, P2892, DOI 10.1021/nl5045988; Jahn IJ, 2017, ANALYST, V142, P1022, DOI 10.1039/c7an00118e; Juncker D, 2002, ANAL CHEM, V74, P6139, DOI 10.1021/ac0261449; Kahraman M, 2017, NANOPHOTONICS-BERLIN, V6, P831, DOI 10.1515/nanoph-2016-0174; Kho KW, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976140; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Lim C, 2010, ANALYST, V135, P837, DOI 10.1039/b919584j; Lin D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04751; Lin SN, 1995, J NEUROSCI METH, V62, P199, DOI 10.1016/0165-0270(95)00077-1; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mahajan S, 2013, J PHYS CHEM LETT, V4, P4153, DOI 10.1021/jz4018688; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McQueenie R, 2012, ANAL CHEM, V84, P5968, DOI 10.1021/ac3006445; MOFFETT JR, 2013, FRONT NEUROENERGETIC, V8; Moore TJ, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8020046; Muniz-Miranda M, 2013, THIN SOLID FILMS, V543, P118, DOI 10.1016/j.tsf.2013.02.057; NADLER JV, 1972, J NEUROCHEM, V19, P313, DOI 10.1111/j.1471-4159.1972.tb01341.x; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Ozbay E, 2006, SCIENCE, V311, P189, DOI 10.1126/science.1114849; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Park A, 2013, CHEMOMETR INTELL LAB, V121, P52, DOI 10.1016/j.chemolab.2012.11.011; PATEL TB, 1979, BIOCHEM J, V184, P539, DOI 10.1042/bj1840539; Pennathur S, 2008, LAB CHIP, V8, P649, DOI 10.1039/b805064n; Piorek BD, 2007, P NATL ACAD SCI USA, V104, P18898, DOI 10.1073/pnas.0708596104; Premasiri WR, 2012, J PHYS CHEM B, V116, P9376, DOI 10.1021/jp304932g; Qian XM, 2008, J AM CHEM SOC, V130, P14934, DOI 10.1021/ja8062502; Rigotti DJ, 2007, AM J NEURORADIOL, V28, P1843, DOI 10.3174/ajnr.A0774; Robertson C., 2015, CRITICAL CARE MANAGE, V4; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Schuff N, 2002, NEUROLOGY, V58, P928, DOI 10.1212/WNL.58.6.928; Sen J, 2005, ACTA NEUROCHIR, V147, P897, DOI 10.1007/s00701-005-0526-2; Shannon RJ, 2016, J NEUROTRAUM, V33, P319, DOI 10.1089/neu.2015.3950; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Shen AG, 2009, J RAMAN SPECTROSC, V40, P550, DOI 10.1002/jrs.2163; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Socrates G., 2001, INFRARED RAMAN CHARA; Srivastava SK, 2015, ANALYST, V140, P3201, DOI 10.1039/c5an00209e; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stovell MG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00426; Szydzik C, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4938391; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Tshibanda J.-F. L., 2012, COMA DISORDERS CONSC, P45; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; Veeramuthu V, 2018, ACAD RADIOL, V25, P1167, DOI 10.1016/j.acra.2018.01.005; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang R, 2018, FRONTIERS ADV MOL SP, P307; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21242; Wang Y, 2014, TECHNOLOGY, V2, P118, DOI 10.1142/S2339547814500125; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Xu WG, 2013, SMALL, V9, P1206, DOI 10.1002/smll.201203097; Yang SK, 2016, P NATL ACAD SCI USA, V113, P268, DOI 10.1073/pnas.1518980113; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	104	13	13	23	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2157-846X			NAT BIOMED ENG	Nat. Biomed. Eng	JUN	2020	4	6					610	623		10.1038/s41551-019-0510-4		FEB 2020	14	Engineering, Biomedical	Engineering	LX9UU	WOS:000510821600003	32015408				2021-06-18	
J	Silverberg, ND; Iaccarino, MA; Panenka, WJ; Iverson, GL; McCulloch, KL; Dams-O'Connor, K; Reed, N; McCrea, M; Cogan, AM; Graf, MJP; Kajankova, M; McKinney, G; Jamora, CW				Silverberg, Noah D.; Iaccarino, Mary Alexis; Panenka, William J.; Iverson, Grant L.; McCulloch, Karen L.; Dams-O'Connor, Kristen; Reed, Nick; McCrea, Michael; Cogan, Alison M.; Graf, Min Jeong Park; Kajankova, Maria; McKinney, Gary; Jamora, Christina Weyer		Amer Congress Rehabil Med Brain In	Management of Concussion and Mild Traumatic Brain Injury: A Synthesis of Practice Guidelines	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain concussion; Brain injuries; traumatic; Practice guidelines as topic; Rehabilitation; Review	PATIENT HEALTH QUESTIONNAIRE-9; CT HEAD RULE; COGNITIVE REHABILITATION; POSTCONCUSSION SYMPTOMS; CHILDREN; RISK; OUTCOMES; SPORT; RECOMMENDATIONS; TRENDS	At least 3 million Americans sustain a mild traumatic brain injury (mTBI) each year, and 1 in 5 have symptoms that persist beyond 1 month. Standards of mTBI care have evolved rapidly, with numerous expert consensus statements and clinical practice guidelines published in the last 5 years. This Special Communication synthesizes recent expert consensus statements and evidenced-based clinical practice guidelines for civilians, athletes, military, and pediatric populations for clinicians practicing outside of specialty mTBI clinics, including primary care providers. The article offers guidance on key clinical decisions in mTBI care and highlights priority interventions that can be initiated in primary care to prevent chronicity. (C) 2019 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada; [Silverberg, Noah D.] GF Strong Rehabil Ctr, Rehabil Res Program, Vancouver, BC, Canada; [Iaccarino, Mary Alexis; Kajankova, Maria] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Iaccarino, Mary Alexis] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Iaccarino, Mary Alexis] Harvard Med Sch, Boston, MA 02115 USA; [Panenka, William J.] BC Mental Hlth & Addict Res Inst, Vancouver, BC, Canada; [Panenka, William J.] British Columbia Prov Neuropsychiat Program, Vancouver, BC, Canada; [Panenka, William J.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] MassGen Hosp, Children Sport Concuss Program, Boston, MA USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [McCulloch, Karen L.] Univ North Carolina Chapel Hill, Dept Allied Hlth Sci, Div Phys Therapy, Sch Med, Chapel Hill, NC USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Reed, Nick] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [McCrea, Michael] Med Coll Wisconsin, Ctr Neurotrauma Res CNTR, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Cogan, Alison M.] Washington DC Vet Affairs Med Ctr, Washington, DC USA; [Graf, Min Jeong Park] Univ Minnesota, Med Sch, Minneapolis, MN 55455 USA; [Graf, Min Jeong Park] Hennepin Healthcare, Dept Phys Med & Rehabil, Minneapolis, MN USA; [Kajankova, Maria] Brain Injury Res Ctr, Houston, TX USA; [McKinney, Gary] Def & Vet Brain Injury Ctr, Silver Spring, MD USA; [Jamora, Christina Weyer] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Jamora, Christina Weyer] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Psychiat, San Francisco, CA 94143 USA	Silverberg, ND (corresponding author), Univ British Columbia, Div Phys Med & Rehabil, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Panenka, William/0000-0001-7143-6512	American Congress of Rehabilitation Medicine Brain Injury Special Interest Group	The American Congress of Rehabilitation Medicine Brain Injury Special Interest Group provided administrative support for the activities of the Task Force and funded the open access fees for this article through a Task Force grant.	Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2017, Br J Sports Med, V51, P851, DOI 10.1136/bjsports-2017-097506SCAT5; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; [Anonymous], 2014, GUID DIAGN MAN PED C; Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Astrand R, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0574-x; Babl FE, 2017, LANCET, V389, P2393, DOI 10.1016/S0140-6736(17)30555-X; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Bloom B, 2018, BRAIN INJURY, V32, P1623, DOI 10.1080/02699052.2018.1532111; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cassidy J. D., 2014, ARCH PHYS MED REHAB, V95, P132; Centers for Disease Control and Prevention, 2019, SURV REP TRAUM BRAIN; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Cnossen MC, 2017, BRAIN INJURY, V31, P800; Collins MW, 2015, NEUROSURGERY, V2016, P1; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; Diener HC, 2016, NAT REV NEUROL, V12, P575, DOI 10.1038/nrneurol.2016.124; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2015, BRAIN INJURY, V29, P185, DOI 10.3109/02699052.2014.965212; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Gioia GA, 2016, J CHILD NEUROL, V31, P93, DOI 10.1177/0883073814555604; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Gravel J, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-63; Haarbauer-Krupa J, 2018, J PEDIATR-US, V197, P241, DOI 10.1016/j.jpeds.2018.01.075; Harvey AG, 1998, J NERV MENT DIS, V186, P333, DOI 10.1097/00005053-199806000-00002; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Hsia RY, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022297; Isokuortti H, 2018, J NEUROSURG, V129, P1588, DOI 10.3171/2017.7.JNS17615; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Kemp S, 2010, J NEUROPSYCHOL, V4, P231, DOI 10.1348/174866409X482614; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Keret A, 2017, J NEUROSURG-PEDIATR, V20, P64, DOI 10.3171/2017.2.PEDS16585; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; King NS, 2011, BRAIN INJURY, V25, P462, DOI 10.3109/02699052.2011.558042; Kristman VL, 2014, ARCH PHYS MED REHAB, V95, P295; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuhl NO, 2018, PHYSICIAN SPORTSMED, V46, P1, DOI 10.1080/00913847.2018.1419775; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laborey M, 2014, J HEAD TRAUMA REHAB, V29, pE28, DOI 10.1097/HTR.0b013e318280f896; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Lange RT, 2007, NEUROPSYCHOLOGY, V21, P590, DOI 10.1037/0894-4105.21.5.590; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Leddy J, 2016, PM R S3, V8, P91; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2853; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; Mann A, 2017, CAN FAM PHYSICIAN, V63, P460; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; Mayer AR, 2018, NEUROSCI BIOBEHAV R, V94, P149, DOI 10.1016/j.neubiorev.2018.08.002; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P877, DOI 10.1136/bjsports-2016-097393; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Minhas H, 2018, BRIT J HAEMATOL, V183, P119, DOI 10.1111/bjh.15509; Minkkinen M, 2019, J NEUROTRAUM, V36, P2904, DOI 10.1089/neu.2018.6351; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Morin M, 2016, J SPORTS MED, V2016, P1; Nygren-de Boussard Catharina, 2014, Arch Phys Med Rehabil, V95, pS257, DOI 10.1016/j.apmr.2013.10.009; O'Connell B, 2018, CLIN J SPORT MED, V28, P561, DOI 10.1097/JSM.0000000000000478; Ontario Neurotrauma Foundation, 2018, GUID CONC MILD TRAUM, V3rd; Ontario Neurotrauma Foundation, 2019, ONTARIO NEUROTRAUMA; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Rao DP, 2018, HEALTH PROMOT CHRON, V38, P147, DOI 10.24095/hpcdp.38.3.05; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Rozbacher A, 2017, J NEUROTRAUM, V34, P2195, DOI 10.1089/neu.2016.4765; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Scheenen ME, 2016, J NEUROTRAUM, V33, P339, DOI 10.1089/neu.2015.3926; Schmidt J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3406; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sullivan KA, 2018, J NEUROTRAUM, V35, P195, DOI 10.1089/neu.2016.4958; Taylor AM, 2015, J PEDIATR-US, V167, P738, DOI 10.1016/j.jpeds.2015.05.036; Taylor DJ, 2014, INT REV PSYCHIATR, V26, P205, DOI 10.3109/09540261.2014.902808; Tepper SJ, 2010, CLEV CLIN J MED, V77, P236, DOI 10.3949/ccjm.77a.09147; Theadom A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191655; Theadom A, 2017, ARCH PHYS MED REHAB, V98, P1560, DOI 10.1016/j.apmr.2017.01.010; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Ungprasert P, 2016, STROKE, V47, P356, DOI 10.1161/STROKEAHA.115.011678; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Veterans Affairs/Department of Defense, 2016, MAN CONC MILD TRAUM; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Wennberg R, 2018, CAN J NEUROL SCI, V45, P275, DOI 10.1017/cjn.2017.300; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zetterberg H, 2016, CONCUSSION, V1	135	13	13	1	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2020	101	2					382	393		10.1016/j.apmr.2019.10.179			12	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	KM6CP	WOS:000514226500021	31654620	Other Gold			2021-06-18	
J	Sandmo, SB; Andersen, TE; Koerte, IK; Bahr, R				Sandmo, Stian Bahr; Andersen, Thor Einar; Koerte, Inga Katharina; Bahr, Roald			Head impact exposure in youth football-Are current interventions hitting the target?	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						concussion; epidemiology; repetitive; soccer; subconcussive; TBI		Restrictions on heading in youth football have been implemented in some countries to limit head impact exposure. However, current interventions remain poorly guided by evidence. Our objective was to quantify heading exposure in youth football, assessing the effects of sex and age. Football matches played during an international youth football tournament with no heading restrictions were directly observed, including players from both sexes (11-19 years). The elite senior level was included for comparison, using video analysis. All heading events were registered, classified, and assigned to individual players. Heading rates were calculated for each sex and age group. We observed a total of 267 matches, corresponding to 4011 player hours (1927 player hours for females, 2083 player hours for males). Males headed more frequently than females (2.7 vs 1.8 headers/player hour; P < .001). Heading rates increased with age (ANOVA, P < .001), approaching the elite senior level for players 16 years and older. There was substantial variation within teams for all age and sex groups, with the widest range (1-18 headers) observed for girls aged 19. Girls younger than 12 years had the lowest exposure, with an average of <2 players per team heading the ball, each with 1-2 headers. In conclusion, age and sex influence head impact exposure in youth football, and warrants careful consideration when introducing injury prevention measures. Males are more frequently exposed than females, heading rates increase with age, and there is substantial variation between players. Heading is a rare event in the youngest age groups, especially among females.	[Sandmo, Stian Bahr; Andersen, Thor Einar; Bahr, Roald] Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, PB 4014 Ulleval Stad, NO-0806 Oslo, Norway; [Sandmo, Stian Bahr] Univ Oslo, Fac Med, Oslo, Norway; [Koerte, Inga Katharina] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Koerte, Inga Katharina] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Dept Psychiat, Boston, MA 02115 USA	Sandmo, SB (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, PB 4014 Ulleval Stad, NO-0806 Oslo, Norway.	s.b.sandmo@nih.no		Andersen, Thor Einar/0000-0003-4172-4518	The Research Council of NorwayResearch Council of Norway Funding Source: Medline; ERA-NET NEURON Funding Source: Medline; The German Federal Ministry of Education and Research Funding Source: Medline		Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; [Anonymous], [No title captured]; [Anonymous], 1987, CURR CONTENTS; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harris A, 2018, GENDER SEX HIST, P1, DOI 10.1007/978-3-319-70811-9_1; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Sandmo SB, 2019, AM J SPORT MED, V47, P974, DOI 10.1177/0363546519826953; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	26	13	13	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	JAN	2020	30	1					193	198		10.1111/sms.13562			6	Sport Sciences	Sport Sciences	PX7GZ	WOS:000611522400021	31584703	Green Published, Other Gold			2021-06-18	
J	Zeiler, FA; Ercole, A; Beqiri, E; Cabeleira, M; Thelin, EP; Stocchetti, N; Steyerberg, EW; Maas, AIR; Menon, DK; Czosnyka, M; Smielewski, P; Anke, A; Beer, R; Helbok, R; Bellander, BM; Nelson, D; Buki, A; Chevallard, G; Chieregato, A; Citerio, G; Czeiter, E; Depreitere, B; Eapen, G; Frisvold, S; Jankowski, S; Kondziella, D; Koskinen, LO; Meyfroidt, G; Moeller, K; Piippo-Karjalainen, A; Raj, R; Radoi, A; Sahuquillo, J; Ragauskas, A; Rocka, S; Rhodes, J; Rossaint, R; Stevanovic, A; Sakowitz, O; Sundstrom, N; Takala, R; Tamosuitis, T; Tenovuo, O; Vajkoczy, P; Vargiolu, A; Vilcinis, R; Wolf, S; Younsi, A				Zeiler, Frederick A.; Ercole, Ari; Beqiri, Erta; Cabeleira, Manuel; Thelin, Eric P.; Stocchetti, Nino; Steyerberg, Ewout W.; Maas, Andrew I. R.; Menon, David K.; Czosnyka, Marek; Smielewski, Peter; Anke, Audny; Beer, Ronny; Helbok, Raimund; Bellander, Bo-Michael; Nelson, David; Buki, Andras; Chevallard, Giorgio; Chieregato, Arturo; Citerio, Giuseppe; Czeiter, Endre; Depreitere, Bart; Eapen, George; Frisvold, Shirin; Jankowski, Stefan; Kondziella, Daniel; Koskinen, Lars-Owe; Meyfroidt, Geert; Moeller, Kirsten; Piippo-Karjalainen, Anna; Raj, Rahul; Radoi, Andreea; Sahuquillo, Juan; Ragauskas, Arminas; Rocka, Saulius; Rhodes, Jonathan; Rossaint, Rolf; Stevanovic, Ana; Sakowitz, Oliver; Sundstrom, Nina; Takala, Riikka; Tamosuitis, Tomas; Tenovuo, Olli; Vajkoczy, Peter; Vargiolu, Alessia; Vilcinis, Rimantas; Wolf, Stefan; Younsi, Alexander		CTR-TBI High Resolution ICU HR ICU	Association between Cerebrovascular Reactivity Monitoring and Mortality Is Preserved When Adjusting for Baseline Admission Characteristics in Adult Traumatic Brain Injury: A CENTER-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; cerebrovascular reactivity; IMPACT; outcome analysis	AUTOREGULATION MEASUREMENT TECHNIQUES; PRESSURE; MANAGEMENT; MODERATE	Cerebral autoregulation, as measured using the pressure reactivity index (PRx), has been related to global patient outcome in adult patients with traumatic brain injury (TBI). To date, this has been documented without accounting for standard baseline admission characteristics and intracranial pressure (ICP). We evaluated this association, adjusting for baseline admission characteristics and ICP, in a multi-center, prospective cohort. We derived PRx as the correlation between ICP and mean arterial pressure in prospectively collected multi-center data from the High-Resolution Intensive Care Unit (ICU) cohort of the Collaborative European NeuroTrauma Effectiveness Research in TBI (CENTER-TBI) study. Multi-variable logistic regression models were analyzed to assess the association between global outcome (measured as either mortality or dichotomized Glasgow Outcome Score-Extended [GOSE]) and a range of covariates (IMPACT [International Mission for Prognosis and Analysis of Clinical Trials] Core and computed tomography [CT] variables, ICP, and PRx). Performance of these models in outcome association was compared using area under the receiver operating curve (AUC) and Nagelkerke's pseudo-R-2. One hundred ninety-three patients had a complete data set for analysis. The addition of percent time above threshold for PRx improved AUC and displayed statistically significant increases in Nagelkerke's pseudo-R-2 over the IMPACT Core and IMPACT Core + CT models for mortality. The addition of PRx monitoring to IMPACT Core +/- CT + ICP models accounted for additional variance in mortality, when compared to models with IMPACT Core +/- CT + ICP alone. The addition of cerebrovascular reactivity monitoring, through PRx, provides a statistically significant increase in association with mortality at 6 months. Our data suggest that cerebrovascular reactivity monitoring may provide complementary information regarding outcomes in TBI.	[Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Beqiri, Erta; Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; Univ Manitoba, Rady Fac Hlth Sci, Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Thelin, Eric P.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Steyerberg, Ewout W.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Maas, Andrew I. R.] Univ Hosp Antwerp, Dept Neurosurg, Edegem, Belgium; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway; [Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bellander, Bo-Michael; Nelson, David] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Buki, Andras] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, Janos Szentagothai Res Ctr, Pecs, Hungary; [Chevallard, Giorgio; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Citerio, Giuseppe] ASST Monza, NeuroIntens Care Unit, Dept Anesthesia & Intens Care, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens care, Tromso, Norway; [Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Kondziella, Daniel] Rigshosp, Dept Neurol, Reg Hovedstaden, Copenhagen, Denmark; [Kondziella, Daniel] Rigshosp, Dept Clin Neurophysiol, Reg Hovedstaden, Copenhagen, Denmark; [Kondziella, Daniel; Moeller, Kirsten] Rigshosp, Dept Neuroanesthesiol, Reg Hovedstaden, Copenhagen, Denmark; [Koskinen, Lars-Owe] Umea Univ, Dept Clin Neurosci, Neurosurg, Umea, Sweden; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Piippo-Karjalainen, Anna; Raj, Rahul] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Radoi, Andreea; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius] Kaunas Univ Technol, Dept Neurosurg, Vilnius, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rhodes, Jonathan] NHS Lothian, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rossaint, Rolf; Stevanovic, Ana] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Sakowitz, Oliver] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Sundstrom, Nina] Umea Univ, Biomed Engn, Dept Radiat Sci, Umea, Sweden; [Takala, Riikka] Turku Univ, Cent Hosp, Perioperat Serv, Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka; Tenovuo, Olli] Univ Turku, Turku, Finland; [Tamosuitis, Tomas] Kaunas Univ Hlth Sci, Neurointens Care Unit, Kaunas, Lithuania; [Tenovuo, Olli] Turku Univ, Cent Hosp, Rehabil & Brain Trauma, Turku, Finland; [Vajkoczy, Peter] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Vargiolu, Alessia] ASST Monza, Dept Anesthesia & Intens Care, NeuroIntens Care Unit, Monza, Italy; [Vilcinis, Rimantas] Kaunas Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Wolf, Stefan] Charite Univ Med Berlin, Interdisciplinary Neuro Intens Care Unit, Berlin, Germany	Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Neurosurg, 750 Bannatyne Ave, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Younsi, Alexander/AAW-7869-2020; Helbok, Raimund/AAA-8361-2021; Raj, Rahul/K-7693-2012; Ercole, Ari/B-6288-2009; Koskinen, Lars-Owe/AAQ-8957-2020; Sahuquillo, Juan/B-3577-2008; Thelin, Eric Peter/K-2144-2012; Moller, Kirsten/A-4751-2009	Younsi, Alexander/0000-0002-8218-9243; Raj, Rahul/0000-0003-4243-9591; Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Thelin, Eric Peter/0000-0002-2338-4364; Zeiler, Frederick/0000-0003-1737-0510; Radoi, Andreea/0000-0002-0677-3544; Moller, Kirsten/0000-0003-3058-1072	European UnionEuropean Commission [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Data used in preparation of this article were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA), and from Integra LifeSciences Corporation (USA).	Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Helbok R, 2014, NEUROCRIT CARE, V21, P85, DOI 10.1007/s12028-014-0040-6; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Nourallah B, 2018, ACTA NEUROCHIR, V160, P1315, DOI 10.1007/s00701-018-3555-3; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1955, DOI 10.1007/s00701-019-03980-8; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085	22	13	13	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2020	37	10					1233	1241		10.1089/neu.2019.6808		DEC 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	LL3VP	WOS:000504889700001	31760893	Green Published			2021-06-18	
J	Feng, JZ; Wang, Y; Peng, J; Sun, MW; Zeng, J; Jiang, H				Feng, Jin-zhou; Wang, Yu; Peng, Jin; Sun, Ming-wei; Zeng, Jun; Jiang, Hua			Comparison between logistic regression and machine learning algorithms on survival prediction of traumatic brain injuries	JOURNAL OF CRITICAL CARE			English	Article						Traumatic brain injury; Machine learning; Logistic regression; Survival prediction; Support vector machine; Critical illness	OUTCOME PREDICTION; PERFORMANCE; VALIDATION; MODELS	Purpose: To compare twenty-two machine learning (ML) models against logistic regression on survival prediction in severe traumatic brain injury (STBI) patients in a single center study. Materials and methods: Data was collected from STBI patients admitted to the Sichuan Provincial People's Hospital between December 2009 and November 2011. Twenty-two machine learning (ML) models were tested, and their predictive performance compared with logistic regression (LR) model. Receiver operating characteristics (ROC), area under curve (AUC), accuracy, F-score, precision, recall and Decision Curve Analysis (DCA) were used as performance metrics. Results: A total of 117 patients were enrolled. AUC of all ML models ranged from 86.3% to 94%. AUC of LR was 83%, and accuracy was 88%. The AUC of Cubic SVM, Quadratic SVM and Linear SVM were higher than that of LR. The precision ratio of LR was 95% and recall ratio was 91%, both were lower than most ML models. The F-Score of LR was 0.93, which was only slightly better than that of Linear Discriminant and Quadratic Discriminant. Conclusions: The twenty-two ML models selected have capabilities comparable to classical LR model for outcome prediction in STBI patients. Of these, Cubic SVM, Quadratic SVM, Linear SVM performed significantly better than LR. (C) 2019 Elsevier Inc. All rights reserved.	[Feng, Jin-zhou; Wang, Yu; Peng, Jin; Sun, Ming-wei; Zeng, Jun; Jiang, Hua] Univ Elect Sci & Technol China, Inst Emergency & Disaster Med, Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp,Sch Med, 32 Yi Huan Lu Xi Er Duan, Chengdu, Sichuan, Peoples R China; [Feng, Jin-zhou; Wang, Yu; Peng, Jin; Zeng, Jun; Jiang, Hua] Sino Finnish Med AI Res Ctr, 32 Yi Huan Lu Xi Er Duan, Chengdu, Sichuan, Peoples R China; [Peng, Jin] Sichuan Univ, West China Sch Basic Med Sci & Forens Med, Dept Histol Embryol & Neurobiol, 17 Peoples South Rd, Chengdu, Sichuan, Peoples R China	Jiang, H (corresponding author), Univ Elect Sci & Technol China, Inst Emergency & Disaster Med, Sichuan Acad Med Sci, Sichuan Prov Peoples Hosp,Sch Med, 32 Yi Huan Lu Xi Er Duan, Chengdu, Sichuan, Peoples R China.	feng720930@126.com; wangyu@traumabank.org; admin@traumabank.org; 653176424@qq.com; zengjun@medmail.com.cn; hua.jiang@traumabank.org			Key Technology Research and Development Programof the Department of Science and Technology of Sichuan [2014FZ0125, 2018FZ0067]	This work was supported by the Key Technology Research and Development Programof the Department of Science and Technology of Sichuan [grant IDs 2014FZ0125, to HJ and 2018FZ0067, to MWS].	Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Belavagi MC, 2016, PROCEDIA COMPUT SCI, V89, P117, DOI 10.1016/j.procs.2016.06.016; Chen C, 2015, IEEE TRANS COMPUT SO, V2, P65, DOI 10.1109/TCSS.2016.2516039; Decruyenaere A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0206-y; Figaji Anthony A, 2013, Can J Neurol Sci, V40, P433; Griesdale DE, 2013, CANADIAN J NEUROLOGI, V40, P433, DOI [10.1017/S0317167100015286, DOI 10.1017/S0317167100015286]; Han JLXG, 2017, WORLD NEUROSURG, V108, P885, DOI 10.1016/j.wneu.2017.08.147; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Jun Zeng, 2017, STUDY SYSTEMS BIOL C; Liu Da-wei, 2010, PRACTICE CRITICAL CA, V156; Liu NT, 2017, SHOCK, V48, P504, DOI 10.1097/SHK.0000000000000898; Majdan M, 2017, J NEUROSCI RURAL PRA, V8, P20, DOI 10.4103/0976-3147.193543; Masashi Sugiyama, 2015, GRAPHIC MACHINE LEAR; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; Ravi D, 2017, IEEE J BIOMED HEALTH, V21, P4, DOI 10.1109/JBHI.2016.2636665; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Senders JT, 2018, WORLD NEUROSURG, V109, P476, DOI 10.1016/j.wneu.2017.09.149; Sun J., 2016, THESIS; Sun Ming-wei, 2014, CHIN J EMERG MED, V23, P308; Tu JV, 1996, J CLIN EPIDEMIOL, V49, P1225, DOI 10.1016/S0895-4356(96)00002-9; Van Calster B, 2015, MED DECIS MAKING, V35, P162, DOI 10.1177/0272989X14547233; Vellido A, 2020, NEURAL COMPUT APPL, V32, P18069, DOI 10.1007/s00521-019-04051-w; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Wang SJ, 2012, MED IMAGE ANAL, V16, P933, DOI 10.1016/j.media.2012.02.005; Zhou Wei-hong, 2013, INJURY MED, V2, P34, DOI [10.3868/j.issn.2095-1566.2013.03.008, DOI 10.3868/J.ISSN.2095-1566.2013.03.008]; Zhou Z IL, 2016, MACHINE LEARNING; 李德培, 2015, [中华神经外科杂志, Chinese Journal of Neurosurgery], V31, P427	29	13	13	2	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	DEC	2019	54						110	116		10.1016/j.jcrc.2019.08.010			7	Critical Care Medicine	General & Internal Medicine	JT4BE	WOS:000500935700021	31408805				2021-06-18	
J	Sabirzhanov, B; Matyas, J; Coll-Miro, M; Yu, LL; Faden, AI; Stoica, BA; Wu, JF				Sabirzhanov, Boris; Matyas, Jessica; Coll-Miro, Marina; Yu, Laina Lijia; Faden, Alan, I; Stoica, Bogdan A.; Wu, Junfang			Inhibition of microRNA-711 limits angiopoietin-1 and Akt changes, tissue damage, and motor dysfunction after contusive spinal cord injury in mice	CELL DEATH & DISEASE			English	Article							TRAUMATIC BRAIN-INJURY; NEURONAL CELL-DEATH; FUNCTIONAL RECOVERY; DOWN-REGULATION; LOCOMOTOR FUNCTION; NEUROPATHIC PAIN; GENE-EXPRESSION; UP-REGULATION; ACTIVATION; ANGIOGENESIS	Spinal cord injury (SCI) causes neuronal cell death and vascular damage, which contribute to neurological dysfunction. Given that many biochemical changes contribute to such secondary injury, treatment approaches have increasingly focused on combined therapies or use of multi-functional drugs. MicroRNAs (miRs) are small (20-23 nucleotide), non-protein-coding RNAs and can negatively regulate target gene expression at the post-transcriptional level. As individual miRs can potentially modulate expression of multiple relevant proteins after injury, they are attractive candidates as upstream regulators of the secondary SCI progression. In the present study we examined the role of miR-711 modulation after SCI. Levels of miR-711 were increased in injured spinal cord early after SCI, accompanied by rapid downregulation of its target angiopoietin-1 (Ang-1), an endothelial growth factor. Changes of miR-711 were also associated with downregulation of the pro-survival protein Akt (protein kinase B), another target of miR-711, with sequential activation of glycogen synthase kinase 3 and the pro-apoptotic BH3-only molecule PUMA. Central administration of a miR-711 hairpin inhibitor after SCI limited decreases of Ang-1/Akt expression and attenuated apoptotic pathways. Such treatment also reduced neuronal/axonal damage, protected microvasculature and improved motor dysfunction following SCI. In vitro, miR-711 levels were rapidly elevated by neuronal insults, but not by activated microglia and astrocytes. Together, our data suggest that post-traumatic miR-711 elevation contributes to neuronal cell death after SCI, in part by inhibiting Ang-1 and Akt pathways, and may serve as a novel therapeutic target.	[Sabirzhanov, Boris; Matyas, Jessica; Coll-Miro, Marina; Yu, Laina Lijia; Faden, Alan, I; Stoica, Bogdan A.; Wu, Junfang] Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; [Sabirzhanov, Boris; Matyas, Jessica; Coll-Miro, Marina; Yu, Laina Lijia; Faden, Alan, I; Stoica, Bogdan A.; Wu, Junfang] Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA; [Faden, Alan, I; Wu, Junfang] Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA	Wu, JF (corresponding author), Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA.; Wu, JF (corresponding author), Sch Med, Ctr Shock Trauma & Anesthesiol Res STAR, Baltimore, MD 21201 USA.; Wu, JF (corresponding author), Univ Maryland, Ctr Adv Chron Pain Res, Baltimore, MD 21201 USA.	junfang.wu@som.umaryland.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS094527, 2R01 NR013601, R01 NS110635, R01 NS110567, RF1 NS110637, R01 NS096002]; Craig H. Nielson Foundation Research [340442]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RF1NS110637, R01NS110567, R01NS096002, R01NS110635, R01NS094527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013601] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The work was supported by the National Institutes of Health Grants R01 NS094527 (J.W.), 2R01 NR013601 (J.W./A.I.F.), R01 NS110635 (J.W./A.I.F.), R01 NS110567 (J.W.), RF1 NS110637 (J.W.), R01 NS096002 (B.A.S./B.S.), and Craig H. Nielson Foundation Research (340442) (A.I.F.).	Ambacher KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046885; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chan WM, 2013, TRANSL STROKE RES, V4, P447, DOI 10.1007/s12975-012-0249-7; Chen JL, 2007, ANN NEUROL, V62, P49, DOI 10.1002/ana.21160; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Datto JP, 2015, J NEUROTRAUM, V32, P1146, DOI 10.1089/neu.2014.3702; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Esau CC, 2007, ADV DRUG DELIVER REV, V59, P101, DOI 10.1016/j.addr.2007.03.007; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Farooque M, 2006, SPINAL CORD, V44, P182, DOI 10.1038/sj.sc.3101816; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Griffiths-Jones S, 2007, ANNU REV GENOM HUM G, V8, P279, DOI 10.1146/annurev.genom.8.080706.092419; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; He ZG, 2010, J BIOMED RES, V24, P2, DOI 10.1016/S1674-8301(10)60002-4; Henshall DC, 2014, CURR OPIN NEUROL, V27, P199, DOI 10.1097/WCO.0000000000000079; Herrera JJ, 2010, J NEUROTRAUM, V27, P2067, DOI 10.1089/neu.2010.1403; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Hu JZ, 2015, BRAIN RES, V1608, P191, DOI 10.1016/j.brainres.2015.02.036; Hu JY, 2016, ONCOL LETT, V11, P2155, DOI 10.3892/ol.2016.4217; Hu LY, 2010, NEUROSCIENCE, V169, P1046, DOI 10.1016/j.neuroscience.2010.05.046; Jee MK, 2012, HUM GENE THER, V23, P508, DOI 10.1089/hum.2011.121; Jee MK, 2012, BRAIN, V135, P1237, DOI 10.1093/brain/aws047; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kosacka J, 2005, CELL TISSUE RES, V320, P11, DOI 10.1007/s00441-004-1068-2; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liao AJ, 2016, ONCOTARGET, V7, P5842, DOI 10.18632/oncotarget.6813; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Liu S, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0469-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Matyas JJ, 2017, J NEUROSCI, V37, P3956, DOI 10.1523/JNEUROSCI.3353-16.2017; Mirnezami AHF, 2009, EJSO-EUR J SURG ONC, V35, P339, DOI 10.1016/j.ejso.2008.06.006; Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666; Mohite A, 2011, BIOCHEMISTRY-US, V50, P1691, DOI 10.1021/bi101654w; Nambu H, 2004, GENE THER, V11, P865, DOI 10.1038/sj.gt.3302230; Nawabi H, 2012, GENE DEV, V26, P1509, DOI 10.1101/gad.198150.112; Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Ohtake Y, 2014, BIOMATERIALS, V35, P4610, DOI 10.1016/j.biomaterials.2014.02.037; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Ponomarev ED, 2013, GLIA, V61, P91, DOI 10.1002/glia.22363; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sabirzhanov B, 2016, CELL DEATH DIFFER, V23, P654, DOI 10.1038/cdd.2015.132; Sabirzhanov B, 2018, J NEUROTRAUM, V35, P2462, DOI 10.1089/neu.2017.5572; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Sipski ML, 2004, ARCH PHYS MED REHAB, V85, P1826, DOI 10.1016/j.apmr.2004.04.031; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tranter M, 2011, J BIOL CHEM, V286, P29828, DOI 10.1074/jbc.M111.221796; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Walker Chandler L, 2013, Front Biol (Beijing), V8, DOI 10.1007/s11515-013-1255-1; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Wang C, 2016, BIOORG MED CHEM LETT, V26, P1287, DOI 10.1016/j.bmcl.2016.01.015; Weiler J, 2006, GENE THER, V13, P496, DOI 10.1038/sj.gt.3302654; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Wu JF, 2016, J NEUROTRAUM, V33, P1919, DOI 10.1089/neu.2015.4348; Wu JF, 2015, CELL CYCLE, V14, P3698, DOI 10.1080/15384101.2015.1104436; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu JF, 2013, J NEUROSCI, V33, P12447, DOI 10.1523/JNEUROSCI.0846-13.2013; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1; Wu JF, 2011, NEUROTHERAPEUTICS, V8, P221, DOI 10.1007/s13311-011-0028-2; Xu LJ, 2015, EXP NEUROL, V264, P1, DOI 10.1016/j.expneurol.2014.11.007; Yan T, 2012, NEUROBIOL DIS, V46, P157, DOI 10.1016/j.nbd.2012.01.001; Yu FS, 2005, NEUROBIOL DIS, V20, P491, DOI 10.1016/j.nbd.2005.04.004; Zhou LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079805; Ziu MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014724	77	13	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	NOV 4	2019	10								839	10.1038/s41419-019-2079-y			14	Cell Biology	Cell Biology	JP0OB	WOS:000497970400012	31685802	DOAJ Gold, Green Published			2021-06-18	
J	Putukian, M; Echemendia, RJ; Chiampas, G; Dvorak, J; Mandelbaum, B; Lemak, LJ; Kirkendall, D				Putukian, Margot; Echemendia, Ruben J.; Chiampas, George; Dvorak, Jiri; Mandelbaum, Bert; Lemak, Lawrence J.; Kirkendall, Don			Head Injury in Soccer: From Science to the Field; summary of the head injury summit held in April 2017 in New York City, New York	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							CHRONIC TRAUMATIC ENCEPHALOPATHY; SPORTS-RELATED CONCUSSION; PROFESSIONAL RUGBY UNION; FEMALE FOOTBALL PLAYERS; STATES HIGH-SCHOOL; WOMENS SOCCER; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; ELITE FOOTBALL; NECK STRENGTH	There has been an increased focus and awareness of head injury and sport-related concussion (SRC) across all sports from the medical and scientific communities, sports organisations, legislators, the media and the general population. Soccer, in particular, has been a focus of attention due to the popularity of the game, the frequency of SRC and the hypothesised effects of repetitive heading of the ball. Major League Soccer, US Soccer and the National Women's Soccer League jointly hosted a conference entitled, 'Head Injury in Soccer: From Science to the Field', on 21-22 April 2017 in New York City, New York. The mission of this conference was to identify, discuss and disseminate evidence-based science related to the findings and conclusions of the fifth International Conference on Concussion in Sport held by the Concussion in Sport Group and apply them to the sport of soccer. In addition, we reviewed information regarding the epidemiology and mechanism of head injuries in soccer at all levels of play, data regarding the biomechanics and effects of repetitive head impacts and other soccer-specific considerations. We discussed how to release the information raised during the summit to key stakeholders including athletes, parents, coaches and healthcare providers. We identified future areas for research and collaboration to enhance the health and safety of soccer (football) players.	[Putukian, Margot] Princeton Univ, Dept Athlet Med, Princeton, NJ 08544 USA; [Echemendia, Ruben J.] Univ Orthopaed Ctr, Dept Concuss Clin, State Coll, PA USA; [Chiampas, George] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med & Orthoped, Chicago, IL 60611 USA; [Dvorak, Jiri] Swiss Concuss Ctr, Zurich, Switzerland; [Dvorak, Jiri] Schulthess Clin, Dept Spine Unit, Zurich, Switzerland; [Mandelbaum, Bert] Santa Monica Orthopaed & Sports Med Grp, Santa Monica, CA USA; [Lemak, Lawrence J.] Lemak Hlth, Birmingham, AL USA; [Kirkendall, Don] Duke Univ Hlth Syst, Duke Sport Sci Inst, Durham, NC USA	Putukian, M (corresponding author), Princeton Univ, Univ Hlth Serv, Athlet Med, Princeton, NJ 08544 USA.	putukian@princeton.edu		Putukian, Margot/0000-0002-1478-8068			Agel J, 2007, J ATHL TRAINING, V42, P270; Akodu A K, 2012, Afr J Med Med Sci, V41, P423; Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Baxter-Johes ADG, 2001, SPORTS MED SPECIFIC, P95; Beaudouin F, 2018, CLIN J SPORT MED, P1; Bible F., 2014, SOCCER BALL SIZES SE; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bjorneboe J, 2013, BRIT J SPORT MED, V47, P508, DOI 10.1136/bjsports-2012-091522; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Broglio SP, 2003, J ATHL TRAINING, V38, P220; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Caccese JB, 2016, SPORTS MED, V46, P1591, DOI 10.1007/s40279-016-0544-7; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Chandran Avinash, 2017, Inj Epidemiol, V4, P28, DOI 10.1186/s40621-017-0127-6; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Chrisman SPD, 2017, CLIN J SPORT MED; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Conley MS, 1997, EUR J APPL PHYSIOL, V75, P443, DOI 10.1007/s004210050186; Conley MS, 1997, J APPL PHYSIOL, V83, P2105; Covassin T, 2003, J ATHL TRAINING, V38, P238; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Davis GA, 2017, BRIT J SPORT MED, V51, P859, DOI 10.1136/bjsports-2017-097492; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Dick R, 2007, J ATHL TRAINING, V42, P278; Dupont G, 2010, AM J SPORT MED, V38, P1752, DOI 10.1177/0363546510361236; Dvorak J, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2006.034579; Dvorak J, 2011, BRIT J SPORT MED, V45, P626, DOI 10.1136/bjsm.2010.079905; Echemendia RE., 2017, MAJ LEAG SOCC 2017 M; Echemendia RJ, 2001, CLIN J SPORT MED, V11, P23, DOI 10.1097/00042752-200101000-00005; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P870, DOI 10.1136/bjsports-2017-097508; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Echemendia RJ, 2018, BRIT J SPORT MED, V52, P1149, DOI 10.1136/bjsports-2016-097090; Eirale C, 2014, J SCI MED SPORT, V17, P34, DOI 10.1016/j.jsams.2013.05.004; Ekstrand J, 2011, BRIT J SPORT MED, V45, P553, DOI 10.1136/bjsm.2009.060582; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Elbin RJ, 2015, RES SPORTS MED, V23, P203, DOI 10.1080/15438627.2015.1005293; Emery CA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097452; Faude O, 2017, SCAND J MED SCI SPOR, V27, P1986, DOI 10.1111/sms.12839; Faude O, 2013, SPORTS MED, V43, P819, DOI 10.1007/s40279-013-0061-x; Federation Internationale de Football Association-FIFA, 2007, FIFA BIG COUNT 2006; FITZPATRICK J, 2017, BRIT J SPORT MED, V5; Forbes CR, 2016, APPL NEUROPSYCH-CHIL, V5, P14, DOI 10.1080/21622965.2014.933108; Fuller CW, 2017, BRIT J SPORT MED, V51, P64, DOI 10.1136/bjsports-2016-096461; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Geary K, 2014, CLIN J SPORT MED, V24, P502, DOI 10.1097/JSM.0000000000000071; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greydanus DE, 2009, PEDIAT PRACTICE SPOR, P15; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hagglund M, 2009, SCAND J MED SCI SPOR, V19, P819, DOI 10.1111/j.1600-0838.2008.00861.x; Hagglund M, 2009, BRIT J SPORT MED, V43, P483, DOI 10.1136/bjsm.2008.056937; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Hanlon E., 2009, THESIS; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Hartmut G, 2010, CLIN J SPORT MED, V20, P264, DOI 10.1097/JSM.0b013e3181e78e33; Hassabi Mohammad, 2010, Asian J Sports Med, V1, P201; Haywood K. M., 2014, LIFE SPAN MOTOR DEV; Hrysomallis C, 2004, J SCI MED SPORT, V7, P156, DOI 10.1016/S1440-2440(04)80005-7; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacobson I, 2007, SCAND J MED SCI SPOR, V17, P84, DOI 10.1111/j.1600-0838.2006.00524.x; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Junge A, 2004, AM J SPORT MED, V32, p80S, DOI 10.1177/0363546503261245; Junge A, 2004, AM J SPORT MED, V32, p23S, DOI 10.1177/0363546503261246; Junge A, 2015, BRIT J SPORT MED, V49, P599, DOI 10.1136/bjsports-2014-094469; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; Junge A, 2007, BRIT J SPORT MED, V41, pI3, DOI 10.1136/bjsm.2007.036020; Kaminski TW, 2008, RES Q EXERCISE SPORT, V79, P235; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Khodaee M, 2017, BRIT J SPORT MED, V51, P185, DOI 10.1136/bjsports-2015-095946; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kroshus E, 2018, HEALTH EDUC BEHAV, V45, P254, DOI 10.1177/1090198117715669; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P182, DOI 10.1177/1090198115599380; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lefebvre C, 1998, ADAPT PHYS ACT Q, V15, P299, DOI 10.1123/apaq.15.4.299; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; McIntosh A, 2004, BRIT J SPORT MED, V38, P46, DOI 10.1136/bjsm.2002.003103; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Mihalik JP, 2017, MED SCI SPORT EXER, V49, P247, DOI 10.1249/MSS.0000000000001089; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Naunheim RS, 2003, ACAD EMERG MED, V10, P85, DOI 10.1197/aemj.10.1.85; NCAA, 2017, CONC ED RES SEC CONC; NCAA, 2017, NCAA INJ SURV PROGR; Nilsson M, 2013, CLIN J SPORT MED, V23, P255, DOI 10.1097/JSM.0b013e31827ee6f8; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; O'Kane JW, 2014, PHYSICIAN SPORTSMED, V42, P39, DOI 10.3810/psm.2014.09.2074; Patricios J, 2017, BRIT J SPORT MED, V51, P888, DOI 10.1136/bjsports-2016-097441; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Prien A, 2018, SPORTS MED, V48, P953, DOI 10.1007/s40279-017-0854-4; Purcell L., 2005, PAEDIAT CHILD HLTH, V16, P343; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rieder C, 2011, ARCH CLIN NEUROPSYCH, V26, P583, DOI 10.1093/arclin/acr055; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Roos KG, 2017, BRIT J SPORT MED, V51, P1029, DOI 10.1136/bjsports-2015-095718; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Salinas CM, 2009, J CLIN SPORT PSYCHOL, V3, P15, DOI 10.1123/jcsp.3.1.15; Schallmo MS, 2017, J BONE JOINT SURG AM, V99, P1314, DOI 10.2106/JBJS.16.01573; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Schneider DK, 2017, BRIT J SPORT MED, V51, P1473, DOI 10.1136/bjsports-2015-095645; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Taubman B, 2016, J CHILD NEUROL, V31, P1555, DOI 10.1177/0883073816664835; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; U.S USSoccer, 2017, SOCC REC 2 REC CONC; United Soccer Coaches, 2017, GET AHEAD SAF SOCC O; Walden M, 2005, SCAND J MED SCI SPOR, V15, P118, DOI 10.1111/j.1600-0838.2004.00393.x; Walden M, 2013, SCAND J MED SCI SPOR, V23, P424, DOI 10.1111/j.1600-0838.2011.01409.x; Walden M, 2007, KNEE SURG SPORT TR A, V15, P1155, DOI 10.1007/s00167-007-0290-3; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Withnall C, 2005, BRIT J SPORT MED, V39, pI40, DOI 10.1136/bjsm.2005.019174; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Yoon YS, 2004, AM J SPORT MED, V32, p36S, DOI 10.1177/0095399703258781; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zuckerman SL, 2018, J ALZHEIMERS DIS, V66, P37, DOI 10.3233/JAD-180218; Zuckerman Scott L, 2016, Neurosurgery, V63 Suppl 1, P102, DOI 10.1227/NEU.0000000000001280; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	153	13	13	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	NOV	2019	53	21					1332	+		10.1136/bjsports-2018-100232			14	Sport Sciences	Sport Sciences	JK8GI	WOS:000495077700005	30760457	Bronze			2021-06-18	
J	Yanuck, SF				Yanuck, Samuel F.			Microglial Phagocytosis of Neurons: Diminishing Neuronal Loss in Traumatic, Infectious, Inflammatory, and Autoimmune CNS Disorders	FRONTIERS IN PSYCHIATRY			English	Article						depression; microglia; neuron; autoimmunity; inflammation; traumatic brain injury; cytokine; excitotoxicity	CENTRAL-NERVOUS-SYSTEM; C-REACTIVE PROTEIN; BLOOD-BRAIN-BARRIER; NF-KAPPA-B; MAJOR DEPRESSIVE DISORDER; PARKINSONS-DISEASE; OXIDATIVE STRESS; ADIPOSE-TISSUE; ENDOTHELIAL DYSFUNCTION; ALZHEIMERS-DISEASE	Errors in neuron-microglial interaction are known to lead to microglial phagocytosis of live neurons and excessive neuronal loss, potentially yielding poorer clinical outcomes. Factors that affect neuron-microglial interaction have the potential to influence the error rate. Clinical comorbidities that unfavorably impact neuron-microglial interaction may promote a higher rate of neuronal loss, to the detriment of patient outcome. This paper proposes that many common, clinically modifiable comorbidities have a common thread, in that they all influence neuron-microglial interactions. Comorbidities like traumatic brain injury, infection, stress, neuroinflammation, loss of neuronal metabolic integrity, poor growth factor status, and other factors, all have the potential to alter communication between neurons and microglia. When this occurs, microglial phagocytosis of live neurons can increase. In addition, microglia can shift into a morphological form in which they express major histocompatibility complex II (MHC-II), allowing them to function as antigen presenting cells that present neuronal debris as antigen to invading T cells. This can increase risk for the development of CNS autoimmunity, or can exacerbate existing CNS autoimmunity. The detrimental influence of these comorbidities has the potential to contribute to the mosaic of factors that determine patient outcome in some CNS pathologies that have neuropsychiatric involvement, including TBI and CNS disorders with autoimmune components, where excessive neuronal loss can yield poorer clinical outcomes. Recognition of the impact of these comorbidities may contribute to an understanding of the common clinical observation that many seemingly disparate factors contribute to the overall picture of case management and clinical outcome in these complex disorders. In a clinical setting, knowing how these comorbidities can influence neuron-microglial interaction can help focus surveillance and care on a broader group of potential therapeutic targets. Accordingly, an interest in the mechanisms underlying the influence of these factors on neuron-microglial interactions is appropriate. Neuronmicroglial interaction is reviewed, and the various mechanisms by which these potential comorbidities influence neuro-microglial interaction are described.	[Yanuck, Samuel F.] Univ N Carolina, Dept Phys Med & Rehabil, Program Integrat Med, Sch Med, Chapel Hill, NC 27515 USA	Yanuck, SF (corresponding author), Univ N Carolina, Dept Phys Med & Rehabil, Program Integrat Med, Sch Med, Chapel Hill, NC 27515 USA.	syanuck@yanuckcenter.com					Aftanas LI, 2018, B EXP BIOL MED+, V165, P195, DOI 10.1007/s10517-018-4128-4; Aharoni R, 2014, J AUTOIMMUN, V54, P81, DOI 10.1016/j.jaut.2014.05.005; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amaral AI, 2013, J INHERIT METAB DIS, V36, P621, DOI 10.1007/s10545-012-9553-3; Andersen K, 2017, J AM SOC NEPHROL, V28, P76, DOI 10.1681/ASN.2015111285; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Ayata P, 2018, NAT NEUROSCI, V21, P1049, DOI 10.1038/s41593-018-0192-3; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Barnett ML, 2018, NEUROIMAGE-CLIN, V17, P596, DOI 10.1016/j.nicl.2017.11.017; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Bhattacharjee S, 2018, PARKINSONS DIS-US, V2018, DOI 10.1155/2018/3402983; Bhattacharjee S, 2017, MULT SCLER INT, V2017, DOI 10.1155/2017/3175358; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bodnar CN, 2018, NEURAL REGEN RES, V13, P1693, DOI 10.4103/1673-5374.238604; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Brown GC, 2014, NAT REV NEUROSCI, V15, P209, DOI 10.1038/nrn3710; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Butterfield DA, 2019, NAT REV NEUROSCI, V20, P148, DOI 10.1038/s41583-019-0132-6; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cai QX, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00627; Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Carvey PM, 2006, CELL TRANSPLANT, V15, P239, DOI 10.3727/000000006783981990; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chang HS, 2015, BEHAV BRAIN RES, V292, P116, DOI 10.1016/j.bbr.2015.06.005; Chou RC, 2016, CNS DRUGS, V30, P1111, DOI 10.1007/s40263-016-0374-z; Chung G, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00376; Clancy JA, 2014, BRAIN STIMUL, V7, P871, DOI 10.1016/j.brs.2014.07.031; Clarkson BDS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09182-5; Cohen S, 2012, P NATL ACAD SCI USA, V109, P5995, DOI 10.1073/pnas.1118355109; Cole SW, 2008, BRAIN BEHAV IMMUN, V22, P1049, DOI 10.1016/j.bbi.2008.02.006; Combrinck MI, 2002, NEUROSCIENCE, V112, P7, DOI 10.1016/S0306-4522(02)00030-1; Corcoran SE, 2016, J CLIN INVEST, V126, P3699, DOI 10.1172/JCI84431; Culmsee C, 2019, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00739; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; Dahl J, 2014, PSYCHONEUROENDOCRINO, V45, P77, DOI 10.1016/j.psyneuen.2014.03.019; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; de Jong PR, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1458-3; De Virgilio A, 2016, AUTOIMMUN REV, V15, P1005, DOI 10.1016/j.autrev.2016.07.022; Deardorff WJ, 2017, EXPERT REV NEUROTHER, V17, P17, DOI 10.1080/14737175.2016.1200972; Denes A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-164; Di Giovangiulio M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00590; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Dong WM, 1998, TOXICOL APPL PHARM, V151, P359, DOI 10.1006/taap.1998.8481; Dooley LN, 2018, NEUROSCI BIOBEHAV R, V94, P219, DOI 10.1016/j.neubiorev.2018.09.006; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Eswarappa M, 2019, BRAIN BEHAV IMMUN, V75, P220, DOI 10.1016/j.bbi.2018.10.012; Eyo UB, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/456857; Feinstein DL, 2016, J NEUROCHEM, V139, P154, DOI 10.1111/jnc.13447; Fernandes A, 2014, CELL MOL LIFE SCI, V71, P3969, DOI 10.1007/s00018-014-1670-8; Fiebich BL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00260; Fisher G, 2011, OBESITY, V19, P1131, DOI 10.1038/oby.2010.310; Ford ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/00001648-200209000-00012; Fricker M, 2012, J NEUROSCI, V32, P2657, DOI 10.1523/JNEUROSCI.4837-11.2012; Fujisaka S, 2013, DIABETOLOGIA, V56, P1403, DOI 10.1007/s00125-013-2885-1; Fumagalli S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00081; Fusco M, 2017, PAIN PRACT, V17, P522, DOI 10.1111/papr.12551; Galloway DA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01575; Galvan A, 2010, HUM BRAIN MAPP, V31, P879, DOI 10.1002/hbm.21029; Ginhoux F, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020537; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Giridharan VV, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00122; Giugliano D, 2006, J AM COLL CARDIOL, V48, P677, DOI 10.1016/j.jacc.2006.03.052; Gomez-Nicola D, 2015, NEUROSCIENTIST, V21, P169, DOI 10.1177/1073858414530512; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greeke EE, 2017, J NEUROL SCI, V380, P236, DOI 10.1016/j.jns.2017.07.047; Grieb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091663; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Harding A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00398; Heilbronn LK, 2001, ARTERIOSCL THROM VAS, V21, P968, DOI 10.1161/01.ATV.21.6.968; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Heninger GR, 1996, PHARMACOPSYCHIATRY, V29, P2, DOI 10.1055/s-2007-979535; Hirad AA, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3460; Honig LS, 2003, ARCH NEUROL-CHICAGO, V60, P1707, DOI 10.1001/archneur.60.12.1707; Horsburgh S, 2015, EXERC IMMUNOL REV, V21, P26; Huang M, 2019, BRAIN BEHAV IMMUN, V75, P200, DOI 10.1016/j.bbi.2018.10.007; Huizinga R, 2012, GLIA, V60, P422, DOI 10.1002/glia.22276; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Hunter RL, 2007, J NEUROCHEM, V100, P1375, DOI 10.1111/j.1471-4159.2006.04327.x; Inoue T, 2016, J CLIN INVEST, V126, P1939, DOI 10.1172/JCI83658; Jayedi A, 2019, NUTR NEUROSCI, V22, P750, DOI 10.1080/1028415X.2018.1436639; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kao LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168106; Kariuki M, 2016, J PAEDIATR CHILD H, V52, P882, DOI 10.1111/jpc.13239; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Khandaker GM, 2012, SCHIZOPHR RES, V139, P161, DOI 10.1016/j.schres.2012.05.023; Kierdorf K, 2017, J CLIN INVEST, V127, P3201, DOI [10.1172/JCI90602, 10.1172/jci90602]; Kimura K, 2016, CELL REP, V14, P2362, DOI 10.1016/j.celrep.2016.02.032; KLEIN CL, 1994, PATHOBIOLOGY, V62, P90, DOI 10.1159/000163883; Kopschina FP, 2017, J PSYCHOPHARMACOL, V31, P1149, DOI DOI 10.1177/0269881117711708; Kuhlmann CRW, 2009, STROKE, V40, P1458, DOI 10.1161/STROKEAHA.108.535930; Kumar A, 2015, J CHILD NEUROL, V30, P749, DOI 10.1177/0883073814543303; Lacroix S, 1998, BRAIN PATHOL, V8, P625, DOI 10.1111/j.1750-3639.1998.tb00189.x; Laflamme N, 1999, J NEUROSCI, V19, P10923; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; LEHMANN PV, 1992, NATURE, V358, P155, DOI 10.1038/358155a0; Leonard BE, 2018, ACTA NEUROPSYCHIATR, V30, P1, DOI 10.1017/neu.2016.69; Leonard BE, 2014, PROG NEURO-PSYCHOPH, V48, P261, DOI 10.1016/j.pnpbp.2013.10.018; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Lin WC, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0749-9; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Liu YJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00451; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Lunnon K, 2011, J IMMUNOL, V186, P7215, DOI 10.4049/jimmunol.0903833; Majkova Z, 2009, TOXICOL APPL PHARM, V237, P1, DOI 10.1016/j.taap.2009.02.016; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; Mangano EN, 2009, NEUROBIOL AGING, V30, P1361, DOI 10.1016/j.neurobiolaging.2007.11.020; Marsland AL, 2017, BRAIN BEHAV IMMUN, V64, P208, DOI 10.1016/j.bbi.2017.01.011; McCaulley Mark E, 2015, Int J Alzheimers Dis, V2015, P515248, DOI 10.1155/2015/515248; MCRAE BL, 1995, J EXP MED, V182, P75, DOI 10.1084/jem.182.1.75; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller ZA, 2013, BRAIN, V136, P3461, DOI 10.1093/brain/awt242; Miyauchi T, 2019, HUM PSYCHOPHARM CLIN, V34, DOI 10.1002/hup.2698; Moller P, 2014, MUTAT RES-REV MUTAT, V762, P133, DOI 10.1016/j.mrrev.2014.09.001; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mrowczynski W, 2019, NEURAL PLAST, V2019, DOI 10.1155/2019/5413067; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Neher JJ, 2013, P NATL ACAD SCI USA, V110, pE4098, DOI 10.1073/pnas.1308679110; Neher JJ, 2011, J IMMUNOL, V186, P4973, DOI 10.4049/jimmunol.1003600; Neniskyte U, 2017, NAT REV NEUROSCI, V18, P658, DOI 10.1038/nrn.2017.110; Neniskyte U, 2011, J BIOL CHEM, V286, P39904, DOI 10.1074/jbc.M111.267583; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Nicklas BJ, 2004, AM J CLIN NUTR, V79, P544; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nocella C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061353; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; O'Connor TG, 2014, J CHILD PSYCHOL PSYC, V55, P615, DOI 10.1111/jcpp.12187; Patrick KL, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00138; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Plaza-Zabala A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030598; Policicchio S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13168-8; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Quan N, 1998, NEUROSCIENCE, V83, P281, DOI 10.1016/S0306-4522(97)00350-3; Quan N, 1997, P NATL ACAD SCI USA, V94, P10985, DOI 10.1073/pnas.94.20.10985; Raison CL, 2011, CURR PSYCHIAT REP, V13, P467, DOI 10.1007/s11920-011-0232-0; Raison CL, 2010, ARCH GEN PSYCHIAT, V67, P1211, DOI 10.1001/archgenpsychiatry.2010.161; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rommer PS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01564; Ruskovska T, 2013, J PROTEOMICS, V92, P323, DOI 10.1016/j.jprot.2013.04.002; Santambrogio L, 2001, P NATL ACAD SCI USA, V98, P6295, DOI 10.1073/pnas.111152498; Schaefer L, 2014, J BIOL CHEM, V289, P35237, DOI 10.1074/jbc.R114.619304; Schrepf A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04648-0; Semenza GL, 2007, SCI STKE, V2007, pcm8, DOI [10.1126/stke.4072007cm8, DOI 10.1126/STKE.4072007CM8]; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Sharma B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00879; Sheehan P, 2019, NEUROSCI LETT, V697, P59, DOI 10.1016/j.neulet.2018.04.013; Silasi G, 2014, NEURON, V83, P1354, DOI 10.1016/j.neuron.2014.08.052; Skaper SD, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00072; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sproston NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00754; Stogsdill JA, 2017, CURR OPIN NEUROBIOL, V42, P1, DOI 10.1016/j.conb.2016.09.016; Strawbridge R, 2017, NEUROPSYCH DIS TREAT, V13, P1245, DOI 10.2147/NDT.S114542; Szepesi Z, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00323; Szic KSV, 2010, BIOCHEM PHARMACOL, V80, P1816, DOI 10.1016/j.bcp.2010.07.029; Temelkova-Kurktschiev T, 2002, METABOLISM, V51, P743, DOI 10.1053/meta.2002.32804; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Thienemann M, 2017, J CHILD ADOL PSYCHOP, V27, P566, DOI 10.1089/cap.2016.0145; Tyler KL, 2009, ARCH NEUROL-CHICAGO, V66, P939, DOI 10.1001/archneurol.2009.153; Uddin MS, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00004; ULVESTAD E, 1994, J LEUKOCYTE BIOL, V56, P732; Urrutia PJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00038; van der Hoek TC, 2011, J NEUROL SCI, V310, P220, DOI 10.1016/j.jns.2011.07.007; van Langenberg DR, 2017, UNITED EUR GASTROENT, V5, P579, DOI 10.1177/2050640616663397; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wraith DC, 2012, J CLIN INVEST, V122, P1172, DOI 10.1172/JCI58648; Wu XB, 2016, NEUROSCI LETT, V611, P40, DOI 10.1016/j.neulet.2015.11.030; Yang GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078355; Yang SN, 2014, ALLERGY ASTHMA IMMUN, V6, P478, DOI 10.4168/aair.2014.6.6.478; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; You TJ, 2004, J CLIN ENDOCR METAB, V89, P1739, DOI 10.1210/jc.2003-031310; Young JJ, 2014, J AFFECT DISORDERS, V169, P15, DOI 10.1016/j.jad.2014.07.032; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zoppini G, 2006, NUTR METAB CARDIOVAS, V16, P543, DOI 10.1016/j.numecd.2005.09.004	196	13	13	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	OCT 3	2019	10								712	10.3389/fpsyt.2019.00712			18	Psychiatry	Psychiatry	JO1EN	WOS:000497328400001	31632307	DOAJ Gold, Green Published			2021-06-18	
J	Lecca, D; Bader, M; Tweedie, D; Hoffman, AF; Jung, YJ; Hsueh, SC; Hoffer, BJ; Becker, RE; Pick, CG; Lupica, CR; Greig, NH				Lecca, Daniela; Bader, Miaad; Tweedie, David; Hoffman, Alexander F.; Jung, Yoo Jin; Hsueh, Shin-Chang; Hoffer, Barry J.; Becker, Robert E.; Pick, Chaim G.; Lupica, Carl R.; Greig, Nigel H.			(-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice	NEUROBIOLOGY OF DISEASE			English	Article						(-)-Phenserine; Traumatic brain injury; Alzheimer's disease; Neurodegeneration; Neuroinflammation; TNF-alpha; Synaptic proteins; Long term potentiation; Cognitive impairment; Therapeutic intervention	LONG-TERM POTENTIATION; SYNAPTIC PROTEINS; TNF-ALPHA; GENE-EXPRESSION; ANIMAL-MODELS; PATHOPHYSIOLOGY; SYNAPTOPHYSIN; CONSEQUENCES; MICROGLIA; MEMORY	Mild traumatic brain injury (mTBI) is a risk factor for neurodegenerative disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD). TBI-derived neuropathologies are promoted by inflammatory processes: chronic microgliosis and release of pro-inflammatory cytokines that further promote neuronal dysfunction and loss. Herein, we evaluated the effect on pre-programmed cell death/neuroinflammation/synaptic integrity and function of (-)-Phenserine tartrate (Phen), an agent originally developed for AD. This was studied at two clinically translatable doses (2.5 and 5.0 mg/kg, BID), in a weight drop (concussive) mTBI model in wild type (WT) and AD APP/PSEN1 transgenic mice. Phen mitigated mTBI-induced cognitive impairment, assessed by Novel Object Recognition and Y-maze behavioral paradigms, in WT mice. Phen fully abated mTBI-induced neurodegeneration, evaluated by counting Fluoro-Jade C-positive (FJC +) cells, in hippocampus and cortex of WT mice. In APP/PSEN1 mice, degenerating cell counts were consistently greater across all experimental groups vs. WT mice. mTBI elevated FJC + cell counts vs. the APP/PSEN1 control (sham) group, and Phen similarly mitigated this. Anti-inflammatory effects on microglial activation (IBA1-immunoreactivity (IR)) and the pro inflammatory cytokine TNF-alpha were evaluated. mTBI increased IBA1-IR and TNF-alpha/IBA1 colocalization vs. sham, both in WT and APP/PSEN1 mice. Phen decreased IBA1-IR throughout hippocampi and cortices of WT mice, and in cortices of AD mice. Phen, likewise, reduced levels of IBA1/TNF-alpha-IR colocalization volume across all areas in WT animals, with a similar trend in APP/PSEN1 mice. Actions on astrocyte activation by mTBI were followed by evaluating GFAP, and were similarly mitigated by Phen. Synaptic density was evaluated by quantifying PSD95 + dendritic spines and Synaptophysin (Syn)-IR. Both were significantly reduced in mTBI vs. sham in both WT and APP/PSEN1 mice. Phen fully reversed the PSD-95 + spine loss in WT and Syn-IR decrease in both WT and APP/PSEN1 mice. To associate immunohistochemical changes in synaptic markers with function, hippocampal long term potentiation (LTP) was induced in WT mice. LTP was impaired by mTBI, and this impairment was mitigated by Phen. In synopsis, clinically translatable doses of Phen ameliorated mTBI-mediated pre-programmed cell death/neuroinflammation/synaptic dysfunction in WT mice, consistent with fully mitigating mTBI-induced cognitive impairments. Phen additionally demonstrated positive actions in the more pathologic brain microenvironment of AD mice, further supporting consideration of its repurposing as a treatment for mTBI.	[Lecca, Daniela; Tweedie, David; Jung, Yoo Jin; Becker, Robert E.; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Bader, Miaad; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Hoffman, Alexander F.; Lupica, Carl R.] NIDA, Electrophysiol Res Sect, Cellular Neurobiol Res Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Hsueh, Shin-Chang; Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Becker, Robert E.] Aristea Translat Med Corp, Park City, UT 84098 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Ctr Biol Addict Dis, IL-69978 Tel Aviv, Israel	Greig, NH (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	Greign@grc.nia.nih.gov	Hoffman, Alexander F/H-3035-2012	Hoffman, Alexander F/0000-0002-2676-0628	Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG057028]; MOST [106-2917-1-038-001]; Ari and Regine Aprijaskis Fund, at Tel-Aviv University, Tel-Aviv, Israel; Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases, Tel-Aviv University, Tel-Aviv, Israel; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311, R56AG057028] Funding Source: NIH RePORTER	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, USA, (ii) NIH grant AG057028 to BJH, (iii) MOST 106-2917-1-038-001, and (iv) the Ari and Regine Aprijaskis Fund, at Tel-Aviv University, and the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases, Tel-Aviv University, Tel-Aviv, Israel to CGP.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bader M, 2019, NEUROBIOL DIS, V124, P439, DOI 10.1016/j.nbd.2018.11.023; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Baratz R, 2010, J NEUROTRAUM, V27, P555, DOI 10.1089/neu.2009.0891; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Becker RE, 2019, J ALZHEIMERS DIS, V68, P489, DOI 10.3233/JAD-181300; Ben Shimon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188524; Bereczki E, 2016, ALZHEIMERS DEMENT, V12, P1149, DOI 10.1016/j.jalz.2016.04.005; Bickford PC, 2017, EXP GERONTOL, V94, P4, DOI 10.1016/j.exger.2017.01.027; Bolouri H., 2015, BRAIN NEUROTRAUMA MO; Cambon K, 2000, NEUROSCIENCE, V97, P685, DOI 10.1016/S0306-4522(00)00065-8; Caplan HW, 2017, J NEUROSCI RES, V95, P509, DOI 10.1002/jnr.23854; CDER U, 2005, GUID IND EST MAX SAF; Chang CF, 2017, BRAIN RES, V1677, P118, DOI 10.1016/j.brainres.2017.09.015; Chen W, 2014, PLOS ONE, V9; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Chen Yuan-Hao, 2018, Oncotarget, V9, P11515, DOI 10.18632/oncotarget.23923; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Craft JM, 2005, EXPERT OPIN THER TAR, V9, P887, DOI 10.1517/14728222.9.5.887; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; d'Avila JC, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1059-y; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Deselms H, 2016, J NEUROSCI METH, V272, P69, DOI 10.1016/j.jneumeth.2016.02.002; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Fann JR, 2018, LANCET PSYCHIAT, V5, P424, DOI 10.1016/S2215-0366(18)30065-8; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greig NH, 2000, ACTA NEUROL SCAND, V102, P74, DOI 10.1034/j.1600-0404.2000.00311.x; Greig Nigel H., 2005, Current Alzheimer Research, V2, P275; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; HEINONEN O, 1995, NEUROSCIENCE, V64, P375, DOI 10.1016/0306-4522(94)00422-2; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Hsueh SC, 2019, CELL TRANSPLANT, V28, P1183, DOI 10.1177/0963689719854693; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Joo H, 2019, PLANTA MED, V85, P231, DOI 10.1055/a-0753-0400; Kadir A, 2008, ANN NEUROL, V63, P621, DOI 10.1002/ana.21345; Kirkley KS, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0871-0; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Liu BJ, 2017, BRAIN RES, V1672, P18, DOI 10.1016/j.brainres.2017.07.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Lynch NJ, 2004, MOL IMMUNOL, V40, P709, DOI 10.1016/j.molimm.2003.08.009; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marchetti C, 2011, REV NEUROSCIENCE, V22, P373, DOI 10.1515/RNS.2011.035; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Mollayeva T, 2018, NAT REV NEUROL, V14, P712, DOI 10.1038/s41582-018-0091-y; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Nordberg A, 2015, J ALZHEIMERS DIS, V47, P691, DOI 10.3233/JAD-132474; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Ogoshi F, 2005, EXP NEUROL, V193, P384, DOI 10.1016/j.expneurol.2004.12.026; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Paxinos G, 2012, PAXINOS FRANKLINS MO; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Rachmany L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03792-9; Rizzo FR, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/8430123; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Stein DG, 2019, NEUROPHARMACOLOGY, V147, P66, DOI 10.1016/j.neuropharm.2018.04.006; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Tsai MC, 2015, J NEUROIMMUNE PHARM, V10, P45, DOI 10.1007/s11481-014-9570-0; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wen ZJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/4296075; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	120	13	13	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2019	130								104528	10.1016/j.nbd.2019.104528			15	Neurosciences	Neurosciences & Neurology	IR6QY	WOS:000481565000036	31295555	Green Accepted			2021-06-18	
J	Zhang, D; Lu, ZF; Man, J; Cui, KF; Fu, XJ; Yu, L; Gao, YF; Liao, LH; Xiao, QQ; Guo, RM; Zhang, YX; Zhang, Z; Liu, XL; Lu, H; Wang, JP				Zhang, Di; Lu, Zhengfang; Man, Jiang; Cui, Kefei; Fu, Xiaojie; Yu, Lie; Gao, Yufeng; Liao, Linghui; Xiao, Qianqian; Guo, Ruiming; Zhang, Yongxin; Zhang, Zhen; Liu, Xianliang; Lu, Hong; Wang, Jianping			Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Wnt-3a; Ischemic stroke; Neuroinflammtion; Microglia/macrophage; Astrocyte; Polarization	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC TRANSFORMATION; REACTIVE ASTROCYTES; MICROGLIA; NEUROPROTECTION; NEUROGENESIS; ACTIVATION; MECHANISMS; EXPRESSION; INHIBITOR	Neuroinflammation crucially influences functional recovery after ischemic stroke. Wnt-3a, a novel Wnt protein that specifically promotes Wnt/beta-catenin signaling pathway, has been shown to regulate apoptosis and cell proliferation, but how it affects ischemic stroke-induced toxic brain inflammation remains unknown. Using a transient middle cerebral artery occlusion (tMCAO) mouse model in this study, we found that intranasal Wnt-3a-treated tMCAO mice had apparently reduced infarct volume and decreased brain water content after being allowed to recover for 72 h, as well as better neurologic outcomes on days 3, 7, and 14. Mice received Wnt-3a had significantly fewer tMCAO-induced peri-infarct TUNEL-positive cells compared with those received vehicle. Further, Wnt-3a-delivered tMCAO mice had notably fewer peri-infarct CD68-positive cells and lower ionized calcium-binding adapter molecule (Iba)-1 protein level. Wnt-3a significantly downregulated the expression of inducible nitric oxide synthase (iNOS) and tumor necrosis factor (TNF)-alpha, and upregulated the expression of arginase 1 (Arg1) and CD206. Finally, Wnt-3a obviously decreased the number of tMCAO-induced peri-infarct glial fibrillary acidic protein (GFAP)/C3-positive cells, increased the number of GFAP/S100A10-positive cells, attenuated the protein levels of GFAP and interleukin 15 (IL15), and elevated IL33 protein level. Our findings suggest that intranasal Wnt-3a could ameliorate toxic responses of microglia/macrophages and astrocytes in ischemic brain injury, supporting that Wnt-3a might be potentially appropriate for ischemic stroke treatment functioning as an immunomodulatory agent.	[Zhang, Di; Lu, Zhengfang; Man, Jiang; Gao, Yufeng; Liao, Linghui; Xiao, Qianqian; Zhang, Yongxin; Zhang, Zhen; Liu, Xianliang; Wang, Jianping] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China; [Cui, Kefei] Zhengzhou Univ, Dept Ultrasound, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Fu, Xiaojie] Zhengzhou Univ, Dept Intervent Neuroradiol, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Yu, Lie; Lu, Hong] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Guo, Ruiming] Zhengzhou Univ, Dept Surg, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China	Wang, JP (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China.	wjpwfy666@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571137, 81771247]	This work was supported by grants from the National Natural Science Foundation of China (81571137 and 81771247).	Bourganis V, 2018, EUR J PHARM BIOPHARM, V128, P337, DOI 10.1016/j.ejpb.2018.05.009; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Crowe TP, 2018, LIFE SCI, V195, P44, DOI 10.1016/j.lfs.2017.12.025; Cuadrado A, 2018, REDOX BIOL, V14, P522, DOI 10.1016/j.redox.2017.10.010; D'Angelo B, 2016, NEUROPHARMACOLOGY, V101, P13, DOI 10.1016/j.neuropharm.2015.09.017; Duan JL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1406-7; Erdo F, 2018, BRAIN RES BULL, V143, P155, DOI 10.1016/j.brainresbull.2018.10.009; Filous AR, 2016, PROG NEUROBIOL, V144, P173, DOI 10.1016/j.pneurobio.2016.03.009; Fujita A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1251-0; Ganger S, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10030116; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Gomez-Nicola D, 2008, GLIA, V56, P494, DOI 10.1002/glia.20628; Guo YN, 2015, 2015 12TH CHINA INTERNATIONAL FORUM ON SOLID STATE LIGHTING (SSLCHINA), P4, DOI 10.1109/SSLCHINA.2015.7360677; Halleskog C, 2013, J NEUROCHEM, V125, P803, DOI 10.1111/jnc.12250; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hanson LR, 2013, JOVE-J VIS EXP, DOI 10.3791/4440; Hendrickx DAE, 2017, J NEUROIMMUNOL, V309, P12, DOI 10.1016/j.jneuroim.2017.04.007; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang SM, 2017, EXP NEUROL, V296, P32, DOI 10.1016/j.expneurol.2017.06.023; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Kanazawa M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102135; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Koizumi S, 2018, NEUROCHEM INT, V119, P107, DOI 10.1016/j.neuint.2018.01.007; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Lambertsen KL, 2019, ACTA NEUROPATHOL, V137, P693, DOI 10.1007/s00401-018-1930-z; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee GA, 2018, BRAIN BEHAV IMMUN, V73, P562, DOI 10.1016/j.bbi.2018.06.021; Li MS, 2017, P NATL ACAD SCI USA, V114, pE396, DOI 10.1073/pnas.1612930114; Li ZG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00523; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Luo QP, 2018, NEUROSCIENCE, V385, P75, DOI 10.1016/j.neuroscience.2018.05.047; Ma QQ, 2019, ASIA PAC J OPER RES, V36, DOI 10.1142/S0217595919500039; Ma YY, 2017, PROG NEUROBIOL, V157, P247, DOI 10.1016/j.pneurobio.2016.01.005; Matei N, 2018, J NEUROSCI, V38, P6787, DOI 10.1523/JNEUROSCI.2352-17.2018; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ramagiri S, 2017, EUR J PHARMACOL, V803, P84, DOI 10.1016/j.ejphar.2017.03.028; Rana AK, 2018, NEUROPHARMACOLOGY, V139, P124, DOI 10.1016/j.neuropharm.2018.07.006; Shen ZB, 2018, REACT CHEM ENG, V3, P34, DOI 10.1039/c7re00201g; Tsuyama J, 2018, SEMIN IMMUNOPATHOL, V40, P523, DOI 10.1007/s00281-018-0707-8; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Wang JP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1226-1; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JP, 2017, BEHAV BRAIN RES, V316, P145, DOI 10.1016/j.bbr.2016.09.007; Wang JY, 2017, TRANSL STROKE RES, V8, P284, DOI 10.1007/s12975-016-0514-2; Wang W, 2016, MOL NEUROBIOL, V53, P7028, DOI 10.1007/s12035-015-9607-2; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang YJ, 2018, ANTIOXID REDOX SIGN, V28, P141, DOI 10.1089/ars.2017.7003; Wei ZZ, 2018, J CEREBR BLOOD F MET, V38, P404, DOI 10.1177/0271678X17702669; Wicher G, 2017, J NEUROTRAUM, V34, P3173, DOI 10.1089/neu.2016.4900; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Xu XT, 2019, J CELL PHYSIOL, V234, P904, DOI 10.1002/jcp.26918; Yang YY, 2017, J NEUROSCI, V37, P4692, DOI 10.1523/JNEUROSCI.3233-16.2017; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871	59	13	14	2	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2019	75								105760	10.1016/j.intimp.2019.105760			9	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	JC0VV	WOS:000488998800013	31323530				2021-06-18	
J	Caccese, JB; Iverson, GL; Cameron, KL; Houston, MN; McGinty, GT; Jackson, JC; O'Donnell, P; Pasquina, PF; Broglio, SP; McCrea, M; McAllister, T; Buckley, TA				Caccese, Jaclyn B.; Iverson, Grant L.; Cameron, Kenneth L.; Houston, Megan N.; McGinty, Gerald T.; Jackson, Jonathan C.; O'Donnell, Patrick; Pasquina, Paul F.; Broglio, Steven P.; McCrea, Michael; McAllister, Thomas; Buckley, Thomas A.			Estimated Age of First Exposure to Contact Sports Is Not Associated with Greater Symptoms or Worse Cognitive Functioning in Male US Service Academy Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; mild traumatic brain injury; neurocognitive; repetitive head impacts	HEAD IMPACT BIOMECHANICS; RUGBY UNION PLAYERS; CONSTRUCT-VALIDITY; LATER-LIFE; CONCUSSION; EPIDEMIOLOGY; FOOTBALL; PARTICIPATION; ACCELERATION; INJURIES	This study examined the association between estimated age of first exposure (eAFE) to contact sport participation and neurocognitive performance and symptom ratings in U.S. service academy National Collegiate Athletic Association (NCAA) athletes. Male cadets (N = 891), who participate in lacrosse (n = 211), wrestling (n = 170), ice hockey (n = 81), soccer (n = 119), rugby (n = 10), or non-contact sports (n = 298), completed the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) test before the season. Generalized linear modeling was used to predict each neurocognitive domain score and total symptom severity score. Predictor variables were entered in the following order: group (contact vs. non-contact); eAFE (eAFE <12 years vs. eAFE >= 12 years); group-by-eAFE; and covariates for learning accommodation status, concussion history, and age. The group-by-eAFE interaction was not significant for any of the ImPACT composite scores (Verbal Memory, Wald chi(2) = 0.073, p = 0.788; Visual Memory, Wald chi(2) = 2.71, p = 0.100; Visual Motor Speed, Wald chi(2) = 0.078, p = 0.780; Reaction Time, Wald chi(2) = 0.003, p = 0.955; Symptom Severity, Wald chi(2) = 2.87, p = 0.090). Learning accommodation history was associated with lower scores on Visual Motor Speed (chi(2) = 6.19, p = 0.013, B = -2.97). Older age was associated with faster reaction time (chi(2) = 4.40, p = 0.036, B = -0.006) and lesser symptom severity (chi(2) = 5.55, p = 0.019, B = -0.068). No other parameters were significant. We observed no association between eAFE, contact sport participation, neurocognitive functioning, or subjectively experienced symptoms in this cohort. Earlier eAFE to contact sport participation is not related to worse neurocognitive performance or greater subjectively experienced symptoms in male U.S. service academy NCAA athletes.	[Caccese, Jaclyn B.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Biomech & Movement Sci Program, Newark, DE USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] MassGeneral Hosp, Children Sports Concuss Program, Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] Ctr Hlth & Rehabil Res, Charlestown, MA USA; [Houston, Megan N.] US Mil Acad, Keller Army Hosp, West Point, NY USA; [McGinty, Gerald T.] US Air Force Acad, Academy, CO USA; [Jackson, Jonathan C.] US Air Force Acad, Med Grp 10, Boston, MA USA; [O'Donnell, Patrick] US Coast Guard Acad Reg Clin, New London, CT USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Ctr Rehabil Sci Res, Bethesda, MD 20814 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Interdisciplinary Biomech & Movement Sci Program, 100 Discovery Blvd, Newark, DE 19713 USA.	tbuckley@udel.edu	Caccese, Jaclyn B./AAH-4571-2020; Buckley, Thomas A/B-7525-2016	Caccese, Jaclyn B./0000-0003-2329-3603; Buckley, Thomas A/0000-0002-0515-0150; Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program [W81XWH-BA170608]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program, endorsed by the Department of Defense under Award No. W81XWH-BA170608. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Office of the Assistant Secretary of Defense for Health Affairs.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Epstein HT, 1999, BRAIN DEV-JPN, V21, P535, DOI 10.1016/S0387-7604(99)00066-2; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hulteen RM, 2017, PREV MED, V95, P14, DOI 10.1016/j.ypmed.2016.11.027; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Irick E., 2015, NCAA SPORTS SPONSORS; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kramer JH, 2000, ARCH CLIN NEUROPSYCH, V15, P83, DOI 10.1016/S0887-6177(99)00022-0; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Larrabee G.J., 2018, COGNITIVE DEFICITS M; Lovell M.R., 2011, CLIN INTERPRETATION; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; National Federation of State High School Associations, 2018, 2017 18 HIGH SCH ATH; O'Connor KL, 2018, MIL MED, V183, pE580, DOI 10.1093/milmed/usx130; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Peng P, 2016, J LEARN DISABIL-US, V49, P3, DOI 10.1177/0022219414521667; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Robertson GJ., 2006, WRAT 4 WIDE RANGE AC; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stemper B.D., 2018, ANN BIOMED ENG, DOI [10.1007/s10439-018-02136-6., DOI 10.1007/S10439-018-02136-6.]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Yang JZ, 2012, J ATHL TRAINING, V47, P198; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	44	13	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					334	339		10.1089/neu.2019.6571		SEP 2019	6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000487163800001	31375052	Green Published			2021-06-18	
J	Zheng, JJ; Dai, QX; Han, KY; Hong, WD; Jia, DY; Mo, YC; Lv, Y; Tang, HL; Fu, HX; Geng, WJ				Zheng, Jianjian; Dai, Qinxue; Han, Kunyuan; Hong, Wandong; Jia, Danyun; Mo, Yunchang; Lv, Ya; Tang, Hongli; Fu, Hongxing; Geng, Wujun			JNK-IN-8, a c-Jun N-terminal kinase inhibitor, improves functional recovery through suppressing neuroinflammation in ischemic stroke	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						ischemia brain injury; JNK; JNK-IN-8; neuroinflammation; NF-kappa B	NEGATIVE BREAST-CANCER; INJURY; INFLAMMATION; ACTIVATION; AUTOPHAGY; PATHWAY; CELLS	C-Jun N-terminal kinase (JNK) is a pivotal MAPK (mitogen-activated protein kinase), which activated by ischemia brain injury and plays a fairly crucial function in cerebral ischemic injury. Emerging studies demonstrated that JNK-IN-8 (a JNK inhibitor with high specificity) regulates traumatic brain injury through controlling neuronal apoptosis and inflammation. However, the function of JNK-IN-8 in ischemic stroke and the mechanisms underlying of JNK-IN-8 about neuroprotection are not well understood. In this work, male rats were treated with JNK-IN-8 after transient middle cerebral artery occlusion, and then the modified improved neurological function score (mNSS), the foot-fault test (FFT), interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF-alpha) levels were assessed. We found that JNK-IN-8-treated rats with MCAO exerted an observable melioration in space learning as tested by the improved mNSS, and showed sensorimotor functional recovery as measured by the FFT. JNK-IN-8 also played anti-inflammatory roles as indicated through decreased activation of microglia and decreased IL-6, IL-1 beta, and TNF-alpha expression. Furthermore, JNK-IN-8 suppressed the activation of JNK and nuclear factor-kappa B (NF-kappa B) signaling as indicated by the decreased level of phosphorylated-JNK and p65. All data demonstrate that JNK-IN-8 inhibits neuroinflammation and improved neurological function by inhibiting JNK/NF-kappa B and is a promising agent for the prevention of ischemic brain injury.	[Zheng, Jianjian] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Di, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Dai, Qinxue; Han, Kunyuan; Jia, Danyun; Mo, Yunchang; Lv, Ya; Tang, Hongli; Geng, Wujun] Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China; [Hong, Wandong] Wenzhou Med Univ, Dept Gastroenterol & Hepatol, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China; [Fu, Hongxing] Wenzhou Med Univ, Sch Pharmaceut, Wenzhou, Zhejiang, Peoples R China	Tang, HL; Geng, WJ (corresponding author), Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China.; Fu, HX (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325000, Zhejiang, Peoples R China.	tanghongli@wzhospital.cn; fuhongxing@wmu.edu.cn; gengwujun@wzhospital.cn		Geng, Wujun/0000-0001-5599-3036	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81603685, 81704180, 81774109, 81973620]; Zhejiang Basic Public Welfare Research Project [GD20H290004]; Wenzhou Science and Technology Plan Project [Y20180496]	National Natural Science Foundation of China, Grant/Award Numbers: 81603685, 81704180, 81774109, 81973620; Zhejiang Basic Public Welfare Research Project, Grant/Award Number: GD20H290004; Wenzhou Science and Technology Plan Project, Grant/Award Number: Y20180496	Amouyel P, 2012, LANCET NEUROL, V11, P931, DOI 10.1016/S1474-4422(12)70235-1; Atochin DN, 2016, NEUROSCI LETT, V618, P45, DOI 10.1016/j.neulet.2016.02.033; Burton MD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-54; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2018, METABOLISM, V83, P256, DOI 10.1016/j.metabol.2018.03.004; Chen YR, 2000, INT J ONCOL, V16, P651; Choudhury S, 2015, FREE RADICAL RES, V49, P1371, DOI 10.3109/10715762.2015.1075016; Ebelt ND, 2017, ONCOTARGET, V8, P104894, DOI 10.18632/oncotarget.20581; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Guan QH, 2006, BRAIN RES, V1092, P36, DOI 10.1016/j.brainres.2006.03.086; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Jiang J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00363; Jin R, 2013, J CARDIOVASC TRANSL, V6, P834, DOI 10.1007/s12265-013-9508-6; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Ramesh G., 2014, CELL SIGNAL, V1, pe111, DOI 10.14800/ics.111; Simmons LJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0703-7; Utsugi M, 2003, J IMMUNOL, V171, P628, DOI 10.4049/jimmunol.171.2.628; Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014; Xie X, 2017, ONCOGENE, V36, P2599, DOI 10.1038/onc.2016.417; Yilmaz G, 2008, NEUROL RES, V30, P783, DOI 10.1179/174313208X341085; Yu J, 2018, EXP NEUROL, V307, P12, DOI 10.1016/j.expneurol.2018.05.022; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhang YL, 2015, J NEUROSURG, V122, P856, DOI 10.3171/2014.11.JNS14770; Zhou XG, 2011, BIOCHEM BIOPH RES CO, V411, P271, DOI 10.1016/j.bbrc.2011.06.117; Zhu YP, 2019, EXP PHYSIOL, V104, P837, DOI 10.1113/EP087656	25	13	14	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	MAR	2020	235	3					2792	2799		10.1002/jcp.29183		SEP 2019	8	Cell Biology; Physiology	Cell Biology; Physiology	OZ4PU	WOS:000487514000001	31541462	Green Published, Other Gold			2021-06-18	
J	Bryden, DW; Tilghman, JI; Hinds, SR				Bryden, Daniel W.; Tilghman, Jessica I.; Hinds, Sidney R., II			Blast-Related Traumatic Brain Injury: Current Concepts and Research Considerations	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Blast; traumatic brain injury; concussion; biomarkers; radiation; biodosimetry	POSTTRAUMATIC-STRESS-DISORDER; SHELL-SHOCK; HEAD-INJURY; FUNCTIONAL OUTCOMES; COMT VAL(158)MET; ASSOCIATION; MILITARY; ACCOUNT; CONCUSSION; BIOMARKERS	Traumatic brain injury (TBI) is a well-known consequence of participation in activities such as military combat or collision sports. But the wide variability in eliciting circumstances and injury severities makes the study of TBI as a uniform disease state impossible. Military Service members are under additional, unique threats such as exposure to explosive blast and its unique effects on the body. This review is aimed toward TBI researchers, as it covers important concepts and considerations for studying blast-induced head trauma. These include the comparability of blast-induced head trauma to other mechanisms of TBI, whether blast overpressure induces measureable biomarkers, and whether a biodosimeter can link blast exposure to health outcomes, using acute radiation exposure as a corollary. This examination is contextualized by the understanding of concussive events and their psychological effects throughout the past century's wars, as well as the variables that predict sustaining a TBI and those that precipitate or exacerbate psychological conditions.	[Bryden, Daniel W.; Tilghman, Jessica I.] US Army, Booz Allen Hamilton, DoD Blast Injury Res Coordinating Off, Res & Dev Command, Ft Detrick, MD USA; [Hinds, Sidney R., II] US Army, DoD Blast Injury Res Coordinating Off, Med Res & Dev Command, Ft Detrick, MD 21702 USA	Hinds, SR (corresponding author), US Army, DoD Blast Injury Res Coordinating Off, Med Res & Dev Command, Ft Detrick, MD 21702 USA.	sidney.r.hinds.mil@mail.mil					Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Agoston DV, 2015, BRAIN NEUROTRAUMA MO, P307; [Anonymous], 2013, MSMR, V20, P9; Armed Forces Health Surveillance Center, 2015, MSMR, V22, P12; Armed Forces Radiobiology Research Institute (AFFRI), ASS RAD INJ BIOD; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Azar S, 2017, METHODS MOL BIOL, V1598, P45, DOI 10.1007/978-1-4939-6952-4_3; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI 10.1089/neu.2009-0898; Bertisch H, 2019, J HEAD TRAUMA REHAB, V34, P36, DOI 10.1097/HTR.0000000000000399; Blakely WF, 2010, HEALTH PHYS, V99, pS184, DOI 10.1097/HP.0b013e3181f26895; BOGACZ T, 1989, J CONTEMP HIST, V24, P227, DOI 10.1177/002200948902400203; Bowen I., 1968, DASA2113; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2015, BRAIN NEUROTRAUMA MO, P629; Cernak I:, 2017, CONCUSSION, V2; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Dainiak N, 2019, RADIAT PROT DOSIM, V186, P130, DOI 10.1093/rpd/ncy294; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Defense and Veterans Brain Injury Center, CONC MILD TRAUM BRAI; Defense and Veterans Brain Injury Center (DVBIC), DOD WORLDW NUMB TBI; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Elliott TR, 1914, BRIT MED J, V1914, P1005, DOI 10.1136/bmj.2.2815.1005; Engel CC, 2018, P FIND EXP REC 7 DEP; Friedlander FG, 1955, PROPAGATION PULSE IN; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Goans RE, 2010, HEALTH PHYS, V99, pS192, DOI 10.1097/HP.0b013e3181ebcef7; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Iverson KM, 2020, J INTERPERS VIOLENCE, V35, P2422, DOI 10.1177/0886260517702491; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Leggieri MJ, 2019, J ROY ARMY MED CORPS, V165, P7, DOI 10.1136/jramc-2018-000963; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Manchester J, 2017, MIL MED, V182, pE1726, DOI 10.7205/MILMED-D-16-00339; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McLellan TM, 2019, NUTR NEUROSCI, V22, P768, DOI 10.1080/1028415X.2018.1443996; Medical Effects of Ionizing Radiation (MEIR) Course, 2013, AC RAD SYNDR COMB IN; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P1050, DOI 10.1080/13803395.2018.1508555; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mott F W, 1917, Br Med J, V2, P612; Mott FW, 1917, BRIT MED J, V1917, P39, DOI 10.1136/bmj.2.2950.39; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Myers CS, 1916, LANCET, V1, P65; Myers CS, 1916, LANCET, V2, P461; Myers CS, 1916, LANCET, V1, P608; Myers CS, 1919, LANCET, V1, P51; Myers CS, 1915, LANCET, V1, P316; Nauman EA, 2018, HAND CLINIC, V158, P245, DOI 10.1016/B978-0-444-63954-7.00024-0; Orgel J, 2019, J SYNCHROTRON RADIAT, V26, P89, DOI 10.1107/S1600577518015035; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Rafaels KA, 2015, J FORENSIC SCI, V60, P219, DOI 10.1111/1556-4029.12570; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sandgren DJ, 2010, HEALTH PHYS, V99, pS171, DOI 10.1097/HP.0b013e3181f0fe6c; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Silver JM, 2019, TXB TRAUMATIC BRAIN; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Stuhmiller JH, 2008, BLAST INJURY TRANSLA; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; WALKER RI, 1989, MED CONSEQUENCES NUC; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Watts S, 2019, J ROY ARMY MED CORPS, V165, P38, DOI 10.1136/jramc-2018-000956; Weisenbach CA, 2018, MIL MED, V183, P287, DOI 10.1093/milmed/usx210; WHITE CS, 1968, ANN NY ACAD SCI, V152, P89, DOI 10.1111/j.1749-6632.1968.tb11969.x; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zajtchuk R, 1991, CONVENTIONAL WARFARE, P241; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhu F, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500656; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	108	13	15	1	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	SEP 12	2019	13								1179069519872213	10.1177/1179069519872213			11	Neurosciences	Neurosciences & Neurology	IY2QA	WOS:000486234700001	31548796	DOAJ Gold, Green Published			2021-06-18	
J	Li, L; Tan, HP; Liu, CY; Yu, LT; Wei, DN; Zhang, ZC; Lu, K; Zhao, KS; Maegele, M; Cai, DZ; Gu, ZT				Li, Li; Tan, Hong-Ping; Liu, Cheng-Yong; Yu, Lin-Tao; Wei, Da-Nian; Zhang, Zi-Chen; Lu, Kui; Zhao, Ke-Sen; Maegele, Marc; Cai, Dao-Zhang; Gu, Zheng-Tao			Polydatin prevents the induction of secondary brain injury after traumatic brain injury by protecting neuronal mitochondria	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; polydatin; mitochondria; endoplasmic reticulum stress; SIRT1; reactive oxygen species; p38; mitochondrial membrane potential; mitochondrial permeability transition pore; lateral fluid percussion; neural regeneration	ENDOPLASMIC-RETICULUM STRESS; SEVERE HEMORRHAGIC-SHOCK; ARTERIAL SMOOTH-MUSCLE; APOPTOSIS; ISCHEMIA; SIRT1; NEUROPROTECTION; HYPOTHERMIA; INHIBITION; DAMAGE	Polydatin is thought to protect mitochondria in different cell types in various diseases. Mitochondrial dysfunction is a major contributing factor in secondary brain injury resulting from traumatic brain injury. To investigate the protective effect of polydatin after traumatic brain injury, a rat brain injury model of lateral fluid percussion was established to mimic traumatic brain injury insults. Rat models were intra-peritoneally injected with polydatin (30 mg/kg) or the SIRT1 activator SRT1720 (20 mg/kg, as a positive control to polydatin). At 6 hours post-traumatic brain injury insults, western blot assay was used to detect the expression of SIRT1, endoplasmic reticulum stress related proteins and p38 phosphorylation in cerebral cortex on the injured side. Flow cytometry was used to analyze neuronal mitochondrial superoxide, mitochondrial membrane potential and mitochondrial permeability transition pore opened. Ultrastructural damage in neuronal mitochondria was measured by transmission electron microscopy. Our results showed that after treatment with polydatin, release of reactive oxygen species in neuronal mitochondria was markedly reduced; swelling of mitochondria was alleviated; mitochondrial membrane potential was maintained; mitochondrial permeability transition pore opened. Also endoplasmic reticulum stress related proteins were inhibited, including the activation of p-PERK, spliced XBP-1 and cleaved ATF6. SIRT1 expression and activity were increased; p38 phosphorylation and cleaved caspase-9/3 activation were inhibited. Neurological scores of treated rats were increased and the mortality was reduced compared with the rats only subjected to traumatic brain injury. These results indicated that polydatin protectrd rats from the consequences of traumatic brain injury and exerted a protective effect on neuronal mitochondria. The mechanisms may be linked to increased SIRT1 expression and activity, which inhibits the p38 phosphorylation-mediated mitochondrial apoptotic pathway.	[Li, Li; Liu, Cheng-Yong; Wei, Da-Nian; Zhang, Zi-Chen; Maegele, Marc; Gu, Zheng-Tao] Southern Med Univ, Affiliated Hosp 3, Acad Orthoped Guangdong Prov, Dept Treatment Ctr Traumat Injuries, Guangzhou, Guangdong, Peoples R China; [Li, Li; Zhao, Ke-Sen; Gu, Zheng-Tao] Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou, Guangdong, Peoples R China; [Tan, Hong-Ping] Guangdong Sanjiu Brain Hosp, Dept Epilepsy Surg, Guangzhou, Guangdong, Peoples R China; [Yu, Lin-Tao; Lu, Kui] Southern Med Univ, Affiliated Hosp 3, Dept Emergency, Acad Orthoped Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Maegele, Marc] UW H, CMMC, Dept Traumatol & Orthoped Surg, Campus Cologne Merheim, Cologne, Germany; [Li, Li; Cai, Dao-Zhang] Southern Med Univ, Acad Orthoped Guangdong Prov, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China	Gu, ZT (corresponding author), Southern Med Univ, Affiliated Hosp 3, Acad Orthoped Guangdong Prov, Dept Treatment Ctr Traumat Injuries, Guangzhou, Guangdong, Peoples R China.; Gu, ZT (corresponding author), Southern Med Univ, Dept Pathophysiol, Guangdong Prov Key Lab Shock & Microcirculat Res, Guangzhou, Guangdong, Peoples R China.; Cai, DZ (corresponding author), Southern Med Univ, Acad Orthoped Guangdong Prov, Affiliated Hosp 3, Dept Orthoped, Guangzhou, Guangdong, Peoples R China.	cdz@smu.edu.cn; guzhengtao@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81501690]; Scientific Research Staring Foundation for Talent Introduction for Southern Medical University	This study was supported by the National Natural Science Foundation of China, No. 81501690 (to ZTG); the Scientific Research Staring Foundation for Talent Introduction for Southern Medical University (to MM). The funding sources had no role in study conception and design, data analysis or interpretation, paper writing or deciding to submit this paper for publication.	Boeck CR, 2013, MOL CELL BIOCHEM, V384, P129, DOI 10.1007/s11010-013-1790-8; Bown D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211684; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Cheng YF, 2006, BRAIN RES, V1110, P193, DOI 10.1016/j.brainres.2006.06.065; Chiu AW, 2017, SEMIN RESP CRIT CARE, V38, P768, DOI 10.1055/s-0037-1607989; Corbett JM, 2020, J NEUROSURG, V132, P545, DOI 10.3171/2018.10.JNS182293; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FLAMENG W, 1980, J THORAC CARDIOV SUR, V79, P413; Fraunberger EA, 2019, BRAIN INJURY, V19, P1; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Gao Y, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00095; Go BS, 2017, MOL NEUROBIOL, V54, P4041, DOI 10.1007/s12035-016-9969-0; Gulyaeva NV, 2015, J NEUROCHEM, V132, P263, DOI 10.1111/jnc.13016; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Khader A, 2017, J SURG RES, V219, P288, DOI 10.1016/j.jss.2017.06.031; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Lee SW, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1423-6; Li FF, 2020, BRAIN IMAGING BEHAV, V14, P907, DOI 10.1007/s11682-019-00053-3; Li H, 2015, J NEUROL SCI, V357, P270, DOI 10.1016/j.jns.2015.08.004; Li P, 2017, INT J MOL MED, V39, P1127, DOI 10.3892/ijmm.2017.2932; Li PY, 2015, EXPERT OPIN THER TAR, V19, P997, DOI 10.1517/14728222.2015.1054806; Li QZ, 2019, J MOL NEUROSCI, V67, P574, DOI 10.1007/s12031-019-01263-6; Li T, 2014, INT J CLIN EXP PATHO, V7, P8401; Liao P, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1749-y; Ling YN, 2016, CLIN SCI, V130, P1641, DOI 10.1042/CS20160082; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lyeth BG, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00217; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Ray B, 2009, J NEUROSCI METH, V184, P294, DOI 10.1016/j.jneumeth.2009.08.018; Ruan WC, 2019, CELL MOL NEUROBIOL, V39, P265, DOI 10.1007/s10571-018-00646-4; Song R, 2011, AM J HYPERTENS, V24, P45, DOI 10.1038/ajh.2010.184; Su SY, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-26; Sun DD, 2017, CELL MOL NEUROBIOL, V37, P1349, DOI 10.1007/s10571-017-0484-2; Sun GZ, 2016, NEURAL REGEN RES, V11, P1260, DOI 10.4103/1673-5374.189190; Takeda K, 2002, GENES CELLS, V7, P1099, DOI 10.1046/j.1365-2443.2002.00591.x; Tan HP, 2018, NEURAL REGEN RES, V13, P827, DOI 10.4103/1673-5374.232477; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wagner AK, 2019, NEUROPHARMACOLOGY, V145, P133, DOI 10.1016/j.neuropharm.2018.09.011; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Wang XM, 2012, AM J PHYSIOL-REG I, V302, pR805, DOI 10.1152/ajpregu.00350.2011; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Zeng Zhenhua, 2016, Oxid Med Cell Longev, V2016, P1737185, DOI 10.1155/2016/1737185; Zeng ZH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/965961; Zeng ZH, 2015, J SURG RES, V198, P192, DOI 10.1016/j.jss.2015.05.041; Zhang XM, 2015, NEUROCHEM INT, V90, P1, DOI 10.1016/j.neuint.2015.06.010; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zheng N, 2017, J CELL PHYSIOL, V232, P2776, DOI 10.1002/jcp.25943	54	13	13	1	11	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	SEP	2019	14	9					1573	1582		10.4103/1673-5374.255972			10	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	HY3XE	WOS:000468060200022	31089056	DOAJ Gold, Green Published			2021-06-18	
J	Maiti, P; Peruzzaro, S; Kolli, N; Andrews, M; Al-Gharaibeh, A; Rossignol, J; Dunbar, GL				Maiti, Panchanan; Peruzzaro, Sarah; Kolli, Nivya; Andrews, Melissa; Al-Gharaibeh, Abeer; Rossignol, Julien; Dunbar, Gary L.			Transplantation of mesenchymal stem cells overexpressing interleukin-10 induces autophagy response and promotes neuroprotection in a rat model of TBI	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						autophagy markers; IL-10 overexpressed MSCs; neuroinflammation; TBI	TRAUMATIC BRAIN-INJURY; NEURONAL SURVIVAL; ALZHEIMER-DISEASE; UNITED-STATES; UP-REGULATION; IL-10; DEATH; APOPTOSIS; INHIBITION; MECHANISMS	Autophagy, including mitophagy, is critical for neuroprotection in traumatic brain injury (TBI). Transplantation of mesenchymal stem cells (MSCs) provides neuroprotection and induces autophagy by increasing anti-inflammatory cytokines, such as interleukin-10 (IL-10). To evaluate these effects of IL10 that are released by MSCs, we genetically engineered MSCs to overexpress IL10 and compared their effects to unaltered MSCs following transplantation near the site of induced TBIs in rats. Adult, male Sprague-Dawley rats were divided into four groups: Sham + vehicle, TBI + vehicle, TBI + MSCs-IL-10 and TBI + MSCs-GFP. Thirty-six hours post-TBI, the first two groups received vehicle (Hanks balance salt solution), whereas last two groups were transplanted with MSCs-IL-10 or MSCs-GFP. Three weeks after transplantation, biomarkers for neurodegenerative changes, autophagy, mitophagy, cell death and survival markers were measured. We observed a significant increase in the number of dead cells in the cortex and hippocampus in TBI rats, whereas transplantation of MSCs-IL-10 significantly reduced their numbers in comparison to MSCs alone. MSCs-IL-10 rats had increased autophagy, mitophagy and cell survival markers, along with decreased markers for cell death and neuroinflammation. These results suggest that transplantation of MSCs-IL-10 may be an effective strategy to protect against TBI-induced neuronal damage.	[Maiti, Panchanan; Peruzzaro, Sarah; Kolli, Nivya; Andrews, Melissa; Al-Gharaibeh, Abeer; Rossignol, Julien; Dunbar, Gary L.] Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Peruzzaro, Sarah; Kolli, Nivya; Andrews, Melissa; Al-Gharaibeh, Abeer; Rossignol, Julien; Dunbar, Gary L.] Cent Michigan Univ, Program Neurosci, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Dunbar, Gary L.] Cent Michigan Univ, Dept Psychol, Mt Pleasant, MI 48859 USA; [Maiti, Panchanan; Dunbar, Gary L.] St Marys Michigan, Field Neurosci Inst, Saginaw, MI USA; [Maiti, Panchanan] Saginaw Valley State Univ, Dept Biol, Saginaw, MI USA; [Maiti, Panchanan] Saginaw Valley State Univ, Brain Res Lab, Saginaw, MI USA; [Rossignol, Julien] Cent Michigan Univ, Coll Med, Mt Pleasant, MI 48859 USA	Maiti, P; Dunbar, GL (corresponding author), Cent Michigan Univ, Field Neurosci Inst, Lab Restorat Neurol, Mt Pleasant, MI 48859 USA.	maiti1p@cmich.edu; dunba1g@cmich.edu	Rossignol, Julien/I-1013-2019	Gharaibeh, Abeer/0000-0003-3549-1826; Rossignol, Julien/0000-0002-8662-0547	Field Neurosciences Institute, St. Mary's of Michigan; John G. Kulhavi Professorship in Neurosciences; Neuroscience Program at Central Michigan University	Supports came from the Field Neurosciences Institute, St. Mary's of Michigan, the John G. Kulhavi Professorship in Neurosciences and the Neuroscience Program at Central Michigan University.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Amelio I, 2011, BIOCHEM BIOPH RES CO, V414, P277, DOI 10.1016/j.bbrc.2011.09.080; Au AK, 2010, BBA-MOL BASIS DIS, V1802, P918, DOI 10.1016/j.bbadis.2009.10.010; Blyth BJ, 2010, EMERG MED CLIN N AM, V28, P571, DOI 10.1016/j.emc.2010.03.003; Brewer KL, 1999, EXP NEUROL, V159, P484, DOI 10.1006/exnr.1999.7173; Chen WQ, 2014, NEURAL REGEN RES, V9, P1210, DOI 10.4103/1673-5374.135329; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Cunningham CJ, 2018, J CEREB BLOOD FLOW M; Dang SP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0245-4; Das G, 2012, COLD SPRING HARB PER, V4, P1; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Erlich S, 2006, AUTOPHAGY, V2, P49, DOI 10.4161/auto.2156; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Fontana ACK, 2016, J NEUROTRAUM, V33, P1073, DOI 10.1089/neu.2015.4079; Garcia JM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00244; Glastras SJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23525; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hu CX, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1114-8; Kapuy O, 2014, FEBS OPEN BIO, V4, P704, DOI 10.1016/j.fob.2014.07.006; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Kyurkchiev Dobroslav, 2014, World J Stem Cells, V6, P552, DOI 10.4252/wjsc.v6.i5.552; Lin LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136959; Luo YW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11458-9; Ma S, 2014, CELL DEATH DIFFER, V21, P216, DOI 10.1038/cdd.2013.158; Maiti P, 2007, BRAIN RES, V1175, P1, DOI 10.1016/j.brainres.2007.06.106; Maiti P, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/9656719; Maiti P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495091; Maiti P, 2010, J NEUROCHEM, V113, P1252, DOI 10.1111/j.1471-4159.2010.06692.x; Matyas JJ, 2017, CELL TRANSPLANT, V26, P1472, DOI 10.1177/0963689717721214; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Metaxakis A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7050037; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Nomoto T, 2009, GENE THER, V16, P383, DOI 10.1038/gt.2008.151; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Peruzzaro ST, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-018-1383-2; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Phinney DG, 2007, CELL CYCLE, V6, P2884, DOI 10.4161/cc.6.23.5095; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; Schlafli AM, 2015, EUR J HISTOCHEM, V59, P137, DOI 10.4081/ejh.2015.2481; Sharma S, 2011, BRAIN RES, V1373, P189, DOI 10.1016/j.brainres.2010.11.096; Shin JY, 2014, AUTOPHAGY, V10, P32, DOI 10.4161/auto.26508; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Vizoso FJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091852; Wu TT, 2016, INT J BIOL SCI, V12, P884, DOI 10.7150/ijbs.15194; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu HZ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/5405104; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou ZG, 2009, EXP NEUROL, V220, P183, DOI 10.1016/j.expneurol.2009.08.018; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	70	13	14	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	AUG	2019	23	8					5211	5224		10.1111/jcmm.14396			14	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	IR6EN	WOS:000481532600034	31162801	DOAJ Gold, Green Published			2021-06-18	
J	Pellegrino, R; Han, PF; Reither, N; Hummel, T				Pellegrino, Robert; Han, Pengfei; Reither, Nicole; Hummel, Thomas			Effectiveness of olfactory training on different severities of posttraumatic loss of smell	LARYNGOSCOPE			English	Article						Smell; olfactory training; impairment; traumatic brain injury; imaging	SUPERIOR FRONTAL GYRUS; BULB VOLUME; SEMANTIC SYSTEM; DYSFUNCTION; DISORDERS; LANGUAGE; HEMISPHERE; HANDEDNESS; INCREASES; RECOVERY	Objective/Hypothesis A common, lasting condition from traumatic brain injury is impairment to smell. In patients with olfactory impairment, recent meta-analyses have demonstrated that olfactory training consistently improves higher-order functions, such as odor identification. The focus of this work was to assess effects of olfactory training (OT) in posttraumatic olfactory loss patients through several metrics including psychophysical, olfactory bulb (OB) volume, and functional magnetic resonance imaging. Study Design Prospective cohort study. Methods Sniffin' Sticks were used to classify two patient groups (anosmic [N = 23] and hyposmic [N = 14]) and measure changes after OT. Additionally patients were asked the intensity, valence, and uncued identification of odors presented (coffee and peach) within the magnetic resonance imaging scanner before and after olfactory training. Olfactory training was performed twice daily with a four-odor training set for 24 weeks, and sets were replaced halfway through the entire training session (similar to 12 weeks). Results Patients had an increase in test scores (threshold and identification) and in-scanner intensity ratings and identification. Anosmic patients showed improved olfactory thresholds to 2-phenylethanol, increased intensity ratings, and activation in the right superior frontal gyrus (SFG) to odors after OT. Hyposmic patients were able to identify odors better after training. This behavior was mirrored with increased, ipsilateral activations in semantic processing areas such as Broca's area, left angular gyrus, and left SFG. Conclusions Taken together, along with neither patient group showing changes in OB volumes, OT improves olfactory performance in patients with posttraumatic olfactory loss and seems to be driven, at least in part, by top-down processes (central) rather than bottom-up (peripheral). Levels of Evidence 2 Laryngoscope, 129:1737-1743, 2019	[Pellegrino, Robert; Han, Pengfei; Reither, Nicole; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Pellegrino, Robert] Univ Tennessee, Inst Agr, Dept Food Sci, Knoxville, TN 37901 USA	Pellegrino, R (corresponding author), Univ Tennessee, Ctr Sensory Sci, 2510 River Dr, Knoxville, TN 37996 USA.	pellegr@utk.edu		Han, Pengfei/0000-0001-8266-6655	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG HU411/18-1]	This research was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG HU411/18-1).	Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Cummings DM, 1997, J NEUROSCI, V17, P7433; Damm M, 2014, LARYNGOSCOPE, V124, P826, DOI 10.1002/lary.24340; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Ferreira RA, 2015, BRAIN LANG, V143, P69, DOI 10.1016/j.bandl.2015.02.005; Fournel A, 2017, HUM BRAIN MAPP, V38, P5958, DOI 10.1002/hbm.23801; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Fujii M, 2015, J NEUROSURG, V122, P1390, DOI 10.3171/2014.10.JNS14945; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gellrich J, 2018, LARYNGOSCOPE, V128, P1531, DOI 10.1002/lary.27045; Gudziol V, 2009, BRAIN, V132, P3096, DOI 10.1093/brain/awp243; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; HASEGAWA S, 1986, ARCH OTO-RHINO-LARYN, V243, P112, DOI 10.1007/BF00453761; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Ikeda Katsuhisa, 1995, Rhinology (Utrecht), V33, P162; Jiang RS, 2015, OTOLARYNG HEAD NECK, V152, P954, DOI 10.1177/0194599815571272; Jiang RS, 2010, EUR ARCH OTO-RHINO-L, V267, P1563, DOI 10.1007/s00405-010-1240-0; Kinoshita M, 2012, J NEUROSURG, V116, P323, DOI 10.3171/2011.10.JNS11434; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Kollndorfer K, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/140419; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Langdon C, 2018, J NEUROTRAUM, V35, P2641, DOI 10.1089/neu.2017.5230; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Lubke K, 2012, CHEMOSENS PERCEPT, V5, P22, DOI 10.1007/s12078-011-9115-3; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Negoias S, 2017, BRAIN IMAGING BEHAV, V11, P998, DOI 10.1007/s11682-016-9567-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pekala K, 2016, INT FORUM ALLERGY RH, V6, P299, DOI 10.1002/alr.21669; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Reden J, 2012, LARYNGOSCOPE, V122, P1906, DOI 10.1002/lary.23405; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rombaux P, 2012, RHINOLOGY, V50, P13, DOI 10.4193/Rhino11.126; Rombaux P, 2009, RHINOLOGY, V47, P3; Royet Jean-Pierre, 2011, Front Hum Neurosci, V5, P65, DOI 10.3389/fnhum.2011.00065; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; Sezille C, 2015, NEUROSCIENCE, V287, P23, DOI 10.1016/j.neuroscience.2014.12.011; Sommer JU, 2012, J NEUROSCI METH, V209, P189, DOI 10.1016/j.jneumeth.2012.05.026; Sorokowska A, 2017, RHINOLOGY, V55, P17, DOI 10.4193/Rhin16.195; Stocker T, 2006, MAGN RESON MED, V56, P824, DOI 10.1002/mrm.21011; SUMNER D, 1967, BRAIN, V90, P187, DOI 10.1093/brain/90.1.187; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Tomii M, 2012, NEUROSURG REV, V35, P555, DOI 10.1007/s10143-012-0378-1; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	58	13	14	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	AUG	2019	129	8					1737	1743		10.1002/lary.27832			7	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	IS0JQ	WOS:000481836100011	30848489				2021-06-18	
J	De Luca, R; Maggio, MG; Maresca, G; Latella, D; Cannavo, A; Sciarrone, F; Lo Voi, E; Accorinti, M; Bramanti, P; Calabro, RS				De Luca, Rosaria; Maggio, Maria Grazia; Maresca, Giuseppa; Latella, Desiree; Cannavo, Antonino; Sciarrone, Francesca; Lo Voi, Emanuele; Accorinti, Maria; Bramanti, Placido; Calabro, Rocco Salvatore			Improving Cognitive Function after Traumatic Brain Injury: A Clinical Trial on the Potential Use of the Semi-Immersive Virtual Reality	BEHAVIOURAL NEUROLOGY			English	Article							REHABILITATION; MILD; ENVIRONMENTS	Traumatic brain injury (TBI) is the most common cause of long-term disability and death among young adults, and it represents an enormous socioeconomic and healthcare burden. Our purpose is to evaluate the effects of a virtual reality training with BTs-Nirvana (BTs-N) on the recovery of cognitive functions in TBI subjects, using the interactive semi-immersive program. One hundred patients with TBI were enrolled in this study and randomized into either the Traditional Cognitive Rehabilitation Group (TCRG: n=50) or the Virtual Reality Training Group (VRTG: n=50). The VRTG underwent a VRT with BTs-N, whereas the TCRG received a standard cognitive treatment. Each treatment session lasted 60 minutes and was repeated three times a week for 8 weeks. All of the patients were evaluated by a specific psychometric battery before (T0) and immediately (T1) after the end of the training. VRTG and TCRG had a significant improvement in cognitive functioning and in mood, but only VRTG presented with a significant increase in cognitive flexibility and shifting skills and in selective attention. In conclusion, our results suggest that VR may be a useful and effective approach for the rehabilitation of patients with TBI, leading to better cognitive and behavioral outcomes.	[De Luca, Rosaria; Maggio, Maria Grazia; Maresca, Giuseppa; Latella, Desiree; Cannavo, Antonino; Sciarrone, Francesca; Lo Voi, Emanuele; Accorinti, Maria; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	salbro77@tiscali.it	Bramanti, Placido/K-5117-2016; Voi, Emanuele Lo/AAK-6304-2020; Maresca, Giusy/AAB-2242-2021; Calabro, Rocco S/K-7520-2016; Accorinti, Maria/AAB-1119-2021; Maggio, Maria Grazia/ABA-1852-2020	Voi, Emanuele Lo/0000-0003-0755-042X; Bramanti, Placido/0000-0003-0394-8166; calabro, rocco salvatore/0000-0002-8566-3166; /0000-0003-0757-2389			Aida J, 2018, NEUROREHABILITATION, V42, P441, DOI 10.3233/NRE-172361; Barman A, 2016, INDIAN J PSYCHOL MED, V38, P172, DOI 10.4103/0253-7176.183086; Calabro RS, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0268-4; Chen SHA, 1997, BRAIN INJURY, V11, P197; Dahdah MN, 2017, NEUROREHABILITATION, V41, P721, DOI 10.3233/NRE-172183; De Luca R, 2018, J STROKE CEREBROVASC, V27, P1055, DOI 10.1016/j.jstrokecerebrovasdis.2017.11.008; De Luca R, 2018, INT J NEUROSCI, V128, P791, DOI 10.1080/00207454.2017.1403915; Doniger Glen M, 2018, Alzheimers Dement (N Y), V4, P118, DOI 10.1016/j.trci.2018.02.005; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dvorkin AY, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-92; Galetto V, 2017, NEUROREHAB NEURAL RE, V31, P800, DOI 10.1177/1545968317723748; Hackenberg K, 2016, NERVENARZT, V87, P203, DOI 10.1007/s00115-015-0051-3; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Inzaghi M. G., 2010, TEST WEIGL MANUALE; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Latella D, 2018, J CLIN NEUROSCI, V58, P1, DOI 10.1016/j.jocn.2018.09.030; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maggio MG, 2018, PSYCHOGERIATRICS, V18, P427, DOI 10.1111/psyg.12333; Maggio MG, 2019, J NEUROSCI NURS, V51, P101, DOI 10.1097/JNN.0000000000000423; Maggio MG, 2019, J CLIN NEUROSCI, V61, P1, DOI 10.1016/j.jocn.2018.12.020; Maggio MG, 2018, J GERIATR PSYCH NEUR, V31, P312, DOI 10.1177/0891988718807973; Maggio MG, 2018, APPL NURS RES, V41, P11, DOI 10.1016/j.apnr.2018.03.005; Manivannan S, 2019, J HEAD TRAUMA REHAB, V34, pE52, DOI 10.1097/HTR.0000000000000412; Maresca G, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013559; Martinez-Moreno JM, 2016, METHOD INFORM MED, V55, P50, DOI 10.3414/ME15-01-0050; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pietrzak E, 2014, GAMES HEALTH J, V3, P202, DOI 10.1089/g4h.2014.0013; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robitaille N, 2017, DISABIL REHABIL-ASSI, V12, P758, DOI 10.1080/17483107.2016.1229048; Russo M, 2018, INT J REHABIL RES, V41, P166, DOI 10.1097/MRR.0000000000000270; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P8; Werner JK, 2015, CURR OPIN NEUROL, V28, P565, DOI 10.1097/WCO.0000000000000265; Yamamoto S, 2018, CURR OPIN NEUROL, V31, P672, DOI 10.1097/WCO.0000000000000624	37	13	13	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.	JUL 30	2019	2019								9268179	10.1155/2019/9268179			7	Clinical Neurology	Neurosciences & Neurology	IS5GE	WOS:000482179700001	31481980	DOAJ Gold, Green Published			2021-06-18	
J	Vigil, FA; Bozdemir, E; Bugay, V; Chung, SH; Hobbs, M; Sanchez, I; Hastings, SD; Veraza, RJ; Holstein, DM; Sprague, SM; Carver, CM; Cavazos, JE; Brenner, R; Lechleiter, JD; Shapiro, MS				Vigil, Fabio A.; Bozdemir, Eda; Bugay, Vladislav; Chung, Sang H.; Hobbs, MaryAnn; Sanchez, Isamar; Hastings, Shayne D.; Veraza, Rafael J.; Holstein, Deborah M.; Sprague, Shane M.; Carver, Chase M.; Cavazos, Jose E.; Brenner, Robert; Lechleiter, James D.; Shapiro, Mark S.			Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K+ currents in neurons	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cell death; K+ channels; KCNQ; seizures; traumatic brain injury	FAMILIAL NEONATAL CONVULSIONS; SOLUBLE CD40 LIGAND; POSTTRAUMATIC SEIZURES; BARRIER DISRUPTION; HEAD-INJURY; MICROGLIAL ACTIVATION; EPILEPTIFORM ACTIVITY; POTASSIUM CHANNELS; MILD IMPAIRMENT; EPILEPSY	Nearly three million people in the USA suffer traumatic brain injury (TBI) yearly; however, there are no pre- or post-TBI treatment options available. KCNQ2-5 voltage-gated K+ channels underlie the neuronal "M current", which plays a dominant role in the regulation of neuronal excitability. Our strategy towards prevention of TBI-induced brain damage is predicated on the suggested hyper-excitability of neurons induced by TBIs, and the decrease in neuronal excitation upon pharmacological augmentation of M/KCNQ K+ currents. Seizures are very common after a TBI, making further seizures and development of epilepsy disease more likely. Our hypothesis is that TBI-induced hyperexcitability and ischemia/hypoxia lead to metabolic stress, cell death and a maladaptive inflammatory response that causes further downstream morbidity. Using the mouse controlled closed-cortical impact blunt TBI model, we found that systemic administration of the prototype M-channel "opener", retigabine (RTG), 30 min after TBI, reduces the post-TBI cascade of events, including spontaneous seizures, enhanced susceptibility to chemo-convulsants, metabolic stress, inflammatory responses, blood-brain barrier breakdown, and cell death. This work suggests that acutely reducing neuronal excitability and energy demand via M-current enhancement may be a novel model of therapeutic intervention against post-TBI brain damage and dysfunction.	[Vigil, Fabio A.; Bugay, Vladislav; Hobbs, MaryAnn; Sanchez, Isamar; Hastings, Shayne D.; Veraza, Rafael J.; Carver, Chase M.; Brenner, Robert; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Bozdemir, Eda; Chung, Sang H.; Holstein, Deborah M.; Lechleiter, James D.] Univ Texas Hlth San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Sprague, Shane M.] Univ Texas Hlth San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Cavazos, Jose E.] Univ Texas Hlth San Antonio, Dept Neurol, San Antonio, TX 78229 USA	Shapiro, MS (corresponding author), Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, South Texas Res Facil, MS 8253,8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu	; Cavazos, Jose/J-4122-2016	Hastings, Shayne/0000-0002-6303-0181; Cavazos, Jose/0000-0001-5777-2608; Vigil, Fabio Antonio/0000-0001-5302-0388	DoD CDMRPUnited States Department of Defense [W81XWH-15-1-0284, W81XWH-13-1-0284]; Morrison Trust; UT Health SA; NIH-NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA54174]; NIH-NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG19316]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by DoD CDMRP grants W81XWH-15-1-0284 (M.S.S. and R.B.) and W81XWH-13-1-0284 (J.D.L.), and Morrison Trust Research grants to M.S.S. and R.B. Images were generated in the Core Optical Imaging Facility, supported by UT Health SA, NIH-NCI P30 CA54174 (CTRC at UT Health SA) and NIH-NIA P01AG19316.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Allen NM, 2014, EPILEPSIA, V55, pE99, DOI 10.1111/epi.12715; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Ambrosino P, 2015, BBA-MOL BASIS DIS, V1852, P1856, DOI 10.1016/j.bbadis.2015.06.012; Barrese V, 2015, J CEREBR BLOOD F MET, V35, P1593, DOI 10.1038/jcbfm.2015.83; Beacher NG, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0102-y; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bellini G, 2010, GENEREVIEWS; Bhat SA, 2017, BRAIN BEHAV IMMUN, V59, P173, DOI 10.1016/j.bbi.2016.09.021; Bierbower SM, 2015, J NEUROSCI, V35, P2101, DOI 10.1523/JNEUROSCI.3805-14.2015; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen KQ, 2006, CELL MOL IMMUNOL, V3, P163; Chen YN, 2016, NEUROBIOL DIS, V94, P139, DOI 10.1016/j.nbd.2016.06.011; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cooper E. C., 2012, JASPERS BASIC MECH E; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DAILEY JW, 1995, NEUROSCI LETT, V195, P77, DOI 10.1016/0304-3940(95)11783-S; Danese S, 2006, J IMMUNOL, V176, P2617, DOI 10.4049/jimmunol.176.4.2617; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Durmaz R, 2003, CAN J NEUROL SCI, V30, P143, DOI 10.1017/S0317167100053415; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Friedman L K, 2015, J Epilepsy Res, V5, P46, DOI 10.14581/jer.15010; Fusco C, 2015, EUR J PAEDIATR NEURO, V19, P102, DOI 10.1016/j.ejpn.2014.08.006; Gamper N, 2015, HDB ION CHANNELS; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Giunta B, 2009, DRUG FUTURE, V34, P333, DOI 10.1358/dof.2009.034.04.1358595; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Greene DL, 2017, CELL MOL LIFE SCI, V74, P495, DOI 10.1007/s00018-016-2359-y; Hanshaw RG, 2005, CHEMBIOCHEM, V6, P2214, DOI 10.1002/cbic.200500149; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kalappa BI, 2015, J NEUROSCI, V35, P8829, DOI 10.1523/JNEUROSCI.5176-14.2015; Ke ZJ, 2005, NEUROCHEM INT, V47, P204, DOI 10.1016/j.neuint.2005.03.002; Ke ZJ, 2005, J NEUROIMMUNOL, V164, P85, DOI 10.1016/j.jneuroim.2005.04.002; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1, P1003; Kirmani BF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00032; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kumar M, 2016, MOL PHARMACOL, V89, P667, DOI 10.1124/mol.115.103200; Laskowitz D., 2016, TRANSLATIONAL RES TR; Lavrnja I, 2015, MEDIATORS INFLAMM, V2015; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Linley JE, 2010, PFLUG ARCH EUR J PHY, V459, P657, DOI 10.1007/s00424-010-0784-6; Lippmann K, 2017, J CEREBR BLOOD F MET, V37, P1803, DOI 10.1177/0271678X16652631; Liu X, 2013, NEUROSCI BULL, V29, P565, DOI 10.1007/s12264-013-1326-y; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Mason S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00043; Mee H, 2019, ACTA NEUROCHIR, V161, P457, DOI 10.1007/s00701-018-3683-9; Miceli F, 2015, EPILEPSIA, V56, pE15, DOI 10.1111/epi.12887; Michels M, 2015, MOL MED, V21, P219, DOI 10.2119/molmed.2015.00070; Mucha M, 2010, J NEUROSCI, V30, P13235, DOI 10.1523/JNEUROSCI.1981-10.2010; Nakamura R, 2013, J TOXICOL PATHOL, V26, P55, DOI 10.1293/tox.26.55; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; NITSCH C, 1983, J NEUROL SCI, V59, P305, DOI 10.1016/0022-510X(83)90016-3; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Owen RT, 2010, DRUG TODAY, V46, P815, DOI 10.1358/dot.2010.46.11.1556435; Paez-Segala MG, 2015, NAT METHODS, V12, P215, DOI [10.1038/nmeth.3225, 10.1038/NMETH.3225]; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Qiu X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.229; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Saadeldin IY, 2013, PEDIATR NEUROL, V48, P63, DOI 10.1016/j.pediatrneurol.2012.09.012; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Salemi J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-3; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Smith BA, 2012, ACS CHEM NEUROSCI, V3, P530, DOI 10.1021/cn3000197; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soh H, 2014, J NEUROSCI, V34, P5311, DOI 10.1523/JNEUROSCI.3919-13.2014; Soldovieri MV, 2014, HUM MUTAT, V35, P356, DOI 10.1002/humu.22500; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stafstrom CE, 2011, NAT REV DRUG DISCOV, V10, P729, DOI 10.1038/nrd3561; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Tompson DJ, 2013, CURR CLIN PHARMACOL, V8, P319, DOI 10.2174/15748847113089990053; Tung CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183726; Tykocki NR, 2019, J PHYSIOL-LONDON, V597, P935, DOI 10.1113/JP277021; Tzour A, 2017, J PHYSIOL-LONDON, V595, P713, DOI 10.1113/JP272547; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vigil FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04355-8; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wang WH, 2018, J NEUROTRAUM, V35, P2306, DOI 10.1089/neu.2018.5688; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Whitmire LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188064; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; ZAPPULLA RA, 1985, NEUROSURGERY, V16, P630, DOI 10.1227/00006123-198505000-00008; Zaugg Brian E, 2017, Retin Cases Brief Rep, V11, P38, DOI 10.1097/ICB.0000000000000283; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zimmermann LL, 2016, NEUROSURG CLIN N AM, V27, P499, DOI 10.1016/j.nec.2016.06.001	131	13	13	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2020	40	6					1256	1273	0271678X19857818	10.1177/0271678X19857818		JUL 2019	18	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	LN5EH	WOS:000479389600001	31272312	Green Published			2021-06-18	
J	Rashno, M; Sarkaki, A; Farbood, Y; Rashno, M; Khorsandi, L; Naseri, MKG; Dianat, M				Rashno, Masome; Sarkaki, Alireza; Farbood, Yaghoob; Rashno, Mohammad; Khorsandi, Layasadat; Naseri, Mohammad Kazem Gharib; Dianat, Mahin			Therapeutic effects of chrysin in a rat model of traumatic brain injury: A behavioral, biochemical, and histological study	LIFE SCIENCES			English	Article						Traumatic brain injury; Chrysin; Learning and memory; Motor coordination; Oxidative stress; Apoptosis	MILD HEAD-INJURY; OXIDATIVE STRESS; DEFICITS; APOPTOSIS; ACID; PATHOPHYSIOLOGY; NANOPARTICLES	Aims: Oxidative stress and apoptosis have major roles in the progression of traumatic brain injury (TBI)-associated motor and cognitive deficits. The present study was aimed to elucidate the putative effects of chrysin, a natural flavonoid compound, against TBI-induced motor and cognitive dysfunctions and possible involved mechanisms. Main methods: Chrysin (25, 50 or 100 mg/kg) was orally administered to rats starting immediately following TBI induction by Marmarou's weight-drop technique and continuously for 3 or 14 days. Neurological functions, motor coordination, learning and memory performances, histological changes, cell apoptosis, expression of pro-and anti-apoptotic proteins, and oxidative status were assayed at scheduled time points after experimental TBI. Key findings: The results indicated that treatment with chrysin improved learning and memory disabilities in passive avoidance task, and ameliorated motor coordination impairment in rotarod test after TBI. These beneficial effects were accompanied by increased the concentrations of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione (GSH), decreased malondialdehyde (MDA) content, prevented neuronal loss, diminished apoptotic index, elevated the expression of anti-apoptotic Bcl-2 protein, and reduced the expression of pro-apoptotic Bax protein in the cerebral cortex and hippocampus tissues. Significance: Our findings suggest that both anti-oxidative and anti-apoptotic properties of chrysin (especially in the dose of 100 mg/kg) are possible mechanisms that improve cognitive/motor deficits and prevent neuronal cell death after TBI.	[Rashno, Masome; Sarkaki, Alireza; Farbood, Yaghoob; Naseri, Mohammad Kazem Gharib; Dianat, Mahin] Ahvaz Jundishapur Univ Med Sci, Fac Med, Physiol Res Ctr, Dept Physiol, Ahwaz, Iran; [Rashno, Mohammad] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Immunol, Ahwaz, Iran; [Rashno, Mohammad; Khorsandi, Layasadat] Ahvaz Jundishapur Univ Med Sci, Cellular & Mol Res Ctr, Ahwaz, Iran	Sarkaki, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Physiol Res Ctr, Farvardin Blvd,Box 45, Ahwaz 6135715794, Iran.	sarkaki_a@ajums.ac.ir	Khorsandi, Layasadat/R-3901-2017; Farbood, Yaghoob/M-3076-2017; Rashno, Masome/AAW-6382-2020	Khorsandi, Layasadat/0000-0002-3391-3055; Farbood, Yaghoob/0000-0002-6390-0079; Rashno, Masome/0000-0002-1290-3499; rashno, mohammad/0000-0001-5473-1384	Ahvaz Physiology Research Center - Ahvaz Jundishapur University of Medical Sciences (Iran) [APRC-9605]	This article was extracted as a part of Masome Rashno's Ph.D. thesis. This work was supported by a grant (APRC-9605) from Ahvaz Physiology Research Center, funded by the Vice Chancellor of Research, Ahvaz Jundishapur University of Medical Sciences (Iran).	Aishwarya V., 2015, INT J PHARMACOGN PHY, V7, P224; Anand KV, 2011, TOXICOL IND HEALTH, V27, P923, DOI 10.1177/0748233711399324; Anitha T. A., 2014, Biomedicine & Preventive Nutrition, V4, P511; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BINDER LM, 1986, J CLIN EXP NEUROPSYC, V8, P323, DOI 10.1080/01688638608401325; BOHNEN N, 1994, BRAIN INJURY, V8, P701, DOI 10.3109/02699059409151024; Chang C, 2018, INT J HUM-COMPUT ST, V117, P4, DOI 10.1016/j.ijhcs.2018.02.006; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Garbarino VR, 2015, ARCH BIOCHEM BIOPHYS, V576, P8, DOI 10.1016/j.abb.2015.01.029; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; He HF, 2018, DRUG DES DEV THER, V12, P629, DOI 10.2147/DDDT.S158313; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Ignowski E, 2018, FREE RADICAL BIO MED, V124, P328, DOI 10.1016/j.freeradbiomed.2018.06.026; Kandhare AD, 2014, J NAT MED-TOKYO, V68, P586, DOI 10.1007/s11418-014-0840-1; Khoshnam SE, 2018, LIFE SCI, V211, P126, DOI 10.1016/j.lfs.2018.08.065; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007868; Leeds PR, 2014, ACS CHEM NEUROSCI, V5, P422, DOI 10.1021/cn500040g; Malkesman O, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00157; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Miotto EC, 2010, ARQ NEURO-PSIQUIAT, V68, P862, DOI 10.1590/S0004-282X2010000600006; Nagababu E, 2003, BBA-GEN SUBJECTS, V1620, P211, DOI 10.1016/S0304-4165(02)00537-8; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Pawlak A, 2018, BIOORG MED CHEM LETT, V28, P1171, DOI 10.1016/j.bmcl.2018.03.006; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Tabatabaei SRF, 2017, BIOMED PHARMACOTHER, V96, P279, DOI 10.1016/j.biopha.2017.09.146; Thangarajan S, 2016, BIOMED PHARMACOTHER, V84, P514, DOI 10.1016/j.biopha.2016.09.070; Vedagiri A, 2016, NEUROPEPTIDES, V58, P111, DOI 10.1016/j.npep.2016.03.002; Wyllie AH, 1997, BRIT MED BULL, V53, P451; Xiao J, 2014, NEUROSCIENCE, V262, P156, DOI 10.1016/j.neuroscience.2014.01.004; Zeinali M, 2017, BIOMED PHARMACOTHER, V92, P998, DOI 10.1016/j.biopha.2017.06.003; Zink BJ, 2010, PSYCHIAT CLIN N AM, V33, P741, DOI 10.1016/j.psc.2010.08.005; 2002, NEUROIMAGING CLIN N, V12, P175; 1993, J NEUROPHYSIOL, V70, P733; 2015, PHARM BIOCH BEHAV, V134, P22, DOI DOI 10.1016/J.PBB.2015.04.010; 2014, INT J MOL SCI, V15, P1227, DOI DOI 10.3390/IJMS150712270; 1997, NAT MED, V3, P614; 2004, PROG NEUROPSYCHOPHAR, V28, P771, DOI DOI 10.1016/J.PNPBP.2004.05.023; 2014, IRAN BIOMED J, V18, P101, DOI DOI 10.6091/IBJ.12912.2013; 2006, INT J DEV NEUROSCI, V24, P357, DOI DOI 10.1016/J.IJDEVNEU.2006.08.003; 2012, J SAFETY RES, V43, P299, DOI DOI 10.1016/J.JSR.2012.08.011; 1999, J NEUROL NEUROSURG P, V66, P207; 2017, EXP THER MED, V13, P2247, DOI DOI 10.3892/ETM.2017.4283; 2014, BIOCHEM PHARMACOL, V89, P503, DOI DOI 10.1016/J.BCP.2014.03.016; 2010, PHYSIOL BEHAV, V101, P660, DOI DOI 10.1016/J.PHYSBEH.2010.09.021; 2013, NAT REV NEUROL, V9, P222, DOI DOI 10.1038/NRNEUROL.2013.33; 2010, J NEUROTRAUM, V27, P1585, DOI DOI 10.1089/NEU.2010.1298; 2004, J NEUROTRAUMA, V21, P1712; 2018, CHEM-BIOL INTERACT, V279, P111, DOI DOI 10.1016/J.CBI.2017.10.019; 2014, INT J MOL SCI, V15, P1216, DOI DOI 10.3390/IJMS15011216; 2014, J EXERC REHABIL, V10, P148, DOI DOI 10.12965/JER.140109; 1990, CANC RES, V50, P7057; 2007, ANN ACAD MED SINGAP, V36, P31; 2005, LEARN MEMORY, V12, P375, DOI DOI 10.1101/LM.81905; 2004, SURGERY, V136, P355, DOI DOI 10.1016/J.SURG.2004.05.011; 2010, NEUROTHERAPEUTICS, V7, P3; 2010, NAT REV NEUROL, V6, P393, DOI DOI 10.1038/NRNEUROL.2010.74; 2015, CAN J PHYSL PHARM, V93, P687, DOI DOI 10.1139/CJPP-2014-0546; 2012, EUR J PHARMACOL, V680, P41, DOI DOI 10.1016/J.EJPHAR.2012.01.025; 2009, MUTAT RES-GEN TOX EN, V674, P137, DOI DOI 10.1016/J.MRGENTOX.2008.09.015; 2016, J ETHNOPHARMACOL, V185, P87, DOI DOI 10.1016/J.JEP.2016.03.018; 2008, NEUROPSYCHOLOGY, V22, P618, DOI DOI 10.1037/0894-4105.22.5.618; 2016, J AGR FOOD CHEM, V64, P5324, DOI DOI 10.1021/ACS.JAFC.6B01707; 2010, TRENDS PHARMACOL SCI, V31, P596, DOI DOI 10.1016/J.TIPS.2010.09.005; 2014, INT J MOL SCI, V15, P2091, DOI DOI 10.3390/IJMS151120913; 2010, NEUROSCI LETT, V485, P143, DOI DOI 10.1016/J.NEULET.2010.08.064; 2006, FREE RADIC BIOL MED, V41, P1694, DOI DOI 10.1016/J.FREERADBIOMED.2006.09.002; 2004, BIOL TRACE ELEM RES, V101, P73; 2019, LIFE SCI, V225, P8, DOI DOI 10.1016/J.LFS.2019.03.078	72	13	13	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205	1879-0631		LIFE SCI	Life Sci.	JUL 1	2019	228						285	294		10.1016/j.lfs.2019.05.007			10	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	HY5RO	WOS:000468185400032	31063733				2021-06-18	
J	Rai, JK; Erdodi, LA				Rai, Jaspreet K.; Erdodi, Laszlo A.			Impact of criterion measures on the classification accuracy of TOMM-1	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Erdodi index; modality specificity; multivariate models; performance validity; Test of Memory Malingering	RECOGNITION MEMORY TEST; VERBAL-LEARNING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; COMPLEX IDEATIONAL MATERIAL; TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; WORD CHOICE TEST; PERFORMANCE VALIDITY; DIGIT SPAN; TRIAL 1	This study was designed to examine the effect of various criterion measures on the classification accuracy of Trial 1 of the Test of Memory Malingering (TOMM-1), a free-standing performance validity test (PVT). Archival data were collected from a case sequence of 91 (M-Age = 42.2 years; M-Education = 12.7) patients clinically referred for neuropsychological assessment. Trials 2 and Retention of the TOMM, the Word Choice Test, and three validity composites were used as criterion PVTs. Classification accuracy varied systematically as a function of criterion PVT. TOMM-1 <= 43 emerged as the optimal cutoff, resulting in a wide range of sensitivity (.47-1.00), with perfect overall specificity. Failing the TOMM-1 was unrelated to age, education or gender, but was associated with elevated self-reported depression. Results support the utility of TOMM-1 as an independent, free-standing, single-trial PVT. Consistent with previous reports, the choice of criterion measure influences parameter estimates of the PVT being calibrated. The methodological implications of modality specificity to PVT research and clinical/forensic practice should be considered when evaluating cutoffs or interpreting scores in the failing range.	[Rai, Jaspreet K.; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, Neuropsychol Track, Windsor, ON, Canada; [Rai, Jaspreet K.] Univ Windsor, Edmonton, AB, Canada	Erdodi, LA (corresponding author), Glenrose Rehabil Hosp, Alberta Hlth Serv, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com					An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Armistead-Jehle P, 2011, APPL NEUROPSYCHOL, V18, P284, DOI 10.1080/09084282.2011.595455; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bauer L, 2007, ASSESSMENT, V14, P215, DOI 10.1177/1073191106297617; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Delis DC, 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Erdodi LA., 2019, PSYCHOL NEUROSCI, V12, P451, DOI [10.1037/pne0000175., DOI 10.1037/PNE0000175, 10.1037/pne0000175]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Green, 2004, GREENS MED SYMPTOM V; Green P., 2003, GREENS WORD MEMORY T; Green P, 2011, APPL NEUROPSYCHOL, V18, P18, DOI 10.1080/09084282.2010.523365; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greiffenstein MF, 2008, ARCH CLIN NEUROPSYCH, V23, P801, DOI 10.1016/j.acn.2008.07.005; Greve KW, 2006, ARCH CLIN NEUROPSYCH, V21, P439, DOI 10.1016/j.acn.2006.06.004; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Heaton RK, 2004, REVISED COMPREHENSIV; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; Hilsabeck RC, 2011, CLIN NEUROPSYCHOL, V25, P1228, DOI 10.1080/13854046.2011.589409; Horner MD, 2006, INT J NEUROSCI, V116, P1181, DOI 10.1080/00207450500514029; Iverson GL, 2000, J HEAD TRAUMA REHAB, V15, P829, DOI 10.1097/00001199-200004000-00006; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kalfon TBO, 2016, J PSYCHOSOM RES, V87, P30, DOI 10.1016/j.jpsychores.2016.06.004; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee, 2012, FORENSIC NEUROPSYCHO, P116; Larrabee G. J, 2007, FORENSIC NEUROPSYCHO; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Lichtenstein J. D., 2019, PSYCHOL INJURY LAW, DOI [10.1007/s12207-019-0935, DOI 10.1007/S12207-019-0935]; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; O'Bryant SE, 2007, CLIN NEUROPSYCHOL, V21, P511, DOI 10.1080/13854040600611368; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Pearson, 2009, ADV CLIN SOLUTIONS W; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Roth R.M., 2017, PSYCHOL NEUROSCI, V10, DOI [https//doi.org/10.1037/pne0000103, DOI 10.1037/PNE0000103]; Schroeder RW, 2013, ARCH CLIN NEUROPSYCH, V28, P21, DOI 10.1093/arclin/acs094; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Slick D., 1997, VSVT VICTORIA SYMPTO; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sweet J. J., 2007, ASSESSMENT FEIGNED C, P152; Tombaugh TN, 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Warrington EK., 1984, RECOGNITION MEMORY T; Williamson DJ, 2012, CLIN NEUROPSYCHOL, V26, P588, DOI 10.1080/13854046.2012.670266; Wisdom NM, 2012, ARCH CLIN NEUROPSYCH, V27, P208, DOI 10.1093/arclin/acr107; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	90	13	13	0	1	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAR 4	2021	28	2					185	196		10.1080/23279095.2019.1613994		JUN 2019	12	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	QJ4GT	WOS:000473643100001	31187632				2021-06-18	
J	Abeare, C; Sabelli, A; Taylor, B; Holcomb, M; Dumitrescu, C; Kirsch, N; Erdodi, L				Abeare, Christopher; Sabelli, Alana; Taylor, Brian; Holcomb, Matthew; Dumitrescu, Claudiu; Kirsch, Ned; Erdodi, Laszlo			The Importance of Demographically Adjusted Cutoffs: Age and Education Bias in Raw Score Cutoffs Within the Trail Making Test	PSYCHOLOGICAL INJURY & LAW			English	Article						Trail making test; Performance validity; Demographic correction; Traumatic brain injury; Erdodi Index	TRAUMATIC BRAIN-INJURY; PERFORMANCE VALIDITY TESTS; ADULT INTELLIGENCE SCALE; VERBAL-LEARNING TEST; SYMPTOM VALIDITY; CLASSIFICATION ACCURACY; DIGIT SPAN; RECOGNITION TRIAL; TEST-II; INVALID PERFORMANCE	This study was designed to develop validity cutoffs by utilizing demographically adjusted T-scores on the trail making test (TMT), with the goal of eliminating potential age and education-related biases associated with the use of raw score cutoffs. Failure to correct for the effect of age and education on TMT performance may lead to increased false positive errors for older adults and examinees with lower levels of education. Data were collected from an archival sample of 100 adult outpatients (M-Age=38.8, 56% male; M-Ed=13.7) who were clinically referred for neuropsychological assessment at an academic medical center in the Midwestern USA after sustaining a traumatic brain injury (TBI). Performance validity was psychometrically determined using the Word Memory Test and two multivariate validity composites based on five embedded performance validity indicators. Cutoffs on the demographically corrected TMT T-scores had generally superior classification accuracy compared to the raw score cutoffs reported in the literature. As expected, the T-scores also eliminated age and education bias that was observed in the raw score cutoffs. Both T-score and raw score cutoffs were orthogonal to injury severity. Multivariate models of T-score based cutoff failed to improve classification accuracy over univariate T-score cutoffs. The present findings provide support for the use of demographically adjusted validity cutoffs within the TMT. They produced superior classification to raw score-based cutoffs, in addition to eliminating the bias against older adults and examinees with lower levels of education.	[Abeare, Christopher; Erdodi, Laszlo] Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Sabelli, Alana; Taylor, Brian] Univ Windsor, Brain Cognit Neurosci Program, Windsor, ON N9B 3P4, Canada; [Holcomb, Matthew] Jefferson Neurobehav Grp, New Orleans, LA USA; [Dumitrescu, Claudiu] Canandgua Vet Adm Hosp, Rochester, NY USA; [Kirsch, Ned] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA	Erdodi, L (corresponding author), Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434	University of Windsor, Faculty of Arts, Humanities, and Social Sciences Collaborative Research Grant	This project received financial support from the University of Windsor, Faculty of Arts, Humanities, and Social Sciences Collaborative Research Grant.	Abeare C., 2018, J HEAD TRAUMA REHABI, V1; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K. B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P189, DOI 10.1093/arclin/acs115; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Conners K. C., 2004, CONNERS CONTINUOUS P; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis DC, 2000, CALIFORNIA VERBAL LE; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Dunn L., 2007, PEABODY PICTURE VOCA, V4th ed.; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL INJ LAW, V10, P96, DOI 10.1007/s12207-017-9282-x; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Golden CJ, 1998, ARCH CLIN NEUROPSYCH, V13, P683, DOI 10.1016/S0887-6177(98)00006-7; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Halstead WC., 1947, BRAIN INTELLIGENCE Q; Hamdan Amer C., 2009, Psychol. Neurosci., V2, P199, DOI 10.3922/j.psns.2009.2.012; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton R., 1993, WISCONSIN CARD SORTI; Heaton RK, 2004, REVISED COMPREHENSIV; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Horton AM, 2001, INT J NEUROSCI, V111, P123, DOI 10.3109/00207450108986557; Hosmer D. W., 2000, APPL LOGISTIC REGRES; Iverson G. L., 1999, J COGNITIVE REHABILI, V17, P4; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Larrabee, 2012, FORENSIC NEUROPSYCHO, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Lichtenstein JD., 2018, J PEDIATR NEUROPSYCH, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCrea M, 2008, MILD TRAUMATIC BRAIN; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mitrushina M., 2005, HDB NORMATIVE DATA N; Newcombe F., 1969, MISSILE WOUNDS BRAIN; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pearson, 2009, ADV CLIN SOL WAIS 4; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Powell MR, 2011, CLIN NEUROPSYCHOL, V25, P108, DOI 10.1080/13854046.2010.532912; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rai J., 2019, PSYCHOL NEUROSCIENCE; Rasmusson DX, 1998, CLIN NEUROPSYCHOL, V12, P169, DOI 10.1076/clin.12.2.169.2005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Roth R.M., 2017, PSYCHOL NEUROSCI, V10, DOI [https//doi.org/10.1037/pne0000103, DOI 10.1037/PNE0000103]; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Salazar X. F., 2007, ASSESSMENT FEIGNED C, P405; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Solomon RE, 2010, CLIN NEUROPSYCHOL, V24, P1243, DOI 10.1080/13854046.2010.514864; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; SPREEN O, 1965, J NERV MENT DIS, V140, P323, DOI 10.1097/00005053-196505000-00002; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; Wechsler D., 2008, TECHNICAL INTERPRETI; Wechsler D., 2009, WECHSLER MEMORY SCAL; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME, V4th; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wolfson D., 1993, HALSTEAD REITAN NEUR; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Yuspeh RL, 2000, ARCH CLIN NEUROPSYCH, V15, P687	122	13	13	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2019	12	2					170	182		10.1007/s12207-019-09353-x			13	Psychology, Clinical	Psychology	IF6ZK	WOS:000473231100006					2021-06-18	
J	Foster, CA; D'Lauro, C; Johnson, BR				Foster, Craig A.; D'Lauro, Christopher; Johnson, Brian R.			Pilots and athletes: Different concerns, similar concussion non-disclosure	PLOS ONE			English	Article							SCHOOL FOOTBALL PLAYERS; TRAUMATIC BRAIN-INJURY; ICE HOCKEY; EDUCATION; KNOWLEDGE; SYMPTOMS; GENDER; NORMS; RISK; ATTITUDES	Objectives Concussion non-disclosure research has focused almost exclusively on athletes. The focus on athletic populations has been sensible considering athletes' demonstrated susceptibility to sustaining and concealing concussions. Nevertheless, the habitual use of athletic populations has allowed researchers and practitioners to omit the development of generalized perceived costs and perceived rewards as critical determinants of concussion self-disclosure. We hypothesized that perceiving concussion disclosure as generally more costly than rewarding would predict negative attitudes towards disclosure and decreased intent to disclose. We also hypothesized that generalized perceived costs and rewards could explain concussion non-disclosure in different populations, athletes and future pilots specifically, even when those populations perceive concussion self-disclosure as costly for different specific reasons. Methods We examined concussion disclosure using 2,504 cadets at the United States Air Force Academy. Cadets completed anonymous surveys assessing their intention to self-disclose undiagnosed concussions (Anticipated Concussion Disclosure) as well as several variables potentially related to concussion self-disclosure: perceived cost, perceived reward, personal identity, attitudes, normative behavior, social support, and self-efficacy. Results The results demonstrate that concussion non-disclosure develops when a population perceives disclosure as more costly (i.e. directly or emotionally) and less rewarding. Perceived Cost and Perceived Reward variables alone accounted for 50% of the variance in Anticipated Conclusion Disclosure (Adjusted R-2 = 0.50, F(2,2312) = 1,145.31, p < 0.001). As expected, Anticipated Conclusion Disclosure developed for different reasons within different sub-populations. Consistent with existing research, cadet intercollegiate athletes reported being primarily concerned that concussion self-disclosure would cause them to miss practice or game time (t (736.7) = 14.20, p <.001, Cohen's d = 0.96). In contrast, cadet future pilots reported being primarily concerned that concussion self-disclosure would have negative United States Air Force career repercussions (t (1828) = 10.25, p < .001, Cohen's d = 0.50). Conclusions These results suggest that cultures of concussion non-disclosure can develop in any population where disclosure is perceived as having undesirable consequences, not just athletic populations. Concussion researchers and practitioners should devote more attention to the perceived cost-benefit structures that create concussion non-disclosure to address this crucial public health issue more effectively.	[Foster, Craig A.; D'Lauro, Christopher] US Air Force Acad, Dept Behav Sci & Leadership, Colorado Springs, CO 80840 USA; [Johnson, Brian R.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA	D'Lauro, C (corresponding author), US Air Force Acad, Dept Behav Sci & Leadership, Colorado Springs, CO 80840 USA.	christopher.dlauro@gmail.com	D'Lauro, Christopher/V-2587-2019; D'Lauro, Christopher/X-1518-2019	D'Lauro, Christopher/0000-0003-0894-6602	National Collegiate Athletic Association (NCAA)-Department of Defense DoD Mind Matters Challenge Award under the Sports Safety Insititue; Sports Safety Institute of the National Collegiate Athletic Association (NCAA) through a Mind Matters research grant; United States Department of Defense through a Mind Matters research grant	The work of all three authors was supported by an National Collegiate Athletic Association (NCAA)-Department of Defense DoD Mind Matters Challenge Award under the auspices of the Sports Safety Insititue. No grant number was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article are those of the authors and do not necessarily reflect those of the United States Air Force Academy or the United States Department of Defense.; We thank Emily Jones for her assistance in developing this manuscript. We thank Lt Col (Ret.) Jerry McGinty and Col. (Ret.) Darren Campbell MD for support and assistance with administration. We thank the entire Summer 2015 USAFA Baseline Concussion team for assistance with administration of surveys. We thank the Sports Safety Institute of the National Collegiate Athletic Association (NCAA) and United States Department of Defense for supporting this research through a Mind Matters research grant. We also thank the cadets who participated so enthusiastically in this research.	Anderson BL, 2016, CLIN J SPORT MED, V26, P206, DOI 10.1097/JSM.0000000000000214; Asken BM, 2018, AM J SPORT MED, V46, P1465, DOI 10.1177/0363546518757984; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Baugh CM, 2014, J LAW MED ETHICS, V42, P314, DOI 10.1111/jlme.12148; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Capraro V, 2018, JUDGM DECIS MAK, V13, P345; Capraro V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06790; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Combs PR, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967118817515; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2011, CLIN SPORT MED, V30, P125, DOI 10.1016/j.csm.2010.08.001; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Engel C, 2016, APPL ECON LETT, V23, P1157, DOI 10.1080/13504851.2016.1139672; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Halstead ME, 2017, BRIT J SPORT MED, V51, P147, DOI 10.1136/bjsports-2016-096674; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Higgins E.Tory., 1989, ADV EXPT SOCIAL PSYC, V22, P93, DOI DOI 10.1016/S0065-2601(08)60306-8; Johnson BR, 2018, MIL MED, V183, P101, DOI 10.1093/milmed/usx106; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Kroshus E, 2015, HEALTH EDUC RES, V30, P1004, DOI 10.1093/her/cyv047; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lininger MR, 2017, ATHL TRAIN SPORTS HL, V9, P71, DOI DOI 10.3928/19425864-20161116-01; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McAvoy K, 2018, NEUROREHABILITATION, V42, P325, DOI 10.3233/NRE-172381; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Rand DG, 2017, J EXP SOC PSYCHOL, V73, P164, DOI 10.1016/j.jesp.2017.06.013; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2017, CLIN J SPORT MED, V27, P321, DOI 10.1097/JSM.0000000000000349; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sarmiento K, 2017, J SCHOOL HEALTH, V87, P790, DOI 10.1111/josh.12552; Schmidt JD, 2017, J NEUROTRAUM, V34, P1571, DOI 10.1089/neu.2016.4668; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Weber JM, 2004, PERS SOC PSYCHOL REV, V8, P281, DOI 10.1207/s15327957pspr0803_4; 2018, ECON LETT, V170, P19, DOI DOI 10.1016/J.ECONLET.2018.05.022; 2013, CLIN J SPORT MED, V23, P339, DOI DOI 10.1097/JSM.0B013E318291D3B3; 1991, ORGAN BEHAV HUM DECI, V50, P179	54	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2019	14	5							e0215030	10.1371/journal.pone.0215030			19	Multidisciplinary Sciences	Science & Technology - Other Topics	HW0KS	WOS:000466370200018	31042725	DOAJ Gold, Green Published			2021-06-18	
J	Oliver, JM; Anzalone, AJ; Stone, JD; Turner, SM; Blueitt, D; Garrison, JC; Askow, AT; Luedke, JA; Jagim, AR				Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig; Askow, Andrew T.; Luedke, Joel A.; Jagim, Andrew R.			Fluctuations in blood biomarkers of head trauma in NCAA football athletes over the course of a season	JOURNAL OF NEUROSURGERY			English	Article						sports-related head trauma; sports-related concussion; mild traumatic brain injury; blood biomarkers of head trauma	SERUM NEUROFILAMENT LIGHT; BRAIN-INJURY; WHITE-MATTER; PROTEIN; TAU; INTEGRITY; IMPACTS; HOCKEY	OBJECTIVE Repetitive subconcussive head trauma is a consequence of participation in contact sports and may be linked to neurodegenerative diseases. The degree of neurological injury caused by subconcussive head trauma is not easily detectible, and this injury does not induce readily identifiable clinical signs or symptoms. Recent advancements in immunoassays make possible the detection and quantification of blood biomarkers linked to head trauma. Identification of a blood biomarker that can identify the extent of neurological injury associated with subconcussive head trauma may provide an objective measure for informed decisions concerning cumulative exposure to subconcussive head trauma. The purpose of the current study was to examine changes in the blood biomarkers of subconcussive head trauma over the course of an American football season. METHODS Thirty-five National Collegiate Athletic Association (NCAA) American football athletes underwent blood sampling throughout the course of a football season. Serial samples were obtained throughout the 2016 season, during which the number and magnitude of head impacts changed. Blood samples were analyzed for plasma concentrations of tau and serum concentrations of neurofilament light polypeptide (NF-L). Athletes were grouped based on their starter status, because athletes identified as starters are known to sustain a greater number of impacts. Between-group differences and time-course differences were assessed. RESULTS In nonstarters, plasma concentrations of tau decreased over the course of the season, with lower values observed in starters; this resulted in a lower area under the curve (AUC) (starters: 416.78 +/- 129.17 pg/ml/day; nonstarters: 520.84 +/- 163.19 pg/ml/day; p = 0.050). Plasma concentrations of tau could not be used to discern between starters and nonstarters. In contrast, serum concentrations of NF-L increased throughout the season as head impacts accumulated, specifically in those athletes categorized as starters. The higher serum concentrations of NF-L observed in starters resulted in a larger AUC (starters: 1605.03 +/- 655.09 pg/ml/day; nonstarters: 1067.29 +/- 272.33 pg/ml/day; p = 0.007). The AUC of the receiver operating characteristic curve analyses displayed fair to modest accuracy to identify athletes who were starters with the use of serum NF-L following periods of repetitive impacts. CONCLUSIONS The different patterns observed in serum NF-L and plasma tau concentrations provide preliminary evidence for the use of blood biomarkers to detect the neurological injury associated with repetitive subconcussive head trauma. Although further investigation is necessary, such findings might lay the foundation for the further development of an objective measure for the detection of neurological injury caused by subconcussive head trauma.	[Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig; Askow, Andrew T.] Texas Christian Univ, Sports Concuss Res Grp, Dept Kinesiol, Ft Worth, TX 76129 USA; [Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig] Texas Hlth Sports Med Concuss Ctr, Ft Worth, TX USA; [Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig] Texas Hlth Sports Med, Ft Worth, TX USA; [Askow, Andrew T.; Jagim, Andrew R.] Univ Wisconsin, Exercise & Sport Sci Dept, La Crosse, WI 54601 USA; [Luedke, Joel A.] Univ Wisconsin, Athlet Dept, La Crosse, WI 54601 USA	Oliver, JM (corresponding author), Texas Christian Univ, Ft Worth, TX 76129 USA.	jonathan.oliver@tcu.edu	Jagim, Andrew/Y-2447-2019	Jagim, Andrew/0000-0002-6651-5096; Askow, Andrew/0000-0002-0757-8943	STRUCT Nutrition	This study was funded in part by a grant from STRUCT Nutrition.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Borna Merchant-, 2017, BRAIN IMAGING BEHAV; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fournier AJ, 2014, FASEB J, V28, P5277, DOI 10.1096/fj.14-251942; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oliver JM, 2017, J NEUROTRAUM, V34, P3295, DOI 10.1089/neu.2017.5064; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; 2008, MOL NEUROBIOL, V38, P27, DOI DOI 10.1007/S12035-008-8033-0; 2015, BRAIN CONNECT, V5, P91, DOI DOI 10.1089/BRAIN.2014.0279; 2017, J NEUROTRAUM, V34, P66, DOI DOI 10.1089/NEU.2015.4333; 2010, J NEUROTRAUM, V27, P1429, DOI DOI 10.1089/NEU.2010.1288	40	13	13	1	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2019	130	5					1655	1662		10.3171/2017.12.JNS172035			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	HW0VW	WOS:000466401100030	29807487	Bronze			2021-06-18	
J	Iverson, GL; Reddi, PJ; Posti, JP; Kotilainen, AK; Tenovuo, O; Ohman, J; Zetterberg, H; Blennow, K; Luoto, TM				Iverson, Grant L.; Reddi, Preethi J.; Posti, Jussi P.; Kotilainen, Anna-Kerttu; Tenovuo, Olli; Ohman, Juha; Zetterberg, Henrik; Blennow, Kaj; Luoto, Teemu M.			Serum Neurofilament Light Is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries	JOURNAL OF NEUROTRAUMA			English	Article						aging; biomarker; blood; neurofilament; traumatic brain injury	CEREBROSPINAL-FLUID; NEURONAL DAMAGE; NF-L; DISEASE; PROTEIN; BIOMARKER; BLOOD; FALLS; MARKER; CHAIN	Neurofilament light (NF-L) might have diagnostic and prognostic potential as a blood biomarker for mild traumatic brain injury (mTBI). However, elevated NF-L is associated with several neurological disorders associated with older age, which could confound its usefulness as a traumatic brain injury biomarker. We examined whether NF-L is elevated differentially following uncomplicated mTBI in older adults with pre-injury neurological disorders. In a case-control study, a sample of 118 adults (mean age = 62.3 years, standard deviation [SD] = 22.5, range = 18-100; 52.5% women) presenting to the emergency department (ED) with an uncomplicated mTBI were enrolled. All participants underwent head computed tomography in the ED and showed no macroscopic evidence of injury. The mean time between injury and blood sampling was 8.3 h (median [Md] = 3.5; SD = 13.5; interquartile range [IQR] = 1.9-6.0, range = 0.8-67.4, and 90% collected within 19 h). A sample of 40 orthopedically-injured trauma control subjects recruited from a second ED also were examined. Serum NF-L levels were measured and analyzed using Human Neurology 4-Plex A assay on a HD-1 Single Molecule Array (Simoa) instrument. A high correlation was found between age and NF-L levels in the total mTBI sample (r = 0.80), within the subgroups without pre-injury neurological diseases (r = 0.76) and with pre-injury neurological diseases (r = 0.68), and in the trauma control subjects (r = 0.76). Those with mTBIs and pre-injury neurological conditions had higher NF-L levels than those with no pre-injury neurological conditions (p < 0.001, Cohen's d = 1.01). Older age and pre-injury neurological diseases are associated with elevated serum NF-L levels in patients with head trauma and in orthopedically-injured control subjects.	[Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Iverson, Grant L.] Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Reddi, Preethi J.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Turku, Finland; [Posti, Jussi P.; Tenovuo, Olli] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Tenovuo, Olli] Univ Turku, Turku, Finland; [Kotilainen, Anna-Kerttu] Univ Tampere, Dept Med & Life Sci, Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, POB 2000,Teiskontie 35, FI-33521 Tampere, Finland; [Ohman, Juha; Luoto, Teemu M.] Univ Tampere, Tampere, Finland; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London, England; [Zetterberg, Henrik] UCL, Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London, England	Luoto, TM (corresponding author), Tampere Univ Hosp, Dept Neurosurg, POB 2000,Teiskontie 35, FI-33521 Tampere, Finland.	Teemu.Luoto@pshp.fi	Posti, Jussi P./Y-2908-2019; Luoto, Teemu/W-6468-2018	Posti, Jussi P./0000-0002-5925-5193; Luoto, Teemu/0000-0002-7329-3284	Finnish State Research Funding; Finnish Medical Society Duodecim; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation sr; Finnish Brain Foundation sr; Torsten Soderberg Foundation; Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; European Research CouncilEuropean Research Council (ERC)European Commission; Dementia Research Institute at UCL	The study was financially supported by the Finnish State Research Funding, and the Finnish Medical Society Duodecim. Dr. Luoto and Dr. Posti have received funding from Government's Special Financial Transfer tied to academic research in Health Sciences (Finland). Dr. Posti has received funding from the Emil Aaltonen Foundation sr and the Finnish Brain Foundation sr. Dr. Blennow acknowledges funding from The Torsten Soderberg Foundation, the Swedish Research Council, and the Swedish Brain Foundation. Dr. Zetterberg is a Wallenberg Academy Fellow and acknowledges support from the Swedish and European Research Council and the Dementia Research Institute at UCL.	Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Brureau A, 2017, NEUROBIOL DIS, V104, P73, DOI 10.1016/j.nbd.2017.04.007; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; De Marchis GM, 2018, EUR J NEUROL, V25, P562, DOI 10.1111/ene.13554; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Feneberg E, 2018, NEUROLOGY, V90, pE22, DOI 10.1212/WNL.0000000000004761; Gardner RC, 2018, J NEUROTRAUM, V35, P889, DOI 10.1089/neu.2017.5371; Gardner RC, 2018, J NEUROTRAUM, V35, P2341, DOI 10.1089/neu.2018.5694; Gattringer T, 2017, NEUROLOGY, V89, P2108, DOI 10.1212/WNL.0000000000004645; Hansson O, 2017, NEUROLOGY, V88, P930, DOI 10.1212/WNL.0000000000003680; HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517; Helling TS, 1999, J TRAUMA, V46, P453, DOI 10.1097/00005373-199903000-00019; Hoidrup S, 2003, SCAND J PUBLIC HEALT, V31, P24, DOI 10.1080/14034940210134185; ISHIKAWA H, 1968, J CELL BIOL, V38, P538, DOI 10.1083/jcb.38.3.538; Johansen A, 2011, EMERG MED J, V28, P25, DOI 10.1136/emj.2009.086330; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kuhle J, 2017, NEUROLOGY, V88, P826, DOI 10.1212/WNL.0000000000003653; Kuhle J, 2016, MULT SCLER J, V22, P1550, DOI 10.1177/1352458515623365; LEE MK, 1993, J CELL BIOL, V122, P1337, DOI 10.1083/jcb.122.6.1337; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Novakova L, 2017, NEUROLOGY, V89, P2230, DOI 10.1212/WNL.0000000000004683; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Posti J.P., 2017, J NEUROTRAUMA; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; SCHLAEPFER WW, 1984, J NEUROCHEM, V43, P857, DOI 10.1111/j.1471-4159.1984.tb12809.x; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shivaji T, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-2; Thompson AGB, 2018, J NEUROL NEUROSUR PS, V89, P955, DOI 10.1136/jnnp-2017-317793; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Wilke C, 2018, J NEUROL, V265, P1618, DOI 10.1007/s00415-018-8893-9; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	42	13	14	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2019	36	16					2400	2406		10.1089/neu.2018.6341		APR 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	IN3NH	WOS:000465474500001	30843469				2021-06-18	
J	Chrisman, SPD; Lowry, S; Herring, SA; Kroshus, E; Hoopes, TR; Higgins, SK; Rivara, FP				Chrisman, Sara P. D.; Lowry, Sarah; Herring, Stanley A.; Kroshus, Emily; Hoopes, Teah R.; Higgins, Shannon K.; Rivara, Frederick P.			Concussion Incidence, Duration, and Return to School and Sport in 5-to 14-Year-Old American Football Athletes	JOURNAL OF PEDIATRICS			English	Article							4TH INTERNATIONAL-CONFERENCE; STATES HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; CONSENSUS STATEMENT; BASE-LINE; CHILDREN; YOUTH; EPIDEMIOLOGY; ZURICH; INJURY	Objective To collect prospective data on concussion incidence, risk factors, duration of symptoms, and return to school and sport in 5-to 14-year-old American football participants. Study design We conducted a prospective cohort study over 2 years collecting data during two 10-week fall seasons. Youth with concussion were followed to determine time to return to school, sport, and baseline level of symptoms. Logistic regression was used to estimate the risk of sustaining a concussion associated with baseline demographic factors. Time to return to school, sport, and baseline symptoms were analyzed using Kaplan-Meier survival curves. Results Of 863 youth followed (996 player-seasons), 51 sustained a football-related concussion, for an athletelevel incidence of 5.1% per season. Youth with history of concussion had a 2-fold increased risk for sustaining an incident concussion (OR, 2.2; 95% CI, 1.1-4.8). Youth with depression had a 5-fold increased risk of concussion (OR, 5.6; 95% CI, 1.7-18.8). After a concussion, 50% of athletes returned to school by 3 days, 50% returned to sport by 13 days, and 50% returned to a baseline level of symptoms by 3 weeks. Conclusions Concussion rates in this study were slightly higher than previously reported, with 5 of every 100 youth sustaining a football-related concussion each season. One-half of youth were still symptomatic 3 weeks after injury. Further research is needed to address the risk of concussion in youth football.	[Chrisman, Sara P. D.; Lowry, Sarah; Kroshus, Emily; Hoopes, Teah R.; Higgins, Shannon K.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,CW 8-6, Seattle, WA 98145 USA; [Chrisman, Sara P. D.; Kroshus, Emily; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Chrisman, Sara P. D.; Herring, Stanley A.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Lowry, Sarah] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med Orthoped & Sports Med, Seattle, WA 98195 USA	Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,CW 8-6, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223	Seattle Pediatric Concussion Research Collaborative; University of Washington Sports Health and Safety Institute	Funded by the Seattle Pediatric Concussion Research Collaborative and the University of Washington Sports Health and Safety Institute. S.H. was previously chair of the medical advisory committee, a member of the board of directors for USA Football, and a member of the medical advisory committee for Pop Warner Little Scholars. He is currently one of the team physicians for the Seattle Seahawks. The other authors declare no conflicts of interest.	Alic S., 2016, US FOOTBALL BLOG; Asken BM, 2018, AM J SPORTS MED, V46; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Brett BL, 2018, ARCH CLIN NEUROPSYCH; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Burman E., 2016, BMJ OPEN SPORT EXERC, V2; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chin EY, 2016, AM J SPORTS MED; Choe Meeryo, 2018, Continuum (Minneap Minn), V24, P300, DOI 10.1212/CON.0000000000000569; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52; Chrisman SPD, 2014, J ADOLESC HLTH; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Davis GA, 2017, BR J SPORTS MED; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fehr SD, 2017, CLIN J SPORT MED, V1; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Heyer GL, 2016, J PEDIAT, V174; Hides JA, 2017, MED SCI SPORTS EXERC, P1; Howell DR, 2018, CLIN J SPORT MED, V1; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2017, CLIN J SPORT MED; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langhorst P., 2016, ENGAGE SPORTS; Leopold SS, 2016, CLIN ORTHOP RELAT R, V474, P1533, DOI 10.1007/s11999-016-4835-y; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moran L., 2012, CHANGES, V29, P997; Myklebust G, 2005, BRIT J SPORT MED, V39, P127, DOI 10.1136/bjsm.2004.010900; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rice S, 2018, EARLY INTERV PSYCHIA; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Terry DP, 2018, CLIN J SPORT MED, V1; Thomas DJ, 2017, CLIN J SPORT MED, V1; Tsushima WT, 2018, ARCH CLIN NEUROPSYCH; Vargas G, 2015, J ATHL TRAINING, V50; Yeung A, 2017, BRAIN INJURY, V31, P542, DOI 10.1080/02699052.2016.1271456; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	63	13	13	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2019	207						176	184		10.1016/j.jpeds.2018.11.003			9	Pediatrics	Pediatrics	HQ1ME	WOS:000462161200034	30554790	Bronze			2021-06-18	
J	Yang, LX; Yang, LK; Zhu, J; Chen, JH; Wang, YH; Xiong, K				Yang, Li-Xiang; Yang, Li-Kun; Zhu, Jie; Chen, Jun-Hui; Wang, Yu-Hai; Xiong, Kun			Expression signatures of long non-coding RNA and mRNA in human traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; human traumatic brain injuries; long noncoding RNA; messenger RNA; GO analysis; real-time quantitative polymerase chain reaction; biomarkers; microarray analysis; biological processes; medical informatics; neural regeneration	PROFILE ANALYSIS; IN-VITRO; S100A12; LNCRNA; MICE; APOPTOSIS; BIOMARKER; PROTECTS; PROMOTES; INVASION	Long non-coding RNAs (lncRNAs) play a key role in craniocerebral disease, although their expression profiles in human traumatic brain injury are still unclear. In this regard, in this study, we examined brain injury tissue from three patients of the 101st Hospital of the People's Liberation Army, China (specifically, a 36-year-old male, a 52-year-old female, and a 49-year-old female), who were diagnosed with traumatic brain injury and underwent brain contusion removal surgery. Tissue surrounding the brain contusion in the three patients was used as control tissue to observe expression characteristics of lncRNAs and mRNAs in human traumatic brain injury tissue. Volcano plot filtering identified 99 lncRNAs and 63 mRNAs differentially expressed in frontotemporal tissue of the two groups (P < 0.05, fold change > 1.2). Microarray analysis showed that 43 lncRNAs were up-regulated and 56 lncRNAs were down-regulated. Meanwhile, 59 mRNAs were up-regulated and 4 mRNAs were down-regulated. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed 27 signaling pathways associated with target genes and, in particular, legionellosis and influenza A signaling pathways. Subsequently, a lncRNA-gene network was generated, which showed an absolute correlation coefficient value > 0.99 for 12 lncRNA-mRNA pairs. Finally, quantitative real-time polymerase chain reaction confirmed different expression of the five most up-regulated mRNAs within the two groups, which was consistent with the microarray results. In summary, our results show that expression profiles of mRNAs and lncRNAs are significantly different between human traumatic brain injury tissue and surrounding tissue, providing novel insight regarding lncRNAs' involvement in human traumatic brain injury. All participants provided informed consent.	[Yang, Li-Xiang; Yang, Li-Kun; Zhu, Jie; Chen, Jun-Hui; Wang, Yu-Hai] 101st Hosp Peoples Liberat Army, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China; [Xiong, Kun] Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China	Wang, YH (corresponding author), 101st Hosp Peoples Liberat Army, Dept Neurosurg, Wuxi, Jiangsu, Peoples R China.; Xiong, K (corresponding author), Cent S Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China.	wangyuhai101@126.com; xiongkun2001@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571939, 81601719, 81772134]; Key Research and Development Program of Hunan Province of China [2018SK2091]; Wu Jie-Ping Medical Foundation of the Minister of Health of China [320.6750.14118]; Teacher Research Foundation of Central South University of China [2014JSJJ026]	This study was supported by the National Natural Science Foundation of China, No. 81571939 (to KX), 81601719 (to JZ) and 81772134 (to KX); the Key Research and Development Program of Hunan Province of China, No. 2018SK2091 (to KX); the Wu Jie-Ping Medical Foundation of the Minister of Health of China, No. 320.6750.14118 (to KX); and the Teacher Research Foundation of Central South University of China, No. 2014JSJJ026 (to KX).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Berrocal-Almanza LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep31798; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Chen G, 2013, NUCLEIC ACIDS RES, V41, pD983, DOI 10.1093/nar/gks1099; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Chowdhary VR, 2015, J IMMUNOL, V195, P4660, DOI 10.4049/jimmunol.1501073; D'haene E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28396; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dorosh A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-42; Eroglu B, 2014, J NEUROCHEM, V130, P626, DOI 10.1111/jnc.12781; Fancy SPJ, 2014, NAT NEUROSCI, V17, P506, DOI 10.1038/nn.3676; Feng MJ, 2018, CLIN CHIM ACTA, V480, P84, DOI 10.1016/j.cca.2018.01.044; Fuchs T, 2002, GENOMICS, V80, P295, DOI 10.1006/geno.2002.6830; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Giera S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7121; Guo Q, 2017, ONCOL REP, V37, P1114, DOI 10.3892/or.2016.5312; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Hirschi R, 2017, NEURAL REGEN RES, V12, P1801, DOI 10.4103/1673-5374.219037; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; Jiang BC, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0047-9; Jiang H, 2017, APMIS, V125, P773, DOI 10.1111/apm.12721; Jiang YZ, 2014, CELL BIOCHEM BIOPHYS, V69, P461, DOI 10.1007/s12013-014-9818-6; Kan EM, 2012, BRAIN RES BULL, V87, P359, DOI 10.1016/j.brainresbull.2012.01.007; Kim AR, 2017, MOL IMMUNOL, V91, P218, DOI 10.1016/j.molimm.2017.09.009; Kinouchi T, 2017, CANCER SCI, V108, P2495, DOI 10.1111/cas.13414; Li Y, 2016, TUMOR BIOL, V37, P13091, DOI 10.1007/s13277-016-5227-3; Liu X, 2017, ZHONGGUO ZUZHI GONGC, V21, P4709; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Qu WR, 2016, NEURAL REGEN RES, V11, P248, DOI 10.4103/1673-5374.177732; Quan ZZ, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00175; Roberts TC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0507; Rockhill CM, 2012, J NEUROTRAUM, V29, P1038, DOI 10.1089/neu.2010.1562; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Shi W, 2011, NEUROCHEM RES, V36, P375, DOI 10.1007/s11064-010-0332-y; Shi ZH, 2015, CELL PHYSIOL BIOCHEM, V36, P542, DOI 10.1159/000430119; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Suarez-Calvet X, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1383-0; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Twiss JL, 2016, NEURAL REGEN RES, V11, P1365, DOI 10.4103/1673-5374.191193; Volders PJ, 2013, NUCLEIC ACIDS RES, V41, pD246, DOI 10.1093/nar/gks915; Wang SC, 2018, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00425; Wang Z, 2018, J CELL PHYSIOL, V233, P4864, DOI 10.1002/jcp.26294; Wegleiter K, 2014, EXP NEUROL, V261, P501, DOI 10.1016/j.expneurol.2014.07.022; Xiong K, 2017, TOXICOL IN VITRO, V44, P1, DOI 10.1016/j.tiv.2017.06.009; Yan Y, 2015, J CANCER RES CLIN, V141, P827, DOI 10.1007/s00432-014-1861-6; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Yu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042377; Zhao JL, 2017, J INVEST DERMATOL, V137, P650, DOI 10.1016/j.jid.2016.10.040; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002	57	13	14	1	14	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2019	14	4					632	641	PMID 30632503	10.4103/1673-5374.247467			10	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	HH7LW	WOS:000455913300016	30632503	DOAJ Gold, Green Published			2021-06-18	
J	Ellis, MJ; McDonald, PJ; Olson, A; Koenig, J; Russell, K				Ellis, Michael J.; McDonald, Patrick J.; Olson, Ashley; Koenig, James; Russell, Kelly			Cervical Spine Dysfunction Following Pediatric Sports-Related Head Trauma	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cervical spine dysfunction; pediatric; predictor; SCIWORA; sports-related concussion; whiplash	CORD-INJURY; RADIOGRAPHIC ABNORMALITY; CONCUSSION; CHILDREN; NEURAPRAXIA; SYMPTOMS; SCIWORA	Objective: To examine the prevalence of cervical spine injuries among children and adolescents referred with suspected and diagnosed sports-related concussion (SRC); and evaluate the effect of cervical spine dysfunction (CSD) on physician-documented clinical recovery following SRC. Setting: A multidisciplinary pediatric concussion program. Participants: A total of 266 patients (6-19 years) referred with suspected SRC. Design: A retrospective cohort study. Main Measures: CSD defined as neurological symptoms localized to the cervical spine or the presence of neck pain, headache, or dizziness and abnormal cervical spine examination findings; physician-documented clinical recovery. Results: One patient was diagnosed with a T1 compression fracture. Of the 246 patients diagnosed with SRC, 80 (32.5%) met the clinical criteria for CSD including 4 patients with central cord neuropraxia and 1 with a spinal cord injury without radiographic abnormality (SCIWORA). Excluding patients with central cord neuropraxia OR SCIWORA, patients with SRC with CSD took longer to achieve physician-documented clinical recovery (28.5 days vs 17 days, P < .0001) and were 3.95 times more likely to experience delayed physician-documented clinical recovery (>4 weeks postinjury) compared with those without CSD. Conclusions: Patients with suspected and diagnosed SRC can present with a wide spectrum of coincident cervical spine injuries. Cervical spine dysfunction may be a risk factor for delayed clinical recovery.	[Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB, Canada; [Koenig, James] Univ Manitoba, Diagnost Radiol, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Ellis, Michael J.; Koenig, James] Pan Clin, Pan Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada; [Ellis, Michael J.; Russell, Kelly] Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada; [Olson, Ashley] Univ Manitoba, Max Rady Coll Med, Winnipeg, MB, Canada; [Ellis, Michael J.; McDonald, Patrick J.; Russell, Kelly] Canada North Concuss Network, Winnipeg, MB, Canada; [Ellis, Michael J.; Koenig, James; Russell, Kelly] Univ Manitoba, Winnipeg, MB, Canada	Ellis, MJ (corresponding author), Pan Clin, Pan Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		Russell, Kelly/0000-0002-9159-9201			Anderson PA, 2010, J ORTHOP TRAUMA, V24, P100, DOI 10.1097/BOT.0b013e3181b16494; Babcock L, 2018, PEDIATR EMERG CARE, V34, P677, DOI 10.1097/PEC.0000000000000819; Boockvar JA, 2001, SPINE, V26, P2709, DOI 10.1097/00007632-200112150-00015; Bosch PP, 2002, SPINE, V27, P2788, DOI 10.1097/00007632-200212150-00009; Cantu RC, 2013, CURR SPORT MED REP, V12, P14, DOI 10.1249/JSR.0b013e31827dc1fb; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; O'Brien AM, 2018, APPL NEUROPSYCH-CHIL, V7, P208, DOI 10.1080/21622965.2017.1290529; Pang D, 2004, NEUROSURGERY, V55, P1325, DOI 10.1227/01.NEU.0000143030.85589.E6; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; POLLACK IF, 1988, J NEUROSURG, V69, P177, DOI 10.3171/jns.1988.69.2.0177; Reneker Jennifer C, 2015, Inj Epidemiol, V2, P22; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Stiell IG, 1997, CAN MED ASSOC J, V156, P1537; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Torg JS, 1997, CLIN SPORT MED, V16, P501, DOI 10.1016/S0278-5919(05)70037-5	32	13	13	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		103	110		10.1097/HTR.0000000000000411			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400013	30045221				2021-06-18	
J	Ojo, JO; Algamal, M; Leary, P; Abdullah, L; Mouzon, B; Evans, JE; Mullan, M; Crawford, F				Ojo, Joseph O.; Algamal, Moustafa; Leary, Paige; Abdullah, Laila; Mouzon, Benoit; Evans, James E.; Mullan, Michael; Crawford, Fiona			Converging and Differential Brain Phospholipid Dysregulation in the Pathogenesis of Repetitive Mild Traumatic Brain Injury and Alzheimer's Disease	FRONTIERS IN NEUROSCIENCE			English	Article						mild traumatic brain injury; Alzheimer's disease; preclinical models; lipidomics; brain phospholipids; sphingomyelin; omega-3 fatty acid; omega-6 fatty acid	N-3 FATTY-ACIDS; AMYLOID-PRECURSOR-PROTEIN; DOCOSAHEXAENOIC ACID; CEREBROSPINAL-FLUID; HEAD-INJURY; OLEIC-ACID; PLASMALOGEN DEFICIENCY; COGNITIVE DECLINE; RISK-FACTOR; RAT-BRAIN	Repetitive mild traumatic brain injury (rmTBI) is a major epigenetic risk factor for Alzheimer's disease (AD). The precise nature of how rmTBI leads to or precipitates AD pathology is currently unknown. Numerous neurological conditions have shown an important role for dysfunctional phospholipid metabolism as a driving factor for the pathogenesis of neurodegenerative diseases. However, the precise role in rmTBI and AD remains elusive. We hypothesized that a detailed phospholipid characterization would reveal profiles of response to injury in TBI that overlap with age-dependent changes in AD and thus provide insights into the TBI-AD relationship. We employed a lipidomic approach examining brain phospholipid profiles from mouse models of rmTBI and AD. Cortex and hippocampal tissue were collected at 24 h, 3, 6, 9, and 12 months post-rmTBI, and at ages representing 'pre', 'peri' and 'post' onset of amyloid pathology (i.e., 3, 9, 15 months-old). Total levels of phosphatidylcholine (PC), phosphatidylethanolamine (PE), LysoPE, and phosphatidylinositol (PI), including their monounsaturated, polyunsaturated and saturated fatty acid (FA) containing species were significantly increased at acute and/or chronic time points post-injury in both brain regions. However, levels of most phospholipid species in PS1/APP mice were nominal in the hippocampus, while in the cortex, levels were significantly decreased at ages post-onset of amyloid pathology. Sphingomyelin and LysoPC levels showed coincidental trends in our rmTBI and AD models within the hippocampus, an increase at acute and/or chronic time points examined. The ratio of arachidonic acid (omega-6 FA) to docosahexaenoic acid (omega-3 FA)-containing PE species was increased at early time points in the hippocampus of injured versus sham mice, and in PS1/APP mice there was a coincidental increase compared to wild type littermates at all time points. This study demonstrates some overlapping and diverse phospholipid profiles in rmTBI and AD models. Future studies are required to corroborate our findings in human post-mortem tissue. Investigation of secondary mechanisms triggered by aberrant downstream alterations in bioactive metabolites of these phospholipids, and their modulation at the appropriate time-windows of opportunity could help facilitate development of novel therapeutic strategies to ameliorate the neurodegenerative consequences of rmTBI or the potential triggering of AD pathogenesis by rmTBI.	[Ojo, Joseph O.; Algamal, Moustafa; Leary, Paige; Abdullah, Laila; Mouzon, Benoit; Evans, James E.; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Ojo, Joseph O.; Abdullah, Laila; Mouzon, Benoit; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Ojo, Joseph O.; Algamal, Moustafa; Abdullah, Laila; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England	Ojo, JO; Crawford, F (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Ojo, JO; Crawford, F (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Ojo, JO; Crawford, F (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England.	jojo@roskampinstitute.org; fcrawford@roskampinstitute.org		Algamal, Moustafa/0000-0002-6215-0122	CDMRP awardUnited States Department of Defense [DOD/W81XWH-13-1-0253]; Roskamp Foundation	This project was supported by the CDMRP award to FC DOD/W81XWH-13-1-0253 and by the Roskamp Foundation. The content presented do not express the views of the Department of Defense or Veteran Affairs or the United States Government.	Abdullah L, 2017, AGING-US, V9, P964, DOI 10.18632/aging.101203; Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bailes JE, 2014, MIL MED, V179, P112, DOI 10.7205/MILMED-D-14-00139; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bandaru VVR, 2009, NEUROBIOL AGING, V30, P591, DOI 10.1016/j.neurobiolaging.2007.07.024; Barnard ND, 2014, NEUROBIOL AGING, V35, pS65, DOI 10.1016/j.neurobiolaging.2014.02.030; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Beydoun MA, 2007, AM J CLIN NUTR, V85, P1103; Carrillo C, 2012, NUTR HOSP, V27, P978, DOI 10.3305/nh.2012.27.4.5783; Cherubini A, 2007, J GERONTOL A-BIOL, V62, P1120, DOI 10.1093/gerona/62.10.1120; Conquer JA, 2000, LIPIDS, V35, P1305, DOI 10.1007/s11745-000-0646-3; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freeman LR, 2012, J CEREBR BLOOD F MET, V32, P643, DOI 10.1038/jcbfm.2011.168; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Heude B, 2003, AM J CLIN NUTR, V77, P803; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hsu TM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00088; Igarashi M, 2011, J ALZHEIMERS DIS, V24, P507, DOI 10.3233/JAD-2011-101608; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Jumpsen J, 1997, J NUTR, V127, P724; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Kosicek M, 2012, NEUROSCI LETT, V516, P302, DOI 10.1016/j.neulet.2012.04.019; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lohner K, 1996, CHEM PHYS LIPIDS, V81, P167, DOI 10.1016/0009-3084(96)02580-7; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Medina JM, 2002, J PHYSIOL-PARIS, V96, P265, DOI 10.1016/S0928-4257(02)00015-3; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mulder C, 2003, J NEURAL TRANSM, V110, P949, DOI 10.1007/s00702-003-0007-9; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pallebage-Gamarallage MMS, 2010, ATHEROSCLEROSIS SUPP, V11, P49, DOI 10.1016/j.atherosclerosissup.2010.04.002; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; SPECTOR R, 1988, NEUROCHEM RES, V13, P785, DOI 10.1007/BF00971603; SPECTOR R, 1988, J NEUROCHEM, V50, P639, DOI 10.1111/j.1471-4159.1988.tb02958.x; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; Takechi R, 2010, PROG LIPID RES, V49, P159, DOI 10.1016/j.plipres.2009.10.004; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; Walter A, 2004, NEUROBIOL AGING, V25, P1299, DOI 10.1016/j.neurobiolaging.2004.02.016; Wengenack TM, 2000, NEUROSCIENCE, V101, P939, DOI 10.1016/S0306-4522(00)00388-2; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130	79	13	13	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 19	2019	13								103	10.3389/fnins.2019.00103			17	Neurosciences	Neurosciences & Neurology	HM0RH	WOS:000459154200001	30837829	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Kramer, AH; Couillard, PL; Zygun, DA; Aries, MJ; Gallagher, CN				Kramer, Andreas H.; Couillard, Philippe L.; Zygun, David A.; Aries, Marcel J.; Gallagher, Clare N.			Continuous Assessment of "Optimal" Cerebral Perfusion Pressure in Traumatic Brain Injury: A Cohort Study of Feasibility, Reliability, and Relation to Outcome	NEUROCRITICAL CARE			English	Article						Autoregulation; Cerebral blood flow (CBF); Cerebral perfusion pressure (CPP); Inter-observer agreement; Pressure reactivity index (PRx); Traumatic brain injury (TBI)	CEREBROVASCULAR AUTOREGULATION; INTRACRANIAL-PRESSURE; THRESHOLDS; REACTIVITY; SCALE; MANAGEMENT; AGREEMENT; DURATION; INSULTS	BackgroundGuidelines recommend maintaining cerebral perfusion pressure (CPP) between 60 and 70mmHg in patients with severe traumatic brain injury (TBI), but acknowledge that optimal CPP may vary depending on cerebral blood flow autoregulation. Previous retrospective studies suggest that targeting CPP where the pressure reactivity index (PRx) is optimized (CPPopt) may be associated with improved recovery.MethodsWe performed a retrospective cohort study involving TBI patients who underwent PRx monitoring to assess issues of feasibility relevant to future interventional studies: (1) the proportion of time that CPPopt could be detected; (2) inter-observer variability in CPPopt determination; and (3) agreement between manual and automated CPPopt estimates. CPPopt was determined for consecutive 6-h epochs during the first week following TBI. Sixty PRx-CPP tracings were randomly selected and independently reviewed by six critical care professionals. We also assessed whether greater deviation between actual CPP and CPPopt (CPP) was associated with poor outcomes using multivariable models.ResultsIn 71 patients, CPPopt could be manually determined in 985 of 1173 (84%) epochs. Inter-observer agreement for detectability was moderate (kappa 0.46, 0.23-0.68). In cases where there was consensus that it could be determined, agreement for the specific CPPopt value was excellent (weighted kappa 0.96, 0.91-1.00). Automated CPPopt was within 5mmHg of manually determined CPPopt in 93% of epochs. Lower PRx was predictive of better recovery, but there was no association between CPP and outcome. Percentage time spent below CPPopt increased over time among patients with poor outcomes (p=0.03). This effect was magnified in patients with impaired autoregulation (defined as PRx>0.2; p=0.003).ConclusionProspective interventional clinical trials with regular determination of CPPopt and corresponding adjustment of CPP goals are feasible, but measures to maximize consistency in CPPopt determination are necessary. Although we could not confirm a clear association between CPP and outcome, time spent below CPPopt may be particularly harmful, especially when autoregulation is impaired.	[Kramer, Andreas H.; Couillard, Philippe L.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kramer, Andreas H.; Couillard, Philippe L.; Gallagher, Clare N.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Zygun, David A.] Univ Alberta, Dept Crit Care Med, Edmonton, AB, Canada; [Aries, Marcel J.] Univ Maastricht, Dept Intens Care, Maastricht, Netherlands	Kramer, AH (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	Andreas.Kramer@AlbertaHealthServices.ca			Department of Clinical Neurosciences at the University of Calgary; Alberta Health Services	This study was performed without any dedicated funding. One of the authors (CG) received funding from the Department of Clinical Neurosciences at the University of Calgary for the purchase of ICM+ licenses and equipment. Alberta Health Services provided information technology support.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Carney N, GUIDELINES MANAGEMEN; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Johnson U, 2014, NEUROCRIT CARE, V21, P259, DOI 10.1007/s12028-014-9954-2; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Needham E, 2016, J NEUROTRAUM, V33, P1, DOI [10.1089/neu.2015.3905, DOI 10.1089/NEU.2015.3905]; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pesek M, 2014, NEUROSURGERY, V75, P163, DOI 10.1227/NEU.0000000000000367; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steijn R, 2017, MINERVA ANESTHESIOL; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Thiara S, 2018, CAN J NEUROL SCI; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zeiler F.A., 2017, J NEUROTRAUM, DOI DOI 10.1089/neu.2017.5364	37	13	13	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					51	61		10.1007/s12028-018-0570-4			11	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700007	29987688				2021-06-18	
J	Skrifvars, MB; Moore, E; Martensson, J; Bailey, M; French, C; Presneill, J; Nichol, A; Little, L; Duranteau, J; Huet, O; Haddad, S; Arabi, Y; McArthur, C; Cooper, DJ; Bellomo, R				Skrifvars, Markus B.; Moore, Elizabeth; Martensson, Johan; Bailey, Michael; French, Craig; Presneill, Jeffrey; Nichol, Alistair; Little, Lorraine; Duranteau, Jacques; Huet, Olivier; Haddad, Samir; Arabi, Yaseen; McArthur, Colin; Cooper, David J.; Bellomo, Rinaldo		EPO-TBI Investigators Anzics Clin	Erythropoietin in traumatic brain injury associated acute kidney injury: A randomized controlled trial	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						acute kidney injury; creatinine; critical care; erythropoietin; renal insufficiency; traumatic brain injury	THERAPEUTIC HYPOTHERMIA; RENAL-FUNCTION; EPIDEMIOLOGY; PREVENTION; HYPOXIA; COSTS; COMA; EPO	Background Acute kidney injury (AKI) in traumatic brain injury (TBI) is poorly understood and it is unknown if it can be attenuated using erythropoietin (EPO). Methods Pre-planned analysis of patients included in the EPO-TBI (ClinicalTrials.gov NCT00987454) trial who were randomized to weekly EPO (40 000 units) or placebo (0.9% sodium chloride) subcutaneously up to three doses or until intensive care unit (ICU) discharge. Creatinine levels and urinary output (up to 7 days) were categorized according to the Kidney Disease Improving Global Outcome (KDIGO) classification. Severity of TBI was categorized with the International Mission for Prognosis and Analysis of Clinical Trials in TBI. Results Of 3348 screened patients, 606 were randomized and 603 were analyzed. Of these, 82 (14%) patients developed AKI according to KDIGO (60 [10%] with KDIGO 1, 11 [2%] patients with KDIGO 2, and 11 [2%] patients with KDIGO 3). Male gender (hazard ratio [HR] 4.0 95% confidence interval [CI] 1.4-11.2, P = 0.008) and severity of TBI (HR 1.3 95% CI 1.1-1.4, P < 0.001 for each 10% increase in risk of poor 6 month outcome) predicted time to AKI. KDIGO stage 1 (HR 8.8 95% CI 4.5-17, P < 0.001), KDIGO stage 2 (HR 13.2 95% CI 3.9-45.2, P < 0.001) and KDIGO stage 3 (HR 11.7 95% CI 3.5-39.7, P < 0.005) predicted time to mortality. EPO did not influence time to AKI (HR 1.08 95% CI 0.7-1.67, P = 0.73) or creatinine levels during ICU stay (P = 0.09). Conclusions Acute kidney injury is more common in male patients and those with severe compared to moderate TBI and appears associated with worse outcome. EPO does not prevent AKI after TBI.	[Skrifvars, Markus B.; Moore, Elizabeth; Bailey, Michael; Nichol, Alistair; Little, Lorraine; Cooper, David J.; Bellomo, Rinaldo] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Skrifvars, Markus B.] Helsinki Univ Hosp, Div Intens Care, Dept Anaesthesiol Intens Care & Pain Med, Helsinki, Finland; [Skrifvars, Markus B.] Univ Helsinki, PB 340, Helsinki 00029, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Emergency Med & Serv, PB 340, Helsinki 00029, Finland; [Martensson, Johan] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anaesthesia & Intens Care, Stockholm, Sweden; [French, Craig] Western Hlth, Dept Intens Care, Melbourne, Vic, Australia; [Presneill, Jeffrey] Royal Melbourne Hosp, Dept Intens Care, Melbourne, Vic, Australia; [Nichol, Alistair] Univ Coll Dublin, Sch Med & Med Sci, Dublin, Ireland; [Nichol, Alistair] St Vincents Univ Hosp, Dublin, Ireland; [Nichol, Alistair; Cooper, David J.] Alfred, Dept Intens Care & Hyperbar Med, Melbourne, Vic, Australia; [Duranteau, Jacques] Univ Paris Sud XI, Dept Anaesthesia & Intens Care, HUPS, Orsay, France; [Huet, Olivier] Univ Bretagne Occidental, Dept Anesthesie Reanimat, Hop Cavale Blanche, CHRU Brest, Blvd Tanguy Prigent, Brest, France; [Haddad, Samir; Arabi, Yaseen] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Haddad, Samir; Arabi, Yaseen] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Haddad, Samir] G&S Med Associates, Urgent Care, Paterson, NJ USA; [McArthur, Colin] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Bellomo, Rinaldo] Austin Hlth, Dept Intens Care, Melbourne, Vic, Australia	Skrifvars, MB (corresponding author), Univ Helsinki, PB 340, Helsinki 00029, Finland.; Skrifvars, MB (corresponding author), Helsinki Univ Hosp, Dept Emergency Med & Serv, PB 340, Helsinki 00029, Finland.	markus.skrifvars@hus.fi	French, Craig/ABF-5087-2020; Cooper, D. James/G-7961-2013; Arabi, Yaseen/ABF-3316-2020	French, Craig/0000-0003-1363-9711; Cooper, D. James/0000-0002-5872-9051; Arabi, Yaseen/0000-0001-5735-6241; Nichol, Alistair/0000-0002-4689-1238	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [545902]; Transport Accident Commission of Victoria [D162]; Medicinska Understodsforeningen Liv och Halsa; Finska Lakaresallskapet; Svenska Kulturfonden; Health Research Board of Ireland	EPO-TBI was supported by grants from the National Health and Medical Research Council of Australia (grant 545902) and the Transport Accident Commission of Victoria (grant D162). Markus Skrifvars has received personal research funding from Medicinska Understodsforeningen Liv och Halsa, Finska Lakaresallskapet and Svenska Kulturfonden. Alistair Nichol has received support from the Health Research Board of Ireland.	Ala-Kokko T, 2006, ACTA ANAESTH SCAND, V50, P828, DOI 10.1111/j.1399-6576.2006.01082.x; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Brandt MM, 2007, J TRAUMA, V62, P1362, DOI 10.1097/TA.0b013e318047983d; BROMAN H, 1995, ACTA PHYSIOL SCAND, V153, P179; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Dardashti A, 2014, ANESTHESIOLOGY, V121, P582, DOI 10.1097/ALN.0000000000000321; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; de Seigneux S, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-132; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Elliott S, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0438-4; Eriksson M, 2015, J TRAUMA ACUTE CARE, V79, P407, DOI 10.1097/TA.0000000000000727; Figueroa YG, 2002, EXP HEMATOL, V30, P1419, DOI 10.1016/S0301-472X(02)00934-7; Gomes E, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-1; Hafer C, 2012, KIDNEY INT, V81, P314, DOI 10.1038/ki.2011.349; Kang DH, 2005, KIDNEY INT, V67, P1683, DOI 10.1111/j.1523-1755.2005.00264.x; Kim JH, 2013, CRIT CARE, V17, DOI 10.1186/cc13081; Kiris I, 2008, J SURG RES, V149, P206, DOI 10.1016/j.jss.2007.12.752; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu KD, 2017, INTENS CARE MED, V43, P898, DOI 10.1007/s00134-017-4810-4; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Matejkova S, 2013, INTENS CARE MED, V39, P497, DOI 10.1007/s00134-012-2766-y; Moore EM, 2011, ANAESTH INTENS CARE, V39, P356, DOI 10.1177/0310057X1103900306; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0528-6; Presneill Jeffrey, 2014, Trials, V15, P501, DOI 10.1186/1745-6215-15-501; Raj R, 2018, CRIT CARE MED, V46, pE302, DOI 10.1097/CCM.0000000000002959; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Siew ED, 2017, AM J RESP CRIT CARE, V195, P1597, DOI 10.1164/rccm.201603-0476OC; Simon F, 2008, CRIT CARE MED, V36, P2143, DOI 10.1097/CCM.0b013e31817d7912; Song YR, 2009, AM J NEPHROL, V30, P253, DOI 10.1159/000223229; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Susantitaphong P, 2012, RESUSCITATION, V83, P159, DOI 10.1016/j.resuscitation.2011.09.023; VAZIRI ND, 1994, AM J PHYSIOL, V266, pF360; Wang GM, 2012, EUR J PHARMACOL, V689, P154, DOI 10.1016/j.ejphar.2012.05.027; Zeiner A, 2004, RESUSCITATION, V60, P253, DOI 10.1016/j.resuscitation.2003.11.006; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	37	13	13	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	FEB	2019	63	2					200	207		10.1111/aas.13244			8	Anesthesiology	Anesthesiology	HG2SP	WOS:000454814700009	30132785	Green Published			2021-06-18	
J	Wang, HHE; Campbell-Sills, L; Kessler, RC; Sun, XY; Heeringa, SG; Nock, MK; Ursano, RJ; Jain, S; Stein, MB				Wang, Hohui E.; Campbell-Sills, Laura; Kessler, Ronald C.; Sun, Xiaoying; Heeringa, Steven G.; Nock, Matthew K.; Ursano, Robert J.; Jain, Sonia; Stein, Murray B.			Pre-deployment insomnia is associated with post-deployment post-traumatic stress disorder and suicidal ideation in US Army soldiers	SLEEP			English	Article						insomnia; sleep disturbance; suicide; PTSD; military personnel; deployment; stress	TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCES; ASSESS RISK; PSYCHIATRIC MORBIDITY; PTSD SYMPTOMS; MILITARY; RESILIENCE; NIGHTMARES; IMPACT; PREDICTORS	Study Objectives: Insomnia is prevalent among military personnel and may increase risk of mental disorders and suicidal ideation. This study examined associations of pre-deployment insomnia with post-deployment post-traumatic stress disorder (PTSD) and suicidal ideation among US Army soldiers. Methods: Soldiers from three Brigade Combat Teams completed surveys 1-2 months before deploying to Afghanistan in 2012 (T0), on return from deployment (T1), 3 months later (T2), and 9 months later (T3). Logistic regression was performed to estimate associations of pre-deployment (T0) insomnia with post-deployment (T2 or T3) PTSD and suicidal ideation among respondents who completed surveys at all waves (n = 4645). A hierarchy of models incorporated, increasing controls for pre-deployment risk factors and deployment experiences. Results: Pre-deployment insomnia was associated with increased risk of post-deployment PTSD (adjusted odds ratio [AOR] = 3.14, 95% confidence interval [CI] = 2.58% to 3.82%, p<.0005) and suicidal ideation (AOR = 2.78, 95% CI = 2.07% to 3.74%, p<.0005) in models adjusting for sociodemographic characteristics and prior deployment history. Adjustment for other pre-deployment risk factors and deployment experiences attenuated these associations; however, insomnia remained significantly associated with post-deployment PTSD (AOR = 1.50, 95% CI = 1.19% to 1.89%, p = .001) and suicidal ideation (AOR = 1.43, 95% CI = 1.04% to 1.95%, p = .027). Subgroup models showed that pre-deployment insomnia was associated with incident PTSD (AOR = 1.55, 95% CI = 1.17% to 2.07%, p = .003) and suicidal ideation (AOR = 1.67, 95% CI = 1.16% to 2.40%, p = .006) among soldiers with no pre-deployment history of these problems. Conclusions: Pre-deployment insomnia contributed to prediction of post-deployment PTSD and suicidal ideation in Army soldiers, suggesting that detection of insomnia could facilitate targeting of risk mitigation programs. Future studies should investigate whether treatment of insomnia helps prevent PTSD and suicidal ideation among deployed service members.	[Wang, Hohui E.; Campbell-Sills, Laura; Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Sun, Xiaoying; Jain, Sonia; Stein, Murray B.] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Heeringa, Steven G.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Nock, Matthew K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA	Wang, HHE (corresponding author), Univ Calif San Francisco, Dept Psychiat, Langley Porter Psychiat Hosp & Clin, 401 Parnassus Ave, San Francisco, CA 94143 USA.	Hohui.Wang@ucsf.edu	Wang, Hohui/AAF-5592-2020; Ursano, Robert/ABE-6533-2020; Nock, Matthew/AAE-8330-2019	Wang, Hohui E./0000-0001-9486-8473	Department of the Army; US Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH) [U01MH087981]; Department of Defense (USUHS grant)United States Department of Defense [HU0001-15-2-0004]	Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement number U01MH087981 (2009-2015) with the US Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/NIMH). Subsequently, STARRS-LS was sponsored and funded by the Department of Defense (USUHS grant number HU0001-15-2-0004). The contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of Health and Human Services, NIMH, the Department of the Army, the Department of Veterans Affairs, or the Department of Defense.	Association AP, 2013, DIAGN STAT MAN MENT; Babson KA, 2010, J ANXIETY DISORD, V24, P1, DOI 10.1016/j.janxdis.2009.08.002; Bernert Rebecca A, 2007, Neuropsychiatr Dis Treat, V3, P735; Bernert RA, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0554-4; Bjorngaard JH, 2011, SLEEP, V34, P1155, DOI 10.5665/SLEEP.1228; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Breslau N, 2004, ARCH GEN PSYCHIAT, V61, P508, DOI 10.1001/archpsyc.61.5.508; Brown CA, 2013, SLEEP DISORD, V2013; Caldwell JA, 2017, J SLEEP RES, V26, P665, DOI 10.1111/jsr.12543; Campbell-Sills L, 2018, PSYCHOL MED, V48, P1624, DOI 10.1017/S0033291717003105; Cox RC, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0773-y; DeViva Jason C, 2004, Behav Sleep Med, V2, P162, DOI 10.1207/s15402010bsm0203_5; EATON WW, 1995, AM J PSYCHIAT, V152, P967; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Feusner J, 2001, PSYCHIAT RES, V104, P109, DOI 10.1016/S0165-1781(01)00296-7; Finan PH, 2013, SLEEP MED REV, V17, P173, DOI 10.1016/j.smrv.2012.03.003; Fisher K, 2017, ARCH SUICIDE RES, V21, P531, DOI 10.1080/13811118.2016.1193077; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Germain A, 2012, J PSYCHOSOM RES, V72, P89, DOI 10.1016/j.jpsychores.2011.11.010; Gilbert KS, 2015, CLIN PSYCHOL REV, V40, P195, DOI 10.1016/j.cpr.2015.05.008; Goldstein TR, 2008, J CONSULT CLIN PSYCH, V76, P84, DOI 10.1037/0022-006X.76.1.84; Hines LA, 2014, CAN J PSYCHIAT, V59, P468, DOI 10.1177/070674371405900903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hom MA, 2016, J PSYCHIATR RES, V79, P108, DOI 10.1016/j.jpsychires.2016.05.008; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Keilp JG, 2013, PSYCHOL MED, V43, P539, DOI 10.1017/S0033291712001419; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2013, INT J METH PSYCH RES, V22, P267, DOI 10.1002/mpr.1401; Kessler RC, 2013, INT J METH PSYCH RES, V22, P303, DOI 10.1002/mpr.1398; Kessler RC, 2013, INT J METH PSYCH RES, V22, P288, DOI 10.1002/mpr.1399; Kessler RC, 2010, SLEEP, V33, P1539, DOI 10.1093/sleep/33.11.1539; Kodaka M, 2014, SLEEP MED, V15, P430, DOI 10.1016/j.sleep.2013.11.789; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1111, DOI 10.1001/jama.2009.342; Lamarche LJ, 2007, J CLIN PSYCHIAT, V68, P1257, DOI 10.4088/JCP.v68n0813; Leger D, 2002, SLEEP, V25, P625; Levin-Rector A, 2018, J TRAUMA STRESS, V31, P568, DOI 10.1002/jts.22316; Li SX, 2010, J CLIN PSYCHIAT, V71, P1440, DOI 10.4088/JCP.09m05661gry; McCall WV, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0389-9; McCall WV, 2013, J CLIN SLEEP MED, V9, P135, DOI 10.5664/jcsm.2408; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; MELLMAN TA, 1995, AM J PSYCHIAT, V152, P1659; Mellman TA, 2007, J TRAUMA STRESS, V20, P893, DOI 10.1002/jts.20246; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Nadorff MR, 2013, J GERONTOL B-PSYCHOL, V68, P145, DOI 10.1093/geronb/gbs061; Nadorff MR, 2011, SLEEP, V34, P93, DOI 10.1093/sleep/34.1.93; Neylan TC, 2010, BIOL PSYCHIAT, V68, P494, DOI 10.1016/j.biopsych.2010.04.035; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Pigeon WR, 2012, AM J PUBLIC HEALTH, V102, pS93, DOI 10.2105/AJPH.2011.300470; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Reist C, 2017, J TRAUMA STRESS, V30, P186, DOI 10.1002/jts.22168; Ressler KJ, 2014, PSYCHIATRY, V77, P120, DOI 10.1521/psyc.2014.77.2.120; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Richardson JD, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1372-5; Riemann D, 2003, J AFFECT DISORDERS, V76, P255, DOI 10.1016/S0165-0327(02)00072-1; Roth T, 2011, BIOL PSYCHIAT, V69, P592, DOI 10.1016/j.biopsych.2010.10.023; Sandman N, 2017, SCI REP-UK, V7, DOI 10.1038/srep44756; Sharafkhaneh A, 2005, SLEEP, V28, P1405, DOI 10.1093/sleep/28.11.1405; Sjostrom N, 2009, PSYCHIAT RES, V170, P208, DOI 10.1016/j.psychres.2008.09.006; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tanskanen A, 2001, SLEEP, V24, P844; Team RC, 2016, R LANG ENV STAT COMP; Troxel Wendy M, 2015, Rand Health Q, V5, P19; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; van Liempt S, 2013, DEPRESS ANXIETY, V30, P469, DOI 10.1002/da.22054; Wells TS, 2011, INT REV PSYCHIATR, V23, P144, DOI 10.3109/09540261.2011.558833; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Woznica AA, 2015, SLEEP MED REV, V22, P37, DOI 10.1016/j.smrv.2014.10.004; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845	72	13	14	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0161-8105	1550-9109		SLEEP	Sleep	FEB	2019	42	2							zsy229	10.1093/sleep/zsy229			9	Clinical Neurology; Neurosciences	Neurosciences & Neurology	HM3BE	WOS:000459346600020	30508139	Green Published, Bronze			2021-06-18	
J	Xia, ZY; Alphonse, VD; Trigg, DB; Harrigan, TP; Paulson, JM; Luong, QT; Lloyd, EP; Barbee, MH; Craig, SL				Xia, Zhiyong; Alphonse, Vanessa D.; Trigg, Doug B.; Harrigan, Tim P.; Paulson, Jeff M.; Luong, Quang T.; Lloyd, Evan P.; Barbee, Meredith H.; Craig, Stephen L.			'Seeing' Strain in Soft Materials	MOLECULES			English	Article						spiropyran; impact strain; poly(dimethyl siloxane); mechanophore; strain sensing	COVALENT BONDS; ACTIVATION	Several technologies can be used for measuring strains of soft materials under high rate impact conditions. These technologies include high speed tensile test, split Hopkinson pressure bar test, digital image correlation and high speed X-ray imaging. However, none of these existing technologies can produce a continuous 3D spatial strain distribution in the test specimen. Here we report a novel passive strain sensor based on poly(dimethyl siloxane) (PDMS) elastomer with covalently incorporated spiropyran (SP) mechanophore to measure impact induced strains. We have shown that the incorporation of SP into PDMS at 0.25 wt% level can adequately measure impact strains via color change under a high strain rate of 1500 s(-1) within a fraction of a millisecond. Further, the color change is fully reversible and thus can be used repeatedly. This technology has a high potential to be used for quantifying brain strain for traumatic brain injury applications.	[Xia, Zhiyong; Alphonse, Vanessa D.; Trigg, Doug B.; Harrigan, Tim P.; Paulson, Jeff M.; Luong, Quang T.; Lloyd, Evan P.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Barbee, Meredith H.; Craig, Stephen L.] Duke Univ, Dept Chem, Durham, NC 27708 USA	Xia, ZY (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	Zhiyong.Xia@jhuapl.edu; vanessa.alphonse@jhuapl.edu; Doug.trigg@jhuapl.edu; Tim.harrigan@jhuapl.edu; jeff.paulson@jhuapl.edu; quang.luong@jhuapl.edu; Evan.lloyd@jhuapl.edu; Meredith.barbee@duke.edu; Stephen.craig@jhuapl.edu	Craig, Stephen L/D-3484-2011	Craig, Stephen L/0000-0002-8810-0369; Lloyd, Evan/0000-0001-6984-7400; Barbee, Meredith/0000-0002-7324-2866	Independent Research and Development Fund (IRAD) from the National Health Mission Area of the Johns Hopkins University/Applied Physics Laboratory - US Army Research Laboratory; Army Research Office [W911NF-15-0143]	This research was supported by the Independent Research and Development Fund (IRAD) from the National Health Mission Area of the Johns Hopkins University/Applied Physics Laboratory. The SP synthesis was partially funded by the US Army Research Laboratory and the Army Research Office under Grant W911NF-15-0143 to S.L.C.	Bauer W.H., 1977, ACTA CRSYT, V33, P2615, DOI [10.1107/S0567740877009029, DOI 10.1107/S0567740877009029]; Beberniss TJ, 2017, MECH SYST SIGNAL PR, V86, P35, DOI 10.1016/j.ymssp.2016.04.014; Bertelson R.C., 2002, ORGANIC PHOTOCHROMIC; Chanda A, 2018, MECH ADV MATER STRUC, V25, P1335, DOI 10.1080/15376494.2016.1143749; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Flory P.J., 1989, STAT MECH CHAIN MOL, P16; Gossweiler GR, 2015, J AM CHEM SOC, V137, P6148, DOI 10.1021/jacs.5b02492; Gossweiler GR, 2014, ACS MACRO LETT, V3, P216, DOI 10.1021/mz500031q; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Klukovich HM, 2013, NAT CHEM, V5, P110, DOI [10.1038/NCHEM.1540, 10.1038/nchem.1540]; Lane B, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8030371; Lee CK, 2010, J AM CHEM SOC, V132, P16107, DOI 10.1021/ja106332g; LIN S, 1997, P CTR DIS CONTR WAYN, P27; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Lukyanov BS, 2005, CHEM HETEROCYCL COMP, V41, P281, DOI DOI 10.1007/S10593-005-0148-X; Olsen Cody S, 2016, Inj Epidemiol, V3, P8; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raisch M, 2018, ADV MATER, V30, DOI 10.1002/adma.201802813; Silberstein M.N., 2017, MECHANOCHEMISTRY MAT, P76; Treloar L.R.G., 2005, PHYS RUBBER ELASTICI, P213; Trexler MM, 2011, J MECH BEHAV BIOMED, V4, P1920, DOI 10.1016/j.jmbbm.2011.06.008; Voo L., 2016, P 13 PERS ARM SYST S; Wang JP, 2014, J AM CHEM SOC, V136, P15162, DOI 10.1021/ja509585g; Wang QM, 2015, J MECH PHYS SOLIDS, V82, P320, DOI 10.1016/j.jmps.2015.05.007; Wang ZY, 2007, EXP MECH, V47, P701, DOI 10.1007/s11340-006-9005-9; Weng SG, 2012, J APPL POLYM SCI, V124, P3765, DOI 10.1002/app.35366	26	13	13	2	16	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1420-3049		MOLECULES	Molecules	FEB 1	2019	24	3							542	10.3390/molecules24030542			10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	HL7PR	WOS:000458934000166	30717294	DOAJ Gold, Green Published			2021-06-18	
J	Zhao, Q; Yan, T; Li, LL; Chopp, M; Venkat, P; Qian, Y; Li, R; Wu, RX; Li, W; Lu, M; Zhang, TL; Chen, JL				Zhao, Qiang; Yan, Tao; Li, Linlin; Chopp, Michael; Venkat, Poornima; Qian, Yu; Li, Ran; Wu, Ruixia; Li, Wei; Lu, Mei; Zhang, Talan; Chen, Jieli			Immune Response Mediates Cardiac Dysfunction after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain-heart interaction; cardiac dysfunction; immune response; splenectomy; traumatic brain injury	HEART INTERACTION; SPLEEN; FIBROSIS; MICE; CARDIOMYOPATHY; CONTRIBUTES; MONOCYTES; IMPACT; DAMAGE; MODEL	Cardiovascular complications are common after traumatic brain injury (TBI) and are associated with increased morbidity and mortality. In this study, we investigated the possible role of the immune system in mediating cardiac dysfunction post-TBI in mice. Adult male C57BL/6J mice were subjected to a TBI model of controlled cortical impact (CCI) with or without splenectomy (n=20/group). Splenectomy was performed immediately prior to induction of TBI. Cardiac function was measured using echocardiography prior to and after TBI. Neurological and cognitive functional tests and flow cytometry and immunostaining were performed. TBI mice exhibited significant cardiac dysfunction identified by decreased left ventricular ejection fraction and fractional shortening at 3 and 30 days post-TBI. In addition, these mice exhibited significantly increased cardiomyocyte apoptosis, inflammation, and oxidative stress at 3 and 30 days post-TBI, as well as cardiac hypertrophy and fibrosis and ventricular dilatation at 30 days after TBI. TBI mice subjected to splenectomy showed significantly improved cardiac function, and decreased cardiac fibrosis, oxidative stress, cardiomyocyte apoptosis, and infiltration of immune cells and inflammatory factor expression in the heart compared with TBI control mice. TBI mice exhibited severe neurological and cognitive function deficits. However, splenectomy did not improve neurological and cognitive functional outcome after TBI compared with the TBI control group. TBI induces immune cell infiltration and inflammatory factor expression in the heart as well as cardiac dysfunction. Splenectomy decreases heart inflammation and improves cardiac function after TBI. Immune response may contribute to TBI-induced cardiac dysfunction.	[Zhao, Qiang; Yan, Tao; Li, Linlin; Qian, Yu; Li, Ran; Wu, Ruixia; Li, Wei] Tianjin Med Univ Gen Hosp, Dept Geriatr, Tianjin, Peoples R China; [Zhao, Qiang; Yan, Tao; Li, Linlin; Qian, Yu; Li, Ran; Wu, Ruixia; Li, Wei] Minist Educ & Tianjin City, Tianjin Neurol Inst, Key Lab Post Neurotrauma Neurorepair & Regenerat, Neurol, Tianjin, Peoples R China; [Chopp, Michael; Venkat, Poornima; Li, Wei; Chen, Jieli] Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA; [Lu, Mei; Zhang, Talan] Henry Ford Hosp, Dept Publ Hlth Sci, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Chen, JL (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 W Grand Blvd, Detroit, MI 48202 USA.; Yan, T (corresponding author), Tianjin Med Univ Gen Hosp, Tianjin Neurol Inst, Dept Neurol, 154 Anshan Rd, Tianjin 300052, Peoples R China.	yantao78@hotmail.com; jchen4@hfhs.org	Yan, Tao/B-2930-2012; Venkat, Poornima/ABF-1558-2020	Yan, Tao/0000-0003-3138-4468; Venkat, Poornima/0000-0001-8938-663X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81300993, 81571145, 81671144]; Tianjin Natural Science FoundationNatural Science Foundation of Tianjin [17JCZDJC36100]	This work was supported by the National Natural Science Foundation of China grant 81300993, 81571145, and 81671144 and Tianjin Natural Science Foundation Grant 17JCZDJC36100.	Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Braunersreuther V, 2013, J MOL CELL CARDIOL, V64, P99, DOI 10.1016/j.yjmcc.2013.09.007; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Chen JL, 2017, TRANSL STROKE RES, V8, P374, DOI 10.1007/s12975-017-0520-z; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; Cui X, 2016, STROKE, V47, P214, DOI 10.1161/STROKEAHA.115.011046; Cuisinier A, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0323-3; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Fujiu K, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0357-x; GALINANES M, 1992, CIRC RES, V71, P1213, DOI 10.1161/01.RES.71.5.1213; GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521; Ismahil MA, 2014, CIRC RES, V114, P266, DOI 10.1161/CIRCRESAHA.113.301720; Jiang HM, 2013, AM J HYPERTENS, V26, P1224, DOI 10.1093/ajh/hpt095; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; KOLIN A, 1984, STROKE, V15, P990, DOI 10.1161/01.STR.15.6.990; Krishnamoorthy V, 2014, INDIAN J CRIT CARE M, V18, P570, DOI 10.4103/0972-5229.140144; Larson BE, 2012, J SURG RES, V173, pE73, DOI 10.1016/j.jss.2011.09.056; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Li YL, 2012, ARTERIOSCL THROM VAS, V32, P1662, DOI 10.1161/ATVBAHA.112.249706; Liu YQ, 2015, INT J CLIN EXP PATHO, V8, P10908; Lunde IG, 2016, CELL TISSUE RES, V365, P539, DOI 10.1007/s00441-016-2454-2; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; Manea M M, 2015, J Med Life, V8, P266; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; Mewhort HEM, 2016, AM J PHYSIOL-HEART C, V310, pH716, DOI 10.1152/ajpheart.00309.2015; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Mito S, 2008, HYPERTENSION, V51, P1570, DOI 10.1161/HYPERTENSIONAHA.107.102566; Najafipour Hamid, 2014, Iranian Biomedical Journal, V18, P225, DOI 10.6091/ibj.13222.2014; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sirker A, 2011, BASIC RES CARDIOL, V106, P735, DOI 10.1007/s00395-011-0190-z; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tian YK, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0583-0; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; van der Laan AM, 2014, EUR HEART J, V35, P376, DOI 10.1093/eurheartj/eht331; Venkat P, 2017, NEUROBIOL AGING, V50, P96, DOI 10.1016/j.neurobiolaging.2016.11.002; Weledji EP, 2014, INT J SURG, V12, P113, DOI 10.1016/j.ijsu.2013.11.017; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zierath D, 2017, STROKE, V48, P497, DOI 10.1161/STROKEAHA.116.016037; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0	46	13	13	3	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					619	629		10.1089/neu.2018.5766			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000459448300012	30045672				2021-06-18	
J	Popovitz, J; Mysore, SP; Adwanikar, H				Popovitz, Juliana; Mysore, Shreesh P.; Adwanikar, Hita			Long-Term Effects of Traumatic Brain Injury on Anxiety-Like Behaviors in Mice: Behavioral and Neural Correlates	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; anxiety behaviors; basolateral amygdala; controlled cortical impact; GABA	CONTROLLED CORTICAL IMPACT; ELEVATED PLUS-MAZE; ANIMAL-MODELS; MILD; FEAR; DEFICITS; AMYGDALA; RATS; SYSTEM; MOTOR	Traumatic brain injury (TBI) has been frequently linked to affective disorders such as anxiety and depression. However, much remains to be understood about the underlying molecular and signaling mechanisms that mediate affective dysfunctions following injury. A lack of consensus in animal studies regarding what the affective sequelae of TBI are has been a major hurdle that has slowed progress, with studies reporting the full range of effects: increase, decrease, and no change in anxiety following injury. Here, we addressed this issue directly by investigating long-term anxiety outcomes in mice following a moderate to severe controlled cortical impact (CCI) injury using a battery of standard behavioral tests-the open field (OF), elevated zero maze (EZM), and elevated plus maze (EPM). Mice were tested on weeks 1, 3, 5 and 7 post-injury. Our results show that the effect of injury is time-and task-dependent. Early on-up to 3 weeks postinjury, there is an increase in anxiety-like behaviors in the elevated plus and zero mazes. However, after 5 weeks post-injury, anxiety-like behavior decreases, as measured in the OF and EZM. Immunostaining in the basolateral amygdala (BLA) for GAD, a marker for GABA, at the end of the behavioral testing showed the late decrease in anxiety behavior was correlated with upregulation of inhibition. The approach adopted in this study reveals a complex trajectory of affective outcomes following injury, and highlights the importance of comparing outcomes in different assays and time-points, to ensure that the affective consequences of injury are adequately assessed.	[Popovitz, Juliana; Mysore, Shreesh P.; Adwanikar, Hita] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Mysore, Shreesh P.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA	Adwanikar, H (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	hita@jhu.edu		Mysore, Shreesh/0000-0002-7781-8252	Johns Hopkins UniversityJohns Hopkins University	This research is funded by a start-up grant awarded to HA by Johns Hopkins University.	Adamec R, 2005, BEHAV BRAIN RES, V159, P73, DOI 10.1016/j.bbr.2004.10.004; Adwanikar H, 2011, NEUROMETHODS, V50, P237, DOI 10.1007/978-1-60761-883-6_10; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Bertoglio LJ, 2000, BEHAV BRAIN RES, V108, P197, DOI 10.1016/S0166-4328(99)00148-5; Bolivar VJ, 2000, BEHAV GENET, V30, P285, DOI 10.1023/A:1026545316455; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Bueno CH, 2005, BRAZ J MED BIOL RES, V38, P1697, DOI 10.1590/S0100-879X2005001100019; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GRIEBEL G, 1993, BEHAV PROCESS, V29, P37, DOI 10.1016/0376-6357(93)90026-N; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Logue SF, 1997, NEUROSCIENCE, V80, P1075, DOI 10.1016/S0306-4522(97)00164-4; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nemeroff Charles B, 2003, Psychopharmacol Bull, V37, P133; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; SANDERS SK, 1995, BIOL PSYCHIAT, V37, P473, DOI 10.1016/0006-3223(94)00183-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	66	13	13	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JAN 23	2019	13								6	10.3389/fnbeh.2019.00006			12	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	HI5WR	WOS:000456525400002	30728770	DOAJ Gold, Green Published			2021-06-18	
J	Baker, EW; Kinder, HA; Hutcheson, JM; Duberstein, KJJ; Platt, SR; Howerth, EW; West, FD				Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Duberstein, Kylee Jo J.; Platt, Simon R.; Howerth, Elizabeth W.; West, Franklin D.			Controlled Cortical Impact Severity Results in Graded Cellular, Tissue, and Functional Responses in a Piglet Traumatic Brain Injury Model	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; functional impairment; pig models; traumatic brain injury	GAIT CHARACTERISTICS; BALANCE ABILITIES; ANIMAL-MODEL; CHILDREN; RECOVERY; DEFICITS; PATHOPHYSIOLOGY; PLASTICITY; OUTCOMES; MOTOR	A number of pre-clinical rodent models have been developed in an effort to recapitulate injury mechanisms and identify potential therapeutics for traumatic brain injury (TBI), which is a major cause of death and long-term disability in the United States. The lack of restorative treatments for TBI, however, has led to considerable criticism of current pre-clinical therapeutic development strategies-namely, the translatability of widely used rodent models to human patients. The use of large animal models, such as the pig, with more brain anatomy and physiology comparable to humans may enhance the translational capacity of current pre-clinical animal models. The objective of this study was to develop and characterize a graded piglet TBI model with quantitative pathological features at the cellular, tissue, and functional level that become more prominent with increasing TBI severity. A graded TBI was produced by controlled cortical impact (CCI) in "toddler-aged" Landrace piglets by increasing impact velocity and/or depth of depression to 2 m/sec; 6 mm; 4 m/sec; 6 mm; 4 m/sec; 12 mm; or 4 m/sec; 15 mm, producing a range of neural injury responses that corresponded to injury severity. Quantitative gait analysis was performed pre-TBI and one, three, and seven days post-TBI, and piglets were sacrificed seven days post-TBI. Increasing impact parameters correlated to increases in lesion size with piglets that sustained a 6 mm depth of depression exhibiting significantly smaller lesions than piglets that sustained a depth of depression of 12 mm or 15 mm. Similarly, the extent of neuronal loss, astrogliosis/astrocytosis, and white matter damage became more prominent as CCI parameters were increased. These cellular and tissue-level changes correlated with motor function deficits including swing/stance time, stride velocity, and two- versus three-limb support. The piglet TBI model described here could serve as a translational platform for studying TBI sequelae across injury severities and identifying novel therapeutics.	[Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Duberstein, Kylee Jo J.; Platt, Simon R.; Howerth, Elizabeth W.; West, Franklin D.] Univ Georgia, Coll Vet Med, Regenerat Biosci Ctr, Athens, GA USA; [Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Duberstein, Kylee Jo J.; West, Franklin D.] Univ Georgia, Coll Vet Med, Dept Anim & Dairy Sci, Athens, GA USA; [Platt, Simon R.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA; [Howerth, Elizabeth W.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA	West, FD (corresponding author), Univ Georgia, Rhodes Ctr Anim & Dairy Sci, Dept Anim & Dairy Sci, Regenerat Biosci Ctr, 425 River Rd, Athens, GA 30602 USA.	westf@uga.edu		Kinder, Holly/0000-0001-8310-7265			Ahmad AS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00172; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Allen KA, 2016, J NEUROSCI NURS, V48, P15, DOI 10.1097/JNN.0000000000000176; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Beretta E, 2009, BRAIN INJURY, V23, P751, DOI 10.1080/02699050903133988; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Coppoletta JM, 1933, AM J PATHOL, V9, P55; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Duberstein KJ, 2014, PHYSIOL BEHAV, V125, P8, DOI 10.1016/j.physbeh.2013.11.004; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gaber ZB, 2011, NEURON, V69, P833, DOI 10.1016/j.neuron.2011.02.037; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kandel E.R., 2013, PRINCIPLES NEURAL SC; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2011, NEUROREHABILITATION, V29, P45, DOI 10.3233/NRE-2011-0676; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kobeissy F.H., 2015, BRAIN NEUROTRAUMA MO; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Meissner A, 2011, EUR SURG RES, V47, P141, DOI 10.1159/000330756; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Platt Simon R, 2014, Exp Transl Stroke Med, V6, P5, DOI 10.1186/2040-7378-6-5; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Sindelar B, 2017, J NEUROTRAUM, V34, P1703, DOI 10.1089/neu.2016.4648; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; THOMAS JM, 1971, GROWTH, V35, P259; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	82	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					61	73		10.1089/neu.2017.5551			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000453863000006	29916303				2021-06-18	
S	Verkhratsky, A; Ho, MS; Vardjan, N; Zorec, R; Parpura, V		Verkhratsky, A; Ho, MS; Zorec, R; Parpura, V		Verkhratsky, Alexei; Ho, Margaret S.; Vardjan, Nina; Zorec, Robert; Parpura, Vladimir			General Pathophysiology of Astroglia	NEUROGLIA IN NEURODEGENERATIVE DISEASES	Advances in Experimental Medicine and Biology		English	Article; Book Chapter						Astrocyte; Neuropathology; Alexander disease; Stroke; Psychiatric diseases; Metabolic diseases; Neurotrauma; Infectious diseases; Systemic	FIBRILLARY ACIDIC PROTEIN; ASTROCYTE GLUTAMINE-SYNTHETASE; DORSOLATERAL PREFRONTAL CORTEX; UP-REGULATES EXPRESSION; GLIAL-CELL DENSITY; REACTIVE ASTROCYTES; ELDERLY-PATIENTS; SENSORINEURAL DEAFNESS; GLUTATHIONE METABOLISM; INFLAMMATORY RESPONSES	Astroglial cells are involved in most if not in all pathologies of the brain. These cells can change the morpho-functional properties in response to pathology or innate changes of these cells can lead to pathologies. Overall pathological changes in astroglia are complex and diverse and often vary with different disease stages. We classify astrogliopathologies into reactive astrogliosis, astrodegeneration with astroglial atrophy and loss of function, and pathological remodelling of astrocytes. Such changes can occur in neurological, neurodevelopmental, metabolic and psychiatric disorders as well as in infection and toxic insults. Mutation in astrocyte-specific genes leads to specific pathologies, such as Alexander disease, which is a leukodystrophy. We discuss changes in astroglia in the pathological context and identify some molecular entities underlying pathology. These entities within astroglia may repent targets for novel therapeutic intervention in the management of brain pathologies.	[Verkhratsky, Alexei] Univ Manchester, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PT, Lancs, England; [Verkhratsky, Alexei] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark; [Verkhratsky, Alexei] Basque Fdn Sci, Achucarro Ctr Neurosci, Ikerbasque, Bilbao 48011, Spain; [Ho, Margaret S.] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Vardjan, Nina; Zorec, Robert] Univ Ljubljana, Inst Pathophysiol, Lab Neuroendocrinol Mol Cell Physiol, Fac Med, Ljubljana, Slovenia; [Vardjan, Nina; Zorec, Robert] Celica BIOMED, Ljubljana, Slovenia; [Parpura, Vladimir] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA	Verkhratsky, A (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Oxford Rd, Manchester M13 9PT, Lancs, England.; Verkhratsky, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Ctr Basic & Translat Neurosci, DK-2200 Copenhagen, Denmark.; Verkhratsky, A (corresponding author), Basque Fdn Sci, Achucarro Ctr Neurosci, Ikerbasque, Bilbao 48011, Spain.	Alexej.Verkhratsky@manchester.ac.uk	Verkhratsky, Alexei/J-4527-2013; Zorec, Robert/AAD-7180-2021; Vardjan, Nina/AAP-1496-2021; Ho, Margaret/K-6310-2017	Verkhratsky, Alexei/0000-0003-2592-9898; Zorec, Robert/0000-0002-7478-3875; Ho, Margaret/0000-0002-2387-7564	National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM123971]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM123971] Funding Source: NIH RePORTER	VP's work is supported by a grant from the National Institute of General Medical Sciences of the National Institutes of Health (R01GM123971). VP is an Honorary Professor at University of Rijeka, Croatia.	Achucarro N., 1910, B GOV HOSP INSANE, V2, P81; Alberdi E, 2013, AGING CELL, V12, P292, DOI 10.1111/acel.12054; Albrecht J, 2010, BIOCHEM PHARMACOL, V80, P1303, DOI 10.1016/j.bcp.2010.07.024; ALEXANDER WS, 1949, BRAIN, V72, P373, DOI 10.1093/brain/72.3.373; Allen JW, 2001, BRAIN RES, V894, P131, DOI 10.1016/S0006-8993(01)01988-6; Alzheimer A, 1910, HISTOLOGISCHE HISTOP, P401; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Andriezen W L, 1893, Br Med J, V2, P227; Armstrong V, 2004, EUR J PHARMACOL, V488, P111, DOI 10.1016/j.ejphar.2004.02.001; Aronica E, 2013, NEUROCHEM INT, V63, P688, DOI 10.1016/j.neuint.2013.01.028; Aronica E, 2011, EPILEPSIA, V52, P1645, DOI 10.1111/j.1528-1167.2011.03115.x; Baker DA, 2008, NEUROPSYCHOPHARMACOL, V33, P1760, DOI 10.1038/sj.npp.1301532; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Barley K, 2009, SCHIZOPHR RES, V112, P54, DOI 10.1016/j.schres.2009.04.019; Basler T, 2002, INTENS CARE MED, V28, P293, DOI 10.1007/s00134-002-1217-6; Bauer D, 2008, SCHIZOPHR RES, V104, P108, DOI 10.1016/j.schres.2008.06.012; Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Bechtholt-Gompf AJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2049, DOI 10.1038/npp.2010.74; Bedner P, 2015, BRAIN, V138, P1208, DOI 10.1093/brain/awv067; Benedetti B, 2011, J PHYSIOL-LONDON, V589, P1159, DOI 10.1113/jphysiol.2010.203224; Bernard R, 2011, MOL PSYCHIATR, V16, P634, DOI 10.1038/mp.2010.44; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; Boison D, 2015, NEUROPHARMACOLOGY, V97, P18, DOI 10.1016/j.neuropharm.2015.04.031; Bordey A, 1998, EPILEPSY RES, V32, P286, DOI 10.1016/S0920-1211(98)00059-X; Bowers MS, 2003, EUR J NEUROSCI, V17, P1273, DOI 10.1046/j.1460-9568.2003.02537.x; Bowley MP, 2002, BIOL PSYCHIAT, V52, P404, DOI 10.1016/S0006-3223(02)01404-X; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Braun K, 2009, NEUROSCIENCE, V160, P629, DOI 10.1016/j.neuroscience.2009.02.074; Breslin K, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006151; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Burnstock G, 2011, CURR TOP MED CHEM, V11, P973, DOI 10.2174/156802611795347627; Butterworth RF, 2011, HEPATOLOGY, V53, P1372, DOI 10.1002/hep.24228; Buttner Andreas, 2006, Forensic Sci Med Pathol, V2, P115, DOI 10.1385/FSMP:2:2:115; Candelario-Jalil E, 2007, J PHARMACOL EXP THER, V323, P488, DOI 10.1124/jpet.107.127035; Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951; Capuani C, 2016, EMBO MOL MED, V8, P967, DOI 10.15252/emmm.201505944; Carpentier PA, 2008, BRAIN BEHAV IMMUN, V22, P140, DOI 10.1016/j.bbi.2007.08.011; Cekanaviciute E, 2016, NEUROTHERAPEUTICS, V13, P685, DOI 10.1007/s13311-016-0477-8; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Chepkova AN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40190; Churchill MJ, 2009, ANN NEUROL, V66, P253, DOI 10.1002/ana.21697; Combes V, 2012, TRENDS PARASITOL, V28, P311, DOI 10.1016/j.pt.2012.05.008; COSTELLO JM, 1977, AUST PAEDIATR J, V13, P114; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Cullen K M, 1994, Alcohol Alcohol Suppl, V2, P253; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Czeh B, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00056; Czeh B, 2013, EUR NEUROPSYCHOPHARM, V23, P171, DOI 10.1016/j.euroneuro.2012.04.017; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; de Carvalho ACC, 1998, BRAIN RES, V790, P304, DOI 10.1016/S0006-8993(97)01523-0; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Demarque M, 2004, J NEUROSCI, V24, P3289, DOI 10.1523/JNEUROSCI.5338-03.2004; Djukic B, 2007, J NEUROSCI, V27, P11354, DOI 10.1523/JNEUROSCI.0723-07.2007; Dong L, 2015, PSYCHOPHARMACOLOGY B; Dringen R, 2000, EUR J BIOCHEM, V267, P4912, DOI 10.1046/j.1432-1327.2000.01597.x; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Eid T, 2013, NEUROCHEM INT, V63, P670, DOI 10.1016/j.neuint.2013.06.008; El-Hage N, 2011, IMMUNOL INVEST, V40, P498, DOI 10.3109/08820139.2011.561904; Esen N, 2004, J NEUROCHEM, V88, P746, DOI 10.1046/j.1471-4159.2003.02202.x; Esen N, 2007, GLIA, V55, P104, DOI 10.1002/glia.20438; Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007; FALKAI P, 1986, EUR ARCH PSY CLIN N, V236, P154, DOI 10.1007/BF00380943; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fatemi SH, 2008, SYNAPSE, V62, P501, DOI 10.1002/syn.20519; Fattore L, 2002, NEUROSCIENCE, V110, P1, DOI 10.1016/S0306-4522(01)00598-X; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Ferrer I., 2018, NEUROGLIA, V1, P126, DOI [10.3390/neuroglia1010010, DOI 10.3390/NEUROGLIA1010010]; FRANKE H, 1995, ACTA HISTOCHEM, V97, P263, DOI 10.1016/S0065-1281(11)80187-X; Friend DM, 2013, J NEUROCHEM, V125, P566, DOI 10.1111/jnc.12201; Frommann C, 1878, UNTERSUCHUNGEN GEWEB; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Giovedi S, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00094; Gleichman AJ, 2014, NEUROSCI LETT, V565, P47, DOI 10.1016/j.neulet.2013.10.055; Gorg B, 2010, GLIA, V58, P691, DOI 10.1002/glia.20955; Gray LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090620; Guilarte TR, 2003, NEUROSCIENCE, V122, P499, DOI 10.1016/S0306-4522(03)00476-7; Gunnarson E, 2005, NEUROSCIENCE, V136, P105, DOI 10.1016/j.neuroscience.2005.07.027; Haack N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105832; Haberle J, 2011, MOL GENET METAB, V103, P89, DOI 10.1016/j.ymgme.2011.02.001; Harvey BK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022135; Heming N, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1643-z; Heneka MT, 2010, BRAIN RES REV, V63, P189, DOI 10.1016/j.brainresrev.2009.11.004; Herman M, 2012, J EXP MED, V209, P1567, DOI 10.1084/jem.20111316; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hinterkeuser S, 2000, EUR J NEUROSCI, V12, P2087, DOI 10.1046/j.1460-9568.2000.00104.x; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Iovino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068408; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Kadoi Y, 1996, CRIT CARE MED, V24, P298, DOI 10.1097/00003246-199602000-00020; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Karlsen AS, 2011, CEREB CORTEX, V21, P2519, DOI 10.1093/cercor/bhr033; Karlsson RM, 2008, BIOL PSYCHIAT, V64, P810, DOI 10.1016/j.biopsych.2008.05.001; Karlsson RM, 2009, NEUROPSYCHOPHARMACOL, V34, P1578, DOI 10.1038/npp.2008.215; Kelly T, 2010, J NEUROCHEM, V115, P1123, DOI 10.1111/j.1471-4159.2010.07009.x; Kelly T, 2009, GLIA, V57, P921, DOI 10.1002/glia.20817; Kidd SA, 2014, PEDIATRICS, V134, P995, DOI 10.1542/peds.2013-4301; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Koss WA, 2012, BRAIN RES, V1466, P24, DOI 10.1016/j.brainres.2012.05.023; Krencik R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5645; Lanciotti A, 2013, TRANSL NEUROSCI, V4, P144, DOI 10.2478/s13380-013-0118-1; Larsen BR, 2014, GLIA, V62, P608, DOI 10.1002/glia.22629; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li TF, 2007, NEURON GLIA BIOL, V3, P353, DOI 10.1017/S1740925X0800015X; Li TF, 2008, NEURON GLIA BIOL, V4, P91, DOI 10.1017/S1740925X09990135; Liang CG, 2014, NEUROCHEM RES, V39, P2127, DOI 10.1007/s11064-014-1406-z; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Liu Z, 2015, AMINO ACIDS, V47, P1045, DOI 10.1007/s00726-015-1936-y; LOTHMAN EW, 1976, ELECTROEN CLIN NEURO, V41, P253, DOI 10.1016/0013-4694(76)90118-8; MAKAR TK, 1994, J NEUROCHEM, V62, P45; Marcaggi P, 2001, PROG NEUROBIOL, V64, P157, DOI 10.1016/S0301-0082(00)00043-5; Marin-Valencia I, 2010, MOL GENET METAB, V101, P9, DOI 10.1016/j.ymgme.2010.05.004; Masino SA, 2011, J CLIN INVEST, V121, P2679, DOI 10.1172/JCI57813; MCALPINE D, 1958, LANCET, V2, P629; McGinnis WR, 2004, ALTERN THER HEALTH M, V10, P22; Messing A, 2012, J NEUROSCI, V32, P5017, DOI 10.1523/JNEUROSCI.5384-11.2012; Miguel-Hidalgo J, 2009, J PSYCHOPHARMACOL, V23, P551, DOI 10.1177/0269881108091074; Miguel-Hidalgo JJ, 2005, ALCOHOL CLIN EXP RES, V29, P766, DOI 10.1097/01.ALC.0000164378.92680.FA; Miguel-Hidalgo JJ, 2006, ALCOHOL CLIN EXP RES, V30, P1845, DOI 10.1111/j.1530-0277.2006.00221.x; Miguel-Hidalgo Jose Javier, 2009, Curr Drug Abuse Rev, V2, P76; Minami T, 1998, ENVIRON TOXICOL PHAR, V5, P35, DOI 10.1016/S1382-6689(97)10004-7; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Miyajima H, 2003, NEUROPATHOLOGY, V23, P345, DOI 10.1046/j.1440-1789.2003.00521.x; Montana V, 2014, CURR NEUROPHARMACOL, V12, P324, DOI 10.2174/1570159X12666140903094700; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; Moussawi K, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00094; Nedergaard M, 1996, ADV NEUROL, V71, P75; NORENBERG MD, 1987, NEUROCHEM PATHOL, V6, P13, DOI 10.1007/BF02833599; Obara-Michlewska M, 2014, NEUROCHEM INT; Oehmichen M, 1996, ACTA NEUROPATHOL, V91, P642, DOI 10.1007/s004010050478; Ohnuma T, 2000, MOL BRAIN RES, V85, P24, DOI 10.1016/S0169-328X(00)00222-9; Oide T, 2006, NEUROPATH APPL NEURO, V32, P170, DOI 10.1111/j.1365-2990.2006.00710.x; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Orellana JA, 2014, J NEUROCHEM, V128, P752, DOI 10.1111/jnc.12492; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Parpura V, 2012, J NEUROCHEM, V121, P4, DOI 10.1111/j.1471-4159.2012.07664.x; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Piva Simone, 2015, Cardiovascular & Hematological Disorders - Drug Targets, V15, P10; Potokar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086219; Prust M, 2011, NEUROLOGY, V77, P1287, DOI 10.1212/WNL.0b013e3182309f72; Qrunfleh AM, 2013, J PSYCHOPHARMACOL, V27, P541, DOI 10.1177/0269881113482529; Quaak I, 2013, INT J ENV RES PUB HE, V10, P3384, DOI 10.3390/ijerph10083384; Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Rao VLR, 2001, J NEUROSCI, V21, P1876, DOI 10.1523/JNEUROSCI.21-06-01876.2001; Reinert LS, 2012, J CLIN INVEST, V122, P1368, DOI 10.1172/JCI60893; Reissner KJ, 2010, BEHAV PHARMACOL, V21, P514, DOI 10.1097/FBP.0b013e32833d41b2; Reissner KJ, 2014, PATHOLOGICAL POTENTI; Ren JN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00061; Rintala J, 2001, ALCOHOL, V23, P1, DOI 10.1016/S0741-8329(00)00116-6; Rodriguez JJ, 2016, CURR ALZHEIMER RES, V13, P343, DOI 10.2174/1567205013666160229112911; Rojas DC, 2014, J NEURAL TRANSM, V121, P891, DOI 10.1007/s00702-014-1216-0; Rose CF, 2013, BIOCHEM SOC T, V41, P1518, DOI 10.1042/BST20130237; Rosenbaum AI, 2011, J NEUROCHEM, V116, P789, DOI 10.1111/j.1471-4159.2010.06976.x; Rossi D, 2008, CELL DEATH DIFFER, V15, P1691, DOI 10.1038/cdd.2008.99; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Sari Y, 2013, J MOL NEUROSCI, V51, P779, DOI 10.1007/s12031-013-0064-y; Sayre NL, 2014, ADV NEUROBIOL, V11, P121, DOI 10.1007/978-3-319-08894-5_7; Schmitt A, 2009, ACTA NEUROPATHOL, V117, P395, DOI 10.1007/s00401-008-0430-y; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Schwarcz R, 2007, SCHIZOPHRENIA BULL, V33, P652, DOI 10.1093/schbul/sbm030; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Shan D, 2013, SCHIZOPHR RES, V144, P1, DOI 10.1016/j.schres.2012.12.019; Sharshar T, 2004, BRAIN PATHOL, V14, P21, DOI 10.1111/j.1750-3639.2004.tb00494.x; Shulyatnikova T, 2020, NEUROCHEM RES, V45, P83, DOI 10.1007/s11064-019-02743-2; Skowronska M, 2012, NEUROTOX RES, V21, P236, DOI 10.1007/s12640-011-9269-4; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sofroniew MV, 2014, NEUROSCIENTIST, V20, P160, DOI 10.1177/1073858413504466; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Spodenkiewicz Marta, 2016, Biology-Basel, V5, P40, DOI 10.3390/biology5040040; Steinhauser C., 2015, NEUROSCIENCE; Stenzel W, 2004, J NEUROPATH EXP NEUR, V63, P631, DOI 10.1093/jnen/63.6.631; Struys-Ponsar C, 2000, EXP NEUROL, V163, P157, DOI 10.1006/exnr.2000.7355; Suarez I, 2000, DEV NEUROSCI-BASEL, V22, P253, DOI 10.1159/000017449; Suarez-Fernandez MB, 1999, BRAIN RES, V835, P125, DOI 10.1016/S0006-8993(99)01536-X; Sun JD, 2012, NEUROPSYCHOPHARMACOL, V37, P1305, DOI 10.1038/npp.2011.319; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tang DL, 2012, IMMUNOL REV, V249, P158, DOI 10.1111/j.1600-065X.2012.01146.x; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; TRAYNELIS SF, 1988, J NEUROPHYSIOL, V59, P259; Valori CF, 2014, CELL MOL LIFE SCI, V71, P287, DOI 10.1007/s00018-013-1429-7; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Varatharaj A, 2017, BRAIN BEHAV IMMUN, V60, P1, DOI 10.1016/j.bbi.2016.03.010; Verkhratsky A., 2013, GLIAL PHYSL PATHOPHY; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Verkhratsky A, 2017, BRAIN PATHOL, V27, P629, DOI 10.1111/bpa.12537; Verkhratsky A, 2017, ADV NEUROBIOL, V15, P427, DOI 10.1007/978-3-319-57193-5_17; Verkhratsky A, 2016, PROG NEUROBIOL, V144, P188, DOI 10.1016/j.pneurobio.2015.09.003; Verkhratsky A, 2016, NEUROBIOL DIS, V85, P254, DOI 10.1016/j.nbd.2015.03.025; Verkhratsky A, 2015, NEUROSCIENTIST, V21, P552, DOI 10.1177/1073858414547132; Verkhratsky A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0595; Verkhratsky A, 2014, NEUROSCIENTIST, V20, P576, DOI 10.1177/1073858413510208; Verkhratsky A, 2013, FUTUR NEUROL, V8, P149, DOI 10.2217/fnl.12.90; Verkhratsky A, 2010, NEUROTHERAPEUTICS, V7, P399, DOI 10.1016/j.nurt.2010.05.017; Verkhratsky A, 2009, MOL NEUROBIOL, V39, P190, DOI 10.1007/s12035-009-8063-2; Virchow R, 1858, CELLULARPATHOLOGIE I; Wang F, 2015, ACTA PHYSIOL, V214, P261, DOI 10.1111/apha.12500; Wang Y, 2009, EXP NEUROL, V220, P293, DOI 10.1016/j.expneurol.2009.08.034; Weber M, 2013, BRAIN RES, V1500, P72, DOI 10.1016/j.brainres.2012.12.048; Webster MJ, 2001, BRAIN BEHAV IMMUN, V15, P388, DOI 10.1006/brbi.2001.0646; Weng YC, 2007, EXP NEUROL, V204, P433, DOI 10.1016/j.expneurol.2006.12.003; Wilson EH, 2004, INT J PARASITOL, V34, P543, DOI 10.1016/j.ijpara.2003.12.010; Wilson JX, 2000, BRAIN RES, V858, P61, DOI 10.1016/S0006-8993(99)02433-6; Windrem MS, 2017, CELL STEM CELL, V21, P195, DOI 10.1016/j.stem.2017.06.012; Xia M, 2014, SCHIZOPHR RES; Yin ZB, 2007, BRAIN RES, V1131, P1, DOI 10.1016/j.brainres.2006.10.070; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeidan-Chulia F, 2014, NEUROSCI BIOBEHAV R, V38, P160, DOI 10.1016/j.neubiorev.2013.11.008; Zhang L, 2014, NEUROCHEM RES, V39, P2407, DOI 10.1007/s11064-014-1445-5; Zhang L, 2013, NEUROREPORT, V24, P526, DOI 10.1097/WNR.0b013e32836206d1; Zhang M, 2008, J NEUROSCI RES, V86, P2848, DOI 10.1002/jnr.21730; Zhang YH, 2005, EXP NEUROL, V196, P41, DOI 10.1016/j.expneurol.2005.07.002; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004; Zorec R, 2019, NEUROSCI LETT, V689, P56, DOI 10.1016/j.neulet.2018.08.003	240	13	14	0	0	SPRINGER-VERLAG SINGAPORE PTE LTD	SINGAPORE	152 BEACH ROAD, #21-01/04 GATEWAY EAST, SINGAPORE, 189721, SINGAPORE	0065-2598	2214-8019	978-981-13-9913-8; 978-981-13-9912-1	ADV EXP MED BIOL	Adv.Exp.Med.Biol.		2019	1175						149	179		10.1007/978-981-13-9913-8_7	10.1007/978-981-13-9913-8		31	Medicine, Research & Experimental; Clinical Neurology; Neurosciences	Research & Experimental Medicine; Neurosciences & Neurology	BO4IN	WOS:000514285100008	31583588	Green Accepted			2021-06-18	
J	Estraneo, A; Loreto, V; Masotta, O; Pascarella, A; Trojano, L				Estraneo, Anna; Loreto, Vincenzo; Masotta, Orsola; Pascarella, Angelo; Trojano, Luigi			Do Medical Complications Impact Long-Term Outcomes in Prolonged Disorders of Consciousness?	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Complications; Minimally conscious state; Outcome; Rehabilitation; Vegetative state	COMA RECOVERY SCALE; TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; NATURAL-HISTORY; COMORBIDITIES; ASSOCIATION; DEFINITION; MORTALITY; RESPONSIVENESS; MULTICENTER	Objective: To investigate medical complications (MCs) occurring within 6 months postinjury in brain-injured patients with prolonged disorders of consciousness (DoC) and to evaluate impact of MC on mortality and long-term clinical outcomes. Design: Prospective observational cohort study. Setting: Rehabilitation unit for acquired DoC. Participants: Patients (N=194) with DoC (142 in vegetative state [VS], 52 in minimally conscious state; traumatic etiology 43, anoxic 69, vascular 82) consecutively admitted to a neurorehabilitation unit within 1-3 months postonset. Interventions: Not applicable. Main Outcome Measures: Mortality and improvements in clinical diagnosis and functional disability level (assessed by Coma Recovery Scale Revised [CRS-R] and Disability Rating Scale) at 12, 24, and 36 months postonset. Results: Within 6 months postinjury, 188 of 194 patients (>95%) developed at least 1 MC and 142 of them (73%) showed at least 1 severe MC. Respiratory and musculoskeletal-cutaneous MCs were the most frequent, followed by endocrino-metabolic abnormalities. Follow-up, complete in 189 of 194 patients, showed that male sex and endocrine-metabolic MCs were associated with higher risk of mortality at all timepoints. Old age, anoxic etiology, lower CRS-R total scores, and diagnosis of VS at study entry predicted no clinical and functional improvements at most timepoints; however, epilepsy predicted no improvement in diagnosis at 24 months postonset only. Conclusions: MCs are very frequent in patients with DoC within at least 6 months after brain injury, regardless of clinical diagnosis, etiology, and age. Endocrino-metabolic MCs are independent predictors of mortality at all timepoints; however,epilepsy predicted poor long-term outcome. Occurrence and severity of MCs in patients with DoC call for long-term appropriate levels of care after the postacute phase. (C) 2018 by the American Congress of Rehabilitation Medicine.	[Estraneo, Anna; Loreto, Vincenzo; Masotta, Orsola; Pascarella, Angelo; Trojano, Luigi] IRCCS Maugeri ICS, Neurorehabil Unit, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy; [Estraneo, Anna; Loreto, Vincenzo; Masotta, Orsola; Pascarella, Angelo; Trojano, Luigi] IRCCS Maugeri ICS, Res Lab Disorder Consciousness, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy; [Trojano, Luigi] Univ Campania Luigi Vanvitelli, Dept Psychol, Neuropsychol Lab, Caserta, Italy	Estraneo, A (corresponding author), IRCCS Maugeri ICS, Neurorehabil Unit, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy.; Estraneo, A (corresponding author), IRCCS Maugeri ICS, Res Lab Disorder Consciousness, Via Bagni Vecchi 1, I-82037 Telese Terme, BN, Italy.	anna.estraneo@icsmaugeri.it	Pascarella, Angelo/A-9813-2016; Trojano, Luigi/F-2396-2016; estraneo, anna/K-5409-2016	Pascarella, Angelo/0000-0002-0085-9494; Trojano, Luigi/0000-0002-0328-9642; estraneo, anna/0000-0001-6646-5626	IRCCS Maugeri ICS	Supported by IRCCS Maugeri ICS.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Baltazar GA, 2015, AM SURGEON, V81, pE61; Bargellesi S, 2018, CLIN REHABIL, V32, P255, DOI 10.1177/0269215517723161; Bernat JL, 2010, NEUROLOGY, V75, P206, DOI 10.1212/WNL.0b013e3181e8e960; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Estraneo A, 2015, EUR J PHYS REHAB MED, V51, P627; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Estraneo A, 2018, COMA DISORDERS CONSC, P17; Estraneo A, 2015, CLIN REHABIL, V29, P803, DOI 10.1177/0269215514556002; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Estraneo A, 2013, NEUROLOGY, V80, P464, DOI 10.1212/WNL.0b013e31827f0f31; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Ganesh S, 2013, ARCH PHYS MED REHAB, V94, P1899, DOI 10.1016/j.apmr.2012.12.026; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P2114, DOI 10.1016/j.apmr.2008.04.013; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Lanzillo B, 2016, EUR J PHYS REHAB MED, V52, P263; Librizzi L, 2012, ANN NEUROL, V72, P82, DOI 10.1002/ana.23567; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Menard S., 1995, APPL LOGISTIC REGRES; Montalcini T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0660-4; Moretta P, 2014, CLIN REHABIL, V28, P717, DOI 10.1177/0269215514521826; MYERS RH, 1990, CLASS MOD REGR APPL; Pagani M, 2014, J NEUROL, V261, P1144, DOI 10.1007/s00415-014-7309-8; Pascarella A, 2016, J NEUROL, V263, P2048, DOI 10.1007/s00415-016-8232-y; Pistoia F, 2015, J NEUROTRAUM, V32, P682, DOI 10.1089/neu.2014.3659; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rau CS, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121203; Romaniello C, 2016, AM J MED SCI, V351, P563, DOI 10.1016/j.amjms.2016.01.024; Sattin D, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.740; Seel RT, 2013, ARCH PHYS MED REHAB, V94, P1908, DOI 10.1016/j.apmr.2012.11.052; Steppacher I, 2014, ANN CLIN TRANSL NEUR, V1, P401, DOI 10.1002/acn3.63; Thibaut A, 2015, EUR J PHYS REHAB MED, V51, P389; Tritos NA, 2015, ENDOCR PRACT, V21, P823, DOI 10.4158/EP14567.DSCR; Wannez S, 2018, NEUROPSYCHOL REHABIL, V28, P1350, DOI 10.1080/09602011.2017.1310656; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1851, DOI 10.1016/j.apmr.2013.07.003; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027	45	13	13	2	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2018	99	12					2523	2531		10.1016/j.apmr.2018.04.024			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	HE2MW	WOS:000453113200014	29807003				2021-06-18	
J	Hsia, RY; Markowitz, AJ; Lin, F; Guo, J; Madhok, DY; Manley, GT				Hsia, Renee Y.; Markowitz, Amy J.; Lin, Feng; Guo, Joanna; Madhok, Debbie Y.; Manley, Geoffrey T.			Ten-year trends in traumatic brain injury: a retrospective cohort study of California emergency department and hospital revisits and readmissions	BMJ OPEN			English	Article							UNITED-STATES; MILD; OUTCOMES; VISITS; CARE; POPULATION; PREDICTORS; RETURN; ASSOCIATION; PREVENTION	Objective To describe visits and visit rates of adults presenting to emergency departments (EDs) with a diagnosis of traumatic brain injury (TBI). TBI is a major cause of death and disability in the USA; yet, current literature is limited because few studies examine longer-term ED revisits and hospital readmission patterns of TBI patients across a broad spectrum of injury severity, which can help inform potential unmet healthcare needs. Design We performed a retrospective cohort study. Setting We analysed non-public patient-level data from California's Office of Statewide Health Planning and Development for years 2005 to 2014. Participants We identified 1.2 million adult patients aged >= 18 years presenting to California EDs and hospitals with an index diagnosis of TBI. Primary and secondary outcome measures Our main outcomes included revisits, readmissions and mortality over time. We also examined demographics, mechanism and severity of injury and disposition at discharge. Results We found a 57.7% increase in the number of TBI ED visits, representing a 40.5% increase in TBI visit rates over the 10-year period (346-487 per 100 000 residents). During this time, there was also a 33.8% decrease in the proportion of patients admitted to the hospital. Older, publicly insured and black populations had the highest visit rates, and falls were the most common mechanism of injury (45.5% of visits). Of all patients with an index TBI visit, 40.5% of them had a revisit during the first year, with 46.7% of them seeking care at a different hospital from their initial hospital or ED visit. Additionally, of revisits within the first year, 13.4% of them resulted in hospital readmission. Conclusions The large proportion of patients with TBI who are discharged directly from the ED, along with the high rates of revisits and readmissions, suggest a role for an established system for follow-up, treatment and care of TBI.	[Hsia, Renee Y.; Guo, Joanna; Madhok, Debbie Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Markowitz, Amy J.] Univ Calif San Francisco, Brain & Spinal Injury Ctr BASIC, San Francisco, CA 94143 USA; [Lin, Feng] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Hsia, RY (corresponding author), Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA.; Hsia, RY (corresponding author), Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA.	renee.hsia@emergency.ucsf.edu		Markowitz, Amy/0000-0001-9314-2814	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1U01 NS086090-01]; One Mind; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090] Funding Source: NIH RePORTER	This study was supported in part by NIH 1U01 NS086090-01 (GTM), One Mind (GTM and AJM) and a gift from the Fisher Family.	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Canner JK, 2016, BRAIN INJURY, V30, P1570, DOI 10.1080/02699052.2016.1199898; Centers for Disease Control and Prevention, 2016, RAT TBI REL EM DEP V; Centers for Disease Control and Prevention [CDC], 2014, WISQARS COST INJ REP; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; de Koning ME, 2017, BRAIN INJURY, V31, P1102, DOI 10.1080/02699052.2017.1296193; Koning ME, 2017, J NEUROTRAUM, V34, P257, DOI 10.1089/neu.2015.4377; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Ganti L, 2015, WEST J EMERG MED, V16, P481, DOI 10.5811/westjem.2015.2.23546; Geiger AA, 2011, J SURG RES, V170, P133, DOI 10.1016/j.jss.2011.03.026; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hsia RY, 2014, J TRAUMA ACUTE CARE, V76, P1048, DOI 10.1097/TA.0000000000000166; Hsia RY, 2011, ARCH SURG-CHICAGO, V146, P585, DOI 10.1001/archsurg.2010.311; Kania K, 2016, J NEUROSURG-PEDIATR, V18, P224, DOI 10.3171/2016.1.PEDS15511; Karlsson MK, 2013, SCAND J PUBLIC HEALT, V41, P442, DOI 10.1177/1403494813483215; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lagbas C, 2013, BIOMED RES INT, V2013, P1; Linton KF, 2014, BRAIN INJURY, V28, P1076, DOI 10.3109/02699052.2014.901558; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Minen M, 2017, AM J EMERG MED, V35, P365, DOI 10.1016/j.ajem.2016.10.076; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Nikpay S, 2017, ANN EMERG MED, V70, P215, DOI 10.1016/j.annemergmed.2017.03.023; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pfortmueller CA, 2014, MINERVA MED, V105, P275; Rising KL, 2014, ACAD EMERG MED, V21, P864, DOI 10.1111/acem.12442; Sabbatini AK, 2016, JAMA-J AM MED ASSOC, V315, P663, DOI 10.1001/jama.2016.0649; Schiraldi M, 2015, J NEUROL SURG PART A, V76, P224, DOI 10.1055/s-0034-1543958; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Southerland LT, 2016, J AM GERIATR SOC, V64, P870, DOI 10.1111/jgs.14041; Staudenmayer K, 2016, J TRAUMA ACUTE CARE, V80, P412, DOI 10.1097/TA.0000000000000956; Staudenmayer KL, 2013, J AM COLL SURGEONS, V217, P569, DOI 10.1016/j.jamcollsurg.2013.06.017; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; The Henry J. Kaiser Family Foundation, 2013, HLTH COV RAC ETHN PO; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Trudel TM, 2007, J REHABIL RES DEV, V44, P1007, DOI 10.1682/JRRD.2006.12.0167; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Vashi AA, 2013, JAMA-J AM MED ASSOC, V309, P364, DOI 10.1001/jama.2012.216219; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; Yue JK, 2017, BRAIN INJURY, V31, P1820, DOI 10.1080/02699052.2017.1351000; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	54	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	DEC	2018	8	12							e022297	10.1136/bmjopen-2018-022297			11	Medicine, General & Internal	General & Internal Medicine	HG9EM	WOS:000455309300044	30552250	DOAJ Gold, Green Published			2021-06-18	
J	Walt, GS; Burris, HM; Brady, CB; Spencer, KR; Alvarez, VE; Huber, BR; Guilderson, L; Rauf, NA; Collins, D; Singh, T; Mathias, R; Averill, JG; Walker, SE; Robey, I; McKee, AC; Kowall, NW; Stein, TD				Walt, Gabriel S.; Burris, Hannah M.; Brady, Christopher B.; Spencer, Keith R.; Alvarez, Victor E.; Huber, Bertrand R.; Guilderson, Latease; Rauf, Nazifa Abdul; Collins, Derek; Singh, Tarnjit; Mathias, Rebecca; Averill, James G.; Walker, Sean E.; Robey, Ian; McKee, Ann C.; Kowall, Neil W.; Stein, Thor D.			Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Amyotrophic lateral sclerosis; Chronic traumatic encephalopathy; Military veterans; Motor neuron degeneration; Motor neuron disease; Traumatic brain injury	FUNCTIONAL RATING-SCALE; ALSFRS-R; NEUROPATHOLOGIC ASSESSMENT; DISEASE PROGRESSION; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; HEAD-INJURY; PATHOLOGY; DIAGNOSIS	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder linked to repetitive head impacts and has been associated with amyotrophic lateral sclerosis (ALS), a fatal, degenerative neuromuscular disorder. The Department of Veterans Affairs Biorepository Brain Bank (VABBB) is a tissue repository that collects antemortem disease progression data and postmortem central nervous system tissue from veterans with ALS. We set out to determine the frequency of co-morbid ALS and CTE in the VABBB cohort and to characterize the clinical, genetic, and pathological distinctions between participants with ALS only and those with both ALS and CTE (ALS+CTE). Of 155 participants, 9 (5.8%) had neuropathologically confirmed ALS+CTE. Participants with ALS+CTE were more likely to have a history of traumatic brain injury (p < 0.001), served during the first Persian Gulf War (p < 0.05), and to have more severe tau pathology within the frontal cortex and spinal cord (p < 0.05). The most common exposures to head impacts included contact sports (n = 5) and military service (n = 2). Clinically, participants with ALSthornCTE were more likely to have bulbar onset ALS (p = 0.006), behavioral changes (p = 0.002), and/or mood changes (p < 0.001). Overall, compared with ALS in isolation, comorbid ALS+CTE is associated with a history of TBI and has a distinct clinical and pathological presentation.	[Walt, Gabriel S.; Burris, Hannah M.; Brady, Christopher B.; Spencer, Keith R.; Alvarez, Victor E.; Huber, Bertrand R.; Guilderson, Latease; Rauf, Nazifa Abdul; Collins, Derek; Singh, Tarnjit; Mathias, Rebecca; McKee, Ann C.; Kowall, Neil W.; Stein, Thor D.] VA Boston Healthcare Syst, Boston, MA USA; [Huber, Bertrand R.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Brady, Christopher B.; Alvarez, Victor E.; Huber, Bertrand R.; Mathias, Rebecca; McKee, Ann C.; Kowall, Neil W.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Brady, Christopher B.] Harvard Med Sch, Brigham & Womens Hosp, Div Aging, Boston, MA USA; [Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.; Kowall, Neil W.; Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA; [Alvarez, Victor E.; Huber, Bertrand R.; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Averill, James G.; Walker, Sean E.; Robey, Ian] Southern Arizona VA Healthcare Syst, Tucson, AZ USA; [McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Stein, TD (corresponding author), VA Boston Healthcare Syst, Dept Pathol & Lab Med, 150 S Huntington Ave, Boston, MA 02130 USA.	thor.stein@va.gov	Brady, Christopher/U-6532-2019	Brady, Christopher/0000-0002-6095-6480	Department of Veterans Affairs, Veterans Health Administration, Veterans Affairs Biorepository [BX002466]; Clinical Sciences Research and Development Merit Award [I01-CX001038]; National Center for PTSD; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, R56AG057768]; National Institute of Aging Boston University AD Center [P30AG13846, 0572063345-5]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038, I01BX002466, I01BX003063] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Veterans Affairs Biorepository (BX002466); Clinical Sciences Research and Development Merit Award (I01-CX001038); National Center for PTSD; National Institute of Aging (RF1AG054156, R56AG057768); National Institute of Aging Boston University AD Center (P30AG13846; supplement 0572063345-5).	Adams JW, 2018, J NEUROPATH EXP NEUR, V77, P757, DOI 10.1093/jnen/nly065; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; Blauwendraat C, 2017, NEUROBIOL AGING, V57, DOI 10.1016/j.neurobiolaging.2017.05.009; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Brady CB, 2013, AMYOTROPH LAT SCL FR, V14, P591, DOI 10.3109/21678421.2013.822516; Brettschneider J, 2013, ANN NEUROL, V74, P20, DOI 10.1002/ana.23937; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cedarbaum JM, 1997, J NEUROL SCI, V152, pS1, DOI 10.1016/S0022-510X(97)00237-2; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Greenfield JG, 2008, GREENFIELDS NEUROPAT; Kaufmann P, 2007, AMYOTROPH LATERAL SC, V8, P42, DOI 10.1080/17482960600888156; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Kehyayan V, 2014, CAN J NEUROL SCI, V41, P246, DOI 10.1017/S0317167100016656; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kollewe K, 2008, J NEUROL SCI, V275, P69, DOI 10.1016/j.jns.2008.07.016; Labra J, 2016, J NEUROL NEUROSUR PS, V87, P628, DOI 10.1136/jnnp-2015-310998; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Moszczynski AJ, 2018, NEUROLOGY, V90, pE380, DOI 10.1212/WNL.0000000000004899; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Saberi S, 2015, NEUROL CLIN, V33, P855, DOI 10.1016/j.ncl.2015.07.012; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Strong MJ, 2017, AMYOTROPH LAT SCL FR, V18, P153, DOI 10.1080/21678421.2016.1267768; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tiryaki Ezgi, 2014, Continuum (Minneap Minn), V20, P1185, DOI 10.1212/01.CON.0000455886.14298.a4; Weisskopf MG, 2015, EPIDEMIOLOGY, V26, P831, DOI 10.1097/EDE.0000000000000376	51	13	13	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	DEC	2018	77	12					1091	1100		10.1093/jnen/nly092			10	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	HI8AA	WOS:000456676400004	30299493	Green Published			2021-06-18	
J	Vande Vyvere, T; Wilms, G; Claes, L; Leon, FM; Nieboer, D; Verheyden, J; van den Hauwe, L; Pullens, P; Maas, AIR; Parizel, PM				Vande Vyvere, Thijs; Wilms, Guido; Claes, Lene; Leon, Francisco Martin; Nieboer, Daan; Verheyden, Jan; van den Hauwe, Luc; Pullens, Pim; Maas, Andrew I. R.; Parizel, Paul M.		CENTER-TBI Investigators	Central versus Local Radiological Reading of Acute Computed Tomography Characteristics in Multi-Center Traumatic Brain Injury Research	JOURNAL OF NEUROTRAUMA			English	Article						agreement; central radiology review; traumatic brain injury	COMMON DATA ELEMENTS; PROGNOSTIC VALUE; HEAD-INJURY; CT; HEMORRHAGE; DIAGNOSIS; FEATURES; SCAN	Observer variability in local radiological reading is a major concern in large-scale multi-center traumatic brain injury (TBI) studies. A central review process has been advocated to minimize this variability. The aim of this study is to compare central with local reading of TBI imaging datasets and to investigate the added value of central review. A total of 2050 admission computed tomography (CT) scans from subjects enrolled in the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) study were analyzed for seven main CT characteristics. Kappa statistics were used to calculate agreement between central and local evaluations and a center-specific analysis was performed. The McNemar test was used to detect whether discordances were significant. Central interobserver and intra-observer agreement was calculated in a subset of patients. Good agreement was found between central and local assessment for the presence or absence of structural pathology (CT+, CT-, kappa = 0.73) and most CT characteristics (kappa = 0.62 to 0.71), except for traumatic axonal injury lesions (kappa = 0.37). Despite good kappa values, discordances were significant in four of seven CT characteristics (i.e., midline shift, contusion, traumatic subarachnoid hemorrhage, and cisternal compression; p = 0.0005). Central reviewers showed substantial to excellent interobserver and intra-observer agreement (kappa = 0.73 to kappa = 0.96), contrasted by considerable variability in local radiological reading. Compared with local evaluation, a central review process offers a more consistent radiological reading of acute CT characteristics in TBI. It generates reliable, reproducible data and should be recommended for use in multi-center TBI studies.	[Vande Vyvere, Thijs; van den Hauwe, Luc; Parizel, Paul M.] Antwerp Univ Hosp, Dept Radiol, Antwerp, Belgium; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Antwerp, Belgium; Univ Antwerp, Antwerp, Belgium; [Wilms, Guido; Claes, Lene; Leon, Francisco Martin; Verheyden, Jan; van den Hauwe, Luc] Icometrix, Res & Dev, Leuven, Belgium; [Wilms, Guido] Univ Hosp Leuven, Dept Radiol, Leuven, Belgium; [Wilms, Guido] Katholieke Univ Leuven, Leuven, Belgium; [Nieboer, Daan] Erasmus Univ, Dept Publ Hlth, Rotterdam, Netherlands; [Pullens, Pim] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium	Vande Vyvere, T (corresponding author), Poelsnepstr 11, B-9000 Ghent, Belgium.	thijs.vandevyvere@uantwerpen.be	Poca, Maria A./B-8475-2008; Sahuquillo, Juan/B-3577-2008; Badenes, Rafael/K-6628-2019; Cooper, D. James/G-7961-2013; Lanyon, Linda/L-9238-2019; Posti, Jussi P./Y-2908-2019; Radoi, Andreea/N-5613-2019; Volovici, Victor/AAZ-8901-2020; Lagares, Alfonso/B-2969-2011; Raj, Rahul/K-7693-2012; Castano-Leon, Ana M/ABF-6322-2020; Boogert, Hugo F den/B-2782-2016; Golubovic, Jagos/AAD-1270-2019; Gomez, Pedro/N-5051-2019; Maas, Andrew IR/C-5584-2013; Bartels, R.H.M.A./L-4184-2015	Poca, Maria A./0000-0002-3831-0536; Sahuquillo, Juan/0000-0003-0713-5875; Badenes, Rafael/0000-0001-7017-0150; Cooper, D. James/0000-0002-5872-9051; Lanyon, Linda/0000-0002-0885-1825; Posti, Jussi P./0000-0002-5925-5193; Radoi, Andreea/0000-0002-0677-3544; Volovici, Victor/0000-0002-5798-5360; Lagares, Alfonso/0000-0003-3996-0554; Raj, Rahul/0000-0003-4243-9591; Castano-Leon, Ana M/0000-0002-7918-5049; Golubovic, Jagos/0000-0001-5524-246X; Gomez, Pedro/0000-0002-4185-5238; Maas, Andrew IR/0000-0003-1612-1264; Wessels, lars/0000-0001-8056-9659; Rossi, Sandra/0000-0002-9963-8121; Sanchez-Porras, Renan/0000-0002-9084-8114; Bartels, R.H.M.A./0000-0002-8638-4660; Blaabjerg, Morten/0000-0001-6007-1861; Newcombe, Virginia/0000-0001-6044-9035; Dawes, Helen/0000-0002-2933-5213; Parizel, Paul M./0000-0002-0221-2854; Esser, Patrick/0000-0002-3227-0115; Kolias, Angelos/0000-0003-3992-0587; Dippel, Diederik/0000-0002-9234-3515; , Johnny/0000-0003-4138-2589; Santos, Edgar/0000-0002-8976-5549	European Commission 7th Framework program [602150]; Hannelore Kohl Foundation (Germany); non-profit organization One Mind	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project supported by the European Commission 7th Framework program (602150). Funding of additional elements has been provided by the Hannelore Kohl Foundation (Germany) and by the non-profit organization One Mind.	Azian AA, 2001, ACTA NEUROCHIR, V143, P711, DOI 10.1007/s007010170051; Bahloul M, 2004, J TRAUMA, V57, P255, DOI 10.1097/01.TA.0000083004.35231.1E; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Chesnut R M, 1991, Neurosurg Clin N Am, V2, P267; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Ford R, 2009, EUR J CANCER, V45, P268, DOI 10.1016/j.ejca.2008.10.031; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Harburg L, 2017, BRAIN INJURY, V31, P174, DOI 10.1080/02699052.2016.1225989; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Huff JS, 2014, AM J EMERG MED, V32, P606, DOI 10.1016/j.ajem.2014.03.010; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Karantanas AH, 2005, C EXTRA CASES, V29, P1; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Kisat M, 2012, J SURG RES, V173, P31, DOI 10.1016/j.jss.2011.04.059; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Marion DW, 2006, NEUROSURGERY, V58, P655; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Provenzale J, 2007, EMERG RADIOL, V14, P1, DOI 10.1007/s10140-007-0587-z; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; US Department of Health and Human Services Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER), 2004, CLIN MED GUID IND DE; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	34	13	13	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1080	1092		10.1089/neu.2018.6061		NOV 2018	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HR6CG	WOS:000450729800001	30259789				2021-06-18	
J	Cherry, JD; Mez, J; Crary, JF; Tripodis, Y; Alvarez, VE; Mahar, I; Huber, BR; Alosco, ML; Nicks, R; Abdolmohammadi, B; Kiernan, PT; Evers, L; Svirsky, S; Babcock, K; Gardner, HM; Meng, GY; Nowinski, CJ; Martin, BM; Dwyer, B; Kowall, NW; Cantu, RC; Goldstein, LE; Katz, DI; Stern, RA; Farrer, LA; McKee, AC; Stein, TD				Cherry, Jonathan D.; Mez, Jesse; Crary, John F.; Tripodis, Yorghos; Alvarez, Victor E.; Mahar, Ian; Huber, Bertrand R.; Alosco, Michael L.; Nicks, Raymond; Abdolmohammadi, Bobak; Kiernan, Patrick T.; Evers, Laney; Svirsky, Sarah; Babcock, Katharine; Gardner, Hannah M.; Meng, Gaoyuan; Nowinski, Christopher J.; Martin, Brett M.; Dwyer, Brigid; Kowall, Neil W.; Cantu, Robert C.; Goldstein, Lee E.; Katz, Douglas I.; Stern, Robert A.; Farrer, Lindsay A.; McKee, Ann C.; Stein, Thor D.			Variation in TMEM106B in chronic traumatic encephalopathy	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Chronic traumatic encephalopathy; TMEM106B; Neuroinflammation; Football; Traumatic brain injury; Tau; Genetics; TDP-43; Dementia	FRONTOTEMPORAL LOBAR DEGENERATION; CENTRAL-NERVOUS-SYSTEM; COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; CRITERIA; MICROGLIA; VARIANTS; BRAIN; NEUROPATHOLOGY	The genetic basis of chronic traumatic encephalopathy (CTE) is poorly understood. Variation in transmembrane protein 106B (TMEM106B) has been associated with enhanced neuroinflammation during aging and with TDP-43-related neurodegenerative disease, and rs3173615, a missense coding SNP in TMEM106B, has been implicated as a functional variant in these processes. Neuroinflammation and TDP-43 pathology are prominent features in CTE. The purpose of this study was to determine whether genetic variation in TMEM106B is associated with CTE risk, pathological features, and ante-mortem dementia. Eighty-six deceased male athletes with a history of participation in American football, informant-reported Caucasian, and a positive postmortem diagnosis of CTE without comorbid neurodegenerative disease were genotyped for rs3173615. The minor allele frequency (MAF=0.42) in participants with CTE did not differ from previously reported neurologically normal controls (MAF=0.43). However, in a case-only analysis among CTE cases, the minor allele was associated with reduced phosphorylated tau (ptau) pathology in the dorsolateral frontal cortex (DLFC) (AT8 density, odds ratio [OR] of increasing one quartile=0.42, 95% confidence interval [CI] 0.22-0.79, p=0.008), reduced neuroinflammation in the DLFC (CD68 density, OR of increasing one quartile=0.53, 95% CI 0.29-0.98, p=0.043), and increased synaptic protein density (=0.306, 95% CI 0.065-0.546, p=0.014). Among CTE cases, TMEM106B minor allele was also associated with reduced ante-mortem dementia (OR=0.40, 95% CI 0.16-0.99, p=0.048), but was not associated with TDP-43 pathology. All case-only models were adjusted for age at death and duration of football play. Taken together, variation in TMEM106B may have a protective effect on CTE-related outcomes.	[Cherry, Jonathan D.; Mez, Jesse; Alvarez, Victor E.; Mahar, Ian; Huber, Bertrand R.; Alosco, Michael L.; Abdolmohammadi, Bobak; Kiernan, Patrick T.; Evers, Laney; Svirsky, Sarah; Babcock, Katharine; Nowinski, Christopher J.; Kowall, Neil W.; Goldstein, Lee E.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 E Concord St,B7800, Boston, MA 02118 USA; [Cherry, Jonathan D.; Mez, Jesse; Alvarez, Victor E.; Mahar, Ian; Huber, Bertrand R.; Alosco, Michael L.; Abdolmohammadi, Bobak; Kiernan, Patrick T.; Evers, Laney; Nowinski, Christopher J.; Dwyer, Brigid; Kowall, Neil W.; Katz, Douglas I.; Stern, Robert A.; Farrer, Lindsay A.; McKee, Ann C.] Boston Univ, Dept Neurol, Sch Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; Svirsky, Sarah; Babcock, Katharine; Gardner, Hannah M.; Meng, Gaoyuan; Kowall, Neil W.; McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA; [Tripodis, Yorghos; Martin, Brett M.; Farrer, Lindsay A.] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02118 USA; [Alvarez, Victor E.; Nicks, Raymond; Svirsky, Sarah; Babcock, Katharine; Meng, Gaoyuan; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Crary, John F.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, Friedman Brain Inst, Dept Pathol,Fishberg Dept Neurosci, New York, NY 10029 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Concuss Legacy Fdn, Boston, MA 02115 USA; [Cantu, Robert C.] Boston Univ, Dept Neurosurg, Sch Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Cantu, Robert C.; Stern, Robert A.] Emerson Hosp, Dept Neurosurg, Concord, MA 01742 USA; [Goldstein, Lee E.] Boston Univ, Mol Aging & Dev Lab, Sch Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Photon Ctr, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Boston, MA 02215 USA; [Dwyer, Brigid; Katz, Douglas I.] Braintree Rehabil Hosp, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, 72 E Concord St,B7800, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, 72 E Concord St,B7800, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Kiernan, Patrick T.] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA	McKee, AC; Stein, TD (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 E Concord St,B7800, Boston, MA 02118 USA.	amckee@bu.edu; tdstein@bu.edu	, Bob/ABA-8507-2020; Dwyer, Brigid/AAI-6199-2020; Farrer, Lindsay/AAS-1035-2020	Dwyer, Brigid/0000-0002-6446-8054; Tripodis, Yorghos/0000-0003-2190-7608	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, R01NS078337, R56NS078337, U01NS093334, K23NS102399]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG046377, P30AG13846, 0572063345, RF1AG057902, RF1AG054156, R56AG057768]; US Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01CX001038]; Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; Department of Defense Peer Reviewed Alzheimer's Research Program [13267017]; Alzheimer's AssociationAlzheimer's Association [NIRG-15-362697, NIRG-305779, AARF-17-529888]; Concussion Legacy Foundation; Andlinger Family Foundation; NFL; Veterans Affairs Biorepository [BX002466]; Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01CX001135]; National Center for PTSD; National Operating Committee on Standards for Athletic Equipment; WWE; Nick and Lynn Buoniconti Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS078337, R56NS078337, U01NS086659, U01NS093334, K23NS102399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846, RF1AG054156, K23AG046377, RF1AG057902, R56AG057768] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001135, I01CX001038, I01BX002466] Funding Source: NIH RePORTER	This study received support from National Institute of Neurological Disorders and Stroke (U01NS086659, R01NS078337, R56NS078337, U01NS093334, and K23NS102399), National Institute on Aging (K23AG046377, P30AG13846 and supplement 0572063345, RF1AG057902, RF1AG054156, R56AG057768), US Department of Defense (grant W81XWH-13-2-0064), US Department of Veterans Affairs (I01CX001038), Veterans Affairs Biorepository (BX002466), Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), Department of Defense Peer Reviewed Alzheimer's Research Program (13267017), Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095, Department of Veterans Affairs CENC Award I01CX001135, National Center for PTSD, National Operating Committee on Standards for Athletic Equipment, Alzheimer's Association (NIRG-15-362697, NIRG-305779, AARF-17-529888), Nick and Lynn Buoniconti Foundation, Concussion Legacy Foundation, Andlinger Family Foundation, WWE, and NFL. The views, opinions and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy or decision, unless so designated by other official documentation.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0411-8; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; Jun G, 2016, MOL PSYCHIATR, V21, P108, DOI 10.1038/mp.2015.23; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez Jesse, 2017, Alzheimers Dement (Amst), V8, P188, DOI 10.1016/j.dadm.2017.07.002; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nelson PT, 2015, J NEUROPATH EXP NEUR, V74, P75, DOI 10.1097/NEN.0000000000000151; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Piras A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0292-9; Rhinn H, 2017, CELL SYST, V4, P404, DOI 10.1016/j.cels.2017.02.009; Rutherford NJ, 2012, NEUROLOGY, V79, P717, DOI 10.1212/WNL.0b013e318264e3ac; Satoh JI, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt247; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Suzuki H, 2016, J BIOL CHEM, V291, P21448, DOI 10.1074/jbc.M116.737171; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Walt GS, 2018, J NEUROPATH EXP NEUR, V77, P1091, DOI 10.1093/jnen/nly092	46	13	13	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	NOV 4	2018	6								115	10.1186/s40478-018-0619-9			9	Neurosciences	Neurosciences & Neurology	GZ1BK	WOS:000449100200001	30390709	DOAJ Gold, Green Published			2021-06-18	
J	Chao, HL; Anthonymuthu, TS; Kenny, EM; Amoscato, AA; Cole, LK; Hatch, GM; Ji, J; Kagan, VE; Bayir, H				Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Amoscato, Andrew A.; Cole, Laura K.; Hatch, Grant M.; Ji, Jing; Kagan, Valerian E.; Bayir, Hulya			Disentangling oxidation/hydrolysis reactions of brain mitochondrial cardiolipins in pathogenesis of traumatic injury	JCI INSIGHT			English	Article							PHOSPHOLIPASE A(2)GAMMA IPLA(2)GAMMA; BARTH-SYNDROME; CYTOCHROME-C; OXIDATIVE LIPIDOMICS; APOPTOSIS; ROTENONE; A(2); SPECIFICITY; DYSFUNCTION; DAMAGE	Mechanical injury to the brain triggers multiple biochemical events whose specific contributions to the pathogenesis define clinical manifestations and the overall outcome. Among many factors, mitochondrial injury has recently attracted much attention due to the importance of the organelle for bioenergetics as well as intra- and extracellular signaling and cell death. Assuming the essentiality of a mitochondria-unique phospholipid, cardiolipin (CL), for the structural and functional organization of mitochondria, here we applied global (phospho) lipidomics and redox lipidomics to reveal and identify CL modifications during controlled cortical impact (CCI). We revealed 2 major pathways activated in the CCI-injured brain as time-specific responses: early accumulation of oxidized CL (CLox) products was followed by hydrolytic reactions yielding monolyso-CLs (mCLs) and free fatty acids. To quantitatively assess possible specific roles of peroxidation and hydrolysis of mitochondrial CL, we performed comparative studies of CL modifications using an animal model of Barth syndrome where deficiency of CL reacylation (Tafazzin [Taz] deficiency) was associated exclusively with the accumulation of mCLs (but not CLox). By comparing the in vitro and in vivo results with genetic manipulation of major CL-, CLox-, and mCL-metabolizing enzymes, calcium-independent phospholipase A(2)gamma and Taz, we concluded that the 2 processes - CL oxidation and CL hydrolysis - act as mutually synergistically enhancing components of the pathogenic mechanism of mitochondrial injury in traumatic brain injury. This emphasizes the need for combined therapeutic approaches preventing the formation of both CLox and mCL.	[Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Ji, Jing; Bayir, Hulya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Safar Ctr Resuscitat Res, Med Ctr, Pittsburgh, PA 15213 USA; [Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Ji, Jing; Bayir, Hulya] Univ Pittsburgh, Childrens Hosp Pittsburgh, Neurosci Inst, Med Ctr, Pittsburgh, PA 15213 USA; [Chao, Honglu; Anthonymuthu, Tamil S.; Kenny, Elizabeth M.; Ji, Jing; Bayir, Hulya] Univ Pittsburgh, Med Ctr, Dept Crit Care Med, Pittsburgh, PA USA; [Chao, Honglu; Ji, Jing] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China; [Amoscato, Andrew A.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Cole, Laura K.; Hatch, Grant M.; Bayir, Hulya] Univ Manitoba, Childrens Hosp, Fac Hlth Sci, Dept Pharmacol & Therapeut,Res Inst Manitoba, Winnipeg, MB, Canada; [Kagan, Valerian E.] IM Sechenov Moscow State Med Univ, Inst Regenerat Med, Lab Nav Redox Lipid, Moscow, Russia	Ji, J (corresponding author), Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.; Kagan, VE (corresponding author), Dept Environm & Occupat Hlth, Publ Hlth Bldg,130 De Soto St, Pittsburgh, PA 15261 USA.; Bayir, H (corresponding author), Univ Pittsburgh, Dept Crit Care Med, John G Rangos Res Ctr, 6th Floor,4401 Penn Ave, Pittsburgh, PA 15224 USA.	jijing@njmu.edu.cn; kagan@pitt.edu; bayihx@ccm.upmc.edu	Anthonymuthu, Tamil/I-5534-2019	Kagan, Valerian E./0000-0002-7245-1885	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL114453, AI068021, NS076511, NS061817, NS084604, CA165065]; Human Frontier Science ProgramHuman Frontier Science Program [HFSP-RGP0013/2014]; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471269]; Jiangsu Province's Natural Science FoundationNatural Science Foundation of Jiangsu Province [BK20160047]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Barth Syndrome Foundation Canada/USA; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA165065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01HL114453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS076511, R01NS084604, R01NS061817] Funding Source: NIH RePORTER	We thank Henry Alexander and Jessie Lewis for technical support in the CCI experiments. This work was supported by the NIH (HL114453, AI068021, NS076511, NS061817, NS084604, and CA165065), Human Frontier Science Program (HFSP-RGP0013/2014), Heart and Stroke Foundation of Canada, Barth Syndrome Foundation Canada/USA, National Natural Science Foundation of China (81471269), Jiangsu Province's Natural Science Foundation (BK20160047), and Jiangsu Province and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). GMH is the Canada Research Chair in Molecular Cardiolipin Metabolism.	Acehan D, 2011, J BIOL CHEM, V286, P899, DOI 10.1074/jbc.M110.171439; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; ADES LC, 1993, AM J MED GENET, V45, P327, DOI 10.1002/ajmg.1320450309; Aprikyan AA, 2013, BRIT J HAEMATOL, V161, P330, DOI 10.1111/bjh.12271; Balasubramanian K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa6179; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Buland JR, 2016, AM J PHYSIOL-LUNG C, V311, pL303, DOI 10.1152/ajplung.00038.2016; Chakraborty K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13944; Chen M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177171; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; CHRISTODOULOU J, 1994, AM J MED GENET, V50, P255, DOI 10.1002/ajmg.1320500309; Chu CT, 2013, NAT CELL BIOL, V15, P1197, DOI 10.1038/ncb2837; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2011, J CELL BIOL, V192, P447, DOI 10.1083/jcb.201008177; Crimi M, 2011, BBA-MOL CELL RES, V1813, P551, DOI 10.1016/j.bbamcr.2010.09.014; Esposti MD, 2003, CELL DEATH DIFFER, V10, P1300, DOI 10.1038/sj.cdd.4401306; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Girgis F, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00008; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Ji J, 2015, J CEREBR BLOOD F MET, V35, P319, DOI 10.1038/jcbfm.2014.204; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kagan VE, 2015, ANTIOXID REDOX SIGN, V22, P1667, DOI 10.1089/ars.2014.6219; Kagan VE, 2014, CHEM PHYS LIPIDS, V179, P64, DOI 10.1016/j.chemphyslip.2013.11.010; Kagan VE, 2009, ADV DRUG DELIVER REV, V61, P1375, DOI 10.1016/j.addr.2009.06.008; Kagan VE, 2009, FREE RADICAL BIO MED, V46, P1439, DOI 10.1016/j.freeradbiomed.2009.03.004; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kagan VE, 2004, FREE RADICAL BIO MED, V37, P1963, DOI 10.1016/j.freeradbiomed.2004.08.016; Kiebish MA, 2013, J LIPID RES, V54, P1312, DOI 10.1194/jlr.M034728; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Liu NK, 2014, ANN NEUROL, V75, P644, DOI 10.1002/ana.24134; Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003; Mancuso DJ, 2003, J BIOL CHEM, V278, P22231, DOI 10.1074/jbc.C300033200; Moon SH, 2012, J BIOL CHEM, V287, P29837, DOI 10.1074/jbc.M112.373654; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; O'Neill LAJ, 2013, CELL METAB, V18, P610, DOI 10.1016/j.cmet.2013.10.013; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Paradies G, 2014, BBA-BIOENERGETICS, V1837, P408, DOI 10.1016/j.bbabio.2013.10.006; Ren MD, 2014, PROG LIPID RES, V55, P1, DOI 10.1016/j.plipres.2014.04.001; Saric A, 2016, FRONT GENET, V6, DOI [10.3389/fgene.2015.00359, 10.3339/fgene.2015.00359]; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2017, J BIOL CHEM, V292, P5499, DOI 10.1074/jbc.M116.769182; Schlame M, 2012, NAT CHEM BIOL, V8, P862, DOI 10.1038/NCHEMBIO.1064; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schlattner U, 2014, CHEM PHYS LIPIDS, V179, P32, DOI 10.1016/j.chemphyslip.2013.12.008; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sparvero LJ, 2016, J NEUROCHEM, V139, P659, DOI 10.1111/jnc.13840; Taylor WA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048628; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; Testa CM, 2005, MOL BRAIN RES, V134, P109, DOI 10.1016/j.molbrainres.2004.11.007; Tyurin VA, 2012, BIOCHEMISTRY-US, V51, P9736, DOI 10.1021/bi301024e; Tyurina YY, 2017, ACS CHEM BIOL, V12, P265, DOI 10.1021/acschembio.6b00995; Tyurina YY, 2014, NAT CHEM, V6, P542, DOI [10.1038/nchem.1924, 10.1038/NCHEM.1924]; Tyurina YY, 2014, CHEM PHYS LIPIDS, V179, P3, DOI 10.1016/j.chemphyslip.2013.12.003; Tyurina YY, 2013, MOL NUTR FOOD RES, V57, P1410, DOI 10.1002/mnfr.201200801; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132638; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7	70	13	13	1	3	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA	2379-3708			JCI INSIGHT	JCI Insight	NOV 2	2018	3	21							e97677	10.1172/jci.insight.97677			15	Medicine, Research & Experimental	Research & Experimental Medicine	GZ2OG	WOS:000449225900022	30385716	Bronze, Green Published			2021-06-18	
J	Abdulle, AE; de Koning, ME; van der Horn, HJ; Scheenen, ME; Roks, G; Hageman, G; Spikman, JM; van der Naalt, J				Abdulle, Amaal Eman; de Koning, Myrthe E.; van der Horn, Harm J.; Scheenen, Myrthe E.; Roks, Gerwin; Hageman, Gerard; Spikman, Jacoba M.; van der Naalt, Joukje			Early Predictors for Long-Term Functional Outcome After Mild Traumatic Brain Injury in Frail Elderly Patients	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aging; brain injuries; depression; follow-up studies; frail elderly; outcome assessment (healthcare); prognosis; rehabilitation	OLDER-ADULTS; HEAD-INJURY; AGE; PREVALENCE; DEPRESSION; COMPLAINTS; MORTALITY; ANXIETY; CARE; MULTICENTER	Objective: To identify the effect of frailty and early postinjury measures on the long-term outcome after mild traumatic brain injury in elderly patients. Setting: Patients admitted to 3 Dutch hospitals designated as level 1 trauma centers. Participants: The elderly (60 years) with mild traumatic brain injury (N = 161). Design: A prospective observational cohort study. Main Measures: Posttraumatic complaints and the Hospital Anxiety and Depression Scale determined 2 weeks postinjury; the Glasgow Outcome Scale Extended and Groningen frailty indicator determined 1 to 3 years postinjury. Results: A total of 102 nonfrail (63%) and 59 frail elderly (37%) patients, mean age of 70.8 (6.3) years were included. Most patients (54%; 72% nonfrail and 24% frail) recovered completely 1 to 3 years postinjury. Two weeks postinjury, 81% had posttraumatic complaints (83% frail and 80% nonfrail elderly), and 30% showed emotional distress (50% frail and 20% nonfrail). Frailty (odds ratio, 2.1; 95% confidence interval, 1.59-2.77) and presence of early complaints (odds ratio, 1.13; 95% confidence interval, 1.01-1.27) (Nagelkerke R-2 = 46%) were found to predict long-term outcome, whereas age was not a significant predictor. Conclusion: The frail elderly had worse long-term outcome, and early complaints were found to be a stronger predictor of unfavorable outcome than age. Understanding the implications of frailty on outcome could help clinicians recognize patients at risk of a poor outcome and allocate care more efficiently.	[Abdulle, Amaal Eman; de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Dept Clin Neuropsychol, Groningen, Netherlands; [Roks, Gerwin] Elisabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Hageman, Gerard] Hosp Med Spectrum Twente, Dept Neurol, Enschede, Netherlands	van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol AB51, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.naalt@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps2012-06]	This study is supported by the Dutch Brain Foundation (grant Ps2012-06).	Aarts S, 2015, J FRALITY AGING, V4, P131, DOI 10.14283/jfa.2015.45; Andersen FH, 2012, ACTA ANAESTH SCAND, V56, P1298, DOI 10.1111/j.1399-6576.2012.02782.x; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Choi J, 2015, J AM MED DIR ASSOC, V16, P548, DOI 10.1016/j.jamda.2015.02.004; Clegg A, 2015, AGE AGEING, V44, P148, DOI 10.1093/ageing/afu157; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P344, DOI 10.1016/j.jamda.2009.11.003; Heikkinen E., 2003, WHAT ARE MAIN RISK F; Hofhuis JGM, 2014, J TRAUMA ACUTE CARE, V76, P549, DOI 10.1097/TA.0b013e3182a9d105; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Le Maguet P, 2014, INTENS CARE MED, V40, P674, DOI 10.1007/s00134-014-3253-4; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mhaolain AMN, 2012, INT PSYCHOGERIATR, V24, P1265, DOI 10.1017/S1041610211002110; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Peters LL, 2015, EXP GERONTOL, V69, P129, DOI 10.1016/j.exger.2015.05.006; Puts MTE, 2005, J AM GERIATR SOC, V53, P40, DOI 10.1111/j.1532-5415.2005.53008.x; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tillou A, 2014, JAMA SURG, V149, P83, DOI 10.1001/jamasurg.2013.4244; Torres OH, 2006, INTENS CARE MED, V32, P1052, DOI 10.1007/s00134-006-0170-1; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Villacampa-Fernandez P, 2017, MATURITAS, V95, P31, DOI 10.1016/j.maturitas.2016.10.008; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	47	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E59	E67		10.1097/HTR.0000000000000368			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600007	29385011				2021-06-18	
J	Bakhsheshian, J; Ding, L; Tang, A; Wen, T; Patel, A; Strickland, BA; Rennert, RC; Amer, A; Gruen, P; Giannotta, S; Mack, WJ; Attenello, FJ				Bakhsheshian, Joshua; Ding, Li; Tang, Austin; Wen, Timothy; Patel, Arati; Strickland, Ben A.; Rennert, Robert C.; Amer, Arun; Gruen, Peter; Giannotta, Steven; Mack, William J.; Attenello, Frank J.			Safety-Net Hospitals Have Higher Complication and Mortality Rates in the Neurosurgical Management of Traumatic Brain Injuries	WORLD NEUROSURGERY			English	Article						Complications; National Database; Quality improvement; Traumatic brain injury; Trauma	RACIAL DISPARITIES; CARE; SURGERY; OUTCOMES; FAILURE; RESCUE; GUIDELINES; BURDEN; HEALTH; VOLUME	BACKGROUND: Clinical outcomes in the surgical management of severe traumatic brain injury (TBI) have been shown to vary across different hospital institutions. The effect of the safety-net burden on postoperative mortality, complication rates, and failure to rescue rates is unclear. We evaluated the relationship of the safety-net burden with outcomes in the treatment of patients with severe TBI undergoing neurosurgery. METHODS: The hospitals were grouped according to their safety-net burden, defined as the proportion of Medicaid and uninsured patient charges for all hospitalizations during that time. Multivariate analyses were performed to examine significant associations with the degree of safety-net burden while controlling for potential confounders. RESULTS: Data from 20,989 encounters in 788 hospitals were included. Compared with low-burden hospitals (LBHs), high-burden hospitals (HBHs; odds ratio [OR], 1.48; 95% confidence interval [CI], 1.04-2.12; P= 0.03) had greater mortality rates. Major complications were more likely to occur at HBHs (OR, 1.44; 95% CI, 1.12-1.84; P< 0.01) compared with LBHs. The failure to rescue rates were similar among all safety-net burden hospital groups. Patients at HBHs also had an increased likelihood of an extended length of stay (OR, 1.92; 95% CI, 1.12-3.29; P = 0.02) and receiving a tracheostomy or gastrostomy (OR, 1.99; 95% CI, 1.36-2.89; P < 0.01) compared with patients at LBHs. CONCLUSIONS: The present study found that a greater hospital safety-net burden was independently associated with greater rates of mortality and major complications in the treatment of patients with severe TBI undergoing neurosurgery. Further research in evaluating the cause of disparities in mortality outcomes at high safety-burden hospitals is needed.	[Bakhsheshian, Joshua; Strickland, Ben A.; Rennert, Robert C.; Amer, Arun; Gruen, Peter; Giannotta, Steven; Mack, William J.; Attenello, Frank J.] Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90007 USA; [Ding, Li] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA; [Tang, Austin; Wen, Timothy; Patel, Arati] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA	Bakhsheshian, J (corresponding author), Univ Southern Calif, Dept Neurol Surg, Los Angeles, CA 90007 USA.	joshuabakh@gmail.com	ding, li/AAN-2113-2020; Ding, Li/G-4031-2019; DING, LI/ABI-1989-2020	Ding, Li/0000-0001-8565-430X; DING, LI/0000-0001-8565-430X; Bakhsheshian, Joshua/0000-0003-2983-6082; Wen, Timothy/0000-0002-1749-3142	NIH SC CTSI KL2 Clinical and Translational Research Scholar AwardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	FJA was the recipient of the NIH SC CTSI KL2 Clinical and Translational Research Scholar Award.	Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Alali AS, 2017, J NEUROTRAUM, V34, P2760, DOI 10.1089/neu.2017.4997; Alali AS, 2017, NEUROSURGERY, V80, P534, DOI 10.1093/neuros/nyw098; Alban RF, 2010, AM SURGEON, V76, P1108; Altman S., 2000, AM HLTH CARE SAFETY; Bakhsheshian J, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16268; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dobson A, 2017, COMMONW FUND, V2017; Faigle R, 2016, JAMA NEUROL, V73, P1151, DOI 10.1001/jamaneurol.2016.1914; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2013, J TRAUMA ACUTE CARE, V74, P1195, DOI 10.1097/TA.0b013e31828c331d; Hoehn RS, 2016, JAMA SURG, V151, P120, DOI 10.1001/jamasurg.2015.3209; Houchens R, 2005, FINAL REPORT CALCULA, P2002; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu N, 2004, J HEALTH CARE POOR U, V15, P618, DOI 10.1353/hpu.2004.0053; McCormick PJ, 2018, J MED SYST, V42, DOI 10.1007/s10916-018-0936-3; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Reyes C, 2017, J AM COLL SURGEONS, V224, P301, DOI 10.1016/j.jamcollsurg.2016.11.010; Rosero EB, 2017, J VASC SURG, V66, P404, DOI 10.1016/j.jvs.2016.12.146; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sharma S, 2014, J AM COLL SURGEONS, V218, P51, DOI 10.1016/j.jamcollsurg.2013.10.005; Shermer CR, 2007, J TRAUMA, V63, P1268; Silber JH, 2007, MED CARE, V45, P918, DOI 10.1097/MLR.0b013e31812e01cc; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wakeam E, 2014, JAMA SURG, V149, P229, DOI 10.1001/jamasurg.2013.3566; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	31	13	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2018	119						E284	E293		10.1016/j.wneu.2018.07.134			10	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GX7IO	WOS:000447941300035	30055361				2021-06-18	
J	Chung, DY; Sugimoto, K; Fischer, P; Bohm, M; Takizawa, T; Sadeghian, H; Morais, A; Harriott, A; Oka, F; Qin, T; Henninger, N; Yaseen, MA; Sakadzic, S; Ayata, C				Chung, David Y.; Sugimoto, Kazutaka; Fischer, Paul; Boehm, Maximilian; Takizawa, Tsubasa; Sadeghian, Homa; Morais, Andreia; Harriott, Andrea; Oka, Fumiaki; Qin, Tao; Henninger, Nils; Yaseen, Mohammad A.; Sakadzic, Sava; Ayata, Cenk			Real-time non-invasive in vivo visible light detection of cortical spreading depolarizations in mice	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Cortical spreading depression; Optical intrinsic signal imaging; Migraine; Stroke; Non-invasive	DEPRESSION	Background: Cortical spreading depolarization (CSD) is a phenomenon classically associated with migraine aura. CSDs have also been implicated in secondary injury following ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and traumatic brain injury; however, most investigations involving these disease processes do not account for the occurrence of CSDs. A major barrier to detection of CSDs in experimental models is that currently validated methods are invasive and require specialized equipment and a high level of expertise to implement. New method: We present a low-cost, easy-to-implement approach to the detection of CSDs in the mouse through full-thickness intact skull. Our method uses the optical intrinsic signal from white light illumination (OIS-WL) and allows for real-time in vivo detection of CSDs using readily available USB cameras. Results: OIS-WL detected 100% of CSDs that were seen with simultaneous electrode recording (69 CSDs in 28 mice), laser Doppler flowmetry (82 CSDs in 10 mice), laser speckle flowmetry (68 CSDs in 25 mice), or combined electrode recording plus laser speckle flowmetry (29 CSDs in 20 mice). OIS-WL detected 1 additional CSD that was missed by laser Doppler flowmetry. Comparison with existing methods: : OIS-WL is less invasive than electrophysiological recordings and easier to implement than laser speckle flowmetry. Moreover, it provides excellent spatial and temporal resolution for dynamic imaging of CSDs in the setting of brain injury. Conclusions: Detection of CSDs with an inexpensive USB camera and white light source provides a reliable method for the in vivo and non-invasive detection of CSDs through unaltered mouse skull.	[Chung, David Y.; Sugimoto, Kazutaka; Fischer, Paul; Boehm, Maximilian; Takizawa, Tsubasa; Sadeghian, Homa; Morais, Andreia; Harriott, Andrea; Oka, Fumiaki; Qin, Tao; Ayata, Cenk] Massachusetts Gen Hosp, Dept Radiol, Neurovasc Res Lab, Charlestown, MA 02129 USA; [Chung, David Y.] Massachusetts Gen Hosp, Dept Neurol, Neurocrit Care & Emergency Neurol, Boston, MA 02114 USA; [Sugimoto, Kazutaka; Oka, Fumiaki] Yamaguchi Univ, Dept Neurosurg, Sch Med, Ube, Yamaguchi, Japan; [Fischer, Paul; Boehm, Maximilian] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Takizawa, Tsubasa] Keio Univ, Dept Neurol, Sch Med, Tokyo, Japan; [Harriott, Andrea; Ayata, Cenk] Massachusetts Gen Hosp, Dept Neurol, Stroke Serv, Boston, MA 02114 USA; [Henninger, Nils] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Henninger, Nils] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; [Yaseen, Mohammad A.; Sakadzic, Sava] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martins Ctr Biomed Imaging, Charlestown, MA 02129 USA	Chung, DY; Ayata, C (corresponding author), Massachusetts Gen Hosp, 149 13th St,6403, Charlestown, MA 02129 USA.	dychung@mgh.harvard.edu; cayata@mgh.harvard.edu	Chung, David/AAG-1359-2019	Chung, David/0000-0002-7149-5851; Fischer, Paul/0000-0001-7673-8552; Morais, Andreia/0000-0002-9351-2552; Harriott, Andrea/0000-0003-0417-7586; Sugimoto, Kazutaka/0000-0002-7666-2620	National Institute of Neurological Disorders and Stroke at the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743, R00AG042026, NS091499, R01NS091230, R01MH111359, P01NS055104, R01NS102969]; American Heart AssociationAmerican Heart Association [18POST34030369]; Brain Aneurysm Foundation's Timothy P. Susco and Andrew David Heitman Foundation Chairs of Research; Aneurysm and AVM Foundation; Japanese Heart Foundation; Bayer Yakuhin Research Grant Abroad; Fondation LeducqLeducq Foundation; Heitman Foundation; Ellison FoundationLawrence Ellison Foundation; International Headache Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD051959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH111359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102969, P01NS055104, R25NS065743, K08NS091499, R01NS091230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R00AG042026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA027097] Funding Source: NIH RePORTER	Funding was provided by the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (R25NS065743 to D.Y.C., R00AG042026 to M.A.Y., NS091499 to N.H., R01NS091230 and R01MH111359 to S.S., and P01NS055104 and R01NS102969 to C.A.); the American Heart Association (18POST34030369 to D.Y.C); the Brain Aneurysm Foundation's Timothy P. Susco and Andrew David Heitman Foundation Chairs of Research to D.Y.C.; the Aneurysm and AVM Foundation to D.Y.C.; the International Headache Society to H.S.; the Japanese Heart Foundation and the Bayer Yakuhin Research Grant Abroad to F.O.; and Fondation Leducq, the Heitman Foundation, and the Ellison Foundation to C.A. We thank Saef Izzy for comments on the manuscript.	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2013, CEPHALALGIA, V33, P604, DOI 10.1177/0333102412470216; Chung D.Y., 2018, CEREB CORTEX; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; Eikermann-Haerter K, 2012, CIRCULATION, V125, P335, DOI 10.1161/CIRCULATIONAHA.111.045096; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Hartings JA, 2016, J CEREB BLOOD FLOW M; Houben T, 2016, J CEREB BLOOD FLOW M; Kaufmann D, 2017, J CEREBR BLOOD F MET, V37, P1748, DOI 10.1177/0271678X16659496; Ma Y, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0360; Oka F, 2016, J CEREB BLOOD FLOW M; Santos E, 2014, NEUROIMAGE, V99, P244, DOI 10.1016/j.neuroimage.2014.05.021; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Silasi G, 2016, J NEUROSCI METH, V267, P141, DOI 10.1016/j.jneumeth.2016.04.012; Yuzawa I, 2012, J CEREBR BLOOD F MET, V32, P376, DOI 10.1038/jcbfm.2011.148	15	13	13	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	NOV 1	2018	309						143	146		10.1016/j.jneumeth.2018.09.001			4	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	GZ1KZ	WOS:000449128300015	30194041	Green Accepted, Bronze			2021-06-18	
J	Kornblith, LZ; Robles, AJ; Conroy, AS; Hendrickson, CM; Calfee, CS; Fields, AT; Callcut, RA; Cohen, MJ				Kornblith, Lucy Z.; Robles, Anamaria J.; Conroy, Amanda S.; Hendrickson, Carolyn M.; Calfee, Carolyn S.; Fields, Alexander T.; Callcut, Rachael A.; Cohen, Mitchell J.			Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		Platelet; ristocetin; trauma; von Willebrand factor	FRESH-FROZEN PLASMA; INDUCED COAGULOPATHY; HEMORRHAGIC-SHOCK; VALPROIC ACID; EX-VIVO; DYSFUNCTION; DESMOPRESSIN; ENDOTHELIOPATHY; RESUSCITATION; TRANSFUSION	BACKGROUND Injury to the blood-brain barrier exposes endothelium rich in von Willebrand factor (vWF), which may play a role in altered platelet aggregation following traumatic brain injury (TBI). Ristocetin is an antimicrobial substance that induces vWF-mediated aggregation of platelets. We examined these mechanisms in injured patients by measuring the aggregation response of platelets to stimulating agonists (including ristocetin) via whole-blood multiple-electrode platelet aggregometry. We hypothesized that patients with TBI have an altered platelet aggregation response to ristocetin stimulation compared with patients without TBI. METHODS Blood was collected from 233 trauma patients without thrombocytopenia. Platelet aggregation was assessed using multiple-electrode platelet aggregometry (Multiplate). Platelet aggregation response to stimulating agonists collagen, thrombin receptor-activating peptide 6, adenosine diphosphate, arachidonic acid, and ristocetin was measured. Factor activity was measured. RESULTS Of the 233 patients, 23% had TBI. There were no differences in platelet aggregation responses to any agonists between TBI and non-TBI patients except ristocetin. Platelet aggregation response to ristocetin stimulation was significantly lower in TBI patients (p = 0.03). Patients with TBI also had higher factor VIII activity (215% vs. 156%, p = 0.01). In multivariate analysis, there was a significant independent association of impaired platelet aggregation response to ristocetin stimulation with TBI (odds ratio, 3.05; p = 0.04). CONCLUSIONS Given the importance of platelets in hemostasis, understanding the mechanisms of impaired platelet aggregation following injury is critical. The impaired platelet aggregation response to ristocetin stimulation and corresponding increase in factor VIII activity in TBI patients may be secondary to a TBI-induced effect on vWF quantity (due to injury-driven consumption of vWF) or vWF function with resultant increase in circulating factor VIII activity (due to impaired carrying capacity of vWF). Given there are multiple known therapies for vWF deficits including desmopressin, purified and recombinant vWF, and estrogens, these lines of investigation are particularly compelling in patients with TBI and hemorrhage. LEVEL OF EVIDENCE Prognostic study, level II.	[Kornblith, Lucy Z.; Robles, Anamaria J.; Conroy, Amanda S.; Fields, Alexander T.; Callcut, Rachael A.] Zuckerberg San Francisco Gen Hosp, Dept Surg, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hendrickson, Carolyn M.; Calfee, Carolyn S.] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Cohen, Mitchell J.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; Univ Colorado, Denver, CO 80202 USA	Kornblith, LZ (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A,1001 Potrero Ave, San Francisco, CA 94110 USA.	lucy.kornblith@ucsf.edu		Robles, Anamaria/0000-0002-3693-314X	DoDUnited States Department of Defense [W911QY-15-C-0044]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01ES026834, UM1HL120877, HL110969];  [K23 HL133495]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL133495, R01HL110969, UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM130892] Funding Source: NIH RePORTER	M.J.C. is supported by DoD W911QY-15-C-0044 and NIH UM1HL120877. R.A.C. is supported by NIH K01ES026834 and DoD W911QY-15-C-0044. C.S.C. is supported by NIH HL110969. C.M.H. is supported by K23 HL133495.	Baimukanova G, 2016, TRANSFUSION, V56, pS65, DOI 10.1111/trf.13532; Baimukanova G, 2016, TRANSFUSION, V56, pS52, DOI 10.1111/trf.13455; Bambakidis T, 2017, BLOOD COAGUL FIBRIN, V28, P479, DOI 10.1097/MBC.0000000000000626; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Davenport RA, 2009, CURR OPIN ANESTHESIO, V22, P261, DOI 10.1097/ACO.0b013e328325a6d9; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Ding N, 2014, CIRC-CARDIOVASC GENE, V7, P615, DOI 10.1161/CIRCGENETICS.113.000398; Diz-Kucukkaya R, 2013, HEMATOL-AM SOC HEMAT, P268, DOI 10.1182/asheducation-2013.1.268; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Eikenboom J C J, 2006, Neth Heart J, V14, P277; Eikenboom JCJ, 2002, THROMB HAEMOSTASIS, V87, P252; FLORDAL PA, 1993, BRIT J SURG, V80, P723, DOI 10.1002/bjs.1800800616; GRATZ I, 1992, J THORAC CARDIOV SUR, V104, P1417; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Henriksen HH, 2017, J SURG RES, V214, P154, DOI 10.1016/j.jss.2017.02.037; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kutcher ME, 2014, ANN SURG, V260, P1103, DOI 10.1097/SLA.0000000000000366; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li RZ, 2016, J TRAUMA ACUTE CARE, V80, P440, DOI 10.1097/TA.0000000000000915; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; National Center for Injury Prevention and Control (NCIPC), NAT VIOL DEATH REP S; Naumann DN, 2018, SHOCK, V49, P420, DOI 10.1097/SHK.0000000000000999; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Pati S, 2016, J TRAUMA ACUTE CARE, V80, P576, DOI 10.1097/TA.0000000000000961; Ranucci M, 2007, J CARDIOTHOR VASC AN, V21, P851, DOI 10.1053/j.jvca.2007.05.009; Rodriguez EG, 2018, SHOCK, V50, P31, DOI 10.1097/SHK.0000000000001036; Rodriguez EG, 2017, J AM COLL SURGEONS, V225, P419, DOI 10.1016/j.jamcollsurg.2017.05.012; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stansbury LG, 2013, TRANSFUSION, V53, P783, DOI 10.1111/j.1537-2995.2012.03828.x; Walters T, 2006, J TRAUMA, V61, P1107, DOI 10.1097/01.ta.0000195655.30837.29; White NJ, 2017, J TRAUMA ACUTE CARE, V82, pS41, DOI 10.1097/TA.0000000000001436; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	48	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					873	880		10.1097/TA.0000000000002025			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100007	29985231	Green Accepted			2021-06-18	
J	Lancaster, MA; Meier, TB; Olson, DV; McCrea, MA; Nelson, LD; Muftuler, LT				Lancaster, Melissa A.; Meier, Timothy B.; Olson, Daniel V.; McCrea, Michael A.; Nelson, Lindsay D.; Muftuler, L. Tugan			Chronic differences in white matter integrity following sport-related concussion as measured by diffusion MRI: 6-Month follow-up	HUMAN BRAIN MAPPING			English	Article						concussion management; concussion symptoms; diffusion kurtosis imaging; diffusion tensor imaging; mild traumatic brain injury; sport-related concussion	TRAUMATIC BRAIN-INJURY; GAUSSIAN WATER DIFFUSION; MILD HEAD-INJURY; FOOTBALL PLAYERS; HIGH-SCHOOL; CELL-DEATH; TENSOR; KURTOSIS; ANISOTROPY; IMPAIRMENT	Recent studies demonstrated evidence of physiological changes in the brain following sport-related concussion (SRC) that persisted beyond the point at which athletes achieved full symptom recovery. Diffusion MRI techniques have been used to study brain white matter (WM) changes following SRC; however, longitudinal studies that follow injured athletes from the acute to chronic stages of injury are sparse. The current study explores potential persisting effects of the injury, which serves as a follow-up to our previous work that reported WM changes in the acute and subacute phase of SRC recovery. Concussed high school and collegiate football players (n =17) and well-matched teammate controls (n = 20) were followed up at 6 months postinjury with diffusion tensor (DTI) and diffusion kurtosis imaging (DKI) as well as measures of self-reported symptoms, cognitive functioning, and balance. Results of tract-based spatial statistics (TBSS) analyses revealed continued widespread decreased mean and axial diffusivity compared to control subjects in 6-month follow-up scans. On the other hand, kurtosis metrics, which were significantly higher in concussed athletes in the acute phase, had normalized. WM tract regions-of-interest (ROIs) were created from significant clusters in the TBSS analysis, and linear mixed effects (LME) analyses were used to look at longitudinal changes in these ROIs over time. LME analyses revealed few timex group interactions indicating findings were relatively stable over time. In addition, acute concussion symptoms predicted diffusivity measures at 6 months postinjury. Findings indicate that DTI and DKI may be useful tools in assessing concussion severity, recovery, and possible long-term effects of concussion.	[Lancaster, Melissa A.; McCrea, Michael A.; Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Lancaster, Melissa A.; Meier, Timothy B.; McCrea, Michael A.; Nelson, Lindsay D.; Muftuler, L. Tugan] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Olson, Daniel V.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Muftuler, L. Tugan] Med Coll Wisconsin, Ctr Imaging Res, Milwaukee, WI 53226 USA	Muftuler, LT (corresponding author), Med Coll Wisconsin, Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	lmuftuler@mcw.edu	Muftuler, L. Tugan/AAG-7539-2021	Muftuler, L. Tugan/0000-0002-6635-5678	Clinical and Translational Science Institute of Southeast Wisconsin [1UL1-RR031973]; NIH Clinical CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC) [8UL1TR000055]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); General Electric; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER	Clinical and Translational Science Institute of Southeast Wisconsin, Grant/Award Number: 1UL1-RR031973; NIH Clinical Center, Grant/Award Number: 8UL1TR000055; National Institutes of Health; National Center for Advancing Translational Sciences; General Electric; U.S. Army Medical Research and Materiel Command, Grant/Award Number: W81XWH-12-1-0004	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Coutu JP, 2014, NEUROBIOL AGING, V35, P1412, DOI 10.1016/j.neurobiolaging.2013.12.001; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Gardner A, 2014, J NEUROTRAUM, V31, P1, DOI 10.1089/neu.2013.3079; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gons RAR, 2013, NEUROLOGY, V81, P971, DOI 10.1212/WNL.0b013e3182a43e33; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Helmick K, 2006, DEFENSE VETERANS BRA; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Hutchinson EB, 2017, MAGN RESON MED, V78, P1767, DOI 10.1002/mrm.26575; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Johnson NF, 2012, NEUROIMAGE, V59, P1514, DOI 10.1016/j.neuroimage.2011.08.032; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murphy Meghan, 2016, Neurosurgery, V63 Suppl 1, P178, DOI 10.1227/01.neu.0000489768.36395.5a; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Paydar A, 2014, AM J NEURORADIOL, V35, P808, DOI 10.3174/ajnr.A3764; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Pfefferbaum A, 2000, MAGNET RESON MED, V44, P259, DOI 10.1002/1522-2594(200008)44:2<259::AID-MRM13>3.0.CO;2-6; Pfefferbaum A, 2003, MAGNET RESON MED, V49, P953, DOI 10.1002/mrm.10452; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tseng BY, 2013, NEUROIMAGE, V82, P510, DOI 10.1016/j.neuroimage.2013.06.011; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	72	13	13	3	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	NOV	2018	39	11					4276	4289		10.1002/hbm.24245			14	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	GW3TW	WOS:000446831900008	29964356	Green Published, Green Accepted, Bronze			2021-06-18	
J	Hogberg, U; Andersson, J; Squier, W; Hogberg, G; Fellman, V; Thiblin, I; Wester, K				Hogberg, Ulf; Andersson, Jacob; Squier, Waney; Hogberg, Goren; Fellman, Vineta; Thiblin, Ingemar; Wester, Knut			Epidemiology of subdural haemorrhage during infancy: A population-based register study	PLOS ONE			English	Article							BENIGN EXTERNAL HYDROCEPHALUS; TRAUMATIC BRAIN-INJURY; SHAKEN-BABY-SYNDROME; ABUSIVE HEAD TRAUMA; YOUNG-CHILDREN; INTRACRANIAL HEMORRHAGE; SUBARACHNOID SPACES; FLUID COLLECTION; RISK-FACTOR; HEMATOMA	Objectives To analyse subdural haemorrhage (SDH) during infancy in Sweden by incidence, SDH category, diagnostic distribution, age, co-morbidity, mortality, and maternal and perinatal risk factors; and its association with accidents and diagnosis of abuse. Methods A Swedish population-based register study comprising infants born between 1997 and 2014, 0-1 years of age, diagnosed with SDH-diagnoses according to the (International Classification of Diseases, 10th version (ICD10), retrieved from the National Patient Register and linked to the Medical Birth Register and the Death Cause Register. Outcome measures were: 1) Incidence and distribution, 2) co-morbidity, 3) fall accidents by SDH category, 4) risk factors for all SDHs in the two age groups, 0-6 and 7-365 days, and for ICD10 SDH subgroups: S06.5 (traumatic SDH), I62.0 (acute nontraumatic), SDH and abuse diagnosis. Results Incidence of SDH was 16.5 per 100 000 infants (n = 306). Median age was 2.5 months. For infants older than one week, the median age was 3.5 months. Case fatality was 6.5%. Male sex was overrepresented for all SDH subgroups. Accidental falls were reported in 1/3 of the cases. One-fourth occurred within 0-6 days, having a perinatal risk profile. For infants aged 7-365 days, acute nontraumatic SDH was associated with multiple birth, preterm birth, and small-for-gestational age. Fourteen percent also had an abuse diagnosis, having increased odds of being born preterm, and being small-for-gestational age. Conclusions The incidence was in the range previously reported. SDH among newborns was associated with difficult birth and neonatal morbidity. Acute nontraumatic SDH and SDH with abuse diagnosis had similar perinatal risk profiles. The increased odds for acute nontraumatic SDH in twins, preterm births, neonatal convulsions or small-for-gestational age indicate a perinatal vulnerability for SDH beyond 1st week of life. The association between prematurity/small-for-gestational age and abuse diagnosis is intriguing and not easily understood.	[Hogberg, Ulf] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Andersson, Jacob; Thiblin, Ingemar] Uppsala Univ, Dept Surg Sci, Forens Med, Uppsala, Sweden; [Squier, Waney] Univ Oxford, John Radcliffe Hosp, Dept Neuropathol, Oxford, England; [Hogberg, Goren] Karolinska Inst, Child & Adolescent Psychiat Unit, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Fellman, Vineta] Lund Univ, Dept Clin Sci, Pediat, Lund, Sweden; [Fellman, Vineta] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Fellman, Vineta] Folkhalsan Res Ctr, Helsinki, Finland; [Wester, Knut] Univ Bergen, Dept Clin Med, Bergen, Norway; [Wester, Knut] Haukeland Hosp, Dept Neurosurg, Bergen, Norway	Hogberg, U (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	ulf.hogberg@kbh.uu.se		Wester, Knut/0000-0001-8489-3931; Andersson, Jacob/0000-0001-8266-1926; Hogberg, Ulf/0000-0002-2121-7511			Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Centre of Epidemiology Swedish National Board of Health and Welfare, 2003, RES REP EPC, V82, P112; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Dlamini N, 2010, NEUROSURG CLIN N AM, V21, P511, DOI 10.1016/j.nec.2010.03.006; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Elinder G, 2018, ACTA PAEDIATR, V107, P3, DOI 10.1111/apa.14473; Gabaeff SC, 2013, LEGAL MED-TOKYO, V15, P177, DOI 10.1016/j.legalmed.2012.12.003; Ghosh PS, 2011, CLIN PEDIATR, V50, P897, DOI 10.1177/0009922811406435; Gilbert R, 2012, LANCET, V379, P758, DOI 10.1016/S0140-6736(11)61087-8; Gout A, 1997, ARCH PEDIATRIE, V4, P983, DOI 10.1016/S0929-693X(97)86096-4; GUTHKELCH AN, 1953, BMJ-BRIT MED J, V1, P233, DOI 10.1136/bmj.1.4804.233; Hellbusch LC, 2007, J NEUROSURG, V107, P119, DOI 10.3171/PED-07/08/119; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Hogberg U, 2018, EUR J PUBLIC HEALTH, V28, P641, DOI 10.1093/eurpub/cky062; Ingraham FD, 1944, J PEDIATR-US, V24, P1, DOI 10.1016/S0022-3476(44)80138-X; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; KAPILA A, 1982, RADIOLOGY, V142, P669, DOI 10.1148/radiology.142.3.6977789; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2014, PEDIATRICS, V134, pE773, DOI 10.1542/peds.2013-3903; Larionov SN, 2008, CHILD NERV SYST, V24, P437, DOI 10.1007/s00381-007-0496-1; Lee HC, 2018, CHILD NERV SYST, V34, P235, DOI 10.1007/s00381-017-3583-y; Looney CB, 2007, RADIOLOGY, V242, P535, DOI 10.1148/radiol.2422060133; Lorente-Pozo S, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00063; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; McNeely PD, 2006, AM J NEURORADIOL, V27, P1725; Medina LS, 2001, AM J NEURORADIOL, V22, P564; Miller D, 2015, AM J FOREN MED PATH, V36, P111, DOI 10.1097/PAF.0000000000000152; Miller R, 2010, AM J FOREN MED PATH, V31, P165, DOI 10.1097/PAF.0b013e3181d96a8e; Minkowitz B, 2017, J PEDIATR ORTHOPED, V37, P23, DOI 10.1097/BPO.0000000000000587; Minns RA, 2005, ARCH DIS CHILD, V90, P883, DOI 10.1136/adc.2004.060657; MORI K, 1993, CHILD NERV SYST, V9, P282, DOI 10.1007/BF00306274; Myhre MC, 2007, ACTA PAEDIATR, V96, P1159, DOI 10.1111/j.1651-2227.2007.00356.x; PARENT AD, 1992, PEDIATR NEUROSURG, V18, P266, DOI 10.1159/000120674; Piatt J H Jr, 1999, Neurosurg Focus, V7, pe4; Ravid S, 2003, PEDIATR NEUROL, V28, P139, DOI 10.1016/S0887-8994(02)00500-3; Rooks VJ, 2008, AM J NEURORADIOL, V29, P1082, DOI 10.3174/ajnr.A1004; Scheimberg I, 2013, PEDIATR DEVEL PATHOL, V16, P149, DOI 10.2350/12-08-1232-OA.1; Squier W, 2016, DEV MED CHILD NEUROL, V58, P1223, DOI 10.1111/dmcn.13202; Squier W, 2009, FORENSIC SCI INT, V187, P6, DOI 10.1016/j.forsciint.2009.02.005; Swedish National Board of Health and Welfare, 2016, HLTH REG STOCKH; Swedish National Board of Health and Welfare, 2016, SWED PAT REG; Tavani F, 2003, NEURORADIOLOGY, V45, P253, DOI 10.1007/s00234-003-0946-8; TILL K, 1968, BRIT MED J, V3, P400, DOI 10.1136/bmj.3.5615.400; Torres-Cuevas I, 2017, REDOX BIOL, V12, P674, DOI 10.1016/j.redox.2017.03.011; Tucker J, 2016, J NEUROSURG-PEDIATR, V18, P16, DOI 10.3171/2015.12.PEDS15600; Vinchon M, 2010, CHILD NERV SYST, V26, P1195, DOI 10.1007/s00381-010-1105-2; Wiig US, 2017, PEDIATR NEUROL, V73, P36, DOI 10.1016/j.pediatrneurol.2017.04.018; Wittschieber D, 2015, AM J NEURORADIOL, V36, P432, DOI 10.3174/ajnr.A3989; World Health Organization, 1992, INT CLASS DIS; Zahl SM, 2011, NEUROSURG REV, V34, P417, DOI 10.1007/s10143-011-0327-4	52	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2018	13	10							e0206340	10.1371/journal.pone.0206340			17	Multidisciplinary Sciences	Science & Technology - Other Topics	GY7VH	WOS:000448823700102	30379890	DOAJ Gold, Green Published			2021-06-18	
J	Wallace, C; Zetterberg, H; Blennow, K; van Donkelaar, P				Wallace, Colin; Zetterberg, Henrik; Blennow, Kaj; van Donkelaar, Paul			No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; EPIDEMIOLOGY; PROTEIN; BIOMARKERS; DISEASE; PLAYERS; CHAIN; RATES	Sport-related concussion (SRC), a mild form of traumatic brain injury (TBI), is a common injury in contact sports. Health care professionals rely on subjective criteria (e.g., symptoms), as there is no objective marker for identification of athletes with SRC. Blood-based biomarkers have shown promise as diagnostic and prognostic tools following TBI and SRC. In the present study, we examined plasma tau and serum NF-L, two biomarkers for neuronal/axonal injury, concentrations at preseason and following SRC in contact sport athletes (n = 11) using ultrasensitive single molecule array (Simoa) assays. Preseason baseline samples were collected, and post-concussion samples were obtained at 6- and 14-days following injury. We found no difference between baseline, 6-day and 14-day post-concussion concentrations of tau (p = 0.14) or NF-L (p = 0.53). Further, no difference was found between preseason baseline and all post-SRC samples for tau (p = 0.22) or NF-L (p = 0.98). The total number of symptoms reported on the Standardized Assessment of Concussion-3(rd) Edition (SCAT3) and associated symptom severity scores increased from preseason to 6-days post-SRC but returned to baseline values at 14-days (p = 0.02 and p = 0.003, respectively). These results suggest that the severity of neuronal injury in this cohort of contact sport athletes with clinical uncomplicated SRC was too low to be detected by tau and NF-L measurements in blood samples obtained at 6- and 14-days post-injury.	[Wallace, Colin; van Donkelaar, Paul] Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Wallace, Colin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Psychiat & Neurochem,Inst Neurosci & Physio, Molndal, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Zetterberg, Henrik] UK Dementia Res Inst UCL, London, England	Wallace, C (corresponding author), Univ British Columbia, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.; Wallace, C (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada.	colin.wallace@alumni.ubc.ca		Wallace, Colin/0000-0002-3720-6526	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [183304]; Canada Foundation for Innovation (CFI)Canada Foundation for Innovation; Mitacs Canada [H14-02996]; Mitacs Accelerate Program	The authors would also like to thank the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Torsten Soderberg Foundation, and Swedish State Support for Clinical Research (ALFGBG). This research was funded by grants to PvD from the Canadian Institutes for Health Research (CIHR) (funding number 183304), Canada Foundation for Innovation (CFI), and Mitacs Canada (funding number H14-02996). CW was supported by the Mitacs Accelerate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Didehbani N., 2017, ANN SPORTS MED RES, V4, P1115; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Junn C, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0519-7; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mayr U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091379; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Shahim P, 2018, NEUROLOGY, V90, pE1780, DOI 10.1212/WNL.0000000000005518; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Vila-Ortiz GJ, 2001, CELL MOL NEUROBIOL, V21, P535, DOI 10.1023/A:1013823524302; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	40	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2018	13	10							e0206466	10.1371/journal.pone.0206466			11	Multidisciplinary Sciences	Science & Technology - Other Topics	GY5SG	WOS:000448641200040	30372457	DOAJ Gold, Green Published			2021-06-18	
J	Davies, DJ; Clancy, M; Dehghani, H; Lucas, SJE; Forcione, M; Yakoub, KM; Belli, A				Davies, David James; Clancy, Michael; Dehghani, Hamid; Lucas, Samuel John Edwin; Forcione, Mario; Yakoub, Kamal Makram; Belli, Antonio			Cerebral Oxygenation in Traumatic Brain Injury: Can a Non-Invasive Frequency Domain Near-Infrared Spectroscopy Device Detect Changes in Brain Tissue Oxygen Tension as Well as the Established Invasive Monitor?	JOURNAL OF NEUROTRAUMA			English	Article						brain tissue oxygen tension; cerebral hypoxia; cerebral non-invasive monitoring; critical care; frequency domain near-infrared spectroscopy; traumatic brain injury	PRESSURE	The cost and highly invasive nature of brain monitoring modality in traumatic brain injury patients currently restrict its utility to specialist neurological intensive care settings. We aim to test the abilities of a frequency domain near-infrared spectroscopy (FD-NIRS) device in predicting changes in invasively measured brain tissue oxygen tension. Individuals admitted to a United Kingdom specialist major trauma center were contemporaneously monitored with an FD-NIRS device and invasively measured brain tissue oxygen tension probe. Area under the curve receiver operating characteristic (AUROC) statistical analysis was utilized to assess the predictive power of FD-NIRS in detecting both moderate and severe hypoxia (20 and 10mm Hg, respectively) as measured invasively. Sixteen individuals were prospectively recruited to the investigation. Severe hypoxic episodes were detected in nine of these individuals, with the NIRS demonstrating a broad range of predictive abilities (AUROC 0.68-0.88) from relatively poor to good. Moderate hypoxic episodes were detected in seven individuals with similar predictive performance (AUROC 0.576-0.905). A variable performance in the predictive powers of this FD-NIRS device to detect changes in brain tissue oxygen was demonstrated. Consequently, this enhanced NIRS technology has not demonstrated sufficient ability to replace the established invasive measurement.	[Davies, David James; Clancy, Michael; Forcione, Mario; Yakoub, Kamal Makram; Belli, Antonio] Univ Hosp Birmingham NHS Fdn Trust, Natl Inst Hlth Res, Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Dehghani, Hamid] Univ Birmingham, Sch Comp Sci, Birmingham, W Midlands, England; [Lucas, Samuel John Edwin] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	Davies, DJ (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, NIHR, SRMRC, Old Queen Elizabeth Hosp, Heritage Bldg, Birmingham B15 2TH, W Midlands, England.	david.davies@uhb.nhs.uk	Belli, Antonio/I-3799-2015; Lucas, Samuel/J-4124-2014; Forcione, Mario/K-2852-2018	Belli, Antonio/0000-0002-3211-9933; Lucas, Samuel/0000-0002-8713-2457; Forcione, Mario/0000-0002-4045-8011; Dehghani, Hamid/0000-0003-4117-0412			Bekar A, 2009, J CLIN NEUROSCI, V16, P236, DOI 10.1016/j.jocn.2008.02.008; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clancy M., 2015, DIFFUSE OPT IMAGING, P9538; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Genbrugge C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0837-5; Ghosh A, 2012, ANESTH ANALG, V115, P1373, DOI 10.1213/ANE.0b013e31826dd6a6; GOPINATH SP, 1993, J NEUROSURG, V79, P43, DOI 10.3171/jns.1993.79.1.0043; Guyot LL, 1998, ACT NEUR S, V71, P47; Helliwell R., 2009, BR J NEUROSCI NURS, V5, P22; Kahraman S, 2006, J TRAUMA, V61, P1480, DOI 10.1097/01.ta.0000197616.10279.48; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; KNOPP JA, 1972, BIOCHIM BIOPHYS ACTA, V279, P393, DOI 10.1016/0304-4165(72)90158-4; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Manley GT, 2013, JAMA-J AM MED ASSOC, V310, P473, DOI 10.1001/jama.2013.169158; McMahon N, 2012, ANAESTHESIA, V67, P1343, DOI 10.1111/j.1365-2044.2012.07302.x; Minagawa-Kawai Y, 2008, DEV NEUROBIOL, V68, P712, DOI 10.1002/dneu.20618; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Sen AN, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031409; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Sussman ES, 2014, J NEUROSURG, V120, P931, DOI 10.3171/2013.12.JNS131685; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Vos JJ, 2014, BRIT J ANAESTH, V113, P67, DOI 10.1093/bja/aeu091; Weatherall A, 2012, ACTA ANAESTH SCAND, V56, P172, DOI 10.1111/j.1399-6576.2011.02591.x; White BR, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3368999; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278	30	13	15	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1175	1183		10.1089/neu.2018.5667		OCT 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HR6CL	WOS:000447717900001	29877139	Green Published			2021-06-18	
J	Toma, M; Nguyen, PDH				Toma, Milan; Nguyen, Paul D. H.			Fluid-structure interaction analysis of cerebrospinal fluid with a comprehensive head model subject to a rapid acceleration and deceleration	BRAIN INJURY			English	Article						Fluid-structure interaction; cerebral spinal fluid; comprehensive head model; brain injury; deceleration; acceleration	FINITE-ELEMENT; DRUG TRANSPORT; BRAIN; INJURIES; SIMULATION; TRAUMA; RAT	Primary Objective: Closed brain injuries are a common danger in contact sports and motorized vehicular collisions. Mild closed brain injuries, such as concussions, are not easily visualized by computed imaging or scans. Having a comprehensive head/brain model and using fluid-structure interaction (FSI) simulations enable us to see the exact movement of the cerebrospinal fluid (CSF) under such conditions and to identify the areas of brain most affected. Research Design: The presented work is based on the first FSI model capable of simulating the interaction between the CSF flow and brain. Methods and Procedures: FSI analysis combining smoothed-particle hydrodynamics and high-order finite-element method is used. Main Outcomes and Results: The interaction between the CSF and brain under rapid acceleration and deceleration is demonstrated. The cushioning effect of the fluid and its effect on brain are shown. Conclusions: The capability to locate areas (down to the exact gyri and sulci) of the brain the most affected under given loading conditions, and therefore assess the possible damage to the brain and consequently predict the symptoms, is shown.	[Toma, Milan] New York Inst Technol, Sch Engn & Comp Sci, Dept Mech Engn, Computat BioFSI Lab, Old Westbury, NY 11568 USA; [Nguyen, Paul D. H.] Penn State Coll Med, Hershey, PA USA	Toma, M (corresponding author), New York Inst Technol, Sch Engn & Comp Sci, Dept Mech Engn, Old Westbury Campus,HSH116A,Northern Blvd, Old Westbury, NY 11568 USA.	tomamil@tomamil.eu	Toma, Milan/D-4178-2011	Toma, Milan/0000-0003-2154-3728			Bailes JE, 2001, J ATHL TRAINING, V36, P236; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Battal B, 2011, BRIT J RADIOL, V84, P758, DOI 10.1259/bjr/66206791; Bei L, 2016, 8 INT C MEAS TECHN M, P756; Brodmann K., 1909, VERGLEICHENDE LOKALI; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; FRY FJ, 1978, J ACOUST SOC AM, V63, P1576, DOI 10.1121/1.381852; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Ghaffari M, 2017, COMPUT BIOL MED, V91, P353, DOI 10.1016/j.compbiomed.2017.10.028; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hsu CY, 2017, MAGN RESON MED, V77, P398, DOI 10.1002/mrm.26087; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Liang ZY, 2015, APPL BIONICS BIOMECH, V2015, P1, DOI 10.1155/2015/837585; Limited TCT Research (ed, 2012, CORT FUNCT; Linninger AA, 2008, J BIOMECH, V41, P2176, DOI 10.1016/j.jbiomech.2008.04.025; Linninger AA, 2016, ANNU REV FLUID MECH, V48, P219, DOI 10.1146/annurev-fluid-122414-034321; Liu GR., 2003, SMOOTHED PARTICLE HY, DOI [10.1142/5340, DOI 10.1142/5340, 10. 1142/5340]; Lui ACP, 1998, CAN J ANAESTH, V45, P297, DOI 10.1007/BF03012018; Luo YH, 2012, P I MECH ENG H, V226, P499, DOI 10.1177/0954411912445729; Madhukar A, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2881; Moore SW, 2011, DEV NEUROBIOL, V71, P1090, DOI 10.1002/dneu.20947; Morrison AL, 1998, AM J FOREN MED PATH, V19, P109, DOI 10.1097/00000433-199806000-00002; POIRIER MP, 2003, CLIN PEDIAT EMERG ME, V4, P179, DOI DOI 10.1016/S1522-8401(03)00061-2; Schonauer M, 1979, J Neurosurg Sci, V23, P279; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sweetman B, 2011, COMPUT BIOL MED, V41, P67, DOI 10.1016/j.compbiomed.2010.12.001; Tangen KM, 2015, J BIOMECH, V48, P2144, DOI 10.1016/j.jbiomech.2015.02.018; Toma M, 2010, INT J SIMUL MODEL, V9, P143, DOI 10.2507/IJSIMM09(3)3.164; Toma M, 2017, SIGNIFIC BIOENGG BIO, V1, pSBB000502; Toma M, 2016, INT J NUMER METH BIO, V33, P4, DOI 10. 1002/cnm. 2815; Toma M, 2016, COMPUT STRUCT, V173, P84, DOI 10.1016/j.compstruc.2016.06.001; Tyler WJ, 2012, NAT REV NEUROSCI, V13, P867, DOI 10.1038/nrn3383; Vorwerk J, 2012, BIOMED ENG-BIOMED TE, V57, P795, DOI [10.1515/bmt-2012-4152, 10.1515/btm-2012-4152]; Watanabe D, 2007, AUTOTECHNOLOGY, V7, P34	37	13	14	2	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2018	32	12					1576	1584		10.1080/02699052.2018.1502470			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GX0EO	WOS:000447382800017	30059633				2021-06-18	
J	Zhang, Y; Liu, YX; Xiao, QX; Liu, Q; Deng, R; Bien, J; Deng, IB; Al-Hawwas, M; Yu, FX				Zhang, Ying; Liu, Yue-Xin; Xiao, Qiu-Xia; Liu, Qing; Deng, Rui; Bien, Jiang; Deng, Isaac Bul; Al-Hawwas, Mohammed; Yu, Feng-Xu			Microarray Expression Profiles of lncRNAs and mRNAs in Postoperative Cognitive Dysfunction	FRONTIERS IN NEUROSCIENCE			English	Article						postoperative cognitive dysfunction; lncRNA; mRNA; Gene Ontology; genetic dysregulation; microarray analysis; bioinformatics analysis	LONG NONCODING RNAS; TRAUMATIC BRAIN-INJURY; TAU HYPERPHOSPHORYLATION; ALZHEIMERS-DISEASE; ELDERLY-PATIENTS; AGED RATS; SURGERY; GENE; NEUROINFLAMMATION; ANESTHESIA	Postoperative cognitive dysfunction (POCD) is serious disorder in the central nervous system common in aged patients after anesthesia. Although its clinical symptoms are well recognized, however, the molecular etiology of the POCD remains unrevealed. Similarly, neither gold standard molecular diagnosis nor effective treatment is available for POCD until the present. Therefore, we aimed to explore the molecular mechanism of this disorder through investigating lncRNAs and mRNAs associated with POCD human patients and investigate their underlying regulatory pathways. In this study, we recruited 200 patients requiring hip or knee replacement surgery. Their neurological functions were assessed at two time points, 1 day before the surgery and 30 days post-surgery. In parallel, serum samples were collected from the participants to analyze lncRNAs and mRNAs differential expression profile between POCD and non-POCD patients using microarray analysis. To further investigate the role differentially expressed mRNA and lncRNAs, Gene Ontology (GO), pathway analyses on mRNAs and lncRNA-mRNA interaction network were performed. As a result, 68 lncRNAs and 115 mRNAs were dysregulated in the POCD group compared to non-POCD group. Among them, the top 10 upregulated lncRNAs and 10 downregulated lncRNAs were listed for enrichment analysis. Interestingly, we found that these lncRNA and mRNA are involved in biological process, molecular function, and cellular component in addition to various signaling pathways, suggesting that the pathogenesis of POCD involves lncRNAs and mRNAs differential expression. Consequently, the genetic dysregulation between the non-POCD and POCD patients participates in the occurrence and development of POCD, and could be served as diagnostic biomarkers and drug targets for POCD treatment.	[Zhang, Ying; Liu, Yue-Xin; Xiao, Qiu-Xia; Liu, Qing; Deng, Rui; Bien, Jiang] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Dept Anesthesiol, Luzhou, Peoples R China; [Deng, Isaac Bul; Al-Hawwas, Mohammed] Univ South Australia, Sch Pharm & Med Sci, Sansom Inst Div Hlth Sci, Adelaide, SA, Australia; [Yu, Feng-Xu] Southwest Med Univ, Affiliated Hosp, Dept Cardiothorac Surg, Luzhou, Peoples R China	Yu, FX (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Cardiothorac Surg, Luzhou, Peoples R China.	yuluchuan@163.com		AL-HAWWAS, MOHAMMED/0000-0003-1778-4393			Aprahamian I, 2010, INT PSYCHOGERIATR, V22, P64, DOI 10.1017/S1041610209991141; Arora SS, 2014, INT J NEUROSCI, V124, P236, DOI 10.3109/00207454.2013.833919; Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Chandel NS, 2000, J IMMUNOL, V165, P1013, DOI 10.4049/jimmunol.165.2.1013; Chen RJ, 2016, NEUROSCIENCE, V319, P123, DOI 10.1016/j.neuroscience.2016.01.033; Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Duan XX, 2018, J THORAC CARDIOV SUR, V155, P958, DOI 10.1016/j.jtcvs.2017.07.073; Gong Y. X., 1992, HDB CHINESE ADAPTED; Gudenas BL, 2015, BIOINFORM BIOL INSIG, V9, P21, DOI 10.4137/BBI.S29435; Guennewig B, 2014, INT REV NEUROBIOL, V116, P153, DOI 10.1016/B978-0-12-801105-8.00007-2; Han CL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0496-y; Hartholt KA, 2012, Z GERONTOL GERIATR, V45, P411, DOI 10.1007/s00391-012-0326-2; Hu N, 2014, BRAIN RES, V1551, P13, DOI 10.1016/j.brainres.2014.01.015; Hu Y, 2017, INT J MOL MED, V39, P57, DOI 10.3892/ijmm.2016.2819; Isin M, 2015, CLIN CHIM ACTA, V444, P280, DOI 10.1016/j.cca.2015.02.046; Johansson P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176760; Kang MK, 2008, CELL PROLIFERAT, V41, P377, DOI 10.1111/j.1365-2184.2008.00537.x; Kong ZH, 2017, J MOL NEUROSCI, V63, P385, DOI 10.1007/s12031-017-0989-7; Krenk L, 2010, ACTA ANAESTH SCAND, V54, P951, DOI 10.1111/j.1399-6576.2010.02268.x; Liang YR, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0582-1; Liu XL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195659; Lou YH, 2018, INT J MOL MED, V42, P91, DOI 10.3892/ijmm.2018.3588; Lu SM, 2015, BRAIN BEHAV IMMUN, V44, P221, DOI 10.1016/j.bbi.2014.10.011; Lyu Q, 2017, CELL TRANSPLANT, V26, P1622, DOI 10.1177/0963689717723014; Maass PG, 2014, J MOL MED, V92, P337, DOI 10.1007/s00109-014-1131-8; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Mathew JP, 2003, STROKE, V34, P508, DOI 10.1161/01.STR.0000053844.09493.58; Min SW, 2018, J NEUROSCI, V38, P3680, DOI 10.1523/JNEUROSCI.2369-17.2018; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Muret K, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-016-0275-0; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Pappa Maria, 2017, Electron Physician, V9, P3768, DOI 10.19082/3768; Planel E, 2007, J NEUROSCI, V27, P3090, DOI 10.1523/JNEUROSCI.4854-06.2007; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Renard P, 1997, BIOCHEM PHARMACOL, V53, P149, DOI 10.1016/S0006-2952(96)00645-4; Valentin LSS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152308; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Shang JL, 2018, INT J MOL MED, V41, P2715, DOI 10.3892/ijmm.2018.3484; Silbert BS, 2014, BRIT J ANAESTH, V113, P784, DOI 10.1093/bja/aeu163; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Taniguchi M, 2017, NEURON, V96, P130, DOI 10.1016/j.neuron.2017.09.015; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Tian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141596; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vacas S, 2014, ANESTHESIOLOGY, V120, P1160, DOI 10.1097/ALN.0000000000000045; Van Blitterswijk M, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.04.016; van Dijk D, 2007, Ned Tijdschr Geneeskd, V151, P1163; van Harten AE, 2012, ANAESTHESIA, V67, P280, DOI 10.1111/j.1365-2044.2011.07008.x; Verma T, 2017, BIOMED PHARMACOTHER, V96, P736, DOI 10.1016/j.biopha.2017.09.150; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wang DQ, 2018, MOL THER-NUCL ACIDS, V10, P269, DOI 10.1016/j.omtn.2017.12.011; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wei CW, 2017, ONCOTARGET, V8, P55901, DOI 10.18632/oncotarget.18362; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013; Wu J, 2017, MOL MED REP, V16, P1846, DOI 10.3892/mmr.2017.6840; Wu ZP, 2018, EXP THER MED, V15, P878, DOI 10.3892/etm.2017.5480; Wynne A, 2010, CURR NEUROPHARMACOL, V8, P268, DOI 10.2174/157015910792246191; Xu J, 2012, CELL MOL NEUROBIOL, V32, P1343, DOI 10.1007/s10571-012-9860-0; Yan W, 2018, BIOCHEM BIOPH RES CO, V496, P1019, DOI 10.1016/j.bbrc.2017.12.149; Yi SQ, 2015, THORAC CARDIOV SURG, V63, P618, DOI 10.1055/s-0034-1393704; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang Q, 2018, BMC ANESTHESIOL, V18, DOI 10.1186/s12871-018-0501-0; Zhang X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0592-9; Zhang YN, 2016, MOL MED REP, V14, P2778, DOI 10.3892/mmr.2016.5556; Zhao FY, 2015, SCI REP-UK, V5, DOI 10.1038/srep13850; Zhao YH, 2017, ONCOTARGET, V8, P64827, DOI 10.18632/oncotarget.17472; Zhou XY, 2017, BRAIN RES BULL, V132, P190, DOI 10.1016/j.brainresbull.2017.06.001; Zizioli D, 2016, NEUROBIOL DIS, V85, P35, DOI 10.1016/j.nbd.2015.10.010	73	13	13	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	OCT 8	2018	12								694	10.3389/fnins.2018.00694			13	Neurosciences	Neurosciences & Neurology	GW1DR	WOS:000446611900001	30349449	DOAJ Gold, Green Accepted, Green Published			2021-06-18	
J	Bigler, ED				Bigler, Erin D.			Structural neuroimaging in sport-related concussion	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Computed tomography (CT); Magnetic resonance imaging (MRI); Sports-related concussion (SRC); Mild traumatic brain injury (mTBI); Quantitative neuroimaging; Diffusion tensor imaging	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; HIGH-SCHOOL FOOTBALL; WHITE-MATTER INTEGRITY; CAVUM SEPTUM PELLUCIDUM; HEAD IMPACT EXPOSURE; RETIRED NFL PLAYERS; DIFFUSION TENSOR; FUNCTIONAL CONNECTIVITY; PROFESSIONAL FOOTBALL	Structural neuroimaging of athletes who have sustained a sports-related concussion (SRC) can be viewed as either standard clinical imaging or with advanced neuroimaging methods that quantitatively assess brain structure. Negative findings from conventional computed tomography (CT) or magnetic resonance imaging (MRI) are the norm in SRC. Nonetheless, these conventional measures remain the first line of neuroimaging of the athlete as they do detect clinically significant pathologies, when present, such as hemorrhagic abnormalities in the form of hematomas, contusions and mircobleeds along with regions of focal encephalomalacia or other signal abnormalities, with CT best capable of detecting skull fractures. However, advanced neuroimaging techniques hold particular promise in detecting subtle neuropathology in the athlete which standard clinical neuroimaging cannot. To best understand what conventional as well as quantitative neuroimaging methods are detecting in SRC, this review begins by covering basic neuroanatomical principles associated with mild traumatic brain injury (mTBI) and the brain regions most vulnerable to injury from SRC, as these regions define where advanced neuroimaging methods most likely detect abnormalities. Advanced MRI techniques incorporate quantitative metrics that include volume, shape, thickness along with diffusion parameters that provide a more fine-grained analysis of brain structure. With advancements in image analysis, multiple quantitative neuroimaging metrics now can be utilized in assessing SRC. Such multimodality approaches are particularly relevant and important for assessing white matter and network integrity of the brain following injury, including SRC. This review focuses just on the structural side of neuroimaging in SRC, but these techniques also are being integrated with functional neuroimaging, where the combination of the two approaches may provide superior methods in assessing the pathological effects of SRC.	[Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, 1001 SWKT, Provo, UT 84602 USA	Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.; Bigler, ED (corresponding author), Brigham Young Univ, Neurosci Ctr, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu			Chronic Effects of Neurotrauma Consortium from the Department of Defense [W81XWH-13-2-0095]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX 002174]	No grant funding was used to write this review. Dr. Bigler co-directs the Neuropsychological Research and Assessment Laboratory at Brigham Young University, which does provide forensic consultation. During the writing of this review the Brain Imaging and Behavior Laboratory at Brigham Young University, which Dr. Bigler also directs was supported by funding from the Chronic Effects of Neurotrauma Consortium from the Department of Defense (W81XWH-13-2-0095) and the US Department of Veterans Affairs (I01 RX 002174). The views expressed here are those of the author and do not necessarily reflect the official policy of position of the Department of Defense, The Department of Veterans Affairs, nor the US Government. The assistance of Tracy Abildskov with illustrations and Jo Ann Petrie, Ph.D. with manuscript preparation is gratefully acknowledged.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Aviv RI, 2010, CAN ASSOC RADIOL J, V61, P29, DOI 10.1016/j.carj.2009.09.002; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Begonia MT, 2014, J BIOMECH, V47, P3704, DOI 10.1016/j.jbiomech.2014.09.026; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2016, BRAIN, V139, P3054, DOI 10.1093/brain/aww277; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00252; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Coughlin J. M, 2016, JAMA NEUROL, DOI [10.1001/jamaneuro1.2016.3764, DOI 10.1001/JAMANEURO1.2016.3764]; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cui JX, 2016, J NEUROPHYSIOL, V116, P2892, DOI 10.1152/jn.00603.2016; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Degen RM, 2016, PHYSICIAN SPORTSMED, V44, P324, DOI 10.1080/00913847.2016.1177475; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Etgen Thorleif, 2008, BMJ Case Rep, V2008, pbcr0620080024, DOI 10.1136/bcr.06.2008.0024; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Gangolli M, 2017, NEUROIMAGE, V153, P152, DOI 10.1016/j.neuroimage.2017.03.059; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Ibrahima F, 2015, INT J SURG CASE REP, V6, P203, DOI 10.1016/j.ijscr.2014.10.024; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; Insel TR, 2013, NEURON, V80, P561, DOI 10.1016/j.neuron.2013.09.041; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jackson GD, 2017, NEUROLOGY, V88, P2017, DOI 10.1212/WNL.0000000000003962; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Kamins J, 2017, BR J SPORTS MED; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kikinis R., 2015, BRAIN INFORM, V2, P167, DOI [10.1007/s40708-015-0019-x, DOI 10.1007/S40708-015-0019-X]; Koerte I.K., 2016, TRANSLATIONAL RES TR; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kuhn Andrew W, 2016, Neurosurgery, V63 Suppl 1, P173, DOI 10.1227/01.neu.0000489753.67038.ae; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Martin G, 2016, BRAIN INJURY, V30, P1517, DOI 10.1080/02699052.2016.1192683; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2017, BITISH J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merritt VC, 2016, J CLIN EXP NEUROPSYC, V38, P941, DOI 10.1080/13803395.2016.1177491; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Monea AG, 2014, J MECH BEHAV BIOMED, V33, P3, DOI 10.1016/j.jmbbm.2013.06.011; Morris Saint-Aaron, 2014, Neurosurgery, V75 Suppl 4, pS96, DOI 10.1227/NEU.0000000000000465; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Omidvarnia A, 2017, NEUROIMAGE-CLIN, V15, P682, DOI 10.1016/j.nicl.2017.05.019; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Raji CA, 2016, AM J GERIAT PSYCHIAT, V24, P784, DOI 10.1016/j.jagp.2016.07.018; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruff RM, 1999, BRAIN INJURY, V13, P943; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shaker M, 2017, MED IMAGE ANAL, V37, P56, DOI 10.1016/j.media.2017.01.005; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shetty T, 2016, SPORTS HEALTH, V8, P26, DOI 10.1177/1941738115588745; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Singh S, 2017, J BIOMECH, V51, P32, DOI 10.1016/j.jbiomech.2016.11.055; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Terry DP, 2018, BRAIN IMAGING BEHAV, V12, P631, DOI 10.1007/s11682-017-9719-6; Toth A., 2015, BRAIN NEUROTRAUMA MO; Treister Daniel S, 2014, Case Rep Radiol, V2014, P143408, DOI 10.1155/2014/143408; Tremblay S, 2017, EUR J NEUROSCI, V46, P1956, DOI 10.1111/ejn.13583; Turner R. C, 2016, BRAIN INJURY, P1, DOI [10.1080/02699052.2016, DOI 10.1080/02699052.2016]; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Van Horn JD, 2014, BRAIN IMAGING BEHAV, V8, P323, DOI 10.1007/s11682-013-9255-y; van Kleeck A, 2010, AM J SPEECH-LANG PAT, V19, P341, DOI 10.1044/1058-0360(2010/09-0038); Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; von Holst H, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00023; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Wilde EA, 2012, NEUROREHABILITATION, V31, P227, DOI 10.3233/NRE-2012-0793; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Xue WQ, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00022; Yu Z, 2009, J NEUROTRAUM, V26, P1135, DOI 10.1089/neu.2008.0810; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	189	13	13	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		105	123		10.1016/j.ijpsycho.2017.09.006			19	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000015	28916167				2021-06-18	
J	Moquin, A; Ji, J; Neibert, K; Winnik, FM; Maysinger, D				Moquin, Alexandre; Ji, Jeff; Neibert, Kevin; Winnik, Francoise M.; Maysinger, Dusica			Encapsulation and Delivery of Neutrophic Proteins and Hydrophobic Agents Using PMOXA-PDMS-PMOXA Triblock Polymersomes	ACS OMEGA			English	Article							NERVE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; DRUG-DELIVERY; TGF-BETA; CANCER; DOXORUBICIN; COPOLYMER; EXOSOMES; CURCUMIN	Polymersomes are attractive nanocarriers for hydrophilic and lipophilic drugs; they are more stable than liposomes, tunable, and relatively easy to prepare. The copolymer composition and molar mass are critical features that determine the physicochemical properties of the polymersomes including the rate of drug release. We used the triblockcopolymer, poly(2-methyl-2-oxazoline)-block-poly-(dimethysiloxane)-block-poly(2-methyl-2-oxazoline) (PIVIOXA-PDIVIS-PMOXA), to form amphipathic polymersomes capable of loading proteins and small hydrophobic agents. The selected agents were unstable neurotrophins (nerve growth factor and brain -derived neurotrophic factor), a large protein CD109, and the fluorescent drug curcumin. We prepared, characterized, and tested polymersomes loaded with selected agents in 2D and 3D biological models. Curcumin-loaded and rhodamine-bound PMOXA-PDMS-PMOXA polymersomes were used to visualize them inside cells. NMethyl-D-aspartate receptor (NNIDAR) agonists and antagonists were also covalently attached to the surface of polymersomes for targeting neurons. Labeled and unlabeled polymersomes with or without loaded agents were characterized using dynamic light scattering (DLS), UV-vis fluorescence spectroscopy, and asymmetrical flow field-flow fractionation (AF(4)). Polymersomes were imaged and tested for biological activity in human and murine fibroblasts, murine macrophages, primary murine dorsal root ganglia, and murine hippocampal cultures. Polymersomes were rapidly internalized and there was a clear intracellular co-localization of the fluorescent drug (curcumin) with the fluorescent rhodamine-labeled polymersomes. Polymersomes containing CD109, a glycosylphosphatidylinositol-anchored protein, promoted cell migration in the model of wound healing. Nerve growth factor-loaded polymersomes effectively enhanced neurite outgrowth in dissociated and explanted dorsal root ganglia. Brain -derived neurotrophic factor increased dendritic spine density in serum-deprived hippocampal slice cultures. NMDAR agonist-and antagomst-functionalized polymersomes targeted selectively neurons over filial cells in mixed cultures. Collectively, the study reveals the successful incorporation into polymersomes of biologically active trophic factors and small hydrophilic agents that retain their biological activity in vitro, as demonstrated in selected central and peripheral tissue models.	[Moquin, Alexandre; Ji, Jeff; Neibert, Kevin; Maysinger, Dusica] McGill Univ, Dept Pharmacol & Therapeut, Fac Med, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada; [Winnik, Francoise M.] Univ Montreal, Dept Chim, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Winnik, Francoise M.] NIMS, Int Ctr Mat Nanoarchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Winnik, Francoise M.] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland	Maysinger, D (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Fac Med, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	dusica.maysinger@mcgill.ca		Maysinger, Dusica/0000-0002-0017-5201	Natural Sciences and Engineering Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This work was supported by a grant from Natural Sciences and Engineering Council of Canada (F.M.W. and D.M.) and Canadian Institutes for Health Research (CIHR) to D.M.	Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Akbik D, 2014, LIFE SCI, V116, P1, DOI 10.1016/j.lfs.2014.08.016; Anajafi T, 2017, MOL PHARMACEUT, V14, P1916, DOI 10.1021/acs.molpharmaceut.7b00014; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ayen WY, 2012, PHARM RES-DORDR, V29, P2522, DOI 10.1007/s11095-012-0783-8; Bai LC, 2014, J MATER CHEM B, V2, P7785, DOI 10.1039/c4tb01383b; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; BOCCHINI V, 1970, EUR J BIOCHEM, V15, P127, DOI 10.1111/j.1432-1033.1970.tb00986.x; Calfa G, 2012, HIPPOCAMPUS, V22, P1493, DOI 10.1002/hipo.20990; Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen Y, 2015, ACS APPL MATER INTER, V7, P2919, DOI 10.1021/am508399w; Christian DA, 2009, EUR J PHARM BIOPHARM, V71, P463, DOI 10.1016/j.ejpb.2008.09.025; Cummings KA, 2015, J GEN PHYSIOL, V145, P513, DOI 10.1085/jgp.201411302; De Oliveira H, 2012, WIRES NANOMED NANOBI, V4, P525, DOI 10.1002/wnan.1183; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Elkabes S, 1996, J NEUROSCI, V16, P2508; Fang Y, 2017, SLAS DISCOV, V22, P456, DOI 10.1177/1087057117696795; Finetti F, 2013, IMMUNOL REV, V251, P97, DOI 10.1111/imr.12018; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gantwerker EA, 2012, CLIN PLAST SURG, V39, P85, DOI 10.1016/j.cps.2011.09.005; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; GERONEMUS RG, 1979, ARCH DERMATOL, V115, P1311, DOI 10.1001/archderm.115.11.1311; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guan LJ, 2015, NANOMEDICINE-UK, V10, P2757, DOI 10.2217/nnm.15.110; HEFTI F, 1986, J NEUROSCI, V6, P2155; Hermes B, 2001, J INVEST DERMATOL, V116, P387, DOI 10.1046/j.1523-1747.2001.01284.x; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kawamoto K, 2004, PROG BRAIN RES, V146, P369; Kempe K, 2010, MACROMOL RAPID COMM, V31, P1869, DOI 10.1002/marc.201000283; KJOLSETH D, 1994, J AM COLL SURGEONS, V179, P305; Krausz AE, 2015, NANOMED-NANOTECHNOL, V11, P195, DOI 10.1016/j.nano.2014.09.004; Kulac M, 2013, J MOL HISTOL, V44, P83, DOI 10.1007/s10735-012-9452-9; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Le Meins JF, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11014-y; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Lee JS, 2012, J CONTROL RELEASE, V161, P473, DOI 10.1016/j.jconrel.2011.10.005; Leitman J, 2013, DNA CELL BIOL, V32, P2, DOI 10.1089/dna.2012.1889; Li C, 2016, BIOCHEM J, V473, P537, DOI 10.1042/BJ20141488; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Ma PL, 2010, BIOMACROMOLECULES, V11, P549, DOI 10.1021/bm901345q; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Maysinger D, 2018, ACS CHEM NEUROSCI, V9, P260, DOI 10.1021/acschemneuro.7b00301; Medda L, 2015, CHEM COMMUN, V51, P6663, DOI 10.1039/c5cc01538c; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Mondal S, 2016, J PHOTOCH PHOTOBIO B, V158, P212, DOI 10.1016/j.jphotobiol.2016.03.004; Morimoto N, 2014, CHEM COMMUN, V50, P8350, DOI 10.1039/c4cc03199g; Muller LK, 2015, BIOCHEM BIOPH RES CO, V468, P411, DOI 10.1016/j.bbrc.2015.08.088; Nakajima K, 2001, J NEUROSCI RES, V65, P322, DOI 10.1002/jnr.1157; Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u; Oltra NS, 2014, ANNU REV CHEM BIOMOL, V5, P281, DOI 10.1146/annurev-chembioeng-060713-040447; Onaca O, 2009, MACROMOL BIOSCI, V9, P129, DOI 10.1002/mabi.200800248; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Saari H., 2015, J CONTROL RELEASE, V10, P2963; Sakane T, 1997, PHARMACEUT RES, V14, P1085, DOI 10.1023/A:1012117815460; Saman S, 2014, J ALZHEIMERS DIS, V40, pS47, DOI 10.3233/JAD-132135; Sampey GC, 2014, J NEUROVIROL, V20, P199, DOI 10.1007/s13365-014-0238-6; Song JB, 2015, ACCOUNTS CHEM RES, V48, P2506, DOI 10.1021/acs.accounts.5b00059; Stoenescu R, 2004, MACROMOL BIOSCI, V4, P930, DOI 10.1002/mabi.200400065; Stroncek John D., 2008, P3; Tam J, 2002, BIOCHEM BIOPH RES CO, V291, P649, DOI 10.1006/bbrc.2002.6497; Tran TH, 2015, CLIN IMMUNOL, V160, P46, DOI 10.1016/j.clim.2015.03.021; Toffoli G., 2015, NANOMEDICINE, V40, pS47; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Upadhyay KK, 2010, MACROMOL BIOSCI, V10, P503, DOI 10.1002/mabi.200900415; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Vorstenbosch J, 2017, J INVEST DERMATOL, V137, P641, DOI 10.1016/j.jid.2016.09.039; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Yallapu MM, 2015, AAPS J, V17, P1341, DOI 10.1208/s12248-015-9811-z; Yildirim T, 2017, BIOMACROMOLECULES, V18, P3280, DOI 10.1021/acs.biomac.7b00931; Zaretski AV, 2016, NANO LETT, V16, P1375, DOI 10.1021/acs.nanolett.5b04821; Zhao LX, 2014, BIOMATERIALS, V35, P1284, DOI 10.1016/j.biomaterials.2013.10.063; Zheng XJ, 2015, J MATER CHEM B, V3, P1921, DOI 10.1039/c4tb01766h; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52; Zou T, 2015, J BIOTECHNOL, V214, P147, DOI 10.1016/j.jbiotec.2015.09.034	83	13	13	4	20	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	OCT	2018	3	10					13882	13893		10.1021/acsomega.8b02311			12	Chemistry, Multidisciplinary	Chemistry	GZ0CZ	WOS:000449026500168	30411053	DOAJ Gold, Green Published			2021-06-18	
J	Tsai, YR; Chang, CF; Lai, JH; Wu, JCC; Chen, YH; Kang, SJ; Hoffer, BJ; Tweedie, D; Luo, WM; Greig, NH; Chiang, YH; Chen, KY				Tsai, Yan-Rou; Chang, Cheng-Fu; Lai, Jing-Huei; Wu, John Chung-Che; Chen, Yen-Hua; Kang, Shuo-Jhen; Hoffer, Barry J.; Tweedie, David; Luo, Weiming; Greig, Nigel H.; Chiang, Yung-Hsiao; Chen, Kai-Yun			Pomalidomide Ameliorates H2O2-Induced Oxidative Stress Injury and Cell Death in Rat Primary Cortical Neuronal Cultures by Inducing Anti-Oxidative and Anti-Apoptosis Effects	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						pomalidomide; neuroprotection; oxidative stress; ischemia; stroke; neurodegeneration	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; NEURODEGENERATIVE DISEASES; CEREBRAL-ISCHEMIA; ALZHEIMERS-DISEASE; ZEBRAFISH EMBRYOS; DAMAGE; ACTIVATION; NEUROINFLAMMATION; NEUROPROTECTION	Due to its high oxygen demand and abundance of peroxidation-susceptible lipid cells, the brain is particularly vulnerable to oxidative stress. Induced by a redox state imbalance involving either excessive generation of reactive oxygen species (ROS) or dysfunction of the antioxidant system, oxidative stress plays a central role in a common pathophysiology that underpins neuronal cell death in acute neurological disorders epitomized by stroke and chronic ones such as Alzheimer's disease. After cerebral ischemia, for example, inflammation bears a key responsibility in the development of permanent neurological damage. ROS are involved in the mechanism of post-ischemic inflammation. The activation of several inflammatory enzymes produces ROS, which subsequently suppress mitochondrial activity, leading to further tissue damage. Pomalidomide (POM) is a clinically available immunomodulatory and anti-inflammatory agent. Using H2O2-treated rat primary cortical neuronal cultures, we found POM displayed neuroprotective effects against oxidative stress and cell death that associated with changes in the nuclear factor erythroid derived 2/superoxide dismutase 2/catalase signaling pathway. POM also suppressed nuclear factor kappa-light-chain-enhancer (NF-B) levels and significantly mitigated cortical neuronal apoptosis by regulating Bax, Cytochrome c and Poly (ADP-ribose) polymerase. In summary, POM exerted neuroprotective effects via its anti-oxidative and anti-inflammatory actions against H2O2-induced injury. POM consequently represents a potential therapeutic agent against brain damage and related disorders and warrants further evaluation.	[Tsai, Yan-Rou; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 11031, Taiwan; [Tsai, Yan-Rou; Chiang, Yung-Hsiao; Chen, Kai-Yun] Natl Hlth Res Inst, Taipei 11031, Taiwan; [Tsai, Yan-Rou; Chang, Cheng-Fu; Lai, Jing-Huei; Wu, John Chung-Che; Chen, Yen-Hua; Kang, Shuo-Jhen; Hoffer, Barry J.; Chiang, Yung-Hsiao; Chen, Kai-Yun] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 11031, Taiwan; [Chang, Cheng-Fu] Taipei City Hosp, Zhongxiao Branch, Dept Neurosurg, Taipei 11556, Taiwan; [Chang, Cheng-Fu; Lai, Jing-Huei; Wu, John Chung-Che; Chen, Yen-Hua; Kang, Shuo-Jhen; Chiang, Yung-Hsiao] Taipei Med Univ, Dept Surg, Coll Med, Taipei 11031, Taiwan; [Wu, John Chung-Che; Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 11031, Taiwan; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Tweedie, David; Luo, Weiming; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program,NIH, Bethesda, MD 20892 USA	Chiang, YH; Chen, KY (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Neural Regenerat Med, Taipei 11031, Taiwan.; Chiang, YH; Chen, KY (corresponding author), Natl Hlth Res Inst, Taipei 11031, Taiwan.; Chiang, YH; Chen, KY (corresponding author), Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei 11031, Taiwan.; Chiang, YH (corresponding author), Taipei Med Univ, Dept Surg, Coll Med, Taipei 11031, Taiwan.; Chiang, YH (corresponding author), Taipei Med Univ Hosp, Dept Neurosurg, Taipei 11031, Taiwan.	aggytsai@hotmail.com; chang3@ms3.hinet.net; m105095006@tmu.edu.tw; dr.jcwu@gmail.com; swallows3366@gmail.com; terbiun@gmail.com; bhoffer@intra.nida.nih.gov; tweedieda@grc.nia.nih.gov; luowe@grc.nia.nih.gov; greign@grc.nia.nih.gov; ychiang@tmu.edu.tw; kychen08@tmu.edu.tw			Ministry of Science and Technology [MOST-102-2314-B-038-025-MY3, MOST-105-2314-532-008, MOST 107-2314-B-038-042]; Taipei Medical University [TMU102-AE1-B27, TMU105-AE1-B03]; Intramural Research Program of the National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000469, ZIAAG000994] Funding Source: NIH RePORTER	This study was supported in part by (i) the Ministry of Science and Technology, Grant numbers MOST-102-2314-B-038-025-MY3, MOST-105-2314-532-008 and MOST 107-2314-B-038-042, (ii) Taipei Medical University TMU102-AE1-B27 and TMU105-AE1-B03 and (iii) the Intramural Research Program of the National Institute on Aging, NIH.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Ahn J, 2006, CLIN CANCER RES, V12, P7063, DOI 10.1158/1078-0432.CCR-06-0039; Becker RE, 2018, ALZHEIMERS DEMENT, V14, P431, DOI 10.1016/j.jalz.2017.11.007; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Chanan-Khan AA, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.38; Chang CF, 2002, NEUROPHARMACOLOGY, V43, P418, DOI 10.1016/S0028-3908(02)00092-8; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Clark IA, 2018, BRIT J PHARMACOL, V175, P3859, DOI 10.1111/bph.14471; Collins TR, 2017, NEUROL TODAY, V17, P1, DOI [10.1097/01.NT.0000527316.80068.88, DOI 10.1097/01.NT.0000527316.80068.88]; Deb P., 2010, PATHOPHYSIOLOGY, V17, P197, DOI DOI 10.1016/J.PATHOPHYS.2009.12.001; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; European Medicines Agency, ASS REP POM CELG; Evans MD, 2004, BIOESSAYS, V26, P533, DOI 10.1002/bies.20027; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Han Z, 2016, EUR J PHARMACOL, V777, P129, DOI 10.1016/j.ejphar.2016.03.006; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hoffmann M, 2013, CANCER CHEMOTH PHARM, V71, P489, DOI 10.1007/s00280-012-2040-6; Hu Y, 2015, INT J MOL SCI, V16, P24895, DOI 10.3390/ijms161024895; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kalaria RN, 2018, NEUROPHARMACOLOGY, V134, P226, DOI 10.1016/j.neuropharm.2017.12.030; KALARIA RN, 1993, ANN NY ACAD SCI, V695, P190, DOI 10.1111/j.1749-6632.1993.tb23050.x; Kalaria RN, 2000, NEUROBIOL AGING, V21, P321, DOI 10.1016/S0197-4580(00)00125-1; Kalogeris T, 2014, REDOX BIOL, V2, P702, DOI 10.1016/j.redox.2014.05.006; Knecht T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122756; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kunz A, 2008, J NEUROSCI, V28, P1649, DOI 10.1523/JNEUROSCI.5205-07.2008; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Li YZ, 2017, EXP NEUROL, V288, P104, DOI 10.1016/j.expneurol.2016.11.010; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Liska Grant M, 2018, Cond Med, V1, P151; Liu PK, 1996, J NEUROSCI, V16, P6795; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Mahony C, 2013, P NATL ACAD SCI USA, V110, P12703, DOI 10.1073/pnas.1307684110; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Neuhaus AA, 2017, BRAIN, V140, P2079, DOI 10.1093/brain/awx126; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Pena Ike Dela, 2017, J Stroke, V19, P50, DOI 10.5853/jos.2016.01515; Perry G, 2002, FREE RADICAL BIO MED, V33, P1475, DOI 10.1016/S0891-5849(02)01113-9; Popa-Wagner A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020356; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Sugawara T, 2003, ANTIOXID REDOX SIGN, V5, P597, DOI 10.1089/152308603770310266; Sugawara Taku, 2004, NeuroRx, V1, P17, DOI 10.1602/neurorx.1.1.17; Terpos E, 2013, ONCOTARGETS THER, V6, P531, DOI 10.2147/OTT.S34498; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Vargesson N, 2013, P NATL ACAD SCI USA, V110, pE4820, DOI 10.1073/pnas.1318475110; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang JY, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0631-6; Wang Y, 2001, STROKE, V32, P2170, DOI 10.1161/hs0901.095650; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Weinberger JM, 2006, J NEUROL SCI, V249, P101, DOI 10.1016/j.jns.2006.06.010; World Health Organisation (WHO), TOP 10 CAUS DEATH; Zhang JX, 2017, INT J MOL MED, V39, P603, DOI 10.3892/ijmm.2017.2882; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	63	13	13	1	7	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1422-0067		INT J MOL SCI	Int. J. Mol. Sci.	OCT	2018	19	10							3252	10.3390/ijms19103252			15	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	GY9HB	WOS:000448951000407	30347766	DOAJ Gold, Green Published			2021-06-18	
J	Vieira, E; Guimaraes, TC; Faquini, IV; Silva, JL; Saboia, T; Andrade, RVCL; Gemir, TL; Neri, VC; Almeida, NS; Azevedo, HRC				Vieira, Eduardo; Guimaraes, Thiago C.; Faquini Jr, Igor, V; Silva, Jose L.; Saboia, Tammy; Andrade, Rodrigo V. C. L.; Gemir, Thais L.; Neri, Valesca C.; Almeida, Nivaldo S.; Azevedo-Filho, Hildo R. C.			Randomized controlled study comparing 2 surgical techniques for decompressive craniectomy: with watertight duraplasty and without watertight duraplasty	JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; traumatic brain injury; brain edema; duraplasty	TRAUMATIC BRAIN-INJURY; CRANIOTOMY; EFFICACY; FLAP	OBJECTIVE Decompressive craniectomy (DC) is a widely used procedure in neurosurgery; however, few studies focus on the best surgical technique for the procedure. The authors' objective was to conduct a prospective randomized controlled trial comparing 2 techniques for performing DC: with watertight duraplasty and without watertight duraplasty (rapid-closure DC). METHODS The study population comprised patients ranging in age from 18 to 60 years who were admitted to the Neurotrauma Service of the Hospital da Restauracao with a clinical indication for unilateral decompressive craniectomy. Patients were randomized by numbered envelopes into 2 groups: with watertight duraplasty (control group) and without watertight duraplasty (test group). After unilateral DC was completed, watertight duraplasty was performed in the control group, while in the test group, no watertight duraplasty was performed and the exposed parenchyma was covered with Surgicel and the remaining dura mater. Patients were then monitored daily from the date of surgery until hospital discharge or death. The primary end point was the incidence of surgical complications (CSF leak, wound infection, brain abscess, or subgaleal fluid collections). The following were analyzed as secondary end points: clinical outcome (analyzed using the Glasgow Outcome Scale [GOS]), surgical time, and hospital costs. RESULTS Fifty-eight patients were enrolled, 29 in each group. Three patients were excluded, leaving 27 in the test group and 28 in the control group. There were no significant differences between groups regarding age, Glasgow Coma Scale score at the time of surgery, GOS score, and number of postoperative follow-up days. There were 9 surgical complications (5 in the control group and 4 in the test group), with no significant differences between the groups. The mean surgical time in the control group was 132 minutes, while in the test group the average surgical time was 101 minutes, a difference of 31 minutes (p = 0.001). The mean reduction in total cost was $420.00 USD (a 23.4% reduction) per procedure in the test group. CONCLUSIONS Rapid-closure DC without watertight duraplasty is a safe procedure. It is not associated with a higher incidence of surgical complications (CSF leak, wound infection, brain abscess, or subgaleal fluid collections), and it decreased surgical time by 31 minutes on average. There was also a hospital cost reduction of $420.00 USD (23.4% reduction) per procedure.	[Vieira, Eduardo; Guimaraes, Thiago C.; Faquini Jr, Igor, V; Silva, Jose L.; Saboia, Tammy; Andrade, Rodrigo V. C. L.; Gemir, Thais L.; Neri, Valesca C.; Almeida, Nivaldo S.; Azevedo-Filho, Hildo R. C.] Hosp Restauracao, Dept Neurol Surg, Ave Agamenon Magalhaes SN, BR-52010040 Recife, PE, Brazil	Vieira, E (corresponding author), Hosp Restauracao, Dept Neurol Surg, Ave Agamenon Magalhaes SN, BR-52010040 Recife, PE, Brazil.	evcj2005@gmail.com	Faquini, Igor/S-4936-2019	Faquini, Igor/0000-0002-1538-396X			Barth M, 2008, NEUROSURGERY, V63, P352, DOI 10.1227/01.NEU.0000310696.52302.99; Csokay A, 2002, SURG NEUROL, V57, P126, DOI 10.1016/S0090-3019(01)00686-3; Cushing H, 1908, SURGERY ITS PRINCIPL, P17; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Holland M, 2004, OPER TECH NEUROSURG, V7, P10; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kempe LK, 2004, KEMPES OPERATIVE NEU, V1, P170; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; KHOO JCM, 1976, J NEUROSURG, V45, P589, DOI 10.3171/jns.1976.45.5.0589; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Peethambaran AK, 2012, NEUROL INDIA, V60, P672, DOI 10.4103/0028-3886.105221; Ragel BT, NEUROSURG FOCUS, V28, pE2; Sade B, 2011, J NEUROSURG, V114, P714, DOI 10.3171/2010.7.JNS10460; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Valenca MM, 2010, J NEUROSURG, V113, P982, DOI 10.3171/2009.11.JNS09674; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	20	13	13	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2018	129	4					1017	1023		10.3171/2017.4.JNS152954			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GV4QL	WOS:000446085200020	29148904	Bronze			2021-06-18	
J	Maneshi, MM; Ziegler, L; Sachs, F; Hua, SZ; Gottlieb, PA				Maneshi, Mohammad M.; Ziegler, Lynn; Sachs, Frederick; Hua, Susan Z.; Gottlieb, Philip A.			Enantiomeric A beta peptides inhibit the fluid shear stress response of PIEZO1	SCIENTIFIC REPORTS			English	Article							ION-CHANNEL PIEZO1; AMYLOID-BETA; MECHANOSENSITIVE CHANNELS; ALZHEIMERS-DISEASE; CELL; FORCE; PROTEIN; GSMTX4; ORIENTATION; MUTATIONS	Traumatic brain injury (TBI) elevates Abeta (A beta) peptides in the brain and cerebral spinal fluid. A beta peptides are amphipathic molecules that can modulate membrane mechanics. Because the mechanosensitive cation channel PIEZO1 is gated by membrane tension and curvature, it prompted us to test the effects of A beta on PIEZO1. Using precision fluid shear stress as a stimulus, we found that A beta monomers inhibit PIEZO1 at femtomolar to picomolar concentrations. The A beta oligomers proved much less potent. The effect of A beta s on Piezo gating did not involve peptide-protein interactions since the D and L enantiomers had similar effects. Incubating a fluorescent derivative of A beta and a fluorescently tagged PIEZO1, we showed that A beta can colocalize with PIEZO1, suggesting that they both had an affinity for particular regions of the bilayer. To better understand the PIEZO1 inhibitory effects of A beta, we examined their effect on wound healing. We observed that over-expression of PIEZO1 in HEK293 cells increased cell migration velocity similar to 10-fold, and both enantiomeric A beta peptides and GsMTx4 independently inhibited migration, demonstrating involvement of PIEZO1 in cell motility. As part of the motility study we examined the correlation of PIEZO1 function with tension in the cytoskeleton using a genetically encoded fluorescent stress probe. A beta peptides increased resting stress in F-actin, and is correlated with A beta block of PIEZO1-mediated Ca2+ influx. A beta inhibition of PIEZO1 in the absence of stereospecific peptide-protein interactions shows that A beta peptides modulate both cell membrane and cytoskeletal mechanics to control PIEZO1-triggered Ca2+ influx.	[Maneshi, Mohammad M.; Ziegler, Lynn; Sachs, Frederick; Hua, Susan Z.; Gottlieb, Philip A.] SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14214 USA; [Maneshi, Mohammad M.; Hua, Susan Z.] SUNY Buffalo, Dept Mech & Aerosp Engn, 340 Jarvis Hall, Buffalo, NY 14260 USA; [Maneshi, Mohammad M.] Feinberg Sch Med, 745 N Fairbanks,Tarry 7-718, Chicago, IL 60611 USA	Gottlieb, PA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14214 USA.	philgott@buffalo.edu	Gottlieb, Philip/C-3113-2019	Gottlieb, Philip/0000-0003-3764-9885; sachs, frederick/0000-0002-4324-2240	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL054887]; National Institute of Health grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS085517]; National Science FoundationNational Science Foundation (NSF) [CMMI-1537239]	This work was supported by National Institutes of Health (HL054887) to F.S., and the National Institute of Health grant (NS085517) and National Science Foundation (CMMI-1537239) to S.Z.H. We thank Seth Alper and Olaf Andersen for their thoughtful comments, and Shermali Gunawardena (SUNY at Buffalo) for the APP-YFP clone. We also thank Wade Sigurdson and the UB confocal imaging facility for assistance with high resolution imaging.	Anishkin A, 2013, P NATL ACAD SCI USA, V110, P4886, DOI 10.1073/pnas.1302018110; Bae C, 2015, J BIOL CHEM, V290, P5167, DOI 10.1074/jbc.M114.604033; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Beaven AH, 2017, BIOPHYS J, V112, P1185, DOI 10.1016/j.bpj.2017.01.028; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Blumenthal NR, 2014, P NATL ACAD SCI USA, V111, P16124, DOI 10.1073/pnas.1412740111; Cox CD, 2017, CURR TOP MEMBR, V79, P59, DOI 10.1016/bs.ctm.2016.09.001; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gnanasambandam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125503; Gnanasambandam R, 2013, BIOPHYS J, V104, p467A, DOI 10.1016/j.bpj.2012.11.2583; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guo J, 2014, P NATL ACAD SCI USA, V111, pE5252, DOI 10.1073/pnas.1411683111; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; HIJMANS W, 1979, CLIN EXP IMMUNOL, V35, P96; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Maneshi MM, 2017, CURR TOP MEMBR, V79, P309, DOI 10.1016/bs.ctm.2016.11.005; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Markin V S, 2015, Open J Biophys, V5, P80; McHugh BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040346; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Meng F., 2018, BIOPHYS J; Meng FJ, 2012, J CELL SCI, V125, P743, DOI 10.1242/jcs.093104; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nishizawa K, 2015, BBA-BIOMEMBRANES, V1848, P2767, DOI 10.1016/j.bbamem.2015.09.003; Nourse JL, 2017, SEMIN CELL DEV BIOL, V71, P3, DOI 10.1016/j.semcdb.2017.06.018; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Qi YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9512; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Sachs F, 2018, BIOPHYS J, V114, P3, DOI 10.1016/j.bpj.2017.10.035; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Syeda R, 2016, CELL REP, V17, P1739, DOI 10.1016/j.celrep.2016.10.033; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x	48	13	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 24	2018	8								14267	10.1038/s41598-018-32572-2			10	Multidisciplinary Sciences	Science & Technology - Other Topics	GU5OL	WOS:000445336600035	30250223	DOAJ Gold, Green Published			2021-06-18	
J	Gorse, KM; Lafrenaye, AD				Gorse, Karen M.; Lafrenaye, Audrey D.			The Importance of Inter-Species Variation in Traumatic Brain Injury-Induced Alterations of Microglial-Axonal Interactions	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; microglia; axonal injury; microglial-neuronal interaction; rat; micro pig; species differences	INTRACRANIAL-PRESSURE; INFLAMMATION; ISOFLURANE; CELLS; ACTIVATION; RECEPTORS; NEURONS; FLUID; TIME	Interactions between microglia and neuronal components are important for normal CNS function. They are also associated with neuroinflammation and many pathological processes and several studies have explored these interactions in terms of phagocytic engulfment. Much progress has also been made in understanding the consequences of chronic neuroinflammatory changes following trauma. However, little is known about acute alterations to these physical non-phagocytic microglial-neuronal interactions following traumatic brain injury (TBI), and particularly to what degree these post-injury interactions may be influenced by the animal species utilized in pre-clinical models of TBI. To investigate these problems, we evaluated the physical interactions between microglia and injured axons acutely (6 h and 1 day) following central fluid percussion injury (cFPI) in both rats and micro pigs. The physical interactions between lba-1+ microglia and either normal MBP+myelinated fibers or APP+ injured axonal swellings in the thalamus were assessed following injury or sham via quantitative image analysis of 3D confocal micrographs. The results indicated that the physical interactions between microglia and injured axonal swellings decreased by nearly half in rats 6 h following cFPI but was consistent with sham control at 1 day post-cFPI. This reduction was also observed in non-injured intact fibers at both timepoints following TBI in the rat. Microglial process interactions with injured axons in the micro pig, however, increased nearly 2-fold compared to interactions with intact axonal segments 1 day post-cFPI. This study shows that the species utilized for in vivo pre-clinical studies influences the manner in which microglial-axonal interactions change following TBI. These species differences can be leveraged to further our understanding of the mechanisms involved in microglial process convergence and how these neuro-immune interactions alter the progression of axonal injury following TBI.	[Gorse, Karen M.; Lafrenaye, Audrey D.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Lafrenaye, AD (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	audrey.lafrenaye@vcuhealth.org			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS096143]; U.S. Army [W81XWH-10-1-0623, WH81XWH-14-2-0018]; NIH-NINDS Center core grant [5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096143, P30NS047463] Funding Source: NIH RePORTER	We would like to thank Dr. John Povlishock for his encouragement throughout this project and Dr. Carmen Sato-Bigbee for editorial insight. We would also like to recognize Dr. Scott Henderson for his expertise in microscopy and image analysis, Dr. Robert Hamm for his biostatistical assistance and knowledge as well as Lynn Davis, Judy Williamson, Frances White, Susan Walker, Masaki Todani and Chuck Blocher for invaluable technical assistance. This work was supported by the NINDS grant 1R01NS096143. This work was also performed as a component of the Operation Brain Trauma Therapy consortium, which is supported by U.S. Army grants W81XWH-10-1-0623 and WH81XWH-14-2-0018. Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant 5P30NS047463.	Altay O, 2014, NEUROBIOL DIS, V62, P365, DOI 10.1016/j.nbd.2013.09.016; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Baalman K, 2015, J NEUROSCI, V35, P2283, DOI 10.1523/JNEUROSCI.3751-14.2015; Bahney J, 2018, ANAT REC, V301, P697, DOI 10.1002/ar.23728; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Benusa SD, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0889-3; Chen ZH, 2016, J NEUROCHEM, V136, P10, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eyo UB, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0209-16.2016; Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006; Eyo UB, 2015, J NEUROSCI, V35, P2417, DOI 10.1523/JNEUROSCI.3279-14.2015; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gorse KM, 2018, J NEUROTRAUM, V35, P1694, DOI 10.1089/neu.2017.5275; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hu WL, 2018, EXP THER MED, V15, P1568, DOI 10.3892/etm.2017.5527; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kato G, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0004-16.2016; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Krabbe G, 2012, BRAIN BEHAV IMMUN, V26, P419, DOI 10.1016/j.bbi.2011.12.002; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lafrenaye AD, 2016, NEURAL REGEN RES, V11, P538, DOI 10.4103/1673-5374.180726; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Solga AC, 2015, GLIA, V63, P531, DOI 10.1002/glia.22754; Sopka S, 2013, ANN ANAT, V195, P166, DOI 10.1016/j.aanat.2012.07.013; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wohleb ES, 2018, BIOL PSYCHIAT, V83, P38, DOI 10.1016/j.biopsych.2017.05.026; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	55	13	13	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 20	2018	9								778	10.3389/fneur.2018.00778			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	GU2PC	WOS:000445111200001	30294296	DOAJ Gold, Green Published			2021-06-18	
J	Keenan, HT; Presson, AP; Clark, AE; Cox, CS; Ewing-Cobbs, L				Keenan, Heather T.; Presson, Angela P.; Clark, Amy E.; Cox, Charles S.; Ewing-Cobbs, Linda			Longitudinal Developmental Outcomes after Traumatic Brain Injury in Young Children: Are Infants More Vulnerable Than Toddlers?	JOURNAL OF NEUROTRAUMA			English	Article						infant; neurodevelopment; pediatric; traumatic brain injury	FUNCTIONAL PLASTICITY; SOCIAL OUTCOMES; WHITE-MATTER; TERM; PREDICTORS	Children under 4 years of age have the highest incidence of traumatic brain injury (TBI) among the non-elderly and may be at high risk of poor developmental outcomes. We prospectively enrolled a cohort of children injured before 31 months old with TBI or orthopedic injury (OI), from 2013 to 2015 at two pediatric level 1 trauma centers to study very young children's developmental outcomes after injury. We used Ages & Stages-3 and Ages & Stages: Social-Emotional screening tools to measure children's development at pre-injury and 3 and 12 months post-injury. The cohort included 123 children with TBI categorized as mild (n=48), complicated-mild or moderate (n=54), and severe (n=21) and 45 children with OI. Generalized linear models examined effects of injury severity and age at injury controlling for pre-injury ratings. Children with mild or complicated-mild/moderate TBI generally remained on developmental track. Compared to OI, children with severe TBI tended to have a negative developmental trajectory with decrements in communication (-7.07; 95% confidence interval [CI], -13.7, -0.48), gross motor (-15.2; 95% CI, -21.1, -9.19), problem solving (-11.6; 95% CI, -17.9, -5.29), personal-social (-16.8; 95% CI, -22.8, -10.8), and social-emotional (21.0; 95% CI, 7.32, 34.7) domains 12 months post-injury. Developmental effects from TBI differed by age at injury: Infants had more difficulties than older children in communication and problem-solving domains. Despite low developmental scores in 28% of the cohort, only 5% were receiving Early Childhood Intervention (ECI) services 12 months after injury. Early age at injury is a vulnerability factor after TBI. Young age and severe injury should prompt evaluation for ECI.	[Keenan, Heather T.; Presson, Angela P.; Clark, Amy E.] Univ Utah, Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA; [Presson, Angela P.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Cox, Charles S.] Univ Texas Houston, Med Sch Houston, Dept Pediat Surg, Houston, TX USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX 77030 USA; [Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX 77030 USA	Keenan, HT (corresponding author), Univ Utah, Dept Pediat, 295 Chipeta Way,POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu			CDCUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01/CE002188]; National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24HD072984]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002538] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002188] Funding Source: NIH RePORTER	This study was supported by the CDC under Cooperative Agreement U01/CE002188. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. This study was supported also by the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; K24HD072984). Neither the NICHD nor the CDC played a role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bernard CO, 2016, J INT NEUROPSYCH SOC, V22, P793, DOI 10.1017/S1355617716000709; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066x.32.7.513; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cheong JL, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4805; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dennis M, 2014, NEUROPSYCHOL REV, V24, P389, DOI 10.1007/s11065-014-9261-x; Dubois J, 2014, NEUROSCIENCE, V276, P48, DOI 10.1016/j.neuroscience.2013.12.044; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; GENNARELLI TA, 2008, ABBREVIATED INJURY S, DOI DOI 10.1089/NEU.2016.4744; HEBB D. O., 1942, PROC AMER PHIL SOC, V85, P275; Kaldoja ML, 2015, J CHILD NEUROL, V30, P860, DOI 10.1177/0883073814544705; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2018, J NEUROTRAUM, V35, P286, DOI 10.1089/neu.2017.5265; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Marr AL., 2004, CENTRAL NERVOUS SYST; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Pinheiro J., 2016, NLME LINEAR NONLINEA; Prasad M.R, 2014, HDB NEUROPSYCHOLOGY; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; R Core Team, 2017, R LANG ENV STAT COMP; REILLY PL, 1988, CHILD NERV SYST, V4, P30; RISEN SR, 2014, J PEDIAT, V164; Rogers CE, 2016, PEDIATR RES, V79, P87, DOI 10.1038/pr.2015.172; Runyan DK, 1998, PEDIATRICS, V101, P12, DOI 10.1542/peds.101.1.12; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; SQUIRES J, 2002, AGES STAGES QUESTION, DOI DOI 10.1016/J.FINEL.2011.05.007; SQUIRES J, 2009, THE ASQ USERS GUIDE, DOI DOI 10.1089/NEU.2013.3268; SQUIRES J, 2009, AGES STAGES QUESTION, DOI DOI 10.1007/S10439-014-1193-3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; *TEX CAR CHILDR ME, 2016, LEFT OUT IMP STAT CU, DOI DOI 10.1148/RADIOL.2016160564; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	43	13	13	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					282	292		10.1089/neu.2018.5687		SEP 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000444042100001	30019631	Green Published			2021-06-18	
J	Anada, RP; Wong, KT; Jayapalan, JJ; Hashim, OH; Ganesan, D				Anada, Raj Poovindran; Wong, Kum Thong; Jayapalan, Jaime Jacqueline; Hashim, Onn Haji; Ganesan, Dharmendra			Panel of serum protein biomarkers to grade the severity of traumatic brain injury	ELECTROPHORESIS			English	Article						Biomarker; Glasgow Coma Scale; iTRAQ; Serum proteins; Traumatic brain injury	GLASGOW COMA SCALE; HEAD-INJURY; EPIDEMIOLOGY; APOLIPOPROTEINS; LOCALIZATION; RECEPTOR	The Glasgow Coma Scale (GCS), which classifies patients into mild, moderate or severe traumatic brain injury (TBI), is a system used to prioritize treatment and prognosticate the severity of head injury. In this study, sera of patients with various stages of TBI, as well as control subjects, were analyzed to screen for proteins that may be used to complement the GCS system. By subjecting pooled serum samples to iTRAQ analysis for quantitative comparison of protein abundance, and attesting their altered levels using ELISA, we have detected increased levels of serum amyloid A, C-reactive protein, leucine-rich alpha-2-glycoprotein, lipopolysaccharide-binding protein, fibronectin, vitronectin and alpha-1-antichymotrypsin in patients across all strata of TBI relative to the controls. However, kininogen was decreased only in moderate and severe TBI, whereas apolipoprotein E and zinc-alpha-2-glycoprotein were only increased in severe TBI. Hence, we propose a panel of serum biomarkers, which if analyzed within 24 h of the injury, can be used to diagnose patients with TBI into mild, moderate or severe stratification objectively, thus complementing the traditional GCS.	[Anada, Raj Poovindran; Ganesan, Dharmendra] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia; [Wong, Kum Thong] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Malaysia; [Jayapalan, Jaime Jacqueline; Hashim, Onn Haji] Univ Malaya, Ctr Prote Res, Fac Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur, Malaysia	Ganesan, D (corresponding author), Univ Malaya, Dept Surg, Fac Med, Div Neurosurg, Kuala Lumpur 50603, Malaysia.	dharmendra@um.edu.my	Hashim, Onn H/B-9459-2010; Jayapalan, Jaime/C-7354-2015; Wong, Kum Thong/B-2788-2010; GANESAN, DHARMENDRA/B-8437-2010	Hashim, Onn H/0000-0002-0196-6793; Jayapalan, Jaime/0000-0001-6708-1800; 	University of Malaya, Kuala Lumpur, MalaysiaUniversiti Malaya [RG249/10HTM, PV064/2011A]	This study was supported by research grants RG249/10HTM and PV064/2011A from the University of Malaya, Kuala Lumpur, Malaysia. This concept has been submitted for patent filing in Malaysia (PI2014700972).	af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; AKIYAMA H, 1991, J NEUROIMMUNOL, V32, P19, DOI 10.1016/0165-5728(91)90067-H; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Colman R. W., 1998, THROMB HAEMOSTASIS, V60, P340; Cunningham Steven C, 2006, Surg Infect (Larchmt), V7, P251, DOI 10.1089/sur.2006.7.251; Davies MG, 1997, BRIT J SURG, V84, P920, DOI 10.1002/bjs.1800840707; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; Hajba L, 2016, ANAL CHIM ACTA, V943, P8, DOI 10.1016/j.aca.2016.08.035; Hashim OH, 2017, PEERJ, V5, DOI 10.7717/peerj.3784; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KABBAJ O, 1989, ANN BIOL CLIN-PARIS, V47, P35; Lee DG, 2005, J KOREAN NEUROTRAUMA, V1, P57; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Lowe G D, 2001, Ann Periodontol, V6, P1, DOI 10.1902/annals.2001.6.1.1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Nakajima M, 2012, ACTA NEUROCHIR SUPPL, V113, P97, DOI 10.1007/978-3-7091-0923-6_20; Nakajima M, 2011, ACTA NEUROCHIR, V153, P1339, DOI 10.1007/s00701-011-0963-z; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Papa L., 2015, SOURCEBRAIN NEUROTRA; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SAILE R, 1990, J CLIN CHEM CLIN BIO, V28, P519; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Wu Y, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0048-y; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058	34	13	13	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	SEP	2018	39	18			SI		2308	2315		10.1002/elps.201700407			8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	GT8OV	WOS:000444799300004	29570807				2021-06-18	
J	Engel, BJ; Gammon, ST; Chaudhari, R; Lu, Z; Pisaneschi, F; Yang, HL; Ornelas, A; Yan, V; Kelderhouse, L; Najjar, AM; Tong, WP; Zhang, SX; Piwnica-Worms, D; Bast, RC; Millward, SW				Engel, Brian J.; Gammon, Seth T.; Chaudhari, Rajan; Lu, Zhen; Pisaneschi, Federica; Yang, Hailing; Ornelas, Argentina; Yan, Victoria; Kelderhouse, Lindsay; Najjar, Amer M.; Tong, William P.; Zhang, Shuxing; Piwnica-Worms, David; Bast, Robert C., Jr.; Millward, Steven W.			Caspase-3 Substrates for Noninvasive Pharmacodynamic Imaging of Apoptosis by PET/CT	BIOCONJUGATE CHEMISTRY			English	Article							VIVO; INHIBITION; DESIGN	Quantitative imaging of apoptosis in vivo could enable real-time monitoring of acute cell death pathologies such as traumatic brain injury, as well as the efficacy and safety of cancer therapy. Here, we describe the development and validation of F-18-labeled caspase-3 substrates for PET/CT imaging of 0 apoptosis. Preliminary studies identified the O-benzylthreonine-containing substrate 2MP-TbD-AFC as a highly caspase 3-selective and cell-permeable fluorescent reporter. This lead compound was converted into the radiotracer [F-18]-TBD, which was obtained at 10% decay-corrected yields with molar activities up to 149 GBq/mu mol on an automated radiosynthesis platform. [F-18]-TBD accumulated in ovarian cancer cells in a caspase- and cisplatin-dependent fashion. PET imaging of a Jo2-induced hepatotoxicity model showed a significant increase in [F-18]-TBD signal in the livers of Jo2-treated mice compared to controls, driven through a reduction in hepatobiliary clearance. A chemical control tracer that could not be cleaved by caspase 3 showed no change in liver accumulation after induction of hepatocyte apoptosis. Our data demonstrate that [F-18]-TBD provides an immediate pharmacodynamic readout of liver apoptosis in mice by dynamic PET/CT and suggest that [F-18]-TBD could be used to interrogate apoptosis in other disease states.	[Engel, Brian J.; Gammon, Seth T.; Pisaneschi, Federica; Ornelas, Argentina; Yan, Victoria; Kelderhouse, Lindsay; Tong, William P.; Piwnica-Worms, David; Millward, Steven W.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Chaudhari, Rajan; Lu, Zhen; Yang, Hailing; Zhang, Shuxing; Bast, Robert C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Najjar, Amer M.] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Zhang, Shuxing] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA	Millward, SW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, 1515 Holcombe Blvd, Houston, TX 77030 USA.	SMillward@mdanderson.org	Pisaneschi, Federica/AAJ-9912-2020; Bast, Robert C/E-6585-2011	Pisaneschi, Federica/0000-0002-1989-4417; Bast, Robert C/0000-0003-4621-8462; Yan, Victoria/0000-0003-0837-5184; Gammon, Seth/0000-0001-8647-0975; Engel, Brian/0000-0002-8464-7885; Lu, Zhen/0000-0002-9596-0148	UTMDACC startup funds; UTMDACC Moonshot Knowledge Gap Pilot Project [1R21CA181994-01, 2R44CA206771]; G.E. In-kind Multi-investigator Imaging (MI2) Research Award; cancer prevention educational award [R25T CA057730]; MD Anderson SPORE in Ovarian Cancer [NCI P50 CA 83639]; National Foundation for Cancer Research; Mossy foundation; Roberson endowment; MD Anderson Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA181994, R25CA057730, R44CA206771, P30CA016672] Funding Source: NIH RePORTER	This work was supported by UTMDACC startup funds (SWM), a UTMDACC Moonshot Knowledge Gap Pilot Project (SWM), 1R21CA181994-01 (SWM, ZL), 2R44CA206771 (SWM), and a G.E. In-kind Multi-investigator Imaging (MI2) Research Award (SWM). AO was supported by a cancer prevention educational award (R25T CA057730, Shine Chang). ZL, HY, and RB were supported by the MD Anderson SPORE in Ovarian Cancer NCI P50 CA 83639, the National Foundation for Cancer Research, the philanthropic support from generous donations from Stuart and Gaye-Lynn Zarrow, the Mossy foundation and the Roberson endowment. MD Anderson's Nuclear Magnetic Resonance Facility and Small Animal Imaging Facility (SAIF) are supported by the MD Anderson Cancer Center Support Grant CA016672 (Pisters).	Bauwens M, 2011, NUCL MED BIOL, V38, P381, DOI 10.1016/j.nucmedbio.2010.09.008; Becker JW, 2004, J MED CHEM, V47, P2466, DOI 10.1021/jm0305523; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bullok KE, 2006, MOL IMAGING, V5, P1, DOI 10.2310/7290.2006.00001; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Demko ZP, 2001, ORG LETT, V3, P4091, DOI 10.1021/ol010220x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Glaser M, 2007, BIOCONJUGATE CHEM, V18, P989, DOI 10.1021/bc060301j; Goetz M, 2011, AM J PHYSIOL-GASTR L, V301, pG764, DOI 10.1152/ajpgi.00175.2011; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu SQ, 2001, CLIN CANCER RES, V7, P1716; Methot N, 2004, J BIOL CHEM, V279, P27905, DOI 10.1074/jbc.M400247200; Micale N, 2004, J MED CHEM, V47, P6455, DOI 10.1021/jm049248f; Neves AA, 2014, J NUCL MED, V55, P1, DOI 10.2967/jnumed.112.114264; Nishimura Y, 1997, INT IMMUNOL, V9, P307, DOI 10.1093/intimm/9.2.307; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pedersen DS, 2011, EUR J ORG CHEM, V2011, P2399, DOI 10.1002/ejoc.201100157; Pisaneschi F, 2017, BIOCONJUGATE CHEM, V28, P583, DOI 10.1021/acs.bioconjchem.6b00678; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Reshef A, 2010, J NUCL MED, V51, P837, DOI 10.2967/jnumed.109.063917; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zhang LJ, 2008, ANTI-CANCER DRUG, V19, P159, DOI 10.1097/CAD.0b013e3282f30d05; Zhou D, 2006, BIOORG MED CHEM LETT, V16, P5041, DOI 10.1016/j.bmcl.2006.07.045	30	13	13	0	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	SEP	2018	29	9					3180	3195		10.1021/acs.bioconjchem.8b00514			16	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	GU6QA	WOS:000445439500032	30168713	Green Accepted			2021-06-18	
J	Landry-Roy, C; Bernier, A; Gravel, J; Beauchamp, MH				Landry-Roy, Catherine; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.			Executive Functions and Their Relation to Sleep Following Mild Traumatic Brain Injury in Preschoolers	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Executive function; Sleep; Child; Cognition; Preschool	CHILD-BEHAVIOR CHECKLIST; SCHOOL-AGE-CHILDREN; YOUNG-CHILDREN; PREFRONTAL CORTEX; INDIVIDUAL-DIFFERENCES; FUNCTION OUTCOMES; CORTISOL-LEVELS; RESTRICTION; CONSEQUENCES; ADOLESCENTS	Objectives: Traumatic brain injury (TBI) sustained during childhood is known to impact children's executive functioning. However, few studies have focused specifically on executive functioning after preschool TBI. TBI has also been associated with sleep disturbances, which are known to impair executive functions in healthy children. The aim of this study was to investigate executive functions in preschoolers with mild TBI, and to determine the role of sleep in the links between TBI and executive functioning. Methods: The sample was drawn from a longitudinal study and included 167 children, aged 18 to 60 months, divided into 2 groups: children with accidental mild TBI (n = 84) and typically developing children (n = 83). Children were assessed 6 months post-injury on executive function measures (inhibition and cognitive flexibility) and sleep measures (actigraphy data and parental rating of sleep problems). Results: The two groups did not differ in their executive abilities. However, relative to controls, children with mild TBI and shorter nighttime sleep duration or increased sleep problems exhibited poorer executive functions. Conclusions: These results support a "double hazard" effect, whereby the combination of sleep disturbances and mild TBI results in poorer executive functions. The findings highlight the importance of assessing and monitoring the quality of sleep even after mild head injuries. Poor sleep may place children at risk for increased cognitive difficulties.	[Landry-Roy, Catherine; Bernier, Annie; Gravel, Jocelyn; Beauchamp, Miriam H.] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Landry-Roy, Catherine; Gravel, Jocelyn; Beauchamp, Miriam H.] CHU St Justine Res Ctr, Montreal, PQ, Canada	Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP11036]	The authors declare no conflicts of interests. This study was funded by the Canadian Institutes of Health Research (MOP11036 to M.H.B.). Thank you to the lab members for their collaborative efforts.	Acebo C, 1999, SLEEP, V22, P95, DOI 10.1093/sleep/22.1.95; Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P319, DOI 10.1080/713755568; Anderson V, 2005, BRAIN INJURY, V19, P459, DOI 10.1080/02699050400004823; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Astill RG, 2012, PSYCHOL BULL, V138, P1109, DOI 10.1037/a0028204; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Beck DM, 2011, J COGN DEV, V12, P169, DOI 10.1080/15248372.2011.563485; Becker SP, 2015, SLEEP MED, V16, P79, DOI 10.1016/j.sleep.2014.09.008; Belanger ME, 2018, J CLIN CHILD ADOLESC, V47, P366, DOI 10.1080/15374416.2015.1079782; Belanger ME, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00158; Belanger ME, 2013, J CLIN SLEEP MED, V9, P701, DOI 10.5664/jcsm.2844; Bellerose J, 2017, NEUROPSYCHOLOGY, V31, P229, DOI 10.1037/neu0000341; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; Benington JH, 2003, PROG NEUROBIOL, V69, P71, DOI 10.1016/S0301-0082(03)00018-2; Bernier A, 2013, CHILD DEV, V84, P1542, DOI 10.1111/cdev.12063; Bernier A, 2010, CHILD DEV, V81, P1739, DOI 10.1111/j.1467-8624.2010.01507.x; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Byars KC, 2011, SLEEP MED, V12, P898, DOI 10.1016/j.sleep.2011.05.002; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Carlson SM, 2005, PSYCHOL SCI, V16, P609, DOI 10.1111/j.1467-9280.2005.01583.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Collins A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001293; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2013, CHILD NEUROPSYCHOL, V19, P113, DOI 10.1080/09297049.2011.651079; Dahl RE, 1996, DEV PSYCHOPATHOL, V8, P3, DOI 10.1017/S0954579400006945; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Durston S, 2006, NEUROPSYCHOLOGIA, V44, P2149, DOI 10.1016/j.neuropsychologia.2005.10.010; Ennis Elaine, 2004, Pediatr Rehabil, V7, P205, DOI 10.1080/13638490410001703316; ESCALONA SK, 1982, PEDIATRICS, V70, P670; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Friedman NP, 2009, SLEEP, V32, P323, DOI 10.1093/sleep/32.3.323; Gagner C, 2018, PSYCHOL MED, V48, P1551, DOI 10.1017/S0033291717003221; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Goldberg E, 2005, PSYCHIAT CLIN N AM, V28, P567, DOI 10.1016/j.psc.2005.05.005; Gregory AM, 2009, PEDIATRICS, V123, P1171, DOI 10.1542/peds.2008-0825; Gruber R, 2011, SLEEP, V34, P315, DOI 10.1093/sleep/34.3.315; Harrison Y, 2000, Q J EXP PSYCHOL-A, V53, P271, DOI 10.1080/027249800390772; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; HORNE JA, 1993, BRIT J PSYCHIAT, V162, P413, DOI 10.1192/bjp.162.3.413; INGVAR DH, 1979, ACTA NEUROL SCAND, V60, P12, DOI 10.1111/j.1600-0404.1979.tb02947.x; Isquith PK, 2005, MENT RETARD DEV D R, V11, P209, DOI 10.1002/mrdd.20075; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Jones K, 2001, SLEEP MED REV, V5, P463, DOI 10.1053/smrv.2001.0203; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; KJELLBERG A, 1977, WAKING SLEEPING, V1, P145; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; KOSLOWSKY M, 1992, CHRONOBIOL INT, V9, P132, DOI 10.3109/07420529209064524; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Lalonde G, 2016, J NEUROPSYCHOL, V12, P1; Landry-Roy C, 2017, J HEAD TRAUMA REHAB, V32, pE13, DOI 10.1097/HTR.0000000000000303; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Muzur A, 2002, TRENDS COGN SCI, V6, P475, DOI 10.1016/S1364-6613(02)01992-7; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Nelson TD, 2015, DEV NEUROPSYCHOL, V40, P167, DOI 10.1080/87565641.2015.1020946; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Owens JA, 2000, SLEEP, V23, P1043; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Randazzo AC, 1998, SLEEP, V21, P861; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Sadeh A, 2015, MONOGR SOC RES CHILD, V80, P33, DOI 10.1111/mono.12143; Sadeh A, 2007, SLEEP MED CLIN, V2, P513, DOI 10.1016/j.jsmc.2007.05.012; Sazonov E, 2004, PHYSIOL MEAS, V25, P1291, DOI 10.1088/0967-3334/25/5/018; Scher A, 2010, DEV PSYCHOBIOL, V52, P44, DOI 10.1002/dev.20410; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Thurber S., 2012, ARCH ASSESSMENT PSYC, V2, P73; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; Uttl B, 2005, PSYCHOL SCI, V16, P460; Wang LJ, 2008, MULTIVAR BEHAV RES, V43, P476, DOI 10.1080/00273170802285941; Ward TM, 2008, BIOL RES NURS, V9, P244, DOI 10.1177/1099800407310158; Wood AG, 2010, STUD NEUROPSYCHOL NE, P203; Zelazo PD, 2006, NAT PROTOC, V1, P297, DOI 10.1038/nprot.2006.46	86	13	13	1	7	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2018	24	8					769	780		10.1017/S1355617718000401			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	HG6MJ	WOS:000455095800002	30113277				2021-06-18	
J	Hossain, I; Tan, C; Doughty, PT; Dutta, G; Murray, TA; Siddiqui, S; Iasemidis, L; Arumugamr, PU				Hossain, Imran; Tan, Chao; Doughty, Phillip T.; Dutta, Gaurab; Murray, Teresa A.; Siddiqui, Shabnam; Iasemidis, Leonidas; Arumugamr, Prabhu U.			A Novel Microbiosensor Microarray for Continuous ex vivo Monitoring o Gamma-Aminobutyric Acid in Real-Time	FRONTIERS IN NEUROSCIENCE			English	Article						electrochemical; GABA; glutamate; biosensor; microarray; neurochemical; ex vivo	PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-VIVO; ELECTROCHEMICAL DETECTION; EXTRACELLULAR GLUTAMATE; SULFITE DERIVATIZATION; MICROELECTRODE ARRAYS; ALPHA-KETOGLUTARATE; HYDROGEN-PEROXIDE; BRAIN; GABA	Gamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter that is essential for normal brain function. It is involved in multiple neuronal activities, including plasticity, information processing, and network synchronization. Abnormal GABA levels result in severe brain disorders and therefore GABA has been the target of a wide range of drug therapeutics. GABA being non-electroactive is challenging to detect in real-time. To date, GABA is detected mainly via microdialysis with a high-performance liquid chromatography (HPLC) system that employs electrochemical (EC) and spectroscopic methodology. However, these systems are bulky and unsuitable for real-time continuous monitoring. As opposed to microdialysis, biosensors are easy to miniaturize and are highly suitable for in vivo studies; they selectively oxidize GABA into a secondary electroactive product (usually hydrogen peroxide, H2O2) in the presence of enzymes, which is then detected by amperometry. Unfortunately, this method requires a rather cumbersome process with prereactors and relies on externally applied reagents. Here, we report the design and implementation of a GABA microarray probe that operates on a newly conceived principle. it consists of two microbiosensors, one for glutamate (Glu) and one for GABA detection, modified with glutamate oxidase and GABASE enzymes, respectively. By simultaneously measuring and subtracting the H2O2 oxidation currents generated from these microbiosensors, GABA and Glu can be detected continuously in real-time in vitro and ex vivo and without the addition of any externally applied reagents. The detection of GABA by this probe is based upon the in-situ generation of alpha-ketoglutarate from the Glu oxidation that takes place at the Glu microbiosensor. A GABA sensitivity of 36 +/- 2.5 pA mu M-1 cm(-2), which is 26-fold higher than reported in the literature, and a limit of detection of 2 +/- 0.12 It M were achieved in an in vitro setting. The GABA probe was successfully tested in an adult rat brain slice preparation. These results demonstrate that the developed GABA probe constitutes a novel and powerful neuroscientific tool that could be employed in the future for in vivo longitudinal studies of the combined role of GABA and Glu (a major excitatory neurotransmitter) signaling in brain disorders, such as epilepsy and traumatic brain injury, as well as in preclinical trials of potential therapeutic agents for the treatment of these disorders.	[Hossain, Imran; Tan, Chao; Dutta, Gaurab; Arumugamr, Prabhu U.] Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA; [Tan, Chao; Doughty, Phillip T.; Murray, Teresa A.; Siddiqui, Shabnam; Iasemidis, Leonidas; Arumugamr, Prabhu U.] Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA	Arumugamr, PU (corresponding author), Louisiana Tech Univ, Inst Micromfg, Ruston, LA 71270 USA.; Arumugamr, PU (corresponding author), Louisiana Tech Univ, Ctr Biomed Engn & Rehabil Sci, Ruston, LA 71270 USA.	parumug@latech.edu	Dutta, Gaurab/A-2675-2019; Murray, Teresa/AAG-3531-2019; Murray, Teresa/AAV-3011-2020	Dutta, Gaurab/0000-0002-8347-5970; Murray, Teresa/0000-0002-8857-154X; Hossain, Md Imran/0000-0002-0308-6052	National Science Foundation through the OIA/EPSCoR [1632891]	This work was supported by the National Science Foundation through the OIA/EPSCoR grant 1632891 on Probing and Understanding the Brain: Micro and Macro Dynamics of Seizure and Memory Networks.	Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x; Auteri M, 2015, CURR PHARM DESIGN, V21, P4996, DOI 10.2174/1381612821666150914121518; Badalyan A., 2007, EP, Patent No. [2505658A1, 2505658]; Badalyan A, 2014, BIOSENSORS-BASEL, V4, P403, DOI 10.3390/bios4040403; Ben-Amor S, 2014, ELECTROCHIM ACTA, V126, P171, DOI 10.1016/j.electacta.2013.11.104; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Boddum K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13572; Burmeister JJ, 2013, ACS CHEM NEUROSCI, V4, P721, DOI 10.1021/cn4000555; Cahill PS, 1996, ANAL CHEM, V68, P3180, DOI 10.1021/ac960347d; CAUDILL WL, 1982, J CHROMATOGR, V227, P331, DOI 10.1016/S0378-4347(00)80387-4; Castro VHC, 2014, CURR NEUROPHARMACOL, V12, P490, DOI 10.2174/1570159X13666141223223657; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; GARGUILO MG, 1994, ANAL CHEM, V66, P2621, DOI 10.1021/ac00089a006; Grabauskas G, 2005, NEUROSCI LETT, V373, P10, DOI 10.1016/j.neulet.2004.09.051; Hascup KN, 2007, FRONT NEUROENG, V1, P407; Hertz Leif, 2013, Front Endocrinol (Lausanne), V4, P59, DOI 10.3389/fendo.2013.00059; Kanamori K, 2011, BRAIN RES, V1371, P180, DOI 10.1016/j.brainres.2010.11.064; Ke Y, 2000, PSYCHIAT RES-NEUROIM, V100, P169, DOI 10.1016/S0925-4927(00)00075-5; KEHR J, 1988, J NEUROCHEM, V51, P1308, DOI 10.1111/j.1471-4159.1988.tb03101.x; Khan R, 2011, ELECTROANAL, V23, P2357, DOI 10.1002/elan.201100348; Long LH, 2011, BIOCHEM BIOPH RES CO, V406, P20, DOI 10.1016/j.bbrc.2011.01.091; Mazzei F, 1996, ANAL CHIM ACTA, V328, P41, DOI 10.1016/0003-2670(96)00089-X; Medina-Ceja L, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0147-5; Monge-Acuna AA, 2009, J NEUROSCI METH, V183, P176, DOI 10.1016/j.jneumeth.2009.06.042; Moussawi K, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00094; NATH KA, 1995, AM J PHYSIOL-CELL PH, V268, pC227; Niwa O, 1998, ANAL CHEM, V70, P89, DOI 10.1021/ac970740z; Reinhoud NJ, 2013, ACS CHEM NEUROSCI, V4, P888, DOI 10.1021/cn400044s; Robinson DL, 2008, CHEM REV, V108, P2554, DOI 10.1021/cr068081q; Robinson DL, 2007, FRONT NEUROENG, V1, P17; Robinson MB, 2016, NEUROCHEM INT, V98, P56, DOI 10.1016/j.neuint.2016.03.014; ROWLEY HL, 1995, J NEUROSCI METH, V57, P93, DOI 10.1016/0165-0270(94)00132-Z; ROWLEY HL, 1995, NEUROSCIENCE, V68, P415, DOI 10.1016/0306-4522(95)00159-G; Sandberg S. G., 2010, ADV NEUROSCIENCE ADD, P120; Sekioka N, 2008, SENSOR ACTUAT B-CHEM, V129, P442, DOI 10.1016/j.snb.2007.08.040; SETHI ML, 1993, J PHARMACEUT BIOMED, V11, P613, DOI 10.1016/0731-7085(93)80013-Q; SMITH S, 1994, J CHROMATOGR B, V652, P228, DOI 10.1016/0378-4347(93)E0391-3; Song CZ, 2005, NEUROPHARMACOLOGY, V48, P869, DOI 10.1016/j.neuropharm.2005.01.003; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Ting Wong C. G., 2003, ANN NEUROL, V54, pS3, DOI DOI 10.1002/ANA.10696; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tseng TTC, 2014, MOLECULES, V19, P7341, DOI 10.3390/molecules19067341; Willuhn I, 2010, CURR TOP BEHAV NEURO, V3, P29, DOI 10.1007/7854_2009_27; Wilson LR, 2018, ANAL CHEM, V90, P888, DOI 10.1021/acs.analchem.7b03770	44	13	14	1	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	AUG 7	2018	12								500	10.3389/fnins.2018.00500			13	Neurosciences	Neurosciences & Neurology	GP7HW	WOS:000441068000001	30131664	DOAJ Gold, Green Published			2021-06-18	
J	Kerr, ZY; Wilkerson, GB; Caswell, SV; Currie, DW; Pierpoint, LA; Wasserman, EB; Knowles, SB; Dompier, TP; Comstock, RD; Marshall, SW				Kerr, Zachary Y.; Wilkerson, Gary B.; Caswell, Shane, V; Currie, Dustin W.; Pierpoint, Lauren A.; Wasserman, Erin B.; Knowles, Sarah B.; Dompier, Thomas P.; Comstock, R. Dawn; Marshall, Stephen W.			The First Decade of Web-Based Sports Injury Surveillance: Descriptive Epidemiology of Injuries in United States High School Football (2005-2006 Through 2013-2014) and National Collegiate Athletic Association Football (2004-2005 Through 2013-2014)	JOURNAL OF ATHLETIC TRAINING			English	Article						concussion; musculoskeletal injuries; lower extremity injuries	ANTERIOR CRUCIATE LIGAMENT; LOWER-EXTREMITY SPRAINS; RISK-FACTORS; CONCUSSION POLICY; RUGBY UNION; NECK-INJURY; PLAYERS; RATES; OSTEOARTHRITIS; PREVENTION	Context: The advent of Web-based sports injury surveillance via programs such as the High School Reporting Information Online system and the National Collegiate Athletic Association Injury Surveillance Program has aided the acquisition of football injury data. Objective: To describe the epidemiology of injuries sustained in high school football in the 2005-2006 through 2013-2014 academic years and collegiate football in the 2004-2005 through 2013-2014 academic years using Web-based sports injury surveillance. Design: Descriptive epidemiology study. Setting: Online injury surveillance from football teams of high school boys (annual average = 100) and collegiate men (annual average = 43). Patients or Other Participants: Football players who participated in practices and competitions during the 2005-2006 through 2013-2014 academic years in high school or the 2004-2005 through 2013-2014 academic years in college. Main Outcome Measure(s): Athletic trainers collected time-loss injury (>= 24 hours) and exposure data. Injury rates per 1000 athlete-exposures (AEs), injury rate ratios (IRRs) with 95% confidence intervals (Cis), and injury proportions by body site and diagnosis were calculated. Results: The High School Reporting Information Online system documented 18 189 time-loss injuries during 4 539 636 AEs; the National Collegiate Athletic Association Injury Surveillance Program documented 22 766 time-loss injuries during 3 121 476 AEs. The injury rate was higher among collegiate than high school (7.29 versus 4.01/1000 AEs; IRR = 1.82; 95% CI = 1.79, 1.86) athletes. Most injuries occurred during competitions in high school (53.2%) and practices in college (60.9%). The competition injury rate was higher than the practice injury rate among both high school (IRR = 5.62; 95% CI = 5.46, 5.78) and collegiate (IRR = 6.59; 95% CI = 6.41, 6.76) players. Most injuries at both levels affected the lower extremity and the shoulder/clavicle and were diagnosed as ligament sprains and muscle/tendon strains. However, concussion was a common injury during competitions among most positions. Conclusions: Injury rates were higher in college than in high school and higher for competitions than for practices. Concussion was a frequent injury sustained during competitions, which confirms the need to develop interventions to mitigate its incidence and severity.	[Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA; [Kerr, Zachary Y.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Wilkerson, Gary B.] Univ Tennessee, Grad Athlet Training Educ Program, Chattanooga, TN USA; [Caswell, Shane, V] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA; [Currie, Dustin W.; Pierpoint, Lauren A.; Comstock, R. Dawn] Univ Colorado, Dept Epidemiol, Aurora, CO USA; [Wasserman, Erin B.] Datalys Ctr Sports Injury Res & Prevent, Indianapolis, IN USA; [Knowles, Sarah B.] Palo Alto Med Fdn Res Inst, Palo Alto, CA USA; [Dompier, Thomas P.] Lebanon Valley Coll, Dept Athlet Training, Annville, PA USA; [Comstock, R. Dawn] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA	Kerr, ZY (corresponding author), Univ N Carolina, Dept Exercise & Sport Sci, 313 Woollen Gym CB 8700, Chapel Hill, NC 27599 USA.	zkerr@email.unc.edu	Wilkerson, Gary B./AAG-4103-2021	Wilkerson, Gary B./0000-0001-8433-7329; Wasserman, Erin/0000-0001-5957-5878	NCAA; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CE000674-01, R49/CE001172-01]; National Center for Research Resources awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2 RR025754]; National Federation of State High School Associations (Indianapolis, IN); National Operating Committee on Standards for Athletic Equipment (Overland Park, KS); DonJoy Orthotics (Vista, CA); EyeBlack (Potomac, MD)	The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The Injury Surveillance Program was funded by the NCAA. Funding for HS RIO was funded in part by the Centers for Disease Control and Prevention grants R49/CE000674-01 and R49/CE001172-01 and the National Center for Research Resources award KL2 RR025754. The authors also acknowledge the research funding contributions of the National Federation of State High School Associations (Indianapolis, IN), National Operating Committee on Standards for Athletic Equipment (Overland Park, KS), DonJoy Orthotics (Vista, CA), and EyeBlack (Potomac, MD). The content of this report is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations. We thank the many ATs who have volunteered their time and efforts to submit data to HS RIO and the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of high school and collegiate student-athletes.	ADKISON JW, 1974, CLIN ORTHOP RELAT R, P131; [Anonymous], FOOTB PRACT GUID 201; [Anonymous], 2013, PAC 12 LIMIT CONTACT; [Anonymous], 2011, IVY LEAGUE LIMITING; [Anonymous], CENS REG US 2009; [Anonymous], PART STAT; [Anonymous], REP 2013 PART SURV; Barenius B, 2014, AM J SPORT MED, V42, P1049, DOI 10.1177/0363546514526139; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Ben Kibler W, 2013, BRIT J SPORT MED, V47, DOI 10.1136/bjsports-2013-092425; Bizzini M, 2015, BRIT J SPORT MED, V49, P577, DOI 10.1136/bjsports-2015-094765; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Boden BP, 2006, AM J SPORT MED, V34, P1223, DOI 10.1177/0363546506288306; Bonza JE, 2009, J ATHL TRAINING, V44, P76, DOI 10.4085/1062-6050-44.1.76; Brown TD, 2006, J ORTHOP TRAUMA, V20, P739, DOI 10.1097/01.bot.0000246468.80635.ef; Buckley WE, 1982, J ATHL TRAINING, V17, P279; Collins CL, 2008, INJURY PREV, V14, P34, DOI 10.1136/ip.2007.017277; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; DELEE JC, 1992, AM J SPORT MED, V20, P575, DOI 10.1177/036354659202000515; Dick R, 2007, J ATHL TRAINING, V42, P221; Dupler TL, 2010, J STRENGTH COND RES, V24, P1975, DOI 10.1519/JSC.0b013e3181e4f9ec; */* E1419, 2015, PEDIATRICS, V136, pE141, DOI DOI 10.1542/PEDS.2015-3282; Feeley BT, 2008, AM J SPORT MED, V36, P1597, DOI 10.1177/0363546508316021; Finch CF, 2015, OSTEOARTHR CARTILAGE, V23, P1138, DOI 10.1016/j.joca.2015.02.165; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Green L., 2014, LEGAL PERSPECTIVES R; Gribble PA, 2016, BRIT J SPORT MED, V50, P1493, DOI 10.1136/bjsports-2016-096188; Grimm NL, 2015, AM J SPORT MED, V43, P2049, DOI 10.1177/0363546514556737; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Halpern B, 1988, Am J Sports Med, V16 Suppl 1, pS113; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Jones B., 2015, STATES ADOPT PLANS L; Kaminski TW, 2013, J ATHL TRAINING, V48, P528, DOI 10.4085/1062-6050-48.4.02; Kerr ZY, 2018, J ATHL TRAINING, V53, P729, DOI 10.4085/1062-6050-143-17; Kerr ZY, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116648441; Kerr ZY, 2016, J ATHL TRAINING, V51, P70, DOI 10.4085/1062-6050-51.3.02; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kilcoyne KG, 2014, SPORTS HEALTH, V6, P402, DOI 10.1177/1941738113491545; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Luc B, 2014, J ATHL TRAINING, V49, P806, DOI 10.4085/1062-6050-49.3.35; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marchi AG, 1999, ARCH DIS CHILD, V81, P324, DOI 10.1136/adc.81.4.324; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; National Collegiate Athletic Association, 2015, STUD ATHL PART 1981; National Collegiate Athletic Association, 2014 15 SPORTS MED H; Nielsen RO, 2016, J ORTHOP SPORT PHYS, V46, P300, DOI 10.2519/jospt.2016.6510; Petrie TA, 1993, J APPL SPORT PSYCHOL, V5, P1, DOI DOI 10.1080/10413209308411301; Powell J., 1985, ATHLETIC TRAINING, V20, P104; Powell JW, 2004, J ATHL TRAINING, V39, P56; Powell JW, 1999, J ATHL TRAINING, V34, P277; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Silvers-Granelli H, 2015, AM J SPORT MED, V43, P2628, DOI 10.1177/0363546515602009; Simon JE, 2016, J ATHL TRAINING, V51, P205, DOI 10.4085/1062-6050-51.4.05; TORG JS, 1985, JAMA-J AM MED ASSOC, V254, P3439, DOI 10.1001/jama.254.24.3439; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Westermann RW, 2016, AM J SPORT MED, V44, P3230, DOI 10.1177/0363546516659290; Wilkerson GB, 2016, J STRENGTH COND RES, V30, P2369, DOI 10.1519/JSC.0000000000001370; Wilkerson GB, 2015, J ATHL TRAINING, V50, P643, DOI 10.4085/1062-6050-50.2.04; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	75	13	13	1	6	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	AUG	2018	53	8					738	751		10.4085/1062-6050-144-17			14	Sport Sciences	Sport Sciences	GW7OJ	WOS:000447157700005	30138047	Bronze, Green Published			2021-06-18	
J	Molina, B; Segura, A; Serrano, JP; Alonso, FJ; Molina, L; Perez-Borrego, YA; Ugarte, MI; Oliviero, A				Molina, B.; Segura, A.; Serrano, J. P.; Alonso, F. J.; Molina, L.; Perez-Borrego, Y. A.; Ugarte, M., I; Oliviero, A.			Cognitive performance of people with traumatic spinal cord injury: a cross-sectional study comparing people with subacute and chronic injuries	SPINAL CORD			English	Article							QUALITY-OF-LIFE; LONGITUDINAL ANALYSIS; BRAIN-INJURY; DEPRESSION; FATIGUE; ANXIETY; DEFICITS; ALCOHOL; IMPACT; MOOD	Study design Cross-sectional study. Objectives To assess the impact of spinal cord injury (SCI) on cognitive function in individuals with subacute and chronic SCI. Setting National Hospital for SCI patients (Spain). Methods The present investigation was designed to determine the nature, pattern, and extent of cognitive deficits in a group of participants with subacute (n = 32) and chronic (n = 34) SCI, using a comprehensive battery of reliable and validated neuropsychological assessments to study a broad range of cognitive functions. Twenty-seven able-bodied subjects matched to the groups with SCI for age and educational level formed the control group. Results The neuropsychological assessment showed alterations in the domain of attention, processing speed, memory and learning, executive functions, and in recognition in participants with SCI. The prevalence of cognitive dysfunction in the chronic stage was also confirmed at the individual level. The comparison of the neuropsychological assessment between the groups with subacute and chronic SCI showed a worsening of cognitive functions in those with chronic SCI compared to the group with subacute SCI. Conclusions In participants with SCI, cognitive dysfunctions are present in the subacute stage and worsen over time. From a clinical point of view, we confirmed the presence of cognitive dysfunction that may interfere with the first stage of rehabilitation which is the most intense and important. Moreover, cognitive dysfunction may be important beyond the end of the first stage of rehabilitation as it can affect an individual's quality of life and possible integration to society.	[Molina, B.; Perez-Borrego, Y. A.; Oliviero, A.] SESCAM, Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain; [Molina, B.] SESCAM, Hosp Nacl Paraplejicos, Nursing Dept, Toledo, Spain; [Segura, A.] Castilla La Mancha Govt, Dept Hlth & Social Affairs, Hlth Sci Inst, Talavera De La Reina, Spain; [Serrano, J. P.] Univ Castilla La Mancha, Dept Psychol, Fac Med, Albacete, Spain; [Alonso, F. J.] Ctr Salud Silleria, Dept Primary Hlth Care, Toledo, Spain; [Molina, L.] SESCAM, Hosp Mancha Ctr, Nursing Dept, Ciudad Real, Spain; [Ugarte, M., I] Univ Castilla La Mancha, Nursing Dept, Toledo, Spain	Oliviero, A (corresponding author), SESCAM, Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain.	antonioo@sescam.jccm.es	Segura, Antonio a/Q-5696-2017; Fragoso, Antonio Segura/AAM-7995-2020; Oliviero, Antonio/ABH-4485-2020	Segura, Antonio a/0000-0003-4884-2242; Fragoso, Antonio Segura/0000-0003-4884-2242; Oliviero, Antonio/0000-0001-7723-0478			Benedet M., 1998, TEST APRENDIZAJE VER; Cotter I, 2008, PSYCHOL ASPECTS ASS, P175; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; CRAIG AR, 1994, PARAPLEGIA, V32, P675, DOI 10.1038/sc.1994.109; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; Craig A, 2013, J PAIN, V14, P911, DOI 10.1016/j.jpain.2013.03.002; Craig A, 2012, J PSYCHOSOM RES, V73, P205, DOI 10.1016/j.jpsychores.2012.07.005; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Engels AS, 2010, COGN AFFECT BEHAV NE, V10, P141, DOI 10.3758/CABN.10.1.141; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; JUDD FK, 1991, PARAPLEGIA, V29, P91, DOI 10.1038/sc.1991.12; Kennedy P, 2000, SPINAL CORD, V38, P498, DOI 10.1038/sj.sc.3101021; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kurylo M, 2001, REHABIL PSYCHOL, V46, P247, DOI 10.1037/0090-5550.46.3.247; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Pena-Casanova J, 1997, Neurologia, V12, P99; Pena-Casanova J., 2005, NORMALIDAD SEMIOLOGI; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sanz J, 2003, CLIN SALUD, V14, P249; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Tun CG, 1997, REHABIL PSYCHOL, V42, P163, DOI 10.1037/0090-5550.42.3.163; Wechsler D., 2004, ESCALA MEMORIA WECHS; Wijesuriya N, 2012, ARCH PHYS MED REHAB, V93, P319, DOI 10.1016/j.apmr.2011.09.008; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016; Wingfield A, 2003, AM J PHYS MED REHAB, V82, P547, DOI 10.1097/00002060-200307000-00009; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; YOUNG ME, 1995, ARCH PHYS MED REHAB, V76, P525, DOI 10.1016/S0003-9993(95)80506-0	33	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	AUG	2018	56	8					796	805		10.1038/s41393-018-0076-0			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GP8JN	WOS:000441156700010	29472608	Bronze			2021-06-18	
J	Khalaf, S; Ahmad, AS; Chamara, KVDR; Dore, S				Khalaf, Saher; Ahmad, Abdullah Shafique; Chamara, K. V. D. Ranga; Dore, Sylvain			Unique Properties Associated with the Brain Penetrant Iron Chelator HBED Reveal Remarkable Beneficial Effects after Brain Trauma	JOURNAL OF NEUROTRAUMA			English	Article						blood; edema; microglia; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; PROSTANOID RECEPTOR; INDUCED ATTENUATION; DEFEROXAMINE; INJURY; OVERLOAD; DELETION; OUTCOMES; EDEMA; RATS	Iron is postulated to contribute to secondary injury after brain trauma through various pathways including oxidative stress and inflammation. Therefore, one goal is to limit iron toxicity by either directly limiting iron activity, or limiting the secondary cascade mediated by iron, therefore rescuing the brain from damage after trauma. The N,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid monohydrochloride (HBED) is a unique iron chelator that has the ability to cross the intact blood-brain barrier; it has a higher affinity to iron, and it has a longer half-life than most commonly used chelators. A controlled-cortical impact model of traumatic brain injury (TBI) was induced in mice. Mice were subcutaneously injected with HBED immediately after TBI, then at 12h after, followed by a twice-a-day regimen until an end-point of 3 days. Neurobehavioral tests were performed daily. Cortical injury volume, hemispheric enlargement, and hippocampal swelling were quantified. Perls' iron immunostaining along with markers of gliosis, oxidative stress, and aquaporin (AQP) 4 were also performed. Data revealed that HBED treatment significantly decreases motor deficits and improves recovery after TBI. It also reduces cortical injury volume by 36.6 +/- 6.8% (p<0.001), hippocampal swelling by 23.4 +/- 3.8% (p<0.05), and total hemispheric volume by 13.3 +/- 2.7% (p<0.01). These effects are related to a reduction in microgliosis and oxidiative stress markers in the impacted corpus callosum area by 39.8 +/- 7.3%, and by 80.5 +/- 0.8% (p<0.05), respectively. AQP4 staining is also attenuated in the hippocampus of HBED-treated mice. Therefore, our results suggest that HBED should be considered as a therapeutic tool to facilitate the recovery process following brain trauma.	[Khalaf, Saher; Ahmad, Abdullah Shafique; Chamara, K. V. D. Ranga; Dore, Sylvain] Univ Florida, Dept Anesthesiol, McKnight Brain Inst, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL USA; [Dore, Sylvain] Univ Florida, Dept Neurol, Gainesville, FL USA; [Dore, Sylvain] Univ Florida, Dept Psychiat, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Pharmaceut, Gainesville, FL USA; [Dore, Sylvain] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Dore, Sylvain] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA	Dore, S (corresponding author), Univ Florida, Coll Med, 1275 Ctr Dr,Biomed Sci J493,PO 100159, Gainesville, FL 32610 USA.	sdore@ufl.edu	Dore, Sylvain/AAG-1470-2020	Dore, Sylvain/0000-0003-3771-5109	McKnight Brain Research Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21NS095166]; Brain and Spinal Cord Injury Research Trust Fund;  [AHA33450010]	This work was supported in part by grants from the McKnight Brain Research Foundation, Brain and Spinal Cord Injury Research Trust Fund, and AHA33450010, and NIH R21NS095166 (SD). The authors would also like to thank Dore Lab team members for providing their feedback on the manuscript and Corey Astrom, ELS, for her editorial expertise.	Abbruzzese G, 2011, HAEMATOL-HEMATOL J, V96, P1708, DOI 10.3324/haematol.2011.043018; Auriat AM, 2012, EXP NEUROL, V234, P136, DOI 10.1016/j.expneurol.2011.12.030; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bergeron RJ, 1998, BLOOD, V91, P1446, DOI 10.1182/blood.V91.4.1446; Bergeron RJ, 2002, BLOOD, V99, P3019, DOI 10.1182/blood.V99.8.3019; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Cui HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127256; Dragsten PR, 2000, J LAB CLIN MED, V135, P57, DOI 10.1016/S0022-2143(00)70021-7; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Frankowski JC, 2015, SCI REP-UK, V5, DOI 10.1038/srep17956; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Glushakov AV, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00034; Glushakov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113689; GRADY RW, 1994, ADV EXP MED BIOL, V356, P351; HALLAWAY PE, 1989, P NATL ACAD SCI USA, V86, P10108, DOI 10.1073/pnas.86.24.10108; Healy S, 2016, SCI REP-UK, V6, DOI 10.1038/srep36410; Kontoghiorghes GJ, 2010, EXPERT OPIN DRUG SAF, V9, P633, DOI 10.1517/14740338.2010.497138; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; LAU EH, 1983, J LAB CLIN MED, V101, P806; Leclerc JL, 2018, J CEREBR BLOOD F MET, V38, P1032, DOI 10.1177/0271678X16679170; Leclerc JL, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0182-2; Leclerc JL, 2015, EUR J NEUROSCI, V41, P1381, DOI 10.1111/ejn.12909; Leclerc JL, 2015, ASN NEURO, V7, DOI 10.1177/1759091415578713; LEE P, 1993, DRUG METAB DISPOS, V21, P640; Li Q, 2017, J CEREBR BLOOD F MET, V37, P3110, DOI 10.1177/0271678X17709186; Li YP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0740-2; Liang FY, 2015, NEUROSCI LETT, V598, P29, DOI 10.1016/j.neulet.2015.05.006; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Nakamura T, 2004, J NEUROSURG, V100, P672, DOI 10.3171/jns.2004.100.4.0672; Ondruschka B, 2018, INT J LEGAL MED, V132, P531, DOI 10.1007/s00414-017-1768-2; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Potts Mathew B, 2006, NeuroRx, V3, P143; Qing WG, 2009, J NEUROSURG, V110, P462, DOI 10.3171/2008.4.JNS17512; Rollet-Labelle E, 1998, FREE RADICAL BIO MED, V24, P563, DOI 10.1016/S0891-5849(97)00292-X; Samuni AM, 2001, FREE RADICAL BIO MED, V30, P170, DOI 10.1016/S0891-5849(00)00459-7; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Thiele N.A., 2017, HBED PRODRUGS USE TH; Tricta F, 2016, AM J HEMATOL, V91, P1026, DOI 10.1002/ajh.24479; Wan S, 2006, ACTA NEUROCHIR SUPPL, V96, P199; Wang BF, 2015, ACTA PHARMACOL SIN, V36, P939, DOI 10.1038/aps.2015.47; Wang L, 2017, BIOSCI REP, V37; WHITTEN CF, 1965, PEDIATRICS, V36, P322; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Yao XM, 2015, J NEUROTRAUM, V32, P1458, DOI 10.1089/neu.2014.3675; Yu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122371; Zhang LJ, 2013, NEUROL SCI, V34, P639, DOI 10.1007/s10072-012-1090-1; Zhao F, 2011, STROKE, V42, P3587, DOI 10.1161/STROKEAHA.111.623926; Zhao JB, 2014, TRANSL STROKE RES, V5, P586, DOI 10.1007/s12975-014-0353-y	52	13	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					43	53		10.1089/neu.2017.5617		JUL 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439949600001	29743006	Green Published			2021-06-18	
J	Han, PF; Winkler, N; Hummel, C; Hhner, A; Gerber, J; Hummel, T				Han, Pengfei; Winkler, Nicole; Hummel, Cornelia; Haehner, Antje; Gerber, Johannes; Hummel, Thomas			Alterations of Brain Gray Matter Density and Olfactory Bulb Volume in Patients with Olfactory Loss after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						gray matter density; olfactory bulb volume; olfactory loss; post-injury duration; traumatic brain injury	ODOR DISCRIMINATION; INDUCED ACTIVATION; NORMATIVE DATA; HEAD-INJURY; DYSFUNCTION; IDENTIFICATION; ANOSMIA; MRI; PATHOPHYSIOLOGY; RETRONASAL	Olfactory loss and traumatic brain injury (TBI) both lead to anatomical brain alterations in humans. Little research has been done on the structural brain changes for TBI patients with olfactory loss. Using voxel-based morphometry, the gray matter (GM) density was examined for 22 TBI patients with hyposmia, 24 TBI patients with anosmia, and 22 age-matched controls. Olfactory bulb (OB) volumes were measured by manual segmentation of acquired T2-weighted coronal slices using a standardized protocol. Brain lesions in the olfactory-relevant areas also were examined for TBI patients. Results showed that patients with anosmia have more frequent lesions in the OB, orbitofrontal cortex (OFC), and the temporal lobe pole, compared with patients with hyposmia. GM density in the primary olfactory area was decreased in both groups of patients. In addition, compared with controls, patients with anosmia showed GM density reduction in several secondary olfactory eloquent regions, including the gyrus rectus, medial OFC, anterior cingulate cortex, insula, and cerebellum. However, patients with hyposmia showed a lesser degree of GM reduction, compared with healthy controls. Smaller OB volumes were found for patients with olfactory loss, compared with controls. TBI patients with anosmia had the smallest OB volumes, which were caused by the lesions for OB. In addition, post-TBI duration was negatively correlated with GM density in the secondary olfactory areas in patients with hyposmia, but was positively correlated with GM density in the frontal and temporal gyrus in patients with anosmia. The GM density and OB volume reduction among TBI patients with olfactory loss was largely dependent on the location and severity of brain lesions in olfactory-relevant regions. Longer post-TBI duration had an impact on brain GM density changes, which indicate a decreased olfactory function in patients with hyposmia and possible compensatory mechanisms in patients with anosmia.	[Han, Pengfei; Winkler, Nicole; Hummel, Cornelia; Haehner, Antje; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Fetscherstr 74, D-01307 Dresden, Germany; [Gerber, Johannes] Tech Univ Dresden, Dept Neuroradiol, Dresden, Germany	Han, PF (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Fetscherstr 74, D-01307 Dresden, Germany.	pengfeihan88@gmail.com	Gerber, Johannes/U-4918-2019	Gerber, Johannes/0000-0001-7465-8700; Han, Pengfei/0000-0001-8266-6655	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG HU 411/18-1]	This research as supported by a grant from the Deutsche Forschungsgemeinschaft to TH (DFG HU 411/18-1).	Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Andersson L, 2014, J PSYCHOSOM RES, V77, P401, DOI 10.1016/j.jpsychores.2014.09.014; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Banks SJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00414; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Billot PE, 2011, NEUROSCIENCE, V189, P370, DOI 10.1016/j.neuroscience.2011.05.035; Bitter T, 2010, BRAIN RES, V1347, P42, DOI 10.1016/j.brainres.2010.06.003; Bitter T, 2010, CHEM SENSES, V35, P407, DOI 10.1093/chemse/bjq028; Boyle JA, 2007, NEUROSCIENCE, V149, P223, DOI 10.1016/j.neuroscience.2007.06.045; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; Coelho DH, 2016, AURIS NASUS LARYNX, V43, P137, DOI 10.1016/j.anl.2015.08.006; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEKRUIJK JR, 2009, BRAIN INJURY, V17, P73, DOI DOI 10.1016/J.JSMC.2015.10.004; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; Delon-Martin C, 2013, NEUROIMAGE, V68, P55, DOI 10.1016/j.neuroimage.2012.11.044; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gardner AJ, 2017, PHYS MED REH CLIN N, V28, P413, DOI 10.1016/j.pmr.2016.12.014; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Grabenhorst F, 2007, J NEUROSCI, V27, P13532, DOI 10.1523/JNEUROSCI.3337-07.2007; Gudziol H, 2010, LARYNGO RHINO OTOL, V89, P477, DOI 10.1055/s-0030-1253372; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Gulyas B, 2004, NEUROCHEM INT, V44, P595, DOI 10.1016/j.neuint.2003.10.003; Han PF, 2017, INT FORUM ALLERGY RH, V7, P551, DOI 10.1002/alr.21922; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kareken DA, 2003, NEUROPSYCHOLOGY, V17, P482, DOI 10.1037/0894-4105.17.3.482; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landis BN, 2010, J NEUROL, V257, P1303, DOI 10.1007/s00415-010-5513-8; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; LIST J, 2015, FRONT HUM NEUROSCI, V9, DOI DOI 10.1378/CHEST.11-1603; Lotsch J, 2016, NEUROIMAGE-CLIN, V11, P99, DOI 10.1016/j.nicl.2016.01.011; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Peng P, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130207; Plailly J, 2006, NEUROIMAGE, V29, P302, DOI 10.1016/j.neuroimage.2005.06.056; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Rolls ET, 2016, BRAIN COGNITION, V110, P4, DOI 10.1016/j.bandc.2015.07.002; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rombaux P, 2006, ARCH OTOLARYNGOL, V132, P1346, DOI 10.1001/archotol.132.12.1346; Savic I, 2004, HUM BRAIN MAPP, V21, P271, DOI 10.1002/hbm.20009; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Schriever VA, 2014, CHEM SENSES, V39, P343, DOI 10.1093/chemse/bju005; Segura B, 2013, BEHAV BRAIN RES, V246, P148, DOI 10.1016/j.bbr.2013.02.025; SHIGA H, 2017, SCI REP-UK, V7, DOI DOI 10.1111/J.1526-4637.2007.00404.X; Sobel N, 1998, J NEUROSCI, V18, P8990; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Vent J, 2010, BRAIN RES, V1320, P1, DOI 10.1016/j.brainres.2010.01.007; Welborn BL, 2009, SOC COGN AFFECT NEUR, V4, P328, DOI 10.1093/scan/nsp028; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; YAO L, 2014, CHEM SENSES, DOI DOI 10.1016/J.SLEEP.2007.11.023; Yao LY, 2013, EUR ARCH OTO-RHINO-L, V270, P2569, DOI 10.1007/s00405-013-2595-9; Yousem DM, 1997, ACAD RADIOL, V4, P264, DOI 10.1016/S1076-6332(97)80027-X; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Yousem DM, 1998, ANN NY ACAD SCI, V855, P546, DOI 10.1111/j.1749-6632.1998.tb10624.x; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	84	13	13	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2632	2640		10.1089/neu.2017.5393		JUL 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000439632400001	29699465				2021-06-18	
J	Erler, KS; Whiteneck, GG; Juengst, SB; Locascio, JJ; Bogner, JA; Kaminski, J; Giacino, JT				Erler, Kimberly S.; Whiteneck, Gale G.; Juengst, Shannon B.; Locascio, Joseph J.; Bogner, Jennifer A.; Kaminski, Jamie; Giacino, Joseph T.			Predicting the Trajectory of Participation After Traumatic Brain Injury: A Longitudinal Analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; longitudinal studies; rehabilitation; social participation	QUALITY-OF-LIFE; 1ST 5 YEARS; COMMUNITY INTEGRATION; OUTCOMES; REHABILITATION; DEPRESSION; VALIDITY; SATISFACTION; HEALTH	Objective: To identify factors that predict trajectories of participation over the first 5 years after moderate to severe traumatic brain injury (TBI). Setting: TBI Model System Programs. Participants: Community-dwelling individuals with TBI, 16 years of age or older (n = 1947). Design: Secondary analysis of a prospective, nonrandomly sampled, longitudinal data registry. Main Measures: Participation Assessment with Recombined ToolsObjective (PART-O). Results: Age at injury and FIM Motor score predicted trajectory of participation over the first 5 years after moderate to severe TBI. Older age predicted generally worse participation overall as well as progressively worsening participation over time. Higher FIM Motor raised the predicted participation values, although it reduced the rate of improvement in participation scores over time. FIM Cognitive scores, race, depression, years of education, and living setting did not predict trajectory but did significantly influence participation consistently at all time points. Conclusion: The trajectories of participation over the first 5 years after TBI can be predicted by age at injury and FIM Motor scores. These findings may enhance the ability of rehabilitation professionals to identify individuals at risk for poor participation after TBI and develop targeted interventions for optimizing involvement in life activities.	[Erler, Kimberly S.; Kaminski, Jamie; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 1st Ave, Charlestown, MA 02129 USA; [Whiteneck, Gale G.] Craig Hosp, Res Dept, Englewood, CO USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Juengst, Shannon B.] Univ Texas Southwestern Med Ctr Dallas, Dept Rehabil Counseling, Dallas, TX 75390 USA; [Locascio, Joseph J.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Bogner, Jennifer A.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA	Erler, KS (corresponding author), Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, 300 1st Ave, Charlestown, MA 02129 USA.	kerler@partners.org	Juengst, Shannon B/AAC-5891-2019; Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698	Harvard Catalyst; Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health Award) [UL1 TR001102]; Harvard University; National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0034, 90DP0039, 90DP0040, 90DP0041]	This work was conducted with support from Harvard Catalyst. The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.; This work was conducted with support from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR; grant numbers 90DP0034, 90DP0039, 90DP0040, 90DP0041). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health & Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and endorsement by the Federal Government should not be assumed.	AMERICAN OCCUPATIONAL THERAPY ASSOCIATION-AOTA, 2008, AM J OCCUPATIONAL S1, V62, P625, DOI [10.5014/ajot.62.6.625, DOI 10.5014/AJOT.2014.682006]; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bogner JA, 2011, ARCH PHYS MED REHAB, V92, P552, DOI 10.1016/j.apmr.2010.11.014; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Centers for Disease Control and Prevention, 2015, REP C TRAUM BRAIN IN; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P828, DOI 10.1016/S0003-9993(97)90195-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Heinemann AW, 1994, TOP STROKE REHABIL, V1, P1; Huebner RA, 2003, AM J OCCUP THER, V57, P177, DOI 10.5014/ajot.57.2.177; Johnston MV, 2005, ARCH PHYS MED REHAB, V86, P735, DOI 10.1016/j.apmr.2004.10.031; Juengst SB, 2014, AM J PHYS MED REHAB, V93, P1086, DOI 10.1097/PHM.0000000000000163; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Larsson J, 2013, J REHABIL MED, V45, P765, DOI 10.2340/16501977-1184; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Locascio JJ, 2011, DEMENT GER COGN D EX, V1, P330, DOI 10.1159/000330228; Malec JF, 2016, ARCH PHYS MED REHAB, V97, P211, DOI 10.1016/j.apmr.2015.09.001; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; National Institute of Neurological Disorders and Stroke, 2016, NINDS COMM DAT EL HA; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; World Health Organization, 2001, INT CLASS FUNCT DIS	40	13	13	2	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2018	33	4					257	265		10.1097/HTR.0000000000000383			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GR6GT	WOS:000442745900012	29385019				2021-06-18	
J	Kardouni, JR; Shing, TL; Mckinnon, CJ; Scofield, DE; Proctor, SP				Kardouni, Joseph R.; Shing, Tracie L.; Mckinnon, Craig J.; Scofield, Dennis E.; Proctor, Susan P.			Risk for Lower Extremity Injury After Concussion: A Matched Cohort Study in Soldiers	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						concussion; lower extremity injury; military; tactical athlete	STABILITY FOLLOWING CONCUSSION; MUSCULOSKELETAL INJURY; POSTURAL CONTROL; DIVIDED ATTENTION; DYNAMIC STABILITY; FOOTBALL PLAYERS; GAIT; INCREASES; RETURN; SPORT	BACKGROUND: Rates of lower extremity musculoskeletal injury are reportedly higher in professional and collegiate athletes following concussions. However, there is a paucity of evidence on this relationship in individuals who are not high-level athletes. OBJECTIVES: To examine the risk of acute lower extremity musculoskeletal injury in soldiers within 2 years of an incident concussion, compared to matched nonconcussed soldiers. METHODS: This was a matched-cohort study that used the medical encounter and personnel data of active-duty US Army soldiers from 2005 to 2011. Incident concussions were identified using International Classification of Diseases-Ninth Revision codes in medical encounter data of all soldiers from 2005 to 2009. One nonconcussed soldier in the US Army during the same month was matched by age, sex, rank, length of service, deployment status, and military career field to each concussed soldier. Hazard ratio (HR) and 95% confidence interval (CI) were calculated for the risk of lower extremity injury within 2 years of the incident concussion. Monthly HRs were compared to identify differences in injury rates between the groups, and an HR for the period of greatest difference was also calculated. RESULTS: A total of 23 044 individuals (11 522 concussed and 11 522 nonconcussed) were included in the study. Within 2 years of concussion, the hazard of lower extremity injury was 38% greater in concussed compared to nonconcussed soldiers (HR, 1.38; 95% CI: 1.30, 1.46), while the 15-month hazard was 45% greater (HR, 1.45; 95% CI: 1.36, 1.56). CONCLUSION: The rate of lower extremity musculoskeletal injury among this population of physically active adults is higher following concussion, and the risk remains elevated for more than a year following injury.	[Kardouni, Joseph R.; Shing, Tracie L.; Mckinnon, Craig J.; Scofield, Dennis E.; Proctor, Susan P.] US Army, Res Inst Environm Med, Natick, MA 01760 USA; [Proctor, Susan P.] VA Boston Healthcare Syst, Res Serv, Boston, MA USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA	Kardouni, JR (corresponding author), US Army, Res Inst Environm Med, Mil Performance Div, 10 Gen Greene Ave,Bldg 42, Natick, MA 01760 USA.	joseph.r.kardouni.mil@mail.mil	Scofield, Dennis/AAC-6775-2019	Scofield, Dennis/0000-0003-4478-9640			Allison P.D., 1995, SURVIVAL ANAL USING; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chiu SL, 2013, GAIT POSTURE, V38, P717, DOI 10.1016/j.gaitpost.2013.03.010; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Fino PC, 2016, GAIT POSTURE, V50, P69, DOI 10.1016/j.gaitpost.2016.08.026; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Fox ZG, 2008, J ATHL TRAINING, V43, P456, DOI 10.4085/1062-6050-43.5.456; Fulton J, 2014, INT J SPORTS PHYS TH, V9, P583; Hutchison M, 2011, AM J SPORT MED, V39, P2331, DOI 10.1177/0363546511413375; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Maruta J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00045; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Oldham JR, 2016, GAIT POSTURE, V49, P437, DOI 10.1016/j.gaitpost.2016.07.327; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Scofield DE, 2015, STRENGTH COND J, V37, P2, DOI 10.1519/SSC.0000000000000149; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; St Sauver JL, 2012, MAYO CLIN PROC, V87, P151, DOI 10.1016/j.mayocp.2011.11.009	28	13	13	0	6	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	JUL	2018	48	7					533	540		10.2519/jospt.2018.8053			8	Orthopedics; Rehabilitation; Sport Sciences	Orthopedics; Rehabilitation; Sport Sciences	GL6MR	WOS:000437301400004	29739302				2021-06-18	
J	Tiruvoipati, R; Pilcher, D; Botha, J; Buscher, H; Simister, R; Bailey, M				Tiruvoipati, Ravindranath; Pilcher, David; Botha, John; Buscher, Hergen; Simister, Robert; Bailey, Michael			Association of Hypercapnia and Hypercapnic Acidosis With Clinical Outcomes in Mechanically Ventilated Patients With Cerebral Injury	JAMA NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; ARTERIAL CARBON-DIOXIDE; POSTRESUSCITATION PARTIAL-PRESSURE; HOSPITAL CARDIAC-ARREST; SUBARACHNOID HEMORRHAGE; PERMISSIVE HYPERCAPNIA; BLOOD-PH; ISCHEMIA; IMPACT; DEATH	IMPORTANCE Clinical studies investigating the effects of hypercapnia and hypercapnic acidosis in acute cerebral injury are limited. The studies performed so far have mainly focused on the outcomes in relation to the changes in partial pressure of carbon dioxide and pH in isolation and have not evaluated the effects of partial pressure of carbon dioxide and pH in conjunction. OBJECTIVE To review the association of compensated hypercapnia and hypercapnic acidosis during the first 24 hours of intensive care unit admission on hospital mortality in adult mechanically ventilated patients with cerebral injury. DESIGN, SETTING, AND PARTICIPANTS Multicenter, binational retrospective review of patients with cerebral injury (traumatic brain injury, cardiac arrest, and stroke) admitted to 167 intensive care units in Australia and New Zealand between January 2000 and December 2015. Patients were classified into 3 groups based on combination of arterial pH and arterial carbon dioxide (normocapnia and normal pH, compensated hypercapnia, and hypercapnic acidosis) during the first 24 hours of intensive care unit stay. MAIN OUTCOMES AND MEASURES Hospital mortality. RESULTS A total of 30 742 patients (mean age, 55 years; 21 827 men [71%]) were included. Unadjusted hospital mortality rates were highest in patients with hypercapnic acidosis. Multivariable logistic regression analysis and Cox proportional hazards analysis in 3 diagnostic categories showed increased odds of hospital mortality (cardiac arrest odds ratio [OR], 1.51; 95% CI, 1.34-1.71; stroke OR, 1.43; 95% CI, 1.27-1.6; and traumatic brain injury OR, 1.22; 95% CI, 1.06-1.42; P < .001) and hazard ratios (HR) (cardiac arrest HR, 1.23; 95% CI, 1.14-1.34; stroke HR, 1.3; 95% CI, 1.21-1.4; traumatic brain injury HR, 1.13; 95% CI, 1-1.27), in patients with hypercapnic acidosis compared with normocapnia and normal pH. There was no difference in mortality between patients who had compensated hypercapnia compared with patients who had normocapnia and normal pH. In patients with hypercapnic acidosis, the adjusted OR of hospital mortality increased with increasing partial pressure of carbon dioxide, while no such increase was noted in patients with compensated hypercapnia. CONCLUSIONS AND RELEVANCE Hypercapnic acidosis was associated with increased risk of hospital mortality in patients with cerebral injury. Hypercapnia, when compensated to normal pH during the first 24 hours of intensive care unit admission, may not be harmful in mechanically ventilated patients with cerebral injury.	[Tiruvoipati, Ravindranath; Botha, John] Frankston Hosp, Dept Intens Care Med, Frankston, Vic 3199, Australia; [Tiruvoipati, Ravindranath; Botha, John] Monash Univ, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Tiruvoipati, Ravindranath; Pilcher, David; Bailey, Michael] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Dept Epidemiol & Prevent Med, Sch Publ Hlth & Prevent Med,Alfred Ctr, Victoria, Melbourne, Vic, Australia; [Pilcher, David; Bailey, Michael] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, Sydney, NSW, Australia; [Pilcher, David] Alfred Hosp, Dept Intens Care, Prahran, Vic, Australia; [Buscher, Hergen] St Vincents Hosp, Dept Intens Care Med, Sydney, NSW, Australia; [Buscher, Hergen] Univ New South Wales, Sydney, NSW, Australia; [Simister, Robert] Univ Coll London Hosp NHS Fdn Trust, Inst Neurol, London, England	Tiruvoipati, R (corresponding author), Frankston Hosp, Dept Intens Care Med, Frankston, Vic 3199, Australia.	travindranath@hotmail.com	Tiruvoipati, Ravindranath/Q-9365-2019; Buscher, Hergen/O-8513-2019; Bailey, Michael J/A-4499-2012	Buscher, Hergen/0000-0002-4531-6151; Bailey, Michael J/0000-0002-5551-1401; Tiruvoipati, Ravindranath/0000-0003-3800-902X			Bennett KS, 2013, CRIT CARE MED, V41, P1534, DOI 10.1097/CCM.0b013e318287f54c; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; CHRISTENSEN MS, 1972, EUR NEUROL, V8, P137, DOI 10.1159/000114566; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Eastwood GM, 2016, RESUSCITATION, V104, P83, DOI 10.1016/j.resuscitation.2016.03.023; Eastwood GM, 2016, RESUSCITATION, V102, P11, DOI 10.1016/j.resuscitation.2016.02.009; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gupta AK, 2004, J NEUROTRAUM, V21, P678, DOI 10.1089/0897715041269722; KATSURA K, 1991, J CEREBR BLOOD F MET, V11, P597, DOI 10.1038/jcbfm.1991.109; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; McKenzie N, 2017, RESUSCITATION, V111, P116, DOI 10.1016/j.resuscitation.2016.09.019; Momiyama Y, 2017, ACUTE MED SURG, V4, P25, DOI 10.1002/ams2.217; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; O'Croinin D, 2005, CRIT CARE, V9, P51, DOI 10.1186/cc2918; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Roberts BW, 2015, RESUSCITATION, V91, P32, DOI 10.1016/j.resuscitation.2015.03.015; Roberts BW, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/2110-5820-4-9; Roberts BW, 2013, CIRCULATION, V127, P2107, DOI 10.1161/CIRCULATIONAHA.112.000168; Sathianathan Kushaharan, 2016, World J Crit Care Med, V5, P103, DOI 10.5492/wjccm.v5.i1.103; Schneider AG, 2013, RESUSCITATION, V84, P927, DOI 10.1016/j.resuscitation.2013.02.014; Solaiman O, 2013, J NEUROSURG ANESTH, V25, P254, DOI 10.1097/ANA.0b013e3182806465; Takaki S, 2013, J EMERG MED, V45, P57, DOI 10.1016/j.jemermed.2012.11.095; Tolner EA, 2011, EPILEPSIA, V52, P104, DOI 10.1111/j.1528-1167.2010.02731.x; Vaahersalo J, 2014, CRIT CARE MED, V42, P1463, DOI 10.1097/CCM.0000000000000228; Warner KJ, 2008, J TRAUMA, V64, P341, DOI 10.1097/TA.0b013e318160dfb3; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Westermaier T, 2014, J NEUROSURG, V121, P1056, DOI 10.3171/2014.7.JNS132611; Zhou Q, 2010, ANESTHESIOLOGY, V112, P288, DOI 10.1097/ALN.0b013e3181ca8257	32	13	13	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6149	2168-6157		JAMA NEUROL	JAMA Neurol.	JUL	2018	75	7					818	826		10.1001/jamaneurol.2018.0123			9	Clinical Neurology	Neurosciences & Neurology	GM5DB	WOS:000438149400010	29554187	Green Published, Bronze			2021-06-18	
J	Wulsin, AC; Franco-Villanueva, A; Romancheck, C; Morano, RL; Smith, BL; Packard, BA; Danzer, SC; Herman, JP				Wulsin, Aynara C.; Franco-Villanueva, Ana; Romancheck, Christian; Morano, Rachel L.; Smith, Brittany L.; Packard, Benjamin A.; Danzer, Steve C.; Herman, James P.			Functional disruption of stress modulatory circuits in a model of temporal lobe epilepsy	PLOS ONE			English	Article							C-FOS EXPRESSION; INDUCED STATUS-EPILEPTICUS; PITUITARY-ADRENOCORTICAL AXIS; TRAUMATIC BRAIN-INJURY; MESSENGER-RNA LEVELS; PILOCARPINE MODEL; RESTRAINT STRESS; TIME-COURSE; RAT-BRAIN; SPONTANEOUS SEIZURES	Clinical data suggest that the neuroendocrine stress response is chronically dysregulated in a subset of patients with temporal lobe epilepsy (TLE), potentially contributing to both disease progression and the development of psychiatric comorbidities such as anxiety and depression. Whether neuroendocrine dysregulation and psychiatric comorbidities reflect direct effects of epilepsy-related pathologies, or secondary effects of disease burden particular to humans with epilepsy (i.e. social estrangement, employment changes) is not clear. Animal models provide an opportunity to dissociate these factors. Therefore, we queried whether epileptic mice would reproduce neuroendocrine and behavioral changes associated with human epilepsy. Male FVB mice were exposed to pilocarpine to induce status epilepticus (SE) and the subsequent development of spontaneous recurrent seizures. Morning baseline corticosterone levels were elevated in pilocarpine treated mice at 1, 7 and 10 weeks post-SE relative to controls. Similarly, epileptic mice had increased adrenal weight when compared to control mice. Exposure to acute restraint stress resulted in hypersecretion of corticosterone 30 min after the onset of the challenge. Anatomical analyses revealed reduced Fos expression in infralimbic and prelimbic prefrontal cortex, ventral subiculum and basal amygdala following restraint. No differences in Fos immunoreactivity were found in the paraventricular nucleus of the hypothalamus, hippocampal subfields or central amygdala. In order to assess emotional behavior, a second cohort of mice underwent a battery of behavioral tests, including sucrose preference, open field, elevated plus maze, 24h home-cage monitoring and forced swim. Epileptic mice showed increased anhedonic behavior, hyperactivity and anxiety-like behaviors. Together these data demonstrate that epileptic mice develop HPA axis hyperactivity and exhibit behavioral dysfunction. Endocrine and behavioral changes are associated with impaired recruitment of forebrain circuits regulating stress inhibition and emotional reactivity. Loss of forebrain control may underlie pronounced endocrine dysfunction and comorbid psychopathologies seen in temporal lobe epilepsy.	[Wulsin, Aynara C.; Franco-Villanueva, Ana; Romancheck, Christian; Morano, Rachel L.; Smith, Brittany L.; Packard, Benjamin A.; Herman, James P.] Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA; [Wulsin, Aynara C.; Danzer, Steve C.] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA	Herman, JP (corresponding author), Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA.	james.herman@uc.edu	Franco-Villanueva, Ana/X-9013-2019	Franco-Villanueva, Ana/0000-0003-4971-0591; Wulsin, Aynara/0000-0002-4501-6845	University of Cincinnati Retention;  [R01-NS-062806];  [R01-NS-065020];  [T32-GM063483];  [F30-NS-095578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM063483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065020, R01NS062806, F30NS095578] Funding Source: NIH RePORTER	This work was supported by University of Cincinnati Retention Grant to James Herman, R01-NS-062806 and R01-NS-065020 to SCD, T32-GM063483 and F30-NS-095578 to ACW. The University of Cincinnati nor NIH had further role in the study design; data collection, analysis and interpretation; writing of the report nor in the decision to submit for publication.	Allendorfer JB, 2014, EPILEPSY BEHAV, V36, P115, DOI 10.1016/j.yebeh.2014.05.003; Barros VN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00072; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Buckmaster PS, 2012, EPILEPSY RES, V102, P153, DOI 10.1016/j.eplepsyres.2012.05.012; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; CHEN X, 1995, NEUROSCIENCE, V64, P675, DOI 10.1016/0306-4522(94)00532-A; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; De Kloet ER, 2016, COPING FORCED SWIM S, P2016; de Oliveira CV, 2015, PHYSIOL BEHAV, V143, P142, DOI 10.1016/j.physbeh.2015.03.004; do Nascimento AL, 2012, BRAIN RES, V1470, P98, DOI 10.1016/j.brainres.2012.06.008; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; FELDMAN RG, 1976, J NERV MENT DIS, V162, P345, DOI 10.1097/00005053-197605000-00005; Figueiredo HF, 2003, EUR J NEUROSCI, V18, P2357, DOI 10.1046/j.1460-9568.2003.02932.x; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Giordano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141221; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Herman JP, 2006, BEHAV BRAIN RES, V174, P215, DOI 10.1016/j.bbr.2006.05.035; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hester MS, 2016, EXP NEUROL, V280, P1, DOI 10.1016/j.expneurol.2016.03.015; Hester MS, 2014, EPILEPSY BEHAV, P2, DOI [10.1016/j.yebeh.2013.12.022, DOI 10.1016/J.YEBEH.2013.12.022]; Hosford B, 2016, J NEUROSCI; Howell K, 2002, EXP PHYSIOL, V87, P747, DOI 10.1113/eph8702477; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Klein S, 2015, EXP NEUROL, V263, P263, DOI 10.1016/j.expneurol.2014.09.004; Kling MA, 2009, DEPRESS ANXIETY, V26, P641, DOI 10.1002/da.20546; Kondziella D, 2007, J NEUROCHEM, V103, P2136, DOI 10.1111/j.1471-4159.2007.04926.x; Lopes MW, 2016, EPILEPSY BEHAV, V55, P92, DOI 10.1016/j.yebeh.2015.12.001; Maccotta L, 2013, NEUROIMAGE-CLIN, V2, P862, DOI 10.1016/j.nicl.2013.06.011; Mahbod P, 2018, ENDOCRINOLOGY, V159, P388, DOI 10.1210/en.2017-00540; Marques AH, 2009, ANN NY ACAD SCI, V1179, P1, DOI 10.1111/j.1749-6632.2009.04987.x; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-X; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; McCullers DL, 2001, J NEUROSCI RES, V64, P277; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McKlveen JM, 2015, J NEUROENDOCRINOL, V27, P446, DOI 10.1111/jne.12272; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Mustafa T, 2015, STRESS, V18, P408, DOI 10.3109/10253890.2015.1025044; Myers B, 2012, CELL MOL NEUROBIOL, V32, P683, DOI 10.1007/s10571-012-9801-y; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; O'Toole KK, 2014, EPILEPSY RES, V108, P29, DOI 10.1016/j.eplepsyres.2013.10.013; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sarkisova K, 2011, PROG NEURO-PSYCHOPH, V35, P854, DOI 10.1016/j.pnpbp.2010.11.010; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Singewald N, 2007, NEUROSCI BIOBEHAV R, V31, P18, DOI 10.1016/j.neubiorev.2006.02.003; Solomon MB, 2010, J NEUROENDOCRINOL, V22, P13, DOI 10.1111/j.1365-2826.2009.01933.x; Soussi R, 2015, BRAIN STRUCT FUNCT, V220, P2449, DOI 10.1007/s00429-014-0800-2; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Steimer T, 2002, DIALOGUES CLIN NEURO, P4; Stewart LS, 2003, EPILEPSY BEHAV, V4, P153, DOI 10.1016/S1525-5050(03)00006-4; Suleymanova EM, 2016, NEUROSCIENCE, V315, P79, DOI 10.1016/j.neuroscience.2015.11.061; Tsukiyama N, 2011, STRESS, V14, P368, DOI 10.3109/10253890.2010.544345; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Umeoka EHL, 2011, BRAIN RES, V1381, P141, DOI 10.1016/j.brainres.2011.01.042; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Varga D, 2015, FRONT BEHAV NEUROSCI, V9, P14, DOI 10.3389/fnbeh.2015.00157; Vollmer LL, 2016, BIOL PSYCHIAT, V80, P541, DOI 10.1016/j.biopsych.2016.04.022; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Webb NE, 2014, NEUROREHABILITATION, V34, P625, DOI 10.3233/NRE-141074; Weinberg MS, 2007, NEUROSCIENCE, V150, P478, DOI 10.1016/j.neuroscience.2007.09.013; Wieser HG, 2004, EPILEPSIA, V45, P32; Wulsin AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00214; Wulsin AC, 2016, PHYSIOL BEHAV, V166, P22, DOI 10.1016/j.physbeh.2016.05.015; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	82	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197955	10.1371/journal.pone.0197955			19	Multidisciplinary Sciences	Science & Technology - Other Topics	GH0HY	WOS:000433084300103	29795651	DOAJ Gold, Green Published			2021-06-18	
J	Jalloh, I; Helmy, A; Howe, DJ; Shannon, RJ; Grice, P; Mason, A; Gallagher, CN; Murphy, MP; Pickard, JD; Menon, DK; Carpenter, TA; Hutchinson, PJ; Carpenter, KLH				Jalloh, Ibrahim; Helmy, Adel; Howe, Duncan J.; Shannon, Richard J.; Grice, Peter; Mason, Andrew; Gallagher, Clare N.; Murphy, Michael P.; Pickard, John D.; Menon, David K.; Carpenter, T. Adrian; Hutchinson, Peter J.; Carpenter, Keri L. H.			A Comparison of Oxidative Lactate Metabolism in Traumatically Injured and Control Brains	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; microdialysis; NMR; 3-C-13 lactate; traumatic brain injury (human)	INTRACRANIAL HYPERTENSIVE EPISODES; MAGNETIC-RESONANCE-SPECTROSCOPY; TRICARBOXYLIC-ACID CYCLE; IN-VIVO; ENERGY-METABOLISM; GLUTAMINE-SYNTHETASE; HYPERTONIC LACTATE; SODIUM LACTATE; BLOOD-FLOW; RAT-BRAIN	Metabolic abnormalities occur after traumatic brain injury (TBI). Glucose is conventionally regarded as the major energy substrate, although lactate can also be an energy source. We compared 3-C-13 lactate metabolism in TBI with "normal" control brain and muscle, measuring C-13-glutamine enrichment to assess tricarboxylic acid (TCA) cycle metabolism. Microdialysis catheters in brains of nine patients with severe TBI, five non-TBI brain surgical patients, and five resting muscle (non-TBI) patients were perfused (24h in brain, 8h in muscle) with 8mmol/L sodium 3-C-13 lactate. Microdialysate analysis employed ISCUS and nuclear magnetic resonance. In TBI, with 3-C-13 lactate perfusion, microdialysate glucose concentration increased nonsignificantly (mean +11.9%, p=0.463), with significant increases (p=0.028) for lactate (+174%), pyruvate (+35.8%), and lactate/pyruvate ratio (+101.8%). Microdialysate C-13-glutamine fractional enrichments (median, interquartile range) were: for C4 5.1 (0-11.1) % in TBI and 5.7 (4.6-6.8) % in control brain, for C3 0 (0-5.0) % in TBI and 0 (0-0) % in control brain, and for C2 2.9 (0-5.7) % in TBI and 1.8 (0-3.4) % in control brain. C-13-enrichments were not statistically different between TBI and control brain, showing both metabolize 3-C-13 lactate via TCA cycle, in contrast to muscle. Several patients with TBI exhibited C-13-glutamine enrichment above the non-TBI control range, suggesting lactate oxidative metabolism as a TBI "emergency option."	[Jalloh, Ibrahim; Helmy, Adel; Shannon, Richard J.; Gallagher, Clare N.; Pickard, John D.; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Howe, Duncan J.; Grice, Peter; Mason, Andrew] Univ Cambridge, Dept Chem, Cambridge, England; [Gallagher, Clare N.] Univ Calgary, Div Neurosurg, Dept Clin Neurosci, Calgary, ON, Canada; [Murphy, Michael P.] Univ Cambridge, MRC Mitochondrial Biol Unit, Cambridge, England; [Pickard, John D.; Menon, David K.; Carpenter, T. Adrian; Hutchinson, Peter J.; Carpenter, Keri L. H.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England	Jalloh, I; Carpenter, KLH (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Box 167,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	ibrahim.jalloh@cantab.net; klc1000@wbic.cam.ac.uk	Helmy, Adel/AAS-3084-2020; Murphy, Michael/C-2120-2009	Helmy, Adel/0000-0002-0531-0556; Hutchinson, Peter/0000-0002-2796-1835; Murphy, Michael/0000-0003-1115-9618	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986 ID79068, G1002277 ID98489, G1002277 ID 98489]; National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); National Institute for Health Research Biomedical Research Centre, CambridgeNational Institute for Health Research (NIHR); KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR); Medical Research Council/Royal College of Surgeons of England Clinical Research Training FellowshipUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0802251]; Raymond and Beverly Sackler Fellowship; Royal College of Surgeons of England; NIHR Cambridge Biomedical Research CentreNational Institute for Health Research (NIHR); National Institute for Health Research Senior Investigator Awards; Medical Research Council UKUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_U105663142]; Wellcome Trust Investigator awardWellcome Trust [110159/Z/15/Z]	The authors thank Mr. John Harwood (Manufacturing Unit, Department of Pharmacy, Ipswich Hospital NHS Trust) for supervising the formulation of the substrate (sodium 3-<SUP>13</SUP>C lactate in CNS perfusion fluid). We thank Dr. Tamara Tajsic (Division of Neurosurgery, University of Cambridge) for assistance with demography (clinical outcomes). The author(s) gratefully acknowledge receipt of the following financial support for the research, authorship, and/or publication of this article: Medical Research Council (Grant Nos. G0600986 ID79068 and G1002277 ID98489) and National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: IJ - Medical Research Council (Grant no. G1002277 ID 98489) and National Institute for Health Research Biomedical Research Centre, Cambridge; KLHC - National Institute for Health Research Biomedical Research Centre, Cambridge (Neuroscience Theme; Brain Injury and Repair Theme); CG - the Canadian Institute of Health Research; AH - Medical Research Council/Royal College of Surgeons of England Clinical Research Training Fellowship (Grant no. G0802251) and Raymond and Beverly Sackler Fellowship; Royal College of Surgeons of England and the NIHR Cambridge Biomedical Research Centre; DKM and JDP - National Institute for Health Research Senior Investigator Awards; MPM - Medical Research Council UK (MC_U105663142) and a Wellcome Trust Investigator award (110159/Z/15/Z). PJH - National Institute for Health Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and the National Institute for Health Research Biomedical Research Centre, Cambridge.	Abe T, 2006, J CEREBR BLOOD F MET, V26, P153, DOI 10.1038/sj.jcbfm.9600175; Berthet C, 2009, J CEREBR BLOOD F MET, V29, P1780, DOI 10.1038/jcbfm.2009.97; Boumezbeur F, 2010, J NEUROSCI, V30, P13983, DOI 10.1523/JNEUROSCI.2040-10.2010; Bouzat P, 2014, INTENS CARE MED, V40, P920, DOI 10.1007/s00134-014-3312-x; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bouzier AK, 2000, J NEUROCHEM, V75, P480, DOI 10.1046/j.1471-4159.2000.0750480.x; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; BROOKS GA, 1986, FASEB J, V45, P2924; Brooks GA, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00408; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Duarte JMN, 2015, J NEUROSCI RES, V93, P1009, DOI 10.1002/jnr.23531; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Halim ND, 2010, GLIA, V58, P1168, DOI 10.1002/glia.20996; Hassel B, 2000, MOL NEUROBIOL, V22, P21, DOI 10.1385/MN:22:1-3:021; Hassel B, 2000, J CEREBR BLOOD F MET, V20, P327, DOI 10.1097/00004647-200002000-00014; Henderson GC, 2004, J APPL PHYSIOL, V97, P317, DOI 10.1152/japplphysiol.01367.2003; Hertz L, 2004, J CEREBR BLOOD F MET, V24, P1241, DOI 10.1097/00004647-200411000-00008; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Hutchinson PJ, 2002, J NEUROL NEUROSUR PS, V72, P99, DOI 10.1136/jnnp.72.1.99; Ichai C, 2013, INTENS CARE MED, V39, P1413, DOI 10.1007/s00134-013-2978-9; Ichai C, 2009, INTENS CARE MED, V35, P471, DOI 10.1007/s00134-008-1283-5; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Jalloh I, 2017, J CEREBR BLOOD F MET, V37, P2626, DOI 10.1177/0271678X16672665; Jalloh I, 2015, J CEREBR BLOOD F MET, V35, P111, DOI 10.1038/jcbfm.2014.177; Machler P, 2016, CELL METAB, V23, P94, DOI 10.1016/j.cmet.2015.10.010; Mintun MA, 2004, P NATL ACAD SCI USA, V101, P659, DOI 10.1073/pnas.0307457100; NORENBERG MD, 1979, BRAIN RES, V161, P303, DOI 10.1016/0006-8993(79)90071-4; Oddo M, 2012, STROKE, V43, P1418, DOI 10.1161/STROKEAHA.111.648568; Pardo Beatriz, 2013, Front Endocrinol (Lausanne), V4, P149, DOI 10.3389/fendo.2013.00149; Patet C, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0638-5; Patet C, 2015, J NEUROTRAUM, V32, P1560, DOI 10.1089/neu.2014.3781; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pellerin L, 2007, GLIA, V55, P1251, DOI 10.1002/glia.20528; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Qu H, 2000, DEV NEUROSCI-BASEL, V22, P429, DOI 10.1159/000017472; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Rosafio K, 2016, NEUROSCIENCE, V317, P108, DOI 10.1016/j.neuroscience.2015.12.052; Rose CF, 2013, BIOCHEM SOC T, V41, P1518, DOI 10.1042/BST20130237; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; SCHOUSBOE A, 1993, DEV NEUROSCI-BASEL, V15, P359, DOI 10.1159/000111356; Tyson RL, 2003, BRAIN RES, V992, P43, DOI 10.1016/j.brainres.2003.08.027; VANDENBERG CJ, 1966, BIOCHEM BIOPH RES CO, V23, P479, DOI 10.1016/0006-291X(66)90753-4; VANDENBERG CJ, 1969, BIOCHEM J, V113, P281, DOI 10.1042/bj1130281; Vlassenko AG, 2006, P NATL ACAD SCI USA, V103, P1964, DOI 10.1073/pnas.0510632103; Waagepetersen HS, 1998, DEV NEUROSCI-BASEL, V20, P310, DOI 10.1159/000017326	50	13	13	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2018	35	17					2025	2035		10.1089/neu.2017.5459		MAY 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GQ7LU	WOS:000432676000001	29690859	Bronze, Green Published			2021-06-18	
J	Edlow, BL; Keene, CD; Perl, DP; Iacono, D; Folkerth, RD; Stewart, W; Mac Donald, CL; Augustinack, J; Diaz-Arrastia, R; Estrada, C; Flannery, E; Gordon, WA; Grabowski, TJ; Hansen, K; Hoffman, J; Kroenke, C; Larson, EB; Lee, P; Mareyam, A; McNab, JA; McPhee, J; Moreau, AL; Renz, A; Richmire, K; Stevens, A; Tang, CY; Tirrell, LS; Trittschuh, EH; van der Kouwe, A; Varjabedian, A; Wald, LL; Wu, O; Yendiki, A; Young, L; Zollei, L; Fischl, B; Crane, PK; Dams-O'Connor, K				Edlow, Brian L.; Keene, C. Dirk; Perl, Daniel P.; Iacono, Diego; Folkerth, Rebecca D.; Stewart, William; Mac Donald, Christine L.; Augustinack, Jean; Diaz-Arrastia, Ramon; Estrada, Camilo; Flannery, Elissa; Gordon, Wayne A.; Grabowski, Thomas J.; Hansen, Kelly; Hoffman, Jeanne; Kroenke, Christopher; Larson, Eric B.; Lee, Patricia; Mareyam, Azma; McNab, Jennifer A.; McPhee, Jeanne; Moreau, Allison L.; Renz, Anne; Richmire, KatieRose; Stevens, Allison; Tang, Cheuk Y.; Tirrell, Lee S.; Trittschuh, Emily H.; van der Kouwe, Andre; Varjabedian, Ani; Wald, Lawrence L.; Wu, Ona; Yendiki, Anastasia; Young, Liza; Zollei, Lilla; Fischl, Bruce; Crane, Paul K.; Dams-O'Connor, Kristen			Multimodal Characterization of the Late Effects of Traumatic Brain Injury: A Methodological Overview of the Late Effects of Traumatic Brain Injury Project	JOURNAL OF NEUROTRAUMA			English	Article						dementia; MRI; neurodegeneration; neuropathology; traumatic brain injury	COMMON DATA ELEMENTS; ALZHEIMERS ASSOCIATION GUIDELINES; ASCENDING AROUSAL SYSTEM; NATIONAL INSTITUTE; NEUROPATHOLOGIC ASSESSMENT; AMYLOID-BETA; DISEASE; HEALTH; LIFE; CONNECTOME	Epidemiological studies suggest that a single moderate-to-severe traumatic brain injury (TBI) is associated with an increased risk of neurodegenerative disease, including Alzheimer's disease (AD) and Parkinson's disease (PD). Histopathological studies describe complex neurodegenerative pathologies in individuals exposed to single moderate-to-severe TBI or repetitive mild TBI, including chronic traumatic encephalopathy (CTE). However, the clinicopathological links between TBI and post-traumatic neurodegenerative diseases such as AD, PD, and CTE remain poorly understood. Here, we describe the methodology of the Late Effects of TBI (LETBI) study, whose goals are to characterize chronic post-traumatic neuropathology and to identify in vivo biomarkers of post-traumatic neurodegeneration. LETBI participants undergo extensive clinical evaluation using National Institutes of Health TBI Common Data Elements, proteomic and genomic analysis, structural and functional magnetic resonance imaging (MRI), and prospective consent for brain donation. Selected brain specimens undergo ultra-high resolution ex vivo MRI and histopathological evaluation including whole-mount analysis. Co-registration of ex vivo and in vivo MRI data enables identification of ex vivo lesions that were present during life. In vivo signatures of postmortem pathology are then correlated with cognitive and behavioral data to characterize the clinical phenotype(s) associated with pathological brain lesions. We illustrate the study methods and demonstrate proof of concept for this approach by reporting results from the first LETBI participant, who despite the presence of multiple in vivo and ex vivo pathoanatomic lesions had normal cognition and was functionally independent until her mid-80s. The LETBI project represents a multidisciplinary effort to characterize post-traumatic neuropathology and identify in vivo signatures of postmortem pathology in a prospective study.	Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Edlow, Brian L.] Harvard Med Sch, Boston, MA USA; [Edlow, Brian L.; Augustinack, Jean; Mareyam, Azma; Moreau, Allison L.; Stevens, Allison; Tirrell, Lee S.; van der Kouwe, Andre; Varjabedian, Ani; Wald, Lawrence L.; Wu, Ona; Yendiki, Anastasia; Zollei, Lilla; Fischl, Bruce] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Edlow, Brian L.; Augustinack, Jean; Mareyam, Azma; Moreau, Allison L.; Stevens, Allison; Tirrell, Lee S.; van der Kouwe, Andre; Varjabedian, Ani; Wald, Lawrence L.; Wu, Ona; Yendiki, Anastasia; Zollei, Lilla; Fischl, Bruce] Harvard Med Sch, Charlestown, MA USA; [Keene, C. Dirk] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Mac Donald, Christine L.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Grabowski, Thomas J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Grabowski, Thomas J.; Young, Liza] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Hoffman, Jeanne] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Trittschuh, Emily H.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA USA; [Perl, Daniel P.; Iacono, Diego; Lee, Patricia] Uniformed Serv Univ Hlth Sci, Brain Tissue Repository & Neuropathol Core, Bethesda, MD USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Iacono, Diego; Lee, Patricia] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Folkerth, Rebecca D.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA USA; [Folkerth, Rebecca D.] City New York Off, New York, NY USA; [Folkerth, Rebecca D.] NYU, Sch Med, New York, NY USA; [Stewart, William] Univ Glasgow, Queen Elizabeth Univ Hosp, Dept Neuropathol, Glasgow, Lanark, Scotland; [Stewart, William] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Diaz-Arrastia, Ramon] Hosp Univ Penn, Dept Neurol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Diaz-Arrastia, Ramon] Hosp Univ Penn, Ctr Brain Injury & Repair, 3400 Spruce St, Philadelphia, PA 19104 USA; [Estrada, Camilo; Hansen, Kelly; Larson, Eric B.; Renz, Anne; Richmire, KatieRose] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Flannery, Elissa; Gordon, Wayne A.; McPhee, Jeanne; Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Tang, Cheuk Y.] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Kroenke, Christopher] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [McNab, Jennifer A.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Trittschuh, Emily H.] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA	Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, Brain Injury Res Ctr, Box 1163,One Gustave L Levy Pl, New York, NY 10029 USA.	kristen.dams-o'connor@mountsinai.org	Wald, Lawrence L/D-4151-2009; Moreau, Allison L./T-2625-2019; Melief, Erica/M-6436-2019; Lang, Steven/AAE-8102-2021; Iacono, Diego/K-8203-2016	Wald, Lawrence L/0000-0001-8278-6307; Moreau, Allison L./0000-0002-8758-8622; Lang, Steven/0000-0003-1669-9146; Iacono, Diego/0000-0001-5511-0950; McPhee, Jeanne/0000-0001-9199-0393; Stewart, William/0000-0003-2199-2582; MICHAUD, ANI/0000-0001-9039-3212; Wu, Ona/0000-0002-5509-9461	National Institutes of Health/National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Child Health and DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U01 NS086625]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U24 RR021382]; National Institute for Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896, R01EB006758, R21EB018907, R01EB019956, 1R01EB023281]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG022381, R01 AG016495, 5R01AG008122, U01AG006781, R21AG046657, P41RR014075, P50AG005136]; National Center for Alternative Medicine [RC1 AT005728-01]; National Institute for Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538, R01NS052585-01, 1R21NS072652-01, 1R01NS070963, R01NS083534, 5U01NS086625]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K01HD074651, R01HD071664]; National Institute on Disability Independent Living and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B040033]; Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [1R49CE001171]; NIH Blueprint for Neuroscience ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5U01-MH093765]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1S10RR023401, 1S10RR019307, 1S10RR023043]; American Academy of Neurology/American Brain Foundation; James S. McDonnell Foundation; Nancy and Buster Alvord Endowment; University of Washington School of Medicine; Seton Brain Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015896, R21EB018907, R01EB019956, R01EB023281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS094538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG016495, U01AG006781, P50AG005136] Funding Source: NIH RePORTER	We thank Michelle Siciliano, Gregory Tirrell, Sebastian Valentin, Terrence Ott, Vahram Haroutunian, and Maxwell Bustamante for assistance in obtaining and processing brain specimens; William Lee for providing database management and data sharing support; and Thomas Benner for implementation of the DWSSFP sequence for ex vivo MRI. We would like to acknowledge Dylan Tisdall and Andre van der Kouwe (Athinoula A. Martinos Center for Biomedical Imaging) and Himanshu Bhat (Siemens Medical Center) for the provision of WIP711D (vNav Motion-Corrected Multiecho MPRAGE) used to acquire MEMPRAGE data. The LETBI Project is supported by the National Institutes of Health/National Institute for Neurological Disorders and Stroke and National Institute of Child Health and Development (U01 NS086625). This research also utilized resources provided by the National Center for Research Resources (U24 RR021382), the National Institute for Biomedical Imaging and Bioengineering (P41EB015896, R01EB006758, R21EB018907, R01EB019956, 1R01EB023281), the National Institute on Aging (AG022381, 5R01AG008122, R01 AG016495, 5R01AG008122, U01AG006781, R21AG046657, P41RR014075, P50AG005136), the National Center for Alternative Medicine (RC1 AT005728-01), the National Institute for Neurological Disorders and Stroke (K23NS094538, R01NS052585-01, 1R21NS072652-01, 1R01NS070963, R01NS083534, 5U01NS086625), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (1K01HD074651, R01HD071664), the National Institute on Disability Independent Living and Rehabilitation Research (H133B040033), and the Centers for Disease Control and Prevention (1R49CE001171). Additional support was provided by the NIH Blueprint for Neuroscience Research (5U01-MH093765), part of the multi-institutional Human Connectome Project. This research also utilized resources provided by National Institutes of Health shared instrumentation grants 1S10RR023401, 1S10RR019307, and 1S10RR023043. Additional support for this project comes from the American Academy of Neurology/American Brain Foundation, the James S. McDonnell Foundation, the Nancy and Buster Alvord Endowment, institutional funds from the University of Washington School of Medicine, and the Seton Brain Research Fund. The opinions expressed herein are those of the authors and are not necessarily representative of those of the Uniformed Services University of the Health Sciences, the Department of Defense, the United States Army, Navy or Air Force, or of any other agency or component of the United States government.	Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], 2009, TRAUMATIC BRAIN INJU; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Benton A, 1989, MULTILINGUAL APHASIA; Bettcher BM, 2017, J ALZHEIMERS DIS, V59, P1307, DOI 10.3233/JAD-161224; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cella D, 2012, NEUROLOGY, V78, P1860, DOI 10.1212/WNL.0b013e318258f744; Coccaro EF, 1997, PSYCHIAT RES, V73, P147, DOI 10.1016/S0165-1781(97)00119-4; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2014, J HEAD TRAUMA REHAB, V29, P479, DOI 10.1097/HTR.0000000000000099; Delis DC, 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Edlow BL, 2016, BRAIN CONNECT, V6, P187, DOI 10.1089/brain.2015.0378; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gordon W.A., 1999, BRAIN INJURY SCREENI; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hays RD, 1995, USERS MANUAL MED OUT; Health IOM COGWA, 2008, GULF WAR AND HLTH; Hibbard M., 1999, BRAIN INJURY SCREENI; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; Mcnab JA, 2009, NEUROIMAGE, V46, P775, DOI 10.1016/j.neuroimage.2009.01.008; Meyers J., REY COMPLEX FIGURE T; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Postelnicu G, 2009, IEEE T MED IMAGING, V28, P508, DOI 10.1109/TMI.2008.2004426; Postupna N, 2017, AM J PATHOL, V187, P884, DOI 10.1016/j.ajpath.2016.12.010; Postupna N, 2015, J NEUROPATH EXP NEUR, V74, P100, DOI 10.1097/NEN.0000000000000153; Postupna N, 2012, BRAIN PATHOL, V22, P472, DOI 10.1111/j.1750-3639.2011.00542.x; Ryff CD, 2012, National Survey of Midlife Development in the United States (MIDUS 2), 2004-2006; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Sours C, 2017, J NEUROTRAUM, V34, pS4, DOI 10.1089/neu.2017.29014.bb; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; van der Kouwe AJW, 2008, NEUROIMAGE, V40, P559, DOI 10.1016/j.neuroimage.2007.12.025; Ware J. E., 2001, SF 36 PHYS MENTAL HL, V2; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wechsler D., 1987, WMS R WECHSLER MEMOR; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	74	13	13	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1604	1619		10.1089/neu.2017.5457		MAY 2018	16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000431463900001	29421973	Green Published, Green Accepted			2021-06-18	
J	Atsumi, N; Nakahira, Y; Tanaka, E; Iwamoto, M				Atsumi, Noritoshi; Nakahira, Yuko; Tanaka, Eiichi; Iwamoto, Masami			Human Brain Modeling with Its Anatomical Structure and Realistic Material Properties for Brain Injury Prediction	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Diffuse axonal injury; Constitutive model; Anisotropy; Viscoelasticity; Brain FE model; Accident reconstruction analyses	AXONAL DAMAGE; ANISOTROPY; HEAD	Impairments of executive brain function after traumatic brain injury (TBI) due to head impacts in traffic accidents need to be obviated. Finite element (FE) analyses with a human brain model facilitate understanding of the TBI mechanisms. However, conventional brain FE models do not suitably describe the anatomical structure in the deep brain, which is a critical region for executive brain function, and the material properties of brain parenchyma. In this study, for better TBI prediction, a novel brain FE model with anatomical structure in the deep brain was developed. The developed model comprises a constitutive model of brain parenchyma considering anisotropy and strain rate dependency. Validation was performed against postmortem human subject test data associated with brain deformation during head impact. Brain injury analyses were performed using head acceleration curves obtained from reconstruction analysis of rear-end collision with a human whole-body FE model. The difference in structure was found to affect the regions of strain concentration, while the difference in material model contributed to the peak strain value. The injury prediction result by the proposed model was consistent with the characteristics in the neuroimaging data of TBI patients due to traffic accidents.	[Atsumi, Noritoshi; Nakahira, Yuko; Iwamoto, Masami] Toyota Cent R&D Labs, Human Sci Res Domain, 41-1 Yokomichi, Nagakute, Aichi 4801192, Japan; [Tanaka, Eiichi] Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan; [Tanaka, Eiichi] Tokai Polytech Coll, 1-2 Furukawa, Ono, Gifu 5010502, Japan	Atsumi, N (corresponding author), Toyota Cent R&D Labs, Human Sci Res Domain, 41-1 Yokomichi, Nagakute, Aichi 4801192, Japan.	atsumi@mosk.tytlabs.co.jp					Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; Atsumi N, 2016, 2016011485 SAE; Atsumi N., 2016, INT J VEHICLE SAF, V9, P1, DOI DOI 10.1504/IJVS.2016.077145; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; El Sayed T, 2008, J BIOMECH, V41, P1458, DOI 10.1016/j.jbiomech.2008.02.023; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franklyn Melanie, 2005, Stapp Car Crash J, V49, P1; Gehre C., 2011, P 22 ESV C; Gehre C., 2009, P 21 ESV C; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C., 2016, STAPP CAR CRASH J, V60, P336; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holzapfel G. A., 2000, NONLINEAR SOLID MECH, P282; Hrapko M, 2006, BIORHEOLOGY, V43, P623; HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P333, DOI 10.1115/1.2891193; Ito D, 2010, J MECH BEHAV BIOMED, V3, P85, DOI 10.1016/j.jmbbm.2009.05.001; Iwamoto M., 2017, P 4 FAST ZER C; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krafft M., 1998, P 16 ESV C; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; OGDEN RW, 1972, PROC R SOC LON SER-A, V328, P567, DOI 10.1098/rspa.1972.0096; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Sahoo D., 2015, P IRCOBI C; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Schunke M, 2009, PROMETHEUS LERNATLAS, P292; Shinoda J., 2013, JPN J NEUROSURG TOKY, V22, P842, DOI DOI 10.7887/JCNS.22.842; Shinoda Jun, 2011, No Shinkei Geka, V39, P115; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; The International Organization for Standardization (ISO), 2013, 16250 ISO ISOTR; The International Organization for Standardization (ISO), 1999, 9790 ISO ISOTR; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhou C, 1995, P 39 STAPP CAR CRASH, V39, P121, DOI DOI 10.4271/952714	43	13	13	2	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAY	2018	46	5					736	748		10.1007/s10439-018-1988-8			13	Engineering, Biomedical	Engineering	GC5GP	WOS:000429815200007	29404847				2021-06-18	
J	Auxemery, Y				Auxemery, Yann			Post-traumatic psychiatric disorders: PTSD is not the only diagnosis	PRESSE MEDICALE			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSIVE DISORDER; STRESS-DISORDER; PSYCHOTIC SYMPTOMS; ANXIETY DISORDER; COMBAT VETERANS; CHILDHOOD TRAUMA; SOCIAL PHOBIA; COMORBID PTSD; HEALTH	Traumatic events and their consequences are often hidden or minimised by patients for reasons linked to the post-traumatic stress disorder itself (inexpressibility, shame, depressive thoughts, fear of stigmatisation, etc.). Although post-traumatic stress disorder (PTSD) remains the most widely known disorder, chronic post-traumatic psychiatric disorders are many and varied. After a trauma, the practitioner has to check for the different clinical forms of post-traumatic psychological consequences: PTSD is not the only diagnosis. Based on our own clinical experience compared to the international literature, we think necessary to build a didactic classification describing chronic post-traumatic symptoms and syndromes. Post traumatic depressions and bereavement lead to high risk of suicidal crisis and self-harm behaviours. Re-experiencing are felt with anxiety, hyper arousal increases anxious reactivity, and avoidance strategies increase anticipatory anxiety, indicating post-traumatic anxiety disorders (agoraphobia, specific phobia, obsessive compulsive disorder, separation anxiety, social phobia). Characterising an often-severe clinical picture, the co-occurrence of post-traumatic and chronic psychotic symptoms is not unusual (post-traumatic schizophrenia, post-traumatic depression with mood-congruent psychotic features, non-schizophrenic post-traumatic psychotic disorder, and bipolar reaction to trauma). A physical injury occurring at the same time as a traumatic exposure increases the risk of developing post-traumatic stress disorder later which, in turn, afflicts the subjective perception of the physical health (development of somatoform and psychosomatic disorders, comorbidity with a post-concussion syndrome). The trauma may cause a rupture in the biography of a person, also in his/her internal physiological functioning as in his/her social activities (impacts of instinctive functions and behaviours, personality changes, and adjustment difficulties on professional and personal life). Although a nomenclature is necessary for semiological descriptions, a thorough analysis of the patient's general psychological functioning must also be conducted.	[Auxemery, Yann] Hop Instruct Armees Percy, Main Aeromed Ctr, Med Psychol Serv Appl Aeronaut, 101 Ave Henri Barbusse, F-92140 Clamart, France	Auxemery, Y (corresponding author), Hop Instruct Armees Percy, Main Aeromed Ctr, Med Psychol Serv Appl Aeronaut, 101 Ave Henri Barbusse, F-92140 Clamart, France.	Yann.auxemery@hotmail.fr					Ahl R, 2017, INJURY, V48, P101, DOI 10.1016/j.injury.2016.10.041; Alarcon RD, 1999, PSYCHIATRY, V62, P114, DOI 10.1080/00332747.1999.11024860; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI [10.1176/appi.books.9780890425596., DOI 10.1176/APPI.BOOKS.9780890425596, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3rd; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; [Anonymous], 1993, ARCH PHYS MED REHAB, V74, pS8; Auxemery Y, 2017, EUR J TRAUMA DISSOC, V1, P137, DOI 10.1016/j.ejtd.2017.03.002; Auxemery Y, 2015, ENCEPHALE, V41, P346, DOI 10.1016/j.encep.2014.07.005; Auxemery Y, 2015, EVOL PSYCHIATR, V80, P659, DOI 10.1016/j.evopsy.2014.05.001; Auxemery Y, 2014, EVOL PSYCHIATR, V79, P287, DOI 10.1016/j.evopsy.2014.01.002; Auxemery Y, 2012, MED HYPOTHESES, V79, P667, DOI 10.1016/j.mehy.2012.08.005; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Brady KT, 1997, J CLIN PSYCHIAT, V58, P12; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Breslau N, 2003, ARCH GEN PSYCHIAT, V60, P289, DOI 10.1001/archpsyc.60.3.289; Brewerton TD, 2017, EAT WEIGHT DISORD-ST, V22, P241, DOI 10.1007/s40519-016-0355-8; Brewin CR, 2003, AM J PSYCHIAT, V160, P783, DOI 10.1176/appi.ajp.160.4.783; Breyer BN, 2016, J TRAUMA STRESS, V29, P229, DOI 10.1002/jts.22097; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Calhoun PS, 2007, SCHIZOPHR RES, V91, P210, DOI 10.1016/j.schres.2006.12.011; Chappelle WL, 2014, MIL MED, V179, P63, DOI 10.7205/MILMED-D-13-00501; Crocq L., 1999, PSYCHOL TRAUMAS WAR; David D, 1999, J CLIN PSYCHIAT, V60, P29, DOI 10.4088/JCP.v60n0106; Deb S, 1999, AM J PSYCHIAT, V156, P374; Ducrocq F, 2001, ENCEPHALE, V27, P159; El-Hage W, 2006, PRESSE MED, V35, P1683, DOI 10.1016/S0755-4982(06)74881-3; Etain B, 2017, J PSYCHIATR RES, V84, P73, DOI 10.1016/j.jpsychires.2016.09.022; Etain B, 2013, J CLIN PSYCHIAT, V74, P991, DOI 10.4088/JCP.13m08353; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Fostick L, 2012, WORLD J BIOL PSYCHIA, V13, P312, DOI 10.3109/15622975.2011.607848; Fox GC, 1999, BRIT J PSYCHIAT, V174, P560; Freeman D, 2013, PSYCHOL MED, V43, P2673, DOI 10.1017/S003329171300038X; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Guina J, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0686-1; Hainsworth C, 2011, J TRAUMA STRESS, V24, P491, DOI 10.1002/jts.20666; Hamner MB, 1998, PSYCHIAT RES, V77, P175, DOI 10.1016/S0165-1781(98)00002-X; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Harder LH, 2011, J NERV MENT DIS, V199, P940, DOI 10.1097/NMD.0b013e3182392bfb; Hartman D, 2001, POSTGRAD MED J, V77, P244, DOI 10.1136/pmj.77.906.244; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Hippocrates, 1923, CORPUS HIPPROCRATICU; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Holterbach L, 2015, ENCEPHALE, V41, P444, DOI 10.1016/j.encep.2015.05.001; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Kondo K., 2015, INTERVENTIONS IMPROV; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Krakow B, 2000, COMPR PSYCHIAT, V41, P49, DOI 10.1016/S0010-440X(00)90131-7; Lin KH, 2016, OCCUP MED-OXFORD, V66, P514, DOI 10.1093/occmed/kqw036; Lucretius, 1910, RERUM NATURA NATURE; McKinney JM, 2017, J AFFECT DISORDERS, V214, P100, DOI 10.1016/j.jad.2017.03.008; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Norman SB, 2012, NEUROPHARMACOLOGY, V62, P542, DOI 10.1016/j.neuropharm.2011.04.032; Orr SP, 2000, J AFFECT DISORDERS, V61, P225, DOI 10.1016/S0165-0327(00)00340-2; Orsillo SM, 1996, J TRAUMA STRESS, V9, P235, DOI 10.1007/BF02110658; Ouimette P, 2010, ADDICT BEHAV, V35, P64, DOI 10.1016/j.addbeh.2009.08.009; Pivar IL, 2004, J ANXIETY DISORD, V18, P745, DOI 10.1016/j.janxdis.2003.09.005; POLLOCK DA, 1990, AM J PSYCHIAT, V147, P772; Price M, 2015, J AFFECT DISORDERS, V186, P149, DOI 10.1016/j.jad.2015.06.012; Prigerson HG, 1999, BRIT J PSYCHIAT, V174, P67, DOI 10.1192/bjp.174.1.67; Resnick SG, 2003, J ABNORM PSYCHOL, V112, P415, DOI 10.1037/0021-843X.112.3.415; Reuber M, 2004, J NEUROL NEUROSUR PS, V75, P743, DOI 10.1136/jnnp.2003.013821; Richman H, 1997, Depress Anxiety, V6, P70, DOI 10.1002/(SICI)1520-6394(1997)6:2<70::AID-DA3>3.0.CO;2-9; Roelofs K, 2005, J NERV MENT DIS, V193, P508, DOI 10.1097/01.nmd.0000172472.60197.4d; Roley ME, 2015, J AFFECT DISORDERS, V180, P116, DOI 10.1016/j.jad.2015.04.006; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Sautter FJ, 2002, AM J PSYCHIAT, V159, P1775, DOI 10.1176/appi.ajp.159.10.1775; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seedat S, 2003, J NERV MENT DIS, V191, P675, DOI 10.1097/01.nmd.0000092177.97317.26; Sellbom M, 2009, J TRAUMA STRESS, V22, P471, DOI 10.1002/jts.20452; Sher L, 2005, MED HYPOTHESES, V65, P205, DOI 10.1016/j.mehy.2005.03.014; Silove D, 2010, J TRAUMA STRESS, V23, P169, DOI 10.1002/jts.20490; SOLOMON Z, 1989, PSYCHIATRY, V52, P428, DOI 10.1080/00332747.1989.11024467; Spiegel D, 2000, AM J PSYCHIAT, V157, P1890, DOI 10.1176/appi.ajp.157.11.1890; Sundquist K, 2016, J PSYCHOSOM RES, V86, P60, DOI 10.1016/j.jpsychores.2016.05.007; Swearingen JM, 2017, MIL MED, V182, P258, DOI 10.7205/MILMED-D-16-00107; Tagay S, 2005, J PSYCHOSOM RES, V58, P439, DOI 10.1016/j.jpsychores.2004.09.007; Teng EJ, 2015, J ANXIETY DISORD, V33, P1, DOI 10.1016/j.janxdis.2015.04.002; Tsai J, 2014, J CLIN PSYCHIAT, V75, P276, DOI 10.4088/JCP.13m08466; Vierling V, 2015, PRESSE MED, V44, pE339, DOI 10.1016/j.lpm.2015.04.039; Vogt D, 2017, SOC PSYCH PSYCH EPID, V52, P341, DOI 10.1007/s00127-016-1321-5; Voon V, 2010, BRAIN, V133, P1526, DOI 10.1093/brain/awq054; Waddington A, 2003, ENCEPHALE, V29, P20; World Health Organisation, 1993, ICD 10 CLASSIFICATIO; Yehuda R, 2015, J SEX MED, V12, P1107, DOI 10.1111/jsm.12856; Zayfert C, 2005, J NERV MENT DIS, V193, P93, DOI 10.1097/01.nmd.0000152795.47479.d9; Zimmerman M, 1999, J CLIN PSYCHIAT, V60, P311, DOI 10.4088/JCP.v60n0508	89	13	14	0	22	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0755-4982	2213-0276		PRESSE MED	Presse Med.	MAY	2018	47	5					423	430		10.1016/j.lpm.2017.12.006			8	Medicine, General & Internal	General & Internal Medicine	GG1RZ	WOS:000432465900004	29580906				2021-06-18	
J	Chang, PP; Weykamp, M; Dennahy, IS; Williams, AM; Bhatti, UF; Liu, BL; Nikolian, VC; Li, YQ; Alam, HB				Chang, Panpan; Weykamp, Michael; Dennahy, Isabel S.; Williams, Aaron M.; Bhatti, Umar F.; Liu, Baoling; Nikolian, Vahagn C.; Li, Yongqing; Alam, Hasan B.			Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Histone deacetylase inhibitors; isoform-selective; valproic acid; hemorrhagic shock; prosurvival pathways	TRAUMATIC BRAIN-INJURY; VALPROIC ACID; CELL-DEATH; PROSURVIVAL PHENOTYPE; RESUSCITATION FLUIDS; MOLECULAR-MECHANISMS; RAT MODEL; RECOVERY; PHOSPHORYLATION; APOPTOSIS	BACKGROUND Hemorrhage is a leading preventable cause of death. Nonselective histone deacetylase inhibitors (HDACIs), such as valproic acid (VPA), have been shown to improve outcomes in hemorrhagic shock (HS). The HDACs can be divided into four functional classes (I, IIa/IIb, III, and IV). Classes I, IIa/IIb, and III have previously been implicated in the pathophysiology of HS. This study aimed to determine which HDAC class, or classes, are responsible for the survival benefit observed with nonselective HDACIs. METHODS Survival study: Sprague-Dawley rats were subjected to lethal HS (50% hemorrhage) and randomized to the following groups (n = 8): (1) no treatment, (2) normal saline vehicle, (3) cyclodextrin vehicle, (4) MS275 (class I HDACI), (5) VPA (class I/IIa HDACI), (6) MC1568 (class IIa HDACI), (7) ACY1083 (class IIb HDACI), and (8) EX527 (class III HDACI). Survival was monitored for 24 hours. Mechanistic study: Sprague-Dawley rats were subjected to sublethal HS (40% hemorrhage) and randomized to the same groups (n = 3), excluding EX527, based on results of the survival study. Tissues were harvested at 3 hours posttreatment, and expression of phosphorylated-AKT, -catenin, acetylated histones H3 and H4, and acetylated -tubulin were analyzed in myocardial tissue. RESULTS Survival rate was 12.5% in the untreated group, and did not improve with vehicle or MS275 treatment. EX527 improved survival to 50%, although this did not achieve statistical significance (p = 0.082). However, treatment with VPA, MC1568, and ACY1083 improved survival rates to 87.5%, 75%, and 75%, respectively (p < 0.05). The VPA-induced acetylation of both histones H3 and H4, while MC1568 and ACY1083 increased acetylation of histone H4. ACY1083 also induced acetylation of -tubulin. All treatment groups, except MS275, increased phosphorylated-AKT, and -catenin. CONCLUSION Inhibition of HDAC classes IIa or IIb, but not class I, activates prosurvival pathways, which may be responsible for the improved outcomes in rodent models of HS.	[Chang, Panpan] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Liaoning, Peoples R China; [Chang, Panpan; Weykamp, Michael; Dennahy, Isabel S.; Williams, Aaron M.; Bhatti, Umar F.; Liu, Baoling; Nikolian, Vahagn C.; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA	Li, YQ (corresponding author), Univ Michigan Hosp, Dept Surg, 2920,Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	yqli@med.umich.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 GM084127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM084127] Funding Source: NIH RePORTER	Funding: NIH RO1 GM084127 (Alam, HB).	Alam HB, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002350; Bambakidis T, 2015, J SURG RES, V196, P159, DOI 10.1016/j.jss.2015.02.036; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Brogdon JL, 2007, BLOOD, V109, P1123, DOI 10.1182/blood-2006-04-019711; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang ZG, 2015, J TRAUMA ACUTE CARE, V79, P905, DOI 10.1097/TA.0000000000000784; Chen CH, 2015, ONCOTARGET, V6, P35991, DOI 10.18632/oncotarget.5475; Chen H, 2007, RESUSCITATION, V74, P526, DOI 10.1016/j.resuscitation.2007.01.031; Collins LM, 2015, MOL NEUROBIOL, V51, P1432, DOI 10.1007/s12035-014-8820-8; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fukudome EY, 2010, J SURG RES, V163, P118, DOI 10.1016/j.jss.2010.04.013; Georgoff PE, 2017, CLIN PHARMACOKINET; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Guida N, 2016, TOXICOL SCI, V154, P227, DOI 10.1093/toxsci/kfw157; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Huang XP, 2009, CANCER RES, V69, P8403, DOI 10.1158/0008-5472.CAN-09-2146; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kochanek AR, 2012, J SURG RES, V176, P185, DOI 10.1016/j.jss.2011.06.007; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; LEE HB, 1985, J NUCL MED, V26, P72; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Li YQ, 2015, J TRAUMA ACUTE CARE, V78, P378, DOI 10.1097/TA.0000000000000510; Liu ZC, 2014, SHOCK, V41, P104, DOI 10.1097/SHK.0000000000000074; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Routy JP, 2005, LANCET, V366, P523, DOI 10.1016/S0140-6736(05)67074-2; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Shires GT, 2005, AM J SURG, V189, P85, DOI 10.1016/j.amjsurg.2004.06.040; Suliman BA, 2012, IMMUNOL CELL BIOL, V90, P23, DOI 10.1038/icb.2011.92; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wu Q, 2015, INT J CLIN EXP PATHO, V8, P9360; Zacharias N, 2011, RESUSCITATION, V82, P105, DOI 10.1016/j.resuscitation.2010.09.469; Zhang L, 2014, CHEMMEDCHEM, V9, P638, DOI 10.1002/cmdc.201300297; Zhao T, 2014, J TRAUMA ACUTE CARE, V77, P913, DOI 10.1097/TA.0000000000000347	49	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2018	84	5					795	801		10.1097/TA.0000000000001824			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	GE7LT	WOS:000431415300015	29401190	Green Accepted			2021-06-18	
J	Patel, NS; Klett, J; Pilarzyk, K; Lee, DI; Kass, D; Menniti, FS; Kelly, MP				Patel, Neema S.; Klett, Jennifer; Pilarzyk, Katy; Lee, Dong Ik; Kass, David; Menniti, Frank S.; Kelly, Michy P.			Identification of new PDE9A isoforms and how their expression and subcellular compartmentalization in the brain change across the life span	NEUROBIOLOGY OF AGING			English	Article						Phosphodiesterase; Hippocampus; Cerebellum; Prefrontal cortex; Striatum; GAPDH; Ponceau; Allen institute for Brain Science; cGMP; Aging; Aging; Development	CGMP-SPECIFIC PHOSPHODIESTERASE; MESSENGER-RNA; RAT-BRAIN; GUANYLYL CYCLASE; INHIBITOR PF-04447943; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; HUMAN STRIATUM; MICE; LOCALIZATION	3',5'-Cyclic nucleotide phosphodiesterases (PDEs) degrade 3',5' cyclic adenonosine monophosphate (cAMP) and 3',5' cyclic guanosine monophosphate (cGMP), with PDE9A having the highest affinity for cGMP. We show PDE9A6 and 3 novel PDE9 isoforms (PDE9X-100, PDE9X-120, and PDE9X-175) are reliably detected in the brain and lung of mice, whereas PDE9A2 and other isoforms are found elsewhere. PDE9A localizes to the membrane in all organs except the bladder, where it is cytosolic. Brain additionally shows PDE9 in the nuclear fraction. PDE9A mRNA expression/localization dramatically changes across neurodevelopment in a manner that is strikingly consistent between mice and humans (i.e., decreased expression in the hippocampus and cortex and inverted-U in the cerebellum). Study of the 4 PDE9 isoforms in the mouse brain from postnatal day 7 through 24 months similarly identifies dramatic effects of age on expression and subcellular compartmentalization that are isoform specific and brain region specific. Finally, PDE9A mRNA is elevated in the aged human hippocampus with dementia when there is a history of traumatic brain injury. Thus, brain PDE9 is localized to preferentially regulate nuclear- and membrane-proximal pools of cGMP, and its function likely changes across the life span. (C) 2018 Elsevier Inc. All rights reserved.	[Patel, Neema S.; Klett, Jennifer; Pilarzyk, Katy; Kelly, Michy P.] Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, 6439 Garners Ferry Rd,VA Bldg 1,3rd Floor,D-12, Columbia, SC 29209 USA; [Lee, Dong Ik; Kass, David] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol,Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Menniti, Frank S.] Univ Rhode Isl, George & Anne Ryan Inst Neurosci, Kingston, RI 02881 USA	Kelly, MP (corresponding author), Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, 6439 Garners Ferry Rd,VA Bldg 1,3rd Floor,D-12, Columbia, SC 29209 USA.	Michy.Kelly@uscmed.sc.edu	Kelly, Michy/K-8409-2014	Kelly, Michy/0000-0002-1735-3342	University of South Carolina Magellan Scholar Program; University of South Carolina Honors College Science Undergraduate Research Fellowship Program; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1R01MH101130]; PfizerPfizer; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH101130] Funding Source: NIH RePORTER	Research supported by the University of South Carolina Magellan Scholar Program (NSP), the University of South Carolina Honors College Science Undergraduate Research Fellowship Program (NSP), and 1R01MH101130 from NIMH (MPK). NSP, JK, KP, DiL, and MPK have no financial conflicts to disclose. DK received research support from Pfizer and serves as a consultant to Merck and Ironwood Pharmaceuticals. FSM is currently Founder/CSO of MindImmune Therapeutics, Inc, and was previously Founder/CSO of Mnemosyne Pharmaceuticals, Inc (neither entity has interests in PDE9A).	Alexander MS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.174; Andreeva SG, 2001, J NEUROSCI, V21, P9068, DOI 10.1523/JNEUROSCI.21-22-09068.2001; Baltrons MA, 2004, NEUROBIOL DIS, V17, P462, DOI 10.1016/j.nbd.2004.07.022; Baltrons MA, 2002, NEUROBIOL DIS, V10, P139, DOI 10.1006/nbdi.2002.0492; Bingham J, 2006, BIOCHEM BIOPH RES CO, V350, P25, DOI 10.1016/j.bbrc.2006.08.180; Boland K, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2569; BONKALE WL, 1995, NEUROSCI LETT, V187, P5, DOI 10.1016/0304-3940(95)11323-O; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Demilly A, 2011, CEREBELLUM, V10, P409, DOI 10.1007/s12311-010-0156-y; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Hashimoto K, 2009, NEUROSCIENCE, V162, P601, DOI 10.1016/j.neuroscience.2008.12.037; Hegde S, 2016, NEUROPSYCHOPHARMACOL, V41, P2920, DOI 10.1038/npp.2016.106; Hegde S, 2016, NEUROSCIENCE, V335, P151, DOI 10.1016/j.neuroscience.2016.08.019; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huai Q, 2004, P NATL ACAD SCI USA, V101, P9624, DOI 10.1073/pnas.0401120101; Hutson PH, 2011, NEUROPHARMACOLOGY, V61, P665, DOI 10.1016/j.neuropharm.2011.05.009; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Kelly MR, 2009, PHARMACOL BIOCHEM BE, V92, P649, DOI 10.1016/j.pbb.2009.03.003; Kelly MP, 2018, CELL SIGNAL, V42, P281, DOI 10.1016/j.cellsig.2017.11.004; Kelly MP, 2014, CELL SIGNAL, V26, P383, DOI 10.1016/j.cellsig.2013.10.007; Kleiman RJ, 2012, J PHARMACOL EXP THER, V341, P396, DOI 10.1124/jpet.111.191353; Kokkonen K, 2017, ANNU REV PHARMACOL, V57, P455, DOI 10.1146/annurev-pharmtox-010716-104756; Kroker KS, 2014, NEUROBIOL AGING, V35, P2072, DOI 10.1016/j.neurobiolaging.2014.03.023; Kroker KS, 2012, NEUROPHARMACOLOGY, V62, P1964, DOI 10.1016/j.neuropharm.2011.12.021; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Liddie S, 2012, J PSYCHOPHARMACOL, V26, P1375, DOI 10.1177/0269881112447991; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacMullen CM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.3; MacMullen CM, 2017, GENE, V606, P17, DOI 10.1016/j.gene.2016.12.033; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Nagy D, 2015, EXP NEUROL, V263, P122, DOI 10.1016/j.expneurol.2014.10.001; Nicholas T., 2009, ALZHEIMER DEMEN, V5, P330; Pathak G, 2017, MOL PSYCHIATR, V22, P1714, DOI 10.1038/mp.2016.155; Pathak G, 2015, NEUROPHARMACOLOGY, V95, P434, DOI 10.1016/j.neuropharm.2015.04.026; Rentero C, 2003, BIOCHEM BIOPH RES CO, V301, P686, DOI 10.1016/S0006-291X(03)00021-4; Schmidt C. J., 2009, ALZHEIMERS DEMENT, V5, P331; Schwam EM, 2014, CURR ALZHEIMER RES, V11, P413, DOI 10.2174/1567205011666140505100858; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Singh N, 2014, LIFE SCI, V106, P1, DOI 10.1016/j.lfs.2014.04.007; STEINER AL, 1972, J BIOL CHEM, V247, P1121; van der Staay FJ, 2008, NEUROPHARMACOLOGY, V55, P908, DOI 10.1016/j.neuropharm.2008.07.005; van Staveren WCG, 2003, J COMP NEUROL, V467, P566, DOI 10.1002/cne.10955; van Staveren WCG, 2002, J NEUROCYTOL, V31, P729, DOI 10.1023/A:1025704031210; van Staveren Wilma C. G., 2005, V307, P75; Vardigan JD, 2011, J NEUROGENET, V25, P120, DOI 10.3109/01677063.2011.630494; Wang P, 2003, GENE, V314, P15, DOI 10.1016/S0378-1119(03)00733-9; Wunderlich G., 2016, ALZHEIMERS DEMENT, V12, pP820; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029	52	13	13	2	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	MAY	2018	65						217	234		10.1016/j.neurobiolaging.2018.01.019			18	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	GA3MO	WOS:000428233700022	29505961	Green Accepted			2021-06-18	
J	Tan, HP; Guo, Q; Hua, G; Chen, JX; Liang, JC				Tan, Hong-Ping; Guo, Qiang; Hua, Gang; Chen, Jun-Xi; Liang, Jun-Chao			Inhibition of endoplasmic reticulum stress alleviates secondary injury after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; endoplasmic reticulum stress; apoptosis; mitochondria; reactive oxygen species; unfolded protein response; secondary brain injury; salubrinal; neural regeneration	OXIDATIVE STRESS; ER STRESS; MITOCHONDRIAL DYSFUNCTION; INDUCED APOPTOSIS; NEURONAL INJURY; CELL-DEATH; DAMAGE; ACTIVATION; RATS; PROTECTS	Apoptosis after traumatic brain injury has been shown to be a major factor influencing prognosis and outcome. Endoplasmic reticulum stress may be involved in mitochondrial mediated neuronal apoptosis. Therefore, endoplasmic reticulum stress has become an important mechanism of secondary injury after traumatic brain injury. In this study, a rat model of traumatic brain injury was established by lateral fluid percussion injury. Fluorescence assays were used to measure reactive oxygen species content in the cerebral cortex. Western blot assays were used to determine expression of endoplasmic reticulum stress-related proteins. Hematoxylin-eosin staining was used to detect pathological changes in the cerebral cortex. Transmission electron microscopy was used to measure ultrastructural changes in the endoplasmic reticulum and mitochondria. Our results showed activation of the endoplasmic reticulum stress-related unfolded protein response. Meanwhile, both the endoplasmic reticulum stress response and mitochondrial apoptotic pathway were activated at different stages post-traumatic brain injury. Furthermore, pretreatment with the endoplasmic reticulum stress inhibitor, salubrinal (1 mg/kg), by intraperitoneal injection 30 minutes before injury significantly inhibited the endoplasmic reticulum stress response and reduced apoptosis. Moreover, salubrinal promoted recovery of mitochondrial function and inhibited activation of the mitochondrial apoptotic pathway post-traumatic brain injury. These results suggest that endoplasmic reticulum stress might be a key factor for secondary brain injury post-traumatic brain injury.	[Tan, Hong-Ping; Liang, Jun-Chao] Southern Med Univ, Guangzhou, Guangdong, Peoples R China; [Tan, Hong-Ping; Guo, Qiang; Hua, Gang; Chen, Jun-Xi] Guangdong Sanjiu Brain Hosp, Dept Epilepsy Surg, Guangzhou, Guangdong, Peoples R China; [Tan, Hong-Ping; Liang, Jun-Chao] Guangzhou Gen Hosp Guangzhou Mil Command, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China	Liang, JC (corresponding author), Southern Med Univ, Guangzhou, Guangdong, Peoples R China.; Liang, JC (corresponding author), Guangzhou Gen Hosp Guangzhou Mil Command, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.	liangjc_n@163.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Begum G, 2013, TRANSL STROKE RES, V4, P635, DOI 10.1007/s12975-013-0282-1; Burton GJ, 2017, PLACENTA, V52, P146, DOI 10.1016/j.placenta.2016.04.001; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Chen B, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-77; Choi JH, 2010, EXP MOL MED, V42, P811, DOI 10.3858/emm.2010.42.12.084; Dash PK, 2015, J NEUROTRAUM, V32, P1608, DOI 10.1089/neu.2014.3772; Gajavelli S, 2015, J BIOENERG BIOMEMBR, V47, P133, DOI 10.1007/s10863-014-9589-1; Go BS, 2017, MOL NEUROBIOL, V54, P4041, DOI 10.1007/s12035-016-9969-0; Gulyaeva NV, 2015, J NEUROCHEM, V132, P263, DOI 10.1111/jnc.13016; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Jin M, 2015, NEURAL REGEN RES, V10, P1830, DOI 10.4103/1673-5374.170313; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111083; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Logsdon AF, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00421; Lopez-Hernandez B, 2015, BRIT J PHARMACOL, V172, P2838, DOI 10.1111/bph.13095; Lorente L, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0485-z; Matsuoka M, 2015, INT J MOL SCI, V16, P16275, DOI 10.3390/ijms160716275; Nakka VP, 2010, NEUROTOX RES, V17, P189, DOI 10.1007/s12640-009-9110-5; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Placido AI, 2017, MOL NEUROBIOL, V54, P154, DOI 10.1007/s12035-015-9640-1; Raghubir R, 2011, METHOD ENZYMOL, V489, P259, DOI 10.1016/B978-0-12-385116-1.00015-7; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Sophonnithiprasert T, 2017, ONCOL LETT, V13, P119, DOI 10.3892/ol.2016.5381; Sun GZ, 2016, NEURAL REGEN RES, V11, P1260, DOI 10.4103/1673-5374.189190; Wang XM, 2013, EXPERT OPIN INV DRUG, V22, P169, DOI 10.1517/13543784.2013.748033; Xue FX, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00049; Xue LX, 2017, NEURAL REGEN RES, V12, P779, DOI 10.4103/1673-5374.206649; Yamamoto A, 2006, J NEUROPATH EXP NEUR, V65, P217, DOI 10.1097/01.jnen.0000202886.22082.2a; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yi G, 2017, ONCOTARGET, V8, P40741, DOI 10.18632/oncotarget.16580; Yin Y, 2017, AGEING RES REV, V34, P3, DOI 10.1016/j.arr.2016.08.008; Zhang JC, 2015, SHOCK, V44, P65, DOI 10.1097/SHK.0000000000000367; Zhou XM, 2014, J NEUROSCI RES, V92, P714, DOI 10.1002/jnr.23359	39	13	13	2	6	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2018	13	5					827	836		10.4103/1673-5374.232477			10	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	GI1LE	WOS:000434131200020	29863013	DOAJ Gold, Green Published			2021-06-18	
J	Townsend, JM; Zabel, TA; Feng, Y; Wang, J; Andrews, BT; Nudo, RJ; Berkland, CJ; Detamore, MS				Townsend, Jakob M.; Zabel, Taylor A.; Feng, Yi; Wang, Jinxi; Andrews, Brian T.; Nudo, Randolph J.; Berkland, Cory J.; Detamore, Michael S.			Effects of tissue processing on bioactivity of cartilage matrix-based hydrogels encapsulating osteoconductive particles	BIOMEDICAL MATERIALS			English	Article						hydrogel; traumatic brain injury; syndrome of the trephined; decellularized; cartilage; calvarial bone; photocrosslinking	DEMINERALIZED BONE-MATRIX; DECOMPRESSIVE CRANIECTOMY; SCAFFOLDS; GELATIN; GROWTH; BIOMATERIALS; REGENERATION; INJURY; REPAIR; GELS	In the treatment of severe traumatic brain injury (TBI), decompressive craniectomy is commonly used to remove a large portion of calvarial bone to allow unimpeded brain swelling. Hydrogels have the potential to revolutionize TBI treatment by permitting a single-surgical intervention, remaining pliable during brain swelling, and tuned to regenerate bone after swelling has subsided. With this motivation, our goal is to present a pliable material capable of regenerating calvarial bone across a critical size defect. We therefore proposed the use of a methacrylated solubilized decellularized cartilage (MeSDCC) hydrogel encapsulating synthetic osteogenic particles of hydroxyapatite nanofibers, bioglass microparticles, or added rat bone marrow-derived mesenchymal stem cells (rMSCs) for bone regeneration in critical-size rat calvarial defects. Fibrin hydrogels were employed as a control material for the study. MeSDCC hydrogels exhibited sufficient rheological performance for material placement before crosslinking (tau(y) > 500 Pa), and sufficient compressive moduli post-crosslinking (E > 150 kPa). In vitro experiments suggested increased calcium deposition for cells seeded on the MeSDCC material; however, in vivo bone regeneration was minimal in both MeSDCC and fibrin groups, even with colloidal materials or added rMSCs. Minimal bone regeneration in the MeSDCC test groups may potentially be attributed to cartilage solubilization after decellularization, in which material signals may have degraded from enzymatic treatment. Looking to the future, an improvement in the bioactivity of the material will be crucial to the success of bone regeneration strategies for TBI treatment.	[Townsend, Jakob M.; Detamore, Michael S.] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA; [Zabel, Taylor A.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66047 USA; [Feng, Yi; Wang, Jinxi] Univ Kansas, Med Ctr, Dept Orthoped Surg, Kansas City, KS 66160 USA; [Andrews, Brian T.] Univ Kansas, Med Ctr, Dept Plast Surg, Kansas City, KS 66160 USA; [Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, Kansas City, KS 66160 USA; [Berkland, Cory J.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA	Townsend, JM (corresponding author), Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK 73019 USA.		Townsend, Jakob/AAH-9637-2019	Detamore, Michael/0000-0002-7525-8132	Kansas Bioscience Authority Rising Star Award; Stephenson Graduate Fellowship; National Institute of Dental and Craniofacial Research of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01 DE022472]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR) [R01DE022472] Funding Source: NIH RePORTER	The authors would like to thank Nanova Biomaterials, Inc. and MO-SCI, Corp. for generously providing the hydroxyapatite nanofibers and bioglass microparticles, respectively. We would like to recognize funding from the Kansas Bioscience Authority Rising Star Award and the Stephenson Graduate Fellowship. Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under Award Number R01 DE022472. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beck EC, 2016, ACTA BIOMATER, V38, P94, DOI 10.1016/j.actbio.2016.04.019; Beck EC, 2016, ANN BIOMED ENG, V44, P1863, DOI 10.1007/s10439-015-1547-5; Beck EC, 2016, TISSUE ENG PT A, V22, P665, DOI [10.1089/ten.tea.2015.0546, 10.1089/ten.TEA.2015.0546]; Beck EC, 2015, ANN BIOMED ENG, V43, P2569, DOI 10.1007/s10439-015-1277-8; Buckley MJ, 2010, ORAL MAXIL SURG CLIN, V22, P195, DOI 10.1016/j.coms.2009.10.008; Choy DKS, 2013, TISSUE ENG PT A, V19, P2382, DOI [10.1089/ten.tea.2012.0733, 10.1089/ten.TEA.2012.0733]; Converse GL, 2012, ACTA BIOMATER, V8, P2722, DOI 10.1016/j.actbio.2012.03.047; Cunniffe GM, 2017, EUR CELLS MATER, V33, P130, DOI 10.22203/eCM.v033a10; Cunniffe GM, 2015, EUR POLYM J, V72, P464, DOI 10.1016/j.eurpolymj.2015.07.021; Cunniffe GM, 2015, ACTA BIOMATER, V23, P82, DOI 10.1016/j.actbio.2015.05.031; Cushing H, 1905, ESTABLISHMENT CEREBR; Dennis SC, 2015, TISSUE ENG PART B-RE, V21, P247, DOI [10.1089/ten.TEB.2014.0419, 10.1089/ten.teb.2014.0419]; Dujovny M, 1999, CRIT REV NEUROSURG, V9, P271, DOI 10.1007/s003290050143; Eberle APR, 2008, IND ENG CHEM RES, V47, P3470, DOI 10.1021/ie070800j; Gawlitta D, 2015, TISSUE ENG PT A, V21, P694, DOI [10.1089/ten.tea.2014.0117, 10.1089/ten.TEA.2014.0117]; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Khader BA, 2016, MAT SCI ENG C-MATER, V66, P315, DOI 10.1016/j.msec.2016.04.101; Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Motherway JA, 2009, J BIOMECH, V42, P2129, DOI 10.1016/j.jbiomech.2009.05.030; NaPier Z, 2016, SEMIN SPINE SURG, V28, P196; O'Reilly EB, 2015, J PLAST RECONSTR AES, V68, P329, DOI 10.1016/j.bjps.2014.11.001; Oladunjoye AO, 2013, J NEUROSURG, V118, P776, DOI 10.3171/2013.1.JNS121475; Rennerfeldt DA, 2013, BIOMATERIALS, V34, P8241, DOI 10.1016/j.biomaterials.2013.07.052; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Samaniuk JR, 2014, AICHE J, V60, P1523, DOI 10.1002/aic.14329; Schallenberger MA, 2014, J CRANIOFAC SURG, V25, P657, DOI 10.1097/SCS.0000000000000610; Schiffer J, 1997, SURG NEUROL, V47, P231, DOI 10.1016/S0090-3019(96)00376-X; Spotnitz William D, 2014, ISRN Surg, V2014, P203943, DOI 10.1155/2014/203943; Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7; Sutherland AJ, 2015, MACROMOL BIOSCI, V15, P979, DOI 10.1002/mabi.201400472; Sutherland AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121966; Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Townsend JM, 2017, AAPS J, V19, P703, DOI 10.1208/s12248-017-0045-0; Visser J, 2015, BIOMATERIALS, V37, P174, DOI 10.1016/j.biomaterials.2014.10.020; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yeung CYC, 2016, WOUND REPAIR REGEN, V24, P1089, DOI 10.1111/wrr.12481; Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025	43	13	13	0	33	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-6041	1748-605X		BIOMED MATER	Biomed. Mater.	MAY	2018	13	3							034108	10.1088/1748-605X/aaad77			11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	FZ6OU	WOS:000427719700002	29411714	Green Accepted			2021-06-18	
J	Wang, D; Xu, X; Wu, YG; Lyu, L; Zhou, ZW; Zhang, JN				Wang, Dong; Xu, Xin; Wu, Yin-Gang; Lyu, Li; Zhou, Zi-Wei; Zhang, Jian-Ning			Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; neuroinflammation; nuclear factor kappa B; NLRP3 inflammasome; brain edema; blood-brain barrier; tight junction proteins; apoptosis; neuroprotection; dexmedetomidine; neural regeneration	ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; NLRP3 INFLAMMASOME; SIGNALING PATHWAY; OXIDATIVE STRESS; DISRUPTION; ACTIVATION; PROTECTS; RATS; TEMPERATURE	Traumatic brain injury induces potent inflammatory responses that can exacerbate secondary blood-brain barrier (BBB) disruption, neuronal injury, and neurological dysfunction. Dexmedetomidine is a novel alpha 2-adrenergic receptor agonist that exert protective effects in various central nervous system diseases. The present study was designed to investigate the neuroprotective action of dexmedetomidine in a mouse traumatic brain injury model, and to explore the possible mechanisms. Adult male C57BL/6J mice were subjected to controlled cortical impact. After injury, animals received 3 days of consecutive dexmedetomidine therapy (25 mu g/kg per day). The modified neurological severity score was used to assess neurological deficits. The rotarod test was used to evaluate accurate motor coordination and balance. Immunofluorescence was used to determine expression of ionized calcium binding adapter molecule-1, myeloperoxidase, and zonula occluden-1 at the injury site. An enzyme linked immunosorbent assay was used to measure the concentration of interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha, and IL-6. The dry-wet weight method was used to measure brain water content. The Evans blue dye extravasation assay was used to measure BBB disruption. Western blot assay was used to measure protein expression of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3), caspase-1 p20, IL-1 beta, nuclear factor kappa B (NF-kappa B) p65, occluding, and zonula occluden-1. Flow cytometry was used to measure cellular apoptosis. Results showed that dexmedetomidine treatment attenuated early neurological dysfunction and brain edema. Further, dexmedetomidine attenuated post-traumatic inflammation, up-regulated tight junction protein expression, and reduced secondary BBB damage and apoptosis. These protective effects were accompanied by down-regulation of the NF-kappa B and NLRP3 inflammasome pathways. These findings suggest that dexmedetomidine exhibits neuroprotective effects against acute (3 days) post-traumatic inflammatory responses, potentially via suppression of NF-kappa B and NLRP3 inflammasome activation.	[Wang, Dong; Xu, Xin; Wu, Yin-Gang; Zhou, Zi-Wei; Zhang, Jian-Ning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Wang, Dong; Xu, Xin; Wu, Yin-Gang; Zhou, Zi-Wei; Zhang, Jian-Ning] Minist Educ & Tianjin City, Key Lab Postneuroinjury Neurorepair & Regenerat C, Tianjin Neurol Inst, Tianjin, Peoples R China; [Lyu, Li] Tianjin Childrens Hosp, Dept Cardiovasc, Tianjin, Peoples R China	Zhou, ZW; Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Zhou, ZW; Zhang, JN (corresponding author), Minist Educ & Tianjin City, Key Lab Postneuroinjury Neurorepair & Regenerat C, Tianjin Neurol Inst, Tianjin, Peoples R China.	ziweizhou2009@hotmail.com; jianningzhang@hotmail.com		Xu, Xin/0000-0003-3395-9923	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81671380]; Natural Science Foundation of Tianjin City of ChinaNatural Science Foundation of Tianjin [17JCZDJC35900]	This work was supported by the National Natural Science Foundation of China, No. 81330029, 81671380; and the Natural Science Foundation of Tianjin City of China, No. 17JCZDJC35900.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Akpinar H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37196; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2017, ISJ-INVERT SURVIV J, V14, P1; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Fang B, 2015, CELL PHYSIOL BIOCHEM, V36, P373, DOI 10.1159/000430107; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liang H, 2017, INFLAMM RES, V66, P399, DOI 10.1007/s00011-017-1023-9; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Luo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00197; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Mamik MK, 2017, BRAIN, V140, P2273, DOI 10.1093/brain/awx133; McAdams RM, 2015, PEDIATR RES, V77, P772, DOI 10.1038/pr.2015.45; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shen ZY, 2013, WORLD J GASTROENTERO, V19, P3583, DOI 10.3748/wjg.v19.i23.3583; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Wang LJ, 2017, BIOMOL THER, V25, P383, DOI 10.4062/biomolther.2015.180; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang SJ, 2018, CELL MOL NEUROBIOL, V38, P595, DOI 10.1007/s10571-017-0526-9; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou KR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9238290; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	31	13	16	1	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2018	13	5					819	826		10.4103/1673-5374.232529			8	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	GI1LE	WOS:000434131200019	29863012	DOAJ Gold, Green Published			2021-06-18	
J	Fiandaca, MS; Mapstone, M; Mahmoodi, A; Gross, T; Macciardi, F; Cheema, AK; Merchant-Borna, K; Bazarian, J; Federoff, HJ				Fiandaca, Massimo S.; Mapstone, Mark; Mahmoodi, Amin; Gross, Thomas; Macciardi, Fabio; Cheema, Amrita K.; Merchant-Borna, Kian; Bazarian, Jeffrey; Federoff, Howard J.			Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls	PLOS ONE			English	Article							C-TERMINAL HYDROLASE; LIPID-PEROXIDATION; CEREBROSPINAL-FLUID; PROTEIN-LEVELS; FATTY-ACIDS; HEAD-INJURY; SERUM; CONCUSSION; S100B; DISEASE	Past and recent attempts at devising objective biomarkers for traumatic brain injury (TBI) in both blood and cerebrospinal fluid have focused on abundance measures of time-dependent proteins. Similar independent determinants would be most welcome in diagnosing the most common form of TBI, mild TBI (mTBI), which remains difficult to define and confirm based solely on clinical criteria. There are currently no consensus diagnostic measures that objectively define individuals as having sustained an acute mTBI. Plasma metabolomic analyses have recently evolved to offer an alternative to proteomic analyses, offering an orthogonal diagnostic measure to what is currently available. The purpose of this study was to determine whether a developed set of metabolomic biomarkers is able to objectively classify college athletes sustaining mTBI from non-injured teammates, within 6 hours of trauma and whether such a biomarker panel could be effectively applied to an independent cohort of TBI and control subjects. A 6-metabolite panel was developed from biomarkers that had their identities confirmed using tandem mass spectrometry (MS/MS) in our Athlete cohort. These biomarkers were defined at <= 6 hours following mTBI and objectively classified mTBI athletes from teammate controls, and provided similar classification of these groups at the 2, 3, and 7 days post-mTBI. The same 6-metabolite panel, when applied to a separate, independent cohort provided statistically similar results despite major differences between the two cohorts. Our confirmed plasma biomarker panel objectively classifies acute mTBI cases from controls within 6 hours of injury in our two independent cohorts. While encouraged by our initial results, we expect future studies to expand on these initial observations.	[Fiandaca, Massimo S.; Mapstone, Mark; Mahmoodi, Amin; Gross, Thomas; Macciardi, Fabio; Federoff, Howard J.] Univ Calif Irvine, Dept Neurol, Translat Lab & Biorepository, Irvine, CA 92717 USA; [Fiandaca, Massimo S.] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA USA; [Fiandaca, Massimo S.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Macciardi, Fabio] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem & Mol, Washington, DC 20007 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Cellular Biol, Washington, DC 20007 USA; [Merchant-Borna, Kian; Bazarian, Jeffrey] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA	Federoff, HJ (corresponding author), Univ Calif Irvine, Dept Neurol, Translat Lab & Biorepository, Irvine, CA 92717 USA.	Federoff@uci.edu		Mahmoodi, Amin/0000-0003-0012-9245; Federoff, Howard/0000-0002-7595-6520	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24 HD064754]; United States (US) Department of Defense (DoD); US Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0107]; Georgetown University Proteomics and Metabolomics Shared Resource through a Cancer Center Support Grant [NIH/NCI P30-CA051008]	This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for the collegiate athlete study (K24 HD064754 to JB), and the United States (US) Department of Defense (DoD), US Army Medical Research and Material Command (USAMRMC) related to this biomarker investigation (W81XWH-09-1-0107 to HJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge the partial support provided to the Georgetown University Proteomics and Metabolomics Shared Resource through a Cancer Center Support Grant (NIH/NCI P30-CA051008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We graciously acknowledge Lawrence L. Latour (Stroke Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD), Rao P. Gullapalli (Diagnostic Radiology and Nuclear Medicine, University of Maryland, Shock Trauma Center, Baltimore, MD), and Lindell K. Weaver (Department of Medicine, University of Utah, Latter Day Saints Hospital, Salt Lake City, UT) for their contributions of de-identified blood specimens and demographic information from their clinical investigations for use in the External cohort of our study. We thank Kirsten Ross, Stephanie Amalfe, and Nikita Bourque for Athlete study coordination, and Eric Rozen for assistance with Athlete study data collection. We acknowledge the partial support provided to the Georgetown University Proteomics and Metabolomics Shared Resource through a Cancer Center Support Grant (NIH/NCI P30-CA051008). We also thank Robert Padilla, Ishmael Conteh, Jamie McCann, Daniele Phelps, Rond Malhas, and Ricardo Miramontes for collecting and processing the study's blood specimens, Tyrone Dowdy and Steven Payton for technical assistance in developing the metabolomic data, and Nick Morris for technical expertise with the MSF Metabolomics website and application.	Abdelmagid SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116195; Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Aylward LL, 2014, J TOXICOL ENV HEAL B, V17, P45, DOI 10.1080/10937404.2013.864250; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1044-3; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI [10.1007/s11306-016-0960-6, DOI 10.1007/S11306-016-0960-6]; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen TL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/298183; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Dambinova SA, 2013, J MOL BIOMARK DIA S1, V3, DOI [10.4172/2155-9929.S3-003, DOI 10.4172/2155-9929.S3-003]; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DVBIC, 2016, DOB TBI WORLD NUMB S; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Farooqui AA, 2000, J MOL NEUROSCI, V14, P123, DOI 10.1385/JMN:14:3:123; Fiandaca MS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00237; Foulon V, 2005, J BIOL CHEM, V280, P9802, DOI 10.1074/jbc.M413362200; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gonzalez-Dominguez R, 2016, EBIOMEDICINE, V12, P8, DOI 10.1016/j.ebiom.2016.09.024; Gronbeck KR, 2016, NEUROCRIT CARE, V25, P153, DOI 10.1007/s12028-015-0225-7; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLM S, 1979, SCAND J STAT, V6, P65; HOSHI M, 1973, J BIOL CHEM, V248, P4123; Huan T, 2017, NAT METHODS, V14, P461, DOI 10.1038/nmeth.4260; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Mapstone M, 2017, NEUROBIOL AGING, V51, P148, DOI 10.1016/j.neurobiolaging.2016.11.007; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; McCrory Paul, 2009, J Athl Train, V44, P434, DOI 10.4085/1062-6050-44.4.434; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Norton WT., 2013, MYELIN, V21, P147, DOI [10.1007/978-1-4757-1830-0_5, DOI 10.1007/978-1-4757-1830-0_5]; O'Bryant SE, 2015, ALZHEIMERS DEMENT, V11, P549, DOI 10.1016/j.jalz.2014.08.099; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pasvogel AE, 2008, BIOL RES NURS, V10, P113, DOI 10.1177/1099800408323218; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Rapoport SI, 1999, NEUROCHEM RES, V24, P1403, DOI 10.1023/A:1022584707352; Romisch-Margl W., 2011, METABOLOMICS, V8, P133, DOI DOI 10.1007/s11306-011-0293-4; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vandal M, 2014, J NEUROCHEM, V129, P516, DOI 10.1111/jnc.12640; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wood PL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt103; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xi Bowei, 2014, Methods Mol Biol, V1198, P333, DOI 10.1007/978-1-4939-1258-2_22; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xie WJ, 2016, CHEM CENT J, V10, DOI 10.1186/s13065-016-0187-7; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	76	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195318	10.1371/journal.pone.0195318			22	Multidisciplinary Sciences	Science & Technology - Other Topics	GD6SO	WOS:000430638900010	29677216	DOAJ Gold, Green Published			2021-06-18	
J	Chaikittisilpa, N; Krishnamoorthy, V; Lele, AV; Qiu, Q; Vavilala, MS				Chaikittisilpa, Nophanan; Krishnamoorthy, Vijay; Lele, Abhijit V.; Qiu, Qian; Vavilala, Monica S.			Characterizing the relationship between systemic inflammatory response syndrome and early cardiac dysfunction in traumatic brain injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; systemic inflammatory response syndrome; inflammation; stress cardiomyopathy; echocardiography	TUMOR-NECROSIS-FACTOR; SUBARACHNOID HEMORRHAGE; MYOCARDIAL DYSFUNCTION; SYSTOLIC DYSFUNCTION; CEREBROSPINAL-FLUID; SEVERE SEPSIS; SEPTIC SHOCK; INTERLEUKIN-6; CARDIOMYOPATHY; SEVERITY	Systolic dysfunction was recently described following traumatic brain injury (TBI), and systemic inflammation may be a contributing mechanism. Our aims were to 1) examine the association between the early systemic inflammatory response syndrome (SIRS) and systolic cardiac dysfunction following TBI, and 2) describe the longitudinal change in SIRS criteria, cardiac function, and hemodynamic parameters during the first week of hospitalization. We used a secondary analysis of a prospective cohort study examining cardiac function (with transthoracic echocardiography on the first day and serially over the first week of hospitalization) in 32 moderate-severe isolated TBI patients, and quantified the admission and daily SIRS response to injury. We determined the association of admission SIRS and systolic dysfunction following TBI. Admission SIRS was present in 7 (21%) patients and was associated with systolic dysfunction on multivariable analysis (relative risk 4.01; 95% 1.16-13.79, p = .028). Both SIRS criteria and systolic cardiac function improved over the first week of hospitalization. In conclusion, early SIRS is common among patients with moderate-severe TBI, and the presence of SIRS criteria on admission is associated with systolic cardiac dysfunction following TBI.	[Chaikittisilpa, Nophanan; Krishnamoorthy, Vijay; Lele, Abhijit V.; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Chaikittisilpa, Nophanan; Krishnamoorthy, Vijay; Qiu, Qian; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA	Vavilala, MS (corresponding author), Harborview Injury Prevent & Res Ctr, 401 Broadway,Box 359960, Seattle, WA 98104 USA.	vavilala@u.washington.edu			Department of Anesthesiology and Pain Medicine, University of WashingtonUniversity of Washington; Harborview Injury Prevention and Research Center; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS095321] Funding Source: NIH RePORTER	We gratefully acknowledge the support from the Department of Anesthesiology and Pain Medicine, University of Washington and Harborview Injury Prevention and Research Center.	Arand M, 2001, LANGENBECK ARCH SURG, V386, P241, DOI 10.1007/s004230100204; Audebert HJ, 2004, STROKE, V35, P2128, DOI 10.1161/01.STR.0000137607.61697.77; Boehme AK, 2013, STROKE, V44, P2321, DOI 10.1161/STROKEAHA.113.001371; Boissier F, 2017, INTENS CARE MED, V43, P633, DOI 10.1007/s00134-017-4698-z; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, CRIT CARE MED, V24, P163, DOI 10.1097/00003246-199601000-00026; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Cheah CF, 2017, NEUROCRIT CARE, V26, P284, DOI 10.1007/s12028-016-0334-y; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Court O, 2002, CRIT CARE, V6, P500, DOI 10.1186/cc1822; Elrifai AM, 1996, STROKE, V27, P737, DOI 10.1161/01.STR.27.4.737; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Flierl MA, 2008, MOL MED, V14, P327, DOI 10.2119/2007-00130.Flierl; Flynn A, 2010, HEART FAIL REV, V15, P605, DOI 10.1007/s10741-010-9176-4; Giannoudis PV, 1998, BRIT J SURG, V85, P986; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hochstadt A, 2011, J CARDIOTHOR VASC AN, V25, P526, DOI 10.1053/j.jvca.2010.11.026; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Horton JW, 2007, SHOCK, V28, P326, DOI 10.1097/01.shk.0000238064.54332.c8; Huang SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12741; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; ICHIJO T, 1994, BRAIN RES BULL, V34, P547, DOI 10.1016/0361-9230(94)90139-2; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Kushi H, 2003, ACTA NEUROCHIR SUPPL, V86, P347; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lou MQ, 2013, CLIN NEUROL NEUROSUR, V115, P904, DOI 10.1016/j.clineuro.2012.09.001; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; Marshall JC, 2000, SHOCK, V14, P586, DOI 10.1097/00024382-200014060-00002; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; Mazzeo AT, 2014, BRIT J ANAESTH, V112, P803, DOI 10.1093/bja/aeu046; McKeating EG, 1997, BRIT J ANAESTH, V78, P520; Mica L, 2012, EUR J TRAUMA EMERG S, V38, P665, DOI 10.1007/s00068-012-0227-5; Mierzewska-Schmidt M, 2015, ANAESTH INTENSIVE TH, V47, P175, DOI 10.5603/AIT.2015.0017; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Nguyen H, 2009, CURR NEUROL NEUROSCI, V9, P486, DOI 10.1007/s11910-009-0071-0; Niederbichler AD, 2006, SHOCK, V25, P176, DOI 10.1097/01.shk.0000192123.91166.e1; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Pulido JN, 2012, MAYO CLIN PROC, V87, P620, DOI 10.1016/j.mayocp.2012.01.018; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995; SEVERN A, 1992, J IMMUNOL, V148, P3441; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Taniguchi T, 1999, CRIT CARE MED, V27, P1262, DOI 10.1097/00003246-199907000-00005; van Diepen S, 2013, CRIT CARE MED, V41, P2080, DOI 10.1097/CCM.0b013e31828a67b2; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Xu Z., 2013, ELECTRON J DIFFER EQ, V2013, P1, DOI [DOI 10.1038/SREP01377, 10.1186/1687-1499-2013-1]; Yoshimoto Y, 2001, STROKE, V32, P1989, DOI 10.1161/hs0901.095646; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006	59	13	13	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		661	670		10.1002/jnr.24100			10	Neurosciences	Neurosciences & Neurology	FV2DK	WOS:000424374300016	28573763	Green Accepted			2021-06-18	
J	Elbogen, EB; Wagner, HR; Kimbrel, NA; Brancu, M; Naylor, J; Graziano, R; Crawford, E				Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Brancu, Mira; Naylor, Jennifer; Graziano, Robert; Crawford, Eric		VA Mid-Atlantic MIRECC Workgrp	Risk Factors for Concurrent Suicidal Ideation and Violent Impulses in Military Veterans	PSYCHOLOGICAL ASSESSMENT			English	Article						suicide; violence; veterans; risk assessment; PTSD	POSTTRAUMATIC-STRESS-DISORDER; AFGHANISTAN WAR VETERANS; IRAQ/AFGHANISTAN-ERA VETERANS; STRUCTURED CLINICAL INTERVIEW; SERVICEMEMBERS ARMY STARRS; VIETNAM COMBAT VETERANS; SUBSTANCE-USE DISORDERS; TRAUMATIC BRAIN-INJURY; ABUSE SCREENING-TEST; PSYCHIATRIC COMORBIDITY	Suicide and violence are significant problems in a subset of Iraq/Afghanistan-era veterans. This study investigates how posttraumatic stress disorder (PTSD) and resilience in veterans are associated with suicidal ideation and violent impulses while controlling for known covariates of both adverse outcomes. Structured clinical interviews were conducted of N = 2,543 Iraq/Afghanistan-era U.S. veterans. Compared with veterans denying suicidal ideation or violent impulses (n = 1,927), veterans endorsing both (n = 171) were more likely to meet diagnostic criteria for PTSD, report childhood abuse, combat exposure, physical pain symptoms, and drug misuse, and less likely to endorse self-direction/life purpose. Veterans reporting concurrent suicidal ideation and violent impulses had higher odds of misusing drugs and reporting pain symptoms relative to veterans reporting suicidal ideation only (n = 186) and had lower odds of endorsing self-direction/life purpose compared with veterans reporting violent impulses only (n = 259). The findings underscore the importance of examining drug abuse, physical pain symptoms, and self-direction/life purpose, as well as PTSD and history of trauma, in the context of clinical assessment and empirical research aimed at optimizing risk management of suicide and violence in military veterans.	[Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Brancu, Mira; Naylor, Jennifer; Crawford, Eric] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Elbogen, Eric B.; Wagner, H. Ryan; Kimbrel, Nathan A.; Brancu, Mira; Naylor, Jennifer] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Graziano, Robert] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA	Elbogen, EB (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27706 USA.	eric.elbogen@duke.edu		Graziano, Robert/0000-0002-9105-0614	VA Mid-Atlantic Mental Illness Research, Education and Clinical Center; National Center for Complementary and Integrative Health [R34 AT008399-01]; Clinical Science Research and Development Service of the VA Office of Research and Development [IK2 CX000525]; Department of Veterans Affairs Rehabilitation Research and Development Career Development AwardUS Department of Veterans Affairs [11K2RX000908]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R34AT008399] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000525] Funding Source: NIH RePORTER	We would like to extend our sincere thanks to the participants who volunteered for this study. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs. Preparation of this report was supported by the VA Mid-Atlantic Mental Illness Research, Education and Clinical Center and a grant from National Center for Complementary and Integrative Health (R34 AT008399-01). Kimbrel was supported by a Career Development Award (IK2 CX000525) from the Clinical Science Research and Development Service of the VA Office of Research and Development. Naylor was funded by a Department of Veterans Affairs Rehabilitation Research and Development Career Development Award (11K2RX000908). The Mid-Atlantic MIRECC Workgroup contributors for this paper include: Jean C. Beckham, Patrick S. Calhoun, Eric Dedert, John A. Fairbank, Kimberly T. Green, Robin A. Hurley, Jason D. Kilts, Angela Kirby, Christine E. Marx, Gregory McCarthy, Scott D. McDonald, Marinell Miller-Mumford, Scott D. Moore, Rajendra A. Morey, Treven C. Pickett, Jared Rowland, Jennifer J. Runnals, Cindy Swinkels, Steven T. Szabo, Katherine H. Taber, Larry A. Tupler, Elizabeth E. Van Voorhees, Richard D. Weiner, Ruth E. Yoash-Gantz.	Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; Babor TF., 2001, AUDIT ALCOHOL USE DI, V2nd; Beck A. T., 1996, BECK DEPRESSION INVE; BECK AT, 1988, J CLIN PSYCHOL, V44, P499, DOI 10.1002/1097-4679(198807)44:4<499::AID-JCLP2270440404>3.0.CO;2-6; Beckham JC, 2000, AGGRESS VIOLENT BEH, V5, P451, DOI 10.1016/S1359-1789(98)00018-4; Begic D, 2001, MIL MED, V166, P671; Brancu M., INT J METHO IN PRESS; Brown GK, 2000, J CONSULT CLIN PSYCH, V68, P371, DOI 10.1037/0022-006X.68.3.371; Clancy CP, 2006, J CLIN PSYCHIAT, V67, P1346, DOI 10.4088/JCP.v67n0904; Cochrane-Brink KA, 2000, GEN HOSP PSYCHIAT, V22, P445, DOI 10.1016/S0163-8343(00)00106-7; Conner KR, 2014, J AFFECT DISORDERS, V166, P1, DOI 10.1016/j.jad.2014.04.067; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dedert EA, 2009, J PSYCHIATR RES, V43, P830, DOI 10.1016/j.jpsychires.2009.01.004; Derogatis L.R, 1994, SYMPTOM CHECKLIST 90; Ejdesgaard BA, 2015, MIL MED, V180, P61, DOI 10.7205/MILMED-D-13-00353; Elbogen EB, 2014, PSYCHOL SERV, V11, P220, DOI 10.1037/a0035088; Elbogen EB, 2014, BRIT J PSYCHIAT, V204, P368, DOI 10.1192/bjp.bp.113.134627; Elbogen EB, 2010, CLIN PSYCHOL REV, V30, P595, DOI 10.1016/j.cpr.2010.03.009; Epidemiology Program Post-Deployment Health Group Office of Public Health Veterans Health Administration Department of Veterans Affairs, 2015, AN VA HLTH CAR UT OP; Fanning JR, 2013, J PSYCHIATR RES, V47, P1766, DOI 10.1016/j.jpsychires.2013.07.015; Fazel S, 2014, LANCET PSYCHIAT, V1, P44, DOI 10.1016/S2215-0366(14)70223-8; Ferrada-Noli M, 1998, J TRAUMA STRESS, V11, P103, DOI 10.1023/A:1024461216994; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Folkman S, 2008, ANXIETY STRESS COPIN, V21, P3, DOI 10.1080/10615800701740457; Gallaway MS, 2012, AGGRESSIVE BEHAV, V38, P357, DOI 10.1002/ab.21436; GANZINI L, 1995, INT J GERIATR PSYCH, V10, P945, DOI 10.1002/gps.930101106; Glenn D Michael, 2002, Violence Vict, V17, P473, DOI 10.1891/vivi.17.4.473.33685; Goldstein G, 2012, PSYCHIAT RES, V199, P37, DOI 10.1016/j.psychres.2012.03.029; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Guerra VS, 2011, J ANXIETY DISORD, V25, P12, DOI 10.1016/j.janxdis.2010.06.025; Guyker WM, 2013, MIL MED, V178, P377, DOI 10.7205/MILMED-D-12-00223; Hellmuth JC, 2012, J TRAUMA STRESS, V25, P527, DOI 10.1002/jts.21732; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Hoffman D. F., 2016, PRESENTED N CAROLINA; Ilgen MA, 2010, SUICIDE LIFE-THREAT, V40, P597, DOI 10.1521/suli.2010.40.6.597; Ilgen MA, 2010, J STUD ALCOHOL DRUGS, V71, P473, DOI 10.15288/jsad.2010.71.473; Jakupcak M, 2007, J TRAUMA STRESS, V20, P945, DOI 10.1002/jts.20258; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kang HK, 2008, JAMA-J AM MED ASSOC, V300, P652, DOI 10.1001/jama.300.6.652; Kaplan MS, 2007, J EPIDEMIOL COMMUN H, V61, P619, DOI 10.1136/jech.2006.054346; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI DOI 10.1037/1040-3590.1.1.53; Kerns RD, 2003, J REHABIL RES DEV, V40, P371, DOI 10.1682/JRRD.2003.09.0371; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Kimbrel NA, 2014, PSYCHIAT RES, V220, P397, DOI 10.1016/j.psychres.2014.07.064; KINNEY RK, 1991, SPINE, V16, P940, DOI 10.1097/00007632-199108000-00013; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lehmann LS, 1999, PSYCHIATR SERV, V50, P384, DOI 10.1176/ps.50.3.384; Lenhardt JM, 2012, J TRAUMA STRESS, V25, P461, DOI 10.1002/jts.21717; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; LUND M, 1984, J CLIN PSYCHOL, V40, P1323, DOI 10.1002/1097-4679(198411)40:6<1323::AID-JCLP2270400607>3.0.CO;2-I; MacManus D, 2012, PSYCHOL MED, V42, P1663, DOI 10.1017/S0033291711002327; Miller MW, 2008, J REHABIL RES DEV, V45, P359, DOI 10.1682/JRRD.2007.06.0085; National Center for Veterans Analysis and Statistics (NCVAS), 2015, PROF POST 9 11 VET 2; Nock MK, 2014, JAMA PSYCHIAT, V71, P514, DOI 10.1001/jamapsychiatry.2014.30; Owens GP, 2014, J INTERPERS VIOLENCE, V29, P1318, DOI 10.1177/0886260513506274; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P720, DOI 10.1016/j.jpsychires.2010.11.015; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Plagge JM, 2013, PAIN MED, V14, P1164, DOI 10.1111/pme.12155; Rasic D, 2011, J PSYCHIATR RES, V45, P848, DOI 10.1016/j.jpsychires.2010.11.014; Rosellini AJ, 2016, PSYCHOL MED, V46, P303, DOI 10.1017/S0033291715001774; SALTSTONE R, 1994, ADDICT BEHAV, V19, P455, DOI 10.1016/0306-4603(94)90001-9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schoenbaum M, 2014, JAMA PSYCHIAT, V71, P493, DOI 10.1001/jamapsychiatry.2013.4417; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Sherman MD, 2006, J MARITAL FAM THER, V32, P479, DOI 10.1111/j.1752-0606.2006.tb01622.x; SKINNER HA, 1986, BRIT J ADDICT, V81, P479; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Snir A, 2017, ARCH SUICIDE RES, V21, P595, DOI 10.1080/13811118.2016.1227740; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Stappenbeck CA, 2014, PSYCHOL TRAUMA-US, V6, P65, DOI 10.1037/a0031468; STEER RA, 1993, BEHAV RES THER, V31, P229, DOI 10.1016/0005-7967(93)90090-H; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Sullivan CP, 2014, LAW HUMAN BEHAV, V38, P1, DOI 10.1037/lhb0000035; Taft CT, 2005, J CONSULT CLIN PSYCH, V73, P151, DOI 10.1037/0022-006X.73.1.151; Teten AL, 2009, J TRAUMA STRESS, V22, P307, DOI 10.1002/jts.20422; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; van der Kolk BA, 2005, J TRAUMA STRESS, V18, P389, DOI 10.1002/jts.20047; Wells TS, 2013, J AFFECT DISORDERS, V148, P77, DOI 10.1016/j.jad.2012.11.052; Werbeloff N, 2016, J AFFECT DISORDERS, V205, P387, DOI 10.1016/j.jad.2016.08.015; WILLIAMS JBW, 1992, ARCH GEN PSYCHIAT, V49, P630; Wisco BE, 2014, J TRAUMA STRESS, V27, P244, DOI 10.1002/jts.21900; Wortzel HS, 2013, J AM ACAD PSYCHIATRY, V41, P274; Yehuda R, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.57; Youssef NA, 2013, ANN CLIN PSYCHIATRY, V25, P59	87	13	13	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	APR	2018	30	4					425	435		10.1037/pas0000490			11	Psychology, Clinical	Psychology	GD3RW	WOS:000430422200001	28627921	Green Accepted, Bronze			2021-06-18	
J	Fuller, GW; Govind, O; Tucker, R; Raftery, M				Fuller, G. W.; Govind, O.; Tucker, R.; Raftery, M.			Sport concussion assessment tool-Third edition normative reference values for professional Rugby Union players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; SCAT3; Rugby; Normative values	BASE-LINE VALUES; EPIDEMIOLOGY; STATEMENT	Objectives: To establish normative reference data for the SCAT3 in professional Rugby Union players. Design: A cross sectional study in professional Rugby Union players competing in national and international professional competitions between 2015 and 2016. Methods: The SCAT3 was administered pre-season or prior to tournaments. Data was collected electronically using a custom tablet application. SCAT3 subcomponents distributions were described and normative ranges determined using percentile cut-offs for average, unusually low/high, and extremely low/high scores. The association between player characteristics and performance in SCAT3 subcomponents was also investigated in exploratory analyses. Results: A total of 3611 professional Rugby Union players were included. The most common baseline symptom was fatigue (14%). The symptom score median (md) was 0 (interquartile range (IQR) = 0-1). Symptom severity md was 0 (IQR = 0-1). The md of the SAC score was 28 (IQR = 26-29). The md of the MBESS was 2 (IQR = 0-4). The Tandem gait md was 11.1 s (IQR = 10.0-12.7 s). Upper limb coordination was normal in 98.4%. Younger age and lower educational level were associated with worse performance on delayed recall and reverse month sub-components of the SCAT3 (p < 0.0001). No statistically significant differences in SCAT3 subcomponents were evident across gender. Conclusions: Representative normative reference values for the SCAT3 among professional Rugby Union players are provided. Baseline performance on concentration and delayed recall tests may be lower in younger athletes or in those with lower educational level. (C) 2017 Published by Elsevier Ltd on behalf of Sports Medicine Australia.	[Fuller, G. W.] Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England; [Govind, O.] Univ Manchester, Humanitarian & Conflict Response Inst, Manchester, Lancs, England; [Tucker, R.; Raftery, M.] World Rugby, World Rugby House, Dublin, Ireland	Fuller, GW (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Ctr Urgent & Emergency Care Res, Sheffield, S Yorkshire, England.	g.fuller@sheffield.ac.uk		Fuller, Gordon Ward/0000-0001-8532-3500	World Rugby; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2015-06-015, CL-2015-04-005] Funding Source: researchfish	Data collection was funded by World Rugby. There was no influence of any sponsor in study design, data collection, analysis, interpretation of data, writing of the report, or the decision to submit the paper for publication. We would like to acknowledge the assistance of team doctors and physicians performing the SCAT3 assessments.	[Anonymous], 2013, Br J Sports Med, V47, P259; Brooks A., 2014, BRIT J SPORT MED, V48, P573, DOI DOI 10.1136/BJSPORTS-2014-093494.38; Clay MB, 2013, J CHIROPR MED, V12, P230, DOI 10.1016/j.jcm.2012.11.005; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fuller CW, 2016, BJSM, V51, P64; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Harrison AG, 2014, ARCH CLIN NEUROPSYCH, V29, P737, DOI 10.1093/arclin/acu048; Helmy A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5748; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; McCrea HJ, 2013, SPORTS HEALTH, V5, P160, DOI 10.1177/1941738112462203; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Meeuwisse WH, 2017, BRIT J SPORT MED, DOI [10.1136/13jsports-2017-097569, DOI 10.1136/13JSPORTS-2017-097569.]; O'Connor P J, 1990, Fam Med, V22, P307; Programme UND, ED IND; Schuessler AA, 1999, P NATL ACAD SCI USA, V96, P10578, DOI 10.1073/pnas.96.19.10578; Snedden TR, 2016, CLIN J SPORT MED; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	20	13	13	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	APR	2018	21	4					347	351		10.1016/j.jsams.2017.07.025			5	Sport Sciences	Sport Sciences	GB5DL	WOS:000429082500005	28843846	Green Accepted			2021-06-18	
J	Lu, Q; Xie, YL; Qi, XC; Li, XW; Yang, SX; Wang, YR				Lu, Qin; Xie, Yonglin; Qi, Xunchen; Li, Xinwei; Yang, Shuxu; Wang, Yirong			Is Early Tracheostomy Better for Severe Traumatic Brain Injury? A Meta-Analysis	WORLD NEUROSURGERY			English	Article						Early tracheostomy; Meta-analysis; Outcome; Traumatic brain injury	INTUBATION; TRIAL; BLUNT; CARE	BACKGROUND: Tracheostomy has proven benefits for patients requiring prolonged mechanical ventilation. However, whether early tracheostomy (ET; <10 days after injury) can also improve outcomes in patients with severe traumatic brain injury (TBI) (Glasgow Coma Scale score <= 8) remains controversial. The aim of this study was to clarify this question. METHODS: We searched 4 databases (PubMed, Web of Science, Elsevier ScienceDirect, and Cochrane Library) for articles comparing the outcomes of ET with late tracheotomy or prolonged intubation in patients with severe TBI. Two reviewers were asked to record the major outcome data as follows: length of intensive care unit (ICU) stay, duration of mechanical ventilation, mortality, and incidence of pneumonia. Both random-effects and fixed-effects models were used. RESULTS: Eight studies met our inclusion criteria, with a total of 797 patients in the ET group and 871 patients in the late tracheostomy or prolonged intubation (not-ET) group. A meta-analysis of these 8 studies suggested that ET could reduce the length of ICU stay (mean difference [MD], -3.08; 95% confidence interval [CI], -3.75 to -2.41), duration of mechanical ventilation (MD, -4.92; 95% CI, -6.82 to -3.02), length of hospital stay (MD, -4.79; 95% CI, -8.63 to - 0.94), and incidence of pneumonia (odds ratio [OR], 0.64; 95% CI, 0.530.78), but seemed to be independent of mortality (OR, 1.25; 95% CI, 0.90-1.75). CONCLUSIONS: The available evidence suggests that ET may reduce the length of ICU and hospital stays, duration of mechanical ventilation, and incidence of pneumonia in patients with severe TBI. Well-designed randomized controlled trials are needed to confirm these findings.	[Lu, Qin; Qi, Xunchen; Li, Xinwei; Yang, Shuxu; Wang, Yirong] Zhejiang Univ, Sch Med, Dept Neurosurg, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China; [Xie, Yonglin] Hangzhou Hosp Zhejiang CAPR, Dept Rehabil, Hangzhou, Zhejiang, Peoples R China	Wang, YR (corresponding author), Zhejiang Univ, Sch Med, Dept Neurosurg, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China.	happycatlq1001@gmail.com		Lu, Qin/0000-0001-8211-6127	Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [Y14H160098]; National Science Foundation for Young Scientists of China [81702974]	This study was supported by the Zhejiang Provincial Natural Science Foundation of China (Grant Y14H160098) and the National Science Foundation for Young Scientists of China (Grant 81702974). The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Alali AS, 2014, J TRAUMA ACUTE CARE, V76, P76; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Cai SQ, 2017, INJURY, V48, P866, DOI 10.1016/j.injury.2017.02.023; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Combes A, 2002, CHEST, V121, P1618, DOI 10.1378/chest.121.5.1618; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Gurkin MA, 2002, AM SURGEON, V68, P324; GURKIN SA, 2002, AM SURGEON, V68, P328; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Kleffmann J, 2012, NEUROCRIT CARE, V17, P85, DOI 10.1007/s12028-012-9709-x; LESNIK I, 1992, AM SURGEON, V58, P346; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Mallick A, 2010, EUR J ANAESTH, V27, P676, DOI 10.1097/EJA.0b013e32833b1ba0; McCredie V, 2017, NEUROCRIT CARE, V26, P14, DOI 10.1007/s12028-016-0297-z; Protheroe RT, 2011, ANAESTHESIA, V66, P1035, DOI 10.1111/j.1365-2044.2011.06874.x; Seder DB, 2012, THE NEURO ICU BOOK, P723; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	28	13	14	4	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						E324	E330		10.1016/j.wneu.2018.01.043			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700038	29337171				2021-06-18	
J	Russell, RT; McDaniel, JK; Cao, WJ; Shroyer, M; Wagener, BM; Zheng, XL; Pittet, JF				Russell, Robert T.; McDaniel, Jenny K.; Cao, Wenjing; Shroyer, Michelle; Wagener, Brant M.; Zheng, X. Long; Pittet, Jean-Francois			Low Plasma ADAMTS13 Activity Is Associated with Coagulopathy, Endothelial Cell Damage and Mortality after Severe Paediatric Trauma	THROMBOSIS AND HAEMOSTASIS			English	Article						paediatric; trauma; injury; coagulopathy; ADAMTS13; von Willebrand Factor; human neutrophil peptide	VON-WILLEBRAND-FACTOR; HUMAN NEUTROPHIL PEPTIDES; PROTEIN-C PATHWAY; BRAIN-INJURY; GLYCOCALYX DEGRADATION; INFLAMMATORY CYTOKINES; ALPHA-DEFENSINS; ORGAN FAILURE; CLEAVAGE; THROMBOSPONDIN-1	Decrease of plasma activity of ADAMTS13, a metalloenzyme that cleaves von Willebrand factor (VWF) and prevents adhesion and aggregation of platelets, has been reported early after onset of systemic inflammation resulting from infections and after severe trauma. Here, we determined whether trauma-induced systemic (sterile) inflammation would be associated with a reduction of plasma ADAMTS13 activity in paediatric patients and its association with disease severity and outcome. Paediatric patients ( n =106) with severe trauma at a level 1 paediatric trauma centre between 2014 and 2016 were prospectively enrolled. Blood samples were collected upon arrival and at 24 hours and analysed for plasma levels of ADAMTS13 activity, VWF antigen, collagen binding activity, human neutrophil peptides (HNP) 1-3, coagulation abnormalities, endothelial glycocalyx damage and clinical outcome. Plasma samples were also collected for similar measurements from 52 healthy paediatric controls who underwent elective minor surgery. The median age of patients was 9 years with 81% sustaining blunt trauma. The median injury severity score was 22 and the mortality rate was 11%. Plasma levels of ADAMTS13 activity were significantly lower and plasma levels of VWF antigen and HNP 1-3 proteins were significantly higher for paediatric trauma patients on admission and at 24 hours when compared with controls. Finally, the lowest plasma ADAMTS13 activity was found in patients who died from their injuries. We conclude that relative plasma deficiency of ADAMTS13 activity may be associated with more severe traumatic injury, significant endothelial glycocalyx damage, coagulation abnormalities and mortality after severe trauma in paediatric patients.	[Russell, Robert T.; Shroyer, Michelle] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35249 USA; [McDaniel, Jenny K.; Cao, Wenjing; Zheng, X. Long] Univ Alabama Birmingham, Dept Pathol, Div Lab Med, WP230K,619 19th St South, Birmingham, AL 35249 USA; [Wagener, Brant M.; Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35249 USA	Zheng, XL (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Lab Med, WP230K,619 19th St South, Birmingham, AL 35249 USA.	xzheng@uabmc.edu	Wagener, Brant/AAI-7480-2020	Zheng, X. Long/0000-0003-1680-5295; Russell, Robert/0000-0002-8531-4249	American College of Surgeons C. James Carrico Fellowship [HL115187, R01 HL126724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL115187, R01HL126724] Funding Source: NIH RePORTER	This study is supported in part by the American College of Surgeons C. James Carrico Fellowship (to R.T.R.), R01 HL126724 (to X.L.Z.) and HL115187 (to X.L.Z).	Albers JM, 2012, CEREBROVASC DIS, V33, P403, DOI 10.1159/000335826; Bandyopadhyay G, 2014, J LEUKOCYTE BIOL, V96, P797, DOI 10.1189/jlb.4MA0214-077R; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Cao WJ, 2008, J THROMB HAEMOST, V6, P1233, DOI 10.1111/j.1538-7836.2008.02989.x; Cao WJ, 2016, HAEMATOLOGICA, V101, P1319, DOI 10.3324/haematol.2016.149021; Chinen Y, 2013, INT J HEMATOL, V97, P511, DOI 10.1007/s12185-013-1308-x; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Christiaans SC, 2013, AM J PHYSIOL-LUNG C, V305, pL455, DOI 10.1152/ajplung.00093.2013; Christian CW, 2010, PEDIATRICS, V126, P592, DOI 10.1542/peds.2010-2006; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Hack CE, 2001, CRIT CARE MED, V29, pS21, DOI 10.1097/00003246-200107001-00011; Hendrickson J E, 2012, J PEDIAT, V160, P204; Horn M, 2012, J THROMB HAEMOST, V10, P647, DOI 10.1111/j.1538-7836.2012.04640.x; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; Hyun J, 2009, THROMB RES, V124, P75, DOI 10.1016/j.thromres.2008.11.020; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Johansson Par I, 2013, J Emerg Trauma Shock, V6, P171, DOI 10.4103/0974-2700.115327; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kumar M, 2017, THROMB HAEMOSTASIS, V117, P691, DOI 10.1160/TH16-11-0834; Lao ZQ, 2012, INT J PREVENTIVE MED, V3, P303; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Liras IN, 2017, J AM COLL SURGEONS, V224, P625, DOI 10.1016/j.jamcollsurg.2016.12.046; Liu L, 2005, J THROMB HAEMOST, V3, P2536, DOI 10.1111/j.1538-7836.2005.01561.x; Mannucci PM, 2004, BRIT J HAEMATOL, V126, P213, DOI 10.1111/j.1365-2141.2004.05009.x; Martin K, 2007, CRIT CARE MED, V35, P2375, DOI 10.1097/01.CCM.0000284508.05247.B3; Meiring M, 2016, INT J MED SCI, V13, P759, DOI 10.7150/ijms.15688; Mimuro J, 2008, THROMB RES, V122, P91, DOI 10.1016/j.thromres.2007.09.011; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Pillai VG, 2016, BLOOD, V128, P110, DOI 10.1182/blood-2015-12-688747; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Raife TJ, 2009, BLOOD, V114, P1666, DOI 10.1182/blood-2009-01-195461; Rodriguez EG, 2017, J AM COLL SURGEONS, V225, P419, DOI 10.1016/j.jamcollsurg.2017.05.012; Russell RT, 2018, SHOCK, V49, P44, DOI 10.1097/SHK.0000000000000902; Schrieber M, 2007, J TRAUMA, V63, P1261; Schwameis M, 2015, THROMB HAEMOSTASIS, V113, P708, DOI 10.1160/TH14-09-0731; Shang DZ, 2006, BLOOD, V108, P2207, DOI 10.1182/blood-2006-02-002139; Soares RPS, 2013, CLINICS, V68, P531, DOI 10.6061/clinics/2013(04)15; Suominen P, 1998, INJURY, V29, P425; Tang N, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-70; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341	51	13	13	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0340-6245	2567-689X		THROMB HAEMOSTASIS	Thromb. Haemost.	APR	2018	118	4					676	687		10.1055/s-0038-1636528			12	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	GB5JP	WOS:000429100700007	29618154	Green Accepted			2021-06-18	
J	Fino, PC; Parrington, L; Walls, M; Sippel, E; Hullar, TE; Chesnutt, JC; King, LA				Fino, Peter C.; Parrington, Lucy; Walls, Merissa; Sippel, Emily; Hullar, Timothy E.; Chesnutt, James C.; King, Laurie A.			Abnormal Turning and Its Association with Self-Reported Symptoms in Chronic Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; gait; head stabilization; inertial sensors; turning	HEAD YAW MOVEMENTS; QUALITY-OF-LIFE; COORDINATION; CONCUSSION; GAIT; PERFORMANCE; STRATEGIES; STABILITY; DIRECTION; TRUNK	Turning is common in daily activity and requires rapid, coordinated reorientation of the head, trunk, and pelvis toward the new direction of travel. Yet, turning gait has not been well explored in populations with mild traumatic brain injury (mTBI) who may alter their turning behavior according to self-perceived symptoms or motor dysfunction. The purpose of this study was to examine turning velocities and coordination in adults with chronic mTBI (>3 months post-injury and still reporting balance complaints) during a task simulating everyday ambulation. We hypothesized that individuals with chronic mTBI would reduce their angular velocity when turning and increase the variability of head-pelvis coordination compared with controls, and that the reduction in velocity and increased variability would be associated with their self-reported symptom score. Forty-two adults (14 chronic mTBI, 28 controls) completed the Neurobehavioral Symptom Inventory before walking 12 laps around a marked course containing two 45-degree turns, four 90-degree turns, and two 135-degree turns. Inertial sensors collected angular velocities of the head and pelvis. After adjusting for covariates, participants with chronic mTBI had significantly slower lap times and peak angular velocities of the pelvis (p < 0.01) compared with the control group. The peak velocity timing (PVT) between peak velocities of the head and pelvis, and the variability of that timing was significantly greater in participants with chronic mTBI (p < 0.01). Within the chronic mTBI group, somatosensory symptoms were associated with slower angular velocities of the head and pelvis (p = 0.03) and increased PVT variability (p < 0.01). The results suggest individuals with chronic mTBI with worse somatic symptoms have impaired head stabilization during turning in situations similar to everyday life. These results encourage future research on turning gait to examine the causal relationship between symptoms and daily locomotor function in adults with chronic mTBI.	[Fino, Peter C.; Parrington, Lucy; Walls, Merissa; Sippel, Emily; King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA; [Hullar, Timothy E.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA	Fino, PC (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,OP-32, Portland, OR 97239 USA.	fino@ohsu.edu		Parrington, Lucy/0000-0001-8507-9974; Fino, Peter/0000-0002-8621-3706	Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0620]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002370, UL1TR002369] Funding Source: NIH RePORTER	The authors would like to thank Clayton Swanson and Heather Belding for assistance in early data collection, Marco Jurado, AuD and Sean Kampel, AuD for performing the vestibular testing, and Jenny Wilhelm, PT for referring subjects and evaluating the clinical diagnoses of participants. This work was supported by the Assistant Secretary of Defense for Health Affairs under Award No. W81XWH-15-1-0620. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.	Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Anastasopoulos D, 2009, EXP BRAIN RES, V193, P323, DOI 10.1007/s00221-008-1627-y; Bernardin D, 2012, EXP BRAIN RES, V223, P65, DOI 10.1007/s00221-012-3241-2; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Fino PC, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0812-7; Fino PC, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0177-y; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Grasso R, 2000, NEUROREPORT, V11, P775, DOI 10.1097/00001756-200003200-00024; Grasso R, 1998, NEUROSCI LETT, V253, P115, DOI 10.1016/S0304-3940(98)00625-9; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollands MA, 2002, EXP BRAIN RES, V143, P221, DOI 10.1007/s00221-001-0983-7; Hollands MA, 2001, EXP BRAIN RES, V140, P223, DOI 10.1007/s002210100811; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Hudson TE, 2005, EXP BRAIN RES, V165, P283, DOI 10.1007/s00221-005-2313-y; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kolev OI, 2016, FUNCT NEUROL, V31, P75; Land MF, 2004, EXP BRAIN RES, V159, P151, DOI 10.1007/s00221-004-1951-9; Littlefield PD, 2016, J NEUROTRAUM, V33, P71, DOI 10.1089/neu.2014.3824; Mancini M, 2015, NEUROREHABILITATION, V37, P3, DOI 10.3233/NRE-151236; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Parker TM, 2008, MED ENG PHYS, V30, P959, DOI 10.1016/j.medengphy.2007.12.006; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Patla AE, 1999, EXP BRAIN RES, V129, P629, DOI 10.1007/s002210050932; Powers KC, 2014, GAIT POSTURE, V39, P728, DOI 10.1016/j.gaitpost.2013.10.005; Raphan T, 2001, ANN NY ACAD SCI, V942, P128; Russell K, 2017, J NEUROTRAUM, V34, P2147, DOI 10.1089/neu.2016.4704; Sandel NK, 2013, APPL NEUROPSYCH-CHIL, V2, P64, DOI 10.1080/21622965.2012.670580; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Sessoms PH, 2015, MIL MED, V180, P135, DOI 10.7205/MILMED-D-14-00386; Solomon D, 2006, EXP BRAIN RES, V173, P475, DOI 10.1007/s00221-006-0393-y; Son EJ, 2015, AM J OTOLARYNG, V36, P823, DOI 10.1016/j.amjoto.2015.07.011; Sreenivasa MN, 2008, EXP BRAIN RES, V191, P313, DOI 10.1007/s00221-008-1525-3; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Vallis LA, 2004, EXP BRAIN RES, V157, P94, DOI 10.1007/s00221-003-1824-7; Vallis LA, 2001, EXP BRAIN RES, V138, P128, DOI 10.1007/s002210100680; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Woodson J., 2015, TRAUMATIC BRAIN INJU; Xu DL, 2004, J MOTOR BEHAV, V36, P316, DOI 10.3200/JMBR.36.3.316-326	46	13	13	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	2018	35	10					1167	1177		10.1089/neu.2017.5231		MAR 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	GF8DL	WOS:000428447700001	29078732	Green Published			2021-06-18	
J	Thelin, EP; Just, D; Frostell, A; Haggmark-Manberg, A; Risling, M; Svensson, M; Nilsson, P; Bellander, BM				Thelin, Eric Peter; Just, David; Frostell, Arvid; Haggmark-Manberg, Anna; Risling, Marten; Svensson, Mikael; Nilsson, Peter; Bellander, Bo-Michael			Protein profiling in serum after traumatic brain injury in rats reveals potential injury markers	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Hypoxia; Serum proteins; Biomarkers; Protein-array	ENDOTHELIAL GROWTH-FACTOR; NEURON-SPECIFIC ENOLASE; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; COMPLEMENT-SYSTEM; BIOMARKER LEVELS; HEAD-INJURY; ALZHEIMERS-DISEASE; TEMPORAL PROFILES; PROGNOSTIC VALUE	Introduction: The serum proteome following traumatic brain injury (TBI) could provide information for outcome prediction and injury monitoring. The aim with this affinity proteomic study was to identify serum proteins over time and between normoxic and hypoxic conditions in focal TBI. Material and methods: Sprague Dawley rats (n = 73) received a 3 mm deep controlled cortical impact ("severe injury"). Following injury, the rats inhaled either a normoxic (22% O-2) or hypoxic (11% O-2) air mixture for 30 min before resuscitation. The rats were sacrificed at day 1, 3, 7, 14 and 28 after trauma. A total of 204 antibodies targeting 143 unique proteins of interest in TBI research, were selected. The sample proteome was analyzed in a suspension bead array set-up. Comparative statistics and factor analysis were used to detect differences as well as variance in the data. Results: We found that complement factor 9 (C9), complement factor B (CFB) and aldolase c (ALDOC) were detected at higher levels the first days after trauma. In contrast, hypoxia inducing factor (HIF)1 alpha, amyloid precursor protein (APP) and WBSCR17 increased over the subsequent weeks. S100A9 levels were higher in hypoxic-compared to normoxic rats, together with a majority of the analyzed proteins, albeit few reached statistical significance. The principal component analysis revealed a variance in the data, highlighting clusters of proteins. Conclusions: Protein profiling of serum following TBI using an antibody based microarray revealed temporal changes of several proteins over an extended period of up to four weeks. Further studies are warranted to confirm our findings. (C) 2016 The Author(s). Published by Elsevier B.V.	[Thelin, Eric Peter; Frostell, Arvid; Svensson, Mikael; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Just, David; Haggmark-Manberg, Anna; Nilsson, Peter] KTH Royal Inst Technol, Sch Biotechnol, Sci Life Lab, Affin Prote, Stockholm, Sweden; [Risling, Marten] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Svensson, Mikael; Bellander, Bo-Michael] Karolinska Univ Hosp, Dept Neurosurg, Stockholm, Sweden	Thelin, EP (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	eric.thelin@ki.se; david.just@scilifelab.se; arvid.frostell@ki.se; anna.haggmark@scilifelab.se; marten.risling@ki.se; Mikael.svensson@ki.se; peter.nilsson@scilifelab.se; bo-michael.bellander@ki.se	Svensson, Mikael/F-8662-2012; Nilsson, Peter/E-4547-2010; Thelin, Eric Peter/K-2144-2012	Svensson, Mikael/0000-0003-1179-7003; Nilsson, Peter/0000-0002-4657-8532; Thelin, Eric Peter/0000-0002-2338-4364; Manberg (Haggmark), Anna/0000-0002-0056-1313	SENSUS Region Mellansverige, Stockholm County (ALF); ProNova VINN Excellence Centre for Protein Technology (VINNOVA, Swedish Governmental Agency for Innovation Systems)Vinnova; Knut and Alice Wallenberg FoundationKnut & Alice Wallenberg Foundation; KTH Center for Applied Proteomics - Erling-Persson Family Foundation	This study was supported by SENSUS Region Mellansverige, Stockholm County (ALF), the ProNova VINN Excellence Centre for Protein Technology (VINNOVA, Swedish Governmental Agency for Innovation Systems), the Knut and Alice Wallenberg Foundation, KTH Center for Applied Proteomics financed through the Erling-Persson Family Foundation.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Boutte A.M., 2015, J NEUROTRAUMA; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dalle Lucca Jurandir J, 2012, J Neurol Sci, V318, P146, DOI 10.1016/j.jns.2012.02.002; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Eriksson L, 2004, ANAL BIOANAL CHEM, V380, P419, DOI 10.1007/s00216-004-2783-y; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; HAIMOTO H, 1987, LAB INVEST, V57, P489; Haqqani AS, 2007, J NEUROTRAUM, V24, P54, DOI 10.1089/neu.2006.0079; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Helmy A., 2015, J CEREB BLOOD FLOW M; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; HURWITZ AA, 1992, J EXP MED, V176, P1631, DOI 10.1084/jem.176.6.1631; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kobeissy FH, 2008, PROTEOM CLIN APPL, V2, P1467, DOI 10.1002/prca.200800011; Landegren U, 2012, ANAL CHEM, V84, P1824, DOI 10.1021/ac2032222; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Li L, 2013, J NEURAL TRANSM, V120, P1511, DOI 10.1007/s00702-013-1031-z; Liang J, 2013, ASIAN PAC J CANCER P, V14, P3851, DOI 10.7314/APJCP.2013.14.6.3851; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McMahon LW, 2009, BIOCHEM BIOPH RES CO, V381, P288, DOI 10.1016/j.bbrc.2009.02.038; Mondello S., 2015, J NEUROTRAUMA; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Mulder J., 2016, MOUSE BRAIN PROTEIN; Ottens A. K., 2010, J NEUROTRAUMA, V27; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; R. D. C. Team, 2008, R LANG ENV STAT COMP; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rostami E, 2013, J NEUROTRAUM, V30, P1954, DOI 10.1089/neu.2012.2583; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Schwenk JM, 2008, J PROTEOME RES, V7, P3168, DOI 10.1021/pr700890b; Schwenk JM, 2010, MOL CELL PROTEOMICS, V9, P2497, DOI 10.1074/mcp.M110.001560; Scornavacca G, 2012, J NEUROCHEM, V122, P1219, DOI 10.1111/j.1471-4159.2012.07874.x; Shao Y, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1925424; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Siman R., 2015, J NEUROTRAUMA, V32; Sjostedt E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130028; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Tasci A, 2003, NEUROL RES, V25, P871, DOI 10.1179/016164103771953998; Tegel H, 2010, PROTEIN EXPRES PURIF, V69, P159, DOI 10.1016/j.pep.2009.08.017; Tegel Hanna, 2009, Biotechnology Journal, V4, P51, DOI 10.1002/biot.200800183; Thelin E. P., 2013, J NEUROTRAUMA, V30; Thelin E. P., 2016, BRAIN INJURY FRONT N, V7, P23, DOI [10.3389/fneur.2016.0002327014178, DOI 10.3389/FNEUR.2016.0002327014178]; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wang C, 2014, ACTA NEUROPATHOL, V127, P507, DOI 10.1007/s00401-013-1208-4; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woertgen C, 2002, ACT NEUR S, V81, P205; YAMAZAKI Y, 1995, SURG NEUROL, V43, P267, DOI 10.1016/0090-3019(95)80012-6; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yu CG, 2015, J NEUROSCI RES, V93, P199, DOI 10.1002/jnr.23503; Yu R, 2001, Chin J Traumatol, V4, P218; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	89	13	13	0	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		71	80		10.1016/j.bbr.2016.08.058			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400008	27591967	Other Gold			2021-06-18	
J	Thomas, TC; Ogle, SB; Rumney, BM; May, HG; Adelson, PD; Lifshitz, J				Thomas, Theresa Currier; Ogle, Sarah B.; Rumney, Benjamin M.; May, Hazel G.; Adelson, P. David; Lifshitz, Jonathan			Does time heal all wounds? Experimental diffuse traumatic brain injury results in persisting histopathology in the thalamus	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Post-concussive symptoms; Thalamus; Whisker-circuit; Somatosensory	ONSET BEHAVIORAL MORBIDITY; TEMPORAL-LOBE EPILEPSY; SPINAL-CORD CONTUSION; CELL-CYCLE ACTIVATION; SYMPTOMS 6 MONTHS; REACTIVE ASTROCYTES; EPILEPTOGENIC NEOCORTEX; POSTCONCUSSION SYNDROME; NEURONAL HYPERTROPHY; SYNAPSE FORMATION	Background: Thalamic dysfunction has been implicated in overall chronic neurological dysfunction after traumatic brain injury (TBI), however little is known about the underlying histopathology. In experimental diffuse TBI (dTBI), we hypothesize that persisting histopathological changes in the ventral posteromedial (VPM) nucleus of the thalamus is indicative of progressive circuit reorganization. Since circuit reorganization in the VPM impacts the whisker sensory system, the histopathology could explain the development of hypersensitivity to whisker stimulation by 28 days post-injury; similar to light and sound hypersensitivity in human TBI survivors. Methods: Adult, male Sprague-Dawley rats underwent craniotomy and midline fluid percussion injury (FPI) (moderate severity; 1.8-2.0 atm) or sham surgery. At I d, 7d, and 28 days post-FPI (d FPI) separate experiments confirmed the cytoarchitecture (Giemsa stain) and evaluated neuropathology (silver stain), activated astrocytes (GFAP), neuron morphology (Golgi stain) and microglial morphology (Iba-1) in the VPM. Results: Cytoarchitecture was unchanged throughout the time course, similar to previously published data; however, neuropathology and astrocyte activation were significantly increased at 7d and 28d and activated microglia were present at all time points. Neuron morphology was dynamic over the time course with decreased dendritic complexity (fewer branch points; decreased length of processes) at 7d FPI and return to sham values by 28d FPI. Conclusions: These data indicate that dTBI results in persisting thalamic histopathology out to a chronic time point. While these changes can be indicative of either adaptive (recovery) or maladaptive (neurological dysfunction) circuit reorganization, they also provide a potential mechanism by which maladaptive circuit reorganization could contribute to the development of chronic neurological dysfunction. Understanding the processes that mediate circuit reorganization is critical to the development of future therapies for TBI patients. (C) 2017 Elsevier B.V. All rights reserved.	[Thomas, Theresa Currier; Ogle, Sarah B.; Adelson, P. David; Lifshitz, Jonathan] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Thomas, Theresa Currier; Ogle, Sarah B.; Adelson, P. David; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ USA; [Thomas, Theresa Currier; Lifshitz, Jonathan] Phoenix VA Hlth Care Syst, Phoenix, AZ USA; [Rumney, Benjamin M.; May, Hazel G.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Adelson, P. David; Lifshitz, Jonathan] Arizona State Univ, Neurosci Program, Tempe, AZ USA; [Adelson, P. David] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ USA; [Ogle, Sarah B.] Banner Univ, Med Ctr, Phoenix Integrated Surg Residency, Phoenix, AZ USA; [Ogle, Sarah B.] Banner Univ, Med Ctr, Dept Surg, Phoenix, AZ USA	Thomas, TC (corresponding author), Univ Arizona, Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Child Hlth,Translat Neurotrauma Res Program, 425 N 5th St ABC-1 Bldg 320, Phoenix, AZ 85004 USA.	theresathomas@email.arizona.edu; sogle@emaiLarizona.edu; ben-rumney@ntlworld.com; Hazelmay094@gmail.com; dadelson@phoenixchildrens.com; jlifshitz@email.arizona.edu	Thomas, Theresa Currier/K-1979-2019; Adelson, David/W-2083-2019	Thomas, Theresa Currier/0000-0002-9619-7666; Ogle, Sarah/0000-0003-0160-5311	Arizona Biomedical Research Commission through the Arizona Department of Health Services [ADHS14-00003606]; National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS-065052]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH R03 NS-077098]; Phoenix Children's Hospital Leadership Circle; Phoenix Children's Hospital Mission Support Funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065052, R03NS077098] Funding Source: NIH RePORTER	Supported by the Arizona Biomedical Research Commission through the Arizona Department of Health Services (ADHS14-00003606), National Institute of Neurological Disorders and Stroke of the National Institutes of Health (R01 NS-065052), National Institutes of Health (NIH R03 NS-077098), Phoenix Children's Hospital Leadership Circle and Phoenix Children's Hospital Mission Support Funds.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Allen NJ, 2013, CURR OPIN NEUROBIOL, V23, P1027, DOI 10.1016/j.conb.2013.06.004; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; Anderson MA, 2014, NEUROSCI LETT, V565, P23, DOI 10.1016/j.neulet.2013.12.030; Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Barker AJ, 2010, NEUROSCIENTIST, V16, P40, DOI 10.1177/1073858409339215; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Beltramino C A, 1993, NIDA Res Monogr, V136, P101; Beltramino CA, 1993, NIDA RES MONOGR, V136, P126; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, NEUROSURGERY, V30, P692; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; Bothwell S, 2001, J NEUROSCI, V21, P4789, DOI 10.1523/JNEUROSCI.21-13-04789.2001; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Card JP, 2005, J NEUROTRAUM, V22, P989, DOI 10.1089/neu.2005.22.989; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Casella EM, 2014, CHILD NERV SYST, V30, P1333, DOI 10.1007/s00381-014-2446-z; Chang TTL, 2007, BRAIN INJURY, V21, P1055, DOI 10.1080/02699050701591437; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; Choudhury GR, 2016, NEUROBIOL DIS, V85, P234, DOI 10.1016/j.nbd.2015.05.003; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Control NCfIPa, 2003, REP C MILD TRAUM BRA; Cuello J. I., 1985, TRES PONENCIAS POLIT; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; FINCH CE, 1993, TRENDS NEUROSCI, V16, P104, DOI 10.1016/0166-2236(93)90134-8; Galvin J, 2009, AM J OCCUP THER, V63, P701, DOI 10.5014/ajot.63.6.701; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Henderson T. A., 1995, CEREBRAL CORTEX BARR, P123; Hillary E. G., 2011, INT J PSYCHOPHYSIOL; Hoffman A. N., 2016, J NEUROTRAUMA; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Hulsebosch CE, 1998, NEUROSCI LETT, V255, P83, DOI 10.1016/S0304-3940(98)00712-5; Hwabejire JO, 2013, SURGERY, V154, P234, DOI 10.1016/j.surg.2013.04.008; Iacono D, 2008, J NEUROPATH EXP NEUR, V67, P578, DOI 10.1097/NEN.0b013e3181772794; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Learoyd A, 2011, J NEUROTRAUM, V28, pA88; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Mattson MP, 2008, ANN NY ACAD SCI, V1144, P97, DOI 10.1196/annals.1418.005; Maxwell W. L., BRAIN NEUROTRAUMA MO; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Miremami JD, 2014, SOMATOSENS MOT RES, V31, P127, DOI 10.3109/08990220.2014.897602; Molofsky AV, 2012, GENE DEV, V26, P891, DOI 10.1101/gad.188326.112; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; POVLISHOCK JT, 1992, J NEUROTRAUM, V9, pS189; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Risher ML, 2015, ALCOHOL CLIN EXP RES, V39, P2403, DOI 10.1111/acer.12913; Robertson CL, 2001, J NEUROTRAUM, V18, P861, DOI 10.1089/089771501750451785; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Sa MJ, 2000, ACTA NEUROPATHOL, V99, P643, DOI 10.1007/s004010051175; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Taylor SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097096; Thomas TC, 2012, J NEUROTRAUM, V29, pA13; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; van der Horn HJ, 2015, BRAIN IMAGING BEHAV; Verkhratsky A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0595; Wang GX, 2008, J NEUROSCI, V28, P11959, DOI 10.1523/JNEUROSCI.3296-08.2008; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wu JF, 2016, PAIN, V157, P488, DOI 10.1097/j.pain.0000000000000393; Wu JF, 2014, CELL CYCLE, V13, P2446, DOI 10.4161/cc.29420; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1; Ziebell JM, 2015, METAB BRAIN DIS, V30, P393, DOI 10.1007/s11011-014-9539-y; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	108	13	13	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		137	146		10.1016/j.bbr.2016.12.038			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400016	28042008	Green Accepted			2021-06-18	
J	Giacci, MK; Bartlett, CA; Huynh, M; Kilburn, MR; Dunlop, SA; Fitzgerald, M				Giacci, Marcus K.; Bartlett, Carole A.; Minh Huynh; Kilburn, Matt R.; Dunlop, Sarah A.; Fitzgerald, Melinda			Three dimensional electron microscopy reveals changing axonal and myelin morphology along normal and partially injured optic nerves	SCIENTIFIC REPORTS			English	Article							RETINAL GANGLION-CELLS; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; CONDUCTION-VELOCITY; CATS RETINA; SECONDARY DEGENERATION; NITRIC-OXIDE; PROTEOLIPID PROTEIN; X-CELLS; Y-CELLS	Following injury to the central nervous system, axons and myelin distinct from the initial injury site undergo changes associated with compromised function. Quantifying such changes is important to understanding the pathophysiology of neurotrauma; however, most studies to date used 2 dimensional (D) electron microscopy to analyse single sections, thereby failing to capture changes along individual axons. We used serial block face scanning electron microscopy (SBF SEM) to undertake 3D reconstruction of axons and myelin, analysing optic nerves from normal uninjured female rats and following partial optic nerve transection. Measures of axon and myelin dimensions were generated by examining 2D images at 5 mu m intervals along the 100 mu m segments. In both normal and injured animals, changes in axonal diameter, myelin thickness, fiber diameter, G-ratio and percentage myelin decompaction were apparent along the lengths of axons to varying degrees. The range of values for axon diameter along individual reconstructed axons in 3D was similar to the range from 2D datasets, encompassing reported variation in axonal diameter attributed to retinal ganglion cell diversity. 3D electron microscopy analyses have provided the means to demonstrate substantial variability in ultrastructure along the length of individual axons and to improve understanding of the pathophysiology of neurotrauma.	[Giacci, Marcus K.; Bartlett, Carole A.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia; [Kilburn, Matt R.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, 35 Stirling Hwy, Perth, WA 6009, Australia; [Minh Huynh] Univ Sydney, Australian Ctr Microscopy & Microanal, City Rd, Sydney, NSW 2006, Australia; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia; [Fitzgerald, Melinda] Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, 8 Verdun St, Nedlands, WA 6009, Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, 35 Stirling Hwy, Perth, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA 6102, Australia.; Fitzgerald, M (corresponding author), Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, 8 Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@curtin.edu.au	Fitzgerald, Melinda/C-4235-2011; Kilburn, Matthew/C-4515-2011	Fitzgerald, Melinda/0000-0002-4823-8179; Kilburn, Matthew/0000-0002-1858-8485; Dunlop, Sarah/0000-0002-1306-3962; Giacci, Marcus/0000-0002-8330-678X			Aiello GL, 2000, J NEUROSCI METH, V103, P145, DOI 10.1016/S0165-0270(00)00308-3; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Arancibia-Carcamo IL, 2017, ELIFE, V6, DOI 10.7554/eLife.23329; BAKER GE, 1990, NATURE, V344, P342, DOI 10.1038/344342a0; BALENTINE JD, 1978, LAB INVEST, V39, P254; Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Bernardi P, 1999, PHYSIOL REV, V79, P1127; Bizzozero OA, 2001, J NEUROCHEM, V76, P1129, DOI 10.1046/j.1471-4159.2001.00116.x; Bizzozero OA, 2001, NEUROCHEM RES, V26, P1127, DOI 10.1023/A:1012370822754; BLIGHT AR, 1983, NEUROSCIENCE, V10, P521, DOI 10.1016/0306-4522(83)90150-1; BOISON D, 1994, P NATL ACAD SCI USA, V91, P11709, DOI 10.1073/pnas.91.24.11709; BONGARZONE ER, 1995, J NEUROSCI RES, V41, P213, DOI 10.1002/jnr.490410209; Bros H, 2014, EXP NEUROL, V261, P127, DOI 10.1016/j.expneurol.2014.06.018; BUNT AH, 1974, BRAIN RES, V73, P215, DOI 10.1016/0006-8993(74)91045-2; Cao Y, 2013, BRAIN RES, V1522, P59, DOI 10.1016/j.brainres.2013.05.033; Carpenter M.B., 1983, HUMAN NEUROANATOMY; Chang KJ, 2016, NAT NEUROSCI, V19, P190, DOI 10.1038/nn.4200; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P421, DOI 10.1113/jphysiol.1974.sp010617; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; CLELAND BG, 1974, J PHYSIOL-LONDON, V240, P457, DOI 10.1113/jphysiol.1974.sp010618; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Cummins N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-98; Davis CHO, 2014, P NATL ACAD SCI USA, V111, P9633, DOI 10.1073/pnas.1404651111; Deerinck TJ., 2010, MICROSCOPY-JPN, P6; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Drenhaus U, 1997, ANAT REC, V249, P103, DOI 10.1002/(SICI)1097-0185(199709)249:1<103::AID-AR13>3.0.CO;2-T; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; FITZGIBBON T, 1994, VISUAL NEUROSCI, V11, P425, DOI 10.1017/S0952523800002364; FRAHER JP, 1978, J NEUROL SCI, V36, P427, DOI 10.1016/0022-510X(78)90049-7; FRAHER JP, 1976, BRAIN RES, V105, P193, DOI 10.1016/0006-8993(76)90421-2; FRAHER JP, 1978, J ANAT, V126, P509; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; FUKUDA Y, 1974, J NEUROPHYSIOL, V37, P749; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; GREENBERG MM, 1990, J NEUROCYTOL, V19, P978, DOI 10.1007/BF01186825; GUTIERREZ R, 1995, NEUROSCI LETT, V195, P93, DOI 10.1016/0304-3940(94)11789-L; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hursh JB, 1939, AM J PHYSIOL, V127, P131; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Levkovitch-Verbin H, 2004, EYE, V18, P1066, DOI 10.1038/sj.eye.6701576; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068881; Maxwell WL, 1995, J NEUROCYTOL, V24, P925, DOI 10.1007/BF01215643; Mills EA, 2015, P NATL ACAD SCI USA, V112, P10509, DOI 10.1073/pnas.1506486112; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Patestas MA, 2016, TXB NEUROANATOMY; Payne SC, 2012, INVEST OPHTH VIS SCI, V53, P6093, DOI 10.1167/iovs.12-10080; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; REESE BE, 1987, NEUROSCIENCE, V22, P1015, DOI 10.1016/0306-4522(87)92977-0; RELES A, 1991, J NEUROCYTOL, V20, P450, DOI 10.1007/BF01252273; Salazar DL, 2008, DEV DEGENERATION REG, P297; SCHRODER JM, 1978, ACTA NEUROPATHOL, V43, P169; Seidl AH, 2014, NEUROSCIENCE, V276, P126, DOI 10.1016/j.neuroscience.2013.06.047; Seidl AH, 2016, GLIA, V64, P487, DOI 10.1002/glia.22941; Seidl AH, 2014, J NEUROSCI, V34, P4914, DOI 10.1523/JNEUROSCI.5460-13.2014; SMITH RS, 1970, AM J PHYSIOL, V219, P1256; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; STANFORD LR, 1987, SCIENCE, V238, P358, DOI 10.1126/science.3659918; STONE J, 1974, J COMP NEUROL, V155, P377, DOI 10.1002/cne.901550402; STONE J, 1974, J NEUROPHYSIOL, V37, P722; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Titus HE, 2017, GLIA, V65, P1990, DOI 10.1002/glia.23209; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Walsh N, 1999, J NEUROCYTOL, V28, P989, DOI 10.1023/A:1007083920206; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Xing YL, 2014, J NEUROSCI, V34, P14128, DOI 10.1523/JNEUROSCI.3491-13.2014; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang CW, 2005, INVEST OPHTH VIS SCI, V46, P1497, DOI 10.1167/iovs.04-0664	75	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	MAR 5	2018	8								3979	10.1038/s41598-018-22361-2			12	Multidisciplinary Sciences	Science & Technology - Other Topics	FY0ZI	WOS:000426540800012	29507421	DOAJ Gold, Green Published			2021-06-18	
J	Arafa, M; Agarwal, A; Al Said, S; Majzoub, A; Sharma, R; Bjugstad, KB; AlRumaihi, K; Elbardisi, H				Arafa, M.; Agarwal, A.; Al Said, S.; Majzoub, A.; Sharma, R.; Bjugstad, K. B.; AlRumaihi, K.; Elbardisi, H.			Semen quality and infertility status can be identified through measures of oxidation-reduction potential	ANDROLOGIA			English	Article						infertility; oxidation-reduction potential; semen analysis; semen quality; spermatozoa	TRAUMATIC BRAIN-INJURY; ANTIOXIDANT CAPACITY; STRESS; FERTILITY; PLASMA; MEN	Standard analyses for evaluating semen quality require technical expertise and are interpretive in nature. Oxidative stress (OS) alters many of the semen parameters; thus, a measure of OS could be an indicator of semen quality. Static oxidation-reduction potential (sORP) is a universal measure of OS traditionally used in environmental applications but is increasingly used in biomedical studies. sORP was measured to determine how well it associates with semen quality and if it differentiates semen from infertile patients and fertile donors. All study participants (Infertile, n=365 and Fertile, n=50) underwent standard semen analyses, and sORP was measured in unprocessed semen. In infertile patients, sORP increased with decreased total sperm number, motility and morphology. sORP values were higher in samples with abnormal quality (low number, motility and/or normal morphology) compared with those of normal quality. Infertile patients had higher sOPR values compared to fertile donors. A sORP cut-off value of 1.38mV/10(6)sperm/ml can differentiate normal from abnormal semen samples, while a cut-off value of 1.41mV/10(6) sperm/ml, can differentiate between infertile and fertile semen samples. In conclusion, sORP provides a quick and unbiased indicator of semen quality that can be a beneficial addition to semen analysis to determine semen quality and fertility status.	[Arafa, M.; Al Said, S.; Majzoub, A.; AlRumaihi, K.; Elbardisi, H.] HMC, Dept Urol, Doha, Qatar; [Arafa, M.] Cairo Univ, Androl Dept, Cairo, Egypt; [Agarwal, A.; Sharma, R.] Cleveland Clin, Amer Ctr Reprod Med, Cleveland, OH 44106 USA; [Bjugstad, K. B.] Aytu BioSci, Englewood, CO USA	Arafa, M (corresponding author), Hamad Gen Hosp, Dept Urol, Male Infertil Unit, Doha, Qatar.	mohamedmostafaarafa@gmail.com	Arafa, Mohamed/I-7829-2019; Haitham, Elbardisi/J-3412-2019; Majzoub, Ahmad/T-1071-2019	Arafa, Mohamed/0000-0003-0107-8857; Haitham, Elbardisi/0000-0003-3902-7924; Majzoub, Ahmad/0000-0001-7423-6241; Sharma, Rakesh/0000-0002-9664-6978; Bjugstad, Kimberly/0000-0002-0473-5413			Agarwal A, 2017, REPROD BIOMED ONLINE, V34, P48, DOI 10.1016/j.rbmo.2016.10.008; Agarwal A, 2016, FERTIL STERIL, V106, P566, DOI 10.1016/j.fertnstert.2016.05.013; Agarwal A, 2014, SYST BIOL REPROD MED, V60, P206, DOI 10.3109/19396368.2014.918675; Benedetti S, 2012, REPROD BIOMED ONLINE, V25, P300, DOI 10.1016/j.rbmo.2012.05.011; Bjugstad K. B., 2016, J NEUROLOGY NEUROPHY, V2016, P1; Bjugstad KB, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6974257; Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019; Colagar AH, 2013, IRAN RED CRESCENT ME, V15, P780, DOI 10.5812/ircmj.6409; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Copeland A, 2014, J AM WATER WORKS ASS, V106, pE10, DOI 10.5942/jawwa.2014.106.0002; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Doshi SB, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-109; Haghighian HK, 2015, FERTIL STERIL, V104, P318, DOI 10.1016/j.fertnstert.2015.05.014; Khosrowbeygi A, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-6; Ko EY, 2014, FERTIL STERIL, V102, P1518, DOI 10.1016/j.fertnstert.2014.10.020; Louis GMB, 2014, FERTIL STERIL, V101, P453, DOI 10.1016/j.fertnstert.2013.10.022; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2015, ELECTROANAL, V27, P2567, DOI 10.1002/elan.201500178; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI [10.1089/neu.2008.0816, 10.1089/neu.2008-0816]; Schmelke F. C., 1933, J AM WATER WORKS ASS, V25, P695; SHAPIRO HM, 1972, J SURG RES, V13, P138, DOI 10.1016/0022-4804(72)90057-1; Walczak-Jedrzejowska R, 2013, CENT EUR J UROL, V66, P60, DOI 10.5173/ceju.2013.01.art19; Wang C, 2014, FERTIL STERIL, V102, P1502, DOI 10.1016/j.fertnstert.2014.10.021; WHO, 2011, GUID DRINK WAT QUAL, P564; World Health Organization, 2010, WHO LAB MAN EX PROC; World Health Organization (WHO), 2006, GUID SAF RECR WAT EN, V2, P146; Wyrobek AJ, 1997, REPROD TOXICOL, V11, P243, DOI 10.1016/S0890-6238(96)00108-6; Zhi LZ, 2013, REDOX REP, V18, P63, DOI 10.1179/1351000213Y.0000000042	29	13	13	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-4569	1439-0272		ANDROLOGIA	Andrologia	MAR	2018	50	2							e12881	10.1111/and.12881			6	Andrology	Endocrinology & Metabolism	FW0PS	WOS:000424997800041	28771782				2021-06-18	
J	Gera, G; Chesnutt, J; Mancini, M; Horak, FB; King, LA				Gera, Geetanjali; Chesnutt, Jim; Mancini, Martina; Horak, Fay B.; King, Laurie A.			Inertial Sensor-Based Assessment of Central Sensory Integration for Balance After Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health System Research Symposium (MHSRS)	2016	FL				ERROR SCORING SYSTEM; VESTIBULAR CONSEQUENCES; BLAST EXPOSURE; CONCUSSION; ORGANIZATION; SENSITIVITY; DISORDERS; STABILITY; DIZZINESS; SYMPTOMS	Introduction: Optimal balance control requires a complex integration of sensory information from the visual, vestibular, and proprioceptive systems. The goal of this study is to determine if the instrumented modified Clinical Test of Sensory Integration and Balance (mCTSIB) was impaired acutely after mild traumatic brain injury (mTBI) when postural sway under varying sensory conditions was measured with a wearable inertial sensor. Materials and Methods: Postural sway was assessed in athletes who had sustained a mTBI within the past 2-3 d (n = 38) and control athletes (n = 81). Postural sway was quantified with a wearable inertial sensor (Opal; APDM, Inc.) during four varying sensory conditions of quiet stance: (1) eyes open (EO) firm surface, (2) eyes closed (EC) firm surface, (3) eyes open (EO) foam surface, and (4) eyes closed (EC) foam surface. Sensory reweighting deficits were computed by comparing the postural sway area in eyes closed versus eyes open conditions for firm and foam condition. Results: Postural sway was higher for mTBI compared with the control group during three of the four conditions of instrumented mCTSIB (EO firm, EC firm, and EC foam; p < 0.05). Sensory reweighting deficits were evident for mTBI individuals compared with control group on foam surface (EC firm vs EO firm; p < 0.05) and not on firm surface (EC firm vs EO firm; p = 0.63). Conclusions: The results from this study highlight the importance of detecting postural sway deficits during sensorimotor integration in mild TBI individuals.	[Gera, Geetanjali; Mancini, Martina; Horak, Fay B.; King, Laurie A.] Univ Kentucky, Dept Rehabil Sci, 900 South Limestone, Lexington, KY 40536 USA; [Chesnutt, Jim] Oregon Hlth & Sci Univ, Dept Orthoped & Rehabil, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Horak, Fay B.] Vet Affairs Portland Healthcare Syst, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA	Gera, G (corresponding author), Univ Kentucky, Dept Rehabil Sci, 900 South Limestone, Lexington, KY 40536 USA.				Oregon Clinical and Translational Research Institute from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH) [KL2TR000152]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [UL1TR000128, R21HD080398]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21HD080398] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000152, UL1TR000128] Funding Source: NIH RePORTER	This project was supported by the Oregon Clinical and Translational Research Institute (KL2TR000152) from the National Center for Advancing Translational Sciences at the National Institutes of Health (NIH); (UL1TR000128) and Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH under Award Number (R21HD080398).	Akin FW, 2017, BRAIN INJURY, V31, P1188, DOI 10.1080/02699052.2017.1288928; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Freeman L, 2017, J GERIATR PHYS THER; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Haran FJ, 2016, J NEUROTRAUM, V33, P705, DOI 10.1089/neu.2015.4060; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; King LA, 2012, J NEUROL PHYS THER, V36, P25, DOI 10.1097/NPT.0b013e31824620d1; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Neville C, 2015, MED DEVICES-EVID RES, V8, P447, DOI 10.2147/MDER.S91719; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Peterka Robert J, 2011, Front Neurol, V2, P57, DOI 10.3389/fneur.2011.00057; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wallmann HW, 2001, J GERONTOL A-BIOL, V56, pM580, DOI 10.1093/gerona/56.9.M580; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607	29	13	13	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2018	183			S			327	332		10.1093/milmed/usx162			6	Medicine, General & Internal	General & Internal Medicine	GC0JM	WOS:000429463600046	29635623	Green Published, Green Accepted, Bronze			2021-06-18	
J	Grassi, DC; da Conceicao, DM; Leite, CD; Andrade, CS				Grassi, Daphine Centola; da Conceicao, David Macedo; Leite, Claudia da Costa; Andrade, Celi Santos			Current contribution of diffusion tensor imaging in the evaluation of diffuse axonal injury	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						magnetic resonance imaging; diffusion tensor imaging; diffuse axonal injury; brain injuries; traumatic.	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE; SPATIAL STATISTICS; HEAD-INJURY; TRACTOGRAPHY; MRI; ABNORMALITIES; DEGENERATION; COEFFICIENT; PRINCIPLES	Traumatic brain injury (TBI) is the number one cause of death and morbidity among young adults. Moreover, survivors are frequently left with functional disabilities during the most productive years of their lives. One main aspect of TBI pathology is diffuse axonal injury, which is increasingly recognized due to its presence in 40% to 50% of all cases that require hospital admission. Diffuse axonal injury is defined as widespread axonal damage and is characterized by complete axotomy and secondary reactions due to overall axonopathy. These changes can be seen in neuroimaging studies as hemorrhagic focal areas and diffuse edema. However, the diffuse axonal injury findings are frequently under-recognized in conventional neuroimaging studies. In such scenarios, diffuse tensor imaging (DTI) plays an important role because it provides further information on white matter integrity that is not obtained with standard magnetic resonance imaging sequences. Extensive reviews concerning the physics of DTI and its use in the context of TBI patients have been published, but these issues are still hazy for many allied-health professionals. Herein, we aim to review the current contribution of diverse state-of-the-art DTI analytical methods to the understanding of diffuse axonal injury pathophysiology and prognosis, to serve as a quick reference for those interested in planning new studies and who are involved in the care of TBI victims. For this purpose, a comprehensive search in Pubmed was performed using the following keywords: "traumatic brain injury", "diffuse axonal injury", and "diffusion tensor imaging".	[Grassi, Daphine Centola; da Conceicao, David Macedo; Leite, Claudia da Costa; Andrade, Celi Santos] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, SP, Brazil	Grassi, DC (corresponding author), HCFMUSP, Dept Radiol, Div Ressonancia Magnet, Av Dr Eneas Carvalho Aguiar 255, BR-05403900 Sao Paulo, SP, Brazil.	daphinecgrassi@gmail.com			Sao Paulo Research Foundation - FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/18136-1, 2016/05547-6, 2017/17065-9]	Grants 2015/18136-1, 2016/05547-6 and 2017/17065-9 from Sao Paulo Research Foundation - FAPESP.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Vieira RDA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00178; Andrade AF, 1992, REV ASSOC MED BRAS, V55, P75, DOI [10.1590/S0104-42302009000100020, DOI 10.1590/S0104-42302009000100020]; Andrade CS, 2017, EVALUATION WHITE MAT, DOI [10.1594/ecr2017/C-0747, DOI 10.1594/ECR2017/C-0747]; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Brandstack N, 2013, RADIOLOGY, V267, P231, DOI 10.1148/radiol.12112570; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chen YJ, 2017, J NEUROIMAGING, V27, P272, DOI 10.1111/jon.12404; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Edlow BL, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-015-0525-8; Garin-Muga A, 2014, STUD HEALTH TECHNOL, V207, P27, DOI 10.3233/978-1-61499-474-9-27; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Karaarslan E, 2008, EUR J RADIOL, V65, P402, DOI 10.1016/j.ejrad.2007.04.023; Koch SBJ, 2017, J PSYCHIATR NEUROSCI, V42, P331, DOI 10.1503/jpn.160129; Le Bihan D, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002203, 10.1371/journal.pbio.1002246]; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Magnoni S, 2010, ARCH NEUROL-CHICAGO, V67, P1068, DOI 10.1001/archneurol.2010.214; Mechtler LL, 2014, NEUROL CLIN, V32, P31, DOI 10.1016/j.ncl.2013.08.002; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Nucifora PGP, 2007, RADIOLOGY, V245, P367, DOI 10.1148/radiol.2452060445; Ogura A, 2016, AM J ROENTGENOL, V207, P1239, DOI 10.2214/AJR.15.15945; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004	52	13	14	0	6	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	MAR	2018	76	3					189	199		10.1590/0004-282X20180007			11	Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	GB9UH	WOS:000429419000011	29809237	DOAJ Gold			2021-06-18	
J	Li, L; Yang, RL; Li, PJ; Lu, HL; Hao, JB; Li, LY; Tucker, D; Zhang, QG				Li, Lei; Yang, Rongli; Li, Pingjing; Lu, Hailong; Hao, Jingbo; Li, Liyan; Tucker, Donovan; Zhang, Quanguang			Combination Treatment with Methylene Blue and Hypothermia in Global Cerebral Ischemia	MOLECULAR NEUROBIOLOGY			English	Article						Methylene blue; Hypothermia; Combination treatment; Global cerebral ischemia; Neuroprotection; Learning and memory	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION; RAT HIPPOCAMPUS; FALCIPARUM-MALARIA; ENERGY-METABOLISM; MILD HYPOTHERMIA	Therapeutic hypothermia (TH) is the most potent therapeutic strategy for global cerebral ischemia (GCI), usually induced by cardiac arrest. TH has been shown both to suppress the delayed neuronal cell death in the vulnerable hippocampal CA1 subregion and to improve neurological outcomes in experimental animals after GCI. However, given the multiple adverse effects resulting from TH, application of such a therapy is typically limited. In recent years, methylene blue (MB) has emerged as a potential therapeutic drug for the treatment of neurodegenerative diseases. In this study, we investigated the beneficial effects of mild TH combined with MB treatment after GCI. We report that both the neuronal survival in the hippocampal CA1 region and the hippocampus-dependent spatial learning and memory in the combined treatment animals were enhanced compared to those in the single treatment animals. Mechanistic studies revealed that combined TH and MB treatment significantly attenuated mitochondrial dysfunction induced by GCI in the hippocampus CA1 region. The combined treatment also markedly suppressed GCI-induced reactive gliosis and inflammation and reduced oxidative stress while enhancing the antioxidant capacity of hippocampal CA1 neurons. Finally, combining TH and MB synergistically attenuated the intrinsic cytochrome c/caspase-3 apoptotic pathway induced by GCI. Our results suggest that TH and MB act synergistically to protect the ischemic brain and suppress cognitive impairment caused by GCI.	[Li, Lei; Yang, Rongli; Li, Pingjing; Lu, Hailong; Hao, Jingbo; Li, Liyan] Xuzhou Med Univ, Affiliated Hosp, Dept Geriatr, Xuzhou 221002, Jiangsu, Peoples R China; [Tucker, Donovan; Zhang, Quanguang] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120 15th St, Augusta, GA 30912 USA	Zhang, QG (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, 1120 15th St, Augusta, GA 30912 USA.	qzhang@augusta.edu			American Heart AssociationAmerican Heart Association [15GRNT25240004]; science and technology project of Xuzhou city, Jiangsu [KC15SH093]; National Institute of Neurological Disorders and Stroke, National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS086929]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086929] Funding Source: NIH RePORTER	This study was supported by Research Grant NS086929 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; an American Heart Association Grant-in-Aid 15GRNT25240004; and a science and technology project of Xuzhou city, Jiangsu (KC15SH093).	ABE K, 1995, STROKE, V26, P1478, DOI 10.1161/01.STR.26.8.1478; Ahmed ME, 2016, NEUROSCIENCE, V336, P39, DOI 10.1016/j.neuroscience.2016.08.036; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Briyal S, 2010, EUR J PHARMACOL, V644, P73, DOI 10.1016/j.ejphar.2010.06.071; CAFE C, 1994, NEUROCHEM RES, V19, P1551, DOI 10.1007/BF00969005; Cai LP, 2016, J NEUROSCI RES, V94, P749, DOI 10.1002/jnr.23740; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; D'Amico F, 2005, BIOTECH HISTOCHEM, V80, P207, DOI 10.1080/10520290600560897; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Dave KR, 2001, J CEREBR BLOOD F MET, V21, P1401, DOI 10.1097/00004647-200112000-00004; Deng G, 2014, J NEUROSCI METH, V222, P34, DOI 10.1016/j.jneumeth.2013.10.015; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dormoi J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-127; Fang Q, 2016, ACTA NEUROCHIR SUPPL, V121, P227, DOI 10.1007/978-3-319-18497-5_41; FLOYD RA, 1992, ANN NEUROL, V32, pS22, DOI 10.1002/ana.410320706; Gillman PK, 2006, ANAESTHESIA, V61, P1013, DOI 10.1111/j.1365-2044.2006.04808.x; Ginimuge Prashant R, 2010, J Anaesthesiol Clin Pharmacol, V26, P517; Gong P, 2013, J CEREBR BLOOD F MET, V33, P928, DOI 10.1038/jcbfm.2013.33; Green SP, 2001, J CEREBR BLOOD F MET, V21, P374, DOI 10.1097/00004647-200104000-00006; Guerra-Wallace MM, 2013, PEDIATR CRIT CARE ME, V14, pE143, DOI 10.1097/PCC.0b013e3182720440; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Ji XM, 2007, FRONT BIOSCI, V12, P1737, DOI 10.2741/2185; Jiang Zhao, 2016, Brain Circ, V2, P48; KARIBE H, 1994, BRAIN RES, V649, P12, DOI 10.1016/0006-8993(94)91043-X; KENNEDY C, 1957, J CLIN INVEST, V36, P1130, DOI 10.1172/JCI103509; Kim YM, 2012, RESUSCITATION, V83, P188, DOI 10.1016/j.resuscitation.2011.07.031; Li PA, 2000, EXP NEUROL, V165, P153, DOI 10.1006/exnr.2000.7459; Lipton P, 1999, PHYSIOL REV, V79, P1431; Lu Q, 2016, MOL NEUROBIOL, V53, P5344, DOI 10.1007/s12035-015-9455-0; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; Madden LK, 2015, J NEUROSCI NURS, V47, P190, DOI 10.1097/JNN.0000000000000142; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Nolan Jerry P, 2010, Int Emerg Nurs, V18, P8, DOI 10.1016/j.ienj.2009.07.001; Oh JS, 2013, AM J EMERG MED, V31, P154, DOI 10.1016/j.ajem.2012.06.033; Ostadal P, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-124; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Racay P, 2009, NEUROCHEM RES, V34, P1469, DOI 10.1007/s11064-009-9934-7; Ramirez Rivera Jose, 2006, Bol Asoc Med P R, V98, P118; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rodriguez P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.478; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Shankaran S, 2012, CURR TREAT OPTION NE, V14, P608, DOI [10.1007/s11940-012-0200-y, 10.1097/MOP.0000000000000199]; SIMS NR, 1992, NEUROCHEM RES, V17, P923, DOI 10.1007/BF00993269; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Sunde K, 2013, REV ESP CARDIOL, V66, P346, DOI 10.1016/j.rec.2012.10.004; Tardivo JP, 2005, PHOTODIAGN PHOTODYN, V2, P175, DOI 10.1016/S1572-1000(05)00097-9; Toader Alina-Mihaela, 2013, Clujul Med, V86, P203; Urrutia PJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00038; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; VINCER MJ, 1987, CAN MED ASSOC J, V136, P503; Weitzdoerfer R, 2004, SEMIN PERINATOL, V28, P249, DOI 10.1053/j.semperi.2004.08.001; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Witte ME, 2010, MITOCHONDRION, V10, P411, DOI 10.1016/j.mito.2010.05.014; Wolman RL, 1999, STROKE, V30, P514, DOI 10.1161/01.STR.30.3.514; Xu CH, 2016, MOL CLIN ONCOL, V5, P279, DOI 10.3892/mco.2016.913; Yang SH, 2017, PROG NEUROBIOL, V157, P273, DOI 10.1016/j.pneurobio.2015.10.005; Zhang H, 2008, NEUROL RES, V30, P332, DOI 10.1179/174313208X300279; Zhang H, 2011, CHINESE MED J-PEKING, V124, P2764, DOI 10.3760/cma.j.issn.0366-6999.2011.17.035; Zhang QG, 2013, BRAIN, V136, P1432, DOI 10.1093/brain/awt046; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhao MY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122078; Zoungrana A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001630	69	13	13	1	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2018	55	3					2042	2055		10.1007/s12035-017-0470-1			14	Neurosciences	Neurosciences & Neurology	FY5TG	WOS:000426897800019	28271403				2021-06-18	
J	Xu, Z; Wang, W; Ren, YT; Zhang, WC; Fang, PL; Huang, LF; Wang, X; Shi, P				Xu, Zhen; Wang, Wei; Ren, Yutian; Zhang, Wenchong; Fang, Peilin; Huang, Linfeng; Wang, Xin; Shi, Peng			Regeneration of cortical tissue from brain injury by implantation of defined molecular gradient of semaphorin 3A	BIOMATERIALS			English	Article						Tissue engineering; Molecular gradient; Brain regeneration; Chemotaxis; Semaphorin	NEURAL STEM-CELLS; GROWTH-FACTOR; SPINAL-CORD; MIGRATION; ISCHEMIA; TRANSPLANTATION; PROLIFERATION; NEUROGENESIS; MECHANISMS; SCAFFOLDS	Despite great efforts in the exploration of therapeutic strategies for treating brain injuries, it is still challenging to regenerate neural tissues and to restore the lost function within an injured brain. In this report, we employed a tissue engineering approach to regenerate cortical tissue from brain injury by implantation of defined semaphorin 3A (Sema3A) gradient packaged in a hydrogel based device. Over a thirty-day recovery period, the implanted Sema3A gradient was sufficient to induce substantial migration of neural progenitor cells to the hydrogel and to promote differentiation of these cells for neuroregeneration at the injury site. As revealed by molecular characterization and RNA transcriptome analysis, the regenerated tissues induced by Sema3A gradient exhibited significant similarity to normal cortical tissues. Many genes associated with neuronal migration and stem cell differentiation were significantly up-regulated. In addition, our result suggested a crosstalk between Sema3A and Wnt/beta-catenin pathways in course of induced brain regeneration. This study demonstrated an innovative strategy to regenerate brain tissue after traumatic injury by controlling the in vivo chemotactic environment with unprecedented sophistication, and also resolved new insights about Sema3A's role in adult neurogenesis. (C) 2017 Elsevier Ltd. All rights reserved.	[Xu, Zhen; Zhang, Wenchong; Fang, Peilin; Shi, Peng] City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China; [Wang, Wei; Ren, Yutian; Huang, Linfeng; Wang, Xin] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Huang, Linfeng; Shi, Peng] City Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518000, Guangdong, Peoples R China	Shi, P (corresponding author), City Univ Hong Kong, Dept Mech & Biomed Engn, Kowloon, Hong Kong, Peoples R China.	pengshi@cityu.edu.hk		Huang, Linfeng/0000-0002-0322-4929; SHI, Peng/0000-0003-0629-4161	General Research Fund from RGC Hong Kong SAR [GRF11278616, GRF11218015, GRF11211314]; Health and Medical Research Fund from the Food and Health Bureau of Hong Kong SAR [HMRF 03141146]; Collaborative Research Fund from RGC Hong Kong SAR [C5015-15G, C1014-15G]	This work was support by General Research Fund from RGC Hong Kong SAR (GRF11278616, GRF11218015, GRF11211314), Health and Medical Research Fund from the Food and Health Bureau of Hong Kong SAR (HMRF 03141146), and also by Collaborative Research Fund from RGC Hong Kong SAR (C5015-15G, C1014-15G).	Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Boyd AS, 2005, ADV DRUG DELIVER REV, V57, P1944, DOI 10.1016/j.addr.2005.08.004; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Cooper JA, 2013, J CELL BIOL, V202, P725, DOI 10.1083/jcb.201305021; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Drive G., 2009, NAT REV NEUROSCI, V10, P682; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hakanen J, 2011, DEV BIOL, V355, P101, DOI 10.1016/j.ydbio.2011.04.016; Hou ST, 2015, SCI REP-UK, V5, DOI 10.1038/srep07890; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; Kolodkin Alex L, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001727; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Larpthaveesarp A, 2015, BRAIN SCI, V5, P165, DOI 10.3390/brainsci5020165; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031; Li SL, 2010, NAT NEUROSCI, V13, P1496, DOI 10.1038/nn.2674; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Lu HY, 2012, STROKE, V43, P838, DOI 10.1161/STROKEAHA.111.635235; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Majed HH, 2006, J NEUROSCI, V26, P1730, DOI 10.1523/JNEUROSCI.0702-05.2006; Marin O, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001834; Niu WZ, 2011, J NEUROSCI, V31, P13816, DOI 10.1523/JNEUROSCI.1038-11.2011; Polleux F, 2000, NATURE, V404, P567; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Scafidi J, 2014, NATURE, V506, P230, DOI 10.1038/nature12880; Teramoto T, 2003, J CLIN INVEST, V111, P1125, DOI 10.1172/JCI200317170; Titomanlio L, 2011, ANN NEUROL, V70, P698, DOI 10.1002/ana.22518; Torisawa YS, 2014, NAT METHODS, V11, P663, DOI [10.1038/NMETH.2938, 10.1038/nmeth.2938]; Vulic K, 2014, BIOMACROMOLECULES, V15, P3867, DOI 10.1021/bm501084u; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998	37	13	15	3	57	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0142-9612	1878-5905		BIOMATERIALS	Biomaterials	MAR	2018	157						125	135		10.1016/j.biomaterials.2017.12.010			11	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	FS1LZ	WOS:000419538800011	29268143				2021-06-18	
J	Bargellesi, S; Cavasin, L; Scarponi, F; De Tanti, A; Bonaiuti, D; Bartolo, M; Boldrini, P; Estraneo, A				Bargellesi, Stefano; Cavasin, Luisa; Scarponi, Federico; De Tanti, Antonio; Bonaiuti, Donatella; Bartolo, Michelangelo; Boldrini, Paolo; Estraneo, Anna		Heterotopic Ossification Cross	Occurrence and predictive factors of heterotopic ossification in severe acquired brain injured patients during rehabilitation stay: cross-sectional survey	CLINICAL REHABILITATION			English	Article						Heterotopic ossification; rehabilitation; severe acquired brain injury	DISABILITY RATING-SCALE; RISK-FACTORS; SPINAL-CORD; CARE-UNIT; RELIABILITY; CONSENSUS; RECOVERY; COMA	Objectives: To report occurrence and identify patient's features and risk factors of heterotopic ossifications in patients with severe acquired brain injury in intensive rehabilitation centres. Design: Multicentre cross-sectional survey. Setting: A total of 48 severe acquired brain injury rehabilitation institutes. Participants: Traumatic and non-traumatic severe brain-injured patients (N = 689) in rehabilitation centres on 28 May 2016. Main Outcome Measure: Occurrence of heterotopic ossifications diagnosed by standard radiological and/or sonographic evaluation on the basis of clinical suspicion. Results: Heterotopic ossification occurred around one or more joints in 94/689 patients (13.6%) with a significantly higher prevalence in young males. Occurrence did not significantly differ in relation to aetiology (16.3% traumatic, 19.2% anoxic, 11.7% vascular and 11.5% other). Prevalence was significantly higher in patients with diffuse (23.3%) rather than focal brain lesions (12.4%) or unspecified lesions (11.2%; chi-square = 7.81, df = 2, P = 0.020); longer duration of coma (P = 0.0016) and ventilation support (P = 0.0145); paroxysmal sympathetic hyperactivity (22.6% versus 11.6%; chi-square = 10.81, df = 1, P = 0.001); and spasticity (22.7% versus 10.1%; chi-square = 18.63, df = 1, P < 0.0001). A longer interval between acute brain injury and admission to rehabilitation centre was significantly associated with higher frequency of heterotopic ossifications. Conclusion: Occurrence of heterotopic ossifications is frequent in patients with severe traumatic and non-traumatic brain-injury in rehabilitation centres. Our study confirms male gender, young age, paroxysmal sympathetic hyperactivity, spasticity, longer duration of coma and ventilation and longer interval between brain injury onset and admission to rehabilitation centre as possible risk factors. Further studies are necessary to investigate the role of early appropriate rehabilitation pathways to reduce occurrence of heterotopic ossifications.	[Bargellesi, Stefano] Ca Foncello Hosp, Severe Brain Injuries Rehabil Unit, Phys Med & Rehabil, Piazza Osped 1, I-31100 Treviso, Italy; [Cavasin, Luisa] Univ Padua, Sch Phys Med & Rehabil, Padua, Italy; [Scarponi, Federico] San Giovanni Battista Hosp, Severe Brain Injuries Rehabil Unit, Foligno, Italy; [De Tanti, Antonio] Santo Stefano Rehabil Inst, Severe Brain Injuries Rehabil Unit, Cardinal Ferrari Rehabil Ctr, Fontanellato, Italy; [Bonaiuti, Donatella] San Gerardo Hosp, Phys Med & Rehabil Unit, Monza, Italy; [Bartolo, Michelangelo] Habilita Inst, Rehabil Dept, Severe Brain Injuries Rehabil Unit, Bergamo, Italy; [Boldrini, Paolo] Azienda ULSS 2, Rehabil Dept, Treviso, Italy; [Boldrini, Paolo] Italian Soc Phys Med & Rehabil SIMFER, Treviso, Italy; [Estraneo, Anna] ICS Maugeri, Neurorehabil Unit, Telese Terme, Italy; [Estraneo, Anna] ICS Maugeri, Res Lab Disorder Consciousness, Telese Terme, Italy	Bargellesi, S (corresponding author), Ca Foncello Hosp, Severe Brain Injuries Rehabil Unit, Phys Med & Rehabil, Piazza Osped 1, I-31100 Treviso, Italy.	stefano.bargellesi@aulss2.veneto.it	mandala, giorgio/AAC-1842-2019; Antenucci, Roberto/AAA-8195-2020; Scarponi, Federico/K-5714-2018	mandala, giorgio/0000-0002-4384-8672; Antenucci, Roberto/0000-0002-7205-8995; Sant'Angelo, Antonino/0000-0001-9972-3679; Scarponi, Federico/0000-0001-9683-8104			Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bartolo M, 2016, EUR J PHYS REHAB MED, V52, P90; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Cameron S, 2015, J CRIT CARE, V30, P664, DOI 10.1016/j.jcrc.2015.03.032; Castro-Avila AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130722; Citak M, 2012, SPINE, V37, P1953, DOI 10.1097/BRS.0b013e31825ee81b; Davies OG, 2015, CALCIFIED TISSUE INT, V97, P432, DOI 10.1007/s00223-015-0034-1; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Gennarelli T A, 1988, Brain Inj, V2, P175, DOI 10.3109/02699058809150942; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Ivanhoe CB, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P385; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Ozcakar L, 2013, AM J PHYS MED REHAB, V92, P805, DOI 10.1097/PHM.0b013e3182971269; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Ranganathan K, 2015, PLAST RECONSTR SURG, V135, P1631, DOI 10.1097/PRS.0000000000001266; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Taricco M, 2000, EURA MEDICOPHYS, V42, P73; TEASDALE G, 1974, LANCET, V2, P81; Teasell R, 2014, HETEROTOPIC OSSIFICA, V11; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; WATANABE TK, 2001, PHYS MED REHABILITAT, V15, P283; Winkler S, 2015, INT ORTHOP, V39, P2495, DOI 10.1007/s00264-015-2995-0; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215	34	13	13	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2018	32	2					255	262		10.1177/0269215517723161			8	Rehabilitation	Rehabilitation	FX3XB	WOS:000426004700013	28805078				2021-06-18	
J	Boer, C; Bossers, SM; Koning, NJ				Boer, C.; Bossers, S. M.; Koning, N. J.			Choice of fluid type: physiological concepts and perioperative indications	BRITISH JOURNAL OF ANAESTHESIA			English	Article						colloids; fluid therapy; surgical procedures	RANDOMIZED-CONTROLLED-TRIAL; HYDROXYETHYL STARCH 130/0.4; LACTATED RINGERS SOLUTION; TRAUMATIC BRAIN-INJURY; VOLUME REPLACEMENT THERAPY; ACUTE KIDNEY INJURY; ACID-BASE-BALANCE; DONOR LIVER-TRANSPLANTATION; CARDIAC-SURGERY PATIENTS; CRITICALLY-ILL PATIENTS	The consensus that i.v. resuscitation fluids should be considered as drugs with specific dose recommendations, contraindications, and side-effects has led to an increased attention for the choice of fluid during perioperative care. In particular, the debate concerning possible adverse effects of unbalanced fluids and hydroxyethyl starches resulted in a re-evaluation of the roles of different fluid types in the perioperative setting. This review provides a concise overview of the current knowledge regarding the efficacy and safety of distinct fluid types for perioperative use. First, basic physiological aspects and possible side-effects are explained. Second, we focus on considerations regarding fluid choice for specific perioperative indications based on an analysis of available randomized controlled trials.	[Boer, C.; Bossers, S. M.; Koning, N. J.] Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Anaesthesiol, Amsterdam, Netherlands	Boer, C (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Cardiovasc Sci, Dept Anaesthesiol, Amsterdam, Netherlands.	c.boer@vumc.nl	Bossers, Sebastiaan/AAE-1085-2020	Bossers, Sebastiaan/0000-0002-2396-2777; Boer, Christa/0000-0002-7781-6951	Department of Anaesthesiology, VU University Medical Center	Department of Anaesthesiology, VU University Medical Center.	Abdallah E, 2014, INT UROL NEPHROL, V46, P2221, DOI 10.1007/s11255-014-0785-z; Ahn HJ, 2008, ANAESTHESIA, V63, P235, DOI 10.1111/j.1365-2044.2007.05345.x; Ando Y, 2008, J ANESTH, V22, P391, DOI 10.1007/s00540-008-0659-6; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; Atasever B, 2012, TRANSFUSION, V52, P2452, DOI 10.1111/j.1537-2995.2012.03802.x; Awad S, 2008, CLIN NUTR, V27, P179, DOI 10.1016/j.clnu.2008.01.008; Base EM, 2011, J CARDIOTHOR VASC AN, V25, P407, DOI 10.1053/j.jvca.2010.12.005; Becker BF, 2015, BRIT J CLIN PHARMACO, V80, P389, DOI 10.1111/bcp.12629; Bethlehem Irene, 2014, J Extra Corpor Technol, V46, P293; Bouwman RA, 2012, BRIT J ANAESTH, V109, P299, DOI 10.1093/bja/aes277; Brandstrup B, 2003, ANN SURG, V238, P641, DOI 10.1097/01.sla.0000094387.50865.23; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Cabrales P, 2005, SHOCK, V24, P66, DOI 10.1097/01.shk.0000167111.80753.ef; Cabrales P, 2004, AM J PHYSIOL-HEART C, V287, pH363, DOI 10.1152/ajpheart.01039.2003; Cabrales P, 2008, RESUSCITATION, V77, P379, DOI 10.1016/j.resuscitation.2008.01.008; Chappell D, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0538-5; Chappell D, 2014, BEST PRACT RES-CLIN, V28, P227, DOI 10.1016/j.bpa.2014.06.003; Chen G, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0088-6; Cho JE, 2014, YONSEI MED J, V55, P625, DOI 10.3349/ymj.2014.55.3.625; Cortes DO, 2014, BRIT J ANAESTH, V112, P968, DOI 10.1093/bja/aeu047; de Crescenzo C, 2017, J TRAUMA ACUTE CARE, V82, P956, DOI 10.1097/TA.0000000000001409; Delano MJ, 2015, SHOCK, V44, P25, DOI 10.1097/SHK.0000000000000368; Demir A, 2015, TRANSPL P, V47, P1883, DOI 10.1016/j.transproceed.2015.05.015; Disma N, 2014, PEDIATR ANESTH, V24, P980, DOI 10.1111/pan.12439; Doherty M, 2012, BRIT J ANAESTH, V109, P69, DOI 10.1093/bja/aes171; Ertmer C, 2014, CRIT CARE, V18, DOI 10.1186/cc13764; Feldheiser A, 2013, BRIT J ANAESTH, V110, P231, DOI 10.1093/bja/aes377; Fenger-Eriksen C, 2009, J THROMB HAEMOST, V7, P1099, DOI 10.1111/j.1538-7836.2009.03460.x; Futier E, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1085-3; Gan TJ, 1999, ANESTH ANALG, V88, P992, DOI 10.1097/00000539-199905000-00005; Gandhi SD, 2007, ANESTHESIOLOGY, V106, P1120, DOI 10.1097/01.anes.0000265422.07864.37; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Gillies MA, 2014, BRIT J ANAESTH, V112, P25, DOI 10.1093/bja/aet303; Godet G, 2008, EUR J ANAESTH, V25, P986, DOI 10.1017/S026502150800447X; Hadimioglu N, 2008, ANESTH ANALG, V107, P264, DOI 10.1213/ane.0b013e3181732d64; Hafizah M, 2017, J NEUROSURG SCI, V61, P263, DOI 10.23736/S0390-5616.16.03221-5; Hanart C, 2009, CRIT CARE MED, V37, P696, DOI 10.1097/CCM.0b013e3181958c81; Hartmann AF, 1932, J CLIN INVEST, V11, P327, DOI 10.1172/JCI100414; Helmy A, 2016, J CLIN ANESTH, V32, P267, DOI 10.1016/j.jclinane.2016.01.025; Iriz E, 2005, ANN THORAC SURG, V79, P666, DOI 10.1016/j.athoracsur.2004.08.002; Jacob M, 2003, ANAESTHESIST, V52, P896, DOI 10.1007/s00101-003-0557-0; Jacob M, 2006, ANESTHESIOLOGY, V104, P1223, DOI 10.1097/00000542-200606000-00018; Jacob M, 2012, CRIT CARE, V16, DOI 10.1186/cc11344; Kammerer T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0866-z; Kancir ASP, 2015, ANESTH ANALG, V120, P608, DOI 10.1213/ANE.0000000000000596; Kancir ASP, 2014, ANESTHESIOLOGY, V121, P948, DOI 10.1097/ALN.0000000000000413; Kasper SM, 2003, ANESTHESIOLOGY, V99, P42, DOI 10.1097/00000542-200307000-00010; Khajavi MR, 2008, RENAL FAILURE, V30, P535, DOI 10.1080/08860220802064770; Kim SY, 2013, TRANSPL P, V45, P2191, DOI 10.1016/j.transproceed.2013.02.124; Kim TK, 2017, ANAESTHESIA, V72, P204, DOI 10.1111/anae.13642; Kimenai DM, 2013, PERFUSION-UK, V28, P512, DOI 10.1177/0267659113491446; Krajewski ML, 2015, BRIT J SURG, V102, P24, DOI 10.1002/bjs.9651; Kuitunen AH, 2004, ANESTH ANALG, V98, P291, DOI 10.1213/01.ANE.0000096006.60716.F6; Lancaster TS, 2016, ANN THORAC SURG, V102, pE77, DOI 10.1016/j.athoracsur.2016.02.070; Lavu H, 2014, ANN SURG, V260, P445, DOI 10.1097/SLA.0000000000000872; Lee JS, 2011, CIRC J, V75, P2397, DOI 10.1253/circj.CJ-11-0404; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Lindroos ACB, 2013, ACTA ANAESTH SCAND, V57, P729, DOI 10.1111/aas.12105; Lindroos AC, 2014, J ANESTH, V28, P189, DOI 10.1007/s00540-013-1711-8; Loffel LM, 2016, ANESTHESIOLOGY, V125, P678, DOI 10.1097/ALN.0000000000001238; Mahmood A, 2007, BRIT J SURG, V94, P427, DOI 10.1002/bjs.5726; Martin G, 2002, J CARDIOTHOR VASC AN, V16, P441, DOI 10.1053/jcan.2002.125146; McCluskey SA, 2013, ANESTH ANALG, V117, P412, DOI 10.1213/ANE.0b013e318293d81e; McLean DJ, 2018, BRIT J ANAESTH, V120, P397, DOI 10.1016/j.bja.2017.11.090; Mercier FJ, 2014, BRIT J ANAESTH, V113, P459, DOI 10.1093/bja/aeu103; Meybohm P, 2013, CRIT CARE, V17, DOI 10.1186/cc12845; Miao N, 2014, PERFUSION-UK, V29, P462, DOI 10.1177/0267659114528267; Mukhtar A, 2009, ANESTH ANALG, V109, P924, DOI 10.1213/ane.0b013e3181aed54f; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Myles PS, 2017, WORLD J SURG, V41, P2457, DOI 10.1007/s00268-017-4055-y; Naumann DN, 2016, SHOCK, V46, P609, DOI 10.1097/SHK.0000000000000687; Nelson Axel, 2016, Intensive Care Med Exp, V4, P6, DOI 10.1186/s40635-016-0080-7; Niemi TT, 2005, ACTA ANAESTH SCAND, V49, P373, DOI 10.1111/j.1399-6576.2005.00619.x; O'Malley CMN, 2005, ANESTH ANALG, V100, P1518, DOI 10.1213/01.ANE.0000150939.28904.81; Paul M, 2003, PAEDIATR ANAESTH, V13, P603, DOI 10.1046/j.1460-9592.2003.01113.x; Paut O, 2002, BRIT J ANAESTH, V88, P277, DOI 10.1093/bja/88.2.277; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Potura E, 2015, ANESTH ANALG, V120, P123, DOI 10.1213/ANE.0000000000000419; Powell M, 2014, INT J OBSTET ANESTH, V23, P330, DOI 10.1016/j.ijoa.2014.06.001; RACKOW EC, 1977, CHEST, V72, P709, DOI 10.1378/chest.72.6.709; Raiman M, 2016, EUR J ANAESTH, V33, P42, DOI 10.1097/EJA.0000000000000328; Rasmussen KC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002720; Rasmussen KC, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0162-1; Rasmussen KC, 2014, ANN SURG, V259, P249, DOI 10.1097/SLA.0000000000000267; Reddy S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1217-5; Rehm M, 2000, ANESTHESIOLOGY, V92, P657, DOI 10.1097/00000542-200003000-00008; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rex S, 2006, EUR J ANAESTH, V23, P1, DOI 10.1017/S0265021505001687; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Riddez L, 1997, CRIT CARE MED, V25, P635, DOI 10.1097/00003246-199704000-00013; Ringer S., 1882, J PHYSL, V3, p[195, 6]; Ross SW, 2015, J TRAUMA ACUTE CARE, V79, P732, DOI 10.1097/TA.0000000000000833; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Sadan O, 2017, CRIT CARE MED, V45, P1382, DOI 10.1097/CCM.0000000000002497; Schramko A, 2015, PERFUSION-UK, V30, P224, DOI 10.1177/0267659114540022; Schramko A, 2010, BRIT J ANAESTH, V104, P691, DOI 10.1093/bja/aeq084; Shao LJZ, 2013, CLINICS, V68, P323, DOI 10.6061/clinics/2013(03)OA07; Shaw AD, 2012, ANN SURG, V255, P821, DOI 10.1097/SLA.0b013e31825074f5; Sirvinskas E, 2007, PERFUSION-UK, V22, P121, DOI 10.1177/0267659107078484; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Standl T, 2008, EUR J ANAESTH, V25, P437, DOI 10.1017/S0265021508003888; Starling E H, 1896, J Physiol, V19, P312; Tamayo E, 2008, ACTA ANAESTH SCAND, V52, P1204, DOI 10.1111/j.1399-6576.2008.01758.x; Terkawi AS, 2016, J ANESTH, V30, P796, DOI 10.1007/s00540-016-2208-z; Tiryakioglu O, 2008, J CARDIOTHORAC SURG, V3, DOI 10.1186/1749-8090-3-45; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Van der Linden P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0830-z; Van der Linden P, 2013, ANESTHESIOLOGY, V119, P1296, DOI 10.1097/ALN.0b013e3182a6b387; Van der Linden PJ, 2005, ANESTH ANALG, V101, P629, DOI 10.1213/01.ANE.0000175216.53374.27; Van Regenmortel N, 2017, BRIT J ANAESTH, V118, P892, DOI 10.1093/bja/aex118; Villela NR, 2009, CURR OPIN ANESTHESIO, V22, P163, DOI 10.1097/ACO.0b013e328328d304; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Weinberg L, 2017, BRIT J ANAESTH, V119, P606, DOI 10.1093/bja/aex163; Weinberg L, 2015, MINERVA ANESTESIOL, V81, P1288; Wettstein R, 2003, CRIT CARE MED, V31, P1824, DOI 10.1097/01.CCM.0000069340.16319.F2; Witt L, 2008, PEDIATR ANESTH, V18, P934, DOI 10.1111/j.1460-9592.2008.02756.x; Woodcock TE, 2012, BRIT J ANAESTH, V108, P384, DOI 10.1093/bja/aer515; Yates DRA, 2014, BRIT J ANAESTH, V112, P281, DOI 10.1093/bja/aet307; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Zausig YA, 2013, CRIT CARE, V17, DOI 10.1186/cc12898; Zazzeron L, 2016, CURR OPIN CRIT CARE, V22, P428, DOI 10.1097/MCC.0000000000000341	122	13	15	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	FEB	2018	120	2					384	396		10.1016/j.bja.2017.10.022			13	Anesthesiology	Anesthesiology	GM5OI	WOS:000438189100022	29406187	Bronze			2021-06-18	
J	Cheever, KM; McDevitt, J; Tierney, R; Wright, WG				Cheever, Kelly M.; McDevitt, Jane; Tierney, Ryan; Wright, W. Geoffrey			Concussion Recovery Phase Affects Vestibular and Oculomotor Symptom Provocation	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						near point convergence; optokinetic stimulation; concussion; vestibular; balance	SPORTS-RELATED CONCUSSION; EXERTIONAL HEAT ILLNESS; FOOTBALL PLAYERS; POSTURAL CONTROL; INJURY; ASSESSMENTS; DIZZINESS; MANAGEMENT; STATEMENT; POSITION	Vestibular and oculomotor testing is emerging as a valuable assessment in sport-related concussion (SRC). However, their usefulness for tracking recovery and guiding return-to-play decisions remains unclear. Therefore the purpose of this study was to evaluate their clinical usefulness for tracking SRC recovery. Vestibular and oculomotor assessments were used to measure symptom provocation in an acute group (n=21) concussed10 days, prolonged symptoms group (n=10) concussed 16 days (median=84 days), healthy group (n=58) no concussions in >6 months. Known-groups approach was used with three groups at three time points (initial, 2-week and 6-week follow-up). Provoked symptoms for Gaze-Stabilization (GST), Rapid Eye Horizontal (REH), Optokinetic Stimulation (OKS), Smooth-Pursuit Slow (SPS) and Fast (SPF) tests, total combined symptoms scores and near point convergence (NPC) distance were significantly greater at initial assessment in both injury groups compared to controls. Injury groups improved on the King-Devick test and combined symptom provocation scores across time. The acute group improved over time on REH and SPF tests, while the prolonged symptoms group improved on OKS. A regression model (REH, OKS, GST) was 90% accurate discriminating concussed from healthy. Vestibular and ocular motor tests give valuable insight during recovery. They can prove beneficial in concussion evaluation given the modest equipment, training and time requirements. The current study demonstrates that when combined, vestibular and oculomotor clinical tests aid in the detection of deficits following a SRC. Additionally, tests such as NPC, GST, REH, SPS, SPF OKS and KD provide valuable information to clinicians throughout the recovery process and may aid in return to play decisions.	[Cheever, Kelly M.; McDevitt, Jane; Tierney, Ryan] Temple Univ, Kinesiol, Philadelphia, PA 19122 USA; [Tierney, Ryan; Wright, W. Geoffrey] Temple Univ, Neuromotor Sci Program, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey] Temple Univ, Phys Therapy, 1301 Cecil B Moore Ave, Philadelphia, PA 19122 USA	Wright, WG (corresponding author), Temple Univ, Phys Therapy, 1301 Cecil B Moore Ave, Philadelphia, PA 19122 USA.	wrightw@temple.edu					Alosco ML, 2012, INT J ATHL THER TRAI, V17, P22, DOI 10.1123/ijatt.17.5.22; Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Eichner ER, 2007, J SPORT REHABIL, V16, P197, DOI 10.1123/jsr.16.3.197; Eichner ER, 1998, INT J SPORTS MED, V19, pS150, DOI 10.1055/s-2007-971983; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Field A., 1998, BRIT PSYCHOL SOC MAT, V6, P13; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; VANDIE GC, 1986, BRAIN RES, V383, P185, DOI 10.1016/0006-8993(86)90019-3; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; Wright WG, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P72, DOI 10.1109/ICVR.2015.7358591; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	38	13	13	0	13	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	FEB	2018	39	2					141	147		10.1055/s-0043-118339			7	Sport Sciences	Sport Sciences	FU8YH	WOS:000424142000009	29190849	Bronze			2021-06-18	
J	de la Tremblaye, PB; O'Neil, DA; LaPorte, MJ; Cheng, JP; Beitchman, JA; Thomas, TC; Bondi, CO; Kline, AE				de la Tremblaye, Patricia B.; O'Neil, Darik A.; LaPorte, Megan J.; Cheng, Jeffrey P.; Beitchman, Joshua A.; Thomas, Theresa Currier; Bondi, Corina O.; Kline, Anthony E.			Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation	NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS			English	Article; Proceedings Paper	Meeting of the International-Behavioral-Neuroscience-Society (IBNS)	JUN 07-12, 2016	Budapest, HUNGARY	Int Behav Neuroscience Soc		Antiepileptic drugs (AEDs); Antipsychotic drugs (APDs); Controlled cortical impact (CCI); Endocannabinoids; Executive function; Fluid percussion (FP) injury; Morris water maze (MWM); Rehabilitation; Stress; Traumatic brain injury (TBI)	CONTROLLED CORTICAL IMPACT; CLOSED-HEAD-INJURY; CORTICOTROPIN-RELEASING HORMONE; COGNITIVE-BEHAVIORAL PREVENTION; DEPRESSIVE-LIKE BEHAVIOR; GATED SODIUM-CHANNELS; OF-THE-LITERATURE; ENVIRONMENTAL ENRICHMENT; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR	The aim of this review is to discuss the research presented in a symposium entitled "Current Progress in characterizing therapeutic strategies and challenges in experimental CNS injury" which was presented at the 2016 International Behavioral Neuroscience Society annual meeting. Herein we discuss diffuse and focal traumatic brain injury (TBI) and ensuing chronic behavioral deficits as well as potential rehabilitative approaches. We also discuss the effects of stress on executive function after TBI as well as the response of the endocrine system and regulatory feedback mechanisms. The role of the endocannabinoids after CNS injury is also discussed. Finally, we conclude with a discussion of antipsychotic and antiepileptic drugs, which are provided to control TBI-induced agitation and seizures, respectively. The review consists predominantly of published data.	[de la Tremblaye, Patricia B.; O'Neil, Darik A.; LaPorte, Megan J.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15224 USA; [de la Tremblaye, Patricia B.; O'Neil, Darik A.; LaPorte, Megan J.; Cheng, Jeffrey P.; Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15224 USA; [Bondi, Corina O.; Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15224 USA; [Kline, Anthony E.] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15224 USA; [Bondi, Corina O.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15224 USA; [Beitchman, Joshua A.; Thomas, Theresa Currier] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Beitchman, Joshua A.; Thomas, Theresa Currier] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ USA; [Thomas, Theresa Currier] Phoenix VA Healthcare Syst, Phoenix, AZ USA; [Beitchman, Joshua A.] Midwestern Univ, Glendale, AZ USA	Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Sch Med,Phys Med & Rehabil, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, John G Rangos Res Ctr, Sch Med,Safar Ctr Resuscitat Res, Room 6126,4401 Penn Ave, Pittsburgh, PA 15224 USA.	klineae@upmc.edu	Thomas, Theresa Currier/K-1979-2019	Thomas, Theresa Currier/0000-0002-9619-7666	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; Arizona Biomedical Research Commission through Arizona Department of Health Services [ADHS14-00003606]; Valley Research Partnership Awards [P2201607, P1201607]; Phoenix Children's Hospital Mission Support Funds; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967, R03NS094950, R21NS099683, T32NS086749, R01NS060005, R21NS099674] Funding Source: NIH RePORTER	This work was supported, in part, by National Institutes of Health grants HD069620, HD069620-S1, NS060005, NS084967 (AEK), NS094950, NS099683 (COB), the University of Pittsburgh Physicians/UPMC Academic Foundation (COB), the Arizona Biomedical Research Commission through the Arizona Department of Health Services (ADHS14-00003606), the Valley Research Partnership Awards (P2201607 and P1201607), and Phoenix Children's Hospital Mission Support Funds (TCT).	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Alves OL, 2003, ANN NY ACAD SCI, V993, P25, DOI 10.1111/j.1749-6632.2003.tb07508.x; Alves W., 1998, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Alwis DS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00156; Angehagen M, 2003, EPILEPSY RES, V54, P63, DOI 10.1016/S0920-1211(03)00039-1; Archer T, 2012, NEUROTOX RES, V21, P418, DOI 10.1007/s12640-011-9297-0; Aso E, 2008, J NEUROCHEM, V105, P565, DOI 10.1111/j.1471-4159.2007.05149.x; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baratz-Goldstein R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157064; Batty R, 2015, J CLIN EXP NEUROPSYC, V37, P917, DOI 10.1080/13803395.2015.1068279; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beaumont A, 1998, ACT NEUR S, V71, P149; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Belayev L, 2001, J NEUROTRAUM, V18, P1031, DOI 10.1089/08977150152693728; Beom J, 2016, JOVE-J VIS EXP, DOI 10.3791/54217; Berardi A, 2016, PHARMACOL RES, V111, P668, DOI 10.1016/j.phrs.2016.07.024; Beyer CE, 2010, NEUROBIOL DIS, V39, P148, DOI 10.1016/j.nbd.2010.03.020; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bondi CO, 2008, NEUROPSYCHOPHARMACOL, V33, P320, DOI 10.1038/sj.npp.1301410; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P917; Butovsky E, 2005, J NEUROCHEM, V93, P802, DOI 10.1111/j.1471-4159.2005.03074.x; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cetnak I., 2005, NEURORX, V2, P410; Chen J, 2012, J NEUROENDOCRINOL, V24, P1055, DOI 10.1111/j.1365-2826.2012.02306.x; Chen MF, 2013, J PHYSIOL-LONDON, V591, P985, DOI 10.1113/jphysiol.2012.241125; Chen S, 2014, NEUROCHEM RES, V39, P1621, DOI 10.1007/s11064-014-1241-2; Chen X, 2013, CRIT CARE, V17, DOI 10.1186/cc13067; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cimolin V, 2012, J HEAD TRAUMA REHAB, V27, P177, DOI 10.1097/HTR.0b013e3182172276; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Cohen-Yeshurun A, 2013, J CEREBR BLOOD F MET, V33, P1242, DOI 10.1038/jcbfm.2013.75; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Cook AM, 2008, NUTR CLIN PRACT, V23, P608, DOI 10.1177/0884533608326060; Cope EC, 2016, EXP NEUROL, V279, P96, DOI 10.1016/j.expneurol.2016.02.017; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; de Diego C, 2013, RESTOR NEUROL NEUROS, V31, P361, DOI 10.3233/RNN-120250; de In Tremblaye P. B., 2016, J NEUROTRAUM, V34, P1610; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Dittmar C, 1997, Appl Neuropsychol, V4, P50, DOI 10.1207/s15324826an0401_6; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dzhala V, 2015, CNS NEUROSCI THER, V21, P173, DOI 10.1111/cns.12369; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P419, DOI 10.1177/1545968315600525; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farber NB, 2002, MOL PSYCHIATR, V7, P726, DOI 10.1038/sj.mp.4001087; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fatouros I, 2010, STRESS, V13, P461, DOI 10.3109/10253891003743432; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Firsching R, 2012, J NEUROL SURG PART A, V73, P204, DOI 10.1055/s-0032-1304815; Folweiler KA, 2017, J NEUROTRAUM, V34, P451, DOI 10.1089/neu.2016.4417; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Goldstein LB, 2002, NEUROREHAB NEURAL RE, V16, P321, DOI 10.1177/154596830201600402; Gomez-Pinilla F, 2008, AGEING RES REV, V7, P49, DOI 10.1016/j.arr.2007.04.003; Gorzalka BB, 2008, NEUROSCI BIOBEHAV R, V32, P1152, DOI 10.1016/j.neubiorev.2008.03.004; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Griesbach GS, 2014, J NEUROTRAUM, V31, P674, DOI 10.1089/neu.2013.3151; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Heffernan ME, 2013, J NEUROTRAUM, V30, P1007, DOI 10.1089/neu.2012.2366; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hernandez T D, 1990, Restor Neurol Neurosci, V1, P323, DOI 10.3233/RNN-1990-1503; Hicks RR, 1998, RESTOR NEUROL NEUROS, V12, P41; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Higashi Y, 2014, J NEUROTRAUM, V31, P1689, DOI 10.1089/neu.2014.3331; Hill MN, 2010, J NEUROSCI, V30, P14980, DOI 10.1523/JNEUROSCI.4283-10.2010; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hoffman JM, 2010, PM&R, V2, P911, DOI 10.1016/j.pmrj.2010.06.008; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Hwabejire JO, 2013, SURGERY, V154, P234, DOI 10.1016/j.surg.2013.04.008; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Javed Zeeshan, 2015, Indian J Endocrinol Metab, V19, P753, DOI 10.4103/2230-8210.167561; Ji XR, 2017, BRAIN RES, V1659, P88, DOI 10.1016/j.brainres.2016.12.031; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; JONES TA, 1992, BEHAV BRAIN RES, V51, P1, DOI 10.1016/S0166-4328(05)80306-7; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Kabadi SV, 2014, J CEREBR BLOOD F MET, V34, P502, DOI 10.1038/jcbfm.2013.228; Kalish BT, 2016, METHODS MOL BIOL, V1462, P193, DOI 10.1007/978-1-4939-3816-2_12; Kapur S, 2000, J PSYCHIATR NEUROSCI, V25, P161; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Katz PS, 2015, J NEUROTRAUM, V32, P297, DOI 10.1089/neu.2014.3508; Kay T., 1992, NEUROPSYCHOLOGY, V6, P371, DOI DOI 10.1037/0894-4105.6.4.371; Keck CA, 2007, RESTOR NEUROL NEUROS, V25, P77; Khan NR, 2016, NEUROSURGERY, V79, P775, DOI 10.1227/NEU.0000000000001445; Khaspekov LG, 2004, EUR J NEUROSCI, V19, P1691, DOI 10.1111/j.1460-9568.2004.03285.x; Khodadad A, 2015, BEHAV BRAIN RES, V284, P249, DOI 10.1016/j.bbr.2015.01.032; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2001, HEAD TRAUMA, P65; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Kosaki Y, 2012, BEHAV BRAIN RES, V227, P81, DOI 10.1016/j.bbr.2011.10.039; Kouzounias K, 2011, NEUROSCIENCE, V183, P171, DOI 10.1016/j.neuroscience.2011.03.069; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Krahulik D., 2016, BIOMED PAP, V161, P80; Kreber LA, 2016, BRAIN RES, V1640, P152, DOI 10.1016/j.brainres.2016.01.016; Kumlien E, 2010, SEIZURE-EUR J EPILEP, V19, P69, DOI 10.1016/j.seizure.2009.11.005; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; LAND PW, 1995, J COMP NEUROL, V355, P573, DOI 10.1002/cne.903550407; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lapiz-Bluhm MDS, 2008, J NEUROENDOCRINOL, V20, P1115, DOI 10.1111/j.1365-2826.2008.01772.x; Leary JB, 2017, J NEUROTRAUM, V34, P444, DOI 10.1089/neu.2016.4438; Lesemann FHP, 2015, NEUROSCI BIOBEHAV R, V51, P126, DOI 10.1016/j.neubiorev.2015.01.005; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lifshitz J, 2007, BEHAV BRAIN RES, V177, P347, DOI 10.1016/j.bbr.2006.11.014; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lim SW, 2017, NEUROCRIT CARE, V26, P122, DOI 10.1007/s12028-016-0290-6; Lin LF, 2015, BRAIN INJURY, V29, P41, DOI 10.3109/02699052.2014.955881; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Liossi C, 2009, J NEUROPSYCH CLIN N, V21, P43, DOI 10.1176/appi.neuropsych.21.1.43; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359; Lippert-Gruner M, 2011, PHYSIOL RES, V60, P367, DOI 10.33549/physiolres.931816; Lisboa SF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00005; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lyeth BG, 2001, EXP NEUROL, V169, P191, DOI 10.1006/exnr.2001.7643; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Mahesh R, 2010, INDIAN J EXP BIOL, V48, P466; Majdan M, 2013, J NEUROTRAUM, V30, P23, DOI 10.1089/neu.2012.2554; Mala H, 2015, BRAIN RES BULL, V116, P34, DOI 10.1016/j.brainresbull.2015.05.006; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Miller L J, 1998, Appl Neuropsychol, V5, P172, DOI 10.1207/s15324826an0504_2; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Milman A, 2008, EUR NEUROPSYCHOPHARM, V18, P181, DOI 10.1016/j.euroneuro.2007.05.007; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Montanez S, 2000, BRAIN RES, V860, P29, DOI 10.1016/S0006-8993(00)01951-X; Montanez S, 2001, J NEUROTRAUM, V18, P1255, DOI 10.1089/089771501317095296; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Mychasiuk R, 2015, BEHAV BRAIN RES, V286, P285, DOI 10.1016/j.bbr.2015.03.010; Nott MT, 2006, BRAIN INJURY, V20, P1175, DOI 10.1080/02699050601049114; O'Dell DM, 2000, RESTOR NEUROL NEUROS, V16, P127; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P132, DOI 10.1080/13803390902858874; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Panikashvili D, 2006, NEUROBIOL DIS, V22, P257, DOI 10.1016/j.nbd.2005.11.004; Panikashvili D, 2005, J CEREBR BLOOD F MET, V25, P477, DOI 10.1038/sj.jcbfm.9600047; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Pelicao R, 2016, NEUROSCI LETT, V624, P17, DOI 10.1016/j.neulet.2016.04.068; Perez-Garcia G., 2016, BEHAV BRAIN RES; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Phelps TI, 2017, NEUROREHAB NEURAL RE, V31, P25, DOI 10.1177/1545968316650281; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pitkanen A, 2014, EPILEPSY RES, V108, P653, DOI 10.1016/j.eplepsyres.2014.02.001; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Purohit MP, 2013, PM&R, V5, P24, DOI 10.1016/j.pmrj.2012.06.012; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Radabaugh HL, 2016, EXP NEUROL, V286, P61, DOI 10.1016/j.expneurol.2016.09.015; Radhakrishnan R, 2016, LANCET PSYCHIAT, V3, P1166, DOI 10.1016/S2215-0366(16)30266-8; RADULOVIC LL, 1995, DRUG METAB DISPOS, V23, P441; Ragnarsson KT, 2002, RESTOR NEUROL NEUROS, V20, P103; Ragsdale DS, 1998, BRAIN RES REV, V26, P16, DOI 10.1016/S0165-0173(97)00054-4; RAGSDALE DS, 1991, MOL PHARMACOL, V40, P756; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Rawas R., 2011, BRAIN RES, V1390, P80; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Renner CIE, 2015, J CLIN MED, V4, P1815, DOI 10.3390/jcm4091815; Riess P, 2001, RESTOR NEUROL NEUROS, V18, P1; Ritter AC, 2016, EPILEPSIA, V57, P1968, DOI 10.1111/epi.13582; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Sahlholm K, 2016, EUR NEUROPSYCHOPHARM, V26, P467, DOI 10.1016/j.euroneuro.2016.01.001; Sajja VSSS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15075; Sanders MJ, 1999, J NEUROTRAUM, V16, P915, DOI 10.1089/neu.1999.16.915; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schaaf M.J., 2000, IMPLICATIONS MEMORY, V3, P201; SCHALLERT T, 1986, BRAIN RES, V379, P104, DOI 10.1016/0006-8993(86)90261-1; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Schurman LD, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00069; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P313, DOI 10.1097/HTR.0b013e3182915cb5; Sitges M, 2016, NEUROCHEM RES, V41, P758, DOI 10.1007/s11064-015-1749-0; Smith DH, 1997, NEUROSCI LETT, V231, P135, DOI 10.1016/S0304-3940(97)00551-X; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Steiner MA, 2008, PHARMACOGENOMICS J, V8, P196, DOI 10.1038/sj.tpj.6500466; Tait DS, 2014, CURR PHARM DESIGN, V20, P5046; Tang YP, 1997, EUR J NEUROSCI, V9, P1720, DOI 10.1111/j.1460-9568.1997.tb01529.x; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thomas TC, 2016, BEHAV BRAIN RES; Thomas TC, 2015, BRAIN NEUROTRAUMA MO; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tyagi IF, 2013, PLOS ONE, V8; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valenti O, 2011, J NEUROSCI, V31, P12330, DOI 10.1523/JNEUROSCI.2808-11.2011; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Vender Haar G., 2014, BRAIN INJURY, V28, P235; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Vonder Haar C, 2014, J NEUROTRAUM, V31, P1711, DOI 10.1089/neu.2014.3459; Wallace AE, 1999, RESTOR NEUROL NEUROS, V14, P35; Wang AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091399; Wang X., 2013, SPRINGER SERIES ADV, V2013, P1, DOI DOI 10.1155/2013/569161.ARTICLE; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Weeks J. J., 2016, BEHAV BRAIN RES; WHITEGBADEBO D, 1993, J NEUROTRAUM, V10, P297, DOI 10.1089/neu.1993.10.297; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wogensen E, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/830871; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Wroblewski BA, 1997, BRAIN INJURY, V11, P37, DOI 10.1080/026990597123791; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Wu AG, 2014, NEUROREHAB NEURAL RE, V28, P75, DOI 10.1177/1545968313498650; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yen HL, 2007, ANN ACAD MED SINGAP, V36, P62; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yunus FW, 2015, J AUTISM DEV DISORD, V45, P3565, DOI 10.1007/s10803-015-2503-9; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36; Zou H., 2015, BRAIN INJURY, V29, P78; Zou IL, 2013, NEUROREHAB NEURAL RE, V27, P878; Zumbrun EE, 2015, J NEUROIMMUNE PHARM, V10, P245, DOI 10.1007/s11481-015-9586-0	305	13	13	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0149-7634	1873-7528		NEUROSCI BIOBEHAV R	Neurosci. Biobehav. Rev.	FEB	2018	85						160	175		10.1016/j.neubiorev.2017.05.022			16	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FR9UO	WOS:000419418800013	28576511	Green Published, Green Accepted, Bronze			2021-06-18	
J	Dillahunt-Aspillaga, C; Pugh, MJ; Cotner, BA; Silva, MA; Haskin, A; Tang, XY; Saylors, ME; Nakase-Richardson, R				Dillahunt-Aspillaga, Christina; Pugh, Mary Jo; Cotner, Bridget A.; Silva, Marc A.; Haskin, Adam; Tang, Xinyu; Saylors, Marie E.; Nakase-Richardson, Risa			Employment Stability in Veterans and Service Members With Traumatic Brain Injury: A Veterans Administration Traumatic Brain Injury Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries, traumatic; Employment; Rehabilitation; Veterans	NEUROBEHAVIORAL SYMPTOM INVENTORY; POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL INDEPENDENCE MEASURE; UNITED-STATES; NEUROPSYCHOLOGICAL OUTCOMES; GALVESTON ORIENTATION; LIFE SATISFACTION; FREEDOM VETERANS; ACUTE PREDICTORS; AMNESIA TEST	Objective: To examine incidence and predictors of employment stability in veterans and military service members with traumatic brain injury (TBI) who return to work. Design: Prospective observational cohort study. Setting: Four rehabilitation centers. Participants: Veterans and military service members (N=110) with mild (26%), moderate (22%), or severe (52%) TBI enrolled in the Department of Veterans Affairs Polytrauma Rehabilitation Centers TBI Model Systems database within 2 years of injury who were discharged between January 2009 and June 2015. Interventions: Not applicable. Main Outcome Measure: Employment stability as reflected by competitive employment at 1- and/or 2-year follow-up. Results: Over half (n=61, 55%) of the participants had stable employment at the time the first competitive employment date was recorded. Individuals with stable employment were more likely to be white (79%) and to have slightly higher cognitive and motor discharge scores on the FIM. Based on univariate analysis, more severe TBI and higher FIIVI motor scores at discharge were significantly associated with employment stability. At follow-up, compared with veterans and military service members who had unstable employment, those with stable employment had higher scores on motor and cognitive FIIVI and lower scores of self-report symptoms on the Neurobehavioral Symptom Inventory, the 9-item Patient Health Questionnaire-Depression, the 7-item Generalized Anxiety Disorder Questionnaire, and the PTSD Checklist-Civilian version. Conclusions: A number of unique factors affect employment stability in veterans and military service members with TBI. Study findings identify veterans and military service members who have stable employment and predictors of employment stability. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Rehabil & Mental Hlth Counseling Program, Tampa, FL USA; [Dillahunt-Aspillaga, Christina; Cotner, Bridget A.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Hlth Serv Res & Dev Serv Ctr Innovat Disabil & Re, Tampa, FL USA; [Pugh, Mary Jo] South Texas Vet Healthcare Syst, Audie L Murphy Vet Affairs Hosp, San Antonio, TX USA; [Cotner, Bridget A.] Univ S Florida, Dept Anthropol, Tampa, FL USA; [Silva, Marc A.; Haskin, Adam; Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Def Ctr Excellence Psychol Hlth & Traumat Brain I, Tampa, FL USA; [Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Tampa, FL USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Haskin, Adam] Gen Dynam Hlth Solut, Tampa, FL USA; [Tang, Xinyu; Saylors, Marie E.] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA	Cotner, BA (corresponding author), Hlth Serv Res & Dev Serv Ctr Innovat Disabil & Re, 8900 Grand Oak Circle, Tampa, FL 33637 USA.	Bridget.Cotner@va.gov	Pugh, Mary Jo/K-5336-2019; Silva, Marc A./J-1874-2019	Pugh, Mary Jo/0000-0003-4196-7763; Silva, Marc A./0000-0002-3879-6054; Dillahunt-Aspillaga, Christina/0000-0002-1231-2023	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VATBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans AffairsUS Department of Veterans Affairs [1 I50 HX001233-01, W81XWH-13-2-0095]; U.S. Department of Defense Congressionally Directed Medical Research Programs; American Congress of Rehabilitation Medicine	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by the VHA Central Office VATBI Model System Program of Research and a subcontract from General Dynamics Health Solutions (contract no. W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, U.S. Army Medical Research and Material Command, U.S. Department of Veterans Affairs grants (grant nos. 1 I50 HX001233-01 and W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs.; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Defense and Veterans Brain Injury Center (DVBIC), 2017, DOD WORLDW NUMB TBI; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Geiling J, 2012, MIL MED, V177, P1235, DOI 10.7205/MILMED-D-12-00031; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Granger CV, 1986, TOP GERIATR REHABIL, V1, P59, DOI 10.1097/00013614-198604000-00007; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hankins AB, 2015, J OCCUP REHABIL, P1; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1977, LANCET, V1, P878; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kupersmith J, 2009, J REHABIL RES DEV, V46, P1; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; O'Neil M., 2014, J INT NEUROPSYCH SOC, V1, P24; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Possl O, 2001, BRAIN INJURY, V15, P15; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Rehabilitation UDS, 1997, GUID UN DAT SET MED; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 2012, PTSD MILD TRAUM BRAI; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Weathers FW, TEH PTSD CHECKLIST D; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williamson MLC, 2016, J HEAD TRAUMA REHAB, V31, P167, DOI 10.1097/HTR.0000000000000111; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	94	13	13	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S23	S32		10.1016/j.apmr.2017.05.012			10	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900004	28629990				2021-06-18	
J	Pressly, JD; Mustafa, SM; Adibi, AH; Alghamdi, S; Pandey, P; Roy, KK; Doerksen, RJ; Moore, BM; Park, F				Pressly, Jeffrey D.; Mustafa, Suni M.; Adibi, Ammaar H.; Alghamdi, Sahar; Pandey, Pankaj; Roy, Kuldeep K.; Doerksen, Robert J.; Moore, Bob M., Jr.; Park, Frank			Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							ACUTE KIDNEY INJURY; CISPLATIN-INDUCED NEPHROTOXICITY; TYPE-2 DIABETIC-NEPHROPATHY; TRAUMATIC BRAIN-INJURY; CB2 RECEPTOR; ENDOCANNABINOID SYSTEM; HOSPITALIZED-PATIENTS; INVERSE AGONIST; MOUSE MODEL; DISEASE	Ischemia-reperfusion injury (IRI) is a common cause of acute kidney injury (AKI), which is an increasing problem in the clinic and has been associated with elevated rates of mortality. Therapies to treat AKI are currently not available, so identification of new targets that can be modulated to ameliorate renal damage upon diagnosis of AKI is essential. In this study, a novel cannabinoid receptor 2 (CB2) agonist, SMM-295 [3'-methyl-4-(2-(thiophen-2-yl)propan-2-yl)biphenyl-2,6-diol], was designed, synthesized, and tested in vitro and in silico. Molecular docking of SMM-295 into a CB2 active-state homology model showed that SMM-295 interacts well with key amino acids to stabilize the active state. In human embryonic kidney 293 cells, SMM-295 was capable of reducing cAMP production with 66-fold selectivity for CB2 versus cannabinoid receptor 1 and dose-dependently increased mitogen-activated protein kinase and Akt phosphorylation. In vivo testing of the CB2 agonist was performed using a mouse model of bilateral IRI, which is a common model to mimic human AKI, where SMM-295 was immediately administered upon reperfusion of the kidneys after the ischemia episode. Histologic damage assessment 48 hours after reperfusion demonstrated reduced tubular damage in the presence of SMM-295. This was consistent with reduced plasma markers of renal dysfunction (i.e., creatinine and neutrophil gelatinase-associated lipocalin) in SMM-295-treated mice. Mechanistically, kidneys treated with SMM-295 were shown to have elevated activation of Akt with reduced terminal deoxynucleotidyl transferase-mediated digoxigenin-deoxyuridine nick-end labeling (TUNEL)-positive cells compared with vehicle-treated kidneys after IRI. These data suggest that selective CB2 receptor activation could be a potential therapeutic target in the treatment of AKI.	[Pressly, Jeffrey D.; Mustafa, Suni M.; Adibi, Ammaar H.; Alghamdi, Sahar; Moore, Bob M., Jr.; Park, Frank] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, 881 Madison Ave,Room 442, Memphis, TN 38163 USA; [Pandey, Pankaj; Roy, Kuldeep K.; Doerksen, Robert J.] Univ Mississippi, Sch Pharm, Div Med Chem, Dept Biomol Sci, University, MS 38677 USA; [Doerksen, Robert J.] Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, University, MS 38677 USA; [Roy, Kuldeep K.] Natl Inst Pharmaceut Educ & Res, Kolkata, W Bengal, India	Moore, BM; Park, F (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, 881 Madison Ave,Room 442, Memphis, TN 38163 USA.	bmoore@uthsc.edu; fpark@uthsc.edu	Roy, Kuldeep K/R-1762-2016; Pandey, Pankaj/AAW-4910-2020; Park, Frank/I-4590-2019	Park, Frank/0000-0003-2324-2937; Abidi, Ammaar/0000-0003-1826-9377; Pressly, Jeffrey/0000-0003-2151-8864; Roy, Kuldeep/0000-0001-9623-0617; Doerksen, Robert/0000-0002-3789-1842; , NIPERKolkata/0000-0003-4906-3988	University of Tennessee Health Science Center; National Institutes of Health National Institute of Diabetes and Digestive and Kidney DiseasesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01-DK090123]; National Institutes of Health National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20-GM104932, R15-GM119061]; National Science FoundationNational Science Foundation (NSF) [MRI1338056]; Mississippi Center for Supercomputer Research; National Institutes of Health Research Facilities Improvements ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [C06-RR14503]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [C06RR014503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK090123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R15GM119061, P20GM104932] Funding Source: NIH RePORTER	This work was partially funded by the University of Tennessee Health Science Center [institutional funds (to F.P.)], the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [Grants R01-DK090123 (to F.P.), and the National Institutes of Health National Institute of General Medical Sciences [Grants P20-GM104932 and R15-GM119061 (to R.J.D.)]. Supercomputer support from the National Science Foundation [Grant MRI1338056] and the Mississippi Center for Supercomputer Research [both to (R.J.D.)] is acknowledged. This investigation was conducted in part in a facility constructed with support from the National Institutes of Health Research Facilities Improvements Program [Grant C06-RR14503 (to R.J.D.)].	Barutta F, 2011, DIABETES, V60, P2386, DOI 10.2337/db10-1809; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brents LK, 2012, XENOBIOTICA, V42, P139, DOI 10.3109/00498254.2011.609570; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; Calvaruso G, 2012, INT J ONCOL, V41, P407, DOI 10.3892/ijo.2012.1476; Cassano T., 2017, NEUROSCIENCE, V11, P30, DOI [10.3389/fnins.2017.0003028210207, DOI 10.3389/FNINS.2017.00030]; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Cichero E, 2011, EUR J MED CHEM, V46, P4489, DOI 10.1016/j.ejmech.2011.07.023; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Deutsch DG, 1997, J CLIN INVEST, V100, P1538, DOI 10.1172/JCI119677; Dore A, 2016, BIOORGAN MED CHEM, V24, P5291, DOI 10.1016/j.bmc.2016.08.055; Feizi A, 2008, EXP TOXICOL PATHOL, V60, P405, DOI 10.1016/j.etp.2008.04.006; Feng ZW, 2014, J CHEM INF MODEL, V54, P2483, DOI 10.1021/ci5002718; Fouad AA, 2012, LIFE SCI, V91, P284, DOI 10.1016/j.lfs.2012.07.030; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Glomme A, 2005, J PHARM SCI-US, V94, P1, DOI 10.1002/jps.20212; Guzman M, 2002, PHARMACOL THERAPEUT, V95, P175, DOI 10.1016/S0163-7258(02)00256-5; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; Heung M, 2014, NEPHRON CLIN PRACT, V127, P30, DOI 10.1159/000363675; Himanshu R, 2013, J DRUG DELIV THER, V3, P20, DOI DOI 10.22270/JDDT.V3I3.506; Horvath B, 2012, FREE RADICAL BIO MED, V52, P1325, DOI 10.1016/j.freeradbiomed.2012.01.014; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Hryciw DH, 2016, CURR OPIN NEPHROL HY, V25, P459, DOI 10.1097/MNH.0000000000000249; Hu JP, 2016, J CHEM INF MODEL, V56, P1152, DOI 10.1021/acs.jcim.5b00739; Hurst DP, 2010, J BIOL CHEM, V285, P17954, DOI 10.1074/jbc.M109.041590; Jenkin KA, 2016, BRIT J PHARMACOL, V173, P1128, DOI 10.1111/bph.13056; Jenkin KA, 2013, CELL PHYSIOL BIOCHEM, V32, P1309, DOI 10.1159/000354529; Jenkin KA, 2010, CELL PHYSIOL BIOCHEM, V26, P879, DOI 10.1159/000323997; Jourdan T, 2014, P NATL ACAD SCI USA, V111, pE5420, DOI 10.1073/pnas.1419901111; Kazory A, 2013, CLIN KIDNEY J, V6, P330, DOI 10.1093/ckj/sft047; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kusakabe K, 2013, BIOORGAN MED CHEM, V21, P3154, DOI 10.1016/j.bmc.2013.03.030; Kwon M, 2012, P NATL ACAD SCI USA, V109, P21462, DOI 10.1073/pnas.1216830110; Lenarczyk M, 2015, J MOL HISTOL, V46, P123, DOI 10.1007/s10735-014-9605-0; Lucchesi V, 2014, J MED CHEM, V57, P8777, DOI 10.1021/jm500807e; Macedo E, 2009, CURR OPIN CRIT CARE, V15, P467, DOI 10.1097/MCC.0b013e328332f6e3; Moore BM, 2011, U.S. patent, Patent No. [7,888,365, 7888365]; Mukhopadhyay P, 2016, BRIT J PHARMACOL, V173, P446, DOI 10.1111/bph.13338; Mukhopadhyay P, 2010, BRIT J PHARMACOL, V160, P657, DOI 10.1111/j.1476-5381.2010.00769.x; Mukhopadhyay P, 2010, FREE RADICAL BIO MED, V48, P457, DOI 10.1016/j.freeradbiomed.2009.11.022; National Research Council, 2011, GUIDE CARE USE LAB A; Nettekoven M, 2016, CHEMMEDCHEM, V11, P179, DOI 10.1002/cmdc.201500218; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Park F, 2008, J AM SOC NEPHROL, V19, P1929, DOI 10.1681/ASN.2007070771; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Presley CS, 2015, BIOORGAN MED CHEM, V23, P5390, DOI 10.1016/j.bmc.2015.07.057; Pressly JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep43196; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Reggio PH, 2010, CURR MED CHEM, V17, P1468, DOI 10.2174/092986710790980005; Regner KR, 2011, FASEB J, V25, P1844, DOI 10.1096/fj.10-169797; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Soethoudt M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13958; Srisung Weeraporn, 2015, Proc (Bayl Univ Med Cent), V28, P475; Tetko IV, 2009, MOL DRUG PROPERTIES, P381; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; Walter L, 2003, J NEUROSCI, V23, P1398; Wang HE, 2012, AM J NEPHROL, V35, P349, DOI 10.1159/000337487; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; White SM, 2014, MOL PHARMACOL, V86, P369, DOI 10.1124/mol.114.092346; Witkamp R, 2014, CURR OPIN CLIN NUTR, V17, P130, DOI 10.1097/MCO.0000000000000027; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang YX, 2011, INT IMMUNOPHARMACOL, V11, P1303, DOI 10.1016/j.intimp.2011.04.013; Zoja C, 2016, NEPHRON, V132, P59, DOI 10.1159/000442679	74	13	13	0	7	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	FEB 1	2018	364	2					287	299		10.1124/jpet.117.245522			13	Pharmacology & Pharmacy	Pharmacology & Pharmacy	FS9BL	WOS:000422709100013	29187590	Bronze, Green Published			2021-06-18	
J	Riedeman, S; Turkstra, L				Riedeman, Sarah; Turkstra, Lyn			Knowledge, Confidence, and Practice Patterns of Speech-Language Pathologists Working With Adults With Traumatic Brain Injury	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							REHABILITATION; PERCEPTIONS	Purpose: Although speech-language pathologists (SLPs) are important members of the health care team serving adults with traumatic brain injury (TBI) with cognitive-communication disorders, little is known about services SLPs deliver and how they rate their own knowledge and skills. The aims of this study were to identify practice patterns, knowledge, and confidence levels of SLPs working with adults with TBI with cognitive-communication disorders. Method: We surveyed 100 SLPs from rural and urban hospitals, skilled nursing facilities, and outpatient clinics in Wisconsin and analyzed data descriptively. Results: SLPs in this sample had a combination of accurate and inaccurate knowledge related to TBI. Although all participants reported working with individuals with TBI, many participants rated themselves as lacking confidence or knowledge in this practice area. SLPs reported variable use of evidence-based procedures and training related to TBI. Conclusion: Results confirmed the high prevalence of TBI-related practice among SLPs in medical settings, but there was variable knowledge, confidence, and use of current evidence in practice. SLP graduate training programs, individual providers, health care administrators, and the American Speech-Language-Hearing Association can use results from this study to advance and improve SLP clinical services for adults with TBI.	[Riedeman, Sarah; Turkstra, Lyn] Univ Wisconsin, Madison, WI 53706 USA; [Riedeman, Sarah] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada	Riedeman, S (corresponding author), Univ Wisconsin, Madison, WI 53706 USA.; Riedeman, S (corresponding author), McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada.	sriedeman@gmail.com					American Speech-Language-Hearing Association, 2005, ROL SPEECH LANG PATH; American Speech-Language-Hearing Association, 2005, KNOWL SKILLS NEED SP; American Speech-Language-Hearing Association, 2007, SCOP PRACT SPEECH LA; Beaulieu CL, 2015, ARCH PHYS MED REHAB, V96, pS222, DOI 10.1016/j.apmr.2014.10.028; Benigas J., 2016, SPACED RETRIEVAL STE; Campbell SM, 2002, QUAL SAF HEALTH CARE, V11, P358, DOI 10.1136/qhc.11.4.358; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Constantinidou F, 2012, BRAIN INJURY, V26, P1549, DOI 10.3109/02699052.2012.698786; Cornis-Pop M, 2012, J REHABIL RES DEV, V49, pXI, DOI 10.1682/JRRD.2012.03.0048; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Duff MC, 2015, BRAIN INJURY, V29, P64, DOI 10.3109/02699052.2014.965747; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Frith M, 2014, BRAIN INJURY, V28, P1657, DOI 10.3109/02699052.2014.947619; Hux K, 1996, LANG SPEECH HEAR SER, V27, P171, DOI 10.1044/0161-1461.2702.171; Kruger J, 1999, J PERS SOC PSYCHOL, V77, P1121, DOI 10.1037/0022-3514.77.6.1121; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Matarazzo BB, 2016, COMMUNITY MENT HLT J, V52, P158, DOI 10.1007/s10597-015-9926-9; Mateer Catherine A., 1992, Seminars in Speech and Language, V13, P280, DOI 10.1055/s-2008-1064203; McGrane SA, 2000, BRAIN INJURY, V14, P975; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Short J, 2014, INT J SPEECH-LANG PA, V16, P219, DOI 10.3109/17549507.2014.882413; Sohlberg M. M., 2011, ATTENTION PROCESS TR; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2016, AM J SPEECH-LANG PAT, V25, DOI 10.1044/2015_AJSLP-15-0060; United States Department of Agriculture, 2013, DOCUMENTATION; US Census Bureau, 2010, 2010 CENS URB RUR CL; Watter K., 2014, J CLIN PRACTICE SPEE, V16, P7	32	13	13	0	10	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	FEB	2018	27	1					181	191		10.1044/2017_AJSLP-17-0011			11	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	FX1XA	WOS:000425847000015	29387881				2021-06-18	
J	Sun, LQ; Zhao, MM; Liu, M; Su, P; Zhang, JB; Li, YX; Yang, XJ; Wu, ZX				Sun, Liqian; Zhao, Manman; Liu, Man; Su, Peng; Zhang, Jingbo; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue			Suppression of FoxO3a attenuates neurobehavioral deficits after traumatic brain injury through inhibiting neuronal autophagy	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Neurobehavioral deficits; FoxO3a; Autophagy; Neuron	APOPTOSIS; CONTRIBUTES; ACTIVATION; DEGRADATION; ASTROCYTES; PATHWAY; DEATH; CELLS; MODEL; AXIS	Traumatic brain injury (TBI) is a serious insult that frequently leads to neurological impairments. Forkhead box O (FoxO) 3a, as transcription factor, has been confirmed to modulate autophagic process. Moreover, FoxO3a is expressed throughout the brain including the hippocampus. However, the role of FoxO3a in the pathophysiology of TBI is unclear. The present study is designed to investigate whether FoxO3a has the neuroprotective effects on rats subjected to TBI, and further to explore the potential molecular mechanisms. Thus, a rat model of TBI was created by using a modified weight-drop device to mimic the insults of TBI. The results showed that FoxO3a was significantly increased in the serum of patients with TBI as well as in experimental animals. Furthermore, our data also demonstrated that TBI stimulated the translocation of FoxO3a from the cytosol to the nucleus. Additionally, we found that knockdown of FoxO3a by siRNA silencing significantly improved neurobehavioral dysfunctions and conferred a better neuroprotective effects after TBI, evidenced by promoting motor behavioral recovery, attenuating learning and memory impairments, and partially reversing neuronal damage in the hippocampus. To further investigate the molecular mechanisms underlying this neuroprotection, we identified that nuclear accumulation of FoxO3a could induce highly expression of autophagy pathway genes including LC-3, Beclin-1, p62, ATG12, and ATG14, and finally initiate neurological impairments. Interestingly, silencing FoxO3a by siRNA remarkably inhibited the induction of neuronal autophagy after TBI, and activated autophagy was closely related to TBI-induced neurological deficits. Taken together, these findings indicated that FoxO3a knockdown conferred neuroprotective effects after TBI through inhibiting the activation of neuronal autophagy.	[Sun, Liqian; Zhang, Jingbo; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China; [Sun, Liqian; Zhang, Jingbo; Li, Youxiang; Yang, Xinjian; Wu, Zhongxue] Capital Med Univ, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China; [Zhao, Manman; Liu, Man; Su, Peng] North China Univ Sci & Technol, Sch Basic Med Sci, Dept Histol & Embryol, Tangshan 063000, Hebei, Peoples R China	Sun, LQ (corresponding author), Beijing Neurosurg Inst, Dept Intervent Neuroradiol, 6 Tiantan Xili, Beijing 100050, Peoples R China.; Sun, LQ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, 6 Tiantan Xili, Beijing 100050, Peoples R China.	slq20000@yeah.net		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672481]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M580117]; Beijing Postdoctoral Research FoundationChina Postdoctoral Science Foundation [2015ZZ-49, 2016ZZ-38]	This work was supported by a grant from the National Natural Science Foundation of China (81672481), the China Postdoctoral Science Foundation (2015M580117), the Project supported by Beijing Postdoctoral Research Foundation (2015ZZ-49 and 2016ZZ-38).	Delbary-Gossart S, 2016, BRAIN, V139, P1762, DOI 10.1093/brain/aww074; Descalzo DLM, 2016, STEM CELL REP, V7, P55, DOI 10.1016/j.stemcr.2016.06.006; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Hsu YWA, 2014, J NEUROSCI, V34, P11366, DOI 10.1523/JNEUROSCI.1861-14.2014; Im J., 2015, AM J PHYSL LUNG CELL, V309; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Li D., 2014, PLOS ONE, V10; Li DY, 2009, J CEREBR BLOOD F MET, V29, P1903, DOI 10.1038/jcbfm.2009.102; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu HG, 2010, SLEEP MED, V11, P205, DOI 10.1016/j.sleep.2009.05.015; Liu R, 2015, AUTOPHAGY, V11, P847, DOI 10.1080/15548627.2015.1037549; Liu W., 2016, LIFE SCI, V169, P699; Liu ZX, 2015, INT J ONCOL, V46, P721, DOI 10.3892/ijo.2014.2771; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nepal S, 2015, ONCOTARGET, V6, P7166, DOI 10.18632/oncotarget.3347; Ni HM, 2013, AM J PATHOL, V183, P1815, DOI 10.1016/j.ajpath.2013.08.011; Nichols JN, 2016, BEHAV BRAIN RES, V298, P111, DOI 10.1016/j.bbr.2015.10.052; Rangarajan P, 2015, NEUROSCIENCE, V311, P398, DOI 10.1016/j.neuroscience.2015.10.048; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shi C., 2016, J MATER SCI, P1; Shi C, 2016, J CELL SCI, V129, P1815, DOI 10.1242/jcs.185009; Staff T. P. O., 2015, PLOS ONE, V10; Stoica BA, 2014, J NEUROTRAUM, V31, P758, DOI 10.1089/neu.2013.3194; Sun LQ, 2015, MOL MED REP, V11, P4419, DOI 10.3892/mmr.2015.3264; Sun LQ, 2014, MOL MED REP, V9, P77, DOI 10.3892/mmr.2013.1787; Sun LQ, 2015, BEHAV BRAIN RES, V291, P315, DOI 10.1016/j.bbr.2015.05.049; Sun LQ, 2014, NEUROL SCI, V35, P677, DOI 10.1007/s10072-013-1575-6; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tong WX, 2016, HEPATOL RES, V46, P933, DOI 10.1111/hepr.12634; Tran H., 2003, SCI STKE; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Yoo KY, 2012, NEUROCHEM RES, V37, P588, DOI 10.1007/s11064-011-0648-2; Yu S, 2016, ONCOTARGET, V7, P34773, DOI 10.18632/oncotarget.8977; Zhao JH, 2008, AUTOPHAGY, V4, P378, DOI 10.4161/auto.5633; Zhao Lin, 2015, Zhonghua Yi Xue Za Zhi, V95, P457; Zhou JY, 2012, AUTOPHAGY, V8, P1712, DOI 10.4161/auto.21830	44	13	13	0	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JAN 30	2018	337						271	279		10.1016/j.bbr.2017.08.042			9	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	FN1TL	WOS:000415774000032	28889023				2021-06-18	
S	Alluri, H; Shaji, CA; Davis, ML; Tharakan, B		Tharakan, B		Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Davis, Matthew L.; Tharakan, Binu			A Mouse Controlled Cortical Impact Model of Traumatic Brain Injury for Studying Blood-Brain Barrier Dysfunctions	TRAUMATIC AND ISCHEMIC INJURY: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Blood-brain barrier; Controlled cortical impact; Traumatic brain injury; Intravital microscopy; Evans Blue; Edema; Intracranial pressure; Central nervous system; Hyperpermeability; Endothelial permeability	INTRAVITAL MICROSCOPY; ADULTS	Traumatic brain injury (TBI) is one of the leading causes of death and disability worldwide. It is a silently growing epidemic with multifaceted pathogenesis, and current standards of treatments aim to target only the symptoms of the primary injury, while there is a tremendous need to explore interventions that can halt the progression of the secondary injuries. The use of a reliable animal model to study and understand the various aspects the pathobiology of TBI is extremely important in therapeutic drug development against TBI-associated complications. The controlled cortical impact (CCI) model of TBI described here, uses a mechanical impactor to inflict a mechanical injury into the mouse brain. This method is a reliable and reproducible approach to inflict mild, moderate or severe injuries to the animal for studying TBI-associated blood-brain barrier (BBB) dysfunctions, neuronal injuries, brain edema, neurobehavioral changes, etc. The present method describes how the CCI model could be utilized for determining the BBB dysfunction and hyperpermeability associated with TBI. Blood-brain barrier disruption is a hallmark feature of the secondary injury that occur following TBI, frequently associated with leakage of fluid and proteins into the extravascular space leading to vasogenic edema and elevation of intracranial pressure. The method described here focuses on the development of a CCI-based mouse model of TBI followed by the evaluation of BBB integrity and permeability by intravital microscopy as well as Evans Blue extravasation assay.	[Alluri, Himakarnika; Shaji, Chinchusha Anasooya; Davis, Matthew L.; Tharakan, Binu] Texas A&M Univ, Coll Med, Baylor Scott & White Res Inst, Dept Surg,Hlth Sci Ctr, Temple, TX 76508 USA	Alluri, H (corresponding author), Texas A&M Univ, Coll Med, Baylor Scott & White Res Inst, Dept Surg,Hlth Sci Ctr, Temple, TX 76508 USA.						Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Cuccurullo S, 2012, AM J PHYS MED REHABI, V91, P727; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P41; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Kasper C, 2015, ANN REV NURSING RES, V33; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kumar P, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001112; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marques PE, 2012, AFR J MICROBIOL RES, V6, P1603, DOI 10.5897/AJMR11.1645; Masedunskas A, 2013, JOVE-J VIS EXP, DOI 10.3791/50558; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; Ramesh BN, 2014, J APP PHARM SCI, V11, P106, DOI 10.7324/JAPS.2014.41119; Scott BNV, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-68; Shen Q, 2009, CELL HEALTH CYTOSKEL, V1, P43; Taqueti VR, 2013, INTEGR BIOL-UK, V5, P278, DOI 10.1039/c2ib20194a; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7	23	13	14	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-7526-6; 978-1-4939-7524-2	METHODS MOL BIOL	Methods Mol. Biol.		2018	1717						37	52		10.1007/978-1-4939-7526-6_4	10.1007/978-1-4939-7526-6		16	Biochemical Research Methods; Biochemistry & Molecular Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Research & Experimental Medicine	BK3CS	WOS:000434764100005	29468582				2021-06-18	
S	Baldwin, GT; Breiding, MJ; Comstock, RD		Hainline, B; Stern, RA		Baldwin, Grant T.; Breiding, Matthew J.; Comstock, R. Dawn			Epidemiology of sports concussion in the United States	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL SPORTS; COLLEGIATE; MANAGEMENT; SYMPTOMS; TRENDS	Sports and recreation-related (SRR) activities are common in the United States. Beyond the benefits to health, SRR activities can create new friendships, give people a sense of belonging, foster teamwork and other leadership skills, and develop sportsmanship and a respect for rules that govern play. Public awareness about the risk of concussion has grown as the long-term consequences of traumatic brain injury (TBI) have become better known, and likely explains the increasing concussion incidence rates. Currently, surveillance systems capture SRR concussions among high school and college athletes participating in sanctioned sports. National estimates of SRR TBI presenting to an emergency department also exist. Persons under the age of 19 sustain a majority of SRR concussions. Concussion risk is greatest for boys in contact/collision sports like football, ice hockey, and lacrosse, and is more likely to occur in competition versus practice settings. Girls have elevated concussion rates in gender-comparable sports. Despite better data, concussions are still underreported, undermanaged, and often not properly identified. This is especially true for concussions occurring outside organized sports, in nonsport recreational activities, and for concussions either not seen or evaluated in nonemergency department settings. A new surveillance system proposed by the Centers for Disease Control and Prevention aims to fill the gap.	[Baldwin, Grant T.; Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unint Injury Prevent, 4770 Buford Hwy NE F-62, Atlanta, GA 30341 USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA	Baldwin, GT (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unint Injury Prevent, 4770 Buford Hwy NE F-62, Atlanta, GA 30341 USA.	gfb3@cdc.gov					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Aspen Institute, 2016, STAT PLAY 2016 TREND; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Centers for Disease Control and Prevention, 2015, CONC PLAY OPP RESH C; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dai SF, 2015, J PHYS ACT HEALTH, V12, pS128, DOI 10.1123/jpah.2015-0038; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ellis MJ, 2016, FRONT NEUROL, V7; Fakhouri Tala H I, 2014, NCHS Data Brief, P1; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haegerich TM, 2015, AM J PREV MED, V48, P219, DOI 10.1016/j.amepre.2014.08.018; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS REL CONC YOUT; Irick E, 2016, NCAA SPORT SPONSORSH; KB Arbogast, 2017, CLIN PEDIATR; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lumba-Brown A, 2018, JAMA PEDIAT; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; National Council for Youth Sports, 2017, PART ORG YOUTH SPORT; National Federation of State High School Associations, 2015, PART STAT; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sarmiento K, 2016, INJURY PREV, V22, pA96, DOI 10.1136/injuryprev-2016-042156.263; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schroeder T, 2001, NATL ELECT INJURY SU; Song M, 2015, J PHYS ACT HEALTH, V12, pS11, DOI 10.1123/jpah.2014-0117; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; United States Census, 2015, SINGL GRAD ENR HIGH; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Watson KB, 2015, J PHYS ACT HEALTH, V12, pS3, DOI 10.1123/jpah.2013-0521; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	46	13	13	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						63	74		10.1016/B978-0-444-63954-7.00007-0			12	Clinical Neurology; Sport Sciences	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100009	30482376				2021-06-18	
J	Callahan, ML; Binder, LM; O'Neil, ME; Zaccari, B; Roost, MS; Golshan, S; Huckans, M; Fann, JR; Storzbach, D				Callahan, Megan L.; Binder, Laurence M.; O'Neil, Maya E.; Zaccari, Belle; Roost, Mai S.; Golshan, Shahrokh; Huckans, Marilyn; Fann, Jesse R.; Storzbach, Daniel			Sensory sensitivity in operation enduring freedom/operation Iraqi freedom veterans with and without blast exposure and mild traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Blast exposure; concussion; light sensitivity; noise sensitivity; posttraumatic stress; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSION SYNDROME; MILITARY PERSONNEL; VISUAL FUNCTION; BASE RATES; SYMPTOMS; CONCUSSION; COMPLAINTS; CONSEQUENCES; ASSOCIATION	To examine factors associated with noise and light sensitivity among returning Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans with a self-reported history of mild traumatic brain injury (mTBI) due to blast exposure, we compared the self-report of noise and light sensitivity of 42 OEF/OIF Veterans diagnosed with mTBI resulting from combat blast-exposure to that of 36 blast-exposed OEF/OIF Veterans without a history of mTBI. Results suggest a statistically significant difference between Veterans with and without a history of mTBI in the experience of noise and light sensitivity, with sensory symptoms reported most frequently in the mTBI group. The difference remains significant even after controlling for symptoms of PTSD, depression, and somatization. These data suggest that while psychological distress is significantly associated with the complaints of noise and light sensitivity, it may not fully account for the experience of sensory sensitivity in a population with mTBI history.	[Callahan, Megan L.; O'Neil, Maya E.; Zaccari, Belle; Roost, Mai S.; Huckans, Marilyn; Storzbach, Daniel] VA Portland Hlth Care Syst, Portland, OR USA; [Binder, Laurence M.; O'Neil, Maya E.; Zaccari, Belle; Huckans, Marilyn; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Binder, Laurence M.; Storzbach, Daniel] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Binder, Laurence M.] Independent Practice, Beaverton, OR USA; [O'Neil, Maya E.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Zaccari, Belle] VA Portland Hlth Care Syst, Northwest Mental Illness Res Educ & Clin Ctr MIRE, Portland, OR USA; [Golshan, Shahrokh] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Fann, Jesse R.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Fann, Jesse R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA	Callahan, ML (corresponding author), 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	megan.callahan@va.gov		Zaccari, Belle/0000-0003-2260-6620	VA Merit Review Awardfrom the Department of Veterans Affairs [B5060R, CIN 13-404]; Agency for Healthcare Research QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K12HS022981] Funding Source: NIH RePORTER	This work was supported by the VA Merit Review Award #B5060R to D.S. from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development, a Veterans Affairs Health Services Research and Development Center of Innovation grant, Center to Improve Veteran Involvement in Care, Award #CIN 13-404, and an Agency for Healthcare Research & Quality-funded PCOR K12 award to M.E.O. (#K12HS022981).	Al-Ozairi A, 2015, J HEAD TRAUMA REHAB, V30, P283, DOI 10.1097/HTR.0000000000000043; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bengtzen R, 2008, NEUROLOGY, V70, P218, DOI 10.1212/01.wnl.0000287090.98555.56; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Defense and Veterans Brain Injury Center, 2013, DOD NUMB TRAUM BRAIN; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; DSM-V American Psychiatric Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Fields H, 1991, COGN BEHAV NEUROL, V4, P83; FOX DD, 1995, NEUROPSYCHOLOGY, V9, P606, DOI 10.1037/0894-4105.9.4.606; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gasquoine P G, 2000, Appl Neuropsychol, V7, P83, DOI 10.1207/S15324826AN0702_3; Geisser ME, 2008, PSYCHOSOMATICS, V49, P235, DOI 10.1176/appi.psy.49.3.235; Goodrich GL, 2014, J REHABIL RES DEV, V51, P547, DOI 10.1682/JRRD.2013.02.0049; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; IBM Corp, 2019, IBM SPSS STAT WIND V; Iverson G.L., 2007, BRAIN INJURY MED PRI, P373; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; Lew HL, 2010, NEUROREHABILITATION, V26, P213, DOI 10.3233/NRE-2010-0557; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; LISHMAN WA, 1988, BRIT J PSYCHIAT, V153, P460, DOI 10.1192/bjp.153.4.460; Lovell MR., 2000, IMPACT IMMEDIATE POS; Machulda MM, 1998, ARCH CLIN NEUROPSYCH, V13, P415, DOI 10.1016/S0887-6177(97)00031-0; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; Mathews A, 2002, COGNITION EMOTION, V16, P331, DOI 10.1080/02699930143000518; McCrea M, 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Morey L, 1996, INTERPRETIVE GUIDE P; Morey L. C., 1991, PERSONALITY ASSESSME; Murphy KR, 2004, STAT POWER ANAL; Nelson NW, 2015, BRIT J PSYCHIAT, V206, P237, DOI 10.1192/bjp.bp.114.149096; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; OHRSTROM E, 1988, PSYCHOL MED, V18, P605, DOI 10.1017/S003329170000828X; Pinto PCL, 2014, J LARYNGOL OTOL, V128, P660, DOI 10.1017/S0022215114001030; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Stansfeld S.A, 1992, PSYCHOL MED        S, V22S, P1, DOI DOI 10.1017/S0264180100001119; STANSFELD SA, 1985, PSYCHOL MED, V15, P243, DOI 10.1017/S0033291700023527; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Weathers F., 1996, MEASUREMENT STRESS T, P250; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; World Health Organization, 1992, ICD 10 INT STAT CLAS	66	13	13	1	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	2					126	136		10.1080/23279095.2016.1261867			11	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	FT9MO	WOS:000423476400004	27929660				2021-06-18	
J	Feng, LY; Sharma, A; Niu, F; Huang, Y; Lafuente, JV; Muresanu, DF; Ozkizilcik, A; Tian, ZR; Sharma, HS				Feng, Lianyuan; Sharma, Aruna; Niu, Feng; Huang, Yin; Vicente Lafuente, Jose; Muresanu, Dafin Fior; Ozkizilcik, Asya; Tian, Z. Ryan; Sharma, Hari Shanker			TiO2-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following Concussive Head Injury	MOLECULAR NEUROBIOLOGY			English	Article						DL-3-n-butylphthalide (DL-NBP); Concussive head injury (CHI); Blood-brain barrier; Brain edema; Neuronal injury; TiO2 nanodelivery; Neuroprotection	NANOWIRED DRUG-DELIVERY; US MILITARY PERSONNEL; SPINAL-CORD; OXIDATIVE STRESS; UP-REGULATION; I-131 SODIUM; NEUROPROTECTION; ANTIOXIDANT; TRAUMA; MODEL	DL-3-n-butylphthalide (DL-NBP) is one of the constituents of Chinese celery extract that is used to treat stroke, dementia, and ischemic diseases. However, its role in traumatic brain injury is less well known. In this investigation, neuroprotective effects of DL-NBP in concussive head injury (CHI) on brain pathology were explored in a rat model. CHI was inflicted in anesthetized rats by dropping a weight of 114.6 g from a height of 20 cm through a guide tube on the exposed right parietal bone inducing an impact of 0.224 N and allowed them to survive 4 to 24 h after the primary insult. DL-NBP was administered (40 or 60 mg/kg, i.p.) 2 and 4 h after injury in 8-h survival group and 8 and 12 h after trauma in 24-h survival group. In addition, TiO2-nanowired delivery of DL-NBP (20 or 40 mg/kg, i.p.) in 8 and 24 h CHI rats was also examined. Untreated CHI showed a progressive increase in blood-brain barrier (BBB) breakdown to Evans blue albumin (EBA) and radioiodine (I[131]-), edema formation, and neuronal injuries. The magnitude and intensity of these pathological changes were most marked in the left hemisphere. Treatment with DL-NBP significantly reduced brain pathology in CHI following 8 to 12 h at 40-mg dose. However, 60-mg dose is needed to thwart brain pathology at 24 h following CHI. On the other hand, TiO2-DL-NBP was effective in reducing brain damage up to 8 or 12 h using a 20-mg dose and only 40-mg dose was needed for neuroprotection in CHI at 24 h. These observations are the first to suggest that (i) DL-NBP is quite effective in reducing brain pathology and (ii) nanodelivery of DL-NBP has far more superior effects in CHI, not reported earlier.	[Feng, Lianyuan] Bethune Int Peace Hosp, Dept Neurol, Zhongshan Rd West, Shijiazhuang, Hebei, Peoples R China; [Sharma, Aruna; Sharma, Hari Shanker] Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care Med, Cerebrovasc Res Lab, SE-75185 Uppsala, Sweden; [Sharma, Hari Shanker] Uppsala Univ, Univ Hosp, Int Expt CNS Injury & Repair IECNSIR, Frodingsgatan 12,Bldg 28, SE-75421 Uppsala, Sweden; [Niu, Feng; Huang, Yin] CSPC NBP Pharmaceut Med, Zhongshan Rd West, Shijiazhuang, Hebei, Peoples R China; [Vicente Lafuente, Jose] Univ Basque Country UPV EHU, Dept Neurosci, LaNCE, Leioa, Bizkaia, Spain; [Muresanu, Dafin Fior] RoNeuro Inst Neurol Res & Diagnost, 37 Mircea Eliade St, Cluj Napoca 400364, Romania; [Muresanu, Dafin Fior] Univ Med & Pharm, Dept Clin Neurosci, Cluj Napoca, Romania; [Vicente Lafuente, Jose] BioCruces Hlth Res Inst, Nanoneurosurg Grp, Baracaldo 48903, Bizkaia, Spain; [Vicente Lafuente, Jose] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile; [Ozkizilcik, Asya] Univ Arkansas, Dept Biomed Engn, Fayetteville, AR 72701 USA; [Tian, Z. Ryan] Univ Arkansas, Dept Chem & Biochem, J William Fulbright Coll Arts & Sci, Fayetteville, AR 72701 USA	Sharma, HS (corresponding author), Uppsala Univ, Dept Surg Sci Anesthesiol & Intens Care Med, Cerebrovasc Res Lab, SE-75185 Uppsala, Sweden.; Sharma, HS (corresponding author), Uppsala Univ, Univ Hosp, Int Expt CNS Injury & Repair IECNSIR, Frodingsgatan 12,Bldg 28, SE-75421 Uppsala, Sweden.	Sharma@surgsci.uu.se	Muresanu, Fior-Dafin/AAI-8120-2021; Tian, Z. Ryan/R-6671-2016	Tian, Z. Ryan/0000-0002-5644-8483; Ozkizilcik, Asya/0000-0002-6261-9533; Lafuente, Jose-Vicente/0000-0001-7246-0987	Ministry of Science and Technology, People Republic of ChinaMinistry of Science and Technology, China; Air Force Office of Scientific Research (EOARD, London, UK)United States Department of DefenseAir Force Office of Scientific Research (AFOSR); Air Force Material Command, USAF [FA8655-05-1-3065]; Alzheimer's AssociationAlzheimer's Association [IIRG-09-132087]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 AG028679]; Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2710-HSS]; Goran Gustafsson Foundation, Stockholm, Sweden; Astra Zeneca, Molndal, SwedenAstraZeneca; University Grants Commission, New Delhi, IndiaUniversity Grants Commission, India; Ministry of Science and Technology, Govt. of India; Indian Medical Research Council, New Delhi, India; India-EU Co-operation Program; Government of Basque Country; University of Basque Country, Spain [UFI 11/32, PPG 17/51]; Society for Neuroprotection and Neuroplasticity (SSNN), Romania;  [IT 901/16]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG028679] Funding Source: NIH RePORTER	Supported by grants from the Ministry of Science and Technology, People Republic of China, the Air Force Office of Scientific Research (EOARD, London, UK), and Air Force Material Command, USAF, under grant number FA8655-05-1-3065; the Alzheimer's Association (IIRG-09-132087), the National Institutes of Health (R01 AG028679); Swedish Medical Research Council (Nr 2710-HSS), Goran Gustafsson Foundation, Stockholm, Sweden (HSS), Astra Zeneca, Molndal, Sweden (HSS/AS), The University Grants Commission, New Delhi, India (HSS/AS), Ministry of Science and Technology, Govt. of India (HSS/AS), Indian Medical Research Council, New Delhi, India (HSS/AS) and India-EU Co-operation Program (RP/AS/HSS) and IT 901/16 (JVL), Government of Basque Country and UFI 11/32 and PPG 17/51 (JVL) University of Basque Country, Spain, and Society for Neuroprotection and Neuroplasticity (SSNN), Romania. We thank Suraj Sharma, Uppsala, Sweden for computer and graphic support. The U.S. Government is authorized to reproduce and distribute reprints for Government purpose notwithstanding any copyright notation thereon. The views and conclusions contained herein are those of the authors and should not be interpreted as necessarily representing the official policies or endorsements, either expressed or implied, of the Air Force Office of Scientific Research or the US Government.	Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chong ZZ, 2000, CHINESE MED J-PEKING, V113, P613; Chong ZZ, 1999, ACTA PHARMACOL SIN, V20, P509; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Deahl MP, 2011, INT REV PSYCHIATR, V23, P201, DOI 10.3109/09540261.2011.557059; DEY P K, 1984, Indian Journal of Physiology and Pharmacology, V28, P177; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122; Emilien G, 1996, ACTA NEUROL BELG, V96, P89; Feng XH, 2012, NEUROPHARMACOLOGY, V62, P1004, DOI 10.1016/j.neuropharm.2011.10.009; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; Gilhooly Jonathan, 2015, Handb Clin Neurol, V127, P379, DOI 10.1016/B978-0-444-52892-6.00024-6; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; He WF, 2011, NEURAL REGEN RES, V6, P2773, DOI 10.3969/j.issn.1673-5374.2011.35.009; Huang JZ, 2010, NEUROSCI LETT, V475, P89, DOI 10.1016/j.neulet.2010.03.053; Jia JP, 2016, ALZHEIMERS DEMENT, V12, P89, DOI 10.1016/j.jalz.2015.04.010; Kerr HA, 2013, CLIN SPORT MED, V32, P273, DOI 10.1016/j.csm.2012.12.008; Koss KM, 2016, ACTA BIOMATER, V44, P2, DOI 10.1016/j.actbio.2016.08.026; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Li JM, 2010, BRAIN RES, V1359, P216, DOI 10.1016/j.brainres.2010.08.061; Li L, 2009, BRAIN RES, V1290, P91, DOI 10.1016/j.brainres.2009.07.020; Li Qi-Fu, 2008, Sichuan Da Xue Xue Bao Yi Xue Ban, V39, P84; Li YM, 2015, BRAIN INJURY, V29, P981, DOI 10.3109/02699052.2014.989405; Logan BW, 2013, BEHAV SCI LAW, V31, P803, DOI 10.1002/bsl.2092; Lu L, 2016, BIOMACROMOLECULES, V17, P1425, DOI 10.1021/acs.biomac.6b00040; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Maguen S, 2012, J TRAUMA STRESS, V25, P3, DOI 10.1002/jts.21669; Muresanu DF, 2015, MOL NEUROBIOL, V52, P837, DOI 10.1007/s12035-015-9298-8; National Institutes of Health, 2011, GUIDE CARE USE LAB A; OLSSON Y, 1990, ACTA NEUROPATHOL, V79, P595, DOI 10.1007/BF00294236; Paskaski M, 2008, NEUROCHEM INT, V53, P103, DOI 10.1016/j.neuint.2008.06.005; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Ruozi B, 2014, CNS NEUROL DISORD-DR, V13, P1475, DOI 10.2174/1871527313666140806145540; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Scremin OU, 2006, BRAIN RES, V1124, P155, DOI 10.1016/j.brainres.2006.09.062; Sharma A, 2016, CNS NEUROL DISORD-DR, V15, P1092, DOI 10.2174/1871527315666160819123059; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Sharma HS, 2013, AMINO ACIDS, V45, P1055, DOI 10.1007/s00726-013-1584-z; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P197, DOI 10.1196/annals.1403.014; Sharma HS, 2016, CNS NEUROL DISORD-DR, V15, P1045, DOI 10.2174/1871527315666160902145145; Sharma HS, 2012, WIRES NANOMED NANOBI, V4, P184, DOI 10.1002/wnan.172; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; SHARMA HS, 1990, BRAIN RES, V517, P215, DOI 10.1016/0006-8993(90)91029-G; SHARMA HS, 1995, RESTOR NEUROL NEUROS, V7, P207, DOI 10.3233/RNN-1994-7403; SHARMA HS, 1990, ACT NEUR S, V51, P383; SHARMA HS, 1986, J NEUROL SCI, V72, P61, DOI 10.1016/0022-510X(86)90036-5; Tian ZR, 2012, CNS NEUROL DISORD-DR, V11, P86; Wang CY, 2016, NEUROBIOL AGING, V38, P32, DOI 10.1016/j.neurobiolaging.2015.10.024; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Xiong NA, 2012, NEUROBIOL AGING, V33, P1777, DOI 10.1016/j.neurobiolaging.2011.03.007; Xue LX, 2016, EXP THER MED, V11, P2015, DOI 10.3892/etm.2016.3139; Zhang LH, 2012, CURR NEUROVASC RES, V9, P167, DOI 10.2174/156720212801618956; Zhang LH, 2012, NEUROCHEM RES, V37, P911, DOI 10.1007/s11064-011-0663-3; Zhang T, 2010, NEUROL RES, V32, P390, DOI 10.1179/016164110X12670144526264; Zhao HR, 2016, J STROKE CEREBROVASC, V25, P752, DOI 10.1016/j.jstrokecerebrovasdis.2015.11.018; Zhao J, 2016, LIFE SCI, V165, P16, DOI 10.1016/j.lfs.2016.09.009; Zhao WH, 2014, NEURAL REGEN RES, V9, P719, DOI 10.4103/1673-5374.131576	65	13	17	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					350	358		10.1007/s12035-017-0746-5			9	Neurosciences	Neurosciences & Neurology	FV6PC	WOS:000424702600034	28856586				2021-06-18	
J	Guenette, JP; Stern, RA; Tripodis, Y; Chua, AS; Schultz, V; Sydnor, VJ; Somes, N; Karmacharya, S; Lepage, C; Wrobel, P; Alosco, ML; Martin, BM; Chaisson, CE; Coleman, MJ; Lin, AP; Pasternak, O; Makris, N; Shenton, ME; Koerte, IK				Guenette, Jeffrey P.; Stern, Robert A.; Tripodis, Yorghos; Chua, Alicia S.; Schultz, Vivian; Sydnor, Valerie J.; Somes, Nathaniel; Karmacharya, Sarina; Lepage, Christian; Wrobel, Pawel; Alosco, Michael L.; Martin, Brett M.; Chaisson, Christine E.; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.; Koerte, Inga K.			Automated versus manual segmentation of brain region volumes in former football players	NEUROIMAGE-CLINICAL			English	Article						Magnetic resonance imaging; Neuroimaging; Head trauma; Traumatic brain injury; Chronic traumatic encephalopathy	CHRONIC TRAUMATIC ENCEPHALOPATHY; VENTRICULAR ENLARGEMENT; HIPPOCAMPUS SEGMENTATION; ALZHEIMERS-DISEASE; AMYGDALA VOLUMES; METAANALYSIS; FREESURFER; ATROPHY; SCHIZOPHRENIA; RELIABILITY	Objectives: To determine whether or not automated FreeSurfer segmentation of brain regions considered important in repetitive head trauma can be analyzed accurately without manual correction. Materials and methods: 3 T MR neuroimaging was performed with automated FreeSurfer segmentation and manual correction of 11 brain regions in former National Football League (NFL) players with neurobehavioral symptoms and in control subjects. Automated segmentation and manually-corrected volumes were compared using an intraclass correlation coefficient (ICC). Linear mixed effects regression models were also used to estimate between-group mean volume comparisons and to correlate former NFL player brain volumes with neurobehavioral factors. Results: Eighty-six former NFL players (55.2 +/- 8.0 years) and 22 control subjects (57.0 +/- 6.6 years) were evaluated. ICC was highly correlated between automated and manually-corrected corpus callosum volumes (0.911), lateral ventricular volumes (right 0.980, left 0.967), and amygdala-hippocampal complex volumes (right 0.713, left 0.731), but less correlated when amygdalae (right -0.170, left -0.090) and hippocampi (right 0.539, left 0.637) volumes were separately delineated and also less correlated for cingulate gyri volumes (right 0.639, left 0.351). Statistically significant differences between former NFL player and controls were identified in 8 of 11 regions with manual correction but in only 4 of 11 regions without such correction. Within NFL players, manually corrected brain volumes were significantly associated with 3 neurobehavioral factors, but a different set of 3 brain regions and neurobehavioral factor correlations was observed for brain region volumes segmented without manual correction. Conclusions: Automated FreeSurfer segmentation of the corpus callosum, lateral ventricles, and amygdala-hippocampus complex may be appropriate for analysis without manual correction. However, FreeSurfer segmentation of the amygdala, hippocampus, and cingulate gyrus need further manual correction prior to performing group comparisons and correlations with neurobehavioral measures.	[Guenette, Jeffrey P.; Schultz, Vivian; Sydnor, Valerie J.; Somes, Nathaniel; Karmacharya, Sarina; Lepage, Christian; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA USA; [Guenette, Jeffrey P.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA; [Stern, Robert A.; Tripodis, Yorghos; Alosco, Michael L.; Chaisson, Christine E.] Boston Univ, BU Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Tripodis, Yorghos; Chua, Alicia S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Schultz, Vivian; Wrobel, Pawel; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Martin, Brett M.; Chaisson, Christine E.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Lin, Alexander P.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Clin Spect, Boston, MA USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Neural Syst Invest, Boston, MA 02114 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA	Koerte, IK (corresponding author), Psychiat Neuroimaging Lab, 1249 Boylston St, Boston, MA 02215 USA.	ikoerte@bwh.harvard.edu	Shenton, Martha/V-8780-2019; , Bob/ABA-8507-2020; Chua, Alicia/AAA-3628-2019	Guenette, Jeffrey/0000-0002-4684-5469; Sydnor, Valerie/0000-0002-8640-668X; Chua, Alicia/0000-0001-6908-8539; Tripodis, Yorghos/0000-0003-2190-7608	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 078337, R01 NS100952, F31 NS 081957, 1F32NS096803-01, P30 AG13846, P41 EB015902, T32GM074905]; JetBlue Airlines; National Football League; NFL Players Association; Else Kroner-Fresenius Foundation, Germany (IK); LMU Munich's Institutional Strategy LMUexcellent; VA Merit AwardUS Department of Veterans Affairs; German Academic Exchange Service PROMOS award; Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral AwardCanadian Institutes of Health Research (CIHR); medical faculty of the Ludwig-Maximillian University Munich; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F32NS096803, F31NS081957, R01NS100952, R01NS078337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	This study was supported by the NIH (R01 NS 078337 (RAS, YT, CMB, NGF, BMM, CC); R01 NS100952 (IK, APL); F31 NS 081957 (JMS); 1F32NS096803-01 (MLA), P30 AG13846 (RAS, YT, MLA, CMB, BMM, CC); P41 EB015902 (OP); T32GM074905 (IW)), and participant travel was partially funded by JetBlue Airlines, the National Football League, and the NFL Players Association. This study was also partly supported by the Else Kroner-Fresenius Foundation, Germany (IK), by LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative, and by a VA Merit Award (MES, MC). PW and VS were supported by the German Academic Exchange Service PROMOS award. PW was also supported by an international research scholarship by the medical faculty of the Ludwig-Maximillian University Munich. This work was completed in partial fulfillment of VS's dissertation. CL was supported by the Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral Award. The sponsors had no role in the design and conduct of the study, the collection, analysis, or the interpretation of the data, nor in the preparation, review, or approval of the manuscript, or the decision of submission for publication.	Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; Akhondi-Asl A, 2011, NEUROIMAGE, V54, pS218, DOI 10.1016/j.neuroimage.2010.03.066; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; BARRON SA, 1976, NEUROLOGY, V26, P1011, DOI 10.1212/WNL.26.11.1011; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; BIGELOW LB, 1983, BRIT J PSYCHIAT, V142, P284, DOI 10.1192/bjp.142.3.284; Buckner RL, 2004, NEUROIMAGE, V23, P724, DOI 10.1016/j.neuroimage.2004.06.018; Busatto Geraldo F, 2008, Expert Rev Neurother, V8, P1691, DOI 10.1586/14737175.8.11.1691; Chera BS, 2009, AM J CLIN ONCOL-CANC, V32, P20, DOI 10.1097/COC.0b013e318178e4e8; Cherbuin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005265; Chua AS, 2015, NEUROIMAGE, V119, P81, DOI 10.1016/j.neuroimage.2015.06.037; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; de Flores R, 2015, HUM BRAIN MAPP, V36, P463, DOI 10.1002/hbm.22640; Dill V, 2015, NEUROINFORMATICS, V13, P133, DOI 10.1007/s12021-014-9243-4; Evangelou N, 2000, BRAIN, V123, P1845, DOI 10.1093/brain/123.9.1845; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOX JH, 1976, JAMA-J AM MED ASSOC, V236, P365, DOI 10.1001/jama.236.4.365; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Gonzalez-Villa S, 2016, ARTIF INTELL MED, V73, P45, DOI 10.1016/j.artmed.2016.09.001; Grimm O, 2015, J NEUROSCI METH, V253, P254, DOI 10.1016/j.jneumeth.2015.05.024; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Haller S, 2016, RADIOLOGY, V281, P337, DOI 10.1148/radiol.2016150789; Inglese P, 2015, PHYS MEDICA, V31, P1085, DOI 10.1016/j.ejmp.2015.08.003; Kantarci K, 2003, NEUROIMAG CLIN N AM, V13, P197, DOI 10.1016/S1052-5149(03)00025-X; Kempton MJ, 2010, SCHIZOPHR RES, V120, P54, DOI 10.1016/j.schres.2010.03.036; Kiernan J A, 2012, Epilepsy Res Treat, V2012, P176157, DOI 10.1155/2012/176157; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Laurent S, 2010, J COMP PATHOL, V143, P75, DOI 10.1016/j.jcpa.2009.12.008; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mendrik AM, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/813696; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Milani ACC, 2017, PSYCHIAT CLIN NEUROS, V71, P154, DOI 10.1111/pcn.12473; Morey RA, 2009, NEUROIMAGE, V45, P855, DOI 10.1016/j.neuroimage.2008.12.033; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Naess-Schmidt E, 2016, INT J COMPUT ASS RAD, V11, P1979, DOI 10.1007/s11548-016-1433-0; Nestor SM, 2008, BRAIN, V131, P2443, DOI 10.1093/brain/awn146; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Olabi B, 2011, BIOL PSYCHIAT, V70, P88, DOI 10.1016/j.biopsych.2011.01.032; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pol HEH, 2008, SCHIZOPHRENIA BULL, V34, P354, DOI 10.1093/schbul/sbm168; Pruessner JC, 2000, CEREB CORTEX, V10, P433, DOI 10.1093/cercor/10.4.433; ROSENTHAL R, 1972, BRIT J PSYCHIAT, V121, P259, DOI 10.1192/bjp.121.3.259; Schoemaker D, 2016, NEUROIMAGE, V129, P1, DOI 10.1016/j.neuroimage.2016.01.038; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shenton Martha E, 2010, Dialogues Clin Neurosci, V12, P317; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Turner B, 2003, MULT SCLER, V9, P21, DOI 10.1191/1352458503ms868oa; Wenger E, 2014, HUM BRAIN MAPP, V35, P4236, DOI 10.1002/hbm.22473; Wible CG, 1997, PSYCHIAT RES-NEUROIM, V76, P29, DOI 10.1016/S0925-4927(97)00060-7	57	13	13	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						888	896		10.1016/j.nicl.2018.03.026			9	Neuroimaging	Neurosciences & Neurology	GH1NG	WOS:000433169000090	29876273	DOAJ Gold, Green Published			2021-06-18	
J	Haarbauer-Krupa, J; Lundine, JP; DePompei, R; King, TZ				Haarbauer-Krupa, Juliet; Lundine, Jennifer P.; DePompei, Roberta; King, Tricia Z.			Rehabilitation and school services following traumatic brain injury in young children	NEUROREHABILITATION			English	Article						Traumatic brain injury; rehabilitation; school service; young children	HEALTH-CARE UTILIZATION; MANAGEMENT; NEEDS	BACKGROUND: Preschool children have the highest incidence of emergency department visits for traumatic brain injury (TBI) with the majority discharged home without a single point of entry into follow-up services. This paper describes families' experience with service access following TBI. OBJECTIVES: To describe parent reported service utilization following preschool TBI and examine predictors of service access. METHODS: Participants (N = 80) were drawn from the first visit of a longitudinal study examining elementary school outcomes following TBI. Parents were interviewed about their service history. Descriptive statistics analyzed sample demographics. Logistic regression examined associations between injury related factors and service utilization. RESULTS: TBI participants had mild injuries (83%) and were either discharged to home or spent less than a week in the hospital. No TBI participants received inpatient rehabilitation and only a portion of the sample (26%) received outpatient treatment. Length of hospital stay was a significant predictor of service access (Wald = 4.33, df = 1, p = 0.040). All children were enrolled in preschool without accommodations. CONCLUSION: Currently no systematic continuum of care exists for children with TBI injured prior to elementary school, despite availability of healthcare, education and state based resources. Healthcare professionals in contact with young children can help with follow-up by educating parents about TBI effects on learning.	[Haarbauer-Krupa, Juliet] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Lundine, Jennifer P.] Ohio State Univ, Sch Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH USA; [DePompei, Roberta] Univ Akron, Sch Speech Language Pathol, Akron, OH 44325 USA; [King, Tricia Z.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [King, Tricia Z.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA	Haarbauer-Krupa, J (corresponding author), 3172 Wicks Creek Trail, Marietta, GA 30062 USA.	jhkrupa@me.com	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G110109]	This study is sponsored by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (Formerly the National Institute National Institute on Disability and Rehabilitation Research (NIDRR)), Grant number H133G110109.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Brain and Spinal Injury Trust Fund Commission, 2010, REP NUMB EM DEP VIS; Ciccia AH, 2016, AM J SPEECH-LANG PAT, V25, P508, DOI 10.1044/2016_AJSLP-15-0087; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greene N. H., 2014, ARCH PHYS MED REHAB, V10, P180; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Haarbauer-Krupa J., 2012, ASHA LEADER, V17, P10, DOI DOI 10.1044/LEADER.FTR1.17082012.10; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Laughlin L., 2013, WHOS MINDING KIDS CH; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Spaw AJ, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000314; Taylor C. A., 2017, MMWR; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; U.S. Department of Education ED Facts DataWarehouse (EDW), IDEA B; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604	25	13	13	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					259	267		10.3233/NRE-172410			9	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300002	29660968				2021-06-18	
J	He, FP; Wu, M; Meng, FX; Hu, YF; Gao, J; Chen, ZQ; Bao, WX; Liu, KH; Luo, BY; Pan, G				He, Fangping; Wu, Min; Meng, Fanxia; Hu, Yangfan; Gao, Jian; Chen, Zhongqin; Bao, Wangxiao; Liu, Kehong; Luo, Benyan; Pan, Gang			Effects of 20Hz Repetitive Transcranial Magnetic Stimulation on Disorders of Consciousness: A Resting-State Electroencephalography Study	NEURAL PLASTICITY			English	Article							MOTOR CORTEX; BRAIN-STIMULATION; VEGETATIVE STATE; COMA; CONNECTIVITY; PLASTICITY; RECOVERY	Repetitive transcranial magnetic stimulation (rTMS) has been proposed as an experimental approach for the treatment of disorders of consciousness (DOC). To date, there has been little research into the use of rTMS in DOC and the therapeutic effects have been variously documented. This study aimed to examine the effects of 20 Hz rTMS on the electroencephalography (EEG) reactivity and clinical response in patients with DOC and to explore the neuromodulatory effects of high-frequency rTMS. In this randomized, sham-controlled, crossover study, real or sham 20 Hz rTMS was applied to the left primary motor cortex (M1) of patients with DOC for 5 consecutive days. Evaluations were blindly performed at the baseline (T0), immediately after the end of the 5 days of treatment (T1) and 1 week after the treatment (T2) using the JFK coma recovery scale-revised (CRS-R) and resting-state EEG. Only one patient, with a history of 2 months of traumatic brain injury, showed long-lasting (T1, T2) behavioral and neurophysiological modifications after the real rTMS stimulation. The 5 remaining patients presented brain reactivity localized at several electrodes, and the EEG modification was not significant. rTMS stimulation may improve awareness and arousal of DOC. Additionally, EEG represents a potential biomarker for the therapeutic efficacy of rTMS.	[He, Fangping; Wu, Min; Meng, Fanxia; Chen, Zhongqin; Bao, Wangxiao; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China; [He, Fangping; Wu, Min; Meng, Fanxia; Chen, Zhongqin; Bao, Wangxiao; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Yangfan; Pan, Gang] Zhejiang Univ, Dept Comp Sci, Hangzhou 310007, Zhejiang, Peoples R China; [Gao, Jian; Liu, Kehong] Zhejiang Armed Police Corps, Hangzhou Hosp, Dept Rehabil, Hangzhou 310051, Zhejiang, Peoples R China; [Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Brain Sci, Hangzhou 310003, Zhejiang, Peoples R China	Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurol, Hangzhou 310003, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Brain Med Ctr, Hangzhou 310003, Zhejiang, Peoples R China.; Pan, G (corresponding author), Zhejiang Univ, Dept Comp Sci, Hangzhou 310007, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Collaborat Innovat Ctr Brain Sci, Hangzhou 310003, Zhejiang, Peoples R China.	luobenyan@zju.edu.cn; gpan@zju.edu.cn	Pan, Gang/B-5978-2013	Pan, Gang/0000-0002-4049-6181; Wu, Min/0000-0001-8753-0327	National Key Basic Research Program of ChinaNational Basic Research Program of China [2013CB329504]; General Project Plan of Zhejiang Medical Technology [2017C03011, 2014RCA007]; Medical Science and Technology Project [2016152769]	This work was supported by grants from the National Key Basic Research Program of China (2013CB329504), the General Project Plan of Zhejiang Medical Technology (2017C03011, 2014RCA007), and the Medical Science and Technology Project cofounded by Zhejiang Province and the Ministry of Health of China (2016152769).	ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; ASHWAL S, 1995, NEW ENGL J MED, V333, P130, DOI 10.1056/NEJM199507133330216; Babiloni C, 2009, CLIN NEUROPHYSIOL, V120, P719, DOI 10.1016/j.clinph.2009.02.157; Chervyakov AV, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00303; Chou YH, 2015, JAMA NEUROL, V72, P432, DOI 10.1001/jamaneurol.2014.4380; Cincotta M, 2015, CORTEX, V71, P368, DOI 10.1016/j.cortex.2015.07.027; Ciurleo R, 2013, DRUGS, V73, P1849, DOI 10.1007/s40265-013-0138-8; Daltrozzo J, 2007, CLIN NEUROPHYSIOL, V118, P606, DOI 10.1016/j.clinph.2006.11.019; Demertzi A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00245; Ferrarelli F, 2010, P NATL ACAD SCI USA, V107, P2681, DOI 10.1073/pnas.0913008107; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Gosseries O, 2011, FUNCT NEUROL, V26, P25; Guse B, 2010, J NEURAL TRANSM, V117, P105, DOI 10.1007/s00702-009-0333-7; Holler Y, 2014, CLIN NEUROPHYSIOL, V125, P1545, DOI 10.1016/j.clinph.2013.12.095; Howell K, 2013, RESUSCITATION, V84, P1409, DOI 10.1016/j.resuscitation.2013.05.015; Johnson JS, 2010, BRAIN TOPOGR, V22, P281, DOI 10.1007/s10548-009-0118-1; Leon-Carrion J, 2008, CLIN NEUROPHYSIOL, V119, P1506, DOI 10.1016/j.clinph.2008.03.030; Liu P, 2016, EUR NEUROL, V76, P1, DOI 10.1159/000447325; Lord V, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00397; Machado C, 2002, NEUROLOGY, V59, P1473; Manganotti P, 2013, BRAIN STIMUL, V6, P913, DOI 10.1016/j.brs.2013.06.006; Naro A., 2014, NEUROREHABILITATION, V29, P603; Okamura H, 2001, J CLIN NEUROPHYSIOL, V18, P318, DOI 10.1097/00004691-200107000-00003; Piccione F, 2011, NEUROREHAB NEURAL RE, V25, P98, DOI 10.1177/1545968310369802; Pisani LR, 2015, CONSCIOUS COGN, V38, P1, DOI 10.1016/j.concog.2015.09.012; Rachid F., 2017, PSYCHIAT RES; Rajan TS, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00457; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rossiter HE, 2014, NEUROIMAGE, V91, P360, DOI 10.1016/j.neuroimage.2014.01.012; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Simis M, 2013, NEUROREPORT, V24, P973, DOI 10.1097/WNR.0000000000000021; Sitt JD, 2014, BRAIN, V137, P2258, DOI 10.1093/brain/awu141; Tergau F, 1999, LANCET, V353, P2209, DOI 10.1016/S0140-6736(99)01301-X; Vernieri F, 2009, CLIN NEUROPHYSIOL, V120, P1188, DOI 10.1016/j.clinph.2009.03.021; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	38	13	15	1	11	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2018	2018								5036184	10.1155/2018/5036184			8	Neurosciences	Neurosciences & Neurology	GC3JY	WOS:000429681300001	29770146	DOAJ Gold, Green Published			2021-06-18	
J	Kreutzer, JS; Marwitz, JH; Sima, AP; Mills, A; Hsu, NH; Lukow, HR				Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Sima, Adam P.; Mills, Ana; Hsu, Nancy H.; Lukow, Herman R.			Efficacy of the resilience and adjustment intervention after traumatic brain injury: a randomized controlled trial	BRAIN INJURY			English	Article						Intervention; resilience; psychological adjustment; psychological distress	CONNOR-DAVIDSON RESILIENCE; COGNITIVE-BEHAVIOR THERAPY; EMOTIONAL ADJUSTMENT; FAMILY INTERVENTION; REHABILITATION; OUTCOMES; METAANALYSIS; PREDICTORS; SCALE; RECOVERY	Objective: Examine a psychoeducational and skill-building intervention's effectiveness for individuals after traumatic brain injury (TBI), using a two-arm, parallel, randomized, controlled trial with wait-listed control.Methods: The Resilience and Adjustment Intervention (RAI) targets adjustment challenges and emphasizes education, skill-building and psychological support. Overall, 160 outpatients were randomly assigned to a treatment or wait-list control (WLC) group. The manualized treatment was delivered in seven 1-h sessions. The Connor-Davidson Resilience Scale (CD-RISC) was the primary outcome measure. Secondary measures included the Mayo Portland Adaptability Inventory-4 (MPAI-4), Brief Symptom Inventory-18 (BSI-18) and 13-Item Stress Test.Results: After adjusting for injury severity, education and time postinjury, the RAI group (N=75) demonstrated a significantly greater increase in resilience (effect size=1.03) compared to the WLC group (N=73). Participants in the RAI group demonstrated more favourable scores on the MPAI-4 Adjustment and Ability Indices, BSI-18 and the 13-item Stress Test. However, only the CD-RISC and BSI-18 demonstrated a clinically significant difference. In addition, RAI participants demonstrated maintenance of gains from pre-treatment to 3-month follow-up; however, only the BSI-18 maintained a clinically significant difference.Conclusions: Investigation provided evidence that a resilience-focused intervention can improve psychological health and adjustment after TBI. Additional research is needed to ascertain the longer term benefits of intervention and the efficacy of alternative delivery methods (e.g., via telephone, Internet).	[Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Mills, Ana; Hsu, Nancy H.; Lukow, Herman R.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA	Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Box 980542, Richmond, VA 23284 USA.	jennifer.marwitz@vcuhealth.org		Sima, Adam/0000-0001-8426-9987	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0033, 90AR5002]	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DP0033, 90AR5002). NIDILRR is a centre within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cosco TD, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0418-6; Derogatis L., 2000, BRIEF SYMPTOM INVENT; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Ellis A., 1975, NEW GUIDE RATIONAL L; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hodgson J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Kreutzer J, 2012, GETTING BETTER BETTE; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Kreutzer JS, 2014, RESILIENCE ADJUSTMEN; Kreutzer JS, 1999, GETTING BETTER BETTE; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Malec JF, 2008, MAYO PORTLAND ADAPTA; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Ungar M, 2013, TRAUMA VIOLENCE ABUS, V14, P255, DOI 10.1177/1524838013487805; Vikane E, 2017, BRAIN INJURY, V31, P1; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2012, ARCH PHYS MED REHAB, V93, pS101, DOI 10.1016/j.apmr.2011.11.040; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	68	13	13	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		963	971		10.1080/02699052.2018.1468577			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400002	29792533				2021-06-18	
J	McAvoy, K; Eagan-Johnson, B; Halstead, M				McAvoy, Karen; Eagan-Johnson, Brenda; Halstead, Mark			Return to learn: Transitioning to school and through ascending levels of academic support for students following a concussion	NEUROREHABILITATION			English	Article						Concussion; return to learn (RTL); return to play (RTP); return to sport (RTS); 504 plan; Individualized Health Plan (IHP); Individualized Education Plan (IEP); Individuals with Disabilities Education Act (IDEA); Traumatic Brain Injury (TBI)		PURPOSE: The purpose of this article is to familiarize healthcare providers and parents with educational language, laws, and processes as they relate to a comprehensive ascending level of academic supports as it pertains to promoting a smooth and supported transition to school following a concussion. BACKGROUND: Returning to learn (RTL) following a concussion is of parallel importance to returning to sport (RTS). A successful RTL is a critical part of concussion management. Many RTL articles advise healthcare providers and parents to request formalized educational supports, also known as Tier 2 or Tier 3 services, for children with concussion as they return to school. FINDINGS: Premature requests for formal (Tier 2 or 3) educational services, rather than allowing for immediate informal educational supports (known as Tier 1), can actually delay academic supports and have the potential to cause adversarial relationships between parents and schools. Additionally, this practice contradicts current research demonstrating the need for fast, flexible, temporary academic supports within the first month post-injury. CONCLUSION: Allowing school districts to direct the application of existing ascending levels of educational support for students with concussion as they return to school can promote robust and positive outcomes.	[McAvoy, Karen] Rocky Mt Hosp Children, Lone Tree, CO USA; [Eagan-Johnson, Brenda] BrainSTEPS Program, New Castle, PA USA; [Halstead, Mark] Washington Univ, Sports Med, St Louis, MO USA	McAvoy, K (corresponding author), 631 Peterson St, Ft Collins, CO 80524 USA.	KarenMcAvoy11@gmail.com					Building the Legacy: IDEA, 2004, BUILD LEG IDEA 2004; Centers for Disease Control and Prevention, 2017, TBI GET THE FACTS; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; McAvoy & Eagan Brown, 2015, GET SCH CONC RET LEA; McCrory P., 2017, BRIT J SPORTS MED; National Association of School Nurses, 2016, CONC ROL SCH NURS; Pennsylvania Department of Education, 2014, SPEC ED TIM; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; US Department of Education, OSEP FUND TECHN ASS; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zirkel PA, 2015, J SCH NURS, V31, P99, DOI 10.1177/1059840514521465	13	13	13	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					325	330		10.3233/NRE-172381			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300008	29660962				2021-06-18	
J	Vik, BMD; Skeie, GO; Vikane, E; Specht, K				Vik, Berit Marie Dykesteen; Skeie, Geir Olve; Vikane, Eirik; Specht, Karsten			Effects of music production on cortical plasticity within cognitive rehabilitation of patients with mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); neuroplasticity; cognitive rehabilitation; fMRI; music-supported intervention	THERAPY	Objective: We explored the effects of playing the piano on patients with cognitive impairment after mild traumatic brain injury (mTBI) and, addressed the question if this approach would stimulate neural networks in re-routing neural connections and link up cortical circuits that had been functional inhibited due to disruption of brain tissue. Functional neuroimaging scans (fMRI) and neuropsychological tests were performed pre-post intervention. Method: Three groups participated, one mTBI group (n=7), two groups of healthy participants, one with music training (n=11), one baseline group without music (n=12). The music groups participated in 8weeks music-supported intervention. Results: The patient group revealed training-related neuroplasticity in the orbitofrontal cortex. fMRI results fit well with outcome from neuropsychological tests with significant enhancement of cognitive performance in the music groups. Ninety per cent of mTBI group returned to work post intervention. Conclusion: Here, for the first time, we demonstrated behavioural improvements and functional brain changes after 8weeks of playing piano on patients with mTBI having attention, memory and social interaction problems. We present evidence for a causal relationship between musical training and reorganisation of neural networks promoting enhanced cognitive performance. These results add a novel music-supported intervention within rehabilitation of patients with cognitive deficits following mTBI.	[Vik, Berit Marie Dykesteen; Specht, Karsten] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Skeie, Geir Olve] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Skeie, Geir Olve] Univ Bergen, Grieg Acad Res Ctr Mus Therapy GAMUT, Bergen, Norway; [Vikane, Eirik] Haukeland Hosp, Dept Phys Med & Rehabil, Bergen, Norway; [Specht, Karsten] UiT, Dept Educ, Tromso, Norway	Vik, BMD (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	vikmusic@online.no	Specht, Karsten/C-3762-2009	Specht, Karsten/0000-0002-9946-3704	Research Council of NorwayResearch Council of Norway [217932]	The authors thank all the participants who took time to participate in the study and the staff of the radiological department of the Haukeland University Hospital (Bergen, Norway) for their help during data acquisition. The study was supported by a grant to KS from the Research Council of Norway (217932: It's time for some music).	Altenmuller E, 2016, CLIN NEUROPHYSIOL, V127, pe22, DOI [10.1016/j.clinph.2015.11.062, DOI 10.1016/J.CLINPH.2015.11.062]; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2006, COMPHR REH 4 C UNPUB; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Dalla Bella S, 2015, ANN NY ACAD SCI, V1337, P77, DOI 10.1111/nyas.12651; Delafresnaye, 1961, BRAIN MECH LEARNING; Deutsch D., 1982, PSYCHOL MUSIC; Gordon HW, 1983, FUNCTIONS RIGHT CERE; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Herholz SC, 2016, CEREB CORTEX, V26, P3125, DOI 10.1093/cercor/bhv138; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Pantev C, 2009, NEUROSCIENCES MUSIC; Parsons L, 2008, BRIT RES ASS M; Parsons LM, 2005, NEUROPSYCHOLOGIA, V43, P199, DOI 10.1016/j.neuropsychologia.2004.11.007; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Rojo N, 2011, BRAIN INJURY, V25, P787, DOI 10.3109/02699052.2011.576305; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2014, CORTEX, V59, P185, DOI 10.1016/j.cortex.2014.01.020; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Sarkamo T, 2013, WIRES COGN SCI, V4, P441, DOI 10.1002/wcs.1237; Schiavio A, 2015, FRONT NEUROL, V19, P6; Schlaug G., 2009, OXFORD HDB MUSIC PSY, P197; Schlaug G, 2009, OXFORD HDB MUSIC PSY; Stewart L, 2001, CURR BIOL, V11, pR125, DOI 10.1016/S0960-9822(01)00058-6; TEASDALE G, 1974, LANCET, V2, P81; Thaut MH, 2010, MUSIC PERCEPT, V27, P281, DOI 10.1525/MP.2010.27.4.281; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Zatorre R, 2007, COGNITIVE NEUROSCIEN, P232	33	13	13	2	26	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					634	643		10.1080/02699052.2018.1431842			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200015	29388854	Bronze			2021-06-18	
J	Wang, JY; Li, HYZ; Ren, YC; Yao, Y; Hu, J; Zheng, MZ; Ding, YM; Chen, YY; Shen, YL; Wang, LL; Zhu, YJ				Wang, Jingyu; Li, Heyangzi; Ren, Yucheng; Yao, Ying; Hu, Jue; Zheng, Mingzhi; Ding, Yuemin; Chen, Ying-ying; Shen, Yueliang; Wang, Lin-lin; Zhu, Yongjian			Local Delivery of beta-Elemene Improves Locomotor Functional Recovery by Alleviating Endoplasmic Reticulum Stress and Reducing Neuronal Apoptosis in Rats with Spinal Cord Injury	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						beta-elemene; Spinal cord injury; Motor neurons; ER stress; Apoptosis	UNFOLDED-PROTEIN RESPONSE; ISCHEMIA-REPERFUSION INJURY; SIGNALING-PATHWAY; STEM-CELLS; MESENCHYMAL TRANSITION; GLIOBLASTOMA CELLS; OXIDATIVE STRESS; EPITHELIAL-CELLS; TRAUMATIC BRAIN; IN-VITRO	Background/Aims: Spinal cord injury (SCI) is a serious global problem that leads to permanent motor and sensory deficits. This study explores the anti-apoptotic and neuroprotective effects of the natural extract beta-elemene in vitro and in a rat model of SCI. Methods: CCK-8 assay was used to evaluate cell viability and lactate dehydrogenase assay was used to evaluate cytotoxicity. A model of cell injury was established using cobalt chloride. Apoptosis was evaluated using a fluorescence-activated cell sorting assay of annexin V-FITC and propidium iodide staining. A rat SCI model was created via the modified Allen's method and Basso, Beattie, and Bresnahan (BBB) scores were used to assess locomotor function. Inflammatory responses were assessed via enzyme-linked immunosorbent assay (ELISA). Apoptotic and surviving neurons in the ventral horn were respectively observed via terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining and Nissl staining. Western blotting was used to measure protein expression. Results: beta-elemene (20 mu g/ml) promoted cell viability by activating phosphorylation of the PI3K-AKT-mTOR pathway. beta-elemene reduced CoCl 2 induced cellular death and apoptosis by suppressing the expression levels of CHOP, cleavedcaspase 12, 78-kilodalton glucose-regulated protein, cleaved-caspase 3, and the Bax/Bcl-2 ratio. In the rat model of SCI, Nissl and TUNEL staining showed that beta-elemene promoted motor neuron survival and reduced neuronal apoptosis in the spinal cord ventral horn. BBB scores showed that beta-elemene significantly promoted locomotor behavioral recovery after SCI. In addition, beta-elemene reduced the ELISA-detected secretion of interleukin (IL)-6 and IL-1 beta. Conclusion: beta-elemene reduces neuronal apoptosis by alleviating endoplasmic reticulum stress in vitro and in vivo. In addition, beta-elemene promotes locomotor function recovery and tissue repair in SCI rats. Thus, our study provides a novel encouraging strategy for the potential treatment of beta-elemene in SCI patients. (c) 2018 The Author(s) Published by S. Karger AG, Basel.	[Wang, Jingyu; Yao, Ying; Zhu, Yongjian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Heyangzi; Ren, Yucheng; Chen, Ying-ying; Shen, Yueliang; Wang, Lin-lin] Zhejiang Univ, Sch Med, Dept Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Hu, Jue; Zheng, Mingzhi] Zhejiang Med Coll, Dept Pharmacol, Hangzhou, Zhejiang, Peoples R China; [Ding, Yuemin] Zhejiang Univ City Coll, Sch Med, Hangzhou, Zhejiang, Peoples R China	Wang, LL; Zhu, YJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310058, Zhejiang, Peoples R China.	wanglinlin@zju.edu.cn; neurosurgery@zju.edu.cn	yongjian, zhu/AAR-5445-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81572229, 81673777, 81371953]	This study was supported by the National Natural Science Foundation of China (No. 81572229, 81673777, and 81371953).	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anna Z, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/3978595; Aufenberg C, 2005, J NEUROTRAUM, V22, P1018, DOI 10.1089/neu.2005.22.1018; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024; Bertolotti A, 2000, NAT CELL BIOL, V2, P326; Bi YH, 2017, CELL PHYSIOL BIOCHEM, V43, P481, DOI 10.1159/000480474; Chen JC, 2015, CHIN J NAT MEDICINES, V13; Chen JC, 2014, BIOORG MED CHEM LETT, V24, P3407, DOI 10.1016/j.bmcl.2014.05.078; Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dobkin BH, 2004, ANNU REV MED, V55, P255, DOI 10.1146/annurev.med.55.091902.104338; Fu PP, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00255; Gao YN, 2017, CELL PHYSIOL BIOCHEM, V43, P1503, DOI 10.1159/000481974; de la Cadena SG, 2016, APOPTOSIS, V21, P763, DOI 10.1007/s10495-016-1247-0; Gu CL, 2017, NEUROSCI LETT, V636, P282, DOI 10.1016/j.neulet.2016.11.032; Harding HP, 1999, NATURE, V397, P271; He JC, 2017, CELL PHYSIOL BIOCHEM, V44, P1224, DOI 10.1159/000485452; He ZL, 2017, AM J TRANSL RES, V9, P1075; Hetz C, 2015, NAT CELL BIOL, V17, P829, DOI 10.1038/ncb3184; Cornejo VH, 2013, IUBMB LIFE, V65, P962, DOI 10.1002/iub.1224; Ji S, 2017, J CANCER, V8, P555, DOI 10.7150/jca.17205; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Li XQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21010; Liang D, 2012, J CANCER RES CLIN, V138, P1865, DOI 10.1007/s00432-012-1256-5; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Lopez-Sanchez LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099143; Mu L, 2016, INT J ONCOL, V49, P1427, DOI 10.3892/ijo.2016.3626; Nicola FD, 2017, BRAIN RES, V1663, P95, DOI 10.1016/j.brainres.2017.03.015; Ohri SS, 2012, J NEUROTRAUM, V29, P579, DOI 10.1089/neu.2011.1940; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Sadidi M, 2009, BIOCHIMIE, V91, P577, DOI 10.1016/j.biochi.2009.01.010; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Taiyab A, 2016, INVEST OPHTH VIS SCI, V57, P5736, DOI 10.1167/iovs.16-20162; Tohda C, 2011, PHARMACOL THERAPEUT, V132, P57, DOI 10.1016/j.pharmthera.2011.05.006; Wang C, 2016, NEUROCHEM INT, V97, P15, DOI 10.1016/j.neuint.2016.04.015; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wu JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00626-6; Yang GL, 2016, MOL MED REP, V13, P2583, DOI 10.3892/mmr.2016.4836; Yao XL, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010473; Yao YQ, 2008, CANCER LETT, V264, P127, DOI 10.1016/j.canlet.2008.01.049; Yeo JE, 2008, CELL PHYSIOL BIOCHEM, V21, P225, DOI 10.1159/000113764; Ying CJ, 2017, BIOMED PHARMACOTHER, V90, P796, DOI 10.1016/j.biopha.2017.04.013; Zhang DP, 2016, CELL PHYSIOL BIOCHEM, V39, P1152, DOI 10.1159/000447822; Zhang J, 2018, J CELL PHYSIOL, V233, P7071, DOI 10.1002/jcp.26630; Zhu LL, 2017, CELL PHYSIOL BIOCHEM, V44, P388, DOI 10.1159/000484919; Zhu TZ, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0727-2; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	52	13	17	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2018	49	2					595	609		10.1159/000492996			15	Cell Biology; Physiology	Cell Biology; Physiology	GT0KA	WOS:000444125900014	30165357	DOAJ Gold			2021-06-18	
J	Zhao, J; Hylin, MJ; Kobori, N; Hood, KN; Moore, AN; Dash, PK				Zhao, Jing; Hylin, Michael J.; Kobori, Nobuhide; Hood, Kimberly N.; Moore, Anthony N.; Dash, Pramod K.			Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier permeability; cholinergic neurotransmission; GABAergic neurodegeneration; memory impairments; microglial polarization	CHOLINERGIC RECEPTOR-BINDING; ADULT HIPPOCAMPAL NEUROGENESIS; CORTICAL IMPACT INJURY; DENTATE GYRUS; ACETYLCHOLINESTERASE INHIBITORS; COGNITIVE IMPAIRMENT; ALLOSTERIC MODULATOR; PATTERN SEPARATION; ALPHA-7 NACHRS; RAT-BRAIN	Acetylcholine is an excitatory neurotransmitter in the central nervous system that plays a key role in cognitive function, including learning and memory. Previous studies have shown that experimental traumatic brain injury (TBI) reduces cholinergic neurotransmission, decreases evoked release of acetylcholine, and alters cholinergic receptor levels. Galantamine (U.S. Food and Drug Administration approved for the treatment of vascular dementia and Alzheimer's disease) has been shown to inhibit acetylcholinesterase activity and allosterically potentiate nicotinic receptor signaling. We investigated whether acute administration of galantamine can reduce TBI pathology and improve cognitive function tested days after the termination of the drug treatment. Post-injury administration of galantamine was found to decrease TBI-triggered blood-brain barrier (BBB) permeability (tested 24h post-injury), attenuate the loss of both GABAergic and newborn neurons in the ipsilateral hippocampus, and improve hippocampal function (tested 10 days after termination of the drug treatment). Specifically, significant improvements in the Morris water maze, novel object recognition, and context-specific fear memory tasks were observed in injured animals treated with galantamine. Although messenger RNAs for both M1 (Nos2, TLR4, and IL-12 beta ) and M2 (Arg1, CCL17, and Mcr1) microglial phenotypes were elevated post-TBI, galantamine treatment did not alter microglial polarization tested 24h and 6 days post-injury. Taken together, these findings support the further investigation of galantamine as a treatment for TBI.	[Zhao, Jing; Hylin, Michael J.; Kobori, Nobuhide; Hood, Kimberly N.; Moore, Anthony N.; Dash, Pramod K.] Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX USA	Dash, PK (corresponding author), UTHlth McGovern Med Sch, Dept Neurobiol & Anat, POB 20036, Houston, TX 77225 USA.	p.dash@uth.tmc.edu	Hylin, Michael/U-2878-2019	Dash, Pramod/0000-0001-6746-1002	Senator Lloyd and B.A. Bentsen Center for Stroke Research; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087149, NS088298]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088298] Funding Source: NIH RePORTER	The authors are thankful of the Senator Lloyd and B.A. Bentsen Center for Stroke Research and NIH (NS087149 and NS088298) who provided funding support.	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Arias E, 2005, J PHARMACOL EXP THER, V315, P1346, DOI 10.1124/jpet.105.090365; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Belluardo N., 2000, Journal of Neural Transmission Supplement, V60, P227; Borovikova LV, 2000, NATURE, V405, P458; Bruchfeld A, 2008, MOL MED, V14, P109, DOI 10.2119/2007-00107.Bruchfeld; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; Drew MR, 2010, BEHAV NEUROSCI, V124, P446, DOI 10.1037/a0020081; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; ENNACEUR A, 1988, 1 BEHAVIORAL DATA BE, V31, P47; Evilsizor M.N., 2015, SOURCEBRAIN NEUROTRA; GALEY D, 1994, BEHAV BRAIN RES, V60, P183, DOI 10.1016/0166-4328(94)90146-5; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; HALL ED, 1993, RES P ARNMD, V71, P81; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Levine YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104530; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; Monbaliu J, 2003, ARZNEIMITTEL-FORSCH, V53, P486; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mortazavian Seyed Mohsen, 2013, Int J Alzheimers Dis, V2013, P121068, DOI 10.1155/2013/121068; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Povlishock J T, 1992, Hum Cell, V5, P345; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Samochocki M, 2000, ACTA NEUROL SCAND, V102, P68, DOI 10.1034/j.1600-0404.2000.00310.x; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schrattenholz A, 1996, MOL PHARMACOL, V49, P1; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; van Beijsterveldt L, 2004, ARZNEIMITTEL-FORSCH, V54, P85; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WESTER P, 1995, STROKE, V26, P444, DOI 10.1161/01.STR.26.3.444; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310	79	13	13	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					362	374		10.1089/neu.2017.5102		DEC 2017	13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000418128700001	29088998	Green Published			2021-06-18	
J	Moran, R; Covassin, T				Moran, R.; Covassin, T.			Risk factors associated with baseline King-Devick performance	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Sports; Youth; Sex; Age	SPORTS-RELATED CONCUSSION; SEX-DIFFERENCES; REFERENCE VALUES; HIGH-SCHOOL; SYMPTOMS; CHILDREN; PLAYERS; BALANCE; VISION; GENDER	Objective: This study examined the effect of baseline risk factors on the King-Devick (K-D) test in youth athletes, including of age, sex, and history of concussion. Methods: A total of 422 youth football and soccer athletes between the ages of 8 and 14 completed a baseline K-D test prior to the start of their respective seasons. Participant age, sex, and history of concussion were analyzed for K-D performance (i.e., errors and baseline time). A series of Mann-Whitney U tests were conducted to determine the effects of risk factors on performance. Correlations and regression analyses were conducted to assess the relationship between risk factors and K-D time and errors. Results: Differences in age (p < 0.001) and sex (p < 0.001) were reported on K-D time and errors. A history of concussion did not have an effect on K-D time (p = 0.15) or errors (p range = 0.15-0.17). Overall, weak to moderate correlations were observed between risk factors and K-D performance (r range = 0.43-0.23). Baseline K-D time and total errors improved with increasing participant age (p < 0.001). Sex was also able to predict K-D time and errors (p < 0.001). History of concussion was not able to predict K-D time (p = 0.18) or errors (p > 0.05). Conclusions: This study demonstrates the influence of risk factors such as sex and age on baseline K-D assessment. Associated risk factors at baseline further emphasize the need for individualized, multifaceted assessment for sport-related concussion diagnosis and management.	[Moran, R.] Univ Alabama, Athlet Training Res Lab, Dept Hlth Sci, Tuscaloosa, AL USA; [Covassin, T.] Michigan State Univ, Sports Injury Res Lab, Dept Kinesiol, E Lansing, MI 48824 USA	Moran, R (corresponding author), 481 Russell Hall,Box 870311, Tuscaloosa, AL 35487 USA.	rnmoran@ches.ua.edu			Michigan State University University Department of Kinesiology and Graduate School	This study was supported by the Michigan State University University Department of Kinesiology and Graduate School.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Burton LA, 2005, DEV NEUROPSYCHOL, V28, P493, DOI 10.1207/s15326942dn2801_3; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Halpern DF, 1997, AM PSYCHOL, V52, P1091, DOI 10.1037/0003-066X.52.10.1091; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X	18	13	13	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	DEC 15	2017	383						101	104		10.1016/j.jns.2017.10.039			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FT9UQ	WOS:000423498200023	29246592				2021-06-18	
J	Caplain, S; Blancho, S; Marque, S; Montreuil, M; Aghakhani, N				Caplain, Sophie; Blancho, Sophie; Marque, Sebastien; Montreuil, Michele; Aghakhani, Nozar			Early Detection of Poor Outcome after Mild Traumatic Brain Injury: Predictive Factors Using a Multidimensional Approach a Pilot Study	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; assessment score; human; post-concussion syndrome; prognostic factors	POST-CONCUSSION SYMPTOMS; QUALITY-OF-LIFE; HEAD-INJURY; PERSISTENT SYMPTOMS; WORKING-MEMORY; POPULATION; DYSFUNCTION; ACTIVATION; DEPRESSION; SEQUELAE	Mild traumatic brain injury (MTBI) is a common condition within the general population, usually with good clinical outcome. However, in 10-25% of cases, a post-concussive syndrome (PCS) occurs. Identifying early prognostic factors for the development of PCS can ensure widespread clinical and economic benefits. The aim of this study was to demonstrate the potential value of a comprehensive neuropsychological evaluation to identify early prognostic factors following MTBI. We performed a multi-center open, prospective, longitudinal study that included 72 MTBI patients and 42 healthy volunteers matched for age, gender, and socioeconomic status. MTBI patients were evaluated 8-21 days after injury, and 6 months thereafter, with a full neurological and psychological examination and brain MRI. At 6 months follow-up, MTBI patients were categorized into two subgroups according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) as having either favorable or unfavorable evolution (UE), corresponding to the presence of major or mild neurocognitive disorder due to traumatic brain injury. Univariate and multivariate logistical regression analysis demonstrated the importance of patient complaints, quality of life, and cognition in the outcome of MTBI patients, but only 6/23 UE patients were detected early via the multivariate logistic regression model. Using several variables from each of these three categories of variables, we built a model that assigns a score to each patient presuming the possibility of UE. Statistical analyses showed this last model to be reliable and sensitive, allowing early identification of patients at risk of developing PCS with 95.7% sensitivity and 77.6% specificity.	[Caplain, Sophie; Montreuil, Michele] Univ Paris 08, Lab Psychopathol & Neuropsychol, St Denis, France; [Blancho, Sophie] Inst Rech Moelle Epiniere & Encephale, Paris, France; [Marque, Sebastien] Capionis Res, Bordeaux, France; [Aghakhani, Nozar] Bicetre Univ Hosp, AP HP, Dept Neurosurg, Le Kremlin Bicetre, France	Aghakhani, N (corresponding author), Bicetre Univ Hosp, AP HP, Dept Neurosurg, Le Kremlin Bicetre, France.	nozar.aghakhani@aphp.fr		aghakhani, nozar/0000-0001-8389-8167	French Garantie, "Mutuelle des Fonctionnaires" (GMF)	The authors thank all study participants. They are also grateful to the French Garantie, "Mutuelle des Fonctionnaires" (GMF), which funded the study, and to the "Institut de Recherche sur la Moelle Epiniere et l'Encephale (IRME)" which initiated it. The authors also express their sincere appreciation to the study group participants Arnaud Messe, Habib Benali, Stephane Lehericy, and Richard Levy from LIB (Laboratoire d'Imagerie Fonctionnelle, Inserm, UPMC Universite Paris 06, UMRS 678, Paris, France) and CENIR (Center for Neuroimaging Research, Paris, France). Authors are grateful to Pr Parsa, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, for english editing of the manuscript.	American Psychiatric Association (APA), 1994, DIAGN STAT MAN MENT, V4th; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; [Anonymous], 2014, J HEAD TRAUMA REHABI; Azouvi P, 2001, REV NEUROPSYCHOL, V11, P383; Azouvi P, 2002, NEUROPSYCHOLOGIE LAT, P193; Brickenkamp R., 1994, TEST D2 AUFMERKSAMKE, V8th ed.; Bryant RA, 2010, SLEEP, V33, P69, DOI 10.1093/sleep/33.1.69; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Hardy P, 1988, PSYCHIATRIE S, V79, P19; HART RP, 1987, J NEUROL NEUROSUR PS, V50, P1263, DOI 10.1136/jnnp.50.10.1263; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kashluba S, 2008, CLIN NEUROPSYCHOL, V22, P195, DOI 10.1080/13854040701263655; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Leman S., 2004, ANXIETE ANXIOLYTIQUE, P71; MACLEOD C, 1991, International Review of Psychiatry, V3, P279, DOI 10.3109/09540269109110407; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Schweitzer M. B., 1990, MANUEL INVENTAIRE AN; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Steptoe A., 1991, ADAPTATION ENV, P150; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Stulemeijer M, 2006, J NEUROTRAUM, V23, P1561, DOI 10.1089/neu.2006.23.1561; Thuillard F, 1983, Rev Med Suisse Romande, V103, P311; TRICHARD C, 1995, PSYCHOL MED, V25, P79, DOI 10.1017/S0033291700028105; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	51	13	13	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 12	2017	8								666	10.3389/fneur.2017.00666			12	Clinical Neurology; Neurosciences	Neurosciences & Neurology	FP6HE	WOS:000417725000001	29312112	DOAJ Gold, Green Published			2021-06-18	
J	Campolettano, ET; Bland, ML; Gellner, RA; Sproule, DW; Rowson, B; Tyson, AM; Duma, SM; Rowson, S				Campolettano, Eamon T.; Bland, Megan L.; Gellner, Ryan A.; Sproule, David W.; Rowson, Bethany; Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven			Ranges of Injury Risk Associated with Impact from Unmanned Aircraft Systems	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Drone; Skull; Brain; Concussion; Cervical spine; Neck	FOOTBALL HELMETS; HEAD; ACCELERATION; CONCUSSION; ACCURACY	Regulations have allowed for increased unmanned aircraft systems (UAS) operations over the last decade, yet operations over people are still not permitted. The objective of this study was to estimate the range of injury risks to humans due to UAS impact. Three commercially-available UAS models that varied in mass (1.2-11 kg) were evaluated to estimate the range of risk associated with UAS-human interaction. Live flight and falling impact tests were conducted using an instrumented Hybrid III test dummy. On average, live flight tests were observed to be less severe than falling impact tests. The maximum risk of AIS 3+ injury associated with live flight tests was 11.6%, while several falling impact tests estimated risks exceeding 50%. Risk of injury was observed to increase with increasing UAS mass, and the larger models tested are not safe for operations over people in their current form. However, there is likely a subset of smaller UAS models that are safe to operate over people. Further, designs which redirect the UAS away from the head or deform upon impact transfer less energy and generate lower risk. These data represent a necessary impact testing foundation for future UAS regulations on operations over people.	[Campolettano, Eamon T.; Bland, Megan L.; Gellner, Ryan A.; Sproule, David W.; Rowson, Bethany; Tyson, Abigail M.; Duma, Stefan M.; Rowson, Steven] Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA	Rowson, S (corresponding author), Virginia Polytech Inst & State Univ, Blacksburg, VA 24061 USA.	srowson@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596			Anand S, 2007, ASTM STAND NEWS, V35, P30; AUVSI, 2013, EC IMP UNM AIRCR SYS; Bangash M. Y. H., 2007, TRAUMA TRAUMATIC INJ, P1; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Dalamagkidis K, 2008, PROG AEROSP SCI, V44, P503, DOI 10.1016/j.paerosci.2008.08.001; Duma SM, 2014, J BIOMECH, V47, P1557, DOI 10.1016/j.jbiomech.2013.08.022; Elias Bart, 2012, PILOTLESS DRONES BAC; Hodgson V. R., 1973, CONCUSSION LEVELS DE, V17; Hodgson V. R., 1970, FRACTURE BEHAV SKULL; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; Mertz H. J, 1996, HEAD INJURY RISK ASS; NHTSA, 2012, TRAFF SAF FACTS 2010; Office U. S. G. A., 2015, UNM AER SYST FAA CON; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman E.J., 2003, NEUROSURGERY, V53, P812, DOI [DOI 10.1227/01.N1'17.0000083559.68424.31;, DOI 10.1093/NEUROSURGERY/53.3.799]; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prasad P., 1985, SAE T, V94, P106; Prasad P., 1984, BIOMECHANICAL ANAL H, V28, P25; Ravich T. M., 2009, N DAK LAW REV, V85, P597; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sances A, 2002, BIOMED SCI INSTRUM, V38, P459; Walker S W., 2010, INTEGRATING DEP DEFE; Wolf H., 2014, COMP FAA ACTIVITIES, P1	24	13	13	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	DEC	2017	45	12					2733	2741		10.1007/s10439-017-1921-6			9	Engineering, Biomedical	Engineering	FN1DS	WOS:000415726200002	28913606	Green Published, Other Gold			2021-06-18	
J	Chorney, SR; Suryadevara, AC; Nicholas, BD				Chorney, Stephen R.; Suryadevara, Amar C.; Nicholas, Brian D.			Audiovestibular symptoms as predictors of prolonged sports-related concussion among NCAA athletes	LARYNGOSCOPE			English	Article; Proceedings Paper	138th Annual Meeting of the American-Laryngological-Association at Combined Otolaryngology Spring Meeting (COSM)	APR 26-30, 2017	San Diego, CA	Amer Laryngol Assoc		Concussion; audiovestibular symptoms; sports-related concussion; NCAA athletes	TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; HIGH-SCHOOL; EPIDEMIOLOGY; DIZZINESS; RECOVERY; TIME	ObjectiveWe looked to determine the rates of audiovestibular symptoms following sports-related concussions among collegiate athletes. Further, we assessed the correlation between these symptoms and the time to return to participation in athletic activity. Study DesignRetrospective analysis of the National Collegiate Athletic Association Injury Surveillance System (NCAA-ISS). MethodsThe NCAA-ISS was queried from 2009 through 2014 for seven men's sports and eight women's sports across divisions 1, 2, and 3. Injuries resulting in concussions were analyzed for audiovestibular symptoms, duration of symptoms, and return to participation times. ResultsFrom 2009 to 2014, there were 1,647 recorded sports-related concussions, with athletes reporting dizziness (68.2%), imbalance (35.8%), disorientation (31.4%), noise sensitivity (29.9%), and tinnitus (8.5%). Concussion symptoms resolved within 1 day (17.1%), within 2 to 7 days (50.0%), within 8 to 30 days (25.9%), or persisted over 1 month (7.0%). Return to participation occurred within 1 week (38.3%), within 1 month (53.0%), or over 1 month (8.7%). Using Mann-Whitney U testing, overall symptom duration and return to competition time were significantly increased when any of these symptoms were present (P < 0.05). Duration of concussion symptom correlated with dizziness (P = 0.043) and noise sensitivity (P = 0.000), whereas return to participation times correlated with imbalance (P = 0.011) and noise sensitivity (P = 0.000). Dizziness and imbalance (odds ratio: 4.15, confidence interval: 3.20-5.38, P < 0.001) were the two symptoms with the strongest association. ConclusionAudiovestibular symptoms are common complaints among collegiate athletes sustaining concussions. Dizziness and noise sensitivity correlated with the duration of concussive symptoms, whereas imbalance and noise sensitivity was correlated with prolonged return to competition time. Level of Evidence4. Laryngoscope, 127:2850-2853, 2017	[Chorney, Stephen R.; Suryadevara, Amar C.; Nicholas, Brian D.] SUNY Upstate Med Univ, Dept Otolaryngol & Commun Sci, Syracuse, NY 13210 USA	Nicholas, BD (corresponding author), SUNY Upstate Med Univ, Dept Otolaryngol & Commun Sci, Syracuse, NY 13210 USA.	nicholab@upstate.edu			NCAA	The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the Datalys Center or the NCAA. We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA Injury Surveillance Program. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Dick R, 2007, J ATHL TRAINING, V42, P173; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	17	13	13	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	DEC	2017	127	12					2850	2853		10.1002/lary.26564			4	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	FM6WY	WOS:000415204100034	28349568				2021-06-18	
J	Faude, O; Rossler, R; Junge, A; Funten, KAD; Chomiak, J; Verhagen, E; Beaudouin, F; Dvorak, J; Feddermann-Demont, N				Faude, O.; Rossler, R.; Junge, A.; Fuenten, K. Aus Der; Chomiak, J.; Verhagen, E.; Beaudouin, F.; Dvorak, J.; Feddermann-Demont, N.			Head injuries in childrens footballresults from two prospective cohort studies in four European countries	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						concussion; heading; soccer; traumatic brain injury; youth	CONSENSUS STATEMENT; SOCCER INJURIES; CONCUSSION; MANAGEMENT; SPORT; EPIDEMIOLOGY; PLAYERS; YOUTH; RISK	Head injuries are considered harmful in children. We analyzed head and neck injuries in organized football in 7- to 12-year-old children. Data for this analysis were obtained from a prospective cohort study over two consecutive football seasons in two European countries, and a randomized intervention trial over one season in four European countries. Football exposure and injuries were documented through an online database. Detailed information regarding injury characteristics and medical follow-up was retrieved from coaches, children and parents by phone. Thirty-nine head injuries and one neck injury (5% of all 791 injuries) were documented during 9933 player-seasons (total football exposure 688045 hours). The incidence was 0.25 [95%CI 0.15, 0.35] head/neck injuries per 1000 match hours (N=23 match injuries) and 0.03 [95%CI 0.02, 0.03] per 1000 training hours. Eleven concussions (27.5%), nine head contusions (22.5%), eight lacerations or abrasions (20%), two nose fractures (2.5%), and two dental injuries (2.5%) occurred. The remaining eight injuries were nose bleeding or other minor injuries. Thirty injuries (75%) resulted from contact with another player, and ten injuries were due to collision with an object, falling or a hit by the ball. Whereas 70% of all head injuries (N=28) were due to frontal impacts, 73% of concussions (N=8) resulted from an impact to the occiput. The incidence and severity of head injuries in childrens football are low. Coaches and parents, however, should be sensitized regarding the potential of concussions, particularly after an impact to the occiput.	[Faude, O.; Rossler, R.] Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland; [Junge, A.] Med Sch Hamburg, Hamburg, Germany; [Junge, A.; Dvorak, J.; Feddermann-Demont, N.] Swiss Concuss Ctr SCC, Zurich, Switzerland; [Junge, A.; Dvorak, J.; Feddermann-Demont, N.] Schulthess Clin, Zurich, Switzerland; [Fuenten, K. Aus Der; Beaudouin, F.] Saarland Univ, FIFA Med Ctr Excellence, Inst Sports & Prevent Med, Saarbrucken, Germany; [Chomiak, J.] Charles Univ Prague, Fac Med 1, Dept Orthopaed, Prague, Czech Republic; [Chomiak, J.] Hosp Na Bulovce, FIFA Med Ctr Excellence, Prague, Czech Republic; [Verhagen, E.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Feddermann-Demont, N.] Univ Hosp, Interdisciplinary Ctr Vertigo & Neurol Visual Dis, Dept Neurol, Zurich, Switzerland; [Feddermann-Demont, N.] Univ Zurich, Zurich, Switzerland	Faude, O (corresponding author), Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland.	oliver.faude@unibas.ch	Rossler, Roland/C-3857-2016; Verhagen, Evert/A-1502-2013	Rossler, Roland/0000-0002-6763-0694; Verhagen, Evert/0000-0001-9227-8234; Junge, Astrid/0000-0002-6815-9793; Faude, Oliver/0000-0002-2832-7780	FIFA	FIFA	Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Blond L, 1999, BRIT J SPORT MED, V33, P110, DOI 10.1136/bjsm.33.2.110; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Emery CA, 2005, AM J SPORT MED, V33, P1882, DOI 10.1177/0363546505279576; Feddermann-Demont N, 2014, J SPORT SCI, V32, P1217, DOI 10.1080/02640414.2014.918273; FIFA Communications Division, 2007, FIFA BIG COUNT 2006; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Fuller CW, 2005, BRIT J SPORT MED, V39, pI3, DOI 10.1136/bjsm.2005.018937; Giannotti M, 2011, PEDIATR EMERG CARE, V27, P81, DOI 10.1097/PEC.0b013e3182094340; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Giza Eric, 2005, Med Sport Sci, V49, P140, DOI 10.1159/000085395; Gomez JE, 2013, J ADOLESCENT HEALTH, V53, P311, DOI 10.1016/j.jadohealth.2013.06.018; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Jones SAV, 2014, BRIT J SPORT MED, V48, P159, DOI 10.1136/bjsports-2013-092758; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Leininger RE, 2007, AM J SPORT MED, V35, P288, DOI 10.1177/0363546506294060; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Makdissi M, 2013, BRIT J SPORT MED, V47, P314, DOI 10.1136/bjsports-2013-092256; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Rossler R, 2016, J SPORT SCI, V34, P549, DOI 10.1080/02640414.2015.1099715; Rossler R, 2016, AM J SPORT MED, V44, P309, DOI 10.1177/0363546515614816; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Tarnutzer AA, 2016, BRIT J SPORT MED, DOI [10.1136/bjsports-2016-096593<original-structure ref=info:doi/10.1136/bjsports-2016-096593></original-structure>, DOI 10.1136/BJSPOTS-2016-096593]; TEASDALE G, 1974, LANCET, V2, P81	30	13	13	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	DEC	2017	27	12					1986	1992		10.1111/sms.12839			7	Sport Sciences	Sport Sciences	FO0DA	WOS:000416411800048	28054391				2021-06-18	
J	Karri, J; Cardenas, JC; Matijevic, N; Wang, YW; Choi, S; Zhu, L; Cotton, BA; Kitagawa, R; Holcomb, JB; Wade, CE				Karri, Jay; Cardenas, Jessica C.; Matijevic, Nena; Wang, Yao-Wei; Choi, Sangbum; Zhu, Liang; Cotton, Bryan A.; Kitagawa, Ryan; Holcomb, John B.; Wade, Charles E.			EARLY FIBRINOLYSIS ASSOCIATED WITH HEMORRHAGIC PROGRESSION FOLLOWING TRAUMATIC BRAIN INJURY	SHOCK			English	Article						Fibrinolysis; progressive hemorrhagic injury; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; COAGULOPATHY; COAGULATION; MORTALITY; PLASMA; HYPERFIBRINOLYSIS; TRANSFUSION; PARAMETERS; MODERATE; PATIENT	Background: Progressive hemorrhagic injury (PHI) is common in patients with severe traumatic brain injury (TBI) and is associated with worse outcomes. PHI pathophysiology remains poorly understood and difficult to predict. We performed an exploratory analysis aimed at identifying markers in need of further investigation to establish their predictive value in PHI following TBI. Methods: We performed a retrospective chart review of prospectively collected data from 424 highest-level activation trauma patients from January 2012 through December 2013. Patients with severe TBI, defined as head acute injury scale (AIS) score >= 3 and intracranial hemorrhage (ICH) on initial CT, were included. Stable hemorrhage (SH) and PHI was determined by measuring ICH expansion on repeat CT within 6 h. Of 424 patients evaluated, 72 met inclusion criteria. Twenty-five patients had repeated samples available and were dichotomized into SH (n = 6, 24%) and PHI (n = 19, 76%). Levels of plasminogen, urokinase and tissue plasminogen activators (uPA, tPA), plasminogen activator inhibitor-1, alpha 2-antiplasmin (alpha 2AP), and D-Dimers (DD) were measured upon admission and 2, 4, and 6 h later. Results: Longitudinal models identified tPA and DD as positively associated and alpha 2AP inversely associated with PHI. High DD levels are strongly associated with developing PHI over time. Using the full TBI cohort of N = 72, receiver operating curve analysis provided a cutoff of 3.04 mu g/mL admission DD to distinguish SH from PHI patients. Conclusion: Our findings support a relationship between markers of fibrinolysis in polytrauma patients with severe TBI and PHI, warranting further investigation into the potential for novel, predictive biomarkers.	[Karri, Jay; Cardenas, Jessica C.; Matijevic, Nena; Wang, Yao-Wei; Cotton, Bryan A.; Holcomb, John B.; Wade, Charles E.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Ctr Translat Injury Res, McGovern Med Sch, Houston, TX 77030 USA; [Choi, Sangbum; Zhu, Liang] Univ Texas Hlth Sci Ctr Houston, Div Clin & Translat Sci, Dept Internal Med, McGovern Med Sch, Houston, TX 77030 USA; [Kitagawa, Ryan] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, McGovern Med Sch, Houston, TX 77030 USA	Wade, CE (corresponding author), Dept Surg, 6431 Fannin,MSB 5-204, Houston, TX 77030 USA.; Wade, CE (corresponding author), Ctr Translat Injury Res CeTIR, 6431 Fannin,MSB 5-204, Houston, TX 77030 USA.	Charles.E.Wade@uth.tmc.edu		holcomb, john/0000-0001-8312-9157			Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Cardenas JC, 2014, SHOCK, V41, P514, DOI 10.1097/SHK.0000000000000161; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Hijazi N, 2015, BLOOD, V125, P2558, DOI 10.1182/blood-2014-08-588442; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kashuk JL, 2010, ANN SURG, V252, P434, DOI 10.1097/SLA.0b013e3181f09191; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; L. S. o. H. a. T. Medicine, 2015, CLIN RAND ANT SIGN H; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Medcalf RL, 2015, BLOOD, V125, P2457, DOI 10.1182/blood-2015-02-629808; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; N. T. R. Institute, 2016, PRE HOSP ANT TRAUM C; Nakae R, 2016, J NEUROTRAUM, V33, P688, DOI 10.1089/neu.2015.4039; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Sanchez CM, 2004, NEUROLOGIA, V19, P44; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Washington U. o., 2015, PREH TRAN ACID US TR; WINTER JP, 1989, ANN EMERG MED, V18, P553, DOI 10.1016/S0196-0644(89)80842-X; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	27	13	14	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	DEC	2017	48	6					644	650		10.1097/SHK.0000000000000912			7	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	FT6WN	WOS:000423294600007	28614144				2021-06-18	
J	Leva, G; Klein, C; Benyounes, J; Halle, F; Bihel, F; Collongues, N; De Seze, J; Mensah-Nyagan, AG; Patte-Mensah, C				Leva, Geraldine; Klein, Christian; Benyounes, Jeremie; Halle, Francois; Bihel, Frederic; Collongues, Nicolas; De Seze, Jerome; Mensah-Nyagan, Ayikoe-Guy; Patte-Mensah, Christine			The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Multiple sclerosis; Experimental autoimmune encephalomyelitis; XBD173; TSPO; Neurodegeneration; Neuroinflammation	18 KDA TSPO; PERIPHERAL BENZODIAZEPINE-RECEPTORS; TRAUMATIC BRAIN-INJURY; THERAPEUTIC TARGET; CELL-DEATH; ALLOPREGNANOLONE; PROGESTERONE; NEUROSTEROIDS; EXPRESSION; MICROGLIA	Multiple sclerosis (MS) is a severe autoimmune disease characterized by inflammatory, demyelinating and neurodegenerative components causing motor, sensory, visual and/or cognitive symptoms. The relapsing-remitting MS affecting 85% of patients is reliably mimicked by the proteolipid-protein (PLP)-induced experimental autoimmune encephalomyelitis (EAE) SJL/J-mouse model. Significant progress was made for MS treatment but the development of effective therapies devoid of severe side-effects remains a great challenge. Here, we combine clinical, behavioral, histopathological, biochemical and molecular approaches to demonstrate that low and well tolerated doses (10-20 mg/kg) of TSPO ligand XBD173 (Emapunil) efficiently ameliorate clinical signs and neuropathology of PLP-EAE mice. In addition to the conventional clinical scoring of symptoms, we applied the robust behavioral Catwalk-method to confirm that XBD173 (10 mg/kg) increases the maximum contact area parameter at EAE-disease peak, indicating an improvement/recovery of motor functions. Consistently, histopathological studies coupled with microscope-cellSens quantification and RT-qPCR analyzes showed that XBD173 prevented demyelination by restoring normal protein and mRNA levels of myelin basic protein that was significantly repressed in PLP-EAE mice spinal cord and brain. Interestingly, ELISA-based measurement revealed that XBD173 increased allopregnanolone concentrations in PLP-EAE mice spinal and brain tissues. Furthermore, flow cytometry assessment demonstrated that XBD173 therapy decreased serum level of pro-inflammatory cytokines, including interleukin-17A, Interleukin-6 and tumor-necrosis-factor alpha in PLP-EAE mice. As the optimal XBD173 dosing exerting the maximal beneficial action in EAE mice is the lower 10 mg/kg dose, the paper opens interesting perspectives for the development of efficient and safe therapies against MS with slight or no side-effects.	[Leva, Geraldine; Klein, Christian; Benyounes, Jeremie; Collongues, Nicolas; De Seze, Jerome; Mensah-Nyagan, Ayikoe-Guy; Patte-Mensah, Christine] Univ Strasbourg, FMTS, INSERM U1119,Fac Med, Biopathol Myelin Neuroprotect & Strategies Therap, Bettiment 3,11 Rue Humann, F-67000 Strasbourg, France; [Halle, Francois; Bihel, Frederic] CNRS UMR 7200, Fac Pharm Strasbourg, LIT, 74 Route Rhin,CS 60024, F-67401 Illkirch Graffenstaden, France	Mensah-Nyagan, AG; Patte-Mensah, C (corresponding author), Univ Strasbourg, FMTS, INSERM U1119,Fac Med, Biopathol Myelin Neuroprotect & Strategies Therap, Bettiment 3,11 Rue Humann, F-67000 Strasbourg, France.	gmensah@unistra.fr; cmensah@unistra.fr	BIHEL, Frederic JJ/B-2895-2008; KLEIN, Christian/J-9893-2016	BIHEL, Frederic JJ/0000-0002-4122-0929; KLEIN, Christian/0000-0002-7580-8536; Halle, Francois/0000-0002-5324-8160	Institut National de la Sante et de la Recherche Medicale (INSERM, France)Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Strasbourg (France)	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM, France) and Universite de Strasbourg (France). Authors would like to thank Dr. Laurence Meyer for the useful advises on the Catwalk test and Dr. Susana Brun for the helpful discussions on flow cytometry.	Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Andrabi SS, 2017, DIS MODEL MECH, V10, P787, DOI 10.1242/dmm.025692; Baulieu EE, 1999, ACTA PAEDIATR, V88, P78, DOI 10.1111/j.1651-2227.1999.tb14408.x; Berger T, 2003, NEW ENGL J MED, V349, P139, DOI 10.1056/NEJMoa022328; Borowicz Kinga K, 2011, Front Endocrinol (Lausanne), V2, P50, DOI 10.3389/fendo.2011.00050; Brinton RD, 2013, NAT REV ENDOCRINOL, V9, P241, DOI 10.1038/nrendo.2013.31; Caruso D, 2014, J NEUROCHEM, V130, P591, DOI 10.1111/jnc.12745; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Costa B, 2016, ACS CHEM NEUROSCI, V7, P1041, DOI 10.1021/acschemneuro.6b00149; COSTA E, 1994, J STEROID BIOCHEM, V49, P385, DOI 10.1016/0960-0760(94)90284-4; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; DEBER CM, 1991, CLIN BIOCHEM, V24, P113, DOI 10.1016/0009-9120(91)90421-A; Desmond JE, 2010, BEHAV NEUROL, V23, P1, DOI 10.3233/BEN-2010-0272; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Eckstein C, 2016, SURV OPHTHALMOL, V61, P318, DOI 10.1016/j.survophthal.2015.12.001; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; Frid K, 2015, ANN CLIN TRANSL NEUR, V2, P711, DOI 10.1002/acn3.207; Gandolfo P, 2000, J NEUROCHEM, V75, P701, DOI 10.1046/j.1471-4159.2000.0750701.x; Garay LI, 2012, NEUROSCIENCE, V226, P40, DOI 10.1016/j.neuroscience.2012.09.032; GARNIER M, 1994, J BIOL CHEM, V269, P22105; Giatti S, 2012, J MOL ENDOCRINOL, V49, pR125, DOI 10.1530/JME-12-0127; Haines JD, 2011, MT SINAI J MED, V78, P231, DOI 10.1002/msj.20246; Hinkley LBN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039804; Hussain R, 2013, BRAIN, V136, P132, DOI 10.1093/brain/aws284; INOUYE H, 1991, J NEUROSCI RES, V28, P1, DOI 10.1002/jnr.490280102; Irwin RW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00203; Kansal K, 2017, BRAIN, V140, P707, DOI 10.1093/brain/aww327; Karlstetter M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-3; Karout M, 2016, J NEUROCHEM, V139, P782, DOI 10.1111/jnc.13693; Kipp M, 2017, BRAIN PATHOL, V27, P123, DOI 10.1111/bpa.12454; Kita A, 2004, BRIT J PHARMACOL, V142, P1059, DOI 10.1038/sj.bjp.0705681; Kita A, 2009, PROG NEURO-PSYCHOPH, V33, P1040, DOI 10.1016/j.pnpbp.2009.05.018; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kuwabara T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3908061; Lassmann H, 2014, EXP NEUROL, V262, P2, DOI 10.1016/j.expneurol.2013.12.003; Leitner H, 2010, MED HYPOTHESES, V75, P229, DOI 10.1016/j.mehy.2010.02.028; Luchtman DW, 2014, CYTOKINE GROWTH F R, V25, P403, DOI 10.1016/j.cytogfr.2014.07.013; Massella A, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-12; McNamara C, 2017, AM J NEURORADIOL, V38, P1672, DOI 10.3174/ajnr.A5148; Mensah-Nyagan AG, 1999, PHARMACOL REV, V51, P63; Messmer K, 1998, NEUROSCI LETT, V241, P53, DOI 10.1016/S0304-3940(97)00967-1; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Nothdurfter C, 2012, J NEUROENDOCRINOL, V24, P82, DOI 10.1111/j.1365-2826.2011.02166.x; Panzica GC, 2012, J NEUROENDOCRINOL, V24, P1, DOI 10.1111/j.1365-2826.2011.02265.x; Papadopoulos V, 2006, NEUROSCIENCE, V138, P749, DOI 10.1016/j.neuroscience.2005.05.063; Papadopoulos V, 2015, MOL CELL ENDOCRINOL, V408, P90, DOI 10.1016/j.mce.2015.03.014; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Patte-Mensah C, 2014, PROG NEUROBIOL, V113, P70, DOI 10.1016/j.pneurobio.2013.07.004; Pawlikowski M., 1993, PERIPHERAL BENZODIAZ, P125; Peterburs J, 2016, CURR OPIN NEUROBIOL, V40, P38, DOI 10.1016/j.conb.2016.06.011; Porcu P, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12351; Qi XL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/162934; Ravikumar B, 2016, NEUROPHARMACOLOGY, V108, P229, DOI 10.1016/j.neuropharm.2016.03.053; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Rupprecht R, 2009, SCIENCE, V325, P490, DOI 10.1126/science.1175055; Schaeffer V, 2010, PROG NEUROBIOL, V92, P33, DOI 10.1016/j.pneurobio.2010.04.009; Scholz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0422-5; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Shan K, 2017, CELL MOL IMMUNOL, V14, P909, DOI 10.1038/cmi.2017.12; Siddiqui Shazia Veqar, 2008, Indian J Psychiatry, V50, P202, DOI 10.4103/0019-5545.43634; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Versijpt J, 2005, MULT SCLER J, V11, P127, DOI 10.1191/1352458505ms1140oa; Vlodavsky E, 2007, J NEURO-ONCOL, V81, P1, DOI 10.1007/s11060-006-9199-9; Vowinckel E, 1997, J NEUROSCI RES, V50, P345, DOI 10.1002/(SICI)1097-4547(19971015)50:2<345::AID-JNR22>3.0.CO;2-5; Wang MH, 2014, J NEUROSCI, V34, P3793, DOI 10.1523/JNEUROSCI.3153-13.2014; Yang T, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1642-2; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021; Yates MA, 2010, J NEUROIMMUNOL, V220, P136, DOI 10.1016/j.jneuroim.2010.01.013; Yu HJ, 2010, NEUROSCI LETT, V476, P42, DOI 10.1016/j.neulet.2010.03.079; Zhang MR, 2007, J NUCL MED, V48, P1853, DOI 10.2967/jnumed.107.043505; Zhang YN, 2017, CLIN SCI, V131, P297, DOI 10.1042/CS20160547	78	13	13	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	1879-260X		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	DEC	2017	1863	12					3016	3027		10.1016/j.bbadis.2017.09.007			12	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	FN1SH	WOS:000415771000002	28899788	Bronze			2021-06-18	
J	Pottker, B; Stober, F; Hummel, R; Angenstein, F; Radyushkin, K; Goldschmidt, J; Schafer, MKE				Poettker, Bruno; Stoeber, Franziska; Hummel, Regina; Angenstein, Frank; Radyushkin, Konstantin; Goldschmidt, Juergen; Schaefer, Michael K. E.			Traumatic brain injury causes long-term behavioral changes related to region-specific increases of cerebral blood flow	BRAIN STRUCTURE & FUNCTION			English	Article						Traumatic brain injury; Gliosis; Behavior; SPECT; Cerebral blood flow; Neural activity	CONTROLLED CORTICAL IMPACT; MICROGLIAL ACTIVATION; GAIT IMPAIRMENT; MOTOR; RAT; NEUROPROTECTION; INFLAMMATION; DEFICITS; AMYGDALA; DEGENERATION	Traumatic brain injury (TBI) is a leading cause of disability and death and survivors often suffer from long-lasting motor impairment, cognitive deficits, anxiety disorders and epilepsy. Few experimental studies have investigated long-term sequelae after TBI and relations between behavioral changes and neural activity patterns remain elusive. We examined these issues in a murine model of TBI combining histology, behavioral analyses and single-photon emission computed tomography (SPECT) imaging of regional cerebral blood flow (CBF) as a proxy for neural activity. Adult C57Bl/6N mice were subjected to unilateral cortical impact injury and investigated at early (15-57 days after lesion, dal) and late (184-225 dal) post-traumatic time points. TBI caused pronounced tissue loss of the parietal cortex and subcortical structures and enduring neurological deficits. Marked perilesional astro- and microgliosis was found at 57 dal and declined at 225 dal. Motor and gait pattern deficits occurred at early time points after TBI and improved over the time. In contrast, impaired performance in the Morris water maze test and decreased anxiety-like behavior persisted together with an increased susceptibility to pentylenetetrazole-induced seizures suggesting alterations in neural activity patterns. Accordingly, SPECT imaging of CBF indicated asymmetric hemispheric baseline neural activity patterns. In the ipsilateral hemisphere, increased baseline neural activity was found in the amygdala. In the contralateral hemisphere, homotopic to the structural brain damage, the hippocampus and distinct cortex regions displayed increased baseline neural activity. Thus, regionally elevated CBF along with behavioral alterations indicate that increased neural activity is critically involved in the long-lasting consequences of TBI.	[Poettker, Bruno; Hummel, Regina; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany; [Stoeber, Franziska] Leibniz Inst Neurobiol, Brenneckestr 6, D-39118 Magdeburg, Germany; [Angenstein, Frank] DZNE, Funct Neuroimaging Grp, Leipziger Str 44, D-39120 Magdeburg, Germany; [Radyushkin, Konstantin] Johannes Gutenberg Univ Mainz, Mouse Behav Unit, Hanns Dieter Husch Weg 19, D-55128 Mainz, Germany; [Radyushkin, Konstantin; Schaefer, Michael K. E.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci FTN, Langenbeckstr 1, D-55131 Mainz, Germany	Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany.; Schafer, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Focus Program Translat Neurosci FTN, Langenbeckstr 1, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Schaefer, Michael K.E./S-1715-2019	Schaefer, Michael K.E./0000-0001-6055-6244			Acosta SA, 2013, PLOS ONE, V8, P3; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Bhattacharya S, 2017, BIOL PSYCHIAT, V81, P124, DOI 10.1016/j.biopsych.2016.03.2107; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Collins R, 2012, TRAUMATIC BRAIN INJU, P223; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Endepols H, 2010, J NEUROSCI, V30, P9708, DOI 10.1523/JNEUROSCI.1202-10.2010; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Gavett BE, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt42; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Goldschmidt J, 2010, NEUROIMAGE, V49, P303, DOI 10.1016/j.neuroimage.2009.08.012; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Harris NG, 2016, EXP NEUROL, V277, P124, DOI 10.1016/j.expneurol.2015.12.020; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Johnk K, 1999, RESTOR NEUROL NEUROS, V14, P143; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jones TA, 1996, BRAIN RES, V733, P142, DOI 10.1016/0006-8993(96)00792-5; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Kolodziej A, 2014, NEUROIMAGE, V103, P171, DOI 10.1016/j.neuroimage.2014.09.023; Kozlowski DA, 1998, BEHAV BRAIN RES, V97, P89, DOI 10.1016/S0166-4328(98)00030-8; Laitinen T, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00128, 10.3389/fnins.2015.00128]; Lee S, 2009, J NEUROSCI, V29, P234, DOI 10.1523/JNEUROSCI.5273-08.2009; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Menzel L, 2016, ACTA NEUROPATHOL, V132, P703, DOI 10.1007/s00401-016-1607-4; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Mukherjee S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00028; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Nissinen J, 2000, EPILEPSY RES, V38, P177, DOI 10.1016/S0920-1211(99)00088-1; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; Palmer LM, 2012, SCIENCE, V335, P989, DOI 10.1126/science.1217276; Peterson TC, 2015, BEHAV BRAIN RES, V294, P254, DOI 10.1016/j.bbr.2015.08.007; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Sierra A, 2015, BRAIN STRUCT FUNCT, V220, P781, DOI 10.1007/s00429-013-0683-7; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Takeuchi N, 2006, BRAIN INJURY, V20, P991, DOI 10.1080/02699050600909771; Thanos PK, 2013, J NEUROSCI, V33, P6343, DOI 10.1523/JNEUROSCI.4997-12.2013; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Titianova EB, 2008, AGING CLIN EXP RES, V20, P131; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Velazquez A, 2015, BRAIN INJURY, V29, P1126, DOI 10.3109/02699052.2015.1018325; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	78	13	14	0	10	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-2653	1863-2661		BRAIN STRUCT FUNCT	Brain Struct. Funct.	DEC	2017	222	9					4005	4021		10.1007/s00429-017-1452-9			17	Anatomy & Morphology; Neurosciences	Anatomy & Morphology; Neurosciences & Neurology	FM8RL	WOS:000415357100010	28589257				2021-06-18	
J	Sajja, VSSS; Jablonska, A; Haughey, N; Bulte, JWM; Stevens, RD; Long, JB; Walczak, P; Janowski, M				Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Haughey, Norman; Bulte, Jeff W. M.; Stevens, Robert D.; Long, Joseph B.; Walczak, Piotr; Janowski, Miroslaw			Sphingolipids and microRNA Changes in Blood following Blast Traumatic Brain Injury: An Exploratory Study	JOURNAL OF NEUROTRAUMA			English	Article						blast; ceramides; miRNA; sphingolipids	PLASMA SPHINGOMYELINS; METABOLISM; EXOSOMES; MILD; EXPRESSION; BIOMARKERS; EXPOSURE; REVEALS; PROTEIN; MODEL	At present, accurate and reliable biomarkers to ascertain the presence, severity, or prognosis of blast traumatic brain injury (bTBI) are lacking. There is an urgent need to establish accurate and reliable biomarkers capable of mbTBI detection. Currently, there are no studies that identify changes in miRNA and lipids at varied severities of bTBI. Various biological components such as lipids, circulating mRNA, and miRNA, could potentially be detected using advanced techniques such as next-generation sequencing and mass spectroscopy. Therefore, plasma analysis is an attractive approach with which to diagnose and treat brain injuries. Subacute changes in plasma microRNA (miRNA) and lipid composition for sphingolipids were evaluated in a murine model of mild-to-moderate bTBI using next-generation sequencing and mass spectroscopy respectively. Animals were exposed at 17, 17 x 3, and 20 psi blast intensities using a calibrated blast simulator. Plasma lipid profiling demonstrated decreased C18 fatty acid chains of sphingomyelins and increased ceramide levels when compared with controls. Plasma levels of brain-enriched miRNA, miR-127 were increased in all groups while let-7a, b, and g were reduced in the 17 x 3 and 20 psi groups, but let 7d was increased in the 17 psi group. The majority of the miRs and lipids are highly conserved across different species, making them attractive to explore and potentially employ as diagnostic markers. It is tempting to speculate that sphingolipids, miR-128, and the let-7 family could predict mTBI, while a combination of miR-484, miR-122, miR-148a, miR-130a, and miR-223 could be used to predict the overall status of injury following blast injury.	[Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Bulte, Jeff W. M.; Stevens, Robert D.; Walczak, Piotr; Janowski, Miroslaw] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Haughey, Norman; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosurg, Richard T Johnson Div Neuroimmunol & Neurol Infec, Baltimore, MD USA; [Haughey, Norman] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Bulte, Jeff W. M.; Stevens, Robert D.; Walczak, Piotr; Janowski, Miroslaw] Johns Hopkins Univ, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD USA; [Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Bulte, Jeff W. M.; Stevens, Robert D.; Walczak, Piotr; Janowski, Miroslaw] Johns Hopkins Univ, Inst Cell Engn, Vasc Biol Program, Baltimore, MD USA; [Sajja, Venkata Siva Sai Sujith] Johns Hopkins Mil & Vet Hlth Inst, Baltimore, MD USA; [Sajja, Venkata Siva Sai Sujith; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Walczak, Piotr] Univ Warmia & Mazury, Dept Radiol, Fac Med Sci, Olsztyn, Poland; [Janowski, Miroslaw] Polish Acad Sci, NeuroRepair Dept, Mossakowski Med Res Ctr, Warsaw, Poland	Janowski, M (corresponding author), 733 N Broadway, Baltimore, MD 21205 USA.	mjanows1@jhmi.edu	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501; Walczak, Piotr/0000-0002-3733-3322	Department of DefenseUnited States Department of Defense [W81XWH-13-1-0389]; Russell Military Scholar Program of the Johns Hopkins Military and Veterans Health Institute	This project was partially funded by the Department of Defense (Award no. W81XWH-13-1-0389) and a young investigator award from the Russell Military Scholar Program of the Johns Hopkins Military and Veterans Health Institute.	Adlakha YK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.46; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Bae M, 2014, J NEUROCHEM, V131, P645, DOI 10.1111/jnc.12834; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bergman P, 2013, J IMMUNOL, V190, P4066, DOI 10.4049/jimmunol.1200728; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Department of Defense, 2016, JEI; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Ellis B, 2015, J ALZHEIMERS DIS, V46, P313, DOI 10.3233/JAD-141899; Fonteh AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125597; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Haughey NJ, 2010, NEUROMOL MED, V12, P301, DOI 10.1007/s12017-010-8135-5; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Ji D, 2015, CELL PHYSIOL BIOCHEM, V36, P1026, DOI 10.1159/000430276; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kastelowitz N, 2014, CHEMBIOCHEM, V15, P923, DOI 10.1002/cbic.201400043; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077068; Liu SX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101770; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Mielke MM, 2015, AGING CELL, V14, P112, DOI 10.1111/acel.12275; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Pang XM, 2015, J NEUROCHEM, V133, P926, DOI 10.1111/jnc.13094; Polikepahad S, 2013, NUCLEIC ACIDS RES, V41, P1164, DOI 10.1093/nar/gks1098; Rahman M, 2014, J BIOL CHEM, V289, P26406, DOI 10.1074/jbc.M114.573592; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Sheinerman KS, 2013, AGING-US, V5, P925, DOI 10.18632/aging.100624; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.356; Wang K. K. W, 2014, RJIIJ, P83; Wang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1770; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wheeler D, 2008, BRAIN, V131, P3092, DOI 10.1093/brain/awn190; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Ying HJ, 2015, J IMMUNOL, V194, P1239, DOI 10.4049/jimmunol.1402088; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200	53	13	14	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					353	361		10.1089/neu.2017.5009		NOV 2017	9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000417107800001	29020847				2021-06-18	
J	Grzelka, K; Kurowski, P; Gawlak, M; Szulczyk, P				Grzelka, Katarzyna; Kurowski, Przemyslaw; Gawlak, Maciej; Szulczyk, Pawel			Noradrenaline Modulates the Membrane Potential and Holding Current of Medial Prefrontal Cortex Pyramidal Neurons via beta(1)-Adrenergic Receptors and HCN Channels	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						pyramidal neurons; prefrontal cortex; adrenergic receptors; HCN channel; beta gamma subunit; membrane potential; holding current; rats	BETA-GAMMA-SUBUNITS; EXCITATORY SYNAPTIC-TRANSMISSION; CURRENT I-H; ACTIVATED CATION CHANNELS; NUCLEOTIDE-GATED CHANNELS; ADRENERGIC-RECEPTOR; LOCUS-COERULEUS; WORKING-MEMORY; NORADRENERGIC MODULATION; GABAERGIC INTERNEURONS	The medial prefrontal cortex (mPFC) receives dense noradrenergic projections from the locus coeruleus. Adrenergic innervation of mPFC pyramidal neurons plays an essential role in both physiology (control of memory formation, attention, working memory, and cognitive behavior) and pathophysiology (attention deficit hyperactivity disorder, posttraumatic stress disorder, cognitive deterioration after traumatic brain injury, behavioral changes related to addiction, Alzheimer's disease and depression). The aim of this study was to elucidate the mechanism responsible for adrenergic receptor-mediated control of the resting membrane potential in layer V mPFC pyramidal neurons. The membrane potential or holding current of synaptically isolated layer V mPFC pyramidal neurons was recorded in perforated-patch and classical wholecell configurations in slices from young rats. Application of noradrenaline (NA), a neurotransmitter with affinity for all types of adrenergic receptors, evoked depolarization or inward current in the tested neurons irrespective of whether the recordings were performed in the perforated-patch or classical whole-cell configuration. The effect of noradrenaline depended on beta(1)- and not alpha(1) -or alpha(2)-adrenergic receptor stimulation. Activation of beta(1)-adrenergic receptors led to an increase in inward Na C current through hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which carry a mixed Na+/K+ current. The protein kinase A-and C-, glycogen synthase kinase3 beta-and tyrosine kinase-linked signaling pathways were not involved in the signal transduction between beta(1)-adrenergic receptors and HCN channels. The transduction system operated in a membrane-delimited fashion and involved the beta gamma subunit of G-protein. Thus, noradrenaline controls the resting membrane potential and holding current in mPFC pyramidal neurons through beta(1)-adrenergic receptors, which in turn activate HCN channels via a signaling pathway involving the beta gamma subunit.	[Grzelka, Katarzyna; Kurowski, Przemyslaw; Gawlak, Maciej; Szulczyk, Pawel] Med Univ Warsaw, Ctr Preclin Res & Technol, Lab Physiol & Pathophysiol, Warsaw, Poland	Grzelka, K; Szulczyk, P (corresponding author), Med Univ Warsaw, Ctr Preclin Res & Technol, Lab Physiol & Pathophysiol, Warsaw, Poland.	katarzyna.grzelka@wum.edu.pl; pawel.szulczyk@wum.edu.pl	Kurowski, Przemyslaw/M-3090-2018	Kurowski, Przemyslaw/0000-0001-5577-0115; Szulczyk, Pawel/0000-0001-6094-7106	National Science Centre, PolandNational Science Centre, Poland [2014/15/N/NZ4/04760]; Medical University of Warsaw [FW5/PM2/16]; CEPT [POIG.02.02.00-14-024/08-00]	The work was supported by the National Science Centre, Poland, grant 2014/15/N/NZ4/04760; Medical University of Warsaw, grant FW5/PM2/16; and CEPT, grant POIG.02.02.00-14-024/08-00.	Agster KL, 2013, J COMP NEUROL, V521, P2195, DOI 10.1002/cne.23270; AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Akaike Norio, 1999, Folia Pharmacologica Japonica, V113, P339, DOI 10.1254/fpj.113.339; Albarran-Juarez J, 2009, J PHARMACOL EXP THER, V331, P35, DOI 10.1124/jpet.109.157230; Andrews GD, 2006, NEUROPSYCHOPHARMACOL, V31, P594, DOI 10.1038/sj.npp.1300818; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Atkinson SE, 2009, J NEUROPHYSIOL, V102, P735, DOI 10.1152/jn.00083.2009; Bateman RJ, 2012, NEUROSCIENCE, V210, P58, DOI 10.1016/j.neuroscience.2012.02.033; Belkouch M, 2011, J NEUROSCI, V31, P18381, DOI 10.1523/JNEUROSCI.3386-11.2011; Benovic Jeffrey L., 2002, Journal of Allergy and Clinical Immunology, V110, pS229, DOI 10.1067/mai.2002.129370; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cellbio.4.1.405; Berger T, 2001, J NEUROPHYSIOL, V85, P855; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Branchereau P, 1996, SYNAPSE, V22, P313; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Cannavo A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00264; Carr DB, 2007, J PHYSIOL-LONDON, V584, P437, DOI 10.1113/jphysiol.2007.141671; Cathel AM, 2014, EUR J NEUROSCI, V40, P3202, DOI 10.1111/ejn.12690; Chamberlain SR, 2013, J PSYCHOPHARMACOL, V27, P694, DOI 10.1177/0269881113480988; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; Cheng QP, 2013, DNA CELL BIOL, V32, P320, DOI 10.1089/dna.2013.2021; Chung S, 2010, EXP PHYSIOL, V95, P982, DOI 10.1113/expphysiol.2010.053355; Claustre Y, 2008, NEUROSCIENCE, V156, P353, DOI 10.1016/j.neuroscience.2008.07.011; COTECCHIA S, 1990, J BIOL CHEM, V265, P63; Croce A, 2003, J NEUROSCI RES, V71, P516, DOI 10.1002/jnr.10516; Currie KPM, 2010, CHANNELS, V4, P497, DOI 10.4161/chan.4.6.12871; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dang VC, 2009, J NEUROSCI, V29, P3322, DOI 10.1523/JNEUROSCI.4749-08.2009; Daniels CR, 2012, AM J PHYSIOL-HEART C, V303, pH1459, DOI 10.1152/ajpheart.00401.2012; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Delmas P, 1999, J PHYSIOL-LONDON, V518, P23, DOI 10.1111/j.1469-7793.1999.0023r.x; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; Devilbiss DM, 2000, SYNAPSE, V37, P273, DOI 10.1002/1098-2396(20000915)37:4<273::AID-SYN4>3.0.CO;2-#; DIFRANCESCO D, 1995, CARDIOVASC RES, V30, P307, DOI 10.1016/0008-6363(95)00029-1; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1982, J PHYSIOL-LONDON, V329, P485, DOI 10.1113/jphysiol.1982.sp014315; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; Fitzgerald PJ, 2015, P NATL ACAD SCI USA, V112, pE3729, DOI 10.1073/pnas.1500682112; Fuxe K, 2015, NEUROCHEM RES, V40, P2600, DOI 10.1007/s11064-015-1574-5; Gamo NJ, 2015, BIOL PSYCHIAT, V78, P860, DOI 10.1016/j.biopsych.2015.01.009; Gannon M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00220; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Gassner M, 2009, PAIN, V145, P204, DOI 10.1016/j.pain.2009.06.021; Gawlak M, 2017, DEV NEUROBIOL, V77, P1371, DOI 10.1002/dneu.22537; Giovannitti Joseph A Jr, 2015, Anesth Prog, V62, P31, DOI 10.2344/0003-3006-62.1.31; Goodfellow NM, 2009, J NEUROSCI, V29, P10094, DOI 10.1523/JNEUROSCI.1960-09.2009; Gu QH, 2007, J APPL PHYSIOL, V102, P1545, DOI 10.1152/japplphysiol.01010.2006; Hatcher-Solis C, 2014, CURR PHARM BIOTECHNO, V15, P987, DOI 10.2174/1389201015666141031111916; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Huang JY, 2014, J CARDIOVASC PHARM, V63, P533, DOI 10.1097/FJC.0000000000000078; Huang Y, 2017, MOL MED REP, V15, P703, DOI 10.3892/mmr.2016.6038; Imbery TE, 2008, BRAIN RES, V1193, P93, DOI 10.1016/j.brainres.2007.12.016; Ishibashi H, 2003, J PHYSIOL-LONDON, V548, P111, DOI 10.1113/jphysiol.2002.033100; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Ji XH, 2008, CEREB CORTEX, V18, P1506, DOI 10.1093/cercor/bhm177; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Kim BG, 2017, SCI REP-UK, V7, DOI 10.1038/srep42217; Knaus A, 2007, CIRCULATION, V115, P872, DOI 10.1161/CIRCULATIONAHA.106.667675; Kobayashi M, 2007, NEUROSCIENCE, V146, P1772, DOI 10.1016/j.neuroscience.2007.04.001; Kobayashi M, 2009, SYNAPSE, V63, P269, DOI 10.1002/syn.20604; Kodama D, 2013, BRIT J PHARMACOL, V168, P1230, DOI 10.1111/bph.12000; Koshimizu T, 2002, BIOL PHARM BULL, V25, P401, DOI 10.1248/bpb.25.401; Kurowski P, 2015, NEUROSCIENCE, V303, P474, DOI 10.1016/j.neuroscience.2015.07.023; Ladno W, 2017, BRAIN RES, V1665, P95, DOI 10.1016/j.brainres.2017.04.009; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Li B, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00300; Li B, 2010, CEREB CORTEX, V20, P1756, DOI 10.1093/cercor/bhp241; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Li YC, 2009, J NEUROSCI, V29, P15551, DOI 10.1523/JNEUROSCI.3336-09.2009; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070390; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luo F, 2015, NEUROSCIENCE, V300, P63, DOI 10.1016/j.neuroscience.2015.04.070; Luo F, 2015, J NEUROCHEM, V132, P38, DOI 10.1111/jnc.12941; Luo F, 2014, EUR J NEUROSCI, V39, P1281, DOI 10.1111/ejn.12495; Lv TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep32430; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1998, J NEUROSCI, V18, P7613; Marzo A, 2010, NEUROSCIENCE, V169, P74, DOI 10.1016/j.neuroscience.2010.04.046; Marzo A, 2009, CURR NEUROPHARMACOL, V7, P286, DOI 10.2174/157015909790031193; Matos SC, 2015, J NEUROSCI, V35, P13244, DOI 10.1523/JNEUROSCI.0799-15.2015; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; Meitzen J, 2011, J NEUROCHEM, V116, P984, DOI 10.1111/j.1471-4159.2010.07137.x; Mesquita TRR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00220; Montezinho LP, 2006, J NEUROCHEM, V96, P1336, DOI 10.1111/j.1471-4159.2005.03654.x; Morioka N, 2014, J CELL PHYSIOL, V229, P323, DOI 10.1002/jcp.24452; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Nakashima N, 2013, J PHYSIOL-LONDON, V591, P1749, DOI 10.1113/jphysiol.2012.247361; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; O'Donnell Patricio, 2008, P219, DOI 10.1007/978-0-387-74351-6_11; Oshima N, 2014, HYPERTENS RES, V37, P976, DOI 10.1038/hr.2014.112; Paspalas CD, 2013, CEREB CORTEX, V23, P1643, DOI 10.1093/cercor/bhs152; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Pisani A, 2003, J NEUROSCI, V23, P5272; Radzicki D, 2017, J NEUROSCI, V37, P2292, DOI 10.1523/JNEUROSCI.1553-16.2017; Ramaswamy S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00233; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Rankovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027474; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026; Santana N, 2013, INT J NEUROPSYCHOPH, V16, P1139, DOI 10.1017/S1461145712001083; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Scheibner J, 2001, BRIT J PHARMACOL, V132, P925, DOI 10.1038/sj.bjp.0703882; Schmidt KT, 2014, MOL PHARMACOL, V85, P640, DOI 10.1124/mol.113.090118; Sheridan MA, 2010, J ATTEN DISORD, V14, P69, DOI 10.1177/1087054709347444; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; Simons SB, 2012, NAT NEUROSCI, V15, P23, DOI 10.1038/nn.2962; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; Socodato R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40912; Stone EA, 2011, BRAIN RES REV, V67, P193, DOI 10.1016/j.brainresrev.2011.02.002; Stott JB, 2015, P NATL ACAD SCI USA, V112, P6497, DOI 10.1073/pnas.1418605112; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Szulczyk B, 2015, NEUROSCI LETT, V595, P87, DOI 10.1016/j.neulet.2015.04.015; Talaia C, 2006, NEUROCHEM INT, V49, P698, DOI 10.1016/j.neuint.2006.07.002; Tyurin-Kuzmin PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32835; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Ursino MG, 2009, PHARMACOL RES, V59, P221, DOI 10.1016/j.phrs.2009.01.002; van Aerde KI, 2015, CEREB CORTEX, V25, P772, DOI 10.1093/cercor/bht274; van Aerde KI, 2015, CEREB CORTEX, V25, P788, DOI 10.1093/cercor/bht278; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang HX, 2013, NEUROSCIENCE, V246, P312, DOI 10.1016/j.neuroscience.2013.05.009; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; WANG Z, 1993, J NEUROSCI, V13, P2199; Wang ZM, 2008, INT J NEUROPSYCHOPH, V11, P611, DOI 10.1017/S1461145707008334; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177; Wolff M, 2007, BRIT J ANAESTH, V98, P353, DOI 10.1093/bja/ael379; Wong CO, 2010, BRIT J PHARMACOL, V159, P1486, DOI 10.1111/j.1476-5381.2010.00636.x; Xing B, 2016, BRAIN RES, V1641, P217, DOI 10.1016/j.brainres.2016.01.005; Yi F, 2013, EUR J NEUROSCI, V38, P2364, DOI 10.1111/ejn.12257; Yuen EY, 2014, J BIOL CHEM, V289, P25177, DOI 10.1074/jbc.M114.567610; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zhang HM, 2009, NEUROSCIENCE, V158, P1577, DOI 10.1016/j.neuroscience.2008.11.039; Zhang WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026581; Zhang ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066122; Zhou HC, 2013, LEARN MEMORY, V20, P274, DOI 10.1101/lm.030411.113; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	144	13	14	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	NOV 2	2017	11								341	10.3389/fncel.2017.00341			22	Neurosciences	Neurosciences & Neurology	FL5HC	WOS:000414262700001	29209170	DOAJ Gold, Green Published			2021-06-18	
J	Alshweki, A; Perez-Munuzuri, A; Lopez-Suarez, O; Bana, A; Couce, ML				Alshweki, Ayham; Perez-Munuzuri, Alejandro; Lopez-Suarez, Olalla; Bana, Ana; Couce, Maria L.			Relevance of urinary S100B protein levels as a short-term prognostic biomarker in asphyxiated infants treated with hypothermia	MEDICINE			English	Article						hypoxic-ischemic encephalopathy; neuron-specific enolase; serum S-100B protein; therapeutic hypothermia; urinary S-100B protein	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; EARLY IDENTIFICATION; BODY HYPOTHERMIA; NEWBORN; DAMAGE; SERUM; BLOOD	The initial diagnosis of neonatal hypoxic-ischemic encephalopathy is based on nervous system clinical manifestations. The use of biomarkers to monitor brain injury and evaluate neuroprotective effects allows early intervention and treatment. This study was designed to determine the short-term prognostic significance of urinary S100B calcium-binding protein (S100B) in asphyxiated newborns treated with hypothermia.An observational prospective study was conducted over a period of 5 years in 31 newborns with hypoxic-ischemic encephalopathy who received therapeutic hypothermia. The patients were divided into 2 groups: Group A (13 newborns with a normal neurological examination before discharge) and Group B (18 newborns who died during admission or had an abnormal neurologic examination before discharge). Urinary S100B was the main variable, serum S100B and neuron-specific enolase (NSE) were considered as secondary variables, and all of them were assessed on the first 3 days of life. The newborns were subsequently divided into groups with normal and abnormal electrophysiological and imaging findings.Mean urinary S100B levels were significantly higher in group B than group A on day 1 (10.5814.82 vs 4.65 +/- 9.16g/L, P=.031) and day 2 (5.16 +/- 7.63 vs 0.88 +/- 2.53, P=.002). The optimal cutoff for urinary S100B on day 1 was >1.11g/L of (sensitivity, 100%; specificity 60%) for the prediction of neonatal death and<0.66g/L (sensitivity 83% and specificity 70%) for the prediction of a normal neurological examination before discharge. It was not possible to calculate cutoffs with a similar accuracy for serum S100B or NSE. Urinary S100B on day 1 was higher in patients with abnormal magnetic resonance imaging findings (7.89 +/- 8.09 vs 4.49 +/- 9.14, P=.039) and abnormal positron emission tomography findings (8.60 +/- 9.29 vs 4.30 +/- 8.28, P=.038). There were no significant differences in S100B levels between patients with normal and abnormal electroencephalography results.Urinary S100B measured in the first days of life can predict neonatal death and short-term prognosis in asphyxiated newborns treated with hypothermia. The method is convenient, noninvasive, and has a higher sensitivity and specificity than measurement of serum S100B or NSE.	[Alshweki, Ayham; Perez-Munuzuri, Alejandro; Lopez-Suarez, Olalla; Bana, Ana; Couce, Maria L.] Santiago de Compostela Univ Hosp, IDIS Hlth Res Inst Santiago de Compostela, Dept Pediat, Neonatal Unit,CIBERER, Santiago De Compostela, Spain	Alshweki, A (corresponding author), Complejo Hosp Univ Santiago de Compostela, Santiago De Compostela 15706, A Coruna, Spain.	drayham@live.com	Couce, Maria Luz/R-8981-2019	Couce, Maria Luz/0000-0003-4861-9905; Perez-Munuzuri, Alejandro/0000-0003-1434-7470			Anand N, 2005, CEREBROVASC DIS, V20, P213, DOI 10.1159/000087701; BABLOK W, 1988, J CLIN CHEM CLIN BIO, V26, P783; Benbadis SR, 2006, SLEEP: A COMPREHENSIVE HANDBOOK, P989; Cornette L, 2012, FACTS VIEWS VIS OBGY, V4, P133; Drury PP, 2010, SEMIN FETAL NEONAT M, V15, P287, DOI 10.1016/j.siny.2010.05.005; Dubowitz L, 2005, MENT RETARD DEV D R, V11, P52, DOI 10.1002/mrdd.20048; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Ergenekon E, 2016, J CLIN NEONATOL, V5, P8, DOI 10.4103/2249-4847.173271; Gancia P, 2012, J MATERN-FETAL NEO M, V25, P94, DOI 10.3109/14767058.2012.715023; Gazzolo D, 2004, CRIT CARE MED, V32, P131, DOI 10.1097/01.CCM.0000104116.91462.CD; Gazzolo D, 2003, ARCH PEDIAT ADOL MED, V157, P1163, DOI 10.1001/archpedi.157.12.1163; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Gazzolo D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004298; Giuseppe D, 2009, CURR NEUROVASC RES, V6, P110, DOI 10.2174/156720209788185614; Graham EM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00196; Hassell KJ, 2015, ARCH DIS CHILD-FETAL, V100, pF541, DOI 10.1136/archdischild-2014-306284; Isgro MA, 2015, ADV EXP MED BIOL, V867, P125, DOI 10.1007/978-94-017-7215-0_9; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Kannan S, 2010, SEMIN PERINATOL, V34, P39, DOI 10.1053/j.semperi.2009.10.004; Lima JE, 2004, BRAZ J MED BIOL RES, V37, P19, DOI 10.1590/S0100-879X2004000100003; Liu L, 2010, NEONATOLOGY, V97, P41, DOI 10.1159/000227292; Lv HY, 2015, CLIN CHIM ACTA, V450, P282, DOI 10.1016/j.cca.2015.08.021; Ma H, 2012, CURR MOL MED, V12, P1282, DOI 10.2174/156652412803833517; Magalhaes M, 2015, SAO PAULO MED J, V133, P314, DOI 10.1590/1516-3180.2013.7740026; Marks K, 2010, ISR MED ASSOC J, V12, P494; Mosalli R, 2012, J CLIN NEONATOL, V1, P101, DOI 10.4103/2249-4847.96777; Oh W, 2008, J PEDIATR-US, V153, P375, DOI 10.1016/j.jpeds.2008.03.041; Papile LA, 2014, PEDIATRICS, V133, P1146, DOI 10.1542/peds.2014-0899; Ruetzler K, 2006, BIOL NEONATE, V89, P260, DOI 10.1159/000090120; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Shankaran S, 2012, J PEDIATR-US, V160, P567, DOI 10.1016/j.jpeds.2011.09.018; Sie LTL, 2000, NEUROPEDIATRICS, V31, P128, DOI 10.1055/s-2000-7496; Silveira RC, 2015, J PEDIAT-BRAZIL, V91, pS78, DOI 10.1016/j.jped.2015.07.004; Strauss J, 2008, EUR J NUCL MED MOL I, V35, P1581; STRAUSS RG, 1995, IMMUNOL INVEST, V24, P341, DOI 10.3109/08820139509062784; Tagin MA, 2012, ARCH PEDIAT ADOL MED, V166, P558, DOI 10.1001/archpediatrics.2011.1772; Wassink G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00040	38	13	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	NOV	2017	96	44							e8453	10.1097/MD.0000000000008453			6	Medicine, General & Internal	General & Internal Medicine	FM5UQ	WOS:000415106800042	29095291	DOAJ Gold, Green Published			2021-06-18	
J	Karelina, K; Gaier, KR; Weil, ZM				Karelina, Kate; Gaier, Kristopher R.; Weil, Zachary M.			Traumatic brain injuries during development disrupt dopaminergic signaling	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Development; Alcohol; Dopamine; Hypodopaminergia	RAT FRONTAL-CORTEX; MESOLIMBIC DOPAMINE; NUCLEUS-ACCUMBENS; TYROSINE-HYDROXYLASE; ALCOHOL-CONSUMPTION; PARKINSONS-DISEASE; SUBSTANCE-ABUSE; EXPRESSION; AMPHETAMINE; TRANSPORTER	Traumatic brain injuries (TBI) sustained during peri-adolescent development produce lasting neuro-behavioral changes that render individuals at an increased risk for developing substance abuse disorders. Experimental and clinical evidence of a prolonged period of hypodopaminergia after TBI have been well documented, but the effect of juvenile TBI on dopaminergic dysfunction and its relationship with substance abuse have not been investigated. In order to determine the effect of juvenile brain injury on dopaminergic signaling, female mice were injured at 21 days of age and then beginning seven weeks later were assessed for behavioral sensitization to amphetamine, a drug that increases synaptic dopamine availability. Together with a histological analysis of tyrosine hydroxylase, dopamine transporter, and dopamine D2 receptor expression, our data are indicative of a persistent state of hypodopaminergia well into adulthood after a juvenile TBI. Further, mice that sustained a juvenile TBI exhibited a significantly reduced activation of cFos in the urocortin-positive cells of the Edinger Westphal nucleus in response to ethanol administration. Taken together, these data provide strong evidence for the vulnerability of juveniles to the development of lasting neuro-behavioral problems following TBI, and indicate a role of injury-induced hypodopaminergia as a risk factor for substance abuse later in life.	[Karelina, Kate; Gaier, Kristopher R.; Weil, Zachary M.] Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Dept Neurosci,Grp Behav Neuroendocrinol, Columbus, OH 43210 USA	Karelina, K (corresponding author), Biomed Res Tower 618,460 West 12th Ave, Columbus, OH 43210 USA.	Ekaterina.karelina@osumc.edu	Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809; Karelina Weil, Kate/0000-0002-6628-0768	Huron Foundation; Ohio State University Wexner Medical Center; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS045758]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS104177, P30NS045758] Funding Source: NIH RePORTER	This work was supported by the Huron Foundation and the Ohio State University Wexner Medical Center Neuroscience Program. Additional support for behavioral experiments was provided by the National Institutes of Health (NINDS NS045758).	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Bachtell RK, 2002, J PHARMACOL EXP THER, V302, P516, DOI 10.1124/jpet.102.036046; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Bolton JM, 2009, J AFFECT DISORDERS, V115, P367, DOI 10.1016/j.jad.2008.10.003; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Calipari ES, 2013, J NEUROSCI, V33, P8923, DOI 10.1523/JNEUROSCI.1033-13.2013; Cantagrel S, 2001, BIOL NEONATE, V80, P68, DOI 10.1159/000047123; Carvey PM, 2003, FRONT BIOSCI-LANDMRK, V8, pS826, DOI 10.2741/1158; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Ceylan-Isik AF, 2010, LIFE SCI, V87, P133, DOI 10.1016/j.lfs.2010.06.002; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Covassin T, 2003, J ATHL TRAINING, V38, P238; Dagher A, 2009, NEURON, V61, P502, DOI 10.1016/j.neuron.2009.01.031; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Donnemiller E, 2000, EUR J NUCL MED, V27, P1410, DOI 10.1007/s002590000308; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Farin A, 2003, J NEUROSURG, V98, P32, DOI 10.3171/jns.2003.98.1.0032; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Galvan A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.006.2010; Giardino WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026997; GOLD LH, 1988, BEHAV NEUROSCI, V102, P544, DOI 10.1037/0735-7044.102.4.544; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Guerri C, 2010, ALCOHOL, V44, P15, DOI 10.1016/j.alcohol.2009.10.003; Heinz A, 2002, EUR PSYCHIAT, V17, P9, DOI 10.1016/S0924-9338(02)00628-4; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Jonsson CA, 2004, BRAIN INJURY, V18, P921, DOI 10.1080/02699050410001671900; Karelina K, 2017, BRAIN BEHAV IMMUN, V60, P304, DOI 10.1016/j.bbi.2016.11.009; KELLY PH, 1976, EUR J PHARMACOL, V40, P45, DOI 10.1016/0014-2999(76)90352-6; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; Koob George F, 2013, Front Psychiatry, V4, P72, DOI 10.3389/fpsyt.2013.00072; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; Melis M, 2005, INT REV NEUROBIOL, V63, P101, DOI 10.1016/S0074-7742(05)63005-X; Morean ME, 2010, ALCOHOL CLIN EXP RES, V34, P385, DOI 10.1111/j.1530-0277.2009.01103.x; NIELSEN JA, 1984, PHARMACOL BIOCHEM BE, V20, P227, DOI 10.1016/0091-3057(84)90247-8; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; ROBERTS DCS, 1980, PHARMACOL BIOCHEM BE, V12, P781, DOI 10.1016/0091-3057(80)90166-5; Sami MB, 2015, ACTA NEUROPSYCHIATR, V27, P317, DOI 10.1017/neu.2015.17; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt K, 2001, PHARMACOPSYCHIATRY, V34, P66, DOI 10.1055/s-2001-15184; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; Sullivan MA, 2001, ANN NY ACAD SCI, V931, P251, DOI 10.1111/j.1749-6632.2001.tb05783.x; Turker T, 1998, NEUROSCI LETT, V248, P147, DOI 10.1016/S0304-3940(98)00347-4; van Bregt DR, 2012, EXP NEUROL, V234, P8, DOI 10.1016/j.expneurol.2011.12.003; VEZINA P, 1989, BRAIN RES, V499, P108, DOI 10.1016/0006-8993(89)91140-2; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; White A, 2015, ALCOHOL CLIN EXP RES, V39, P1712, DOI 10.1111/acer.12815; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Yan HQ, 2001, NEUROREPORT, V12, P2323, DOI 10.1097/00001756-200108080-00009; Yang ZJ, 2007, J CEREBR BLOOD F MET, V27, P1339, DOI 10.1038/sj.jcbfm.9600440	66	13	14	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	NOV	2017	297						110	117		10.1016/j.expneurol.2017.08.003			8	Neurosciences	Neurosciences & Neurology	FJ3GA	WOS:000412617300011	28802560	Green Accepted			2021-06-18	
J	Kokiko-Cochran, ON; Saber, M; Puntambekar, S; Bemiller, SM; Katsumoto, A; Lee, YS; Bhaskar, K; Ransohoff, RM; Lamb, BT				Kokiko-Cochran, Olga N.; Saber, Maha; Puntambekar, Shweta; Bemiller, Shane M.; Katsumoto, Atsuko; Lee, Yu-Shang; Bhaskar, Kiran; Ransohoff, Richard M.; Lamb, Bruce T.			Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery	JOURNAL OF NEUROTRAUMA			English	Article						MAPT; neuroinflammation; spatial memory; TBI	TAU PATHOLOGY; MOUSE MODEL; ACTIVATION; HYPERPHOSPHORYLATION; NEUROINFLAMMATION; DEGENERATION; INFLAMMATION; MICROGLIA; ATROPHY; MATTER	Traumatic brain injury (TBI) induces widespread neuroinflammation and accumulation of microtubule associated protein tau (MAPT): two key pathological features of tauopathies. This study sought to characterize the microglial/macrophage response to TBI in genomic-based MAPT transgenic mice in a Mapt knockout background (called hTau). Two-month-old hTau and age-matched control male and female mice received a single lateral fluid percussion TBI or sham injury. Separate groups of mice were aged to an acute (3 days post-injury [DPI]) or chronic (135 DPI) post-injury time point. As judged by tissue immunostaining for macrophage markers, microglial/macrophage response to TBI was enhanced at 3 DPI in hTau mice compared with control TBI and sham mice. However, MAPT phosphorylation increased in hTau mice regardless of injury group. Flow cytometric analysis revealed distinct populations of microglia and macrophages within all groups at 135 DPI. Unexpectedly, microglial reactivity was significantly reduced in hTau TBI mice compared with all other groups. Instead, hTau TBI mice showed a persistent macrophage response. In addition, TBI enhanced MAPT pathology in the temporal cortex and hippocampus of hTau TBI mice compared with controls 135 DPI. A battery of behavioral tests revealed that TBI in hTau mice resulted in compromised use of spatial search strategies to complete a water maze task, despite lack of motor or visual deficits. Collectively, these data indicate that the presence of wild-type human tau alters the microglial/macrophage response to a single TBI, induces delayed, region-specific MAPT pathology, and alters cognitive recovery; however, the causal relationship between these events remains unclear. These results highlight the potential significance of communication between MAPT and microglia/macrophages following TBI, and emphasize the role of neuroinflammation in post-injury recovery.	[Kokiko-Cochran, Olga N.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA; [Saber, Maha] Univ Arizona, Coll Med, Barrow Neurol Inst, Translat Neurotrauma Res Program, Phoenix, AZ USA; [Puntambekar, Shweta; Bemiller, Shane M.; Katsumoto, Atsuko; Lamb, Bruce T.] Indiana Univ, Stark Neurosci Res Inst, Med & Mol Genet, Indianapolis, IN 46204 USA; [Lee, Yu-Shang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Bhaskar, Kiran] Univ New Mexico, Dept Mol Genet Microbiol & Neurol, Albuquerque, NM 87131 USA; [Ransohoff, Richard M.] Biogen, Neuroimmunol Acute Neurol & Pain Res & Early Disc, Cambridge, MA USA	Kokiko-Cochran, ON (corresponding author), Ohio State Univ, Dept Neurosci, 257 Inst Behav Med Res Bldg,460 Med Ctr Dr, Columbus, OH 43210 USA.	olga.kokiko-cochran@osumc.edu	Bhaskar, Kiran/AAF-2755-2020	Katsumoto, Atsuko/0000-0002-5582-3050	Department of DefenseUnited States Department of Defense; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [W81XWH-12-1-0629, R21NS077089, R01NS083704, R21NS093442]; Rodent Behavioral Core at the Lerner Research Institute within the Cleveland Clinic; Flow Cytometry Core at the Lerner Research Institute within the Cleveland Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [RF1NS083704, R01NS083704, R21NS093442, R01NS069765] Funding Source: NIH RePORTER	This work was supported by the Department of Defense and National Institutes of Health (W81XWH-12-1-0629, BTL; R21NS077089, R01NS083704, R21NS093442, K.B.). We thank the Rodent Behavioral Core and the Flow Cytometry Core at the Lerner Research Institute within the Cleveland Clinic for technical advice and support. We thank Dr. Imad Najm for use of the fluid percussion device. Author contributions: O.K-C. designed, performed, and analyzed all experiments and wrote the manuscript; M.S. performed surgeries, TBIs, and flow cytometry experiments; S.P. analyzed all flow cytometry data and assisted in interpretation of results; S.B. performed silver staining and assisted with biochemical analysis of data; A.K. performed immunohistochemistry and assisted with data analysis; Y-S.L. provided expertise in use of the fluid percussion device and analysis of data. K.B. provided expertise in use of the hTau mouse model and analysis of data; R.M.R. provided funding and expertise in data analysis and interpretation; and B.T.L. provided funding and expertise and co-edited the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; HOLNESS CL, 1993, BLOOD, V81, P1607; Holtzman DM, 2016, ALZHEIMERS DEMENT, V12, P1033, DOI 10.1016/j.jalz.2016.03.018; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Katsumoto A, 2014, J IMMUNOL, V193, P2615, DOI 10.4049/jimmunol.1400716; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Komuro Y, 2015, NEUROBIOL AGING, V36, P2034, DOI 10.1016/j.neurobiolaging.2015.03.002; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lin HH, 2010, ADV EXP MED BIOL, V706, P149; Maphis N, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0221-y; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Miyasaka T, 2010, FEBS LETT, V584, P3227, DOI 10.1016/j.febslet.2010.06.014; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015	47	13	13	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					73	84		10.1089/neu.2017.5203		NOV 2017	12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000414522900001	28859549	Green Published			2021-06-18	
J	Liu, PL; Zhang, ZJ; Wang, QD; Guo, RD; Mei, W				Liu, Peilin; Zhang, Zijuan; Wang, Qingde; Guo, Rundong; Mei, Wei			Lithium Chloride Facilitates Autophagy Following Spinal Cord Injury via ERK-dependent Pathway	NEUROTOXICITY RESEARCH			English	Article						Lithiumchloride; Autophagy flux; Spinal cord injury; ERK	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; ORAL LITHIUM; CANCER CELLS; PROTEIN; APOPTOSIS; NEURONS; MICE; LINE; CYTOTOXICITY	Spinal cord injury (SCI) is one major cause of death and results in long-term disability even in the most productive periods of human lives with few efficacious drugs. Autophagy is a potential therapeutic target for SCI. In the present study, we examined the role of lithium in functional recovery in the rat model of SCI and explored the related mechanism. Locomotion tests were employed to assess the functional recovery after SCI, Western blotting and RT-PCT to determine the level of p-ERK and LC3-II as well as p62, immunofluorescence imaging to localize LC3 and p62. Here, we found that both the expression of LC3-II and p62 were increased after SCI. However, lithium chloride enhanced the level of LC3-II while abrogated the abundance of p62. Furthermore, lithium treatment facilitated ERK activation in vivo, and inhibition of MEK/ERK signaling pathway suppressed lithium-evoked autophagy flux. Taken together, our results illustrated that lithium facilitated functional recovery by enhancing autophagy flux.	[Liu, Peilin; Wang, Qingde; Guo, Rundong; Mei, Wei] Zhengzhou Orthopaed Hosp, Dept Spine Surg, Zhengzhou, Henan, Peoples R China; [Zhang, Zijuan] Henan Univ Chinese Med, Sch Basic Med Sci, Expt Teaching Ctr, Zhengzhou, Henan, Peoples R China	Mei, W (corresponding author), Zhengzhou Orthopaed Hosp, Dept Spine Surg, Zhengzhou, Henan, Peoples R China.	zzhospital03@126.com					Bartholomeusz C, 2008, CANCER RES, V68, P9302, DOI 10.1158/0008-5472.CAN-08-2592; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Casella GTB, 2006, EXP NEUROL, V202, P8, DOI 10.1016/j.expneurol.2006.05.028; Chang JW, 2011, J NEUROCHEM, V116, P659, DOI 10.1111/j.1471-4159.2010.07158.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cohen-Kaplan V, 2016, ONCOTARGET, V7, P83833, DOI 10.18632/oncotarget.13805; Cohen-Kaplan V, 2016, P NATL ACAD SCI USA, V113, pE7490, DOI 10.1073/pnas.1615455113; Corcelle E, 2006, CANCER RES, V66, P6861, DOI 10.1158/0008-5472.CAN-05-3557; Del Grosso A, 2016, J NEUROSCI RES, V94, P1246, DOI 10.1002/jnr.23910; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Fabrizi C, 2017, J APPL TOXICOL, V37, P207, DOI 10.1002/jat.3344; Gong X, 2016, AM J TRANSL RES, V8, P2127; Guttuso T, 2016, J NEUROL SCI, V368, P221, DOI 10.1016/j.jns.2016.07.027; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hou LL, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0222-y; Hull M, 2014, J CELL BIOCHEM, V115, P71, DOI 10.1002/jcb.24634; Kim EC, 2013, BRIT J OPHTHALMOL, V97, P1068, DOI 10.1136/bjophthalmol-2012-302881; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lenzi P, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00078; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li Q, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.33; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.527; Matsuzaki T, 2015, INT J DEV NEUROSCI, V41, P63, DOI 10.1016/j.ijdevneu.2014.11.006; Mattingly RR, 2006, J PHARMACOL EXP THER, V316, P456, DOI 10.1124/jpet.105.091454; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; O'Donovan TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134676; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Pardo R, 2003, J NEUROCHEM, V87, P417, DOI 10.1046/j.1471-4159.2003.02015.x; Raja M, 2015, MOVEMENT DISORD, V30, P1438, DOI 10.1002/mds.26260; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shimada K, 2012, NEUROBIOL DIS, V46, P101, DOI 10.1016/j.nbd.2011.12.050; SMITH RG, 1994, P NATL ACAD SCI USA, V91, P3393, DOI 10.1073/pnas.91.8.3393; Wang C, 2016, BIOCHEM BIOPH RES CO, V477, P534, DOI 10.1016/j.bbrc.2016.05.148; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Wang YA, 2017, AUTOPHAGY, V13, P212, DOI 10.1080/15548627.2016.1245262; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Wong DJL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-194; Wong YW, 2011, SPINAL CORD, V49, P94, DOI 10.1038/sc.2010.69; Yang ML, 2012, SPINAL CORD, V50, P141, DOI 10.1038/sc.2011.126; Zassadowski F, 2015, LEUKEMIA, V29, P2277, DOI 10.1038/leu.2015.159; Zhang DL, 2017, MULTIMED TOOLS APPL, V76, P7175, DOI 10.1007/s11042-016-3359-5; Zhang ZJ, 2016, CELL PHYSIOL BIOCHEM, V40, P1529, DOI 10.1159/000453203	46	13	15	0	19	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	NOV	2017	32	4					535	543		10.1007/s12640-017-9758-1			9	Neurosciences	Neurosciences & Neurology	FH2DV	WOS:000410949900001	28593525				2021-06-18	
J	Tjong, VK; Baker, HP; Cogan, CJ; Montoya, M; Lindley, TR; Terry, MA				Tjong, Vehniah K.; Baker, Hayden P.; Cogan, Charles J.; Montoya, Melissa; Lindley, Tory R.; Terry, Michael A.			Concussions in NCAA Varsity Football Athletes: A Qualitative Investigation of Player Perception and Return to Sport	JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS GLOBAL RESEARCH AND REVIEWS			English	Article							TRAUMATIC BRAIN-INJURY; DEPRESSION; SYMPTOMS; EDUCATION; IMPACT	Background: The objective of this study was to understand the experiences and perspectives of varsity football athletes on return to play following a concussion injury. Methods: Two experienced interviewers conducted qualitative, semistructured interviews of college-level football players who had sustained at least one concussion during their varsity careers. Results: Twenty varsity football players who averaged 2.3 concussions each (range, 1-5) were interviewed regarding peer pressure, the culture of football, and player awareness as factors affecting return to sport following a concussion. Less common secondary factors included risk management, severity and timing of the injury, and team support. Conclusions: Psychological stressors, the culture of football, and increased awareness were the most influential factors affecting collegiate football players' deciding to return to sport following a concussion.	[Tjong, Vehniah K.; Cogan, Charles J.; Montoya, Melissa; Lindley, Tory R.; Terry, Michael A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Baker, Hayden P.] Univ Illinois, Coll Med, Chicago, IL USA	Tjong, VK (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Baker, Hayden/0000-0002-9306-7006			American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ardern CL, 2013, BRIT J SPORT MED, V47, P1120, DOI 10.1136/bjsports-2012-091203; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, pe333; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Diehl E, 2010, JL HLTH, V23, P85; Flanigan DC, 2013, ARTHROSCOPY, V29, P1322, DOI 10.1016/j.arthro.2013.05.015; Galgano MA, 2016, CUREUS, V8, DOI 10.7759/cureus.532; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harmon Kimberly G, 2016, J Pediatr, V168, P253, DOI 10.1016/j.jpeds.2015.10.071; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Houck Z, 2016, AM J SPORT MED, V44, P2269, DOI 10.1177/0363546516645070; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kurowski BG, 2015, J TRAUMA ACUTE CARE, V79, pS21, DOI 10.1097/TA.0000000000000675; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Mainwaring LM, 2010, BRAIN INJURY, V24, P589, DOI 10.3109/02699051003610508; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Miyashita TL, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114554549; Mizobuchi Yoshifumi, 2016, Korean J Neurotrauma, V12, P1, DOI 10.13004/kjnt.2016.12.1.1; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Morrey MA, 1999, CLIN J SPORT MED, V9, P63, DOI 10.1097/00042752-199904000-00004; Multani N, 2016, J NEUROL, V263, P1342, DOI 10.1007/s00415-016-8172-6; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Podlog L, 2006, J APPL SPORT PSYCHOL, V18, P44, DOI 10.1080/10413200500471319; Richmond TS, 2009, PSYCHOL MED, V39, P1709, DOI 10.1017/S0033291709005376; Roiger T, 2015, J ATHL TRAINING, V50, P256, DOI 10.4085/1062-6050-49.3.83; Simpson JR, 2014, J AM ACAD PSYCHIATRY, V42, P159; Smith AM, 1996, SPORTS MED, V22, P391, DOI 10.2165/00007256-199622060-00006; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Strauss A, 1990, BASIS QUALITATIVE RE; Sullivan L, 2016, INT J ADOLESC MED HL, V29; Takahata Keisuke, 2016, Brain Nerve, V68, P849, DOI 10.11477/mf.1416200517; Tjong VK, 2014, AM J SPORT MED, V42, P336, DOI 10.1177/0363546513508762; Wright MJ, 2016, J CLIN EXP NEUROPSYC, V38, P561, DOI 10.1080/13803395.2016.1139057	45	13	13	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2474-7661			JAAOS GLOB RES REV	J. Am. Acad. Orthop. Surg. Glob. Res. Rev.	NOV	2017	1	8							e070	10.5435/JAAOSGlobal-D-17-00070			6	Orthopedics	Orthopedics	VI1JX	WOS:000461095500007	30211371	DOAJ Gold, Green Published			2021-06-18	
J	Zhu, W; Chi, N; Zou, P; Chen, HG; Tang, GT; Zhao, W				Zhu, Wei; Chi, Nan; Zou, Peng; Chen, Hongguang; Tang, Guotai; Zhao, Wei			Effect of docosahexaenoic acid on traumatic brain injury in rats	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						B-cell lymphoma 2; B-cell lymphoma 2-associated X protein; caspase-3; docosahexaenoic acid; traumatic brain injury	CEREBRAL-ISCHEMIA; FATTY-ACIDS; CELL-DEATH; OMEGA-3-FATTY-ACIDS; DHA; SUPPLEMENTATION; HOMEOSTASIS; APOPTOSIS; CASPASE-3; SEQUELAE	The present study aimed to investigate the protective effects of docosahexaenoic acid (DHA) on traumatic brain injury (TBI) in rats. A model of TBI was induced by lateral fluid percussion injury in adult rats and rats were randomly divided into the TBI-model group, TBI-low DHA group and TBI-high DHA group, while other healthy rats were assigned to the sham-operated group. Motor recovery was tested with beam-walking trials at 2, 7 and 15 days post-TBI. Cognitive recovery was tested with Morris water maze trials at 15 days post-TBI. The expression levels of caspase-3, B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax) were measured by western blotting. DHA protected against motor deficits induced by TBI in beam walking tests. All TBI-model groups had longer escape latency and swimming distances than the sham groups. Compared with the TBI-low DHA group, the TBI-high DHA group demonstrated shorter escape latency and swimming distances. DHA inhibited the expression of caspase-3 and the inhibition effect was more obvious at a high dosage. Furthermore, DHA dose-dependently rescued neurons by upregulating the Bcl-2: Bax ratio. DHA supplementation was a viable strategy to mitigate injury from TBI.	[Zhu, Wei; Chi, Nan; Zou, Peng; Chen, Hongguang; Tang, Guotai; Zhao, Wei] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China	Zhu, W (corresponding author), Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, 20 Yuhuangding East Rd, Yantai 264000, Shandong, Peoples R China.	zhuwei20162016@126.com					Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bao HJ, 2012, NEUROCHEM RES, V37, P2856, DOI 10.1007/s11064-012-0880-4; Bousquet M, 2011, AGEING RES REV, V10, P453, DOI 10.1016/j.arr.2011.03.001; Chang PKY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0244-5; Chen WQ, 2005, INVEST OPHTH VIS SCI, V46, P4342, DOI 10.1167/iovs.05-0601; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cole GM, 2010, NUTR REV, V68, pS102, DOI 10.1111/j.1753-4887.2010.00345.x; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Florent S, 2006, J NEUROCHEM, V96, P385, DOI 10.1111/j.1471-4159.2005.03541.x; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hara A, 1996, VIRCHOWS ARCH, V429, P249; Kalmijn S, 1997, AM J EPIDEMIOL, V145, P33, DOI 10.1093/oxfordjournals.aje.a009029; Kao TK, 2006, NEUROCHEM INT, V48, P166, DOI 10.1016/j.neuint.2005.10.008; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Lauterbach MD, 2015, NEUROPSYCH DIS TREAT, V11, P1601, DOI 10.2147/NDT.S80457; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Martin A, 2011, MOL IMAGING BIOL, V13, P10, DOI 10.1007/s11307-010-0324-y; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Nguemeni C, 2010, PHARMACOL RES, V61, P226, DOI 10.1016/j.phrs.2009.12.007; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pusceddu MM, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw078; Raghupathi R, 2002, NEUROSCIENCE, V110, P605, DOI 10.1016/S0306-4522(01)00461-4; Salakou S, 2007, IN VIVO, V21, P123; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Wei L, 2005, NEUROBIOL DIS, V19, P183, DOI 10.1016/j.nbd.2004.12.016; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Xiao DaLiao, 2008, Int J Med Sci, V5, P295	35	13	13	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	NOV	2017	14	5					4411	4416		10.3892/etm.2017.5054			6	Medicine, Research & Experimental	Research & Experimental Medicine	FM4GS	WOS:000414973100063	29075341	Green Published, Bronze			2021-06-18	
J	Bodanapally, UK; Dreizin, D; Issa, G; Archer-Arroyo, KL; Sudini, K; Fleiter, TR				Bodanapally, U. K.; Dreizin, D.; Issa, G.; Archer-Arroyo, K. L.; Sudini, K.; Fleiter, T. R.			Dual-Energy CT in Enhancing Subdural Effusions that Masquerade as Subdural Hematomas: Diagnosis with Virtual High-Monochromatic (190-keV) Images	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPOTENSION; IODINATED CONTRAST; HEMORRHAGE; ANGIOGRAPHY; ENHANCEMENT	BACKGROUND AND PURPOSE: Extravasation of iodinated contrast into subdural space following contrast-enhanced radiographic studies results in hyperdense subdural effusions, which can be mistaken as acute subdural hematomas on follow-up noncontrast head CTs. Our aim was to identify the factors associated with contrast-enhancing subdural effusion, characterize diffusion and washout kinetics of iodine in enhancing subdural effusion, and assess the utility of dual-energy CT in differentiating enhancing subdural effusion from subdural hematoma. MATERIALS AND METHODS: We retrospectively analyzed follow-up head dual-energy CT studies in 423 patients with polytrauma who had undergone contrast-enhanced whole-body CT. Twenty-four patients with enhancing subdural effusion composed the study group, and 24 randomly selected patients with subdural hematoma were enrolled in the comparison group. Postprocessing with syngo.via was performed to determine the diffusion and washout kinetics of iodine. The sensitivity and specificity of dual-energy CT for the diagnosis of enhancing subdural effusion were determined with 120-kV, virtual monochromatic energy (190-keV) and virtual noncontrast images. RESULTS: Patients with enhancing subdural effusion were significantly older (mean, 69 years; 95% CI, 60-78 years; P < .001) and had a higher incidence of intracranial hemorrhage (P = .001). Peak iodine concentration in enhancing subdural effusions was reached within the first 8 hours of contrast administration with a mean of 0.98 mg/mL (95% CI, 0.81-1.13 mg/mL), and complete washout was achieved at 38 hours. For the presence of a hyperdense subdural collection on 120-kV images with a loss of hyperattenuation on 190-keV and virtual noncontrast images, when considered as a true-positive for enhancing subdural effusion, the sensitivity was 100% (95% CI, 85.75%-100%) and the specificity was 91.67% (95% CI, 73%-99%). CONCLUSIONS: Dual-energy CT has a high sensitivity and specificity in differentiating enhancing subdural effusion from subdural hematoma. Hence, dual-energy CT has a potential to obviate follow-up studies.	[Bodanapally, U. K.; Dreizin, D.; Issa, G.; Archer-Arroyo, K. L.; Fleiter, T. R.] Univ Maryland, Med Ctr, Dept Diagnost Radiol & Nucl Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Sudini, K.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Fleiter, TR (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, Baltimore, MD 21201 USA.	tfleiter@gmail.com		Fleiter, Thorsten/0000-0001-6255-9027			Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Brightbill TC, 2000, HEADACHE, V40, P292, DOI 10.1046/j.1526-4610.2000.00043.x; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; FISHMAN RA, 1993, NEUROLOGY, V43, P609, DOI 10.1212/WNL.43.3_Part_1.609; Gupta R, 2010, RADIOLOGY, V257, P205, DOI 10.1148/radiol.10091806; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Koss SA, 2003, AM J NEURORADIOL, V24, P704; MOKRI B, 1995, NEUROLOGY, V45, P1801, DOI 10.1212/WNL.45.10.1801; Mori K, 2000, SURG NEUROL, V53, P303, DOI 10.1016/S0090-3019(00)00199-3; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Paldino M, 2003, NEUROSURG FOCUS, V15, P2, DOI DOI 10.3171/FOC.2003.15.6.8; PANNULLO SC, 1993, NEUROLOGY, V43, P919, DOI 10.1212/WNL.43.5.919; Phan CM, 2012, AM J NEURORADIOL, V33, P1088, DOI 10.3174/ajnr.A2909; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Postma Alida A, 2015, Curr Radiol Rep, V3, P16; Potter CA, 2016, RADIOGRAPHICS, V36, P2186, DOI 10.1148/rg.2016160069; Rennert J, 2010, J COMPUT ASSIST TOMO, V34, P249, DOI 10.1097/RCT.0b013e3181c6e704; SAGE MR, 1983, AM J NEURORADIOL, V4, P897; Shinohara Y, 2014, ACTA RADIOL, V55, P1015, DOI 10.1177/0284185113510492; Tan LA, 2016, J NEUROSURG, V124, P279, DOI 10.3171/2015.5.JNS15953; Willmann JK, 2002, AM J ROENTGENOL, V179, P437, DOI 10.2214/ajr.179.2.1790437; YAMADA H, 1980, SURG NEUROL, V13, P441; Zamora CA, 2015, J NEUROSURG, V123, P1184, DOI 10.3171/2014.10.JNS142172	23	13	13	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2017	38	10					1946	1952		10.3174/ajnr.A5318			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FI4PQ	WOS:000411955100026	28798216	Other Gold, Green Published			2021-06-18	
J	Burke, D; Linder, S; Hirsch, J; Dey, T; Kana, D; Ringenbach, S; Schindler, D; Alberts, J				Burke, Daniel; Linder, Susan; Hirsch, Joshua; Dey, Tanujit; Kana, Daniel; Ringenbach, Shannon; Schindler, David; Alberts, Jay			Characterizing Information Processing With a Mobile Device: Measurement of Simple and Choice Reaction Time	ASSESSMENT			English	Article						information processing; reaction time; mobile technology; cognitive assessment	PARKINSONS-DISEASE; HEAD-INJURY; PERFORMANCE; ATTENTION; ACCURACY; DEFICITS; SPEED; RELIABILITY; CONCUSSION; COMPLEXITY	Information processing is typically evaluated using simple reaction time (SRT) and choice reaction time (CRT) paradigms in which a specific response is initiated following a given stimulus. The measurement of reaction time (RT) has evolved from monitoring the timing of mechanical switches to computerized paradigms. The proliferation of mobile devices with touch screens makes them a natural next technological approach to assess information processing. The aims of this study were to determine the validity and reliability of using of a mobile device (Apple iPad or iTouch) to accurately measure RT. Sixty healthy young adults completed SRT and CRT tasks using a traditional test platform and mobile platforms on two occasions. The SRT was similar across test modality: 300, 287, and 280 milliseconds (ms) for the traditional, iPad, and iTouch, respectively. The CRT was similar within mobile devices, though slightly faster on the traditional: 359, 408, and 384 ms for traditional, iPad, and iTouch, respectively. Intraclass correlation coefficients ranged from 0.79 to 0.85 for SRT and from 0.75 to 0.83 for CRT. The similarity and reliability of SRT across platforms and consistency of SRT and CRT across test conditions indicate that mobile devices provide the next generation of assessment platforms for information processing.	[Burke, Daniel; Linder, Susan; Hirsch, Joshua; Dey, Tanujit; Kana, Daniel; Schindler, David; Alberts, Jay] Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Ringenbach, Shannon] Arizona State Univ, Phoenix, AZ USA	Alberts, J (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	albertj@ccf.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS058706, R01-NS673717]; Edward and Barbara Bell Family	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (Grants R01-NS058706, R01-NS673717 to JLA) and the Edward and Barbara Bell Family.	Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; BERKSON G, 1960, J MENT DEFIC RES, V4, P59; BLOXHAM CA, 1987, J NEUROL NEUROSUR PS, V50, P1178, DOI 10.1136/jnnp.50.9.1178; DeLuca J, 2004, J INT NEUROPSYCH SOC, V10, P101; EVARTS EV, 1981, BRAIN, V104, P167, DOI 10.1093/brain/104.1.167; FITTS PM, 1966, J EXP PSYCHOL, V71, P849, DOI 10.1037/h0023232; Gauntlett-Gilbert J, 1998, NEUROSCI BIOBEHAV R, V22, P865, DOI 10.1016/S0149-7634(98)00014-1; Gonzalez R, 2003, J INT NEUROPSYCH SOC, V9, P64, DOI 10.1017/S1355617703910071; HAMSHER KDS, 1977, CORTEX, V13, P306; Heinemann A., 2014, REHABILITATION MEASU; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; JAHANSHAHI M, 1992, BRAIN, V115, P539, DOI 10.1093/brain/115.2.539; Kay M., 2013, 7 INT C PERV COMP TE; KLAPP ST, 1995, J EXP PSYCHOL HUMAN, V21, P1015, DOI 10.1037/0096-1523.21.5.1015; Lafayette Instrument, 2004, VIS CHOIC REACT TIM; Laming D. R. J., 1968, INFORM THEORY CHOICE; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Luce R.D., 1986, RESPONSE TIMES THEIR; MCDONALD RD, 1964, J NERV MENT DIS, V138, P241, DOI 10.1097/00005053-196403000-00004; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; OLBRICH R, 1972, J NERV MENT DIS, V155, P356; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; REPPERGER DW, 1985, J MED ENG TECHNOL, V9, P270, DOI 10.3109/03091908509032111; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Schatz P, 2015, ASSESSMENT, V22, P405, DOI 10.1177/1073191114566622; Schmidt R. A. R., 2000, MOTOR LEARNING PERFO; Schwenk M, 2012, PHYSIOL MEAS, V33, P1931, DOI 10.1088/0967-3334/33/11/1931; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; TEICHNER WH, 1974, PSYCHOL REV, V81, P75, DOI 10.1037/h0035867; Thomas J., 1997, HIST EXERCISE SPORT; Thomas J.R., 2010, RES METHODS PHYS ACT; Tun PA, 2008, DEV PSYCHOL, V44, P1421, DOI 10.1037/a0012845; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; WELFORD AT, 1984, EXP AGING RES, V10, P73, DOI 10.1080/03610738408258548; WELFORD AT, 1988, ANN NY ACAD SCI, V515, P1, DOI 10.1111/j.1749-6632.1988.tb32958.x; Welford AT, 1980, REACTION TIMES; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630	44	13	13	1	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	OCT	2017	24	7					885	895		10.1177/1073191116633752			11	Psychology, Clinical	Psychology	FH4LC	WOS:000411124400004	26933140				2021-06-18	
J	Canchi, S; Kelly, K; Hong, Y; King, MA; Subhash, G; Sarntinoranont, M				Canchi, Saranya; Kelly, Karen; Hong, Yu; King, Michael A.; Subhash, Ghatu; Sarntinoranont, Malisa			Controlled single bubble cavitation collapse results in jet-induced injury in brain tissue	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Single bubble cavitation; Blast neurotrauma; DIC; Rodent model; Strain maps	POSSIBLE DAMAGE MECHANISM; SHOCK-WAVES; RAT-BRAIN; DYNAMICS; ULTRASOUND; INDUCTION	Multiscale damage due to cavitation is considered as a potential mechanism of traumatic brain injury (TBI) associated with explosion. In this study, we employed a TBI relevant hippocampal ex vivo slice model to induce bubble cavitation. Placement of single reproducible seed bubbles allowed control of size, number, and tissue location to visualize and measure deformation parameters. Maximum strain value was measured at 45 mu s after bubble collapse, presented with a distinct contour and coincided temporally and spatially with the liquid jet. Composite injury maps combined this maximum strain value with maximum measured bubble size and location along with histological injury patterns. This facilitated the correlation of bubble location and subsequent jet direction to the corresponding regions of high strain which overlapped with regions of observed injury. A dynamic threshold strain range for tearing of cerebral cortex was estimated to be between 0.5 and 0.6. For a seed bubble placed underneath the hippocampus, cavitation induced damage was observed in hippocampus (local), proximal cerebral cortex (marginal) and the midbrain/forebrain (remote) upon histological evaluation. Within this test model, zone of cavitation injury was greater than the maximum radius of the bubble. Separation of apposed structures, tissue tearing, and disruption of cellular layers defined early injury patterns that were not detected in the blast-exposed half of the brain slice. Ultrastructural pathology of the neurons exposed to cavitation was characterized by disintegration of plasma membrane along with loss of cellular content. The developed test system provided a controlled experimental platform to study cavitation induced high strain deformations on brain tissue slice. The goal of the future studies will be to lower underpressure magnitude and cavitation bubble size for more sensitive evaluation of injury.	[Canchi, Saranya; Hong, Yu; Subhash, Ghatu; Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Kelly, Karen] Univ Florida, ICBR Electron Microscope Facil, Gainesville, FL USA; [King, Michael A.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [King, Michael A.] North Florida South Georgia VA Med Ctr, Gainesville, FL USA	Sarntinoranont, M (corresponding author), Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.	msarnt@ufl.edu	Subhash, Ghatu/J-4851-2017	Subhash, Ghatu/0000-0002-5996-0909	Army Research Office [W911NF-10-1-0276]; North Florida/South Georgia Veterans Health System, Gainesville, FL	This research was funded by the Army Research Office award no. W911NF-10-1-0276. This work was supported by resources provided by the North Florida/South Georgia Veterans Health System, Gainesville, FL. The contents do not represent the views of the U.S Department of Veterans Affairs or the United States Government. The authors would like to thank Dr. Yuquing Li for technical assistance with EM data and Dr. Stephen J. Blackband for allowing us to use his laboratory facilities.	Adhikari U, 2016, PHYS CHEM CHEM PHYS, V18, P32638, DOI 10.1039/c6cp06704b; Arieli R, 2013, RESP PHYSIOL NEUROBI, V188, P49, DOI 10.1016/j.resp.2013.04.013; Barrow MS, 2004, J FLUID ENG-T ASME, V126, P162, DOI 10.1115/1.1667889; BENEDICT JV, 1970, J BASIC ENG-T ASME, V92, P597, DOI 10.1115/1.3425083; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Brujan EA, 2001, J FLUID MECH, V433, P283, DOI 10.1017/S0022112000003335; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; Dalecki D, 2000, ULTRASOUND MED BIOL, V26, P1327, DOI 10.1016/S0301-5629(00)00297-0; DEAR JP, 1988, NATURE, V332, P505, DOI 10.1038/332505a0; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; HARIRI RJ, 1994, BRAIN RES, V636, P139, DOI 10.1016/0006-8993(94)90188-0; Hong Y., 2015, EXP MECH, P1; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Krasovitski B, 2011, P NATL ACAD SCI USA, V108, P3258, DOI 10.1073/pnas.1015771108; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Liu QL, 2006, MECH MATER, V38, P1105, DOI 10.1016/j.mechmat.2006.01.001; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; LUBOCK P, 1980, J BIOMECH, V13, P1041, DOI 10.1016/0021-9290(80)90048-2; Mason W., 1971, P SOC EXP BIOL MED, V136; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Moosavi-Nejad SF, 2006, CANCER SCI, V97, P296, DOI 10.1111/j.1349-7006.2006.00172.x; Morrison B, 2003, J NEUROTRAUM, V20, P1079; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; NUSHOLTZ GS, 1995, J NEUROTRAUM, V12, P707, DOI 10.1089/neu.1995.12.707; Ohl CD, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.214502; Ohl CD, 2006, BIOPHYS J, V91, P4285, DOI [10.1529/biophysj.105.075366, 10.1529/biophysj.106.075366]; Pan B, 2012, OPT LASER ENG, V50, P586, DOI 10.1016/j.optlaseng.2011.05.005; Pan B, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/6/062001; Panzer MB, 2012, J TRAUMA ACUTE CARE, V72, P454, DOI 10.1097/TA.0b013e31821e8270; Papadopoulou V, 2014, ADV COLLOID INTERFAC, V206, P239, DOI 10.1016/j.cis.2014.01.017; Papadopoulou V, 2013, ADV COLLOID INTERFAC, V191, P22, DOI 10.1016/j.cis.2013.02.002; PAXINOS G, 1997, RAT BRAIN STEREOTAXI; Penn-Barwell JG, 2015, CURR REV MUSCULOSKE, V8, P312, DOI 10.1007/s12178-015-9289-4; PHILIPP A, 1993, J ACOUST SOC AM, V93, P2496, DOI 10.1121/1.406853; Pishchalnikov YA, 2003, J ENDOUROL, V17, P435, DOI 10.1089/089277903769013568; Rau KR, 2004, APPL PHYS LETT, V84, P2940, DOI 10.1063/1.1705728; Rayleigh, 1917, PHILOS MAG, V34, P94, DOI 10.1080/14786440808635681; Saijo A., 2011, NEUROIMAGE S1, V54, pS83; Salzar RS, 2017, J NEUROTRAUM, V34, P1589, DOI 10.1089/neu.2016.4600; Sarntinoranont M, 2012, J NEUROTRAUM, V29, P418, DOI 10.1089/neu.2011.1772; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sheikov N, 2004, ULTRASOUND MED BIOL, V30, P979, DOI 10.1016/j.ultrasmedbio.2004.04.010; SHIMA A, 1981, J FLUID ENG-T ASME, V103, P370; Skyba DM, 1998, CIRCULATION, V98, P290, DOI 10.1161/01.CIR.98.4.290; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Subhash G., 2000, SPLIT HOPKINSON PRES, P497; Tachibana K, 1999, LANCET, V353, P1409, DOI 10.1016/S0140-6736(99)01244-1; Takhounts E., 2003, STAPP CAR CRASH J, V47, P107, DOI DOI 10.4271/2003-22-0007; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Tsokos M, 2003, AM J RESP CRIT CARE, V168, P549, DOI 10.1164/rccm.200304-528OC; VERGUNST H, 1989, ANN SURG, V210, P565, DOI 10.1097/00000658-198911000-00001; von See C, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-6; Wu JR, 2002, ULTRASOUND MED BIOL, V28, P125, DOI 10.1016/S0301-5629(01)00497-5; Zhang LY, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00088; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhong P, 2001, ULTRASOUND MED BIOL, V27, P119, DOI 10.1016/S0301-5629(00)00322-7	63	13	13	0	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	OCT	2017	74						261	273		10.1016/j.jmbbm.2017.06.018			13	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	FG4RP	WOS:000410253500029	28645069				2021-06-18	
J	Heneghan, JA; Pollack, MM				Heneghan, Julia A.; Pollack, Murray M.			Morbidity Changing the Outcome Paradigm for Pediatric Critical Care	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Morbidity; Functional status; Quality; Outcomes; Outcomes research; Critical care; Pediatric critical care; Pediatric intensive care	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FUNCTIONAL STATUS SCALE; RANDOMIZED CONTROLLED-TRIAL; CHILD HEALTH QUESTIONNAIRE; ADAPTIVE-BEHAVIOR SCALES; INTENSIVE-CARE; CRITICAL ILLNESS; PERFORMANCE CATEGORY; SURVEY FORM	The focus of critical care has evolved from saving lives to preservation of function. Morbidity rates in pediatric critical care are approximately double mortality rates. Morbidity includes complications of disease and medical care. In pediatric critical care, functional status morbidity is an intermediate outcome in the progression toward death and is the result of the same factors associated with mortality, including physiologic profiles and case-mix factors. The Functional Status Scale developed by Collaborative Pediatric Critical Care Research Network is a validated, granular, age-independent measure of functional status that has proved valuable and practical even in large outcome studies.	[Heneghan, Julia A.; Pollack, Murray M.] Childrens Natl Hlth Syst, Crit Care Med, 111 Michigan Ave Northwest, Washington, DC 20010 USA; [Pollack, Murray M.] George Washington Univ, Crit Care Med, Childrens Natl Hlth Syst, Sch Med & Hlth Sci,Dept Pediat, 111 Michigan Ave Northwest, Washington, DC 20010 USA	Pollack, MM (corresponding author), Childrens Natl Hlth Syst, Crit Care Med, 111 Michigan Ave Northwest, Washington, DC 20010 USA.; Pollack, MM (corresponding author), George Washington Univ, Crit Care Med, Childrens Natl Hlth Syst, Sch Med & Hlth Sci,Dept Pediat, 111 Michigan Ave Northwest, Washington, DC 20010 USA.	mpollack@childrensnational.org			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [UG1 HD049981, U10 HD063114, U10 HD049981] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U10HD049981, UG1HD049981, U10HD063114] Funding Source: NIH RePORTER		Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Als LC, 2015, CRIT CARE MED, V43, pE312, DOI 10.1097/CCM.0000000000001075; Als LC, 2013, CRIT CARE MED, V41, P1094, DOI 10.1097/CCM.0b013e318275d032; Amer Coll of Surgeon, 2015, AM COLL SURGEON; Aspesberro F, 2015, INTENS CARE MED, V41, P1235, DOI 10.1007/s00134-015-3780-7; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Berger JT, 2017, J THORAC CARDIOVASC; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Boyd JM, 2016, ANN SURG; Committee on the future of emergency care, 2006, FUT EM CAR EM CAR CH; Davydow DS, 2010, ARCH PEDIAT ADOL MED, V164, P377, DOI 10.1001/archpediatrics.2010.10; Drotar D, 2006, J PEDIATR PSYCHOL, V31, P127, DOI 10.1093/jpepsy/jsi078; Dumas Helene M, 2004, Pediatr Phys Ther, V16, P157, DOI 10.1097/01.PEP.0000136004.69289.01; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Jacobs ML, 2013, J THORAC CARDIOV SUR, V145, P1046, DOI 10.1016/j.jtcvs.2012.06.029; Jardine J, 2014, PEDIATRICS, V134, pE1129, DOI 10.1542/peds.2014-0352; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kronman MP, 2008, PEDIATRICS, V121, pE1653, DOI 10.1542/peds.2007-2831; Larsen GY, 2016, NEUROCRIT CARE, V24, P353, DOI 10.1007/s12028-015-0218-6; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Oakland, 2003, ABAS 2 ADAPTIVE BEHA; Ong C, 2016, PEDIATR CRIT CARE ME, V17, pE247, DOI 10.1097/PCC.0000000000000706; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Polinder S, 2005, PEDIATRICS, V116, pE810, DOI 10.1542/peds.2005-1035; POLLACK MM, 1987, NEW ENGL J MED, V316, P134, DOI 10.1056/NEJM198701153160304; Pollack MM, 2016, PEDIATR CRIT CARE ME, V17, P2, DOI 10.1097/PCC.0000000000000558; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Raat H, 2002, J CLIN EPIDEMIOL, V55, P67, DOI 10.1016/S0895-4356(01)00411-5; RAGGIO DJ, 1993, PERCEPT MOTOR SKILL, V77, P931, DOI 10.2466/pms.1993.77.3.931; RAGGIO DJ, 1994, PERCEPT MOTOR SKILL, V79, P203, DOI 10.2466/pms.1994.79.1.203; Ridgeon EE, 2016, CRIT CARE MED, V44, P1278, DOI 10.1097/CCM.0000000000001670; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Sparrow S.S., 2005, VINELAND 2 VINELAND; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812	47	13	14	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	OCT	2017	64	5					1147	+		10.1016/j.pcl.2017.06.011			20	Pediatrics	Pediatrics	FL5KI	WOS:000414275300014	28941541	Green Accepted			2021-06-18	
J	Katiyar, KS; Winter, CC; Struzyna, LA; Harris, JP; Cullen, DK				Katiyar, Kritika S.; Winter, Carla C.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy			Mechanical elongation of astrocyte processes to create living scaffolds for nervous system regeneration	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						astrocyte; tissue engineering; cell transplant; regeneration; neurotrauma; neurodegeneration	IN-VITRO; ENGINEERED CONSTRUCTS; CELL-CULTURES; INJURY MODEL; BRAIN-INJURY; RADIAL GLIA; TISSUE; GROWTH; STRETCH; AXONS	Following brain injury or neurodegenerative disease, successful regeneration requires orchestrated migration of neurons and reformation of long-distance communication fibres, or axons. Such extensive regeneration does not occur in the mature brain; however, during embryonic development, pathways formed by glial cells extend several millimeters (mm) to create 'living scaffolds' for targeted neural cell migration and axonal pathfinding. Techniques to recapitulate long process outgrowth in glial cells have proven elusive, preventing the exploitation of this developmental mechanism for regeneration. In the current study, astrocytes were induced to form a network of interconnected processes that were subjected to controlled mechanical tension in vitro using custom-built mechanobioreactors. We discovered a specific micron (mu m)-scale mechanical growth regime that induced elongation of the astrocytic processes to a remarkable length of 2.5 mm at an optimal rate of 12.5 mu m/h. More rapid mechanical regimes (> 20 mu m/h) caused greater incidence of process degeneration or outright breakage, whereas slow regimes (< 4 mu m/h) led to adaptive motility, thus failing to achieve process elongation. Cellular phenotype for this astrocytic 'stretch-growth' was confirmed based on presentation of the intermediate filament glial fibrillary acidic protein (GFAP). Mechanical elongation resulted in the formation of dense bundles of aligned astrocytic processes. Importantly, seeded neurons readily adhered to, and extended neurites directly along, the elongated astrocytic processes, demonstrating permissiveness to support neuronal growth. This is the first demonstration of the controlled application ofmechanical forces to create long astrocytic processes, which may form the backbone of tissue-engineered 'living scaffolds' that structurally emulate radial glia to facilitate neuroregeneration. Copyright (C) 2016 John Wiley & Sons, Ltd.	[Katiyar, Kritika S.; Winter, Carla C.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Katiyar, Kritika S.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	Cullen, DK (corresponding author), 105 E Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu		Harris, James/0000-0002-8458-5434	US Army Medical Research and Materiel Command through Joint Warfighter Medical Research Program [W81XWH-13-207004]; National Science FoundationNational Science Foundation (NSF) [DGE-1321851]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-NS043126]; Department of Veterans AffairsUS Department of Veterans Affairs [B1097-I]; Penn Medicine Neuroscience Center; Penn's Center for Undergraduate Research and Fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS043126, F31NS090746, U01NS094340] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003748] Funding Source: NIH RePORTER	Financial support was provided by the US Army Medical Research and Materiel Command through the Joint Warfighter Medical Research Program (Grant No. W81XWH-13-207004), the National Science Foundation (Graduate Research Fellowship No. DGE-1321851), the National Institutes of Health (NIH; Grant No. T32-NS043126), the Department of Veterans Affairs (RR&D Merit Review No. B1097-I), the Penn Medicine Neuroscience Center, and Penn's Center for Undergraduate Research and Fellowships.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.741951000000000.x; Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2007, J NEURAL ENG, V4, P159, DOI 10.1088/1741-2560/4/2/015; Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201; Cullen D Kacy, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P636; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GAUL G, 1992, P ROY SOC B-BIOL SCI, V249, P57, DOI 10.1098/rspb.1992.0083; Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JAEGER CB, 1988, GLIA, V1, P31, DOI 10.1002/glia.440010105; JOOSTEN EAJ, 1989, NEUROSCIENCE, V31, P439, DOI 10.1016/0306-4522(89)90386-2; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Liverman C.T., 2005, SPINAL CORD INJURY P; Mattotti M, 2012, BIOMATERIALS, V33, P1759, DOI 10.1016/j.biomaterials.2011.10.086; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Pfister BJ, 2006, J NEUROSCI METH, V153, P95, DOI 10.1016/j.jneumeth.2005.10.012; PIXLEY SKR, 1987, J NEUROSCI RES, V18, P402, DOI 10.1002/jnr.490180304; Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045; Scemes E, 2012, FRONT NEUROSCI, P1; Smith DH, 2009, PROG NEUROBIOL, V89, P231, DOI 10.1016/j.pneurobio.2009.07.006; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]; Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943; Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004; Vukasinovic J, 2009, BIOMED MICRODEVICES, V11, P1155, DOI 10.1007/s10544-009-9332-6; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu T, 2006, J CELL BIOCHEM, V99, P1096, DOI 10.1002/jcb.20979; ZHOU HF, 1990, J COMP NEUROL, V292, P320, DOI 10.1002/cne.902920213	42	13	13	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	OCT	2017	11	10					2737	2751		10.1002/term.2168			15	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Cell Biology; Biotechnology & Applied Microbiology; Engineering	FL5LO	WOS:000414287300005	27273796	Bronze, Green Accepted			2021-06-18	
J	Quinn, T; Moskowitz, J; Khan, MW; Shutter, L; Goldberg, R; Col, N; Mazor, KM; Muehlschlegel, S				Quinn, Thomas; Moskowitz, Jesse; Khan, Muhammad W.; Shutter, Lori; Goldberg, Robert; Col, Nananda; Mazor, Kathleen M.; Muehlschlegel, Susanne			What Families Need and Physicians Deliver: Contrasting Communication Preferences Between Surrogate Decision-Makers and Physicians During Outcome Prognostication in Critically Ill TBI Patients	NEUROCRITICAL CARE			English	Article						Shared decision making; Goals-of-care decisions; Decision aid; Qualitative research; Traumatic brain injury; Critical care; Surrogate decision-maker	TRAUMATIC BRAIN-INJURY; CARE; AIDS; WITHDRAWAL; FRAMEWORK; MEMBERS	Surrogate decision-makers ("surrogates") and physicians of incapacitated patients have different views of prognosis and how it should be communicated, but this has not been investigated in neurocritically ill patients. We examined surrogates' communication preferences and physicians' practices during the outcome prognostication for critically ill traumatic brain injury (ciTBI) patients in two level-1 trauma centers and seven academic medical centers in the USA. We used qualitative content analysis and descriptive statistics of transcribed interviews to identify themes in surrogates (n = 16) and physicians (n = 20). The majority of surrogates (82%) preferred numeric estimates describing the patient's prognosis, as they felt it would increase prognostic certainty, and limit the uncertainty perceived as frustrating. Conversely, 75% of the physicians reported intentionally omitting numeric estimates during prognostication meetings due to low confidence in family members' abilities to appropriately interpret probabilities, worry about creating false hope, and distrust in the accuracy and data quality of existing TBI outcome models. Physicians felt that these models are for research only and should not be applied to individual patients. Surrogates valued compassion during prognostication discussions, and acceptance of their goals-of-care decision by clinicians. Physicians and surrogates agreed on avoiding false hope. We identified fundamental differences in the communication preferences of prognostic information between ciTBI patient surrogates and physicians. These findings inform the content of a future decision aid for goals-of-care discussions in ciTBI patients. If validated, these findings may have important implications for improving communication practices in the neurointensive care unit independent of whether a formal decision aid is used.	[Quinn, Thomas; Moskowitz, Jesse; Khan, Muhammad W.; Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Neurol Neurocrit Care, 55 Lake Ave North,S-5, Worcester, MA 01655 USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Goldberg, Robert] Univ Massachusetts, Med Sch, Dept Quantitat Hlth Sci, Worcester, MA USA; [Col, Nananda] Shared Decis Making Resources, Georgetown, ME USA; [Mazor, Kathleen M.] Univ Massachusetts, Med Sch, Meyers Primary Care Inst, Worcester, MA USA; [Mazor, Kathleen M.] Univ Massachusetts, Med Sch, Dept Internal Med, Worcester, MA USA; [Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Anesthesiol Crit Care, Worcester, MA 01655 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Surg, Worcester, MA 01655 USA	Muehlschlegel, S (corresponding author), Univ Massachusetts, Med Sch, Dept Neurol Neurocrit Care, 55 Lake Ave North,S-5, Worcester, MA 01655 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Med Sch, Dept Anesthesiol Crit Care, Worcester, MA 01655 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Med Sch, Dept Surg, Worcester, MA 01655 USA.	susanne.muehlschlegel@umassmemorial.org	Shutter, Lori A/G-2957-2013; Col, Nananda/AAE-3445-2019	Muehlschlegel, Susanne/0000-0002-5717-9246; Shutter, Lori/0000-0002-1390-0628	NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971]; University of Massachusetts Medical School Center for Clinical and Translational Science - NIH Clinical and Translational Science Award [UL1TR000161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000161] Funding Source: NIH RePORTER	Funded by NIH/NICHD Grant 5K23HD080971 (PI Muehlschlegel). This project was additionally supported by the University of Massachusetts Medical School Center for Clinical and Translational Science which is funded by the NIH Clinical and Translational Science Award to the University of Massachusetts Medical School (UL1TR000161).	Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Arozullah AM, 2007, MED CARE, V45, P1026, DOI 10.1097/MLR.0b013e3180616c1b; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Col N., 2011, SHARED DECISION MAKI; Cox CE, 2012, CRIT CARE MED, V40, P2327, DOI 10.1097/CCM.0b013e3182536a63; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Gerteis M., 1993, PATIENTS EYES UNDERS; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Legare F, 2006, CAN FAM PHYSICIAN, V52, P476; Legare F, 2006, MED DECIS MAKING, V26, P373, DOI 10.1177/0272989X06290492; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; OHRI Ottawa Hospital Research Institute, DEC DEV TOOLK; Ottawa Hospital Research Institute, 2014, DDEC AID IMPL TOOLK; Skrobik Y, 2006, CAN J ANAESTH, V53, P432, DOI 10.1007/BF03022613; Stacey D, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012	24	13	13	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2017	27	2					154	162		10.1007/s12028-017-0427-2			9	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	FJ4VC	WOS:000412739900002	28685395	Green Accepted			2021-06-18	
J	Yu, P; Li, SJ; Zhang, ZF; Wen, XL; Quan, W; Tian, QL; Gao, C; Su, WQ; Zhang, JN; Jiang, RC				Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai			Progesterone-mediated angiogenic activity of endothelial progenitor cell and angiogenesis in traumatic brain injury rats were antagonized by progesterone receptor antagonist	CELL PROLIFERATION			English	Article							ENHANCES NEUROGENESIS; CLINICAL-TRIAL; GROWTH-FACTOR; IN-VIVO; EXPRESSION; PROLIFERATION; MECHANISM; NEUROPROTECTION; TRANSPLANTATION; VASCULOGENESIS	ObjectivesProgesterone (P4) has the potential therapeutic effects for traumatic brain injury (TBI) whose recovery depended on the enhanced angiogenesis. Endothelial progenitor cell (EPC) plays an essential role in vascular biology. We previously demonstrated that P4 administration improved circulating EPC level and neurological recovery of rat with TBI. Here, we hypothesized that P4 augmented angiogenic potential of EPC and the angiogenesis-related neurorestoration after TBI through classical progesterone receptor (PR). Materials and methodsEPC derived from rats were stimulated with graded concentrations (0, 10(-10), 10(-9), 5x10(-9), 10(-8), 10(-7)mol/L) of P4 or 10(-6)mol/L ulipristal acetate (UPA, a PR antagonist). Male rats were subjected to cortical impact injury and treated with (i) DMSO (dimethyl sulfoxide), (ii) P4 and (iii) P4 and UPA. ResultsIt showed that P4 improved the angiogenic potential of EPC, including tube formation, adhesion, migration and vascular endothelial growth factor secretion, in a dose-dependent fashion with the maximal effect achieved at 10(-9)mol/L P4. High concentration (10(-7)mol/L) of P4 impaired the angiogenic potential of EPC. Notably, 10(-6)mol/L UPA antagonized the stimulatory effects of 10(-9)mol/L P4. After administrating P4, a significant improvement of neurological function and the restoration of the leaked blood-brain barrier were observed as well as a reduction of the brain water content. Both vessel density and expression of occludin of vessels were increased. When UPA was administered with P4, the neural restoration and angiogenesis were all reversed. Western blot showed that 10(-9)mol/L P4 increased the content of PRA and PRB of EPC, while 10(-7)mol/L P4 reduced the content of both PR isoforms, but there was no change found in the TBI rats. ConclusionsIt may suggest that P4-mediated angiogenic activity of EPC and angiogenesis in TBI rats were antagonized by PR antagonist.	[Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai] Tianjin Med Univ, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China; [Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai] Tianjin Neurol Inst, Tianjin, Peoples R China; [Yu, Peng; Li, Shengjie; Zhang, Zhifei; Wen, Xiaolong; Quan, Wei; Tian, Qilong; Gao, Chuang; Su, Wanqiang; Zhang, Jianning; Jiang, Rongcai] Minist Educ & Tianjin City, Key Lab Postneurotrauma Neurorepair & Regenerat C, Tianjin, Peoples R China	Zhang, JN; Jiang, RC (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp, Tianjin, Peoples R China.	jianningzhang@hotmail.com; jiang116216@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100920, 81200907, 81301629, 81271359]; Tianjin Research Program of Application Foundation and Advanced Technology [11JCZDJC18100]; Ontario-China Research and Innovation Fund [2011DFG33430]; Tianjin colleges and universities of science and technology development fund [2010013]	National Natural Science Foundation of China, Grant/Award Number: 81100920, 81200907, 81301629 and 81271359; Tianjin Research Program of Application Foundation and Advanced Technology, Grant/Award Number: 11JCZDJC18100; Ontario-China Research and Innovation Fund, Grant/Award Number: 2011DFG33430; Tianjin colleges and universities of science and technology development fund, Grant/Award Number: 2010013	Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bharti JN, 2015, J CLIN DIAGN RES, V9, pEC5, DOI 10.7860/JCDR/2015/10591.5447; Botelho MC, 2015, SM J REPROD HLTH INF, V1, P1; Candolfi M, 2005, ENDOCRINOLOGY, V146, P736, DOI 10.1210/en.2004-1276; Chen G, 2008, J SURG RES, V147, P92, DOI 10.1016/j.jss.2007.05.029; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Conneely OM, 2002, RECENT PROG HORM RES, V57, P339, DOI 10.1210/rp.57.1.339; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Dai D, 2002, CANCER RES, V62, P881; ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122; Esber N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140795; Frontczak-Baniewicz M, 2003, ACTA NEUROBIOL EXP, V63, P65; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Girling JE, 2007, ENDOCRINOLOGY, V148, P5433, DOI 10.1210/en.2007-0856; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; He L, 2014, NEUROCHEM RES, V39, P2251, DOI 10.1007/s11064-014-1427-7; Herbrig K, 2006, ANN RHEUM DIS, V65, P157, DOI 10.1136/ard.2005.035378; Hsu SP, 2008, CELL MOL LIFE SCI, V65, P3839, DOI 10.1007/s00018-008-8441-3; Hsu SP, 2011, MOL ENDOCRINOL, V25, P421, DOI 10.1210/me.2010-0424; Ichioka M, 2015, J STEROID BIOCHEM, V147, P103, DOI 10.1016/j.jsbmb.2014.12.008; Inoue T, 2002, J CLIN ENDOCR METAB, V87, P5325, DOI 10.1210/jc.2002-012096; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kempisty B, 2015, J BIOL REG HOMEOS AG, V29, P39; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Lee O, 2016, CANCER LETT, V376, P310, DOI 10.1016/j.canlet.2016.04.010; Lee TS, 2015, J CELL BIOCHEM, V116, P1411, DOI 10.1002/jcb.25101; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Leo JCL, 2008, INT J CANCER, V122, P230, DOI 10.1002/ijc.23081; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Matsubara Y, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-2; Nallasamy S, 2013, REPROD SCI, V20, P371, DOI 10.1177/1933719112459239; Neubauer Nikki L., 2011, Hormones & Cancer, V2, P170, DOI 10.1007/s12672-011-0065-7; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Okada H, 2011, FERTIL STERIL, V96, P786, DOI 10.1016/j.fertnstert.2011.06.048; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Selvaraj V, 2014, INT J NANOMED, V9, P1379, DOI 10.2147/IJN.S52625; Semenza GL, 2007, J CELL BIOCHEM, V102, P840, DOI 10.1002/jcb.21523; Shao RJ, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.381; Shimizu T, 2007, ANIM REPROD SCI, V102, P228, DOI 10.1016/j.anireprosci.2006.11.012; Si DW, 2014, EXP THER MED, V8, P1010, DOI 10.3892/etm.2014.1840; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Talaulikar VS, 2012, EUR J OBSTET GYN R B, V165, P135, DOI 10.1016/j.ejogrb.2012.07.023; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Thomas P, 2013, STEROIDS, V78, P583, DOI 10.1016/j.steroids.2013.01.003; Tsukada S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt168; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Walter LM, 2005, REPRODUCTION, V129, P765, DOI 10.1530/rep.1.00625; Wang XY, 2013, EXP THER MED, V6, P263, DOI 10.3892/etm.2013.1116; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Westin SN, 2012, CANCER BIOL THER, V13, P1, DOI 10.4161/cbt.13.1.18438; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xu FF, 2014, BRAIN INJURY, V28, P1594, DOI 10.3109/02699052.2014.943289; Yeh CH, 1998, BLOOD, V92, P3268, DOI 10.1182/blood.V92.9.3268.421k41_3268_3276; Yu P, 2016, CELL PROLIFERAT, V49, P48, DOI 10.1111/cpr.12231; Yuan JJ, 2015, REPROD SCI, V22, P1516, DOI 10.1177/1933719115589409; Zhang RL, 2006, J NEUROSCI RES, V83, P1213, DOI 10.1002/jnr.20813; Zhang YQ, 2013, J SURG RES, V185, P441, DOI 10.1016/j.jss.2013.05.073; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4	70	13	16	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7722	1365-2184		CELL PROLIFERAT	Cell Prolif.	OCT	2017	50	5							e12362	10.1111/cpr.12362			13	Cell Biology	Cell Biology	FF7LQ	WOS:000409197900009	28752929	Green Published			2021-06-18	
J	Henderson, TA; Morries, LD				Henderson, Theodore A.; Morries, Larry D.			Multi-Watt Near-Infrared Phototherapy for the Treatment of Comorbid Depression: An Open-Label Single-Arm Study	FRONTIERS IN PSYCHIATRY			English	Article						major depression; near-infrared; laser; photobiomodulation; near-infrared light therapy; suicidal ideation; antidepressant	DEEP BRAIN-STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT-RESISTANT DEPRESSION; REPORT QIDS-SR; OXIDATIVE STRESS; MAJOR DEPRESSION; QUICK INVENTORY; KETAMINE; THERAPY; INJURY	Background: The treatment of depression has been hampered by low efficacy of antidepressant medications and safety concerns with alternative modalities. Recent work demonstrated that multi-Watt transcranial near-infrared light therapy (NILT) can effectively treat traumatic brain injury (TBI). The current objective is to explore multi-Watt NILT efficacy in a proof-of-concept study as a treatment for depression. Methods: Thirty-nine sequential patients treated for TBI between March 2013 and May 2017 provided depression self-assessment data and/or were administered the Hamilton depression rating scale. Each completed the Quick Inventory of Depression Symptomatology-Self Report (QIDS) before and after treatment. Patients received multi-Watt NILT using near-infrared lasers (810/980 nm at 8-15 W) applied to forehead and temporal regions bilaterally for 9-12 min to each area. Pre-and posttreatment scores were analyzed by paired t-tests. Results: All met QIDS criteria for mild to severe depression and 69% had prior antidepressant trials. For 36 of the 39 patients, after 16.82 +/- 6.26 treatments, QIDS scores indicated a robust response (decrease of QIDS total score by >= 50%). For 32 of 39 patients, posttreatment QIDS scores indicated a remission from depression (decrease of QIDS total score <= 5). Overall, the QIDS score fell from 14.10 +/- 3.39 to 3.41 +/- 3.30 SD (p = 6.29 x 10(-19)). With 12 or fewer treatments, QIDS score dropped from 14.83 +/- 2.55 to 4.17 +/- 3.93. Patients receiving >= 13 treatments showed a change in QIDS score from 13.67 +/- 3.64 to 3.11 +/- 3.14. Those (N = 15) who received the entire treatment course within <= 8 weeks (5.33 +/- 1.72 weeks) showed a change in QIDS score from 13.86 +/- 3.14 to 4.5 +/- 3.94. Suicidal ideation resolved in all, but two patients. Patients remained in remission for up to 55 months after a single course of treatment. Conclusion: This is the first report of high-powered NILT showing efficacy for depression. Multi-Watt NILT showed far greater efficacy and persistent benefit compared to low-power (<1 Watt) infrared light treatments. Patients saw benefit often within four treatments and resolution of depressive symptoms occurred within 4 weeks for some. These data raise an intriguing possibility-that multi-Watt NILT may be a safe, effective, and rapid treatment for depression comorbid with TBI and possibly primary major depression disorder. A double-blind, placebo controlled trial is warranted to verify these proof-of-concept data.	[Henderson, Theodore A.; Morries, Larry D.] Neurolaser Fdn, Centennial, CO 80122 USA; [Henderson, Theodore A.] Synapt Space Inc, Centennial, CO 80122 USA; [Henderson, Theodore A.] Neuroluminance Inc, Centennial, CO 80122 USA; [Henderson, Theodore A.] Dr Theodore Henderson Inc, Centennial, CO 80122 USA	Henderson, TA (corresponding author), Neurolaser Fdn, Centennial, CO 80122 USA.; Henderson, TA (corresponding author), Synapt Space Inc, Centennial, CO 80122 USA.; Henderson, TA (corresponding author), Neuroluminance Inc, Centennial, CO 80122 USA.; Henderson, TA (corresponding author), Dr Theodore Henderson Inc, Centennial, CO 80122 USA.	thesynapticspace7@gmail.com					Berlim MT, 2014, J AFFECT DISORDERS, V159, P31, DOI 10.1016/j.jad.2014.02.016; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Browne CA, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00161; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Connolly KR, 2011, DRUGS, V71, P43, DOI 10.2165/11587620-000000000-00000; Cook SC, 2004, J NEUROBIOL, V60, P236, DOI 10.1002/neu.20025; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Ghaemi N., 2013, MEDSCAPE CONNECT; Goldstein BJ, 1998, J PSYCHOPHARMACOL, V12, pS55, DOI 10.1177/0269881198012003041; Gumnick JF, 2000, J CLIN PSYCHIAT, V61, P5; Henderson TA, 2016, NEURAL REGEN RES, V11, P563, DOI 10.4103/1673-5374.180737; Henderson TA, 2016, NEURAL REGEN RES, V11, P195, DOI 10.4103/1673-5374.177708; Henderson Theodore A, 2015, Adv Mind Body Med, V29, P27; Henderson TA, 2015, NEUROPSYCH DIS TREAT, V11, P2191, DOI 10.2147/NDT.S78182; Iosifescu DV, 2008, BIOL PSYCHIAT, V63, P1127, DOI 10.1016/j.biopsych.2007.11.020; Janicak PG, 2015, NEUROPSYCH DIS TREAT, V11, P1549, DOI 10.2147/NDT.S67477; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Lapchak PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127580; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McAvoy K, 2015, HIPPOCAMPUS, V25, P1429, DOI 10.1002/hipo.22464; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Mohr P, 2011, NEUROPSYCHOBIOLOGY, V64, P170, DOI 10.1159/000325225; Morais M, 2014, J PSYCHOPHARMACOL, V28, P1178, DOI 10.1177/0269881114553646; Morishita T, 2014, NEUROTHERAPEUTICS, V11, P475, DOI 10.1007/s13311-014-0282-1; Morries LD, 2015, NEUROPSYCH DIS TREAT, V11, P2159, DOI 10.2147/NDT.S65809; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Naeser MA, 2011, PHOTOMED LASER SURG, V29, P351, DOI 10.1089/pho.2010.2814; Newport DJ, 2015, AM J PSYCHIAT, V172, P950, DOI 10.1176/appi.ajp.2015.15040465; Ozcan ME, 2004, INT CLIN PSYCHOPHARM, V19, P89, DOI 10.1097/01.yic.0000110796.97676.89; Pigott HE, 2010, PSYCHOTHER PSYCHOSOM, V79, P267, DOI 10.1159/000318293; Ren JJ, 2014, PROG NEURO-PSYCHOPH, V51, P181, DOI 10.1016/j.pnpbp.2014.02.004; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sarandol A, 2007, HUM PSYCHOPHARM CLIN, V22, P67, DOI 10.1002/hup.829; Scheuing L, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00249; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Steffens D C, 1997, Depress Anxiety, V6, P10, DOI 10.1002/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Thase ME, 2001, BRIT J PSYCHIAT, V178, P234, DOI 10.1192/bjp.178.3.234; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	52	13	13	0	7	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-0640			FRONT PSYCHIATRY	Front. Psychiatry	SEP 29	2017	8								187	10.3389/fpsyt.2017.00187			8	Psychiatry	Psychiatry	FI4IV	WOS:000411935500001	29033859	DOAJ Gold, Green Published			2021-06-18	
J	Nagendran, T; Larsen, RS; Bigler, RL; Frost, SB; Philpot, BD; Nudo, RJ; Taylor, AM				Nagendran, Tharkika; Larsen, Rylan S.; Bigler, Rebecca L.; Frost, Shawn B.; Philpot, Benjamin D.; Nudo, Randolph J.; Taylor, Anne Marion			Distal axotomy enhances retrograde presynaptic excitability onto injured pyramidal neurons via trans-synaptic signaling	NATURE COMMUNICATIONS			English	Article							SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; PRIMARY MOTOR CORTEX; CORTICAL-NEURONS; GABAERGIC INHIBITION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; AXONAL INJURY; NITRIC-OXIDE	Injury of CNS nerve tracts remodels circuitry through dendritic spine loss and hyper-excitability, thus influencing recovery. Due to the complexity of the CNS, a mechanistic understanding of injury-induced synaptic remodeling remains unclear. Using microfluidic chambers to separate and injure distal axons, we show that axotomy causes retrograde dendritic spine loss at directly injured pyramidal neurons followed by retrograde presynaptic hyper-excitability. These remodeling events require activity at the site of injury, axon-to-soma signaling, and transcription. Similarly, directly injured corticospinal neurons in vivo also exhibit a specific increase in spiking following axon injury. Axotomy-induced hyperexcitability of cultured neurons coincides with elimination of inhibitory inputs onto injured neurons, including those formed onto dendritic spines. Netrin-1 downregulation occurs following axon injury and exogenous netrin-1 applied after injury normalizes spine density, presynaptic excitability, and inhibitory inputs at injured neurons. Our findings show that intrinsic signaling within damaged neurons regulates synaptic remodeling and involves netrin-1 signaling.	[Nagendran, Tharkika; Taylor, Anne Marion] Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Campus Box 7575, Chapel Hill, NC 27599 USA; [Nagendran, Tharkika; Larsen, Rylan S.; Philpot, Benjamin D.; Taylor, Anne Marion] Univ N Carolina, UNC Neurosci Ctr, Campus Box 7250, Chapel Hill, NC 27599 USA; [Larsen, Rylan S.; Philpot, Benjamin D.] Univ N Carolina, Dept Cell Biol & Physiol, Campus Box 7545, Chapel Hill, NC 27599 USA; [Bigler, Rebecca L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Frost, Shawn B.; Nudo, Randolph J.] Univ Kansas, Med Ctr, Landon Ctr Aging, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Frost, Shawn B.; Nudo, Randolph J.] Univ Kansas, Med Ctr, Dept Rehabil Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Philpot, Benjamin D.; Taylor, Anne Marion] Carolina Inst Dev Disabil, Campus Box 7255, Chapel Hill, NC 27599 USA; [Larsen, Rylan S.] Allen Inst Brain Sci, 615 Westlake Ave North, Seattle, WA 98109 USA	Taylor, AM (corresponding author), Univ N Carolina, UNC NCSU Joint Dept Biomed Engn, Campus Box 7575, Chapel Hill, NC 27599 USA.; Taylor, AM (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Campus Box 7250, Chapel Hill, NC 27599 USA.; Taylor, AM (corresponding author), Carolina Inst Dev Disabil, Campus Box 7255, Chapel Hill, NC 27599 USA.	anne.marion.taylor@gmail.com	Nagendran, Tharkika/N-2335-2019; Taylor, Anne Marion/F-4454-2012	Taylor, Anne Marion/0000-0003-0998-087X; Larsen, Rylan/0000-0002-7136-1175	American Heart AssociationAmerican Heart Association [17GRNT33700108]; Eunice Kennedy Shriver NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD073945]; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R42 MH097377]; Alfred P. Sloan Research FellowshipAlfred P. Sloan Foundation; NIH-NINDS Neuroscience Center Support Grant [P30 NS045892]; NIH- NICHD Intellectual and Developmental Disabilities Research Center Support Grant [U54 D079124]; NRSA predoctoral fellowshipUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 MH091817]; UNC Department of Cell Biology and Physiology's Dr Susan Fellner fellowship; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [5T32 GM007092]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS085093, R01 NS30853]; Ronald D. Deffenbaugh Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD073945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [F31MH091817, R42MH097377] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS085093, P30NS045892, R01NS030853] Funding Source: NIH RePORTER	We thank Stephanie Gupton for netrin-1, Kelly Carstens for preliminary gene expression work, Cassie Meeker for technical support, and Fabio Urbina for assistance in statistical analysis. We thank Richard Segal (MUSC), Julius Dewald (RIC), and Taylor lab members for their advice and discussions. A.M.T. acknowledges support from the American Heart Association (17GRNT33700108), Eunice Kennedy Shriver NICHD (K12 HD073945), NIMH (R42 MH097377), and an Alfred P. Sloan Research Fellowship. Imaging was partially performed at the Neuroscience Center Microscopy Core Facility, supported, in part, by funding from the NIH-NINDS Neuroscience Center Support Grant P30 NS045892 and the NIH- NICHD Intellectual and Developmental Disabilities Research Center Support Grant U54 D079124. R.S.L was supported by NRSA predoctoral fellowship F31 MH091817 and the UNC Department of Cell Biology and Physiology's Dr Susan Fellner fellowship. R.L.B. was supported in part by NIGMS grant 5T32 GM007092. B.D.P was supported by NINDS grant R01 NS085093. R.J.N. was supported by NINDS grant R01 NS30853 and the Ronald D. Deffenbaugh Family Foundation.	Ahn KJ, 2007, NEUROSCI LETT, V419, P43, DOI 10.1016/j.neulet.2007.03.068; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARRON KD, 1988, J NEUROPATH EXP NEUR, V47, P62, DOI 10.1097/00005072-198801000-00008; BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Canty AJ, 2013, J NEUROSCI, V33, P10374, DOI 10.1523/JNEUROSCI.0254-13.2013; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Du GH, 2011, RADIAT RES, V176, P706, DOI 10.1667/RR2592.1; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Frost SB, 2015, J NEUROTRAUM, V32, P1666, DOI 10.1089/neu.2015.3961; Fu MM, 2014, AUTOPHAGY, V10, P2079, DOI 10.4161/auto.34451; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Ghosh A, 2012, CEREB CORTEX, V22, P1309, DOI 10.1093/cercor/bhr191; Goldman JS, 2013, J NEUROSCI, V33, P17278, DOI 10.1523/JNEUROSCI.1085-13.2013; Gonzalez-Forero D, 2014, NEUROSCIENCE, V283, P138, DOI 10.1016/j.neuroscience.2014.08.021; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Han XF, 2017, MOL NEUROBIOL, V54, P1684, DOI 10.1007/s12035-016-9723-7; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Henry FE, 2012, J NEUROSCI, V32, P17128, DOI 10.1523/JNEUROSCI.2149-12.2012; Higley MJ, 2014, NAT REV NEUROSCI, V15, P567, DOI 10.1038/nrn3803; Horn KE, 2013, CELL REP, V3, P173, DOI 10.1016/j.celrep.2012.12.005; Ikeda S, 1998, BRAIN RES, V792, P164, DOI 10.1016/S0006-8993(98)00213-3; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jaerve A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049812; Kim BG, 2006, EXP NEUROL, V198, P401, DOI 10.1016/j.expneurol.2005.12.010; Larsen RS, 2014, NEURON, V83, P879, DOI 10.1016/j.neuron.2014.07.039; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Lu Haiyan, 2011, Front Med, V5, P86, DOI 10.1007/s11684-011-0118-x; Manitt C, 2006, J NEUROSCI RES, V84, P1808, DOI 10.1002/jnr.21070; Manitt C, 2009, J NEUROSCI, V29, P11065, DOI 10.1523/JNEUROSCI.0947-09.2009; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McIlwain DL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-19; MCKINLEY PA, 1990, J NEUROSCI, V10, P1429; Menon S, 2015, DEV CELL, V35, P698, DOI 10.1016/j.devcel.2015.11.022; Nagendran T, 2011, NEUROSCIENCE, V199, P548, DOI 10.1016/j.neuroscience.2011.09.048; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Neto E, 2016, J NEUROSCI, V36, P11573, DOI 10.1523/JNEUROSCI.1748-16.2016; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144; NUDO RJ, 1995, J COMP NEUROL, V358, P181, DOI 10.1002/cne.903580203; Oudega M, 2012, J PHYSIOL-LONDON, V590, P3647, DOI 10.1113/jphysiol.2012.233189; Persson AK, 2013, J NEUROSCI, V33, P19250, DOI 10.1523/JNEUROSCI.2148-13.2013; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Stavoe AKH, 2012, J CELL BIOL, V197, P75, DOI 10.1083/jcb.201110127; Sun H, 2011, NEUROBIOL DIS, V44, P73, DOI 10.1016/j.nbd.2011.06.006; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; Takechi U, 2014, CLIN NEUROPHYSIOL, V125, P2055, DOI 10.1016/j.clinph.2014.01.034; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Taylor AM, 2009, J NEUROSCI, V29, P4697, DOI 10.1523/JNEUROSCI.6130-08.2009; Taylor AM, 2013, J NEUROSCI, V33, P5584, DOI 10.1523/JNEUROSCI.2944-12.2013; Tu HJ, 2015, NEURON, V86, P1407, DOI 10.1016/j.neuron.2015.05.013; Urban ETR, 2012, MOL CELL BIOCHEM, V369, P267, DOI 10.1007/s11010-012-1390-z; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Xu K, 2014, SCIENCE, V344, P1275, DOI 10.1126/science.1255149; Yamada J, 2004, J PHYSIOL-LONDON, V557, P829, DOI 10.1113/jphysiol.2004.062471; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	65	13	13	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	SEP 20	2017	8								625	10.1038/s41467-017-00652-y			16	Multidisciplinary Sciences	Science & Technology - Other Topics	FH6VJ	WOS:000411317800001	28931811	DOAJ Gold, Green Published			2021-06-18	
J	Beauchamp, MH; Landry-Roy, C; Gravel, J; Beaudoin, C; Bernier, A				Beauchamp, Miriam H.; Landry-Roy, Catherine; Gravel, Jocelyn; Beaudoin, Cindy; Bernier, Annie			Should Young Children with Traumatic Brain Injury Be Compared with Community or Orthopedic Control Participants?	JOURNAL OF NEUROTRAUMA			English	Article						community controls; injured controls; pediatric brain injury; traumatic brain injury	MILD HEAD-INJURY; EXECUTIVE FUNCTION; PRESCHOOL-CHILDREN; EARLY-CHILDHOOD; NEUROCOGNITIVE OUTCOMES; SYMPTOMS; ADOLESCENTS; RISK; PREVALENCE; PREDICTOR	Pediatric traumatic brain injury (TBI) research depends on comparisons of profiles and outcomes between brain-injured individuals and groups consisting either of injured controls (e.g., orthopedic injuries, OI) or uninjured, typically developing children recruited from the community (community controls, CC). Children with OI are thought to provide optimal comparisons for individuals with TBI because they share injury-related experiences and pre-morbid characteristics; however, a study by Mathias and colleagues (2013) 1 in adults has called into question the added value of injury control groups in TBI research. The comparability of these control groups has not been established in young children. Seventy-two children with OI and 84 CC aged between 18 and 60 months were compared on a range of demographic variables, developmental and medical history, pre-injury behavioral and adaptive profiles, as well as on measures of adaptive functioning, behavior, family functioning, post-concussive symptoms, and cognition (intellectual functioning, verbal abilities, executive functioning, social cognition) 6 months after the OI. There were no statistically significant differences between the OI and CC groups on any of the variables tested, whether they related to pre-injury or post-injury characteristics. The findings are applicable to studies seeking to identify appropriate control groups in the context of preschool TBI research, and suggest no clear advantage in recruiting OI controls based on the variables studied and the methodology used. However, further work is necessary to verify additional factors and outcomes relevant to pediatric TBI research, as well as to compare outcomes between these two groups at more acute stages (i.e., prior to 6 months post-injury).	[Beauchamp, Miriam H.; Landry-Roy, Catherine; Beaudoin, Cindy; Bernier, Annie] Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Beauchamp, Miriam H.; Landry-Roy, Catherine; Gravel, Jocelyn; Beaudoin, Cindy] Ste Justine Hosp Res Ctr, Montreal, PQ, Canada	Beauchamp, MH (corresponding author), Univ Montreal, Dept Psychol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	miriam.beauchamp@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP11036]	This study was supported by the Canadian Institutes of Health Research (MOP11036 to M.H.B). Thank you to the LION study members and the ED team for their collaborative efforts.	Abidin RR., 1995, PARENTING STRESS IND; Achenbach TM, 2001, MANUAL ASEBA SCH AGE; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bayley N., 2006, BAYLEY SCALES INFANT; Beck DM, 2011, J COGN DEV, V12, P169, DOI 10.1080/15248372.2011.563485; Bellerose J, 2015, J INT NEUROPSYCH SOC, V21, P483, DOI 10.1017/S1355617715000569; BIJUR PE, 1990, PEDIATRICS, V86, P337; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BLISHEN BR, 1987, CAN REV SOC ANTHROP, V24, P465; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catroppa C, 2015, NEW FRONTIERS PEDIAT; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Goldstrohm SL, 2005, ARCH CLIN NEUROPSYCH, V20, P675, DOI 10.1016/j.acn.2005.02.005; Harrison P., 2003, ADAPTIVE BEHAV ASSES; Hughes C, 2005, DEV NEUROPSYCHOL, V28, P645, DOI 10.1207/s15326942dn2802_5; Hughes C, 2011, J EXP CHILD PSYCHOL, V108, P96, DOI 10.1016/j.jecp.2010.07.012; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; KLONOFF H, 1971, AM J PUBLIC HEALTH N, V61, P2405, DOI 10.2105/AJPH.61.12.2405; Kochanska G, 2000, DEV PSYCHOL, V36, P220, DOI 10.1037//0012-1649.36.2.220; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1595, DOI 10.1016/S0890-8567(09)66570-9; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2010, INJURY PREV, V16, P31, DOI 10.1136/ip.2009.022483; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Pears KC, 2003, SOC DEV, V12, P1, DOI 10.1111/1467-9507.00219; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Studer M, 2014, J INT NEUROPSYCH SOC, V20, P982, DOI 10.1017/S1355617714000927; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; Wechsler, 2002, WECHSLER PRESCHOOL P; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Winqvist S, 2007, BRAIN INJURY, V21, P1079, DOI 10.1080/02699050701553221; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zelazo PD, 2006, NAT PROTOC, V1, P297, DOI 10.1038/nprot.2006.46	55	13	13	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2545	2552		10.1089/neu.2016.4868			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200007	28398160				2021-06-18	
J	Dong, HJ; Shang, CZ; Li, G; Niu, Q; Luo, YC; Yang, Y; Meng, HP; Yin, HJ; Zhang, HX; Zhao, ML; Lin, L				Dong, Hua-Jiang; Shang, Chong-Zhi; Li, Gang; Niu, Qing; Luo, Yue-Chen; Yang, Yue; Meng, Hui-Peng; Yin, Hui-Juan; Zhang, Hai-Xia; Zhao, Ming-Liang; Lin, Ling			The Distribution of Transplanted Umbilical Cord Mesenchymal Stem Cells in Large Blood Vessel of Experimental Design With Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Homing; human umbilical cord mesenchymal stem cells; large blood vessels; rat; traumatic brain injury; vascular endothelial growth factor	BONE-MARROW; MECHANISMS; THERAPY; RATS; DISEASE; DAMAGE	The authors aim to track the distribution of human umbilical cord mesenchymal stem cells (MSCs) in large blood vessel of traumatic brain injury-rats through immunohistochemical method and small animal imaging system. After green fluorescent protein (GFP) gene was transfected into 293T cell, virus was packaged and MSCs were transfected. Mesenchymal stem cells containing GFP were transplanted into brain ventricle of rats when the infection rate reaches 95%. The immunohistochemical and small animal imaging system was used to detect the distribution of MSCs in large blood vessels of rats. Mesenchymal stem cells could be observed in large vessels with positive GFP expression 10 days after transplantation, while control groups (normal group and traumatic brain injury group) have negative GFP expression. The vascular endothelial growth factor in transplantation group was higher than that in control groups. The in vivo imaging showed obvious distribution of MSCs in the blood vessels of rats, while no MSCs could be seen in control groups. The intravascular migration and homing of MSCs could be seen in rats received MSCs transplantation, and new angiogenesis could be seen in MSCs-transplanted blood vessels.	[Dong, Hua-Jiang; Li, Gang; Yang, Yue; Meng, Hui-Peng; Lin, Ling] Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin 300072, Peoples R China; [Shang, Chong-Zhi; Zhao, Ming-Liang] Logist Univ Chinese Peoples Armed Police Forces, Tianjin Key Lab Neurotrauma Repair, Neurol Hosp, Affiliated Hosp, Tianjin 300161, Peoples R China; [Niu, Qing; Luo, Yue-Chen] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China; [Niu, Qing; Luo, Yue-Chen] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Niu, Qing; Luo, Yue-Chen] Peking Union Med Coll, Tianjin, Peoples R China; [Yin, Hui-Juan; Zhang, Hai-Xia] Chinese Acad Med Sci, Biomed Engn Inst, Tianjin, Peoples R China	Lin, L (corresponding author), Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin 300072, Peoples R China.; Zhao, ML (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Tianjin Key Lab Neurotrauma Repair, Neurol Hosp, Affiliated Hosp, Tianjin 300161, Peoples R China.	linling@tju.edu.cn		, Dong/0000-0002-4141-3077	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8140060952]	This project was supported by Natural Science Foundation of China, Project: Role of Dendritic Cell Expressed Voltage-Gated Sodium Channel Mediated Immunomodulation in the Therapy of Acute Myeloid Leukemia (8140060952).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Chung HJ, 2016, J VET SCI, V17, P97, DOI 10.4142/jvs.2016.17.1.97; Cui BZ, 2014, EXP THER MED, V7, P1233, DOI 10.3892/etm.2014.1608; Fan HC, 2015, CELL TRANSPLANT, V24, P471, DOI 10.3727/096368915X686931; Harris T, 2012, POSTGRAD MED J, V88, P588, DOI 10.1136/postgradmedj-2010-74245; He H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.417; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Li JP, 2015, GENET MOL RES, V14, P19005, DOI 10.4238/2015.December.29.8; Liu-DeRyke X, 2008, PHARMACOTHERAPY, V28, P485, DOI 10.1592/phco.28.4.485; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Mareschi K, 2001, HAEMATOLOGICA, V86, P1099; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Nam HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144218; Oliveira-Sales EB, 2016, AM J PHYSIOL-RENAL, V310, pF6, DOI 10.1152/ajprenal.00341.2015; Ozdemir M, 2012, STEM CELL REV REP, V8, P953, DOI 10.1007/s12015-012-9376-5; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; de Freitas ALP, 2014, ACTA CIR BRAS, V29, P29, DOI 10.1590/S0102-86502014001400006; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Siegel G, 2009, TRANSPLANTATION, V87, pS45, DOI 10.1097/TP.0b013e3181a285b0; Souza MC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0093-2; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Tokalov SV, 2007, STEM CELLS DEV, V16, P439, DOI 10.1089/scd.2006.0078; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Yuan Y, 2014, INT J NEUROSCI, V124, P524, DOI 10.3109/00207454.2013.859144; Zhao FY, 2014, INT J DEV NEUROSCI, V38, P147, DOI 10.1016/j.ijdevneu.2014.06.014	28	13	14	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2017	28	6					1615	1619		10.1097/SCS.0000000000003563			5	Surgery	Surgery	FO7IW	WOS:000417048300085	28863113				2021-06-18	
J	Snedden, TR; Brooks, MA; Hetzel, S; McGuine, T				Snedden, Traci R.; Brooks, Margaret Alison; Hetzel, Scott; McGuine, Tim			Normative Values of the Sport Concussion Assessment Tool 3 (SCAT3) in High School Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; cognitive; SCAT3; adolescent; sports; high school	PERFORMANCE; STATEMENT; SYMPTOMS; CHILDREN	Objective: Establish sex, age, and concussion history-specific normative baseline sport concussion assessment tool 3 (SCAT3) values in adolescent athletes. Design: Prospective cohort. Setting: Seven Wisconsin high schools. Participants: Seven hundred fifty-eight high school athletes participating in 19 sports. Independent Variables: Sex, age, and concussion history. Main Outcome Measures: Sport Concussion Assessment Tool 3 (SCAT3): total number of symptoms; symptom severity; total Standardized Assessment of Concussion (SAC); and each SAC component (orientation, immediate memory, concentration, delayed recall); Balance Error Scoring System (BESS) total errors (BESS, floor and foam pad). Results: Males reported a higher total number of symptoms [median (interquartile range): 0 (0-2) vs 0 (0-1), P = 0.001] and severity of symptoms [0 (0-3) vs 0 (0-2), P = 0.001] and a lower mean (SD) total SAC [26.0 (2.3) vs 26.4 (2.0), P = 0.026], and orientation [5 (4-5) vs 5 (5-5), P = 0.021]. There was no difference in baseline scores between sex for immediate memory, concentration, delayed recall or BESS total errors. No differences were found for any test domain based on age. Previously, concussed athletes reported a higher total number of symptoms [1 (0-4) vs 0 (0-2), P = 0.001] and symptom severity [2 (0-5) vs 0 (0-2), P = 0.001]. BESS total scores did not differ by concussion history. Conclusion: This study represents the first published normative baseline SCAT3 values in high school athletes. Results varied by sex and history of previous concussion but not by age. The normative baseline values generated from this study will help clinicians better evaluate and interpret SCAT3 results of concussed adolescent athletes.	[Snedden, Traci R.] Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA; [Brooks, Margaret Alison; McGuine, Tim] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped, Madison, WI 53705 USA; [Brooks, Margaret Alison] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53705 USA; [Hetzel, Scott] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI 53705 USA	Snedden, TR (corresponding author), Univ Wisconsin, Sch Nursing, 701 Highland Ave, Madison, WI 53705 USA.	tsnedden@wisc.edu		Snedden, Traci/0000-0002-1550-2340			Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bay RC, 2012, AM J SPORTS MED, V40, P927; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Khanna NK, 2015, SPORTS HEALTH, V7, P341, DOI 10.1177/1941738115571508; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrea M, 1996, STANDARDIZED ASSESSM; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2002, CLIN J SPORT MED, V12, P6; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; R Core Team, 2017, R LANG ENV STAT COMP; RIO, 2016, 2014 15 SUMM REP NAT; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	19	13	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2017	27	5					462	467		10.1097/JSM.0000000000000389			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	FG2HS	WOS:000409915300012	27606952				2021-06-18	
J	Liu, XX; Qiu, JH; Alcon, S; Hashim, J; Meehan, WP; Mannix, R				Liu, Xixia; Qiu, Jianhua; Alcon, Sasha; Hashim, Jumana; Meehan, William P., III; Mannix, Rebekah			Environmental Enrichment Mitigates Deficits after Repetitive Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						animal model; concussion; enrichment; mild traumatic brain injury; synaptic plasticity	ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; RATS; RECOVERY; EXPRESSION; SUBUNIT; MICE; PHOSPHORYLATION; INCREASES; NEURODEGENERATION	Although environmental enrichment has been shown to improve functional and histologic outcomes in pre-clinical moderate-to-severe traumatic brain injury (TBI), there are a paucity of pre-clinical data regarding enrichment strategies in the setting of repetitive mild traumatic brain injury (rmTBI). Given the vast numbers of athletes and those in the military who sustain rmTBI, the mounting evidence of the long-term and progressive sequelae of rmTBI, and the lack of targeted therapies to mitigate these sequelae, successful enrichment interventions in rmTBI could have large public health significance. Here, we evaluated enrichment strategies in an established pre-clinical rmTBI model. Seventy-one male C57BL/6 mice were randomized to two different housing conditions, environmental enrichment (EE) or normal condition (NC), then subjected to rmTBI injury (seven injuries in 9 days) or sham injury (anesthesia only). Functional outcomes in all four groups (NC-TBI, EE-TBI, NC-sham, and EE-sham) were assessed by motor, exploratory/anxiety, and mnemonic behavioral tests. At the synaptic level, N-methyl D-aspartate receptor (NMDAR) subunit expression of phosphorylated glutamate receptor 1 (GluR1), phosphorylated Ca2+/calmodulin-dependent protein kinase II (CaMKII), and calpain were evaluated by western blot. Compared to injured NC-TBI mice, EE-TBI mice had improved memory and decreased anxiety and exploratory activity post-injury. Treatment with enrichment also corresponded to normal NMDAR subunit expression, decreased GluR1 phosphorylation, decreased phosphorylated CaMKII, and normal calpain expression post-rmTBI. These data suggest that enrichment strategies may improve functional outcomes and mitigate synaptic changes post-rmTBI. Given that enrichment strategies are feasible in the clinical setting, particularly for athletes and soldiers for whom the risk of repetitive injury is greatest, these data suggest that clinical trials may be warranted.	[Liu, Xixia] Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China; [Qiu, Jianhua; Alcon, Sasha; Hashim, Jumana; Meehan, William P., III; Mannix, Rebekah] Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA; [Qiu, Jianhua; Meehan, William P., III; Mannix, Rebekah] Harvard Med Sch, Boston, MA USA; [Meehan, William P., III] Sports Concuss Clin, Div Sports Med, Boston, MA USA; [Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA	Mannix, R (corresponding author), Boston Childrens Hosp, Div Emergency Med, 300 Longwood Ave, Boston, MA 02115 USA.	Rebekah.Mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020		ABC-Clio publishing; Harvard Catalyst (the National Football League Players Association); National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32 HD040128]; CHB IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025758] Funding Source: NIH RePORTER	Dr. Meehan receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A guide for coaches and parents, and from Springer International for the book Head and Neck Injuries in Young Athlete and from and royalties from Wolters Kluwer for working as an author for UpToDate. He is under contract with ABC-Clio publishing for a future book entitled, Concussions. His research is funded, in part, by a grant from Harvard Catalyst (the National Football League Players Association mechanism) and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.; Dr. Mannix is funded, in part, by the NICHD T32 HD040128, a grant from Harvard Catalyst (the National Football League Players Association mechanism), and by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament.; The research presented in this article is supported by CHB IDDRC.	Anggono V, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8256196; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; BENNETT EL, 1964, SCIENCE, V146, P610, DOI 10.1126/science.146.3644.610; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Chang XL, 2016, MOL NEUROBIOL, V53, P3349, DOI 10.1007/s12035-015-9264-5; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/s38; Dupont G., 2003, SENSITIVITY CAM KINA; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; GENTILE AM, 1987, BEHAV NEURAL BIOL, V47, P321, DOI 10.1016/S0163-1047(87)90435-3; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Jang A, 2013, CURR ALZHEIMER RES, V10, P829; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Mines Marjelo A, 2011, Int J Alzheimers Dis, V2011, P861072, DOI 10.4061/2011/861072; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rongo C, 1999, NATURE, V402, P195; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Torasdotter M, 1998, BEHAV BRAIN RES, V93, P83, DOI 10.1016/S0166-4328(97)00142-3; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Woo CC, 2015, BEHAV NEUROSCI, V129, P412, DOI 10.1037/bne0000068; Zhang XQ, 2016, MOL MED REP, V14, P2231, DOI 10.3892/mmr.2016.5470; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739	53	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2445	2455		10.1089/neu.2016.4823			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400007	28376667	Green Published			2021-06-18	
J	Gollihue, JL; Patel, SP; Mashburn, C; Eldahan, KC; Sullivan, PG; Rabchevsky, AG				Gollihue, Jenna L.; Patel, Samir P.; Mashburn, Charlie; Eldahan, Khalid C.; Sullivan, Patrick G.; Rabchevsky, Alexander G.			Optimization of mitochondrial isolation techniques for intraspinal transplantation procedures	JOURNAL OF NEUROSCIENCE METHODS			English	Article						PC-12 cells; Bioenergetics; Spinal cord injury; MitoTracker; Transgenic labeling	SPINAL-CORD-INJURY; ACETYL-L-CARNITINE; ISCHEMIA-REPERFUSION INJURY; GREEN FLUORESCENT PROTEIN; CELL-DEATH; NONSYNAPTIC MITOCHONDRIA; FUNCTIONAL RECOVERY; UNCOUPLING AGENT; ANTIOXIDANT; RESCUE	Background: Proper mitochondrial function is essential to maintain normal cellular bioenergetics and ionic homeostasis. In instances of severe tissue damage, such as traumatic brain and spinal cord injury, mitochondria become damaged and unregulated leading to cell death. The relatively unexplored field of mitochondrial transplantation following neurotrauma is based on the theory that replacing damaged mitochondria with exogenous respiratory-competent mitochondria can restore overall tissue bioenergetics. New method: We optimized techniques in vitro to prepare suspensions of isolated mitochondria for transplantation in vivo. Mitochondria isolated from cell culture were genetically labeled with turbo-green fluorescent protein (tGFP) for imaging and tracking purposes in vitro and in vivo. Results: We used time-lapse confocal imaging to reveal the incorporation of exogenous fluorescently-tagged mitochondria into PC-12 cells after brief co-incubation. Further, we show that mitochondria can be injected into the spinal cord with immunohistochemical evidence of host cellular uptake within 24 h. Comparison to existing methods: Our methods utilize transgenic fluorescent labeling of mitochondria for a nontoxic and photostable alternative to other labeling methods. Substrate addition to isolated mitochondria helped to restore state III respiration at room temperature prior to transplantation. These experiments delineate refined methods to use transgenic cell lines for the purpose of isolating well coupled mitochondria that have a permanent fluorescent label that allows real time tracking of transplanted mitochondria in vitro, as well as imaging in situ. Conclusions: These techniques lay the foundation for testing the potential therapeutic effects of mitochondrial transplantation following spinal cord injury and other animal models of neurotrauma. (C) 2017 Elsevier B.V. All rights reserved.	[Gollihue, Jenna L.; Patel, Samir P.; Eldahan, Khalid C.; Rabchevsky, Alexander G.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Gollihue, Jenna L.; Patel, Samir P.; Mashburn, Charlie; Eldahan, Khalid C.; Sullivan, Patrick G.; Rabchevsky, Alexander G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA	Rabchevsky, AG (corresponding author), B471,BBSRB,741 S Limestone, Lexington, KY 40536 USA.	agrab@uky.edu	Rabchevsky, Alexander/AAQ-2451-2021	Rabchevsky, Alexander/0000-0002-1991-0915	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5T32NS077889, F31NS093904, R21NS096670, 2P30NS051220]; Conquer Paralysis Now "Out-of-Box" Award; University of Kentucky Spinal Cord and Brain Injury Center Chair Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096670, T32NS077889, F31NS093904, P30NS051220] Funding Source: NIH RePORTER	We would like to thank David Cox for his assistance in surgical procedures. This work was supported by NIH/NINDS 5T32NS077889 (JLG), NIH/NINDS F31NS093904 (JLG), NIH/NINDS R21NS096670 (AGR), Conquer Paralysis Now "Out-of-Box" Award (AGR), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowment (AGR), NIH/NINDS 2P30NS051220.	Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Chang J., 2013, CHANGHUA J MED, V11, P8; Chang JC, 2013, NEUROSIGNALS, V21, P160, DOI 10.1159/000341981; CLARK MA, 1982, NATURE, V295, P605, DOI 10.1038/295605a0; Cselenyak A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-29; Cunha FM, 2011, CURR DRUG TARGETS, V12, P783; Elliott RL, 2012, BREAST CANCER RES TR, V136, P347, DOI 10.1007/s10549-012-2283-2; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Han JY, 2013, BBA-GEN SUBJECTS, V1830, P5130, DOI 10.1016/j.bbagen.2013.07.001; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Rodriguez-Jimenez FJ, 2012, STEM CELLS, V30, P2221, DOI 10.1002/stem.1189; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; Katrangi E, 2007, REJUV RES, V10, P561, DOI 10.1089/rej.2007.0575; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; Kitani T, 2014, TRANSPL P, V46, P1233, DOI 10.1016/j.transproceed.2013.11.133; Kitani T, 2014, J CELL MOL MED, V18, P1694, DOI 10.1111/jcmm.12316; Lin HC, 2013, SHOCK, V39, P304, DOI 10.1097/SHK.0b013e318283035f; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008; Minamikawa T, 1999, J CELL SCI, V112, P2419; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Patel SP, 2009, INVEST OPHTH VIS SCI, V50, P180, DOI 10.1167/iovs.08-1911; PETRUZZELLA V, 1992, ARCH GERONTOL GERIAT, V14, P131, DOI 10.1016/0167-4943(92)90048-9; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Rizzuto R, 1996, CURR BIOL, V6, P183, DOI 10.1016/S0960-9822(02)00451-7; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Yang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks639	51	13	14	1	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	AUG 1	2017	287						1	12		10.1016/j.jneumeth.2017.05.023			12	Biochemical Research Methods; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	FC0YY	WOS:000406565800001	28554833	Green Accepted, Green Published			2021-06-18	
J	Molloy, JH; Murphy, I; Gissane, C				Molloy, John H.; Murphy, Ian; Gissane, Conor			The King-Devick (K-D) test and concussion diagnosis in semi-professional rugby union players	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						King-Devick test; Sport concussion assessment tool; Brain concussion; Post-concussion syndrome; Vision tests; Rugby	VISUAL SCREENING TOOL	Objectives: To determine the utility of the King-Devick (K-D) test in identifying sports-related concussion in semi-professional rugby players. Design: Descriptive cohort study. Methods: 176 male players were recruited from a semi-professional rugby union competition in New Zealand (NZ). Baseline K-D scores were obtained in the pre-season. Post-match K-D and Pitch Side Concussion Assessment Version 2 (PSCA2) scores were obtained in those with suspected concussion. Post-match K-D scores were also administered to selected control players. Results: 19 concussions in 18 players were analysed. In addition, 33 controls were used for analysis. A positive K-D test was identified in 53% of players with concussion post-match. Conversely, a positive test was identified in 33% of controls. The sensitivity and specificity of the K-D test was calculated as 53% and 69% respectively. The positive predictive value and negative predictive value was 48% and 73% respectively. The PSCA2 correctly identified 74% of concussions. The K-D test identified 3 cases not identified by the PSCA2. When the PSCA2 and K-D were combined, 89% of concussions were correctly identified. Conclusions: The K-D test does not appear to be effective if used as a stand-alone test for the diagnosis of concussion. However, if used alongside current side-line cognitive and balance tests, it may assist in more accurately diagnosing sports-related concussion. Further research should look to utilise the K-D test in in-match protocols to establish if this improves the diagnostic accuracy of in-match protocols for sports-related concussion. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Molloy, John H.] Australasian Coll Sport & Exercise Phys, Melbourne, Vic, Australia; [Murphy, Ian] New Zealand Rugby Union, Wellington, New Zealand; [Gissane, Conor] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England	Molloy, JH (corresponding author), Australasian Coll Sport & Exercise Phys, Melbourne, Vic, Australia.	drjohnmolloy@gmail.com	Gissane, Conor/I-3661-2019	Gissane, Conor/0000-0003-4677-3853			Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2015, J NEURO-OPHTHALMOL, P1; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Marindes Z, 2014, NEUROL CLIN PRACT, P1; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; WorldRugby, 2015, WORLD RUGB CONC MAN	13	13	13	1	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	AUG	2017	20	8					708	711		10.1016/j.jsams.2017.02.002			4	Sport Sciences	Sport Sciences	FC5PE	WOS:000406893400002	28258820	Green Accepted			2021-06-18	
J	Liu, Y; Wang, R; Zhao, ZW; Dong, W; Zhang, X; Chen, X; Ma, LN				Liu, Yuan; Wang, Rong; Zhao, Zhiwei; Dong, Wen; Zhang, Xu; Chen, Xi; Ma, Lina			Short-term caloric restriction exerts neuroprotective effects following mild traumatic brain injury by promoting autophagy and inhibiting astrocyte activation	BEHAVIOURAL BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Caloric restriction; Learning ability; Autophagy	CLOSED-HEAD INJURY; SPATIAL MEMORY; COGNITIVE DEFICITS; REACTIVE ASTROCYTES; NEUROTROPHIC FACTOR; CELL-DEATH; RAT MODEL; HIGH-FAT; MICE; IMPAIRMENT	Cognitive deficits may occur after mild traumatic brain injury (mTBI), but effective treatment modalities are presently unavailable. Caloric restriction (CR) has beneficial effects on neurodegenerative diseases and brain injury. However, the underlying mechanisms have not yet been clearly defined. Therefore, the aim of the present study was to investigate the short-term effects of CR treatment on cognitive function in mice after mTBI. Forty-five 12-week-old C57/BL6 mice were subjected to closed-head mTBI using a weight drop device. The mice were then randomly divided into three groups according to their diet for 30 days: the normal calorie group (mTBI + NC group, n = 15), the caloric restriction group (mTBI + CR group, n = 15), and the high energy group (mTBI + HE group, n = 15). After 30 days, the Morris water maze test was performed to evaluate learning abilities. Nissl staining, immunohistochemistry, and western blotting were used to monitor pathological changes and changes in autophagy-associated proteins in the hippocampus. The average escape latency was significantly shorter in the mTBI + CR group than in the mTBI + NC and mTBI + HE groups, and the number of target platform crossings in the mTBI + CR group was significantly higher than in the other two groups. In the hippocampus, the expression of GFAP and mTOR was increased in the mTBI + HE group and decreased in the mTBI + CR group. Conversely, the expression of LC3B was decreased in the mTBI + HE group and increased in the mTBI + CR group. Our findings suggest that short-term CR after mTBI may ameliorate cognitive dysfunction induced by mTBI by increasing the level of autophagy and suppressing astrocyte activation.	[Liu, Yuan; Wang, Rong; Zhao, Zhiwei; Dong, Wen; Zhang, Xu] Capital Med Univ, Xuan Wu Hosp, Beijing Inst Brain Disorders, Cent Lab,Ctr Alzheimers Dis, Beijing 100053, Peoples R China; [Wang, Rong] Minist Educ, Beijing Geriatr Med Res Ctr, Key Lab Neurodegenerat Dis, Beijing 100053, Peoples R China; [Chen, Xi] Inner Mongolia Med Univ, Chifeng Clin Med Coll, Chifeng City Hosp, Dept Infect Dis, Chifeng 024000, Inner Mongolia, Peoples R China; [Ma, Lina] Capital Med Univ, Xuan Wu Hosp, Dept Geriatr, Beijing 100053, Peoples R China	Wang, R (corresponding author), Capital Med Univ, Xuan Wu Hosp, Beijing Inst Brain Disorders, Cent Lab,Ctr Alzheimers Dis, Beijing 100053, Peoples R China.; Wang, R (corresponding author), Minist Educ, Beijing Geriatr Med Res Ctr, Key Lab Neurodegenerat Dis, Beijing 100053, Peoples R China.	rong_wang72@126.com			Beijing Natural Science FoundationBeijing Natural Science Foundation [7132033, 7132044, 7174310]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81600927]	This work was supported by the following grants: Beijing Natural Science Foundation (7132033, 7132044, 7174310), and National Natural Science Foundation of China (81600927).	Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chen A, 2013, MOL MED REP, V8, P1011, DOI 10.3892/mmr.2013.1628; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Crino PB, 2016, NAT REV NEUROL, V12, P379, DOI 10.1038/nrneurol.2016.81; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dong W, 2016, AGING CLIN EXP RES, V28, P303, DOI 10.1007/s40520-015-0398-0; Dong W, 2015, INT J CLIN EXP MED, V8, P11843; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fitzwalter BE, 2015, FEBS J, V282, P4279, DOI 10.1111/febs.13515; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HANDELMANN GE, 1981, BRAIN RES, V217, P41, DOI 10.1016/0006-8993(81)90183-9; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kanoski SE, 2010, J EXP PSYCHOL-ANIM B, V36, P313, DOI 10.1037/a0017228; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Li GM, 2013, NEUROL SCI, V34, P963, DOI 10.1007/s10072-012-1173-z; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Ma LN, 2014, NEUROL SCI, V35, P1381, DOI 10.1007/s10072-014-1717-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; McNeilly AD, 2011, BEHAV BRAIN RES, V217, P134, DOI 10.1016/j.bbr.2010.10.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Newcombe V.F., 2013, BMJ-BRIT MED J, V346; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Papp G, 2007, LEARN MEMORY, V14, P732, DOI 10.1101/lm.687407; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Ruether E, 2001, INT CLIN PSYCHOPHARM, V16, P253, DOI 10.1097/00004850-200109000-00002; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Terry AV, 2009, FRONT NEUROSCI, P267; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271	58	13	13	1	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUL 28	2017	331						135	142		10.1016/j.bbr.2017.04.024			8	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	EZ6FZ	WOS:000404815100017	28495608				2021-06-18	
J	Ware, JB; Hart, T; Whyte, J; Rabinowitz, A; Detre, JA; Kim, J				Ware, Jeffrey B.; Hart, Tessa; Whyte, John; Rabinowitz, Amanda; Detre, John A.; Kim, Junghoon			Inter-Subject Variability of Axonal Injury in Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cognitive function; diffusion tensor imaging; traumatic axonal injury; traumatic brain injury	WHITE-MATTER MICROSTRUCTURE; MR-IMAGES; TENSOR; MODEL; MODERATE; REGISTRATION; ORIENTATION; PERFORMANCE; INFERENCE; SCLEROSIS	Traumatic brain injury (TBI) is a leading cause of cognitive morbidity worldwide for which reliable biomarkers are needed. Diffusion tensor imaging (DTI) is a promising biomarker of traumatic axonal injury (TAI); however, existing studies have been limited by a primary reliance on group-level analytic methods not well suited to account for inter-subject variability. In this study, 42 adults with TBI of at least moderate severity were examined 3 months following injury and compared with 35 healthy controls. DTI data were used for both traditional group-level comparison and subject-specific analysis using the distribution-corrected Z-score (DisCo-Z) approach. Inter-subject variation in TAI was assessed in a threshold-invariant manner using a threshold-weighted overlap map derived from subject-specific analysis. Receiver operator curve analysis was used to examine the ability of subject-specific DTI analysis to identify TBI subjects with significantly impaired processing speed in comparison with region of interest-based fractional anisotropy (FA) measurements and clinical characteristics. Traditional group-wise analysis demonstrated widespread reductions of white matter FA within the TBI group (voxel-wise p<0.05, corrected), despite relatively low consistency of subject-level effects secondary to widespread variation in the spatial distribution of TAI. Subject-specific mapping of TAI with the DisCo-Z approach was the best predictor of impaired processing speed, achieving high classification accuracy (area under the curve [AUC]=0.94). In moderate-to-severe TBI, there is substantial inter-subject variation in TAI, with extent strongly correlated to post-traumatic deficits in processing speed. Significant group-level effects do not necessarily represent consistent effects at the individual level. Better accounting for inter-subject variability in neurobiological manifestations of TBI may substantially improve the ability to detect and classify patterns of injury.	[Ware, Jeffrey B.] Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Detre, John A.] Hosp Univ Penn, Dept Neurol, 3400 Spruce St, Philadelphia, PA 19104 USA; [Hart, Tessa; Whyte, John; Rabinowitz, Amanda; Kim, Junghoon] Moss Rehabil Res Inst, Philadelphia, PA USA; [Kim, Junghoon] CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, 160 Convent Ave, New York, NY 10031 USA	Kim, J (corresponding author), CUNY, Sch Med, Dept Physiol Pharmacol & Neurosci, 160 Convent Ave, New York, NY 10031 USA.	jkim@med.cuny.edu	Kim, Junghoon John/I-6702-2019	Kim, Junghoon John/0000-0001-5729-8993; Ware, Jeffrey/0000-0002-3495-9733; Whyte, John/0000-0002-4381-1474	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS065980, 2T32EB004311-11]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065980] Funding Source: NIH RePORTER	We would like to acknowledge and thank H. Branch Coslett, MD, and Wooyoung Choi, BA, for their assistance in lesion segmentation for this paper. This work was supported by the National Institutes of Health grants 5R01NS065980 (principal investigator[PI]: J.K.) and 2T32EB004311-11 (PI: Mitchell Schnall, MD, PhD).	Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Cremers LGM, 2016, NEUROBIOL AGING, V39, P108, DOI 10.1016/j.neurobiolaging.2015.11.021; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Haberg AK, 2015, J NEUROSCI RES, V93, P1109, DOI 10.1002/jnr.23534; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keihaninejad S, 2013, NEUROIMAGE, V72, P153, DOI 10.1016/j.neuroimage.2013.01.044; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mayer AR, 2014, HUM BRAIN MAPP, V35, P5457, DOI 10.1002/hbm.22563; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Peng HL, 2009, NEUROIMAGE, V46, P967, DOI 10.1016/j.neuroimage.2009.03.046; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rokem A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123272; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Seghier ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep20170; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shen K, 2015, P NATL ACAD SCI USA, V112, P6473, DOI 10.1073/pnas.1503436112; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Strauss S. B., 2016, A J N R AM J NEURORA; STRICH SJ, 1961, LANCET, V2, P443; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; WANG Y, 2017, BIOMED ENG ONLINE, V16; Watts R, 2014, RADIOLOGY, V272, P217, DOI 10.1148/radiol.14131856; White T, 2009, PSYCHIAT RES-NEUROIM, V174, P110, DOI 10.1016/j.pscychresns.2009.04.014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zhang H, 2007, LECT NOTES COMPUT SC, V4792, P211; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhang H, 2006, MED IMAGE ANAL, V10, P764, DOI 10.1016/j.media.2006.06.004; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	52	13	13	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2017	34	14					2243	2253		10.1089/neu.2016.4817			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EZ8RQ	WOS:000404995000007	28314375	Green Published			2021-06-18	
J	Bai, W; Zhu, WL; Ning, YL; Li, P; Zhao, Y; Yang, N; Chen, X; Jiang, YL; Yang, WQ; Jiang, DP; Chen, LY; Zhou, YG				Bai, Wei; Zhu, Wan-Li; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Chen, Xing; Jiang, Yu-Lin; Yang, Wen-Qun; Jiang, Dong-Po; Chen, Li-Yong; Zhou, Yuan-Guo			Dramatic increases in blood glutamate concentrations are closely related to traumatic brain injury-induced acute lung injury	SCIENTIFIC REPORTS			English	Article							NEUROGENIC PULMONARY-EDEMA; PLASMA GLUTAMATE; RISK-FACTORS; MECHANISMS; MANAGEMENT; MORTALITY; SEVERITY	Traumatic brain injury-induced acute lung injury (TBI-ALI) is a serious complication after brain injury for which predictive factors are lacking. In this study, we found significantly elevated blood glutamate concentrations in patients with TBI or multiple peripheral trauma (MPT), and patients with more severe injuries showed higher blood glutamate concentrations and longer durations of elevated levels. Although the increase in amplitude was similar between the two groups, the duration was longer in the patients with TBI. There were no significant differences in blood glutamate concentrations in the patients with MPT with regard to ALI status, but the blood glutamate levels were significantly higher in the patients with TBI-ALI than in those without ALI. Moreover, compared to patients without ALI, patients with TBI showed a clearly enhanced inflammatory response that was closely correlated with the blood glutamate levels. The blood glutamate concentration was also found to be a risk factor (adjusted odds ratio, 2.229; 95% CI, 1.082-2.634) and was a better predictor of TBI-ALI than the Glasgow Coma Scale (GCS) score. These results indicated that dramatically increased blood glutamate concentrations were closely related to the occurrence of TBI-ALI and could be used as a predictive marker for "at-risk" patients.	[Bai, Wei; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Chen, Xing; Jiang, Yu-Lin; Zhou, Yuan-Guo] Third Mil Med Univ, Res Inst Surg, Mol Biol Ctr, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Bai, Wei; Zhu, Wan-Li; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Chen, Xing; Jiang, Yu-Lin; Yang, Wen-Qun; Jiang, Dong-Po; Chen, Li-Yong; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Zhu, Wan-Li] Third Mil Med Univ, Res Inst Surg, Dept Neurosurg, Chongqing, Peoples R China; [Yang, Wen-Qun; Jiang, Dong-Po] Third Mil Med Univ, Res Inst Surg, Dept ICU, Chongqing, Peoples R China; [Chen, Li-Yong] Third Mil Med Univ, Res Inst Surg, Dept Anesthesiol, Chongqing, Peoples R China	Zhou, YG (corresponding author), Third Mil Med Univ, Res Inst Surg, Mol Biol Ctr, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.; Chen, LY; Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China.; Chen, LY (corresponding author), Third Mil Med Univ, Res Inst Surg, Dept Anesthesiol, Chongqing, Peoples R China.	mzkcly@aliyun.com; ygzhou@tmmu.edu.cn	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171022]	We gratefully acknowledge the assistance and cooperation of the physicians, nurses and patients included in this study. We also thank the technicians and statisticians for their help and guidance. This study was partially supported by the National Natural Science Foundation of China (31171022).	Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Arbour RB, 2013, CRIT CARE NURS CLIN, V25, P297, DOI 10.1016/j.ccell.2013.02.010; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Busl KM, 2015, CRIT CARE MED, V43, P1710, DOI 10.1097/CCM.0000000000001101; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Cohen-Kashi-Malina K, 2012, J CEREBR BLOOD F MET, V32, P177, DOI 10.1038/jcbfm.2011.121; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; da Cunha AA, 2010, CHEST, V137, P297, DOI 10.1378/chest.09-1570; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83; Harr JN, 2013, CRIT CARE MED, V41, P399, DOI 10.1097/CCM.0b013e31826ab38b; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Maillet I, 2016, CLIN SCI, V130, P1939, DOI 10.1042/CS20160530; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Muroi C, 2008, J NEUROSURG ANESTH, V20, P188, DOI 10.1097/ANA.0b013e3181778156; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Ortiz GG, 2006, BIOMED PHARMACOTHER, V60, P86, DOI 10.1016/j.biopha.2005.07.012; Otero HJ, 2014, PEDIATR EMERG CARE, V30, P845, DOI 10.1097/PEC.0000000000000309; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pyeron A M, 2001, J Neurosci Nurs, V33, P203; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rogachev B, 2013, J NEUROSURG ANESTH, V25, P262, DOI 10.1097/ANA.0b013e318283f86a; Rogachev B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.002; Rowell SE, 2011, J TRAUMA, V71, pS384, DOI 10.1097/TA.0b013e3182287c8d; Said SI, 2001, TRENDS PHARMACOL SCI, V22, P344, DOI 10.1016/S0165-6147(00)01744-2; Sedy J, 2015, J NEUROTRAUM, V32, P1135, DOI 10.1089/neu.2014.3609; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; STEGINK LD, 1979, J NUTR, V109, P2173; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Wu JS, 2012, J EMERG MED, V43, P407, DOI 10.1016/j.jemermed.2009.05.024; Yamagishi T, 2014, J EMERG MED, V46, P683, DOI 10.1016/j.jemermed.2013.11.094; Yuan Q, 2015, CRIT CARE MED, V43, P1405, DOI 10.1097/CCM.0000000000000965	44	13	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 14	2017	7								5380	10.1038/s41598-017-05574-9			9	Multidisciplinary Sciences	Science & Technology - Other Topics	FA5EA	WOS:000405464200017	28710466	DOAJ Gold, Green Published			2021-06-18	
J	Ouyang, J; Pace, E; Lepczyk, L; Kaufman, M; Zhang, J; Perrine, SA; Zhang, JS				Ouyang, Jessica; Pace, Edward; Lepczyk, Laura; Kaufman, Michael; Zhang, Jessica; Perrine, Shane A.; Zhang, Jinsheng			Blast-Induced Tinnitus and Elevated Central Auditory and Limbic Activity in Rats: A Manganese-Enhanced MRI and Behavioral Study	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VENTRAL COCHLEAR NUCLEUS; ENRICHED ACOUSTIC ENVIRONMENT; RESONANCE-IMAGING MEMRI; NEURAL ACTIVITY; HEARING-LOSS; PSYCHIATRIC-DISORDERS; INFERIOR COLLICULUS; EVOKED POTENTIALS	Blast-induced tinitus is the number one service-connected disability that currently affects military personnel and veterans. To elucidate its underlying mechanisms, we subjected 13 Sprague Dawley adult rats to unilateral 14 psi blast exposure to induce tinnitus and measured auditory and limbic brain activity using manganese-enhanced MRI (MEMRI). Tinnitus was evaluated with a gap detection acoustic startle reflex paradigm, while hearing status was assessed with prepulse inhibition (PPI) and auditory brainstem responses (ABRs). Both anxiety and cognitive functioning were assessed using elevated plus maze and Morris water maze, respectively. Five weeks after blast exposure, 8 of the 13 blasted rats exhibited chronic tinnitus. While acoustic PPI remained intact and ABR thresholds recovered, the ABR wave P1-N1 amplitude reduction persisted in all blast-exposed rats. No differences in spatial cognition were observed, but blasted rats as a whole exhibited increased anxiety. MEMRI data revealed a bilateral increase in activity along the auditory pathway and in certain limbic regions of rats with tinnitus compared to age-matched controls. Taken together, our data suggest that while blast-induced tinnitus may play a role in auditory and limbic hyperactivity, the non-auditory effects of blast and potential traumatic brain injury may also exert an effect.	[Ouyang, Jessica; Pace, Edward; Lepczyk, Laura; Kaufman, Michael; Zhang, Jessica; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Detroit, MI 48201 USA; [Perrine, Shane A.] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA; [Zhang, Jinsheng] Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, Detroit, MI 48201 USA	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol & Head & Neck Surg, Detroit, MI 48201 USA.; Zhang, JS (corresponding author), Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]; AANA Foundation	This work was supported by a grant from the Department of Defense (grant award #W81XWH-11-2-0031) to J.S. Zhang and a grant from the AANA Foundation to J. Ouyang. We would like to thank Drs. Pamela Vande Vord and Srinivas Kallakuri for assisting with the blast procedure. We would also like to thank Drs. Bruce Berkowitz and David Bissig for their assistance in using the 7T MRI scanner and MEMRI data analysis. We would like to thank Dr. Gulrez Mahmood for his assistance during MEMRI scanning. Lastly, we would like to thank Senior Biostatistician Dr. George Divine for his assistance in power analysis and statistics.	Aldhafeeri FM, 2012, NEURORADIOLOGY, V54, P883, DOI 10.1007/s00234-012-1044-6; Andersson G, 2000, J SPEECH LANG HEAR R, V43, P1168, DOI 10.1044/jslhr.4305.1168; Andersson G, 2009, SCAND J PSYCHOL, V50, P517, DOI 10.1111/j.1467-9450.2009.00752.x; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bauer C.A., 2008, J NEUROSCI RES; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Benson RR, 2014, HEARING RES, V309, P8, DOI 10.1016/j.heares.2013.10.005; Bissig D, 2014, NEUROBIOL AGING, V35, P1453, DOI 10.1016/j.neurobiolaging.2013.12.019; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Boyen K, 2014, HEARING RES, V312, P48, DOI 10.1016/j.heares.2014.03.001; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Brozoski TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077674; Brozoski TJ, 2012, JARO-J ASSOC RES OTO, V13, P55, DOI 10.1007/s10162-011-0290-3; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.901970410; Cacace AT, 2014, HEARING RES, V311, P49, DOI 10.1016/j.heares.2014.02.003; Cacace AT, 1999, AUDIOL NEURO-OTOL, V4, P258, DOI 10.1159/000013849; Carpenter-Thompson JR, 2014, BRAIN RES, V1567, P28, DOI 10.1016/j.brainres.2014.04.024; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen GD, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/658741; Chen GD, 2012, BRAIN RES, V1485, P63, DOI 10.1016/j.brainres.2012.03.016; Cho SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067618; Chuang KH, 2009, MAGN RESON IMAGING, V27, P594, DOI 10.1016/j.mri.2008.10.006; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Dehmel S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00042; DOBIE RA, 1993, AM J OTOL, V14, P18; Dong SY, 2010, EUR J NEUROSCI, V31, P1616, DOI 10.1111/j.1460-9568.2010.07183.x; Du XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080138; Eagle AL, 2013, NEUROSCI RES, V75, P130, DOI 10.1016/j.neures.2012.11.001; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Feng Y, 2014, CHINESE MED J-PEKING, V127, P522, DOI 10.3760/cma.j.issn.0366-6999.20132245; Fraticelli-Torres AI, 2010, ETHNIC DIS, V20; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; Furman AC, 2013, J NEUROPHYSIOL, V110, P577, DOI 10.1152/jn.00164.2013; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Hallam RS, 2004, INT J AUDIOL, V43, P218, DOI 10.1080/14992020400050030; HALLBERG LRM, 1993, BRIT J AUDIOL, V27, P19, DOI 10.3109/03005369309077885; Hebert S, 2011, J SLEEP RES, V20, P38, DOI 10.1111/j.1365-2869.2010.00860.x; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Henry JA, 2009, J REHABIL RES DEV, V46, P619, DOI 10.1682/JRRD.2008.11.0157; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Husain FT, 2011, BRAIN RES, V1369, P74, DOI 10.1016/j.brainres.2010.10.095; Jehel L, 2003, EUR PSYCHIAT, V18, P172, DOI 10.1016/S0924-9338(03)00043-9; Jung DJ, 2014, NEUROIMAGE, V100, P642, DOI 10.1016/j.neuroimage.2014.06.055; Kallai J, 2005, BEHAV BRAIN RES, V159, P187, DOI 10.1016/j.bbr.2004.10.015; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; KERR AG, 1975, BRIT MED J, V1, P559, DOI 10.1136/bmj.1.5957.559; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kraus KS, 2011, NEUROSCIENCE, V194, P309, DOI 10.1016/j.neuroscience.2011.07.056; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Langguth B, 2006, ACTA OTO-LARYNGOL, V126, P84, DOI 10.1080/03655230600895317; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Lanting CP, 2008, ACTA OTO-LARYNGOL, V128, P415, DOI 10.1080/00016480701793743; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lee YJ, 2007, J CLIN NEUROSCI, V14, P515, DOI 10.1016/j.jocn.2006.10.002; Leonardi AD, 2011, J NEUROTRAUM, V28, P85, DOI 10.1089/neu.2010.1324; Lewis J E, 2002, J Am Acad Audiol, V13, P339; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Luo H, 2017, NEUROSCIENCE, V340, P515, DOI 10.1016/j.neuroscience.2016.11.014; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Luo H, 2012, NEUROSCI LETT, V522, P16, DOI 10.1016/j.neulet.2012.05.072; Lyche P, 2011, CLIN NEUROPSYCHOL, V25, P359, DOI 10.1080/13854046.2010.547518; Mac Donald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055823; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Mahmood G, 2014, NEUROSCIENCE, V269, P367, DOI 10.1016/j.neuroscience.2014.03.020; Mahoney CJ, 2011, J NEUROL NEUROSUR PS, V82, P1274, DOI 10.1136/jnnp.2010.235473; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Maudoux A, 2012, BRAIN RES, V1485, P10, DOI 10.1016/j.brainres.2012.05.006; MCKENNA L, 2000, TINNITUS HDB, P59; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229; Mrena R, 2004, ACTA OTO-LARYNGOL, V124, P946, DOI 10.1080/00016480310017045; Muhlau M, 2006, CEREB CORTEX, V16, P1283, DOI 10.1093/cercor/bhj070; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2006, NEUROREPORT, V17, P559, DOI 10.1097/00001756-200604240-00001; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Nowotny M, 2011, J ACOUST SOC AM, V130, P2827, DOI 10.1121/1.3646902; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Pautler Robia G, 2006, Methods Mol Med, V124, P365; PAXINOS G, 1998, RAT BRAIN STEREOTAXI, V4; Plewnia C, 2007, J NEUROL NEUROSUR PS, V78, P152, DOI 10.1136/jnnp.2006.095612; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Rizzardo R, 1998, J OTOLARYNGOL, V27, P21; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Rodriguez O, 2016, J NEUROTRAUM, V33, P662, DOI 10.1089/neu.2015.4002; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sample PL, 2012, BRAIN INJURY, V26, P1670, DOI 10.3109/02699052.2012.700090; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schmidt SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076488; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Shulman A., 1995, INT TINNITUS J, V1, P13; Shussman N, 2011, J TRAUMA, V70, P1546, DOI 10.1097/TA.0b013e318202edcf; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Singer W, 2013, MOL NEUROBIOL, V47, P261, DOI 10.1007/s12035-012-8372-8; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Snow GW, 2004, TINNITUS THEORY MANA, P16; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tchantchou F, 2014, NEUROPHARMACOLOGY, V85, P427, DOI 10.1016/j.neuropharm.2014.06.006; Thuen M, 2008, J MAGN RESON IMAGING, V28, P855, DOI 10.1002/jmri.21504; Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; Tyler Richard S., 1993, Seminars in Hearing, V14, P377, DOI 10.1055/s-0028-1085135; Valiyaveettil M, 2012, J REHABIL RES DEV, V49, P1153, DOI 10.1682/JRRD.2011.09.0182; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Wang HT, 2001, CHINESE MED J-PEKING, V114, P848; Watts LT, 2015, J NEUROTRAUM, V32, P1001, DOI 10.1089/neu.2014.3737; Xie K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064907; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yoo Done-Sik, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1870; Zhang JS, 2011, JARO-J ASSOC RES OTO, V12, P185, DOI 10.1007/s10162-010-0246-z; Zhang JS, 2003, EXP BRAIN RES, V153, P655, DOI 10.1007/s00221-003-1612-4; Zheng Y, 2011, NEUROSCIENCE, V193, P143, DOI 10.1016/j.neuroscience.2011.07.026; Zheng Y, 2011, NEUROSCIENCE, V186, P48, DOI 10.1016/j.neuroscience.2011.04.052; Zheng Y, 2011, NEUROSCIENCE, V180, P75, DOI 10.1016/j.neuroscience.2011.02.040; Zoger S, 2001, AUDIOLOGY, V40, P133; Zoger S, 2006, PSYCHOSOMATICS, V47, P282, DOI 10.1176/appi.psy.47.4.282	162	13	14	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 7	2017	7								4852	10.1038/s41598-017-04941-w			17	Multidisciplinary Sciences	Science & Technology - Other Topics	EZ8JI	WOS:000404970900014	28687812	DOAJ Gold, Green Published			2021-06-18	
J	Becchi, S; Buson, A; Foot, J; Jarolimek, W; Balleine, BW				Becchi, Serena; Buson, Alberto; Foot, Jonathan; Jarolimek, Wolfgang; Balleine, Bernard W.			Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							IN-VIVO; MICROGLIAL ACTIVATION; SYSTEMIC INFLAMMATION; LEUKOCYTE RECRUITMENT; CONCISE GUIDE; BRAIN; VAP-1/SSAO; OXIDASE; PHARMACOLOGY; MORPHOLOGY	BACKGROUND AND PURPOSE Neuroinflammation is initiated by a variety of stimuli including infections, sepsis, neurodegenerative diseases or traumatic brain injury and, if not adequately controlled, can lead to various degrees of neuronal damage and behavioural impairment. A critical event in the initial steps of inflammation is neutrophil extravasation. Semicarbazide-sensitive amine oxidase (SSAO, also known as vascular adhesion protein 1 or VAP-1) regulates neutrophil adhesion and extravasation. Here, we elucidate the role of SSAO/VAP-1 in the early stage inflammatory response after LPS insult in the brain. EXPERIMENTAL APPROACH PXS-4681A, a selective and irreversible SSAO/VAP-1 inhibitor, was tested in two rat models of neuroinflammation, following systemic or i.c.v. LPS. Immunohistochemical and immunofluorescence techniques were used to measure neutrophils and microglia. VAP-1 was quantitated by Western blotting. KEY RESULTS Both systemic and i.c.v. administration of LPS induced an increase in neutrophil recruitment and microglial response in various brain areas including the substantia nigra and striatum. PXS-4681A produced a significant inhibition of neutrophil recruitment and extravasation after i.c.v. LPS injection and also reversed microglial cell recruitment and morphological changes to the level of the sham controls in both LPS models. CONCLUSIONS AND IMPLICATIONS PXS-4681A acted as an effective anti-inflammatory agent after both systemic and i.c.v. LPS injections suggesting that SSAO/VAP-1 inhibition could be beneficial in the treatment of brain inflammation.	[Becchi, Serena; Balleine, Bernard W.] Univ NSW, Sch Psychol, Kensington, NSW 2052, Australia; [Becchi, Serena; Balleine, Bernard W.] Univ Sydney, Brain & Mind Ctr, Camperdown, NSW, Australia; [Buson, Alberto; Foot, Jonathan; Jarolimek, Wolfgang] Pharmaxis Ltd, Frenchs Forest, NSW, Australia	Balleine, BW (corresponding author), Univ NSW, Sch Psychol, Kensington, NSW 2052, Australia.	bernard.balleine@unsw.edu.au		Jarolimek, Wolfgang/0000-0002-1757-5420; Balleine, Bernard/0000-0001-8618-7950	Laureate Fellowship from the Australian Research CouncilAustralian Research Council [FL0992409]; Research in Business Award from the Australian Research Council; Pharmaxis Ltd	This project was supported by a Laureate Fellowship from the Australian Research Council, Grant #FL0992409, a Research in Business Award from the Australian Research Council, and with additional research funding provided by Pharmaxis Ltd supporting S.B.	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Abella A, 2004, DIABETOLOGIA, V47, P429, DOI 10.1007/s00125-004-1346-2; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P6024, DOI 10.1111/bph.13354; Andonegui G, 2002, J IMMUNOL, V169, P2111, DOI 10.4049/jimmunol.169.4.2111; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Beynon SB, 2012, NEUROSCIENCE, V225, P162, DOI 10.1016/j.neuroscience.2012.07.029; Carvalho-Tavares J, 2000, CIRC RES, V87, P1141, DOI 10.1161/01.RES.87.12.1141; Castillo V, 1998, NEUROCHEM INT, V33, P415, DOI 10.1016/S0197-0186(98)00045-X; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; DALLAIRE L, 1991, BIOCHEM J, V276, P745, DOI 10.1042/bj2760745; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Ear T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-14; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Ferrer I, 2002, NEUROSCI LETT, V321, P21, DOI 10.1016/S0304-3940(01)02465-X; Foot JS, 2013, J PHARMACOL EXP THER, V347, P365, DOI 10.1124/jpet.113.207613; Fukushima S, 2015, J NEUROIMMUNOL, V285, P31, DOI 10.1016/j.jneuroim.2015.05.014; Garcia-Vicente S, 2005, J PHYSIOL BIOCHEM, V61, P395, DOI 10.1007/BF03167057; GIULIAN D, 1995, J NEUROSCI, V15, P7712; Hernandez-Guillamon M, 2012, CEREBROVASC DIS, V33, P55, DOI 10.1159/000333370; Hinwood M, 2013, CEREB CORTEX, V23, P1784, DOI 10.1093/cercor/bhs151; Holz O, 2010, EUR RESPIR J, V35, P564, DOI 10.1183/09031936.00048509; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Ji KA, 2008, GLIA, V56, P1039, DOI 10.1002/glia.20677; Ji KA, 2007, GLIA, V55, P1577, DOI 10.1002/glia.20571; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Korytko PJ, 1996, NEUROPHARMACOLOGY, V35, P231, DOI 10.1016/0028-3908(95)00162-X; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; McGrath JC, 2015, BRIT J PHARMACOL, V172, P3189, DOI 10.1111/bph.12955; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Reinert KRS, 2014, BRAIN RES, V1557, P164, DOI 10.1016/j.brainres.2014.02.005; Salmi M, 2001, TRENDS IMMUNOL, V22, P211, DOI 10.1016/S1471-4906(01)01870-1; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 1996, J EXP MED, V183, P569, DOI 10.1084/jem.183.2.569; Salter-Cid LM, 2005, J PHARMACOL EXP THER, V315, P553, DOI 10.1124/jpet.105.089649; Schilter HC, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0200-z; Southan C, 2016, NUCLEIC ACIDS RES, V44, pD1054, DOI 10.1093/nar/gkv1037; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Tohka S, 2001, FASEB J, V15, P373, DOI 10.1096/fj.00-0240com; Tsushima H, 2000, BRAIN RES, V852, P367, DOI 10.1016/S0006-8993(99)02177-0; Zhou H, 2006, J IMMUNOL, V177, P8103, DOI 10.4049/jimmunol.177.11.8103; Zhou H, 2009, J IMMUNOL, V183, P5244, DOI 10.4049/jimmunol.0901309; Zhou Y, 2012, J NEUROCHEM, V123, P771, DOI 10.1111/jnc.12010	50	13	13	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	JUL	2017	174	14					2302	2317		10.1111/bph.13832			16	Pharmacology & Pharmacy	Pharmacology & Pharmacy	EZ0PI	WOS:000404407600013	28437839	Bronze, Green Published			2021-06-18	
J	Brooks, MA; Snedden, TR; Mixis, B; Hetzel, S; McGuine, TA				Brooks, M. Alison; Snedden, Traci R.; Mixis, Benjamin; Hetzel, Scott; McGuine, Timothy A.			Establishing Baseline Normative Values for the Child Sport Concussion Assessment Tool	JAMA PEDIATRICS			English	Article							HIGH-SCHOOL; SCAT2; ADOLESCENTS; RECOVERY; INJURY; AGE	IMPORTANCE The Child Sport Concussion Assessment Tool (SCAT3) is a postconcussion sideline assessment tool measuring symptoms, cognition, and balance in preadolescent children. Minimal normative baseline data exist to aid decision making in clinical and athletic settings. OBJECTIVE To collect normative baseline data for the Child SCAT3 in a large cohort of young athletes. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional study was conducted from May 31 to August 12, 2014, at various sporting events (basketball, soccer, baseball, and swimming) in Central Wisconsin among children 5 to 13 years of age who were English-speaking and did not report a lower leg injury within the past 2 months or a concussion within the past month. Data were analyzed between October 8, 2014, and September 12, 2016. MAIN OUTCOMES AND MEASURES All Child SCAT3 components were assessed: child and parent report of symptom number and severity, cognition (Standardized Assessment of Concussion-child version [SAC-C]), and balance (modified Balance Error Scoring System [mBESS] and tandem gait). Summary statistics, mean differences, and effect sizes were calculated for each test component. RESULTS Participants included 478 children (234 girls and 241 boys; mean [SD] age, 9.9 [1.9] years]) and their parents. Age had the largest effect on all Child SCAT3 components, with children 5 to 7 years of age reporting higher mean (SD) symptom severity scores compared with those 11 to 13 years of age (18.2 [10.0] vs 11.3 [9.0]; mean difference, 6.86 [95% CI, 4.22-9.50]; effect size, 0.74) and performing more poorly on the total SAC-C (mean [SD] score, 19.5 [5.1] vs 26.1 [2.1]; mean difference, -6.59 [95% CI, -7.49 to -5.68]; effect size, -2.1), mBESS (mean [SD] score, 1.67 [1.8] vs 0.76 [1.2]; mean difference, 0.91 [95% CI, 0.53-1.29]; effect size, 0.68), and tandem gait (mean [SD] time, 22.2 [8.3] vs 14.0 [3.7] seconds; mean difference, 8.23 seconds [95% CI, 6.63-9.82]; effect size, 1.55). Sex had a small effect on the mean (SD) number and severity of symptoms reported by the child (severity: boys, 15.1 [9.8] vs girls, 11.8 [9.2]; mean difference, 3.31 [95% CI, 1.60-5.02]; effect size, 0.35), mean (SD) number and severity of symptoms reported by the parent (severity: boys, 11.1 [7.7] vs girls, 9.4 [8.1]; mean difference, 1.63 [95% CI, 0.21-3.05]; effect size, 0.21), mean (SD) total SAC-C score (boys, 23.9 [3.9] vs girls, 24.9 [3.5]; mean difference, -0.92 [95% CI, -1.61 to -0.23]; effect size, -0.25), and mean (SD) mBESS score (boys, 1.21 [1.5] vs girls, 0.71 [1.0]; mean difference, 0.50 [95% CI, 0.27-0.74]; effect size, 0.38). CONCLUSIONS AND RELEVANCE Child SCAT3 baseline normative symptom, cognitive, and balance scores were different, with a large main effect for age and a small effect for sex. These findings may assist health care professionals with interpretation of Child SCAT3 scores for young athletes with a concussion in athletic and clinical settings.	[Brooks, M. Alison; McGuine, Timothy A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Pediat, 1685 Highland Ave, Madison, WI 53705 USA; [Brooks, M. Alison; McGuine, Timothy A.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Snedden, Traci R.] Univ Wisconsin, Sch Nursing, Madison, WI USA; [Mixis, Benjamin] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Hetzel, Scott] Univ Wisconsin, Biostat & Med Informat, Madison, WI USA	Brooks, MA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Pediat, 1685 Highland Ave, Madison, WI 53705 USA.	brooks@ortho.wisc.edu		Snedden, Traci/0000-0002-1550-2340	American Medical Society for Sports Medicine	This project was funded by a research grant from the American Medical Society for Sports Medicine.	Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Bazarian JJ, 2005, BRAIN INJ, V19; Berk L.E., 2000, CHILD DEV, V5th; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Glaviano NR, 2015, CLIN J SPORT MED, V25, P373, DOI 10.1097/JSM.0000000000000154; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Nelson LD, 2016, CLIN J SPORTS MED; Porter S, 2015, BMJ OPEN SPORT EXERC, V1; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Purcell L, 2008, CLIN PEDIATR, V47, P106, DOI 10.1177/0009922807306053; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Wadsworth BJ, PIAGETS THEORY COGNI; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	27	13	13	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	JUL	2017	171	7					670	677		10.1001/jamapediatrics.2017.0592			8	Pediatrics	Pediatrics	EZ3IK	WOS:000404604400013	28492862	Green Published			2021-06-18	
J	Carroll-Alfano, M				Carroll-Alfano, Miriam			Mandated High School Concussion Education and Collegiate Athletes' Understanding of Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						legislation; student-athletes; traumatic brain injuries	FOOTBALL PLAYERS; KNOWLEDGE; ATTITUDES; COACHES; IMPACT	Context: Concussions in student-athletes are a serious problem. Most states have enacted legislation mandating concussion education for student-athletes, under the assumption that education leads to better self-reporting of concussions and improved knowledge of symptoms. Objectives: (1) To determine the effect of state-based concussion legislation on the proportion of student-athletes receiving concussion education and to assess the moderation of this effect by gender and sport and (2) to assess the effect of concussion education on student-athletes' knowledge of concussion symptoms and likelihood of seeking treatment after a concussion. Design: Cross-sectional study. Setting: Private university. Patients or Other Participants: A total of 249 National Association of Intercollegiate Athletics collegiate athletes attending St Xavier University; 160 were surveyed prelegislation and 89 were surveyed postlegislation. Main Outcome Measure(s): Participants completed an anonymous survey that assessed previous involvement in concussion-education programs, degree of self-reporting after a concussion, and ability to enumerate symptoms. Results: The number of athletes who reported having received education increased after the implementation of concussion legislation; however, almost 25% still reported not having received education. Athletes who played football were more likely to report having received education than those who played volleyball. The student-athletes' ability to name a diversity of concussion symptoms or to report seeking medical attention after a concussion did not improve in the postlegislation period relative to the prelegislation period. Conclusions: Legislation has been passed in all 50 states to address concussions in student-athletes; however, improvements are still needed. Concussion education must be delivered in a uniform, effective manner to all student-athletes across sports and genders. Concussion education should emphasize the diversity of symptoms, especially cognitive and behavioral symptoms. We must develop and disseminate evidence-based educational programs that are clinically proven to be effective in improving athletes' knowledge and behaviors.	[Carroll-Alfano, Miriam] St Xavier Univ, Dept Commun Sci & Disorders, 3700 West 103rd St, Chicago, IL 60655 USA	Carroll-Alfano, M (corresponding author), St Xavier Univ, Dept Commun Sci & Disorders, 3700 West 103rd St, Chicago, IL 60655 USA.	alfano@sxu.edu					Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Ellenbogen Richard G, 2014, Neurosurgery, V75 Suppl 4, pS122, DOI 10.1227/NEU.0000000000000495; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Kroshus E, 2014, HEALTH EDUC BEHAV, V42, P153; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Stoler DR, 2013, COPING CONCUSSION MI; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482	26	13	13	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2017	52	7					689	697		10.4085/1062-6050-52.3.08			9	Sport Sciences	Sport Sciences	FB4RH	WOS:000406128700009	28535096	Bronze, Green Published			2021-06-18	
J	Durber, CM; Yeates, KO; Taylor, HG; Walz, NC; Stancin, T; Wade, SL				Durber, Chelsea M.; Yeates, Keith Owen; Taylor, H. Gerry; Walz, Nicolay Chertkoff; Stancin, Terry; Wade, Shari L.			The Family Environment Predicts Long-Term Academic Achievement and Classroom Behavior Following Traumatic Brain Injury in Early Childhood	NEUROPSYCHOLOGY			English	Article						home environment; academic achievement; behavioral functioning; parents	YOUNG-CHILDREN; OUTCOMES; SCHOOL; RECOVERY; TBI; SKILLS	Objective: This study examined how the family environment predicts long-term academic and behavioral functioning in school following traumatic brain injury (TBI) in early childhood. Method: Using a concurrent cohort, prospective design, 15 children with severe TBI, 39 with moderate TBI, and 70 with orthopedic injury (OI) who were injured when they were 3-7 years of age were compared on tests of academic achievement and parent and teacher ratings of school performance and behavior on average 6.83 years postinjury. Soon after injury and at the longer term follow-up, families completed measures of parental psychological distress, family functioning, and quality of the home environment. Hierarchical linear regression analyses examined group differences in academic outcomes and their associations with measures of the early and later family environment. Results: The severe TBI group, but not the moderate TBI group, performed worse than did the OI group on all achievement tests, parent ratings of academic performance, and teacher ratings of internalizing problems. Higher quality early and late home environments predicted stronger academic skills and better classroom behavior for children with both TBI and OI. The early family environment more consistently predicted academic achievement, whereas the later family environment more consistently predicted classroom functioning. The quality of the home environment predicted academic outcomes more strongly than did parental psychological distress or family functioning. Conclusion: TBI in early childhood has long-term consequences for academic achievement and school performance and behavior. Higher quality early and later home environments predict better school outcomes for both children with TBI and children with OI.	[Durber, Chelsea M.] Univ Calgary, Werklund Sch Educ, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Walz, Nicolay Chertkoff] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cleveland, OH USA; [Walz, Nicolay Chertkoff] Univ Cincinnati, Coll Med, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH 45221 USA; [Stancin, Terry] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Stancin, Terry] MetroHlth Med Ctr, Cleveland, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Rehabil, Cincinnati, OH 45229 USA; [Wade, Shari L.] Univ Cincinnati, Coll Med, Div Pediat Rehabil, Cincinnati, OH 45221 USA	Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, Adm Bldg 254,2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD42729]; U.S. Public Health Service National Institutes of HealthUnited States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA [M01 RR 08084]; State of Ohio Emergency Medical Services; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000077-04]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD042729] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001425, UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR008084] Funding Source: NIH RePORTER	The research reported here was supported by National Institute of Child Health and Human Development Grant R01 HD42729, in part by U.S. Public Health Service National Institutes of Health Grant M01 RR 08084, and by trauma research grants from the State of Ohio Emergency Medical Services. The project described was also supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8 UL1 TR000077-04.	Achenbach T. M., 2001, MANUAL ASEBA PRESCHO; Achenbach T. M., 1991, MANUAL CHILD BEHAV C; Achenbach T.M., 1991, MANUAL TEACHERS REPO; Al-Nhar T., 1999, ED PSYCHOL, V19, P37; Aldrich EM, 2012, CAN J SCH PSYCHOL, V27, P291, DOI 10.1177/0829573512455016; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRADLEY RH, 1993, GENET SOC GEN PSYCH, V119, P439; Bradley RH, 2000, J RES ADOLESCENCE, V10, P247, DOI 10.1207/SJRA1003_1; Brown FL, 2013, J HEAD TRAUMA REHAB, V28, P349, DOI 10.1097/HTR.0b013e318245fed5; Caldwell B. M., 1984, HOME OBSERVATION MEA; Camara-Costa H, 2016, ARCH PEDIATRIE, V23, P136, DOI 10.1016/j.arcped.2015.11.007; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2007, CHILD NEUROPSYCHOL, V13, P240, DOI 10.1080/09297040600837362; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Ciping D., 2015, EARLY CHILDHOOD RES, V33, P12; Derogatis L, 1983, BRIEF SYMPTOM INVENT, V13, P595, DOI DOI 10.1017/S0033291700048017; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Gerrard-Morris A, 2010, J INT NEUROPSYCH SOC, V16, P157, DOI 10.1017/S1355617709991135; Hawley C A, 2005, Pediatr Rehabil, V8, P117; Kellaghan T., 1993, HOME ENV SCH LEARNIN; Marjoribanks K., 2005, EDUC PSYCHOL-US, V25, P647, DOI [10.1080/01443410500344704, DOI 10.1080/01443410500344704]; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Melhuish EC, 2008, J SOC ISSUES, V64, P95, DOI 10.1111/j.1540-4560.2008.00550.x; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Silberg T, 2015, BRAIN INJURY, V29, P481, DOI 10.3109/02699052.2014.984758; SUGLAND BW, 1995, J FAM ISSUES, V16, P632, DOI 10.1177/019251395016005007; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG., 2006, EXCEPTIONALITY, V14, P141, DOI [10.1207/s15327035ex1403_3, DOI 10.1207/S15327035EX1403_3, DOI 10.1207/S15327035EX1403_]; TEASDALE G, 1974, LANCET, V2, P81; Thaler NS, 2012, APPL NEUROPSYCH-CHIL, V1, P30, DOI 10.1080/21622965.2012.665776; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Woodcock R.W., 2001, WOODCOCKJOHNSON 3 TE; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	40	13	13	1	19	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2017	31	5					499	507		10.1037/neu0000351			9	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	EY1GE	WOS:000403713200003	28541083	Green Accepted, Bronze			2021-06-18	
J	Feng, Y; Ju, YR; Cui, JZ; Wang, LQ				Feng, Yan; Ju, Yaru; Cui, Jianzhong; Wang, Liqun			Bone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in rats	MOLECULAR MEDICINE REPORTS			English	Article						bone marrow stromal cells; traumatic brain injury; vascular endothelial growth factor; brain derived neurotrophic factor; sex determining region Y; synaptophysin	MESENCHYMAL STEM-CELLS; EXPERIMENTAL ISCHEMIC-STROKE; SPINAL-CORD-INJURY; TRANSPLANTATION; SIMVASTATIN; MARKERS; MODEL; MICE; BMSC	It has previously been demonstrated that bone marrow stromal cells (BMSCs) exhibit great therapeutic potential in neuronal injuries; however, there is limited understanding of the precise underlying mechanisms that contribute to functional improvement following brain injury. The aim of the present study was to assess the effect of BMSC treatment on traumatic brain injury (TBI) in rats, and investigate if they migrate to injured areas and promote neuromotor functional recovery via upregulation of neurotrophic factors and synaptic proteins. BMSCs were cultured in vitro from female Sprague Dawley (SD) rat bone marrow and were subsequently infused into male adult SD rats via the tail vein, following induction of TBI. The results demonstrated that treatment with BMSCs significantly reduced TBI-induced neuromotor impairment and neuronal loss, as assessed by rota rod testing, western blot analysis, modified neurological severity score and immunohistochemistry. The distribution of transplanted BMSCs was tracked by monitoring the expression of sex determining region Y (SRY) in rats. The number of cells double-positive for SRY/neuronal nuclear antigen or SRY/glial fibrillary acidic protein was increased in the BMSC group, which demonstrated that BMSCs migrated to injured areas and differentiated into neurons and astrocytes, following TBI. Furthermore, administration of BMSCs increased expression of vascular endothelial growth factor and brain derived neurotrophic factor. Protein expression levels of synaptophysin were downregulated following TBI and this was reversed in part by treatment with BMSCs. These findings uncovered some underlying mechanisms of action of BMSCs, and may lead to their potential use as a future effective therapeutic agent for the treatment of TBI.	[Feng, Yan; Wang, Liqun] Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Ju, Yaru] Fourth Hosp Shijiazhuang, Dept Obstet, Shijiazhuang 050011, Hebei, Peoples R China; [Cui, Jianzhong] Tangshan Workers Hosp, Dept Neurosurg, Tangshan 063000, Hebei, Peoples R China	Wang, LQ (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurosurg, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China.	lqwangdr@163.com					Aizawa-Kohama M, 2013, CELL TRANSPLANT, V22, P1613, DOI 10.3727/096368912X658791; Bae KS, 2011, YONSEI MED J, V52, P401, DOI 10.3349/ymj.2011.52.3.401; Bhakta S, 2006, CARDIOVASC REVASCULA, V7, P19, DOI 10.1016/j.carrev.2005.10.008; BROCK TO, 1987, J NEUROSCI, V7, P931; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cui X, 2009, NEUROBIOL DIS, V36, P35, DOI 10.1016/j.nbd.2009.06.012; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Haar CV, 2012, RESTOR NEUROL NEUROS, V30, P291, DOI 10.3233/RNN-2012-110196; Han XG, 2012, NEUROSCI LETT, V521, P136, DOI 10.1016/j.neulet.2012.05.071; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Kim JH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-22; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nishida H, 2012, VET SURG, V41, P437, DOI 10.1111/j.1532-950X.2011.00959.x; Osanai T, 2012, NEUROSURGERY, V70, P435, DOI 10.1227/NEU.0b013e318230a795; Pati S, 2016, CURR STEM CELL RES T, V11, P149, DOI 10.2174/1574888X10666151019120050; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Song MK, 2013, CELL TRANSPLANT, V22, P2001, DOI 10.3727/096368912X657909; Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077; Ye XC, 2013, INT J MOL SCI, V14, P22221, DOI 10.3390/ijms141122221; Zhang HY, 2011, ASIAN J ANDROL, V13, P231, DOI 10.1038/aja.2010.162; Zhao L, 2012, HEPATO-GASTROENTEROL, V59, P2389, DOI 10.5754/hge12288	26	13	14	0	3	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	JUL	2017	16	1					654	660		10.3892/mmr.2017.6619			7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	EZ9TZ	WOS:000405074100086	28560414	Green Published, Other Gold			2021-06-18	
J	Fraser, MA; Grooms, DR; Guskiewicz, KM; Kerr, ZY				Fraser, Melissa A.; Grooms, Dustin R.; Guskiewicz, Kevin M.; Kerr, Zachary Y.			Ball-Contact Injuries in 11 National Collegiate Athletic Association Sports: The Injury Surveillance Program, 2009-2010 Through 2014-2015	JOURNAL OF ATHLETIC TRAINING			English	Article						injury rates; injury prevention; protective equipment; head injuries; hand injuries	WOMENS GYMNASTICS INJURIES; DESCRIPTIVE EPIDEMIOLOGY; HIGH-SCHOOL; BASKETBALL INJURIES; LACROSSE INJURIES; SOCCER INJURIES; UNITED-STATES; SYSTEM; BASEBALL; CONCUSSIONS	Context: Surveillance data regarding injuries caused by ball contact in collegiate athletes have not been well examined and are mostly limited to discussions of concussions and catastrophic injuries. Objective: To describe the epidemiology of ball-contact injuries in 11 National Collegiate Athletic Association (NCAA) sports during the 2009-2010 through 2014-2015 academic years. Design: Descriptive epidemiology study. Setting: Convenience sample of NCAA programs in 11 sports (men's football, women's field hockey, women's volleyball, men's baseball, women's softball, men's and women's basketball, men's and women's lacrosse, and men's and women's soccer) during the 2009-2010 through 2014-2015 academic years. Patients or Other Participants: Collegiate student-athletes participating in 11 sports. Main Outcome Measure(s): Ball-contact-injury rates, proportions, rate ratios, and proportion ratios with 95% confidence intervals were based on data from the NCAA Injury Surveillance Program during the 2009-2010 through 2014-2015 academic years. Results: During the 2009-2010 through 2014-2015 academic years, 1123 ball-contact injuries were reported, for an overall rate of 3.54/10 000 AEs. The sports with the highest rates were women's softball (8.82/10 000 AEs), women's field hockey (7.71/10 000 AEs), and men's baseball (7.20/10 000 AEs). Most ball-contact injuries were to the hand/wrist (32.7%) and head/face (27.0%) and were diagnosed as contusions (30.5%), sprains (23.1%), and concussions (16.1%). Among sex-comparable sports (ie, baseball/softball, basketball, and soccer), women had a larger proportion of ball-contact injuries diagnosed as concussions than men (injury proportion ratio = 2.33; 95% confidence interval = 1.63, 3.33). More than half (51.0%) of ball-contact injuries were non-time loss (ie, participation-restriction time,24 hours), and 6.6% were severe (ie, participation-restriction time >= 21 days). The most common severe ball-contact injuries were concussions (n = 18) and finger fractures (n = 10). Conclusion: Ball-contact-injury rates were the highest in women's softball, women's field hockey, and men's baseball. Although more than half were non-time-loss injuries, severe injuries such as concussions and fractures were reported.	[Fraser, Melissa A.] Univ N Carolina, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Kerr, Zachary Y.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Grooms, Dustin R.] Ohio Univ, Sch Appl Hlth & Wellness, Div Athlet Training, Athens, OH 45701 USA; [Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Fraser, Melissa A.] Texas State Univ, Div Athlet Training, Dept Hlth & Human Performance, 601 Univ Dr,Jowers A126, San Marcos, TX 78666 USA	Fraser, MA (corresponding author), Texas State Univ, Div Athlet Training, Dept Hlth & Human Performance, 601 Univ Dr,Jowers A126, San Marcos, TX 78666 USA.	missyfraser@txstate.edu		Fraser, Missy/0000-0002-5753-8798	NCAA	The NCAA-ISP data were provided by the Datalys Center for Sports Injury Research and Prevention, Inc. The ISP was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NCAA. We thank the many ATs who have volunteered their time and efforts to submit data to the NCAA-ISP. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes.	Agel J, 2007, J ATHL TRAINING, V42, P295; Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P202; [Anonymous], STUD ATHL PART 1981; Boden BP, 2004, AM J SPORT MED, V32, P1189, DOI 10.1177/0363546503262161; Carniol ET, 2015, OTOLARYNG HEAD NECK, V153, P957, DOI 10.1177/0194599815602668; Comstock R. D., 2006, Morbidity and Mortality Weekly Report, V55, P1037; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Dalton SL, 2015, AM J SPORT MED, V43, P2671, DOI 10.1177/0363546515599631; Darrow CJ, 2009, AM J SPORT MED, V37, P1798, DOI 10.1177/0363546509333015; Dick R, 2007, J ATHL TRAINING, V42, P278; Dick R, 2007, J ATHL TRAINING, V42, P262; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P221; Dick R, 2007, J ATHL TRAINING, V42, P183; Dick R, 2007, J ATHL TRAINING, V42, P194; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Kerr ZY, 2015, MMWR-MORBID MORTAL W, V64, P1330, DOI 10.15585/mmwr.mm6448a2; Kerr ZY, 2015, J ATHL TRAINING, V50, P870, DOI 10.4085/1062-6050-50.7.02; Kerr ZY, 2015, AM J SPORT MED, V43, P1134, DOI 10.1177/0363546515570622; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kerr ZY, 2011, CLIN PEDIATR, V50, P594, DOI 10.1177/0009922810390513; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Marshall SW, 2007, J ATHL TRAINING, V42, P286; Marshall SW, 2007, J ATHL TRAINING, V42, P234; Marshall SW, 2003, JAMA-J AM MED ASSOC, V289, P568, DOI 10.1001/jama.289.5.568; Nicholls RL, 2004, SPORTS MED, V34, P17, DOI 10.2165/00007256-200434010-00003; Post A, 2016, COMPUT METHOD BIOMEC, V19, P1; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Yamamoto K, 2009, DENT TRAUMATOL, V25, P194, DOI 10.1111/j.1600-9657.2008.00747.x; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	34	13	13	1	12	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2017	52	7					698	707		10.4085/1062-6050-52.3.10			10	Sport Sciences	Sport Sciences	FB4RH	WOS:000406128700010	28535098	Green Published, Bronze			2021-06-18	
J	Harch, PG; Andrews, SR; Fogarty, EF; Lucarini, J; Van Meter, KW				Harch, Paul G.; Andrews, Susan R.; Fogarty, Edward F.; Lucarini, Juliette; Van Meter, Keith W.			Case control study: hyperbaric oxygen treatment of mild traumatic brain injury persistent post-concussion syndrome and post-traumatic stress disorder	MEDICAL GAS RESEARCH			English	Article						hyperbaric oxygen; traumatic brain injury; persistent post concussion syndrome; post traumatic stress disorder; single photon emission computed tomography; cognitive assessment; brain injury treatment; combat veterans	CEREBRAL BLOOD-FLOW; PHASE-I; DECOMPRESSION ILLNESS; SERVICE MEMBERS; GENE-EXPRESSION; THERAPY; PRESSURE; BLAST; SYMPTOMS; QUALITY	Mild traumatic brain injury (TBI) persistent post-concussion syndrome (PPCS) and post-traumatic stress disorder (PTSD) are epidemic in United States Iraq and Afghanistan War veterans. Treatment of the combined diagnoses is limited. The aim of this study is to assess safety, feasibility, and effectiveness of hyperbaric oxygen treatments (HBOT) for mild TBI PPCS and PTSD. Thirty military subjects aged 18 -65 with PPCS with or without PTSD and from one or more blast-induced mild-moderate traumatic brain injuries that were a minimum of 1 year old and occurred after 9/11/2001 were studied. The measures included symptom lists, physical exam, neuropsychological and psychological testing on 29 subjects (1 dropout) and SPECT brain imaging pre and post HBOT. Comparison was made using SPECT imaging on 29 matched Controls. Side effects (30 subjects) experienced due to the HBOT: reversible middle ear barotrauma (n = 6), transient deterioration in symptoms (n = 7), reversible bronchospasm (n = 1), and increased anxiety (n = 2; not related to confinement); unrelated to HBOT: ureterolithiasis (n = 1), chest pain (n = 2). Significant improvement (29 subjects) was seen in neurological exam, symptoms, intelligence quotient, memory, measures of attention, dominant hand motor speed and dexterity, quality of life, general anxiety, PTSD, depression (including reduction in suicidal ideation), and reduced psychoactive medication usage. At 6-month follow-up subjects reported further symptomatic improvement. Compared to Controls the subjects' SPECT was significantly abnormal, significantly improved after 1 and 40 treatments, and became statistically indistinguishable from Controls in 75% of abnormal areas. HBOT was found to be safe and significantly effective for veterans with mild to moderate TBI PPCS with PTSD in all four outcome domains: clinical medicine, neuropsychology, psychology, and SPECT imaging. Veterans also experienced a significant reduction in suicidal ideation and reduction in psychoactive medication use.	[Harch, Paul G.; Andrews, Susan R.; Lucarini, Juliette; Van Meter, Keith W.] Louisiana State Univ, Sch Med, New Orleans, LA 70112 USA; [Fogarty, Edward F.] Univ North Dakota, Sch Med, Bismarck, ND USA	Harch, PG (corresponding author), Louisiana State Univ, Sch Med, New Orleans, LA 70112 USA.	paulharchmd@gmail.com			Marine Corps Law Enforcement Foundation; Semper Fi Fund; Coalition to Salute Americas Heroes; Harch Hyperbaric Research Fund of the Baromedical Research Institute of New Orleans; Van Kampen Foundation; N.Y. Community Trust; Louis and Candace Hughes Trust; Sutton Foundation; Caulkins Family; New Orleans Natural Resource Group; Health Freedom Foundation; Tim and Libby Brown Foundation	The Marine Corps Law Enforcement Foundation, The Semper Fi Fund, The Coalition to Salute Americas Heroes, John and Resa Wing, the Harch Hyperbaric Research Fund of the Baromedical Research Institute of New Orleans, Frederick Lowther, Mr. Chris Anderson of the Van Kampen Foundation, Stanley Horton, John Staley IV, N.Y. Community Trust, Louis and Candace Hughes Trust, James Rooney, Marshall Wallach, Mr. Poindexter, Richard and Meg Lyon, The Sutton Foundation, The Caulkins Family, George Wood, Mr. Caleb Gates, New Orleans Natural Resource Group, Rubie and Bryan Bell, Margaret Hoffmann, John and Virginia Weinmann, Peter Roy Carney, John Fox, Dr. Warren Thomas, Joan C. White, James Wallace, Isabel Sanders, Edgar Jannotta, Thomas Petrie, Health Freedom Foundation, Tim and Libby Brown Foundation, Lisa Ethier, Operation Homefront Louisiana, Mr. Theodore Solomon, and Shoney's Restaurant (Gretna, LA). Twenty-five doses of the SPECT agent Ethyl Cysteinate Dimer were donated by Dupont Merck Pharma Radiopharmaceuticals, North Billerica, MA, USA for use in LSU IRB #3511, Tc99m ECD SPECT Brain Imaging in Neurologically Normal Individuals and Neurologically and Cognitively Abnormal Nitrogen Tetroxide Exposed Patients.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 2008, US NAVY DIVING MANUA, V1, P42; Armistead-Jehle P, 2012, J NEUROTRAUM, V29, P2513, DOI 10.1089/neu.2012.2400; Barratt DM, 2002, NEUROLOGIST, V8, P186, DOI 10.1097/00127893-200205000-00005; Beauregard M, 2009, NORD J PSYCHIAT, V63, P5, DOI 10.1080/08039480802421182; Belanger HG, 2011, CLIN NEUROPSYCHOL, V25, P702, DOI 10.1080/13854046.2011.566892; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Centers for Medicare and Medicaid Services, 2006, CTR MED MED SERV P 1; Chen Y, 2009, NEUROCHEM RES, V34, P1047, DOI 10.1007/s11064-008-9873-8; Churchill S, 2013, UNDERSEA HYPERBAR M, V40, P165; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; CLARK JM, 1993, PHYSL MED DIVING, P121; Congress of the United States Congressional Budget Office, 2012, CBO STUD VET HLTH AD; Dougherty G, 1996, MED ENG PHYS, V18, P557, DOI 10.1016/1350-4533(96)00011-2; Duncan LE, LARGEST GWAS PTSD N; Figueroa XA, 2016, NEUROLOGY, V87, P1400, DOI 10.1212/WNL.0000000000003146; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Garcia AJ, 2010, J APPL PHYSIOL, V109, P804, DOI 10.1152/japplphysiol.91429.2008; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Godman CA, 2010, CELL STRESS CHAPERON, V15, P431, DOI 10.1007/s12192-009-0159-0; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Greenberg L., 1996, TEST VARIABLES ATTEN; GUR RC, 1982, SCIENCE, V217, P659, DOI 10.1126/science.7089587; Harch P.G., 2002, P 2 INT S HYP OXYG C; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; Harch PG, 2013, J NEUROTRAUM, V30, P1995, DOI 10.1089/neu.2012.2799; Harch PG, 2013, UNDERSEA HYPERBAR M, V40, P469; Harch PG, 2012, J NEUROTRAUM, V29, P2516, DOI 10.1089/neu.2012.2608; Harch PG, 2012, J NEUROTRAUM, V29, P2425, DOI 10.1089/neu.2012.2544; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Harch Paul G, 2009, Cases J, V2, P6538, DOI 10.4076/1757-1626-2-6538; Harch PG, 1996, TXB HYPERBARIC MED, P480; Harch PG, 2017, TXB HYPERBARIC MED, V20, P269; Harch PG, 2004, TXB HYPERBARIC MED, P223; Harch PG, 2009, TXB HYPERBARIC MED, P505; Harch PG, 1996, UNDERSEA HYPERB ME S, V23, P48; Harch PG, 2009, TXB HYPERBARIC MED, P235; Harch PG, 1996, TREATMENT DECOMPRESS, P203; Harch PG, 1994, UNDERSEA HYPERB ME S, V21, P30; Harch PG, 1999, TXB HYPERBARIC MED, P319; Harch PG, 2015, HYPERBARIC OXYGEN TH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jarcho JM, 2009, CLIN PHARMACOL THER, V86, P352, DOI 10.1038/clpt.2009.126; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI DOI 10.1037/1040-3590.1.1.53; Kendall AC, 2013, UNDERSEA HYPERBAR M, V40, P115; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lesak M, 2004, NEUROPSYCHOLOGICAL A, P776; Lesak MD, 2004, NEUROPSYCHOLOGICAL A; LIDVALL HF, 1975, LANCET, V1, P100; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Marx RE, 1988, PROBLEM WOUNDS ROLE, P65; MEYER JS, 1968, CIRCULATION, V37, P1036, DOI 10.1161/01.CIR.37.6.1036; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Mulvaney SW, 2014, MIL MED, V179, P1133, DOI 10.7205/MILMED-D-14-00151; NEUBAUER RA, 1994, SOUTHERN MED J, V87, P933, DOI 10.1097/00007611-199409000-00015; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Oh S, 2008, CELL STRESS CHAPERON, V13, P447, DOI 10.1007/s12192-008-0041-5; PALMER AC, 1992, NEUROPATH APPL NEURO, V18, P113, DOI 10.1111/j.1365-2990.1992.tb00773.x; PATRICK DL, 1988, J GEN INTERN MED, V3, P218, DOI 10.1007/BF02596335; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Powell JM, 2001, ARCH PHYS MED REHAB, V82, P1025, DOI 10.1053/apmr.2001.25082; PTSD Checklist-Military, 2009, PTSD CHECKLIST MILIT; Quitkin FM, 1999, AM J PSYCHIAT, V156, P829, DOI 10.1176/ajp.156.6.829; RAICHLE ME, 1976, ARCH NEUROL-CHICAGO, V33, P523, DOI 10.1001/archneur.1976.00500080001001; Raji CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091088; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Robb MA, 2016, JAMA-J AM MED ASSOC, V315, P1107, DOI 10.1001/jama.2016.2240; Rossignol DA, 2007, MED HYPOTHESES, V68, P1208, DOI 10.1016/j.mehy.2006.09.064; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Scorza KA, 2013, UNDERSEA HYPERBARIC; Shandley S, 2017, UNDERSEA HYPERBAR M, V44, P257; Shields TG, 1997, OCCUP ENVIRON MED, V54, P247, DOI 10.1136/oem.54.4.247; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Steenkamp MM, 2015, JAMA-J AM MED ASSOC, V314, P489, DOI 10.1001/jama.2015.8370; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; SYMONDS C, 1962, LANCET, V1, P1; Tanielian T, 2008, INVISIBLE WOUNDS WAR; Thorsen E, 1998, EUR RESPIR J, V12, P1442, DOI 10.1183/09031936.98.12061442; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; VANMETER KW, 1994, ANN EMERG MED, V24, P283, DOI 10.1016/S0196-0644(05)83748-5; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Weaver LK, 2014, HYPERBARIC OXYGEN TH, V13th; Wechsler D., 2001, WECHSLER TEST ADULT; Wilson B. A., 1985, RIVERMEAD BEHAV MEMO; Wolf EG, 2015, UNDERSEA HYPERBAR M, V42, P313; Wolf EG, 2012, UNDERSEA HYPERBAR M, V39, P1075; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Wolfson D., 1993, HALSTEAD REITAN NEUR; Wortzel HS, 2012, J NEUROTRAUM, V29, P2421, DOI 10.1089/neu.2012.2426; Wright JK, 2009, UNDERSEA HYPERBAR M, V36, P391; Zhang T, 2010, BRAIN INJURY, V24, P1350, DOI 10.3109/02699052.2010.504525	104	13	13	1	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2045-9912			MED GAS RES	Med. Gas Res.	JUL-SEP	2017	7	3					156	+		10.4103/2045-9912.215745			93	Medicine, Research & Experimental	Research & Experimental Medicine	FK3DK	WOS:000413365100003	29152209	Green Published			2021-06-18	
J	Hunnicutt, G; Lundgren, K; Murray, C; Olson, L				Hunnicutt, Gwen; Lundgren, Kristine; Murray, Christine; Olson, Loreen			The Intersection of Intimate Partner Violence and Traumatic Brain Injury: A Call for Interdisciplinary Research	JOURNAL OF FAMILY VIOLENCE			English	Article						Gender; Domestic violence; Public health; Socio-ecological framework	POSTTRAUMATIC-STRESS-DISORDER; BATTERED WOMEN; DOMESTIC VIOLENCE; COGNITIVE IMPAIRMENT; HEALTH CONSEQUENCES; HEAD-INJURIES; MENTAL-HEALTH; HELP-SEEKING; VICTIMS; RISK	An emerging body of research suggests that survivors of intimate partner violence (IPV) are at a high risk for sustaining traumatic brain injury (TBI). However, most scholars and practitioners working on the problem of IPV have not examined how TBI could be related to their familiar subject of study. Concomitantly, little work in the brain injury field has been done to examine TBI in the context of IPV. In this paper, we encourage cross-collaboration among these fields. To that end, we consider the relationship between IPV and TBI; the difficulty in detecting and measuring the IPV-related TBI and ethical concerns that may arise when addressing this issue. Our work emphasizes the need to recognize the complex interplay among psycho-physiological health and socio-cultural contexts. As such, we present a socio-ecological perspective of IPV-related TBI to provide a contextual framework to guide future interdisciplinary research. Finally, we outline directions for future research.	[Hunnicutt, Gwen] Univ North Carolina Greensboro, Dept Sociol & Womens Gender Studies, 316 Graham Bldg,POB 26170, Greensboro, NC 27402 USA; [Lundgren, Kristine] Univ North Carolina Greensboro, Dept Commun Sci & Disorders, 320 Ferguson Bldg, Greensboro, NC 27402 USA; [Murray, Christine] Univ North Carolina Greensboro, Dept Counseling & Educ Dev, 221 Curry Bldg, Greensboro, NC 27402 USA; [Olson, Loreen] Univ North Carolina Greensboro, Dept Commun Studies, 102 Ferguson Bldg,POB 26170, Greensboro, NC 27402 USA	Hunnicutt, G (corresponding author), Univ North Carolina Greensboro, Dept Sociol & Womens Gender Studies, 316 Graham Bldg,POB 26170, Greensboro, NC 27402 USA.	gchunnic@uncg.edu; k_lundgr@uncg.edu; cemurray@uncg.edu; lnolson@uncg.edu	Hunnicutt, Gwen/AAS-1272-2020				Ackerman RJ, 2003, WOMEN THER, V26, P343, DOI 10.1300/J015v26n03_11; Alderman N, 2002, BRAIN INJURY, V16, P469, DOI 10.1080/02699050110118458; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Banks ME, 2002, WOMEN THER, V25, P133, DOI 10.1300/J015v25n03_10; Belson K, 2013, NY TIMES; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; CDC, 2014, SOC EC MOD FRAM PREV; Centers for Disease Control, 2010, OV INT PART VIOL US; Committee on Mild Traumatic Brain Injury and American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P48; Corrigan J. D., 2001, AM J OBSTET GYNECOL, V188, P571; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Diaz-Olavarrieta C, 1999, ARCH NEUROL-CHICAGO, V56, P681, DOI 10.1001/archneur.56.6.681; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Helfrich CA, 2008, J INTERPERS VIOLENCE, V23, P437, DOI 10.1177/0886260507312942; Housecamp M. J., 1991, J INTERPERS VIOLENCE, V6, P367; Hughes K, 2012, LANCET, V379, P1621, DOI 10.1016/S0140-6736(11)61851-5; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McKee A. C., 2012, J NEUROL, P1, DOI [10.1093/brain/aws307, DOI 10.1093/BRAIN/AWS307]; Mechanic MB, 2008, VIOLENCE AGAINST WOM, V14, P1148, DOI 10.1177/1077801208323792; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Murray CE, 2013, RESPONDING TO FAMILY VIOLENCE: A COMPREHENSIVE, RESEARCH-BASED GUIDE FOR THERAPISTS, P1; Murray C. E., PARTNER VIO IN PRESS; Olson L. G., 2004, J FAMILY COMMUNICATI, V4, P209; Overstreet NM, 2013, BASIC APPL SOC PSYCH, V35, P109, DOI 10.1080/01973533.2012.746599; Plichta SB, 2004, J INTERPERS VIOLENCE, V19, P1296, DOI 10.1177/0886260504269685; Rapoport MJ, 2005, J NEUROPSYCH CLIN N, V17, P61, DOI 10.1176/appi.neuropsych.17.1.61; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Reeves RR, 2012, J PSYCHOSOC NURS MEN, V50, P32, DOI 10.3928/02793695-20120207-02; Reichard AA, 2007, J HEAD TRAUMA REHAB, V22, P390, DOI 10.1097/01.HTR.0000300234.36361.b1; Richard L, 2011, ANNU REV PUBL HEALTH, V32, P307, DOI 10.1146/annurev-publhealth-031210-101141; Roberts AR, 2005, J SOC SERV RES, V32, P33, DOI 10.1300/J079v32n01_03; Stern Judith M, 2004, Curr Neurol Neurosci Rep, V4, P179, DOI 10.1007/s11910-004-0034-4; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Tjaden P, 2000, NIJ PUBLICATION; Twamley EW, 2009, J INT NEUROPSYCH SOC, V15, P879, DOI 10.1017/S135561770999049X; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Wenner K., 2012, NY TIMES; WHO, 2012, UND ADDR VIOL WOM; Wuest J, 2009, PAIN MED, V10, P739, DOI 10.1111/j.1526-4637.2009.00624.x	49	13	13	0	17	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7482	1573-2851		J FAM VIOLENCE	J. Fam. Violence	JUL	2017	32	5					471	480		10.1007/s10896-016-9854-7			10	Psychology, Clinical; Family Studies	Psychology; Family Studies	EW7NR	WOS:000402701400001		Green Accepted			2021-06-18	
J	Mahoney, PF; Carr, DJ; Delaney, RJ; Hunt, N; Harrison, S; Breeze, J; Gibb, I				Mahoney, P. F.; Carr, D. J.; Delaney, R. J.; Hunt, N.; Harrison, S.; Breeze, J.; Gibb, I.			Does preliminary optimisation of an anatomically correct skull-brain model using simple simulants produce clinically realistic ballistic injury fracture patterns?	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Head; Military helmet; Assessment; 7.62 x 39 mm bullet; AK47	SURROGATES; BONE	Ballistic head injury remains a significant threat to military personnel. Studying such injuries requires a model that can be used with a military helmet. This paper describes further work on a skull-brain model using skulls made from three different polyurethane plastics and a series of skull 'fills' to simulate brain (3, 5, 7 and 10% gelatine by mass and PermaGel (TM)). The models were subjected to ballistic impact from 7.62 x 39 mm mild steel core bullets. The first part of the work compares the different polyurethanes (mean bullet muzzle velocity of 708 m/s), and the second part compares the different fills (mean bullet muzzle velocity of 680 m/s). The impact events were filmed using high speed cameras. The resulting fracture patterns in the skulls were reviewed and scored by five clinicians experienced in assessing penetrating head injury. In over half of the models, one or more assessors felt aspects of the fracture pattern were close to real injury. Limitations of the model include the skull being manufactured in two parts and the lack of a realistic skin layer. Further work is ongoing to address these.	[Mahoney, P. F.] ICT Ctr, Royal Ctr Def Med, Res Pk, Birmingham B15 2SQ, W Midlands, England; [Mahoney, P. F.; Carr, D. J.] Cranfield Univ, Def Acad United Kingdom, Ctr Def Engn, Swindon SN6 8LA, Wilts, England; [Delaney, R. J.] South West Forens Pathol Grp Practice, POB 388, Bristol BS9 0DB, Avon, England; [Hunt, N.] Forens Pathol Serv, Grove Technol Pk, Wantage OX12 9FA, Oxon, England; [Harrison, S.; Breeze, J.] RCDM, Acad Dept Mil Surg & Trauma, Birmingham, W Midlands, England; [Gibb, I.] HM Naval Base, Med Ctr, Xray Dept, HMS Nelson, Portsmouth PO1 3HH, Hants, England	Mahoney, PF (corresponding author), ICT Ctr, Royal Ctr Def Med, Res Pk, Birmingham B15 2SQ, W Midlands, England.; Mahoney, PF (corresponding author), Cranfield Univ, Def Acad United Kingdom, Ctr Def Engn, Swindon SN6 8LA, Wilts, England.	p.f.mahoney@cranfield.ac.uk	; Carr, Debra/K-6845-2013	Breeze, John/0000-0002-2352-1365; Carr, Debra/0000-0002-9476-2166; Harrisson, Stuart/0000-0003-4995-4270			Betz P, 1997, FORENSIC SCI INT, V86, P155, DOI 10.1016/S0379-0738(97)02121-X; Bir C, 2016, FORENSIC SCI INT, V261, P1, DOI 10.1016/j.forsciint.2016.01.023; Carr D, 2015, INT J LEGAL MED, V129, P505, DOI 10.1007/s00414-014-1073-2; Clason D.L., 1994, J AGR ED, V35, P31, DOI [10.5032/jae.1994.04031, DOI 10.5032/JAE.1994.04031]; COE JI, 1982, AM J FOREN MED PATH, V3, P215, DOI 10.1097/00000433-198209000-00006; Di Maio VJM., 2016, GUNSHOT WOUNDS PRACT, V3rd ed; Falland-Cheung L, 2015, FORENSIC SCI MED PAT, V11, P552, DOI 10.1007/s12024-015-9718-0; Hejna P, 2011, INT J LEGAL MED, V125, P587, DOI 10.1007/s00414-011-0553-x; Karger B, 2008, FORENSIC PATHOL REV, V5, P139, DOI 10.1007/978-1-59745-110-9_9; Keene DD, 2016, J ROY ARMY MED CORPS, V162, P355, DOI 10.1136/jramc-2015-000490; Leestma IE, 2014, FORENSIC NEUROPATHOL, P655; Lu HC, 2015, J SURG RES, V199, P698, DOI 10.1016/j.jss.2015.01.006; Mabbott A, 2016, INT J LEGAL MED, V130, P1353, DOI 10.1007/s00414-015-1309-9; Mabbott A, 2013, 27TH INTERNATIONAL SYMPOSIUM ON BALLISTICS, VOLS. 1 AND 2, P648; Puskas CM, 2003, J FORENSIC SCI, V48, P1219; Raymond DE, 2015, J FORENSIC SCI, V60, P370, DOI 10.1111/1556-4029.12693; Rennick SL, 2005, J FORENSIC SCI, V50, P1016; Russell R, 2014, J ROY ARMY MED CORPS, V160, P150, DOI 10.1136/jramc-2013-000215; Sarron JC, 2004, J TRAUMA, V57, P236, DOI 10.1097/01.TA.0000133575.48065.3F; Saukko P, 2016, KNIGHTS FORENSIC PAT, P241; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Smith MJ, 2015, LEGAL MED-TOKYO, V17, P427, DOI 10.1016/j.legalmed.2015.06.007; Thali MJ, 2002, FORENSIC SCI INT, V125, P178, DOI 10.1016/S0379-0738(01)00637-5; Viel G, 2009, FORENSIC SCI MED PAT, V5, P22, DOI 10.1007/s12024-008-9062-8	24	13	13	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JUL	2017	131	4					1043	1053		10.1007/s00414-017-1557-y			11	Medicine, Legal	Legal Medicine	EZ4DP	WOS:000404662500020	28271364	Green Published			2021-06-18	
J	Papa, L; Mittal, MK; Ramirez, J; Silvestri, S; Giordano, P; Braga, CF; Tan, CN; Ameli, NJ; Lopez, MA; Haeussler, CA; Giordano, DM; Zonfrillo, MR				Papa, Linda; Mittal, Manoj K.; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco A.; Haeussler, Crystal A.; Giordano, Diego Mendez; Zonfrillo, Mark R.			Neuronal Biomarker Ubiquitin C-Terminal Hydrolase Detects Traumatic Intracranial Lesions on Computed Tomography in Children and Youth with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adolescents; biomarkers; children; computed tomography; concussion; diagnosis; head trauma; mild traumatic brain injury; pediatric; sensitivity; specificity; ubiquitin C-terminal hydrolase (UCH-L1); youth	FIBRILLARY ACIDIC PROTEIN; SERUM CONCENTRATIONS; RECOMMENDATIONS	This study examined the performance of serum ubiquitin C-terminal hydrolase (UCH-L1) in detecting traumatic intracranial lesions on computed tomography (CT) scan (+CT) in children and youth with mild and moderate TBI (mmTBI) and assessed its performance in trauma control patients without head trauma. This prospective cohort study enrolled children and youth presenting to three level 1 trauma centers after blunt head trauma and a Glasgow Coma Scale (GCS) score of 9-15 as well as trauma control patients with GCS 15 that did not have blunt head trauma. The primary outcome measure was the presence of intracranial lesions on initial CT scan. Blood samples were obtained in all patients within 6 h of injury and measured by enzyme-linked immunosorbent assay ELISA for UCH-L1 (ng/mL). A total of 256 children and youth were enrolled in the study and had serum samples drawn within 6 h of injury for analysis; 196 had blunt head trauma and 60 were trauma controls. CT scan of the head was performed in 151 patients and traumatic intracranial lesions on CT scan were evident in 17 (11%), all of whom had a GCS of 13-15. The area under the receiver operating characteristic curve (AUC) for UCH-L1 in detecting children and youth with traumatic intracranial lesions on CT was 0.83 (95% confidence interval [CI], 0.73-0.93). In those presenting with a GCS of 15, the AUC for detecting lesions was 0.83 (95% CI, 0.72-0.94). Similarly, in children under 5 years of age, the AUC was 0.79 (95% CI, 0.59-1.00). Performance for detecting intracranial lesions at a UCH-L1 cut-off level of 0.18 ng/mL yielded a sensitivity of 100%, a specificity of 47%, and a negative predictive value of 100%. UCH-L1 showed good performance in infants and toddlers younger than 5 years and performed well in children and youth with a GCS score of 15. Before clinical application, further study in larger cohort of children and youth with mild TBI is warranted.	[Papa, Linda; Silvestri, Salvatore; Giordano, Philip; Braga, Carolina F.; Tan, Ciara N.; Ameli, Neema J.; Lopez, Marco A.; Haeussler, Crystal A.; Giordano, Diego Mendez] Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 West Underwood S-200, Orlando, FL 32806 USA; [Papa, Linda; Ramirez, Jose; Silvestri, Salvatore; Giordano, Philip] Arnold Palmer Hosp Children, Dept Pediat Emergency Med, Orlando, FL USA; [Mittal, Manoj K.] Childrens Hosp Philadelphia, Div Emergency Med, Philadelphia, PA 19104 USA; [Mittal, Manoj K.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Dept Emergency Med, Alpert Med Sch, Providence, RI 02912 USA; [Zonfrillo, Mark R.] Hasbro Childrens Hosp, Providence, RI USA	Papa, L (corresponding author), Orlando Reg Med Ctr Inc, Dept Emergency Med, 86 West Underwood S-200, Orlando, FL 32806 USA.	1pstat@aol.com	Zonfrillo, Mark R./H-9403-2017	Zonfrillo, Mark R./0000-0002-0610-9563	National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS057676] Funding Source: NIH RePORTER	The project described was supported, in part, by Award Number R01NS057676 from the National Institute of Neurological Disorders and Stroke (NINDS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NINDS or the National Institutes of Health.	Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2007, J NEUROTRAUM, V24, P1793, DOI 10.1089/neu.2007.0316; Brenner DJ, 2010, RADIAT RES, V174, P809, DOI 10.1667/RR1859.1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Easter JS, 2014, ANN EMERG MED, V64, P145, DOI 10.1016/j.annemergmed.2014.01.030; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Long A E, 1985, Emerg Med Clin North Am, V3, P437; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Papa L, 2016, SPORTS MED ARTHROSC, V24, P108, DOI 10.1097/JSA.0000000000000117; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Papa L, 2015, ACAD EMERG MED, V22, P1274, DOI 10.1111/acem.12795; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149	26	13	14	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2017	34	13					2132	2140		10.1089/neu.2016.4806			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EZ2HM	WOS:000404530400451	28158951	Green Published			2021-06-18	
J	Vezzani, A; Pascente, R; Ravizza, T				Vezzani, Annamaria; Pascente, Rosaria; Ravizza, Teresa			Biomarkers of Epileptogenesis: The Focus on Glia and Cognitive Dysfunctions	NEUROCHEMICAL RESEARCH			English	Article						Epilepsy; Biomarker; Imaging; Inflammation; Astrocytes; Co-morbidity	TEMPORAL-LOBE EPILEPSY; LITHIUM-PILOCARPINE MODEL; TRAUMATIC BRAIN-INJURY; TOLL-LIKE RECEPTOR; MOBILITY GROUP BOX-1; MAGNETIC-RESONANCE-SPECTROSCOPY; C-11 DEUTERIUM-DEPRENYL; GLYCATION END-PRODUCTS; STATUS EPILEPTICUS; IN-VIVO	The need to find measures that reliably predict the onset of epilepsy after injurious events or how the patient will respond to anti-seizure drugs led to intensive pre-clinical and clinical research to discover non-invasive biomarkers that could increase the sensitivity of existing clinical indicators. The use of experimental models of epileptogenesis and of drug-resistance is instrumental to select the most promising approaches to explore such biomarkers in the pre-clinical setting for further clinical validation. The approaches most frequently used to find clinically useful biomarkers of epileptogenesis include molecular brain imaging, EEG signal analysis and the measure of soluble molecules in biofluids which may reflect brain intrinsic events involved in epilepsy development. Among those, we focused our attention on proton magnetic resonance imaging (H-1-MRS)-based analysis of astrocytic activation, and related blood biomarkers, since this cell population appears to be pivotally involved in various epileptogenesis processes triggered by differing insults. Moreover, we also investigated behavioral biomarkers by focusing on cognitive dysfunctions since this deficit represents a typical co-morbidity in epilepsy which may manifest even before the onset of spontaneous seizures. In this review article, we will report our recently published evidence supporting the utility of measuring astrocyte activation, the soluble molecules they release, and the associated cognitive deficits during epileptogenesis for early stratification of animals developing epilepsy. We will discuss the potential clinical translation of our findings for enriching the patient population in preventive clinical trials designed to study anti-epileptogenic treatments.	[Vezzani, Annamaria; Pascente, Rosaria; Ravizza, Teresa] IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy	Vezzani, A (corresponding author), IRCCS Ist Ric Farmacol Mario Negri, Dept Neurosci, Via G La Masa 19, I-20156 Milan, Italy.	annamaria.vezzani@marionegri.it	Ravizza, Teresa/AAB-1440-2020; Vezzani, Annamaria/AAB-1882-2020	Ravizza, Teresa/0000-0002-9578-018X; Vezzani, Annamaria/0000-0003-0573-6175	European Union's Seventh Framework Programme (FP7) [602102 (EPITARGET)]; Citizen United for Research in Epilepsy (CURE)	We acknowledge the grant support by the European Union's Seventh Framework Programme (FP7/2007-2013) under Grant Agreement No. 602102 (EPITARGET), and Citizen United for Research in Epilepsy (CURE).	Achour SB, 2010, NEUROCHEM INT, V57, P440, DOI 10.1016/j.neuint.2010.02.013; Amhaoul H, 2015, NEUROBIOL DIS, V82, P526, DOI 10.1016/j.nbd.2015.09.004; Aronica E, 2012, GLIA, V60, P1258, DOI 10.1002/glia.22312; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Austin JK, 2001, PEDIATRICS, V107, P115, DOI 10.1542/peds.107.1.115; Balosso S, 2014, ANTIOXID REDOX SIGN, V21, P1726, DOI 10.1089/ars.2013.5349; Barkas L, 2012, BRAIN, V135, P2358, DOI 10.1093/brain/aws176; Berg AT, 2005, DEV MED CHILD NEUROL, V47, P749, DOI 10.1017/S001216220500157X; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; Boer K, 2006, J NEUROIMMUNOL, V173, P188, DOI 10.1016/j.jneuroim.2006.01.002; Boison D, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00109; Brackhan M, 2016, J NUCL MED, V57, P1302, DOI 10.2967/jnumed.116.172494; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Broer S, 2015, EPILEPSY BEHAV, V53, P98, DOI 10.1016/j.yebeh.2015.09.028; Bronisz E, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/7369020; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Butler T, 2016, EPILEPSIA, V57, pE191, DOI 10.1111/epi.13457; Chauviere L, 2009, J NEUROSCI, V29, P5402, DOI 10.1523/JNEUROSCI.4699-08.2009; Cilio MR, 2003, EPILEPSIA, V44, P518, DOI 10.1046/j.1528-1157.2003.48802.x; Cleary RA, 2013, EPILEPSY RES, V106, P264, DOI 10.1016/j.eplepsyres.2013.03.015; de Araujo GM, 2012, SEIZURE-EUR J EPILEP, V21, P619, DOI 10.1016/j.seizure.2012.07.002; Depaulis A, 2016, J NEUROSCI METH, V260, P159, DOI 10.1016/j.jneumeth.2015.05.022; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Dube C, 2001, EXP NEUROL, V167, P227, DOI 10.1006/exnr.2000.7561; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Filibian M, 2012, EPILEPSIA, V53, P1907, DOI 10.1111/j.1528-1167.2012.03685.x; Friedman A, 2012, JASPERS BASIC MECH; Friedman A, 2009, EPILEPSY RES, V85, P142, DOI 10.1016/j.eplepsyres.2009.03.005; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Gastens AM, 2008, EPILEPSIA, V49, P1759, DOI 10.1111/j.1528-1167.2008.01659.x; GERLAI R, 1995, LEARN MEMORY, V2, P26, DOI 10.1101/lm.2.1.26; Gershen LD, 2015, JAMA NEUROL, V72, P882, DOI 10.1001/jamaneurol.2015.0941; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Haik S, 2008, ARCH NEUROL-CHICAGO, V65, P545, DOI 10.1001/archneur.65.4.545; Hammen T, 2008, NMR BIOMED, V21, P545, DOI 10.1002/nbm.1222; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Henshall DC, 2016, LANCET NEUROL, V15, P1368, DOI 10.1016/S1474-4422(16)30246-0; Hermann B, 2006, BRAIN, V129, P2609, DOI 10.1093/brain/awl196; Hirvonen J, 2012, J NUCL MED, V53, P234, DOI 10.2967/jnumed.111.091694; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Hort J, 2000, BEHAV BRAIN RES, V112, P77, DOI 10.1016/S0166-4328(00)00163-7; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iori V, 2013, NEUROBIOL DIS, V58, P102, DOI 10.1016/j.nbd.2013.03.006; Ito S, 2013, NEUROBIOL DIS, V49, P29, DOI 10.1016/j.nbd.2012.08.003; Kanner AM, 2009, NEUROLOGY, V72, P793, DOI 10.1212/01.wnl.0000343850.85763.9c; Kleen JK, 2012, JASPERS BASIC MECH; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Kubova H, 2004, EUR J NEUROSCI, V19, P3255, DOI 10.1111/j.0953-816X.2004.03410.x; KUMLIEN E, 1992, EPILEPSIA, V33, P610, DOI 10.1111/j.1528-1157.1992.tb02336.x; Kumlien E, 2001, ACTA NEUROL SCAND, V103, P360, DOI 10.1034/j.1600-0404.2001.103006360.x; KUMLIEN E, 1995, EPILEPSIA, V36, P712, DOI 10.1111/j.1528-1157.1995.tb01051.x; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Leroy C, 2011, NEUROBIOL DIS, V43, P588, DOI 10.1016/j.nbd.2011.05.007; LIU Z, 1994, EPILEPSY RES, V19, P191, DOI 10.1016/0920-1211(94)90062-0; Loscher W, 2011, SEIZURE-EUR J EPILEP, V20, P359, DOI 10.1016/j.seizure.2011.01.003; Mader I, 2008, EUR J RADIOL, V67, P250, DOI 10.1016/j.ejrad.2008.02.033; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Marques-Carneiro JE, 2016, NEUROSCIENCE, V316, P389, DOI 10.1016/j.neuroscience.2015.12.048; Mazarati A, 2011, EXP NEUROL, V232, P143, DOI 10.1016/j.expneurol.2011.08.012; Mizuno S, 2000, ACTA NEUROL SCAND, V102, P175, DOI 10.1034/j.1600-0404.2000.102003175.x; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Morquette P, 2015, NAT NEUROSCI, V18, P844, DOI 10.1038/nn.4013; Morris GP, 2013, NEUROBIOL LEARN MEM, V105, P40, DOI 10.1016/j.nlm.2013.07.002; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Oakley JC, 2011, EPILEPSIA, V52, P59, DOI 10.1111/j.1528-1167.2011.03004.x; Oostrom KJ, 2003, PEDIATRICS, V112, P1338, DOI 10.1542/peds.112.6.1338; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Ota Y, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/185463; Pascente R, 2016, NEUROBIOL DIS, V93, P146, DOI 10.1016/j.nbd.2016.05.001; Pauletti A, 2017, BRAIN IN PRESS; Pennacchio LA, 1998, NAT GENET, V20, P251; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pitkanen A, 2016, LANCET NEUROL, V15, P185, DOI 10.1016/S1474-4422(15)00248-3; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2011, BIOMARK MED, V5, P629, DOI [10.2217/bmm.11.67, 10.2217/BMM.11.67]; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Ravizza T, 2006, NEUROBIOL DIS, V24, P128, DOI 10.1016/j.nbd.2006.06.003; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Roch C, 2002, EPILEPSIA, V43, P325, DOI 10.1046/j.1528-1157.2002.11301.x; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sankar R, 2000, ANN NEUROL, V48, P580, DOI 10.1002/1531-8249(200010)48:4<580::AID-ANA4>3.3.CO;2-2; Sayin U, 2004, EPILEPSIA, V45, P1539, DOI 10.1111/j.0013-9580.2004.54903.x; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shapiro LA, 2008, EPILEPSIA, V49, P33, DOI 10.1111/j.1528-1167.2008.01491.x; Snitker S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066277; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Todd KJ, 2006, J PHYSIOLOGY-PARIS, V99, P75, DOI 10.1016/j.jphysparis.2005.12.002; Turkdogan-Sozuer D, 2000, EUR RADIOL, V10, P962, DOI 10.1007/s003300051045; van Vliet EA, 2017, EPILEPSIA, V58, P315, DOI 10.1111/epi.13621; Wagner S, 2006, CURR MED CHEM, V13, P2819, DOI 10.2174/092986706778522002; Walker LE, 2017, J CLIN INV IN PRESS; Wang N, 2015, NEUROSCIENCE, V287, P144, DOI 10.1016/j.neuroscience.2014.12.021; Weissberg I, 2015, NEUROBIOL DIS, V78, P115, DOI 10.1016/j.nbd.2015.02.029; Witt JA, 2015, SEIZURE-EUR J EPILEP, V26, P65, DOI 10.1016/j.seizure.2015.01.018; Worrell GA, 2004, BRAIN, V127, P1496, DOI 10.1093/brain/awh149; Wu YJ, 2015, J CEREBR BLOOD F MET, V35, P1862, DOI 10.1038/jcbfm.2015.145; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Zucker S, 2004, ADV CLIN CHEM, V38, P37, DOI 10.1016/S0065-2423(04)38002-9; Zurolo E, 2011, BRAIN, V134, P1015, DOI 10.1093/brain/awr032	105	13	15	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUL	2017	42	7			SI		2089	2098		10.1007/s11064-017-2271-3			10	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	FA3GA	WOS:000405329600026	28434163				2021-06-18	
J	Tan, HJ; Yang, WJ; Wu, CG; Liu, BL; Lu, H; Wang, H; Yan, H				Tan, Huajun; Yang, Weijian; Wu, Chenggang; Liu, Baolong; Lu, Hao; Wang, Hong; Yan, Hua			Assessment of the role of intracranial hypertension and stress on hippocampal cell apoptosis and hypothalamic-pituitary dysfunction after TBI	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; EXPERIMENTAL EPIDURAL HEMATOMA; SUBARACHNOID HEMORRHAGE; MASS LESION; HYPOPITUITARISM; RATS; RODENTS; AXIS	In recent years, hypopituitarism caused by traumatic brain injury (TBI) has been explored in many clinical studies; however, few studies have focused on intracranial hypertension and stress caused by TBI. In this study, an intracranial hypertension model, with epidural hematoma as the cause, was used to explore the physiopathological and neuroendocrine changes in the hypothalamic-pituitary axis and hippocampus. The results demonstrated that intracranial hypertension increased the apoptosis rate, caspase-3 levels and proliferating cell nuclear antigen (PCNA) in the hippocampus, hypothalamus, pituitary gland and showed a consistent rate of apoptosis within each group. The apoptosis rates of hippocampus, hypothalamus and pituitary gland were further increased when intracranial pressure (ICP) at 24 hour (h) were still increased. The change rates of apoptosis in hypothalamus and pituitary gland were significantly higher than hippocampus. Moreover, the stress caused by surgery may be a crucial factor in apoptosis. To confirm stress leads to apoptosis in the hypothalamus and pituitary gland, we used rabbits to establish a standard stress model. The results confirmed that stress leads to apoptosis of neuroendocrine cells in the hypothalamus and pituitary gland, moreover, the higher the stress intensity, the higher the apoptosis rate in the hypothalamus and pituitary gland.	[Tan, Huajun; Yang, Weijian; Lu, Hao] Tianjin Med Univ, Grad Sch, Tianjin 300070, Peoples R China; [Tan, Huajun; Yang, Weijian; Wang, Hong; Yan, Hua] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300350, Peoples R China; [Wu, Chenggang] Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurosurg, Tianjin 300151, Peoples R China; [Liu, Baolong] Tianjin Huanhu Hosp, Dept Ultrasonog, Tianjin 300350, Peoples R China; [Yan, Hua] Tianjin Key Lab Cerebral Vasc & Neurodegenerat Di, Tianjin 300350, Peoples R China	Yan, H (corresponding author), Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300350, Peoples R China.; Yan, H (corresponding author), Tianjin Key Lab Cerebral Vasc & Neurodegenerat Di, Tianjin 300350, Peoples R China.	yanhua20042007@sina.com			Tianjin Municipal Commission of Health and Family Planning [15KG106, 14KG115, 2015KY15, 12KG115]	This study was financially supported by the grants (No. 15KG106, No. 14KG115, No. 2015KY15, No. 12KG115) awarded by Tianjin Municipal Commission of Health and Family Planning.	Balikci M, 2008, NEUROL RES, V30, P450, DOI 10.1179/016164107X251637; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Burger R, 2003, J NEUROTRAUM, V20, P543, DOI 10.1089/089771503767168474; Burger R, 2002, J NEUROSURG, V97, P1410, DOI 10.3171/jns.2002.97.6.1410; Ciccocioppo R, 2014, J NEUROSCI, V34, P363, DOI 10.1523/JNEUROSCI.2400-13.2014; Conti AC, 1998, J NEUROSCI, V18, P5663; Dusick JR, 2012, PITUITARY, V15, P2, DOI 10.1007/s11102-008-0130-6; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Gardner CJ, 2015, EUR J ENDOCRINOL, V172, P371, DOI 10.1530/EJE-14-0654; Giannoudis PV, 2006, INJURY, V37, pS3, DOI 10.1016/S0020-1383(07)70005-0; Goncharova Nadezhda D, 2013, Front Endocrinol (Lausanne), V4, P26, DOI 10.3389/fendo.2013.00026; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Karamouzis I, 2016, ENDOCRINE, V52, P441, DOI 10.1007/s12020-015-0796-2; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Lavrnja I, 2014, PHYSIOL BEHAV, V125, P30, DOI 10.1016/j.physbeh.2013.11.005; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Masel BE, 2015, J NEUROTRAUM, V32, P1902, DOI 10.1089/neu.2014.3526; Olivecrona Z, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-33; Pan AH, 2013, J NEUROSCI RES, V91, P249, DOI 10.1002/jnr.23148; Patchev Vladimir K, 2006, Dialogues Clin Neurosci, V8, P417; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Prasanna KL, 2015, BRAIN INJURY, V29, P336, DOI 10.3109/02699052.2014.955882; Richmond E, 2014, ENDOCRINE, V45, P3, DOI 10.1007/s12020-013-0049-1; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Taylor AN, 2013, J NEUROTRAUM, V30, P1250, DOI 10.1089/neu.2012.2847; Tritos NA, 2015, ENDOCR PRACT, V21, P823, DOI 10.4158/EP14567.DSCR; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142561; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019	37	13	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 19	2017	7								3805	10.1038/s41598-017-04008-w			12	Multidisciplinary Sciences	Science & Technology - Other Topics	EY0LT	WOS:000403650300048	28630478	DOAJ Gold, Green Published			2021-06-18	
J	Badenes, R; Oddo, M; Suarez, JI; Antonelli, M; Lipman, J; Citerio, G; Taccone, FS				Badenes, Rafael; Oddo, Mauro; Suarez, Jose I.; Antonelli, Massimo; Lipman, Jeffrey; Citerio, Giuseppe; Taccone, Fabio Silvio			Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: an international survey	CRITICAL CARE			English	Article						Hemoglobin; Transfusion; Threshold; Brain injury; Outcome	BLOOD-CELL TRANSFUSION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL OXYGEN DELIVERY; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE; CLINICAL-TRIAL; SEVERE SEPSIS; ANEMIA; STRATEGIES; MANAGEMENT	Background: The optimal hemoglobin (Hb) threshold at which to initiate red blood cell (RBC) transfusion in patients with acute brain injury is unknown. The aim of this survey was to investigate RBC transfusion practices used with these patients. Methods: We conducted a web-based survey within various societies of critical care medicine for intensive care unit (ICU) physicians who currently manage patients with primary acute brain injury. Results: A total of 868 responses were obtained from around the world, half of which (n = 485) were from European centers; 204 (24%) respondents had a specific certificate in neurocritical care, and most were specialists in anesthesiology or intensive care and had less than 15 years of practice experience. Four hundred sixty-six respondents (54%) said they used an Hb threshold of 7-8 g/dl to initiate RBC transfusion after acute brain injury, although half of these respondents used a different threshold (closer to 9 g/dl) in patients with traumatic brain injury, subarachnoid hemorrhage, or ischemic stroke. Systemic and cerebral factors were reported as influencing the need for higher Hb thresholds. Most respondents agreed that a randomized clinical trial was needed to compare two different Hb thresholds for RBC transfusion, particularly in patients with traumatic brain injury, subarachnoid hemorrhage, and ischemic stroke. Conclusions: The Hb threshold used for RBC transfusion after acute brain injury was less than 8 g/dl in half of the ICU clinicians who responded to our survey. However, more than 50% of these physicians used higher Hb thresholds in certain conditions.	[Badenes, Rafael] Hosp Clin Univ, Dept Anesthesiol & Surg Intens Care, Valencia, Spain; [Oddo, Mauro] Lausanne Univ Hosp, CHUV, Dept Intens Care Med, CH-1011 Lausanne, Switzerland; [Suarez, Jose I.] Baylor Coll Med, Dept Neurol, CHI Baylor St Lukes Baylor St Lukes Med Ctr, Div Vasc Neurol & Neurocrit Care, Houston, TX 77030 USA; [Antonelli, Massimo] Catholic Univ, Fdn Policlin Agostino Gemelli Univ Hosp, Dept Anesthesiol & Intens Care Med, Rome, Italy; [Lipman, Jeffrey] Royal Brisbane & Womens Hosp, Intens Care Serv, Herston, Qld, Australia; [Lipman, Jeffrey] Univ Queensland, Burns Trauma Crit Care Res Ctr, Herston, Qld, Australia; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Neurointens Care, Monza, Italy; [Taccone, Fabio Silvio] Free Univ Brussels ULB, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium	Taccone, FS (corresponding author), Free Univ Brussels ULB, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	ftaccone@ulb.ac.be	Badenes, Rafael/K-6628-2019; Citerio, Giuseppe/B-1839-2015; Lipman, Jeffrey/G-2211-2010	Badenes, Rafael/0000-0001-7017-0150; Citerio, Giuseppe/0000-0002-5374-3161; Lipman, Jeffrey/0000-0002-5965-9876			Amer Soc Anesthesiologists, 2015, ANESTHESIOLOGY, V122, P241, DOI 10.1097/ALN.0000000000000463; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Frank SM, 2012, ANESTHESIOLOGY, V117, P99, DOI 10.1097/ALN.0b013e318255e550; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hare GMT, 2013, BEST PRACT RES-CLIN, V27, P85, DOI 10.1016/j.bpa.2012.12.002; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Hofmann A, 2012, CURR OPIN ANESTHESIO, V25, P66, DOI 10.1097/ACO.0b013e32834eb726; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2011, CRIT CARE, V15, DOI 10.1186/cc9977; Kramer AH, 2009, NEUROCRIT CARE, V10, P157, DOI 10.1007/s12028-008-9171-y; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Meier J, 2016, BRIT J ANAESTH, V116, P255, DOI 10.1093/bja/aev456; Napolitano LM, 2010, CRIT CARE MED, V38, P1621, DOI 10.1097/CCM.0b013e3181e922ba; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Pendem S, 2006, NEUROCRIT CARE, V4, P63, DOI 10.1385/NCC:4:1:063; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sadaka F, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-46; Safaeian N, 2013, J CEREBR BLOOD F MET, V33, P1633, DOI 10.1038/jcbfm.2013.119; Sakr Y, 2007, CRIT CARE MED, V35, P1639, DOI 10.1097/01.CCM.0000269936.73788.32; Schneider WH, 2013, TRANSFUS MED REV, V27, P21, DOI 10.1016/j.tmrv.2012.08.001; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Theusinger OM, 2012, CURR OPIN ANESTHESIO, V25, P59, DOI 10.1097/ACO.0b013e32834dec98; Walsh TS, 2006, INTENS CARE MED, V32, P100, DOI 10.1007/s00134-005-2855-2; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Weiskopf RB, 2005, CLIN NEUROPHYSIOL, V116, P1028, DOI 10.1016/j.clinph.2004.12.009; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	37	13	14	1	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JUN 17	2017	21								159	10.1186/s13054-017-1748-4			10	Critical Care Medicine	General & Internal Medicine	FH0KN	WOS:000410829100001	28623949	DOAJ Gold, Green Published			2021-06-18	
J	Righy, C; do Brasil, PEA; Valles, J; Bozza, FA; Martin-Loeches, I				Righy, Cassia; Americano do Brasil, Pedro Emmanuel; Valles, Jordi; Bozza, Fernando A.; Martin-Loeches, Ignacio			Systemic antibiotics for preventing ventilator-associated pneumonia in comatose patients: a systematic review and meta-analysis	ANNALS OF INTENSIVE CARE			English	Article						Systematic review; Meta-analysis; Ventilator-associated pneumonia; Coma	TRAUMATIC BRAIN-INJURY; EARLY-ONSET PNEUMONIA; INTENSIVE-CARE-UNIT; HOSPITAL-ACQUIRED PNEUMONIA; RISK-FACTORS; PROPHYLAXIS; INFECTIONS; MORTALITY; PATHOGENS; IMPACT	Background: Early-onset ventilator-associated pneumonia (EO-VAP) is the leading cause of morbidity and mortality in comatose patients. However, VAP prevention bundles focus mainly on late-onset VAP and may be less effective in preventing EO-VAP in comatose patients. Systemic antibiotic administration at the time of intubation may have a role in preventing EO-VAP. Therefore, we evaluated the effectiveness of systemic antibiotic administration in VAP prevention in comatose patients through a systematic review and meta-analysis. Methods: We searched for studies published through December 2015 that evaluated systemic antibiotic prophylaxis in comatose patients. Two authors independently selected and evaluated full-length reports of randomized clinical trials or prospective cohorts in patients aged > 16 years that evaluated the impact of systemic antibiotics at the time of intubation on EO-VAP compared to placebo or no prophylaxis. The outcome variables were the incidence of EOVAP, the duration of mechanical ventilation, ICU length of stay, and ICU mortality. Results: We identified 10,988 citations, yielding 26 articles for further analysis; three studies with 267 patients were finally analyzed. Most patients (n = 135) were comatose due to head trauma. Systemic antibiotic administration was associated with decreased incidence of EO-VAP (RR 0.32; 95% CI 0.19-0.54) and shorter ICU LOS (standardized mean difference -0.32; 95% CI -0.56 to -0.08), but had no effect on mortality (RR 1.03; 95% CI 0.7-1.53) or duration of mechanical ventilation (standardized mean difference -0.16; 95% CI -0.41 to 0.08). Conclusions: Antibiotic prophylaxis in comatose patients reduced the incidence of EO-VAP and decreased the ICU stay slightly. Future trials are needed to confirm these results.	[Righy, Cassia; Americano do Brasil, Pedro Emmanuel; Bozza, Fernando A.] Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil; [Righy, Cassia] Paulo Niemeyer Brain Inst, ICU, Rio De Janeiro, Brazil; [Valles, Jordi; Martin-Loeches, Ignacio] CIBERES, Barcelona, Spain; [Valles, Jordi] Hosp Sabadell, Crit Care Ctr, CIBER Enfermedades Resp, Sabadell, Spain; [Bozza, Fernando A.] DOr Inst Res & Educ, IDOR, Rio De Janeiro, Brazil; [Martin-Loeches, Ignacio] St Jamess Univ Hosp Dublin, Dept Clin Med, Trinity Ctr Hlth Sci, MICRO,Wellcome Trust,HRB Clin Res, Dublin, Ireland; [Martin-Loeches, Ignacio] ICVB, Dublin, Ireland	Righy, C (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil.	cassiarighy@gmail.com	Shinotsuka, Cassia Righy/H-9181-2013; Brasil, Pedro E A A/B-4357-2008; Bozza, Fernando A/A-2618-2013; martin-loeches, Prof. Ignacio/Q-6645-2018	Shinotsuka, Cassia Righy/0000-0002-9206-9552; Brasil, Pedro E A A/0000-0002-6700-2268; Bozza, Fernando A/0000-0003-4878-0256; martin-loeches, Prof. Ignacio/0000-0002-5834-4063	Clinical Research Collaboration (CRC) by European Respiratory Society	Clinical Research Collaboration (CRC) by European Respiratory Society.	Acquarolo A, 2005, INTENS CARE MED, V31, P510, DOI 10.1007/s00134-005-2585-5; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Berrouane Y, 1998, J HOSP INFECT, V40, P275, DOI 10.1016/S0195-6701(98)90303-6; Boehme AK, 2013, J STROKE CEREBROVASC, V22, pE582, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.020; Bornstain C, 2004, CLIN INFECT DIS, V38, P1401, DOI 10.1086/386321; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Depuydt PO, 2008, CRIT CARE, V12, DOI 10.1186/cc7119; Finlayson O, 2011, NEUROLOGY, V77, P1338, DOI 10.1212/WNL.0b013e31823152b1; Giard M, 2008, J CRIT CARE, V23, P27, DOI 10.1016/j.jcrc.2007.08.005; Gould CV, 2006, INFECT CONT HOSP EP, V27, P920, DOI 10.1086/507280; Harbarth S, 2000, CIRCULATION, V101, P2916, DOI 10.1161/01.CIR.101.25.2916; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Imran H, 2008, EUR J CLIN MICROBIOL, V27, P53, DOI 10.1007/s10096-007-0397-y; Jovanovic B, 2016, MED PRIN PRACT, V25, P435, DOI 10.1159/000447566; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Liu Y, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009413.pub2; Maier IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116836; Martin-Loeches I, 2015, LANCET RESP MED, V3, P859, DOI 10.1016/S2213-2600(15)00326-4; Mascia L, 2009, NEUROCRIT CARE, V11, P417, DOI 10.1007/s12028-009-9242-8; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.ijsu.2010.02.007]; Nseir S, 2014, CRIT CARE, V18, DOI 10.1186/cc13940; Pileggi C, 2011, CRIT CARE, V15, DOI 10.1186/cc10285; de Antonio LAR, 2011, NEUROLOGIA, V26, P150, DOI 10.1016/j.nrl.2010.07.030; Ruhnke AM, ONLINE SUPPLEMENTARY; Scheitz JF, 2015, INT J STROKE, V10, P61, DOI 10.1111/j.1747-4949.2012.00864.x; Schuts EC, 2016, LANCET INFECT DIS, V16, P847, DOI 10.1016/S1473-3099(16)00065-7; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Shah SV, 2015, J STROKE CEREBROVASC, V24, P1969, DOI 10.1016/j.jstrokecerebrovasdis.2015.04.037; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Sykora M, 2015, STROKE, V46, P1269, DOI 10.1161/STROKEAHA.114.008260; Valles J, 2007, INTENS CARE MED, V33, P1363, DOI 10.1007/s00134-007-0721-0; Valles J, 2013, CHEST, V143, P1219, DOI 10.1378/chest.12-1361; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Winklewski PJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0213-4; Zilahi G, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0199-4	40	13	15	0	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	2110-5820			ANN INTENSIVE CARE	Ann. Intensive Care	JUN 15	2017	7								67	10.1186/s13613-017-0291-4			8	Critical Care Medicine	General & Internal Medicine	EZ5QV	WOS:000404773400001	28620893	DOAJ Gold, Green Published			2021-06-18	
J	Streijger, F; Skinnider, MA; Rogalski, JC; Balshaw, R; Shannon, CP; Prudova, A; Belanger, L; Ritchie, L; Tsang, A; Christie, S; Parent, S; Mac-Thiong, JM; Bailey, C; Urquhart, J; Ailon, T; Paquette, S; Boyd, M; Street, J; Fisher, CG; Dvorak, MF; Borchers, CH; Foster, LJ; Kwon, BK				Streijger, Femke; Skinnider, Michael A.; Rogalski, Jason C.; Balshaw, Robert; Shannon, Casey P.; Prudova, Anna; Belanger, Lise; Ritchie, Leanna; Tsang, Angela; Christie, Sean; Parent, Stefan; Mac-Thiong, Jean-Marc; Bailey, Christopher; Urquhart, Jennifer; Ailon, Tamir; Paquette, Scott; Boyd, Michael; Street, John; Fisher, Charles G.; Dvorak, Marcel F.; Borchers, Christoph H.; Foster, Leonard J.; Kwon, Brian K.			A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; CSF; injury severity; proteomics; SCI	TRAUMATIC BRAIN-INJURY; COAGULATION-FACTOR-XII; ISCHEMIA-REPERFUSION INJURY; KALLIKREIN-KININ SYSTEM; CLINICAL-TRIALS; NEUROLOGICAL CLASSIFICATION; INTERNATIONAL STANDARDS; STRUCTURAL BIOMARKERS; THERAPEUTIC TARGET; CONTUSION INJURY	Efforts to validate novel therapies in acute clinical trials for spinal cord injury (SCI) are impeded by the lack of objective quantitative measures that reflect injury severity and accurately predict neurological recovery. Therefore, a strong rationale exists for establishing neurochemical biomarkers that objectively quantify injury severity and predict outcome. Here, we conducted a targeted proteomics analysis of cerebrospinal fluid (CSF) samples derived from 29 acute SCI patients (American Spinal Injury Association Impairment Scale [AIS] A, B, or C) acquired at 24, 48, and 72h post-injury. From a total of 165 proteins, we identified 27 potential biomarkers of injury severity (baseline AIS A, B, or C), with triosephosphate isomerase having the strongest relationship to AIS grade. The majority of affected proteins (24 of 27) were more abundant in samples from AIS A patients than in those from AIS C patients, suggesting that for the most part, these proteins are released into the CSF more readily with more severe trauma to the spinal cord. We then analyzed the relationship between CSF protein abundance and neurological recovery. For AIS grade improvement over 6 months, we identified 34 proteins that were associated with AIS grade conversion (p<0.05); however, these associations were not statistically significant after adjusting for multiple comparisons. For total motor score (TMS) recovery over 6 months, after adjusting for baseline neurological injury level, we identified 46 proteins with a statistically significant association with TMS recovery. Twenty-two of these proteins were among the 27 proteins that were related to baseline AIS grade, consistent with the notion that protein markers that reflect a more severe injury also appropriately predict a poorer recovery of motor function. In summary, this study provides a description of the CSF proteome changes that occur after acute human SCI, and reveals a number of protein candidates for further validation as potential biomarkers of injury severity.	[Streijger, Femke; Kwon, Brian K.] Univ British Columbia, Int Collaborat Repair Discoveries ICORD, Blusson Spinal Cord Ctr, Vancouver, BC, Canada; [Skinnider, Michael A.; Rogalski, Jason C.; Prudova, Anna; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Skinnider, Michael A.; Rogalski, Jason C.; Prudova, Anna; Foster, Leonard J.] Univ British Columbia, Michael Smith Labs, Vancouver, BC, Canada; [Skinnider, Michael A.] Univ British Columbia, Genome Sci & Technol Grad Program, Vancouver, BC, Canada; [Ailon, Tamir; Paquette, Scott; Boyd, Michael] Univ British Columbia, Vancouver Spine Surg Inst, Div Neurosurg, Vancouver, BC, Canada; [Ailon, Tamir; Paquette, Scott; Boyd, Michael] Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada; [Balshaw, Robert] BC Ctr Dis Control, Vancouver, BC, Canada; [Balshaw, Robert; Shannon, Casey P.] PROOF Ctr Excellence, Vancouver, BC, Canada; [Belanger, Lise; Ritchie, Leanna; Tsang, Angela] Vancouver Spine Program, Vancouver, BC, Canada; [Christie, Sean] Dalhousie Univ, Halifax Infirm Halifax, Div Neurosurg, Halifax, NS, Canada; [Parent, Stefan; Mac-Thiong, Jean-Marc] Univ Montreal, Hop Sacre Coeur Montreal, Dept Surg, Montreal, PQ, Canada; [Parent, Stefan; Mac-Thiong, Jean-Marc] Univ Montreal, Dept Surg, Chu St Justine, Montreal, PQ, Canada; [Bailey, Christopher; Urquhart, Jennifer] Univ Western Ontario, London Hlth Sci Ctr, Div Orthopaed Surg, London, ON, Canada; [Borchers, Christoph H.] UVic Genome BC Prote Ctr, Victoria, BC, Canada	Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Int Collaborat Repair Discoveries ICORD, Blusson Spinal Cord Ctr, 6th Floor,VGH 818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	brian.kwon@ubc.ca	Bailey, Chris S/L-7522-2015; Urquhart, Jennifer/Q-7604-2016; BORCHERS, Christoph/U-5964-2019; Parent, Stefan/AAO-7492-2020	Bailey, Chris S/0000-0001-5508-8415; Urquhart, Jennifer/0000-0002-9393-814X; Parent, Stefan/0000-0002-4854-2816; Dvorak, Marcel/0000-0002-9404-8448; Skinnider, Michael/0000-0002-2168-1621; Christie, Sean/0000-0002-3540-6022; Shannon, Casey/0000-0002-5687-3156	Rick Hansen Institute; Paralyzed Veterans of America; Craig Neilsen Foundation; Brain Canada; VGH & UBC Hospital Foundation	The authors gratefully acknowledge the assistance of Allan Aludino and Leilani Reichl of the Vancouver Spine Research Program for support of the clinical trial, Daniel Rogers of the Rick Hansen Institute for managing the Canadian Multicentre CSF Monitoring and Biomarker (CAMPER) study, and Sara Assadian for managing the Brain Canada Multi-Investigator Research Initiative (MIRI). The clinical trial and proteomics analysis were generously supported by the Rick Hansen Institute, Paralyzed Veterans of America, Craig Neilsen Foundation, Brain Canada, and the VGH & UBC Hospital Foundation. The mass spectrometry infrastructure used here was supported by the Canada Foundation for Innovation, the BC Knowledge Development Fund and the BC Proteomics Network. M.F.D. is the Paetzold Chair in Spinal Cord Injury, and B.K.K. is the Canada Research Chair in Spinal Cord Injury and the VGH & UBC Hospital Foundation Dvorak Chair of Spinal Trauma.	Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Albert-Weissenberger C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00345; Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Bergamaschini L, 1998, ALZ DIS ASSOC DIS, V12, P102, DOI 10.1097/00002030-199810000-00005; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Boulos S, 2007, J NEUROSCI RES, V85, P3089, DOI 10.1002/jnr.21429; Burkhard PR, 2001, NEUROLOGY, V56, P1528, DOI 10.1212/WNL.56.11.1528; Burns AS, 2003, J NEUROTRAUM, V20, P477, DOI 10.1089/089771503765355540; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Chan QWT, 2006, MOL CELL PROTEOMICS, V5, P2252, DOI 10.1074/mcp.M600197-MCP200; Chen AS, 2013, NEUROCHEM RES, V38, P2247, DOI 10.1007/s11064-013-1132-y; Chen AS, 2010, J NEUROTRAUM, V27, P263, DOI 10.1089/neu.2009.1051; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; De Simoni MG, 2004, AM J PATHOL, V164, P1857, DOI 10.1016/S0002-9440(10)63744-3; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Fehlings MG, 2010, SPINE, V35, pS166, DOI 10.1097/BRS.0b013e3181f386f6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gao Q, 2012, NEURAL REGEN RES, V7, P1534, DOI 10.3969/j.issn.1673-5374.2012.20.002; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gobel K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11626; Gomes-Osman J, 2016, J NEUROTRAUM, V33, P425, DOI 10.1089/neu.2014.3812; Hawryluk GWJ, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E14; Heydenreich N, 2012, STROKE, V43, P2457, DOI 10.1161/STROKEAHA.112.660340; Hopp S, 2016, ANN NEUROL, V79, P970, DOI 10.1002/ana.24655; Hopp S, 2015, NEURAL REGEN RES, V10, P885, DOI 10.4103/1673-5374.158339; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Krueger H, 2013, CHRON DIS INJ CAN, V33, P113; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kwon BK, 2017, J NEUROTRAUM, V34, P567, DOI 10.1089/neu.2016.4435; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lammertse DP, 2013, SPINAL CORD, V51, P2, DOI 10.1038/sc.2012.137; Lee RS, 2012, J CLIN NEUROSCI, V19, P1338, DOI 10.1016/j.jocn.2012.02.015; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Longhi L, 2008, ACTA NEUROCHIR SUPPL, V102, P381, DOI 10.1007/978-3-211-85578-2_73; Longhi L, 2009, CRIT CARE MED, V37, P659, DOI 10.1097/CCM.0b013e318195998a; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Marincola FM, 2011, J INTERN MED, V270, P123, DOI 10.1111/j.1365-2796.2011.02402.x; Marklund N, 2006, NEUROCHEM RES, V31, P1085, DOI 10.1007/s11064-006-9120-0; Moghieb A, 2016, MOL CELL PROTEOMICS, V15, P2379, DOI 10.1074/mcp.M116.058115; Mohammed Y, 2014, J PROTEOMICS, V106, P151, DOI 10.1016/j.jprot.2014.04.018; Mostacada K, 2015, EXP NEUROL, V271, P390, DOI 10.1016/j.expneurol.2015.07.006; Namikawa K, 1998, MOL BRAIN RES, V55, P315, DOI 10.1016/S0169-328X(98)00012-6; Ng MTL, 2011, TRANSL STROKE RES, V2, P474, DOI 10.1007/s12975-011-0109-x; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Percy AJ, 2014, J PROTEOME RES, V13, P3733, DOI 10.1021/pr500317d; Pouw MH, 2014, SPINAL CORD, V52, P428, DOI 10.1038/sc.2014.26; Priebe MM, 2007, ARCH PHYS MED REHAB, V88, pS84, DOI 10.1016/j.apmr.2006.12.005; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sengupta MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110885; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Takahashi H, 1999, CLIN DIAGN LAB IMMUN, V6, P983, DOI 10.1128/CDLI.6.6.983-985.1999; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tei R, 2008, NEUROL RES, V30, P761, DOI 10.1179/174313208X284241; Van Dijk W., 2013, LANDES BIOSCIENCE, P633; Walden K, 2016, SPINAL CORD, V54, P197, DOI 10.1038/sc.2015.137; Wang CY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-13; Xie J, 2003, BLOOD, V101, P4005, DOI 10.1182/blood-2002-11-3368; Yan XD, 2010, NEUROCHEM INT, V56, P971, DOI 10.1016/j.neuint.2010.04.007; Yan XD, 2009, J NEUROTRAUM, V26, P179, DOI 10.1089/NEU.2008.0533; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zetterberg H., 2016, REV CELL BIOL MOL ME, V2, P62	74	13	14	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 15	2017	34	12					2054	2068		10.1089/neu.2016.4879			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EX0AN	WOS:000402880600006	28276985				2021-06-18	
J	Vascak, M; Sun, JL; Baer, M; Jacobs, KM; Povlishock, JT				Vascak, Michal; Sun, Jianli; Baer, Matthew; Jacobs, Kimberle M.; Povlishock, John T.			Mild Traumatic Brain Injury Evokes Pyramidal Neuron Axon Initial Segment Plasticity and Diffuse Presynaptic Inhibitory Terminal Loss	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						mild traumatic brain injury; axon initial segment; GABAergic synapse; plasticity; action potential initiation; layer 5 pyramidal neurons; transgenic mouse models; excitation-inhibition balance	ACTION-POTENTIAL INITIATION; ACTIVITY-DEPENDENT RELOCATION; LAYER-V; FUNCTIONAL CONNECTIVITY; PARVALBUMIN INTERNEURONS; PERISOMATIC INHIBITION; SYNAPTIC PROPERTIES; CHANDELIER CELLS; SODIUM-CHANNELS; CEREBRAL-CORTEX	The axon initial segment (AIS) is the site of action potential (AP) initiation, thus a crucial regulator of neuronal activity. In excitatory pyramidal neurons, the high density of voltage-gated sodium channels (NaV1.6) at the distal AIS regulates AP initiation. A surrogate AIS marker, ankyrin-G (ankG) is a structural protein regulating neuronal functional via clustering voltage-gated ion channels. In neuronal circuits, changes in presynaptic input can alter postsynaptic output via AIS structural-functional plasticity. Recently, we showed experimental mild traumatic brain injury (mTBI) evokes neocortical circuit disruption via diffuse axonal injury (DAI) of excitatory and inhibitory neuronal systems. A key finding was that mTBI-induced neocortical electrophysiological changes involved non-DAI/intact excitatory pyramidal neurons consistent with AIS-specific alterations. In the current study we employed Thy1-yellow fluorescent protein (YFP)-H mice to test if mTBI induces AIS structural and/or functional plasticity within intact pyramidal neurons 2 days after mTBI. We used confocal microscopy to assess intact YFP+ pyramidal neurons in layer 5 of primary somatosensory barrel field (S1BF), whose axons were continuous from the soma of origin to the subcortical white matter (SCWM). YFP+ axonal traces were superimposed on ankG and NaV1.6 immunofluorescent profiles to determine AIS position and length. We found that while mTBI had no effect on ankG start position, the length significantly decreased from the distal end, consistent with the site of AP initiation at the AIS. However, NaV1.6 structure did not change after mTBI, suggesting uncoupling from ankG. Parallel quantitative analysis of presynaptic inhibitory terminals along the postsynaptic perisomatic domain of these same intact YFP+ excitatory pyramidal neurons revealed a significant decrease in GABAergic bouton density. Also within this non-DAI population, patch-clamp recordings of intact YFP+ pyramidal neurons showed AP acceleration decreased 2 days post-mTBI, consistent with AIS functional plasticity. Simulations of realistic pyramidal neuron computational models using experimentally determined AIS lengths showed a subtle decrease is NaV1.6 density is sufficient to attenuate AP acceleration. Collectively, these findings highlight the complexity of mTBI-induced neocortical circuit disruption, involving changes in extrinsic/presynaptic inhibitory perisomatic input interfaced with intrinsic/postsynaptic intact excitatory neuron AIS output.	[Vascak, Michal; Sun, Jianli; Baer, Matthew; Jacobs, Kimberle M.; Povlishock, John T.] Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA	Povlishock, JT (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	john.povlishock@vcuhealth.org	Jacobs, Kimberle/AAW-7526-2020	Vascak, Michal/0000-0001-8916-0796	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077675]	This work was funded by National Institutes of Health (NIH) Grant NS077675.	Aarts E, 2014, NAT NEUROSCI, V17, P491, DOI 10.1038/nn.3648; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; [Anonymous], 2011, EUR J NEUROSCI, V34, P1609, DOI [10.1111/j.1460-9568.2011.07875.x, DOI 10.1111/J.1460-9568.2011.07875.X]; Anton-Fernandez A, 2015, BRAIN STRUCT FUNCT, V220, P869, DOI 10.1007/s00429-013-0689-1; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bashir S, 2012, RESTOR NEUROL NEUROS, V30, P277, DOI 10.3233/RNN-2012-110207; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bender KJ, 2012, ANNU REV NEUROSCI, V35, P249, DOI 10.1146/annurev-neuro-062111-150339; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cesarovic N, 2010, LAB ANIM-UK, V44, P329, DOI 10.1258/la.2010.009085; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Clark KC, 2016, GLIA, V64, P1190, DOI 10.1002/glia.22991; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Evans MD, 2015, CELL REP, V13, P1233, DOI 10.1016/j.celrep.2015.09.066; Evans MD, 2013, J NEUROSCI, V33, P6950, DOI 10.1523/JNEUROSCI.0277-13.2013; Ewald Andrew J, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5563; Fairen A., 1984, CEREB CORTEX, P201; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fish KN, 2011, CEREB CORTEX, V21, P2450, DOI 10.1093/cercor/bhr007; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Gasser A, 2012, J NEUROSCI, V32, P7232, DOI 10.1523/JNEUROSCI.5434-11.2012; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Grimm KA., 2015, VET ANESTHESIA ANALG, V5th ed; Grubb MS, 2011, J NEUROSCI, V31, P16049, DOI 10.1523/JNEUROSCI.4064-11.2011; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Gutzmann A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00011; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Hamada MS, 2016, P NATL ACAD SCI USA, V113, P14841, DOI 10.1073/pnas.1607548113; Hamada MS, 2015, J NEUROSCI, V35, P7272, DOI 10.1523/JNEUROSCI.4747-14.2015; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hattox AM, 2007, J NEUROPHYSIOL, V98, P3330, DOI 10.1152/jn.00397.2007; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hinman JD, 2013, STROKE, V44, P182, DOI 10.1161/STROKEAHA.112.668749; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Huang MX, 2017, J NEUROTRAUM, V34, P1412, DOI 10.1089/neu.2016.4581; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jacob V, 2012, NEURON, V73, P391, DOI 10.1016/j.neuron.2011.11.034; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; King AN, 2014, J COMP NEUROL, V522, P2594, DOI 10.1002/cne.23551; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Kriebel M, 2012, INT J BIOCHEM CELL B, V44, P694, DOI 10.1016/j.biocel.2012.01.012; Kuba H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9815; Kuba H, 2014, J NEUROSCI, V34, P3443, DOI 10.1523/JNEUROSCI.4357-13.2014; Kuba H, 2012, J PHYSIOL-LONDON, V590, P5571, DOI 10.1113/jphysiol.2012.237305; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lazarus MS, 2015, CEREB CORTEX, V25, P1290, DOI 10.1093/cercor/bht322; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Ling JM, 2013, NEUROLOGY, V81, P2121, DOI 10.1212/01.wnl.0000437302.36064.b1; Lorincz A, 2008, J NEUROSCI, V28, P9083, DOI 10.1523/JNEUROSCI.2494-08.2008; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Maas CJM, 2004, STAT NEERL, V58, P127, DOI 10.1046/j.0039-0402.2003.00252.x; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Manning CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038313; Mannix R, 2016, NAT REV NEUROL, V12, P486, DOI 10.1038/nrneurol.2016.99; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; MOREHEAD M, 1994, J NEUROTRAUM, V11, P657, DOI 10.1089/neu.1994.11.657; Mountcastle V., 1979, NEUROSCIENCES 4 STUD, P21; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Popovic MA, 2011, J PHYSIOL-LONDON, V589, P4167, DOI 10.1113/jphysiol.2011.209015; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.67; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Reeves TM, 2007, BRAIN RES, V1154, P225, DOI 10.1016/j.brainres.2007.04.002; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Scholl B, 2015, NEURON, V87, P424, DOI 10.1016/j.neuron.2015.06.030; Schrader Harald, 2009, BMC Med Imaging, V9, P11, DOI 10.1186/1471-2342-9-11; Schubert D, 2001, J NEUROSCI, V21, P3580, DOI 10.1523/JNEUROSCI.21-10-03580.2001; Schubert D, 2006, CEREB CORTEX, V16, P223, DOI 10.1093/cercor/bhi100; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Singleton RH, 2002, J NEUROSCI, V22, P791, DOI 10.1523/JNEUROSCI.22-03-00791.2002; SNIJDERS TAB, 1993, J EDUC STAT, V18, P237, DOI 10.3102/10769986018003237; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Sun JL, 2016, FRONT SYST NEUROSCI, V10, DOI [10.3389/fnsys.2016.00063, 10.3389/hsys.2015.00063]; Takacs VT, 2015, BRAIN STRUCT FUNCT, V220, P919, DOI 10.1007/s00429-013-0692-6; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Thome C, 2014, NEURON, V83, P1418, DOI 10.1016/j.neuron.2014.08.013; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vascak M, 2018, CEREB CORTEX, V28, P1625, DOI 10.1093/cercor/bhx058; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; WALSH JE, 1947, ANN MATH STAT, V18, P88, DOI 10.1214/aoms/1177730495; Wefelmeyer W, 2015, P NATL ACAD SCI USA, V112, P9757, DOI 10.1073/pnas.1502902112; Wolf JA, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00043; Woodruff AR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00201; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	154	13	13	0	6	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	JUN 6	2017	11								157	10.3389/fncel.2017.00157			24	Neurosciences	Neurosciences & Neurology	EX5WA	WOS:000403312200001	28634442	DOAJ Gold, Green Published			2021-06-18	
J	Christie, SA; Kornblith, LZ; Howard, BM; Conroy, AS; Kunitake, RC; Nelson, MF; Hendrickson, CM; Calfee, CS; Callcut, RA; Cohen, MJ				Christie, S. Ariane; Kornblith, Lucy Z.; Howard, Benjamin M.; Conroy, Amanda S.; Kunitake, Ryan C.; Nelson, Mary F.; Hendrickson, Carolyn M.; Calfee, Carolyn S.; Callcut, Rachael A.; Cohen, Mitchell Jay			Characterization of distinct coagulopathic phenotypes in injury: Pathway-specific drivers and implications for individualized treatment	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Phenotype; precision medicine; resuscitation; traumatic coagulopathy	ACUTE TRAUMATIC COAGULOPATHY; ORGAN FAILURE; BRAIN-INJURY; COAGULATION; MANAGEMENT; MORTALITY; EFFICACY; SAFETY; CARE	BACKGROUND: International normalized ratio (INR) and partial thromboplastin time (PTT) are used interchangeably to diagnose acute traumatic coagulopathy but reflect disparate activation pathways. In this study, we identified injury/patient characteristics and coagulation factors that drive contact pathway, tissue factor pathway (TF), and common pathway dysfunction by examining injured patients with discordant coagulopathies. We hypothesized that patients with INR/PTT discordance reflect differing phenotypes representing contact versus tissue factor pathway perturbations and that characterization will provide targets to guide individualized resuscitation. METHODS: Plasma samples were prospectively collected from 1,262 critically injured patients at a single Level I trauma center. Standard coagulation measures and an extensive panel of procoagulant and anticoagulant factors were assayed and analyzed with demographic and outcome data. RESULTS: Fourteen percent of patients were coagulopathic on admission. Among these, 48% had abnormal INR and PTT (BOTH), 43% had isolated prolonged PTT (PTT-CONTACT), and 9% had isolated elevated INR (INR-TF). PTT-CONTACT and BOTH had lower Glasgow Coma Scale score than INR-TF (p < 0.001). INR-TF had decreased factor VII activity compared with PTT-CONTACT, whereas PTT-CONTACT had decreased factor VIII activity compared with INR-TF. All coagulopathic patients had factor V deficits, but activity was lowest in BOTH, suggesting an additive downstream effect of disordered activation pathways. Patients with PTT-CONTACT received half as much packed red blood cell and fresh frozen plasma as did the other groups (p < 0.001). Despite resuscitation, mortality was higher for coagulopathic patients; mortality was highest in BOTH and higher in PTT-CONTACT than in INR-TF (71%, 60%, 41%; p = 0.04). CONCLUSIONS: Discordant phenotypes demonstrate differential factor deficiencies consistent with dysfunction of contact versus tissue factor pathways with additive effects from common pathway dysfunction. Recognition and treatment of pathway-specific factor deficiencies driving different coagulopathic phenotypes in injured patients may individualize resuscitation and improve outcomes. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Christie, S. Ariane; Kornblith, Lucy Z.; Howard, Benjamin M.; Conroy, Amanda S.; Kunitake, Ryan C.; Nelson, Mary F.; Hendrickson, Carolyn M.; Calfee, Carolyn S.; Callcut, Rachael A.] San Francisco Gen Hosp, Dept Surg, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cohen, Mitchell Jay] Denver Hlth Med Ctr, 777 Bannock St MC 0206, Denver, CO 80204 USA; [Cohen, Mitchell Jay] Univ Colorado, Denver, CO 80202 USA	Cohen, MJ (corresponding author), Denver Hlth Med Ctr, 777 Bannock St MC 0206, Denver, CO 80204 USA.	Mitchell.Cohen@dhha.org			PCORIPatient-Centered Outcomes Research Institute - PCORI [R-IMC-1306-02735]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01ES026834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL133495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER	This study was supported by PCORI R-IMC-1306-02735 (to M.J.C.), NIH #K01ES026834 (to R.A.C.).	Acharya SS, 2013, PEDIATRICS, V132, P882, DOI 10.1542/peds.2012-3662; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; Downes KA, 2001, TRANSFUSION, V41, P570, DOI 10.1046/j.1537-2995.2001.41040570.x; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Howard BM, 2015, J TRAUMA ACUTE CARE, V79, P1009, DOI 10.1097/TA.0000000000000707; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Knudson MM, 2011, J AM COLL SURGEONS, V212, P87, DOI 10.1016/j.jamcollsurg.2010.08.020; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P9; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levi M, 2005, CRIT CARE MED, V33, P883, DOI 10.1097/01.CCM.0000159087.85970.38; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; MILLER RS, 1994, J TRAUMA, V37, P442, DOI 10.1097/00005373-199409000-00019; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Schrieber M, 2007, J TRAUMA, V63, P1261; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; SUCHMAN AL, 1986, ANN INTERN MED, V104, P810, DOI 10.7326/0003-4819-104-6-810; TEASDALE G, 1974, LANCET, V2, P81	29	13	13	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2017	82	6					1055	1062		10.1097/TA.0000000000001423			8	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	EV5MV	WOS:000401811900016	28338598	Green Accepted			2021-06-18	
J	Davis, RL; Stevens, CW; Curtis, JT				Davis, Randall L.; Stevens, Craig W.; Curtis, J. Thomas			The opioid antagonist, beta-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice	PHYSIOLOGY & BEHAVIOR			English	Article						Opioid; beta-FNA; LPS; Cytokine; Chemokine; Anti-inflammatory	CHEMOKINE EXPRESSION; RECEPTOR; INFLAMMATION; MECHANISMS; CYTOKINES; MICROGLIA; ANTIDEPRESSANTS; INTERLEUKIN-6; DEPRESSION; ANXIETY	Brain pathologies such as neurodegenerative diseases, infection, traumatic brain injury, and mood disorders produce enormous personal and economic burdens. It is well established that neuroinflammation plays an important role in the etiology and/or manifestation of such disorders. Previously, we discovered that betafunaltrexamine (beta-FNA) inhibits inflammatory signaling in human astrocytes in vitro, resulting in reduced expression of proinflammatory cytokines/chemokines. The present study examines the effects of peripherally administered beta-FNA on lipopolysaccharide (LPS)-induced neuroinflammation and sickness behavior in vivo. Adult male C57BL/6J mice were administered beta-FNA and were then immediately administered bacterial lipopolysaccharide (LPS). At 24 h post-injections, sickness behavior was assessed in an open-field test. Following behavioral analysis plasma and brains were collected. Levels of interleukin-6 (IL-6), interferon-gamma inducible protein-10 (CXCL10), and monocyte chemoattractant protein-1(CCL2) were determined by enzyme-linked immunosorbant assay (ELISA). At 24 h post-LPS injection, IL-6, CCL2 and CXCL10 were increased in the plasma, whereas, only CCL2 and CXCL10 were elevated in the brain. beta-FNA significantly inhibited LPS-induced CXCL10 and CCL2 expression in brain, but minimally or not at all in the plasma. LPS-induced sickness behavior, as indicated by a reduction in distance moved, was prevented by beta-FNA. Overall, CXCL10 expression in the brain was most positively and significantly correlated with sickness behavior; whereas, anxiety-like behavior was most positively and signifitantly correlated with IL-6 and CCL2 levels in the plasma and levels of CXCL10 and CCL2 in the brain. The reduction in sickness behavior may be in part due to decreased chemokine expression in the brain; further examination of the anti-inflammatory and neuroprotective effects of beta-FNA is warranted. (C) 2017 Elsevier Inc. All rights reserved.	[Davis, Randall L.; Stevens, Craig W.; Curtis, J. Thomas] Oklahoma State Univ, Ctr Hlth Sci, Dept Pharmacol Physiol, 1111 W 17th St, Tulsa, OK 74107 USA	Davis, RL (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Dept Pharmacol Physiol, 1111 W 17th St, Tulsa, OK 74107 USA.	randall.davis@okstate.edu; cw.stevens@okstate.edu; tom.curtis@okstate.edu	Curtis, J. Thomas/J-4193-2019		Oklahoma Health Research Program [HR 14-007]	The authors thank Daniell Buck, Kelly McCracken and Eric Bates for their technical assistance. This work was supported in part by Oklahoma Health Research Program HR 14-007 (RLD)	Bai YM, 2015, BIPOLAR DISORD, V17, P269, DOI 10.1111/bdi.12259; Bailey KR, 2009, FRONT NEUROSCI, P77; Barbosa IG, 2013, EUR ARCH PSY CLIN N, V263, P159, DOI 10.1007/s00406-012-0327-6; Biesmans S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271359; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Bluthe RM, 2000, PHYSIOL BEHAV, V70, P367, DOI 10.1016/S0031-9384(00)00269-9; Burton MD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-54; Chen SL, 2012, J NEUROIMMUNE PHARM, V7, P656, DOI 10.1007/s11481-012-9382-z; Choi SS, 2003, PHARMACOL BIOCHEM BE, V75, P447, DOI 10.1016/S0091-3057(03)00144-8; Curtis JT, 2011, NEUROSCI LETT, V504, P40, DOI 10.1016/j.neulet.2011.08.053; Davis RL, 2008, J NEUROIMMUNE PHARM, V3, P150, DOI 10.1007/s11481-008-9102-x; Davis RL, 2007, J NEUROIMMUNOL, V186, P141, DOI 10.1016/j.jneuroim.2007.03.021; Davis RL, 2015, EUR J PHARMACOL, V762, P193, DOI 10.1016/j.ejphar.2015.05.040; Davis RL, 2013, NEUROCHEM INT, V62, P478, DOI 10.1016/j.neuint.2013.01.013; Davis RL, 2002, ALCOHOL CLIN EXP RES, V26, P1404, DOI 10.1097/01.ALC.0000030841.92766.80; Dodd S, 2013, PROG NEURO-PSYCHOPH, V42, P135, DOI 10.1016/j.pnpbp.2012.11.007; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Harden LM, 2006, PHYSIOL BEHAV, V89, P146, DOI 10.1016/j.physbeh.2006.05.016; Hutchinson MR, 2014, NEUROPHARMACOLOGY, V76, P218, DOI 10.1016/j.neuropharm.2013.05.039; JANG Y, 1991, EUR J PHARMACOL, V197, P135; Khansari Parto S., 2012, Inflammopharmacology, V20, P103, DOI 10.1007/s10787-012-0124-x; Kolb SA, 1999, J NEUROIMMUNOL, V93, P172, DOI 10.1016/S0165-5728(98)00223-9; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Lasselin J, 2016, BRAIN BEHAV IMMUN, V57, P30, DOI 10.1016/j.bbi.2016.01.003; Le Thuc O., 2016, EMBO REP; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Liu YX, 2002, J PHARMACOL EXP THER, V302, P1212, DOI 10.1124/jpet.102.035956; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mangus LM, 2015, J NEUROPATH EXP NEUR, V74, P38, DOI 10.1097/NEN.0000000000000148; Noto C, 2015, WORLD J BIOL PSYCHIA, V16, P422, DOI 10.3109/15622975.2015.1062552; Ohgi Y, 2013, PHARMACOL BIOCHEM BE, V103, P853, DOI 10.1016/j.pbb.2012.12.003; Ramachandra V, 2011, ALCOHOL CLIN EXP RES, V35, P929, DOI 10.1111/j.1530-0277.2010.01423.x; Salazar A, 2012, HORM BEHAV, V62, P202, DOI 10.1016/j.yhbeh.2012.03.010; Shattuck EC, 2016, BRAIN BEHAV IMMUN, V57, P255, DOI 10.1016/j.bbi.2016.05.002; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Whitton PS, 2010, CURR OPIN INVEST DR, V11, P788; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	43	13	13	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	MAY 1	2017	173						52	60		10.1016/j.physbeh.2017.01.037			9	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	EP9LW	WOS:000397696100008	28130086				2021-06-18	
J	Helbok, R; Schiefecker, AJ; Friberg, C; Beer, R; Kofler, M; Rhomberg, P; Unterberger, I; Gizewski, E; Hauerberg, J; Moller, K; Lackner, P; Broessner, G; Pfausler, B; Ortler, M; Thome, C; Schmutzhard, E; Fabricius, M				Helbok, Raimund; Schiefecker, Alois Josef; Friberg, Christian; Beer, Ronny; Kofler, Mario; Rhomberg, Paul; Unterberger, Iris; Gizewski, Elke; Hauerberg, John; Moller, Kirsten; Lackner, Peter; Broessner, Gregor; Pfausler, Bettina; Ortler, Martin; Thome, Claudius; Schmutzhard, Erich; Fabricius, Martin			Spreading depolarizations in patients with spontaneous intracerebral hemorrhage: Association with perihematomal edema progression	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Spreading depolarization; electrocorticography; intracerebral hemorrhage; perihematomal edema; secondary brain damage	ISCHEMIC NEUROLOGICAL DEFICITS; HEALTH-CARE PROFESSIONALS; EXTRACELLULAR POTASSIUM; SUBARACHNOID HEMORRHAGE; NATURAL-HISTORY; BRAIN; DEPRESSION; STROKE; MANAGEMENT; GUIDELINES	Pathophysiologic mechanisms of secondary brain injury after intracerebral hemorrhage and in particular mechanisms of perihematomal-edema progression remain incompletely understood. Recently, the role of spreading depolarizations in secondary brain injury was established in ischemic stroke, subarachnoid hemorrhage and traumatic brain injury patients. Its role in intracerebral hemorrhage patients and in particular the association with perihematomal-edema is not known. A total of 27 comatose intracerebral hemorrhage patients in whom hematoma evacuation and subdural electrocorticography was performed were studied prospectively. Hematoma evacuation and subdural strip electrode placement was performed within the first 24 h in 18 patients (67%). Electrocorticography recordings started 3 h after surgery (IQR, 3-5 h) and lasted 157 h (median) per patient and 4876 h in all 27 patients. In 18 patients (67%), a total of 650 spreading depolarizations were observed. Spreading depolarizations were more common in the initial days with a peak incidence on day 2. Median electrocorticography depression time was longer than previously reported (14.7 min, IQR, 9-22min). Postoperative perihematomal-edema progression (85% of patients) was significantly associated with occurrence of isolated and clustered spreading depolarizations. Monitoring of spreading depolarizations may help to better understand pathophysiologic mechanisms of secondary insults after intracerebral hemorrhage. Whether they may serve as target in the treatment of intracerebral hemorrhage deserves further research.	[Helbok, Raimund; Schiefecker, Alois Josef; Beer, Ronny; Kofler, Mario; Unterberger, Iris; Lackner, Peter; Broessner, Gregor; Pfausler, Bettina; Schmutzhard, Erich] Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Innsbruck, Austria; [Friberg, Christian; Fabricius, Martin] Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Rhomberg, Paul; Gizewski, Elke] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria; [Hauerberg, John] Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Moller, Kirsten] Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Ortler, Martin; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria	Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@tirol-kliniken.at	Moller, Kirsten/A-4751-2009; Helbok, Raimund/AAA-8361-2021	Moller, Kirsten/0000-0003-3058-1072; Gizewski, Elke Ruth/0000-0001-6859-8377	Austrian National Bank [OeNB-Nr.: 14082]; NovoNordisk FoundationNovo Nordisk Foundation; Toyota-Fonden	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by a grant of the Austrian National Bank (OeNB-Nr.: 14082), the NovoNordisk Foundation and the Toyota-Fonden.	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Antunes AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13916; Bereczki D, 2008, HEADACHE, V48, P1226, DOI 10.1111/j.1526-4610.2008.01183.x; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; de Crespigny AJ, 1999, STROKE, V30, P2212, DOI 10.1161/01.STR.30.10.2212; DOCZI T, 1985, ACTA NEUROCHIR, V77, P110, DOI 10.1007/BF01476215; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Elijovich L, 2008, SEMIN NEUROL, V28, P657, DOI 10.1055/s-0028-1105974; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hartings JA, 2016, J CEREBR BL IN PRESS; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Herweh C, 2010, J NEUROIMAGING, V20, P350, DOI 10.1111/j.1552-6569.2009.00408.x; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kempski O, 2000, ACT NEUR S, V76, P251; Kollmar R, 2012, INT J STROKE, V7, P168, DOI 10.1111/j.1747-4949.2011.00707.x; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Mun-Bryce S, 2001, BRAIN RES, V888, P248, DOI 10.1016/S0006-8993(00)03068-7; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107; Ohta O., 1983, VASCULAR NEUROEFFECT, P353; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Orakcioglu Berk, 2012, Acta Neurochir Suppl, V114, P369, DOI 10.1007/978-3-7091-0956-4_71; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Reinert M, 2000, Neurosurg Focus, V8, pe10; Rincon F, 2014, INT J STROKE, V9, P646, DOI 10.1111/ijs.12220; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Schiefecker AJ, 2015, NEUROCRIT CARE, V22, P293, DOI 10.1007/s12028-014-0050-4; Seule M, 2015, NEUROCRIT CARE, V23, P108, DOI 10.1007/s12028-015-0111-3; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care, 2000, J NEUROTRAUM, V17, P597; Venkatasubramanian C, 2011, STROKE, V42, P73, DOI 10.1161/STROKEAHA.110.590646; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	58	13	13	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1871	1882		10.1177/0271678X16651269			12	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200023	27207168	Bronze, Green Published			2021-06-18	
J	Maguigan, KL; Dennis, BM; Hamblin, SE; Guillamondegui, OD				Maguigan, Kelly L.; Dennis, Bradley M.; Hamblin, Susan E.; Guillamondegui, Oscar D.			Method of Hypertonic Saline Administration: Effects on Osmolality in Traumatic Brain Injury Patients	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Traumatic brain injury; Hypertonic saline; Osmolality; Intracranial pressure	RAISED INTRACRANIAL-PRESSURE; ACUTE KIDNEY INJURY; ILL PATIENTS; HYPERTENSION; CARE; MANAGEMENT; MANNITOL; INFUSION; CHLORIDE; THERAPY	Hypertonic saline (HTS) is an effective therapy for reducing intracranial pressure (ICP). The ideal method of administration is unknown. The purpose of this study was to evaluate the method of HTS infusion and time to goal osmolality. A retrospective cohort analysis was conducted in severe TBI patients with ICP monitoring in place who received 2 doses of HTS. Patients were divided into bolus versus continuous infusion HTS cohorts. The primary outcome was median time to goal osmolality. Secondary outcomes included percentage of patients reaching goal osmolality, percent time at goal osmolality, mean cerebral perfusion pressure (CPP) and ICP, ICU length of stay, and mortality. Safety outcomes included rates of hyperchloremia, hypernatremia, and acute kidney injury (AKI). 162 patients were included with similar baseline characteristics. Time to goal osmolality was similar between cohorts (bolus 9.78 h vs. continuous 11.4 h, p = 0.817). A significant difference in the percentage of patients reaching goal osmolality favoring the continuous group was found (93.9% vs 73.3%, p = 0.003). The continuous group was maintained at goal osmolality for a higher percentage of osmolality values after reaching goal (80% vs. 50%, p = 0.032). No difference was seen in CPP, ICP, length of stay and mortality. Rates of hypernatremia were similar, but significant higher rates of hyperchloremia (0.77 vs 1.58 events per HTS days, p < 0.001) and AKI (0% vs 12.9%, p = 0.025) were observed in the continuous cohort. Although no difference in time to goal osmolality was observed, continuous HTS was associated with a higher percentage of patients achieving goal osmolality. (C) 2017 Elsevier Ltd. All rights reserved.	[Maguigan, Kelly L.; Hamblin, Susan E.] Vanderbilt Univ, Med Ctr, Dept Pharmaceut Serv, 1211 Med Ctr Dr,B131 VUH, Nashville, TN 37232 USA; [Dennis, Bradley M.; Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Dept Trauma & Surg Crit Care, 1211 21st Ave South,404 Med Arts Bldg, Nashville, TN 37232 USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, 1161 21st Ave So,T4224 Med Ctr North, Nashville, TN 37232 USA	Hamblin, SE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmaceut Serv, 1211 Med Ctr Dr,B131 VUH, Nashville, TN 37232 USA.	Susan.hamblin@vanderbilt.edu					Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Bratton S, 2007, J NEUROTRAUM, V24, P14; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Fink Matthew E, 2012, Continuum (Minneap Minn), V18, P640, DOI 10.1212/01.CON.0000415432.84147.1e; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Froelich M, 2009, CRIT CARE MED, V37, P1433, DOI 10.1097/CCM.0b013e31819c1933; Harukuni Izumi, 2002, J Anesth, V16, P229, DOI 10.1007/s005400200030; Huang SJ, 2006, SURG NEUROL, V65, P539, DOI 10.1016/j.surneu.2005.11.019; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Li M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000736; Luo XY, 2014, CRIT CARE, V18, DOI 10.1186/cc13977; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Muizelaar JP, 2009, CRIT CARE MED, V37, P1521, DOI 10.1097/CCM.0b013e31819d3ea0; Ropper AH, 2012, NEW ENGL J MED, V367, P746, DOI 10.1056/NEJMct1206321; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sakowitz OW, 2007, J TRAUMA, V62, P292, DOI 10.1097/01.ta.0000203560.03937.2d; Scalfani MT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.008; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wagner I, 2011, STROKE, V42, P1540, DOI 10.1161/STROKEAHA.110.609479; WILCOX CS, 1983, J CLIN INVEST, V71, P726, DOI 10.1172/JCI110820; Young P, 2015, JAMA-J AM MED ASSOC, V314, P1701, DOI 10.1001/jama.2015.12334; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356	25	13	14	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2017	39						147	150		10.1016/j.jocn.2017.01.025			4	Clinical Neurology; Neurosciences	Neurosciences & Neurology	ET0ND	WOS:000399958200036	28215427				2021-06-18	
J	Yang, R; Guo, L; Huang, L; Wang, P; Tang, Y; Ye, JC; Chen, K; Hu, XM; Cai, ZP; Lu, CY; Wu, YF; Shen, HY				Yang, Rui; Guo, Lan; Huang, Lin; Wang, Peng; Tang, Yong; Ye, Jichao; Chen, Keng; Hu, Xuming; Cai, Zhaopeng; Lu, Ciyong; Wu, Yanfeng; Shen, Huiyong			Epidemiological Characteristics of Traumatic Spinal Cord Injury in Guangdong, China	SPINE			English	Article						China; epidemiology; retrospective study; traumatic spinal cord injuries	PRESSURE ULCERS; RISK-FACTORS; OUTCOMES; CANADA; COMPLICATIONS; AUSTRALIA; FEATURES; TIANJIN; COSTS; CARE	Study Design. A hospital-based retrospective epidemiological study. Objective. The aim of this study was to examine the demographic and epidemiological characteristics of patients with traumatic spinal cord injury (TSCI) in Guangdong to help healthrelated institutions develop measures to determine the best allocation of medical resources. Summary of Background Data. TSCI is a highly disabling and deadly injury. Currently, there is little information regarding the epidemiological characteristics for TSCI in Guangdong. Methods. We retrospectively reviewed the medical records of partial second-grade class-A hospitals (mainly capturing general city and county hospitals and some large-scale affiliated hospitals) in Guangdong province according to the International Classification of Disease Version 10 (ICD-10) and diagnostic code of TSCI. Results. The study included the medical records of 1340 patients with TSCI, and the annual number of TSCI admissions increased during the 2003 to 2011 period. The male-to-female ratio was approximately 3.5: 1. The major causes of spinal cord injuries were high falls (41.0%) and traffic accidents (37.8%). The most common injury among patients with TSCI was cervical injury (818 cases). In addition, 62.9% of the patients had spinal fractures, 24.0% had other fractures, and 13.7% had brain injuries. Furthermore, 25.1% (337/1340) of the patients experienced clinical complications. The differences in the number of patients with and without complete injury who accepted surgery and hyperbaric oxygen therapy were statistically significant (P<0.05), and the difference in total medical cost was significant ( P<0.05). Conclusion. There are specific epidemiological characteristics of TSCI patients in Guangdong, and preventive measures are suggested to focus on high-risk populations, such as adult men.	[Yang, Rui; Huang, Lin; Wang, Peng; Tang, Yong; Ye, Jichao; Chen, Keng; Hu, Xuming; Cai, Zhaopeng; Wu, Yanfeng; Shen, Huiyong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510120, Guangdong, Peoples R China; [Guo, Lan; Lu, Ciyong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China	Shen, HY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510120, Guangdong, Peoples R China.	shenh.y.@163.com			Department of Health of Guangdong Province, People's Republic of China [C20010021]	Department of Health of Guangdong Province, People's Republic of China (C20010021) funds were received in support of this work.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Behrman AL, 2012, DEV MED CHILD NEUROL, V54, P1078, DOI 10.1111/j.1469-8749.2012.04440.x; Chopra T, 2016, AM J INFECT CONTROL, V44, P315, DOI 10.1016/j.ajic.2015.10.002; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Dong Q, 2004, CHINESE J HOSP STAT, V11, P120; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Galvin J, 2013, SPINE, V38, pE878, DOI 10.1097/BRS.0b013e318294e839; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Guzelkucuk U, 2015, SPINAL CORD, V53, P441, DOI 10.1038/sc.2014.211; Jang HJ, 2011, ANN REHABIL MED-ARM, V35, P798, DOI 10.5535/arm.2011.35.6.798; Joseph C, 2016, SPINAL CORD, V54, P535, DOI 10.1038/sc.2015.189; Karacan I, 2000, SPINAL CORD, V38, P697, DOI 10.1038/sj.sc.3101064; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Li J, 2011, SPINAL CORD, V49, P777, DOI 10.1038/sc.2011.8; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; Ning GZ, 2011, SPINAL CORD, V49, P386, DOI 10.1038/sc.2010.130; Ning GZ, 2016, J SPINAL CORD MED, V39, P455, DOI 10.1080/10790268.2015.1101982; Noe BB, 2015, SPINAL CORD, V53, P436, DOI 10.1038/sc.2014.181; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; Pagliacci MC, 2007, SPINAL CORD, V45, P404, DOI 10.1038/sj.sc.3101991; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Wang HF, 2013, SPINAL CORD, V51, P20, DOI 10.1038/sc.2012.92	26	13	17	1	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY 1	2017	42	9					E555	E561		10.1097/BRS.0000000000001896			7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	EU4QL	WOS:000401015100008	27607312				2021-06-18	
J	Buckley, TA; Baugh, CM; Meehan, WP; DiFabio, MS				Buckley, Thomas A.; Baugh, Christine M.; Meehan, William P., III; DiFabio, Melissa S.			Concussion Management Plan Compliance: A Study of NCAA Power 5 Conference Schools	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; best practices; public health; head trauma; health policy	CHRONIC TRAUMATIC ENCEPHALOPATHY; FOOTBALL PLAYERS; HEAD IMPACTS; ATHLETIC TRAINERS; PRACTICE PATTERNS; COLLEGIATE; SEASON	Background: In response to concerns over concussions and repeated head impacts that occur during sports, the National Collegiate Athletic Association (NCAA) mandated that all member institutions enact a concussion management plan (CMP). Although institutional and health care provider self-reports have been investigated, compliance with NCAA protocol recommendations has not been examined. Purpose: To examine the CMPs from the 65 institutions within the NCAA Power 5 conferences for compliance with the NCAA 2015 concussion guidelines. Study Design: Descriptive epidemiology study. Methods: Each institution's publicly available CMP was obtained in 2015, reviewed, and coded for compliance with each of the required 47 components. Overall compliance rate, item-level, category-level, and institution-level compliance was assessed. Independent predictors of compliance, including each institution's athletic training staff size, academic performance, and athletic performance, were examined with quasi-binomial regression. Results: CMPs varied substantially in length and level of detail. The overall compliance rate for all components across all institutions was 94.3% (2880/3055). Twelve components achieved 100% (65/65) compliance, and the lowest levels of compliance were clustered in "return to learn." There were 22 institutions that achieved a 100% compliance rate; the lowest institutional compliance was 59.6%. There were no significant associations between the independent predictors and institutional compliance. Conclusion: Overall compliance with NCAA concussion management requirements was high, but there remains room for improvement. The lowest level of compliance was clustered in the return-to-learn section. There were limited details provided in the reducing head trauma component. Items with lower compliance (reducing head trauma, return to learn) tended to be outside the core competencies of the medical staff, indicating an area for improvement. Encouragingly, many institutions and specific components demonstrated full compliance.	[Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.; DiFabio, Melissa S.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Micheli Ctr Sport Injury Prevent, Waltham, MA USA	Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Human Performance Lab 150, 541 South Coll Ave, Newark, DE 19716 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016; Baugh, Christine/AAG-2324-2020	Buckley, Thomas A/0000-0002-0515-0150; Baugh, Christine/0000-0002-9340-6338	NCAA, NCAA/DoD CARE consortium [W81XWH-14-2-0151]; Football Players' Health Study - NFL Players' Association; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; NCAA; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: T.A.B. has received research-related funding from the NCAA as part of the NCAA/DoD CARE consortium (award number W81XWH-14-2-0151). W.P.M. receives royalties from ABC-Clio Publishing, Springer, and Wolters Kluwer, and his research is funded in part by a grant from the Football Players' Health Study, funded by the NFL Players' Association, and philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. C.M.B. receives research support from the Football Players' Health Study, funded by the NFL Players' Association; has received funding from the NCAA; and is supported by the National Institute of Mental Health (award number T32MH019733).	[Anonymous], CONC MAN PLAN; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Baugh CM, 2016, CONCUSSION, V1, P1; Benson M., 1994, 1994 95 NCAA SPORTS; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Buckley TA, 2015, CURR RES CONCUSSION, V2, P59; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Diamond D., 2012, ARIZONA JUST BROKE N; Ferrara MS, 2001, J ATHL TRAINING, V36, P145; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; National Athletic Trainers' Association, 2011, ATHL TRAIN ED COMP; National Collegiate Athletic Association, CONC SAF PROT COMM R; National Collegiate Athletic Association, GRAD SUCC RAT; National Collegiate Athletic Association, 1933, NAT COLL ATHL ASS ME; National Collegiate Athletic Association, 3 2 4 17 1 CONC MAN; National Collegiate Athletic Association, IND MED CAR GUID; National Collegiate Athletic Association, CONC SAF; National Collegiate Athletic Association Sport Science Institute, CONC SAF PROT CHECKL; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P11, DOI DOI 10.3928/19425864-20121217-02; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; SMITH RK, 2000, MARQ SPORTS L REV, V11, P9; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Zuckerman SL, 2016, AM J SPORT MED, V44, pNP5, DOI 10.1177/0363546515623241	43	13	13	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR 25	2017	5	4							2325967117702606	10.1177/2325967117702606			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	ET5ER	WOS:000400307500001	28473995	DOAJ Gold, Green Published			2021-06-18	
J	Manktelow, AE; Menon, DK; Sahakian, BJ; Stamatakis, EA				Manktelow, Anne E.; Menon, David K.; Sahakian, Barbara J.; Stamatakis, Emmanuel A.			Working Memory after Traumatic Brain Injury: The Neural Basis of Improved Performance with Methylphenidate	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; working memory; methylphenidate; functional connectivity; cerebellum; fMRI; cognitive function	BASAL GANGLIA; CEREBELLAR CONTRIBUTIONS; FUNCTIONAL-ORGANIZATION; SUBTHALAMIC NUCLEUS; RESPONSE-INHIBITION; TEMPORAL DYNAMICS; CEREBRAL-CORTEX; DOPAMINE; NETWORKS; ANATOMY	Traumatic brain injury (TBI) often results in cognitive impairments for patients. The aim of this proof of concept study was to establish the nature of abnormalities, in terms of activity and connectivity, in the working memory network of TBI patients and how these relate to compromised behavioral outcomes. Further, this study examined the neural correlates of working memory improvement following the administration of methylphenidate. We report behavioral, functional and structural MRI data from a group of 15 Healthy Controls (HC) and a group of 15 TBI patients, acquired during the execution of the N-back task. The patients were studied on two occasions after the administration of either placebo or 30mg ofmethylphenidate. Between group tests revealed a significant difference in performance when HCs were compared to TBI patients on placebo [F (1, 28) = 4.426, p < 0.05, eta p(2) = 0.136]. This difference disappeared when the patients took methylphenidate [F (1, 28) = 3.665, p = 0.66]. Patients in the middle range of baseline performance demonstrated the most benefit from methylphenidate. Changes in the TBI patient activation levels in the Left Cerebellum significantly and positively correlated with changes in performance (r = 0.509, df = 13, p = 0.05). Whole-brain connectivity analysis using the Left Cerebellum as a seed revealed widespread negative interactions between the Left Cerebellumand parietal and frontal cortices as well as subcortical areas. Neither the TBI group onmethylphenidate nor the HC group demonstrated any significant negative interactions. Our findings indicate that (a) TBI significantly reduces the levels of activation and connectivity strength between key areas of the working memory network and (b) Methylphenidate improves the cognitive outcomes on a working memory task. Therefore, we conclude that methylphenidate may render the working memory network in a TBI group more consistent with that of an intact working memory network.	[Manktelow, Anne E.; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Menon, David K.; Sahakian, Barbara J.; Stamatakis, Emmanuel A.] Univ Cambridge, Dept Clin Neurosci, Wolfson Brain Imaging Ctr, Cambridge, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, MRC Wellcome Trust Behav & Clin Neurosci Inst, Cambridge, England	Manktelow, AE (corresponding author), Univ Cambridge, Div Anaesthesia, Cambridge, England.	am807@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Evelyn Trust [06/20]; Neuroscience Theme of the NIHR Cambridge Biomedical; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	This work was supported by the Evelyn Trust (grant number 06/20). The Evelyn Trust had no role in the conduct of the research for the preparation of the manuscript. DM is supported by the Neuroscience Theme of the NIHR Cambridge Biomedical	Aarts E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00163; Allen G, 2005, NEUROIMAGE, V28, P39, DOI 10.1016/j.neuroimage.2005.06.013; Aravamuthan BR, 2007, NEUROIMAGE, V37, P694, DOI 10.1016/j.neuroimage.2007.05.050; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Baddeley A., 2007, WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Baddeley A. D., 1986, WORKING MEMORY; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Ben-Yehudah G, 2007, CEREBELLUM, V6, P193, DOI 10.1080/14734220701286195; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Brown P, 2001, J NEUROSCI, V21, P1033; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Chen SHA, 2005, NEUROPSYCHOLOGIA, V43, P1227, DOI 10.1016/j.neuropsychologia.2004.12.015; Chen SHA, 2005, NEUROIMAGE, V24, P332, DOI 10.1016/j.neuroimage.2004.08.032; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cools R, 2004, PHILOS T R SOC A, V362, P2871, DOI 10.1098/rsta.2004.1468; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Costa A, 2013, CEREB CORTEX, V23, P1179, DOI 10.1093/cercor/bhs107; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00116; Desmond JE, 1997, J NEUROSCI, V17, P9675; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Elliott R, 1997, PSYCHOPHARMACOLOGY, V131, P196, DOI 10.1007/s002130050284; Fallon SJ, 2017, J COGNITIVE NEUROSCI, V29, P652, DOI 10.1162/jocn_a_01065; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gilbert DL, 2006, NEUROPSYCHOPHARMACOL, V31, P442, DOI 10.1038/sj.npp.1300806; Goldman-Rakic PS, 2000, BRAIN RES REV, V31, P295, DOI 10.1016/S0165-0173(99)00045-4; Green D., 1966, SIGNAL DETECTION THE; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Henson RNA, 2000, NEUROPSYCHOLOGIA, V38, P426, DOI 10.1016/S0028-3932(99)00098-6; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Hockey A, 2004, INTELLIGENCE, V32, P591, DOI 10.1016/j.intell.2004.07.009; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; Koch G, 2007, EXP BRAIN RES, V179, P291, DOI 10.1007/s00221-006-0791-1; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Landau SM, 2009, CEREB CORTEX, V19, P445, DOI 10.1093/cercor/bhn095; Leung HC, 2007, NEUROIMAGE, V35, P368, DOI 10.1016/j.neuroimage.2006.12.012; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Macmillan N. A., 2005, DETECTION THEORY USE; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Marquand AF, 2011, NEUROPSYCHOPHARMACOL, V36, P1237, DOI 10.1038/npp.2011.9; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McDonald BC, 2017, NEUROPSYCHOPHARMACOL, V42, P1766, DOI 10.1038/npp.2016.261; McGurn B, 2004, NEUROLOGY, V62, P1184, DOI 10.1212/01.WNL.0000103169.80910.8B; Medaglia JD, 2012, HUM BRAIN MAPP, V33, P979, DOI 10.1002/hbm.21264; Mehta MA, 2000, J NEUROSCI, V20; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Middleton FA, 1997, INT REV NEUROBIOL, V41, P61, DOI 10.1016/S0074-7742(08)60347-5; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Moreno-Lopez L, 2017, EUR NEUROPSYCHOPHARM, V27, P159, DOI 10.1016/j.euroneuro.2016.12.002; Mueller S, 2014, HUM BRAIN MAPP, V35, P5379, DOI 10.1002/hbm.22557; Newcombe VFJ, 2016, NEUROREHAB NEURAL RE, V30, P49, DOI 10.1177/1545968315584004; Newsome MR, 2009, BRAIN IMAGING BEHAV, V3, P298, DOI 10.1007/s11682-009-9072-5; Nichelli P, 1996, NEUROPSYCHOLOGIA, V34, P863, DOI 10.1016/0028-3932(96)00001-2; Oliveri M, 2007, CEREBELLUM, V6, P95, DOI 10.1080/14734220701213421; Owen AM, 1999, EUR J NEUROSCI, V11, P567, DOI 10.1046/j.1460-9568.1999.00449.x; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; PARENT A, 1995, BRAIN RES REV, V20, P128, DOI 10.1016/0165-0173(94)00008-D; Parente R, 2011, NEUROREHABILITATION, V29, P117, DOI 10.3233/NRE-2011-0685; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ramasubbu Rajamannar, 2008, Neuropsychiatr Dis Treat, V4, P1251; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Salmon E, 1996, BRAIN, V119, P1617, DOI 10.1093/brain/119.5.1617; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Stoodley CJ, 2012, CEREBELLUM, V11, P352, DOI 10.1007/s12311-011-0260-7; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Swets J.A., 1982, EVALUATION DIAGNOSTI; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Volkow N D, 2001, J Neurosci, V21, pRC121; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156	92	13	14	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	APR 5	2017	11								58	10.3389/fnbeh.2017.00058			15	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	EQ9NO	WOS:000398411400001	28424597	DOAJ Gold, Green Published			2021-06-18	
J	Bagwe, S; Chung, LK; Lagman, C; Voth, BL; Barnette, NE; Elhajjmoussa, L; Yang, I				Bagwe, Shefali; Chung, Lawrance K.; Lagman, Carlito; Voth, Brittany L.; Barnette, Natalie E.; Elhajjmoussa, Lekaa; Yang, Isaac			Blood transfusion indications in neurosurgical patients: A systematic review	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Blood transfusion; Cerebral neoplasm; Intracranial aneurysm; Neurosurgery; Subarachnoid hemorrhage; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; INTRAOPERATIVE AUTOLOGOUS BLOOD; CELL TRANSFUSION; CEREBRAL OXYGENATION; HEAD-INJURY; CLINICAL-PRACTICE; CRITICAL-CARE; ANEMIA; HEMOGLOBIN	Neurosurgical procedures can be complicated by significant blood losses that have the potential to decrease tissue perfusion to critical brain tissue. Red blood cell transfusion is used in a variety of capacities both inside, and outside, of the operating room to prevent untoward neurologic damage. However, evidence-based guidelines concerning thresholds and indications for transfusion in neurosurgery remain limited. Consequently, transfusion practices in neurosurgical patients are highly variable and based on institutional experiences. Recently, a paradigm shift has occurred in neurocritical intensive care units, whereby restrictive transfusion is increasingly favored over liberal transfusion but the ideal strategy remains in clinical equipoise. The authors of this study perform a systematic review of the literature with the objective of capturing the changing landscape of blood transfusion indications in neurosurgical patients. (C) 2017 Elsevier B.V. All rights reserved.	[Bagwe, Shefali; Chung, Lawrance K.; Lagman, Carlito; Voth, Brittany L.; Barnette, Natalie E.; Elhajjmoussa, Lekaa; Yang, Isaac] Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 562,5th Floor Wasserman Bld, Los Angeles, CA 90095 USA; [Yang, Isaac] Univ Calif Los Angeles, Radiat Oncol, Los Angeles, CA USA; [Yang, Isaac] Univ Calif Los Angeles, Head & Neck Surg, Los Angeles, CA USA; [Yang, Isaac] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	Yang, I (corresponding author), Univ Calif Los Angeles, Dept Neurosurg, 300 Stein Plaza,Suite 562,5th Floor Wasserman Bld, Los Angeles, CA 90095 USA.	iyang@mednet.ucla.edu	Yang, Isaac/AAT-5897-2020	Yang, Isaac/0000-0002-5176-5615	AMA Foundation Seed Grant; Gurtin Skull Base Research Fellowship; Visionary Fund Grant; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research UCLA Scholars in Translational Medicine Program Award; UCLA Honberger Endowment Brain Tumor Research Seed Grant; ASIA Carolyn L. Kuckein Student Research Fellowship; Stop Cancer (US) Research Career Development Award; Jason Dess el Memorial Seed Grant	Lawrance K. Chung is supported by an AMA Foundation Seed Grant and an ASIA Carolyn L. Kuckein Student Research Fellowship. Carlito Lagman is supported by a Gurtin Skull Base Research Fellowship. Isaac Yang is partially supported by a Visionary Fund Grant, an Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research UCLA Scholars in Translational Medicine Program Award, the Jason Dess el Memorial Seed Grant, the UCLA Honberger Endowment Brain Tumor Research Seed Grant and the Stop Cancer (US) Research Career Development Award. The remaining authors have no disclosures or conflicts of interest.	Acker SN, 2014, J TRAUMA ACUTE CARE, V76, P1082, DOI 10.1097/TA.0000000000000095; Al-Dorzi H. M., 2015, CRIT CARE RES PRACT, V2015; Almeida KJ, 2016, ARQ NEURO-PSIQUIAT, V74, P644, DOI 10.1590/0004-282X20160093; Awada WN, 2015, J CLIN MONIT COMPUT, V29, P733, DOI 10.1007/s10877-015-9660-4; Bejjani GK, 1999, SURG NEUROL, V52, P577, DOI 10.1016/S0090-3019(99)00108-1; Bellapart J, 2012, J TRAUMA ACUTE CARE, V73, P997, DOI 10.1097/TA.0b013e318265cede; Blajchman MA, 2001, TRANSFUS CLIN BIOL, V8, P207, DOI 10.1016/S1246-7820(01)00136-7; BORGSTROM L, 1975, ACTA PHYSIOL SCAND, V93, P505, DOI 10.1111/j.1748-1716.1975.tb05842.x; Broessner G, 2009, CRIT CARE MED, V37, P1886, DOI 10.1097/CCM.0b013e31819ffd7f; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Carson JL, 2002, TRANSFUS MED REV, V16, P187, DOI 10.1053/tmrv.2002.33461; Cataldi S, 1997, NEUROSURGERY, V40, P765, DOI 10.1097/00006123-199704000-00021; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Couture DE, 2002, STROKE, V33, P994, DOI 10.1161/hs0402.105296; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Durak MA, 2016, BIOMED RES-INDIA, V27, P849; Ekelund A, 2002, ACTA NEUROCHIR, V144, P703, DOI 10.1007/s00701-002-0959-9; Festic E, 2013, NEUROCRIT CARE, V18, P209, DOI 10.1007/s12028-012-9777-y; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kleinert K., 2009, HSSJ, V6, P190; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kudo H, 2004, SURG NEUROL, V62, P195, DOI 10.1016/j.surneu.2003.10.044; Kumar MA, 2014, NEUROCRIT CARE, V20, P84, DOI 10.1007/s12028-013-9819-0; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; Le Roux PD, 2001, NEUROSURGERY, V49, P1068, DOI 10.1097/00006123-200111000-00009; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Lelubre C, 2016, MINERVA ANESTESIOL, V82, P112; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; Liang H, 2009, SURG NEUROL, V71, P74, DOI 10.1016/j.surneu.2007.11.015; Linsler S, 2012, ACTA NEUROCHIR, V154, P1303, DOI 10.1007/s00701-012-1373-6; Luostarinen T, 2015, WORLD NEUROSURG, V84, P446, DOI 10.1016/j.wneu.2015.03.053; McEwen J, 2009, CURR OPIN ANESTHESIO, V22, P566, DOI 10.1097/ACO.0b013e32832ff4a2; McGirr A, 2014, CAN J NEUROL SCI, V41, P583, DOI 10.1017/cjn.2014.14; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; McLaren AT, 2007, AM J PHYSIOL-REG I, V292, pR403, DOI 10.1152/ajpregu.00403.2006; Mebel D, 2016, ANESTH ANALG, V122, P503, DOI 10.1213/ANE.0000000000001065; Naidech AM, 2011, TRANSFUSION MED, V21, P130, DOI 10.1111/j.1365-3148.2010.01048.x; Naidech AM, 2008, NEUROCRIT CARE, V9, P198, DOI 10.1007/s12028-008-9113-8; Naidech AM, 2007, CRIT CARE MED, V35, P2383, DOI 10.1097/01.CCM.0000284516.17580.2C; Naidech AM, 2010, NEUROCRIT CARE, V13, P313, DOI 10.1007/s12028-010-9424-4; Napolitano Lena M, 2004, Curr Opin Crit Care, V10, P311; Napolitano LM, 2009, J TRAUMA, V67, P1439, DOI 10.1097/TA.0b013e3181ba7074; Naqash Imtiaz A, 2011, J Anaesthesiol Clin Pharmacol, V27, P54; Oddo M, 2009, STROKE, V40, P1275, DOI 10.1161/STROKEAHA.108.527911; Pasternak JJ, 2008, J NEUROSURG ANESTH, V20, P15, DOI 10.1097/ANA.0b013e318155b1c4; Peerdeman SM, 2000, INTENS CARE MED, V26, P662, DOI 10.1007/s001340051230; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Seicean A, 2015, J NEUROSURG, V123, P91, DOI 10.3171/2014.10.JNS14551; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Shander A., 2011, BR J ANAESTH S1, V107, pi49; SHIMADA N, 1989, J CEREBR BLOOD F MET, V9, P603, DOI 10.1038/jcbfm.1989.86; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Springer MV, 2009, NEUROSURGERY, V65, P1043, DOI 10.1227/01.NEU.0000359317.15269.20; Stehling LC, 1996, ANESTHESIOLOGY, V84, P732; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Treggiari MM, 2009, CURR OPIN CRIT CARE, V15, P83, DOI 10.1097/MCC.0b013e32832922d1; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Vassal O, 2016, PEDIATR ANESTH, V26, P199, DOI 10.1111/pan.12810; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wei NL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144551; Yamal JM, 2015, J TRAUMA ACUTE CARE, V79, P843, DOI 10.1097/TA.0000000000000834; Yee JN, 2017, J CLIN ANESTH, V36, P164, DOI 10.1016/j.jclinane.2016.10.031; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	76	13	14	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	APR	2017	155						83	89		10.1016/j.clineuro.2017.02.006			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	ER4FD	WOS:000398753600016	28282628				2021-06-18	
J	Cnossen, MC; Polinder, S; Andriessen, TM; van der Naalt, J; Haitsma, I; Horn, J; Franschman, G; Vos, PE; Steyerberg, EW; Lingsma, H				Criossen, Maryse C.; Polinder, Suzanne; Andriessen, Teuntje M.; van der Naalt, Joukje; Haitsma, Iain; Horn, Janneke; Franschman, Gaby; Vos, Pieter E.; Steyerberg, Ewout W.; Lingsma, Hester			Causes and Consequences of Treatment Variation in Moderate and Severe Traumatic Brain Injury: A Multicenter Study	CRITICAL CARE MEDICINE			English	Article						Glasgow Outcome Scale-Extended; intracranial pressure monitoring; observational studies; traumatic brain injury; treatment variation	SEVERE HEAD-INJURY; MANAGEMENT; EPIDEMIOLOGY; CARE	Objectives: Although guidelines have been developed to standardize care in traumatic brain injury, between-center variation in treatment approach has been frequently reported. We examined variation in treatment for traumatic brain injury by assessing factors influencing treatment and the association between treatment and patient outcome. Design: Secondary analysis of prospectively collected data. Setting: Five level I trauma centers in the Netherlands (2008-2009). Patients: Five hundred three patients with moderate or severe traumatic brain injury (Glasgow Coma Scale, 3-13). Interventions: We examined variation in seven treatment parameters: direct transfer, involvement of mobile medical team, mechanical ventilation, intracranial pressure monitoring, vasopressors, acute neurosurgical intervention, and extracranial operation. Measurements and Main Results: Data were collected on patient characteristics, treatment, and 6-month Glasgow Outcome Scale-Extended. Multivariable logistic regression models were used to assess the extent to which treatment was determined by patient characteristics. To examine whether there were between-center differences in treatment, we used unadjusted and adjusted random effect models with the seven treatment parameters as dependent variables. The influence of treatment approach in a center (defined as aggressive and non aggressive based on the frequency intracranial pressure monitoring) on outcome was assessed using multivariable random effect proportional odds regression models in those patients with an indication for intracranial pressure monitoring. Sensitivity analyses were performed to test alternative definitions of aggressiveness. Treatment was modestly related to patient characteristics (Nagelkerke R-2 range, 0.12-0.52) and varied widely among centers, even after case-mix correction. Outcome was more favorable in patients treated in aggressive centers than those treated in nonaggressive centers (OR, 1.73; 95% CI, 1.05-3.15). Sensitivity analyses, however, illustrated that the aggressiveness-outcome association was dependent on the definition used. Conclusions: The considerable between-center variation in treatment for patients with brain injury can only partly be explained by differences in patient characteristics. An aggressive treatment approach may imply better outcome although further confirmation is required. (Crit Care Med 2017; 45:660-669)	[Criossen, Maryse C.; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Andriessen, Teuntje M.] RIVAS Healthcare Grp, Dept Psychol, Gorinchem, Netherlands; [van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Haitsma, Iain] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Horn, Janneke] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [Franschman, Gaby] VU Univ Med Ctr Amsterdam, Dept Anesthesiol, Amsterdam, Netherlands; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands	Cnossen, MC (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl			Dutch Brain Foundation [Hersenstichting-HSN-07-01]; European Union FP 7th Framework program CENTER-TBI [602150]; Dutch brain foundation (Hersenstichting); University Medical Center Nijmegen, Department of Neurology; Ever Neuropharma; EU FP7 programmeEuropean Commission; European Union (FP7)European Commission	The POCON study is funded by the Dutch Brain Foundation (Hersenstichting-HSN-07-01).r Dr. Cnossen received support for article research from The European Union FP 7th Framework program (grant 602150) CENTER-TBI. Dr. Andriessen's institution received funding from Dutch brain foundation (Hersenstichting). Dr. Haitsma's institution received funding from University Medical Center Nijmegen, Department of Neurology. Dr. Vos' institution received funding from Dutch Brain Foundation (Hersenstichting), and he received funding from Ever Neuropharma (consultancy). Dr. Steyerberg's institution received funding from EU FP7 programme. Dr. Lingsma received support for article research from European Union (FP7). The remaining authors have disclosed that they do not have any potential conflicts of interest.	Akaike H, 1973, 2 INT S INF THEOR; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bosco JLF, 2010, J CLIN EPIDEMIOL, V63, P64, DOI 10.1016/j.jclinepi.2009.03.001; Brain Trauma Foundation, 2007, J NEUROTRAUMA; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Carney N, 2016, NEUROSURGERY; Christensen RHB, ORD REGR MOD ORD DAT; Cnossen M.C., 2016, J NEUROTRAUMA; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Hoogmartens O, 2014, PREHOSP EMERG CARE, V18, P265, DOI 10.3109/10903127.2013.856506; Kahol K, 2011, J BIOMED INFORM, V44, P425, DOI 10.1016/j.jbi.2011.04.003; Lingsma HF, 2010, QJM-INT J MED, V103, P99, DOI 10.1093/qjmed/hcp169; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; National Institute of Neurological Disorders and Stroke (NINDS), NINDS COMM DAT EL TR; R core team and contributors worldwide, R GRAPH PACK R PACK; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Signorello Lisa B, 2002, Am J Ther, V9, P199, DOI 10.1097/00045391-200205000-00005; Skoglund K, 2013, J NEUROSCI NURS, V45, P360, DOI 10.1097/JNN.0b013e3182a3cf4f; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	30	13	13	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2017	45	4					660	669		10.1097/CCM.0000000000002263			10	Critical Care Medicine	General & Internal Medicine	EO6JQ	WOS:000396798700013	28169945				2021-06-18	
J	Dobrachinski, F; Gerbatin, RD; Sartori, G; Marques, NF; Zemolin, AP; Silva, LFA; Franco, JL; Royes, LFF; Fighera, MR; Soares, FAA				Dobrachinski, Fernando; Gerbatin, Rogerio da Rosa; Sartori, Glaubia; Marques, Naiani Ferreira; Zemolin, Ana Paula; Almeida Silva, Luiz Fernando; Franco, Jeferson Luis; Freire Royes, Luiz Fernando; Fighera, Michele Rechia; Antunes Soares, Felix Alexandre			Regulation of Mitochondrial Function and Glutamatergic System Are the Target of Guanosine Effect in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion injury; glutamate; glutamate transporters; mitochondria redox system; purinergic nucleoside	HIPPOCAMPAL SLICES; NITRIC-OXIDE; CELL-DEATH; OXIDATIVE STRESS; OXYGEN/GLUCOSE DEPRIVATION; SUPEROXIDE-DISMUTASE; PATHWAY ACTIVATION; NEURONAL INJURY; DYSFUNCTION; RATS	Traumatic brain injury (TBI) is a highly complex multi-factorial disorder. Experimental trauma involves primary and secondary injury cascades that underlie delayed neuronal dysfunction and death. Mitochondrial dysfunction and gluta-matergic excitotoxicity are the hallmark mechanisms of damage. Accordingly, a successful pharmacological intervention requires a multi-faceted approach. Guanosine (GUO) is known for its neuromodulator effects in various models of brain pathology, specifically those that involve the glutamatergic system. The aim of the study was to investigate the GUO effects against mitochondrial damage in hippocampus and cortex of rats subjected to TBI, as well as the relationship of this effect with the glutamatergic system. Adult male Wistar rats were subjected to a unilateral moderate fluid percussion brain injury (FPI) and treated 15 min later with GUO (7.5 mg/kg) or vehicle (saline 0.9%). Analyses were performed in hippocampus and cortex 3 h post-trauma and revealed significant mitochondrial dysfunction, characterized by a disrupted membrane potential, unbalanced redox system, decreased mitochondrial viability, and complex I inhibition. Further, disruption of Ca2+ homeostasis and increased mitochondrial swelling was also noted. Our results showed that mitochondrial dysfunction contributed to decreased glutamate uptake and levels of glial glutamate transporters (glutamate transporter 1 and glutamate aspartate transporter), which leads to excitotoxicity. GUO treatment ameliorated mitochondrial damage and glutamatergic dyshomeostasis. Thus, GUO might provide a new efficacious strategy for the treatment acute physiological alterations secondary to TBI.	[Dobrachinski, Fernando; Gerbatin, Rogerio da Rosa; Sartori, Glaubia; Marques, Naiani Ferreira; Zemolin, Ana Paula; Almeida Silva, Luiz Fernando; Franco, Jeferson Luis; Freire Royes, Luiz Fernando; Fighera, Michele Rechia; Antunes Soares, Felix Alexandre] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Bioquim & Biol Mol, Campus UFSM, BR-97105900 Santa Maria, RS, Brazil; [Gerbatin, Rogerio da Rosa; Freire Royes, Luiz Fernando] Univ Fed Santa Maria, Lab Bioquim Exercicio, Santa Maria, RS, Brazil; [Fighera, Michele Rechia] Univ Fed Santa Maria, Ctr Ciencias Saude, Dept Neuropsiquiatria, Santa Maria, RS, Brazil; [Franco, Jeferson Luis] Univ Fed Pampa, Programa Posgrad Ciencias Biol, Campus Sao Gabriel, Sao Gabriel, RS, Brazil; [Dobrachinski, Fernando] Univ Coimbra, Fac Med, CNC Ctr Neurociencias & Biol Celular, Coimbra, Portugal	Soares, FAA (corresponding author), Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Bioquim & Biol Mol, Campus UFSM, BR-97105900 Santa Maria, RS, Brazil.	felix@ufsm.br	Fighera, Michele R/J-9576-2014; Soares, Felix AA/K-7611-2012; Dobrachinski, Fernando/C-4316-2014; Franco, Jeferson Luis/F-7797-2012; SARTORI, GLAUBIA/J-3435-2014; Soares, Felix/AAE-6251-2020	Soares, Felix AA/0000-0002-6453-7902; Dobrachinski, Fernando/0000-0002-3948-1273; Franco, Jeferson Luis/0000-0002-3874-8618; SARTORI, GLAUBIA/0000-0002-1088-8731; Soares, Felix/0000-0002-6453-7902; Almeida Silva, Luiz Fernando/0000-0002-7621-4836	INCT for excitotoxicity and neuroprotection-MCT/CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); CAPESCoordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPERGS/PRONEMFundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS) [11/2029-1]	This study was supported by INCT for excitotoxicity and neuroprotection-MCT/CNPq. J.L.F., L.F.R., M.R.F., and F.A.A.S. received a fellowship by CNPq; F.D., R.R.G., G.S.S., and N.F.M received a fellowship by CAPES. Additional support was given by FAPERGS/PRONEM 11/2029-1.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; Bettio LEB, 2016, PURINERG SIGNAL, V12, P411, DOI 10.1007/s11302-016-9509-4; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bringold U, 2000, FREE RADICAL BIO MED, V29, P343, DOI 10.1016/S0891-5849(00)00318-X; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Ciruela F, 2013, J NEUROCHEM, V126, P425, DOI 10.1111/jnc.12328; Clark RSB, 2007, J CEREBR BLOOD F MET, V27, P316, DOI 10.1038/sj.jcbfm.9600338; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; Dal-Cim T, 2011, NEUROSCIENCE, V183, P212, DOI 10.1016/j.neuroscience.2011.03.022; Dal-Cim T, 2016, NEUROTOX RES, V29, P460, DOI 10.1007/s12640-015-9595-z; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Dal-Cim T, 2012, NEUROCHEM INT, V61, P397, DOI 10.1016/j.neuint.2012.05.021; Danbolt NC, 2016, NEUROCHEM INT, V98, P29, DOI 10.1016/j.neuint.2016.05.009; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dobrachinski F, 2012, NEUROCHEM RES, V37, P1993, DOI 10.1007/s11064-012-0820-3; Finkel E, 2001, SCIENCE, V292, P624, DOI 10.1126/science.292.5517.624; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; Franco JL, 2010, TOXICOL SCI, V113, P150, DOI 10.1093/toxsci/kfp245; Frizzo MED, 2002, CELL MOL NEUROBIOL, V22, P353; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Jackson EK, 2013, AM J PHYSIOL-CELL PH, V304, pC406, DOI 10.1152/ajpcell.00212.2012; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jiang SC, 2007, PURINERG SIGNAL, V3, P411, DOI 10.1007/s11302-007-9079-6; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Li LB, 2006, J NEUROCHEM, V97, P759, DOI 10.1111/j.1471-4159.2006.03743.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Molz S, 2011, J NEUROSCI RES, V89, P1400, DOI 10.1002/jnr.22681; Nicholls DG, 2008, ANN NY ACAD SCI, V1147, P53, DOI 10.1196/annals.1427.002; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Pandya Jignesh D, 2013, Front Neuroenergetics, V5, P10, DOI 10.3389/fnene.2013.00010; Rathbone MP, 2011, BRAIN RES, V1407, P79, DOI 10.1016/j.brainres.2011.06.027; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Soares FA, 2004, BRAIN RES, V1005, P182, DOI 10.1016/j.brainres.2004.01.053; Stout AK, 1998, NAT NEUROSCI, V1, P366; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wang GJ, 2002, J NEUROPHYSIOL, V87, P740, DOI 10.1152/jn.00345.2001; White RJ, 1996, J NEUROSCI, V16, P5688; Xiong Y, 2005, J NEUROCHEM, V95, P732, DOI 10.1111/j.1471-4159.2005.03412.x; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857	67	13	14	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1318	1328		10.1089/neu.2016.4563			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600003	27931151				2021-06-18	
J	Feddermann-Demont, N; Junge, A; Weber, KP; Weller, M; Dvorak, J; Tarnutzer, AA				Feddermann-Demont, Nina; Junge, Astrid; Weber, Konrad P.; Weller, Michael; Dvorak, Jiri; Tarnutzer, Alexander A.			Prevalence of potential sports-associated risk factors in Swiss amyotrophic lateral sclerosis patients	BRAIN AND BEHAVIOR			English	Article						amyotrophic lateral sclerosis; football (soccer); head trauma; ice hockey; physical activity	MOTOR-NEURON DISEASE; PHYSICAL-ACTIVITY; HEAD-INJURY; SOCCER PLAYERS; POPULATION; TRAUMA; ALS	ObjectivesAmyotrophic lateral sclerosis (ALS) has been reported to occur with increased incidence amongst physically active people. The role of extrinsic risk factors as physical activity, head trauma and drug/pesticide-exposure in the pathophysiology of ALS and especially in the context of practising sports remains controversial. Materials and MethodsWe retrospectively studied exposure to extrinsic factors in 92 ALS patients in the presymptomatic stage. Metabolic equivalents (METs) were calculated and the association of physical activity, drug intake, head trauma and participation in specific sports (football [soccer], ice hockey) with age at symptom-onset was evaluated. ResultsNinety-five percent of patients considered themselves physically active before symptom-onset. Total MET-values varied broadly and there was no correlation between vigorous physical activity and age at symptom-onset. Mild traumatic brain injury (prevalence=16.7%) was the most frequent diagnosis after head/neck injury. A history of 1 head/neck injuries was associated with a younger age at symptom-onset (61.811.0 vs. 54.1 +/- 13.0, p=.013). In former football and ice hockey players the rate of vigorous physical activities was increased (p<.05), whereas total MET-values, frequency of head injuries and analgesic intake were not different compared to other ALS patients. ConclusionsHistory of head injuries was the only extrinsic risk factor associated with accelerated neurodegeneration in ALS. There was no evidence for extrinsic factors predisposing former football and ice hockey players to ALS. Our data therefore support the hypothesis that not increased physical activity per se, but other unknown environmental factors and/or genetic profile or lifestyle-promoting physical fitness increases ALS susceptibility.	[Feddermann-Demont, Nina; Weber, Konrad P.; Weller, Michael; Tarnutzer, Alexander A.] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland; [Feddermann-Demont, Nina; Weber, Konrad P.; Weller, Michael; Tarnutzer, Alexander A.] Univ Zurich, Zurich, Switzerland; [Feddermann-Demont, Nina; Junge, Astrid; Weber, Konrad P.; Dvorak, Jiri; Tarnutzer, Alexander A.] Schulthess Clin, Swiss Concuss Ctr, Zurich, Switzerland; [Feddermann-Demont, Nina; Junge, Astrid; Dvorak, Jiri] FIFA Med Assessment & Res Ctr F MARC, Zurich, Switzerland; [Junge, Astrid; Dvorak, Jiri] Schulthess Clin, Zurich, Switzerland; [Junge, Astrid] MSH, Hamburg, Germany; [Weber, Konrad P.] Univ Hosp Zurich, Dept Ophthalmol, Zurich, Switzerland; [Dvorak, Jiri] Federat Int Football Assoc, Zurich, Switzerland	Tarnutzer, AA (corresponding author), Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland.; Tarnutzer, AA (corresponding author), Univ Zurich, Zurich, Switzerland.	alexander.tarnutzer@access.uzh.ch	Tarnutzer, Alexander/H-3236-2019; Weber, Konrad P/A-1941-2013	Tarnutzer, Alexander/0000-0002-6984-6958; Weber, Konrad P/0000-0003-2526-4582; Junge, Astrid/0000-0002-6815-9793; Weller, Michael/0000-0002-1748-174X	Federation Internationale de Football Association (FIFA)	The study was funded by the Federation Internationale de Football Association (FIFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Chalabi A, 2005, BRAIN, V128, P451, DOI 10.1093/brain/awh426; Alonso A, 2009, EUR J NEUROL, V16, P745, DOI 10.1111/j.1468-1331.2009.02586.x; Armon C, 2007, J NEUROL SCI, V262, P45, DOI 10.1016/j.jns.2007.06.021; Armon C, 2012, AMYOTROPH LATERAL SC, V13, P351, DOI 10.3109/17482968.2012.660954; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Beghi E, 2007, NEUROLOGY, V68, P141, DOI 10.1212/01.wnl.0000250339.14392.bb; Beghi E, 2013, AMYOTROPH LAT SCL FR, V14, P501, DOI 10.3109/21678421.2013.809764; Beghi E, 2010, AMYOTROPH LATERAL SC, V11, P289, DOI 10.3109/17482960903384283; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chio A, 2001, NEUROLOGY, V56, P239; Cronin S, 2007, NEUROLOGY, V68, P1002, DOI 10.1212/01.wnl.0000258551.96893.6f; Fondell E, 2012, AMYOTROPH LATERAL SC, V13, P573, DOI 10.3109/17482968.2012.703209; Fournier CN, 2015, NEUROLOGY, V84, P1788, DOI 10.1212/WNL.0000000000001522; Frantseva M, 2002, PROG BRAIN RES, V137, P171; Gotkine M, 2014, AMYOTROPH LAT SCL FR, V15, P534, DOI 10.3109/21678421.2014.932383; Hamidou B, 2014, EUR J EPIDEMIOL, V29, P459, DOI 10.1007/s10654-014-9923-2; Harwood CA, 2009, AMYOTROPH LATERAL SC, V10, P191, DOI 10.1080/17482960802549739; Huisman MHB, 2013, J NEUROL NEUROSUR PS, V84, P976, DOI 10.1136/jnnp-2012-304724; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; LONGSTRETH WT, 1991, MED HYPOTHESES, V34, P144, DOI 10.1016/0306-9877(91)90183-Y; Peters TL, 2013, AMYOTROPH LAT SCL FR, V14, P267, DOI 10.3109/21678421.2012.754043; Popat RA, 2007, AMYOTROPH LATERAL SC, V8, P157, DOI 10.1080/17482960601179456; Pupillo E, 2012, EUR J NEUROL, V19, P1509, DOI 10.1111/j.1468-1331.2012.03723.x; Pupillo E, 2014, ANN NEUROL, V75, P708, DOI 10.1002/ana.24150; Schmidt S, 2010, J NEUROL SCI, V291, P22, DOI 10.1016/j.jns.2010.01.011; Seelen M, 2014, J NEUROL, V261, P1949, DOI 10.1007/s00415-014-7445-1; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; SUVA Medical, 2014, VERS ARB REH; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Turner MR, 2012, J NEUROL NEUROSUR PS, V83, P395, DOI 10.1136/jnnp-2011-301161; Turner MR, 2010, J NEUROL SCI, V288, P45, DOI 10.1016/j.jns.2009.10.010; Uenal H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093932; Vanacore N, 2006, PARKINSONISM RELAT D, V12, P327, DOI 10.1016/j.parkreldis.2005.11.007; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C	39	13	14	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	APR	2017	7	4							e00630	10.1002/brb3.630			10	Behavioral Sciences; Neurosciences	Behavioral Sciences; Neurosciences & Neurology	ES3TQ	WOS:000399452500001	28413696	DOAJ Gold, Green Published, Green Accepted			2021-06-18	
J	Franchow, EI; Suchy, Y				Franchow, E. I.; Suchy, Yana			Expressive Suppression Depletes Executive Functioning in Older Adulthood	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Affect suppression; Emotional suppression; Emotion regulation; Executive control; Depletion; Cognitive aging	TRAUMATIC BRAIN-INJURY; DEMENTIA RATING-SCALE; EMOTION REGULATION; LIFE-SPAN; ALZHEIMERS-DISEASE; SELF-CONTROL; INTRAINDIVIDUAL VARIABILITY; INSTRUMENTAL ACTIVITIES; COGNITIVE IMPAIRMENT; ECOLOGICAL VALIDITY	Objectives: Accurate detection of executive dysfunction in neuropsychological assessments is complicated by the fact that executive functioning (EF) is vulnerable to temporary disruption (i.e., lapses), with more frequent lapses in older adulthood. Effortful regulation of affect (i.e., expressive suppression) is a well-known source of executive lapses in younger adults, but the generalizability of this depleting effect to older adults is unknown. The purpose of this study was to (1) determine whether EF is subject to depletion via expressive suppression and (2) to examine whether this effect is unique to EF, or whether it also applies to lower-order component processes in older adults. Methods: Ninety-seven non-demented, community-dwelling older adults were randomly assigned to either an expressive suppression group or control group. We compared performance of the groups on a battery of tests measuring EF and component processes both before and after exposure to emotionally evocative stimuli. Results: Consistent with the hypothesized depletion effect, suppressing participants showed an attenuated practice effect on post-manipulation EF relative to controls, while performance on lower-order component processes was unaffected by suppression. Conclusions: These results suggest that depletion contributes to executive lapses in older adulthood.	[Franchow, E. I.; Suchy, Yana] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Franchow, EI (corresponding author), Dept Psychol, 380 S 1530 E Room 502, Salt Lake City, UT 84112 USA.	emilie.franchow@psych.utah.edu		Suchy, Yana/0000-0001-6513-565X			Baudouin A, 2009, BRAIN COGNITION, V71, P240, DOI 10.1016/j.bandc.2009.08.007; Baumeister RF, 1998, J PERS SOC PSYCHOL, V74, P1252, DOI 10.1037/0022-3514.74.5.1252; Baumeister RF, 2009, SELF IDENTITY, V8, P115, DOI 10.1080/15298860802501474; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802; Brown GG, 1999, J GERIATR PSYCH NEUR, V12, P180, DOI 10.1177/089198879901200403; BRUCE ML, 1994, AM J PUBLIC HEALTH, V84, P1796, DOI 10.2105/AJPH.84.11.1796; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cummings J.L., 2007, HUMAN FRONTAL LOBES, V2nd ed, P12; Dawson DR, 2000, BRAIN COGNITION, V44, P35; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Delis DC, 2004, J INT NEUROPSYCH SOC, V10, P301, DOI 10.1017/S1355617704102191; Demaree HA, 2004, COGNITION EMOTION, V18, P1079, DOI 10.1080/02699930441000085; Engelborghs S, 2005, INT J GERIATR PSYCH, V20, P1028, DOI 10.1002/gps.1395; Ewert S., 2014, CURRENT POPULATION P, P70; Franchow EI, 2015, EMOTION, V15, P78, DOI 10.1037/emo0000013; Gallo JJ, 1997, J AM GERIATR SOC, V45, P570, DOI 10.1111/j.1532-5415.1997.tb03089.x; Gamaldo AA, 2012, NEUROPSYCHOLOGY, V26, P534, DOI 10.1037/a0028686; Goldberg E., 1987, FRONTAL LOBES REVISI, P159; Gross J.J., 2007, HDB EMOTION REGULATI; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gunstad J, 2007, INT J NEUROSCI, V117, P477, DOI 10.1080/00207450600773483; Heaton RK, 2001, ARCH CLIN NEUROPSYCH, V16, P75, DOI 10.1016/S0887-6177(99)00062-1; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; HUBERT W, 1993, PSYCHONEUROENDOCRINO, V18, P265, DOI 10.1016/0306-4530(93)90023-E; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Insel K, 2006, J GERONTOL B-PSYCHOL, V61, pP102, DOI 10.1093/geronb/61.2.P102; Inzlicht M, 2007, PSYCHOL SCI, V18, P933, DOI 10.1111/j.1467-9280.2007.02004.x; John OP, 2004, J PERS, V72, P1301, DOI 10.1111/j.1467-6494.2004.00298.x; Johns M, 2008, J EXP PSYCHOL GEN, V137, P691, DOI 10.1037/a0013834; Jongsma MLA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023363; Jurica PJ, 2001, DRS 2 DEMENTIA RATIN; Karp JF, 2006, PAIN MED, V7, P444, DOI 10.1111/j.1526-4637.2006.00212.x; KOVNER R, 1992, J SUBST ABUSE TREAT, V9, P133, DOI 10.1016/0740-5472(92)90080-8; Krampe RT, 2002, NEUROSCI BIOBEHAV R, V26, P769, DOI 10.1016/S0149-7634(02)00064-7; Kraybill ML, 2013, CLIN NEUROPSYCHOL, V27, P238, DOI 10.1080/13854046.2012.735702; Kraybill ML, 2011, CLIN NEUROPSYCHOL, V25, P210, DOI 10.1080/13854046.2010.542489; Lang FR, 1998, J GERONTOL B-PSYCHOL, V53, pP21, DOI 10.1093/geronb/53B.1.P21; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Levy JA, 2007, J GERIATR PSYCH NEUR, V20, P227, DOI 10.1177/0891988707308806; Lezak M.D., 2013, NEUROPSYCHOLOGICAL A; Lindau M, 2000, DEMENT GERIATR COGN, V11, P286, DOI 10.1159/000017251; Luria A. R., 1992, NEUROSCIENCES PATHS, VI, P335; Martin EA, 2011, COGNITION EMOTION, V25, P265, DOI 10.1080/02699931.2010.491652; Mayr U, 2001, PSYCHOL AGING, V16, P96, DOI 10.1037/0882-7974.16.1.96; McDaniel WF, 2000, CLIN NEUROPSYCHOL, V14, P72, DOI 10.1076/1385-4046(200002)14:1;1-8;FT072; Meiran N, 2001, EUR J COGN PSYCHOL, V13, P165, DOI 10.1080/09541440042000269; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; MITRUSHINA M, 1991, J CLIN PSYCHOL, V47, P790, DOI 10.1002/1097-4679(199111)47:6<790::AID-JCLP2270470610>3.0.CO;2-C; Mitsis E. M., 2004, PROQUEST INFORM LEAR; Muraven M, 1998, J PERS SOC PSYCHOL, V74, P774, DOI 10.1037/0022-3514.74.3.774; Nes LS, 2009, ANN BEHAV MED, V37, P173, DOI 10.1007/s12160-009-9096-5; Niermeyer MA, 2016, J INT NEUROPSYCH SOC, V22, P671, DOI 10.1017/S1355617716000473; Oaksford M, 1996, J EXP PSYCHOL LEARN, V22, P476, DOI 10.1037/0278-7393.22.2.476; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; PARASURAMAN R, 1991, PSYCHOL AGING, V6, P155, DOI 10.1037/0882-7974.6.2.155; Pietrzak RH, 2009, HUM PSYCHOPHARM CLIN, V24, P113, DOI 10.1002/hup.998; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; Reimers S, 2005, DEV PSYCHOL, V41, P661, DOI 10.1037/0012-1649.41.4.661; Riediger M, 2014, PSYCHOL AGING, V29, P103, DOI 10.1037/a0035766; Royall DR, 2004, J AM GERIATR SOC, V52, P346, DOI 10.1111/j.1532-5415.2004.52104.x; Royall DR, 2005, J AM GERIATR SOC, V53, P11, DOI 10.1111/j.1532-5415.2005.53004.x; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Schmeichel BJ, 2003, J PERS SOC PSYCHOL, V85, P33, DOI 10.1037/0022-3514.85.1.33; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P357, DOI 10.1007/978-0-387-76978-3_14; Stuss D. T., 2001, FRONTAL LOBES NEUROP, P101; Suchy Y, 2015, EXECUTIVE FUNCTIONIN; Suchy Y, 2011, J INT NEUROPSYCH SOC, V17, P101, DOI 10.1017/S135561771000130X; SULTZER DL, 1993, AM J PSYCHIAT, V150, P1806; Sutter C, 2012, NEUROPSYCHOLOGY, V26, P768, DOI 10.1037/a0030033; Szaflarski JP, 2002, NEUROLOGY, V59, P238, DOI 10.1212/WNL.59.2.238; WEGNER DM, 1990, J PERS SOC PSYCHOL, V58, P409, DOI 10.1037/0022-3514.58.3.409; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; West R, 2001, EUR J COGN PSYCHOL, V13, P91, DOI 10.1080/09541440042000232; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	81	13	13	1	10	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2017	23	4					341	351		10.1017/S1355617717000054			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	ES2YO	WOS:000399394000006	28287061				2021-06-18	
J	Greenberg, JK; Yan, Y; Carpenter, CR; Lumba-Brown, A; Keller, MS; Pineda, JA; Brownson, RC; Limbrick, DD				Greenberg, Jacob K.; Yan, Yan; Carpenter, Christopher R.; Lumba-Brown, Angela; Keller, Martin S.; Pineda, Jose A.; Brownson, Ross C.; Limbrick, David D.			Development and Internal Validation of a Clinical Risk Score for Treating Children With Mild Head Trauma and Intracranial Injury	JAMA PEDIATRICS			English	Article							BRAIN-INJURY; MULTIPLE IMPUTATION; EPIDEMIOLOGY	IMPORTANCE The appropriate treatment of children with mild traumatic brain injury (mTBI) and intracranial injury (ICI) on computed tomographic imaging remains unclear. Evidence-based risk assessments may improve patient safety and reduce resource use. OBJECTIVE To derive a risk score predicting the need for intensive care unit observation in children with mTBI and ICI. DESIGN, SETTING, AND PARTICIPANTS This retrospective analysis of the prospective Pediatric Emergency Care Applied Research Network (PECARN) head injury cohort study included patients enrolled in 25 North American emergency departments from 2004 to 2006. We included patients younger than 18 years with mTBI (Glasgow Coma Scale [GCS] score, 13-15) and ICI on computed tomography. The data analysis was conducted from May 2015 to October 2016. MAIN OUTCOMES AND MEASURES The primary outcome was the composite of neurosurgical intervention, intubation for more than 24 hours for TBI, or death from TBI. Multivariate logistic regression was used to predict the outcome. The C statistic was used to quantify discrimination, and model performance was internally validated using 10-fold cross-validation. Based on this modeling, the Children's Intracranial Injury Decision Aid score was created. RESULTS Among 15 162 children with GCS 13 to 15 head injuries who received head computed tomographic imaging in the emergency department, 839 (5.5%) had ICI. The median ages of those with and without a composite outcome were 7 and 5 years, respectively. Among those patients with ICI, 8.7%(n = 73) experienced the primary outcome, including 8.3%(n = 70) who had a neurosurgical intervention. The only clinical variable significantly associated with outcome was GCS score (odds ratio [OR], 3.4; 95% CI, 1.5-7.4 for GCS score 13 vs 15). Significant radiologic predictors included midline shift (OR, 6.8; 95% CI, 3.4-13.8), depressed skull fracture (OR, 6.5; 95% CI, 3.7-11.4), and epidural hematoma (OR, 3.4; 95% CI, 1.8-6.2). The model C statistic was 0.84 (95% CI, 0.79-0.88); the 10-fold cross-validated C statistic was 0.83. Based on this modeling, we developed the Children's Intracranial Injury Decision Aid score, which ranged from 0 to 24 points. The negative predictive value of having 0 points (ie, none of these risk factors) was 98.8% (95% CI, 97.3%-99.6%). CONCLUSIONS AND RELEVANCE Lower GCS score, midline shift, depressed skull fracture, and epidural hematoma are key risk factors for needing intensive care unit-level care in children with mTBI and ICI. Based on these results, the Children's Intracranial Injury Decision Aid score is a potentially novel tool to risk stratify this population, thereby aiding management decisions.	[Greenberg, Jacob K.; Limbrick, David D.] Washington Univ, Sch Med St Louis, Dept Neurosurg, St Louis, MO USA; [Yan, Yan; Keller, Martin S.; Brownson, Ross C.] Washington Univ, Sch Med St Louis, Dept Surg, St Louis, MO USA; [Carpenter, Christopher R.; Pineda, Jose A.] Washington Univ, Sch Med St Louis, Dept Neurol, Div Emergency Med, St Louis, MO USA; [Lumba-Brown, Angela; Pineda, Jose A.] Washington Univ, Dept Pediat, Sch Med St Louis, St Louis, MO 63130 USA; [Brownson, Ross C.] Washington Univ, Alvin J Siteman Canc Ctr, Sch Med St Louis, St Louis, MO USA; [Brownson, Ross C.] Washington Univ, Prevent Res Ctr, Sch Med St Louis, St Louis, MO USA	Greenberg, JK (corresponding author), Washington Univ, Sch Med, St Louis Childrens Hosp, 1 Childrens Pl,Ste 4S20, St Louis, MO 63110 USA.	greenbergj@wudosis.wustl.edu	Pineda, Jose/W-2806-2019; Carpenter, Christopher R./E-3720-2013	Carpenter, Christopher R./0000-0002-2603-7157; Lumba-Brown, Angela/0000-0002-9102-8791; Yan, Yan/0000-0002-5917-1475	Washington University School of Medicine Faculty Practice Plan [FPP-1501]; St Louis Children's Hospital Foundation; Health Resources Services Administration/Maternal Child Health Bureau/Emergency Medical Services for Children	This work was supported by grant FPP-1501 from the Washington University School of Medicine Faculty Practice Plan and the St Louis Children's Hospital Foundation. The Pediatric Emergency Care Applied Research Network was funded by the Health Resources Services Administration/Maternal Child Health Bureau/Emergency Medical Services for Children.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; [Anonymous], 2015, RMS REGR MOD STRAT C; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Balluffi Andrew, 2004, Pediatr Crit Care Med, V5, P547, DOI 10.1097/01.PCC.0000137354.19807.44; Bell MJ, 2016, INTENS CARE MED, V42, P1618, DOI 10.1007/s00134-016-4401-9; Boran BO, 2006, PEDIATR NEUROSURG, V42, P203, DOI 10.1159/000092355; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Burns EC, 2019, PEDIATR EMERG CARE, V35, P161, DOI 10.1097/PEC.0000000000000950; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.1186/s12916-014-0241-z]; Colville Gillian, 2009, Intensive Crit Care Nurs, V25, P72, DOI 10.1016/j.iccn.2008.10.002; Di F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142983; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hess EP, 2015, ACAD EMERG MED, V22, P856, DOI 10.1111/acem.12703; Holsti M, 2005, PEDIATR EMERG CARE, V21, P639, DOI 10.1097/01.pec.0000181426.25342.a9; Hunter B, 2015, DOING RES EMERGENCY, P139; Kanzaria HK, 2015, ACAD EMERG MED, V22, P399, DOI 10.1111/acem.12627; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mannix R, 2012, J PEDIAT, V160; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Shudy M, 2006, PEDIATRICS, V118, pS203, DOI 10.1542/peds.2006-0951B; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wang HE, 2012, ANN EMERG MED, V60, P632, DOI 10.1016/j.annemergmed.2012.02.020; Wang MY, 2000, NEUROSURGERY, V46, P1093, DOI 10.1097/00006123-200005000-00014; Wells BJ, 2008, DIABETES CARE, V31, P2301, DOI 10.2337/dc08-1047; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	39	13	13	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	APR 1	2017	171	4					342	349		10.1001/jamapediatrics.2016.4520			8	Pediatrics	Pediatrics	ER1FO	WOS:000398535500013	28192567				2021-06-18	
J	Nyam, TTE; Ao, KH; Hung, SY; Shen, ML; Yu, TC; Kuo, JR				Nyam, Tee-Tau Eric; Ao, Kam-Hou; Hung, Shu-Yu; Shen, Mei-Li; Yu, Tzu-Chieh; Kuo, Jinn-Rung			FOUR Score Predicts Early Outcome in Patients After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						FOUR score; Glasgow Coma Scale; APACHE II; Therapeutic Interventions Scoring System; Traumatic brain injury; ROC curve	GLASGOW COMA SCALE; VALIDATION; CONSCIOUSNESS; SEVERITY	The aim of the study was to determine whether the Full Outline of UnResponsiveness (FOUR) score, which includes eyes opening (E), motor function (M), brainstem reflex (B), and respiratory pattern (R), can be used as an alternate method to the Glasgow Coma Scale (GCS) in predicting intensive care unit (ICU) mortality in traumatic brain injury (TBI) patients. From January 2015 to June 2015, patients with isolated TBI admitted to the ICU were enrolled. Three advanced practice nurses administered the FOUR score, GCS, Acute Physiology and Chronic Health Evaluation II (APACHE II), and Therapeutic Intervention Scoring System (TISS) concurrently from ICU admissions. The endpoint of observation was mortality when the patients left the ICU. Data are presented as frequency with percentages, mean with standard deviation, or median with interquartile range. Each measurement tool used area under the receiver operating characteristic curve to compare the predictive power between these four tools. In addition, the difference between survival and death was estimated using the Wilcoxon rank sum test. From 55 TBI patients, males (72.73 %) were represented more than females, the mean age was 63.1 +/- 17.9, and 19 of 55 observations (35 %) had a maximum FOUR score of 16. The overall mortality rate was 14.6 %. The area under the receiver operating characteristic curve was 74.47 % for the FOUR score, 74.73 % for the GCS, 81.78 % for the APACHE II, and 53.32 % for the TISS. The FOUR score has similar predictive power of mortality compared to the GCS and APACHE II. Each of the parameters-E, M, B, and R-of the FOUR score showed a significant difference between mortality and survival group, while the verbal and eye-opening components of the GCS did not. Having similar predictive power of mortality compared to the GCS and APACHE II, the FOUR score can be used as an alternative in the prediction of early mortality in TBI patients in the ICU.	[Nyam, Tee-Tau Eric; Ao, Kam-Hou; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan; [Hung, Shu-Yu; Shen, Mei-Li; Yu, Tzu-Chieh] Chi Mei Med Ctr, Dept Nursing, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan	Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, 901 Chung Hwa Rd, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com			 [CMHCR10401]	Research has been funded by CMHCR10401 grants.	Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Fugate JE, 2010, NEUROCRIT CARE, V13, P205, DOI 10.1007/s12028-010-9407-5; Gill M, 2005, ANN EMERG MED, V45, P37, DOI 10.1016/j.annemergmed.2004.07.429; Gorji Mohammad Ali Heidari, 2015, Int J Appl Basic Med Res, V5, P92, DOI 10.4103/2229-516X.157152; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; Jalali R, 2014, CRIT CARE RES PRACT, V2014, DOI 10.1155/2014/289803; KEENE AR, 1983, CRIT CARE MED, V11, P1, DOI 10.1097/00003246-198301000-00001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lambert J, 2008, SAS GLOB FOR 2008; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Padilha KG, 2007, INTENS CRIT CARE NUR, V23, P162, DOI 10.1016/j.iccn.2006.07.004; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Stead LG, 2009, NEUROCRIT CARE, V10, P50, DOI 10.1007/s12028-008-9145-0; Stevens RD, 2006, CRIT CARE MED, V34, P31, DOI 10.1097/01.CCM.0000194534.42661.9F; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Weiss N, 2009, REV NEUROL-FRANCE, V165, P796, DOI 10.1016/j.neurol.2009.01.045; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	23	13	13	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					225	231		10.1007/s12028-016-0326-y			7	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300010	27873233				2021-06-18	
J	Robertson, CS; McCarthy, JJ; Miller, ER; Levin, H; McCauley, SR; Swank, PR				Robertson, Claudia S.; McCarthy, James J.; Miller, Emmy R.; Levin, Harvey; McCauley, Stephen R.; Swank, Paul R.		Mission Connect Mild TBI	Phase II Clinical Trial of Atorvastatin in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						clinical trial; cognitive function; traumatic brain injury	INTRACEREBRAL HEMORRHAGE; NEURONAL SURVIVAL; SIMVASTATIN; RATS; INCREASE; STATINS; NEUROGENESIS; ANGIOGENESIS; THROMBOSIS; REDUCTION	Statins constitute a class of medications commonly used in the treatment of elevated cholesterol. However, in experimental studies, statins also have other non-cholesterol-mediated mechanisms of action, which may have neuroprotective effects. The aim of this study was to determine whether administration of atorvastatin for 7 days post-injury would improve neurological recovery in patients with mild traumatic brain injury (mTBI). The hypothesis was that atorvastatin administration would reduce post-concussion symptoms and also that atorvastatin administration for 1 week post-injury would be safe. One hundred forty patients with mTBI were planned to be enrolled and randomly assigned to receive atorvastatin 1 mg/kg (up to 80 mg/kg) per day or placebo for 7 days starting within 24 h of injury. Assessments of post-concussion syndrome, post-traumatic stress and depressive symptoms, cognition, memory, verbal fluency, functional, and work status were performed at baseline, 1 week, and 1 and 3 months. The result on the Rivermead Post-Concussion Symptoms Questionnaire at 3 months was the primary outcome. Enrollment in the trial was stopped early because of difficulty in recruiting sufficient numbers of subjects. Fifty-two patients with mTBI were enrolled; 28 patients received atorvastatin and 24 received placebo. The median Rivermead score was 2 for the atorvastatin group, compared to 3.5 for the placebo group, at 3 months post-injury (chi(2) (1) = 0.0976; p = 0.7547). The change in the Rivermead score between baseline and 3 months was also analyzed. The median decrease in score was 4 for the atorvastatin group and 10.5 for the placebo group (chi(2) (1) = 0.8750; p = 0.3496). No serious adverse events occurred, and there was no significant difference in the incidence of adverse events in the two treatment groups. Atorvastatin administration for 7 days post-injury was safe, but there were no significant differences in neurological recovery post-mTBI with atorvastatin.	[Robertson, Claudia S.; Miller, Emmy R.; Levin, Harvey; McCauley, Stephen R.] Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA; [McCarthy, James J.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Levin, Harvey] Michael E De Bakey Vet Affairs Med Ctr, Houston, TX USA; [Swank, Paul R.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Houston, TX 77030 USA; [Miller, Emmy R.] Virginia Commonwealth Univ, Richmond, VA USA	Robertson, CS (corresponding author), Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA.	claudiar@bcm.edu			Department of DefenseUnited States Department of Defense [W81XWH-08-2-0132, W81XWH-08-2-0131, W81XWH-08-2-0133, W81XWH-08-2-0142]	This study was supported by the Department of Defense (grant nos. W81XWH-08-2-0132 [Robertson], W81XWH-08-2-0131 [McCarthy], W81XWH-08-2-0133 [Levin], and W81XWH-08-2-0142 [Swank]).	Amarenco P, 2006, NEW ENGL J MED, V355, P549; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Department of Defense, 2007, TRAUM BRAIN INJ DEF; Farooqui AA, 2007, BRAIN RES REV, V56, P443, DOI 10.1016/j.brainresrev.2007.09.004; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Indraswari F, 2012, J NEUROTRAUM, V29, P1388, DOI 10.1089/neu.2011.2117; Johnson-Anuna LN, 2007, J NEUROCHEM, V101, P77, DOI 10.1111/j.1471-4159.2006.04375.x; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Lu DY, 2004, J NEUROTRAUM, V21, P1756, DOI 10.1089/0897715042664885; Lu DY, 2004, J NEUROSURG, V101, P822, DOI 10.3171/jns.2004.101.5.0822; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Lu DY, 2004, J NEUROSURG, V101, P813, DOI 10.3171/jns.2004.101.5.0813; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Mountney A, 2016, J NEUROTRAUM, V33, P567, DOI 10.1089/neu.2015.4130; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Naval NS, 2008, NEUROCRIT CARE, V8, P6, DOI 10.1007/s12028-007-0080-2; Pan YS, 2014, CNS NEUROSCI THER, V20, P548, DOI 10.1111/cns.12274; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; Stoll Lynn L, 2005, Timely Top Med Cardiovasc Dis, V9, pE1; Tapia-Perez JH, 2008, J NEUROTRAUM, V25, P1011, DOI 10.1089/neu.2008.0554; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369	32	13	13	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1394	1401		10.1089/neu.2016.4717			8	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600009	28006970				2021-06-18	
J	Brandel, MG; Hirshman, BR; McCutcheon, BA; Tringale, K; Carroll, K; Richtand, NM; Perry, W; Chen, CC; Carter, BS				Brandel, Michael G.; Hirshman, Brian R.; McCutcheon, Brandon A.; Tringale, Kathryn; Carroll, Kate; Richtand, Neil M.; Perry, William; Chen, Clark C.; Carter, Bob S.			The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mortality; OSHPD; outcomes; psychiatric comorbidities; TBI	HOSPITAL MORTALITY; SCHIZOPHRENIA; DISORDERS; GLUTAMATE; HEALTH; REHABILITATION; COMPLICATIONS; DEPRESSION; DISCHARGE; RELEASE	It is well established that traumatic brain injury (TBI) is associated with the development of psychiatric disorders. However, the impact of psychiatric disorders on TBI outcome is less well understood. We examined the outcomes of patients who experienced a traumatic subdural hemorrhage and whether a comorbid psychiatric disorder was associated with a change in outcome. A retrospective observational study was performed in the California Office of Statewide Health Planning and Development (OSHPD) and the Nationwide Inpatient Sample (NIS). Patients hospitalized for acute subdural hemorrhage were identified using International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes. Patients with coexisting psychiatric diagnoses were identified. Outcomes studied included mortality and adverse discharge disposition. In OSPHD, diagnoses of depression (OR=0.64, p<0.001), bipolar disorder (OR=0.45, p<0.05), and anxiety (OR=0.37, p<0.001) were associated with reduced mortality during hospitalization for TBI, with a trend toward psychosis (OR=0.56, p=0.08). Schizophrenia had no effect. Diagnoses of psychosis (OR=2.12, p<0.001) and schizophrenia (OR=2.60, p<0.001) were associated with increased adverse discharge. Depression and bipolar disorder had no effect, and anxiety was associated with reduced adverse discharge (OR=0.73, p=0.01). Results were confirmed using the NIS. Analysis revealed novel associations between coexisting psychiatric diagnoses and TBI outcomes, with some subgroups having decreased mortality and increased adverse discharge. Potential mechanisms include pharmacological effects of frequently prescribed psychiatric medications, the pathophysiology of individual psychiatric disorders, or under-coding of psychiatric illness in the most severely injured patients. Because pharmacological mechanisms, if validated, might lead to improved outcome in TBI patients, further studies may provide significant public health benefit.	[Brandel, Michael G.; Hirshman, Brian R.; Tringale, Kathryn; Carroll, Kate] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Chen, Clark C.; Carter, Bob S.] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA; [Hirshman, Brian R.] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [McCutcheon, Brandon A.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [McCutcheon, Brandon A.] Mayo Clin Fdn, Rochester, MN USA; [Richtand, Neil M.; Perry, William] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Richtand, Neil M.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA USA	Carter, BS (corresponding author), Univ Calif San Diego, 3855 Hlth Sci Dr,MC 0987, La Jolla, CA 92093 USA.	bobcarter@ucsd.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324	Czech Duck Research Fellowship	We thank Dr. Hoi Sang U for his guidance and endowment of the Czech Duck Research Fellowship, which funded this project.	Abrams TE, 2008, J GEN INTERN MED, V23, P317, DOI 10.1007/s11606-008-0518-z; Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; Albrecht JS, 2012, AM J MED QUAL, V27, P503, DOI 10.1177/1062860612436576; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Berends AC, 2005, CNS DRUG REV, V11, P379; Boland RJ, 1996, GEN HOSP PSYCHIAT, V18, P28, DOI 10.1016/0163-8343(95)00089-5; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1928, DOI 10.1016/j.jocn.2015.05.034; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Daumit GL, 2006, ARCH GEN PSYCHIAT, V63, P267, DOI 10.1001/archpsyc.63.3.267; Dawodu ST, 2015, TRAUMATIC BRAIN INJU; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dossa A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-311; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Feinberg M, 2015, SEMIN NEUROL, V35, P50, DOI 10.1055/s-0035-1544244; FRENK H, 1983, BRAIN RES REV, V6, P197, DOI 10.1016/0165-0173(83)90039-5; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hoang U, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5422; Hoffman S, 2013, J LAW MED ETHICS, V41, P56, DOI 10.1111/jlme.12040; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Kendler KS, 2010, ARCH GEN PSYCHIAT, V67, P1120, DOI 10.1001/archgenpsychiatry.2010.136; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; MARGOLIS RL, 1994, PSYCHOSOMATICS, V35, P485, DOI 10.1016/S0033-3182(94)71743-6; Meller R, 2002, J NEUROSCI RES, V67, P399, DOI 10.1002/jnr.10126; Meyer JM, 2009, ACTA PSYCHIAT SCAND, V119, P4, DOI 10.1111/j.1600-0447.2008.01317.x; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Patil CG, 2007, CANCER, V110, P625, DOI 10.1002/cncr.22819; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prina AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034821; Rathore SS, 2008, ARCH GEN PSYCHIAT, V65, P1402, DOI 10.1001/archpsyc.65.12.1402; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Wang SJ, 2005, SYNAPSE, V55, P156, DOI 10.1002/syn.20104; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068; YAMAMOTO BK, 1992, J NEUROCHEM, V58, P1736, DOI 10.1111/j.1471-4159.1992.tb10048.x	42	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1005	1016		10.1089/neu.2016.4504			12	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200005	27573722				2021-06-18	
J	Carlson, SW; Yan, H; Dixon, CE				Carlson, Shaun W.; Yan, Hong; Dixon, C. Edward			Lithium increases hippocampal SNARE protein abundance after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Synapse; SNARE; Hippocampus; Cognition; Vesicle	CONTROLLED CORTICAL IMPACT; SYNAPTIC VESICLE DOCKING; CYSTEINE STRING PROTEIN; REDUCED EVOKED RELEASE; IN-VITRO; RAT-BRAIN; NEUROTROPHIC FACTOR; MESSENGER-RNA; KNOCKOUT MICE; CSP-ALPHA	Rodent models of traumatic brain injury (TBI) reproduce secondary injury sequela and cognitive impairments observed in patients afflicted by a TBI. Impaired neurotransmission has been reported in the weeks following experimental TBI, and may be a contributor to behavioral dysfunction. The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex, the machinery facilitating vesicular docking and fusion, is a highly-conserved mechanism important for neurotransmission. Following TBI, there is a reduction in both the formation of the SNARE complex and the abundance of multiple SNARE proteins, including the chaperone protein cysteine string protein alpha (CSP alpha). Treatment with lithium in na ve rats reportedly increases the expression of CSPa. In the context of TBI, brain-injured rats treated with lithium exhibit improved outcome in published reports, but the mechanisms underlying the improvement are poorly understood. The current study evaluated the effect of lithium administration on the abundance of SNARE proteins and SNARE complex formation, hemispheric tissue loss, and neurobehavioral performance following controlled cortical impact (CCI). Sprague Dawley rats were subjected to CCI or sham injury, and treated daily with lithium chloride or vehicle for up to 14 days. Administration of lithium after TBI modestly improved spatial memory at 14 days post-injury. Semi-quantitative immunoblot analysis of hippocampal lysates revealed that treatment with lithium attenuated reductions in key SNARE proteins and SNARE complex formation at multiple time points post-injury. These findings highlight that treatment with lithium increased the abundance of synaptic proteins that facilitate neurotransmission and may contribute to improved cognitive function after TBI. Published by Elsevier Inc.	Univ Pittsburgh, Dept Neurosurg, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA	Dixon, CE (corresponding author), Safar Ctr Resuscitat Res, Dept Neurosurg, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixoec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-NS40125, NIH-NS060672, 1-F32NS090748]; VA Healthcare System [VAI01RX001127]; Walter L. Copeland Fund of The Pittsburgh Foundation [UN2014-73618]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091062, F32NS090748, R01NS079061, R01NS060672, R01NS040125] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [NIH-NS40125 (CED), NIH-NS060672 (CED), 1-F32NS090748 (SWC)] the VA Healthcare System [VAI01RX001127 (CED)] and The Walter L. Copeland Fund of The Pittsburgh Foundation [UN2014-73618 (SWC)].	Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cordeiro ML, 2003, J NEUROSCI RES, V73, P865, DOI 10.1002/jnr.10707; Cordeiro ML, 2000, J NEUROCHEM, V74, P2365, DOI 10.1046/j.1471-4159.2000.0742365.x; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Fiorentini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014382; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Jacobsen JPR, 2004, BRAIN RES, V1024, P183, DOI 10.1016/j.brainres.2004.07.065; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Kim YH, 2011, J NEUROSCI RES, V89, P1666, DOI 10.1002/jnr.22700; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Scarr Elizabeth, 2012, Clin Psychopharmacol Neurosci, V10, P25, DOI 10.9758/cpn.2012.10.1.25; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Son H, 2003, J NEUROCHEM, V85, P872, DOI 10.1046/j.1471-4159.2003.01725.x; Sudhof TC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005637; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vardar G, 2016, J NEUROSCI, V36, P7911, DOI 10.1523/JNEUROSCI.1314-16.2016; Wada A, 2005, J PHARMACOL SCI, V99, P307, DOI 10.1254/jphs.CRJ05009X; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; Youdim MBH, 2004, NEUROPHARMACOLOGY, V46, P1130, DOI 10.1016/j.neuropharm.2004.02.005; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	50	13	14	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2017	289						55	63		10.1016/j.expneurol.2016.12.006			9	Neurosciences	Neurosciences & Neurology	EJ9JF	WOS:000393541700006	28011122	Green Accepted			2021-06-18	
J	Ellis, MJ; Ritchie, L; Selci, E; Chu, S; McDonald, P; Russell, K				Ellis, Michael J.; Ritchie, Lesley; Selci, Erin; Chu, Stephanie; McDonald, Patrick; Russell, Kelly			Googling Concussion Care: A Critical Appraisal of Online Concussion Healthcare Providers and Practices in Canada	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; concussion clinic; healthcare provider; online; Google	INTERNATIONAL-CONFERENCE; SPORT; MANAGEMENT; STATEMENT	Background:Concussion is an emerging public health concern, but care of patients with a concussion is presently unregulated in Canada.Methods:Independent, blinded Google Internet searches were conducted for the terms concussion and concussion clinic and each of the Canadian provinces and territories. The first 10 to 15 concussion healthcare providers per province were identified. A critical appraisal of healthcare personnel and services offered on the provider's Web site was conducted.Results:Fifty-eight concussion healthcare providers were identified using this search methodology. Only 40% listed the presence of an on-site medical doctor (M.D.) as a member of the clinical team. Forty-seven percent of concussion healthcare providers advertised access to a concussion clinic, program, or center on their Web site. Professionals designated as team leaders, directors, or presidents among concussion clinics, programs, and centers included a neuropsychologist (15%), sports medicine physician (7%), neurologist (4%), and neurosurgeon (4%). Services offered by providers included baseline testing (67%), physiotherapy (50%), and hyperbaric oxygen therapy (2%).Conclusions:This study indicates that there are numerous concussion healthcare providers in Canada offering diverse services with clinics operated by professionals with varying levels of training in traumatic brain injury. In some cases, the practices of these concussion clinics do not conform to current expert consensus guidelines.	[Ellis, Michael J.; McDonald, Patrick] Canada North Concuss Network, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.; Selci, Erin; Chu, Stephanie; McDonald, Patrick; Russell, Kelly] Canada North Concuss Network, Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.; McDonald, Patrick] Univ Manitoba, Sect Neurosurg, Canada North Concuss Network, Winnipeg, MB, Canada; [Ellis, Michael J.; Ritchie, Lesley; McDonald, Patrick] Canada North Concuss Network, Pan Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; Selci, Erin; Chu, Stephanie; McDonald, Patrick; Russell, Kelly] Children Hosp Res Inst Manitoba, Canada North Concuss Network, Winnipeg, MB, Canada; [Ritchie, Lesley] Canada North Concuss Network, Clin Hlth Psychol, Winnipeg, MB, Canada	Ellis, MJ (corresponding author), Pan Am Clin, Pan Am Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		Russell, Kelly/0000-0002-9159-9201			Carson J, 2006, CAN FAM PHYSICIAN, V52, P756; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36	7	13	13	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2017	27	2					179	182		10.1097/JSM.0000000000000305			4	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	EM8PJ	WOS:000395573100013	26867204				2021-06-18	
J	Lund-Johansen, M; Laeke, T; Tirsit, A; Munie, T; Abebe, M; Sahlu, A; Biluts, H; Wester, K				Lund-Johansen, Morten; Laeke, Tsegazeab; Tirsit, Abenezer; Munie, Tadios; Abebe, Mersha; Sahlu, Abat; Biluts, Hagos; Wester, Knut			An Ethiopian Training Program in Neurosurgery with Norwegian Support	WORLD NEUROSURGERY			English	Article						Education; Neurosurgery; Sub-Sahara; Training	HEAD CIRCUMFERENCE; DATA-COLLECTION; GLOBAL SURGERY; NEUROTRAUMA; SITUATION; EDUCATION; TRAUMA; HEALTH	After a 4-year planning period, a joint Ethiopian/Norwegian training program in neurosurgery was started in June 2006. The collaborating partners were Addis Ababa University; Department of Surgery, Tikur Anbessa Specialized Hospital; University of Bergen; Haukeland University Hospital; and Myungsung Christian Medical Center, a Korean missionary hospital in Addis Ababa, Ethiopia. A memorandum of understanding was signed at dean/chief executive officer levels. Although other initiatives have been involved in supporting neurosurgery in Addis Ababa during the same period, this institutionally founded program has been the main external contributor to neurosurgical capacity building through the education of 21 Ethiopian neurosurgeons, and in supporting a sustainable environment for neurosurgical training within a network of 5 centers in Addis Ababa. This article gives an account of the strategies underlying the program planning, the history of the program, and on the experience gained by it. Finally, ethical problems and challenges encountered in the program are discussed.	[Lund-Johansen, Morten; Wester, Knut] Univ Bergen, Dept Clin Med K1, Bergen, Norway; [Lund-Johansen, Morten; Wester, Knut] Haukeland Hosp, Dept Neurosurg, Bergen, Norway; [Laeke, Tsegazeab; Tirsit, Abenezer; Munie, Tadios; Abebe, Mersha; Sahlu, Abat; Biluts, Hagos] Univ Addis Ababa, Tikur Anbessa Specialized Hosp, Dept Surg, Addis Ababa, Ethiopia	Lund-Johansen, M (corresponding author), Univ Bergen, Dept Clin Med K1, Bergen, Norway.; Lund-Johansen, M (corresponding author), Haukeland Hosp, Dept Neurosurg, Bergen, Norway.	mljo@helse-bergen.no					Amare EB, 2015, WORLD NEUROSURG, V84, P1566, DOI 10.1016/j.wneu.2015.08.045; Bagan M, 2010, WORLD NEUROSURG, V73, P289, DOI 10.1016/j.wneu.2010.03.007; Bernstein M, 2004, CAN J SURG, V47, P170; Carlson L, 2015, WORLD J SURG, V39, P813, DOI 10.1007/s00268-014-2938-8; El Khamlichi A, 2001, NEUROSURGERY, V48, P1344, DOI 10.1097/00006123-200106000-00034; Eriksen AA, 2016, WORLD NEUROSURG, V91, P592, DOI 10.1016/j.wneu.2016.04.132; Idowu OE, 2014, INJURY, V45, P1717, DOI 10.1016/j.injury.2014.05.028; Lavy C, 2011, WORLD J SURG, V35, P262, DOI 10.1007/s00268-010-0885-6; Lehre MA, 2015, J NEUROSURG-SPINE, V23, P772, DOI 10.3171/2015.3.SPINE141282; Meara JG, 2015, SURGERY, V157, P834, DOI 10.1016/j.surg.2015.02.009; Mefire AC, 2010, S AFR J SURG, V48, P90; Mitchell KB, 2013, CAN J SURG, V56, P199, DOI 10.1503/cjs.028911; O'Flynn E, 2016, WORLD J SURG, V40, P2620, DOI 10.1007/s00268-016-3601-3; Peter Noel Aaron, 2015, Lancet, V385 Suppl 2, pS43, DOI 10.1016/S0140-6736(15)60838-8; Prinja S, 2015, ESSENTIAL SURG DIS C, V1, P317; Sahlu A, 2016, J NEUROSCI RURAL PRA, V7, P143, DOI 10.4103/0976-3147.165357; Sahlu A, 2016, ACTA NEUROCHIR, V158, P611, DOI 10.1007/s00701-016-2710-y; Shawar YR, 2015, LANCET GLOB HEALTH, V3, pE487, DOI 10.1016/S2214-109X(15)00098-4; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Wall LL, 2006, INT UROGYNECOL J, V17, P559, DOI 10.1007/s00192-005-0056-8	20	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2017	99						403	408		10.1016/j.wneu.2016.12.051			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EP2CH	WOS:000397190100057	28017754				2021-06-18	
J	O'Day, KM; Koehling, EM; Vollavanh, LR; Bradney, D; May, JM; Breedlove, KM; Breedlove, EL; Blair, P; Nauman, EA; Bowman, TG				O'Day, Kathleen M.; Koehling, Elizabeth M.; Vollavanh, Lydia R.; Bradney, Debbie; May, James M.; Breedlove, Katherine M.; Breedlove, Evan L.; Blair, Price; Nauman, Eric A.; Bowman, Thomas G.			Comparison of head impact location during games and practices in Division III men's lacrosse players	CLINICAL BIOMECHANICS			English	Article						Sensor; Linear acceleration; Rotational acceleration	COLLEGIATE FOOTBALL PLAYERS; CONCUSSION; ACCELERATIONS; GENDER	Background: Head impacts have been studied extensively in football, but little similar research has been conducted in men's lacrosse. It is important to understand the location and magnitude of head impacts during men's lacrosse to recognize the risk of head injury. Methods: Descriptive epidemiology study set on collegiate lacrosse fields. Eleven men's lacrosse players (age = 20.9 +/- 1.13 years, mass = 83.91 +/- 9.04 kg, height = 179.88 +/- 5.99 cm) volunteered to participate. We applied X2 sensors behind the right ear of participants for games and practices. Sensors recorded data on linear and rotational accelerations and the location of head impacts. We calculated incidence rates per 1000 exposures with 95% confidence intervals for impact locations and compared the effect of impact location on linear and rotational accelerations with Kruskal-Wallis tests. Findings: We verified 167 head impacts (games = 112; practices = 55). During games, the incidence rate was 651.16 (95% confidence interval = 530.57-771.76). The high and low incidence rates for head impact locations during games were: side = 410.7 (95% confidence interval = 292.02-529.41) and top = 26.79 (95% confidence interval = 3.53-57.10). For games and practices combined, the impact locations did not significantly affect linear (chi(2)(3) = 6.69, P = 0.08) or rotational acceleration (chi(2)(3) = 6.34, P = 0.10). Interpretation: We suggest further research into the location of head impacts during games and practices. We also suggest player and coach education on head impacts as well as behavior modification in men's lacrosse athletes to reduce the incidence of impacts to the side of the head in an effort to reduce potential injury. (C) 2017 Elsevier Ltd. All rights reserved.	[O'Day, Kathleen M.; Koehling, Elizabeth M.; Vollavanh, Lydia R.; Bradney, Debbie; Blair, Price; Bowman, Thomas G.] Lynchburg Coll, Lynchburg, VA 24501 USA; [May, James M.] Univ Idaho, Moscow, ID 83843 USA; [Breedlove, Katherine M.; Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, W Lafayette, IN 47907 USA; [O'Day, Kathleen M.] 289 Railroad Ave, Norwood, MA 02062 USA	O'Day, KM (corresponding author), Lynchburg Coll, Lynchburg, VA 24501 USA.; O'Day, KM (corresponding author), 289 Railroad Ave, Norwood, MA 02062 USA.	koday@marathonphysicaltherapy.com; koehling.e@gmail.com; lvollavanh@gmail.com; bradney@lynchburg.edu; mayj@uidaho.edu; Blair.p@lynchburg.edu; bowman.t@lynchburg.edu	Bowman, Thomas/AAA-3036-2020; Bowman, Tom/AAU-6473-2020	Bowman, Thomas/0000-0002-0034-2946; 			Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Breedlove K.M., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cummiskey B., 2016, J SPORTS ENG TECH, P1; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kindschi K., 2014, THESIS; Krasuski JS, 1998, BIOL PSYCHIAT, V43, P60, DOI 10.1016/S0006-3223(97)00013-9; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Morrison M., 2015, J BIOSENS BIOELECTRO, V6, P1; Nevens D., 2015, PROOCEDIA ENG, V112, P175; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Patton DA, 2016, REV INSTRUMENTED EQU; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Reynolds B.B., 2016, J NEUROTRAUMA; Rowson S., 2009, J BIOMECH ENG, V13, P1; Squire LR, 1996, HIPPOCAMPUS, V6, P546; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Trick E., 2013, NCAA SPORTS SPONSORS; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	22	13	13	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	MAR	2017	43						23	27		10.1016/j.clinbiomech.2017.01.013			5	Engineering, Biomedical; Orthopedics; Sport Sciences	Engineering; Orthopedics; Sport Sciences	ES9DD	WOS:000399855400004	28178579				2021-06-18	
J	Palm, S; Ronnback, L; Johansson, B				Palm, Samuel; Ronnback, Lars; Johansson, Birgitta			LONG-TERM MENTAL FATIGUE AFTER TRAUMATIC BRAIN INJURY AND IMPACT ON EMPLOYMENT STATUS	JOURNAL OF REHABILITATION MEDICINE			English	Article						mental fatigue; traumatic brain injury; employment status; post-concussion	FOLLOW-UP; HEAD-INJURY; SYMPTOMS; RECOVERY; RETURN; METHYLPHENIDATE; DISABILITY; COMPLAINTS; FREQUENCY; QUALITY	Objective: Long-term mental fatigue following traumatic brain injury is endorsed as one of the most distressing symptoms, interfering considerably with return to work and social life. The objective of this cross-sectional study was to estimate the prevalence of long-term mental fatigue after traumatic brain injury and to evaluate its association with employment status. Methods: All patients (age range 19-65 years) diagnosed with traumatic brain injury irrespective of severity at Kungalv Hospital, Kungalv, Sweden, over a period of 5 years (n = 613) were invited by post to respond to questions about their injury, employment status and complete a questionnaire about mental fatigue, the Mental Fatigue Scale (MFS). Results: A response rate of 38% was achieved. Among respondents, 39% scored above the MFS cutoff of 10.5. Higher MFS scores were associated with decreased employment status (p < 0.001). Rating on the MFS was higher for women, for those with a longer initial duration of acute post-traumatic brain injury symptoms, and for those who had previously experienced a traumatic brain injury. No association was found between mental fatigue and age, severity of injury, or time since injury. Conclusion: Long-term mental fatigue was frequent among people who had experienced a traumatic brain injury, and a higher rating on the MFS was associated with decreased employment status.	[Palm, Samuel; Ronnback, Lars; Johansson, Birgitta] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden	Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Bla Str 7, SE-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142	Health & Medical Care Committee of the Region, Vastra Gotaland	The study was funded by grants from The Health & Medical Care Committee of the Region, Vastra Gotaland.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2015, MINDFULNESS, V6, P1356, DOI 10.1007/s12671-015-0406-7; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	42	13	14	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2017	49	3					228	233		10.2340/16501977-2190			6	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	EQ4MA	WOS:000398050300006	28150857	DOAJ Gold			2021-06-18	
J	Ratiu, I; Azuma, T				Ratiu, Ileana; Azuma, Tamiko			Language control in bilingual adults with and without history of mild traumatic brain injury	BRAIN AND LANGUAGE			English	Article						Traumatic brain injury; Bilingualism; Executive function; Language control	WORKING-MEMORY; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; EYE-MOVEMENTS; BIMODAL BILINGUALS; STRESS-DISORDER; TASK; REPRESENTATION; 2ND-LANGUAGE; ATTENTION	Adults with a history of traumatic brain injury often show deficits in executive functioning (EF), including the ability to inhibit, switch, and attend to tasks. These abilities are critical for language processing in bilinguals. This study examined the effect of mild traumatic brain injury (mTBI) on EF and language processing in bilinguals using behavioral and eye-tracking measures. Twenty-two bilinguals with a history of mTBI and twenty healthy control bilinguals were administered executive function and language processing tasks. Bilinguals with a history of mTBI showed deficits in specific EFs and had higher rates of language processing errors than healthy control bilinguals. Additionally, individuals with a history of mTBI have different patterns of eye movements during reading than healthy control bilinguals. These data suggest that language processing deficits are related to underlying EF abilities. The findings provide important information regarding specific EF and language control deficits in bilinguals with a history mTBI. (C) 2016 Elsevier Inc. All rights reserved.	[Ratiu, Ileana; Azuma, Tamiko] Arizona State Univ, Tempe, AZ 85287 USA; [Ratiu, Ileana] Midwestern Univ, Glendale, AZ USA; [Azuma, Tamiko] Arizona State Univ, Dept Speech & Hearing Sci, POB 870102, Tempe, AZ 85287 USA	Ratiu, I (corresponding author), Midwestern Univ, Dept Speech Language Pathol, 19555 N 59th Ave, Glendale, AZ 85308 USA.	iratiu@midwestern.edu; azuma@asu.edu			American Speech Language-Hearing Foundation; Graduate and Professional Student Association of Arizona State University	This research was supported in part by the American Speech Language-Hearing Foundation and the Graduate and Professional Student Association of Arizona State University.	Abutalebi J, 2008, ACTA PSYCHOL, V128, P466, DOI 10.1016/j.actpsy.2008.03.014; Abutalebi J, 2008, CEREB CORTEX, V18, P1496, DOI 10.1093/cercor/bhm182; Altarriba J, 1996, MEM COGNITION, V24, P477, DOI 10.3758/BF03200936; Anderson TM, 2010, J CLIN EXP NEUROPSYC, V32, P1074, DOI 10.1080/13803391003733560; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Betthauser LM, 2012, NEUROPSYCHOL REV, V22, P35, DOI 10.1007/s11065-012-9191-4; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Cooper J. D., 1993, NEUROEPIDEMIOLOGY, V2, P70; Corsi PM, 1972, THESIS; Court JH, 1998, MANUAL RAVENS PROGR; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dijkstra T, 2002, BILINGUALISM LANGUAG, V5; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Dunabeitia JA, 2010, EXP PSYCHOL, V57, P98, DOI 10.1027/1618-3169/a000013; Dunn L. M., 1997, PPVT 3 PEABODY PICTU; Emmorey K, 2008, PSYCHOL SCI, V19, P1201, DOI 10.1111/j.1467-9280.2008.02224.x; ESLINGER PJ, 1995, NEUROREHABILITATION, V5, P161, DOI 10.3233/NRE-1995-5206; Fabbro F, 2001, BRAIN LANG, V79, P211, DOI 10.1006/brln.2001.2481; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Garbin G, 2010, NEUROIMAGE, V53, P1272, DOI 10.1016/j.neuroimage.2010.05.078; Garner JK, 2009, J PSYCHOL, V143, P405, DOI 10.3200/JRLP.143.4.405-426; GILHOOLY KJ, 1980, BEHAV RES METH INSTR, V12, P395, DOI 10.3758/BF03201693; Gollan TH, 2014, PSYCHOL SCI, V25, P585, DOI 10.1177/0956797613512661; Gollan TH, 2011, PSYCHOL SCI, V22, P1155, DOI 10.1177/0956797611417002; Green D. W., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/s1366728998000133.]; Green DW, 2013, J COGN PSYCHOL, V25, P515, DOI 10.1080/20445911.2013.796377; Hernandez AE, 2009, BRAIN LANG, V109, P133, DOI 10.1016/j.bandl.2008.12.005; Hunt AW, 2013, NEUROPSYCHOL REHABIL, V23, P914, DOI 10.1080/09602011.2013.835739; Illes J, 1999, BRAIN LANG, V70, P347, DOI 10.1006/brln.1999.2186; Jimenez N, 2013, PEDIATRICS, V131, pE1850, DOI 10.1542/peds.2012-3354; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kucera H, 1967, COMPUTATIONAL ANAL P; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Lehtonen MH, 2005, NEUROREPORT, V16, P607, DOI 10.1097/00001756-200504250-00018; Leunissen I, 2014, CORTEX, V51, P67, DOI 10.1016/j.cortex.2013.10.009; Libben MR, 2009, J EXP PSYCHOL LEARN, V35, P381, DOI 10.1037/a0014875; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lorenzen B, 2008, AM J SPEECH-LANG PAT, V17, P299, DOI 10.1044/1058-0360(2008/026); Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Marian V, 2003, BRAIN LANG, V86, P70, DOI 10.1016/S0093-934X(02)00535-7; Marian V., 2003, BILING-LANG COGN, V6, P97; Marien P, 2005, NEUROCASE, V11, P385, DOI 10.1080/13554790500212880; Marion V, 2007, J SPEECH LANG HEAR R, V50, P940, DOI 10.1044/1092-4388(2007/067); Marrero MZ, 2002, CLIN PSYCHOL REV, V22, P463, DOI 10.1016/S0272-7358(01)00109-X; Martin N., 2012, RECEPTIVE ONE WORD P; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Ozen LJ, 2010, J INT NEUROPSYCH SOC, V16, P556, DOI 10.1017/S1355617710000202; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Pavio A., 1968, J EXPT PSYCHOL M 2 S, V76; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; Prior A, 2011, J INT NEUROPSYCH SOC, V17, P682, DOI 10.1017/S1355617711000580; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1986, MEM COGNITION, V14, P191, DOI 10.3758/BF03197692; RAYNER K, 1979, PERCEPTION, V8, P21, DOI 10.1068/p080021; Rayner K., 2011, OXFORD HDB EYE MOVEM, P751, DOI [10.1093/oxfordhb/9780199539789.013.0041, DOI 10.1093/OXFORDHB/9780199539789.013.0041]; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Schneider W., 2002, E PRIME VERSION 1 0; Sebastian-Galles N., 2000, LEXESP LEXICO INFORM; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Slovarp L, 2012, BRAIN INJURY, V26, P48, DOI 10.3109/02699052.2011.635355; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spivey MJ, 1999, PSYCHOL SCI, V10, P281, DOI 10.1111/1467-9280.00151; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Terry DP, 2012, BRAIN INJURY, V26, P1684, DOI 10.3109/02699052.2012.722259; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Unsworth N, 2007, PSYCHOL BULL, V133, P1038, DOI 10.1037/0033-2909.133.6.1038; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zou LJ, 2012, NEUROIMAGE, V62, P1367, DOI 10.1016/j.neuroimage.2012.05.062	80	13	13	1	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	MAR	2017	166						29	39		10.1016/j.bandl.2016.12.004			11	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	EL4AH	WOS:000394561800003	28039735				2021-06-18	
J	Scandola, M; Aglioti, SM; Avesani, R; Bertagnoni, G; Marangoni, A; Moro, V				Scandola, Michele; Aglioti, Salvatore Maria; Avesani, Renato; Bertagnoni, Gianettore; Marangoni, Anna; Moro, Valentina			Corporeal illusions in chronic spinal cord injuries	CONSCIOUSNESS AND COGNITION			English	Article						Spinal cord injuries; Corporeal illusions; Embodied cognition theory; Pain; Body representation	RUBBER-HAND ILLUSION; MOTOR IMAGERY; BODY-IMAGE; PARAPLEGIC PATIENTS; PHANTOM SENSATIONS; PERIPERSONAL SPACE; MENTAL ROTATION; ITALIAN VERSION; HUMAN BRAIN; PAIN	While several studies have investigated corporeal illusions in patients who have suffered from a stroke or undergone an amputation, only anecdotal or single case reports have explored this phenomenon after spinal cord injury. Here we examine various different types of bodily misperceptions in a comparatively large group of 49 people with spinal cord injury in the post-acute and chronic phases after the traumatic lesion onset. An extensive battery of questionnaires concerning a variety of body related feelings was administered and the results were correlated to the main clinical variables. Six different typologies of Corporeal Illusion emerged: Sensations of Body Loss; Body-Part Misperceptions; Somatoparaphrenia-like sensations; Disownership-like sensations; Illusory motion and Misoplegia. All of these (with the exception of Misoplegia) are modulated by clinical variables such as pain (visceral, neuropathic and musculoskeletal), completeness of the lesion, level of the lesion and the length of time since lesion onset. In contrast, no significant correlations between bodily illusions and personality variables were found. These results support data indicating that at least some cognitive functions (in particular the body, action and space representations) are embodied and that somatosensory input and motor output may be necessary to build and maintain a typical self-body representation. (C) 2017 Elsevier Inc. All rights reserved.	[Scandola, Michele; Moro, Valentina] Univ Verona, Dept Human Sci, NPsy Lab VR, Verona, Italy; [Scandola, Michele; Aglioti, Salvatore Maria] IRCCS Fdn S Lucia, Rome, Italy; [Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, SCNLab, Rome, Italy; [Avesani, Renato] Sacra Cuore Hosp, Dept Rehabil, Verona, Italy; [Bertagnoni, Gianettore; Marangoni, Anna] San Bortolo Hosp, Dept Funct Recovery & Rehabil, Vicenza, Italy	Scandola, M (corresponding author), Lungadige Porta Vittoria 17, I-37129 Verona, Italy.	michele.scandola@univr.it	Aglioti, Salvatore M/E-9829-2012; Scandola, Michele/D-8107-2013; Moro, Valentina/AAM-2224-2021; Moro, Valentina/K-6464-2016	Scandola, Michele/0000-0003-0853-8975; Moro, Valentina/0000-0002-7119-7264; Moro, Valentina/0000-0002-7119-7264	EU Information and Communication Technologies Grant (VERE project) [FP7-ICT-2009-5, 257695]; Italian Ministry of HealthMinistry of Health, Italy [RF-2010-2312912]; MIUR ItalyMinistry of Education, Universities and Research (MIUR) [PRIN 20159CZFJK]; University of Verona (grant "La rappresentazione del corpo nei soggetti con lesione spinale") [4469, 7220]; Progetto di Avvio alla Ricerca University of Rome "Sapienza" [C26N13TMFT]	We would like to thank Rosanna Mignolli, Anna Scaia, Stefania Amato, Elena Facci and Valeria Gobbetto for their invaluable help. This work was supported by the EU Information and Communication Technologies Grant (VERE project, FP7-ICT-2009-5, Prot. Num. 257695), the Italian Ministry of Health (RF-2010-2312912) and from MIUR Italy (PRIN 20159CZFJK). M.S. was funded by the University of Verona (grant "La rappresentazione del corpo nei soggetti con lesione spinale", Prot. Num. 4469; COOPERINT project 2014, Prot. Num. 7220) and by the Progetto di Avvio alla Ricerca 2013 University of Rome "Sapienza" (Prot. Num. C26N13TMFT).	AGLIOTI S, 1994, NEUROREPORT, V5, P473, DOI 10.1097/00001756-199401120-00026; AGLIOTI S, 1994, P ROY SOC B-BIOL SCI, V255, P273, DOI 10.1098/rspb.1994.0039; Aglioti S, 1997, BEHAV NEUROSCI, V111, P867, DOI 10.1037/0735-7044.111.5.867; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Arrighi R, 2011, CURR BIOL, V21, pR910, DOI 10.1016/j.cub.2011.09.048; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; BORS E, 1951, AMA ARCH NEUROL PSY, V66, P610, DOI 10.1001/archneurpsyc.1951.02320110075007; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Brugger P, 2000, P NATL ACAD SCI USA, V97, P6167, DOI 10.1073/pnas.100510697; Burke C. D., 1969, PAIN PHANTOM SENSATI; Canzoneri E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02844; Caraceni A, 1996, PAIN, V65, P87, DOI 10.1016/0304-3959(95)00156-5; CONOMY JP, 1973, NEUROLOGY, V23, P842, DOI 10.1212/WNL.23.8.842; Conson M, 2008, NEUROPSYCHOLOGIA, V46, P2622, DOI 10.1016/j.neuropsychologia.2008.04.015; Coslett HB, 2010, EUR J PAIN, V14, P1007, DOI 10.1016/j.ejpain.2010.04.001; Cruz VT, 2003, NEUROREHABILITATION, V18, P299; Curt A, 2011, SPINAL CORD, V49, P588, DOI 10.1038/sc.2010.143; Desmond D, 2001, 10 WORLD C INT SOC P; DiStefano C, 2009, PRACT ASSESS RES EVA, V14, DOI DOI 10.7275/DA8T-4G52; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; ETTLIN TM, 1980, EUR NEUROL, V19, P12, DOI 10.1159/000115122; EVANS JH, 1962, BRAIN, V85, P687, DOI 10.1093/brain/85.4.687; Fiori F, 2013, EXP BRAIN RES, V226, P537, DOI 10.1007/s00221-013-3465-9; Fiori F, 2014, J NEUROPSYCHOL, V8, P199, DOI 10.1111/jnp.12020; Fiorio M, 2006, BRAIN, V129, P47, DOI 10.1093/brain/awh630; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Funk M, 2008, J INT NEUROPSYCH SOC, V14, P81, DOI 10.1017/S1355617708080041; Fusco G, 2016, RESTOR NEUROL NEUROS, V34, P815, DOI 10.3233/RNN-160660; Gandola M, 2012, CORTEX, V48, P1165, DOI 10.1016/j.cortex.2011.06.012; Giummarra MJ, 2010, PERCEPTION, V39, P103, DOI 10.1068/p6519; Glenberg AM, 2015, CAN J EXP PSYCHOL, V69, P165, DOI 10.1037/cep0000056; GUTTMANN L, 1969, HDB CLINICAL NEUROLO, V2, P178; Hatchett P. E., 2016, J SPINAL CORD MED; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Invernizzi M, 2010, DISABIL REHABIL, V32, P1194, DOI 10.3109/09638280903437246; Ionta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20144; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Knecht S, 1996, BRAIN, V119, P1213, DOI 10.1093/brain/119.4.1213; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Lenggenhager B, 2013, NEUROREHAB NEURAL RE, V27, P704, DOI 10.1177/1545968313491009; Lenggenhager B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050757; Lomman D., 2006, Australasian Physical & Engineering Sciences in Medicine, V29, P62; MacLachlan M, 2003, J REHABIL RES DEV, V40, P59, DOI 10.1682/JRRD.2003.01.0059; Manson GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110250; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Melzack R., 2006, ANN NY ACAD SCI, V933, P157; Moro V, 2011, BEHAV BRAIN RES, V225, P259, DOI 10.1016/j.bbr.2011.07.010; Nishimura Y, 2009, NEUROSCIENTIST, V15, P436, DOI 10.1177/1073858408331375; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Perruchoud D, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/041001; POCKETT S, 1995, ANESTH ANALG, V80, P173, DOI 10.1097/00000539-199501000-00026; R Core Team, 2015, R LANG ENV STAT COMP; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Revelle W., 2015, PSYCH PROCEDURES PSY, V1; Riddoch G, 1941, BRAIN, V64, P197, DOI 10.1093/brain/64.4.197; Saurat MT, 2011, CONSCIOUS COGN, V20, P1425, DOI 10.1016/j.concog.2011.05.015; Scandola M., PAIN SCALE DIFFERENT; Scandola M, 2017, J NEUROPSYCHOL, V11, P305, DOI 10.1111/jnp.12098; Scandola M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24126; Scandola M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00404; Sierra M, 2000, PSYCHIAT RES, V93, P153, DOI 10.1016/S0165-1781(00)00100-1; Song YG, 2015, ANN REHABIL MED-ARM, V39, P696, DOI 10.5535/arm.2015.39.5.696; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Tidoni E, 2014, RESTOR NEUROL NEUROS, V32, P611, DOI 10.3233/RNN-130385; Tieri G, 2015, EXP BRAIN RES, V233, P1247, DOI 10.1007/s00221-015-4202-3; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Vocat R, 2010, BRAIN, V133, P3578, DOI 10.1093/brain/awq297; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	81	13	13	1	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	MAR	2017	49						278	290		10.1016/j.concog.2017.01.010			13	Psychology, Experimental	Psychology	EQ1NC	WOS:000397835800025	28222382				2021-06-18	
J	Turtle, JD; Strain, MM; Aceves, M; Huang, YJ; Reynolds, JA; Hook, MA; Grau, JW				Turtle, Joel D.; Strain, Misty M.; Aceves, Miriam; Huang, Yung-Jen; Reynolds, Joshua A.; Hook, Michelle A.; Grau, James W.			Pain Input Impairs Recovery after Spinal Cord Injury: Treatment with Lidocaine	JOURNAL OF NEUROTRAUMA			English	Article						cell death; pain; polytrauma; secondary injury; spinal cord injury	RATS; BRAIN; INFLAMMATION; PYROPTOSIS; APOPTOSIS; NECROSIS; MORPHINE; MODERATE; SURGERY; MODEL	More than 90% of spinal cord injuries are caused by traumatic accidents and are often associated with other tissue damage (polytrauma) that can provide a source of continued pain input during recovery. In a clinically relevant spinal cord contusion injury model, prior work has shown that noxious stimulation at an intensity that engages pain (C) fibers soon after injury augments secondary injury and impairs functional recovery. Noxious input increases the expression of proinflammatory cytokines (interleukin 1 beta and 18), cellular signals associated with cell death (caspase 3 and 8), and physiological signs of hemorrhage. Here, it is shown that reducing neural excitability after spinal cord injury (SCI) with the local anesthetic lidocaine (micro-injected by means of a lumbar puncture) blocks these adverse cellular effects. In contrast, treatment with an analgesic dose of morphine had no effect. Contused rats that received nociceptive stimulation soon after injury exhibited poor locomotor recovery, less weight gain, and greater tissue loss at the site of injury. Prophylactic application of lidocaine blocked the adverse effect of nociceptive stimulation on behavioral recovery and reduced tissue loss from secondary injury. The results suggest that quieting neural excitability using lidocaine can reduce the adverse effect of pain input (from polytrauma or surgery) after SCI.	[Turtle, Joel D.; Strain, Misty M.; Huang, Yung-Jen; Reynolds, Joshua A.; Grau, James W.] Texas A&M Univ, Dept Psychol, Behav & Cellular Neurosci, College Stn, TX 77843 USA; [Aceves, Miriam; Hook, Michelle A.] Texas A&M Univ, Coll Med, Neurosci & Expt Therapeut, College Stn, TX USA	Turtle, JD (corresponding author), Texas A&M Univ, Dept Psychol, Behav & Cellular Neurosci, College Stn, TX 77843 USA.	joelturtle@gmail.com	Hook, Michelle/M-3140-2019; Grau, James/S-2372-2019	Strain, Misty/0000-0002-7264-7087; Hook, Michelle/0000-0002-8709-936X; Aceves Rodriguez, Miriam/0000-0002-1778-0213; Reynolds, Joshua/0000-0001-6680-5993	Craig H. Neilsen Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS091723]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091723] Funding Source: NIH RePORTER	The authors would like to thank Mabel Terminel, Melissa Brumley, Ashley DeLeon, and Julia Forsberg for their help with this work. This work was supported by grants from the Craig H. Neilsen Foundation and NIH (NINDS NS091723) to JWG.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Burke D, 1999, REGION ANESTH PAIN M, V24, P519, DOI 10.1016/S1098-7339(99)90042-1; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Crown ED, 2002, PHYSIOL BEHAV, V77, P259, DOI 10.1016/S0031-9384(02)00859-4; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/0897715042441747; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Garraway SM, 2011, NEUROSCIENCE, V199, P86, DOI 10.1016/j.neuroscience.2011.10.007; Garraway SM, 2014, PAIN, V155, P2344, DOI 10.1016/j.pain.2014.08.034; Grau JW, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00100; Grau JW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00262; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/neu.2004.21.1795; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Haas Daniel A, 2002, J Can Dent Assoc, V68, P546; Hollmann MW, 2000, ANESTHESIOLOGY, V93, P858, DOI 10.1097/00000542-200009000-00038; Hook MA, 2004, J NEUROTRAUM, V21, P109, DOI 10.1089/089771504772695995; Hook MA, 2007, BEHAV BRAIN RES, V179, P281, DOI 10.1016/j.bbr.2007.02.035; Hook MA, 2009, J NEUROTRAUM, V26, P741, DOI 10.1089/neu.2008.0710; Joynes RL, 2003, BEHAV BRAIN RES, V141, P159, DOI 10.1016/S0166-4328(02)00372-8; Lidocaine Wildsmith J., 2011, P HIST ANAESTH SOC, V43, P9; McDonnell JG, 2007, ANESTH ANALG, V104, P193, DOI 10.1213/01.ane.0000250223.49963.0f; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Michelle J. K., 2011, NAT VITAL STAT REP, V59; Caracas HCPM, 2009, J DENT, V37, P93, DOI 10.1016/j.jdent.2008.10.005; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Turtle J, 2015, J NEUROTRAUM, V32, pA91; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; van der Wal S, 2015, ACTA ANAESTH SCAND, V59, P47, DOI 10.1111/aas.12417	31	13	13	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2017	34	6					1200	1208		10.1089/neu.2016.4778			9	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EN7ZR	WOS:000396221200008	27912032	Green Published			2021-06-18	
J	Zhang, MY; Shan, HY; Chang, P; Ma, L; Chu, Y; Shen, X; Wu, Q; Wang, ZF; Luo, CL; Wang, T; Chen, XP; Tao, LY				Zhang, Mingyang; Shan, Haiyan; Chang, Pan; Ma, Lu; Chu, Yang; Shen, Xi; Wu, Qiong; Wang, Zufeng; Luo, Chengliang; Wang, Tao; Chen, Xiping; Tao, Luyang			Upregulation of 3-MST Relates to Neuronal Autophagy After Traumatic Brain Injury in Mice	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						3-mercaptopyruvate sulfurtransferase; Traumatic brain injury; Autophagic cell death; Mice	CONTROLLED CORTICAL IMPACT; MERCAPTOPYRUVATE SULFURTRANSFERASE; HYDROGEN-SULFIDE; CELL-DEATH; NEURODEGENERATIVE DISEASE; OXIDATIVE STRESS; APOPTOSIS; THERAPY; PATHOPHYSIOLOGY; INTERMEDIATE	3-mercaptopyruvate sulfurtransferase (3-MST) was a novel hydrogen sulfide (H2S)-synthesizing enzyme that may be involved in cyanide degradation and in thiosulfate biosynthesis. Over recent years, considerable attention has been focused on the biochemistry and molecular biology of H2S-synthesizing enzyme. In contrast, there have been few concerted attempts to investigate the changes in the expression of the H2S-synthesizing enzymes with disease states. To investigate the changes of 3-MST after traumatic brain injury (TBI) and its possible role, mice TBI model was established by controlled cortical impact system, and the expression and cellular localization of 3-MST after TBI was investigated in the present study. Western blot analysis revealed that 3-MST was present in normal mice brain cortex. It gradually increased, reached a peak on the first day after TBI, and then reached a valley on the third day. Importantly, 3-MST was colocalized with neuron. In addition, Western blot detection showed that the first day post injury was also the autophagic peak indicated by the elevated expression of LC3. Importantly, immunohistochemistry analysis revealed that injury-induced expression of 3-MST was partly colabeled by LC3. However, there was no colocalization of 3-MST with propidium iodide (cell death marker) and LC3 positive cells were partly colocalized with propidium iodide. These data suggested that 3-MST was mainly located in living neurons and may be implicated in the autophagy of neuron and involved in the pathophysiology of brain after TBI.	[Zhang, Mingyang; Ma, Lu; Chu, Yang; Shen, Xi; Wu, Qiong; Wang, Zufeng; Luo, Chengliang; Wang, Tao; Chen, Xiping; Tao, Luyang] Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China; [Zhang, Mingyang] Minist Justice, Shanghai Key Lab Forens Med, Inst Forens Sci, Shanghai 200063, Peoples R China; [Shan, Haiyan] North Dist Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou 215008, Jiangsu, Peoples R China; [Chang, Pan] Xian Med Coll, Affiliated Hosp 2, Cent Lab, Xian 710038, Peoples R China	Zhang, MY; Tao, LY (corresponding author), Soochow Univ, Inst Forens Sci, Suzhou 215123, Jiangsu, Peoples R China.; Zhang, MY (corresponding author), Minist Justice, Shanghai Key Lab Forens Med, Inst Forens Sci, Shanghai 200063, Peoples R China.	mingyangzhang@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763; Shen, Xi/0000-0001-7568-7335	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172911, 81271379, 81301039, 81530062]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020503]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M570476]; Shanghai Key Lab of Forensic Medicine [KF1502]; Suzhou Science and Technology Development Project [SYSD2015119]	This work was supported by the National Natural Science Foundation of China (No. 81172911, No. 81271379, No. 81301039, No. 81530062); National High Technology Research and Development Program of China (863 Program, No. 2015AA020503); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); China Postdoctoral Science Foundation funded project (No. 2015M570476); Shanghai Key Lab of Forensic Medicine (KF1502); Suzhou Science and Technology Development Project (SYSD2015119).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bellander BM, 2011, ACTA NEUROCHIR, V153, P90, DOI 10.1007/s00701-010-0737-z; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Frasdorf B, 2014, J BIOL CHEM, V289, P34543, DOI 10.1074/jbc.M114.605733; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Giordano S, 2014, REDOX BIOL, V2, P82, DOI 10.1016/j.redox.2013.12.013; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Jeruc J, 2006, AM J KIDNEY DIS, V48, P410, DOI 10.1053/j.ajkd.2006.05.019; Jiang T, 2015, FREE RADICAL BIO MED, V88, P199, DOI 10.1016/j.freeradbiomed.2015.06.014; Kimura H, 2015, HANDB EXP PHARMACOL, V230, P61, DOI 10.1007/978-3-319-18144-8_3; Kimura H, 2014, MOLECULES, V19, P16146, DOI 10.3390/molecules191016146; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moon HE, 2015, EXP NEUROBIOL, V24, P103, DOI 10.5607/en.2015.24.2.103; Nagahara N, 1996, SEIKAGAKU, V68, P197; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nagahara Noriyuki, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P198, DOI 10.2174/1568008033340162; Nagahara N, 2013, ANTIOXID REDOX SIGN, V19, P1792, DOI 10.1089/ars.2012.5031; Nagahara N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01986; Nagahara N, 2012, ANTIOXID REDOX SIGN, V16, P747, DOI 10.1089/ars.2011.4468; Navarro-Yepes J, 2014, PHARMACOL THERAPEUT, V142, P206, DOI 10.1016/j.pharmthera.2013.12.007; Ozacmak VH, 2016, NUTR NEUROSCI, V19, P176, DOI 10.1179/1476830515Y.0000000027; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI 10.1089/ARS.2008.2253; Smith JA, 2013, NEUROCHEM INT, V62, P764, DOI 10.1016/j.neuint.2013.02.013; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Xiong N, 2011, NEUROSCIENCE, V199, P292, DOI 10.1016/j.neuroscience.2011.10.031; Zhang L, 2015, FREE RADICAL BIO MED, V89, P452, DOI 10.1016/j.freeradbiomed.2015.08.030; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhao H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067322	49	13	13	1	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAR	2017	37	2					291	302		10.1007/s10571-016-0369-9			12	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	EL2EB	WOS:000394431800009	27038311				2021-06-18	
J	Ouyang, W; Yan, QC; Zhang, Y; Fan, ZH				Ouyang, Wei; Yan, Qichao; Zhang, Yu; Fan, Zhiheng			Moderate injury in motor-sensory cortex causes behavioral deficits accompanied by electrophysiological changes in mice adulthood	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LATERAL FLUID PERCUSSION; SPATIAL MEMORY; RECOGNITION MEMORY; THETA-FREQUENCY; WORKING-MEMORY; HIPPOCAMPAL; STIMULATION; MODEL; ANTAGONISTS	Moderate traumatic brain injury (TBI) in children often happen when there's a sudden blow to the frontal bone, end with long unconscious which can last for hours and progressive cognitive deficits. However, with regard to the influences of moderate TBI during children adulthood, injury-induced alterations of locomotive ability, long-term memory performance, and hippocampal electrophysiological firing changes have not yet been fully identified. In this study, lateral fluid percussion (LFP) method was used to fabricate moderate TBI in motor and somatosensory cortex of the 6-weeks-old mice. The motor function, learning and memory function, extracellular CA1 neural spikes were assessed during acute and subacute phase. Moreover, histopathology was performed on day post injury (DPI) 16 to evaluate the effect of TBI on tissue and cell morphological changes in cortical and hippocampal CA1 subregions. After moderate LFP injury, the 6-weeks-old mice showed severe motor deficits at the early stage in acute phase but gradually recovered later during adulthood. At the time points in acute and subacute phase after TBI, novel object recognition (NOR) ability and spatial memory functions were consistently impaired in TBI mice; hippocampal firing frequency and burst probability were hampered. Analysis of the altered burst firing shows a clear hippocampal theta rhythm drop. These electrophysiological impacts were associated with substantially lowered NOR preference as compared to the sham group during adulthood. These results suggest that moderate TBI introduced at motorsenory cortex in 6-weeks- old mice causes obvious motor and cognitive deficits during their adulthood. While the locomotive ability progressively recovers, the cognitive deficits persisted while the mice mature as adult mice. The cognitive deficits may be attributed to the general suppressing of whole neural network, which could be labeled by marked reduction of excitability in hippocampal CA1 subregion.	[Ouyang, Wei; Yan, Qichao; Fan, Zhiheng] Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China; [Zhang, Yu] Shanxi Med Univ, Dept Physiol, Taiyuan, Shanxi, Peoples R China	Ouyang, W (corresponding author), Zhejiang Normal Univ, Coll Phys Educ & Hlth Sci, Jinhua, Zhejiang, Peoples R China.	wouyang@zjnu.cn		Ouyang, Wei/0000-0003-2866-491X	Zhejiang Province Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY15H090012]; General Administration of Sport of China [2014B101]	This work was supported by Zhejiang Province Natural Science Foundation (no. LY15H090012) and the General Administration of Sport of China (no. 2014B101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; Barker GRI, 2011, J NEUROSCI, V31, P10721, DOI 10.1523/JNEUROSCI.6413-10.2011; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Constantinou M, 2015, BIOSYSTEMS, V136, P73, DOI 10.1016/j.biosystems.2015.08.004; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Deshpande LS, 2008, NEUROSCI LETT, V441, P115, DOI 10.1016/j.neulet.2008.05.113; Dewan MC, 2016, EPIDEMIOLOGY GLOBAL; Eakin K, 2012, J NEUROTRAUM, V29, P1180, DOI 10.1089/neu.2011.2192; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Fedor M, 2010, J NEUROTRAUM, V27, P1605, DOI 10.1089/neu.2010.1370; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Floresco SB, 1997, J NEUROSCI, V17, P1880; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Guderian S, 2015, J NEUROSCI, V35, P14123, DOI 10.1523/JNEUROSCI.0801-15.2015; Gurkoff G, 2013, PHARMACEUTICALS, V6, P788, DOI 10.3390/ph6070788; Ho JW, 2015, J NEUROSCI, V35, P13323, DOI 10.1523/JNEUROSCI.2278-15.2015; Horneman G, 2009, BRAIN INJURY, V23, P907, DOI 10.1080/02699050903283239; Hoy K. E., 2015, CEREBRAL CORTEX; Huang TN, 2014, NAT NEUROSCI, V17, P240, DOI 10.1038/nn.3626; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; Kirkcaldie MTK, 2011, MOUSE NERVOUS SYSTEM; KUBIE JL, 1990, J NEUROSCI, V10, P1110; LARSON J, 1986, BRAIN RES, V368, P347, DOI 10.1016/0006-8993(86)90579-2; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Matyas F, 2010, SCIENCE, V330, P1240, DOI 10.1126/science.1195797; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Miller JP, 2015, BRAIN, V138, P1833, DOI 10.1093/brain/awv095; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Munyon C, 2014, BRAIN RES, V1582, P220, DOI 10.1016/j.brainres.2014.07.036; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Parker A, 1997, EUR J NEUROSCI, V9, P2423, DOI 10.1111/j.1460-9568.1997.tb01659.x; PARKIN AJ, 1994, NEUROPSYCHOLOGIA, V32, P39, DOI 10.1016/0028-3932(94)90067-1; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Qin SZ, 2014, NAT NEUROSCI, V17, P1263, DOI 10.1038/nn.3788; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Robinson L, 2007, BRIT J PHARMACOL, V151, P688, DOI 10.1038/sj.bjp.0707273; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sun DA, 2008, EUR J NEUROSCI, V27, P1659, DOI 10.1111/j.1460-9568.2008.06156.x; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Verleye M, 2003, NEUROSCI LETT, V353, P127, DOI 10.1016/j.neulet.2003.09.010; Warburton EC, 2015, BEHAV BRAIN RES, V285, P131, DOI 10.1016/j.bbr.2014.09.050; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Young JS, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0719-9	61	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2017	12	2							e0171976	10.1371/journal.pone.0171976			20	Multidisciplinary Sciences	Science & Technology - Other Topics	EL2BA	WOS:000394423900040	28196142	DOAJ Gold, Green Published			2021-06-18	
J	Armstrong, RA; Mckee, AC; Stein, TD; Alvarez, VE; Cairns, NJ				Armstrong, R. A.; Mckee, A. C.; Stein, T. D.; Alvarez, V. E.; Cairns, N. J.			A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						astrocytic tangles; chronic traumatic encephalopathy; neurofibrillary tangles; principal components analysis; tau	ARGYROPHILIC GRAIN DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; DEMENTIA-PUGILISTICA; DIAGNOSTIC-CRITERIA; FRONTAL-CORTEX; PICKS-DISEASE; BRAIN-INJURY; HEAD-INJURY; NEUROPATHOLOGY	Aims: To quantify tau pathology of chronic traumatic encephalopathy (CTE) and investigate influence of dot-like lesions (DL), brain region, comorbidity and sporting career length. Methods: Densities of neurofibrillary tangles (NFT), astrocytic tangles (AT), DL, oligodendroglial inclusions (GI), neuropil threads (NT), vacuoles, neurons and enlarged neurons (EN) were measured in tau-immunoreactive sections of upper cortical laminae of frontal and temporal lobes, hippocampus (HC), amygdala and substantia nigra (SN) in 11 cases of CTE. Results: DL were a consistent finding in CTE. Densities of NFT, NT and DL were greatest in sectors CA1 and CA2 of the HC. Densities of AT were lower than NFT, small numbers of GI were recorded in temporal lobe and low densities of vacuoles and EN were consistently present. beta-Amyloid-containing neuritic plaques (NP) also occurred at low density. Densities of NFT, NT, DL and AT were greater in sulci than gyri, while vacuole density was greater in gyri. Principal components analysis (PCA) suggested that sporting career length and densities of NFT in entorhinal cortex, NT in CA2 and SN and vacuolation in the DG were significant sources of variation among cases. Conclusion: DL are frequent in CTE suggesting affinity with argyrophilic grain disease (AGD) and Parkinson's disease dementia (PD-Dem). Densities of AT in all regions and NT/DL in sectors CA2/4 were consistent features of CTE. The 11 cases are neuropathologically heterogeneous which may result from genetic diversity, and variation in anatomical pathways subjected to trauma.	[Armstrong, R. A.] Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England; [Mckee, A. C.] VA Boston HealthCare Syst, Boston, MA USA; [Mckee, A. C.; Alvarez, V. E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Mckee, A. C.; Stein, T. D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Stein, T. D.; Alvarez, V. E.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Cairns, N. J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cairns, N. J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Armstrong, RA (corresponding author), Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England.	R.A.Armstrong@aston.ac.uk	Armstrong, Richard A/H-4557-2012; Cairns, Nigel/AAB-9713-2020; Armstrong, Richard/AAU-4580-2020	Armstrong, Richard A/0000-0002-5046-3199; Cairns, Nigel/0000-0001-9858-3344; Armstrong, Richard/0000-0002-5046-3199; Stein, Thor/0000-0001-6954-4477	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1UO1NS086659- 01]; Department of Veterans Affairs, the Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA from the National Institute on Aging [P50 AG05681, P01 AG03991]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005681, P01AG003991, P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA). We also gratefully acknowledge the help of all members of the Chronic Traumatic Encephalopathy Program at Boston University School of Medicine, VA Boston and the Bedford VA, as well as the individuals and families whose participation and contributions made this work possible. This work was supported by the National Institute of Neurological Disorders and Stroke (1UO1NS086659- 01); Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501); the Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); the Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C); and the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5). This work was supported by the Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA (P50 AG05681 and P01 AG03991) from the National Institute on Aging.	Armstrong R, 1999, NEUROPATHOLOGY, V19, P64, DOI 10.1046/j.1440-1789.1999.00219.x; ARMSTRONG RA, 1994, DEMENTIA, V5, P1, DOI 10.1159/000106686; Armstrong RA, 2000, EXP NEUROL, V163, P348, DOI 10.1006/exnr.2000.7392; Armstrong RA, 2015, J NEURAL TRANSM, V122, P1355, DOI 10.1007/s00702-015-1402-8; Armstrong RA, 2014, J NEURAL TRANSM, V121, P171, DOI 10.1007/s00702-013-1084-z; Armstrong RA, 2010, J NEURAL TRANSM, V117, P227, DOI 10.1007/s00702-009-0350-6; Braak H, 1998, J NEURAL TRANSM, V105, P801, DOI 10.1007/s007020050096; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Ding ZT, 2006, ACTA NEUROPATHOL, V111, P450, DOI 10.1007/s00401-005-0015-y; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GENTLEMAN SM, 1992, NEUROSCI LETT, V142, P9, DOI 10.1016/0304-3940(92)90608-A; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Josephs KA, 2008, NEUROBIOL AGING, V29, P566, DOI 10.1016/j.neurobiolaging.2006.10.032; Kieman PT, 2015, SEMIN NEUROL, V35, P20; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P229, DOI 10.1097/WAD.0b013e318199d833; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Snedecor G.W., 1980, STAT METHODS, V7th; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tolnay M, 1999, PATHOLOGE, V20, P159, DOI 10.1007/s002920050339; Zhukareva V, 2002, AM J PATHOL, V161, P1135, DOI 10.1016/S0002-9440(10)64390-8; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	41	13	13	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	FEB	2017	43	2					154	166		10.1111/nan.12323			13	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	EO8JB	WOS:000396934200005	26998921	Green Accepted			2021-06-18	
J	Daley, MJ; Enright, Z; Nguyen, J; Ali, S; Clark, A; Aydelotte, JD; Teixeira, PG; Coopwood, TB; Brown, CVR				Daley, M. J.; Enright, Z.; Nguyen, J.; Ali, S.; Clark, A.; Aydelotte, J. D.; Teixeira, P. G.; Coopwood, T. B.; Brown, C. V. R.			Adenosine diphosphate platelet dysfunction on thromboelastogram is independently associated with increased morality in traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Thromboelastogram; TEG; Platelet dysfunction; Traumatic brain injury	MILD HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; ANTIPLATELET AGENTS; COAGULOPATHY; TRANSFUSION; COAGULATION; MANAGEMENT; MORTALITY; HEMATOMA	The purpose of this study is to determine if adenosine diphosphate (ADP) platelet dysfunction on thromboelastogram (TEG) is associated with increased in-hospital mortality in patients with head trauma. The hypothesis is that ADP dysfunction is associated with increased mortality. This retrospective review evaluated trauma patients admitted to a level 1 trauma center from February 2011 to October 2013 who received a TEG. Patients were included if the TEG was drawn within the first 24 h of admission and the head abbreviated injury score was greater than or equal to three. Patients were categorized as severe ADP dysfunction if the degree of ADP inhibition on TEG exceeded 60 %. A total of 90 patients were included (no ADP dysfunction n = 37; ADP dysfunction n = 53). Initial Glasgow Coma Scale [GCS (12 +/- 4 vs. 11 +/- 5; p = 0.26)] and use of pre-injury antiplatelet agents (30 vs. 28 %; p = 0.88) were similar. Patients with ADP dysfunction on TEG had a higher in-hospital mortality rate (8 vs. 32 %; p < 0.01). ADP dysfunction was independently associated with in-hospital mortality upon fixed logistic regression (OR 6.2; 95 % CI 1.2-33) while controlling for age, gender, hypotension, pre-injury antiplatelet agents, GCS and Injury Severity Score. ADP dysfunction on TEG is associated with increased mortality in patients with traumatic brain injury.	[Daley, M. J.; Enright, Z.; Nguyen, J.] Univ Med Ctr Brackenridge, Dept Pharmaceut Serv, 601 E 15th St, Austin, TX 78701 USA; [Daley, M. J.; Enright, Z.; Nguyen, J.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Ali, S.; Clark, A.; Aydelotte, J. D.; Teixeira, P. G.; Coopwood, T. B.; Brown, C. V. R.] Univ Med Ctr Brackenridge, Dept Trauma Serv, 601 E 15th St, Austin, TX 78701 USA; [Aydelotte, J. D.; Teixeira, P. G.; Coopwood, T. B.; Brown, C. V. R.] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA	Daley, MJ (corresponding author), Univ Med Ctr Brackenridge, Dept Pharmaceut Serv, 601 E 15th St, Austin, TX 78701 USA.; Daley, MJ (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.	mjdaley@seton.org; Sali@seton.org; Sali@seton.org; jdaydelotte@seton.org; pgteixeira@seton.org; tbcoopwoodjr@seton.org; cvrbrown@seton.org					Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chen LQ, 2004, J THORAC CARDIOV SUR, V128, P425, DOI 10.1016/j.jtcvs.2004.02.019; de Gans K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-19; Downey DM, 2009, AM SURGEON, V75, P1100; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P417, DOI 10.1097/TA.0000000000000372; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Leon C, 2004, BLOOD, V103, P594, DOI 10.1182/blood-2003-05-1385; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Marini JJ, 2015, JAMA-J AM MED ASSOC, V313, P893, DOI 10.1001/jama.2014.18484; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	29	13	13	1	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2017	43	1					105	111		10.1007/s00068-016-0643-z			7	Emergency Medicine	Emergency Medicine	EL0MG	WOS:000394315900015	26888580				2021-06-18	
J	Gagne, M; Moore, L; Sirois, MJ; Simard, M; Beaudoin, C; Kuimi, BLB				Gagne, Mathieu; Moore, Lynne; Sirois, Marie-Josee; Simard, Marc; Beaudoin, Claudia; Kuimi, Brice Lionel Batomen			Performance of International Classification of Diseases-based injury severity measures used to predict in-hospital mortality and intensive care admission among traumatic brain-injured patients	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						In-hospital mortality; International Classification of Diseases; trauma severity indices; traumatic brain injury	GLASGOW COMA SCALE; ADMINISTRATIVE DATA; MULTIPLE INJURIES; PROGNOSTIC VALUE; HEAD-INJURIES; SCORE; OUTCOMES; IMPACT; RISK; VALIDATION	BACKGROUND: The International Classification of Diseases (ICD) is the main classification system used for population-based traumatic brain injury (TBI) surveillance activities but does not contain direct information on injury severity. International Classification of Diseases-based injury severity measures can be empirically derived or mapped to the Abbreviated Injury Scale, but no single approach has been formally recommended for TBI. OBJECTIVE: The aim of this study was to compare the accuracy of different ICD-based injury severity measures for predicting in-hospital mortality and intensive care unit (ICU) admission in TBI patients. METHODS: We conducted a population-based retrospective cohort study. We identified all patients 16 years or older with a TBI diagnosis who received acute care between April 1, 2006, and March 31, 2013, from the Quebec Hospital Discharge Database. The accuracy of five ICD-based injury severity measures for predicting mortality and ICU admission was compared using measures of discrimination (area under the receiver operating characteristic curve [AUC]) and calibration (calibration plot and the Hosmer-Lemeshow goodness-of-fit statistic). RESULTS: Of 31,087 traumatic brain-injured patients in the study population, 9.0% died in hospital, and 34.4% were admitted to the ICU. Among ICD-based severity measures that were assessed, the multiplied derivative of ICD-based Injury Severity Score (ICISS-Multiplicative) demonstrated the best discriminative ability for predicting in-hospital mortality (AUC, 0.858; 95% confidence interval, 0.852-0.864) and ICU admissions (AUC, 0.813; 95% confidence interval, 0.808-0.818). Calibration assessments showed good agreement between observed and predicted in-hospital mortality for ICISS measures. All severity measures presented high agreement between observed and expected probabilities of ICU admission for all deciles of risk. CONCLUSIONS: The ICD-based injury severity measures can be used to accurately predict in-hospitalmortality and ICU admission in TBI patients. The ICISS-Multiplicative generally outperformed other ICD-based injury severity measures and should be preferred to control for differences in baseline characteristics between TBI patients in surveillance activities or injury research when only ICD codes are available. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Gagne, Mathieu; Simard, Marc; Beaudoin, Claudia] Inst Natl Sante Publ Quebec, Bur Informat & Etud Sante Populat, Quebec City, PQ, Canada; [Gagne, Mathieu; Moore, Lynne; Beaudoin, Claudia; Kuimi, Brice Lionel Batomen] Univ Laval, Fac Med, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Moore, Lynne; Kuimi, Brice Lionel Batomen] Ctr Hosp Univ CHU Quebec, Hop Enfants Jesus, Ctr Rech, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada; [Moore, Lynne; Kuimi, Brice Lionel Batomen] Ctr Hosp Univ CHU Quebec, Hop Enfants Jesus, Ctr Rech, Trauma Emergency Crit Care Med, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Ctr Excellence Vieillissement Quebec, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Ctr Hosp Univ CHU Quebec, Hop Enfants Jesus, Ctr Rech, Quebec City, PQ, Canada; [Sirois, Marie-Josee] Univ Laval, Fac Med, Dept Readaptat, Quebec City, PQ, Canada	Gagne, M (corresponding author), Bur Informat & Etud Sante Populat, 945 Ave Wolfe,5e Etage St Foy, Quebec City, PQ G1V 5B3, Canada.	mathieu.gagne@inspq.qc.ca	Kuimi, Brice Lionel Batomen/AAF-3970-2020; Simard, Marc/AAA-8541-2019	Kuimi, Brice Lionel Batomen/0000-0002-5772-120X; 			Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Bergstrom MF, 2011, INJURY PREV, V17, P108, DOI 10.1136/ip.2010.028951; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Cook A., 2013, ICD9 ICD 10 COD; Cook Alan, 2014, J Trauma Acute Care Surg, V76, P47, DOI 10.1097/TA.0b013e3182ab0d5d; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Cryer C, 2006, INJURY PREV, V12, P67, DOI 10.1136/ip.2006.011668; Demetriades D, 2004, J AM COLL SURGEONS, V199, P216, DOI 10.1016/j.jamcollsurg.2004.02.030; Di Bartolomeo S, 2011, ACCIDENT ANAL PREV, V43, P1955, DOI 10.1016/j.aap.2011.05.013; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gagne M, 2016, J TRAUMA ACUTE CARE, V80, P419, DOI 10.1097/TA.0000000000000944; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gedeborg R, 2014, J TRAUMA ACUTE CARE, V76, P358, DOI 10.1097/TA.0b013e3182a9cd31; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Haas B, 2012, CAN J SURG, V55, P21, DOI 10.1503/cjs.017510; Haider AH, 2012, J TRAUMA ACUTE CARE, V72, P1695, DOI 10.1097/TA.0b013e318256a010; Haring RS, 2015, J SURG RES, V195, P1, DOI 10.1016/j.jss.2015.01.017; Hosmer DW, 2000, APPL LOGISTIC REGRES, P160, DOI DOI 10.1002/0471722146.CH5; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kilgo PD, 2003, J TRAUMA, V55, P599, DOI 10.1097/01.TA.0000085721.47738.BD; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Lavoie A, 2005, INJURY, V36, P477, DOI 10.1016/j.injury.2004.09.039; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; Meredith JW, 2003, J TRAUMA, V55, P933, DOI 10.1097/01.TA.0000085646.71451.5F; Moore L, ANN SURG; Moore L, 2008, J TRAUMA, V64, P420, DOI 10.1097/01.ta.0000241201.34082.d4; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Nakahara S, 2011, B WORLD HEALTH ORGAN, V89, P238, DOI 10.2471/BLT.10.078964; Orman JAL., 2012, INJURY RES, P61; Osler T, 1996, J TRAUMA, V41, P380, DOI 10.1097/00005373-199609000-00002; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Parsons Daria, 2012, BMC Res Notes, V5, P584, DOI 10.1186/1756-0500-5-584; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Tepas JJ, 2013, J TRAUMA ACUTE CARE, V74, P143, DOI 10.1097/TA.0b013e3182788b5a; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Van Belleghem G, 2016, INJURY, V47, P141, DOI 10.1016/j.injury.2015.08.025; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549	50	13	13	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2017	82	2					374	382		10.1097/TA.0000000000001319			9	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	EJ8GO	WOS:000393463600025	28107311				2021-06-18	
J	Moreno-Lopez, L; Manktelow, AE; Sahakian, BJ; Menon, DK; Stamatakis, EA				Moreno-Lopez, Laura; Manktelow, Anne E.; Sahakian, Barbara J.; Menon, David K.; Stamatakis, Emmanuel A.			Anything goes? Regulation of the neural processes underlying response inhibition in TBI patients	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article						Traumatic brain injury; Response inhibition; Functional connectivity; Methylphenidate	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; STATE FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; PATTERN-CLASSIFICATION; SALIENCE NETWORK; WORKING-MEMORY; RESTING BRAIN; METHYLPHENIDATE	Despite evidence for beneficial use of methylphenidate in response inhibition, no studies so far have investigated the effects of this drug in the neurobiology of inhibitory control in traumatic brain injury (TBI), even though impulsive behaviours are frequently reported in this patient group. We investigated the neural basis of response inhibition in a group of TBI patients using functional magnetic resonance imaging and a stop-signal paradigm. In a randomised double blinded crossover study, the patients received either a single 30 mg dose of methylphenidate or placebo and performed the stop-signal task. Activation in the right inferior frontal gyrus (RIFG), an area associated with response inhibition, was significantly lower in patients compared to healthy controls. Poor response inhibition in this group was associated with greater connectivity between the RIFG and a set of regions considered to be part of the default mode network (DMN), a finding that suggests the interplay between DMN and frontal executive networks maybe compromised. A single dose of methylphenidate rendered activity and connectivity profiles of the patients RIFG near normal. The results of this study indicate that the neural circuitry involved in response inhibition in TBI patients may be partially restored with methylphenidate. Given the known mechanisms of action of methylphenidate, the effect we observed may be due to increased dopamine and noradrenaline levels. (C) 2016 Elsevier B.V. and ECNP. All rights reserved.	[Moreno-Lopez, Laura; Manktelow, Anne E.; Menon, David K.; Stamatakis, Emmanuel A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England; [Sahakian, Barbara J.] Univ Cambridge, Dept Psychiat, Herchel Smith Bldg Brain & Mind Sci,Forvie Site, Cambridge CB2 0SZ, England; [Sahakian, Barbara J.] Univ Cambridge, MRC Wellcome Trust Behav, Cambridge CB2 3EB, England; [Sahakian, Barbara J.] Univ Cambridge, Clin Neurosci Inst, Cambridge CB2 3EB, England	Moreno-Lopez, L (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Box 93,Hills Rd, Cambridge CB2 0QQ, England.	lm618@cam.ac.uk	Sahakian, Barbara/AAW-1198-2020	Sahakian, Barbara/0000-0001-7352-1745; Stamatakis, Emmanuel Andreas/0000-0001-6955-9601	Evelyn Trust [06/20]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	The study was funded by the Evelyn Trust - Grant no. 06/20. The Evelyn Trust had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	An L, 2013, NEUROPSYCHOPHARMACOL, V38, P1287, DOI 10.1038/npp.2013.27; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2003, BIOL PSYCHIAT, V54, P1465, DOI 10.1016/S0006-3223(03)00609-7; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chamberlain SR, 2007, BIOL PSYCHIAT, V62, P977, DOI 10.1016/j.biopsych.2007.03.003; Chamberlain SR, 2011, J ALZHEIMERS DIS, V24, P125, DOI 10.3233/JAD-2010-100450; Chamberlain SR, 2009, BIOL PSYCHIAT, V65, P550, DOI 10.1016/j.biopsych.2008.10.014; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; Costa A, 2013, CEREB CORTEX, V23, P1179, DOI 10.1093/cercor/bhs107; FARAJ BA, 1974, J PHARMACOL EXP THER, V191, P535; Fassbender C, 2009, BRAIN RES, V1273, P114, DOI 10.1016/j.brainres.2009.02.070; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Gardani M, 2015, ARCH PHYS MED REHAB, V96, P1691, DOI 10.1016/j.apmr.2015.05.006; Ghahremani DG, 2012, J NEUROSCI, V32, P7316, DOI 10.1523/JNEUROSCI.4284-11.2012; Gilbert DL, 2006, NEUROPSYCHOPHARMACOL, V31, P442, DOI 10.1038/sj.npp.1300806; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104021; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Kasahara M, 2011, BRAIN INJURY, V25, P1170, DOI 10.3109/02699052.2011.608210; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Liddle EB, 2011, J CHILD PSYCHOL PSYC, V52, P761, DOI 10.1111/j.1469-7610.2010.02333.x; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Marquand AF, 2011, NEUROPSYCHOPHARMACOL, V36, P1237, DOI 10.1038/npp.2011.9; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Pauls AM, 2012, BIOL PSYCHIAT, V72, P142, DOI 10.1016/j.biopsych.2012.03.028; Peterson BS, 2009, AM J PSYCHIAT, V166, P1286, DOI 10.1176/appi.ajp.2009.08050724; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Rubia K, 2007, HUM BRAIN MAPP, V28, P1163, DOI 10.1002/hbm.20347; Rubia K, 2014, BIOL PSYCHIAT, V76, P616, DOI 10.1016/j.biopsych.2013.10.016; Sagaspe P, 2007, J SLEEP RES, V16, P381, DOI 10.1111/j.1365-2869.2007.00607.x; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Silk T. J., 2016, BRAIN IMAGI IN PRESS; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sripada CS, 2013, NEUROIMAGE, V81, P213, DOI 10.1016/j.neuroimage.2013.05.016; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; TEASDALE G, 1974, LANCET, V2, P81; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; van Rooij D, 2015, NEUROIMAGE-CLIN, V7, P325, DOI 10.1016/j.nicl.2015.01.004; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Vink M, 2005, HUM BRAIN MAPP, V25, P336, DOI 10.1002/hbm.20111; Ward B., 2000, SIMULTANEOUS INFEREN; Wen XT, 2013, J NEUROSCI, V33, P6444, DOI 10.1523/JNEUROSCI.4939-12.2013; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197	62	13	13	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	FEB	2017	27	2					159	169		10.1016/j.euroneuro.2016.12.002			11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	EL1RU	WOS:000394399500006	28012706				2021-06-18	
J	Pruitt, P; Penn, J; Peak, D; Borczuk, P				Pruitt, Peter; Penn, Joshua; Peak, David; Borczuk, Pierre			Identifying patients with mild traumatic intracranial hemorrhage at low risk of decompensation who are safe for ED observation	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	National Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 12-15, 2015	San Diego, CA	Soc Acad Emergency Med		Traumatic intracranial hemorrhage; Subarachnoid hemorrhage; Subdural hematoma; Intraparenchymal hemorrhage; Observation medicine	DEPARTMENT OBSERVATION UNIT; MINOR HEAD-INJURY; BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; ADULT PATIENTS; MANAGEMENT; ADMISSION; PROTOCOL; CARE	Background: Patients with traumatic intracranial hemorrhage and mild traumatic brain injury (mTIH) receive broadly variable care which often includes transfer to a trauma center, neurosurgery consultation and ICU admission. However, there may be a low risk cohort of patients who can be managed without utilizing such significant resources. Objective: Describe mTIH patients who are at low risk of clinical or radiographic decompensation and can be safely managed in an ED observation unit (EDOU). Methods: Retrospective evaluation of patients age >= 16, GCS >= 13 with ICH on CT. Primary outcomes included clinical/neurologic deterioration, CT worsening or need for neurosurgery. Results: 1185 consecutive patients were studied. 814 were admitted and 371 observed patients (OP) were monitored in the EDOU or discharged from the ED after a period of observation. None of the OP deteriorated clinically. 299 OP (81%) had a single lesion on CT; 72 had mixed lesions. 120 patients had isolated subarachnoid hemorrhage (iSAH) and they did uniformly well. Of the 119 OP who had subdural hematoma (SDH), 6 had worsening CT scans and 3 underwent burr hole drainage procedures as inpatients due to persistent SDH without new deficit. Of the 39 OP who had cerebral contusions, 3 had worsening CT scans and one required NSG admission. No patient returned to the ED with a complication. Follow-up was obtained on 81% of OP. 2 patients with SDH required burr hole procedure >2 weeks after discharge. Conclusions: Patients with mTIH, particularly those with iSAH, have very low rates of clinical or radiographic deterioration and may be safe for monitoring in an emergency department observation unit. (C) 2016 Elsevier Inc. All rights reserved.	[Pruitt, Peter] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL USA; [Penn, Joshua] Winchester Hosp, Dept Emergency Med, Winchester, MA USA; [Peak, David; Borczuk, Pierre] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA USA; [Peak, David; Borczuk, Pierre] Harvard Med Sch, Boston, MA USA	Pruitt, P (corresponding author), 211 East Ontario St,Suite 200, Chicago, IL 60611 USA.	peter.pruitt@northwestern.edu			Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [(AHRQ)T[HYPHEN]32 HS 000078]	Dr Pruitt is a National Research Service Award postdoctoral fellow supported by Agency for Healthcare Research and Quality (AHRQ)T[HYPHEN]32 HS 000078 (PI: Jane L. Holl, MD, MPH). AHRQ was not involved in the design or execution of this research.	Baugh CW, 2011, HEALTH CARE MANAGE R, V36, P28, DOI 10.1097/HMR.0b013e3181f3c035; CONRAD L, 1985, Journal of Emergency Medicine, V2, P325, DOI 10.1016/0736-4679(85)90285-9; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holly J, 2012, AM J EMERG MED, V30, P1402, DOI 10.1016/j.ajem.2011.10.012; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; MACKENZIE EJ, 1990, J TRAUMA, V30, P1096, DOI 10.1097/00005373-199009000-00005; Nishijima DK, 2014, ANN EMERG MED, V63, P448, DOI 10.1016/j.annemergmed.2013.11.003; Nishijima DK, 2013, ANN EMERG MED, V61, P509, DOI 10.1016/j.annemergmed.2012.08.024; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Ross Michael A, 2012, Crit Pathw Cardiol, V11, P128; Rydman RJ, 1998, MED CARE, V36, P599, DOI 10.1097/00005650-199804000-00015; Schaller B, 2010, EMERG MED J, V27, P537, DOI 10.1136/emj.2009.073031; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Welch RD, 2001, EMERG MED CLIN N AM, V19, P137, DOI 10.1016/S0733-8627(05)70172-3; Wu C, 2015, WEST J EMERG MED, V16, P707, DOI 10.5811/westjem.2015.7.27458	18	13	13	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	FEB	2017	35	2					255	259		10.1016/j.ajem.2016.10.064			5	Emergency Medicine	Emergency Medicine	EL9FE	WOS:000394924600011	27838043				2021-06-18	
J	Tanaka, Y; Tsugawa, T; Maeda, Y				Tanaka, Yuto; Tsugawa, Tsuyoshi; Maeda, Yoshinobu			Effect of mouthguards on impact to the craniomandibular complex	DENTAL TRAUMATOLOGY			English	Article						mouthguard; teeth-clenching; temporomandibular joint; craniomandibular complex; concussion	COLLEGIATE FOOTBALL PLAYERS; SOLEUS H-REFLEX; HEAD IMPACTS; MANDIBULAR CONDYLE; DENTAL INJURIES; FRACTURES; CONCUSSION; ACCELERATION; MODULATION; FIXATION	BackgroundThe aim of this study was to investigate the effect of wearing a mouthguard and teeth-clenching on impact to the head and temporomandibular joint (TMJ) during a blow to the jaw. Material and MethodsA custom-made mouthguard was fabricated for five participants. A 4.1-N impact load was applied to the chin with a pendulum. Two acceleration sensors were attached to the forehead and left TMJ. The amplitudes and durations of the accelerations were obtained under five conditions: mouth-open without mouthguard; light teeth-clenching without mouthguard; maximum voluntary clenching (MVC) without mouthguard; mouth-open with mouthguard and MVC with mouthguard. ResultsWearing a mouthguard led to significant decreases in the amplitude (mouth-open with mouthguard vs mouth-open without mouthguard, P = 0.035 at forehead, P = 0.022 at TMJ) and duration (mouth-open with mouthguard vs mouth-open without mouthguard, P = 0.043 at forehead, not significant at TMJ). Similarly, teeth-clenching caused significant decreases in the amplitude (mouth-open without mouthguard vs MVC without mouthguard, P = 0.024 at forehead, P = 0.025 at TMJ) and duration (mouth-open without mouthguard vs MVC without mouthguard, P = 0.033 at forehead, not significant at TMJ). Furthermore, wearing a mouthguard in itself provided an impact reduction effect similar to the combination of teeth-clenching and wearing a mouthguard. ConclusionsWearing a mouthguard and/or teeth-clenching reduced the impact to the head and TMJ during a blow to the jaw. However, it should be noted that the findings are the results from a small impact load to the jaw.	[Tanaka, Yuto; Tsugawa, Tsuyoshi; Maeda, Yoshinobu] Osaka Univ, Dept Prosthodont Gerodontol & Oral Rehabil, Grad Sch Dent, 1-8 Yamadaoka Suita, Suita, Osaka 5650871, Japan	Tanaka, Y (corresponding author), Osaka Univ, Dept Prosthodont Gerodontol & Oral Rehabil, Grad Sch Dent, 1-8 Yamadaoka Suita, Suita, Osaka 5650871, Japan.	yutotanaka.0106@gmail.com	Tanaka, Yuto/I-1786-2019	Tanaka, Yuto/0000-0001-5859-5519	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [23249086]	We are grateful to Satoshi Fukuzawa (Assistant Professor at Tokyo Women's Medical University) for professional advice regarding oral surgery. This research was supported by a Grant-in-Aid for Scientific Research (number 23249086) from the Japan Society for the Promotion of Science.	Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Fredericson Michael, 2006, Top Magn Reson Imaging, V17, P309; Gandhi S, 2011, DENT TRAUMATOL, V27, P257, DOI 10.1111/j.1600-9657.2011.00996.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hasegawa K, 2014, DENT TRAUMATOL, V30, P259, DOI 10.1111/edt.12082; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kumar GBA, 2015, J MAXILLOFAC ORAL SU, V14, P138, DOI 10.1007/s12663-013-0583-7; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lim D, 2005, CLIN J SPORT MED, V15, P313, DOI 10.1097/01.jsm.0000180019.22018.3c; Maeda Y, 2006, BRIT J SPORT MED, V40, P1006, DOI 10.1136/bjsm.2006.030874; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Maxen M, 2011, DENT TRAUMATOL, V27, P95, DOI 10.1111/j.1600-9657.2010.00960.x; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miyahara T, 1996, J NEUROPHYSIOL, V76, P2033; Nogami S, 2014, J ORAL REHABIL, V41, P141, DOI 10.1111/joor.12124; Nogami S, 2012, J CRANIOFAC SURG, V23, P1815, DOI 10.1097/SCS.0b013e3182710393; Nowinski Chris, 2013, Cerebrum, V2013, P2; Nozaki K, 2013, DENT TRAUMATOL, V29, P139, DOI 10.1111/j.1600-9657.2012.01140.x; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063; Takeda T, 2004, DENT TRAUMATOL, V20, P150, DOI 10.1111/j.1600-4469.2004.00247.x; Takeda T, 2014, DENT TRAUMATOL, V30, P76, DOI 10.1111/edt.12050; Tanaka Y, 2015, INT J SPORTS MED, V36, P684, DOI 10.1055/s-0034-1398655; Tanaka Y, 2015, INT J SPORTS MED, V36, P254, DOI 10.1055/s-0034-1390498; Tuna EB, 2014, SPORTS MED, V44, P777, DOI 10.1007/s40279-014-0167-9; Tuncer M, 2007, ARCH ORAL BIOL, V52, P374, DOI 10.1016/j.archoralbio.2006.12.011; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854	31	13	14	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2017	33	1					51	56		10.1111/edt.12283			6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	EK0GR	WOS:000393605300009	27207582				2021-06-18	
J	Tolli, A; Borg, J; Bellander, BM; Johansson, F; Hoybye, C				Tolli, A.; Borg, J.; Bellander, B. -M.; Johansson, F.; Hoybye, C.			Pituitary function within the first year after traumatic brain injury or subarachnoid haemorrhage	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Pituitary; Hormone disturbance; Traumatic brain injury; Subarachnoidal haemorrhage	CHRONIC HYPOPITUITARISM; ACUTE-PHASE; HIGH-RISK; DYSFUNCTION; PREVALENCE; EPIDEMIOLOGY; INSUFFICIENCY; UNCOMMON	Purpose Reports on long-term variations in pituitary function after traumatic brain injury (TBI) and subarachnoid haemorrhage (SAH) diverge. The aim of the current study was to evaluate the prevalence and changes in pituitary function during the first year after moderate and severe TBI and SAH and to explore the relation between pituitary function and injury variables. Methods Adults with moderate and severe TBI or SAH were evaluated at 10 days, 3, 6 and 12 months post-injury/ illness. Demographic, clinical, radiological, laboratory, including hormonal data were collected. Results A total of 91 adults, 56 (15 women/41 men) with TBI and 35 (27 women/8 men) with SAH were included. Perturbations in pituitary function were frequent early after the event but declined during the first year of follow-up. The most frequent deficiency was hypogonadotrope hypogonadism which was seen in approximately 25 % of the patients. Most of the variations were transient and without clinical significance. At 12 months, two patients were on replacement with hydrocortisone, four men on testosterone and one man on replacement with growth hormone. No relations were seen between hormonal levels and injury variables. Conclusions Perturbations in pituitary function continue to occur during the first year after TBI and SAH, but only a few patients need replacement therapy. Our study could not identify a marker of increased risk of pituitary dysfunction that could guide routine screening. However, data demonstrate the need for systematic follow-up of pituitary function after moderate or severe TBI or SAH.	[Tolli, A.; Borg, J.] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden; [Bellander, B. -M.] Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Stockholm, Sweden; [Johansson, F.] Danderyd Hosp, Med Lib, Stockholm, Sweden; [Hoybye, C.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Hoybye, C.] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabetol, Stockholm, Sweden	Tolli, A (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden.	anna.tolli@ki.se		Borg, Jorgen/0000-0002-2372-7478	Pfizer, SwedenPfizer; Stockholm County Council (ALF-grants)Stockholm County Council; NovoNordiskNovo Nordisk	The study was partly funded by an unrestricted research grant from Pfizer, Sweden. Anna Tolli has received support by grants from Stockholm County Council (ALF-grants) and NovoNordisk.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Braet V, 2002, EMERG MED J, V19, P510; Can A, 2016, NEUROSURGERY, V79, P253, DOI 10.1227/NEU.0000000000001157; Castinetti F, 2015, J ENDOCRINOL INVEST, V38, P1, DOI 10.1007/s40618-014-0141-2; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Hilding A, 1999, J CLIN ENDOCR METAB, V84, P2013, DOI 10.1210/jc.84.6.2013; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; INAGAWA T, 1995, STROKE, V26, P761, DOI 10.1161/01.STR.26.5.761; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; JACOBS HS, 1969, BRIT MED J, V2, P595, DOI 10.1136/bmj.2.5657.595; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Khajeh L, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0205-0; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2015, J CLIN MED, V4, P1480, DOI 10.3390/jcm4071480; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; TEASDALE G, 1974, LANCET, V2, P81; Tolli A, 2015, INT J CLIN MED, V6, P411, DOI DOI 10.4236/ijcm.2015.66054; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; TURNERSTOKES L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Zheng P, 2015, J NEUROSURG, V123, P75, DOI 10.3171/2014.12.JNS132308	50	13	15	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0391-4097	1720-8386		J ENDOCRINOL INVEST	J. Endocrinol. Invest.	FEB	2017	40	2					193	205		10.1007/s40618-016-0546-1			13	Endocrinology & Metabolism	Endocrinology & Metabolism	EO7OR	WOS:000396880500010	27671168	Green Published, Other Gold			2021-06-18	
J	Troakes, C; Smyth, R; Noor, F; Maekawa, S; Killick, R; King, A; Al-Sarraj, S				Troakes, Claire; Smyth, Rachel; Noor, Farzana; Maekawa, Satomi; Killick, Richard; King, Andrew; Al-Sarraj, Safa			Clusterin expression is upregulated following acute head injury and localizes to astrocytes in old head injury	NEUROPATHOLOGY			English	Article						astrocytes; clusterin; head injury; neurodegeneration; timing	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-J EXPRESSION; MESSENGER-RNA EXPRESSION; ALZHEIMERS-DISEASE; PLASMA CLUSTERIN; RAT-BRAIN; BETA-APP; PROTEIN; RISK; COMPLEMENT	There is mounting evidence linking traumatic brain injury (TBI) to neurodegeneration. Clusterin (apolipoprotein J or ApoJ) is a complement inhibitor that appears to have a neuroprotective effect in response to tissue damage and has been reported to be upregulated in Alzheimer's disease. Here we investigated the time course and cellular expression pattern of clusterin in human TBI. Tissue from 32 patients with TBI of varying survival times (from under 30min to 10 months) was examined using immunohistochemistry for clusterin alongside other markers of neurodegeneration and neuroinflammation. TBI cases were compared to ischemic brain damage, Alzheimer's disease and controls. Double immunofluorescence was carried out in order to examine cellular expression. Clusterin was initially expressed in an axonal location less than 30min following TBI and increased in intensity and the frequency of deposits with increasing survival time up to 24h, after which it appeared to reduce in intensity but was still evident several weeks after injury. Clusterin was first evident in astrocytes after 45min, being increasingly seen up to 48h but remaining intense in TBI cases with long survival times. Our results suggest clusterin plays a role in modulating the inflammatory response of acute and chronic TBI and that it is a useful marker for TBI, particularly in cases with short survival times. Its prominent accumulation in astrocytes, alongside a mounting inflammatory response and activation of microglial cells supports a potential role in the neurodegenerative changes that occur as a result of TBI.	[Troakes, Claire; Smyth, Rachel; Noor, Farzana; Maekawa, Satomi; King, Andrew; Al-Sarraj, Safa] Kings Coll London, Inst Psychiat Psychol & Neurosci, Basic & Clin Neurosci Dept, London, England; [Killick, Richard] Kings Coll London, Inst Psychiat Psychol & Neurosci, Maurice Wohl Clin Neurosci Inst, Old Age Psychiat Dept, London, England; [King, Andrew] Kings Coll Hosp NHS Fdn Trust, Clin Neuropathol Dept, London, England	King, A (corresponding author), Kings Coll Hosp London, Dept Clin Neuropathol, Acad Neurosci Bldg,Denmark Hill, London SE5 9RS, England.	andrewking@nhs.net		Troakes, Claire/0000-0002-1790-7376	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Brains for Dementia Research program - Alzheimer's Research UK; Brains for Dementia Research program - Alzheimer's Society; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L016397/1, G1100695] Funding Source: researchfish	The London Neurodegenerative Diseases Brain Bank receives funding from the MRC and as part of the Brains for Dementia Research program, jointly funded by Alzheimer's Research UK and Alzheimer's Society. We thank the staff of the Clinical Neuropathology Department at King's College Hospital for diagnostic and technical assistance. We also thank the donors and their families.	Baleriola J, 2015, NEUROTHERAPEUTICS, V12, P57, DOI 10.1007/s13311-014-0308-8; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Braskie MN, 2011, J NEUROSCI, V31, P6764, DOI 10.1523/JNEUROSCI.5794-10.2011; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Craggs LJL, 2016, NEUROPATH APPL NEURO, V42, P194, DOI 10.1111/nan.12248; Giannakopoulos P, 1998, ACTA NEUROPATHOL, V95, P387, DOI 10.1007/s004010050815; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Klimaschewski L, 2001, CELL TISSUE RES, V306, P209, DOI 10.1007/s004410100431; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; Maekawa S, 2009, NEUROPATHOLOGY, V29, P672, DOI 10.1111/j.1440-1789.2009.01029.x; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Mulder SD, 2014, GLIA, V62, P493, DOI 10.1002/glia.22619; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Nuutinen T, 2007, NEUROCHEM INT, V50, P540, DOI 10.1016/j.neuint.2006.11.002; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; PASINETTI GM, 1994, J COMP NEUROL, V339, P387, DOI 10.1002/cne.903390307; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Sasaki K, 2002, ACTA NEUROPATHOL, V103, P199, DOI 10.1007/s004010100456; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Strocchi P, 1999, NEUROREPORT, V10, P1789; Tao R, 1999, J NEUROCYTOL, V28, P559, DOI 10.1023/A:1007067305837; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Tornqvist E, 1996, NEUROBIOL AGING, V17, P695; Troakes C, 2017, NEUROPATHOLOGY, V37, P12, DOI 10.1111/neup.12320; Wiggins AK, 2003, MOL BRAIN RES, V114, P20, DOI 10.1016/S0169-328X(03)00124-4; Wright MC, 2014, J NEUROSCI, V34, P1689, DOI 10.1523/JNEUROSCI.3822-13.2014; ZWAIN IH, 1994, MOL CELL NEUROSCI, V5, P229, DOI 10.1006/mcne.1994.1027	45	13	13	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2017	37	1					12	24		10.1111/neup.12320			13	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	EL5KR	WOS:000394660500002	27365216				2021-06-18	
J	Ndode-Ekane, XE; Kharatishvili, I; Pitkanen, A				Ndode-Ekane, Xavier Ekolle; Kharatishvili, Irina; Pitkanen, Asla			Unfolded Maps for Quantitative Analysis of Cortical Lesion Location and Extent after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						beam balance; lateral fluid percussion; Morris water-maze; MRI; TBI; unfolded map	LATERAL FLUID-PERCUSSION; MORRIS WATER MAZE; PERIRHINAL CORTEX; CEREBRAL-CORTEX; TIME-COURSE; RAT; DEFICITS; EPIDEMIOLOGY; MRI; SEVERITY	We aimed to generate two-dimensional (2D) unfolded cortical maps from magnetic resonance (MR) images to delineate the location of traumatic brain injury (TBI)-induced cortical damage in functionally diverse cytoarchitectonic areas of the cerebral cortex, and to predict the severity of functional impairment after TBI based on the lesion location and extent. Lateral fluid-percussion injury was induced in adult rats and T2 maps were acquired with magnetic resonance imaging (MRI) at 3 days post-TBI. Somatomotor deficits were assessed based on the composite neuroscore and beam balance test, and spatial learning was assessed in the Morris water maze. Animals were perfused for histology at 13 days post-injury. A 2D template was generated by unfolding the cerebral cortex from 26 sections of the rat brain atlas, covering the lesion extent. Next, 2D unfolded maps were generated from T2 maps and thionin-stained histological sections from the same animals. Unfolding of the T2 maps revealed the lesion core in the auditory, somatosensory, and visual cortices. The unfolded histological lesion at 13 days post-injury was 12% greater than the MRI lesion at 3 days post-TBI, as the lesion area increased laterally and caudally; the larger the MRI lesion area, the larger the histological lesion area. Further, the larger the MRI lesion area in the barrel field of the primary somatosensory cortex (S1BF), upper lip of the primary somatosensory cortex (S1ULp), secondary somatosensory division (S2), and ectorhinal (Ect) and perirhinal (PRh) cortices, the more impaired the performance in the beam balance and Morris water maze tests. Subsequent receiver operating characteristic analysis indicated that severity of the MRI lesion in S1ULp and S2 was a sensitive and specific predictor of poor performance in the beam balance test. Moreover, MRI lesions in the S1ULp, S2, S1BF, and Ect and PRh cortices predicted poor performance in the Morris water maze test. Our findings indicate that 2D-unfolded cortical maps generated from MR images delineate the distribution of cortical lesions in functionally different cytoarchitectonic regions, which can be used to predict the TBI-induced functional impairment.	[Ndode-Ekane, Xavier Ekolle; Kharatishvili, Irina; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland	Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Ndode-Ekane, Xavier Ekolle/0000-0001-5682-5632	Academy of FinlandAcademy of FinlandEuropean Commission; ERA-NET Neuron (TBI Epilepsy); FP7-HEALTH project [602102]	This study was supported by the Academy of Finland, ERA-NET Neuron (TBI Epilepsy), and FP7-HEALTH project 602102 (EPITARGET). We thank Dr. Olli Grohn for his helpful comments regarding the manuscript, and Jarmo Hartikainen and Merja Lukkari for their excellent technical assistance.	Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Bota M, 2015, P NATL ACAD SCI USA, V112, pE2093, DOI 10.1073/pnas.1504394112; Bouilleret V, 2009, J NEUROTRAUM, V26, P1999, DOI 10.1089/neu.2009.0943; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Burwell RD, 1995, HIPPOCAMPUS, V5, P390, DOI 10.1002/hipo.450050503; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kim J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00052; Liu P, 1998, HIPPOCAMPUS, V8, P114; Liu P, 1998, BEHAV NEUROSCI, V112, P304, DOI 10.1037/0735-7044.112.2.304; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Paxinos G, 2007, MOUSE BRAIN STEREOTA; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ramos JMJ, 2005, PHYSIOL BEHAV, V86, P118, DOI 10.1016/j.physbeh.2005.07.004; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2006, RESTOR NEUROL NEUROS, V24, P109; VANESSEN DC, 1980, J COMP NEUROL, V191, P255, DOI 10.1002/cne.901910208; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456	34	13	13	1	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					459	474		10.1089/neu.2016.4404			16	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800022	26997032				2021-06-18	
J	Luo, H; Pace, E; Zhang, JS				Luo, Hao; Pace, Edward; Zhang, Jinsheng			BLAST-INDUCED TINNITUS AND HYPERACTIVITY IN THE AUDITORY CORTEX OF RATS	NEUROSCIENCE			English	Article						blast; tinnitus; traumatic brain injury (TBI); auditory cortex; spontaneous activity; bursting; rat	DORSAL COCHLEAR NUCLEUS; ENRICHED ACOUSTIC ENVIRONMENT; INDUCED HEARING-LOSS; INFERIOR COLLICULUS; NEURAL ACTIVITY; TRAUMA; MECHANISMS; SYNCHRONY; SOUND; CAT	Blast exposure can cause tinnitus and hearing impairment by damaging the auditory periphery and direct impact to the brain, which trigger neural plasticity in both auditory and non-auditory centers. However, the underlying neurophysiological mechanisms of blast-induced tinnitus are still unknown. In this study, we induced tinnitus in rats using blast exposure and investigated changes in spontaneous firing and bursting activity in the auditory cortex (AC) at one day, one month, and three months after blast exposure. Our results showed that spontaneous activity in the tinnitus-positive group began changing at one month after blast exposure, and manifested as robust hyperactivity at all frequency regions at three months after exposure. We also observed an increased bursting rate in the low frequency region at one month after blast exposure and in all frequency regions at three months after exposure. Taken together, spontaneous firing and bursting activity in the AC played an important role in blast-induced chronic tinnitus as opposed to acute tinnitus, thus favoring a bottom-up mechanism. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Luo, Hao; Pace, Edward; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA; [Zhang, Jinsheng] Wayne State Univ, Coll Liberal Arts & Sci, Dept Commun Sci & Disorders, Detroit, MI USA	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Otolaryngol Head & Neck Surg, 5E-UHC,4201 St Antoine, Detroit, MI 48201 USA.	jinzhang@med.wayne.edu			Department of DefenseUnited States Department of Defense [W81XWH-11-2-0031]	This work was supported by the Department of Defense (grant award #W81XWH-11-2-0031). The authors thank Drs. Pamela VandeVord and Srini Kallakuri for their assistance during blast exposure using a shock tube in the Department of Biomedical Engineering, Wayne State University.	Bauer CA, 2008, J NEUROSCI RES, V86, P2564, DOI 10.1002/jnr.21699; Bauer Carol A, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P413, DOI 10.1097/01.moo.0000134443.29853.09; Bilak M, 1997, EXP NEUROL, V147, P256, DOI 10.1006/exnr.1997.6636; Browne CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033272; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chambers AR, 2016, NEURON, V89, P867, DOI 10.1016/j.neuron.2015.12.041; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2000, J NEUROPHYSIOL, V83, P2708; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Eggermont JJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00029; Finlayson PG, 2009, HEARING RES, V256, P104, DOI 10.1016/j.heares.2009.07.006; Geckle L., 2004, FORC HLTH PROT C ALB; Henry JA, 2005, J SPEECH LANG HEAR R, V48, P1204, DOI 10.1044/1092-4388(2005/084); Hughes LF, 2010, HEARING RES, V264, P79, DOI 10.1016/j.heares.2009.09.005; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kimura M, 1999, HEARING RES, V135, P146, DOI 10.1016/S0378-5955(99)00104-5; Krishnan A, 2009, AUDIOL NEURO-OTOL, V14, P88, DOI 10.1159/000158537; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926; Llano DA, 2012, J NEUROSCI, V32, P16141, DOI 10.1523/JNEUROSCI.2499-12.2012; Luo H, 2014, NEUROSCI LETT, V580, P47, DOI 10.1016/j.neulet.2014.07.041; Luo H, 2014, J NEUROSCI RES, V92, P1466, DOI 10.1002/jnr.23424; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mulders WHAM, 2013, HEARING RES, V298, P104, DOI 10.1016/j.heares.2012.12.008; Mulders WHAM, 2011, J COMP NEUROL, V519, P2637, DOI 10.1002/cne.22644; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Norena AJ, 2006, NEUROREPORT, V17, P559, DOI 10.1097/00001756-200604240-00001; Richardson BD, 2012, BRAIN RES; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Shore SE, 2016, NAT REV NEUROL, V12, P150, DOI 10.1038/nrneurol.2016.12; Swadlow HA, 2001, NAT NEUROSCI, V4, P402, DOI 10.1038/86054; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wu C, 2016, J NEUROSCI, V36, P2068, DOI 10.1523/JNEUROSCI.3960-15.2016; Zhang J, 2015, HEAR RES; Zhang JS, 1998, NEUROSCI LETT, V250, P197, DOI 10.1016/S0304-3940(98)00482-0	40	13	13	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 6	2017	340						515	520		10.1016/j.neuroscience.2016.11.014			6	Neurosciences	Neurosciences & Neurology	EH8RK	WOS:000392039800043	27865868	Bronze			2021-06-18	
J	Altaf, F; Griesdale, DE; Belanger, L; Ritchie, L; Markez, J; Ailon, T; Boyd, MC; Paquette, S; Fisher, CG; Street, J; Dvorak, MF; Kwon, BK				Altaf, F.; Griesdale, D. E.; Belanger, L.; Ritchie, L.; Markez, J.; Ailon, T.; Boyd, M. C.; Paquette, S.; Fisher, C. G.; Street, J.; Dvorak, M. F.; Kwon, B. K.			The differential effects of norepinephrine and dopamine on cerebrospinal fluid pressure and spinal cord perfusion pressure after acute human spinal cord injury	SPINAL CORD			English	Article							TRAUMATIC BRAIN-INJURY; CORTICAL IMPACT INJURY; MANAGEMENT; AUTOREGULATION; MECHANISMS; EDEMA; RATS	Study design: Prospective vasopressor cross-over interventional study Objectives: To examine how two vasopressors used in acute traumatic spinal cord injury (SCI) affect intrathecal cerebrospinal fluid pressure and the corresponding spinal cord perfusion pressure (SCPP). Setting: Vancouver, British Columbia, Canada. Methods: Acute SCI patients over the age of 17 with cervical or thoracic ASIA Impairment Scale (AIS). A, B or C injuries were enrolled in this study. Two vasopressors, norepinephrine and dopamine, were evaluated in a 'crossover procedure' to directly compare their effect on the intrathecal pressure (ITP). The vasopressor cross-over procedures were performed in the intensive care unit where ITP, mean arterial pressure (MAP) and heart rate were being continuously measured. The SCPP was calculated as the difference between MAP and ITP. Results: A total of 11 patients were enrolled and included in our analysis. There were 6 patients with AIS A, 3 with AIS B and 2 with AIS C injuries at baseline. We performed 24 cross-over interventions in these 11 patients. There was no difference in MAP with the use of norepinephrine versus dopamine (84 +/- 1 mm Hg for both; P=0.33). Conversely, ITP was significantly lower with the use of norepinephrine than with dopamine (17 +/- 1 mm Hg vs 20 +/- 1 mm Hg, respectively, P<0.001). This decrease in ITP with norepinephrine resulted in an increased SCPP during the norepinephrine infusion when compared with dopamine (67 +/- 1 mm Hg vs 65 +/- 1 mm Hg respectively, P=0.0049). Conclusion: Norepinephrine was able to maintain MAP with a lower ITP and a correspondingly higher SCPP as compared with dopamine in this study. These results suggest that norepinephrine may be preferable to dopamine if vasopressor support is required post SCI to maintain elevated MAPs in accordance with published guidelines.	[Altaf, F.; Fisher, C. G.; Street, J.; Dvorak, M. F.; Kwon, B. K.] Univ British Columbia, Dept Orthopaed, Vancouver Spine Surg Inst, Blusson Spinal Cord Ctr, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada; [Griesdale, D. E.] Univ British Columbia Crit Care Med, Vancouver Gen Hosp, Dept Anesthesiol Pharmacol & Therapeut, Div Crit Care, Vancouver, BC, Canada; [Belanger, L.; Ritchie, L.] Vancouver Gen Hosp, Vancouver Spine Res Program, Vancouver, BC, Canada; [Markez, J.] Vancouver Gen Hosp, Dept Biomed Engn, Vancouver, BC, Canada; [Ailon, T.; Boyd, M. C.; Paquette, S.] Univ British Columbia, Vancouver Spine Surg Inst, Div Neurosurg, Dept Surg, Vancouver, BC, Canada; [Street, J.; Dvorak, M. F.; Kwon, B. K.] Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada	Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Vancouver Spine Surg Inst, Blusson Spinal Cord Ctr, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	Brian.Kwon@ubc.ca		Ailon, Tamir/0000-0002-1966-5323; Dvorak, Marcel/0000-0002-9404-8448; Griesdale, Donald/0000-0001-5985-8624	Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Craig H. Neilsen Foundation; Rick Hansen Institute (RHI); VGH & UBC Hospital Foundation Best of Health Fund	We acknowledge the research staff of the Vancouver Spine Research Program, in particular Allan Aludino, Leilani Reichl, Angela Tsang and Jiwan Gill for their assistance with this study. We also acknowledge support for the conduct of this study from the Michael Smith Foundation for Health Research, the Craig H. Neilsen Foundation and the Rick Hansen Institute (RHI), including Daniel Rogers of RHI for project management. Dr Griesdale is supported by the VGH & UBC Hospital Foundation Best of Health Fund. MFD holds the Paetzold Chair in Spinal Cord Injury Research. FKK holds the Canada Research Chair in Spinal Cord Injury and VGH & UBC Hospital Foundation Dvorak Chair in Spine Trauma.	Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Beaumont A, 2000, ACT NEUR S, V76, P147; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Consortium for Spinal Cord Medicine, 2008, J SPINAL CORD MED, V31, P403; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Eriksen VR, 2014, ACTA PAEDIATR, V103, P1221, DOI 10.1111/apa.12817; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kong CY, 2013, SPINAL CORD, V51, P466, DOI 10.1038/sc.2013.32; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; Muzevich KM, 2009, NEUROCRIT CARE, V11, P112, DOI 10.1007/s12028-009-9214-z; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Readdy WJ, 2015, J NEUROSURG SPINE; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Tator C H, 1996, J Spinal Cord Med, V19, P206; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Varsos GV, 2015, J NEUROSURG-SPINE, V14, P1; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028	31	13	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2017	55	1					33	38		10.1038/sc.2016.79			6	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EK9XA	WOS:000394276000006	27271117	Bronze			2021-06-18	
J	Clark, AL; Bangen, KJ; Sorg, SF; Schiehser, DM; Evangelista, ND; McKenna, B; Liu, TT; Delano-Wood, L				Clark, Alexandra L.; Bangen, Katherine J.; Sorg, Scott F.; Schiehser, Dawn M.; Evangelista, Nicole D.; McKenna, Benjamin; Liu, Thomas T.; Delano-Wood, Lisa			Dynamic association between perfusion and white matter integrity across time since injury in Veterans with history of TBI	NEUROIMAGE-CLINICAL			English	Article						Perfusion; Arterial spin labeling; ASL; Cerebral blood flow; CBF; White matter microstructure; Diffusion tensor imaging; DTI; Traumatic brain injury; TBI; Time since injury; White matter	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; POSTTRAUMATIC-STRESS-DISORDER; DIFFUSION-TENSOR; POSTCONCUSSIVE SYMPTOMS; COGNITIVE DYSFUNCTION; RISK-FACTORS; BLAST; NEUROPATHOLOGY; ABNORMALITIES	Objective: Cerebral blood flow (CBF) plays a critical role in the maintenance of neuronal integrity, and CBF alterations have been linked to deleterious white matter changes. Although both CBF and white matter microstructural alterations have been observed within the context of traumatic brain injury (TBI), the degree to which these pathological changes relate to one another and whether this association is altered by time since injury have not been examined. The current study therefore sought to clarify associations between resting CBF and white matter microstructure post-TBI. Methods: 37 veterans with history of mild or moderate TBI (mmTBI) underwent neuroimaging and completed health and psychiatric symptom questionnaires. Resting CBF was measured with multiphase pseudocontinuous arterial spin labeling (MPPCASL), and white matter microstructural integrity was measured with diffusion tensor imaging (DTI). The cingulate cortex and cingulum bundle were selected as a priori regions of interest for the ASL and DTI data, respectively, given the known vulnerability of these regions to TBI. Results: Regression analyses controlling for age, sex, and posttraumatic stress disorder (PTSD) symptoms revealed a significant time since injury x resting CBF interaction for the left cingulum (p < 0.005). Decreased CBF was significantly associated with reduced cingulum fractional anisotropy (FA) in the chronic phase; however, no such association was observed for participants with less remote TBI. Conclusions: Our results showed that reduced CBF was associated with poorer white matter integrity in those who were further removed from their brain injury. Findings provide preliminary evidence of a possible dynamic association between CBF and white matter microstructure that warrants additional consideration within the context of the negative long-term clinical outcomes frequently observed in those with history of TBI. Additional cross-disciplinary studies integrating multiple imaging modalities (e.g., DTI, ASL) and refined neuropsychiatric assessment are needed to better understand the nature, temporal course, and dynamic association between brain changes and clinical outcomes post-injury. Published by Elsevier Inc.	[Clark, Alexandra L.] San Diego State Univ Univ Calif San Diego SDSU UC, La Jolla, CA 92093 USA; [Clark, Alexandra L.; Bangen, Katherine J.; Sorg, Scott F.; Schiehser, Dawn M.; Evangelista, Nicole D.; McKenna, Benjamin; Delano-Wood, Lisa] VASDHS, San Diego, CA USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Bangen, Katherine J.; Sorg, Scott F.; Schiehser, Dawn M.; Evangelista, Nicole D.; McKenna, Benjamin; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Liu, Thomas T.] Univ Calif San Diego, Dept Radiol, Keck Ctr Funct MRI, La Jolla, CA 92093 USA	Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu		Liu, Thomas/0000-0002-1978-7486; mcKenna, Benjamin/0000-0002-5607-6376	Veterans Affair [2-065-10S, 829-MR-NB-25860]; Department of Defense Investigator-Initiated Research [W81XWH-10-2-0169]	This work was supported by grants awarded by the Veterans Affairs: a Career Development Award to D.S. (2-065-10S) and Merit Award to L.D.-W(829-MR-NB-25860). This work was further supported by a Department of Defense Investigator-Initiated Research Grant to L.D.-W. (W81XWH-10-2-0169).	Appelman APA, 2008, J CEREBR BLOOD F MET, V28, P633, DOI 10.1038/sj.jcbfm.9600563; Bangen KJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00159; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Beason-Held LL, 2012, STROKE, V43, P1542, DOI 10.1161/STROKEAHA.111.638437; Beck A.T., 1996, MANUAL BECK DEPRESSI; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bernbaum M, 2015, J CEREBR BLOOD F MET, V35, P1610, DOI 10.1038/jcbfm.2015.92; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Burzynska AZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120315; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062082; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Clark AL, 2016, BRAIN IMAGING BEHAV, V11, P1; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Defense and Veterans Brain Injury Center, 2016, DEP DEF NUMB TBI WOR; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Department of Veterans Affairs Department of Defense, 2009, VA DOD CLIN PRACT GU; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Duering M, 2012, NEUROLOGY, V79, P2025, DOI 10.1212/WNL.0b013e3182749f39; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fridley J, 2015, J NEUROTRAUM, V32, P75, DOI 10.1089/neu.2014.3350; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.3.CO;2-H; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Jung Y, 2010, MAGN RESON MED, V64, P799, DOI 10.1002/mrm.22465; Keane T.M., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI DOI 10.1037/1040-3590.1.1.53; Kenney K., 2015, EXP NEUROL; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maillard P, 2015, NEUROBIOL AGING, V36, P1670, DOI 10.1016/j.neurobiolaging.2015.01.007; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ponto LLB, 2016, J NEUROPSYCH CLIN N, V28, P89, DOI 10.1176/appi.neuropsych.15050106; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Promjunyakul N, 2015, NEUROIMAGE-CLIN, V8, P224, DOI 10.1016/j.nicl.2015.04.012; Promjunyakul NO, 2016, J CEREBR BLOOD F MET, V36, P1528, DOI 10.1177/0271678X16651268; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Salat DH, 2014, NEUROSCIENCE, V276, P174, DOI 10.1016/j.neuroscience.2013.11.041; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Shin DD, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00021; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steketee RME, 2016, NEUROBIOL AGING, V43, P119, DOI 10.1016/j.neurobiolaging.2016.03.031; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Tanielian T, 2008, INVISIBLE WOUNDS WAR; ten Dam VH, 2007, RADIOLOGY, V243, P198, DOI 10.1148/radiol.2431052111; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang R, 2007, P INT SOC MAG RESON, V15, P3720; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F. W., 1993, ANN M INT SOC TRAUM; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wirth M., 2016, J CEREB BLOOD FLOW M; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	93	13	14	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	14						308	315		10.1016/j.nicl.2016.12.017			8	Neuroimaging	Neurosciences & Neurology	FB2OY	WOS:000405984300033	28210542	DOAJ Gold, Green Published			2021-06-18	
J	Clark, JM; Hoshizaki, TB; Gilchrist, MD				Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Protective capacity of an ice hockey goaltender helmet for three events associated with concussion	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Brain injury; impact biomechanics; dynamic response; finite element modeling; brain tissue response	TRAUMATIC BRAIN-INJURY; SYSTEMATIC VIDEO ANALYSIS; ACCIDENT RECONSTRUCTION; PROFESSIONAL FOOTBALL; HEAD-INJURIES; LEAGUE NHL; IMPACT; BIOMECHANICS; PLAYER; MECHANISMS	The purpose of this study was to assess the protective capacity of an ice hockey goaltender helmet for three concussive impact events. A helmeted and unhelmeted headform was used to test three common impact events in ice hockey (fall, puck impacts and shoulder collisions). Peak linear acceleration, rotational acceleration and rotational velocity as well as maximum principal strain and von Mises stress were measured for each impact condition. The results demonstrated the tested ice hockey goaltender helmet was well designed to manage fall and puck impacts but does not consistently protect against shoulder collisions and an opportunity may exist to improve helmet designs to better protect goaltenders from shoulder collisions.	[Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada	Clark, JM (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.; Clark, JM (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	michio.clark@ucd.i.e			Ontario Graduate Scholarship in Science and Technology; European Union's Horizon 2020 research and innovation programme under the Marie Skiodowska-Curie [642, 662]	This work was supported by Ontario Graduate Scholarship in Science and Technology (to J.M.C); European Union's Horizon 2020 research and innovation programme under the Marie Skiodowska-Curie [grant agreement number 642,662].	Agel J, 2007, J ATHL TRAINING, V42, P241; American Society for Testing and Materials, 2014, F158712A ASTM INT, DOI [10.1520/F1587-12A, DOI 10.1520/F1587-12A]; Bancroft RW, 1993, SAFETY ICE HOCKEY, V2, DOI [10.1520/STP13121S, DOI 10.1520/STP13121S]; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Canadian Standards Association, 2009, Z262109 CAN STAND AS; Canadian Standards Association, 2009, Z262209 CAN STAND AS; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Clark J. M, 2015, EVALUATION PROTECTIV; Clark JM, 2016, ISBS C TSUKUBA JAPAN, V1, P395; Da Silva VD, 2005, MECH STRENGTH MAT, DOI 10.1007/3-540-30813-X; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Forero Rueda MA, 2009, EQUESTRIAN HELMET DE; Fournier E., 2000, IRCOBI INT RES COUNC, V2000, P223; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2012, P I MECH ENG P-J SPO, V226, P226, DOI 10.1177/1754337112448765; Hunt H, 1989, P IRCOBI STOCKH SWED; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; International Organization for Standardization, 2003, 10256 ISO; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kendall M., 2016, COMP CHARACTERIZATIO; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; Kendall M, 2014, AM SOC TEST MATER, V1552, P142, DOI 10.1520/STP155220120150; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPrade R, 2009, P 5 INT S SAF IC HOC, DOI [10.1520/STP48862S, DOI 10.1520/STP48862S]; Liberman M, 2007, CLIN J SPORT MED, V17, P61, DOI 10.1097/01.jsm.0000168072.44003.98; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nur Sarah, 2015, Sports Biomech, V14, P459, DOI 10.1080/14763141.2015.1084035; Ouckama R., 2014, IRCOBI P, P62; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pashby T, 2001, CLIN J SPORT MED, V11, P211, DOI 10.1097/00042752-200110000-00001; Post A, SPORTS ENG; Post A., 2014, P IRCOBI C BERL GERM, P72; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Powell JW, 2001, J ATHL TRAINING, V36, P307; Rousseau P, 2014, AM SOC TEST MATER, V1552, P196, DOI 10.1520/STP155220120159; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Rousseau P, 2009, P 5 INT S SAF IC HOC; Rousseau P, 2014, ANAL CONCUSSION METR; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Ruan J. S., 1994, IMPACT BIOMECHANICS; Seemann M. R., 1986, P 30 STAPP CAR CRASH, V30, P291; Sim F, 1977, AM J SPORTS MED, V6, P378; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Trosseille X, 1992, 01487191 SAE, P19; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walsh E. S, 2012, P I MECH ENG P; Walsh ES, 2012, P ASTM S MECH CONC S; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/cras.8.6.605.19261; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, P STAPP CAR CRASH J, P121	72	13	13	1	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2017	20	12					1299	1311		10.1080/10255842.2017.1341977			13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Computer Science; Engineering	FH0GM	WOS:000410817600004	28685612	Green Accepted			2021-06-18	
S	Czosnyka, M; Pickard, JD; Steiner, LA		Wijdicks, EFM; Kramer, AH		Czosnyka, M.; Pickard, J. D.; Steiner, L. A.			Principles of intracranial pressure monitoring and treatment	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; PROMISING TREATMENT MODALITY; DECOMPRESSIVE CRANIECTOMY; INTENSIVE-CARE; BLOOD-PRESSURE; PLATEAU WAVES; CEREBROVASCULAR REACTIVITY; INTRACEREBRAL HEMORRHAGE; THERAPEUTIC HYPOTHERMIA	Intracranial pressure (ICP) is governed by volumes of intracranial blood, cerebrospinal fluid, and brain tissue. Expansion of any of these volumes will trigger compensatory changes in the other compartments, resulting in initially limited change in ICP. Due to the rigid skull, once compensatory mechanisms are exhausted, ICP rises very rapidly. Intracranial hypertension is associated with unfavorable outcome in brain-injured patients. This chapter discusses the pathophysiology of raised ICP, as well as typical waveforms, monitoring techniques, and clinical management. The dynamics of ICP are more important than the absolute value at any given time point, but mean ICP exceeding 20 - 25 mmHg is usually treated aggressively. Algorithms based on data from patients with traumatic brain injury are applied also in other conditions. However, an understanding of the underlying pathophysiology allows adaptation of therapies to other pathologies. Typically, a three-staged approach is used, starting with restoration of systemic physiology, sedation, and analgesia. If these measures are insufficient, surgical options, such as drainage of cerebrospinal fluid or evacuation of mass lesions, are considered. In the absence of surgical options, stage 2 treatments are initiated, consisting of either mannitol or hypertonic saline. If these measures are insufficient, stage 3 therapies include hypothermia, metabolic suppression, or craniectomy.	[Czosnyka, M.; Pickard, J. D.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Steiner, L. A.] Univ Hosp Basel, Dept Anesthesia Surg Intens Care Prehosp Emergenc, Basel, Switzerland	Czosnyka, M (corresponding author), Univ Cambridge, Dept Clin Neurosci, Brain Phys, Cambridge, England.	mc141@medschl.cam.ac.uk	Steiner, Luzius/J-1987-2019		Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986, G9439390, G0001237] Funding Source: Medline		AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R, 1986, INTRACRANIAL PRESSUR, VVI, P229; Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS31; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2005, ACT NEUR S, V95, P25; BARZO P, 1993, NEUROSURGERY, V32, P611; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS87; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Brain Trauma Foundation, 2016, GUID MAN SEV TRAUM B; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; CZOSNYKA M, 1994, ACTA NEUROCHIR, V126, P113, DOI 10.1007/BF01476419; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; da Costa CS, 2015, J PEDIATR-US, V167, P86, DOI 10.1016/j.jpeds.2015.03.041; DAVSON H, 1970, Brain Behavior and Evolution, V93, P665, DOI 10.1093/brain/93.4.665; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; DEWEY RC, 1974, J NEUROSURG, V41, P597, DOI 10.3171/jns.1974.41.5.0597; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; GUILLAUME J, 1951, REV NEUROL, V84, P131; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Higgins JNP, 2002, LANCET, V359, P228, DOI 10.1016/S0140-6736(02)07440-8; Holsgrove DT, 2014, ACTA NEUROCHIR SUPPL, V119, P53, DOI 10.1007/978-3-319-02411-0_9; Hu X, 2010, PHYSIOL MEAS, V31, P679, DOI 10.1088/0967-3334/31/5/006; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Kam PCA, 2007, ANAESTHESIA, V62, P690, DOI 10.1111/j.1365-2044.2007.05055.x; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Lam JMK, 1997, STROKE, V28, P906, DOI 10.1161/01.STR.28.5.906; LASSEN NA, 1964, CIRC RES, V15, P201; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; Miller J D, 1972, Prog Brain Res, V35, P411; Munch EC, 2001, CRIT CARE MED, V29, P976; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/s0140-6736(04)17188-2; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; PIPER IR, 1993, NEUROSURGERY, V32, P805, DOI 10.1227/00006123-199305000-00014; PIPER IR, 1990, J NEUROSURG, V73, P871, DOI 10.3171/jns.1990.73.6.0871; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Radolovich DK, 2011, NEUROCRIT CARE, V15, P379, DOI 10.1007/s12028-011-9553-4; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Robba C, 2016, ACTA NEUROL SCAND, V134, P4, DOI 10.1111/ane.12527; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; ROBERTSON CS, 1989, J NEUROSURG, V71, P673, DOI 10.3171/jns.1989.71.5.0673; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt EA, 2001, J NEUROL NEUROSUR PS, V70, P198, DOI 10.1136/jnnp.70.2.198; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Varelas PN, 2013, NEUROSURG CLIN N AM, V24, P393, DOI 10.1016/j.nec.2013.03.005; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Zweifel C, 2010, J NEUROTRAUM, V27, P1951, DOI 10.1089/neu.2010.1388	79	13	16	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						67	89		10.1016/B978-0-444-63600-3.00005-2			23	Critical Care Medicine; Clinical Neurology	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500007	28187815				2021-06-18	
J	Dodick, D; Starling, AJ; Wethe, J; Pang, Y; Messner, LV; Smith, C; Master, CL; Halker-Singh, RB; Vargas, BB; Bogle, JM; Mandrekar, J; Talaber, A; Leong, D				Dodick, David; Starling, Amaal J.; Wethe, Jennifer; Pang, Yi; Messner, Leonard V.; Smith, Craig; Master, Christina L.; Halker-Singh, Rashmi B.; Vargas, Bert B.; Bogle, Jamie M.; Mandrekar, Jay; Talaber, Alexandra; Leong, Danielle			The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students: A Randomized Controlled Trial	JOURNAL OF CHILD NEUROLOGY			English	Article						reading; eye movements; saccadic training; intervention; randomized controlled trial	BRAIN-INJURY MTBI; EYE-MOVEMENTS; KING-DEVICK; CHILDREN; ASSOCIATIONS; CONCUSSION; TRACKING; HYPOXIA; DISEASE; TESTS	Efficient eye movements provide a physical foundation for proficient reading skills. We investigated the effect of in-school saccadic training on reading performance. In this cross-over design, study participants (n = 327, 165 males; mean age [SD]: 7 y 6 mo [1y 1 mo]) were randomized into treatment and control groups, who then underwent eighteen 20-minute training sessions over 5 weeks using King-Devick Reading Acceleration Program Software. Pre-and posttreatment reading assessments included fluency, comprehension, and rapid number naming performance. The treatment group had significantly greater improvement than the control group in fluency (6.2% vs 3.6%, P =.0277) and comprehension (7.5% vs 1.5%, P =.0002). The high-needs student group significantly improved in fluency (P <.001) and comprehension (P <.001). We hypothesize these improvements to be attributed to the repetitive practice of reading-related eye movements, shifting visuospatial attention, and visual processing. Consideration should be given to teaching the physical act of reading within the early education curriculum.	[Dodick, David; Starling, Amaal J.; Wethe, Jennifer; Halker-Singh, Rashmi B.; Vargas, Bert B.; Bogle, Jamie M.] Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA; [Pang, Yi; Messner, Leonard V.; Leong, Danielle] Illinois Eye Inst, Chicago, IL USA; [Smith, Craig] Bill & Melinda Gates Fdn, Seattle, WA USA; [Master, Christina L.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Mandrekar, Jay] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Talaber, Alexandra; Leong, Danielle] King Devick Test Inc, Oak Brook Terrace, IL USA	Dodick, D (corresponding author), Mayo Clin, Dept Neurol, 5777 East Mayo Blvd, Phoenix, AZ 85054 USA.	dodick.david@mayo.edu		Master, Christina/0000-0002-6717-4270	King-Devick Test, Inc.	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by King-Devick Test, Inc.	Allen M, 2012, M AM OPT ASS OPT CHI; [Anonymous], 2015, KING DEV TEST READ T; [Anonymous], 2013, EARL READ PROF US, P1; [Anonymous], 2013, NATL ASSESSMENT ED P; Ayaz H, 2014, J NEUROSCI NEUROENGI, V3, P1; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Biscaldi M, 1998, NEUROPSYCHOLOGIA, V36, P1189, DOI 10.1016/S0028-3932(97)00170-X; Chetwood ASA, 2012, SURG ENDOSC, V26, P2003, DOI 10.1007/s00464-011-2143-x; Convergence insufficiency treatment trial investigator group, 2009, ARCH OPHTHALMOL-CHIC, V126, P1336; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Denton CA, 2011, SCI STUD ST BONAVENT, V15; Dore-Mazars K, 2004, PSYCHOL RES-PSYCH FO, V69, P67, DOI 10.1007/s00426-003-0166-1; EDEN GF, 1994, VISION RES, V34, P1345, DOI 10.1016/0042-6989(94)90209-7; Feder KP, 2007, DEV MED CHILD NEUROL, V49, P312, DOI 10.1111/j.1469-8749.2007.00312.x; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fernandez G, 2013, INVEST OPHTH VIS SCI, V54, P8345, DOI 10.1167/iovs.13-12877; FIORAVANTI F, 1995, VISION RES, V35, P3217, DOI 10.1016/0042-6989(95)00152-5; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Hosp MK, 2005, SCHOOL PSYCHOL REV, V34, P9; Leong DF, 2014, CLIN PEDIATR, V53, P858, DOI 10.1177/0009922814532520; Lesnick J, 2010, LONGITUDINAL ANAL 3, P1; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Luna B, 2008, BRAIN COGNITION, V68, P293, DOI 10.1016/j.bandc.2008.08.019; Miles SB, 2006, CHILD DEV, V77, P103, DOI 10.1111/j.1467-8624.2006.00859.x; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Peltsch A, 2014, EUR J NEUROSCI, V39, P2000, DOI 10.1111/ejn.12617; Quaid P, 2013, GRAEF ARCH CLIN EXP, V251, P169, DOI 10.1007/s00417-012-2135-0; Seassau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070261; Stepanek J, 2014, AVIAT SPACE ENVIR MD, V85, P700, DOI 10.3357/ASEM.3645.2014; Stepanek J, 2013, AVIAT SPACE ENVIR MD, V84, P1017, DOI 10.3357/ASEM.3616.2013; Thiagarajan P, 2014, BRAIN INJURY, V28, P930, DOI 10.3109/02699052.2014.888761; Thiagarajan P, 2014, NEUROREHABILITATION, V34, P129, DOI 10.3233/NRE-131025; van Wyk A, 2014, NEUROREHAB NEURAL RE, V28, P856, DOI 10.1177/1545968314526306; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Wethe J, 2012, VIS DEV REHABIL	37	13	13	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2017	32	1					104	111		10.1177/0883073816668704			8	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	EP2KX	WOS:000397213000014	28257277				2021-06-18	
J	Dretsch, MN; Williams, K; Staver, T; Grammer, G; Bleiberg, J; DeGraba, T; Lange, RT				Dretsch, Michael N.; Williams, Kathy; Staver, Tara; Grammer, Geoffrey; Bleiberg, Joseph; DeGraba, Thomas; Lange, Rael T.			Evaluating the clinical utility of the Validity-10 for detecting amplified symptom reporting for patients with mild traumatic brain injury and comorbid psychological health conditions	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Mild traumatic brain injury; neurobehavioral symptom inventory; post-concussive symptoms; Validity-10	MILITARY SERVICE MEMBERS; POSTCONCUSSION SYNDROME; INVENTORY; EXAGGERATION; SCALE	The objective of this study was to compare the Validity-10 scale with the PAI Negative Impression Management Scale (PAI-NIM) for detecting exaggerated symptom reporting in active-duty military service members (SMs) admitted with unremitting mild TBI symptoms and comorbid psychological health conditions (mTBI/PH). Data were analyzed from 254 SMs who completed the Neurobehavioral Symptom Inventory (NSI) and Personality Assessment Inventory (PAI) as a part of a larger battery of self-report symptom scales upon admission to the intensive-outpatient TBI treatment program at a military medical center. Symptom exaggeration was operationalized using the PAI Negative Impression Management Scale (PAI-NIM). A PAI-NIM score of 73 was categorized as positive for symptom exaggeration (SVTpos), while a lower score was categorized as negative for symptom exaggeration (SVTneg). SMs in the SVTpos group (n=34) had significantly higher scores (p.004) on the PAI clinical scales as well as on the NSI total score (range: d=0.59-1.91) compared to those who were SVTneg (n=220). The optimal cut-score for the NSI Val-10 scale to identify possible symptom exaggeration was 26 (sensitivity=.29, specificity=.95, PPP=.74, NPP=.71). In patients suffering from mTBI/PH, the Validity-10 requires a higher cut-score than previously reported to be useful as a metric of exaggerated symptom reporting.	[Dretsch, Michael N.; Williams, Kathy; Staver, Tara; Grammer, Geoffrey; Bleiberg, Joseph; DeGraba, Thomas; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Dretsch, Michael N.] Headquarters US Army Training & Doctrine Command, Human Dimens Div, Ft Eustis, VA USA; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA	Dretsch, MN (corresponding author), HQ TRADOC, Human Dimens Div, 950 Jefferson Ave, Ft Eustis, VA 23604 USA.	dretschphd@gmail.com		Bleiberg, Joseph/0000-0003-0867-5494			CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Morey L. C., 1991, PERSONALITY ASSESSME; Morey LC., 2007, PERSONALITY ASSESSME; Rohling Martin L, 2002, CNS Spectr, V7, P387; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e	14	13	13	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	4					376	380		10.1080/23279095.2016.1220947			5	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	EW6FW	WOS:000402605300009	27556139				2021-06-18	
J	Gao, M; Dong, Q; Yao, H; Zhang, Y; Yang, Y; Dang, YY; Zhang, HT; Yang, ZJ; Xu, MH; Xu, RX				Gao, Mou; Dong, Qin; Yao, Hui; Zhang, Yan; Yang, Yang; Dang, Yuanyuan; Zhang, Hongtian; Yang, Zhijun; Xu, Minhui; Xu, Ruxiang			Induced neural stem cells modulate microglia activation states via CXCL12/CXCR4 signaling	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Induced neural stem cell; Microglia; CXCR4; Closed head injury; Immunomodulation	NF-KAPPA-B; IMMUNE-RESPONSES; BRAIN; INJURY; INFLAMMATION; MODEL; NEUROGENESIS; MOBILIZATION; MECHANISMS; MIGRATION	We previously reported that induced neural stem cells (iNSCs) directly reprogrammed from mouse embryonic fibroblasts can expand and differentiate into neurons, astrocytes and oligodendrocytes. Whether iNSCs have immunoregulatory properties in addition to facilitating cell replacement remains uncertain. In this study, we aimed to characterize the immunomodulatory effects of iNSCs on the activation states of microglia and to elucidate the mechanisms underlying these effects. Using a mouse model of closed head injury (CHI), we observed that iNSC grafts decreased the levels of ED1(+)/Iba1(+) and TNF-alpha(+)/Iba1(+) microglia but increased the levels of IGF1(+)/Iba1(+) microglia in the injured cortex. Subsequently, using a Transwell co-culture system, we discovered that iNSCs could modulate LPS-pretreated microglia phenotypes in vitro via CXCL12/CXCR4 signaling, which we demonstrated through the administration of the CXCR4 antagonist AMD3100 and CXCR4-specific siRNA treatment. An in vivo loss-of-function study also revealed that iNSC grafts regulated the behavior of resident microglia via CXCL12/CXCR4 signaling, influencing their activation state such that they promoted neurological functional recovery and neuron survival. Furthermore, the beneficial effects of iNSC transplantation were significantly diminished by CXCR4 knockdown. In short, iNSCs have the potential to influence microglia activation and the acquisition of neuroprotective phenotypes via CXCL12/CXCR4 signaling. (C) 2016 Elsevier Inc. All rights reserved.	[Gao, Mou; Xu, Minhui] Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China; [Gao, Mou; Yao, Hui; Zhang, Yan; Yang, Yang; Dang, Yuanyuan; Zhang, Hongtian; Yang, Zhijun; Xu, Ruxiang] PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Dong, Qin] Capital Med Univ, Fu Xing Hosp, Dept Neurol, Beijing 100038, Peoples R China	Xu, MH (corresponding author), Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China.; Xu, RX (corresponding author), PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.	dpmhxu@126.com; jzprofxu@126.com	Yang, Yang/AAL-1670-2020	Yang, Yang/0000-0001-6645-2454	Military Twelfth Five-Year Key Sci-Tech Research Projects [BWS11J002, BWS12J010]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2013M532138]	We thank Dr. Shanshan Wang, Dr. Cuiying Wu, Dr. Mingming Zou, Ms. Chen Chen, Dr. Weiqiang Jia, Dr. Xiaohu Nie, Ms. Ning Liu and Ms. Qinqin Wang for technical support. This work was supported by the Military Twelfth Five-Year Key Sci-Tech Research Projects (Grant Nos. BWS11J002 and BWS12J010) and the China Postdoctoral Science Foundation (2013M532138).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Amor S., 2014, IMMUNOLOGY, V18, P531; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Cartier N, 2014, ACTA NEUROPATHOL, V128, P363, DOI 10.1007/s00401-014-1330-y; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Dou GR, 2016, SCI REP-UK, V6, DOI 10.1038/srep28617; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29955; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Goldman SA, 2016, CELL STEM CELL, V18, P174, DOI 10.1016/j.stem.2016.01.012; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hopewell EL, 2013, J CLIN INVEST, V123, P2509, DOI 10.1172/JCI67250; Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kaur C, 2014, BRAIN STRUCT FUNCT, V219, P151, DOI 10.1007/s00429-012-0491-5; Kim HS, 2014, STEM CELL RES, V12, P60, DOI 10.1016/j.scr.2013.09.007; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lowe JM, 2014, CANCER RES, V74, P2182, DOI 10.1158/0008-5472.CAN-13-1070; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Rabenstein M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0098-x; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tonges L, 2014, GLIA, V62, P217, DOI 10.1002/glia.22601; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137211; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	49	13	13	1	16	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2017	59						288	299		10.1016/j.bbi.2016.09.020			12	Immunology; Neurosciences; Psychiatry	Immunology; Neurosciences & Neurology; Psychiatry	EF8YU	WOS:000390618700028	27650112				2021-06-18	
J	Grossbard, J; Malte, CA; Lapham, G; Pagulayan, K; Turner, AP; Rubinsky, AD; Bradley, KA; Saxon, AJ; Hawkins, EJ				Grossbard, Joel; Malte, Carol A.; Lapham, Gwen; Pagulayan, Kathleen; Turner, Aaron P.; Rubinsky, Anna D.; Bradley, Katharine A.; Saxon, Andrew J.; Hawkins, Eric J.			Prevalence of Alcohol Misuse and Follow-Up Care in a National Sample of OEF/OIF VA Patients With and Without TBI	PSYCHIATRIC SERVICES			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PERSISTENT POSTCONCUSSIVE SYMPTOMS; IDENTIFICATION TEST AUDIT; SERVICES-TASK-FORCE; BRIEF INTERVENTION; MILITARY PERSONNEL; CONSUMPTION QUESTIONS; RISK DRINKING; US VETERANS	Objective: Information on prevalence and management of alcohol misuse among Afghanistan and Iraq veterans with traumatic brain injury (TBI) is limited. This study compared rates of alcohol misuse and follow-up care-brief intervention (BI) and addiction treatment-among Afghanistan and Iraq veterans with and without TBI receiving care from the Department of Veterans Affairs (VA). Methods: The sample included veterans ages 18 and older screened with the Alcohol Use Disorders Identification Test alcohol consumption questions (AUDIT-C) in 2012 who received VA health care in the prior year (N=358,417). Overall and age-specific estimates of alcohol misuse (AUDIT-C score >= 5) were compared for men and women with and without TBI by logistic regression. BI and addiction treatment after screening were compared between groups by using multivariable logistic regression. Results: Alcohol misuse was higher among men with TBI than among men without TBI (20.3%, 95% confidence interval [CI]=19.9-20.8, versus 16.4%, CI=16.3-16.6) and among women with TBI than among women without TBI (6.8%, CI=5.8-8.1, versus 5.6%, CI=5.4-5.8); younger (age<30) patients with TBI had the highest rates. BI rates did not differ by TBI status (76.4%-280.2%). Addiction treatment rates for those with severe misuse were higher among those with TBI (men, 20.0%, CI=18.4-21.6, versus 15.4%, CI=14.9-15.9; women, 36.6%, CI=21.8-51.3, versus 21.1%, CI=18.2-24.0). Conclusions: Alcohol misuse is common among Iraq and Afghanistan veterans with TBI, particularly young men. BI rates were high and did not vary by TBI status, although addiction treatment rates were higher among patients with TBI than among those without TBI.	[Grossbard, Joel; Malte, Carol A.; Turner, Aaron P.; Rubinsky, Anna D.; Saxon, Andrew J.; Hawkins, Eric J.] Puget Sound Hlth Care Syst, Dept Vet Affairs VA, Ctr Excellence Substance Abuse Treatment & Educ, Seattle, WA 98108 USA; [Turner, Aaron P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Pagulayan, Kathleen; Saxon, Andrew J.; Hawkins, Eric J.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Rubinsky, Anna D.] Seattle Ctr Innovat Vet Ctr & Value Driven Care, VA Hlth Serv Res & Dev HSR&D, Seattle, WA USA; [Lapham, Gwen; Bradley, Katharine A.] Grp Hlth Res Inst, Seattle, WA USA; [Bradley, Katharine A.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA	Hawkins, EJ (corresponding author), Puget Sound Hlth Care Syst, Dept Vet Affairs VA, Ctr Excellence Substance Abuse Treatment & Educ, Seattle, WA 98108 USA.	eric.hawkins@va.gov	Rubinsky, Anna D/U-8314-2018; Pagulayan, Kati/AAR-9225-2020; Rubinsky, Anna/AAJ-7065-2021; Turner, Aaron/A-7902-2009	Rubinsky, Anna D/0000-0002-8977-4779; Turner, Aaron/0000-0001-6897-8003	VA Polytrauma and Blast-Related Injury Quality Enhancement Research Initiative [QLP 56-007]; Veterans Health AdministrationUS Department of Veterans Affairs; VA Center of Excellence in Substance Abuse Treatment and Education; National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [1R21AA02894-01A1]; VA Clinical Sciences R&D Career Development Award Program [IK2 CX000516]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K24AA022128] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2CX000516] Funding Source: NIH RePORTER	The research reported here was supported by VA Polytrauma and Blast-Related Injury Quality Enhancement Research Initiative (QLP 56-007), Veterans Health Administration; by the VA Center of Excellence in Substance Abuse Treatment and Education; by the National Institute on Alcohol Abuse and Alcoholism (grant 1R21AA02894-01A1); and by VA Clinical Sciences R&D Career Development Award Program (IK2 CX000516). These organizations had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the manuscript for publication.	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bradley KA, 2003, ARCH INTERN MED, V163, P821, DOI 10.1001/archinte.163.7.821; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1097/00000374-199811000-00034; Bradley KA, 2004, ALCOHOL CLIN EXP RES, V28, P448, DOI 10.1097/01.ALC.0000117836.38108.38; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Grossbard JR, 2013, J SUBST ABUSE TREAT, V45, P409, DOI 10.1016/j.jsat.2013.04.007; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heltemes KJ, 2012, INJURY, V43, P1990, DOI 10.1016/j.injury.2011.07.021; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Jorge RE, 2005, CURR OPIN PSYCHIATR, V18, P289, DOI 10.1097/01.yco.0000165600.90928.92; Kaner EFS, 2001, BRIT J GEN PRACT, V51, P822; Lapham GT, 2012, MED CARE, V50, P179, DOI 10.1097/MLR.0b013e3181e35743; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Mainio A, 2007, BRAIN INJURY, V21, P851, DOI 10.1080/02699050701504265; Mashhoon Y, 2014, ALCOHOL CLIN EXP RES, V38, P1955, DOI 10.1111/acer.12475; Miles SR, 2015, MIL MED, V180, P45, DOI 10.7205/MILMED-D-14-00187; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; National Institute on Alcohol Abuse Alcoholism, 2007, HELP PAT WHO DRINK T; Olson-Madden JH, 2013, COMMUNITY MENT HLT J, V49, P220, DOI 10.1007/s10597-012-9572-4; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Polusny MA, 2011, PSYCHOL MED, V41, P687, DOI 10.1017/S0033291710002047; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Ponsford J, 2012, J HEAD TRAUMA REHAB, V27, P342, DOI 10.1097/HTR.0b013e318265a576; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Rubinsky AD, 2010, DRUG ALCOHOL DEPEN, V108, P29, DOI 10.1016/j.drugalcdep.2009.11.009; Sander AM, 2012, J HEAD TRAUMA REHAB, V27, P319, DOI 10.1097/HTR.0b013e318269838c; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Shu IW, 2014, PSYCHIAT RES-NEUROIM, V224, P58, DOI 10.1016/j.pscychresns.2014.07.010; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Taylor BC, 2014, J REHABIL RES DEV, V51, pVII, DOI 10.1682/JRRD.2014.06.0155; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Department of Veterans Affairs/Department of Defense, 2015, VA DOD CLIN PRACT GU; Volk RJ, 1996, J STUD ALCOHOL, V57, P203, DOI 10.15288/jsa.1996.57.203; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Williams EC, 2014, ADDICTION, V109, P1472, DOI 10.1111/add.12600; Winqvist S, 2008, BRAIN INJURY, V22, P780, DOI 10.1080/02699050802339397; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492	50	13	13	0	4	AMER PSYCHIATRIC PUBLISHING, INC	ARLINGTON	1000 WILSON BOULEVARD, STE 1825, ARLINGTON, VA 22209-3901 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JAN 1	2017	68	1					48	55		10.1176/appi.ps.201500290			8	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	EP0PQ	WOS:000397089600009	27476804	Green Accepted, Bronze			2021-06-18	
J	Kaup, AR; Peltz, C; Kenney, K; Kramer, JH; Diaz-Arrastia, R; Yaffe, K				Kaup, Allison R.; Peltz, Carrie; Kenney, Kimbra; Kramer, Joel H.; Diaz-Arrastia, Ramon; Yaffe, Kristine			Neuropsychological Profile of Lifetime Traumatic Brain Injury in Older Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Head injury; Aging; Veterans; Cognition; Cognitive deficits	ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; DEMENTIA; RISK; MILD; TBI; IDENTIFICATION; DYSFUNCTION; MEMORY; STATE	Objectives: The aim of this study was to characterize the neuropsychological profile of lifetime traumatic brain injury (TBI) in older Veterans. Methods: Participants were 169 older Veterans [mean age = 79.1 years (range, 51-97 years), 89% male, 92% Caucasian], 88 with lifetime TBI and 81 without TBI, living in Veterans' retirement homes in independent residence. TBI history was ascertained with the Ohio State TBI Identification Method structured interview. Cognition was assessed with neuropsychological tests: Raw scores were converted to Z-scores compared to age-corrected normative data and combined into five domain composite Z-scores (attention/working memory, learning/memory, language, processing speed, executive functioning). We investigated the association between TBI and performance in each cognitive domain in linear mixed effects models, with and without adjustment for demographics, medical comorbidities, and psychiatric variables. Results: Compared to those without TBI, older Veterans with TBI had greater deficits in processing speed (estimate = -.52; p = .01; f(2) = .08 in fully adjusted model) and executive functioning (estimate = -.41; p = .02; f(2) = .06 in fully adjusted model) but performed similarly in the attention/working memory, learning/memory, and language domains (all p > .05). TBI-associated deficits were most prominent among individuals with multiple mild TBIs and those with any moderate-to-severe TBI, but were not clearly present among those with single mild TBI. Conclusions: The neuropsychological profile of lifetime TBI in older Veterans is characterized by slowed processing speed and executive dysfunction, especially among those with greater injury burden. This pattern may reflect long-standing deficits or a TBI-associated cognitive decline process distinct from Alzheimer's disease.	[Kaup, Allison R.] Univ Calif San Francisco, San Francisco VA Healthcare Syst, Res Serv, San Francisco, CA 94143 USA; [Kaup, Allison R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Peltz, Carrie] NCIRE Vet Hlth Res Inst, San Francisco, CA USA; [Peltz, Carrie] San Francisco VA Healthcare Syst, 4150 Clement St,116B, San Francisco, CA 94121 USA; [Kenney, Kimbra; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Rockville, MD USA; [Kramer, Joel H.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA	Kaup, AR (corresponding author), San Francisco VA Healthcare Syst, 4150 Clement St,116B, San Francisco, CA 94121 USA.	allison.kaup@ucsf.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	Department of Defense grantsUnited States Department of Defense [W81XWH-12-1-0581, W81XWH-14-2-0132]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155]; U.S. Department of Veterans Affairs, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1IK2RX001629]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX001629] Funding Source: NIH RePORTER	The authors thank our research participants, the Armed Forces Retirement Home in Washington, DC, the Veterans Home of California in Yountville, CA, and our dedicated study staff including Kim Kelley, Ross Passo, Leah Harburg, Daniel Freimer, and Margaret Gross. This research was supported by Department of Defense grants W81XWH-12-1-0581 and W81XWH-14-2-0132 (awarded to K.Y.); and in part by NIA grant K24AG031155 (awarded to K.Y.). This research was also supported by Career Development Award 1IK2RX001629 (awarded to A.R.K.) from the U.S. Department of Veterans Affairs, Rehabilitation Research and Development Service. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	[Anonymous], 2012, NINDS COMM DAT EL TR; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Department of Veterans Affairs, 2009, CLIN PRACT GUID MAN; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Ivnik R. J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Ivnik RJ, 1992, CLIN NEUROPSYCHOL, V6, P83; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaplan E., 1983, BOSTON NAMING TEST; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kramarow EA, 2012, AGE OMAHA, V25, P25; Kramer J. H., 2014, NIH EXAMINER B UNPUB; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Qiu CX, 2015, NAT REV CARDIOL, V12, P267, DOI 10.1038/nrcardio.2014.223; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Reitan R.M, 1985, HALSTEAD REITAN NEUR, V4; Rey A., 1941, ARCH PSYCHOL; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Scholten A.C., 2016, J NEUROTRAUMA; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Taylor E.M., 1959, PSYCHOL APPRAISAL CH; U. S. Department of Veterans Affairs & National Center for PTSD, 2014, US PTSD CHECKL DSM 4; Verma M, 2012, INT J GERIATR PSYCH, V27, P1209, DOI 10.1002/gps.3766; Wechsler D., 1987, WMS R WECHSLER MEMOR; Wechsler D., 1981, WAIS R MANUAL WECHSL; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	64	13	13	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2017	23	1					56	64		10.1017/S1355617716000849			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	EL4GS	WOS:000394580300006	27697088	Green Accepted			2021-06-18	
J	Kehle-Forbes, SM; Campbell, EH; Taylor, BC; Scholten, J; Sayer, N				Kehle-Forbes, Shannon M.; Campbell, Emily Hagel; Taylor, Brent C.; Scholten, Joel; Sayer, Nina			Does Co-Occurring Traumatic Brain Injury Affect VHA Outpatient Health Service Utilization and Associated Costs Among Veterans With Posttraumatic Stress Disorder? An Examination Based on VHA Administrative Data	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare costs; healthcare utilization; posttraumatic; stress disorders; TBI (traumatic brain injury); veterans	PTSD SPECIALTY TREATMENT; AFGHANISTAN VETERANS; OEF/OIF VETERANS; IRAQ; VA; PREVALENCE; DIAGNOSES	Objective: To examine whether a traumatic brain injury (TBI) diagnosis was associated with increased outpatient service utilization and associated costs among Iraq and Afghanistan (Operation Enduring Freedom [OEF]/Operation Iraqi Freedom [OIF]/Operation New Dawn [OND]) War veterans with posttraumatic stress disorder (PTSD) who used Veterans Health Affairs (VHA) care in a 1-year period. Setting: N/A. Participants: OEF/OIF/OND veterans with a diagnosis of PTSD and/or TBI who utilized VHA services during fiscal year 2012 (N = 164 644). Design: Observational study using VHA administrative data. Main Measures: Outpatient VHA utilization (total and by category of care) and associated costs (total and by VA Health Economic Resource Center cost category). Results: Veterans in the comorbid PTSD/TBI group had significantly more total outpatient appointment than veterans with PTSD but no TBI. This pattern held for all categories of care except orthopedics. The comorbid TBI/PTSD group ($5769) incurred greater median outpatient healthcare costs than the PTSD ($3168) or TBI-alone ($2815) group. Conclusions: Co-occurring TBI increases the already high level of healthcare utilization by veterans with PTSD, suggesting that OEF/OIF/OND veterans with comorbid PTSD/TBI have complex and wide-ranging healthcare needs. Key words: healthcare costs, healthcare utilization, posttraumatic, stress disorders, TBI (traumatic brain injury), veterans	[Kehle-Forbes, Shannon M.; Campbell, Emily Hagel; Taylor, Brent C.; Sayer, Nina] Minneapolis VHA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Kehle-Forbes, Shannon M.; Taylor, Brent C.; Sayer, Nina] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Sayer, Nina] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Scholten, Joel] Washington DC VA Med Ctr, Phys Med & Rehabil Serv, Washington, DC USA	Kehle-Forbes, SM (corresponding author), Minneapolis VA Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA.	Shannon.Kehle-Forbes@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Polytrauma and Blast-Related Injuries Quality Enhancement Research Initiative [PLY 05-2010-2]	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Polytrauma and Blast-Related Injuries Quality Enhancement Research Initiative, through a locally initiated project grant (#PLY 05-2010-2).	Aakre JM, 2014, PSYCHIAT SERV, V65, P1066, DOI 10.1176/appi.ps.201300117; [Anonymous], 2014, AN VA HLTH CAR UT OP; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Kehle SM, 2010, J TRAUMA STRESS, V23, P33, DOI 10.1002/jts.20480; King PR, 2013, MIL BEHAV HLTH, V1, P74, DOI DOI 10.1080/21635781.2012.759168; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Lu MW, 2011, PSYCHIAT SERV, V62, P943, DOI 10.1176/ps.62.8.pss6208_0943; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Taylor BC, FISCAL YEAR 2012 VA; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; VHA Health Information Management Office of Health Data and Informatics, 2009, FACT SHEET INT COD G; Wagner TH, 2003, MED CARE RES REV, V60, p15S, DOI 10.1177/1077558703256485	23	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					E16	E23		10.1097/HTR.0000000000000227			8	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400008	27022960				2021-06-18	
J	Kolarova, M; Sengupta, U; Bartos, A; Ricny, J; Kayed, R				Kolarova, Michala; Sengupta, Urmi; Bartos, Ales; Ricny, Jan; Kayed, Rakez			Tau Oligomers in Sera of Patients with Alzheimer's Disease and Aged Controls	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Alzheimer's disease; oligomers; serum; tau protein	CEREBROSPINAL FLUID SYSTEM; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; CHOROID-PLEXUS; NEUROFIBRILLARY TANGLES; MOUSE MODEL; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; NEURONAL-ACTIVITY	Although tau protein was long regarded as an intracellular protein with several functions inside the cell, new evidence has shown tau secretion into the extracellular space. The active secretion of tau could be a physiological response of neurons to increased intracellular amounts of tau during the progression of tau pathology. We looked for potential differences in the serum levels of toxic tau oligomers in regards to cognitive impairment of subjects. We detected tau oligomers in the serum of Alzheimer's disease (AD) patients, but they were also present to some extent in the serum of healthy older subjects where the levels positively correlated with aging (Spearman r = 0.26, p = 0.016). On the contrary, we found lower levels of tau oligomers in the serum of mild cognitive impairment (MCI) (p = 0.033) and MCI-AD (p = 0.006) patients. These results could suggest that clearance of extracellular tau proteins takes place, in part, in the periphery. In the case of MCI patients, the lower levels of tau oligomers could be the result of impaired clearance of tau protein from interstitium to blood and consequent accumulation of tau aggregates in the brain.	[Kolarova, Michala; Bartos, Ales; Ricny, Jan] Natl Inst Mental Hlth, Klecany, Czech Republic; [Kolarova, Michala] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Sengupta, Urmi; Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Sengupta, Urmi; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA	Kayed, R (corresponding author), 301 Univ Blvd,Route 1045, Galveston, TX 77555 USA.; Kolarova, M (corresponding author), Topolova 748, Klecany 25067, Czech Republic.	michala.kolarova@nudz.cz; rakayed@utmb.edu	Ricny, Jan/V-1662-2018; Kolarova, Michala/P-3369-2016; Bartos, Ales/C-4353-2019	Ricny, Jan/0000-0003-2625-057X; Kolarova, Michala/0000-0002-5679-540X; Bartos, Ales/0000-0002-8020-8252	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1AG054025, RO1NS094557, LO1611]; MEYS under the NPU I program [GACR 13-26601S, PROGRES Q35]; Alzheimer Foundation Czech Republic (AVASTipendium for the human brain); grant Mobility of Charles University in Prague; Mitchell Center for Neurodegenerative Diseases; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG054025] Funding Source: NIH RePORTER	This study was supported by the grants from National Institute of Health RO1AG054025, RO1NS094557 project Nr. LO1611 with a financial support from the MEYS under the NPU I program, GACR 13-26601S, PROGRES Q35, The Alzheimer Foundation Czech Republic (AVASTipendium for the human brain), grant Mobility of Charles University in Prague and the Mitchell Center for Neurodegenerative Diseases.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Bartos A, 2007, J NEUROL, V254, P20, DOI 10.1007/s00415-006-0185-0; Bartos A, 2012, J NEUROIMMUNOL, V252, P100, DOI 10.1016/j.jneuroim.2012.08.001; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; Bitsch A, 2002, EUR NEUROL, V47, P45, DOI 10.1159/000047946; Brion JP, 2001, BIOCHEM SOC SYMP, V67, P81; Brkic M, 2015, J NEUROSCI, V35, P12766, DOI 10.1523/JNEUROSCI.0006-15.2015; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Castillo-Carranza DL, 2014, J NEUROSCI, V34, P4260, DOI 10.1523/JNEUROSCI.3192-13.2014; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; Crossgrove JS, 2005, EXP BIOL MED, V230, P771, DOI 10.1177/153537020523001011; Deisenhammer F, 2006, EUR J NEUROL, V13, P913, DOI 10.1111/j.1468-1331.2006.01493.x; Emerich DF, 2005, BIOESSAYS, V27, P262, DOI 10.1002/bies.20193; Farias G, 2012, J ALZHEIMERS DIS, V31, P65, DOI 10.3233/JAD-2012-120304; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fritschi SK, 2014, BRAIN, V137, P2909, DOI 10.1093/brain/awu255; Holtzman DM, 2011, NEUROBIOL AGING, V32, pS4, DOI 10.1016/j.neurobiolaging.2011.09.003; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Kolarova Michala, 2012, Int J Alzheimers Dis, V2012, P731526, DOI 10.1155/2012/731526; Krzyzanowska A, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00075; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Maccioni RB, 2001, ARCH MED RES, V32, P367, DOI 10.1016/S0188-4409(01)00316-2; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Neumann K, 2011, J ALZHEIMERS DIS, V25, P103, DOI 10.3233/JAD-2011-101641; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Preston JE, 2001, MICROSC RES TECHNIQ, V52, P31, DOI 10.1002/1097-0029(20010101)52:1<31::AID-JEMT5>3.3.CO;2-K; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; Sagripanti A, 1998, EXP GERONTOL, V33, P891, DOI 10.1016/S0531-5565(98)00047-3; Saman S, 2014, J ALZHEIMERS DIS, V40, pS47, DOI 10.3233/JAD-132135; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Scheltens P, 1992, Ned Tijdschr Geneeskd, V136, P2459; Sengupta U, 2017, ANN CLIN TRANSL NEUR, V4, P226, DOI 10.1002/acn3.382; Serot JM, 2012, J ALZHEIMERS DIS, V30, P17, DOI 10.3233/JAD-2012-111964; Serot JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS515, DOI 10.2741/1085; Serot JM, 2000, ACTA NEUROPATHOL, V99, P105, DOI 10.1007/PL00007412; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Sparks D Larry, 2012, Am J Neurodegener Dis, V1, P99; Spector R, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-28; Spires-Jones TL, 2011, J MOL NEUROSCI, V45, P438, DOI 10.1007/s12031-011-9566-7; Sui XJ, 2014, NEUROSCI BULL, V30, P233, DOI 10.1007/s12264-013-1412-1; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zetterberg H, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt163	53	13	13	0	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	58	2					471	478		10.3233/JAD-170048			8	Neurosciences	Neurosciences & Neurology	EX1OP	WOS:000402994400015	28453485				2021-06-18	
J	Kroshus, E; Kerr, ZY; DeFreese, JD; Parsons, JT				Kroshus, Emily; Kerr, Zachary Y.; DeFreese, J. D.; Parsons, John T.			Concussion Knowledge and Communication Behaviors of Collegiate Wrestling Coaches	HEALTH COMMUNICATION			English	Article							SELF-DETERMINATION THEORY; HIGH-SCHOOL; NEED SATISFACTION; INTRINSIC MOTIVATION; MEDICINE CLINICIAN; AUTONOMY SUPPORT; ATHLETIC CAREER; INJURY; SPORT; RISK	Sport coaches can play an important role in shaping a team's approach to concussion safety through their communication with team members. However, across all sports, there is limited knowledge about factors that make coaches more or less likely to engage in safety-supportive communication. The objectives of this study were to assess the concussion-related knowledge and attitudes of wrestling coaches, as well as the extent to which they engage in autonomy-supportive coaching practices, and to determine how these factors are related to communication with athletes in support of concussion safety. Data were collected through an online survey of head coaches of National Collegiate Athletic Association (NCAA) wrestling teams (n=89, 40.5% response rate). On average, coaches answered five out of a possible nine knowledge questions correctly and were significantly more likely to think it was acceptable for an athlete to continue playing after sustaining a concussion during a national qualifying competition as compared to during an early-season competition. Engaging in autonomy-supportive coaching behaviors was the coach factor explaining the largest percentage of variability in communication. Findings suggest that while knowledge deficits and attitudes about the acceptability of continued play while symptomatic during more consequential competitive matches should be addressed in educational programming for collegiate wrestling coaches, these changes alone may not be a sufficient for adequately increasing concussion safety communication. Targeting more distal factors such as autonomy-supportive approaches to coaching may hold promise for intervention design and should be explored in future prospective research.	[Kroshus, Emily] Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kerr, Zachary Y.; DeFreese, J. D.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Parsons, John T.] Natl Collegiate Athlet Assoc, Indianapolis, IN USA	Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Kerr, Zachary/0000-0003-1423-1259			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Amorose AJ, 2007, PSYCHOL SPORT EXERC, V8, P654, DOI 10.1016/j.psychsport.2006.11.003; Amorose AJ, 2009, RES Q EXERCISE SPORT, V80, P386, DOI 10.1080/02701367.2009.10599575; Banack HR, 2011, RES Q EXERCISE SPORT, V82, P722, DOI 10.1080/02701367.2011.10599809; Bartholomew KJ, 2010, J SPORT EXERCISE PSY, V32, P193, DOI 10.1123/jsep.32.2.193; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; CURRY TJ, 1993, SYMB INTERACT, V16, P273, DOI 10.1525/si.1993.16.3.273; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gagne M, 2003, J APPL SPORT PSYCHOL, V15, P372, DOI 10.1080/714044203; Hollembeak J, 2005, J APPL SPORT PSYCHOL, V17, P20, DOI 10.1080/10413200590907540; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jowett S, 2009, MEAS PHYS EDUC EXERC, V13, P34, DOI 10.1080/10913670802609136; Koester MC, 2000, J ATHL TRAINING, V35, P466; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Mageau GA, 2003, J SPORT SCI, V21, P883, DOI 10.1080/0264041031000140374; National Collegiate Athletic Association, 2015, MEM HEAD WRESTL COAC; National Collegiate Athletic Association, 2014, 2013 2014 NCAA SPORT; National Federation of High School Sports, 2014, 2013 2014 HIGH SCH A; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Ntoumanis N, 2009, J APPL SPORT PSYCHOL, V21, P365, DOI 10.1080/10413200903036040; Podlog L, 2010, J SPORT SCI, V28, P1197, DOI 10.1080/02640414.2010.487873; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Stebbings J, 2012, J SPORT EXERCISE PSY, V34, P481, DOI 10.1123/jsep.34.4.481; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	35	13	13	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.		2017	32	8					963	969		10.1080/10410236.2016.1196417			7	Communication; Health Policy & Services	Communication; Health Care Sciences & Services	EV0XA	WOS:000401468900006	27462963				2021-06-18	
J	Laukkanen, H; Scheiman, M; Hayes, JR				Laukkanen, Hannu; Scheiman, Mitchell; Hayes, John R.			Brain Injury Vision Symptom Survey (BIVSS) Questionnaire	OPTOMETRY AND VISION SCIENCE			English	Article						mTBI (mild traumatic brain injury); symptoms; survey; questionnaire; BIVSS (Brain Injury Vision Symptom Survey); Rasch; Likert scale	EPIDEMIOLOGY	Purpose. Validation of the Brain Injury Vision Symptom Survey (BIVSS), a self-administered survey for vision symptoms related to traumatic brain injury (TBI). Methods. A 28-item vision symptom questionnaire was completed by 107 adult subjects (mean age 42.1, 16.2 SD, range 18-75) who self-reported as having sustained mild-to-moderate TBI and two groups of reference adult subjects (first-year optometry students: mean age 23.2, 2.8 SD, range 20-39; and 71 third-year optometry students: mean age 26.0, 2.9 SD, range 22-42) without TBI. Both a Likert-style method of analysis with factor analysis and a Rasch analysis were used. Logistic regression was used to determine sensitivity and specificity. Results. At least 27 of 28 questions were completed by 93.5% of TBI subjects, and all 28 items were completed by all of the 157 reference subjects. BIVSS sensitivity was 82.2% for correctly predicting TBI and 90.4% for correctly predicting the optometry students. Factor analysis identified eight latent variables; six factors were positive in their risk for TBI. Other than dry eye and double vision, the TBI patients were significantly more symptomatic than either cohort of optometry students by at least one standard deviation (p < 0.001). Twenty-five of 28 questions were within limits for creating a single-dimension Rasch scale. Conclusions. Nearly all of the adult TBI subjects were able to self-complete the BIVSS, and there was significant mean score separation between TBI and non-TBI groups. The Rasch analysis revealed a single dimension associated with TBI. Using the Likert method with the BIVSS, it may be possible to identify different vision symptom profiles with TBI patients. The BIVSS seems to be a promising tool for better understanding the complex and diverse nature of vision symptoms that are associated with brain injury.	[Laukkanen, Hannu; Hayes, John R.] Univ Pacific, Coll Optometry, 2043 Coll Way, Forest Grove, OR 97116 USA; [Scheiman, Mitchell] Salus Univ, Penn Coll Optometry, Philadelphia, PA USA	Laukkanen, H (corresponding author), Univ Pacific, Coll Optometry, 2043 Coll Way, Forest Grove, OR 97116 USA.	laukkanh@pacificu.edu		Scheiman, Mitchell/0000-0002-9274-5696			Anderson R.D., 1956, P 3 BERK S MATH STAT, V5, P111; [Anonymous], 2015, SPSS COMP PROGR VERS; Centers for Disease Control and Prevention, TRAUM BRAIN INJ US E; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Gianutsos R., 1998, J BEHAV OPTOMETRY, V9, P3; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Kapoor N, 2012, VISUAL DIAGNOSIS CAR, P95; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Likert R, 1932, Arch Psychol, V22, P5, DOI [DOI 10.1108/17538331211269648, DOI 10.4135/9781412961288.N454]; Linacre JM, TABLE 23 1 23 11 PRI; Linacre JM., 2015, WINSTEPS RASCH MEASU; Massof RW, 2002, OPTOMETRY VISION SCI, V79, P516, DOI 10.1097/00006324-200208000-00015; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	18	13	13	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					43	50		10.1097/OPX.0000000000000940			8	Ophthalmology	Ophthalmology	EM5ZZ	WOS:000395393900007	28027193				2021-06-18	
J	Mishra, SK; Rana, P; Khushu, S; Gangenahalli, G				Mishra, Sushanta Kumar; Rana, Poonam; Khushu, Subash; Gangenahalli, Gurudutta			Therapeutic Prospective of Infused Allogenic Cultured Mesenchymal Stem Cells in Traumatic Brain Injury Mice: A Longitudinal Proton Magnetic Resonance Spectroscopy Assessment	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Mesenchymal stem cells; Magnetic resonance imaging; Stem cell therapy; Proton magnetic resonance spectroscopy; Traumatic brain injury	CORTICAL IMPACT INJURY; METABOLIC-CHANGES; IN-VIVO; BONE-MARROW; TIME-COURSE; RATS; NEUROPROTECTION; MOUSE; GLUTAMATE/GLUTAMINE; TRANSPLANTATION	Improved therapeutic assessment of experimental traumatic brain injury (TBI), using mesenchymal stem cells (MSCs), would immensely benefit its therapeutic management. Neurometabolite patterns at injury site, measured with proton magnetic resonance spectroscopy (1H-MRS) after MSCs transplantation, may serve as a bio-indicator of the recovery mechanism. This study used in vivo magnetic resonance imaging and1H-MRSto evaluate the therapeutic prospects of implanted MSCsat injury site in experimental mice longitudinally up to 21 days. Negative tissue contrast and cytotoxic edema formation were observed in susceptibility-based contrast (T2*) and an apparent diffusion coefficient map, respectively. Lesion site showed decreased N-acetylaspartate, total choline, myo-inositol, total creatine, glutamate-glutamine complex, and taurine neurometabolic concentrations by 1H-MRS investigation. There was a considerable decrease in locomotor activity, depression index, and cognitive index after TBI. It may, therefore, be inferred that MSC transplantation prompted recovery by decreasing negative signals and edema, restoring metabolites to baseline concentrations, and enhancing behavioral activity. Overall findings support the potential of MSC transplantation for the enhancement of endogenous neuroprotective responses, which may provide future clinical applications for translating laboratory research into therapeutic clinical advances.	[Mishra, Sushanta Kumar; Rana, Poonam; Khushu, Subash] Inst Nucl Med & Allied Sci, NMR Res Ctr, Def Res & Dev Org, Delhi 110054, India; [Mishra, Sushanta Kumar; Gangenahalli, Gurudutta] Inst Nucl Med & Allied Sci, Div Stem Cell & Gene Therapy Res, Def Res & Dev Org, Delhi 110054, India	Khushu, S (corresponding author), Inst Nucl Med & Allied Sci, NMR Res Ctr, Def Res & Dev Org, Delhi 110054, India.; Gangenahalli, G (corresponding author), Inst Nucl Med & Allied Sci, Div Stem Cell & Gene Therapy Res, Def Res & Dev Org, Delhi 110054, India.	skhushu@yahoo.com; gugdutta@rediffmail.com	Mishra, Sushanta Kumar/N-5958-2019	Mishra, Sushanta/0000-0002-3403-6891	Defence Research and Development Organization, Ministry of Defence, Government of IndiaDefence Research & Development Organisation (DRDO) [INM-311, 4.1]; Council of Medical Research	The S & T project (INM-311, 4.1) was supported by funding from the Defence Research and Development Organization, Ministry of Defence, Government of India, and we thank them for their valuable assistance. We also express gratitude to Dr. Kailash Manda and Seenu Haridas (research fellow) of the NeuroBehavior Laboratory at Institute of Nuclear Medicine and Allied Sciences, for their guidance and unstinted support in the behavioral study. S.K.M. acknowledges and sincerely thanks the Indian Council of Medical Research for providing a research fellowship in support of the project.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Bensidhoum M, 2004, BLOOD, V103, P3313, DOI 10.1182/blood-2003-04-1121; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Duan XH, 2012, EUR J RADIOL, V81, P2154, DOI 10.1016/j.ejrad.2011.06.050; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Haridas S, 2013, PHYSIOL BEHAV, V119, P201, DOI 10.1016/j.physbeh.2013.06.015; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Herynek V, 2009, MAGN RESON MATER PHY, V22, P211, DOI 10.1007/s10334-009-0166-2; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Rana P, 2013, INT J RADIAT BIOL, V89, P212, DOI 10.3109/09553002.2013.734944; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Sharma A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0794-0; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Takeuchi H, 2007, NEUROSCI LETT, V426, P69, DOI 10.1016/j.neulet.2007.08.048; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; VERBALIS JG, 1991, BRAIN RES, V567, P274, DOI 10.1016/0006-8993(91)90806-7; VIDEEN JS, 1995, J CLIN INVEST, V95, P788, DOI 10.1172/JCI117728; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	45	13	13	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	JAN	2017	6	1					316	329		10.5966/sctm.2016-0087			14	Cell & Tissue Engineering	Cell Biology	EQ6MB	WOS:000398194800033	28170180	DOAJ Gold, Green Published			2021-06-18	
J	Sartore-Baldwin, ML; McCullough, B; Quatman-Yates, C				Sartore-Baldwin, Melanie L.; McCullough, Brian; Quatman-Yates, Catherine			Shared Responsibility and Issues of Injustice and Harm within Sport	QUEST			English	Article						Harm; oppression; shared responsibility; social justice; sport	CORPORATE SOCIAL-RESPONSIBILITY; ORGANIZATIONAL JUSTICE; CONCUSSION EDUCATION; KNOWLEDGE TRANSFER; SEXUAL-ABUSE; IGNORANCE; PERCEPTIONS; CULTURE; IMPACT; POLICY	The purpose of this article is to present a conceptual model of shared responsibility within the sport context. Focusing on issues of harm and injustice, this model proposes that organized sport can exist as an oppressive social structure that endorses ignorance through the presence of asymmetrical power relations. This ignorance reinforces oppressive structures as well as fosters vulnerability, a byproduct that, in turn, also reinforces oppressive structures. Rather than assigning responsibility to any one entity specifically, however, this article proposes that each and every individual with a vested interest in sport possess some degree of responsibility in securing safe, fair, and just sport experiences. Thus, the concept of shared responsibility is offered as a moderating factor through which the processes that result from oppressive structures may be interrupted and the structures themselves broken down.	[Sartore-Baldwin, Melanie L.] East Carolina Univ, Dept Exercise & Sport Sci, Greenville, NC USA; [McCullough, Brian] Seattle Univ, Coll Arts & Sci, Seattle, WA 98122 USA; [Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA	Sartore-Baldwin, ML (corresponding author), East Carolina Univ, Dept Kinesiol, 152 Minges Coliseum, Greenville, NC 27858 USA.	sartorem@ecu.edu	Quatman-Yates, Catherine/U-9580-2019; McCullough, Brian P./H-8898-2013; Quatman-Yates, Catherine/AAK-4507-2021	McCullough, Brian P./0000-0002-9085-7926; 			Banerjee SB, 2014, CRIT PERSPECT INT BU, V10, P84, DOI 10.1108/cpoib-06-2013-0021; Best J, 2012, ECON SOC, V41, P84, DOI 10.1080/03085147.2011.637333; Blaikie P., 1994, RISK NATURAL HAZARDS; Brackenridge C. H., 1994, International Review for the Sociology of Sport, V29, P287, DOI 10.1177/101269029402900304; Brown TJ, 1997, J MARKETING, V61, P68, DOI 10.2307/1252190; Burton LJ, 2015, SPORT MANAG REV, V18, P155, DOI 10.1016/j.smr.2014.02.004; Butler Judith, 2004, UNDOING GENDER; Colquitt JA, 2001, J APPL PSYCHOL, V86, P386, DOI 10.1037//0021-9010.86.3.386; Cooky C, 2012, CULT STUD-CRIT METHO, V12, P326, DOI 10.1177/1532708612446432; Cunningham G.B., 2015, DIVERSITY INCLUSION, V3rd ed.; Cunningham GB, 2008, SEX ROLES, V58, P3, DOI 10.1007/s11199-007-9360-8; David P., 2005, HUMAN RIGHTS YOUTH S; Doherty A. J., 1999, J SPORT MANAGEMENT, V13; Douglass Frederick, 1962, LIFE TIMES F DOUGLAS; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; Eitzen S., 2000, HDB SPORTS STUDIES, P370; Fainaru-Wada M., 2013, LEAGUE DENIAL NFL CO; Feenan D, 2007, SOC LEGAL STUD, V16, P509, DOI 10.1177/0964663907082733; Foucault, 1978, HIST SEXUALITY INTRO, Vume 1; Freire P., 1996, PEDAGOGY OPPRESSED; Frerks G., 2004, MAPPING VULNERABILIT, P1; Frisby W, 2005, J SPORT MANAGE, V19, P1, DOI 10.1123/jsm.19.1.1; Gilson E, 2011, HYPATIA, V26, P308, DOI 10.1111/j.1527-2001.2010.01158.x; GREENBERG J, 1990, J MANAGE, V16, P399, DOI 10.1177/014920639001600208; Johnson A., 2001, PRIVILEGE POWER DIFF; Kerr GA, 2008, QUEST, V60, P307, DOI 10.1080/00336297.2008.10483583; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2013, AM J PREV MED, V44, P8, DOI 10.1016/j.amepre.2012.09.058; Leahy T, 2008, INT J SPORT EXERC PS, V6, P366, DOI 10.1080/1612197X.2008.9671880; May L., 1993, SHARING RESPONSIBILI; Merkel DL, 2013, OPEN ACCESS J SPORTS, V4, P151, DOI 10.2147/OAJSM.S33556; Merkel DL, 2012, INT J SPORTS PHYS TH, V7, P242; Messner M.A., 2002, TAKING FIELD WOMEN M; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; MOODYADAMS MM, 1994, ETHICS, V104, P291, DOI 10.1086/293601; Moore EE, 2012, CULT STUD-CRIT METHO, V12, P361, DOI 10.1177/1532708612446439; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Noble J, 2014, CHILD YOUTH SERV REV, V38, P52, DOI 10.1016/j.childyouth.2014.01.011; Parent S, 2011, CHILD ABUSE REV, V20, P120, DOI 10.1002/car.1135; Pava ML, 1996, J BUS ETHICS, V15, P321, DOI 10.1007/BF00382958; Prentice DA, 1996, ADV EXP SOC PSYCHOL, V28, P161, DOI 10.1016/S0065-2601(08)60238-5; Proctor RN., 1995, CANC WARS; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Rappert B, 2012, ECON SOC, V41, P42, DOI 10.1080/03085147.2011.637334; Rayner S, 2012, ECON SOC, V41, P107, DOI 10.1080/03085147.2011.637335; Rogers W, 2012, INT J FEM APPROACHES, V5, P11; Sartore-Baldwin M.L., 2013, SEXUAL MINORITIES SP, P1; Schrempf J, 2014, BUS SOC, V53, P300, DOI 10.1177/0007650312449577; Schroder-Butterfill E, 2006, AGEING SOC, V26, P9, DOI 10.1017/S0144686X05004423; SMITHSON M, 1985, J THEOR SOC BEHAV, V15, P151, DOI 10.1111/j.1468-5914.1985.tb00049.x; Stafford A, 2013, CHILD ABUSE REV, V22, P287, DOI 10.1002/car.2289; Stirling AE, 2014, J AGGRESS MALTREAT T, V23, P116, DOI 10.1080/10926771.2014.872747; Stirling AE, 2009, SPORT SOC, V12, P227, DOI 10.1080/17430430802591019; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Tuana N., 2006, HYPATIA, V21, P1, DOI DOI 10.1111/J.1527-2001.2006.TB01110.X; TUANA Nancy, 2004, HYPATIA, V19, P194, DOI DOI 10.1111/J.1527-2001.2004.TB01275.X; Walker NA, 2015, J SPORT MANAGE, V29, P257, DOI 10.1123/jsm.2013-0079; Washington M, 2011, SPORT MANAG REV, V14, P1, DOI 10.1016/j.smr.2010.06.003; Weinberg R, 2013, J CLIN SPORT PSYCHOL, V7, P41, DOI 10.1123/jcsp.7.1.41; Young IM, 2006, SOC PHILOS POLICY, V23, P102, DOI 10.1017/S0265052506060043; Young IM, 2011, RESPONSIBILITY JUSTI; Young Iris-Marion., 2004, OPPRESSION PRIVILEGE, P37	63	13	13	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0033-6297	1543-2750		QUEST	Quest		2017	69	3					366	383		10.1080/00336297.2016.1238769			18	Education & Educational Research; Sport Sciences	Education & Educational Research; Sport Sciences	FM4PO	WOS:000415001800005					2021-06-18	
J	Simon, M; Maerlender, A; Metzger, K; Decoster, L; Hollingworth, A; McLeod, TV				Simon, Madeline; Maerlender, Arthur; Metzger, Katelyn; Decoster, Laura; Hollingworth, Amy; McLeod, Tamara Valovich			Reliability and Concurrent Validity of Select C3 Logix Test Components	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CONCUSSION; SPORTS; ASSOCIATION; STATEMENT; STABILITY	We sought to investigate the one-week and within-session reliability of the instrumented balance error scoring system test and the concurrent validity/one-week reliability of two neurocognitive assessments available through C3 Logix. (n = 37) Participants completed two balance error scoring system tests separated by the Trails A, Trails B, and Symbol Digit Modality test available through C3 Logix, and with paper and pencil. We found that the instrumented balance error scoring system test demonstrated strong one-week reliability and that neuropsychological tests available through C3 Logix show acceptable concurrent validity with standard (comparable) paper and pencil measures.	[Simon, Madeline; Metzger, Katelyn; Decoster, Laura; Hollingworth, Amy] New Hampshire Musculoskeletal Inst, 35 Kosciuszko St, Manchester, NH 03101 USA; [Maerlender, Arthur] Univ Nebraska Lincoln, Ctr Brain Biol & Behav, Lincoln, NE USA; [McLeod, Tamara Valovich] AT Still Univ, Athlet Training Programs, Mesa, AZ USA; [McLeod, Tamara Valovich] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA	Simon, M (corresponding author), New Hampshire Musculoskeletal Inst, 35 Kosciuszko St, Manchester, NH 03101 USA.	mtsimon45@hotmail.com	McLeod, Tamara/AAU-9435-2020				Alberts JL, 2015, J ATHL TRAINING, V50, P578, DOI 10.4085/1062-6050-50.2.01; Amin DJ, 2014, J SPORTS SCI, V2, P200, DOI DOI 10.17265/2332-7839/2014.04.005; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; BARTH JT, 1989, MILD HEAD INJURY SPO, V1, P257; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brown HJ, 2014, MED SCI SPORT EXER, V46, P1610, DOI 10.1249/MSS.0000000000000263; Cantu Robert C, 2006, Neurosurg Focus, V21, pE3; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Coppel DB, 2011, PHYS MED REH CLIN N, V22, P653, DOI 10.1016/j.pmr.2011.08.006; COPPEL DB, 2011, PHYS MED REHABILITAT, V22, pR8; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Kushner DS, 2001, AM FAM PHYSICIAN, V64, P1007; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; MCCRORY P, 2009, J SCI MED SPORT, V16, P83; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Nanda Anil, 2012, J La State Med Soc, V164, P246; Reitan R. M, 1992, TRAIL MAKING TEST; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Siu KC, 2015, J AGROMEDICINE, V20, P327, DOI 10.1080/1059924X.2015.1042615; Smith A., 1982, SYMBOL DIGIT MODALIT; STEFANSKY W, 1972, J TECHNOMETRICS, V14, P469; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677	30	13	13	2	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2017	42	7-8					446	459		10.1080/87565641.2017.1383994			14	Psychology, Developmental; Psychology; Psychology, Experimental	Psychology	FY5WP	WOS:000426908800002	29068702	Green Published			2021-06-18	
J	Stephens, J; Salorio, C; Denckla, M; Mostofsky, S; Suskauer, S				Stephens, J.; Salorio, C.; Denckla, M.; Mostofsky, S.; Suskauer, S.			Subtle Motor Findings During Recovery from Pediatric Traumatic Brain Injury: A Preliminary Report	JOURNAL OF MOTOR BEHAVIOR			English	Article						motor; pediatric; rehabilitation; traumatic brain injury	UPPER-LIMB FUNCTION; CHILDREN; GAIT; CONCUSSION; STABILITY; SIGNS	Pediatric traumatic brain injury (TBI) is a heterogeneous condition, varying in both severity and sequelae. The long-term motor deficits following severe TBI requiring inpatient rehabilitation are better established than those following milder forms of TBI. The authors examined motor performance 2 and 12 months postinjury in children without overt motor impairment using standard measures of upper limb function and the Physical and Neurological Examination for Subtle Signs (PANESS). The PANESS was sensitive to differences between children with TBI and uninjured children as well as to changes in children with TBI over time. These data suggest that subtle motor deficits are present after milder forms of TBI and, particularly those related to balance and gait, may persist even 12 months postinjury.	[Stephens, J.; Salorio, C.; Denckla, M.; Mostofsky, S.; Suskauer, S.] Kennedy Krieger Inst, 716 N Broadway,Off 306, Baltimore, MD 21205 USA; [Stephens, J.; Suskauer, S.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Denckla, M.; Mostofsky, S.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Denckla, M.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [Mostofsky, S.; Suskauer, S.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA	Stephens, J (corresponding author), Kennedy Krieger Inst, 716 N Broadway,Off 306, Baltimore, MD 21205 USA.	StephensJ@kennedykrieger.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD061611]; NIH/ NCRR CTSA ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [UL1TR001079-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD079123, K23HD061611, T32HD007414] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER	This research was funded by NIH K23HD061611 and NIH/ NCRR CTSA Program UL1TR001079-01.	Ahlander AC, 2013, J REHABIL MED, V45, P815, DOI 10.2340/16501977-1203; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Delis D.C., 2001, DELIS KAPLAN EXECUTI; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gaddis A, 2015, PSYCHIAT RES-NEUROIM, V233, P488, DOI 10.1016/j.pscychresns.2015.08.001; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; MacNeil LK, 2012, NEUROPSYCHOLOGY, V26, P165, DOI 10.1037/a0026955; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Rhine T., 2015, J HEAD TRAUMA REHABI; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; VITIELLO B, 1989, J AM ACAD CHILD PSY, V28, P749, DOI 10.1097/00004583-198909000-00017; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620	23	13	13	3	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-2895	1940-1027		J MOTOR BEHAV	J. Mot. Behav.	JAN-FEB	2017	49	1					20	26		10.1080/00222895.2016.1204267			7	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	EN5EN	WOS:000396028500003	27635631	Green Accepted			2021-06-18	
J	Tierney, GJ; Simms, CK				Tierney, Gregory J.; Simms, Ciaran K.			The effects of tackle height on inertial loading of the head and neck in Rugby Union: A multibody model analysis	BRAIN INJURY			English	Article						Sport; biomechanics; rugby	WORLD-CUP; CERVICAL RANGE; PLAYERS; INJURIES; IMPACT; CONTACT; CONCUSSION; MATCH; ACCELERATION; FORCES	Objective: There is evidence of chronic injury to the head-and-neck region of Rugby Union players. The aim of this study was to use multibody simulations to examine the effects of tackle height on both Tackier and Ball Carrier head kinematics and neck dynamics.& para;& para;Research Design: Quantitative Exploratory Study & para;& para; Methods and procedures: 45 front-on shoulder tackles with no direct contact to the head/neck were simulated with the MADYMO pedestrian model and used to assess differences between upper body tackles and lower body tackles. The average resultant head linear and angular accelerations as well as neck forces and moments were assessed.& para;& para;Main outcomes and results: Much higher Ball Carrier head kinematic values and neck loading were predicted for upper body tackles compared to lower body tackles, and principal findings were unaffected by a sensitivity analysis. Tackier results were less straightforward and trends were influenced by the sensitivity analysis for muscle activation.& para;& para;Conclusion: Although further model validation is required, the results of this study indicate the need for further research on tackle heights and inertial head-and-neck loading in the tackle phase of play in Rugby Union.	[Tierney, Gregory J.; Simms, Ciaran K.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland	Tierney, GJ (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dept Mech & Mfg Engn, Dublin 2, Ireland.	gtierne@tcd.ie	Simms, Ciaran/K-3100-2019	Simms, Ciaran/0000-0001-5564-1620; Tierney, Gregory/0000-0002-4666-4473	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	Acknowledgment should be given to the Irish Research Council for funding this study.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Best JP, 2005, BRIT J SPORT MED, V39, P812, DOI 10.1136/bjsm.2004.016402; BOUQUET R, 1994, FOURTEENTH INTERNATIONAL TECHNICAL CONFERENCE ON ENHANCED SAFETY OF VEHICLES, PROCEEDINGS, VOLS 1 AND 2, P100; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Elliott JR, 2012, P I MECH ENG K-J MUL, V226, P266, DOI 10.1177/1464419311430176; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Frechede B, 2007, P ENH SAF VEH C, P18; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Fuller CW, 2008, BRIT J SPORT MED, V42, P452, DOI 10.1136/bjsm.2008.047035; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Kajzer J., 1993, P P IRCOBI C, P105; KIM W, 1994, HUM MOVEMENT SCI, V13, P221, DOI 10.1016/0167-9457(94)90038-8; King D, 2016, SPORTS MED, V46, P151, DOI 10.1007/s40279-015-0423-7; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Lark SD, 2007, J SPORT SCI, V25, P887, DOI 10.1080/02640410600944543; Lark SD, 2009, J SPORT SCI, V27, P491, DOI 10.1080/02640410802632136; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; McIntosh AS, 2014, BMJ OPEN, V4, P5, DOI [10.1136/bmjopen-2014-005078., DOI 10.1136/BMJOPEN-2014-005078.]; Meyer E, 1994, CHOC LATERAL LEPAULE; Munoz D, 2005, P ENH SAF VEH C, P6; Pain MTG, 2008, J SPORT SCI, V26, P855, DOI 10.1080/02640410801910319; Pinsault N, 2010, PHYS THER SPORT, V11, P66, DOI 10.1016/j.ptsp.2010.02.004; Portero P, 2003, ISOKINET EXERC SCI, V11, P1; Sankarasubramanian H, 2011, P ENH SAF VEH C, P1; Scher A., 1978, DRUG RES, V5, P197; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Smart DJ, 2008, BRIT J SPORT MED, V42, P198, DOI 10.1136/bjsm.2007.040162; Takarada Y, 2003, BRIT J SPORT MED, V37, P416, DOI 10.1136/bjsm.37.5.416; Talantikite Y, 1998, P ENH SAF VEH C, P1542; Tierney G.J., 2015, P INT RES COUNC BIOM, P180, DOI DOI 10.1002/NET.21589; Tierney G.J., 2016, ISBS C P ARCHIVE, P108, DOI DOI 10.1016/J.PUHE.2015.10.038; Tierney Gregory J, 2018, J Sci Med Sport, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P415, DOI 10.1177/1747954117751345; Tierney Gregory J, 2018, Sports Biomech, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; TNO, 2015, MAD HUM BOD MOD MAN, P103; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; van Rooij L., 2003, P ENH SAF VEH C, P468; Viano DC., 1989, SAE TECHNICAL PAPER; World Rugby, 2016, DESCR TACKL TACKL TY; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yang J., 1995, SAE TECHNICAL PAPER; Yin S, 2017, ACCIDENT ANAL PREV, V106, P285, DOI 10.1016/j.aap.2017.06.005	51	13	13	0	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	13-14					1925	1931		10.1080/02699052.2017.1385853			7	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	FO2MD	WOS:000416612500027	29064724				2021-06-18	
J	Von der Brelie, C; Seifert, M; Rot, S; Tittel, A; Sanft, C; Meier, U; Lemcke, J				Von der Brelie, Christian; Seifert, Michael; Rot, Sergej; Tittel, Anja; Sanft, Carsten; Meier, Ullrich; Lemcke, Johannes			Sedation of Patients with Acute Aneurysmal Subarachnoid Hemorrhage with Ketamine Is Safe and Might Influence the Occurrence of Cerebral Infarctions Associated with Delayed Cerebral Ischemia	WORLD NEUROSURGERY			English	Article						Cerebral aneurysm; Delayed cerebral ischemia; Intracranial pressure; Ketamine; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; LONG-TERM MORTALITY; SPREADING DEPOLARIZATIONS; INTRACRANIAL-PRESSURE; CARE; VASOSPASM; PROPOFOL; ARTERIES; TRIAL	BACKGROUND: Ketamine has neuroprotective characteristics as well as beneficial cardiocirculatory properties and may thus reduce vasopressor consumption. In contrast, sedation with ketamine (like any other sedative drug) has side effects. This study assesses the influence of ketamine on intracranial pressure (ICP), on the consumption of vasopressors in induced hypertension therapy, and on the occurrence of delayed cerebral ischemia (DCI)-associated cerebral infarctions, with particular focus on the complications of sedation in patients with aneurysmal subarachnoid hemorrhage (SAH). METHODS: This is a retrospective, observational study. Sixty-five patients with SAH who underwent a period of sedation were included. The clinical course variables (Richmond Agitation and Sedation scale score, ICP values, consumption of vasopressors, complications of sedation, outcome, and other clinical parameters) were analyzed. Cranial computed tomography results were analyzed. RESULTS: Forty-one patients underwent sedation including ketamine (63.1%). Ketamine decreased the ICP in 92.7% of the cases. Vasopressors was reduced in 53.6%. DCI-associated cerebral infarctions occurred significantly less often in the patient cohort being treated with sedation including ketamine (7.3% vs. 25% in the nonketamine group; P = 0.04). The rate of major complications was not higher in the ketamine group. Outcome was not different regarding the groups if they were sedated with or without ketamine. CONCLUSIONS: Ketamine decreases the ICP and is not associated with a higher rate of complications. The rate of DCI-associated cerebral infarctions was lower in the ketamine group. Ketamine administration led to a reduction of vasopressors used for induced hypertension.	[Von der Brelie, Christian] Univ Gottingen, Dept Neurosurg, Gottingen, Germany; [Von der Brelie, Christian; Rot, Sergej; Meier, Ullrich; Lemcke, Johannes] Unfallkrankenhaus Berlin, Dept Neurosurg, Berlin, Germany; [Seifert, Michael; Sanft, Carsten] Unfallkrankenhaus Berlin, Dept Anesthesiol, Berlin, Germany; [Tittel, Anja] Unfallkrankenhaus Berlin, Dept Radiol, Berlin, Germany	Von der Brelie, C (corresponding author), Univ Gottingen, Dept Neurosurg, Gottingen, Germany.; Von der Brelie, C (corresponding author), Unfallkrankenhaus Berlin, Dept Neurosurg, Berlin, Germany.	cvdb@gmx.net		Lemcke, Johannes/0000-0002-8073-1625			Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Dasenbrock HH, 2016, WORLD NEUROSURG, V88, P459, DOI 10.1016/j.wneu.2015.10.054; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; FUKUDA S, 1983, ANESTH ANALG, V62, P553; Grace RF, 2003, ANAESTHESIA, V58, P904, DOI 10.1046/j.1365-2044.2003.03341.x; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Joffe A R, 2000, Pediatr Crit Care Med, V1, P151, DOI 10.1097/00130478-200010000-00011; Kamel IR, 2008, J NEUROSURG ANESTH, V20, P241, DOI 10.1097/ANA.0b013e31817f523f; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; Lindquist L A, 2003, J Wound Care, V12, P272; Mees SMD, 2012, J NEUROL, V259, P679, DOI 10.1007/s00415-011-6243-2; Page RL, 2016, CIRCULATION, V134, pE32, DOI 10.1161/CIR.0000000000000426; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Rodrigues Junior Geraldo Rolim, 2004, Sao Paulo Med. J., V122, P8, DOI 10.1590/S1516-31802004000100003; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Sanchez-Porras R, 2014, NEUROPHARMACOLOGY, V84, P52, DOI 10.1016/j.neuropharm.2014.04.018; Sessler CN, 2001, SEMIN RESP CRIT CARE, V22, P211, DOI 10.1055/s-2001-13834; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Siu K H, 1994, J Clin Neurosci, V1, P243, DOI 10.1016/0967-5868(94)90064-7; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Villa F, 2012, CRIT CARE MED, V40, P2797, DOI 10.1097/CCM.0b013e31825b8bc6; Werner C, 1997, ZBL NEUROCHIR, V58, P90; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y	31	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						374	382		10.1016/j.wneu.2016.09.121			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400051	27742511				2021-06-18	
J	Weise, KK; Swanson, MW; Penix, K; Hale, MH; Ferguson, D				Weise, Katherine K.; Swanson, Mark W.; Penix, Kimberly; Hale, Matthew Heath; Ferguson, Drew			King-Devick and Pre-season Visual Function in Adolescent Athletes	OPTOMETRY AND VISION SCIENCE			English	Article						King-Devick; convergence; pupillometer; alignment; concussion; adolescent; sport	CONCUSSION SCREENING TOOL; ICE HOCKEY PLAYERS; FOOTBALL PLAYERS; REFERENCE VALUES; VISION; ASSOCIATIONS; TESTS	Purpose. The King-Devick test (KD) has been studied as a remove-from-play sideline test in college-age athletes and older; however, studies in younger athletes are limited. A cross-sectional study of the KD and other vision correlates was completed on school-aged athletes during pre-season physicals for a variety of sports to determine the repeatability of the KD. The study also evaluated how convergence, alignment, or pupil function contributed to a slower King-Devick baseline reading. Methods. Seven hundred eighty-five athletes underwent vision screenings in a hospital or school setting by trained/certified staff as part of pre-season physicals. Six hundred nineteen had KD testing completed per the manufacturer's suggested protocol and repeated. Other baseline vision testing included visual acuity, Modified Thorington testing for alignment, convergence testing, and pupil function using the NeurOptics (NPI-200) NPi. Results. The mean fastest, error-minimized KD time for all participants was 43.9 seconds(s) (SD +/- 11.6, range 24-120). Median KD time got faster (+) with age (p < 0.0001). The inter-class correlation coefficient for all scores was 0.92. The absolute mean time difference for any two tests was 3.5 s (SD +/- 2.5, range 0-23). There was no association between the best KD time and reduced NPC (p = 0.63), Modified Thorington measure of alignment (p = 0.55), or NPi pupil function (p = 0.79). The Bland Altman repeated measure limits of agreement was +/- 6.5 seconds for those in the 10th to 12th grades, and +/- 10.2 seconds for those in the 6th to 9th grades. Conclusions. King-Devick score in junior high and high school athletes is variable but gets faster and more repeatable with increasing age. The KD does not correlate significantly with reduced convergence, alignment, or pupil function. Based on grouped data, a slowing of 10 seconds for younger athletes and 6 seconds for older athletes on a second administration represents a true difference in testing speed. Within-player variability should be considered when removal-from-play decisions are influenced by KD results.	[Weise, Katherine K.; Swanson, Mark W.; Penix, Kimberly; Hale, Matthew Heath; Ferguson, Drew] Univ Alabama Birmingham, Sports Med Clin, Childrens Alabama, Birmingham, AL USA	Weise, KK (corresponding author), Univ Alabama Birmingham, Sch Optometry, Henry B Peters Bldg,1716 Univ Blvd, Birmingham, AL 35294 USA.	kweise@uab.edu			UAB Department of Optometry; UAB Vision Science Research Center's National Institutes of Health [P30 EY003039]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY003039] Funding Source: NIH RePORTER	This study was supported by the UAB Department of Optometry and the UAB Vision Science Research Center's National Institutes of Health P30 EY003039 core grant.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Campbell IG, 2012, P NATL ACAD SCI USA, V109, P5740, DOI 10.1073/pnas.1120860109; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King Devick Test, KING DEV TEST; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Scheiman M, 2015, VIS DEV REH, V1, P214; Scheiman M, 2008, OPHTHAL EPIDEMIOL, V15, P24, DOI 10.1080/09286580701772037; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223	25	13	14	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					89	95		10.1097/OPX.0000000000000938			7	Ophthalmology	Ophthalmology	EM5ZZ	WOS:000395393900012	27464573	Green Accepted			2021-06-18	
J	Zhang, HB; Cheng, SX; Tu, Y; Zhang, S; Hou, SK; Yang, Z				Zhang, Hai-Bo; Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai; Hou, Shi-Ke; Yang, Zhen			Protective effect of mild-induced hypothermia against moderate traumatic brain injury in rats involved in necroptotic and apoptotic pathways	BRAIN INJURY			English	Article						Traumatic brain injury; hypothermia; RIPK-1; necroptosis; apoptosis	INDUCED CELL-DEATH; KINASE-DEPENDENT APOPTOSIS; CEREBRAL-BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; NEURONAL DEATH; RIP1 KINASE; EXPRESSION; CONTRIBUTES; IDENTIFICATION	Aim: To investigate the protective effect of hypothermia (HT) on brain injury in moderate traumatic brain injury (TB) rat models and the potential mechanisms, especially the involvement of RIPK1 in apoptosis and necroptosis. Methods: Adult Sprague-Dawley rats were randomized to four groups: sham+normothermia (sham+NT), sham+hypothermia (sham+HT), moderate TBI+normothermia (TBI+NT) and moderate TBI+hypotherMia.(TBI+HT). The sham+HT and TBI+HT groups were submitted to 32 degrees C for 6 hours. The regional cerebral blood flow (rCBF) was assessed 24 hours after TBI; 24 and 48 hours after TBI, the modified neurological severity score (mNSS), was assessed. Immediately after behavioural tests, rats were sacrificed to harvest the brain tissues. Results: mNSS scores were lower in the IBI+HT group compared with the TBI+NT group (p < 0.01) and cerebral, blood flow was better (p < 0.01). H&E staining of the cortex and ipsilateral hippocampus showed pyknotic and irregularly shaped neuron in TBI+NT rats, which were less frequent in TBI+HT rats. The TBI+NT and TBI+HT groups showed higher TNF-alpha, TRAIL, FasL, FADD, caspase-3, caspase-8, PARP-1, RIPK-1 and RIPK-3 levels than the sham+NT group (all p < 0.05), but the levels of these proteins were all lower in the TBI+HT group compared with the TBI+NT group (all p < 0.01). Conclusion: HT treatment significantly reduced RIPK-1 upregulation, which, may inhibit necroptosis and apoptosis pathways after moderate TBI.	[Zhang, Hai-Bo; Cheng, Shi-Xiang; Tu, Yue; Zhang, Sai; Hou, Shi-Ke; Yang, Zhen] Chinese Peoples Armed Police Forces PAP, Inst Traumat Brain Injury & Neurosci, Tianjin Key Lab Neurotrauma Repair, Neurosurg & Neurol Hosp PAP, 220 Chen Lin Rd, Tianjin 300162, Peoples R China	Zhang, S (corresponding author), Chinese Peoples Armed Police Forces PAP, Inst Traumat Brain Injury & Neurosci, Tianjin Key Lab Neurotrauma Repair, Neurosurg & Neurol Hosp PAP, 220 Chen Lin Rd, Tianjin 300162, Peoples R China.	zhangsaintmed@sina.com			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [31200809]; Chinese People's Armed Police Forces Grant [WJHQ2012-20]; Science and Technology Program of Tianjin [15ZXLCSY00040]; Logistics College of PAP [WHTD201306]	The authors report no conflicts of interest. This work was supported by grants by the National Natural Science Foundation of China (NSFC No. 31200809), the Chinese People's Armed Police Forces Grant (WJHQ2012-20), the Science and Technology Program of Tianjin (15ZXLCSY00040), and the Logistics College of PAP (WHTD201306).	Alanazi I, 2013, APOPTOSIS, V18, P1291, DOI 10.1007/s10495-013-0887-6; Barbosa RR, 2012, J TRAUMA ACUTE CARE, V73, pS307, DOI 10.1097/TA.0b013e3182701885; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng SX, 2013, THER HYPOTHERMIA TEM, V3, P132, DOI 10.1089/ther.2013.0005; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Hayashi N, 1997, NEUROCHEMISTRY, P97; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Kaibara T, 1999, J NEUROSURG, V90, P339, DOI 10.3171/jns.1999.90.2.0339; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Lee EW, 2012, BMB REP, V45, P496, DOI 10.5483/BMBRep.2012.45.9.186; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Management of Concussion/m TBIWG, 2009, J REHABILITATION RES, V46, pCP1; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Marion DW, 1996, J NEUROTRAUM, V13, P139, DOI 10.1089/neu.1996.13.139; Meloni BP, 2011, J NEUROSCI METH, V195, P67, DOI 10.1016/j.jneumeth.2010.11.023; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; MITANI A, 1991, BRAIN RES, V562, P159, DOI 10.1016/0006-8993(91)91201-B; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Shindo R, 2013, BIOCHEM BIOPH RES CO, V436, P212, DOI 10.1016/j.bbrc.2013.05.075; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wallace JA, 2002, J CEREBR BLOOD F MET, V22, P1303, DOI 10.1097/01.WCB.0000040943.89393.c1; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	54	13	15	1	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					406	415		10.1080/02699052.2016.1225984			10	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900019	28140659				2021-06-18	
J	Chigurupati, H; Auddy, B; Biyani, M; Stohs, SJ				Chigurupati, Harsha; Auddy, Biswajit; Biyani, M.; Stohs, Sidney J.			Hepatoprotective Effects of a Proprietary Glycyrrhizin Product during Alcohol Consumption: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study	PHYTOTHERAPY RESEARCH			English	Article						alcohol; glycyrrhizin; D-mannitol; hepatoprotection; glutathione; AST; ALT; GGT	TRAUMATIC BRAIN-INJURY; INDUCED LIVER-INJURY; MODERATE DRINKERS; OXIDATIVE STRESS; CARBON-TETRACHLORIDE; PLASMA GLUTATHIONE; ACID; RAT; MANNITOL; DAMAGE	Traditionally, licorice has been used to treat liver problems. Glycyrrhizin, the primary active compound, has been shown to suppress elevations in liver enzymes that occur when the liver becomes diseased or damaged. This randomized, double-blind, placebo-controlled, crossover study evaluated the hepatoprotective effects of a proprietary glycyrrhizin product during alcohol consumption. Twelve healthy individuals (six male and six female subjects) in a clinic setting consumed vodka nightly for 12 days with the glycyrrhizin product or placebo (blank control), achieving a blood alcohol level of 0.12%. Liver function enzymes including alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), and alkaline phosphatase and serum reduced glutathione were measured at overnight visits 1, 6, and 12. In the alcohol only group, AST, ALT, and GGT significantly increased from baseline (overnight visit 1) to overnight visit 12. In the active group, no statistically significant increases were observed for AST, ALT, and GGT, while alkaline phosphatase significantly decreased and plasma glutathione decreased relative to the alcohol control group. These results suggest that consumption of the proprietary glycyrrhizin study product during alcohol consumption may support improved liver health compared with drinking alcohol alone. Copyright (C) 2016 John Wiley & Sons, Ltd.	[Chigurupati, Harsha; Auddy, Biswajit; Biyani, M.] Chigurupati Technol Private Ltd, Hyderabad, Andhra Pradesh, India; [Stohs, Sidney J.] Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA	Stohs, SJ (corresponding author), Creighton Univ, 7068 Maumee Valley Court, Frisco, TX 75034 USA.	sid.stohs9@gmail.com		biyani, manish/0000-0001-7622-5650	Chigurupati Technologies Private Limited	Funding for this study and the study product (NTX (R)) were provided by Chigurupati Technologies Private Limited. The authors thank Medicus Research for their assistance in conducting the study.	Ablise M, 2004, CHEM PHARM BULL, V52, P1436, DOI 10.1248/cpb.52.1436; ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749; Alatalo P, 2009, ALCOHOL ALCOHOLISM, V44, P199, DOI 10.1093/alcalc/agn099; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Bruha R, 2012, WORLD J HEPATOL, V4, P81, DOI 10.4254/wjh.v4.i3.81; Cao Zong-xin, 2006, Chin J Integr Med, V12, P268, DOI 10.1007/s11655-006-0268-1; CEDERBAUM AI, 1983, BIOCHEM J, V210, P107, DOI 10.1042/bj2100107; Chang YY, 2013, J AGR FOOD CHEM, V61, P11016, DOI 10.1021/jf4038419; Cheel J, 2010, PHARMACOGN MAG, V6, P26, DOI 10.4103/0973-1296.59963; Cosentino M, 2013, WORLD J UROL, V31, P977, DOI 10.1007/s00345-012-1003-1; Danielsson J, 2014, WORLD J GASTROENTERO, V20, P11743, DOI 10.3748/wjg.v20.i33.11743; Deshpande N, 2014, WORLD J NUTR HLTH, V2, P24, DOI DOI 10.12691/JNH-2-2-3; Dhanda AD, 2015, WORLD J GASTROENTERO, V21, P11904, DOI 10.3748/wjg.v21.i42.11904; ENGLAND MD, 1986, CIRCULATION, V74, P134; FREZZA M, 1990, NEW ENGL J MED, V322, P95, DOI 10.1056/NEJM199001113220205; Gandhi NM, 2004, J RADIAT RES, V45, P461, DOI 10.1269/jrr.45.461; Gharzouli K, 2001, EXP TOXICOL PATHOL, V53, P175, DOI 10.1078/0940-2993-00175; Gong G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089450; Gong G, 2012, ACTA PHARMACOL SIN, V33, P11, DOI 10.1038/aps.2011.151; Gu XJ, 2014, CHIN J TRAUMATOL, V17, P1, DOI 10.3760/cma.j.issn.1008-1275.2014.01.001; Han KH, 2016, WORLD J GASTROENTERO, V22, P37, DOI 10.3748/wjg.v22.i1.37; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hietala J, 2005, ALCOHOL ALCOHOLISM, V40, P511, DOI 10.1093/alcalc/agh201; Hou SZ, 2014, INT J MOL SCI, V15, P15026, DOI 10.3390/ijms150915026; Hsiang CY, 2015, PHYTOMEDICINE, V22, P768, DOI 10.1016/j.phymed.2015.05.053; Hu CC, 2001, MUTAT RES-GEN TOX EN, V496, P117, DOI 10.1016/S1383-5718(01)00214-5; Hurley TD, 2002, PHARMACOGENOMICS SEA, P417; IKEDA Y, 1995, P NATL ACAD SCI USA, V92, P126, DOI 10.1073/pnas.92.1.126; Ishida T, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/650514; Izzo AA, 2016, PHYTOTHER RES, V30, P691, DOI 10.1002/ptr.5591; Jeong HG, 2002, FEBS LETT, V513, P208, DOI 10.1016/S0014-5793(02)02311-6; Jerca L, 1993, Rev Med Chir Soc Med Nat Iasi, V97, P253; Jung JC, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-0997-0; Kaur P, 2012, PHARMACOGN RES, V4, P189, DOI 10.4103/0974-8490.102260; Kim HJ, 2015, PAK J MED SCI, V31, P1043, DOI 10.12669/pjms.315.8025; Kim MS, 2016, WORLD J GASTROENTERO, V22, P8, DOI 10.3748/wjg.v22.i1.8; Laconi S, 2014, PHYTOTHER RES, V28, P1890, DOI 10.1002/ptr.5189; LAUTERBURG BH, 1984, J PHARMACOL EXP THER, V230, P7; LAUTERBURG BH, 1988, GUT, V29, P1153, DOI 10.1136/gut.29.9.1153; LECOMTE E, 1994, AM J CLIN NUTR, V60, P255; Lee CH, 2007, BIOL PHARM BULL, V30, P1898, DOI 10.1248/bpb.30.1898; Lee TD, 2004, ALCOHOL CLIN EXP RES, V28, P173, DOI 10.1097/01.ALC.0000108654.77178.03; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Li XL, 2012, MOLECULES, V17, P716, DOI 10.3390/molecules17010716; Liang B, 2015, WORLD J GASTROENTERO, V21, P5271, DOI 10.3748/wjg.v21.i17.5271; LIU J, 1994, FUND APPL TOXICOL, V22, P34, DOI 10.1006/faat.1994.1005; Llerena S, 2015, WORLD J HEPATOL, V7, P2703, DOI 10.4254/wjh.v7.i27.2703; Loguercio C, 1997, ITAL J GASTROENTEROL, V29, P168; Loguercio C, 1999, ALCOHOL CLIN EXP RES, V23, P1780, DOI 10.1111/j.1530-0277.1999.tb04073.x; Mathurin P, 2012, J HEPATOL, V56, pS39, DOI 10.1016/S0168-8278(12)60005-1; MICHELET F, 1995, CLIN CHEM, V41, P1509; Nagamma T, 2012, ASIAN PAC J CANCER P, V13, P3513, DOI 10.7314/APJCP.2012.13.7.3513; NEMESANSZKY E, 1988, CLIN CHEM, V34, P525; Nwozo SO, 2014, J INTEGR MED-JIM, V12, P59, DOI 10.1016/S2095-4964(14)60006-6; Nyblom H, 2004, ALCOHOL ALCOHOLISM, V39, P336, DOI 10.1093/alcalc/agh074; O'Shea RS, 2010, AM J GASTROENTEROL, V105, P14, DOI 10.1038/ajg.2009.593; Omar HR, 2012, THER ADV ENDOCRINOL, V3, P125, DOI 10.1177/2042018812454322; Orazizadeh M, 2014, CHEM-BIOL INTERACT, V220, P214, DOI 10.1016/j.cbi.2014.07.001; Panda Vandana, 2012, Interdiscip Toxicol, V5, P207, DOI 10.2478/v10102-012-0034-1; Patel TK, 2016, TRENDS PLANT SCI, V21, P486, DOI 10.1016/j.tplants.2016.01.006; Pemberton PW, 2005, SCAND J GASTROENTERO, V40, P1102, DOI 10.1080/00365520510023495; PIERSON JL, 1986, BIOCHEM PHARMACOL, V35, P1533, DOI 10.1016/0006-2952(86)90121-8; Pisa PT, 2015, J HEALTH POPUL NUTR, V33, P146; Quan ZY, 2009, J SHANDONG U, V47, P80; Qureshi MS, 2015, PROF MED J, V22, P896; REINKE LA, 1987, P NATL ACAD SCI USA, V84, P9223, DOI 10.1073/pnas.84.24.9223; Shah D M, 1996, Cardiovasc Surg, V4, P97; Sil R, 2015, MOL CELL BIOCHEM, V409, P177, DOI 10.1007/s11010-015-2523-y; Sripradha Ramalingam, 2010, Indian J Med Sci, V64, P476; Thomes PG, 2013, AUTOPHAGY, V9, P63, DOI 10.4161/auto.22490; Tripathi M, 2009, FOOD CHEM TOXICOL, V47, P339, DOI 10.1016/j.fct.2008.11.028; VENDEMIALE G, 1989, J HEPATOL, V9, P359, DOI 10.1016/0168-8278(89)90146-3; Wang F, 2016, MOLECULES, V21, DOI 10.3390/molecules21010064; Wang J, 1999, Zhonghua Gan Zang Bing Za Zhi, V7, P42; Wang JM, 2015, CAN J PHYSIOL PHARM, V93, P261, DOI 10.1139/cjpp-2014-0536; Wang W, 2013, INT J NANOMED, V8, P1377, DOI 10.2147/IJN.S37788; Wang XY, 2015, INT J BIOL MACROMOL, V78, P354, DOI 10.1016/j.ijbiomac.2015.04.024; Whitfield JB, 2013, ALCOHOL CLIN EXP RES, V37, P575, DOI 10.1111/acer.12015; Wu CH, 2015, J AGR FOOD CHEM, V2015; Yildirim AO, 2013, EUR REV MED PHARMACO, V17, P2981; Yilmaz N, 2007, BRAIN RES, V1164, P132, DOI 10.1016/j.brainres.2007.06.017; Yu J, 2014, PHYTOTHER RES, V28, P933, DOI 10.1002/ptr.5072; Zelickson BR, 2011, BBA-BIOENERGETICS, V1807, P1573, DOI 10.1016/j.bbabio.2011.09.011; Zhang YJ, 2016, ENV RES PUBL HLTH, V13, P339, DOI [10.3390/iherph.13040399, DOI 10.3390/IHERPH.13040399]	84	13	13	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0951-418X	1099-1573		PHYTOTHER RES	Phytother. Res.	DEC	2016	30	12					1943	1953		10.1002/ptr.5699			11	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	ED9PK	WOS:000389204700005	27539273				2021-06-18	
J	Joseph, B; Khalil, M; Harrison, C; Swartz, T; Kulvatunyou, N; Haider, AA; Jokar, TO; Burk, D; Mahmoud, A; Latifi, R; Rhee, P				Joseph, Bellal; Khalil, Mazhar; Harrison, Caitlyn; Swartz, Tianyi; Kulvatunyou, Narong; Haider, Ansab A.; Jokar, Tahereh O.; Burk, David; Mahmoud, Ali; Latifi, Rifat; Rhee, Peter			Assessing the Efficacy of Prothrombin Complex Concentrate in Multiply Injured Patients With High-Energy Pelvic and Extremity Fractures	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						extremity fractures; PCC; traumatic coagulopathy; prothrombin complex; coagulopathy reversal	FRESH-FROZEN PLASMA; TRAUMATIC BRAIN-INJURY; EMERGENCY ANTICOAGULATION REVERSAL; EARLY COAGULOPATHY; FACTOR-VIIA; ASSOCIATION; MANAGEMENT; WARFARIN; SURGERY	Objectives: Prothrombin complex concentrate (PCC) is being increasingly used for reversing induced coagulopathy of trauma. However, the use of PCC for reversing coagulopathy in multiply injured patients with pelvic and/or lower extremity fractures remains unclear. The aim of our study was to assess the efficacy of PCC for reversing coagulopathy in this group of patients. Design: Two-year retrospective analysis. Setting: Our level I trauma center. Patients/Participants: All coagulopathic [International normalized ratio (INR) >= 1.5] trauma patients. Patients with femur, tibia, or pelvic fracture were included. Patients were divided into 2 groups: PCC (single dose) and fresh frozen plasma (FFP). Patients in the 2 groups were matched using propensity score matching. Main Outcome Measurements: Time to correction of INR, time to intervention, development of thromboembolic complications, mortality, and cost of therapy. Results: A total of 81 patients (PCC: 27, FFP: 54) were included. Patients who received PCC had faster correction of INR and shorter time to surgical intervention in comparison to patients who received FFP. PCC therapy was also associated with lower overall blood product requirement (P = 0.02) and lower transfusion costs (P = 0.0001). Conclusions: In a matched cohort of multiply injured patients with pelvic and/or lower extremity fractures, administration of a single dose of PCC significantly reduced the time to correction of INR and time to intervention compared with patients who received FFP therapy. This may allow orthopaedic surgeons to more safely proceed with early, definitive fixation strategies.	[Joseph, Bellal; Khalil, Mazhar; Harrison, Caitlyn; Swartz, Tianyi; Kulvatunyou, Narong; Haider, Ansab A.; Jokar, Tahereh O.; Burk, David; Mahmoud, Ali; Latifi, Rifat; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA	Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burns & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu		Latifi, Rifat/0000-0003-1091-3682			Beck KH, 2000, INFUS THER TRANSFUS, V27, P144; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Cullinane DC, 2011, J TRAUMA, V71, P1850, DOI 10.1097/TA.0b013e31823dca9a; Davis JW, 2008, J TRAUMA, V65, P1012, DOI 10.1097/TA.0b013e318189a836; Demeyere R, 2010, VOX SANG, V99, P251, DOI 10.1111/j.1423-0410.2010.01339.x; Dickneite G, 2009, BRIT J ANAESTH, V102, P345, DOI 10.1093/bja/aen391; Dickneite G, 2010, J TRAUMA, V68, P1151, DOI 10.1097/TA.0b013e3181b06364; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Eastridge BJ, 2002, J TRAUMA, V53, P446, DOI 10.1097/00005373-200209000-00009; Guest JF, 2010, CLIN THER, V32, P2478, DOI 10.1016/j.clinthera.2011.01.011; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Joseph B, 2015, NEUROSURGERY, V76, P601, DOI 10.1227/NEU.0000000000000685; Joseph B, 2014, WORLD J SURG, V38, P1875, DOI 10.1007/s00268-014-2631-y; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; Lankiewicz MW, 2006, J THROMB HAEMOST, V4, P967, DOI 10.1111/j.1538-7836.2006.01815.x; Lubetsky A, 2004, THROMB RES, V113, P371, DOI 10.1016/j.thromres.2004.04.004; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Magnussen RA, 2007, J ORTHOP TRAUMA, V21, P603, DOI 10.1097/BOT.0b013e3181599c27; Makris M, 2011, BLOOD TRANSFUS-ITALY, V9, P117, DOI 10.2450/2011.0111-10; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Pandit V, 2015, J AM COLL SURGEONS, V221, pE23, DOI 10.1016/j.jamcollsurg.2015.08.358; Purmonen T, 2015, DRUGS R&D, V15, P155, DOI 10.1007/s40268-015-0088-6; Schurr MJ, 2004, J TRAUMA, V57, P718; Stein DM, 2008, INJURY, V39, P1054, DOI 10.1016/j.injury.2008.03.032; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; White NJ, 2013, HEMATOL-AM SOC HEMAT, P660, DOI 10.1182/asheducation-2013.1.660; Yang L, 2012, TRANSFUSION, V52, P1673, DOI 10.1111/j.1537-2995.2011.03515.x	31	13	13	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	DEC	2016	30	12					653	658		10.1097/BOT.0000000000000665			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	ED6CG	WOS:000388941600010	27875491				2021-06-18	
J	Nagata, K; Kumasaka, K; Browne, KD; Li, SJ; St-Pierre, J; Cognetti, J; Marks, J; Johnson, VE; Smith, DH; Pascual, JL				Nagata, Katsuhiro; Kumasaka, Kenichiro; Browne, Kevin D.; Li, Shengjie; St-Pierre, Jesse; Cognetti, John; Marks, Joshua; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.			Unfractionated heparin after TBI reduces in vivo cerebrovascular inflammation, brain edema and accelerates cognitive recovery	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Heparin; traumatic brain injury; leukocyte	INHIBIT LEUKOCYTE ACCUMULATION; NEUROGENIC PULMONARY-EDEMA; MOLECULAR-WEIGHT HEPARIN; FOCAL CEREBRAL-ISCHEMIA; ACUTE LUNG INJURY; RAT MODEL; ENDOTHELIAL ACTIVATION; NEUROLOGIC RECOVERY; ENOXAPARIN; HEMORRHAGE	BACKGROUND: Severe traumatic brain injury (TBI) may increase the risk of venous thromboembolic complications; however, early prevention with heparinoids is often withheld for its anticoagulant effect. New evidence suggests low molecular weight heparin reduces cerebral edema and improves neurological recovery after stroke and TBI, through blunting of cerebral leukocyte (LEU) recruitment. It remains unknown if unfractionated heparin (UFH) similarly affects brain inflammation and neurological recovery post-TBI. We hypothesized that UFH after TBI reduces cerebral edema by reducing LEU-mediated inflammation and improves neurological recovery. METHODS: CD1 male mice underwent either TBI by controlled cortical impact (CCI) or sham craniotomy. UFH (75 U/kg or 225 U/kg) or vehicle (VEH, 0.9% saline) was administered 2, 11, 20, 27, and 34 hours after TBI. At 48 hours, pial intravital microscopy through a craniotomy was used to visualize live brain LEUs interacting with endothelium and microvascular fluorescein isothiocyanate-albumin leakage. Neurologic function (Garcia Neurological Test, GNT) and body weight loss ratios were evaluated 24 and 48 hours after TBI. Cerebral and lung wet-to-dry ratios were evaluated post mortem. ANOVA with Bonferroni correction was used to determine significance (p < 0.05). RESULTS: Compared to positive controls (CCI), both UFH doses reduced post-TBI in vivo LEU rolling on endothelium, concurrent cerebrovascular albumin leakage, and ipsilateral cerebral water content after TBI. Additionally, only low dose UFH(75 U/kg) improved GNT at both 24 and 48 hours after TBI. High dose UFH (225 U/kg) significantly increased body weight loss above sham at 48 hours. Differences in lung water content and blood pressure between groups were not significant. CONCLUSIONS: UFH after TBI reduces LEU recruitment, microvascular permeability, and brain edema to injured brain. Lower UFH doses concurrently improve neurological recovery whereas higher UFH may worsen functional recovery. Further study is needed to determine if this is caused by increased bleeding from injured brain with higher UFH doses. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Nagata, Katsuhiro; St-Pierre, Jesse; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Browne, Kevin D.; Cognetti, John; Johnson, Victoria E.; Smith, Douglas H.; Pascual, Jose L.] Univ Penn, Perelman Sch Med, Dept Neurosurg, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Marks, Joshua] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Li, Shengjie] Shandong Univ, Dept Neurosurg, Qianfoshan Hosp, Jinan, Peoples R China; [Kumasaka, Kenichiro] Tokyo Med Univ, Hachioji Med Ctr, Dept Emergency & Crit Care Med, Tokyo, Japan	Pascual, JL (corresponding author), Univ Penn, Sch Med, Div Traumatol Surg Crit Care & Emergency Surg, 51 N 39th St,Med Off Bldg,1st Fl Suite 120, Philadelphia, PA 19104 USA.	jose.pascual@uphs.upenn.edu	Pascual, Jose/ABI-2291-2020	Pascual, Jose/0000-0002-1613-7912	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398, R01 NS094003] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094003, R01NS092398] Funding Source: NIH RePORTER		Antonenko D, 2013, AM J SURG, V206, P845; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dzieciuchowicz Lukasz, 2002, Med Sci Monit, V8, pCR657; Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Gajic O, 2007, CRIT CARE MED, V35, P1979, DOI 10.1097/01.CCM.0000277254.12230.7D; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Glassner S, 2013, RAMBAM MAIMONIDES ME, V4, DOI 10.5041/RMMJ.10101; Hao LN, 2011, BRAIN RES BULL, V86, P355, DOI 10.1016/j.brainresbull.2011.08.018; Hazeldine J, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00235; Kim Luke, 2014, J Emerg Trauma Shock, V7, P141, DOI 10.4103/0974-2700.136846; Kubes P, 2000, BRAIN PATHOL, V10, P127; Lee JH, 2008, KOREAN J PHYSIOL PHA, V12, P231, DOI 10.4196/kjpp.2008.12.5.231; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li LF, 2009, CRIT CARE, V13, DOI 10.1186/cc7949; Li SJ, 2016, J TRAUMA ACUTE CARE, V80, P381, DOI 10.1097/TA.0000000000000935; Li SJ, 2015, J TRAUMA ACUTE CARE, V79, P78, DOI 10.1097/TA.0000000000000697; Li X, 2013, INFLAMMATION, V36, P1201, DOI 10.1007/s10753-013-9656-5; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Lukaszewicz AC, 2011, CURR OPIN ANESTHESIO, V24, P138, DOI 10.1097/ACO.0b013e32834458af; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P179, DOI 10.1007/978-3-7091-0693-8_30; Miller SJ, 1998, THROMB HAEMOSTASIS, V80, P481; Moxon-Emre I, 2011, J NEUROPATH EXP NEUR, V70, P218, DOI 10.1097/NEN.0b013e31820d94a5; Paschoa AF, 2016, J THROMB THROMBOLYS, V41, P636, DOI 10.1007/s11239-015-1261-z; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sen O, 2011, TURK NEUROSURG, V21, P203, DOI 10.5137/1019-5149.JTN.3646-10.1; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stutzmann JM, 2002, CNS DRUG REV, V8, P1; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Vestweber D, 2012, CURR OPIN HEMATOL, V19, P212, DOI 10.1097/MOH.0b013e3283523e78; Wahl F, 2000, J NEUROTRAUM, V17, P1055, DOI 10.1089/neu.2000.17.1055; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; WANG P, 1990, AM J PHYSIOL, V259, pR645; WANG P, 1993, J SURG RES, V54, P499, DOI 10.1006/jsre.1993.1077; Weber JR, 1997, J CEREBR BLOOD F MET, V17, P1221, DOI 10.1097/00004647-199711000-00011; Xie X, 1997, BRIT J PHARMACOL, V122, P906, DOI 10.1038/sj.bjp.0701454; Yanaka K, 1996, J NEUROSURG, V85, P1108, DOI 10.3171/jns.1996.85.6.1108; Yanaka K, 1996, J NEUROSURG, V85, P1102, DOI 10.3171/jns.1996.85.6.1102; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	48	13	15	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2016	81	6					1088	1094		10.1097/TA.0000000000001215			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	EE0BH	WOS:000389237900013	27533909	Green Accepted			2021-06-18	
J	Taubman, B; Rosen, F; McHugh, J; Grady, MF; Elci, OU				Taubman, Bruce; Rosen, Florence; McHugh, Jennifer; Grady, Matthew F.; Elci, Okan U.			The Timing of Cognitive and Physical Rest and Recovery in Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; cognitive rest; physical rest; recovery; management	SPORT-RELATED CONCUSSION; PROLONGED RECOVERY; STATEMENT; SYMPTOMS; SCALE	Immediate cognitive and physical rest in the concussed patient is almost universally recommended in the concussion literature. The authors conducted a prospective observational in a primary care pediatric office to examine the effect of delayed cognitive and physical rest had on recovery time in pediatric concussion. The authors found that patients who started cognitive and physical rest immediately after injury were more likely to recover within 30 days compared to patients who delayed cognitive and physical rest for 1-7 days after their injury (67% vs 35%, P = .016). Within the group of patients who recovered within 30 days those with immediate cognitive and physical rest recovered 4.6 days sooner than those with delayed cognitive and physical rest (10.29 +/- 5.83 vs 14.42 +/- 6.15 days, P = .005). These data support the recommendation that cognitive and physical rest should be implemented immediately after injury in concussed patients.	[Taubman, Bruce; Rosen, Florence; McHugh, Jennifer] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Gen Pediat,Advocare Cherry Hill P, 600 W Marlton Pike, Cherry Hill, NJ 08002 USA; [Grady, Matthew F.] Univ Penn, Childrens Hosp Philadelphia, Div Sports Med, Dept Surg,Perelman Sch Med, Cherry Hill, NJ USA; [Elci, Okan U.] Childrens Hosp Philadelphia, Westat Biostat & Management Core, Philadelphia, PA 19104 USA	Taubman, B (corresponding author), Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Gen Pediat,Advocare Cherry Hill P, 600 W Marlton Pike, Cherry Hill, NJ 08002 USA.	taubman@email.chop.edu	Taubman, Bruce/ABG-4612-2020	Taubman, Bruce/0000-0002-7976-1907			Burke MJ, 2014, BRAIN INJURY, V10, P1; Centers for Disease Control and Prevention, 2013, SPORTS CONC; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; DiFazio MP, 2012, PEDIATRICS; Eastman A, 2015, NEUROREHABILITATION, V37, P235, DOI 10.3233/NRE-151256; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Institute of Medicine and National Research Council, 2013, SPORTS REL CONC YOUT; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McAbee GN, 2015, J CHILD NEUROL, V30, P1378, DOI 10.1177/0883073814551794; McCrea M, 2014, PROG NEUROL SURG, V28, P112, DOI 10.1159/000358769; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Terrell TR, 2014, SOUTH MED J, V107, P115, DOI 10.1097/SMJ.0000000000000063; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	23	13	13	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2016	31	14					1555	1560		10.1177/0883073816664835			6	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	EB7DG	WOS:000387545600006	27581848				2021-06-18	
J	Vaiman, M; Sigal, T; Kimiagar, I; Bekerman, I				Vaiman, Michael; Sigal, Tal; Kimiagar, Itzhak; Bekerman, Inessa			Intracranial Pressure Assessment in Traumatic Head Injury with Hemorrhage Via Optic Nerve Sheath Diameter	JOURNAL OF NEUROTRAUMA			English	Article						CT scan; hematoma; intracranial pressure; optic nerve sheath diameter; traumatic head injury	BRAIN-INJURY; PERFUSION CT; ADULTS; TOMOGRAPHY; STROKE	Our purpose was to improve the technique of measuring optic nerve sheath diameter (ONSD) for intracranial pressure (ICP) monitoring in cases of traumatic head injury with hemorrhage. In a retrospective study, computed tomography (CT) data of 312 adult patients were collected and analyzed. ONSDs were measured at 3mm and 8-10mm distance from the globe together with the eyeball transverse diameter (ETD). The ONSD/ETD ratio was calculated. The correlation analysis was performed with gender, age, Glasgow Coma Scale score, and Glasgow Outcome Score. ONSD was enlarged in all cases when CT scans indicated hematoma. Enlarged right/left ONSDs were 6.5 +/- 1.5/6.4 +/- 1.3 mm at 3 mm and 6.6 +/- 0.8/6.6 +/- 0.6 mm at 8-10 mm from the globe (cut-off value >5.5 mm). ONSD/ETD ratio was 0.29 +/- 0.05, compared with 0.19 +/- 0.02 in healthy adults (p < 0.01). We did not find a correlation between ONSD/ETD ratio and initial Glasgow Coma Scale score, but there was an inverse correlation between ONSD/ETD ratio and Glasgow Outcome Score (r = -0.83). We conclude that in cases with a traumatic head injury with hemorrhage, the ONSD is significantly enlarged, indicating elevated ICP. In ICP assessment, the most accurate results can be obtained if the ONSD is measured 8-10 mm from the globe and the ONSD/ETD ratio is calculated.	[Vaiman, Michael] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Otolaryngol Head & Neck Surg, Tel Aviv, Israel; [Sigal, Tal; Bekerman, Inessa] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Radiol, Tel Aviv, Israel; [Kimiagar, Itzhak] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Neurol, Tel Aviv, Israel	Vaiman, M (corresponding author), 33 Shapiro St, IL-59561 Bat Yam, Israel.	vaimed@yahoo.com					Bekerman I, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/503645; Chauvet D, 2010, NEUROSURG REV, V33, P287, DOI 10.1007/s10143-010-0261-x; Chen H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0361-x; Cihangiroglu M, 2002, NEUROL RES, V24, P7, DOI 10.1179/016164102101199440; Eide PK, 2006, ACTA NEUROCHIR, V148, P1267, DOI 10.1007/s00701-006-0908-0; Giger-Tobler C, 2015, KLIN MONATSBL AUGENH, V232, P467, DOI 10.1055/s-0035-1545711; Granacher R, 2003, TRAUMATIC BRAIN INJU; Kalra MK, 2006, RADIOLOGY, V241, P657, DOI 10.1148/radiol.2413060102; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masquere P, 2013, CRIT CARE, V17, DOI 10.1186/cc12728; Osborn AG, 2004, DIAGNOSTIC IMAGING B, pI6; Smith WS, 2003, AM J NEURORADIOL, V24, P688; Vaiman M, 2015, INT J OPHTHALMOL-CHI, V8, P1240, DOI 10.3980/j.issn.2222-3959.2015.06.30; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Wintermark M, 2005, AM J NEURORADIOL, V26, P104; Zimmerman R. A., 1999, CRANIAL MRI AND CT	21	13	13	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2147	2153		10.1089/neu.2015.4293			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800010	27048793				2021-06-18	
J	Konczalla, J; Wanderer, S; Mrosek, J; Gueresir, E; Schuss, P; Platz, J; Seifert, V; Vatter, H				Konczalla, Juergen; Wanderer, Stefan; Mrosek, Jan; Gueresir, Erdem; Schuss, Patrick; Platz, Johannes; Seifert, Volker; Vatter, Hartmut			Levosimendan, a new therapeutic approach to prevent delayed cerebral vasospasm after subarachnoid hemorrhage?	ACTA NEUROCHIRURGICA			English	Article						Levosimendan; dCVS; Delayed cerebral vasospasm; Takotsubo cardiomyopathy; Subarachnoid hemorrhage; SAH; ET-(A) receptor; ET-(B-1) receptor; ET-1; Endothelin; Prostaglandin F2alpha; PGF	ENDOTHELIN-B RECEPTORS; CEREBROSPINAL-FLUID; REPERFUSION INJURY; CARDIOGENIC-SHOCK; BASILAR ARTERY; BRAIN-INJURY; SPINAL-CORD; IN-VITRO; RAT; ISCHEMIA	Under physiological cerebral conditions, levosimendan, a calcium-channel sensitizer, has a dose-dependent antagonistic effect on prostaglandin F2alpha (PGF)-induced vasoconstriction. This circumstance could be used in antagonizing delayed cerebral vasospasm (dCVS), one of the main complications after subarachnoid hemorrhage (SAH), leading to delayed cerebral ischemia and ischemic neurological deficits. Data already exist that identified neuroprotective effects of levosimendan in a traumatic brain injury model and additionally, it has been proven that this compound prevents narrowing of the basilar artery (BA) luminal area after SAH in an in vitro rabbit model. Takotsubo cardiomyopathy, a severe ventricular dysfunction, is also a well-known complication after SAH, associated with pulmonary edema and prolonged intubation. The polypeptide endothelin-1 (ET-1) plays a key role in the development of dCVS after SAH. Therefore, the aim of the present investigation was to detect functional interactions between the calcium-sensitizing and the ET-1-dependent vasoconstriction after experimental-induced SAH; interactions between levosimendan and a substrate-specific vasorelaxation in the BA were also examined. It was reviewed whether levosimendan has a beneficial influence on endothelin(A) and/or endothelin(B-1) receptors (ET-(A) and ET-(B-1) receptors) in cerebral vessels after SAH. We also examined whether this drug could have antagonistic effects on a PGF-induced vasoconstriction. Under treatment with levosimendan after SAH, the endothelin system seems to be affected. The ET-1-induced contraction is decreased, not significantly. In addition, we detected changes in the nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway. Preincubation with levosimendan causes a modulatory effect on the ET-(B-1) receptor-dependent vasorelaxation. It induces an upregulation of the NO-cGMP pathway with a significantly increased relaxation. Even after PGF-induced precontraction a dose-dependent relaxation was registered, which was significantly higher (E-max) and earlier (pD(2)) compared to the concentration-effect curve without levosimendan. After experimental-induced dCVS, levosimendan seems to restore the well-known impaired function of the vasorelaxant ET-(B-1) receptor. Levosimendan also reversed the PGF-induced contraction dose-dependently. Both of these mechanisms could be used for antagonizing dCVS in patients suffering SAH. Levosimendan could even be used additionally in treating patients developing takotsubo cardiomyopathy.	[Konczalla, Juergen; Mrosek, Jan; Platz, Johannes; Seifert, Volker] Goethe Univ Frankfurt, Dept Neurosurg, Frankfurt, Germany; [Wanderer, Stefan] Inselspital Univ Hosp Bern, Dept Neurosurg, Freiburgstr 4, CH-3010 Bern, Switzerland; [Gueresir, Erdem; Schuss, Patrick; Vatter, Hartmut] Univ Bonn, Dept Neurosurg, Bonn, Germany	Wanderer, S (corresponding author), Inselspital Univ Hosp Bern, Dept Neurosurg, Freiburgstr 4, CH-3010 Bern, Switzerland.	stefan.wanderer@insel.ch	Schuss, Patrick/ABC-6469-2020; Konczalla, Juergen/AAJ-8528-2021; guresir, erdem/AAL-4484-2020	Schuss, Patrick/0000-0002-5806-2576; Konczalla, Juergen/0000-0001-9771-7806; guresir, erdem/0000-0002-6624-6885; Guresir, Erdem/0000-0001-8319-0847			Antonini M, 2010, ACTA ANAESTH SCAND, V54, P119, DOI 10.1111/j.1399-6576.2009.02105.x; Archan S, 2008, CURR OPIN ANESTHESIO, V21, P78, DOI 10.1097/ACO.0b013e3282f357a5; Asaeda M, 2005, NEUROSCI LETT, V373, P222, DOI 10.1016/j.neulet.2004.10.008; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Busani S, 2010, J TRAUMA, V68, pE108, DOI 10.1097/TA.0b013e31817c4284; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Dreier JP, 2013, ACTA NEUROCHIR SUPPL, V115, P125, DOI 10.1007/978-3-7091-1192-5_26; Figgitt DP, 2001, DRUGS, V61, P613, DOI 10.2165/00003495-200161050-00006; Fujii M, 2013, TRANSL STROKE RES, V4, P432, DOI 10.1007/s12975-013-0257-2; Guresir E, 2013, J NEUROL SCI, V332, P128, DOI 10.1016/j.jns.2013.07.004; Hansen-Schwartz J, 2004, ACTA NEUROL SCAND, V109, P33, DOI 10.1034/j.1600-0404.2003.00170.x; Hein M, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-106; Jensen H, 2011, SCAND CARDIOVASC J, V45, P307, DOI 10.3109/14017431.2011.583356; Karakus E, 2013, BASIC CLIN PHARMACOL, V112, P156, DOI 10.1111/bcpt.12004; Karvouniaris M, 2012, AM J EMERG MED, V30, DOI 10.1016/j.ajem.2011.02.030; KASSELL NF, 1990, J NEUROSURG, V73, P18, DOI 10.3171/jns.1990.73.1.0018; KASSELL NF, 1982, NEUROSURGERY, V11, P337, DOI 10.1227/00006123-198209000-00001; Katircioglu SF, 2008, J CARDIAC SURG, V23, P44, DOI 10.1111/j.1540-8191.2007.00486.x; KITAZONO T, 1995, J PHARMACOL EXP THER, V273, P1; Konczalla J, 2006, EXP BIOL MED, V231, P1064; Konczalla J, 2016, WORLD NEUROSURG, V88, P488, DOI 10.1016/j.wneu.2015.10.033; Konczalla J, 2013, CURR NEUROVASC RES, V10, P335, DOI 10.2174/15672026113109990030; Konczalla J, 2013, CURR NEUROVASC RES, V10, P126, DOI 10.2174/1567202611310020005; Koskinen LOD, 2009, ACTA NEUROCHIR, V151, P595, DOI 10.1007/s00701-009-0295-4; Lafci B, 2008, EUR SURG RES, V41, P1, DOI 10.1159/000121394; Mayer SA, 1999, STROKE, V30, P780, DOI 10.1161/01.STR.30.4.780; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; Nilsson T, 1997, NEUROSURGERY, V40, P346, DOI 10.1097/00006123-199702000-00023; Padayachee L, 2007, HEART LUNG CIRC S3, V16, P65; Papanikolaou J, 2014, INT J CARDIOL, V176, P1435, DOI 10.1016/j.ijcard.2014.08.039; Provencio JJ, 2013, ACTA NEUROCHIR SUPPL, V115, P233, DOI 10.1007/978-3-7091-1192-5_42; Roehl AB, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-81; Roehl AB, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-97; SALOM JB, 1995, CEREBROVAS BRAIN MET, V7, P131; Santoro F, 2013, CARDIOVASC THER, V31, pE133, DOI 10.1111/1755-5922.12047; SCHILLING L, 1995, J CEREBR BLOOD F MET, V15, P699, DOI 10.1038/jcbfm.1995.86; SEIFERT V, 1995, J NEUROSURG, V82, P55, DOI 10.3171/jns.1995.82.1.0055; SEIFERT V, 1987, SURG NEUROL, V27, P243, DOI 10.1016/0090-3019(87)90037-1; Taccone FS, 2013, INTENS CARE MED, V39, P1497, DOI 10.1007/s00134-013-2945-5; Tung P, 2004, STROKE, V35, P548, DOI 10.1161/01.STR.0000114874.96688.54; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66; Vatter H, 2002, NEUROSURGERY, V51, P445, DOI 10.1097/00006123-200208000-00027; Vatter H, 2007, J NEUROSURG, V107, P121, DOI 10.3171/JNS-07/07/0121; Vatter H, 2007, NEUROSURGERY, V60, P1100, DOI 10.1227/01.NEU.0000255471.75752.4B; Vatter H, 2011, ACTA NEUROCHIR SUPPL, V110, P177, DOI 10.1007/978-3-7091-0353-1_31	45	13	15	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	NOV	2016	158	11					2075	2083		10.1007/s00701-016-2939-5			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EA1OR	WOS:000386362200008	27614436				2021-06-18	
J	Pfaller, AY; Nelson, LD; Apps, JN; Walter, KD; McCrea, MA				Pfaller, Adam Y.; Nelson, Lindsay D.; Apps, Jennifer N.; Walter, Kevin D.; McCrea, Michael A.			Frequency and Outcomes of a Symptom-Free Waiting Period After Sport-Related Concussion	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussion; sports; head injury; mild traumatic brain injury; symptom-free waiting period; clinical management	INTERNATIONAL-CONFERENCE; STANDARDIZED ASSESSMENT; CONSENSUS STATEMENT; HEAD-INJURY; HIGH-SCHOOL; FOOTBALL; MANAGEMENT; PLAYERS; ZURICH	Background: Guidelines and practices for the management of sport-related concussion (SRC) have evolved swiftly over the past 2 decades. Despite common recommendations for a symptom-free waiting period (SFWP) before returning to sport, past reports have suggested poor utilization rates for this intervention. Purpose: To obtain current estimates of the utilization and characterization of SFWPs with high school and collegiate athletes. Study Design: Descriptive epidemiology study. Methods: Data were extracted from a larger prospective study that followed athletes with SRC across 13 institutions in southeastern Wisconsin from 2012 to 2014. Participants included 143 contact and collision sport athletes who were followed serially through their recoveries after SRCs. Results: In the current study sample, 99.3% of athletes used an SFWP. The mean self-reported symptom duration was 6.35 days (median, 5 days), with 72.7% reporting symptom recovery within 1 week of injury, 93.7% within 2 weeks, and 99.3% within 30 days. Rate of same-season repeat concussion was low (3.8%) and was similar to or lower than the overall rate of concussion (4.3%). Five same-season repeat concussions occurred at a range of 8 to 42 days after initial injuries. Conclusion: In comparison with prior published data collected from 1999 to 2004, utilization and duration of SFWPs were higher in the current study samples (99.3% vs 60.3% of athletes reported an SFWP; mean duration, 6.1 vs 3.2 days), and athletes were withheld from sports for more days than previously reported (12.3 vs 7.4 days). Rate of same-season repeat concussion was equivalent to that of prior published data. The findings support improved adherence to clinical management guidelines through increased utilization of SFWPs after SRC.	[Pfaller, Adam Y.; Nelson, Lindsay D.; Apps, Jennifer N.; Walter, Kevin D.; McCrea, Michael A.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Pfaller, Adam Y.; Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Apps, Jennifer N.] Med Coll Wisconsin, Dept Psychiat & Behav Med, Milwaukee, WI 53226 USA; [Walter, Kevin D.] Med Coll Wisconsin, Dept Orthopaed Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Walter, Kevin D.] Childrens Hosp Wisconsin, Dept Pediat & Adolescent Sports Med, Milwaukee, WI 53201 USA	Pfaller, AY (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 8701 West Watertown Plank Rd, Milwaukee, WI 53226 USA.	apfaller@mcw.edu			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-12-1-0004]; Clinical and Translational Science Institute [1ULI-RR031973 (-01)]; National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [8ULITR000055]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: This work was supported by the US Army Medical Research and Materiel Command (award No. W81XWH-12-1-0004). The REDCap electronic database service used for the study was supported by the Clinical and Translational Science Institute (grant 1ULI-RR031973 (-01)) and by the National Center for Advancing Translational Sciences, National Institutes of Health (grant 8ULITR000055).	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Colorado Medical Society School and Sports Medicine Committee, 1990, COLO MED, V87, P4; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Helmick K, 2006, DEFENSE VETERANS BRA, P1; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Kelly JP, 1997, NEUROLOGY, V48, P581; LaRoche AA, 2016, CLIN J SPORT MED, V26, P33, DOI 10.1097/JSM.0000000000000192; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; National Collegiate Athletic Association, CONC GUID DIAGN MAN; National Federation of State High School Associations, REP JUL 2014 NFHS CO; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wisconsin Interscholastic Athletic Association, WIAA CONC POL	29	13	13	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2016	44	11					2941	2946		10.1177/0363546516651821			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	EB4RE	WOS:000387359900007	27371548	Green Accepted			2021-06-18	
J	Ransom, DM; Burns, AR; Youngstrom, EA; Vaughan, CG; Sady, MD; Gioia, GA				Ransom, Danielle M.; Burns, Alison R.; Youngstrom, Eric A.; Vaughan, Christopher G.; Sady, Maegan D.; Gioia, Gerard A.			Applying an Evidence-Based Assessment Model to Identify Students at Risk for Perceived Academic Problems following Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injury; Post-concussion symptoms; Pediatrics; Receiver operating characteristic; Academics; Evidence based practice	TRAUMATIC BRAIN-INJURY; CHILDREN; ADOLESCENTS; PSYCHOLOGY; MANAGEMENT; INVENTORY; IMPACT; SPORT; SPEED; ROC	Objectives: The aim of this study was to demonstrate the utility of an evidence-based assessment (EBA) model to establish a multimodal set of tools for identifying students at risk for perceived post-injury academic problems. Methods: Participants included 142 students diagnosed with concussion (age: M=14.95; SD=1.80; 59% male), evaluated within 4 weeks of injury (median=16 days). Demographics, pre-injury history, self- and parent-report measures assessing symptom severity and executive functions, and cognitive test performance were examined as predictors of self-reported post-injury academic problems. Results: Latent class analysis categorized participants into high (44%) and low (56%) levels of self-reported academic problems. Receiver operating characteristic analyses revealed significant discriminative validity for self- and parent-reported symptom severity and executive dysfunction and self-reported exertional response for identifying students reporting low versus high academic problems. Parent-reported symptom ratings [area under the receiver operating characteristic curve (AUC)=.79] and executive dysfunction (AUC=.74), and self-reported ratings of executive dysfunction (AUC=.84), symptoms (AUC=.80), and exertional response (AUC=.70) each classified students significantly better than chance (ps<.001). Hierarchical logistic regression indicated that, of the above, self-reported symptoms and executive dysfunction accounted for the most variance in the prediction of self-reported academic problems. Conclusions: Post-concussion symptom severity and executive dysfunction significantly predict perceived post-injury academic problems. EBA modeling identified the strongest set of predictors of academic challenges, offering an important perspective in the management of concussion by applying traditional strengths of neuropsychological assessment to clinical decision making.	[Ransom, Danielle M.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Burns, Alison R.; Vaughan, Christopher G.; Sady, Maegan D.; Gioia, Gerard A.] Childrens Natl Hlth Syst, Washington, DC USA; [Burns, Alison R.; Vaughan, Christopher G.; Sady, Maegan D.; Gioia, Gerard A.] George Washington Univ, Sch Med, Washington, DC USA; [Youngstrom, Eric A.] Univ N Carolina, Chapel Hill, NC USA	Gioia, GA (corresponding author), Childrens Natl Med Ctr, Div Neuropsychol, 15425 Shady Grove Rd,Suite 350, Rockville, MD 20850 USA.	ggioia@childrensnational.org	Youngstrom, Eric A./ABE-3258-2020	Youngstrom, Eric A./0000-0003-2251-6860	Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC) [P30HD040677]; Clinical and Translational Science Award [UL1TR000075]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000075] Funding Source: NIH RePORTER	This work was supported by the Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC; P30HD040677) and the Clinical and Translational Science Award (UL1TR000075).	Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Centers for Disease Control and Prevention, 2015, WHAT AR SIGNS SYMPT; Chelune GJ, 2010, CLIN NEUROPSYCHOL, V24, P454, DOI 10.1080/13854040802360574; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Evidence-Based Medicine Working Group, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI DOI 10.1001/JAMA.1992.03490170092032; Findling RL, 2013, BIPOLAR DISORD, V15, P669, DOI 10.1111/bdi.12100; Gioia G. A., 2014, J CHILD NEUROL; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Hagenaars JA, 2002, APPL LATENT CLASS AN; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hunsley J, 2007, ANNU REV CLIN PSYCHO, V3, P29, DOI 10.1146/annurev.clinpsy.3.022806.091419; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Kraemer H.C., 1992, EVALUATING MED TESTS; Kraemer HC, 1999, PSYCHOL METHODS, V4, P257, DOI 10.1037/1082-989X.4.3.257; Lovell MR., 2000, IMPACT IMMEDIATE POS; Magidson, 2005, LATENT GOLD CHOICE 4; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCutcheon A., 1987, LATENT CLASS ANAL; McGill C., 2011, J INT NEUROPSYCH SOC, V17, P297; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Newman JB, 2013, CLIN NEUROPSYCHOL, V27, P779, DOI 10.1080/13854046.2013.789552; Pepe MS., 2004, STAT EVALUATION MED; R Core Team, 2013, R LANG ENV STAT COMP; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Sady MD, 2013, J INT NEUROPSYCH SOC, V19, P194, DOI DOI 10.1017/S1355617713000362; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Straus S.E., 2011, EVIDENCE BASED MED P; Venkatraman ES, 1996, BIOMETRIKA, V83, P835, DOI 10.1093/biomet/83.4.835; Youngstrom E, 2006, DEV PSYCHOPATHOL, V18, P989, DOI 10.1017/S0954579406060494; Youngstrom EA, 2014, J PEDIATR PSYCHOL, V39, P204, DOI 10.1093/jpepsy/jst062; Youngstrom EA, 2013, J CLIN CHILD ADOLESC, V42, P139, DOI 10.1080/15374416.2012.736358; Zhou X.-H., 2002, STAT METHODS DIAGNOS	37	13	13	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	NOV	2016	22	10			SI		1038	1049		10.1017/S1355617716000916			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Neurosciences & Neurology; Psychiatry; Psychology	EF4WM	WOS:000390332700009	27903334				2021-06-18	
J	Sun, GZ; Yagmurlu, K; Belykh, E; Lei, T; Preul, MC				Sun, Guozhu; Yagmurlu, Kaan; Belykh, Evgenii; Lei, Ting; Preul, Mark C.			Management Strategy of a Transorbital Penetrating Pontine Injury by a Wooden Chopstick	WORLD NEUROSURGERY			English	Article						Foreign object; Penetrating orbitocranial injury; Pontine injury; Traumatic brain injury	BRAIN-STEM INJURY; ORBITOCRANIAL INJURY; SURGICAL-MANAGEMENT; INTRACRANIAL INJURY	BACKGROUND: Transorbital penetrating pontine injuries from small spear-like objects, which are extremely rare, provide neurosurgeons with life-threatening and challenging conditions to manage. CASE DESCRIPTION: We present an unusual case of transorbital penetrating pontine injury and discuss imaging, diagnosis, management strategy, and anatomy-injury correlation. A 23-year-old man sustained a penetrating cranial injury from a bamboo chopstick that extended from the right orbit to the pons and cerebellum. Using a frontotemporal approach, we successfully removed the chopstick. Follow-up studies confirmed a good outcome. CONCLUSIONS: Preoperative imaging, correct diagnosis, and surgical treatment are necessary to manage transorbital penetrating pontine injuries caused by spear-like objects, with specific attention paid to effective exposure and inventive means with total removal of the foreign object without causing further injury. A trajectory through the superior orbital fissure and paralateral to the cavernous sinus and into the pons seems to be the most prevalent and influences management of removal and injuries.	[Sun, Guozhu] Hebei Med Univ, Hosp 2, Dept Neurosurg, Shijiazhuang, Hebei, Peoples R China; [Sun, Guozhu; Yagmurlu, Kaan; Belykh, Evgenii; Lei, Ting; Preul, Mark C.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Belykh, Evgenii] Irkutsk State Med Univ, Dept Neurosurg, Irkutsk, Russia	Preul, MC (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.	Neuropub@dignityhealth.org	; Belykh, Evgenii/O-8279-2017	YAGMURLU, KAAN/0000-0002-7635-2809; Belykh, Evgenii/0000-0003-2060-5739			Arslan M, 2012, J NEUROSCI RURAL PRA, V3, P178, DOI 10.4103/0976-3147.98228; Cavalcanti DD, 2016, J NEUROSURG, V124, P1359, DOI 10.3171/2015.4.JNS141945; Cosan TE, 2006, EUR ARCH OTO-RHINO-L, V263, P327, DOI 10.1007/s00405-005-1009-z; de Andrade AF, 2006, J NEUROSURG, V104, P853, DOI 10.3171/jns.2006.104.5.853; Fezza J, 1999, OPHTHALMIC PLAST REC, V15, P366, DOI 10.1097/00002341-199909000-00012; GUNENC U, 1992, DOC OPHTHALMOL, V81, P369; Gupta SK, 2012, J NEUROSURG-PEDIATR, V9, P103, DOI 10.3171/2011.10.PEDS11230; HANSEN JE, 1988, J NEUROSURG, V68, P752, DOI 10.3171/jns.1988.68.5.0752; HUNGERFORD J, 1982, J NEUROL NEUROSUR PS, V45, P1072, DOI 10.1136/jnnp.45.11.1072-a; ILDAN F, 1994, J TRAUMA, V36, P116, DOI 10.1097/00005373-199401000-00020; Kadota K, 1988, Neurol Med Chir (Tokyo), V28, P1128, DOI 10.2176/nmc.28.1128; Kahler RJ, 1998, NEUROSURGERY, V42, P1370, DOI 10.1097/00006123-199806000-00108; Kaneko-Ohtaki A, 2011, CLIN OPHTHALMOL, V5, P927, DOI 10.2147/OPTH.S22821; Kitakami A, 1999, NEUROL MED-CHIR, V39, P150, DOI 10.2176/nmc.39.150; Lasky JB, 1997, J TRAUMA, V42, P555, DOI 10.1097/00005373-199703000-00030; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; Matsumoto S, 1998, AM J NEURORADIOL, V19, P1163; Matsuyama T, 2001, NEUROL MED-CHIR, V41, P345, DOI 10.2176/nmc.41.345; Mitilian D, 2009, ACTA NEUROCHIR, V151, P1295, DOI 10.1007/s00701-009-0418-y; Mzimbiri JM, 2016, NEUROSURGERY, V78, pE753, DOI 10.1227/NEU.0000000000001198; Paiva WS, 2012, BRIT J NEUROSURG, V26, P779, DOI 10.3109/02688697.2012.655809; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Quinn LM, 2006, ARCH OPHTHALMOL-CHIC, V124, P915, DOI 10.1001/archopht.124.6.915; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Shin TH, 2012, J KOREAN NEUROSURG S, V52, P414, DOI 10.3340/jkns.2012.52.4.414; Teymoorian S, 2012, J NEUROIMAGING, V22, P201, DOI 10.1111/j.1552-6569.2010.00519.x; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; Xu FF, 2013, BRAIN INJURY, V27, P951, DOI 10.3109/02699052.2013.775502; Yagmurlu K., 2014, NEUROSURGERY S4, V10, P619; Yagmurlu K, 2014, OPER NEUROSURG, V10, P602, DOI 10.1227/NEU.0000000000000466	30	13	14	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	NOV	2016	95								6220000000	10.1016/j.wneu.2016.07.104			9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EF5EZ	WOS:000390354800115	27506405				2021-06-18	
J	Towns, SJ; Zeitzer, J; Kamper, J; Holcomb, E; Silva, MA; Schwartz, DJ; Nakase-Richardson, R				Towns, Stephanie J.; Zeitzer, Jamie; Kamper, Joel; Holcomb, Erin; Silva, Marc A.; Schwartz, Daniel J.; Nakase-Richardson, Risa			Implementation of Actigraphy in Acute Traumatic Brain Injury (TBI) Neurorehabilitation Admissions: A Veterans Administration TBI Model Systems Feasibility Study	PM&R			English	Article							SLEEP DISTURBANCES; PREVALENCE; CARE; REHABILITATION; PARAMETERS; DISORDERS; FATIGUE; BATTERY	Background: Sleep problems and disorders are prevalent in patients with traumatic brain injury (TBI) and are associated with negative outcomes. Incidence varies because of challenges including differences in assessment methods, particularly in the acute stages of recovery when patients are cognitively impaired and unable to complete traditional self-report methods. Actigraphy (ACG) recently has been validated in the acute TBI rehabilitation setting and may serve as a superior method of assessing sleep wake patterns at this stage of recovery. Although a few studies with small sample sizes have described the use of ACG, none have described feasibility and implementation protocols. Objective: To describe the feasibility and implementation protocol of ACG to evaluate sleep-wake patterns and white-light exposure data in patients with acute TBI during inpatient rehabilitation. Sleep-wake patterns and light exposure data are presented to characterize the sample using these methods to inform future research. Design: Retrospective study. Setting: Acute inpatient rehabilitation unit at a Veterans' Affairs Polytrauma Rehabilitation Center. Participants: Veterans (age >= 18 years) admitted to inpatient rehabilitation and enrolled in the Traumatic Brain Injury Model Systems study who were admitted and discharged in the calendar year 2013. Methods: Veterans underwent actigraph watch placement as soon as possible after admission. Records from the calendar year 2013 were reviewed to determine the number of admissions that met study criteria and what percentage of those patients had 3 days of continuous ACG data collected. The barriers to successful watch placement in this population were reviewed. Average sleep, light, and wake data from available records were collected for the study sample. Main Outcome Measurements: Percentage of patients who met study criteria and who had 72 hours of continuous ACG data collected. The barriers to successful watch placement in this population were reviewed. Average sleep, light, and wake data from available records were collected. Results: Of 22 eligible Traumatic Brain Injury Model Systems admissions, 3 consecutive nights of ACG data were successfully obtained for 86% (n = 19) of the sample. Barriers to data collection included patient access due to abbreviated lengths of stay, staff availability for ACG placement, and data collection protocols to prevent loss of data in Veterans' Affairs computing systems. Conclusions: ACG is feasible for collecting data about sleep, wake, and light exposure in patients who are in acute TBI inpatient rehabilitation settings.	[Towns, Stephanie J.; Kamper, Joel; Holcomb, Erin; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA; [Zeitzer, Jamie] Stanford Univ, Stanford Ctr Sleep Sci & Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Zeitzer, Jamie] VA Palo Alto Hlth Care Syst, Mental Illness Res Educ & Clin Ctr, Palo Alto, CA USA; [Silva, Marc A.; Nakase-Richardson, Risa] DVBIC, Tampa, FL 33620 USA; [Schwartz, Daniel J.] James A Haley Vet Hosp, Dept Med, Tampa, FL 33612 USA; [Schwartz, Daniel J.; Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL 33620 USA; [Nakase-Richardson, Risa] HSR&D Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL 33620 USA	Nakase-Richardson, R (corresponding author), James A Haley Vet Hosp, Polytrauma Mail Code 117,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.; Nakase-Richardson, R (corresponding author), DVBIC, Tampa, FL 33620 USA.; Nakase-Richardson, R (corresponding author), Univ S Florida, Dept Med, Tampa, FL 33620 USA.; Nakase-Richardson, R (corresponding author), HSR&D Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL 33620 USA.	risa.richardson@va.gov	Zeitzer, Jamie M/A-1168-2007; Zeitzer, Jamie/AAO-2103-2020; Kamper, Joel/V-2450-2019; Towns, Stephanie/AAF-2035-2020; Silva, Marc A./J-1874-2019	Zeitzer, Jamie M/0000-0001-6174-5282; Zeitzer, Jamie/0000-0001-6174-5282; Kamper, Joel/0000-0001-5098-5176; Silva, Marc A./0000-0002-3879-6054	General Dynamics Information Technology [W91YTZ-13-C-0015]; Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC) [W91YTZ-13-C-0015]; Veterans Affairs Health Services Research and Development Grant Center of Innovation on Disability Rehabilitation and Research [1 I50 HX001233-01]	grant, General Dynamics Information Technology (money to institution); grant, General Dynamics Information Technology W91YTZ-13-C-0015 (money to institution); The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions(W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), Veterans Affairs Health Services Research and Development Grant Center of Innovation on Disability Rehabilitation and Research (1 I50 HX001233-01).	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Attarian HP, 2004, ARCH NEUROL-CHICAGO, V61, P525, DOI 10.1001/archneur.61.4.525; Baker FC, 1999, J PSYCHOSOM RES, V47, P335, DOI 10.1016/S0022-3999(99)00017-3; Berger AM, 2008, J PAIN SYMPTOM MANAG, V36, P191, DOI 10.1016/j.jpainsymman.2007.10.008; Cellini N, 2013, CHRONOBIOL INT, V30, P691, DOI 10.3109/07420528.2013.782312; COHEN M, 1992, J NEUROL NEUROSUR PS, V55, P313, DOI 10.1136/jnnp.55.4.313; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Cruse D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-18; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hylkema T, 2009, J INTELL DISABIL RES, V53, P695, DOI 10.1111/j.1365-2788.2009.01177.x; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kamper J, 2015, P INT NEUR SOC ANN C; Kamper JE, 2016, J HEAD TRAUMA REHAB, V31, P117, DOI 10.1097/HTR.0000000000000215; Kushida CA, 2001, SLEEP MED, V2, P389, DOI 10.1016/S1389-9457(00)00098-8; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Littner M, 2003, SLEEP, V26, P337, DOI 10.1093/sleep/26.3.337; Makley MJ, 2008, NEUROREHAB NEURAL RE, V22, P341, DOI 10.1177/1545968308315598; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Meadows R, 2010, CHRONOBIOL INT, V27, P842, DOI 10.3109/07420521003797732; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Morgenthaler T, 2007, SLEEP, V30, P519, DOI 10.1093/sleep/30.4.519; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Okifuji A, 2011, CLIN J PAIN, V27, P289, DOI 10.1097/AJP.0b013e31820485db; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Rao V, 2008, BRAIN INJURY, V22, P381, DOI 10.1080/02699050801935260; Richardson A, 2007, J CLIN NURS, V16, P1660, DOI 10.1111/j.1365-2702.2005.01546.x; Spivak E, 2007, SPINAL CORD, V45, P765, DOI 10.1038/sj.sc.3102040; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x; Zinkhan M, 2014, SLEEP MED, V15, P1107, DOI 10.1016/j.sleep.2014.04.015; Zoltman FS, 2010, BRAIN INJURY, V24, P748	34	13	13	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	NOV	2016	8	11					1046	1054		10.1016/j.pmrj.2016.04.005			9	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	ED0SX	WOS:000388553300003	27178377				2021-06-18	
J	Alhourani, A; Wozny, TA; Krishnaswamy, D; Pathak, S; Walls, SA; Ghuman, AS; Krieger, DN; Okonkwo, DO; Richardson, RM; Niranjan, A				Alhourani, Ahmad; Wozny, Thomas A.; Krishnaswamy, Deepa; Pathak, Sudhir; Walls, Shawn A.; Ghuman, Avniel S.; Krieger, Donald N.; Okonkwo, David O.; Richardson, R. Mark; Niranjan, Ajay			Magnetoencephalography-based identification of functional connectivity network disruption following mild traumatic brain injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						traumatic brain injury; magnetoencephalography; functional connectivity; resting-state analysis; graph theory; default mode network; concussion; phase locking value	DEFAULT-MODE NETWORK; GRAPH-THEORETICAL ANALYSIS; RESTING-STATE; DELTA WAVES; MEG; EEG; DISEASE; ELECTROENCEPHALOGRAPHY; COMPLAINTS	Mild traumatic brain injury (mTBI) leads to long-term cognitive sequelae in a significant portion of patients. Disruption of normal neural communication across functional brain networks may explain the deficits in memory and attention observed after mTBI. In this study, we used magnetoencephalography (MEG) to examine functional connectivity during a resting state in a group of mTBI subjects (n = 9) compared with age-matched control subjects (n = 15). We adopted a data-driven, exploratory analysis in source space using phase locking value across different frequency bands. We observed a significant reduction in functional connectivity in band-specific networks in mTBI compared with control subjects. These networks spanned multiple cortical regions involved in the default mode network (DMN). The DMN is thought to subserve memory and attention during periods when an individual is not engaged in a specific task, and its disruption may lead to cognitive deficits after mTBI. We further applied graph theoretical analysis on the functional connectivity matrices. Our data suggest reduced local efficiency in different brain regions in mTBI patients. In conclusion, MEG can be a potential tool to investigate and detect network alterations in patients with mTBI. The value of MEG to reveal potential neurophysiological biomarkers for mTBI patients warrants further exploration.	[Alhourani, Ahmad; Wozny, Thomas A.; Ghuman, Avniel S.; Krieger, Donald N.; Okonkwo, David O.; Richardson, R. Mark; Niranjan, Ajay] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Krishnaswamy, Deepa; Pathak, Sudhir; Ghuman, Avniel S.; Richardson, R. Mark] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Ghuman, Avniel S.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Ghuman, Avniel S.; Richardson, R. Mark] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Ghuman, Avniel S.; Richardson, R. Mark] Univ Pittsburgh, Inst Brain, Pittsburgh, PA USA; [Walls, Shawn A.] Univ Pittsburgh, Med Ctr, Brain Mapping Ctr, Pittsburgh, PA USA	Niranjan, A (corresponding author), Univ Pittsburgh, Dept Neurosurg, UPMC Presbyterian, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	niranjana@upmc.edu		alhourani, ahmad/0000-0002-3523-6131; Ghuman, Avniel/0000-0003-1746-4656			Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Ghuman AS, 2011, NEUROIMAGE, V56, P69, DOI 10.1016/j.neuroimage.2011.01.046; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Kida T, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00713; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; van Dellen E, 2014, ANESTHESIOLOGY, V121, P328, DOI 10.1097/ALN.0000000000000329; van Dellen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050122; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	56	13	14	0	12	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	OCT	2016	116	4					1840	1847		10.1152/jn.00513.2016			8	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	EA7RC	WOS:000386828400028	27466136	Green Published, Bronze			2021-06-18	
J	Gardner, EC; Chan, WW; Sutton, KM; Blaine, TA				Gardner, Elizabeth C.; Chan, Wayne W.; Sutton, Karen M.; Blaine, Theodore A.			Shoulder Injuries in Men's Collegiate Lacrosse, 2004-2009	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						lacrosse; shoulder; injury prevention; epidemiology	SURVEILLANCE SYSTEM; HIGH-SCHOOL; UNITED-STATES; EPIDEMIOLOGY; CONCUSSIONS; PREVENTION; SOCCER; GIRLS; BOYS; HEAD	Background: Men's lacrosse has been one of the fastest growing team sports in the United States, at both the collegiate and high school levels. Uniquely, it combines both continuous overhead and contact activity. Thus, an understanding of its injury epidemiology and mechanisms is vital. Shoulder injuries have been shown to be common in the sport, but thus far there has been no dedicated analysis of these injuries with which to better inform injury prevention strategies. Study Design: Descriptive epidemiology study. Methods: All athlete exposures (AEs) and shoulder injuries reported to the National Collegiate Athletic Association (NCAA) Injury Surveillance System for intercollegiate men's lacrosse athletes from 2004-2005 through 2008-2009 were collected. Type of injury was documented and the injury incidence per 1000 AEs was calculated. Event type, injury mechanism, specific injury, outcome, and time lost were recorded. Statistical analysis was performed using 95% CIs, calculated based on a normal approximation to Poisson distribution. Results: There were a total of 124 observed shoulder injuries during 229,591 monitored AEs. With weights, this estimates 1707 shoulder injuries over 2,873,973 AEs, for an incidence of 0.59 per 1000 AEs (95% CI, 0.56-0.62). The incidence of shoulder injury during competition was 1.89 per 1000 AEs (95% CI, 1.76-2.02), compared with 0.35 per 1000 AEs (95% CI, 0.33-0.38) during practice. Acromioclavicular joint injuries were most common (0.29 per 1000 AEs; 95% CI, 0.27-0.31). Labral injuries and instability events were also frequent (0.11 per 1000 AEs; 95% CI, 0.10-0.13). Player-to-player contact caused 57% of all shoulder injuries, with 25% due to contact with the playing surface. The average time lost was 11.0 days, with 41.9% of all shoulder injuries requiring 10 days. Clavicle fractures and posterior shoulder dislocation were particularly severe, with no athletes returning to play during the same season. Conclusion: Shoulder injuries are common in NCAA men's lacrosse and are an important source of lost playing time. Acromioclavicular injuries were the most frequent injury in this series, but labral and instability injuries were also common. In this increasingly popular contact sport, an understanding of the epidemiology and mechanism of shoulder injuries may be used to improve protective equipment and develop injury prevention.	[Gardner, Elizabeth C.; Chan, Wayne W.; Sutton, Karen M.; Blaine, Theodore A.] Yale Univ, Sch Med, Dept Orthopaed Surg, 800 Howard Ave,1st Floor, New Haven, CT 06519 USA	Gardner, EC (corresponding author), Yale Univ, Sch Med, Dept Orthopaed Surg, 800 Howard Ave,1st Floor, New Haven, CT 06519 USA.	elizabeth.gardner@yale.edu			National College Athletic Association (NCAA)	One or more of the authors has declared the following potential conflict of interest or source of funding: The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the National College Athletic Association (NCAA).	Arendt EA, 1999, J ATHL TRAINING, V34, P86; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P173; Dragoo JL, 2012, AM J SPORT MED, V40, P2066, DOI 10.1177/0363546512454653; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Mair SD, 1998, AM J SPORT MED, V26, P753, DOI 10.1177/03635465980260060301; Mihata LCS, 2006, AM J SPORT MED, V34, P899, DOI 10.1177/0363546505285582; Owens BD, 2009, AM J SPORT MED, V37, P1750, DOI 10.1177/0363546509334591; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; US Lacrosse, 2013, 2013 PART SURV; Williams RJ, 2003, AM J SPORT MED, V31, P203, DOI 10.1177/03635465030310020801; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914	20	13	13	2	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2016	44	10					2675	2681		10.1177/0363546516644246			7	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	DY8JC	WOS:000385374900033	27159306				2021-06-18	
J	Jacob, R; Cox, M; Koral, K; Greenwell, C; Xi, Y; Vinson, L; Reeder, K; Weprin, B; Huang, R; Booth, TN				Jacob, R.; Cox, M.; Koral, K.; Greenwell, C.; Xi, Y.; Vinson, L.; Reeder, K.; Weprin, B.; Huang, R.; Booth, T. N.			MR Imaging of the Cervical Spine in Nonaccidental Trauma: A Tertiary Institution Experience	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							ABUSIVE HEAD TRAUMA; SUBDURAL HEMORRHAGE; PEDIATRIC TRAUMA; INJURY; CHILDREN; CORD	BACKGROUND AND PURPOSE: Cervical MR imaging has demonstrated a utility for detecting soft tissue injury in nonaccidental trauma. The purpose of this study was to identify the incidence and types of cervical spine injury on MR imaging in nonaccidental trauma and to correlate cervical spine injury with parenchymal injury on brain MR imaging and findings on head CT. MATERIALS AND METHODS: A retrospective review of children diagnosed with nonaccidental trauma in a tertiary referral pediatric hospital over 8 years was performed. Inclusion criteria were children younger than 5 years of age, a confirmed diagnosis of nonaccidental trauma, and cervical spine MR imaging within 1 week of presentation. Brain and cervical spine MR imaging, head CT, cervical radiographs, and skeletal surveys were reviewed. RESULTS: There were 89 patients included in this study (48 males; mean age, 9.1 months [range, 1-59 months]). Cervical spine injury on MR imaging was found in 61 patients (69%). Ligamentous injury was seen in 60 patients (67%), with interspinous ligaments being most commonly involved. Abnormal capsular fluid (atlanto-occipital and atlantoaxial) was present in 28 patients (32%). Cervical spine injury on MR imaging was significantly associated with parenchymal restricted diffusion on brain MR imaging and parenchymal injury on head CT (P = .0004 and P = .0104, respectively). Children with restricted diffusion on brain MR imaging were 6.22 (point estimate) times more likely to have cervical spine injury on MR imaging. CONCLUSIONS: There is a high incidence of cervical spine injury in pediatric nonaccidental trauma. Positive findings may affect management and suggest a traumatic etiology.	[Jacob, R.; Koral, K.; Xi, Y.; Booth, T. N.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Childrens Med Ctr Dallas, Childrens Hlth, Dallas, TX USA; [Greenwell, C.; Vinson, L.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Dallas, Childrens Hlth, Dept Pediat Surg, Dallas, TX 75390 USA; [Weprin, B.] Univ Texas Southwestern Med Ctr Dallas, Childrens Med Ctr Dallas, Childrens Hlth, Dept Neurol Surg, Dallas, TX 75390 USA	Booth, TN (corresponding author), Childrens Med Ctr Dallas, Dept Radiol, 1935 Med Dist Dr, Dallas, TX 75235 USA.	tim.booth@childrens.com	xi, yin/M-2268-2016	xi, yin/0000-0001-9743-3010; Jacob, Roy/0000-0003-4599-2894; Greenwell, Cynthia/0000-0003-4822-2211; weprin, bradley/0000-0003-4466-4549			Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Benedetti PF, 2000, AM J ROENTGENOL, V175, P661, DOI 10.2214/ajr.175.3.1750661; Booth TN, 2012, AM J ROENTGENOL, V198, pW417, DOI 10.2214/AJR.11.8150; Choudhary AK, 2014, PEDIATR RADIOL, V44, P1130, DOI 10.1007/s00247-014-2959-3; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; Feldman KW, 2008, PEDIATR EMERG CARE, V24, P222, DOI 10.1097/PEC.0b013e31816b7aa4; Feldman KW, 2001, PEDIATRICS, V108, P636, DOI 10.1542/peds.108.3.636; Hofbauer M, 2012, J TRAUMA ACUTE CARE, V73, P156, DOI 10.1097/TA.0b013e31824e32b5; Kadom N, 2014, PEDIATR RADIOL, V44, P839, DOI 10.1007/s00247-014-2874-7; Katz JS, 2010, J NEUROSURG-PEDIATR, V5, P470, DOI 10.3171/2009.11.PEDS09291; Kemp AM, 2010, ARCH DIS CHILD, V95, P355, DOI 10.1136/adc.2009.169110; Kemp A, 2014, PEDIATR RADIOL, V44, P604, DOI 10.1007/s00247-014-3066-1; Koch BL, 2007, AM J NEURORADIOL, V28, P1811, DOI 10.3174/ajnr.A0634; Koumellis P, 2009, ARCH DIS CHILD, V94, P216, DOI 10.1136/adc.2008.141671; Rooks VJ, 1998, PEDIATR RADIOL, V28, P193, DOI 10.1007/s002470050330; Rutty GN, 2005, NEUROPATH APPL NEURO, V31, P247, DOI 10.1111/j.1365-2990.2004.00633.x; Silva CT, 2010, AM J ROENTGENOL, V194, P500, DOI 10.2214/AJR.09.2837; Silvera VM, 2014, PEDIATR RADIOL, V44, P621, DOI 10.1007/s00247-014-3170-2	18	13	13	0	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2016	37	10					1944	1950		10.3174/ajnr.A4817			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DW9MR	WOS:000383984600035	27231224	Other Gold, Green Published			2021-06-18	
J	Osborne-Crowley, K; McDonald, S				Osborne-Crowley, Katherine; McDonald, Skye			Hyposmia, Not Emotion Perception, Is Associated With Psychosocial Outcome After Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury (TBI); social disinhibition; hyposmia; smell impairment; emotion perception	BLUNT HEAD-INJURY; NEUROPSYCHIATRIC INVENTORY; SOCIAL-PERCEPTION; OLFACTORY DYSFUNCTION; FACIAL EXPRESSION; RECOGNITION; ANOSMIA; BEHAVIOR; DEFICITS; SADNESS	Objective: The current study aimed to determine whether 2 variables associated with orbitofrontal damage, hyposmia and emotion perception deficits, are associated with socially disinhibited behavior and psychosocial outcome after traumatic brain injury (TBI). Methods: The Brief Smell Identification Test (BSIT), an emotion labeling task, an emotion intensity rating task, and an observational measure of social disinhibition were completed by 23 individuals with severe TBI. The disinhibition domain of the Neuropsychiatric Inventory and the interpersonal relationships subscale of the Sydney Psychosocial Reintegration Scale (SPRS-IR) were completed by a close other. Fifteen control participants provided norms against which to assess performance on the emotion intensity rating task. Results: BSIT scores predicted informant-reported change in interpersonal relationships on the SPRS-IR. Hyposmia, though, was not associated with informant-reported or observed social disinhibition. An impairment in accuracy scores on both emotion perceptions tasks was found for participants with TBI, yet intensity ratings did not differ between groups. This suggests that people with TBI are not actually impaired at detecting intensity of emotion but are less likely to perceive the target emotion as the dominant emotion. Emotion perception was not related to disinhibition or change in interpersonal relationships. Conclusions: These results support previous claims that hyposmia has prognostic significance following TBI. On the other hand, emotion perception impairment measured by standardized tasks does not appear to be an important factor in interpersonal outcomes. Finally, these results suggest that standardized emotion perception tasks may underestimate the emotion perception capabilities of people with TBI.	[Osborne-Crowley, Katherine; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia	Osborne-Crowley, K (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	k.osbornecrowley@unsw.edu.au		Osborne-Crowley, Katherine/0000-0003-0295-1849			Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Barker C., 1994, RES METHODS CLIN COU; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Benson P. J., 1991, EUROPEAN J COGNITIVE, V3, P105, DOI DOI 10.1080/09541449108406222; Bitter T, 2010, BRAIN RES, V1347, P42, DOI 10.1016/j.brainres.2010.06.003; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Boraston Z, 2007, NEUROPSYCHOLOGIA, V45, P1501, DOI 10.1016/j.neuropsychologia.2006.11.010; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; CANTAGALLO A, 2002, EURA MEDICOPHYS, V38, P167; Monsalve BC, 2012, REV PSIQUIATR SALUD, V5, P160, DOI 10.1016/j.rpsm.2012.02.004; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Correia S, 2001, ARCH CLIN NEUROPSYCH, V16, P477, DOI 10.1016/S0887-6177(00)00059-7; Costanzo RM, 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; CROWE SF, 1996, PSYCHIAT PSYCHOL LAW, V3, P39, DOI DOI 10.1080/13218719609524873; Crowe SF, 2013, J CLIN EXP NEUROPSYC, V35, P298, DOI 10.1080/13803395.2013.771616; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jennett B, 1981, MANAGEMENT HEAD INJU; Kats-Gold I, 2007, J ABNORM CHILD PSYCH, V35, P363, DOI 10.1007/s10802-006-9096-x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Leppanen JM, 2001, SCAND J PSYCHOL, V42, P429, DOI 10.1111/1467-9450.00255; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V5, P213, DOI DOI 10.1037/0894-4105.5.3.213; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; Namiki C, 2008, NEUROCASE, V14, P474, DOI 10.1080/13554790802459494; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Osborne-Crowley K, 2016, J CLIN EXP NEUROPSYC, V38, P341, DOI 10.1080/13803395.2015.1115824; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sergi MJ, 2006, AM J PSYCHIAT, V163, P448, DOI 10.1176/appi.ajp.163.3.448; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TROWER P, 1980, J CONSULT CLIN PSYCH, V48, P327, DOI 10.1037/0022-006X.48.3.327; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	64	13	13	0	16	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2016	30	7					820	829		10.1037/neu0000293			10	Psychology, Clinical; Neurosciences; Psychology	Psychology; Neurosciences & Neurology	DY9FX	WOS:000385440400005	27149553				2021-06-18	
J	Perez, EJ; Cepero, ML; Perez, SU; Coyle, JT; Sick, TJ; Liebl, DJ				Perez, Enmanuel J.; Cepero, Maria L.; Perez, Sebastian U.; Coyle, Joseph T.; Sick, Thomas J.; Liebl, Daniel J.			EphB3 signaling propagates synaptic dysfunction in the traumatic injured brain	NEUROBIOLOGY OF DISEASE			English	Article						EphB3 receptors; D-serine; Synapse damage; Synaptic plasticity; Traumatic brain injury	METHYL-D-ASPARTATE; CONTROLLED CORTICAL IMPACT; TRANSIENT CEREBRAL-ISCHEMIA; D-SERINE; SELECTIVE VULNERABILITY; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; COMMISSURAL AXONS; NMDA RECEPTORS; DENTATE GYRUS	Traumatic brain injury (TBI), ranging from mild concussion to severe penetrating wounds, can involve brain regions that contain damaged or lost synapses in the absence of neuronal death. These affected regions significantly contribute to sensory, motor and/or cognitive deficits. Thus, studying the mechanisms responsible for synaptic instability and dysfunction is important for protecting the nervous system from the consequences of progressive TBI. Our controlled cortical impact (CCI) injury produces similar to 20% loss of synapses and mild changes in synaptic protein levels in the CA3-CA1 hippocampus without neuronal losses. These synaptic changes are associated with functional deficits, indicated by >50% loss in synaptic plasticity and impaired learning behavior. We show that the receptor tyrosine kinase EphB3 participates in CCI injury-induced synaptic damage, where EphB3(-/-) mice show preserved long-term potentiation and hippocampal-dependent learning behavior as compared with wild type (WT) injured mice. Improved synaptic function in the absence of EphB3 results from attenuation in CCI injury -induced synaptic losses and reduced D-serine levels compared with WT injured mice. Together, these findings suggest that EphB3 signaling plays a deleterious role in synaptic stability and plasticity after TBI. (C) 2016 The Authors. Published by Elsevier Inc.	[Perez, Enmanuel J.; Cepero, Maria L.; Perez, Sebastian U.; Liebl, Daniel J.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Sick, Thomas J.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Coyle, Joseph T.] Harvard Med Sch, McLean Hosp, Dept Psychiat, Boston, MA 02115 USA	Liebl, DJ (corresponding author), Univ Miami, Miami Project Cure Paralysis, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@miami.edu			Miami Project to Cure Paralysis; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS049545, NS30291, F31NS089335]; Lois Pope Life fellowship; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH051290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS089335, P50NS030291, R01NS098740, R01NS049545] Funding Source: NIH RePORTER	We thank Peggy Bates in the electron microscopy core facilities at the Miami Project to Cure Paralysis and Jessica Landau for assisting in our synaptic analyses. We also thank Jennifer Brazill for critical reading of the manuscript and assisting with experimental revisions, as well as Jose Mier for assistance with animal husbandry. This work was supported by the Miami Project to Cure Paralysis, NIH/NINDS NS049545 (DJL), NS30291 (DJL), F31NS089335 (EJP) and the Lois Pope Life fellowship (EJP).	Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; Antion MD, 2010, MOL CELL NEUROSCI, V45, P378, DOI 10.1016/j.mcn.2010.07.011; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Assis-Nascimento P, 2016, J NEUROSCI METH, V263, P57, DOI 10.1016/j.jneumeth.2016.01.025; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Balu DT, 2014, CELL MOL NEUROBIOL, V34, P419, DOI 10.1007/s10571-014-0027-z; BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brown KM, 2004, DEV BRAIN RES, V152, P61, DOI 10.1016/j.devbrainres.2004.06.001; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Carlson S. W., 2015, J NEUROTRAUMA; Chen YC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00100; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; DeFelipe J, 1999, CEREB CORTEX, V9, P722, DOI 10.1093/cercor/9.7.722; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; GUALTIERI T, 1991, Brain Injury, V5, P219, DOI 10.3109/02699059109008093; Gundersen V, 2015, PHYSIOL REV, V95, P695, DOI 10.1152/physrev.00024.2014; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hama Y, 2006, NEUROSCI RES, V56, P279, DOI 10.1016/j.neures.2006.07.008; Han H., 2015, PHARM BIOCH BEHAV; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Hruska M., 2015, NAT NEUROSCI; Hsu JC, 1998, J CEREBR BLOOD F MET, V18, P768, DOI 10.1097/00004647-199807000-00008; Hunt DL, 2012, CURR OPIN NEUROBIOL, V22, P496, DOI 10.1016/j.conb.2012.01.007; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Irie F, 2005, NAT CELL BIOL, V7, P501, DOI 10.1038/ncb1252; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Katsuki H, 2004, J PHARMACOL EXP THER, V311, P836, DOI 10.1124/jpet.104.070912; Klein R, 2009, NAT NEUROSCI, V12, P15, DOI 10.1038/nn.2231; Kotapka MJ, 1991, J NEUROTRAUM, V8, P247, DOI 10.1089/neu.1991.8.247; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lin CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132204; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Marrone DF, 2004, BRAIN RES, V996, P19, DOI 10.1016/j.brainres.2003.09.073; Martone ME, 1999, J NEUROSCI, V19, P1988; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Moon JY, 2015, PHARMACOL RES, V100, P353, DOI 10.1016/j.phrs.2015.08.019; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Osier ND, 2015, BRAIN NEUROTRAUMA MO; Osteen CL, 2004, NEUROSCIENCE, V128, P305, DOI 10.1016/j.neuroscience.2004.06.034; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pena A, 2005, ACT NEUR S, V95, P333; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Rodenas-Ruano A, 2006, DEV BIOL, V292, P34, DOI 10.1016/j.ydbio.2006.01.004; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Small DL, 1997, NEUROSCI LETT, V232, P87, DOI 10.1016/S0304-3940(97)00592-2; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zhang YP, 2014, TRANSL STROKE RES, V5, P454, DOI 10.1007/s12975-014-0327-0; Zhu YJ, 2015, J NEUROSCI METH, V254, P73, DOI 10.1016/j.jneumeth.2015.07.022; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010	87	13	13	0	13	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2016	94						73	84		10.1016/j.nbd.2016.06.007			12	Neurosciences	Neurosciences & Neurology	DT9QF	WOS:000381836700008	27317833	Other Gold, Green Accepted, Green Published			2021-06-18	
J	Scott, GG; Margulies, SS; Coats, B				Scott, Gregory G.; Margulies, Susan S.; Coats, Brittany			Utilizing multiple scale models to improve predictions of extra-axial hemorrhage in the immature piglet	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Subarachnoid space; Microstructure; Traumatic brain injury; Finite element modeling; Arachnoid trabeculae	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; FINITE-ELEMENT; BIOMECHANICAL PROPERTIES; BOUNDARY-CONDITIONS; LARGE-DEFORMATION; HEAD; IMPACT; ACCELERATION; RESPONSES	Traumatic brain injury (TBI) is a leading cause of death and disability in the USA. To help understand and better predict TBI, researchers have developed complex finite element (FE) models of the head which incorporate many biological structures such as scalp, skull, meninges, brain (with gray/white matter differentiation), and vasculature. However, most models drastically simplify the membranes and substructures between the pia and arachnoid membranes. We hypothesize that substructures in the pia-arachnoid complex (PAC) contribute substantially to brain deformation following head rotation, and that when included in FE models accuracy of extra-axial hemorrhage prediction improves. To test these hypotheses, microscale FE models of the PAC were developed to span the variability of PAC substructure anatomy and regional density. The constitutive response of these models were then integrated into an existing macroscale FE model of the immature piglet brain to identify changes in cortical stress distribution and predictions of extra-axial hemorrhage (EAH). Incorporating regional variability of PAC substructures substantially altered the distribution of principal stress on the cortical surface of the brain compared to a uniform representation of the PAC. Simulations of 24 non-impact rapid head rotations in an immature piglet animal model resulted in improved accuracy of EAH prediction (to 94 % sensitivity, 100 % specificity), as well as a high accuracy in regional hemorrhage prediction (to 82-100 % sensitivity, 100 % specificity). We conclude that including a biofidelic PAC substructure variability in FE models of the head is essential for improved predictions of hemorrhage at the brain/skull interface.	[Scott, Gregory G.; Coats, Brittany] Univ Utah, Dept Mech Engn, 1495 E 100 S,1550 MEK, Salt Lake City, UT 84112 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Coats, B (corresponding author), Univ Utah, Dept Mech Engn, 1495 E 100 S,1550 MEK, Salt Lake City, UT 84112 USA.	brittany.coats@utah.edu			Primary Children's Medical Center Foundation	This study was funded by the Primary Children's Medical Center Foundation.	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Armstrong DL, 2002, ARCH DIS CHILD-FETAL, V86, P124; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; BYLSKI DI, 1986, J BIOMECH, V19, P19, DOI 10.1016/0021-9290(86)90105-3; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Couper Z, 2008, BIOMECH MODEL MECHAN, V7, P105, DOI 10.1007/s10237-007-0079-9; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul M, 2010, TRAUMATIC BRAIN INJU; Frankel DA, 1998, J ULTRAS MED, V17, P411; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Hagmann CF, 2011, EARLY HUM DEV, V87, P341, DOI 10.1016/j.earlhumdev.2011.01.044; Higgins M, 2007, J ATHL TRAINING, V42, P5; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; KUIJPERS AHWM, 1995, J NEUROTRAUM, V12, P715, DOI 10.1089/neu.1995.12.715; Lam WWM, 2001, PEDIATR NEUROL, V25, P380, DOI 10.1016/S0887-8994(01)00349-6; Ma C, 2008, BIOINF BIOM ENG ICBE; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Nahum A. M., 1977, P 21 STAPP CAR CRASH; Pang Q, 2001, J VASC RES, V38, P83, DOI 10.1159/000051033; Paolini Brielle M, 2009, Biomed Sci Instrum, V45, P161; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Scott G., 2015, IEEE T MED IMAG; Scott G, 2014, ANATOMY BIOMECHANICS; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI 10.1080/10255840903064897	48	13	13	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	OCT	2016	15	5					1101	1119		10.1007/s10237-015-0747-0			19	Biophysics; Engineering, Biomedical	Biophysics; Engineering	DW4KM	WOS:000383611800008	26586144				2021-06-18	
J	Ahmed, OH; Lee, H; Struik, LL				Ahmed, Osman H.; Lee, Hopin; Struik, Laura L.			A picture tells a thousand words: A content analysis of concussion-related images online	PHYSICAL THERAPY IN SPORT			English	Article						Concussion; Social media; Knowledge translation; Public health	KNOWLEDGE TRANSFER; SOCIAL MEDIA; INFORMATION; PINTEREST; RECALL	Background and aim: Recently image-sharing social media platforms have become a popular medium for sharing health-related images and associated information. However within the field of sports medicine, and more specifically sports related concussion, the content of images and meta-data shared through these popular platforms have not been investigated. The aim of this study was to analyse the content of concussion-related images and its accompanying meta-data on image-sharing social media platforms. Methods: We retrieved 300 images from Pinterest, Instagram and Flickr by using a standardised search strategy. All images were screened and duplicate images were removed. We excluded images if they were: non-static images; illustrations; animations; or screenshots. The content and characteristics of each image was evaluated using a customised coding scheme to determine major content themes, and images were referenced to the current international concussion management guidelines. Results: From 300 potentially relevant images, 176 images were included for analysis; 70 from Pinterest, 63 from Flickr, and 43 from Instagram. Most images were of another person or a scene (64%), with the primary content depicting injured individuals (39%). The primary purposes of the images were to share a concussion-related incident (33%) and to dispense education (19%). For those images where it could be evaluated, the majority (91%) were found to reflect the Sports Concussion Assessment Tool 3 (SCAT3) guidelines. Conclusions: The ability to rapidly disseminate rich information though photos, images, and infographics to a wide-reaching audience suggests that image-sharing social media platforms could be used as an effective communication tool for sports concussion. Public health strategies could direct educative content to targeted populations via the use of image-sharing platforms. Further research is required to understand how image-sharing platforms can be used to effectively relay evidence-based information to patients and sports medicine clinicians. (C) 2016 Elsevier Ltd. All rights reserved.	[Ahmed, Osman H.] Bournemouth Univ, Fac Hlth & Social Sci, Royal London House,Christchurch Rd, Bournemouth BH1 3LT, Dorset, England; [Ahmed, Osman H.] Poole Hosp NHS Trust, Dept Physiotherapy, Poole, Dorset, England; [Ahmed, Osman H.] FA Ctr Disabil Football Res, St Georges Pk, Burton Upon Trent, England; [Lee, Hopin] Neurosci Res Australia, Sydney, NSW, Australia; [Lee, Hopin] Univ New South Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Struik, Laura L.] Univ British Columbia, Okanagan Campus, Vancouver, BC V5Z 1M9, Canada	Ahmed, OH (corresponding author), Bournemouth Univ, Fac Hlth & Social Sci, Royal London House,Christchurch Rd, Bournemouth BH1 3LT, Dorset, England.	osman.hassan.ahmed@gmail.com		Ahmed, Osman/0000-0002-1439-0076; Lee, Hopin/0000-0001-5692-0314			Adams SA, 2010, INT J MED INFORM, V79, P391, DOI 10.1016/j.ijmedinf.2010.01.006; Ahmed OH, 2012, BRIT J SPORT MED, V46, P675, DOI 10.1136/bjsm.2010.081620; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; [Anonymous], 2014, THE IRISH NEWS  0501; [Anonymous], 2013, BRIT J SPORT MED, V47, P259; [Anonymous], 2014, NY TIMES; [Anonymous], 2013, BBC NEWS; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Houts PS, 2006, PATIENT EDUC COUNS, V61, P173, DOI 10.1016/j.pec.2005.05.004; Houts PS, 1998, PATIENT EDUC COUNS, V35, P83, DOI 10.1016/S0738-3991(98)00065-2; Marketing Charts, 2013, DEM INST SNAPCH US; McCrory P., 2008, BRIT J SPORT MED, V2009, pi76; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; O'Mara B, 2013, HEALTH PROMOT INT, V28, P466, DOI 10.1093/heapro/das014; Paige SR, 2015, AM J HEALTH EDUC, V46, P241, DOI 10.1080/19325037.2015.1044586; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Renner B., 2012, PLOS ONE, P7; Shellenbarger T, 2013, NURS EDUC, V38, P206, DOI 10.1097/NNE.0b013e3182a0e5e7; Smiciklas M., 2012, INFOGRAPHICS USING P; Stellrecht E, 2012, J CONS HLTH INTERNET, V16, P403, DOI 10.1080/15398285.2012.723987; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; The Pew Internet and American Life Project, 2013, PHOT VID SHAR GROW O; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Yom-Tov E, 2012, J MED INTERNET RES, V14, P233, DOI 10.2196/jmir.2239; Zeng XH, 2013, INFORM SYST RES, V24, P71, DOI 10.1287/isre.1120.0464	28	13	13	0	60	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1466-853X			PHYS THER SPORT	Phys. Ther. Sport	SEP	2016	21						82	86		10.1016/j.ptsp.2016.03.001			5	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DW0FF	WOS:000383315600013	27311926	Green Accepted, Green Published			2021-06-18	
J	Albrecht, JS; McCunn, M; Stein, DM; Simoni-Wastila, L; Smith, GS				Albrecht, Jennifer S.; McCunn, Maureen; Stein, Deborah M.; Simoni-Wastila, Linda; Smith, Gordon S.			Sex differences in mortality following isolated traumatic brain injury among older adults	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; mortality; sex differences	GLASGOW COMA SCALE; SEVERITY SCORE; CLINICAL-TRIAL; OUTCOMES; PROGESTERONE; GENDER; AGE; PREDICTION; STEROIDS; CRITERIA	BACKGROUND Older adults have the highest rates of hospitalization and mortality from traumatic brain injury (TBI), yet outcomes in this population are not well studied. In particular, contradictory reports on the protective effect of female sex on mortality following TBI may have been related to age differences in TBI and other injury severity and mechanism. The objective of this study was to determine if there are sex differences in mortality following isolated TBI among older adults and compare with findings using all TBI. A secondary objective was to characterize TBI severity and mechanism by sex in this population. METHODS This was a retrospective cohort study conducted among adults aged 65 and older treated for TBI at a single large Level I trauma center from 1996 to 2012 (n = 4,854). Individuals treated for TBI were identified using International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM) codes. Isolated TBI was defined as an Abbreviated Injury Scale score of 0 for other body regions. Our primary outcome was mortality at discharge. RESULTS Among those with isolated TBI (n = 1,320), women (45% of sample) were older (mean [SD], 78.9 [7.7] years) than men (76.8 [7.5] years) (p < 0.001). Women were more likely to have been injured in a fall (91% vs. 84%; p < 0.001). Adjusting for multiple injury severity measures, female sex was not significantly associated with decreased odds of mortality following isolated TBI (odds ratio, 1.01; 95% confidence interval, 0.66-1.54). Using all TBI cases, adjusted analysis found that female sex was significantly associated with decreased odd of mortality (odds ratio, 0.73; 95% confidence interval, 0.59-0.89). CONCLUSION We found no sex differences in mortality following isolated TBI among older adults, in contrast with other studies and our own analyses using all TBI cases. Researchers should consider isolated TBI in outcome studies to prevent residual confounding by severity of other injuries. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level IV.	[Albrecht, Jennifer S.; Smith, Gordon S.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Anesthesiol,Div Trauma Anesthesiol, Baltimore, MD 21201 USA; [McCunn, Maureen] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Anesthesiol,Div Surg Crit Care, Baltimore, MD 21201 USA; [Stein, Deborah M.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Div Surg Crit Care,Dept Surg, Baltimore, MD 21201 USA; [Simoni-Wastila, Linda] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA	Albrecht, JS (corresponding author), Univ Maryland, Sch Med, 10 S Pine St,MSTF 334C, Baltimore, MD 21201 USA.	jalbrecht@epi.umaryland.edu		Albrecht, Jennifer/0000-0003-4838-2274; Smith, Gordon/0000-0002-2911-3071; Stein, Deborah/0000-0003-3683-3963	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K12HD43489-14]; US National Institute on Alcohol Abuse and AlcoholismUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA18707]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K01HS024560] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD043489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R01AA018707, R01AA018313] Funding Source: NIH RePORTER	JSA was supported by NIH grant K12HD43489-14 (Tracey, PI). GSS was supported by a grant from the US National Institute on Alcohol Abuse and Alcoholism (R01AA18707). The remaining authors declare no conflicts of interest.	American Heart Association, UND BLOOD PRESS READ; [Anonymous], 1971, JAMA, V215, P277; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Brazinova A, 2010, J NEUROTRAUM, V27, P1549, DOI 10.1089/neu.2010.1315; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Cauley JA, 2015, STEROIDS, V99, P11, DOI 10.1016/j.steroids.2014.12.010; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Leitgeb J, 2011, J TRAUMA, V71, P1620, DOI 10.1097/TA.0b013e318226ea0e; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Marr AL., 2004, CENTRAL NERVOUS SYST; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Rogers E, 2006, J HEAD TRAUMA REHAB, V21, P279, DOI 10.1097/00001199-200605000-00008; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Sasser SM, 2011, MMWR-MORBID MORTAL W, V61, P1; Scheetz LJ, 2015, INT EMERG NURS, V23, P162, DOI 10.1016/j.ienj.2014.09.003; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman DJ., 1995, GUIDELINES SURVEILLA; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao Guo-min, 2007, Zhonghua Wai Ke Za Zhi, V45, P106; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	39	13	14	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2016	81	3					486	492		10.1097/TA.0000000000001118			7	Critical Care Medicine; Surgery	General & Internal Medicine; Surgery	DW8MX	WOS:000383911200012	27280939	Green Accepted			2021-06-18	
J	Dekker, SE; Duvekot, A; de Vries, HM; Geeraedts, LMG; Peerdeman, SM; de Waard, MC; Boer, C; Schober, P				Dekker, Simone E.; Duvekot, Anne; de Vries, Hielke-Martijn; Geeraedts, Leo M. G., Jr.; Peerdeman, Saskia M.; de Waard, Monique C.; Boer, Christa; Schober, Patrick			Relationship between tissue perfusion and coagulopathy in traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Traumatic brain injury; Coagulopathy; Perfusion; Oxygenation; Bleeding	NEAR-INFRARED SPECTROSCOPY; OXYGENATION CHANGES; CEREBRAL-ISCHEMIA; HYPOPERFUSION; BIOMARKERS; IMPACT	Background: Traumatic brain injury (TBI) erelated coagulopathy appears to be most prevalent in patients with tissue hypoperfusion, but evidence for this association is scarce. This study investigated the relationship between tissue perfusion and hemostatic derangements in TBI patients. Materials and methods: Coagulation parameters were measured on emergency department admission in patients with TBI (head abbreviated injury scale >= 3). The level of hypoperfusion was simultaneously assessed by near-infrared spectroscopy (NIRS) at the forehead and arm, and by base excess and lactate. Coagulopathy was defined as an international normalized ratio > 1.2 and/or activated partial thromboplastin time > 40 s and/or thrombocytopenia (< 120 x 10(9)/L). Results: TBI patients with coagulopathy (42%) had more signs of tissue hypoperfusion as indicated by increased lactate levels (2.1 [1.1-3.2] mmol/L versus 1.2 [1.0-1.7] mmol/L; P = 0.017) and a larger base deficit (-3.0 [-4.6 to -2.0] mmol/L versus -0.1 [-2.5 to 1.8] mmol/L; P < 0.001). There was no difference in the cerebral or somatic tissue oxygenation index. However, there was a distinct trend toward a moderate inverse association between the cerebral tissue oxygenation index and D-dimer levels (r = -0.40; P = 0.051) as marker of fibrinolysis. The presence of coagulopathy was associated with an increased inhospital mortality rate (45.5% versus 6.7%; P = 0.002). Conclusions: This is the first study to investigate the relationship between hemostatic derangements and tissue oxygenation using NIRS in TBI patients. This study showed that TBI-related coagulopathy is more profound in patients with metabolic acidosis and increased lactate levels. Although there was no direct relationship between tissue oxygenation and coagulopathy, we observed an inverse relationship between NIRS tissue oxygenation levels and fibrinolysis. (C) 2016 Elsevier Inc. All rights reserved.	[Dekker, Simone E.; Duvekot, Anne; de Vries, Hielke-Martijn; Boer, Christa; Schober, Patrick] Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands; [Geeraedts, Leo M. G., Jr.] Vrije Univ Amsterdam, Med Ctr, Dept Surg, Amsterdam, Netherlands; [Peerdeman, Saskia M.] Vrije Univ Amsterdam, Med Ctr, Dept Neurosurg, Amsterdam, Netherlands; [de Waard, Monique C.] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands	Dekker, SE (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Anesthesiol, De Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	s.dekker@vumc.nl	Schober, Patrick/G-7400-2012	Schober, Patrick/0000-0003-0814-081X; Boer, Christa/0000-0002-7781-6951	Department of Anesthesiology, VU University Medical Center, Amsterdam, the NetherlandsNetherlands Government	This study was supported by the Department of Anesthesiology, VU University Medical Center, Amsterdam, the Netherlands.	Al-Rawi PG, 2001, STROKE, V32, P2492, DOI 10.1161/hs1101.098356; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Davenport R, 2011, CRIT CARE MED, V39, P2652, DOI 10.1097/CCM.0b013e3182281af5; Davie SN, 2012, ANESTHESIOLOGY, V116, P834, DOI 10.1097/ALN.0b013e31824c00d7; Dekker SE, 2014, ANESTHESIOLOGY, V121, P89, DOI 10.1097/ALN.0000000000000229; Duvekot A, 2015, ANESTHESIOLOGY, V123, P820, DOI 10.1097/ALN.0000000000000806; Franschman G, 2012, BRAIN INJURY, V26, P1464, DOI 10.3109/02699052.2012.694566; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Ganter MT, 2010, BEST PRACT RES-CLIN, V24, P15, DOI 10.1016/j.bpa.2009.09.010; Genet GF, 2013, J NEUROTRAUM, V30, P301, DOI 10.1089/neu.2012.2612; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Lin BS, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0465-3; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Merzagora AC, 2011, J INNOV OPT HEAL SCI, V4, P251, DOI 10.1142/S1793545811001551; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Plomgaard AM, 2016, PEDIATR RES, V79, P528, DOI 10.1038/pr.2015.266; Ragaller Max, 2010, J Emerg Trauma Shock, V3, P1, DOI 10.4103/0974-2700.58649; Scheeren TWL, 2012, J CLIN MONIT COMPUT, V26, P279, DOI 10.1007/s10877-012-9348-y; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Schober P, 2013, HOSP HEALTHCARE EURO, P128; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taussky P, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.12.FOCUS11280; VANDERSANDE JJ, 1978, J NEUROSURG, V49, P357, DOI 10.3171/jns.1978.49.3.0357; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang CC, 2016, J SURG RES, V200, P669, DOI 10.1016/j.jss.2015.10.005; Wolf T, 1997, J CEREBR BLOOD F MET, V17, P950, DOI 10.1097/00004647-199709000-00004; Yousef KM, 2014, INTENS CRIT CARE NUR, V30, P346, DOI 10.1016/j.iccn.2014.05.001	37	13	15	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	SEP	2016	205	1					147	154		10.1016/j.jss.2016.06.023			8	Surgery	Surgery	DW0VE	WOS:000383360300021	27621012				2021-06-18	
J	Huang, SY; Lo, PH; Liu, WM; Cherng, YG; Yeh, CC; Chen, TL; Liao, CC				Huang, Shih-Yu; Lo, Po-Han; Liu, Wei-Min; Cherng, Yih-Giun; Yeh, Chun-Chieh; Chen, Ta-Liang; Liao, Chien-Chang			Outcomes After Nonobstetric Surgery in Pregnant Patients: A Nationwide Study	MAYO CLINIC PROCEEDINGS			English	Article							POSTOPERATIVE ADVERSE OUTCOMES; POPULATION-BASED-COHORT; TRAUMATIC BRAIN-INJURY; NONCARDIAC SURGERY; BREAST-CANCER; ACUTE APPENDICITIS; NONPREGNANT WOMEN; MANAGEMENT; RISK; CHOLECYSTECTOMY	Objective: To evaluate outcomes after nonobstetric surgical procedures in pregnant patients. Methods: We conducted a retrospective cohort study of 5591 pregnant women who underwent nonobstetric surgical procedures using Taiwan's National Health Insurance Research Database 2008-2012 claims data. Using a propensity score matching procedure, 22,364 nonpregnant women were selected for comparison. Logistic regression was used to calculate the odds ratios (ORs) and 95% CIs of postoperative complications and in-hospital mortality associated with pregnancy. Results: Pregnant women had higher risks of postoperative septicemia (OR = 1.75; 95% CI, 1.47-2.07), pneumonia (OR = 1.47; 95% CI, 1.01-2.13), urinary tract infection (OR = 1.29; 95% CI, 1.08-1.54), and in-hospital mortality (OR = 3.94; 95% CI, 2.62-5.92) compared with nonpregnant women. Pregnant women also had longer hospital stays and higher medical expenditures after nonobstetric surgical procedures than controls. Higher rates of postoperative adverse events in pregnant women receiving nonobstetric surgery were noted in all age groups. Conclusion: Surgical patients with pregnancy showed more adverse events, with a risk of in-hospital mortality approximately 4-fold higher after nonobstetric surgery compared with nonpregnant patients. These findings suggest the urgent need to revise the protocols for postoperative care for this population. (C) 2016 Mayo Foundation for Medical Education and Research	[Huang, Shih-Yu; Lo, Po-Han; Cherng, Yih-Giun] Shuang Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Huang, Shih-Yu; Lo, Po-Han; Cherng, Yih-Giun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Liu, Wei-Min] Taipei Med Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Liu, Wei-Min] Taipei Med Univ, Coll Med, Sch Med, Dept Obstet & Gynecol, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Sch Chinese Med, Taichung, Taiwan	Chen, TL; Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	ccliao@tmu.edu.tw; jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Cherng, Yih-Giun/0000-0002-0201-4380	Shuang Ho Hospital, Taipei Medical University [104TMU-SHH-23]; Taiwan's Ministry of Science and Technology [MOST104-2314-B-038-027-MY2, NSC102-2314-B-038-021-MY3]; Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]	This study was supported in part by grants from Shuang Ho Hospital, Taipei Medical University (104TMU-SHH-23), Taiwan's Ministry of Science and Technology (MOST104-2314-B-038-027-MY2; NSC102-2314-B-038-021-MY3), and Taiwan's Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019).	Abbasi N, 2014, BJOG-INT J OBSTET GY, V121, P1509, DOI 10.1111/1471-0528.12736; Ali SA, 2012, BREAST J, V18, P139, DOI 10.1111/j.1524-4741.2011.01201.x; Andersson REB, 2001, INT J EPIDEMIOL, V30, P1281, DOI 10.1093/ije/30.6.1281; Aydin Y, 1999, J NEUROSURG, V91, P322, DOI 10.3171/jns.1999.91.2.0322; Azim HA, 2011, EUR J CANCER, V47, P74, DOI 10.1016/j.ejca.2010.09.007; Bagger JP, 2004, LANCET, V363, P706, DOI 10.1016/S0140-6736(04)15647-X; Berry C, 2011, AM J SURG, V201, P429, DOI 10.1016/j.amjsurg.2010.10.008; Cardonick E, 2010, CANCER J, V16, P76, DOI 10.1097/PPO.0b013e3181ce46f9; Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Chemg YG, 2013, PLOS ONE, V8; Cohen-Kerem R, 2005, AM J SURG, V190, P467, DOI 10.1016/j.amjsurg.2005.03.033; Erekson EA, 2012, J MATERN-FETAL NEO M, V25, P2639, DOI 10.3109/14767058.2012.704445; Fardiazar Zahra, 2014, Pak J Biol Sci, V17, P260; Hatch Q, 2014, J SURG RES, V190, P41, DOI 10.1016/j.jss.2014.03.028; Hernandez AF, 2004, J AM COLL CARDIOL, V44, P1446, DOI 10.1016/j.jacc.2004.06.059; Jeong JS, 2011, SURG LAPARO ENDO PER, V21, P24, DOI 10.1097/SLE.0b013e3182051e44; Jin F, 2001, BRIT J ANAESTH, V87, P608, DOI 10.1093/bja/87.4.608; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Kristensen SD, 2014, EUR HEART J, V35, P2383, DOI 10.1093/eurheartj/ehu282; Kuy S, 2009, SURGERY, V146, P358, DOI 10.1016/j.surg.2009.03.033; Kuy S, 2009, ARCH SURG-CHICAGO, V144, P399, DOI 10.1001/archsurg.2009.48; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Maia Paula C, 2008, Rev Port Cardiol, V27, P321; McMaster J, 2014, GYNECOL ONCOL, V135, P539, DOI 10.1016/j.ygyno.2013.09.006; Moore HB, 2015, JAMA SURG, V150, P637, DOI 10.1001/jamasurg.2015.91; Neligan PJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10256; Nguyen GC, 2010, GASTROINTEST ENDOSC, V72, P954, DOI 10.1016/j.gie.2010.07.018; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Sadot E, 2010, SURG ENDOSC, V24, P383, DOI 10.1007/s00464-009-0571-7; Silvestri MT, 2011, OBSTET GYNECOL, V118, P1261, DOI 10.1097/AOG.0b013e318234d7bc; Tan EK, 2013, BEST PRACT RES CL OB, V27, P791, DOI 10.1016/j.bpobgyn.2013.08.001; van Mook WNKA, 2005, CURR OPIN CRIT CARE, V11, P430, DOI 10.1097/01.ccx.0000179807.15328.f0; Vartak S, 2008, MED CARE, V46, P25, DOI 10.1097/MLR.0b013e3181484927; Vogel TR, 2010, ANN SURG, V252, P1065, DOI 10.1097/SLA.0b013e3181dcf36e; Wijeysundera DN, 2008, LANCET, V372, P562, DOI 10.1016/S0140-6736(08)61121-6; Yates Martin T, 2015, J Thorac Cardiovasc Surg, V149, P607, DOI 10.1016/j.jtcvs.2014.10.038; Yeh CC, 2013, DIABETES CARE, V36, P3216, DOI 10.2337/dc13-0770; Zingone F, 2015, ANN SURG, V261, P332, DOI 10.1097/SLA.0000000000000780	39	13	13	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0025-6196	1942-5546		MAYO CLIN PROC	Mayo Clin. Proc.	SEP	2016	91	9					1166	1172		10.1016/j.mayocp.2016.06.021			7	Medicine, General & Internal	General & Internal Medicine	DZ6AK	WOS:000385943700008	27594184				2021-06-18	
J	Kreber, LA; Griesbach, GS; Ashley, MJ				Kreber, Lisa A.; Griesbach, Grace S.; Ashley, Mark J.			Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical management of CNS injury; growth hormone deficiency; hypopituitarism; human studies	GH DEFICIENCY; LONG-TERM; PITUITARY DYSFUNCTION; INPATIENT REHABILITATION; CONSENSUS GUIDELINES; UNITED-STATES; RATING-SCALE; HYPOPITUITARISM; PREVALENCE; GLUCAGON	This study examined the prevalence of growth hormone deficiency (GHD) in patients with traumatic brain injury (TBI) during the post-acute phase of recovery and whether GHD was associated with increased disability, decreased independence, and depression. A secondary objective was to determine the accuracy of insulin-like growth factor-1 (IGF-1) levels in predicting GHD in patients with TBI. Anterior pituitary function was assessed in 235 adult patients with TBI through evaluation of fasting morning hormone levels. GH levels were assessed through provocative testing, specifically the glucagon stimulation test. GHD was diagnosed in a significant number of patients, with 45% falling into the severe GHD (<= 3 mu g/L) category. IGF-1 levels were not predictive of GHD. Patients with GHD were more disabled and less independent compared with those patients who were not GHD. Those patients with more severe GHD also showed decreased levels of cortisol and testosterone. Symptoms of depression were also more prevalent in this group. In addition, patients with severe GHD had delayed admission to post-acute rehabilitation. This study confirms the high prevalence of GHD in patients with TBI and the necessity to monitor clinical symptoms and perform provocative testing to definitively diagnose GHD.	[Kreber, Lisa A.; Griesbach, Grace S.; Ashley, Mark J.] UCLA, David Geffen Sch Med, Ctr Neuro Skills, Bakersfield, CA USA; [Griesbach, Grace S.] UCLA, David Geffen Sch Med, Dept Neurosurg, Bakersfield, CA USA; [Kreber, Lisa A.; Griesbach, Grace S.; Ashley, Mark J.] UCLA, David Geffen Sch Med, Ctr Neuro Skills, Clin Educ & Res Fdn, Bakersfield, CA USA	Kreber, LA (corresponding author), Ctr Neuro Skills, 5215 Ashe Rd, Bakersfield, CA 93313 USA.	lkreber@neuroskills.com					Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Arce VM, 2013, NEUROSCI RES, V76, P179, DOI 10.1016/j.neures.2013.03.014; Ashley MJ, 2001, BRAIN INJURY, V15, P435, DOI 10.1080/02699050010005896; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beck A. T., 1996, BECK DEPRESSION INVE, VII; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Devesa J, 2010, MED CLIN-BARCELONA, V135, P665, DOI 10.1016/j.medcli.2009.10.017; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Freda Pamela U, 2003, Pituitary, V6, P135, DOI 10.1023/B:PITU.0000011174.79946.10; Freda PU, 1998, J CLIN ENDOCR METAB, V83, P3808, DOI 10.1210/jc.83.11.3808; Gabellieri E, 2010, FRONT HORM RES, V38, P139, DOI 10.1159/000318503; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCGAULEY GA, 1990, HORM RES, V33, P52, DOI 10.1159/000181584; Popvic V., 2004, J ENDOCRINOL INVEST, V27, P1048; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Wang C, 2004, J CLIN ENDOCR METAB, V89, P2085, DOI 10.1210/jc.2003-032006; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299; Zgaljardic DJ, 2011, CLIN ENDOCRINOL, V74, P365, DOI 10.1111/j.1365-2265.2010.03935.x	49	13	14	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1607	1613		10.1089/neu.2015.4127			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300006	26414093	Green Published, Other Gold			2021-06-18	
J	Kreutzer, JS; Mills, A; Marwitz, JH				Kreutzer, Jeffrey S.; Mills, Ana; Marwitz, Jennifer H.			Ambiguous Loss and Emotional Recovery After Traumatic Brain Injury	JOURNAL OF FAMILY THEORY & REVIEW			English	Article						Ambiguous loss; families; resilience; traumatic brain injury	FAMILY INTERVENTION IMPACT; HEAD-INJURY; MILD; CAREGIVERS; PREDICTORS; EXPERIENCE; RELATIVES; MODERATE; MEMBERS	Traumatic brain injury (TBI) is highly prevalent, with many survivors experiencing long-term disability as a consequence of cognitive impairments, adverse personality changes, and emotional and communication difficulties. Because family members most often assume the long-term role of caregiver, their feelings, relationships, and life plans are often negatively affected. Boss has defined a type of ambiguous loss in which the person is physically present but psychologically absent, which is the case for many families after brain injury. Over the past 2 decades we have developed interventions incorporating ambiguous loss theory to enhance resilience and improve psychological outcomes in families after TBI. This article provides a brief overview of TBI, discusses ambiguous loss in families after TBI, and describes the therapeutic goals and framework of empirically supported family interventions using the lens of ambiguous loss theory.	[Kreutzer, Jeffrey S.; Mills, Ana; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Box 980542, Richmond, VA 23298 USA	Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Box 980542, Richmond, VA 23298 USA.	jennifer.marwitz@vcuhealth.org			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0033-01-00, 90AR5002-01-01]	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR Grant Nos. 90DP0033-01-00 and 90AR5002-01-01). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and readers should not assume endorsement by the federal government.	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Bertalanffy LV, 1968, GEN SYSTEM THEORY FD; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Boss P, 2002, J CLIN PSYCHOL, V58, P1351, DOI 10.1002/jclp.10083; Boss P., 2006, LOSS TRAUMA RESILIEN; Boss P., 2011, LOVING SOMEONE WHO H; Boss P., 1999, AMBIGUOUS LOSS LEARN; Boss P, 2016, J FAM THEOR REV, V8, P269, DOI 10.1111/jftr.12152; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crimmins C., 2000, IS MANGO PRINCESS; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Ellis A., 1975, NEW GUIDE RATIONAL L; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Giovannetti AM, 2015, BRAIN INJURY, V29, P473, DOI 10.3109/02699052.2014.990514; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Kean S, 2010, NURS CRIT CARE, V15, P66, DOI 10.1111/j.1478-5153.2010.00379.x; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kreutzer J., 2004, BRAIN INJURY FAMILY; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kreutzer JS, 1999, GETTING BETTER BETTE; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI DOI 10.1037/1091-7527.26.1.69; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McAllister TW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1034; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA	48	13	13	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-2570	1756-2589		J FAM THEOR REV	J. Fam. Theory. Rev.	SEP	2016	8	3			SI		386	397		10.1111/jftr.12150			12	Family Studies	Family Studies	ED6EU	WOS:000388949500009					2021-06-18	
J	Osler, T; Cook, A; Glance, LG; Lecky, F; Bouamra, O; Garrett, M; Buzas, JS; Hosmer, DW				Osler, Turner; Cook, Alan; Glance, Laurent G.; Lecky, Fiona; Bouamra, Omar; Garrett, Mark; Buzas, Jeffery S.; Hosmer, David W.			The differential mortality of Glasgow Coma Score in patients with and without head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Glasgow Coma Score; Traumatic brain injury; Mortality; Logistic	TRAUMA; SCALE; PREDICTION; MODEL	Importance: The GCS was created forty years ago as a measure of impaired consciousness following head injury and thus the association of GCS with mortality in patients with traumatic brain injury (TBI) is expected. The association of GCS with mortality in patients without TBI (non-TBI) has been assumed to be similar. However, if this assumption is incorrect mortality prediction models incorporating GCS as a predictor will need to be revised. Objective: To determine if the association of GCS with mortality is influenced by the presence of TBI. Design/setting/participants: Using the National Trauma Data Bank (2012; N = 639,549) we categorized patients as isolated TBI (12.8%), isolated non-TBI (33%), both (4.8%), or neither (49.4%) based on the presence of AIS codes of severity 3 or greater. We compared the ability GCS to discriminate survivors from non-survivors in TBI and in non-TBI patients using logistic models. We also estimated the odds ratios of death for TBI and non-TBI patients at each value of GCS using linear combinations of coefficients. Main outcome measure: Death during hospital admission. Results: As the sole predictor in a logistic model GCS discriminated survivors from non-survivors at an acceptable level (c-statistic = 0.76), but discriminated better in the case of TBI patients (c-statistic = 0.81) than non-TBI patients (c-statistic = 0.70). In both unadjusted and covariate adjusted models TBI patients were about twice as likely to die as non-TBI patients with the same GCS for GCS values <8; for GCS values >8 TBI and non-TBI patients were at similar risk of dying. Conclusions: A depressed GCS predicts death better in TBI patients than non-TBI patients, likely because in non-TBI patients a depressed GCS may simply be the result of entirely reversible intoxication by alcohol or drugs; in TBI patients, by contrast, a depressed GCS is more ominous because it is likely due to a head injury with its attendant threat to survival. Accounting for this observation into trauma mortality datasets and models may improve the accuracy of outcome prediction. (C) 2016 Elsevier Ltd. All rights reserved.	[Osler, Turner] Univ Vermont, Dept Surg, 789 Orchard Shore Rd, Colchester, VT 05446 USA; [Cook, Alan] Chandler Reg Med Ctr, Trauma Res Program, Chandler, AZ USA; [Cook, Alan] Univ Arizona, Coll Med, Dept Surg, Phoenix, AZ USA; [Glance, Laurent G.] Univ Rochester, Dept Anesthesiol, Rochester, NY 14627 USA; [Lecky, Fiona] Univ Sheffield, Emergency Med, Sheffield S10 2TN, S Yorkshire, England; [Lecky, Fiona; Bouamra, Omar] Trauma Audit & Res Network, Salford, Lancs, England; [Garrett, Mark] Chandler Reg Med Ctr, Chandler, AZ USA; [Buzas, Jeffery S.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; [Hosmer, David W.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA	Osler, T (corresponding author), Univ Vermont, Dept Surg, 789 Orchard Shore Rd, Colchester, VT 05446 USA.	tosler@uvm.edu; alan.cook@dignityhealth.org; Laurent_glance@umc.rochester.edu; fiona.lecky@manchester.ac.uk; omar.bouamra@manchester.ac.uk; mark.garrett@bnaneuro.net; jbuzas@uvm.edu; hosmer@schoolph.umass.edu		bouamra, omar/0000-0002-3155-4634			Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; GENNARELLI TA, 1994, J TRAUMA, V37, P962, DOI 10.1097/00005373-199412000-00016; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hosmer DW., 2013, APPL LOGISTIC REGRES, V3rd ed.; Hosmer Jr DW, 2013, APPL LOGISTIC REGRES, P177; JENNETT B, 1983, INTRO NEUROSURGERY; Marina K, 2002, P 2002 JOINT STAT M; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Moskopp D, 1995, NEUROSURG REV, V18, P253, DOI 10.1007/BF00383876; Osler T, 2008, ANN SURG, V247, P1041, DOI 10.1097/SLA.0b013e31816ffb3f; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Royston P, 2008, Multivariable model-building. A pragmatic approach to regression analysis based on fractional polynomials for modelling continuous variables; TEASDALE G, 1974, LANCET, V2, P81	15	13	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2016	47	9					1879	1885		10.1016/j.injury.2016.04.016			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DU5QG	WOS:000382265800003	27129906				2021-06-18	
J	Rehman, H; Khan, MS; Nafees, M; Attique-ur-Rehman; Habib, A				Rehman, Hina; Khan, Muhammad Saim; Nafees, Muhammad; Attique-ur-Rehman; Habib, Asad			Optic Nerve Sheath Diameter on Sonography in Idiopathic Intracranial Hypertension Versus Normal	JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN			English	Article						Optic nerve sheath diameter; Idiopethic intracranial hypertension; Benign intracranial hypertension; Pseudotumor cerebri	TRAUMATIC BRAIN-INJURY; PSEUDOTUMOR CEREBRI; PRESSURE	Objective: To compare the mean optic nerve sheath diameter (ONSD) in patients with idiopathic intracranial hypertension (IIH) versus normal healthy individuals using B-scan ultrasonography as diagnostic tool. Study design: Cross-sectional analytical study. Place and duration of study: Armed Forces Institute of Radiology and Imaging, Rawalpindi, Pakistan, from June to December 2015. Methodology: Participants aged 30 - 50 years were divided into two groups. Group A(GP) comprised of patients who were diagnosed cases of idiopathic intracranial hypertension while normal healthy adults who volunteered to participate in the study were included in Group B (GC). Ocular B mode ultrasound scan was performed on all the participants and each eye was considered separately. The optic nerve head was visualized as a linear hypoechoic structure, and ONSD was measured 3 mm behind the retina. Atotal of three readings were taken by the same radiologist and the average of three was recorded. Mean values of both groups were compared by t-test with significance at p < 0.05. Results: Fifty-two eyes of 26 patients (26 eyes in each group) were included in the study. Twenty-four out of 26 in Group A(GP) and 23 out of 26 in Group B (GC) were females. Mean age of the patients was 33.92 +/- 4.89 years in group A(GP) while it was 34.69 +/- 4.79 years in group B (GC). Mean ONSD was 6.61 +/- 0.39 mm in group A(GP) and 4.33 +/- 0.38 mm in group B(GC) which was significantly different (p < 0.001). Conclusion: Ultrasound can provide a reliable, non-invasive tool to measure optic nerve sheath diameter in monitoring the patients with benign intracranial hypertension (BIH).	[Rehman, Hina; Nafees, Muhammad; Attique-ur-Rehman] Armed Forces Inst Radiol & Imaging, Dept Radiol, Rawalpindi, Pakistan; [Khan, Muhammad Saim; Habib, Asad] Armed Forces Inst Ophthalmol, Dept Ophthalmol, Rawalpindi, Pakistan	Khan, MS (corresponding author), Armed Forces Inst Ophthalmol, Rawalpindi, Pakistan.	saim_amc@hotmail.com					Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; D'Amico D, 2012, NEUROL SCI, V33, pS189, DOI 10.1007/s10072-012-1065-2; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Ertl M, 2014, ULTRASCHALL MED, V35, P422, DOI 10.1055/s-0034-1366113; Frattalone AR, 2011, INTENS CARE MED, V37, P1051, DOI 10.1007/s00134-011-2226-0; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KELMAN SE, 1991, OPHTHALMOLOGY, V98, P1449; Kesler A, 2001, J NEURO-OPHTHALMOL, V21, P15, DOI 10.1097/00041327-200103000-00004; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Mehrpour M, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/146059; RADHAKRISHNAN K, 1994, MAYO CLIN PROC, V69, P169, DOI 10.1016/S0025-6196(12)61045-3; Shirodkar CG, 2015, INDIAN J CRIT CARE M, V19, P466, DOI 10.4103/0972-5229.162465; SMITH JL, 1985, J CLIN NEURO-OPHTHAL, V5, P55; Wang LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117939	17	13	13	0	2	COLL PHYSICIANS & SURGEONS PAKISTAN	KARACHI	SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN	1022-386X	1681-7168		JCPSP-J COLL PHYSICI	JCPSP-J. Coll. Physicians Surg.	SEP	2016	26	9					758	760					3	Medicine, General & Internal	General & Internal Medicine	DZ5LP	WOS:000385903900008	27671180				2021-06-18	
J	Uccella, L; Zoia, C; Perlasca, F; Bongetta, D; Codeca, R; Gaetani, P				Uccella, Laura; Zoia, Cesare; Perlasca, Francesco; Bongetta, Daniele; Codeca, Roberta; Gaetani, Paolo			Mild Traumatic Brain Injury in Patients on Long-Term Anticoagulation Therapy: Do They Really Need Repeated Head CT Scan?	WORLD NEUROSURGERY			English	Article						Anticoagulants; GCS 15; Head CT scan; Mild traumatic brain injury; Minor head trauma	NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; RULE; RISK	BACKGROUND: Mild traumatic brain injury (mTBI), defined as blunt trauma to the head resulting in witnessed loss of consciousness, definite amnesia, or witnessed disorientation with a Glasgow Coma Scale (GCS) score of 14 or 15 is a common occurrence in the emergency department. In mTBI, oral anticoagulation is known to be an important risk factor for hemorrhage. Clinical guidelines recommend baseline computed tomographic (CT) scan and observation for 24 hours plus a CT scan before discharge. METHODS: We compared the non-anticoagulated and anticoagulated patients presenting at our emergency department with mTBI and no neurologic signs (GCS[ 15). Every non-anticoagulated patient underwent only a baseline CT scan, whereas the anticoagulated group underwent a second CT scan after a 24-hour observation period. RESULTS: Between April 2012 and April 2013, we observed 908 adult patients with mTBI and a GCS score of 15; 74 patients (8.1%) were taking oral anticoagulant drugs as long-term therapy, whereas the remaining 834 patients (91.9%) were not. In the non-anticoagulation group, 38 patients (4.6%) were positive for hemorrhage. Two patients underwent neurosurgical intervention. In the anticoagulation group, 5 patients (6.8%) were positive for hemorrhage. No patient underwent neurosurgical intervention. None of them died. The differences between the two groups were not statistically significant. CONCLUSIONS: Patients with a GCS score of 15 who are taking long-term anticoagulation therapy and who present with mTBI have a risk of cranial hemorrhage that is likely to be similar to that of non-anticoagulated patients. It may be reasonable to envision a protocol including only one CT scan and an appropriate observation period.	[Uccella, Laura; Perlasca, Francesco; Codeca, Roberta] Osped Circolo & Fdn Macchi, Emergency Dept, Varese, Italy; [Zoia, Cesare; Bongetta, Daniele; Gaetani, Paolo] IRCCS Fdn Policlin San Matteo, Neurosurg Unit, Pavia, Italy; [Bongetta, Daniele] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy	Zoia, C (corresponding author), IRCCS Fdn Policlin San Matteo, Neurosurg Unit, Pavia, Italy.	gioiaoffice@gmail.com	Zoia, Cesare/ABE-5286-2020; Zoia, Cesare/B-8463-2015	Zoia, Cesare/0000-0001-7304-6120; Zoia, Cesare/0000-0001-7304-6120; Gaetani, Paolo/0000-0003-0662-5872			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Agenzia per i Servizi Sanitari Regionali, 2007, TREATM MIN SEV HEAD; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies , 2006, HLTH RISKS EXP LOW L; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Docimo S, 2014, AM SURGEON, V80, P610; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Garcia DA, 2011, J FAM PRACTICE, V60, P70; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Joseph B, 2014, AM SURGEON, V80, P43; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; National Clinical Guideline Centre. National Institute for Health and Clinical Excellence: Guidance, 2014, HEAD INJ TRIAG ASS I; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Study Group on Head Injury of the Italian Society for Neurosurgery, 1996, J NEUROSURG SCI, V40, P11	17	13	13	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	SEP	2016	93						100	103		10.1016/j.wneu.2016.05.061			4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	EF5DX	WOS:000390352000016	27245564				2021-06-18	
J	Song, Y; Pimentel, C; Walters, K; Boller, L; Ghiasvand, S; Liu, J; Staley, KJ; Berdichevsky, Y				Song, Yu; Pimentel, Corrin; Walters, Katherine; Boller, Lauren; Ghiasvand, Shabnam; Liu, Jing; Staley, Kevin J.; Berdichevsky, Yevgeny			Neuroprotective levels of IGF-1 exacerbate epileptogenesis after brain injury	SCIENTIFIC REPORTS			English	Article							GROWTH-FACTOR-I; TEMPORAL-LOBE EPILEPSY; TUBEROUS SCLEROSIS COMPLEX; HIPPOCAMPAL SLICE CULTURES; MAMMALIAN TARGET; RAT-BRAIN; SIGNALING PATHWAY; CELL-DEATH; POSTTRAUMATIC EPILEPSY; SYNAPTIC CONNECTIONS	Exogenous Insulin-Like Growth Factor-1 (IGF-1) is neuroprotective in animal models of brain injury, and has been considered as a potential therapeutic. Akt-mTOR and MAPK are downstream targets of IGF-1 signaling that are activated after brain injury. However, both brain injury and mTOR are linked to epilepsy, raising the possibility that IGF-1 may be epileptogenic. Here, we considered the role of IGF-1 in development of epilepsy after brain injury, using the organotypic hippocampal culture model of post-traumatic epileptogenesis. We found that IGF-1 was neuroprotective within a few days of injury but that long-term IGF-1 treatment was pro-epileptic. Pro-epileptic effects of IGF-1 were mediated by Akt-mTOR signaling. We also found that IGF-1-mediated increase in epileptic activity led to neurotoxicity. The dualistic nature of effects of IGF-1 treatment demonstrates that anabolic enhancement through IGF-1 activation of mTOR cascade can be beneficial or harmful depending on the stage of the disease. Our findings suggest that epilepsy risk may need to be considered in the design of neuroprotective treatments for brain injury.	[Song, Yu; Pimentel, Corrin; Boller, Lauren; Ghiasvand, Shabnam; Berdichevsky, Yevgeny] Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA; [Walters, Katherine] Lehigh Univ, IDEAS Program, Bethlehem, PA 18015 USA; [Liu, Jing; Berdichevsky, Yevgeny] Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA; [Staley, Kevin J.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02129 USA; [Staley, Kevin J.] Harvard Med Sch, Boston, MA 02129 USA	Berdichevsky, Y (corresponding author), Lehigh Univ, Bioengn Program, Bethlehem, PA 18015 USA.; Berdichevsky, Y (corresponding author), Lehigh Univ, Dept Elect & Comp Engn, Bethlehem, PA 18015 USA.	berdichevsky@lehigh.edu		Berdichevsky, Yevgeny/0000-0001-7539-601X	Taking Flight Award from Citizens United for Research in Epilepsy (CURE); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS034700, R37NS077908] Funding Source: NIH RePORTER	This work was supported by Taking Flight Award from Citizens United for Research in Epilepsy (CURE).	BACH MA, 1991, MOL BRAIN RES, V10, P43; Banerjee PN, 2008, EPILEPSY COMPREHENSI, V1, P45; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bausch SB, 2000, J NEUROPHYSIOL, V84, P2918; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Beilharz EJ, 1998, MOL BRAIN RES, V59, P119, DOI 10.1016/S0169-328X(98)00122-3; Benarroch EE, 2012, NEUROLOGY, V79, P2148, DOI 10.1212/WNL.0b013e3182752eef; Berdichevsky Y, 2013, J NEUROSCI, V33, P9056, DOI 10.1523/JNEUROSCI.3870-12.2013; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; BONDY CA, 1993, ANN NY ACAD SCI, V692, P33; Brewster AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057808; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; Carrera E, 2006, NEUROLOGY, V67, P99, DOI 10.1212/01.wnl.0000223361.90278.ca; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Crino P. B., 2015, COLD SPRING HARB PER, V5; Crino PB, 2011, TRENDS MOL MED, V17, P734, DOI 10.1016/j.molmed.2011.07.008; Crino PB, 2009, EPILEPSIA, V50, P3, DOI 10.1111/j.1528-1167.2009.02289.x; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dupraz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054462; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Fernandez AM, 2012, NAT REV NEUROSCI, V13, P225, DOI 10.1038/nrn3209; Galanopoulou AS, 2012, EPILEPSIA, V53, P1119, DOI 10.1111/j.1528-1167.2012.03506.x; Goldberg EM, 2013, NAT REV NEUROSCI, V14, P337, DOI 10.1038/nrn3482; Goto J, 2011, P NATL ACAD SCI USA, V108, pE1070, DOI 10.1073/pnas.1106454108; Guan J, 2003, PROG NEUROBIOL, V70, P443, DOI 10.1016/j.pneurobio.2003.08.002; GUAN J, 1993, J CEREBR BLOOD F MET, V13, P609, DOI 10.1038/jcbfm.1993.79; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; GUTHRIE KM, 1995, J COMP NEUROL, V352, P147, DOI 10.1002/cne.903520111; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Jiang GH, 2015, CLIN SCI, V129, P1047, DOI 10.1042/CS20150312; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Lee WH, 1996, J CEREBR BLOOD F MET, V16, P227, DOI 10.1097/00004647-199603000-00007; LEE WH, 1992, MOL CELL NEUROSCI, V3, P36, DOI 10.1016/1044-7431(92)90006-N; Madathil SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067204; Madathil SK, 2010, J NEUROTRAUM, V27, P95, DOI 10.1089/neu.2009.1002; Madathil SK., 2015, BRAIN NEUROTRAUMA MO; MCBAIN CJ, 1989, J NEUROSCI METH, V27, P35, DOI 10.1016/0165-0270(89)90051-4; MILLER LDP, 1994, NEUROSCIENCE, V63, P471, DOI 10.1016/0306-4522(94)90544-4; National Research Council, 2003, GUIDELINES CARE USE, DOI [10.17226/10732, DOI 10.17226/10732]; O'Kusky JR, 2000, J NEUROSCI, V20, P8435, DOI 10.1523/JNEUROSCI.20-22-08435.2000; Ostendorf AP, 2015, CNS DRUGS, V29, P91, DOI 10.1007/s40263-014-0223-x; Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789; Park J, 2012, J CEREBR BLOOD F MET, V32, P330, DOI 10.1038/jcbfm.2011.131; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Pitkanen A, 2011, NEUROSCI LETT, V497, P163, DOI 10.1016/j.neulet.2011.02.033; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618; Sliwa A, 2012, NEUROSCI LETT, V509, P105, DOI 10.1016/j.neulet.2011.12.051; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; van Vliet EA, 2012, EPILEPSIA, V53, P1254, DOI 10.1111/j.1528-1167.2012.03513.x; Walter HJ, 1997, ENDOCRINOLOGY, V138, P3024, DOI 10.1210/en.138.7.3024; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Wine RN, 2009, NEUROTOX RES, V16, P280, DOI 10.1007/s12640-009-9060-y; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801	68	13	13	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 26	2016	6								32095	10.1038/srep32095			12	Multidisciplinary Sciences	Science & Technology - Other Topics	DU1KN	WOS:000381966700003	27561791	DOAJ Gold, Green Published			2021-06-18	
J	Xu, J; Sisniega, A; Zbijewski, W; Dang, H; Stayman, JW; Wang, XH; Foos, DH; Aygun, N; Koliatsos, VE; Siewerdsen, JH				Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Wang, Xiaohui; Foos, David H.; Aygun, Nafi; Koliatsos, Vassillis E.; Siewerdsen, Jeffrey H.			Evaluation of detector readout gain mode and bowtie filters for cone-beam CT imaging of the head	PHYSICS IN MEDICINE AND BIOLOGY			English	Article						cone-beam CT; Bowtie filter; detector readout mode; image quality; dose; head imaging; flat-panel detector	FLAT-PANEL IMAGERS; X-RAY-DETECTOR; ACTIVE-MATRIX; BREAST CT; STATISTICAL RECONSTRUCTION; DIAGNOSTIC-RADIOLOGY; COMPUTED-TOMOGRAPHY; NOISE PERFORMANCE; OPTIMIZATION; QUALITY	The effects of detector readout gain mode and bowtie filters on cone-beam CT (CBCT) image quality and dose were characterized for a new CBCT system developed for point-of-care imaging of the head, with potential application to diagnosis of traumatic brain injury, intracranial hemorrhage (ICH), and stroke. A detector performance model was extended to include the effects of detector readout gain on electronic digitization noise. The noise performance for high-gain (HG), low-gain (LG), and dual-gain (DG) detector readout was evaluated, and the benefit associated with HG mode in regions free from detector saturation was quantified. Such benefit could be realized (without detector saturation) either via DG mode or by incorporation of a bowtie filter. Therefore, three bowtie filters were investigated that varied in thickness and curvature. A polyenergetic gain correction method was developed to equalize the detector response between the flood-field and projection data in the presence of a bowtie. The effect of bowtie filters on dose, scatter-to-primary ratio, contrast, and noise was quantified in phantom studies, and results were compared to a high-speed Monte Carlo (MC) simulation to characterize x-ray scatter and dose distributions in the head. Imaging in DG mode improved the contrast-to-noise ratio (CNR) by similar to 15% compared to LG mode at a dose (D-0, measured at the center of a 16 cm CTDI phantom) of 19 mGy. MC dose calculations agreed with CTDI measurements and showed that bowtie filters reduce peripheral dose by as much as 50% at the same central dose. Bowtie filters were found to increase the CNR per unit square-root dose near the center of the image by similar to 5-20% depending on bowtie thickness, but reduced CNR in the periphery by similar to 10-40%. Images acquired at equal CTDIw with and without a bowtie demonstrated a 24% increase in CNR at the center of an anthropomorphic head phantom. Combining a thick bowtie filter with a short arc (180 degrees + fan angle) scan centered on the posterior of the head reduced dose to the eye lens by up to 90%. Acquisition in DG mode (without a bowtie filter) was beneficial to the detection of small, low contrast lesions (e.g. subtle ICH) in CBCT. While bowtie filters were found to reduce dose, mitigate sensor saturation at the periphery in HG mode, and improve CNR at the center of the image, the image quality at the periphery was slightly reduced compared to DG mode, and the use of a bowtie required careful implementation of the polyenergetic flood-field correction to avoid artifacts.	[Xu, Jennifer; Sisniega, Alejandro; Zbijewski, Wojciech; Dang, Hao; Stayman, J. Webster; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA; [Wang, Xiaohui; Foos, David H.] Carestream Hlth, Rochester, NY 14608 USA; [Aygun, Nafi; Siewerdsen, Jeffrey H.] Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA; [Koliatsos, Vassillis E.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA	Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA.; Siewerdsen, JH (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA.	jeff.siewerdsen@jhu.edu	Dang, Hao/U-4865-2018	Dang, Hao/0000-0001-5861-6535; Sisniega, Alejandro/0000-0003-2030-2711; Stayman, Joseph/0000-0003-4358-378X			Antonuk LE, 2000, MED PHYS, V27, P289, DOI 10.1118/1.598831; Badal A, 2009, MED PHYS, V36, P4878, DOI 10.1118/1.3231824; Bartolac S, 2011, MED PHYS, V38, pS2, DOI 10.1118/1.3574885; Chen B, 2002, MED PHYS, V29, P755, DOI 10.1118/1.1461843; Daly MJ, 2006, MED PHYS, V33, P3767, DOI 10.1118/1.2349687; Dang H, 2015, PHYS MED BIOL, V60, P6153, DOI 10.1088/0031-9155/60/16/6153; Heiland M, 2004, DENTOMAXILLOFAC RAD, V33, P130, DOI 10.1259/dmfr/15309653; Hernandez AM, 2014, MED PHYS, V41, DOI 10.1118/1.4866216; Hsieh SS, 2013, MED PHYS, V40, DOI 10.1118/1.4789630; JOSEPH PM, 1978, J COMPUT ASSIST TOMO, V2, P100, DOI 10.1097/00004728-197801000-00017; Konstantinidis AC, 2012, NUCL INSTRUM METH A, V689, P12, DOI 10.1016/j.nima.2012.06.024; Koskinen SK, 2013, SKELETAL RADIOL, V42, P649, DOI 10.1007/s00256-012-1516-0; Lee D L, 2004, OPT SCI TECHN SPIE 4, P126; Lindfors KK, 2008, RADIOLOGY, V246, P725, DOI 10.1148/radiol.2463070410; Mail N, 2009, MED PHYS, V36, P22, DOI 10.1118/1.3017470; Maolinbay M, 2000, MED PHYS, V27, P1841, DOI 10.1118/1.1286721; Miracle AC, 2009, AM J NEURORADIOL, V30, P1088, DOI 10.3174/ajnr.A1653; Mozzo P, 1998, EUR RADIOL, V8, P1558, DOI 10.1007/s003300050586; Prakash P, 2011, MED PHYS, V38, P5612, DOI 10.1118/1.3633937; Roos P G, 2004, SPIE MED IMAGING 200, P139; Schafer S, 2011, MED PHYS, V38, P4563, DOI 10.1118/1.3597566; Scheuermann JR, 2016, PROC SPIE, V9783, DOI 10.1117/12.2217002; Shin MS, 2013, IEEE T ELECTRON DEV, V60, P1169, DOI 10.1109/TED.2013.2238674; Siewerdsen J.H., 2007, SPIE MED IMAGING 200; Siewerdsen JH, 1998, MED PHYS, V25, P614, DOI 10.1118/1.598243; Siewerdsen JH, 2004, MED PHYS, V31, P3057, DOI 10.1118/1.1758350; Siewerdsen JH, 1997, MED PHYS, V24, P71, DOI 10.1118/1.597919; Siewerdsen JH, 2000, MED PHYS, V27, P1903, DOI 10.1118/1.1286590; Sisniega A, 2013, MED PHYS, V40, DOI 10.1118/1.4801895; Stayman J W, 2016, SPIE MED IMAGING; Szczykutowicz TP, 2014, PHYS MED BIOL, V59, DOI 10.1088/0031-9155/59/5/1305; Tkaczyk J E, 2004, SPIE MED IMAGING 200, P403; Toth T L, 2005, SPIE MED IMAGING, P283; Wang AS, 2014, PHYS MED BIOL, V59, P1005, DOI 10.1088/0031-9155/59/4/1005; Xu J, 2016, PHYS MED BIOL, V61, P3180, DOI 10.1088/0031-9155/61/8/3180; Xu J, 2012, MED PHYS, V39, P4932, DOI 10.1118/1.4736805; Xu J, 2016, SPIE MED IMAGING; Yamamoto K, 2003, Orthod Craniofac Res, V6 Suppl 1, P160, DOI 10.1034/j.1600-0544.2003.249.x; Yang K, 2010, MED PHYS, V37, P3527, DOI 10.1118/1.3447720; Yang WT, 2007, AM J ROENTGENOL, V189, P1312, DOI 10.2214/AJR.07.2403; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5; Zbijewski W, 2011, MED PHYS, V38, P4700, DOI 10.1118/1.3611039; Zbijewski W, 2009, SPIE MED IMAGING; Zhao W, 2015, PHYS MED BIOL, V60, P1339, DOI 10.1088/0031-9155/60/3/1339; Zhao Z, 2014, MED PHYS, V41, DOI 10.1118/1.4875688	45	13	13	0	7	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0031-9155	1361-6560		PHYS MED BIOL	Phys. Med. Biol.	AUG 21	2016	61	16					5973	5992		10.1088/0031-9155/61/16/5973			20	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Engineering; Radiology, Nuclear Medicine & Medical Imaging	DX2NZ	WOS:000384208600011	27435162				2021-06-18	
J	Wang, YQ; Wang, DF; Zhang, LZ; Ye, FY; Li, MM; Wen, K				Wang, Yuqing; Wang, Dongfei; Zhang, Lizhi; Ye, Fangyu; Li, Mengmeng; Wen, Ke			Role of JAK-STAT pathway in reducing cardiomyocytes hypoxia/reoxygenation injury induced by S1P postconditioning	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						H9c2; S1P; JAK-STAT pathway; AG490; Stattic	ISCHEMIA-REPERFUSION INJURY; TRAUMATIC BRAIN-INJURY; APOPTOSIS; DYSFUNCTION; PROTECTION; CALCIUM; CELLS; DEATH; CARDIOPROTECTION; MITOCHONDRIA	This experiment was designed to explore the protection of sphingosine1-phosphate (S1P) post conditioning on rat myocardial cells injured by hypoxia/reoxygenation acting via the Janus kinase-signal transducer and activator of transcription (JAK-STAT) signal pathway. The data showed that S1P could significantly increase cell viability, lower the rate of apoptosis, decrease the content of lactate dehydrogenase (LDH) and caspase3 activity in the culture medium, increase the activity of total superoxide dismutase (T-SOD) and manganese superoxide dismutase (Mn-SOD), reduce the loss of mitochondrial membrane potential and the fluorescence intensity of intracellular calcium, as well as increase the phosphorylation of JAK2 and STAT3 in comparison with the H/R group. When the JAK inhibitor AG490 or the STAT inhibitor stattic were added, the effects of S1P were inhibited. Our date shows that S1P protects H9c2 cells from hypoxia/reoxygenation injury and that the protection by S1P was inhibited by AG490 and stattic. Therefore S1P protects H9c2 cells against hypoxia/reoxygenation injury via the JAK-STAT pathway. (C) 2016 Elsevier B.V. All rights reserved.	[Wang, Yuqing; Wang, Dongfei; Li, Mengmeng; Wen, Ke] Tianjin Med Univ, Dept Pharmacol, Tianjin 300070, Peoples R China; [Zhang, Lizhi] Tianjin First Ctr Hosp, Dept Obstet & Gynecol, Tianjin 300192, Peoples R China; [Ye, Fangyu] Beijing Univ Chem Technol, Coll Mat Sci & Engn, Beijing 100029, Peoples R China	Wen, K (corresponding author), Tianjin Med Univ, Dept Pharmacol, Tianjin 300070, Peoples R China.	wenke@tijmu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81173058, 81502419]; National Natural Science Foundation of Tianjin [10JCZDJC20900]	The authors declare no conflict of interest. This work was supported by grants from the National Natural Science Foundation of China (Nos. 81173058 and 81502419) and National Natural Science Foundation of Tianjin (No. 10JCZDJC20900).	Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; Booz GW, 2002, J MOL CELL CARDIOL, V34, P1443, DOI 10.1006/jmcc.2002.2076; Brulhart-Meynet MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119664; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Crisostomo PR, 2006, J AM COLL SURGEONS, V202, P797, DOI 10.1016/j.jamcollsurg.2005.12.002; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Das A, 2012, J MOL CELL CARDIOL, V53, P858, DOI 10.1016/j.yjmcc.2012.09.007; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Dhar-Mascareno M, 2005, FREE RADICAL BIO MED, V38, P1311, DOI 10.1016/j.freeradbiomed.2005.01.017; Ding J, 2010, MOL CELL NEUROSCI, V43, P201, DOI 10.1016/j.mcn.2009.11.001; Faiksen LW., 2001, LEUKEMIA, V15, P787; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Fiorillo C, 2006, CELL MOL LIFE SCI, V63, P3061, DOI 10.1007/s00018-006-6345-7; Fu WG, 2013, J SURG RES, V183, P876, DOI 10.1016/j.jss.2013.01.044; Gao L, 2011, BRIT J PHARMACOL, V162, P633, DOI 10.1111/j.1476-5381.2010.01071.x; Garcia R, 1998, J BIOMED SCI, V5, P79, DOI 10.1007/BF02258360; Goodman MD, 2008, AM J PHYSIOL-HEART C, V295, pH1649, DOI 10.1152/ajpheart.00692.2008; Gorina R, 2005, J NEUROCHEM, V92, P505, DOI 10.1111/j.1471-4159.2004.02878.x; Green DR, 1998, CELL, V94, P695, DOI 10.1016/S0092-8674(00)81728-6; Gross ER, 2006, AM J PHYSIOL-HEART C, V291, pH827, DOI 10.1152/ajpheart.00003.2006; Hattori R, 2001, J MOL CELL CARDIOL, V33, P1929, DOI 10.1006/jmcc.2001.1456; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; He Miao, 2013, Chinese Pharmacological Bulletin, V29, P1369, DOI 10.3969/j.issn.1001-1978.2013.10.010; Heim MH, 1999, J RECEPT SIGNAL TR R, V19, P75, DOI 10.3109/10799899909036638; Hou Q, 2005, AM J PHYSIOL-HEART C, V289, pH477, DOI 10.1152/ajpheart.00879.2004; IGARASHI K, 1994, J BIOL CHEM, V269, P14333; JOLLY SR, 1984, CIRC RES, V54, P277, DOI 10.1161/01.RES.54.3.277; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Li YP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048115; Liu W, 2014, TOXICOL LETT, V224, P1, DOI 10.1016/j.toxlet.2013.10.009; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ma SH, 2015, CELL CALCIUM, V58, P286, DOI 10.1016/j.ceca.2015.06.006; Mascareno E, 2001, CIRCULATION, V104, P325; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Podewski EK, 2003, CIRCULATION, V107, P798, DOI 10.1161/01.CIR.0000057545.82749.FF; Qin J, 2014, Drug Res (Stuttg), V64, P47, DOI 10.1055/s-0033-1349101; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Somers SJ, 2012, CARDIOVASC DRUG THER, V26, P227, DOI 10.1007/s10557-012-6376-2; Sun GB, 2012, TOXICOL APPL PHARM, V265, P229, DOI 10.1016/j.taap.2012.10.002; Wang TT, 2013, FREE RADICAL BIO MED, V63, P291, DOI 10.1016/j.freeradbiomed.2013.05.043; Wang Y, 2015, ADV DIFFER EQU-NY, DOI 10.1186/s13662-015-0358-1; Wen SH, 2012, SHOCK, V38, P411, DOI 10.1097/SHK.0b013e3182662266; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Williamson CL, 2008, AM J PHYSIOL-HEART C, V294, pH249, DOI 10.1152/ajpheart.00775.2007; Woo AYH, 2008, J PHARMACOL EXP THER, V325, P226, DOI 10.1124/jpet.107.133918; Woo AYH, 2005, CARDIOVASC RES, V65, P244, DOI 10.1016/j.cardiores.2004.09.027; Xu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024036; Xuan YT, 2001, P NATL ACAD SCI USA, V98, P9050, DOI 10.1073/pnas.161283798; Yang NS, 2008, NEPHROL DIAL TRANSPL, V23, P91, DOI 10.1093/ndt/gfm509; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zheng X., 2014, J NANOMATER, V2014, P1, DOI DOI 10.1155/2014/751907	55	13	14	1	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	AUG 5	2016	784						129	136		10.1016/j.ejphar.2016.05.024			8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	DR1GI	WOS:000379653600014	27215146				2021-06-18	
J	Palzur, E; Sharon, A; Shehadeh, M; Soustiel, JF				Palzur, Eilam; Sharon, Aviram; Shehadeh, Mona; Soustiel, Jean Francois			INVESTIGATION OF THE MECHANISMS OF NEUROPROTECTION MEDIATED BY Ro5-4864 IN BRAIN INJURY	NEUROSCIENCE			English	Article						18-kDa translocator protein; mitochondrial permeability transition pore; Ro5-4864; cyclosporine A; traumatic brain injury; neuroinflammation	PERIPHERAL BENZODIAZEPINE-RECEPTOR; CONTROLLED CORTICAL IMPACT; TUMOR-NECROSIS-FACTOR; PROTEIN 18 KDA; RAT-BRAIN; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; TEMPORAL PROFILE; CANCER-CELLS; HEAD-INJURY	Increasing evidence has established the involvement of the 18-kDa translocator protein (TSPO) in the process of mitochondrial membrane permeabilization and subsequent apoptosis through modulation of the mitochondrial permeability transition pore. Recent studies have shown that treatment with Ro5-4864, a TSPO ligand, resulted in a neuroprotective effect in traumatic brain injury. Yet, the nature of this effect remained uncertain as mature neurons are considered to be lacking the TSPO protein. In order to investigate the mechanism of Ro5-4864-mediated neuroprotection, the neuro-inflammatory and neurosteroid response to cortical injury was tested in sham-operated, vehicle, cyclosporine A (CsA) and Ro5-4864-treated rats. As anticipated, the levels of interleukin 1 beta and tumor necrosis factor alpha, as well as the astrocyte and microglia cellular density in the injured area were all decreased by CsA in comparison with the vehicle group. By contrast, no visible effect could be observed in Ro5-4864-treated animals. None of the groups showed any significant difference with any other in respect with the expression of brain-derived neurotrophic factor. Double immunofluorescence staining with NeuN and TSPO confirmed the absence of TSPO in native neurons though showed clear evidence of co-localization of TSPO in the cytoplasm of NeuN-stained injured neurons. Altogether, this study shows that the neuronal protection mediated by Ro5-4864 in brain injury cannot be solely attributed to an indirect effect of the ligand on glial TSPO but may also represent the consequence of the modulation of upregulated TSPO in injured neurons. This observation may be of importance for future pharmacological research in neurotrauma. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Palzur, Eilam; Shehadeh, Mona; Soustiel, Jean Francois] Bar Ilan Univ, Eliachar Res Lab, Med Ctr Galilee, Fac Med Galilee, IL-22100 Nahariyya, Israel; [Sharon, Aviram; Soustiel, Jean Francois] Bar Ilan Univ, Dept Neurosurg, Med Ctr Galilee, Fac Med Galilee, IL-22100 Nahariyya, Israel	Soustiel, JF (corresponding author), Galilee Med Ctr, Dept Neurosurg, POB 21, IL-22100 Nahariyya, Israel.	JeanS@gmc.gov.il		Palzur, Eilam/0000-0003-2032-2974			Aguirre CC, 2009, EUR J NEUROSCI, V29, P447, DOI 10.1111/j.1460-9568.2008.06591.x; Arieli Ran, 1994, Journal of Basic and Clinical Physiology and Pharmacology, V5, P277; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Banker DE, 2002, LEUKEMIA RES, V26, P91, DOI 10.1016/S0145-2126(01)00112-6; Bartels AL, 2010, PARKINSONISM RELAT D, V16, P57, DOI 10.1016/j.parkreldis.2009.05.005; Bono F, 1999, BIOCHEM BIOPH RES CO, V265, P457, DOI 10.1006/bbrc.1999.1683; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Choi J, 2011, GLIA, V59, P219, DOI 10.1002/glia.21091; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Decaudin D, 2002, CANCER RES, V62, P1388; di Michele F, 2000, NEUROSCI LETT, V284, P65, DOI 10.1016/S0304-3940(00)00965-4; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Giatti S, 2009, NEUROSCIENCE, V164, P520, DOI 10.1016/j.neuroscience.2009.08.005; Girard C, 2012, J NEUROENDOCRINOL, V24, P71, DOI 10.1111/j.1365-2826.2011.02215.x; Golani I, 2001, BIOCHEMISTRY-US, V40, P10213, DOI 10.1021/bi010431+; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Gulyas B, 2012, J NEUROL SCI, V320, P110, DOI 10.1016/j.jns.2012.06.026; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Iwamoto Y, 1996, NEUROREPORT, V7, P609, DOI 10.1097/00001756-199601310-00056; Lacor P, 1999, BRAIN RES, V815, P70, DOI 10.1016/S0006-8993(98)01105-6; Lee TH, 2002, NEUROREPORT, V13, P2271, DOI 10.1097/00001756-200212030-00020; Maaser K, 2001, BRIT J CANCER, V85, P1771, DOI 10.1054/bjoc.2001.2181; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Mills CD, 2005, MOL CELL NEUROSCI, V30, P228, DOI 10.1016/j.mcn.2005.07.010; Mills C, 2008, EUR J NEUROSCI, V27, P937, DOI 10.1111/j.1460-9568.2008.06065.x; Naert G, 2007, PSYCHONEUROENDOCRINO, V32, P1062, DOI 10.1016/j.psyneuen.2007.09.002; Nakamoto Y, 1996, BRAIN RES, V717, P91, DOI 10.1016/0006-8993(96)00033-9; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Shiotani T, 2000, BRAIN RES, V859, P255, DOI 10.1016/S0006-8993(00)01971-5; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; Soustiel JF, 2011, PHARM RES-DORDR, V28, P2945, DOI 10.1007/s11095-011-0463-0; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Varga B, 2009, NEUROSCI LETT, V462, P257, DOI 10.1016/j.neulet.2009.06.051; Veiga S, 2005, J NEUROSCI RES, V80, P129, DOI 10.1002/jnr.20430; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021	47	13	13	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 4	2016	329						162	170		10.1016/j.neuroscience.2016.05.014			9	Neurosciences	Neurosciences & Neurology	DO6ZW	WOS:000377933000015	27223627				2021-06-18	
J	Guo, ZN; Shao, AW; Tong, LS; Sun, WY; Liu, J; Yang, Y				Guo, Zhen-Ni; Shao, Anwen; Tong, Lu-Sha; Sun, Weiyi; Liu, Jia; Yang, Yi			The Role of Nitric Oxide and Sympathetic Control in Cerebral Autoregulation in the Setting of Subarachnoid Hemorrhage and Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Cerebral autoregulation; Nitric oxide; Sympathetic nerve; Subarachnoid hemorrhage; Traumatic brain injury	CORTICAL IMPACT INJURY; BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; HEAD-INJURY; SYNTHASE; INHIBITION; VASOSPASM; PRESSURE	Cerebral autoregulation is defined as the mechanism by which constant cerebral blood flow is maintained despite changes of arterial blood pressure, and arterial blood pressure represents the principle aspect of cerebral autoregulation. The impairment of cerebral autoregulation is reported to be involved in several diseases. However, the concept, mechanisms, and pathological dysfunction of cerebral autoregulation are beyond full comprehension. Nitric oxide control and sympathetic control are main contributors to cerebral autoregulation. Although impaired cerebral autoregulation after nitric oxide inhibition or sympathetic ganglia blockade is reported, managing the inhibition or blockade can have negative consequences and needs further exploration. Additionally, impaired cerebral autoregulation following subarachnoid hemorrhage and traumatic brain injury has been proven by several descriptive studies, although without corresponding explanations. As the most important mechanisms of cerebral autoregulation, the changes of nitric oxide and sympathetic stimulation play significant roles in these insults. Therefore, the in-depth researches of nitric oxide and sympathetic nerve in cerebral autoregulation may help to develop new therapeutic targets.	[Guo, Zhen-Ni; Yang, Yi] Jilin Univ, Dept Neurol, Neurosci Ctr, Hosp 1, Xinmin St 71, Changchun 130021, Peoples R China; [Shao, Anwen] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Tong, Lu-Sha] Zhejiang Univ, Sch Med, Dept Neurol, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Sun, Weiyi] Jilin Univ, Coll Automobile Engn, Changchun, Peoples R China; [Liu, Jia] Chinese Acad Sci, Shenzhen Inst Adv Technol, Xueyuan Ave, Shenzhen, Peoples R China	Yang, Y (corresponding author), Jilin Univ, Dept Neurol, Neurosci Ctr, Hosp 1, Xinmin St 71, Changchun 130021, Peoples R China.	doctor_yangyi@hotmail.com	Shao, Anwen/L-4860-2019; 邵, 安文/R-9023-2019	Shao, Anwen/0000-0001-5616-0394; Shao, Anwen/0000-0001-9986-6290	Jilin Provincial government [440020031172]; Youth development foundation of First Hospital of Jilin University	This article was supported by Jilin Provincial government (Changbai mountain scholars, 440020031172) to Yi Yang and Youth development foundation of First Hospital of Jilin University to Zheni-Ni Guo.	Aguado F, 2002, J NEUROSCI, V22, P9430; Ainslie PN, 2012, J APPL PHYSIOL, V113, P1058, DOI 10.1152/japplphysiol.00463.2012; Ainslie Philip N, 2014, F1000Prime Rep, V6, P14, DOI 10.12703/P6-14; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Azevedo E, 2011, CLIN AUTON RES, V21, P395, DOI 10.1007/s10286-011-0129-3; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Banki NM, 2005, CIRCULATION, V112, P3314, DOI 10.1161/CIRCULATIONAHA.105.558239; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; BOHLEN HG, 1984, CIRC RES, V55, P554, DOI 10.1161/01.RES.55.4.554; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Carrera E, 2009, J NEUROL SCI, V285, P191, DOI 10.1016/j.jns.2009.06.041; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Claassen JAHR, 2011, J CEREBR BLOOD F MET, V31, P1572, DOI 10.1038/jcbfm.2011.69; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Ding D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/727428; EDVINSSON L, 1975, STROKE, V6, P525, DOI 10.1161/01.STR.6.5.525; EKLOF B, 1971, ACTA PHYSIOL SCAND, V82, P172, DOI 10.1111/j.1748-1716.1971.tb04956.x; Gierthmuhlen J, 2011, ACTA NEUROL SCAND, V123, P332, DOI 10.1111/j.1600-0404.2010.01424.x; Gommer ED, 2008, PHYSIOL MEAS, V29, P1293, DOI 10.1088/0967-3334/29/11/005; GORDON RD, 1967, J CLIN INVEST, V46, P599, DOI 10.1172/JCI105561; Guo ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104849; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Hamner JW, 2014, STROKE, V45, P1771, DOI 10.1161/STROKEAHA.114.005293; Hamner JW, 2012, J PHYSIOL-LONDON, V590, P6343, DOI 10.1113/jphysiol.2012.245100; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jordan J, 2000, HYPERTENSION, V36, P383, DOI 10.1161/01.HYP.36.3.383; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kajita Y, 1998, NEUROSURGERY, V42, P834, DOI 10.1097/00006123-199804000-00087; Kim H, 2014, INT J NANOMED, V9, P155, DOI 10.2147/IJN.S48856; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Liu P, 2013, BRAIN RES, V1522, P67, DOI 10.1016/j.brainres.2013.05.032; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Mathew RJ, 1997, PSYCHIAT RES-NEUROIM, V74, P93, DOI 10.1016/S0925-4927(97)03106-5; MCCARRON JG, 1989, BLOOD VESSELS, V26, P315; Moussouttas M, 2014, J CLIN NEUROSCI, V21, P256, DOI 10.1016/j.jocn.2013.03.036; Murkin JM, 2007, SEMIN CARDIOTHORAC V, V11, P269, DOI 10.1177/1089253207311159; Osuka K, 2012, NEUROSCI LETT, V514, P2, DOI 10.1016/j.neulet.2011.12.041; Otite F, 2014, STROKE, V45, P677, DOI 10.1161/STROKEAHA.113.002630; Papadimos Thomas J, 2008, J Trauma Manag Outcomes, V2, P1, DOI 10.1186/1752-2897-2-1; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Phillips AA, 2013, BRAIN SCI, V3, P781, DOI 10.3390/brainsci3020781; Preckel MP, 1996, INT J MICROCIRC, V16, P277, DOI 10.1159/000179186; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Sabri M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017062; Sabri M, 2011, J CEREBR BLOOD F MET, V31, P190, DOI 10.1038/jcbfm.2010.76; SAGAWA K, 1961, AM J PHYSIOL, V200, P711; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Tan CO, 2014, EXP PHYSIOL, V99, P3, DOI 10.1113/expphysiol.2013.072355; TANAKA K, 1993, NEUROREPORT, V4, P267, DOI 10.1097/00001756-199303000-00010; Terashvili M, 2006, PEDIATR CLIN N AM, V53, P1029, DOI 10.1016/j.pcl.2006.08.003; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Thompson BG, 1996, J NEUROSURG, V84, P71, DOI 10.3171/jns.1996.84.1.0071; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vellimana AK, 2011, STROKE, V42, P776, DOI 10.1161/STROKEAHA.110.607200; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; White RP, 2000, CLIN SCI, V99, P555, DOI 10.1042/CS20000064; Zhang HL, 2012, NEUROSCI BULL, V28, P723, DOI 10.1007/s12264-012-1282-y; Zhang R, 2004, AM J PHYSIOL-HEART C, V286, pH863, DOI 10.1152/ajpheart.00373.2003; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Zhang R, 2007, STROKE, V38, P1238, DOI 10.1161/01.STR.0000260095.94175.d0	74	13	13	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2016	53	6					3606	3615		10.1007/s12035-015-9308-x			10	Neurosciences	Neurosciences & Neurology	DR2AO	WOS:000379707600009	26108186				2021-06-18	
J	Hanks, RA; Rapport, LJ; Perrine, BW; Millis, SR				Hanks, Robin A.; Rapport, Lisa J.; Perrine, Brigid Waldron; Millis, Scott R.			Correlates of Resilience in the First 5 Years After Traumatic Brain Injury	REHABILITATION PSYCHOLOGY			English	Article						traumatic brain injury; resilience; psychosocial; positive psychology	SPINAL-CORD-INJURY; STRESSFUL LIFE EVENTS; SCALE CD-RISC; NEGATIVE AFFECT; REHABILITATION; PERSONALITY; ADULTS; TRAJECTORIES; PREDICTORS; DISTRESS	Purpose/Objective: To examine resilience in the context of adjustment to traumatic brain injury (TBI), including the relative roles of demographic and theoretically related constructs such as coping, social support, and positive affectivity on resilience within the first 5 years postinjury. Research Method/Design: This was a cross-sectional, observational study of 67 persons with medically documented mild complicated to severe TBI. Participants completed a battery of measures including cognitive tests; questionnaires assessing self-report of emotional symptoms, perceived social support, and coping style; and a measure of resilience. Results: Approximately 60% of the sample endorsed moderate to high levels of resilience during the first 5 years postinjury. Brain injury severity, premorbid intelligence, and cognitive flexibility did not predict resilience, as measured by the Connor-Davidson Resilience Scale. By contrast, task-oriented coping and perceived social support were strong and unique covariates of resilience. Positive and negative affectivity were related to resilience but were not unique covariates of it in the presence of task-oriented coping and perceived social support. Discriminant validity of resilience as a concept and the means of assessing it was supported by findings that emotion-oriented and avoidance coping were not meaningfully related to resilience. Conclusions/Implications: Overall, the findings indicate that the majority of individuals in this sample reported high levels of resilience after brain injury and that correlates of resilience in adults with TBI is similar to that observed in adults without the history of cognitive impairment. Impact and Implications Although there has been a great deal of discussion about why people do well after brain injury during the postacute period of recovery after traumatic brain, there is a paucity of data on resilience in this population. This exploratory study is the first to examine the relationship between demographic, brain injury characteristics, and theoretically related constructs with regard to resilience after moderate to severe traumatic brain injury. The study lays the foundation for understanding resiliency in this rehabilitation population. In this report, there were high levels of resilience after brain injury, and the level of resilience in adults with TBI was similar to that in adults without cognitive impairment. In rehabilitation settings, assessment of resilience and development of positive coping strategies may be beneficial to recovery. Specifically, evaluation of scores on these measures may be useful in developing treatment plans to improve positive outcomes for persons with traumatic brain injury.	[Hanks, Robin A.; Perrine, Brigid Waldron; Millis, Scott R.] Wayne State Univ, Rehabil Inst Michigan, Dept Phys Med & Rehabil, Detroit, MI 48201 USA; [Rapport, Lisa J.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA	Hanks, RA (corresponding author), Rehabil Inst Michigan, Dept Rehabil Psychol & Neuropsychol, Suite 555,261 Mack Blvd, Detroit, MI 48201 USA.	rhanks@med.wayne.edu			U.S. Department of Education/National Institute on Disability and Rehabilitation Research Grant [H133G080064-10]	This research was supported by U.S. Department of Education/National Institute on Disability and Rehabilitation Research Grant H133G080064-10.	Beasley M, 2003, PERS INDIV DIFFER, V34, P77, DOI 10.1016/S0191-8869(02)00027-2; Bertisch H, 2014, NEUROREHABILITATION, V34, P573, DOI 10.3233/NRE-141059; Black R, 2015, J HEALTH PSYCHOL, V20, P1434, DOI 10.1177/1359105313512879; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Bonanno GA, 2012, SOC SCI MED, V74, P753, DOI 10.1016/j.socscimed.2011.11.022; Burns RA, 2010, PERS INDIV DIFFER, V48, P527, DOI 10.1016/j.paid.2009.11.026; Campbell-Sills L, 2006, BEHAV RES THER, V44, P585, DOI 10.1016/j.brat.2005.05.001; Catalano D, 2011, REHABIL PSYCHOL, V56, P200, DOI 10.1037/a0024571; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cutrona CE., 1987, ADV PERSONAL RELATIO, V1, P37; Daniels JK, 2012, J CLIN PSYCHIAT, V73, P327, DOI 10.4088/JCP.10m06293; Elisei S, 2013, PSYCHIAT DANUB, V25, pS263; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; Gilbert DT, 2004, PSYCHOL SCI, V15, P346, DOI 10.1111/j.0956-7976.2004.00681.x; Green KT, 2014, ADDICT BEHAV, V39, P406, DOI 10.1016/j.addbeh.2013.08.024; Hanks RA, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P218; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hayter MR, 2014, SPINAL CORD, V52, P167, DOI 10.1038/sc.2013.152; Hjemdal O, 2012, SCAND J PSYCHOL, V53, P174, DOI 10.1111/j.1467-9450.2011.00928.x; JENNETT B, 1976, LANCET, V307, P1031; Jones TG, 2003, CLIN NEUROPSYCHOL, V17, P3, DOI 10.1076/clin.17.1.3.15626; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KERCHER K, 1992, RES AGING, V14, P131, DOI 10.1177/0164027592142001; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; Lyons JA., 1991, J TRAUMA STRESS, V4, P93, DOI [DOI 10.1007/BF00976011, 10.1002/jts.2490040108, DOI 10.1002/JTS.2490040108]; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McWilliams LA, 2003, J CLIN PSYCHOL, V59, P423, DOI 10.1002/jclp.10080; Monden KR, 2014, SPINAL CORD, V52, P197, DOI 10.1038/sc.2013.159; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; Padesky CA, 2012, CLIN PSYCHOL PSYCHOT, V19, P283, DOI 10.1002/cpp.1795; Psychological Corporation, 2001, WECHSLER TEST ADULT; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Sells D, 2009, CHRONIC ILLN, V5, P92, DOI 10.1177/1742395309104166; Shin JI, 2012, ANN REHABIL MED-ARM, V36, P815, DOI 10.5535/arm.2012.36.6.815; Snyder CR, 2006, REHABIL PSYCHOL, V51, P89, DOI 10.1037/0090-5550.51.2.89; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Waldron-Perrine B, 2011, REHABIL PSYCHOL, V56, P107, DOI 10.1037/a0023552; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; White JH, 2012, ANN FAM MED, V10, P435, DOI 10.1370/afm.1374; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Wingo AP, 2014, J PSYCHIATR RES, V51, P93, DOI 10.1016/j.jpsychires.2014.01.007; Wolfson D., 1993, HALSTEAD REITAN NEUR; Wrenn GL, 2011, J NATL MED ASSOC, V103, P560, DOI 10.1016/S0027-9684(15)30381-3; Zannas AS, 2014, NEUROSCIENCE, V264, P157, DOI 10.1016/j.neuroscience.2013.12.003	51	13	14	1	27	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2016	61	3					269	276		10.1037/rep0000069			8	Psychology, Clinical; Rehabilitation	Psychology; Rehabilitation	DV9HR	WOS:000383251900006	26855130				2021-06-18	
J	Kuhn, AW; Zuckerman, SL; Totten, D; Solomon, GS				Kuhn, Andrew W.; Zuckerman, Scott L.; Totten, Douglas; Solomon, Gary S.			Performance and Style of Play After Returning From Concussion in the National Hockey League	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						ice hockey; National Hockey League; concussion; athletic performance	4TH INTERNATIONAL-CONFERENCE; ELITE ICE HOCKEY; CONSENSUS STATEMENT; NOVEMBER 2012; KING-DEVICK; INJURIES; OUTCOMES; SPORT; FOOTBALL; ZURICH	Background: Few studies have empirically examined outcomes of concussion in the National Hockey League (NHL) and whether these athletes return to games after concussion at a performance level comparable to preconcussion play. Hypothesis: NHL players would not demonstrate changes in performance or style of play after returning from a concussion when compared with a group of control athletes. Study Design: Cohort study; Level of evidence, 3. Methods: NHL players with a reported hockey-related concussion during the 2008-2009 through 2014-2015 seasons were identified utilizing secondary media sources. Players who missed games for non-injury related causes were selected as the control group. Performance was operationally defined as the statistics for goals, assists, points, plus-minus, and shots, and style of play was operationally defined as the statistics for penalty minutes, blocked shots, hits, giveaways, and time on ice. Each gameplay statistic was recorded and totaled for the 5 games before and after each players injury or absence. After meeting strict inclusion criteria, the 2 groups were compared across each postconcussion/absence statistic by generalized linear models while incorporating the particular preconcussion/absence statistic, position played, games missed, and concussion history as covariates to control for intraplayer and between-group differences. Results: A total of 287 players sustained a concussion; 130 missed time for non-injury related reasons and were identified as controls. After the exclusion criteria were applied, 94 concussed players were compared with 58 controls. None of the models reached statistical significance, indicating that the concussion and control groups did not differ across performance or style of play after returning from a concussion or non-injury related absence. Conclusions: When compared with a control group, players who returned to consistent play after concussion did not demonstrate changes in performance or style of play.	[Kuhn, Andrew W.; Zuckerman, Scott L.; Totten, Douglas; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Kuhn, Andrew W.] Univ Michigan Hlth Syst, MedSport Sports Med & Phys Therapy, Ann Arbor, MI USA; [Zuckerman, Scott L.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Totten, Douglas] Carleton Coll, Minneapolis, MN USA	Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Solomon, Gary/K-9011-2019; Kuhn, Andrew W/AAM-4820-2020	Kuhn, Andrew W/0000-0003-1836-7575	Department of DefenseUnited States Department of Defense	One or more of the authors has declared the following potential conflict of interest or source of funding: A.W.K.'s father is the team physician for the National Hockey League's Nashville Predators Hockey Club. G.S.S. serves as the team neuropsychologist for the National Hockey League's Nashville Predators Hockey Club. However, no funding was received for this study, and neither the Nashville Predators nor the National Hockey League had any input into the design, execution, analysis, or decision to pursue or publish this study. G.S.S. is a consultant for University of Tennessee and Tennessee Tech Athletics, and Tennessee Titans; all monies paid to institution. He is a consultant for a Department of Defense grant, paid to institution.	Agel J, 2010, CAN J SURG, V53, P319; Amin NH, 2013, AM J SPORT MED, V41, P1864, DOI 10.1177/0363546513490659; [Anonymous], 2013, IBM SPSS STAT COMP P; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Brooks DA, 2007, NEUROREHABILITATION, V22, P169; Clark J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048925; Comper P, 2013, BRIT J SPORT MED, V47, pe1; Donaldson L, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041016; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Forward KE, 2014, PAED CHILD HEALT-CAN, V19, P418, DOI 10.1093/pch/19.8.418; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gray R, 2004, J EXP PSYCHOL-APPL, V10, P42, DOI 10.1037/1076-898X.10.1.42; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; HOLM S, 1979, SCAND J STAT, V6, P65; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; Jakoi A, 2013, AM J SPORT MED, V41, P107, DOI 10.1177/0363546512462679; Kuhn AW, 2015, CONCUSSION, P1; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Kutac P, 2015, J HUM KINET, V45, P187, DOI 10.1515/hukin-2015-0019; Kuzuhara K, 2009, J ATHL TRAINING, V44, P208, DOI 10.4085/1062-6050-44.2.208; LORENTZON R, 1988, AM J SPORT MED, V16, P389, DOI 10.1177/036354658801600414; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Milzman D, 2014, BRIT J SPORT MED, V48, P639; Muraskin J., 2013, 7 ANN MIT SLOAN SPOR; Radlo SJ, 2001, RES Q EXERCISE SPORT, V72, P22, DOI 10.1080/02701367.2001.10608928; Schroeder GD, 2013, AM J SPORT MED, V41, P2604, DOI 10.1177/0363546513499229; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596	31	13	13	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	AUG	2016	44	8					2152	2157		10.1177/0363546516638327			6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	DU4UM	WOS:000382208100033	27159319				2021-06-18	
J	Szczygielski, J; Gund, SM; Schwerdtfeger, K; Steudel, WI; Oertel, J				Szczygielski, Jacek; Gund, Sina-Maria; Schwerdtfeger, Karsten; Steudel, Wolf-Ingo; Oertel, Joachim			Factors Affecting Outcome in Treatment of Chronic Subdural Hematoma in ICU Patients: Impact of Anticoagulation	WORLD NEUROSURGERY			English	Article						Anticoagulation; Chronic subdural hematoma; Human; Intensive care; Risk factors	RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; BURR-HOLE TREPANATION; ANTITHROMBOTIC THERAPY; WARFARIN USE; CLINICAL ARTICLE; HEAD-INJURIES; RISK-FACTORS; METAANALYSIS; HEMORRHAGE	BACKGROUND: The use of anticoagulants and older age are the main risk factors for chronic subdural hematoma (CSDH). Because the age of the population and use of anticoagulants are increasing, a growing number of CSDH cases is expected. To address this issue, we analyzed the impact of anticoagulants on postsurgical outcome in patients in the intensive care unit (ICU). METHODS: Demographic data, coagulation parameters, surgical details, radiologic appearance of hematoma, Glasgow Coma Scale (GCS) score on admission, and Glasgow Outcome Scale (GOS) score on discharge were retrieved and retrospectively analyzed in 98 patients with CSDH treated in the neurosurgical ICU using correlation coefficient tests and multivariate analysis test. RESULTS: Overall outcome was good (GOS score 4 and 5) in 55.1% of patients. Overall mortality was 9.1%. There was a correlation between GCS score on admission and GOS score. There was no correlation between hematoma thickness/radiologic appearance and impaired coagulation. Disturbance in thrombocyte function (usually resulting from aspirin intake) correlated with improved outcome, whereas warfarin-related coagulopathy correlated with poor recovery. Nevertheless, patients with thrombocytopathy presented with better initial GCS scores. Neither hematoma size nor recurrence rate affected the outcome. CONCLUSIONS: The size of CSDH was not associated with poor outcome and is not necessarily determined by the use of anticoagulants. Coagulopathy does not rule out a good outcome, but the impact of anticoagulation on treatment results in CSDH varies between the main groups of drugs (warfarin vs. antiplatelet drugs). Patients in good neurologic condition on ICU admission have better chances of recovery.	[Szczygielski, Jacek] Univ Saarland, Med Ctr, Dept Neurosurg, Homburg, Saarland, Germany; Univ Saarland, Fac Med, Homburg, Saarland, Germany	Szczygielski, J (corresponding author), Univ Saarland, Med Ctr, Dept Neurosurg, Homburg, Saarland, Germany.	jacek.szczygielski@uks.eu	Oertel, Joachim/AAO-5012-2021	Szczygielski, Jacek/0000-0002-3157-2824			Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Amirjamshidi A, 2007, J CLIN NEUROSCI, V14, P1240, DOI 10.1016/j.jocn.2006.03.030; Andreotti F, 2015, EUR HEART J, V36, P3238, DOI 10.1093/eurheartj/ehv304; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; Baechli H, 2004, NEUROSURG REV, V27, P263, DOI 10.1007/s10143-004-0337-6; Bellut D, 2012, WORLD NEUROSURG, V77, P111, DOI 10.1016/j.wneu.2011.05.036; Borger V, 2012, ACTA NEUROCHIR, V154, P1549, DOI 10.1007/s00701-012-1434-x; Chari A, 2015, J NEUROTRAUMA; Chari A, 2014, BRIT J NEUROSURG, V28, P2, DOI 10.3109/02688697.2013.812184; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; Diamond T, 1988, Br J Neurosurg, V2, P351, DOI 10.3109/02688698809001006; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Forster MT, 2010, J CLIN NEUROSCI, V17, P975, DOI 10.1016/j.jocn.2009.11.023; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; Gonugunta V, 2001, BRIT J NEUROSURG, V15, P514, DOI 10.1080/02688690120097822; Huang YH, 2011, NEUROCRIT CARE, V14, P253, DOI 10.1007/s12028-011-9509-8; Javadi A, 2011, WORLD NEUROSURG, V75, P731, DOI 10.1016/j.wneu.2010.11.042; Jukovic Mirela, 2014, Med Pregl, V67, P277; Kim Junhak, 2015, Korean J Neurotrauma, V11, P63, DOI 10.13004/kjnt.2015.11.2.63; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Ledic Darko, 2014, Coll Antropol, V38, P1195; Lee JY, 2004, SURG NEUROL, V61, P523, DOI 10.1016/j.surneu.2003.10.026; Lega BC, 2010, J NEUROSURG, V113, P615, DOI 10.3171/2009.9.JNS08825; Leroy HA, 2015, J CLIN NEUROSCI, V22, P1895, DOI 10.1016/j.jocn.2015.03.064; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; Liu WM, 2014, J NEUROSURG, V121, P665, DOI 10.3171/2014.5.JNS132715; Marshall AL, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0309-2; MATTLE H, 1989, J NEUROL NEUROSUR PS, V52, P829, DOI 10.1136/jnnp.52.7.829; Miranda LB, 2011, J NEUROSURG, V114, P72, DOI 10.3171/2010.8.JNS10298; Mondorf Y, 2009, BRIT J NEUROSURG, V23, P612, DOI 10.3109/02688690903370297; Mulligan P, 2013, J NEUROSCI RURAL PRA, V4, P250, DOI 10.4103/0976-3147.118760; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Regan JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115085; REYMOND MA, 1992, NEUROSURG REV, V15, P21, DOI 10.1007/BF02352062; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Santarius T, 2010, WORLD NEUROSURG, V73, P747, DOI 10.1016/j.wneu.2010.03.031; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Schwarz F, 2015, CLIN NEUROL NEUROSUR, V138, P66, DOI 10.1016/j.clineuro.2015.08.002; Secil Y, 2014, J STROKE CEREBROVASC, V23, P321, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.008; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; TANAKA A, 1992, NEUROSURGERY, V30, P370, DOI 10.1227/00006123-199203000-00010; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Traynelis V C, 1991, Clin Geriatr Med, V7, P583; Unterhofer C, 2016, WORLD NEUROSURG, V92, P31, DOI 10.1016/j.wneu.2016.04.081; Van der Veken J, 2014, ACTA NEUROCHIR, V156, P981, DOI 10.1007/s00701-014-2042-8; Xu C, 2016, NEUROL MED-CHIR, V56, P62, DOI 10.2176/nmc.ra.2015-0013	51	13	14	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2016	92						426	433		10.1016/j.wneu.2016.05.049			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DX1XI	WOS:000384160300059	27241090				2021-06-18	
J	Cho, YE; Latour, LL; Kim, H; Turtzo, LC; Olivera, A; Livingston, WS; Wang, D; Martin, C; Lai, C; Cashion, A; Gill, J				Cho, Young-Eun; Latour, Lawrence L.; Kim, Hyungsuk; Turtzo, L. Christine; Olivera, Anlys; Livingston, Whitney S.; Wang, Dan; Martin, Christiana; Lai, Chen; Cashion, Ann; Gill, Jessica			Older Age Results in Differential Gene Expression after Mild Traumatic Brain Injury and Is Linked to Imaging Differences at Acute Follow-up	FRONTIERS IN AGING NEUROSCIENCE			English	Article						traumatic brain injury; aging; inflammation; gene expression; imaging	ACTIVATION; DISEASE; CELLS; TRANSCRIPTOME; INFLAMMATION; METAANALYSIS; MICROARRAY; PREDICTION; RECOVERY; CORTEX	Older age consistently relates to a lesser ability to fully recover from a traumatic brain injury (TBI); however, there is limited data to explicate the nature of age-related risks. This study was undertaken to determine the relationship of age on gene-activity following a TBI, and how this biomarker relates to changes in neuroimaging findings. A young group (between the ages of 19 and 35 years), and an old group (between the ages of 60 and 89 years) were compared on global gene-activity within 48 h following a TBI, and then at follow-up within 1-week. At each time-point, gene expression profiles, and imaging findings from both magnetic resonance imaging (MRI) and computed tomography were obtained and compared. The young group was found to have greater gene expression of inflammatory regulatory genes at 48 h and 1-week in genes such as basic leucine zipper transcription factor 2 (BACH2), leucine-rich repeat neuronal 3 (LRRN3), and lymphoid enhancer-binding factor 1 (LEF1) compared to the old group. In the old group, there was increased activity in genes within S100 family, including calcium binding protein P (S100P) and S100 calcium binding protein A8 (S100A8), which previous studies have linked to poor recovery from TBI. The old group also had reduced activity of the noggin (NOG) gene, which is a member of the transforming growth factorT supertamily and is linked to neurorecovery and neuroregeneration compared to the young group. We link these gene expression findings that were validated to neuroimaging, reporting that in the old group with a MRI finding of TBI-related damage, there was a lesser likelihood to then have a negative MRI finding at follow-up compared to the young group. Together, these data indicate that age impacts gene activity following a TBI, and suggest that this differential activity related to immune regulation and neurorecovery contributes to a lesser likelihood of neuronal recovery in older patients as indicated through neuroimaging.	[Cho, Young-Eun; Kim, Hyungsuk; Olivera, Anlys; Livingston, Whitney S.; Wang, Dan; Martin, Christiana; Lai, Chen; Cashion, Ann; Gill, Jessica] NINR, NIH, Bethesda, MD 20892 USA; [Latour, Lawrence L.; Turtzo, L. Christine] Natl Inst Neurol Disorders, NIH, Bethesda, MD USA	Cashion, A; Gill, J (corresponding author), NINR, NIH, Bethesda, MD 20892 USA.	ann.cashion@nih.gov; gillj@mail.nih.gov	Gill, Gill M/Q-2020-2017; Latour, Larry/AAH-5663-2021	Latour, Larry/0000-0001-6160-5263; Martin, Christiana/0000-0002-4484-6134	Intramural Research Program of National Institute of Nursing Research in NIH; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [ZIANS003120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [ZIANR000015, ZIANR000030] Funding Source: NIH RePORTER	This research was supported by the Intramural Research Program of National Institute of Nursing Research in NIH. This research was also supported by the Center for Neuroscience and Regenerative Medicine.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Barr TL, 2011, BIOL RES NURS, V13, P140, DOI 10.1177/1099800410385671; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cao JN, 2010, AGING CELL, V9, P453, DOI 10.1111/j.1474-9726.2010.00569.x; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cribbs DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-179; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Dummula K, 2011, J NEUROSCI, V31, P12068, DOI 10.1523/JNEUROSCI.0013-11.2011; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Ghorbani P, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-18; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Gupta RK, 2016, MOL NEUROBIOL, V53, P3377, DOI 10.1007/s12035-015-9287-y; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; Heinzelmann M, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00198; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; Kumar A, 2013, NEUROBIOL AGING, V34, P1397, DOI 10.1016/j.neurobiolaging.2012.11.013; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lamprecht M.R., 2016, J NEUROTRAUM, DOI [10.1089/neu.2015.4.306, DOI 10.1089/NEU.2015.4.306]; Li P., 2013, IMMUNOLOGICAL MECH T, P9; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; Mellergard P, 2012, J NEUROTRAUM, V29, P112, DOI 10.1089/neu.2010.1732; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; [National Center for Injury Prevention and Control Centers for Disease Control and Prevention [CDC]], 2003, REP C MILD TRAUM BRA; Polychronakos C, 2011, NAT REV GENET, V12, P781, DOI 10.1038/nrg3069; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Remondini D, 2010, MOL BIOSYST, V6, P1983, DOI 10.1039/c004635c; Ritzel RM, 2015, NEUROBIOL AGING, V36, P2153, DOI 10.1016/j.neurobiolaging.2015.02.016; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Samanta J, 2010, STROKE, V41, P357, DOI 10.1161/STROKEAHA.109.565523; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Sherer M, 2015, CLIN NEUROPSYCHOL, V29, P522, DOI 10.1080/13854046.2015.1052763; Staffa K, 2012, J NEUROTRAUM, V29, P2716, DOI 10.1089/neu.2011.2246; Stamova BS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-49; TEASDALE G, 1974, LANCET, V2, P81; Tierney KJ, 2016, J NEUROSURG, V124, P538, DOI 10.3171/2015.4.JNS142440; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yousef H, 2015, STEM CELLS, V33, P1577, DOI 10.1002/stem.1943; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zeevi N, 2010, J AM GERIATR SOC, V58, P1749, DOI 10.1111/j.1532-5415.2010.03011.x; Zhao W, 2013, J ALZHEIMERS DIS, V34, P417, DOI 10.3233/JAD-121894; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	66	13	14	0	8	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	JUL 13	2016	8								168	10.3389/fnagi.2016.00168			11	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	DR6XH	WOS:000380044100001	27468266	DOAJ Gold, Green Published			2021-06-18	
J	Buchele, F; Morawska, MM; Schreglmann, SR; Penner, M; Muser, M; Baumann, CR; Noain, D				Buchele, Fabian; Morawska, Marta M.; Schreglmann, Sebastian R.; Penner, Marco; Muser, Markus; Baumann, Christian R.; Noain, Daniela			Novel Rat Model of Weight Drop-Induced Closed Diffuse Traumatic Brain Injury Compatible with Electrophysiological Recordings of Vigilance States	JOURNAL OF NEUROTRAUMA			English	Article						rat model; sleep recording; TBI; traumatic axonal injury; weight drop	AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; HEAD-INJURY; COGNITIVE DEFICITS; SLEEP; MICE; IMPACT; MEMORY; MILD; BETA	Traumatic brain injury (TBI) is a major cause of persistent disabilities such as sleep-wake disorders (SWD). Rodent studies of SWD after TBI are scarce, however, because of lack of appropriate TBI models reproducing acceleration deceleration forces and compatible with electroencephalography/myography (EEG/EMG)-based recordings of vigilance states. We therefore adapted the Marmarou impact acceleration model to allow for compatibility with EEG-headset implantation. After implantation of EEG/EMG electrodes, we induced closed TBI by a frontal, angular hit with a weight drop device (56 rats, weight 2500 g, fall height 25 cm). Subsequently, we tested our model's usefulness for long-term studies on a behavioral, electrophysiological, and histological level. Neurological, motor, and memory deficits were assessed with the neurological severity score, open field, and novel object recognition tests, respectively. EEG/EMG recordings were performed in both Sham (n = 7) and TBI (n = 7) rats before and 1, 7, and 28 days after trauma to evaluate sleep-wake proportions and post-traumatic implant stability. Histological assessments included hematoxylin and eosin staining for parenchymal damage and hemorrhage and amyloid precursor protein staining for diffuse axonal damage. All rats survived TBI without major neurological or motor deficits. Memory function was impaired after TBI at weeks 1, 2, and 3 and recovered at week 4. EEG implants were stable for at least 1 month and enabled qualitative and quantitative sleep analyses. Histological assessments revealed no major bleedings or necrosis but intense diffuse axonal damage after TBI. This approach fulfills major pre-conditions for experimental TBI models and offers a possibility to electrophysiologically study behavioral states before and after trauma.	[Buchele, Fabian; Morawska, Marta M.; Schreglmann, Sebastian R.; Penner, Marco; Baumann, Christian R.; Noain, Daniela] Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland; [Morawska, Marta M.] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Muser, Markus] Swiss Fed Inst Technol, Working Grp Accid Mech, Zurich, Switzerland	Noain, D (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	daniela.noain@usz.ch		Baumann, Christian/0000-0003-3417-1978; Morawska, Marta/0000-0003-1612-6786; Buechele, Fabian/0000-0001-7091-1676			Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2006, SLEEP, V29, P1339, DOI 10.1093/sleep/29.10.1339; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cam E, 2013, EXP NEUROL, V247, P673, DOI 10.1016/j.expneurol.2013.03.003; Carre E, 2004, J NEUROSCI METH, V140, P23, DOI 10.1016/j.jneumeth.2004.04.037; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fabian Buchele, 2016, J NEUROTRAUM, V33, P1171; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Geeraerts T, 2006, J NEUROTRAUM, V23, P1059, DOI 10.1089/neu.2006.23.1059; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hodor A, 2015, NEUROSCIENCE, V284, P18, DOI 10.1016/j.neuroscience.2014.08.061; Hodor A, 2014, ANN CLIN TRANSL NEUR, V1, P765, DOI 10.1002/acn3.115; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Pierce JES, 1996, J NEUROSCI, V16, P1083; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Thomasy Hannah E., 2016, NEUROBIOLOGY SLEEP C; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	58	13	14	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2016	33	13					1171	+		10.1089/neu.2015.4001			11	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DP2QY	WOS:000378336200383	26414556				2021-06-18	
J	Cai, LS; Qu, BX; Hurtle, BT; Dadiboyena, S; Diaz-Arrastia, R; Pike, VW				Cai, Lisheng; Qu, Baoxi; Hurtle, Bryan T.; Dadiboyena, Sureshbabu; Diaz-Arrastia, Ramon; Pike, Victor W.			Candidate PET Radioligand Development for Neurofibrillary Tangles: Two Distinct Radioligand Binding Sites Identified in Postmortem Alzheimer's Disease Brain	ACS CHEMICAL NEUROSCIENCE			English	Article						Radioligand; in vitro assay; tangle; tau; Alzheimer's disease; PET	BETA-AMYLOID PATHOLOGY; SENILE DEMENTIA; FLORBETAPIR-PET; TAU-PATHOLOGY; PLAQUES; TRACER; TISSUE; DIAGNOSIS; SEVERITY; DEPOSITS	[F-18]THK-523 and [F-18]807 are promising radioligands for imaging neurofibrillary tangles (NFTs) with positron emission tomography (PET) in neurodegenerative diseases, such as Alzheimer's disease (AD) and traumatic brain injury. Although [F-18]THK-523 and [F-18]T807 are considered high-affinity selective radioligands for NFTs, uncertainty has existed as to whether PET radioligands for imaging NFTs bind to the same molecular site because in vitro assays for ligands binding to NFTs have been lacking. We labeled THK-523 and T807 with tritium to serve as reference radioligands for in vitro binding assays with AD brain homogenates for newly synthesized ligands. With these radioligands, we identified two distinct binding sites for small molecules, one site with high affinity for THK-523 and the other with high affinity for T807. Moreover, binding assays with [H-3]PIB confirmed that the two newly identified binding sites are also distinct from the thioflavin-T binding site where all current clinically useful PET radioligands for imaging beta-amyloid plaque bind with high affinity. The two newly identified binding sites are considered to reside on NFTs rather than on beta-amyloid plaques. Furthermore, we applied all three binding assays to a set of newly prepared compounds, based on chain modifications to THK-523. Some compounds with high affinity and selectivity for the THK-523 binding site emerged from this set, including one with amenability to labeling with. fluorine-18, namely, ligand 10b.	[Cai, Lisheng; Hurtle, Bryan T.; Dadiboyena, Sureshbabu; Pike, Victor W.] NIMH, Mol Imaging Branch, NIH, 10 Ctr Dr,Bldg 10,Room B3 C346, Bethesda, MD 20892 USA; [Qu, Baoxi; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Rockville, MD 20851 USA	Cai, LS (corresponding author), NIMH, Mol Imaging Branch, NIH, 10 Ctr Dr,Bldg 10,Room B3 C346, Bethesda, MD 20892 USA.	LishengCai@mail.nih.gov	Pike, Victor/AAJ-4139-2020	Diaz-Arrastia, Ramon/0000-0001-6051-3594	Intramural Research Program of the NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIA-MH0023793]; Henry Jackson Foundation [306135-10.01-60855]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [ZIAMH002793] Funding Source: NIH RePORTER	This research was supported by the Intramural Research Program of the NIH, specifically the NIMH (ZIA-MH0023793), and by the Henry Jackson Foundation (Grant Award Number 306135-10.01-60855).	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cai LS, 2007, CURR MED CHEM, V14, P19, DOI 10.2174/092986707779313471; Carome M, 2011, JAMA-J AM MED ASSOC, V305, P1857, DOI 10.1001/jama.2011.579; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; Clark CM, 2011, JAMA-J AM MED ASSOC, V305, P275, DOI 10.1001/jama.2010.2008; DELAERE P, 1990, NEUROSCI LETT, V116, P87, DOI 10.1016/0304-3940(90)90391-L; DELAERE P, 1989, ACTA NEUROPATHOL, V77, P645, DOI 10.1007/BF00687893; Dickson DW, 1997, NEUROBIOL AGING, V18, pS21, DOI 10.1016/S0197-4580(97)00065-1; DUYCKAERTS C, 1987, ACTA NEUROPATHOL, V73, P167, DOI 10.1007/BF00693783; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Ganzer S, 2003, J NEURAL TRANSM, V110, P1149, DOI 10.1007/s00702-003-0017-7; Hampel H, 2010, EXP GERONTOL, V45, P30, DOI 10.1016/j.exger.2009.10.010; Hampel H, 2009, J CLIN PSYCHIAT, V70, P922, DOI 10.4088/JCP.08m04606; Harada R, 2016, J NUCL MED, V57, P208, DOI 10.2967/jnumed.115.164848; Harada R, 2015, EUR J NUCL MED MOL I, V42, P1052, DOI 10.1007/s00259-015-3035-4; KATZMAN R, 1988, ANN NEUROL, V23, P138, DOI 10.1002/ana.410230206; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lemoine L, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0220-4; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Miyata O, 2008, TETRAHEDRON, V64, P1270, DOI 10.1016/j.tet.2007.11.081; Ni RQ, 2013, BRAIN, V136, P2217, DOI 10.1093/brain/awt142; Okamura N, 2005, J NEUROSCI, V25, P10857, DOI 10.1523/JNEUROSCI.1738-05.2005; Rowe CC, 2007, NEUROLOGY, V68, P1718, DOI 10.1212/01.wnl.0000261919.22630.ea; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rowe CC, 2013, J NUCL MED, V54, P880, DOI 10.2967/jnumed.112.114785; Selkoe DJ, 2001, PHYSIOL REV, V81, P741; Stocklin G., 1993, RADIOPHARMACEUTICALS; Szardenings AK, 2012, Patent, Patent No. [US/ 2012/ 0302755 A1, 0302755]; van Wieringen JP, 2014, J MED CHEM, V57, P391, DOI 10.1021/jm401384w; Wolk DA, 2011, ARCH NEUROL-CHICAGO, V68, P1398, DOI 10.1001/archneurol.2011.153; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712; Zhuang ZP, 2001, J MED CHEM, V44, P1905, DOI 10.1021/jm010045q	39	13	13	0	17	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-7193			ACS CHEM NEUROSCI	ACS Chem. Neurosci.	JUL	2016	7	7					897	911		10.1021/acschemneuro.6b00051			15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Neurosciences	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Neurosciences & Neurology	DS0OV	WOS:000380297500007	27171905	Green Accepted			2021-06-18	
J	Chiaravalloti, ND; Sandry, J; Moore, NB; DeLuca, J				Chiaravalloti, Nancy D.; Sandry, Joshua; Moore, Nancy B.; DeLuca, John			An RCT to Treat Learning Impairment in Traumatic Brain Injury: The TBI-MEM Trial	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; new learning; memory; cognitive rehabilitation	SYSTEMS BEHAVIOR SCALE; OF-THE-LITERATURE; COGNITIVE REHABILITATION; MULTIPLE-SCLEROSIS; EVERYDAY MEMORY; VISUAL-IMAGERY; HEAD-INJURY; PERFORMANCE; DEFICITS; RECOMMENDATIONS	Objective. To examine the efficacy of the modified Story Memory Technique (mSMT) to improve learning (ie, acquisition) and memory in participants with TBI. The mSMT is a behavioral intervention that teaches context and imagery to facilitate learning within 10 sessions over 5 weeks. Methods. A total of 69 participants with moderate-severe Traumatic Brain Injury (TBI), 35 in the treatment group and 34 in the placebo control group, completed this double-blind, placebo-controlled randomized clinical trial. A baseline neuropsychological assessment was administered, including questionnaires assessing everyday memory. Repeat assessments were conducted immediately posttreatment and 6 months following treatment. Participants in the treatment group were randomly assigned to a booster session or a non-booster session group after completion of treatment with the mSMT to examine the efficacy of monthly booster sessions in facilitating the treatment effect over time. Results. The treatment group demonstrated significant improvement on a prose memory task relative to the placebo group posttreatment ((2) = 0.064 medium effect). Similar results were noted on objective measures of everyday memory, specifically prospective memory (Cohen's w = 0.43, medium effect), and family report of disinhibition in daily life ((2) = 0.046, medium effect). Conclusion. The mSMT is effective for improving learning and memory in TBI. Classification of evidence. Based on widely accepted classification systems for treatment study design, this study provides class I evidence that the mSMT behavioral intervention improves both objective memory and everyday memory in persons with TBI over 5 weeks. Thus, this study extends the evidence for efficacy of the treatment protocol to a sample of persons with TBI.	[Chiaravalloti, Nancy D.; Sandry, Joshua; Moore, Nancy B.; DeLuca, John] Kessler Fdn, W Orange, NJ USA; [Chiaravalloti, Nancy D.; Sandry, Joshua; DeLuca, John] Rutgers State Univ, Newark, NJ 07102 USA	Chiaravalloti, ND (corresponding author), Kessler Fdn, Traumat Brain Injury Res, 300 Execut Dr,Suite 70, W Orange, NJ 07052 USA.	nchiaravalloti@kesslerfoundation.org		Chiaravalloti, Nancy/0000-0003-2943-7567	NIDRR [H133A070037]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The contents of this article were developed under the NIDRR Grant H133A070037. However, these contents do not necessarily represent the policy of the Department of Education, and endorsement by the Federal Government should not be assumed.	Allen DN, 1998, J REHABIL RES DEV, V35, P405; Allen DN, 1995, INT J REHABIL HLTH, V1, P189, DOI DOI 10.1007/BF02214731; American Association of Neurologic Surgeons, 2007, GUID MAN SEV HEAD IN; Ball K, 2007, J GERONTOL B-PSYCHOL, V62, P19, DOI 10.1093/geronb/62.special_issue_1.19; Berg I. J., 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI [DOI 10.1080/09602019108401384, 10.1080/09602019108401384]; BOLLER F, 1966, BRAIN, V89, P815, DOI 10.1093/brain/89.4.815; Bourgeois MS, 2007, BRAIN INJURY, V21, P1245, DOI 10.1080/02699050701727452; Brewer GA, 2011, CONSCIOUS COGN, V20, P901, DOI 10.1016/j.concog.2011.02.015; Chiaravalloti ND, 2013, NEUROLOGY, V81, P2066, DOI 10.1212/01.wnl.0000437295.97946.a8; Chiaravalloti ND, 2012, J NEUROL, V259, P1337, DOI 10.1007/s00415-011-6353-x; Chiaravalloti N, 2009, CLIN NEUROPSYCHOL, V23, P231, DOI 10.1080/13854040802121158; Chiaravalloti ND, 2005, MULT SCLER, V11, P58, DOI 10.1191/1352458505ms1118oa; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; Delis DC, 2000, CALIFORNIA VERBAL LE; DeLuca J, 2000, ARCH PHYS MED REHAB, V81, P1327, DOI 10.1053/apmr.2000.9390; Deshpande SA, 1996, J CLIN EXP NEUROPSYC, V18, P836, DOI 10.1080/01688639608408306; Diamond BJ, 1997, BRAIN, V120, P1015, DOI 10.1093/brain/120.6.1015; Dou ZL, 2006, BRAIN INJURY, V20, P219, DOI 10.1080/02699050500488215; Ernst A, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/820240; Flavia M, 2010, J NEUROL SCI, V288, P101, DOI 10.1016/j.jns.2009.09.024; Glosser G, 2002, NEUROPSYCHOLOGY, V16, P190, DOI 10.1037//0894-4105.16.2.190; Goldstein G, 1996, CLIN NEUROPSYCHOL, V10, P66, DOI 10.1080/13854049608406664; GOLDSTEIN G, 1988, CLIN NEUROPSYCHOL, V2, P251; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Grilli MD, 2011, NEUROPSYCHOL REHABIL, V21, P847, DOI 10.1080/09602011.2011.627263; Hancock LM, 2015, J CLIN EXP NEUROPSYC, V37, P113, DOI 10.1080/13803395.2014.989818; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Karzmark P, 2012, APPL NEUROPSYCH-ADUL, V19, P81, DOI 10.1080/09084282.2011.643942; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Kerner M, 1985, COGNIT REHABIL, V11, P26; Krupp LB, 2011, NEUROLOGY, V76, P1500, DOI 10.1212/WNL.0b013e318218107a; Kurz A, 2009, INT J GERIATR PSYCH, V24, P163, DOI 10.1002/gps.2086; Lange G, 2000, ARCH PHYS MED REHAB, V81, P89, DOI 10.1016/S0003-9993(00)90227-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leavitt VM, 2014, BRAIN IMAGING BEHAV, V8, P394, DOI 10.1007/s11682-012-9183-2; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Lezak MD, 1995, NEUROPSYCHOLOGICAL A; Ludbrook J, 2013, CLIN EXP PHARMACOL P, V40, P357, DOI 10.1111/1440-1681.12086; McKinlay W, 1999, REHABILITATION ADULT, V3, P74; MILLIS SR, 1994, J CLIN EXP NEUROPSYC, V16, P498, DOI 10.1080/01688639408402661; NINDS Common Data Elements, TRAUMATIC BRAIN INJU; Ownsworth TL, 1999, BRAIN INJURY, V13, P605, DOI 10.1080/026990599121340; Potvin MJ, 2011, NEUROPSYCHOL REHABIL, V21, P899, DOI 10.1080/09602011.2011.630882; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Rosenthal M, 2000, HDB REHABILITATION P; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Sandry J., NEURODEGENE IN PRESS; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; SCHMITTEREDGECOMBE M, 1995, J CONSULT CLIN PSYCH, V63, P484; STALLINGS G, 1995, J CLIN EXP NEUROPSYC, V17, P706, DOI 10.1080/01688639508405160; Thoene A I, 1995, J Int Neuropsychol Soc, V1, P29; Tiersky LA, 2005, ARCH PHYS MED REHAB, V86, P1565, DOI 10.1016/j.apmr.2005.03.013; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Vanderploeg RD, 2014, J CLIN EXP NEUROPSYC, V36, P58, DOI 10.1080/13803395.2013.864600; Velikonja D, 2014, J HEAD TRAUMA REHAB, V29, P369, DOI 10.1097/HTR.0000000000000069; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams JM, 1991, MEMORY ASSESSMENT SC; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946; Wu JH, 2012, FRONT HUM NEUROSCI, V6, DOI [10.3389/fnhum.2012.00305, 10.3389/fnhum.2012.00314]	68	13	13	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUL	2016	30	6					539	550		10.1177/1545968315604395			12	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DP3VE	WOS:000378423100004	26359341				2021-06-18	
J	Ciulli, S; Citi, L; Salvadori, E; Valenti, R; Poggesi, A; Inzitari, D; Mascalchi, M; Toschi, N; Pantoni, L; Diciotti, S				Ciulli, Stefano; Citi, Luca; Salvadori, Emilia; Valenti, Raffaella; Poggesi, Anna; Inzitari, Domenico; Mascalchi, Mario; Toschi, Nicola; Pantoni, Leonardo; Diciotti, Stefano			Prediction of Impaired Performance in Trail Making Test in MCI Patients With Small Vessel Disease Using DTI Data	IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS			English	Article						Diffusion tensor imaging; executive functions; machine learning; mild cognitive impairment; neuroimaging	MILD COGNITIVE IMPAIRMENT; UNDERLIES EXECUTIVE DYSFUNCTION; ISCHEMIC VASCULAR-DISEASE; TRAUMATIC BRAIN-INJURY; DIFFUSION TENSOR MRI; WHITE-MATTER; LEUKOARAIOSIS; DAMAGE; DISCONNECTION; REGISTRATION	Mild cognitive impairment (MCI) is a common condition in patients with diffuse hyperintensities of cerebral white matter (WM) in T2-weightedmagnetic resonance images and cerebral small vessel disease (SVD). In MCI due to SVD, the most prominent feature of cognitive impairment lies in degradation of executive functions, i.e., of processes that supervise the organization and execution of complex behavior. The trail making test is a widely employed test sensitive to cognitive processing speed and executive functioning. MCI due to SVD has been hypothesized to be the effect of WM damage, and diffusion tensor imaging (DTI) is a well-established technique for in vivo characterization of WM. We propose a machine learning scheme tailored to 1) predicting the impairment in executive functions in patients with MCI and SVD, and 2) examining the brain substrates of this impairment. We employed data from 40 MCI patients with SVD and created feature vectors by averaging mean diffusivity (MD) and fractional anisotropy maps within 50 WM regions of interest. We trained support vector machines (SVMs) with polynomial as well as radial basis function kernels using different DTI-derived features while simultaneously optimizing parameters in leave-one-out nested cross validation. The best performance was obtained using MD features only and linear kernel SVMs, which were able to distinguish an impaired performance with high sensitivity (72.7%-89.5%), specificity (71.4%-83.3%), and accuracy (77.5%-80.0%). While brain substrates of executive functions are still debated, feature ranking confirm that MD in several WM regions, not limited to the frontal lobes, are truly predictive of executive functions.	[Ciulli, Stefano] Univ Florence, Dept Clin & Expt Biomed Sci, I-50134 Florence, Italy; [Ciulli, Stefano; Citi, Luca] Univ Essex, Sch Comp Sci & Elect Engn, Colchester CO4 3SQ, Essex, England; [Ciulli, Stefano; Toschi, Nicola] Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, I-00173 Rome, Italy; [Salvadori, Emilia; Valenti, Raffaella; Poggesi, Anna; Inzitari, Domenico; Pantoni, Leonardo] Univ Florence, Neurosci Sect, NEUROFARBA Dept, I-50134 Florence, Italy; [Mascalchi, Mario] Univ Florence, Dept Clin & Expt Biomed Sci, I-50134 Florence, Italy; [Toschi, Nicola] Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02129 USA; [Diciotti, Stefano] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, I-47521 Cesena, Italy	Ciulli, S (corresponding author), Univ Florence, Dept Clin & Expt Biomed Sci, I-50134 Florence, Italy.; Ciulli, S (corresponding author), Univ Essex, Sch Comp Sci & Elect Engn, Colchester CO4 3SQ, Essex, England.; Ciulli, S (corresponding author), Univ Roma Tor Vergata, Med Phys Sect, Dept Biomed & Prevent, I-00173 Rome, Italy.	stefano.ciulli@gmail.com; lciti@essex.ac.uk; emilia.salvadori@unifi.it; raffyvalenti@gmail.com; anna.poggesi@unifi.it; domenico.inzitari@unifi.it; m.mascalchi@dfc.unifi.it; toschi@med.uniroma2.it; leonardo.pantoni@unifi.it; stefano.diciotti@unibo.it	Valenti, Raffaella/AAB-7974-2019; Inzitari, Domenico/AAH-8722-2020; Salvadori, Emilia/B-1115-2013; Poggesi, Anna/AAK-5492-2021; Toschi, Nicola/J-2555-2012; Diciotti, Stefano/C-4167-2008; Citi, Luca/G-2270-2011	Valenti, Raffaella/0000-0002-4975-3754; Salvadori, Emilia/0000-0003-0404-0053; Toschi, Nicola/0000-0003-1929-5833; Diciotti, Stefano/0000-0001-8778-7819; Ciulli, Stefano/0000-0002-9386-3088; Citi, Luca/0000-0001-8702-5654	Tuscany Region (Italy); Italian Health Ministry (Bando Ricerca Finalizzata) [RF-2010-2321706, NCT02033850]	This work was supported in part by Tuscany Region (Italy) and in part by the Italian Health Ministry (Bando Ricerca Finalizzata 2010, Grant number: RF-2010-2321706, ClinicalTrials.gov Identifier: NCT02033850, PI Leonardo Pantoni).	Alpaydin E., 2010, INTRO MACHINE LEARNI; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Arsigny V, 2006, MAGN RESON MED, V56, P411, DOI 10.1002/mrm.20965; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bishop CM., 2006, PATTERN RECOGNITION; Bishop CM., 1995, NEURAL NETWORKS PATT; Bondi MW, 2014, J INT NEUROPSYCH SOC, V20, P129, DOI 10.1017/S1355617714000010; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Cohen JR, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00075; Cook P. A., 2006, 14 SCI M INT SOC MAG, P2759; Della Nave R, 2007, AM J NEURORADIOL, V28, P1313, DOI 10.3174/ajnr.A0555; Diciotti S, 2013, AM J NEURORADIOL, V34, pE107, DOI 10.3174/ajnr.A3685; FILLEY CM, 2001, BEHAV NEUROLOGY WHIT; Ghosh SS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00004; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Goveas J, 2015, MAGN RESON IMAGING, V33, P853, DOI 10.1016/j.mri.2015.04.006; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Haykin Simon, 1998, NEURAL NETWORKS COMP; Jokinen H, 2007, J NEUROL NEUROSUR PS, V78, P491, DOI 10.1136/jnnp.2006.096792; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Lamar M, 2008, NEUROPSYCHOLOGIA, V46, P2597, DOI 10.1016/j.neuropsychologia.2008.04.007; Lamar M, 2009, BEHAV NEUROL, V22, P53, DOI 10.3233/BEN-2009-0237; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lin L, 2015, J MOL NEUROSCI, V56, P363, DOI 10.1007/s12031-015-0550-5; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Mascalchi M, 2014, HUM BRAIN MAPP, V35, P819, DOI 10.1002/hbm.22216; Meola A, 2015, HUM BRAIN MAPP, V36, P4964, DOI 10.1002/hbm.22990; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nowrangi MA, 2014, J NEUROPSYCH CLIN N, V26, P114, DOI 10.1176/appi.neuropsych.12070176; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; O'Sullivan M, 2004, J NEUROL NEUROSUR PS, V75, P441, DOI 10.1136/jnnp.2003.014910; O'Sullivan M, 2005, NEUROLOGY, V65, P1584, DOI 10.1212/01.wnl.0000184480.07394.fb; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; O'Sullivan M, 2001, NEUROLOGY, V57, P2307, DOI 10.1212/WNL.57.12.2307; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Otsuka Y, 2012, AM J NEURORADIOL, V33, P726, DOI 10.3174/ajnr.A2853; Pantoni L, 2005, NEUROEPIDEMIOLOGY, V24, P51, DOI 10.1159/000081050; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Sachdev PS, 1999, MED J AUSTRALIA, V170, P81, DOI 10.5694/j.1326-5377.1999.tb126889.x; Salvadori E., ALZHEIMERS IN PRESS; Salvadori E, 2015, J ALZHEIMERS DIS, V43, P1313, DOI 10.3233/JAD-141449; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Tuladhar AM, 2015, NEUROIMAGE-CLIN, V7, P518, DOI 10.1016/j.nicl.2015.02.003; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Witten IH, 2011, MOR KAUF D, P1; Xu Q, 2010, DEMENT GERIATR COGN, V30, P317, DOI 10.1159/000320491; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784; Zhou AH, 2009, J INT NEUROPSYCH SOC, V15, P898, DOI 10.1017/S1355617709990816	57	13	15	3	12	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	2168-2194			IEEE J BIOMED HEALTH	IEEE J. Biomed. Health Inform.	JUL	2016	20	4					1026	1033		10.1109/JBHI.2016.2537808			8	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Medical Informatics	Computer Science; Mathematical & Computational Biology; Medical Informatics	DR8DJ	WOS:000380128300007	26960231	Green Accepted			2021-06-18	
J	Mathema, P; Evans, D; Moore, IS; Ranson, C; Martin, R				Mathema, Prabhat; Evans, Daniel; Moore, Isabel S.; Ranson, Craig; Martin, Rhodri			Concussed or Not? An Assessment of Concussion Experience and Knowledge Within Elite and Semiprofessional Rugby Union	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; head injury; signs and symptoms of concussion	SPORTS-RELATED CONCUSSION; PLAYERS; FOOTBALL; HISTORY; STATEMENT; INJURY; ZURICH; HEAD	Objective: The primary aim was to assess experience and knowledge of adult concussion among international, professional and semiprofessional players, coaches, medical staff, and referees within Rugby Union. The secondary aim was to identify preferred education dissemination routes. Design: Questionnaires devised specifically for players, coaches, medical staff, and referees. Setting and Participants: A total of 370 players, 44 coaches, 40 medical staff, and 33 referees from within Wales were surveyed. Main Outcome Measures: Knowledge of the signs and symptoms of concussion, return to play guidelines and consequences of concussion were investigated along with experiences of, and attitudes towards, concussion. Results: The respondents had extensive experience of sustaining or witnessing rugby-related concussion. Medical staff had the greatest level of concussion knowledge, with coaches having the least. Players and coaches exhibited a disconnection between being "knocked-out" and practically applying this when managing concussion. Almost half of the players and coaches did not indicate concussion could impair performance. Eighty percent of medical staff had felt pressured to clear a concussed player. Most players (82%), coaches (66%), and referees (64%) incorrectly believed protective equipment prevents concussion. Players and coaches prefer concussion education from medical staff, whereas medical staff and referees prefer such education from governing body Web sites or training courses. Conclusions: Several role-specific misconceptions and deficiencies in concussion knowledge were identified and should be targeted through education. Medical staff had the highest level of concussion knowledge and were the preferred sources of education for players and coaches. Therefore, they are encouraged to play a greater role in providing concussion education.	[Mathema, Prabhat; Ranson, Craig] Welsh Rugby Union, Med Serv, Cardiff, S Glam, Wales; [Evans, Daniel] Cardiff Univ, Sch Med, Cardiff, S Glam, Wales; [Evans, Daniel] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Moore, Isabel S.; Ranson, Craig] Cardiff Metropolitan Univ, Cardiff Sch Sport, Sports Injury Res Grp, Cyncoed Campus, Cardiff CF23 6XD, S Glam, Wales; [Martin, Rhodri] Cwm Taf Univ, Hlth Board, Sport & Exercise Med, Abercynon, Wales	Moore, IS (corresponding author), Cardiff Metropolitan Univ, Cardiff Sch Sport, Sports Injury Res Grp, Cyncoed Campus, Cardiff CF23 6XD, S Glam, Wales.	imoore@cardiffmet.ac.uk	Ranson, Craig/AAQ-5452-2020	Moore, Isabel/0000-0002-4746-3390; Ranson, Craig/0000-0002-3783-0505	Welsh Rugby Union	The study was funded by the Welsh Rugby Union.	Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Craton N, 2014, CLIN J SPORT MED, V24, P93, DOI 10.1097/JSM.0000000000000023; Cusimano MD, 2009, CAN J NEUROL SCI, V36, P315, DOI 10.1017/S0317167100007046; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2013, BRIT J SPORT MED, V47, P1184, DOI 10.1136/bjsports-2012-091155; Fuller GW, 2015, BRIT J SPORT MED, V49, P529, DOI 10.1136/bjsports-2014-093498; Hagglund M, 2013, BRIT J SPORT MED, V47, P738, DOI 10.1136/bjsports-2013-092215; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; IRB, IRB CONC MAN; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McLeod TCV, 2007, CLIN J SPORT MED, V17, P140; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moore IS, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115596194; Mrazik M, 2011, CLIN J SPORT MED, V21, P315, DOI 10.1097/JSM.0b013e31821e2b78; National Institute for Health and Care Excellence (NICE), 2007, BEH CHANG PRINC EFF; RFU, CONC RET PLAY; RFU, 2014, ENGL PROF RUGB INJ S; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; Tremblay S, 2014, BRAIN, V137, P2997, DOI 10.1093/brain/awu236; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; WRU, CONC REC REM DOWNL G	34	13	13	0	24	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JUL	2016	26	4					320	325		10.1097/JSM.0000000000000256			6	Orthopedics; Physiology; Sport Sciences	Orthopedics; Physiology; Sport Sciences	DQ8DC	WOS:000379438300010	26513391	Green Accepted			2021-06-18	
J	Yorke, AM; Littleton, S; Alsalaheen, BA				Yorke, Amy M.; Littleton, Sheila; Alsalaheen, Bara A.			Concussion Attitudes and Beliefs, Knowledge, and Clinical Practice: Survey of Physical Therapists	PHYSICAL THERAPY			English	Article							INTERNATIONAL-CONFERENCE; VESTIBULAR REHABILITATION; CONSENSUS STATEMENT; SPORT CONCUSSION; MANAGEMENT; EDUCATION; PLAYERS; ZURICH; HEADS	Background. A concussion is considered a mild traumatic brain injury that may cause physical, cognitive, affective, and sleep dysfunction. Physical therapists have been identified as health care providers involved in the multidisciplinary care of a patient with concussion. Objective. The purpose of this study was to describe the current attitudes and beliefs, knowledge, and practice of physical therapists in the treatment of patients with concussion. Methods. A 55-question electronic survey divided into 6 sections (1) demographics, (2) current practice in concussion, (3) youth concussion legislation, (4) attitudes and beliefs toward concussion management, (5) concussion knowledge, and (6) clinical decision making was developed and distributed online through selected American Physical Therapy Association sections. Results. A total of 1,272 physical therapists completed the survey. Seventy percent of the respondents (n=894) reported having concussion training. Although supportive of the role of the physical therapist in the treatment of a person with concussion, the respondents demonstrated less confidence when making return-to-play decisions. Respondents correctly answered, on average, 13 (out of 15) concussion knowledge questions, with gaps exhibited in understanding the clinical utilization of concussion severity scales, the conservative treatment of youth who sustain a concussion, and anticipated normal computed tomography and magnetic resonance imaging after a concussion. When provided with clinical scenarios, respondents were able to recognize when a referral to a physician was indicated; however, they demonstrated variability in identifying a need for vestibular or manual physical therapy. Limitations. Convenience sampling was utilized, limiting generalizability of the results of the study to the physical therapy profession as a whole. Conclusion. Physical therapists demonstrated a solid foundation of concussion knowledge, but gaps still existed. Future professional development opportunities should be developed to target identified gaps in knowledge and current practice patterns.	[Yorke, Amy M.; Alsalaheen, Bara A.] Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA; [Littleton, Sheila] Dept Intellectual & Dev Disabil, Nashville, TN USA	Yorke, AM (corresponding author), Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA.	amyorke@umflint.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313			Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Adler RH, 2011, PHYS MED REH CLIN N, V22, P721, DOI 10.1016/j.pmr.2011.08.010; Ajzen I., 2005, ATTITUDES PERSONALIT, P117; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; American Physical Therapy Association, 2012, PHYS THER ROL MAN PE; American Youth Soccer Organization, CONC INF; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Borich MR, 2013, J NEUROL PHYS THER, V37, P133, DOI 10.1097/NPT.0b013e31829f7460; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carl RL, 2014, CLIN PEDIATR, V53, P689, DOI 10.1177/0009922814526979; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, CONC IN SPORTS; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Dessy AM., 2015, NEUROSURG QUART, V25, P423, DOI [10.1097/WNQ.0000000000000085, DOI 10.1097/WNQ.0000000000000085]; Dillman D.A., 2009, INTERNET MAIL MIXED; Giebel S, 2011, J EMERG MED, V41, P649, DOI 10.1016/j.jemermed.2011.03.021; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Jones CA, 2015, PHYS THER, V95, P663, DOI 10.2522/ptj.20130512; Lebrun CM, 2013, BRIT J SPORT MED, V47, P54, DOI 10.1136/bjsports-2012-091480; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; McGlashan AJ, 2010, SPORTS MED, V40, P841, DOI 10.2165/11534960-000000000-00000; McGrann P., 2012, RCSI STUD MED J, V5, P33; Menon A, 2009, J REHABIL MED, V41, P1024, DOI 10.2340/16501977-0451; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; National Conference of State Legislatures, TRAUM BRAIN INJ YOUT; National Football League, 2014, 2014 PLAY HLTH SAF R; Pardini D., 2004, BR J SPORTS MED, V38, P661; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Wainwright SF, 2011, PHYS THER, V91, P87, DOI 10.2522/ptj.20100161; White PE, 2014, BRIT J SPORT MED, V48, P119, DOI 10.1136/bjsports-2013-092785; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	43	13	13	0	19	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	JUL	2016	96	7					1018	1028		10.2522/ptj.20140598			11	Orthopedics; Rehabilitation	Orthopedics; Rehabilitation	DQ1RK	WOS:000378977900011	26637654	Bronze			2021-06-18	
J	Hu, JZ; Yang, ZM; Li, XN; Lu, HB				Hu, Jianzhong; Yang, Zhiming; Li, Xiaoning; Lu, Hongbin			C-C motif chemokine ligand 20 regulates neuroinflammation following spinal cord injury via Th17 cell recruitment	JOURNAL OF NEUROINFLAMMATION			English	Article						Spinal cord injury; Neuroinflammation; CCL20; Th17; Chemokine; Flow cytometry	INFLAMMATORY RESPONSE; CONSEQUENCES; REGENERATION; EXPRESSION; BRAIN	Background: Spinal cord injury (SCI) is a severe traumatic injury that often leads to paralysis. The neuroinflammation following SCI plays an important role during the secondary injury phase. C-C motif chemokine ligand 20 (CCL20) works like a magnet to attract inflammatory cells and subsequently regulate inflammation. However, the role and mechanisms of CCL20 in neuroinflammation following traumatic injury are poorly understood. Methods: A modified Allen's weight drop method was applied to induce a rat moderate contusion injury model. HE staining was used to assess spinal cord histopathology, and the water content test was used to estimate spinal cord edema. Motor function scores were quantified to evaluate locomotor ability, and leukocyte infiltration was observed by CD45 immunofluorescence and flow cytometry. Additionally, qRT-PCR and ELISA were used to determine inflammatory mediator gene expression. Th17 cell recruitment was identified by flow cytometry. Results: Compared with the injury control groups, histological analysis of the lesion area and tissue edema revealed reduced spinal cord edema and decreased lesion volume in the group administrated with CCL20 neutralizing antibody. Locomotor activity, as assessed by Basso, Beattie, and Bresnahan (BBB) score, showed that CCL20 blockade was beneficial for motor function recovery. Results also showed that leukocyte infiltration was reduced by neutralizing CCL20 at 7 days post-injury. More importantly, expression levels of IL-1 beta, IL-6, and TNF-alpha at 24 h after SCI demonstrated that a reduced inflammatory reaction in the CCL20 antibody group compared with the injury controls. Although CCL20 altered the expression of IL-1 beta, IL-6, and TNF-alpha, it had no effect on anti-inflammatory IL-10 expression at 24 h after damage. Notably, tissue flow cytometry confirmed that Th17 cell recruitment in the CCL20 antibody group was decreased compared with the control groups at 14 days post-injury. Additionally, IL-17A expression, which is mainly secreted by Th17 cell, suggested that CCL20 blockade also reduced IL-17A levels at 14 days after SCI. Conclusions: These results suggested that CCL20 aggravates neuroinflammation following SCI via regulation of Th17 cell recruitment and IL-17A level. Thus, CCL20-target therapy could be a promising clinical application for the treatment of SCI.	[Li, Xiaoning; Lu, Hongbin] Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China; [Hu, Jianzhong; Yang, Zhiming] Cent S Univ, Xiangya Hosp, Dept Spine Surg, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China	Lu, HB (corresponding author), Cent S Univ, Xiangya Hosp, Res Ctr Sports Med, Dept Sports Med, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China.	hongbinlu@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698, 81371956]; Specialized Research Fund for the Doctoral Program of Higher EducationSpecialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130162110078]	This work was supported by grants from the National Natural Science Foundation of China (No. 81171698 and No. 81371956) and from the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20130162110078).	Alcaide P, 2012, J IMMUNOL, V188, P1421, DOI 10.4049/jimmunol.1101647; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bethea JR, 2000, PROG BRAIN RES, V128, P33; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blight AR, 2002, NAT NEUROSCI, V5, P1051, DOI 10.1038/nn939; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; David Samuel, 2012, Handb Clin Neurol, V109, P485, DOI 10.1016/B978-0-444-52137-8.00030-9; Dohlman TH, 2013, INVEST OPHTH VIS SCI, V54, P4081, DOI 10.1167/iovs.12-11216; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Fee D, 2003, J NEUROIMMUNOL, V136, P54, DOI 10.1016/S0165-5728(03)00008-0; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Ge R, 2013, BRAIN RES, V1527, P40, DOI 10.1016/j.brainres.2013.06.009; Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7; Gris D, 2004, J NEUROSCI, V24, P4043, DOI 10.1523/JNEUROSCI.5343-03.2004; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hu JZ, 2013, J NEUROTRAUM, V30, P1349, DOI 10.1089/neu.2012.2748; Kuypers NJ, 2013, EXP NEUROL, V247, P615, DOI 10.1016/j.expneurol.2013.02.014; Leonardo CC, 2012, TRANSL STROKE RES, V3, P357, DOI 10.1007/s12975-012-0203-8; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Meng T, 2014, PLOS ONE, V9; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Morishima Y, 2013, CLIN DEV IMMUNOL, V2013, P162; National Spinal Cord Injury Statistical Center, 2013, J Spinal Cord Med, V36, P1, DOI 10.1179/1079026813Z.000000000136; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Schnell L, 1999, EUR J NEUROSCI, V11, P3648, DOI 10.1046/j.1460-9568.1999.00792.x; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Terao Y, 2009, NEUROSCI RES, V64, P75, DOI 10.1016/j.neures.2009.01.017; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Yin YQ, 2006, NAT NEUROSCI, V9, P843, DOI 10.1038/nn1701; Yu M, 2013, CELL PHYSIOL BIOCHEM, V32, P1437, DOI 10.1159/000356581	41	13	15	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1742-2094		J NEUROINFLAMM	J. Neuroinflamm.	JUN 23	2016	13								162	10.1186/s12974-016-0630-7			14	Immunology; Neurosciences	Immunology; Neurosciences & Neurology	DQ0BW	WOS:000378863800001	27334337	DOAJ Gold, Green Published			2021-06-18	
J	Baratz-Goldstein, R; Deselms, H; Heim, LR; Khomski, L; Hoffer, BJ; Atlas, D; Pick, CG				Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael; Khomski, Lena; Hoffer, Barry J.; Atlas, Daphne; Pick, Chaim G.			Thioredoxin-Mimetic-Peptides Protect Cognitive Function after Mild Traumatic Brain Injury (mTBI)	PLOS ONE			English	Article							N-ACETYLCYSTEINE AMIDE; NECROSIS-FACTOR-ALPHA; FOCAL CEREBRAL-ISCHEMIA; ALLERGIC AIRWAY DISEASE; NEURONAL CELL-DEATH; OXIDATIVE STRESS; RAT-BRAIN; MITOCHONDRIAL BIOENERGETICS; NEURODEGENERATIVE DISEASES; DOPAMINERGIC-NEURONS	Mild traumatic brain injury (mTBI) is recognized as a common injury among children, sportsmen, and elderly population. mTBI lacks visible objective structural brain damage but patients frequently suffer from long-lasting cognitive, behavioral and emotional difficulties associated with biochemical and cellular changes. Currently there is no effective treatment for patients with mTBI. The thioredoxin reductase/thioredoxin pathway (TrxR/Trx1) has both anti-inflammatory and anti-oxidative properties. If the system is compromised, Trx1 remains oxidized and triggers cell death via an ASK1-Trx1 signal transduction mechanism. We previously showed tri and tetra peptides which were derived from the canonical -CxxC- motif of the Trx1-active site, called thioredoxin mimetic (TXM) peptides, reversed inflammatory and oxidative stress damage mimicking Trx1 activity. Here, TXM-peptides were examined for protecting cognitive function following weight drop closed-head injury in a mouse model of mTBI. TXM-CB3 (AcCys-Pro-CysNH(2)), TXM-CB13 (DY-70; AcCys-Met-Lys-CysNH(2)) or AD4 (ACysNH(2)) were administered at 50 mg/kg, 60 min after injury and cognitive performance was monitored by the novel-object-recognition and Y-maze tests. Behavioral deficits subsequent to mTBI injury were reversed by a single dose of TXM-CB3, TXM-CB13 and, to a lesser extent, by AD4. TXM-CB13 similar to TXM-CB3 and AD4 reversed oxidative stress-induced phosphorylation of mitogen-activated kinases, p38(MAPK) and c-Jun N-terminal kinase, (JNK) in human neuronal SH-SY5Y cells. We conclude that significantly improved cognitive behavior post mTBI by the TXM-peptides could result from anti-apoptotic, and/or anti-inflammatory activities. Future preclinical studies are required to establish the TXM-peptides as potential therapeutic drugs for brain injuries.	[Baratz-Goldstein, Renana; Deselms, Hanna; Heim, Leore Raphael] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Khomski, Lena; Atlas, Daphne] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Baratz-Goldstein, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel.; Atlas, D (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	renanaba@post.tau.ac.il; daphne.atlas@mail.huji.ac.il	Meijer, Anna/K-5118-2016		Ari and Regine Aprijaskis Fund at Tel-Aviv University; H.L Lauterbach Fund (Hebrew University)	This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University) to DA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Ari and Regine Aprijaskis Fund at Tel-Aviv University, and by The H.L Lauterbach Fund (Hebrew University).	Allen JW, 1999, FASEB J, V13, P1875; Amer J, 2008, BBA-GEN SUBJECTS, V1780, P249, DOI 10.1016/j.bbagen.2007.11.009; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bachnoff N, 2011, FREE RADICAL BIO MED, V50, P1355, DOI 10.1016/j.freeradbiomed.2011.02.026; Bahat-Stroomza M, 2005, EUR J NEUROSCI, V21, P637, DOI 10.1111/j.1460-9568.2005.03889.x; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cohen-Kutner M, 2014, REDOX BIOL, V2, P447, DOI 10.1016/j.redox.2013.12.018; Cohen-Kutner M, 2013, BIOCHEM PHARMACOL, V85, P977, DOI 10.1016/j.bcp.2013.01.003; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; DELLU F, 1992, BRAIN RES, V588, P132, DOI 10.1016/0006-8993(92)91352-F; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; FAN PY, 1995, CLIN IMMUNOL IMMUNOP, V75, P125, DOI 10.1006/clin.1995.1061; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Finme JW, 2008, VET PATHOL, V45, P307, DOI 10.1354/vp.45-3-307; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Frankola KA, 2011, CNS NEUROL DISORD-DR, V10, P391; Grinberg L, 2005, FREE RADICAL BIO MED, V38, P136, DOI 10.1016/j.freeradbiomed.2004.09.025; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054163; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Kim SR, 2011, AM J RESP CRIT CARE, V183, P1015, DOI 10.1164/rccm.200906-0902OC; Kronenfeld G, 2015, FREE RADICAL BIO MED, V79, P138, DOI 10.1016/j.freeradbiomed.2014.11.021; Lee KS, 2007, EXP MOL MED, V39, P756, DOI 10.1038/emm.2007.82; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nakamura T, 2016, TRENDS PHARMACOL SCI, V37, P73, DOI 10.1016/j.tips.2015.10.002; Offen D, 2004, J NEUROCHEM, V89, P1241, DOI 10.1111/j.1471-4159.2004.02428.x; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Shenk JC, 2009, J NEUROL SCI, V283, P199, DOI 10.1016/j.jns.2009.03.002; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Stelmasiak Z, 2000, Med Sci Monit, V6, P426; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Yan MS, 2008, NEOPLASIA, V10, P160, DOI 10.1593/neo.07935; Zaitone SA, 2012, PHARMACOL BIOCHEM BE, V100, P347, DOI 10.1016/j.pbb.2011.09.002; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008; Zohar J, 2003, CNS SPECTR, V8, P634, DOI 10.1017/S1092852900008798	59	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2016	11	6							e0157064	10.1371/journal.pone.0157064			19	Multidisciplinary Sciences	Science & Technology - Other Topics	DO1UG	WOS:000377564000037	27285176	DOAJ Gold, Green Published			2021-06-18	
J	Baron, DM; Hochrieser, H; Metnitz, PGH; Mauritz, W				Baron, David Marek; Hochrieser, Helene; Metnitz, Philipp G. H.; Mauritz, Walter			Tracheostomy is associated with decreased hospital mortality after moderate or severe isolated traumatic brain injury	WIENER KLINISCHE WOCHENSCHRIFT			English	Article						Isolated traumatic brain injury; Tracheostomy; Hospital mortality; Outcome	INTRACRANIAL-PRESSURE; INTENSIVE-CARE; PERCUTANEOUS TRACHEOSTOMY; MECHANICAL VENTILATION; TRACHEOTOMY; IMPACT; METAANALYSIS; INTUBATION; SYSTEM; SCORE	Data regarding the impact and timing of tracheostomy in patients with isolated traumatic brain injury (TBI) are ambiguous. Our goal was to evaluate the impact of tracheostomy on hospital mortality in patients with moderate or severe isolated TBI. We performed a retrospective cohort analysis of data prospectively collected at 87 Austrian intensive care units (ICUs). All patients continuously admitted between 1998 and 2010 were evaluated for the study. In total, 4,735 patients were admitted to ICUs with isolated TBI. Of these patients, 2,156 had a moderate or severe TBI (1,603 patients were endotracheally intubated only, 553 patients underwent tracheostomy). Epidemiological data (trauma severity, treatment, and outcome) of the two groups were compared. Patients with moderate or severe isolated TBI undergoing tracheostomy had a similar Glasgow Coma Scale score, median (interquartile range): 6 (3-8) vs 6 (3-8); p = 0.90, and Simplified Acute Physiology Score II, 45 (37-54) vs 45 (35-56); p = 0.86, compared with intubated patients not undergoing tracheostomy. Furthermore, patients undergoing tracheostomy exhibited higher Abbreviated Injury Scale Head scores and had a longer ICU stay for survivors, 30 (22-42) vs 9 (3-17) days; p < 0.0001). In contrast, risk-adjusted mortality was lower in patients undergoing tracheostomy compared with patients who remained intubated, observed-to-expected mortality ratio (95 % confidence interval): 0.62 (0.53-0.72) vs 1.00 (0.95-1.05) respectively. Despite the greater severity of head injury, patients with isolated TBI who underwent tracheostomy had a lower risk-adjusted mortality than patients who remained intubated. Reasons for this difference in outcome may be multifactorial and require further investigation.	[Baron, David Marek; Metnitz, Philipp G. H.] Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Managemen, Vienna, Austria; [Hochrieser, Helene] Med Univ Vienna, Dept Med Stat, Vienna, Austria; [Metnitz, Philipp G. H.] Med Univ Graz, Dept Anesthesiol & Intens Care Med, Graz, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Dept Anesthesia & Crit Care Med, Vienna, Austria	Metnitz, PGH (corresponding author), Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Managemen, Vienna, Austria.	philipp@metnitz.biz					Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Alali AS, 2014, J TRAUMA ACUTE CARE, V76, P6; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; DAMELIO LF, 1994, AM SURGEON, V60, P180; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Silva BNG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub2; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Imperiale C, 2009, ANESTH ANALG, V108, P588, DOI 10.1213/ane.0b013e31818f601b; Kluger Y, 1996, Eur J Emerg Med, V3, P95, DOI 10.1097/00063110-199606000-00007; Kocaeli H, 2008, ACTA NEUROCHIR, V150, P1263, DOI 10.1007/s00701-008-0153-9; Lane PL, 2000, CAN J SURG, V43, P442; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LESNIK I, 1992, AM SURGEON, V58, P346; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Metnitz PGH, 1999, CRIT CARE MED, V27, P1486, DOI 10.1097/00003246-199908000-00014; Metnitz PGH, 1997, WIEN KLIN WOCHENSCHR, V109, P132; Milanchi S, 2008, J TRAUMA, V65, P73, DOI 10.1097/TA.0b013e31814693f2; Miranda DR, 1996, CRIT CARE MED, V24, P64, DOI 10.1097/00003246-199601000-00012; Nieszkowska A, 2005, CRIT CARE MED, V33, P2527, DOI 10.1097/01.CCM.0000186898.58709.AA; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Rizk EB, 2011, NEUROCRIT CARE, V15, P481, DOI 10.1007/s12028-011-9615-7; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2000, INTENS CARE MED, V26, P1101, DOI 10.1007/s001340051324; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; TEASDALE G, 1974, LANCET, V2, P81; Teoh WHL, 2001, ANN ACAD MED SINGAP, V30, P234; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Wang F, 2011, CHEST, V140, P1456, DOI 10.1378/chest.11-2024; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Young D, 2013, JAMA-J AM MED ASSOC, V309, P2121, DOI 10.1001/jama.2013.5154	38	13	13	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0043-5325	1613-7671		WIEN KLIN WOCHENSCHR	Wien. Klin. Wochen.	JUN	2016	128	11-12					397	403		10.1007/s00508-016-1004-y			7	Medicine, General & Internal	General & Internal Medicine	DP8WY	WOS:000378779800001	27220338	Other Gold, Green Published			2021-06-18	
J	Cepeda, S; Gomez, PA; Castano-Leon, AM; Munarriz, PM; Paredes, I; Lagares, A				Cepeda, Santiago; Gomez, Pedro A.; Maria Castano-Leon, Ana; Munarriz, Pablo M.; Paredes, Igor; Lagares, Alfonso			Contrecoup Traumatic Intracerebral Hemorrhage: A Geometric Study of the Impact Site and Association with Hemorrhagic Progression	JOURNAL OF NEUROTRAUMA			English	Article						contrecoup; contusion; intracerebral hematoma; TICH; traumatic brain injury	SEVERE HEAD-INJURY; FINITE-ELEMENT-ANALYSIS; BRAIN-INJURY; CEREBRAL CONTUSIONS; RISK-FACTORS; EXTRADURAL HEMATOMA; DATA-BASE; MECHANISM; BIOMECHANICS; CONCUSSION	Traumatic intracerebral hemorrhage (TICH) represents 13-48% of the lesions after a traumatic brain injury (TBI). The frequency of TICH-hemorrhagic progression (TICH-HP) is estimated to be approximately 38-63%. The relationship between the impact site and TICH location has been described in many autopsy-based series. This association, however, has not been consistently demonstrated since the introduction of computed tomography (CT) for studying TBI. This study aimed to determine the association between the impact site and TICH location in patients with moderate and severe TBI. We also analyzed the associations between the TICH location, the impact site, the production mechanism (coup or contrecoup), and hemorrhagic progression. We retrospectively analyzed the records of 408 patients after a moderate or severe TBI between January 2010 and November 2014. We identified 177 patients with a total of 369 TICHs. We found a statistically significant association between frontal TICHs and impact sites located on the anterior area of the head (OR 5.8, p<0.001). The temporal TICH location was significantly associated with impact sites located on the posterior head area (OR 4.9, p<0.001). Anterior and lateral TICHs were associated with impact sites located at less than 90 degrees (coup) (OR 1.64, p=0.03) and more than 90 degrees (contrecoup), respectively. Factors independently associated with TICH-HP obtained through logistic regression included an initial volume of <1cc, cisternal compression, falls, acute subdural hematoma, multiple TICHs, and contrecoup TICHs. We demonstrated a significant association between the TICH location and impact site. The contrecoup represents a risk factor independently associated with hemorrhagic progression.	[Cepeda, Santiago; Gomez, Pedro A.; Maria Castano-Leon, Ana; Munarriz, Pablo M.; Paredes, Igor; Lagares, Alfonso] Univ Complutense Madrid, Hosp 12 Octubre, Dept Neurosurg, Madrid, Spain	Cepeda, S (corresponding author), Hosp 12 Octubre, Dept Neurosurg, Avda Cordoba S-N, E-28041 Madrid, Spain.	cepeda_santiago@hotmail.com	Castano-Leon, Ana M/ABF-6322-2020; Munarriz, Pablo M/S-3398-2018; Lagares, Alfonso/B-2969-2011; Sansinenea, Igor Paredes/S-6281-2019; Gomez, Pedro/N-5051-2019; Cepeda, Santiago/AAE-3200-2021	Castano-Leon, Ana M/0000-0002-7918-5049; Munarriz, Pablo M/0000-0002-9888-7046; Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238; Cepeda, Santiago/0000-0003-1667-8548	Mutua Madrilena Foundation (Spain) [2010-007]; FIS - Instituto de Salud Carlos III (ISCIII)Instituto de Salud Carlos III [PI14/01457]; FEDEREuropean Commission	This study was funded by grant no. 2010-007 from the Mutua Madrilena Foundation (Spain) to Pedro A. Gomez, MD, PhD, and by grant FIS PI14/01457 co-financed by Instituto de Salud Carlos III (ISCIII) and FEDER. Portions of this work were presented in abstract form as proceedings at the XX Congress of the Spanish Society of Neurological Surgery, Pamplona, Spain, May 19, 2015.	Adams F, 1849, GENUINE WORKS HIPPOC; ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; [Anonymous], 1996, J Neurosurg Sci, V40, P11; BALASUBRAMANIAM V, 1991, SURG NEUROL, V36, P462, DOI 10.1016/0090-3019(91)90161-2; Besenski N, 1996, NEURORADIOLOGY, V38, pS36; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; COURVILLE C B, 1950, Bull Los Angel Neuro Soc, V15, P72; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P22; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; DAWSON SL, 1980, HUM PATHOL, V11, P155, DOI 10.1016/S0046-8177(80)80136-5; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FUKAMACHI A, 1985, ACTA NEUROCHIR, V74, P35, DOI 10.1007/BF01413274; Gean A, 1994, IMAGING HEAD TRAUMA; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gomez PA, 1999, NEUROCIRUGIA, V10, P297; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; GURDJIAN ES, 1958, J NEUROSURG, V15, P125, DOI 10.3171/jns.1958.15.2.0125; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; HIRSCH CS, 1975, J NEUROSURG, V42, P530, DOI 10.3171/jns.1975.42.5.0530; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kurosawa Y, 2009, IEEE ENG MED BIO, P7224, DOI 10.1109/IEMBS.2009.5335260; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; Lobato R. D., 2013, NEUROCIRURGIA, V16, P217; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Makela T, 1965, Suom Laakaril, V20, P1869; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mitsuyama T, 2004, NEUROL MED-CHIR, V44, P584, DOI 10.2176/nmc.44.584; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OKAMOTO H, 1983, SURG NEUROL, V20, P461, DOI 10.1016/0090-3019(83)90028-9; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Pena A, 2005, ACT NEUR S, V95, P333; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Ratnaike TE, 2011, BRIT J NEUROSURG, V25, P410, DOI 10.3109/02688697.2010.548879; Rowbotham G. F., 1945, ACUTE INJURIES HEAD; Sano K, 1967, Neurol Med Chir (Tokyo), V9, P21, DOI 10.2176/nmc.9.21; Sato S, 2009, J CLIN NEUROSCI, V16, P834, DOI 10.1016/j.jocn.2008.08.023; SCHNEIDER RC, 1953, J NEUROSURG, V10, P122, DOI 10.3171/jns.1953.10.2.0122; Servadei F, 2000, NEUROSURGERY, V46, P70; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Stewart O W, 1944, Proc R Soc Med, V37, P381; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; VILALTA J, 1991, REV CLIN ESP, V188, P393; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Yamada SM, 2014, CLIN NEUROL NEUROSUR, V125, P106, DOI 10.1016/j.clineuro.2014.07.021; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	78	13	14	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1034	1046		10.1089/neu.2015.4153			13	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600007	26391755				2021-06-18	
J	Chen, P; Ward, I; Khan, U; Liu, Y; Hreha, K				Chen, Peii; Ward, Irene; Khan, Ummais; Liu, Yan; Hreha, Kimberly			Spatial Neglect Hinders Success of Inpatient Rehabilitation in Individuals With Traumatic Brain Injury: A Retrospective Study	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						hemispatial neglect; traumatic brain injury; rehabilitation outcome; length of stay	UNILATERAL NEGLECT; VISUAL DISORIENTATION; HEMISPATIAL NEGLECT; STROKE PATIENTS; CONSEQUENCES; RELIABILITY; AWARENESS; NETWORKS; WALKING; IMPACT	Background. Current knowledge about spatial neglect and its impact on rehabilitation mostly originates from stroke studies. Objective. To examine the impact of spatial neglect on rehabilitation outcome in individuals with traumatic brain injury (TBI). Methods. The retrospective study included 156 consecutive patients with TBI (73 women; median age = 69.5 years; interquartile range = 50-81 years) at an inpatient rehabilitation facility (IRF). We examined whether the presence of spatial neglect affected the Functional Independence Measure (FIM) scores, length of stay, or discharge disposition. Based on the available medical records, we also explored whether spatial neglect was associated with tactile sensation or muscle strength asymmetry in the extremities and whether specific brain injuries or lesions predicted spatial neglect. Results. In all, 30.1% (47 of 156) of the sample had spatial neglect. Sex, age, severity of TBI, or time postinjury did not differ between patients with and without spatial neglect. In comparison to patients without spatial neglect, patients with the disorder stayed in IRF 5 days longer, had lower FIM scores at discharge, improved slower in both Cognitive and Motor FIM scores, and might have less likelihood of return home. In addition, left-sided neglect was associated with asymmetric strength in the lower extremities, specifically left weaker than the right. Finally, brain injury-induced mass effect predicted left-sided neglect. Conclusions. Spatial neglect is common following TBI, impedes rehabilitation progress in both motor and cognitive domains, and prolongs length of stay. Future research is needed for linking specific traumatic injuries and lesioned networks to spatial neglect and related impairment.	[Chen, Peii] Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA; [Chen, Peii; Ward, Irene; Khan, Ummais; Liu, Yan] Rutgers State Univ, Newark, NJ 07102 USA; [Ward, Irene; Hreha, Kimberly] Kessler Inst Rehabil, W Orange, NJ USA; [Hreha, Kimberly] Columbia Univ, New York, NY USA	Chen, P (corresponding author), Kessler Fdn, 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	PChen@KesslerFoundation.org		Chen, Peii/0000-0002-6724-7046	Kessler Foundation; Wallerstein Foundation for Geriatric Life Improvement	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by the Kessler Foundation and the Wallerstein Foundation for Geriatric Life Improvement.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Appelros P, 2007, ACTA NEUROL SCAND, V116, P15, DOI 10.1111/j.1600-0404.2006.00756.x; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Azouvi P, 1996, NEUROPSYCHOL REHABIL, V6, P133, DOI 10.1080/713755501; Berti A, 2002, NEUROPSYCHOLOGY, V16, P390, DOI 10.1037//0894-4105.16.3.390; BISIACH E, 1990, NEUROLOGY, V40, P1278, DOI 10.1212/WNL.40.8.1278; Brain WR, 1941, BRAIN, V64, P244, DOI 10.1093/brain/64.4.244; Chen P., 2015, KF NAP 2015 MANUAL; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P1458, DOI 10.1016/j.apmr.2015.03.019; Chen PI, 2015, ARCH PHYS MED REHAB, V96, P869, DOI 10.1016/j.apmr.2014.10.023; Chen P, 2012, TOP STROKE REHABIL, V19, P423, DOI 10.1310/tsr1905-423; Chen P, 2012, J NEUROPSYCHOL, V6, P270, DOI 10.1111/j.1748-6653.2012.02028.x; Corbetta M, 2011, ANNU REV NEUROSCI, V34, P569, DOI 10.1146/annurev-neuro-061010-113731; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Gillen R, 2005, ARCH PHYS MED REHAB, V86, P763, DOI 10.1016/j.apmr.2004.10.029; Gutschalk Alexander, 2015, Handb Clin Neurol, V129, P557, DOI 10.1016/B978-0-444-62630-1.00031-7; Halligan PW, 2003, TRENDS COGN SCI, V7, P125, DOI 10.1016/S1364-6613(03)00032-9; Harvey M, 2012, NEUROPSYCHOLOGIA, V50, P1018, DOI 10.1016/j.neuropsychologia.2011.09.030; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Heilman K. M., 2012, INT J CLIN NEUROPSYC, P296; Heilman KM, 2004, FRONT BIOSCI-LANDMRK, V9, P694, DOI 10.2741/1261; Hillis AE, 2006, NEUROSCIENTIST, V12, P153, DOI 10.1177/1073858405284257; Jehkonen M, 2006, RESTOR NEUROL NEUROS, V24, P209; Karnath HO, 2009, CEREB CORTEX, V19, P2331, DOI 10.1093/cercor/bhn250; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LAPLANE D, 1983, J NEUROL NEUROSUR PS, V46, P152, DOI 10.1136/jnnp.46.2.152; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lindell AB, 2007, CLIN NEUROPSYCHOL, V21, P479, DOI 10.1080/13854040600630061; Lisa LP, 2013, NEUROREHABILITATION, V33, P611, DOI 10.3233/NRE-130986; McKenna K, 2006, BRAIN INJURY, V20, P507, DOI 10.1080/02699050600664368; Na DL, 1998, J NEUROL NEUROSUR PS, V64, P331, DOI 10.1136/jnnp.64.3.331; Nijboer TCW, 2014, NEUROREPORT, V25, P1381, DOI 10.1097/WNR.0000000000000277; Nijboer TCW, 2013, CORTEX, V49, P2021, DOI 10.1016/j.cortex.2012.11.006; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Paolucci S, 2001, ARCH PHYS MED REHAB, V82, P743, DOI 10.1053/apmr.2001.23191; Paternostro-Sluga T, 2008, J REHABIL MED, V40, P665, DOI 10.2340/16501977-0235; Pavlovskaya M, 2007, BRAIN COGNITION, V64, P21, DOI 10.1016/j.bandc.2006.10.003; Riddoch G, 1935, BRAIN, V58, P376, DOI 10.1093/brain/58.3.376; Ronchi R, 2012, NEUROPSYCHOLOGY, V26, P588, DOI 10.1037/a0029216; Rousseaux M, 2013, CORTEX, V49, P2607, DOI 10.1016/j.cortex.2013.07.007; Rousseaux M, 2013, NEUROLOGY, V81, P1291, DOI 10.1212/WNL.0b013e3182a823a7; Salvato G, 2014, NEUROPSYCHOLOGY, V28, P706, DOI 10.1037/neu0000062; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P691, DOI 10.1093/cercor/bhs351; TRIGGS WJ, 1994, NEUROLOGY, V44, P1164, DOI 10.1212/WNL.44.6.1164; TROMP E, 1995, NEUROPSYCHOL REHABIL, V5, P319, DOI 10.1080/09602019508401475; Ugur C, 2000, J NEUROL NEUROSUR PS, V69, P649, DOI 10.1136/jnnp.69.5.649; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; WEBSTER JS, 1995, ARCH PHYS MED REHAB, V76, P924, DOI 10.1016/S0003-9993(95)80068-9; Wee JYM, 2008, AM J PHYS MED REHAB, V87, P910, DOI 10.1097/PHM.0b013e31818a58bd; Wilkinson D, 2012, ARCH PHYS MED REHAB, V93, P1191, DOI 10.1016/j.apmr.2012.01.010; Wilson BA, 1991, NEUROPSYCHOL REHABIL, V1, P5, DOI DOI 10.1080/09602019108401377; Yang NYH, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00187	53	13	14	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2016	30	5					451	460		10.1177/1545968315604397			10	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DL6BR	WOS:000375723200007	26338431	Bronze			2021-06-18	
J	Plenger, P; Krishnan, K; Cloud, M; Bosworth, C; Qualls, D; de la Plata, CM				Plenger, Patrick; Krishnan, Kamini; Cloud, Matthew; Bosworth, Chris; Qualls, Devin; de la Plata, Carlos Marquez			fNIRS-based investigation of the Stroop task after TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						fNIRS; TBI; Stroop; Frontal lobe; Interference effect; HbO	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; PREFRONTAL ACTIVATION; FUNCTIONAL MRI; FMRI; INTERFERENCE; PERFORMANCE; DEFICITS; CORTEX; FACILITATION	To evaluate neural changes during a Stroop task among individuals with TBI using functional near-infrared spectroscopy (fNIRS). Thirteen healthy controls and 14 patients with moderate to severe TBI were included in this study. Oxygenated hemoglobin (HbO) was recorded every tenth of a second using a 52-channel fNIRS unit. Data were acquired using a block design during a Stroop task (i.e., Condition A = Dot Color Naming, Condition B = Incongruent Condition). Visual stimuli were presented on a computer monitor. Behaviorally, response accuracy was similar between groups for condition A, but the TBI group made more errors than the control group during condition B. During condition A, the patient group demonstrated significant increases in HbO within bilateral frontal regions compared to controls (p<0.01). When examining the Stroop interference effect (B-A), controls showed increased HbO in bilateral frontal lobes and left inferior parietal region suggesting increased neural response to increased cognitive demand, whereas no differences were detected among the TBI group (p<0.05). No between group differences in latency of HbO response was observed during either condition. While the TBI group performed as accurately as controls on the simpler dot color naming condition of the Stroop task, neural activity was greater within the frontal lobes during this relatively simple task among the TBI group suggesting neural inefficiency. Furthermore, the spatial distribution of neural activity related to the interference effect was not different among patients, suggesting the neural demand for the simpler task was comparable to that of the more cognitive demanding task among the TBI sample. The results suggest that fNIRS can identify frontal lobe inefficiency in TBI commonly observed with fMRI.	[Plenger, Patrick; Krishnan, Kamini; Cloud, Matthew; Qualls, Devin; de la Plata, Carlos Marquez] Pate Rehabil, 2655 Villa Creek Dr,Suite 140, Dallas, TX 75234 USA; [Plenger, Patrick; Krishnan, Kamini; Bosworth, Chris; de la Plata, Carlos Marquez] Univ Texas Southwestern Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Bosworth, Chris; de la Plata, Carlos Marquez] Univ Texas Dallas, Ctr BrainHlth, 2200 W Mockingbird Ln, Dallas, TX 75235 USA	Plenger, P (corresponding author), Pate Rehabil, 2655 Villa Creek Dr,Suite 140, Dallas, TX 75234 USA.; Plenger, P (corresponding author), Univ Texas Southwestern Med Ctr, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	pplenger@paterehab.com					Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Banich MT, 2000, J COGNITIVE NEUROSCI, V12, P988, DOI 10.1162/08989290051137521; Ben-David BM, 2011, J INT NEUROPSYCH SOC, V17, P354, DOI 10.1017/S135561771000175X; Binder JR, 1997, J NEUROSCI, V17, P353; Boas DA, 2004, NEUROIMAGE, V23, pS275, DOI 10.1016/j.neuroimage.2004.07.011; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Coronado VG, 2014, J SAFETY RES, V48, P117, DOI 10.1016/j.jsr.2013.12.006; Devlin JT, 2003, J COGNITIVE NEUROSCI, V15, P71, DOI 10.1162/089892903321107837; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Herrmann MJ, 2004, J NEUROPSYCH CLIN N, V16, P170, DOI 10.1176/appi.neuropsych.16.2.170; Hickok G, 1999, BRAIN LANG, V66, P233, DOI 10.1006/brln.1998.1995; Holtzer R, 2011, J GERONTOL A-BIOL, V66, P879, DOI 10.1093/gerona/glr068; Iidaka T, 2000, COGNITIVE BRAIN RES, V9, P73, DOI 10.1016/S0926-6410(99)00047-6; Indefrey P., 2000, NEW COGNITIVE NEUROS, P845; Lague-Beauvais M, 2013, NEUROIMAGE, V64, P485, DOI 10.1016/j.neuroimage.2012.09.042; MACLEOD CM, 1992, J EXP PSYCHOL GEN, V121, P12, DOI 10.1037/0096-3445.121.1.12; Malec JF., 2005, The Mayo-Portland Adaptability Inventory; MALLOY P, 1993, ARCH CLIN NEUROPSYCH, V8, P185, DOI 10.1016/0887-6177(93)90035-Y; Mani TM, 2007, NEUROCASE, V13, P229, DOI 10.1080/13554790701594862; Morris T, 2010, HANDBOOK OF MEDICAL NEUROPSYCHOLOGY: APPLICATIONS OF COGNITIVE NEUROSCIENCE, P17, DOI 10.1007/978-1-4419-1364-7_2; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Roche RAP, 2004, NEUROSCI LETT, V362, P1, DOI 10.1016/j.neulet.2003.11.064; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Sliwinska MW, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00161; Soeda A, 2005, NEURORADIOLOGY, V47, P501, DOI 10.1007/s00234-005-1372-x; Sozda CN, 2011, INT J PSYCHOPHYSIOL, V82, P97, DOI 10.1016/j.ijpsycho.2011.06.019; Steinbrink J, 2006, MAGN RESON IMAGING, V24, P495, DOI 10.1016/j.mri.2005.12.034; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Topper R, 1998, EXP BRAIN RES, V121, P371, DOI 10.1007/s002210050471; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Yagishita S, 2008, NEUROIMAGE, V41, P1142, DOI 10.1016/j.neuroimage.2008.03.008	40	13	14	4	17	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2016	10	2					357	366		10.1007/s11682-015-9401-9			10	Neuroimaging	Neurosciences & Neurology	DU7JK	WOS:000382390000004	26058665				2021-06-18	
J	Rowell, SE; Fair, KA; Barbosa, RR; Watters, JM; Bulger, EM; Holcomb, JB; Cohen, MJ; Rahbar, MH; Fox, EE; Schreiber, MA				Rowell, Susan E.; Fair, Kelly A.; Barbosa, Ronald R.; Watters, Jennifer M.; Bulger, Eileen M.; Holcomb, John B.; Cohen, Mitchell J.; Rahbar, Mohammad H.; Fox, Erin E.; Schreiber, Martin A.		PROMMTT Study Grp	The Impact of Pre-Hospital Administration of Lactated Ringer's Solution versus Normal Saline in Patients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical management of CNS injury; head trauma; traumatic brain injury	UNCONTROLLED HEMORRHAGIC-SHOCK; HYPERTONIC SALINE; FLUID RESUSCITATION; RENAL-TRANSPLANTATION; CONTROLLED-TRIAL; DOUBLE-BLIND; SWINE MODEL; MANAGEMENT; EXPERIENCE; INFUSION	Lactated Ringer's (LR) and normal saline (NS) are both used for resuscitation of injured patients. NS has been associated with increased resuscitation volume, blood loss, acidosis, and coagulopathy compared with LR. We sought to determine if pre-hospital LR is associated with improved outcome compared with NS in patients with and without traumatic brain injury (TBI). We included patients receiving pre-hospital LR or NS from the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study. Patients with TBI (Abbreviated Injury Scale [AIS] head 3) and without TBI (AIS head 2) were compared. Cox proportional hazards models including Injury Severity Score (ISS), AIS head, AIS extremity, age, fluids, intubation status, and hospital site were generated for prediction of mortality. Linear regression models were generated for prediction of red blood cell (RBC) and crystalloid requirement, and admission biochemical/physiological parameters. Seven hundred ninety-one patients received either LR (n=117) or NS (n=674). Median ISS, AIS head, AIS extremity, and pre-hospital fluid volume were higher in TBI and non-TBI patients receiving LR compared with NS (p<0.01). In patients with TBI (n=308), LR was associated with higher adjusted mortality compared with NS (hazard rate [HR]=1.78, confidence interval [CI] 1.04-3.04, p=0.035). In patients without TBI (n=483), no difference in mortality was demonstrated (HR=1.49, CI 0.757-2.95, p=0.247). Fluid type had no effect on admission biochemical or physiological parameters, 6-hour RBC, or crystalloid requirement in either group. LR was associated with increased mortality compared with NS in patients with TBI. These results underscore the need for a prospective randomized trial comparing pre-hospital LR with NS in patients with TBI.	[Rowell, Susan E.; Fair, Kelly A.; Watters, Jennifer M.; Schreiber, Martin A.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Barbosa, Ronald R.] Legacy Emanuel Hosp & Hlth Ctr, Portland, OR USA; [Bulger, Eileen M.] Univ Washington, Harborview Med Ctr, 325 9Th Ave, Seattle, WA 98104 USA; [Holcomb, John B.; Rahbar, Mohammad H.; Fox, Erin E.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Cohen, Mitchell J.] Univ Calif San Francisco, Med Ctr, San Francisco, CA USA	Fair, KA (corresponding author), Oregon Hlth & Sci Univ, Div Trauma Crit Care & Acute Care Surg, 3181 SW Sam Jackson Pk Rd,Mail Code L611, Portland, OR 97239 USA.	fair@ohsu.edu	Rowell, Susan/S-7480-2019	holcomb, john/0000-0001-8312-9157	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-C-0712]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 RR024148]; Haemonetics Corp.; KCI USA, Inc.; Winkenwerder Co.; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024148] Funding Source: NIH RePORTER	This work was supported by subcontract W81XWH-08-C-0712 from the U.S. Army Medical Research and Materiel Command. Infrastructure for the Data Coordinating Center was supported by Clinical and Translational Science Awards funds of grant UL1 RR024148 from the National Institutes of Health.; Dr. Holcomb has served on the board for Tenaxis, the Regional Advisory Council for Trauma, and the National Trauma Institute; has provided expert testimony for the Department of Justice; and has received grants funded by Haemonetics Corp. and KCI USA, Inc. and consultant fees from The Winkenwerder Co. No additional competing financial interests exist.	Alam HB, 2007, SURG CLIN N AM, V87, P55, DOI 10.1016/j.suc.2006.09.015; American College of Surgeons Committee on Trauma, 2008, ATLS ADV TRAUM LIF S; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Coimbra R, 2006, J TRAUMA, V60, P41, DOI 10.1097/01.ta.0000197417.03460.0a; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; Deree J, 2008, J TRAUMA, V64, P1230, DOI 10.1097/TA.0b013e31816a4391; Deree J, 2007, J TRAUMA, V62, P104, DOI 10.1097/TA.0b013e31802d96cb; Didwania A, 1997, CRIT CARE MED, V25, P1851, DOI 10.1097/00003246-199711000-00024; FELDMAN Z, 1995, J NEUROSURG, V83, P1060, DOI 10.3171/jns.1995.83.6.1060; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Fox EE, 2013, J TRAUMA ACUTE CARE, V75, pS3, DOI 10.1097/TA.0b013e31828fa3a0; Healey MA, 1998, J TRAUMA, V45, P894, DOI 10.1097/00005373-199811000-00010; KAWESKI SM, 1990, J TRAUMA, V30, P1215, DOI 10.1097/00005373-199010000-00005; Khajavi MR, 2008, RENAL FAILURE, V30, P535, DOI 10.1080/08860220802064770; Kiraly LN, 2006, J TRAUMA, V61, P57, DOI 10.1097/01.ta.0000220373.29743.69; Koustova E, 2002, J TRAUMA, V52, P872, DOI 10.1097/00005373-200205000-00009; Moore FA, 2011, J TRAUMA, V70, pS15, DOI 10.1097/TA.0b013e31821a4d6e; Nolan J, 2001, RESUSCITATION, V48, P57, DOI 10.1016/S0300-9572(00)00318-X; O'Malley CMN, 2005, ANESTH ANALG, V100, P1518, DOI 10.1213/01.ANE.0000150939.28904.81; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; Rahbar MH, 2012, RESUSCITATION, V83, P459, DOI 10.1016/j.resuscitation.2011.09.019; Schreiber MA, 2011, J TRAUMA, V70, pS13, DOI 10.1097/TA.0b013e31821a4ba5; Shackford SR, 2011, J TRAUMA, V70, pS32, DOI 10.1097/TA.0b013e31821a5858; Simma B, 1998, CRIT CARE MED, V26, P1265, DOI 10.1097/00003246-199807000-00032; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Todd SR, 2007, J TRAUMA, V62, P636, DOI 10.1097/TA.0b013e31802ee521; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; Waters JH, 2001, ANESTH ANALG, V93, P817, DOI 10.1097/00000539-200110000-00004; Watters JM, 2004, SHOCK, V22, P283, DOI 10.1097/01.shk.0000135288.54535.8a; Williams EL, 1999, ANESTH ANALG, V88, P999, DOI 10.1097/00000539-199905000-00006	31	13	14	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1054	1059		10.1089/neu.2014.3478			6	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600009	26914721	Green Published			2021-06-18	
J	Wilson, TJ; Chang, KWC; Yang, LJS				Wilson, Thomas J.; Chang, Kate W. C.; Yang, Lynda J. -S.			Depression and Anxiety in Traumatic Brachial Plexus Injury Patients Are Associated With Reduced Motor Outcome After Surgical Intervention for Restoration of Elbow Flexion	NEUROSURGERY			English	Article						Brachial plexus; Depression; Nerve transfer	CLINICAL-OUTCOMES; SURGERY; SYMPTOMS; HEALTH	BACKGROUND:Depression has been associated with poor outcomes in neurosurgical patients, including increased pain, poorer functional recovery, delayed return to work, and decreased patient satisfaction. No reports exist regarding an association of psychiatric diagnoses with outcomes after brachial plexus reconstruction. As outcomes and patient satisfaction become increasingly important to payers and physician reimbursement, assessing modifiable preoperative risk factors for their association with poor outcome and patient satisfaction is imperative.OBJECTIVE:To analyze patients undergoing brachial plexus reconstruction to assess the relationship of depression/anxiety with functional outcome.METHODS:Data were collected retrospectively on all patients who underwent brachial plexus reconstruction to restore elbow flexion between 2005 and 2013. Elbow flexion, graded via the Medical Research Council scale, was assessed at latest follow-up. Multiple variables, including the presence of Axis I psychiatric diagnoses, were assessed for their association with the dichotomous outcome of Medical Research Council scale score 3 (antigravity) vs <3 elbow flexion. Standard statistical methods were used.RESULTS:Thirty-seven patients met inclusion criteria. The median postsurgical follow-up time was 21 months. Operations included neurolysis (n = 3), nerve graft repair (n = 6), and nerve transfer (n = 28). Depression was present in 10 of 37 patients (27%). Of variables tested, only depression was associated with poor elbow flexion outcome (odds ratio: 6.038; P = .04).CONCLUSION:Preoperative depression is common after brachial plexus injury. The presence of depression is associated with reduced elbow flexion recovery after reconstruction. Our data suggest assessment and treatment of preoperative mental health is important in designing a comprehensive postoperative management plan to optimize outcomes and patient satisfaction.ABBREVIATIONS:MRC, Medical Research CouncilTBI, traumatic brain injury	[Wilson, Thomas J.; Chang, Kate W. C.; Yang, Lynda J. -S.] Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Room 3552 TC, Ann Arbor, MI 48109 USA	Wilson, TJ (corresponding author), Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Room 3552 TC, Ann Arbor, MI 48109 USA.	thowil@med.umich.edu					Ali ZS, 2015, J NEUROSURG, V122, P195, DOI 10.3171/2014.9.JNS132823; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Bell D, 2011, CANCER BIOL THER, V11, P765, DOI 10.4161/cbt.11.8.15277; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Carlsen BT, 2011, PLAST RECONSTR SURG, V127, P269, DOI 10.1097/PRS.0b013e3181f95be7; Dubuisson AS, 2002, NEUROSURGERY, V51, P673, DOI 10.1097/00006123-200209000-00011; Fann JR, 2015, JAMA PSYCHIAT, V72, P247, DOI 10.1001/jamapsychiatry.2014.2482; Franzblau L, 2015, DISABIL REHABIL, V37, P135, DOI 10.3109/09638288.2014.911971; Franzblau LE, 2015, J NEUROSURG, V122, P1413, DOI 10.3171/2015.2.JNS132686; Garg R, 2011, J BONE JOINT SURG AM, V93A, P819, DOI 10.2106/JBJS.I.01602; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Helmerhorst GTT, 2014, J BONE JOINT SURG AM, V96A, P495, DOI 10.2106/JBJS.L.01406; Kao LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116436; Kim DH, 2003, J NEUROSURG, V98, P1005, DOI 10.3171/jns.2003.98.5.1005; Lubelski D, 2015, J NEUROSURG-SPINE, V22, P267, DOI 10.3171/2014.10.SPINE14220; Matsuzaki S, 2015, J AFFECT DISORDERS, V176, P56, DOI 10.1016/j.jad.2015.01.020; McHugh GA, 2013, BONE JOINT RES, V2, P248, DOI 10.1302/2046-3758.211.2000206; Pakarinen M, 2014, SPINE J, V14, P2392, DOI 10.1016/j.spinee.2014.01.047; Parker SL, 2015, WORLD NEUROSURG, V83, P608, DOI 10.1016/j.wneu.2014.12.018; Raspopovic ED, 2014, PSYCHOGERIATRICS, V14, P118, DOI 10.1111/psyg.12049; Reynolds CF, 2012, ANNU REV PUBL HEALTH, V33, P123, DOI 10.1146/annurev-publhealth-031811-124544; Urban-Baeza A, 2015, J NEUROSURG-SPINE, V22, P75, DOI 10.3171/2014.10.SPINE131106	23	13	14	0	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUN	2016	78	6					844	849		10.1227/NEU.0000000000001086			6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DN2GO	WOS:000376882300033	26516821				2021-06-18	
J	Li, L; Sun, G; Liu, K; Li, M; Li, B; Qian, SW; Yu, LL				Li, Li; Sun, Gang; Liu, Kai; Li, Min; Li, Bo; Qian, Shao-Wen; Yu, Li-Li			White Matter Changes in Posttraumatic Stress Disorder Following Mild Traumatic Brain Injury: A Prospective Longitudinal Diffusion Tensor Imaging Study	CHINESE MEDICAL JOURNAL			English	Article						Diffusion Tensor Imaging; Mild Traumatic Brain Injury; Posttraumatic Stress Disorder; Tract-based Spatial Statistics	VOXELWISE ANALYSIS; PTSD; INTEGRITY	Background: The ability to predict posttraumatic stress disorder (PTSD) is a critical issue in the management of patients with mild traumatic brain injury (mTBI), as early medical and rehabilitative interventions may reduce the risks of long-term cognitive changes. The aim of the present study was to investigate how diffusion tensor imaging (DTI) metrics changed in the transition from acute to chronic phases in patients with mTBI and whether the alteration relates to the development of PTSD. Methods: Forty-three patients with mTBI and 22 healthy volunteers were investigated. The patients were divided into two groups: successful recovery (SR, n = 22) and poor recovery (PR, n = 21), based on neurocognitive evaluation at 1 or 6 months after injury. All patients underwent magnetic resonance imaging investigation at acute (within 3 days), subacute (10-20 days), and chronic (1-6 months) phases after injury. Group differences of fractional anisotropy (FA) and mean diffusivity (MD) were analyzed using tract-based spatial statistics (TBSS). The accuracy of DTI metrics for classifying PTSD was estimated using Bayesian discrimination analysis. Results: TBSS showed white matter (WM) abnormalities in various brain regions. In the acute phase, FA values were higher for PR and SR patients than controls (all P < 0.05). In subacute phase, PR patients have higher mean MD than SR and controls (all P < 0.05). In the chronic phase, lower FA and higher MD were observed in PR compared with both SR and control groups (all P < 0.05). PR and SR groups could be discriminated with a sensitivity of 73%, specificity of 78%, and accuracy of 75.56%, in terms of MD value in subacute phase. Conclusions: Patients with mTBI have multiple abnormalities in various WM regions. DTI metrics change over time and provide a potential indicator at subacute stage for PTSD following mTBI.	[Li, Li] Second Mil Med Univ, Inst Postgrad, Shanghai 200032, Peoples R China; [Li, Li; Sun, Gang; Liu, Kai; Li, Min; Li, Bo; Qian, Shao-Wen] Jinan Mil Gen Hosp, Dept Med Imaging, Jinan 250031, Shandong, Peoples R China; [Yu, Li-Li] Jinan Mil Gen Hosp, Dept Stat, Jinan 250031, Shandong, Peoples R China	Sun, G (corresponding author), Jinan Mil Gen Hosp, Dept Med Imaging, Jinan 250031, Shandong, Peoples R China.	cjr.sungang@vip.163.com		Li, Min/0000-0002-7649-3900	Jinan Military General Hospital [2014MS07]	This work was supported by a grant from the Jinan Military General Hospital (No. 2014MS07).	Abrams TE, 2013, RADIOLOGY, V267, P470, DOI 10.1148/radiol.13121593; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1002/jts.2490080106; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daniels JK, 2013, DEPRESS ANXIETY, V30, P207, DOI 10.1002/da.22044; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ohry A, 1996, BRAIN INJURY, V10, P687, DOI 10.1080/026990596124106; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Podoll K, 2000, FORTSCHR NEUROL PSYC, V68, P458, DOI 10.1055/s-2000-7736; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Zhong Y, 2015, ACTA RADIOL, V56, P746, DOI 10.1177/0284185114537927	32	13	16	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999	2542-5641		CHINESE MED J-PEKING	Chin. Med. J.	MAY 5	2016	129	9					1091	1099		10.4103/0366-6999.180518			9	Medicine, General & Internal	General & Internal Medicine	DK6CU	WOS:000375009800015	27098796	DOAJ Gold, Green Published			2021-06-18	
J	Bye, N; Christie, KJ; Turbic, A; Basrai, HS; Turnley, AM				Bye, Nicole; Christie, Kimberly J.; Turbic, Alisa; Basrai, Harleen S.; Turnley, Ann M.			Rho kinase inhibition following traumatic brain injury in mice promotes functional improvement and acute neuron survival but has little effect on neurogenesis, glial responses or neuroinflammation	EXPERIMENTAL NEUROLOGY			English	Article						Rho GTPase; Astrocytic gliosis; Y27632; Fasudil; Microglia; Controlled cortical impact; Horizontal ladder test; NeuN	CONTROLLED CORTICAL IMPACT; NEURITE OUTGROWTH; ROCK INHIBITOR; IN-VITRO; DOPAMINERGIC-NEURONS; AXONAL REGENERATION; LESIONAL EXPRESSION; FAMILY GTPASES; MOUSE MODEL; FASUDIL	Inhibition of the Rho/Rho kinase pathway has been shown to be beneficial in a variety of neural injuries and diseases. In this manuscript we investigate the role of Rho kinase inhibition in recovery from traumatic brain injury using a controlled cortical impact model in mice. Mice subjected to a moderately severe TBI were treated for 1 or 4 weeks with the Rho kinase inhibitor Y27632, and functional outcomes and neuronal and glial cell responses were analysed at 1, 7 and 35 days post-injury. We hypothesised that Y27632-treated mice would show functional improvement, with augmented recruitment of neuroblasts from the SVZ and enhanced survival of newborn neurons in the pericontusional cortex, with protection against neuronal degeneration, neuroinflammation and modulation of astrocyte reactivity and blood-brain-barrier permeability. While Rho kinase inhibition enhanced recovery of motor function after trauma, there were no substantial increases in the recruitment of DCX+ neuroblasts or the number of BrdU(+) or EdU(+) labelled newborn neurons in the pericontusional cortex of Y27632-treated mice. Inhibition of Rho kinase significantly reduced the number of degenerating cortical neurons at 1 day post-injury compared to saline controls but had no longer term effect on neuronal degeneration, with only modest effects on astrocytic reactivity and macrophage/microglial responses. Overall, this study showed that Rho kinase contributes to acute neurodegenerative processes in the injured cortex but does not play a significant role in SVZ neural precursor cell-derived adult neurogenesis, glial responses or blood-brain barrier permeability following a moderately severe brain injury. (C) 2016 Elsevier Inc. All rights reserved.	[Bye, Nicole; Christie, Kimberly J.; Turbic, Alisa; Basrai, Harleen S.; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia	Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Melbourne Brain Ctr, Royal Parade Genet Lane, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au		Turnley, Ann/0000-0002-8442-127X	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [1045125, 628344]; Stem Cells Australia	This work was supported by the National Health and Medical Research Council of Australia (Project grant 1045125 and Fellowship (to AMT)) 628344 and Stem Cells Australia.	Barcia C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00809; Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5; Brabeck C, 2004, J NEUROTRAUM, V21, P697, DOI 10.1089/0897715041269597; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; Brown MD, 2000, J NEUROBIOL, V43, P352, DOI 10.1002/1097-4695(20000615)43:4<352::AID-NEU4>3.0.CO;2-T; Chan CCM, 2005, EXP NEUROL, V196, P352, DOI 10.1016/j.expneurol.2005.08.011; Christie KJ, 2013, NEUROSCIENCE, V247, P75, DOI 10.1016/j.neuroscience.2013.05.019; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Cui QH, 2013, NEURAL REGEN RES, V8, P1180, DOI 10.3969/j.issn.1673-5374.2013.13.003; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Dergham P, 2002, J NEUROSCI, V22, P6570; Ding J, 2010, J NEUROCHEM, V114, P1619, DOI 10.1111/j.1471-4159.2010.06876.x; Ding J, 2010, MOL CELL NEUROSCI, V43, P201, DOI 10.1016/j.mcn.2009.11.001; Dottori M, 2008, STEM CELLS, V26, P1146, DOI 10.1634/stemcells.2007-1118; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Fournier AE, 2003, J NEUROSCI, V23, P1416; Fuentes EO, 2008, J BRACHIAL PLEX PERI, V3, DOI 10.1186/1749-7221-3-19; Fujii M, 2012, NEUROCHEM INT, V60, P327, DOI 10.1016/j.neuint.2011.12.014; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; Grunwald IC, 2002, CURR OPIN NEUROBIOL, V12, P250, DOI 10.1016/S0959-4388(02)00323-9; Gunther R, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00304; Holtje M, 2005, J NEUROCHEM, V95, P1237, DOI 10.1111/j.1471-4159.2005.03443.x; Hotta R, 2009, STEM CELLS, V27, P2896, DOI 10.1002/stem.208; Jeon BT, 2013, NEUROTOX RES, V23, P238, DOI 10.1007/s12640-012-9339-2; Jou TS, 1998, J CELL BIOL, V142, P101, DOI 10.1083/jcb.142.1.101; Katoh H, 1998, J BIOL CHEM, V273, P2489, DOI 10.1074/jbc.273.5.2489; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Koyanagi M, 2008, J NEUROSCI RES, V86, P270, DOI 10.1002/jnr.21502; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kubo T, 2008, J NEUROCHEM, V105, P113, DOI 10.1111/j.1471-4159.2007.05125.x; Kubo T, 2007, CURR PHARM DESIGN, V13, P2493; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; Lau CL, 2012, J CELL PHYSIOL, V227, P1199, DOI 10.1002/jcp.22838; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Lemmens R, 2013, HUM MOL GENET, V22, P2214, DOI 10.1093/hmg/ddt073; Leong SY, 2011, NEUROCHEM INT, V59, P382, DOI 10.1016/j.neuint.2010.12.024; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284; Lingor P, 2007, J NEUROCHEM, V103, P181, DOI 10.1111/j.1471-4159.2007.04756.x; Lord-Fontaine S, 2008, J NEUROTRAUM, V25, P1309, DOI 10.1089/neu.2008.0613; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Machesky LM, 1997, J CELL BIOL, V138, P913, DOI 10.1083/jcb.138.4.913; Newcomb JK, 1999, EXP NEUROL, V158, P76, DOI 10.1006/exnr.1999.7071; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; O'Shea RD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00050; Postma FR, 1996, EMBO J, V15, P2388, DOI 10.1002/j.1460-2075.1996.tb00595.x; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Satoh S, 2001, LIFE SCI, V69, P1441, DOI 10.1016/S0024-3205(01)01229-2; Satoh SI, 2008, BRAIN RES, V1193, P102, DOI 10.1016/j.brainres.2007.11.050; Satoh S, 2010, BRAIN RES BULL, V81, P191, DOI 10.1016/j.brainresbull.2009.08.021; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Stankiewicz TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00314; Tatenhorst L, 2014, J NEUROPATH EXP NEUR, V73, P770, DOI 10.1097/NEN.0000000000000095; Tonges L, 2012, BRAIN, V135, P3355, DOI 10.1093/brain/aws254; Wu JH, 2012, CELL MOL NEUROBIOL, V32, P1187, DOI 10.1007/s10571-012-9845-z; Yamashita K, 2007, BRAIN RES, V1154, P215, DOI 10.1016/j.brainres.2007.04.013; Zhang ZB, 2012, NEUROCHEM RES, V37, P948, DOI 10.1007/s11064-011-0687-8	60	13	13	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						86	95		10.1016/j.expneurol.2016.02.012			10	Neurosciences	Neurosciences & Neurology	DK0OU	WOS:000374612900007	26896832				2021-06-18	
J	Graves, JM; Kannan, N; Mink, RB; Wainwright, MS; Groner, JI; Bell, MJ; Giza, CC; Zatzick, DF; Ellenbogen, RG; Boyle, LN; Mitchell, PH; Rivara, FP; Wang, J; Rowhani-Rahbar, A; Vavilala, MS				Graves, Janessa M.; Kannan, Nithya; Mink, Richard B.; Wainwright, Mark S.; Groner, Jonathan I.; Bell, Michael J.; Giza, Christopher C.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Wang, Jin; Rowhani-Rahbar, Ali; Vavilala, Monica S.		Pediat Guideline Adherence	Guideline Adherence and Hospital Costs in Pediatric Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injuries; costs and cost analysis; injuries; pediatrics; quality of healthcare	CARE; CHILDREN; IMPROVEMENT; MANAGEMENT; MORTALITY; REDUCE	Objectives: Adherence to pediatric traumatic brain injury guidelines has been associated with improved survival and better functional outcome. However, the relationship between guideline adherence and hospitalization costs has not been examined. To evaluate the relationship between adherence to pediatric severe traumatic brain injury guidelines, measured by acute care clinical indicators, and the total costs of hospitalization associated with severe traumatic brain injury. Design: Retrospective cohort study. Setting: Five regional pediatric trauma centers affiliated with academic medical centers. Patients: Demographic, injury, treatment, and charge data were included for pediatric patients (17 yr) with severe traumatic brain injury. Interventions: Percent adherence to clinical indicators was determined for each patient. Cost-to-charge ratios were used to estimate ICU and total hospital costs for each patient. Generalized linear models evaluated the association between healthcare costs and adherence rate. Measurements and Main Results: Cost data for 235 patients were examined. Estimated mean adjusted hospital costs were $103,485 (95% CI, 98,553-108,416); adjusted ICU costs were $82,071 (95% CI, 78,559-85,582). No association was found between adherence to guidelines and total hospital or ICU costs, after adjusting for patient and injury characteristics. Adjusted regression model results provided cost ratio equal to 1.01 for hospital and ICU costs (95% CI, 0.99-1.03 and 0.99-1.02, respectively). Conclusions: Adherence to severe pediatric traumatic brain injury guidelines at these five leading pediatric trauma centers was not associated with increased hospitalization and ICU costs. Therefore, cost should not be a factor as institutions and providers strive to provide evidence-based guideline driven care of children with severe traumatic brain injury.	[Graves, Janessa M.] Washington State Univ, Coll Nursing Spokane, Spokane, WA 99202 USA; [Graves, Janessa M.; Kannan, Nithya; Rivara, Frederick P.; Wang, Jin; Rowhani-Rahbar, Ali; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Kannan, Nithya; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Kannan, Nithya; Vavilala, Monica S.] Univ Washington, Dept Pain Med, Seattle, WA 98195 USA; [Mink, Richard B.] Harbor UCLA & Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA USA; [Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Neurosurg, Div Pediat Neurol, Los Angeles, CA USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; [Rivara, Frederick P.; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.; Wang, Jin; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Graves, JM (corresponding author), Washington State Univ, Coll Nursing Spokane, Spokane, WA 99202 USA.; Graves, JM (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	janessa.graves@wsu.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS R01 NS072308-03]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NCAA-DOD; Joseph Drown Foundation; UCLA Steve Tisch BrainSPORT Program; NFL-GE; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); NIH/NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	Dr. Graves received support for article research from the National Institutes of Health (NIH). Her institution received grant support from the NIH/NINDS (The source of support for this work including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript was NINDS R01 NS072308-03). Drs. Kannan, Wainwright, Groner, Bell, Zatzick, Boyle, Mitchell, Wang, Rowhani-Rahbar, and Vavilala received support for article research from the NIH. Drs. Kannan, Wainwright, Groner, Bell, Zatzick, Boyle, Mitchell, Wang, Rowhani-Rahbar, and Vavilala and their institutions received grant support from the NIH. Dr. Mink served as a board member for the American Board of Pediatrics (Received honorarium as a member of the Education and Training Committee) and received support for article research from the NIH. Dr. Mink and his institution received grant support from the NIH. His institution received grant support from the NIH (Subcontract with UCLA). Dr. Giza consulted for the NCAA, Major League Soccer, U.S. Soccer Federation (Travel reimbursement for attendance at meetings); Pearson PLC (One-time consultation); and Alcobra (One-time consultation). He lectured for Medical Education Speakers Network, individual institutions (Honoraria for 1-3 medical or educational lectures per month related to pediatric neurology), received royalties from Blackwell Publishing (Royalties from Neurological Differential Diagnosis: A Prioritized Approach book), and received support for article research from the NIH. Dr. Giza and his institution received grant support from the NIH. His institution provided expert testimony for Medicolegal cases (one or two cases annually) and received grant support from NCAA-DOD, Joseph Drown Foundation, UCLA Steve Tisch BrainSPORT Program, NFL-GE, DARPA (Multiple research grants from both public and private funding sources). Dr. Ellenbogen received grant support from the NIH/NCI and received support for article research from the NIH. Dr. Ellenbogen and his institution received grant support from the NIH. Dr. Rivara received support for article research from the NIH. His institution received grant support from the NIH. Dr. Vavilala received support for this article research form National Institute of Neurological Disorders and Stroke (R01 NS072308-03).	Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Hebert PL, 2014, HEALTH AFFAIR, V33, P980, DOI 10.1377/hlthaff.2013.0893; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Koeck C, 1998, BRIT MED J, V317, P1267, DOI 10.1136/bmj.317.7168.1267; Kouznetsov E, 2012, PEDIATR NEUROSURG, V48, P1, DOI 10.1159/000340068; Letton C, 2013, J OBSTET GYNAECOL, V33, P296, DOI 10.3109/01443615.2012.758693; Penner S. J., 2004, INTRO HLTH CARE EC F; Pronovost PJ, 2004, J CRIT CARE, V19, P158, DOI 10.1016/j.jcrc.2004.07.003; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Sherr K, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-55; Shortell SM, 2007, JAMA-J AM MED ASSOC, V298, P673, DOI 10.1001/jama.298.6.673; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wagner ECK, 2012, GUIDING TRANSFORMATI	20	13	13	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2016	17	5					438	443		10.1097/PCC.0000000000000698			6	Critical Care Medicine; Pediatrics	General & Internal Medicine; Pediatrics	DR0KH	WOS:000379595900015	26934664	Green Accepted			2021-06-18	
J	Kawa, L; Barde, S; Arborelius, UP; Theodorsson, E; Agoston, D; Risling, M; Hokfelt, T				Kawa, Lizan; Barde, Swapnali; Arborelius, Ulf P.; Theodorsson, Elvar; Agoston, Denes; Risling, Marten; Hokfelt, Tomas			Expression of galanin and its receptors are perturbed in a rodent model of mild, blast-induced traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Anxiety; Cholecystokinin (CCK); Depression; Neuropeptide; Periaqueductal gray; Receptor; Transcriptional regulation; Translational regulation; Transmitter coexistence	POSTTRAUMATIC-STRESS-DISORDER; PREPROGALANIN MESSENGER-RNA; LOCUS-COERULEUS NEURONS; NEUROPEPTIDE-Y; HUMANS AGE; RAT; DEPRESSION; ANXIETY; AFGHANISTAN; IRAQ	The symptomatology, mood and cognitive disturbances seen in post-traumatic stress disorder (PTSD) and mild blast-induced traumatic brain injury (mbTBI) overlap considerably. However the pathological mechanisms underlying the two conditions are currently unknown. The neuropeptide galanin has been suggested to play a role in the development of stress and mood disorders. Here we applied bio- and histochemical methods with the aim to elucidate the nature of any changes in the expression of galanin and its receptors in a rodent model of mbTBI. In situ hybridization and quantitative polymerase chain reaction studies revealed significant, injury induced changes, in some cases lasting at least for one week, in the mRNA levels of galanin and/or its three receptors, galanin receptor 1-3 (GalR1-3). Such changes were seen in several forebrain regions, and the locus coeruleus. In the ventral periaqueductal gray GalR1 mRNA levels were increased, while GalR2 were decreased. Analysis of galanin peptide levels using radioimmunoassay demonstrated an increase in several brain regions including the locus coeruleus, dorsal hippocampal formation and amygdala. These findings suggest a role for the galanin system in the endogenous response to mbTBI, and that pharmacological studies of the effects of activation or inhibition of different galanin receptors in combination with functional assays of behavioral recovery may reveal promising targets for new therapeutic strategies in mbTBI. (C) 2016 Elsevier Inc. All rights reserved.	[Kawa, Lizan; Barde, Swapnali; Arborelius, Ulf P.; Agoston, Denes; Risling, Marten; Hokfelt, Tomas] Karolinska Inst, Dept Neurosci, Retzius Vag 8, SE-17177 Stockholm, Sweden; [Theodorsson, Elvar] Linkoping Univ, Dept Clin Chem, Linkoping, Sweden; [Agoston, Denes] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA	Kawa, L (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, SE-17177 Stockholm, Sweden.	lizan.kawa@ki.se; Marten.Risling@ki.se	Theodorsson, Elvar/H-2096-2011	Theodorsson, Elvar/0000-0003-0756-7723	Swedish Armed Forces RD [AF.9221006]; Swedish Research CouncilSwedish Research CouncilEuropean Commission [04X-2887]; Karolinska Institutet Funds	This work was supported by the Swedish Armed Forces R&D (AF.9221006) (MR), the Swedish Research Council (04X-2887) (TH) and Karolinska Institutet Funds (TH and MR). The valuable contribution of Maria Angeria is gratefully acknowledged. We thank Professor Jens Rehfeld, University of Copenhagen, Copenhagen, Denmark, for the generous donation of the CCK antiserum.	Andreollo NA, 2012, ABCD-ARQ BRAS CIR DI, V25, P49, DOI 10.1590/S0102-67202012000100011; Barrera G, 2005, NEUROPEPTIDES, V39, P289, DOI 10.1016/j.npep.2004.12.008; Barrera G, 2006, SYNAPSE, V59, P27, DOI 10.1002/syn.20208; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BIGUET NF, 1986, EMBO J, V5, P287, DOI 10.1002/j.1460-2075.1986.tb04211.x; BRADWEJN J, 1984, NATURE, V312, P363, DOI 10.1038/312363a0; Branchek TA, 2000, TRENDS PHARMACOL SCI, V21, P109, DOI 10.1016/S0165-6147(00)01446-2; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brumovsky P, 2007, TRENDS PHARMACOL SCI, V28, P93, DOI 10.1016/j.tips.2006.12.003; Brunner SM, 2014, P NATL ACAD SCI USA, V111, P7138, DOI 10.1073/pnas.1318066111; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Davenport N.D., 2015, BRAIN IMAGING BEHAV; DODD J, 1981, BRAIN RES, V205, P337, DOI 10.1016/0006-8993(81)90344-9; Drake AI, 2010, NEUROREHABILITATION, V26, P183, DOI 10.3233/NRE-2010-0554; Fuxe K, 1998, ANN NY ACAD SCI, V863, P274, DOI 10.1111/j.1749-6632.1998.tb10702.x; FUXE K, 1990, SEROTONIN, P169; Fuxe K., 1991, GALANIN A NEW MULTIF; GABRIEL SM, 1995, J NEUROSCI, V15, P5526; Golub Y, 2011, J PSYCHIATR RES, V45, P650, DOI 10.1016/j.jpsychires.2010.10.014; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; HABERTORTOLI E, 1994, P NATL ACAD SCI USA, V91, P9780, DOI 10.1073/pnas.91.21.9780; Harro J, 2001, BRAIN RES REV, V38, P79, DOI 10.1016/S0165-0173(01)00082-0; HARRO J, 1993, TRENDS PHARMACOL SCI, V14, P244, DOI 10.1016/0165-6147(93)90020-K; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hokfelt T, 2003, LANCET NEUROL, V2, P463, DOI 10.1016/S1474-4422(03)00482-4; Hokfelt T, 1999, HORM METAB RES, V31, P330, DOI 10.1055/s-2007-978748; HOLETS VR, 1988, NEUROSCIENCE, V24, P893, DOI 10.1016/0306-4522(88)90076-0; Holmes A, 2003, TRENDS PHARMACOL SCI, V24, P580, DOI 10.1016/j.tips.2003.09.011; Holmes A., 2006, CNS & Neurological Disorders-Drug Targets, V5, P225, DOI 10.2174/187152706776359600; HOLMES PV, 1995, PHARMACOL BIOCHEM BE, V50, P655, DOI 10.1016/0091-3057(94)00334-3; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Karlsson RM, 2006, AMINO ACIDS, V31, P231, DOI 10.1007/s00726-006-0336-8; Kawa L., 2014, J NEUROTRAUMA; Kennedy JE, 2010, NEUROREHABILITATION, V26, P223, DOI 10.3233/NRE-2010-0558; Khoshbouei H, 2002, PHARMACOL BIOCHEM BE, V71, P407, DOI 10.1016/S0091-3057(01)00683-9; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Kozlovsky N, 2009, BIOL PSYCHIAT, V65, P383, DOI 10.1016/j.biopsych.2008.10.034; Kuteeva E, 2008, NEUROPSYCHOPHARMACOL, V33, P2573, DOI 10.1038/sj.npp.1301660; Kuteeva E, 2010, EXPERIENTIA SUPPL, V102, P163, DOI 10.1007/978-3-0346-0228-0_12; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Lang R, 2015, PHARMACOL REV, V67, P118, DOI 10.1124/pr.112.006536; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; LIU SL, 1994, J NEUROTRAUM, V11, P73, DOI 10.1089/neu.1994.11.73; Lu XY, 2008, NEUROPEPTIDES, V42, P387, DOI 10.1016/j.npep.2008.04.009; Lu Xiaoying, 2007, CNS & Neurological Disorders-Drug Targets, V6, P183, DOI 10.2174/187152707780619335; Lu XY, 2005, P NATL ACAD SCI USA, V102, P874, DOI 10.1073/pnas.0408891102; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Maubach KA, 1999, CURR OPIN CHEM BIOL, V3, P481, DOI 10.1016/S1367-5931(99)80070-2; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mazarati AM, 1998, J NEUROSCI, V18, P10070; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; MELANDER T, 1986, NEUROSCIENCE, V19, P223, DOI 10.1016/0306-4522(86)90017-5; MELANDER T, 1986, J COMP NEUROL, V248, P475, DOI 10.1002/cne.902480404; Melander T., 1986, GABA NEUROPEPTIDES R, V6, P3640; Millan MJ, 2006, PHARMACOL THERAPEUT, V110, P135, DOI 10.1016/j.pharmthera.2005.11.006; Moller C, 1999, NEUROPSYCHOPHARMACOL, V21, P507, DOI 10.1016/S0893-133X(98)00102-X; Nemeroff CB, 2005, J CLIN PSYCHIAT, V66, P5; ODONNELL D, 2003, HAND CHEM N, V20, P195; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Parker D, 1998, J NEUROSCI, V18, P4800; Paxinos G., 2007, THE RAT BRAIN IN STR; Picciotto MR, 2010, BRAIN RES, V1314, P206, DOI 10.1016/j.brainres.2009.08.033; Pieribone VA, 1998, ANN NY ACAD SCI, V863, P264, DOI 10.1111/j.1749-6632.1998.tb10701.x; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; REHFELD JF, 1987, P NATL ACAD SCI USA, V84, P3019, DOI 10.1073/pnas.84.9.3019; Rehfeld JF, 1992, MULTIPLE CHOLECYSTOK, P117; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sabban E.L., 2015, NEUROPEPTIDES; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sciolino NR, 2012, NEUROSCI BIOBEHAV R, V36, P1965, DOI 10.1016/j.neubiorev.2012.06.005; SEUTIN V, 1989, EUR J PHARMACOL, V164, P373, DOI 10.1016/0014-2999(89)90481-0; SEVCIK J, 1993, EUR J PHARMACOL, V230, P223, DOI 10.1016/0014-2999(93)90806-S; Shen PJ, 2003, EUR J NEUROSCI, V18, P1362, DOI 10.1046/j.1460-9568.2003.02860.x; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; SKOFITSCH G, 1985, PEPTIDES, V6, P509, DOI 10.1016/0196-9781(85)90118-4; Steckler T., 2008, HDB ANXIETY FEAR; SUTIN EL, 1988, J COMP NEUROL, V270, P243, DOI 10.1002/cne.902700206; Sweerts BW, 1999, MOL BRAIN RES, V69, P113, DOI 10.1016/S0169-328X(99)00095-9; TATEMOTO K, 1983, FEBS LETT, V164, P124, DOI 10.1016/0014-5793(83)80033-7; Theodorsson E, 2000, SCAND J CLIN LAB INV, V60, P411; Thompson JM, 2008, CAN FAM PHYSICIAN, V54, P1549; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Vila-Porcile E, 2009, J COMP NEUROL, V516, P199, DOI 10.1002/cne.22105; Wang P., 2011, NEUROSCI, V2011; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Waters SM, 2000, NEUROSCIENCE, V95, P265; Weiss JM, 2005, NEUROPEPTIDES, V39, P281, DOI 10.1016/j.npep.2004.12.028; Weiss JM, 1998, ANN NY ACAD SCI, V863, P364, DOI 10.1111/j.1749-6632.1998.tb10707.x; WILKINSON LO, 1988, EXP NEUROL, V101, P445, DOI 10.1016/0014-4886(88)90055-6; Wu G, 2011, EXPERT OPIN THER TAR, V15, P1317, DOI 10.1517/14728222.2011.628314; XU Z, 1992, NEUROSCI LETT, V145, P185, DOI 10.1016/0304-3940(92)90018-3; Xu ZQD, 1998, J COMP NEUROL, V392, P227, DOI 10.1002/(SICI)1096-9861(19980309)392:2<227::AID-CNE6>3.0.CO;2-4; Xu ZQD, 1998, ANN NY ACAD SCI, V863, P459, DOI 10.1111/j.1749-6632.1998.tb10724.x; Xu ZQD, 2005, NEUROPEPTIDES, V39, P269, DOI 10.1016/j.npep.2005.02.003; Xu ZQD, 1997, J CHEM NEUROANAT, V13, P169, DOI 10.1016/S0891-0618(97)00043-4; Yoshitake T, 2003, NEUROSCI LETT, V339, P239, DOI 10.1016/S0304-3940(03)00020-X	100	13	13	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						159	167		10.1016/j.expneurol.2016.02.019			9	Neurosciences	Neurosciences & Neurology	DK0OU	WOS:000374612900014	26928087				2021-06-18	
J	Key-DeLyria, SE; Altmann, LJP				Key-DeLyria, Sarah E.; Altmann, Lori J. P.			Executive Function and Ambiguous Sentence Comprehension	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							WORKING-MEMORY CAPACITY; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; BROCAS AREA; INDIVIDUAL-DIFFERENCES; FLUID INTELLIGENCE; PREFRONTAL CORTEX; FRONTAL LOBES	Purpose: Sentence comprehension is a critical skill in today's literate society. Recent evidence suggests that processing and comprehending language taps cognitive as well as linguistic abilities, a finding that has critical import for clinicians who have clients with language disorders. To promote awareness of the impact of cognition, especially executive function (EF) and working memory (WM), this opinion article presents current views of how sentences are processed and links the various steps of the process to specific EF and WM subcomponents. Method: The article focuses on ambiguous sentences, pointing out the similar types of processing needed when resolving an ambiguity and performing EF tasks. Results: We discuss the potential overlap between the neurobiology of sentence processing and EF and the evidence supporting a link between EF and sentence processes. Conclusion: Awareness of the potential role of EF and WM in sentence comprehension will help clinicians be more aware of potential cognitive-linguistic deficits in their clients. Future research will help to clarify the link between EF and sentence comprehension.	[Key-DeLyria, Sarah E.] Portland State Univ, Portland, OR 97207 USA; [Altmann, Lori J. P.] Univ Florida, Gainesville, FL USA	Key-DeLyria, SE (corresponding author), Portland State Univ, Portland, OR 97207 USA.	keydel@pdx.edu		Key-DeLyria, Sarah/0000-0002-1202-7871; Altmann, Lori/0000-0002-4935-3574			Altemeier LE, 2008, J CLIN EXP NEUROPSYC, V30, P588, DOI 10.1080/13803390701562818; Altmann GTM, 1998, TRENDS COGN SCI, V2, P146, DOI 10.1016/S1364-6613(98)01153-X; Altmann LJP, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/238956; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; American Speech-Language-Hearing Association, 2003, TECHNICAL REPORT; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A. D., 1986, WORKING MEMORY; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Broadway JM, 2010, BEHAV RES METHODS, V42, P563, DOI 10.3758/BRM.42.2.563; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Burgess P. W., 1997, METHODOLOGY FRONTAL, P81, DOI DOI 10.1024//1016-264X.10.2.123; BUTLERHINZ S, 1990, J SPEECH HEAR RES, V33, P269, DOI 10.1044/jshr.3302.269; Cannizzaro MS, 2013, J PSYCHOLINGUIST RES, V42, P527, DOI 10.1007/s10936-012-9231-5; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Caplan D, 2013, PSYCHON B REV, V20, P243, DOI 10.3758/s13423-012-0369-9; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; Carrow-Woolfolk E., 1999, CASL COMPREHENSIVE A; CHAPMAN RS, 1991, J SPEECH HEAR RES, V34, P1106, DOI 10.1044/jshr.3405.1106; Chapman RS, 1997, MENT RETARD DEV D R, V3, P307; Cho-Reyes S, 2012, APHASIOLOGY, V26, P1250, DOI 10.1080/02687038.2012.693584; Christianson K, 2001, COGNITIVE PSYCHOL, V42, P368, DOI 10.1006/cogp.2001.0752; Christianson K, 2010, J EXP PSYCHOL LEARN, V36, P538, DOI 10.1037/a0018027; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Collette F, 2006, NEUROSCIENCE, V139, P209, DOI 10.1016/j.neuroscience.2005.05.035; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Cowan N, 2006, MEM COGNITION, V34, P1754, DOI 10.3758/BF03195936; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Engle R.W., 1999, MODELS WORKING MEMOR, P102, DOI DOI 10.1017/CBO9781139174909.007; Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160; Farmer TA, 2012, CAMBRIDGE HDB PSYCHO, P354; Fedorenko E, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00335; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Fedorenko E, 2012, BRAIN LANG, V120, P187, DOI 10.1016/j.bandl.2011.01.001; Fernandez-Duque D, 2001, J CLIN EXP NEUROPSYC, V23, P74, DOI 10.1076/jcen.23.1.74.1217; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Garnsey SM, 1997, J MEM LANG, V37, P58, DOI 10.1006/jmla.1997.2512; Golden C., 1978, STROOP COLOR WORD TE; Grossman M, 2002, BRAIN LANG, V80, P603, DOI 10.1006/brln.2001.2630; HAMMILL DD, 1994, TEST ADOLESCENT ADUL; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; Hart DJ, 2003, INT J GERIATR PSYCH, V18, P1037, DOI 10.1002/gps.1013; Heitz RP, 2006, BEHAV BRAIN SCI, V29, P135, DOI 10.1017/S0140525X06319036; Helm-Estabrooks N., 2001, COGNITIVE LINGUISTIC; Henry LA, 2012, J CHILD PSYCHOL PSYC, V53, P37, DOI 10.1111/j.1469-7610.2011.02430.x; Hill EL, 2004, TRENDS COGN SCI, V8, P26, DOI 10.1016/j.tics.2003.11.003; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; Hussey EK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00158; Im-Bolter N, 2006, CHILD DEV, V77, P1822, DOI 10.1111/j.1467-8624.2006.00976.x; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; January D, 2009, J COGNITIVE NEUROSCI, V21, P2434, DOI 10.1162/jocn.2008.21179; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kane MJ, 2003, J EXP PSYCHOL GEN, V132, P47, DOI 10.1037/0096-3445.132.1.47; Kane MJ, 2002, PSYCHON B REV, V9, P637, DOI 10.3758/BF03196323; Kay J., 2009, PALPA PSYCHOLINGUIST; Kehagia AA, 2013, NEURODEGENER DIS, V11, P79, DOI 10.1159/000341998; Kemper S, 2001, PSYCHOL AGING, V16, P312, DOI 10.1037//0882-7974.16.2.312; Kempler D, 1998, BRAIN LANG, V64, P297, DOI 10.1006/brln.1998.1980; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Key-DeLyria S., J SPEECH LANGUAGE HE; KIMBALL J, 1973, COGNITION, V2, P15, DOI 10.1016/0010-0277(72)90028-5; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kray J, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00180; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lehto JH, 1996, Q J EXP PSYCHOL-A, V49, P29, DOI 10.1080/027249896392793; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Lezak M.D., 2004, NEUROPSYCHOLOGICAL A, Vfourth; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; LIEBERMAN P, 1992, BRAIN LANG, V43, P169, DOI 10.1016/0093-934X(92)90127-Z; Luo J, 2004, NEUROREPORT, V15, P2013, DOI 10.1097/00001756-200409150-00004; MACDONALD MC, 1994, PSYCHOL REV, V101, P676, DOI 10.1037/0033-295X.101.4.676; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Martin RC, 2014, ACTA PSYCHOL, V152, P120, DOI 10.1016/j.actpsy.2014.08.006; Martin RC, 2006, COGN NEUROPSYCHOL, V23, P74, DOI 10.1080/02643290500179987; Mazuka R, 2009, LANG LINGUIST COMPAS, V3, P59, DOI 10.1111/j.1749-818x.2008.00102.x; McCabe DP, 2010, NEUROPSYCHOLOGY, V24, P222, DOI 10.1037/a0017619; McKinlay A, 2010, J INT NEUROPSYCH SOC, V16, P268, DOI 10.1017/S1355617709991299; Merkley TL, 2013, J INT NEUROPSYCH SOC, V19, P899, DOI 10.1017/S135561771300074X; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Montgomery JW, 2000, J SPEECH LANG HEAR R, V43, P293, DOI 10.1044/jslhr.4302.293; Moran C, 2004, BRAIN INJURY, V18, P273, DOI 10.1080/02699050310001617415; Murray L.L., 2006, NEUROGENIC DISORDERS; Murray LL, 2012, AM J SPEECH-LANG PAT, V21, pS51, DOI 10.1044/1058-0360(2012/11-0067); Murray LL, 2006, J COMMUN DISORD, V39, P37, DOI 10.1016/j.jcomdis.2005.06.001; Myers P.S., 1999, RIGHT HEMISPHERE DAM; Nigg JT, 2002, J AM ACAD CHILD PSY, V41, P59, DOI 10.1097/00004583-200201000-00012; Novais-Santos S, 2007, NEUROIMAGE, V37, P361, DOI 10.1016/j.neuroimage.2007.03.077; Novick JM, 2014, LANG COGN NEUROSCI, V29, P186, DOI 10.1080/01690965.2012.758297; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; Novick JM, 2009, COGN NEUROPSYCHOL, V26, P527, DOI 10.1080/02643290903519367; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; NOVICK JM, 2004, 17 ANN CUNY C HUM SE; Nozari N, 2011, COGNITIVE PSYCHOL, V63, P1, DOI 10.1016/j.cogpsych.2011.05.001; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; RAYNER K, 1987, Q J EXP PSYCHOL-A, V39, P657, DOI 10.1080/14640748708401808; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; Reilly J, 2010, J COMMUN DISORD, V43, P438, DOI 10.1016/j.jcomdis.2010.04.011; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rogalski Y, 2010, J COMMUN DISORD, V43, P212, DOI 10.1016/j.jcomdis.2010.02.001; Rowe J, 2006, BRIT J CLIN PSYCHOL, V45, P5, DOI 10.1348/014466505X29594; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; SIMON HA, 1975, COGNITIVE PSYCHOL, V7, P268, DOI 10.1016/0010-0285(75)90012-2; Small JA, 2000, BRAIN LANG, V75, P232, DOI 10.1006/brln.2000.2355; Smith-Spark JH, 2003, EUR J COGN PSYCHOL, V15, P567, DOI 10.1080/09541440340000024; Sohlberg M. M., 2001, COGNITIVE REHABILITA; Sohlberg MM., 2011, OPTIMIZING COGNITIVE; Spreen O., 1998, COMPENDIUM NEUROPSYC; Stocco A, 2012, COGN AFFECT BEHAV NE, V12, P611, DOI 10.3758/s13415-012-0117-7; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Swets B, 2007, J EXP PSYCHOL GEN, V136, P64, DOI 10.1037/0096-3445.136.1.64; Thothathiri M, 2012, NEUROPSYCHOLOGIA, V50, P3284, DOI 10.1016/j.neuropsychologia.2012.09.021; Thothathiri M, 2012, BRAIN LANG, V120, P259, DOI 10.1016/j.bandl.2011.12.004; Trueswell JC, 1999, COGNITION, V73, P89, DOI 10.1016/S0010-0277(99)00032-3; Turkstra LS, 1998, J SPEECH LANG HEAR R, V41, P137, DOI 10.1044/jslhr.4101.137; Vuong LC, 2014, LANG COGN NEUROSCI, V29, P312, DOI 10.1080/01690965.2013.836231; Vuong LC, 2011, BRAIN LANG, V116, P22, DOI 10.1016/j.bandl.2010.09.012; Waters GS, 1996, MEM COGNITION, V24, P342, DOI 10.3758/BF03213298; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Weighall AR, 2008, J EXP CHILD PSYCHOL, V99, P75, DOI 10.1016/j.jecp.2007.10.004; Wiig E. H., 1989, TLC EXPANDED TEST LA; Wilson SP, 1998, DEV REV, V18, P86, DOI 10.1006/drev.1997.0445; Wiseheart R, 2009, ANN DYSLEXIA, V59, P151, DOI 10.1007/s11881-009-0028-7; Ye Z, 2008, BRAIN RES, V1203, P103, DOI 10.1016/j.brainres.2008.01.090; Ye Z, 2009, NEUROSCI BIOBEHAV R, V33, P1168, DOI 10.1016/j.neubiorev.2009.03.003; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590; Zacks Rose T., 1994, P241; Zimmer B., 2010, NY TIMES	149	13	13	0	2	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	MAY	2016	25	2								10.1044/2015_AJSLP-14-0111			16	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	DO6AE	WOS:000377863600013	27214025				2021-06-18	
J	Khan, F; Amatya, B; Judson, R; Chung, P; Truesdale, M; Elmalik, A; Galea, MP				Khan, Fary; Amatya, Bhasker; Judson, Rodney; Chung, Pearl; Truesdale, Melinda; Elmalik, Alaeldin; Galea, Mary P.			FACTORS ASSOCIATED WITH LONG-TERM FUNCTIONAL AND PSYCHOLOGICAL OUTCOMES IN PERSONS WITH MODERATE TO SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; rehabilitation; disability; participation; outcome	QUALITY-OF-LIFE; CAREGIVER STRAIN; FOLLOW-UP; REHABILITATION; SCALE; POSTINJURY; VALIDATION; PEOPLE	Objective: To examine factors impacting long-term functional and psychological outcomes in persons with moderate-severe traumatic brain injury. Methods: A prospective cross-sectional study (n = 103) assessed the long-term (up to 5 years) impact of traumatic brain injury on participants' current activity and restriction in participation using validated questionnaires. Results: Participants' median age was 49.5 years (interquartile range (IQR) 20.4-23.8), the majority were male (77%), and 49% had some form of previous rehabilitation. The common causes of traumatic brain injury were falls (42%) and motor vehicle accidents (27%). Traumatic brain injury-related symptoms were: pain/headache (47%), dizziness (36%), bladder/bowel impairment (34%), and sensoryperceptual deficits (34%). Participants reported minimal change in their physical function and cognition (Functional Assessment Measure: motor (median 102, IQR 93-111) and cognition (median 89, IQR 78-95)). Participants were well adjusted to community-living; however, they reported high levels of depression. Factors significantly associated with poorer current level of functioning/well-being included: older age (>= 60 years), presence of traumatic brain injury-related symptoms, a lack of previous rehabilitation and those classified in "severe disability categories" at admission. Caregivers reported high levels of strain and burden (55%). Conclusion: Cognitive and psychosocial problems are more commonly reported than physical disability in the longer-term. A greater focus on participation and ageing with disability in these persons is needed.	[Khan, Fary; Amatya, Bhasker; Chung, Pearl; Elmalik, Alaeldin; Galea, Mary P.] Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Melbourne, Vic 3052, Australia; [Khan, Fary; Galea, Mary P.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3050, Australia; [Khan, Fary] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Amatya, Bhasker] Royal Melbourne Hosp, Trauma Serv, Parkville, Vic 3050, Australia; [Truesdale, Melinda] Royal Melbourne Hosp, Emergency Serv, Parkville, Vic 3050, Australia	Khan, F (corresponding author), Royal Melbourne Hosp, Dept Rehabil Med, 34-54 Poplar Rd, Melbourne, Vic 3052, Australia.	fary.khan@mh.org.au	Galea, Mary/F-4242-2010; Amatya, Bhasker/E-1062-2017	Galea, Mary/0000-0003-0045-7978; Amatya, Bhasker/0000-0003-4793-1104; Chung, Pearl/0000-0002-9572-2860			Access Economics, 2009, EC COSTS SPIN CORD I; Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; Australian Institute of Health and Welfare (AIHW), 2008, AUSTR I HLTH WELF HL, V35; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Boycott N, 2013, J HEAD TRAUMA REHAB, V28, P106, DOI 10.1097/HTR.0b013e31823fe07e; Brain Injury Association of America (BIAA), 2011, FACTS TRAUM BRAIN IN; Brasure M, 2012, PUBLICATION AGENCY H; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; COCKERILL R, 1990, J REHABIL, V56, P41; De Silva M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006422.pub3; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Khan F, 2012, BRIT J SURG, V99, P88, DOI 10.1002/bjs.7776; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Khan F, 2007, DISABIL REHABIL, V29, P1241, DOI 10.1080/01443610600964141; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; Lu J, 2008, J NEUROTRAUM, V25, P641, DOI 10.1089/neu.2007.0510; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Senathi-Raja D, 2010, J HEAD TRAUMA REHAB, V25, P330, DOI 10.1097/HTR.0b013e3181ccc893; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; Sloan S, 2008, ACQUIRED BRAIN INJUR; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Turner-Stokes L, 1999, CLIN REHABIL, V13, P277, DOI 10.1191/026921599676896799; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; van Exel NJA, 2004, CLIN REHABIL, V18, P203, DOI 10.1191/0269215504cr723oa; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Winker PA, 2007, TRAUMATIC BRAIN INJU, P532; World Health Organization, 2001, INT CLASS FUNCT DIS	40	13	13	0	10	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2016	48	5					442	448		10.2340/16501977-2084			7	Rehabilitation; Sport Sciences	Rehabilitation; Sport Sciences	DL6MM	WOS:000375753300005	27058885	DOAJ Gold			2021-06-18	
J	Li, M; Jia, Q; Chen, TH; Zhao, ZL; Chen, JL; Zhang, JN				Li, Min; Jia, Qiang; Chen, Tongheng; Zhao, Zilong; Chen, Jieli; Zhang, Jianning			The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Vascular endothelial growth factor; Vascular endothelial growth inhibitor; TNFSF15; Clinical outcome; Traumatic brain injury; Dynamic change; Prognostic marker	RAT-BRAIN; VEGF; ANGIOGENESIS; PERMEABILITY; INFLAMMATION; BIOLOGY; CELL	Objectives: Tumor necrosis factor superfamily-15 (TNFSF15) also known as vascular endothelial growth inhibitor (VEGI) is a cytokine that modulates anti-angiogenesis and inflammation. Vascular endothelial growth factor (VEGF) promotes angiogenesis and vascular permeability following traumatic brain injury (TBI). The balance of VEGF and VEGI may play a key role in the maintenance of vascular and immune system homeostasis in the brain. However, the dynamic changes of circulating VEGF and VEGI after traumatic brain injury (TBI) and the correlation between plasma VEGF and plasma VEGI remains obscure. In this study, we were to investigate whether circulating VEGF and VEGI can be used as prognostic markers for patients with TBI. Patients and methods: A prospective clinical study was conducted in two neurosurgical intensive care units of Tianjin Medical University General Hospital and Tianjin Huanhu Hospital (Tianjin, China). 40 patients and 30 healthy controls were recruited. The recruited subjects were aged over 18 with randomized gender and GCS. 1 mL of blood was withdrawn on 1, 4, 7, 14, and 21 days after TBI. Blood samples were centrifuged at 3000 rpm and the supernatants were used to measure VEGF and VEGI by ELISA kit. Results: 1) Circulating VEGF in TBI patients was decreased on the 1st day after TBI, then climbed up on the 4th day, reaching a maximum level on the 14th day after TBI, as compared to normal controls. VEGF level returned to normal level on 21th day after TBI. 2) Circulating VEGI in TBI patients was decreased on the 1st and 4th day after TBI, then climbed up on the 7th day after TBI, reaching a maximum level on 14th day after TBI, as compared to normal controls. VEGI levels declined to normal level on 21th day after TBI. 3) There was a significant positive correlation between circulating VEGF and VEGI. 4) However, TBI patients whose conditions had improved exhibited lower VEGF levels 7 days after TBI when compared to TBI patients whose condition had deteriorated. Survivors exhibited higher VEGI levels 7 days after TBI when compared to non-survivors. 5)TBI patients whose condition had improved exhibited higher VEGI levels when compared to TBI patients whose condition had deteriorated 21 days after TBI. Patients with mild TBI exhibited higher VEGI levels than those with moderate and severe TBI 21 days after TBI. 6) A lower rate of recovery and higher hospital mortality were found in patients with VEGF/VEGI ratio >= 2.366 as compared to those with VEGF/VEGI ratio <2.366 7 days after TBI. Conclusions: 1) VEGF level positively correlates with VEGI after TBI. 2) The elevation of VEGF exhibits an adverse effect from 4 to 14 days after TBI while it has an advantageous effect from 14 to 21 days after TBI. Increasing VEGI levels are beneficial in recovery after TBI. Controlling the ratio of VEGF/VEGI may benefit the clinical outcome following TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Li, Min; Zhao, Zilong; Zhang, Jianning] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Jia, Qiang] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300060, Peoples R China; [Chen, Tongheng] Tianjin Med Univ, Dept Neurosurg, Hosp 2, Tianjin 300211, Peoples R China; [Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA	Zhang, JN (corresponding author), Tianjin Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	812879698@qq.com	Zhao, Zilong/AAZ-2196-2020				Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Ryu JK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-18; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218	15	13	14	0	9	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2016	144						7	13		10.1016/j.clineuro.2016.02.032			7	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DL4TH	WOS:000375629600002	26945876				2021-06-18	
J	Pugh, MJ; Jaramillo, CA; Leung, KW; Faverio, P; Fleming, N; Mortensen, E; Amuan, ME; Wang, CP; Eapen, B; Restrepo, M; Morris, MJ				Pugh, Mary Jo; Jaramillo, Carlos A.; Leung, Kar-wei; Faverio, Paola; Fleming, Nicholas; Mortensen, Eric; Amuan, Megan E.; Wang, Chen-Pin; Eapen, Blessen; Restrepo, Marcos; Morris, Michael J.			Increasing Prevalence of Chronic Lung Disease in Veterans of the Wars in Iraq and Afghanistan	MILITARY MEDICINE			English	Article							RESPIRATORY SYMPTOMS; PARTICULATE MATTER; HEALTH; DEPLOYMENT; SOLDIERS; EXPLOSIONS; PNEUMONIA; INJURIES; EXPOSURE; FREEDOM	Research from the wars in Afghanistan and Iraq have focused on traumatic brain injury (TBI) and mental health conditions; however, it is becoming clear that other health concerns, such as respiratory illnesses, warrant further scientific inquiry. Early reports from theater and postdeployment health assessments suggested an association with deployment-related exposures (e.g., sand, burn pits, chemical, etc.) and new-onset respiratory symptoms. We used data from Veterans Affairs medical encounters between fiscal years 2003 and 2011 to identify trends in chronic obstructive pulmonary disease, asthma, and interstitial lung disease in veterans. We used data from Veterans Affairs and Department of Defense sources to identify sociodemographic (age, sex, race), military (e.g., service branch, multiple deployments) and clinical characteristics (TBI, smoking) of individuals with and without chronic lung diseases. Generalized estimating equations found significant increases over time for chronic obstructive pulmonary disease and asthma in both unadjusted and adjusted analyses. Trends for interstitial lung disease were significant only in adjusted analyses. Age, smoking, and TBI were also significantly associated with chronic lung diseases; however, multiple deployments were not associated. Research is needed to identify which characteristics of deployment-related exposures are linked with chronic lung disease.	[Pugh, Mary Jo; Jaramillo, Carlos A.; Eapen, Blessen; Restrepo, Marcos] South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Pugh, Mary Jo; Jaramillo, Carlos A.; Leung, Kar-wei; Fleming, Nicholas; Wang, Chen-Pin; Eapen, Blessen; Restrepo, Marcos] Univ Texas Hlth Sci Ctr San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Faverio, Paola] Univ Milano Bicocca, AO San Gerardo, Clin Pneumol, Dept Hlth Sci, Via Pergolesi 22, Monza, Italy; [Mortensen, Eric] North Texas Vet Hlth Care Syst, 4500 South Lancaster Rd, Dallas, TX 75216 USA; [Amuan, Megan E.] Edith Nourse Rogers VA Med Ctr, 200 Springs Rd, Bedford, MA 01730 USA; [Morris, Michael J.] Uniformed Serv Univ Hlth Sci, Brooke Army Med Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA	Pugh, MJ (corresponding author), South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.; Pugh, MJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.		Mortensen, Eric/AAF-2713-2020; Pugh, Mary Jo/K-5336-2019; Faverio, Paola/A-3660-2019	Pugh, Mary Jo/0000-0003-4196-7763; faverio, paola/0000-0002-0360-1237; Mortensen, Eric/0000-0002-3880-5563	VA Health Services Research and Development ServiceUS Department of Veterans Affairs [DHI 09-237]	Data were obtained with the assistance of the VA Office of Environmental Epidemiology for the Operation Enduring Freedom/Operation Iraqi Freedom Roster file. This study was funded by the VA Health Services Research and Development Service (DHI 09-237). The content, of this article is solely the responsibility of the authors and does not necessarily reflect the official views of the Veterans' Health Administration or the Department of Defense. The funding organizations had no role in the design and conduct of die study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. This retrospective data study received approval including a waiver of informed consent and Health Insurance Portability and Accountability Act authorization by the institutional review boards of the University of Texas Health Science Center San Antonio and the Edith Nourse Rogers Memorial VA Hospital.	Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P733, DOI 10.1097/JOM.0b013e318253356c; Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P740, DOI 10.1097/JOM.0b013e318252969a; American Lung Association, 2012, TRENDS ASTHM MORB MO; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Barth SK, 2014, MIL MED, V179, P241, DOI 10.7205/MILMED-D-13-00338; Committee on Gulf War and Health, 2014, LONG TERM EFFECTS BL, V9; DelVecchio SP, 2014, J ASTHMA, V52, P263; Finlay SE, 2012, PREHOSP DISASTER MED, V27, P385, DOI 10.1017/S1049023X12000891; Government Accountabilility Office, 2010, AFGH IR DOD SHOULD I; Green Michael E, 2015, CMAJ Open, V3, pE15, DOI 10.9778/cmajo.20140040; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Matthews T, 2014, MIL MED, V179, P1273, DOI 10.7205/MILMED-D-14-00066; Mortensen EM, 2012, CLIN INFECT DIS, V55, P1466, DOI 10.1093/cid/cis733; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Roop SA, 2007, MIL MED, V172, P1264, DOI 10.7205/MILMED.172.12.1264; Shorr AF, 2004, JAMA-J AM MED ASSOC, V292, P2997, DOI 10.1001/jama.292.24.2997; Sine C, 2011, CHEST, V140, p675A; Singleton JAG, 2013, J TRAUMA ACUTE CARE, V75, pS269, DOI 10.1097/TA.0b013e318299d93e; Skabelund A, 2013, CHEST, V144, DOI 10.1378/chest.1704368; Smith B, 2008, AM J PREV MED, V35, P539, DOI 10.1016/j.amepre.2008.07.009; Smith B, 2012, J OCCUP ENVIRON MED, V54, P708, DOI 10.1097/JOM.0b013e31825107f9; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Szema AM, 2011, J OCCUP ENVIRON MED, V53, P961, DOI 10.1097/JOM.0b013e31822c9f05; Szema AM, 2010, ALLERGY ASTHMA PROC, V31, pE67, DOI 10.2500/aap.2010.31.3383; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Weese CB, 2009, INHAL TOXICOL, V21, P291, DOI [10.1080/08958370802672891 , 10.1080/08958370802672891]	27	13	13	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2016	181	5					476	481		10.7205/MILMED-D-15-00035			6	Medicine, General & Internal	General & Internal Medicine	DN5MZ	WOS:000377114400015	27136656	Bronze			2021-06-18	
J	Silk-Eglit, GM; Lynch, JK; McCaffrey, RJ				Silk-Eglit, Graham M.; Lynch, Julie K.; McCaffrey, Robert J.			Validation of Victoria Symptom Validity Test Cutoff Scores among Mild Traumatic Brain Injury Litigants Using a Known-Groups Design	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Forensic neuropsychology; Malingering/symptom validity testing; Head injury; Traumatic brain injury	DEFINED MALINGERING GROUPS; FALSE-POSITIVE RATES; PERFORMANCE VALIDITY; NEUROPSYCHOLOGICAL TESTS; CLASSIFICATION ACCURACY; RESPONSE BIAS; TEST FAILURE; MULTIPLE PERFORMANCE; MEMORY IMPAIRMENT; INADEQUATE EFFORT	The Victoria Symptom Validity Test (VSVT) is one of the most accurate performance validity tests. Previous research has recommended several cutoffs for performance invalidity classification on the VSVT. However, only one of these studies used a known groups design and no study has investigated these cutoffs in an exclusively mild traumatic brain injury (mTBI) medico-legal sample. The current study used a known groups design to validateVSVT cutoffs among mild traumatic brain injury litigants and explored the best approach for using the multiple recommended cutoffs for this test. Cutoffs of <18 Hard items correct, <41 Total items correct, an Easy-Hard items correct difference. 6, and <5 items correct on any block yielded the strongest classification accuracy. Using multiple cutoffs in conjunction reduced classification accuracy. Given convergence across studies, a cutoff of <18 Hard items correct is the most appropriate for use with mTBI litigants.	[Silk-Eglit, Graham M.; McCaffrey, Robert J.] SUNY Albany, Dept Psychol, Albany, NY 12222 USA; [Silk-Eglit, Graham M.] Vet Adm San Diego Healthcare Syst, San Diego, CA USA; [Lynch, Julie K.; McCaffrey, Robert J.] Albany Neuropsychol Associates, Guilderland, NY USA	Silk-Eglit, GM (corresponding author), SUNY Albany, Dept Psychol, Albany, NY 12222 USA.	grahammse@gmail.com		Eglit, Graham/0000-0001-7592-9859			Babikian T., 2006, ARCH CLIN NEUROPSYCH, V26, P592; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Brennan AM, 2006, APPL NEUROPSYCHOL, V13, P1, DOI 10.1207/s15324826an1301_1; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Committee on Mild Traumatic Brain Injury American Congress of Rehabilitation Medicine (ACRM), 1993, J HEAD TRAUMA REHAB, V8, P86; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; DiCarlo MA, 2000, ARCH CLIN NEUROPSYCH, V15, P399, DOI 10.1016/S0887-6177(99)00031-1; Dickens S. E., 1992, STRUCTURED INTERVIEW; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, GREENS WORD MEMORY T; Green P., 2005, MANUAL WORD MEMORY T; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Greiffenstein M.F., 1994, PSYCHOL ASSESSMENT, V6, P218, DOI [https://doi.org/10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2008, CLIN NEUROPSYCHOL, V22, P896, DOI 10.1080/13854040701565208; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Grote C.L., 2007, ASSESSMENT MALINGERE, P44; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Hayden SR, 1999, ANN EMERG MED, V33, P575, DOI 10.1016/S0196-0644(99)70346-X; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1373, DOI 10.1080/13854046.2013.851740; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Keary TA, 2013, J INT NEUROPSYCH SOC, V19, P314, DOI 10.1017/S1355617712001397; Larrabee G.J., 2007, ASSESSMENT MALINGERE, P334; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lezak M., 2012, NEUROPSYCHOLOGICAL A, V5th; Loring DW, 2007, CLIN NEUROPSYCHOL, V21, P522, DOI 10.1080/13854040600611384; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Macciocchi SN, 2006, ARCH CLIN NEUROPSYCH, V21, P395, DOI 10.1016/j.acn.2006.06.003; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Randolph C, 1998, REPEATABLE BATTERY A; Rogers R., 2008, CLIN ASSESSMENT MALI; Rogers R., 1997, CLIN ASSESSMENT MALI, V2nd; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P271, DOI 10.1080/23279095.2014.921167; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Slick D., 1997, VICTORIA SYMPTOM VAL; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Stenclik JH, 2013, APPL NEUROPSYCH-ADUL, V20, P243, DOI 10.1080/09084282.2012.704603; Strauss E, 2002, ARCH CLIN NEUROPSYCH, V17, P423, DOI 10.1016/S0887-6177(01)00126-3; Tombaugh TN, 1996, TEST MEMORY MALINGER; Vickery CD, 2001, ARCH CLIN NEUROPSYCH, V16, P45, DOI 10.1016/S0887-6177(99)00058-X; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Wolfson D., 1993, HALSTEAD REITAN NEUR	58	13	13	0	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2016	31	3					231	245		10.1093/arclin/acv108			15	Psychology, Clinical; Psychology	Psychology	DL1WX	WOS:000375424900004	26795609	Bronze			2021-06-18	
J	Haran, FJ; Slaboda, JC; King, LA; Wright, WG; Houlihan, D; Norris, JN				Haran, F. Jay; Slaboda, Jill C.; King, Laurie A.; Wright, W. Geoff; Houlihan, Daniel; Norris, Jacob N.			Sensitivity of the Balance Error Scoring System and the Sensory Organization Test in the Combat Environment	JOURNAL OF NEUROTRAUMA			English	Article						BESS; military; mTBI; SOT	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; POSTURAL STABILITY; POSTCONCUSSIVE SYMPTOMS; RELIABLE CHANGE; CONCUSSION; PERFORMANCE; RECOVERY; CONSEQUENCES; MILITARY	This study evaluated the utility of the Balance Error Scoring System (BESS) and the Sensory Organization Test (SOT) as tools for the screening and monitoring of Service members (SMs) with mild traumatic brain injury (mTBI) in a deployed setting during the acute and subacute phases of recovery. Patient records (N = 699) were reviewed for a cohort of SMs who sustained a blast-related mTBI while deployed to Afghanistan and were treated at the Concussion Restoration Care Center (CRCC) at Camp Leatherneck. On initial intake into the CRCC, participants completed two assessments of postural control, the BESS, and SOT. SMs with mTBI performed significantly worse on the BESS and SOT when compared with comparative samples. When the SOT data were further examined using sensory ratios, the results indicated that postural instability was primarily a result of vestibular and visual integration dysfunction (r > 0.62). The main finding of this study was that the sensitivity of the SOT composite score (50-58%) during the acute phase was higher than previous sensitivities found in the sports medicine literature for impact-related trauma.	[Haran, F. Jay] Navy Expt Diving Unit, Panama City Beach, FL USA; [Slaboda, Jill C.] Geneva Fdn, Tacoma, WA USA; [King, Laurie A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Wright, W. Geoff] Temple Univ, Dept Phys Therapy, Philadelphia, PA 19122 USA; [Houlihan, Daniel] Tufts Univ, Dept Occupat Therapy, Medford, MA 02155 USA; [Norris, Jacob N.] Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20910 USA	Norris, JN (corresponding author), Naval Med Res Ctr, Neurotrauma Dept, Silver Spring, MD 20910 USA.	jacob.n.norris.mil@mail.mil					Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Casscells SW, 2007, TRAUMATIC BRAIN INJU; Chang JO, 2014, CLIN J SPORT MED, V24, P256, DOI 10.1097/JSM.0000000000000016; Chelune GJ, 1993, NEUROPSYCHOLOGY, V7, P41, DOI DOI 10.1037/0894-4105.7.1.41; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Conaton E., 2012, 649011 DODI; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Denis A. M., 2007, INTENS CARE MED, P1011; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dickin DC, 2007, CLIN J SPORT MED, V17, P109, DOI 10.1097/JSM.0b013e31803bf647; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Haran FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079595; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, PSYCHOL REP, V89, P457, DOI 10.2466/pr0.2001.89.2.457; Iverson GL, 2013, REHABIL RES PRACT, V2013, DOI 10.1155/2013/846418; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Levinson DM, 1997, ARCH CLIN NEUROPSYCH, V12, P155, DOI 10.1016/S0887-6177(96)00026-1; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Mendez MF, 2013, NEUROREHABILITATION, V32, P397, DOI 10.3233/NRE-130861; Moritz S, 2003, APPL NEUROPSYCHOL, V10, P115, DOI 10.1207/S15324826AN1002_07; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Scherer MR, 2013, PHYS THER, V93, P1254, DOI 10.2522/ptj.20120143; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Sylvia FR, 2001, MIL MED, V166, P918; Weber AF, 2013, J ATHL TRAINING, V48, P153, DOI 10.4085/1062-6050-48.1.07; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	62	13	13	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2016	33	7					705	711		10.1089/neu.2015.4060			7	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DI6QK	WOS:000373624700010	26560740				2021-06-18	
J	Johnson, T; Koria, P				Johnson, Tamina; Koria, Piyush			Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration	BIODRUGS			English	Article							NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; ESCHERICHIA-COLI; DRUG-DELIVERY; GENE-THERAPY; SIGNALING ENDOSOMES; CONTROLLED-RELEASE; HEPARAN-SULFATE; NANOPARTICLES; SYSTEM	Background Neural injuries such as spinal cord injuries, traumatic brain injuries, or nerve transection injuries pose a major health problem. Neurotrophins such as nerve growth factor (NGF) or brain-derived neurotrophic factor (BDNF) have been shown to improve the outcome of neural injuries in several pre-clinical models, but their use in clinics is limited by the lack of a robust delivery system that enhances their bioavailability and half-life. Objectives We describe two fusion proteins comprising NGF or BDNF fused with elastin-like peptides (ELPs). The aim of this study was to investigate the biological activity of neurotrophin-ELP (N-ELP) fusion proteins via in vitro culture models. Methods NGF and BDNF were cloned in front of an elastin-like polypeptide sequence V40C2. These proteins were expressed in bacteria as inclusion bodies. These fusion proteins underwent solubilization via 8 M urea and purification via inverse transition cycling (ITC). We measured the particle size and the effect of temperature on precipitated particles using dynamic light scattering (DLS). We used western blot analysis to confirm the specificity of NGF-ELP to tropomyosin receptor kinase A (TrkA) antibody and to confirm the specificity of BDNF-ELP to TrkB antibody. PC12 cells were used to perform a neurite outgrowth assay to determine the biological activity of NGF-ELP. Bioactivity of BDNF-ELP was ascertained via transfecting human epithelial kidney (HEK 293-T) cells to express the TrkB receptor. Results The proteins were successfully purified to high homogeneity by exploiting the phase transition property of ELPs and urea, which solubilize inclusion bodies. Using PC12 neurite outgrowth assay, we further demonstrated that the biological activity of NGF was retained in the fusion. Similarly, BDNF-ELP phosphorylated the TrkB receptor, suggesting the biological activity of BDNF was also retained in the fusion. We further show that owing to the phase transition property of ELPs in the fusion, these proteins self-assembled into nanoparticles at their respective transition temperatures. Conclusion These fusion proteins are useful for neural regeneration, as they not only retain the biological activity of the neurotrophin but also self-assemble into nanoparticles, thereby simultaneously serving as drug-delivery vehicles. These nanoparticles can serve as drug depots and will increase bioavailability by limiting neurotrophin loss due to diffusion, thereby allowing controlled spatio-temporal delivery of the neurotrophin.	[Johnson, Tamina; Koria, Piyush] Univ S Florida, Dept Chem & Biomed Engn, 4202 E Fowler Ave,ENB 118, Tampa, FL 33620 USA	Koria, P (corresponding author), Univ S Florida, Dept Chem & Biomed Engn, 4202 E Fowler Ave,ENB 118, Tampa, FL 33620 USA.	pkoria@usf.edu			University of South Florida; American Cancer SocietyAmerican Cancer Society [93-032-16]; NSF Florida Georgia Louis Stokes Alliance for Minority Participation Bridge [1139850]; USF Graduate Student Success Diversity Fellowship; Alfred P. Sloan Minority Ph.D. Program	This work was funded by startup funds from the University of South Florida (PK) and the new researcher grant (PK) from University of South Florida, and in part by Institutional Research Grant number 93-032-16 from the American Cancer Society (PK). Tamina Johnson was supported by NSF Florida Georgia Louis Stokes Alliance for Minority Participation Bridge to the Doctorate Award HRD #1139850, the USF Graduate Student Success Diversity Fellowship, and The Alfred P. Sloan Minority Ph.D. Program.	Angelova A, 2013, DRUG DISCOV TODAY, V18, P1263, DOI 10.1016/j.drudis.2013.07.010; Angelova A, 2013, INT J PHARMACEUT, V454, P625, DOI 10.1016/j.ijpharm.2013.06.006; Asai D, 2012, BIOMATERIALS, V33, P5451, DOI 10.1016/j.biomaterials.2012.03.083; Bidwell GL, 2010, ADV DRUG DELIVER REV, V62, P1486, DOI 10.1016/j.addr.2010.05.003; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Byrnes CK, 2001, WOUND REPAIR REGEN, V9, P341, DOI 10.1046/j.1524-475x.2001.00341.x; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; DICOU E, 1992, NEUROCHEM INT, V20, P129, DOI 10.1016/0197-0186(92)90136-F; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; George EM, 2015, VASC CELL, V7, DOI 10.1186/s13221-014-0026-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grill R, 1997, J NEUROSCI, V17, P5560; Hirsch T, 2007, FRONT BIOSCI-LANDMRK, V12, P2507, DOI 10.2741/2251; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iglesias R, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0708-6; Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.10; Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108; Le DHT, 2015, BIOPOLYMERS, V103, P175, DOI 10.1002/bip.22582; Lindsey S, 2015, BIOMACROMOLECULES, V16, P2672, DOI 10.1021/acs.biomac.5b00541; Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; MEYER SL, 1994, J NEUROCHEM, V62, P825; Mie M, 2008, J BIOMED MATER RES B, V86B, P283, DOI 10.1002/jbm.b.31019; Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001; Mortazavi MM, 2011, CHILD NERV SYST, V27, P1307, DOI 10.1007/s00381-010-1365-x; NEGRO A, 1992, BIOCHEM BIOPH RES CO, V186, P1553, DOI 10.1016/S0006-291X(05)81584-0; Park E, 1998, J DRUG TARGET, V6, P53, DOI 10.3109/10611869808997881; RATNER N, 1985, J CELL BIOL, V101, P744, DOI 10.1083/jcb.101.3.744; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300; Sandow SL, 2000, IMMUNOL CELL BIOL, V78, P430, DOI 10.1046/j.1440-1711.2000.00924.x; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sly DJ, 2012, JARO-J ASSOC RES OTO, V13, P1, DOI 10.1007/s10162-011-0297-9; SNOW AD, 1990, AM J PATHOL, V137, P1253; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037; Trumble TE, 2000, HAND CLIN, V16, P105; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Wang TY, 2012, J BIOMATER APPL, V27, P369, DOI 10.1177/0885328212443297; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844; Wolfe D, 2012, NEUROSCI LETT, V527, P85, DOI 10.1016/j.neulet.2012.04.047; Yao F, 2000, WOUND REPAIR REGEN, V8, P443, DOI 10.1046/j.1524-475x.2000.00443.x	48	13	13	0	24	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-8804	1179-190X		BIODRUGS	Biodrugs	APR	2016	30	2					117	127		10.1007/s40259-016-0159-4			11	Oncology; Immunology; Pharmacology & Pharmacy	Oncology; Immunology; Pharmacology & Pharmacy	DM6ZG	WOS:000376501000006	26820997				2021-06-18	
J	Pan, J; Connolly, ID; Dangelmajer, S; Kintzing, J; Ho, AL; Grant, G				Pan, James; Connolly, Ian D.; Dangelmajer, Sean; Kintzing, James; Ho, Allen L.; Grant, Gerald			Sports-related brain injuries: connecting pathology to diagnosis	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; neurodegeneration; biomarkers; imaging; concussion; chronic traumatic encephalopathy; sports	CHRONIC TRAUMATIC ENCEPHALOPATHY; NEURON-SPECIFIC ENOLASE; CEREBRAL-BLOOD-FLOW; WHITE-MATTER; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; PHOSPHORYLATED TAU; SUBARACHNOID HEMORRHAGE; STANDARDIZED ASSESSMENT; SERUM BIOMARKERS	Brain injuries are becoming increasingly common in athletes and represent an important diagnostic challenge. Early detection and management of brain injuries in sports are of utmost importance in preventing chronic neurological and psychiatric decline. These types of injuries incurred during sports are referred to as mild traumatic brain injuries, which represent a heterogeneous spectrum of disease. The most dramatic manifestation of chronic mild traumatic brain injuries is termed chronic traumatic encephalopathy, which is associated with profound neuropsychiatric deficits. Because chronic traumatic encephalopathy can only be diagnosed by postmortem examination, new diagnostic methodologies are needed for early detection and amelioration of disease burden. This review examines the pathology driving changes in athletes participating in high-impact sports and how this understanding can lead to innovations in neuroimaging and biomarker discovery.	[Pan, James; Connolly, Ian D.; Ho, Allen L.; Grant, Gerald] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Dangelmajer, Sean] Stanford Univ, Sch Med, Dept Orthopaed Surg, Stanford, CA 94305 USA; [Kintzing, James] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Grant, G (corresponding author), Stanford Univ, Med Ctr, Dept Neurosurg, 300 Pasteur Dr, Stanford, CA 94305 USA.	gerald.grant@stanford.edu					Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Azad TD, 2016, WORLD NEUROSURG, V86, DOI 10.1016/j.wneu.2015.10.032; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Borogovac A, 2012, INT J BIOMED IMAGING, V2012; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Campion S, 2013, EXPERT OPIN DRUG MET, V9, P1391, DOI 10.1517/17425255.2013.827170; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P160; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; da Costa L, 2015, J NEUROL NEUROSUR PS, V86, P1008, DOI 10.1136/jnnp-2014-308571; Davis GA, 2015, NEUROSURGERY, V76, P643, DOI 10.1227/NEU.0000000000000722; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Drucker E, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-7; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Geser F, 2011, PROG NEUROBIOL, V95, P649, DOI 10.1016/j.pneurobio.2011.08.011; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham MR, 2011, INT J IMMUNOPATH PH, V24, P119, DOI 10.1177/039463201102400114; GRONWALL D, 1975, LANCET, V2, P995; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; HAIMOTO H, 1987, LAB INVEST, V57, P489; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132093, 10.3171/2013.12.JNS132090]; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI 10.1016/j.jen.2008.12.010; James OG, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00038; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnston KM, 2001, CLIN J SPORT MED, V11, P166, DOI 10.1097/00042752-200107000-00007; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Lin AP, 2012, BRAIN IMAGING BEHAV, V6, P208, DOI 10.1007/s11682-012-9181-4; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; MAWDSLEY C, 1963, LANCET, V2, P795; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McKee AC, 2015, ACTA NEUROPATHOL, P1; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan W, 2015, NEUROLOGY, V85, P1504, DOI 10.1212/WNL.0000000000001893; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Moseley ME, 2009, NEUROL CLIN, V27, P1, DOI 10.1016/j.ncl.2008.09.006; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nakamura K, 2013, CURR MOL MED, V13, P1098; Nakamura K, 2013, PRION, V7, P117, DOI 10.4161/pri.22849; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; National Institute of Neurological Disorders and Stroke, 1 NIH CONS C DEF NEU; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen ML, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00091; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Berger RP, 2006, PEDIATR CRIT CARE ME, V7, P557, DOI 10.1097/01.PCC.0000244426.37793.23; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Pelinka LE, 2004, SHOCK, V21, P72, DOI 10.1097/01.shk.0000101672.49265.14; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Petcharunpaisan S, 2010, WORLD J RADIOL, V2, P384, DOI 10.4329/wjr.v2.i10.384; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Roberts AH., 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; Rodriguez-Rodriguez A, 2012, CLIN CHIM ACTA, V414, P228, DOI 10.1016/j.cca.2012.09.025; Romeo MJ, 2005, EXPERT REV PROTEOMIC, V2, P57, DOI 10.1586/14789450.2.1.57; Ross SA, 1996, BRIT J NEUROSURG, V10, P471, DOI 10.1080/02688699647104; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Solomon GS, 2015, BRAIN INJURY, V29, P164, DOI 10.3109/02699052.2014.965205; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Wang Y, 2015, DEV NEUROPSYCHOL, V40, P40, DOI 10.1080/87565641.2014.979927; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wilde EA, 2015, J NEUROTRAUMA; Wolk DA, 2012, CURR OPIN NEUROL, V25, P421, DOI 10.1097/WCO.0b013e328354ff0a; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang W, 2012, J ALZHEIMERS DIS, V31, P601, DOI 10.3233/JAD-2012-120712; Zhang ZJ, 2011, J CLIN LAB ANAL, V25, P402, DOI 10.1002/jcla.20491; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	151	13	13	0	37	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	APR	2016	40	4							E14	10.3171/2016.1.FOCUS15607			16	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DI4NL	WOS:000373476500004	27032917	Bronze			2021-06-18	
J	Schmitt-Sody, M; Kurz, S; REiser, M; Kanz, KG; Kirchhoff, C; Peschel, O; Kirchhoff, S				Schmitt-Sody, MArkus; Kurz, Stefanie; REiser, MAximilian; Kanz, Karl Georg; Kirchhoff, Chlodwig; Peschel, Oliver; Kirchhoff, Sonja			Analysis of death in major trauma: value of prompt post mortem computed tomography (pmCT) in comparison to office hour autopsy	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							VIRTUAL AUTOPSY; POSTMORTEM; INJURY; VIRTOPSY; RADIOLOGY; VICTIMS; UTILITY; MSCT; MRI	Background: To analyze diagnostic accuracy of prompt post mortem Computed Tomography (pmCT) in determining causes of death in patients who died during trauma room management and to compare the results to gold standard autopsy during office hours. Methods: Multiple injured patients who died during trauma room care were enrolled. PmCT was performed immediately followed by autopsy during office hours. PmCT and autopsy were analyzed primarily regarding pmCT ability to find causes of death and secondarily to define exact causes of death including accurate anatomic localizations. For the secondary analysis data was divided in group-I with equal results of pmCT and autopsy, group-II with autopsy providing superior results and group-III with pmCT providing superior information contributing to but not majorly causing death. Results: Seventeen multiple trauma patients were enrolled. Since multiple trauma patients were enrolled more injuries than patients are provided. Eight patients sustained deadly head injuries (47.1 %), 11 chest (64.7 %), 4 skeletal system (23.5 %) injuries and one patient drowned (5.8 %). Primary analysis revealed in 16/17 patients (94.1 %) causes of death in accordance with autopsy. Secondary analysis revealed in 9/17 cases (group-I) good agreement of autopsy and pmCT. In seven cases autopsy provided superior results (group-II) whereas in 1 case pmCT found more information (group-III). Discussion: The presented work studied the diagnostic value of pmCT in defining causes of death in comparison to standard autopsy. Primary analysis revealed that in 94.1% of cases pmCT was able to define causes of death even if only indirect signs were present. Secondary analysis showed that pmCT and autopsy showed equal results regarding causes of death in 52.9%. Conclusions: PmCT is useful in traumatic death allowing for an immediate identification of causes of death and providing detailed information on bony lesions, brain injuries and gas formations. It is advisable to conduct pmCT especially in cases without consent to autopsy to gain information about possible causes of death and to rule out possible clinical errors.	[Schmitt-Sody, MArkus; Kurz, Stefanie; REiser, MAximilian; Kanz, Karl Georg; Kirchhoff, Chlodwig; Peschel, Oliver; Kirchhoff, Sonja] Klinikum Univ Munchen, Munich, Germany	Kirchhoff, S (corresponding author), Klinikum Univ Munchen, Munich, Germany.	sonja.kirchhoff@med.uni-muenchen.de					Bolliger SA, 2008, EUR RADIOL, V18, P273, DOI 10.1007/s00330-007-0737-4; Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Christe A, 2009, J TRAUMA, V66, P1302, DOI 10.1097/TA.0b013e31818c1441; Dirnhofer R, 2006, RADIOGRAPHICS, V26, P1305, DOI 10.1148/rg.265065001; DONCHIN Y, 1994, J TRAUMA, V37, P552, DOI 10.1097/00005373-199410000-00006; Eisenmenger W, 2001, DEUT MED WOCHENSCHR, V126, P257; Farkash U, 2000, J TRAUMA, V48, P303, DOI 10.1097/00005373-200002000-00018; Federal Statistical Office, 2008, TOD DEUTSCHL GEST DE; Hoey BA, 2007, J TRAUMA, V63, P979, DOI 10.1097/TA.0b013e318154011f; Huber-Wagner S, 2009, LANCET, V373, P1455, DOI 10.1016/S0140-6736(09)60232-4; Imanishi M, 1998, NEURORADIOLOGY, V40, P154, DOI 10.1007/s002340050557; Jacobsen C, 2010, FORENSIC SCI INT, V194, P9, DOI 10.1016/j.forsciint.2009.10.001; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leth PM, 2010, J TRAUMA, V68, P1413, DOI 10.1097/TA.0b013e3181b251b8; Levy AD, 2010, AM J FOREN MED PATH, V31, P12, DOI 10.1097/PAF.0b013e3181c65e1a; O'Donnell C, 2008, CLIN RADIOL, V63, P1189, DOI 10.1016/j.crad.2008.05.008; Paperno S, 2005, ROFO-FORTSCHR RONTG, V177, P130, DOI 10.1055/s-2004-813735; Poulsen K, 2007, FORENSIC SCI INT, V171, P190, DOI 10.1016/j.forsciint.2006.05.041; Richens D, 2002, EUR J CARDIO-THORAC, V21, P288, DOI 10.1016/S1010-7940(01)01095-8; Scholing M, 2009, EUR RADIOL, V19, P2333, DOI 10.1007/s00330-009-1440-4; Shiotani S, 2008, RADIAT MED, V26, P253, DOI 10.1007/s11604-007-0223-6; Sochor MR, 2008, J TRAUMA, V65, P659, DOI 10.1097/TA.0b013e3181238d66; Stein KM, 2009, RADIOLOGE, V49, P73, DOI 10.1007/s00117-008-1732-8; Thali MJ, 2003, J FORENSIC SCI, V48, P386; Yen K, 2005, INT J LEGAL MED, V119, P129, DOI 10.1007/s00414-004-0507-7; Yen K, 2007, FORENSIC SCI INT, V173, P21, DOI 10.1016/j.forsciint.2007.01.027	27	13	13	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 29	2016	24								38	10.1186/s13049-016-0231-6			9	Emergency Medicine	Emergency Medicine	DI7FM	WOS:000373664700001	27025705	DOAJ Gold, Green Published			2021-06-18	
J	Wang, ZQ; Wu, WZ; Liu, YK; Wang, TY; Chen, X; Zhang, JH; Zhou, GX; Chen, R				Wang, Zhongqiu; Wu, Wenzhong; Liu, Yongkang; Wang, Tianyao; Chen, Xiao; Zhang, Jianhua; Zhou, Guoxing; Chen, Rong			Altered Cerebellar White Matter Integrity in Patients with Mild Traumatic Brain Injury in the Acute Stage	PLOS ONE			English	Article							AXONAL INJURY; DEFICITS	Background and Purpose Imaging studies of traumatic brain injury demonstrate that the cerebellum is often affected. We aim to examine fractional anisotropy alteration in acute-phase mild traumatic brain injury patients in cerebellum-related white matter tracts. Materials and Methods This prospective study included 47 mild traumatic brain injury patients in the acute stage and 37 controls. MR imaging and neurocognitive tests were performed in patients within 7 days of injury. White matter integrity was examined by using diffusion tensor imaging. We used three approaches, tract-based spatial statistics, graphical-model-based multivariate analysis, and region-of-interest analysis, to detect altered cerebellar white matter integrity in mild traumatic brain injury patients. Results Results from three analysis methods were in accordance with each other, and suggested fractional anisotropy in the middle cerebellar peduncle and the pontine crossing tract was changed in the acute-phase mild traumatic brain injury patients, relative to controls (adjusted p-value < 0.05). Higher fractional anisotropy in the middle cerebellar peduncle was associated with worse performance in the fluid cognition composite (r = -0.289, p-value = 0.037). Conclusion Altered cerebellar fractional anisotropy in acute-phase mild traumatic brain injury patients is localized in specific regions and statistically associated with cognitive deficits detectable on neurocognitive testing.	[Wang, Zhongqiu; Liu, Yongkang; Chen, Xiao] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wu, Wenzhong] Nanjing Univ Chinese Med, Affiliated Hosp, Dept Acupuncture & Rehabil, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Tianyao] Fudan Univ, Peoples Hosp Shanghai 5, Dept Radiol, Shanghai 200240, Peoples R China; [Zhang, Jianhua; Zhou, Guoxing] Tongji Univ, Sch Med, Shanghai East Hosp, Dept Radiol, Shanghai 200120, Peoples R China; [Chen, Rong] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA	Wang, ZQ (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp, Dept Radiol, 155 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.; Chen, R (corresponding author), Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA.	Zhq2001us@163.com; rchen@umm.edu					Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; American Congress of Rehabilitation Medicine (ACRM), 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Chen R, 2005, IEEE T MED IMAGING, V24, P1237, DOI 10.1109/TMI.2005.854305; Chen R, 2007, NEUROIMAGE, V35, P635, DOI 10.1016/j.neuroimage.2006.11.040; Chen R, 2012, NEUROINFORMATICS, V10, P119, DOI 10.1007/s12021-011-9129-7; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ellison-Wright I, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-99; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mendoza J, 2007, CLIN NEUROANATOMY NE; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Ravizza SM, 2006, BRAIN, V129, P306, DOI 10.1093/brain/awh685; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Wang JY, 2011, NEUROLOGY, V77, P818, DOI 10.1212/WNL.0b013e31822c61d7	34	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2016	11	3							e0151489	10.1371/journal.pone.0151489			13	Multidisciplinary Sciences	Science & Technology - Other Topics	DG3SC	WOS:000371989200059	26967320	DOAJ Gold, Green Published			2021-06-18	
J	Adil, MM; Bestow, LA; Qureshi, AI; Malik, AA; Jordan, LC				Adil, Malik M.; Bestow, Lauren A.; Qureshi, Adnan I.; Malik, Ahmed A.; Jordan, Lori C.			Hypertension Is Associated With Increased Mortality in Children Hospitalized With Arterial Ischemic Stroke	PEDIATRIC NEUROLOGY			English	Article						pediatric stroke; ischemic stroke; hypertension; mortality	TRAUMATIC BRAIN-INJURY; BLOOD-PRESSURE; RISK-FACTORS; CEREBROVASCULAR-DISEASE; CLINICAL-FEATURES; ADOLESCENTS; TRENDS; PREVALENCE; INFANTS; HEALTH	BACKGROUND: Recently a single-center study suggested that hypertension after stroke in children was a risk factor for mortality. Our goal was to assess the association between hypertension and outcome after arterial ischemic stroke in children from a large national sample. METHODS: Using the Healthcare Cost and Utilization Project Kids' Inpatient Database, children (1-18 years) with a primary diagnosis of ischemic stroke (International Classification of Diseases, Ninth Revision [ICD-9] codes 433-437.1) who also had a diagnosis of elevated blood pressure (ICD-9 code 796.2) or hypertension (ICD-9 codes 401 and 405) from 2003, 2006, and 2009 were identified. Clinical characteristics, discharge outcomes, and length of stay were assessed. Multivariable logistic regression was used to assess the relationship between hypertension and in-hospital mortality or discharge outcomes. RESULTS: Of 2590 children admitted with arterial ischemic stroke, 156 (6%) also had a diagnosis of hypertension. Ten percent of children with hypertension also had renal failure. Among patients with arterial ischemic stroke, hypertension was associated with increased mortality (7.4% vs 2.8%; P = 0.01) and increased length of stay (mean 11 +/- 17 vs 7 +/- 12 days; P = 0.004) compared with those without hypertension. After adjusting for age, sex, intubation, presence of a fluid and electrolyte disorder, and renal failure, children with hypertension had an increased odds of in-hospital death (odds ratio 1.2, 95% confidence interval [1.1-3.3, P = 0.04]). CONCLUSION: Hypertension was associated with an increased risk of in-hospital death for children presenting with arterial ischemic stroke. Further prospective study of blood pressure in children with stroke is needed.	[Adil, Malik M.] Ochsner Clin Fdn, Ochsner Neurosci Inst, Dept Neurol, New Orleans, LA 70121 USA; [Adil, Malik M.; Qureshi, Adnan I.; Malik, Ahmed A.] Zeenat Qureshi Stroke Inst, St Cloud, MN USA; [Bestow, Lauren A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Bestow, Lauren A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Jordan, Lori C.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Pediat Neurol, Nashville, TN 37212 USA	Adil, MM (corresponding author), Ochsner Clin Fdn, 1514 Jefferson Hwy, New Orleans, LA 70121 USA.	malikmuhammad.adil@gmail.com	Adil, Malik M/I-8355-2019; Jordan, Lori/U-3167-2019	Adil, Malik M/0000-0002-4635-6462; Qureshi, Adnan/0000-0003-4962-540X			Beslow LA, 2011, STROKE, V42, P941, DOI 10.1161/STROKEAHA.110.604199; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BRODERICK J, 1993, J CHILD NEUROL, V8, P250, DOI 10.1177/088307389300800308; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Brush LN, 2013, NEUROLOGY, V80, P1225, DOI 10.1212/WNL.0b013e3182896ffb; Buckalew VM, 1996, AM J KIDNEY DIS, V28, P811, DOI 10.1016/S0272-6386(96)90380-7; deVeber G, 2003, ANN NEUROL, V53, P149, DOI 10.1002/ana.10461; Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24; Falkner B, 2006, J PEDIATR-US, V148, P195, DOI 10.1016/j.jpeds.2005.10.030; Flynn JT, 2002, PEDIATRICS, V110, P89, DOI 10.1542/peds.110.1.89; Fullerton HJ, 2003, NEUROLOGY, V61, P189, DOI 10.1212/01.WNL.0000078894.79866.95; Ganesan V, 2003, ANN NEUROL, V53, P167, DOI 10.1002/ana.10423; GIROUD M, 1995, J CLIN EPIDEMIOL, V48, P1343, DOI 10.1016/0895-4356(95)00039-9; KANTER RK, 1985, CLIN PEDIATR, V24, P320, DOI 10.1177/000992288502400603; Lee CY, 2012, PEDIATR NEPHROL, V27, P2301, DOI 10.1007/s00467-012-2254-1; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Mallamaci F, 2014, NAT REV NEPHROL, V10, P623, DOI 10.1038/nrneph.2014.175; Mallick AA, 2014, LANCET NEUROL, V13, P35, DOI 10.1016/S1474-4422(13)70290-4; McNiece KL, 2007, J PEDIATR-US, V150, P640, DOI 10.1016/j.jpeds.2007.01.052; Muntner P, 2004, JAMA-J AM MED ASSOC, V291, P2107, DOI 10.1001/jama.291.17.2107; Ostchega Y, 2009, AM J HYPERTENS, V22, P59, DOI 10.1038/ajh.2008.312; Roach ES, 2008, STROKE, V39, P2644, DOI 10.1161/STROKEAHA.108.189696; Salorio CF, 2008, PEDIATR CRIT CARE ME, V9, P47, DOI 10.1097/01.PCC.0000298638.66240.0E; SCHOENBERG BS, 1978, NEUROLOGY, V28, P763, DOI 10.1212/WNL.28.8.763; Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12; Tran CL, 2012, HYPERTENSION, V60, P296, DOI 10.1161/HYPERTENSIONAHA.111.188813; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; You RX, 1997, STROKE, V28, P1913, DOI 10.1161/01.STR.28.10.1913	28	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	MAR	2016	56						25	29		10.1016/j.pediatrneurol.2015.11.002			5	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	DH3JN	WOS:000372683400007	26746784				2021-06-18	
J	Brown, EA; Kenardy, J; Chandler, B; Anderson, V; McKinlay, L; Le Brocque, R				Brown, Erin A.; Kenardy, Justin; Chandler, Bronwyn; Anderson, Vicki; McKinlay, Lynne; Le Brocque, Robyne			Parent-Reported Health-Related Quality of Life in Children With Traumatic Brain Injury: A Prospective Study	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						accidents and injuries; adolescents; assessment; children; quality of life	POSTTRAUMATIC-STRESS-DISORDER; EVENT SCALE; ADOLESCENTS; IMPACT; CHILDHOOD; SEVERITY; DISTRESS	Objective To identify which specific aspects of health-related quality of life (HRQL) are affected by traumatic brain injury (TBI) injury severity (Severity), time since injury (Time), and the interaction between Severity and Time, in a pediatric sample. It was hypothesized that Severity would decrease HRQL, Time would increase HRQL, and time to recover would be protracted for children with severe TBI. Methods This study followed a pediatric sample (n = 182, aged 6-14 years, recruited through three Australian hospitals) who sustained a mild or moderate-severe TBI across 3, 6, 12, and 18 months post-TBI. 12 specific HRQL outcomes were assessed via the Child Health Questionnaire-Parent Form 50 questionnaire. Results Dimensions of HRQL were differentially affected. Children with moderate-severe TBI generally experienced greater initial dysfunction than children with mild TBI; however, this difference disappeared by 18 months post-TBI. Conclusions Specific time points where HRQL outcomes may remediate are identified, and clinical recommendations regarding intervention strategies are discussed.	[Brown, Erin A.; Kenardy, Justin; Chandler, Bronwyn; Le Brocque, Robyne] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld 4029, Australia; [Anderson, Vicki] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Parkville, Vic, Australia	Brown, EA (corresponding author), Univ Queensland, Royal Brisbane & Womens Hosp, Level UQ Oral Hlth Ctr 7, CONROD, Herston, Qld 4029, Australia.	e.brown5@uq.edu.au	Le Brocque, Robyne/F-4848-2010; Kenardy, Justin/F-2085-2010; Kenardy, Justin A/H-6603-2014	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; Brown, Erin A./0000-0001-9963-1192; McKinlay, Lynne/0000-0002-6677-0628	National Health and Medical Research Council, AustraliaNational Health and Medical Research Council of Australia [301103]	This work was supported by the National Health and Medical Research Council, Australia (grant number 301103).	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2012, DISABIL REHABIL, V34, P1639, DOI 10.3109/09638288.2012.656789; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Brown EA, 2014, J PEDIATR PSYCHOL, V39, P512, DOI 10.1093/jpepsy/jsu014; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; De Young AC, 2014, J CHILD ADOL PSYCHOP, V24, P9, DOI 10.1089/cap.2013.0066; DeMatteo CA, 2014, BRAIN INJURY, V28, P114, DOI 10.3109/02699052.2013.848380; Di Battista A, 2012, J NEUROTRAUM, V29, P1717, DOI 10.1089/neu.2011.2157; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Jennett B., 1974, LANCET, V2, P8; Kenardy J, 2012, J CLIN CHILD ADOLESC, V41, P5, DOI 10.1080/15374416.2012.632348; Landgraf JM, 1996, CHILD HLTH QUESTIONN, V1st; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2000, TRAUMATIC BRAIN INJU; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Micklewright JL, 2012, J INT NEUROPSYCH SOC, V18, P343, DOI 10.1017/S1355617711001792; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Moran LM, 2012, J PEDIATR PSYCHOL, V37, P736, DOI 10.1093/jpepsy/jsr087; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Waters E, 2000, J PEDIATR PSYCHOL, V25, P381, DOI 10.1093/jpepsy/25.6.381; Weiss D., 1997, ASSESSING PSYCHOL TR	29	13	13	0	6	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	MAR	2016	41	2					244	255		10.1093/jpepsy/jsv090			12	Psychology, Developmental	Psychology	DJ4QY	WOS:000374193600008	26395759	Bronze, Green Published			2021-06-18	
J	Keser, Z; Ucisik-Keser, FE; Hasan, KM				Keser, Zafer; Ucisik-Keser, Fehime Eymen; Hasan, Khader M.			Quantitative Mapping of Human Brain Vertical-Occipital Fasciculus	JOURNAL OF NEUROIMAGING			English	Article						Vertical-occipital fasciculus; quantitative mapping; deterministic; tractography	WERNICKE PERPENDICULAR FASCICULUS; THEORETICAL-ANALYSIS; IN-VIVO; TENSOR; TRACTOGRAPHY; VALIDATION; DISSECTION; PATHWAYS	PURPOSEThe vertical-occipital fasciculus (VOF), historically named as the fasciculus occipitalis verticalis of Wernicke, has been recently brought to the attention of the neuroscience community. In this study, we delineated and quantified this tract with deterministic diffusion tensor imaging protocol. METHODSFive (all males aged 24-37 years) and 10 (7 males and 3 females aged 20-51 years) right-handed healthy subjects were studied with 1 and 2 mm DT-MRI data sets, respectively. The DTI attributes of this pathway along with its cortical representation (Brodmann areas) were presented in standard Montreal Neurological Institute space. Nearby pathways such as inferior fronto-occipital (IFOF) and inferior longitudinal fasciculi (ILF) were used as reference pathways. RESULTSThe total volume of VOF has been found to be approximately .8-1% of whole brain in both data sets. The fractional anisotropy and axial diffusivity of this tract have been found to be relatively 10-15% lower than adjacent pathways such as IFOF and ILF in both data sets. Although IFOF and ILF showed somewhat leftward asymmetry in diffusivity, no right-left asymmetry has been observed in VOF. CONCLUSIONWe believe that our work will pave the way for future imaging studies investigating VOF in different conditions such as stroke, traumatic brain injury, and multiple sclerosis.	[Keser, Zafer] Univ Texas Hlth Sci Ctr Houston, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Keser, Zafer] Univ Texas Hlth Sci Ctr Houston, TIRR Mem Hermann Neurorecovery Res Ctr, Houston, TX 77030 USA; [Ucisik-Keser, Fehime Eymen] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Imaging, Houston, TX 77030 USA; [Hasan, Khader M.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Radiol, Houston, TX 77030 USA	Hasan, KM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Diagnost & Intervent Imaging Dept, Sch Med, 6431 Fannin St, Houston, TX 77030 USA.	Khader.M.Hasan@uth.tmc.edu	Hasan, Khader M./ABB-5767-2020; Keser, Zafer/J-4586-2019	Keser, Zafer/0000-0001-6415-0874	Dunn Research Foundation	This work is funded by the Dunn Research Foundation. We thank Vipul Kumar Patel for helping in data acquisition.	Bartsch AJ, 2013, NEUROSURGERY, V73, pE381, DOI 10.1227/01.neu.0000430298.25585.1d; Blumenfeld H, 2011, NEUROANATOMY CLIN CA, P25; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Curran EJ, 1909, J COMP NEUROL PSYCHO, V19, P645, DOI 10.1002/cne.920190603; De Benedictis A, 2014, J ANAT, V225, P132, DOI 10.1111/joa.12204; Gerstmann J, 1940, ARCH NEURO PSYCHIATR, V44, P398, DOI 10.1001/archneurpsyc.1940.02280080158009; Hasan KM, 2007, MAGN RESON IMAGING, V25, P1196, DOI 10.1016/j.mri.2007.02.011; Hasan KM, 2011, J NEUROSCI, V31, P16826, DOI 10.1523/JNEUROSCI.4184-11.2011; Hasan KM, 2011, COMPUT BIOL MED, V41, P1062, DOI 10.1016/j.compbiomed.2010.10.008; Hasan KM, 2010, BRAIN STRUCT FUNCT, V214, P361, DOI 10.1007/s00429-009-0238-0; Hasan KM, 2009, MAGN RESON IMAGING, V27, P631, DOI 10.1016/j.mri.2008.10.007; Hasan KM, 2003, MAGNET RESON MED, V50, P589, DOI 10.1002/mrm.10552; Hoeve HJH, 1909, ANAT REC, V3, P247; Homola GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049451; Kamali A, 2014, NEUROSCIENCE, V277, P577, DOI 10.1016/j.neuroscience.2014.07.035; Kamali A, 2014, MAGN RESON IMAGING, V32, P796, DOI 10.1016/j.mri.2014.04.002; Keser Z, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00041; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Martino J, 2013, NEUROSURGERY, V73, pE382, DOI 10.1227/01.neu.0000430303.56079.0e; Martino J, 2013, NEUROSURGERY, V72, P87, DOI 10.1227/NEU.0b013e318274294b; Mendoza J, 2007, CLIN NEUROANATOMY NE, P281; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; Takemura H, 2016, CEREB CORTEX, V26, P2205, DOI 10.1093/cercor/bhv064; Thiebaut de Schotten M, 2008, CORTEX, V44, P1097, DOI 10.1016/j.cortex.2008.02.003; Wahl M, 2010, NEUROIMAGE, V51, P531, DOI 10.1016/j.neuroimage.2010.02.072; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yeatman JD, 2014, P NATL ACAD SCI USA, V111, pE5214, DOI 10.1073/pnas.1418503111; Yeatman JD, 2013, BRAIN LANG, V125, P146, DOI 10.1016/j.bandl.2012.04.010	29	13	13	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	MAR-APR	2016	26	2					188	193		10.1111/jon.12268			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DG0DW	WOS:000371734400005	26073705				2021-06-18	
J	Talari, HR; Fakharian, E; Mousavi, N; Abedzadeh-Kalahroudi, M; Akbari, H; Zoghi, S				Talari, Hamid Reza; Fakharian, Esmaeil; Mousavi, Nooshin; Abedzadeh-Kalahroudi, Masoumeh; Akbari, Hossein; Zoghi, Sommayeh			The Rotterdam Scoring System Can Be Used as an Independent Factor for Predicting Traumatic Brain Injury Outcomes	WORLD NEUROSURGERY			English	Article						Computed tomography; Head trauma; Rotterdam scoring system	PROGNOSTIC VALUE; CLASSIFICATION; HEMATOMA	OBJECTIVE: Predicting outcomes in patients with traumatic brain injury is critically important for making sound clinical decisions. This study aimed at determining the prognostic value of the Rotterdam scoring system to predict early death among these patients. MATERIALS AND METHODS: This study was performed prospectively on 150 patients with traumatic brain injury hospitalized in Shahid Beheshti Hospital, Kashan, Iran, Patients' demographic and clinical characteristics such as age, sex, mechanism of trauma, initial Glasgow Coma Scale score, and accompanying lesions were documented. A brain computed tomography was performed for each patient and scored by use of the Rotterdam system, Patients were monitored for 2 weeks after hospital discharge, and their outcomes were documented. Univariate and multiple logistic regression analysis and prognostic values of Rotterdam system were conducted by SPSS software. RESULTS: Nineteen patients (12.7%) died during the course of the study. The mean age of the dead patients was significantly greater than those who survived (P = 0.037). The sensitivity and the specificity of the Rotterdam scoring system at the cutoff score of 4 were 842% and 962%, respectively. Rotterdam score was significantly correlated with patient outcomes (P < 0.0001). Moreover, logistic regression analyses revealed that factors such as age, sex, Glasgow Coma Scale score, and Rotterdam score significantly contributed to patient outcomes. CONCLUSIONS: Rotterdam score is an independent factor for predicting outcomes among patients with traumatic brain injury. At the cutoff score of 4, the Rotterdam system can predict outcomes among patients suffering from traumatic brain injury with acceptable sensitivity and specificity.	[Talari, Hamid Reza; Fakharian, Esmaeil; Mousavi, Nooshin; Abedzadeh-Kalahroudi, Masoumeh; Akbari, Hossein; Zoghi, Sommayeh] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran	Abedzadeh-Kalahroudi, M (corresponding author), Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran.	abedzadeh@kaums.ac.ir	Akbari, Hossein/G-4737-2017; Abedzadeh-Kalahroudi, Masoumeh/G-4114-2017; Talari, Hamidreza/H-7838-2017; Fakharian, Esmaeil/A-1338-2018	Akbari, Hossein/0000-0001-7486-8580; Abedzadeh-Kalahroudi, Masoumeh/0000-0002-7318-6294; Talari, Hamidreza/0000-0001-6736-8449; Moosavi Buki, Nooshin/0000-0003-0888-0068	Kashan University of Medical Sciences, Kashan, Iran [9185]	This study supported by deputy of research, Kashan University of Medical Sciences, Kashan, Iran (grant no: 9185). All Author declare that they have no competing interests.	Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Haaga JR., 2009, CT MRI WHOLE BODY; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marshall SB, 1991, J NEUROSURG S, V75, P14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Pillai SV, 2003, NEUROL INDIA, V51, P345; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Segun T., TRAUMATIC BRAIN INJU; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	16	13	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2016	87						195	199		10.1016/j.wneu.2015.11.055			5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DI3HR	WOS:000373390200027	26704195				2021-06-18	
J	Schulz-Heik, RJ; Poole, JH; Dahdah, MN; Sullivan, C; Date, ES; Salerno, RM; Schwab, K; Harris, O				Schulz-Heik, R. Jay; Poole, John H.; Dahdah, Marie N.; Sullivan, Campbell; Date, Elaine S.; Salerno, Rose M.; Schwab, Karen; Harris, Odette			Long-term outcomes after moderate-to-severe traumatic brain injury among military veterans: Successes and challenges	BRAIN INJURY			English	Article						rehabilitation; Outcome; social reintegration; work; traumatic brain injury	HEAD TRAUMA; PREDICTION; LIFE; REHABILITATION; SATISFACTION; SYMPTOMS	Objective: To assess long-term outcomes after traumatic brain injury (TBI) among veterans and service members. Setting: Regional Veterans Affairs medical centre. Participants: One hundred and eighteen veterans and military personnel, aged 23-70 years (median = 35 years), 90% male, had moderate-to-severe TBI (82% in coma > 1 day, 85% amnesic > 7 days), followed by acute interdisciplinary rehabilitation 5-16 years ago (median = 8 years). Design: Cross-sectional analysis of live interviews conducted via telephone. Main measures: TBI follow-up interview (occupational, social, cognitive, neurologic and psychiatric ratings), Community Integration Questionnaire, Disability Rating Scale (four indices of independent function) and Satisfaction with Life Scale. Results: At follow-up, 52% of participants were working or attending school; 34% ended or began marriages after TBI, but the overall proportion married changed little. Finally, 22% were still moderately-to-severely disabled. However, 62% of participants judged themselves to be as satisfied or more satisfied with life than before injury. Injury severity, especially post-traumatic amnesia, was correlated with poorer outcomes in all functional domains. Conclusions: After moderate-severe TBI, most veterans assume productive roles and are satisfied with life. However, widespread difficulties and functional limitations persist. These findings suggest that veteran and military healthcare systems should continue periodic, comprehensive follow-up evaluations long after moderate-to-severe TBI.	[Schulz-Heik, R. Jay; Poole, John H.; Salerno, Rose M.; Harris, Odette] Def & Vet Brain Injury Ctr, 3801 Miranda Ave,PSC-117, Palo Alto, CA 94304 USA; [Dahdah, Marie N.] Baylor Inst Rehabil, Baylor Reg Med Ctr Plano, Plano, TX USA; [Sullivan, Campbell] Johns Hopkins Sch Med, Baltimore, MD USA; [Date, Elaine S.] Remedy Med Grp, Redwood City, CA USA; [Schwab, Karen] Def & Vet Brain Injury Ctr, Rockville, MD USA	Schulz-Heik, RJ (corresponding author), Def & Vet Brain Injury Ctr, 3801 Miranda Ave,PSC-117, Palo Alto, CA 94304 USA.	jay.schulzheik@gmail.com			Defense and Veterans Brain Injury Center, US Army Medical Research and Materiel Command (USAMRMC)	This material is based upon work supported in part by the Defense and Veterans Brain Injury Center, US Army Medical Research and Materiel Command (USAMRMC). The authors report no conflicts of interest. The views, opinions, and/or findings contained in this article are those of the authors and should not be construed as an official Department of Defense position, policy or decision unless so designated by other official documentation.	Bradshaw D, 2008, REPORT SURG GEN TRAU; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bryan CJ, 2013, BRAIN INJURY, V27, P1333, DOI 10.3109/02699052.2013.823651; Bryan CJ, 2013, SLEEP, V36, P941, DOI 10.5665/sleep.2730; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Defense and Veterans Brain Injury Center, 2015, DOD WORLDW NUMB TBI; Department of Defense, 2012, TRAUM BRAIN INJ SPEC; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2014, UNDERSTANDING SCORES; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Faul M, TRAUMATIC BRAIN INJU; Gray M, 2011, J TRAUMA, V71, P1465, DOI 10.1097/TA.0b013e31821f82f5; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Institute of Medicine, 2008, GULF WAR AND HLTH, V7; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Klonoff PS, 2006, BRAIN INJURY, V20, P601, DOI 10.1080/02699050600744301; Kolakowsky-Hayner SA, 2012, BRAIN INJURY, V26, P1328, DOI 10.3109/02699052.2012.706353; Kreider RM, 2011, NUMBER TIMING MARRIA; MacKenzie EJ, 2002, J TRAUMA, V52, P527, DOI 10.1097/00005373-200203000-00018; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Poole Jh, FEASIBILITY NEUROPSY; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Sherer M, 1999, BRAIN INJURY, V13, P973; Silverberg ND, 2013, J NEUROTRAUM, V30, P1398, DOI 10.1089/neu.2012.2827; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; Willemse-Van Son AHP, 2009, J REHABIL MED, V41, P521, DOI 10.2340/16501977-0377; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Willer B., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI DOI 10.1097/00001199-199308020-00009; Wood RLI, 2006, J NEUROL NEUROSUR PS, V77, P1180, DOI 10.1136/jnnp.2006.091553; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	46	13	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					271	279		10.3109/02699052.2015.1113567			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900004	26853377				2021-06-18	
J	Allitt, BJ; Johnstone, VPA; Richards, K; Yan, EB; Rajan, R				Allitt, Benjamin J.; Johnstone, Victoria P. A.; Richards, Katrina; Yan, Edwin B.; Rajan, Ramesh			Progesterone Exacerbates Short-Term Effects of Traumatic Brain Injury on Supragranular Responses in Sensory Cortex and Over-Excites Infragranular Responses in the Long Term	JOURNAL OF NEUROTRAUMA			English	Article						diffuse TBI; electrophysiology; neuronal encoding; progesterone; sensory cortex	RAT BARREL CORTEX; GABA-A RECEPTOR; SPREADING DEPRESSION; COGNITIVE DEFICITS; PREFRONTAL CORTEX; CLINICAL-TRIAL; AXONAL INJURY; CELL-DEATH; ALLOPREGNANOLONE; DYSFUNCTION	Progesterone (P4) has been suggested as a neuroprotective agent for traumatic brain injury (TBI) because it ameliorates many post-TBI sequelae. We examined the effects of P4 treatment on the short-term (4 days post-TBI) and long-term (8 weeks post-TBI) aftermath on neuronal processing in the rodent sensory cortex of impact acceleration-induced diffuse TBI. We have previously reported that in sensory cortex, diffuse TBI induces a short-term hypoexcitation that is greatest in the supragranular layers and decreases with depth, but a long-term hyperexcitation that is exclusive to the supragranular layers. Now, adult male TBI-treated rats administered P4 showed, in the short term, even greater suppression in neural responses in supragranular layers but a reversal of the TBI-induced suppression in granular and infragranular layers. In long-term TBI there were only inconsistent effects of P4 on the TBI-induced hyperexcitation in supragranular responses but infragranular responses, which were not affected by TBI alone, were elevated by P4 treatment. Intriguingly, the effects in the injured brain were almost identical to P4 effects in the normal brain, as seen in sham control animals treated with P4: in the short term, P4 effects in the normal brain were identical to those exercised in the injured brain and in the long term, P4 effects in the normal brain were rather similar to what was seen in the TBI brain. Overall, these results provide no support for any protective effects of P4 treatment on neuronal encoding in diffuse TBI, and this was reflected in sensorimotor and other behavior tasks also tested here. Additionally, the effects suggest that mechanisms used for P4 effects in the normal brain are also intact in the injured brain.	[Allitt, Benjamin J.; Johnstone, Victoria P. A.; Richards, Katrina; Yan, Edwin B.; Rajan, Ramesh] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia; [Johnstone, Victoria P. A.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia	Allitt, BJ (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	Ben.allitt@monash.edu	rajan, ramesh/L-4842-2019	Richards, Katrina/0000-0002-0065-1255; Rajan, Ramesh/0000-0001-9862-0520; Dell, Katrina/0000-0002-3552-6411			Abelson-Mitchell N, 2008, J CLIN NURS, V17, P46, DOI 10.1111/j.1365-2702.2007.01941.x; Aitken PG, 1998, J NEUROPHYSIOL, V80, P1514; Alwis DS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00156; Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Basarsky TA, 1998, J NEUROSCI, V18, P7189; Baykara B, 2013, BIOTECH HISTOCHEM, V88, P250, DOI 10.3109/10520295.2013.769630; BITRAN D, 1991, BRAIN RES, V561, P157, DOI 10.1016/0006-8993(91)90761-J; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; BOHNEN N, 1992, J NEUROL NEUROSUR PS, V55, P222, DOI 10.1136/jnnp.55.3.222; CALLACHAN H, 1987, PROC R SOC SER B-BIO, V231, P359, DOI 10.1098/rspb.1987.0049; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Corbo J, 2004, ANN EMERG MED, V44, P57, DOI 10.1016/j.annemergmed.2003.11.010; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Espinoza TR, 2011, J HEAD TRAUMA REHAB, V26, P497, DOI 10.1097/HTR.0b013e31823088fa; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Follesa P, 2001, BRAIN RES REV, V37, P81, DOI 10.1016/S0165-0173(01)00125-4; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goss CW, 2003, PHARMACOL BIOCHEM BE, V76, P231, DOI 10.1016/j.pbb.2003.07.003; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; HERRERAS O, 1993, BRAIN RES, V610, P276, DOI 10.1016/0006-8993(93)91411-K; Ishrat T, 2010, EXP NEUROL, V226, P183, DOI 10.1016/j.expneurol.2010.08.023; Johnstone V. P., 2015, J NEUROTRAUMA; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Krebs CJ, 2000, P NATL ACAD SCI USA, V97, P12816, DOI 10.1073/pnas.97.23.12816; Lancel M, 1996, AM J PHYSIOL-ENDOC M, V271, pE763; Larkum ME, 2013, NAT NEUROSCI, V16, P114, DOI 10.1038/nn.3317; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; Ma JP, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub3; Ma JP, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008409.pub2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Marmarou A, 2003, ACT NEUR S, V86, P7; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meffre D, 2013, NEUROSCIENCE, V231, P111, DOI 10.1016/j.neuroscience.2012.11.039; Meyer HS, 2010, CEREB CORTEX, V20, P2287, DOI 10.1093/cercor/bhq069; Pascual JL, 2013, AM J SURG, V206, P840, DOI 10.1016/j.amjsurg.2013.07.016; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Petersen C. C. H., 2009, ENCY NEUROSCIENCE, P41; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Rajan R, 2007, EUR J NEUROSCI, V25, P2383, DOI 10.1111/j.1460-9568.2007.05481.x; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; Rancan M, 2001, J NEUROSCI RES, V63, P438, DOI 10.1002/1097-4547(20010301)63:5<438::AID-JNR1039>3.0.CO;2-P; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Salin P, 1995, J NEUROSCI, V15, P8234; Sarno S, 2003, BRAIN INJURY, V17, P413, DOI 10.1080/0269905031000070161; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Sayeed I, 2009, BRAIN RES, V1263, P165, DOI 10.1016/j.brainres.2009.01.045; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Si DW, 2013, NEUROSCI LETT, V553, P18, DOI 10.1016/j.neulet.2013.07.052; Singh M, 2013, HORM BEHAV, V63, P284, DOI 10.1016/j.yhbeh.2012.06.003; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SMITH SS, 1987, BRAIN RES BULL, V18, P739, DOI 10.1016/0361-9230(87)90209-7; SMITH SS, 1987, BRAIN RES, V400, P353, DOI 10.1016/0006-8993(87)90634-2; Somjen GG, 2001, PHYSIOL REV, V81, P1065; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Theriot JJ, 2012, J NEUROSCI, V32, P15252, DOI 10.1523/JNEUROSCI.2092-12.2012; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yan EB, 2013, NEUROSCIENCE, V248, P17, DOI 10.1016/j.neuroscience.2013.05.045; Yan EB, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-147; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656	99	13	13	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					375	389		10.1089/neu.2015.3946			15	Critical Care Medicine; Clinical Neurology; Neurosciences	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800007	26258958				2021-06-18	
J	Wilson, NM; Titus, DJ; Oliva, AA; Furones, C; Atkins, CM				Wilson, Nicole M.; Titus, David J.; Oliva, Anthony A., Jr.; Furones, Concepcion; Atkins, Coleen M.			Traumatic Brain Injury Upregulates Phosphodiesterase Expression in the Hippocampus	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						cAMP; CREB; fluid-percussion; hippocampus; inflammation; phosphodiesterase; traumatic brain injury	LONG-TERM POTENTIATION; CONTROLLED CORTICAL IMPACT; ADENYLYL-CYCLASE; COGNITIVE DEFICITS; SPATIAL MEMORY; IN-VITRO; ROLIPRAM; INHIBITORS; AGE; MOUSE	Traumatic brain injury (TBI) results in significant impairments in hippocampal synaptic plasticity. A molecule critically involved in hippocampal synaptic plasticity, 3',5'-cyclic adenosine monophosphate, is downregulated in the hippocampus after TBI, but the mechanism that underlies this decrease is unknown. To address this question, we determined whether phosphodiesterase (PDE) expression in the hippocampus is altered by TBI. Young adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury. Animals were analyzed by western blotting for changes in PDE expression levels in the hippocampus. We found that PDE1A levels were significantly increased at 30 min, 1 h and 6 h after TBI. PDE4B2 and 4D2 were also significantly increased at 1, 6, and 24 h after TBI. Additionally, phosphorylation of PDE4A was significantly increased at 6 and 24 h after TBI. No significant changes were observed in levels of PDE1B, 1C, 3A, 8A, or 8B between 30 min to 7 days after TBI. To determine the spatial profile of these increases, we used immunohistochemistry and flow cytometry at 24 h after TBI. PDE1A and phospho-PDE4A localized to neuronal cell bodies. PDE4B2 was expressed in neuronal dendrites, microglia and infiltrating CD11b(+) immune cells. PDE4D was predominantly found in microglia and infiltrating GD11 b(+) immune cells. To determine if inhibition of PDE4 would improve hippocampal synaptic plasticity deficits after TBI, we treated hippocampal slices with rolipram, a pan-PDE4 inhibitor. Rolipram partially rescued the depression in basal synaptic transmission and converted a decaying form of long-term potentiation (UP) into long-lasting LIP. Overall, these results identify several possible PDE targets for reducing hippocampal synaptic plasticity deficits and improving cognitive function acutely after TBI.	[Wilson, Nicole M.; Titus, David J.; Oliva, Anthony A., Jr.; Furones, Concepcion; Atkins, Coleen M.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA	Atkins, CM (corresponding author), Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA.	catkins@med.miami.edu		Atkins, Coleen/0000-0003-4718-7493	National Institutes of Health/NINDS Grants [R01 NS069721, P31 NS089351]; Miami Project to Cure Paralysis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069721, F31NS089351] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health/NINDS Grants R01 NS069721 and P31 NS089351, and The Miami Project to Cure Paralysis.	Amen DG, 2011, J PSYCHOACTIVE DRUGS, V43, P1, DOI 10.1080/02791072.2011.566489; Araki T, 1995, BRAIN RES, V704, P227, DOI 10.1016/0006-8993(95)01117-X; Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Atkins CM, 2012, J NEUROSCI RES, V90, P1861, DOI 10.1002/jnr.23069; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Atkins CM, 2011, TRANSL STROKE RES, V2, P546, DOI 10.1007/s12975-011-0123-z; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Blackman BE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203604; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Carito V, 2012, BBA-GEN SUBJECTS, V1820, P96, DOI 10.1016/j.bbagen.2011.10.015; Chen CC, 2010, NEUROPSYCHOPHARMACOL, V35, P1605, DOI 10.1038/npp.2010.33; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; Dong HL, 2010, BIOCHEM PHARMACOL, V79, P321, DOI 10.1016/j.bcp.2009.09.001; Faul M.D., 2010, TRAUMATIC BRAIN INJU; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Ghosh M, 2012, GLIA, V60, P1839, DOI 10.1002/glia.22401; Giachini FR, 2011, HYPERTENSION, V57, P655, DOI 10.1161/HYPERTENSIONAHA.110.164327; Giralt A, 2013, HIPPOCAMPUS, V23, P684, DOI 10.1002/hipo.22128; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Haering C, 2015, J BIOL CHEM, V290, P9767, DOI 10.1074/jbc.M115.640656; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hansen RT, 2015, CURR PHARM DESIGN, V21, P291; Heckman PRA, 2015, CURR PHARM DESIGN, V21, P317; Henkel-Tigges J., 1990, MOL PHARM, V37, P7; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Imanishi T, 1997, EUR J PHARMACOL, V321, P273, DOI 10.1016/S0014-2999(96)00969-7; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Johansson EM, 2012, NEUROSCI LETT, V525, P1, DOI 10.1016/j.neulet.2012.07.050; KATO H, 1995, EUR J PHARMACOL, V272, P107, DOI 10.1016/0014-2999(94)00694-3; Kelly MP, 2009, PROG BRAIN RES, V179, P67, DOI 10.1016/S0079-6123(09)17908-6; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Klann E, 1998, J BIOL CHEM, V273, P4516, DOI 10.1074/jbc.273.8.4516; Kunal SB, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-25; Kuroiwa M, 2012, PSYCHOPHARMACOLOGY, V219, P1065, DOI 10.1007/s00213-011-2436-8; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lew HL, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.05.0054; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; MacKenzie KF, 2011, BIOCHEM J, V435, P755, DOI 10.1042/BJ20101184; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Martinez A, 2014, EXPERT OPIN THER PAT, V24, P1311, DOI 10.1517/13543776.2014.968127; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Middei S, 2013, HIPPOCAMPUS, V23, P488, DOI 10.1002/hipo.22108; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mons N, 2004, NEUROBIOL AGING, V25, P1095, DOI 10.1016/j.neurobiolaging.2003.10.014; Nagakura A, 2002, NEUROSCI LETT, V317, P69, DOI 10.1016/S0304-3940(01)02421-1; Navakkode S, 2004, J NEUROSCI, V24, P7740, DOI 10.1523/JNEUROSCI.1796-04.2004; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oliva AA, 2012, J NEUROCHEM, V123, P1019, DOI 10.1111/jnc.12049; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Perez-Torres S, 2000, J CHEM NEUROANAT, V20, P349, DOI 10.1016/S0891-0618(00)00097-1; Ramos BP, 2003, NEURON, V40, P835, DOI 10.1016/S0896-6273(03)00694-9; Reneerkens OAH, 2009, PSYCHOPHARMACOLOGY, V202, P419, DOI 10.1007/s00213-008-1273-x; Rutten K, 2008, PSYCHOPHARMACOLOGY, V196, P643, DOI 10.1007/s00213-007-0999-1; Rutten K, 2008, EUR J NEUROSCI, V28, P625, DOI 10.1111/j.1460-9568.2008.06349.x; Schaal SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043634; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shepherd MC, 2004, BRIT J PHARMACOL, V142, P339, DOI 10.1038/sj.bjp.0705770; Shimizu-Albergine M, 2012, MOL PHARMACOL, V81, P556, DOI 10.1124/mol.111.076125; Sierksma ASR, 2014, NEUROPHARMACOLOGY, V77, P120, DOI 10.1016/j.neuropharm.2013.09.015; Soler F, 2015, EUR J PHARMACOL, V765, P429, DOI 10.1016/j.ejphar.2015.09.001; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Suhasini A. N., 2015, LEUKEMIA; Temple MD, 2001, J NEUROTRAUM, V18, P47, DOI 10.1089/089771501750055767; Titus DJ, 2013, NEUROSCIENCE, V231, P182, DOI 10.1016/j.neuroscience.2012.12.002; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; Wiescholleck V, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.17; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Yamamoto M, 2000, BBA-MOL BASIS DIS, V1535, P60, DOI 10.1016/S0925-4439(00)00083-1; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	82	13	13	0	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	FEB 5	2016	10								5	10.3389/fnsys.2016.00005			13	Neurosciences	Neurosciences & Neurology	DD0HW	WOS:000369602000001	26903822	DOAJ Gold, Green Published			2021-06-18	
J	Glass, L; Moody, L; Grafman, J; Krueger, F				Glass, Leila; Moody, Lara; Grafman, Jordan; Krueger, Frank			Neural signatures of third-party punishment: evidence from penetrating traumatic brain injury	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						neurolaw; social cognition; altruistic punishment; morality; prefrontal cortex; traumatic brain injury	TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; SOCIAL NORMS; ALTRUISTIC PUNISHMENT; DECISION-MAKING; MIND; SELF; NEUROBIOLOGY; JUDGMENTS; COGNITION	The ability to survive within a cooperative society depends on impartial third-party punishment (TPP) of social norm violations. Two cognitive mechanisms have been postulated as necessary for the successful completion of TPP: evaluation of legal responsibility and selection of a suitable punishment given the magnitude of the crime. Converging neuroimaging research suggests two supporting domain-general networks; a mentalizing network for evaluation of legal responsibility and a central-executive network for determination of punishment. A whole-brain voxel-based lesion-symptom mapping approach was used in conjunction with a rank-order TPP task to identify brain regions necessary for TPP in a large sample of patients with penetrating traumatic brain injury. Patients who demonstrated atypical TPP had specific lesions in core regions of the mentalizing (dorsomedial prefrontal cortex [PFC], ventromedial PFC) and central-executive (bilateral dorsolateral PFC, right intraparietal sulcus) networks. Altruism and executive functioning (concept formation skills) were significant predictors of TPP: altruism was uniquely associated with TPP in patients with lesions in right dorsolateral PFC and executive functioning was uniquely associated with TPP in individuals with lesions in left PFC. Our findings contribute to the extant literature to support underlying neural networks associated with TPP, with specific brain-behavior causal relationships confirming recent functional neuroimaging research.	[Glass, Leila] SDSU UCSD Joint Doctoral Program Clin Psychol, Dept Psychol, San Diego, CA USA; [Moody, Lara] Virginia Tech, Carilion Res Inst, Roanoke, VA USA; [Moody, Lara] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA	Krueger, F (corresponding author), George Mason Univ, Mol Neurosci Dept, Dept Psychol, 4400 Univ Dr,Mail Stop 2A1, Fairfax, VA 22030 USA.	FKrueger@gmu.edu			U.S. National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31 AA022261]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31AA022261] Funding Source: NIH RePORTER	This study was conducted and supported by the U.S. National Institute of Neurological Disorders and Stroke Intramural Research Program and took place at the National Institutes of Health Clinical Research Center. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the US Government. For further information about the Vietnam Head Injury Study, contact J.G. at jgrafman@northwestern.edu. Additional support was provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant number F31 AA022261.	Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Baumgartner T, 2013, NEUROIMAGE, V81, P317, DOI 10.1016/j.neuroimage.2013.05.047; Bayroff AG, 1963, DEV ARMED FORCES QUA; Beck AT., 1996, BECK DEPRESSION INVE, V2; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Chatterjee A, 2005, J COGNITIVE NEUROSCI, V17, P847, DOI 10.1162/0898929054021085; DAMASIO AR, 1990, TRENDS NEUROSCI, V13, P95, DOI 10.1016/0166-2236(90)90184-C; Davis M., 1983, J PERS SOC PSYCHOL, V44; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Feng CL, 2015, HUM BRAIN MAPP, V36, P591, DOI 10.1002/hbm.22649; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Flesch R., 1949, ART READABLE WRITING; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Glenn AL, 2008, PSYCHIAT CLIN N AM, V31, P463, DOI 10.1016/j.psc.2008.03.004; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Guo XY, 2013, NEUROIMAGE, V77, P246, DOI 10.1016/j.neuroimage.2013.03.048; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; Harris LT, 2005, NEUROIMAGE, V28, P763, DOI 10.1016/j.neuroimage.2005.05.021; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kaller CP, 2013, HUM BRAIN MAPP, V34, P36, DOI 10.1002/hbm.21423; Kaller CP, 2011, CEREB CORTEX, V21, P307, DOI 10.1093/cercor/bhq096; Kaplan E., 2001, BOSTON NAMING TEST 2; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koenigs M, 2011, MOL PSYCHIATR, V16, P792, DOI 10.1038/mp.2010.124; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Krueger F, 2014, SOC COGN AFFECT NEUR, V9, P1143, DOI 10.1093/scan/nst092; Krueger F, 2013, SOC COGN AFFECT NEUR, V8, P494, DOI 10.1093/scan/nss026; Krueger F, 2011, HUM BRAIN MAPP, V32, P1419, DOI 10.1002/hbm.21119; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Latzman RD, 2010, ASSESSMENT, V17, P172, DOI 10.1177/1073191109356254; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; McNeil M. R., 1978, REVISED TOKEN TEST; Mendez MF, 2009, CNS SPECTRUMS, V14, P608, DOI 10.1017/S1092852900023853; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Pia L, 2009, BRAIN COGNITION, V69, P81, DOI 10.1016/j.bandc.2008.05.007; Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Robinson PH, 2007, MINN LAW REV, V91, P1829; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schleim S, 2011, SOC COGN AFFECT NEUR, V6, P48, DOI 10.1093/scan/nsq010; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shen FX, 2011, NEW YORK U LAW REV, V86, P1306; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger C.D., 1999, STATE TRAIT ANGER EX; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; SULTZER DL, 1992, J AM GERIATR SOC, V40, P549, DOI 10.1111/j.1532-5415.1992.tb02101.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wechsler D., 2011, WECHLSER ABBREVIATED; Wechsler D., 1997, WMS 3 WECHSLER MEMOR; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yamada M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1757; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107	79	13	16	1	26	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	FEB	2016	11	2					253	262		10.1093/scan/nsv105			10	Neurosciences; Psychology; Psychology, Experimental	Neurosciences & Neurology; Psychology	DJ5DL	WOS:000374226900007	26276809	Green Published, Other Gold			2021-06-18	
J	Lemke, S; Cockerham, GC; Glynn-Milley, C; Lin, R; Cockerham, KP				Lemke, Sonne; Cockerham, Glenn C.; Glynn-Milley, Catherine; Lin, Richard; Cockerham, Kimberly P.			Automated Perimetry and Visual Dysfunction in Blast-Related Traumatic Brain Injury	OPHTHALMOLOGY			English	Article							FALSE-NEGATIVE RESPONSES; FULL THRESHOLD; SITA STANDARD; RELIABILITY INDEXES; REPRODUCIBILITY; MANIFEST; STRATEGY; SUSPECT; SYSTEM; TESTS	Purpose: To evaluate feasibility and results of automated perimetry in veterans with combat blast neurotrauma. Design: Prospective, longitudinal, observational case series. Participants: Sixty-one patients in a Veterans Affairs Polytrauma Center diagnosed with traumatic brain injury (TBI) from combat blast exposure. Methods: Study participants underwent automated perimetry at baseline (median interval, 2 months after injury) (Humphrey Field Analyzer, Carl Zeiss Meditec, Dublin, CA, Swedish Interactive Threshold Algorithm 30-2 Standard or Fast), and 36 of them were followed up (median interval, 10 months after baseline). Presence of significant mean deviation and pattern standard deviation was determined for testing with reliability indices <= 20% for fixation loss, 15% for false-positives, and 33% for false-negatives. Test-retest stability of global visual field indices was assessed for tests with these cutoffs or with elevated fixation loss. Associations between global visual field defects and predictors were examined. Main Outcome Measures: Global visual field indices (mean deviation and pattern standard deviation). Results: Among 61 study participants (109 study eyes) with baseline testing, a field that met reliability cutoffs was obtained for 48 participants (79%) and 78 eyes (72%). Fixation loss was found in 29% of eyes in initial testing. Nine study participants (15%) demonstrated hemianopia or quadrantanopia, and an additional 36% had an abnormal global visual field index. Global indices were relatively stable at follow-up testing for tests meeting fixation-loss cutoffs and tests that did not. Visual scotomas due to post-chiasmal lesions were associated with moderate to severe TBI or penetrating head injury, but other visual field deficits were prevalent across the range of mild to severe TBI. Ocular injury to the retina or choroid, poorer visual acuity, and pupillary defect were associated with visual field defects. Participants with depressed visual field sensitivity reported lower visual quality of life. Conclusions: Reliable automated perimetry can be accomplished in most patients with TBI from combat blast exposure and reveals high rates of visual field deficits, indicating that blast forces may significantly affect the eye and visual pathways. (C) 2016 Published by Elsevier on behalf of the American Academy of Ophthalmology.	[Lemke, Sonne] Vet Adm Palo Alto Hlth Care Syst, Program Evaluat & Resource Ctr, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.; Glynn-Milley, Catherine; Cockerham, Kimberly P.] Vet Adm Palo Alto Hlth Care Syst, Ophthalmol, Palo Alto, CA 94304 USA; [Cockerham, Glenn C.; Cockerham, Kimberly P.] Stanford Univ, Sch Med, Ophthalmol, Stanford, CA 94305 USA; [Lin, Richard] Scripps Clin Med Grp, Ophthalmol, La Jolla, CA USA	Cockerham, GC (corresponding author), Vet Adm Palo Alto Hlth Care Syst, Ophthalmol 112 B1, 3801 Miranda Ave, Palo Alto, CA 94304 USA.	glenn.cockerham@va.gov	Cockerham, Kimberly/AAR-5917-2021		Veterans Administration Merit Review AwardUS Department of Veterans Affairs [C5018R]; Department of Veterans AffairsUS Department of Veterans Affairs [C5018-R]	Funded by Veterans Administration Merit Review Award C5018R. The sponsor had no role in the design or conduct of this research.; This article is based on work supported by the Department of Veterans Affairs Merit Review Award Grant C5018-R. The views expressed in this article are those of the authors and do not necessarily reflect the position or policies of the Department of Veterans Affairs or the US government.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Anderson DR, 2011, OPHTHALMOL MANAGE; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Bengtsson B, 2000, ACTA OPHTHALMOL SCAN, V78, P519, DOI 10.1034/j.1600-0420.2000.078005519.x; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Bengtsson B, 1998, ACTA OPHTHALMOL SCAN, V76, P268, DOI 10.1034/j.1600-0420.1998.760303.x; Bengtsson B, 1998, ACTA OPHTHALMOL SCAN, V76, P165, DOI 10.1034/j.1600-0420.1998.760208.x; Birt CM, 1997, OPHTHALMOLOGY, V104, P1126, DOI 10.1016/S0161-6420(97)30173-0; Bosworth C F, 2000, Semin Ophthalmol, V15, P172, DOI 10.3109/08820530009037869; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Cockerham GC, 2014, OPHTHALMOLOGY, V121, P2165, DOI 10.1016/j.ophtha.2014.06.009; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Committee on Gulf War and Health, 2014, GULF WAR AND HLTH, V7, P93; Deakin JB, 2004, PSYCHOPHARMACOLOGY, V173, P88, DOI 10.1007/s00213-003-1695-4; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ishiyama Y, 2014, INVEST OPHTH VIS SCI, V55, P8149, DOI 10.1167/iovs.14-15541; JOHNSON CA, 1993, OPHTHALMOLOGY, V100, P269; Johnson CA, 2014, J GLAUCOMA, V23, P288, DOI 10.1097/IJG.0b013e31829463ab; KATZ J, 1991, OPHTHALMOLOGY, V98, P70; Kunimatsu, 2000, Jpn J Ophthalmol, V44, P190, DOI 10.1016/S0021-5155(99)00209-9; Lemke S, 2013, JAMA OPHTHALMOL, V131, P1602, DOI 10.1001/jamaophthalmol.2013.5028; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; Montolio FGJ, 2012, INVEST OPHTH VIS SCI, V53, P7010, DOI 10.1167/iovs.12-10268; Newkirk MR, 2006, INVEST OPHTH VIS SCI, V47, P4632, DOI 10.1167/iovs.05-1598; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Petras JM, 1997, TOXICOLOGY, V121, P41, DOI 10.1016/S0300-483X(97)03654-8; Pieramici DJ, 1997, AM J OPHTHALMOL, V123, P820, DOI 10.1016/S0002-9394(14)71132-8; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; SANABRIA O, 1991, OPHTHALMOLOGY, V98, P76; Shao X, 2011, J CLIN EXPT OPHTHALM, V2; Snyder PJ, 2005, HUM PSYCHOPHARM CLIN, V20, P263, DOI 10.1002/hup.692; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff Irwin B, 2008, Optometry, V79, P259, DOI 10.1016/j.optm.2007.10.012; Szatmary G, 2002, ARCH OPHTHALMOL-CHIC, V120, P1162; THOMPSON JR, 1993, BRIT J OPHTHALMOL, V77, P115, DOI 10.1136/bjo.77.2.115; Wall M, 2001, INVEST OPHTH VIS SCI, V42, P528; Wall M, 2008, J GLAUCOMA, V17, P626, DOI 10.1097/IJG.0b013e318168f03e	42	13	13	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	FEB	2016	123	2					415	424		10.1016/j.ophtha.2015.10.003			10	Ophthalmology	Ophthalmology	DB2TK	WOS:000368362200036	26581554				2021-06-18	
J	Lynall, RC; Kerr, ZY; Parr, MS; Hackney, AC; Mihalik, JP				Lynall, Robert C.; Kerr, Zachary Y.; Parr, Matthew S.; Hackney, Anthony C.; Mihalik, Jason P.			Division I College Football Concussion Rates Are Higher at Higher Altitudes	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article						elevation; mild traumatic brain injury; sports epidemiology; sports injury	INJURY SURVEILLANCE SYSTEM; CONSENSUS STATEMENT; POSTURAL STABILITY; MOUNTAIN-SICKNESS; MOUTHGUARDS; SENSITIVITY; DEFICITS; IMPACTS; BATTERY; PLAYERS	STUDY DESIGN: Retrospective cohort. BACKGROUND: Participating in sports at high altitude may have a protective effect on the brain, according to research studies. Research using validated data-collection methods in a previously unexplored cohort may better estimate the association between concussion injury risk and altitude. OBJECTIVES: To determine the association between concussion rates and altitude during college football games. METHODS: Athletic trainers from 21 Division I football programs provided exposure and injury data to the National Collegiate Athletic Association (NCAA) Injury Surveillance Program (ISP) from the 2009-2010 to 2013-2014 academic years. The elevation of each stadium was determined. Concussion rates per 1000 athlete-exposures (AEs) were compared in 2 ways, based on the sample of stadium elevations: (1) median split (elevation higher than 178 m or lower than 178 m), and (2) quartile split. Rate ratios (RRs), rate differences, and 95% confidence intervals (CIs) were computed. RESULTS: One hundred sixty-nine concussions were reported over 49 040 AEs (3.45/1000 AEs). Using the median split, the concussion rate above 178 m (RR = 4.18/1000 AEs) was 1.47 times the concussion rate below 178 m (RR = 2.84/1000 AEs; 95% CI: 1.09, 2.00; P =.01). The concussion rate at the highest altitude quartile (higher than 284 m; RR = 5.01/1000 AEs) was 1.67 times greater than the concussion rate at the lowest altitude quartile (lower than 43 m; RR = 3.00/1000 AEs; 95% CI: 1.13, 2.48; P =.01). CONCLUSION: College football game concussion rates appear to increase at higher altitudes. The clinical significance of this relatively small increase is unknown. Future research should explore potential physiologic underpinnings associated with concussion risk at relatively higher and lower altitudes.	[Lynall, Robert C.; Parr, Matthew S.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Lynall, Robert C.; Hackney, Anthony C.; Mihalik, Jason P.] Univ N Carolina, Curriculum Human Movement Sci, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC USA; [Kerr, Zachary Y.] Datalys Ctr Sports Injury Res & Prevent Inc, Indianapolis, IN USA; [Hackney, Anthony C.] Univ N Carolina, Dept Exercise & Sport Sci, Appl Physiol Lab, Chapel Hill, NC USA; [Hackney, Anthony C.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Mihalik, Jason P.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA	Lynall, RC (corresponding author), 2207 Stallings Evans Sports Med Ctr, Campus Box 8700, Chapel Hill, NC 27599 USA.	rlynall@live.unc.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640; Kerr, Zachary/0000-0003-1423-1259	NCAA	The Research Review Board of the National Collegiate Athletic Association (NCAA) approved the Injury Surveillance Program and the University of North Carolina-Chapel Hill Institutional Review Board deemed the additional altitude analyses exempt. The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the Datalys Center or the NCAA. The authors certify that they have no affiliations with or financial involvement in any organization or entity with a direct financial interest in the subject matter or materials discussed in the article.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Council of Ivy Group Presidents, 2011, IVY MANUAL 2011 2012; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; Lewis MD, 2011, MIL MED, V176, P1120, DOI 10.7205/MILMED-D-10-00466; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2007, DENT TRAUMATOL, V23, P14, DOI 10.1111/j.1600-9657.2006.00488.x; Myer GD, 2014, J ORTHOP SPORT PHYS, V44, P164, DOI 10.2519/jospt.2014.5298; National Collegiate Athletic Association, FOOTBALL PRACTICE GU; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; ROSS RT, 1985, LANCET, V1, P990; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith DW, 2013, ORTHOP J SPORTS MED, V1, DOI 10.1177/2325967113511588; Sutherland AI, 2008, BRIT J SPORT MED, V42, P183, DOI 10.1136/bjsm.2007.045286; Takeda T, 2005, DENT TRAUMATOL, V21, P134, DOI 10.1111/j.1600-9657.2005.00320.x; Viano DC, 2012, ANN BIOMED ENG, V40, P47, DOI 10.1007/s10439-011-0399-x; Weihe W H, 1966, Schweiz Z Sportmed, V14, P177; Yarnell PR, 2000, SEMIN NEUROL, V20, P209, DOI 10.1055/s-2000-9830; Zavorsky GS, 2014, J ORTHOP SPORT PHYS, V44, P458, DOI 10.2519/jospt.2014.0201	30	13	13	0	10	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	FEB	2016	46	2					96	103		10.2519/jospt.2016.6315			8	Orthopedics; Rehabilitation; Sport Sciences	Orthopedics; Rehabilitation; Sport Sciences	DC3NN	WOS:000369126100008	26755407				2021-06-18	
J	Manchester, LC; Lee, V; Schmithorst, V; Kochanek, PM; Panigrahy, A; Fink, EL				Manchester, Leah C.; Lee, Vince; Schmithorst, Vincent; Kochanek, Patrick M.; Panigrahy, Ashok; Fink, Ericka L.			Global and Regional Derangements of Cerebral Blood Flow and Diffusion Magnetic Resonance Imaging after Pediatric Cardiac Arrest	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; OXYGEN-METABOLISM; IN-VIVO; PERFUSION; CHILDREN; CARE; ASTROCYTES; OUTCOMES; LACTATE	Objective To quantify and examine the relationship between global and regional cerebral blood flow (CBF) and water diffusion on brain magnetic resonance imaging (MRI) in children after cardiac arrest. Study design Children admitted to a tertiary care children's hospital from July 2011 to April 2013 who received a brain MRI within 2 weeks after cardiac arrest that included arterial spin labeling and apparent diffusion coefficient (ADC) sequences were studied. CBF and ADC values were calculated globally and in 19 regions of interest. Outcome variables included survival and favorable neurologic outcome, which was defined as Pediatric Cerebral Performance Category <= 3 at 6 months. We examined global and regional relationships between CBF and ADC and their association with outcome. Results This sample included 14 pediatric patients (mean time to MRI 6 +/- 4 days), 9 of whom survived and 6 who survived with favorable outcome. Global ADC was significantly decreased in patients with unfavorable outcome (P = .02). Increased CBF and decreased ADC often were colocalized in the same region, especially in children who had unfavorable outcomes. Conclusions In this exploratory study, global restricted water diffusion on ADC after pediatric cardiac arrest was associated with unfavorable outcome. MRI assessments of perfusion and diffusion may have prognostic value after pediatric cardiac arrest.	[Manchester, Leah C.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Lee, Vince; Schmithorst, Vincent; Panigrahy, Ashok] Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.; Fink, Ericka L.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kochanek, Patrick M.; Fink, Ericka L.] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA	Fink, EL (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, 4401 Penn Ave,Fac Pavil,2nd Floor, Pittsburgh, PA 15224 USA.	FinkEL@ccm.upmc.edu		Fink, Ericka/0000-0002-3683-4571; Lee, Vincent/0000-0002-1444-8055	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS065132, K23NS063371]; Laerdal Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS065132, K23NS063371] Funding Source: NIH RePORTER	Funded by the National Institutes of Health (K23 NS065132 [to E.F.] and K23NS063371 [to A.P.]) and Laerdal Foundation (to E.F.). The authors declare no conflicts of interest.	Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Ashwal S, 1997, ANN NEUROL, V41, P470, DOI 10.1002/ana.410410410; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Blood AB, 2002, J PHYSIOL-LONDON, V543, P1015, DOI 10.1113/jphysiol.2002.023077; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Drabek T, 2014, RESUSCITATION, V85, P964, DOI 10.1016/j.resuscitation.2014.03.314; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fink EL, 2013, NEUROCRIT CARE, V19, P31, DOI 10.1007/s12028-012-9706-0; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Manole MD, 2012, J CEREBR BLOOD F MET, V32, P560, DOI 10.1038/jcbfm.2011.165; Manole MD, 2009, J CEREBR BLOOD F MET, V29, P197, DOI 10.1038/jcbfm.2008.112; Meaney PA, 2006, PEDIATRICS, V118, P2424, DOI 10.1542/peds.2006-1724; Miyasaka N, 2000, AM J NEURORADIOL, V21, P60; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Pienaar R, 2012, NEUROIMAGE, V63, P1510, DOI 10.1016/j.neuroimage.2012.07.062; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Pollock JM, 2008, AM J NEURORADIOL, V29, P1302, DOI 10.3174/ajnr.A1095; Roy C S, 1890, J Physiol, V11, P85; Takahashi T, 1999, AM J NEURORADIOL, V20, P917; Topjian AA, 2008, PEDIATRICS, V122, P1086, DOI 10.1542/peds.2007-3313; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; White ML, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120464; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wintermark P, 2011, AM J NEURORADIOL, V32, P2023, DOI 10.3174/ajnr.A2708	35	13	13	1	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2016	169						28	+		10.1016/j.jpeds.2015.10.003			9	Pediatrics	Pediatrics	DB6AK	WOS:000368595300008	26561380	Green Accepted			2021-06-18	
J	Norris, CM; Sompol, P; Roberts, KN; Ansari, M; Scheff, SW				Norris, Christopher M.; Sompol, Pradoldej; Roberts, Kelly N.; Ansari, Mubeen; Scheff, Stephen W.			Pycnogenol protects CA3-CA1 synaptic function in a rat model of traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Hippocampus; Synaptic transmission; Oxidative stress; Pycnogenol (R)	LONG-TERM DEPRESSION; CONSTITUTIVELY ACTIVE CALCINEURIN; CONTROLLED CORTICAL IMPACT; DELAYED NEURONAL DEATH; AMYLOID-BETA PROTEIN; OXIDATIVE STRESS; GLUTAMATE-RECEPTOR; HIPPOCAMPAL SLICES; AREA CA1; POTENTIATION	Pycnogenol (PYC) is a patented mix of bioflavonoids with potent anti-oxidant and anti-inflammatory properties. Previously, we showed that PYC administration to rats within hours after a controlled cortical impact (CCI) injury significantly protects against the loss of several synaptic proteins in the hippocampus. Here, we investigated the effects of PYC on CA3-CA1 synaptic function following CCI. Adult Sprague-Dawley rats received an ipsilateral CCI injury followed 15 min later by intravenous injection of saline vehicle or PYC (10 mg/kg). Hippocampal slices from the injured (ipsilateral) and uninjured (contralateral) hemispheres were prepared at seven and fourteen days post-CCI for electrophysiological analyses of CA3-CA1 synaptic function and induction of long-term depression (LTD). Basal synaptic strength was impaired in slices from the ipsilateral, relative to the contralateral, hemisphere at seven days post-CCI and susceptibility to LTD was enhanced in the ipsilateral hemisphere at both post injury timepoints. No interhemispheric differences in basal synaptic strength or LTD induction were observed in rats treated with PYC. The results show that PYC preserves synaptic function after CCI and provides further rationale for investigating the use of PYC as a therapeutic in humans suffering from neurotrauma. (C) 2015 Elsevier Inc. All rights reserved.	[Norris, Christopher M.] Univ Kentucky, Coll Med, Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Norris, Christopher M.; Sompol, Pradoldej; Roberts, Kelly N.; Ansari, Mubeen; Scheff, Stephen W.] Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Scheff, Stephen W.] Univ Kentucky, Coll Med, Anat & Neurobiol, Lexington, KY 40536 USA	Norris, CM (corresponding author), Univ Kentucky, Coll Med, Pharmacol & Nutr Sci, Lexington, KY 40536 USA.; Norris, CM; Scheff, SW (corresponding author), Univ Kentucky, Coll Med, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.	cnorr2@uky.edu; pradoldej.sompol@uky.edu; knrobe2@uky.edu; mubeen.ansari@uky.edu; sscheff@email.uky.edu			Kentucky Spinal Cord and Head Injury Research Trust Fund [12-16A, 12-10A]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG027297] Funding Source: NIH RePORTER	This work was supported by grants from the Kentucky Spinal Cord and Head Injury Research Trust Fund (12-16A to SWS and 12-10A to CMN). Special thanks are due to Erin Abner, Richard J. Kryscio, and Frederick Schmitt of the Sanders-Brown Center on Aging for help on statistical analyses.	Abdul HM, 2011, AGING CELL, V10, P103, DOI 10.1111/j.1474-9726.2010.00645.x; Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Ansari MA, 2013, J NEUROTRAUM, V30, P1542, DOI 10.1089/neu.2013.2910; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P1510, DOI 10.1016/j.freeradbiomed.2008.08.025; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bales JW, 2010, J NEUROTRAUM, V27, P109, DOI 10.1089/neu.2009.1072; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Campbell JN, 2012, J NEUROTRAUM, V29, P218, DOI 10.1089/neu.2011.1762; Chen CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030294; Chen X, 2013, NEUROSCIENCE, V253, P435, DOI 10.1016/j.neuroscience.2013.08.054; Coussens CM, 1997, J NEUROPHYSIOL, V78, P1; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Darwish H, 2012, BRAIN INJURY, V26, P1763, DOI [10.3109/02699052.2012.741452, 10.3109/02699052.2011.635362]; del Rey A, 2013, BRAIN BEHAV IMMUN, V33, P15, DOI 10.1016/j.bbi.2013.05.011; Dumas TC, 2012, HIPPOCAMPUS, V22, P188, DOI 10.1002/hipo.20881; Foster TC, 1997, HIPPOCAMPUS, V7, P602, DOI 10.1002/(SICI)1098-1063(1997)7:6<602::AID-HIPO3>3.0.CO;2-G; Foster TC, 2007, NEUROBIOL LEARN MEM, V87, P522, DOI 10.1016/j.nlm.2006.12.009; Foy MR, 2008, BEHAV NEUROSCI, V122, P301, DOI 10.1037/0735-7044.122.2.301; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Furling D, 2000, P NATL ACAD SCI USA, V97, P4351, DOI 10.1073/pnas.060574597; Furman JL, 2012, J NEUROSCI, V32, P16129, DOI 10.1523/JNEUROSCI.2323-12.2012; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Griesbach GS, 2008, NEUROSCIENCE, V154, P530, DOI 10.1016/j.neuroscience.2008.04.003; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kobayashi MS, 2000, FREE RADICAL RES, V32, P115, DOI 10.1080/10715760000300121; Kumar A, 2002, J NEUROSCI RES, V67, P781, DOI 10.1002/jnr.10181; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8; Li ZZ, 2014, J NEUROL SCI, V338, P112, DOI 10.1016/j.jns.2013.12.027; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu FJ, 2000, BIOL PHARM BULL, V23, P735, DOI 10.1248/bpb.23.735; Liu X, 2014, J NEUROSCI, V34, P8741, DOI 10.1523/JNEUROSCI.2752-13.2014; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Maimoona A, 2011, J ETHNOPHARMACOL, V133, P261, DOI 10.1016/j.jep.2010.10.041; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; Mathis DM, 2011, JOVE-J VIS EXP, DOI 10.3791/2330; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Mills F, 2014, P NATL ACAD SCI USA, V111, P8631, DOI 10.1073/pnas.1404670111; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nelson AB, 1998, DRUG DEV IND PHARM, V24, P139, DOI 10.3109/03639049809085598; Norris CM, 2009, J NEUROTRAUM, V26, P2269, DOI 10.1089/neu.2009.1029; Norris CM, 2010, NEUROBIOL AGING, V31, P328, DOI 10.1016/j.neurobiolaging.2008.03.026; Norris CM, 1998, J NEUROSCI, V18, P3171; Norris CM, 1996, J NEUROSCI, V16, P5382; O'Dell T J, 1994, Learn Mem, V1, P129; Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8; Park Y, 2013, J CEREBR BLOOD F MET, V33, P1642, DOI 10.1038/jcbfm.2013.121; Peng QL, 2002, MOL BRAIN RES, V104, P55, DOI 10.1016/S0169-328X(02)00263-2; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Rezzani R, 2010, HYPERTENSION, V55, P1373, DOI 10.1161/HYPERTENSIONAHA.109.148254; Robillard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020676; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; RONG YQ, 1995, BIOTECHNOL THER, V5, P117; Ryan J, 2008, J PSYCHOPHARMACOL, V22, P553, DOI 10.1177/0269881108091584; Sama DM, 2013, AGEING RES REV, V12, P982, DOI 10.1016/j.arr.2013.05.008; Sama DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038170; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Scheff SW, 2013, EXP NEUROL, V239, P183, DOI 10.1016/j.expneurol.2012.09.019; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shioda N, 2007, J NEUROCHEM, V102, P1506, DOI 10.1111/j.1471-4159.2007.04600.x; Shioda N, 2006, J NEUROCHEM, V98, P310, DOI 10.1111/j.1471-4159.2006.03874.x; Sick TJ, 1998, BRAIN RES, V785, P287, DOI 10.1016/S0006-8993(97)01418-2; Spencer JPE, 2008, BRIT J NUTR, V99, pES60, DOI 10.1017/S0007114508965776; Spencer JPE, 2009, CHEM SOC REV, V38, P1152, DOI 10.1039/b800422f; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Vouimba RM, 2000, BRAIN RES BULL, V53, P783, DOI 10.1016/S0361-9230(00)00377-4; WAGNER JJ, 1995, J NEUROSCI, V15, P1577; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang JW, 2014, J SURG RES, V186, P328, DOI 10.1016/j.jss.2013.08.027; Watson JB, 2006, J NEUROSCI RES, V84, P1564, DOI 10.1002/jnr.21040; WEXLER EM, 1993, NEUROREPORT, V4, P591, DOI 10.1097/00001756-199305000-00034; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Williams RJ, 2012, FREE RADICAL BIO MED, V52, P35, DOI 10.1016/j.freeradbiomed.2011.09.010; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yan HQ, 2014, BRAIN RES, V1548, P63, DOI 10.1016/j.brainres.2013.12.028	87	13	13	0	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	FEB	2016	276						5	12		10.1016/j.expneurol.2015.11.006			8	Neurosciences	Neurosciences & Neurology	DC8LF	WOS:000369470400002	26607913	Green Accepted			2021-06-18	
J	Spitz, G; McKenzie, D; Attwood, D; Ponsford, JL				Spitz, Gershon; McKenzie, Dean; Attwood, David; Ponsford, Jennie L.			Cost prediction following traumatic brain injury: model development and validation	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							POSTTRAUMATIC AMNESIA; MULTICENTER; CHARGES; LENGTH; SELECTION; DURATION; VETERANS; UTILITY; SCALE; STAY	Objective The ability to predict costs following a traumatic brain injury (TBI) would assist in planning treatment and support services by healthcare providers, insurers and other agencies. The objective of the current study was to develop predictive models of hospital, medical, paramedical, and long-term care (LTC) costs for the first 10 years following a TBI. Methods The sample comprised 798 participants with TBI, the majority of whom were male and aged between 15 and 34 at time of injury. Costing information was obtained for hospital, medical, paramedical, and LTC costs up to 10 years postinjury. Demographic and injury-severity variables were collected at the time of admission to the rehabilitation hospital. Results Duration of PTA was the most important single predictor for each cost type. The final models predicted 44% of hospital costs, 26% of medical costs, 23% of paramedical costs, and 34% of LTC costs. Greater costs were incurred, depending on cost type, for individuals with longer PTA duration, obtaining a limb or chest injury, a lower GCS score, older age at injury, not being married or defacto prior to injury, living in metropolitan areas, and those reporting premorbid excessive or problem alcohol use. Conclusions This study has provided a comprehensive analysis of factors predicting various types of costs following TBI, with the combination of injury-related and demographic variables predicting 23-44% of costs. PTA duration was the strongest predictor across all cost categories. These factors may be used for the planning and case management of individuals following TBI.	[Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Spitz, Gershon; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean] Epworth Healthcare, Clin Trials & Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Attwood, David] Transport Accid Commiss, Geelong, Vic, Australia	Spitz, G (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	Gershon.Spitz@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480	Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This study was funded by the Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR). The cost data used in the current study was supplied by the TAC.	Akaike H, 1973, INT S INF THEOR; [Anonymous], 2009, EC COST SPINAL CORD, P1; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Billah B, 2010, EUR J CARDIO-THORAC, V37, P1086, DOI 10.1016/j.ejcts.2009.11.021; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; Burnham K. P., 2002, MODEL SELECTION INFE; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Finkelstein EA., 2006, INCIDENCE EC BURDEN; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; HOCKING RR, 1967, TECHNOMETRICS, V9, P531, DOI 10.2307/1266192; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McKenzie DP, 2006, ADDICT BEHAV, V31, P1683, DOI 10.1016/j.addbeh.2005.12.027; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Norusis M. J, 2011, IBM SPSS STAT 19 STA; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Prang KH, 2012, BRAIN INJURY, V26, P441; Ryan T., 2009, MODERN REGRESSION ME; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Witten IH, 2011, MOR KAUF D, P1; ZAR JH, 2006, BIOSTATISTICAL ANAL	32	13	13	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	FEB	2016	87	2					173	180		10.1136/jnnp-2014-309479			8	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	DB0CA	WOS:000368175000012	25694473				2021-06-18	
J	Yadav, K; Sarioglu, E; Choi, HA; Cartwright, WB; Hinds, PS; Chamberlain, JM				Yadav, Kabir; Sarioglu, Efsun; Choi, Hyeong-Ah; Cartwright, Walter B.; Hinds, Pamela S.; Chamberlain, James M.			Automated Outcome Classification of Computed Tomography Imaging Reports for Pediatric Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							RADIOLOGY REPORTS; LANGUAGE; STROKE	BackgroundThe authors have previously demonstrated highly reliable automated classification of free-text computed tomography (CT) imaging reports using a hybrid system that pairs linguistic (natural language processing) and statistical (machine learning) techniques. Previously performed for identifying the outcome of orbital fracture in unprocessed radiology reports from a clinical data repository, the performance has not been replicated for more complex outcomes. ObjectivesTo validate automated outcome classification performance of a hybrid natural language processing (NLP) and machine learning system for brain CT imaging reports. The hypothesis was that our system has performance characteristics for identifying pediatric traumatic brain injury (TBI). MethodsThis was a secondary analysis of a subset of 2,121 CT reports from the Pediatric Emergency Care Applied Research Network (PECARN) TBI study. For that project, radiologists dictated CT reports as free text, which were then deidentified and scanned as PDF documents. Trained data abstractors manually coded each report for TBI outcome. Text was extracted from the PDF files using optical character recognition. The data set was randomly split evenly for training and testing. Training patient reports were used as input to the Medical Language Extraction and Encoding (MedLEE) NLP tool to create structured output containing standardized medical terms and modifiers for negation, certainty, and temporal status. A random subset stratified by site was analyzed using descriptive quantitative content analysis to confirm identification of TBI findings based on the National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements project. Findings were coded for presence or absence, weighted by frequency of mentions, and past/future/indication modifiers were filtered. After combining with the manual reference standard, a decision tree classifier was created using data mining tools WEKA 3.7.5 and Salford Predictive Miner 7.0. Performance of the decision tree classifier was evaluated on the test patient reports. ResultsThe prevalence of TBI in the sampled population was 159 of 2,217 (7.2%). The automated classification for pediatric TBI is comparable to our prior results, with the notable exception of lower positive predictive value. Manual review of misclassified reports, 95.5% of which were false-positives, revealed that a sizable number of false-positive errors were due to differing outcome definitions between NINDS TBI findings and PECARN clinical important TBI findings and report ambiguity not meeting definition criteria. ConclusionsA hybrid NLP and machine learning automated classification system continues to show promise in coding free-text electronic clinical data. For complex outcomes, it can reliably identify negative reports, but manual review of positive reports may be required. As such, it can still streamline data collection for clinical research and performance improvement.	[Yadav, Kabir] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Sarioglu, Efsun] Portland State Univ, Dept Comp Sci, Portland, OR 97207 USA; [Choi, Hyeong-Ah] George Washington Univ, Dept Comp Sci, Washington, DC USA; [Cartwright, Walter B.] Howard Univ, Sch Med, Washington, DC 20059 USA; [Hinds, Pamela S.] Childrens Natl Hlth Syst, Childrens Res Inst, Washington, DC USA; [Chamberlain, James M.] Childrens Natl Hlth Syst, Div Emergency Med, Washington, DC USA	Yadav, K (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA.	kabir@emedharbor.edu	Kayi, Efsun Sarioglu/AAG-2060-2021; Hinds, Pamela/W-8115-2019	Yadav, Kabir/0000-0002-1092-9935	National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000075, KL2TR000076]; National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM010016, R01LM008635]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR000076, UL1TR000075] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM008635, R01LM010016] Funding Source: NIH RePORTER	This publication is supported through the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, grants UL1TR000075 and KL2TR000076. The CTSA program is led by the NIH's National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. MedLEE was developed with support from the National Library of Medicine (R01LM010016 and R01LM008635).	Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Elkins JS, 2000, COMPUT BIOMED RES, V33, P1, DOI 10.1006/cbmr.1999.1535; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Johnson J, 2013, RAD SOC N AM 2013 SC; Krippendorff K. H., 2003, CONTENT ANAL INTRO I; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mendonca EA, 2005, J BIOMED INFORM, V38, P314, DOI 10.1016/j.jbi.2005.02.003; Meystre S M, 2008, Yearb Med Inform, P128; Pham AD, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-266; Salton G., 1989, AUTOMATIC TEXT PROCE; Stanfill MH, 2010, J AM MED INFORM ASSN, V17, P646, DOI 10.1136/jamia.2009.001024; Yadav K, 2013, ACAD EMERG MED, V20, P848, DOI 10.1111/acem.12174; Yu S, 2014, J BIOMED INFORM, V52, P386, DOI 10.1016/j.jbi.2014.08.001	16	13	13	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	FEB	2016	23	2					171	178		10.1111/acem.12859			8	Emergency Medicine	Emergency Medicine	DD8EX	WOS:000370159300007	26766600	Green Accepted, Bronze			2021-06-18	
J	Yokobori, S; Yamaguchi, M; Igarashi, Y; Hironaka, K; Onda, H; Kuwamoto, K; Araki, T; Fuse, A; Yokota, H				Yokobori, Shoji; Yamaguchi, Masahiro; Igarashi, Yutaka; Hironaka, Kohei; Onda, Hidetaka; Kuwamoto, Kentaro; Araki, Takashi; Fuse, Akira; Yokota, Hiroyuki			Outcome and Refractory Factor of Intensive Treatment for Geriatric Traumatic Brain Injury: Analysis of 1165 Cases Registered in the Japan Neurotrauma Data Bank	WORLD NEUROSURGERY			English	Article						Geriatric traumatic brain injury; Intraventricular hemorrhage; Intensive treatment; Morbidity; Mortality	HEAD-INJURY; INTRAVENTRICULAR HEMORRHAGE; HEALTH-CARE; AGE; MANAGEMENT; PROGNOSIS; ADULT; COSTS	OBJECTIVE: With the increase in the aged population, geriatric traumatic brain injury (gTBI) is also rapidly increasing in Japan. There is thus a need to review the effect of intensive treatments for gTBIs. The aim of this study was 1) to assess how intensive treatments influenced patient outcome and 2) to identify the refractory factor against these intensive treatments in gTBI, from the Japan Neurotrauma Data Bank (JNTDB). METHODS: Of all 3194 patients in the JNTDB, 1165 (>= 65 years old) with severe gTBIs were enrolled in this study. The clinical features and their outcomes based on the Glasgow Outcome Scale on discharge and 6 months after injury were compared. RESULTS: Intensive treatments were administered to 71.4% of all patients with severe gTBI showing a significant increase over 15 years. Accordingly, mortality decreased significantly (from 62.7% to 51.1%, P = 0.001). On the other hand, severely disabled dependent survivors, who need daily help from others for living, increased accordingly (from 63.2% to 68.4%). The existence of intraventricular hemorrhage (IVH) rather than the patient's age was identified as the strongest refractory factor (odds ratio, 5.762; 95% confidence interval, 1.317-25.216) against intensive treatment. CONCLUSIONS: This study clarified that 1) intensive treatments are associated with higher survival rates (however, they also increase the incidence of severely disabled survivors) and 2) the strongest refractory factor for intensive treatment in cases of severe gTBI was not age but the existence of IVH. These results warrant further establishment of a seamless strategy for both the acute and the chronic phase of gTBI.	[Yokobori, Shoji; Yamaguchi, Masahiro; Igarashi, Yutaka; Onda, Hidetaka; Kuwamoto, Kentaro; Araki, Takashi; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, 1-1-5 Sendagi, Tokyo 113, Japan; [Hironaka, Kohei] Nippon Med Sch, Dept Neurosurg, 1-1-5 Sendagi, Tokyo 113, Japan	Yokobori, S (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, 1-1-5 Sendagi, Tokyo 113, Japan.	shoji@nms.ac.jp			General Insurance Association of Japan	This work was supported by the General Insurance Association of Japan.	Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Clemente JC, 2010, BIOCOMPUT-PAC SYM, P3; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; Miyata H, 2015, LANCET, V385, P2549, DOI 10.1016/S0140-6736(15)61135-7; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; National Institute of Population and Social Security Research, 2013, EST POP JAP; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Yokobori S, 2011, NEUROL MED-CHIR, V51, P265, DOI 10.2176/nmc.51.265	24	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2016	86						127	+		10.1016/j.wneu.2015.09.105			8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	DD0QU	WOS:000369625300042	26459712				2021-06-18	
J	Zangbar, B; Khalil, M; Rhee, P; Joseph, B; Kulvatunyou, N; Tang, A; Friese, RS; O'Keeffe, T				Zangbar, Bardiya; Khalil, Mazhar; Rhee, Peter; Joseph, Bellal; Kulvatunyou, Narong; Tang, Andrew; Friese, Randall S.; O'Keeffe, Terence			Metoprolol improves survival in severe traumatic brain injury independent of heart rate control	JOURNAL OF SURGICAL RESEARCH			English	Article						Beta-blockers; Traumatic brain injury; Metoprolol; Heart rate control; Propensity score matching	BETA-BLOCKERS; CEREBRAL PERFUSION; PROPRANOLOL	Background: Multiple prior studies have suggested an association between survival and beta-blocker administration in patients with severe traumatic brain injury (TBI). However, it is unknown whether this benefit of beta-blockers is dependent on heart rate control. The aim of this study was to assess whether rate control affects survival in patients receiving metoprolol with severe TBI. Our hypothesis was that improved survival from beta-blockade would be associated with a reduction in heart rate. Methods: We performed a 7-y retrospective analysis of all blunt TBI patients at a level-1 trauma center. Patients aged >16 y with head abbreviated injury scale 4 or 5, admitted to the intensive care unit (ICU) from the operating room or emergency room (ER), were included. Patients were stratified into two groups: metoprolol and no beta-blockers. Using propensity score matching, we matched the patients in two groups in a 1: 1 ratio controlling for age, gender, race, admission vital signs, Glasgow coma scale, injury severity score, mean heart rate monitored during ICU admission, and standard deviation of heart rate during the ICU admission. Our primary outcome measure was mortality. Results: A total of 914 patients met our inclusion criteria, of whom 189 received beta-blockers. A propensity-matched cohort of 356 patients (178: metoprolol and 178: no beta-blockers) was created. Patients receiving metoprolol had higher survival than those patients who did not receive beta-blockers (78% versus 68%; P = 0.04); however, there was no difference in the mean heart rate (89.9 +/- 13.9 versus 89.9 +/- 15; P = 0.99). Nor was there a difference in the mean of standard deviation of the heart rates (14.7 +/- 6.3 versus 14.4 +/- 6.5; P = 0.65) between the two groups. In Kaplane-Meier survival analysis, patients who received metoprolol had a survival advantage (P = 0.011) compared with patients who did not receive any beta-blockers. Conclusions: Our study shows an association with improved survival in patients with severe TBI receiving metoprolol, and this effect appears to be independent of any reduction in heart rate. We suggest that beta-blockers should be administered to all severe TBI patients irregardless of any perceived beta-blockade effect on heart rate. Published by Elsevier Inc.	[Zangbar, Bardiya; Khalil, Mazhar; Rhee, Peter; Joseph, Bellal; Kulvatunyou, Narong; Tang, Andrew; Friese, Randall S.; O'Keeffe, Terence] Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, Tucson, AZ 85727 USA	O'Keeffe, T (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care Burn & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	tokeeffe@surgery.arizona.edu					Abu Khaber H, 2010, CRIT CARE MED, V38, pU21; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; [Anonymous], TRAUM BRAIN INJ US F; [Anonymous], TBI STAT; Arbabi S, 2007, J TRAUMA, V62, P-2; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; ASGEIRSSON B, 1995, ACTA ANAESTH SCAND, V39, P347, DOI 10.1111/j.1399-6576.1995.tb04075.x; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chou EK, 2010, J TRAUMA, V69, P239, DOI 10.1097/TA.0b013e3181647c81; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; HORTNAGL H, 1980, INTENS CARE MED, V6, P169, DOI 10.1007/BF01757299; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Kendall MJ, 1997, AM J CARDIOL, V80, pJ15, DOI 10.1016/S0002-9149(97)00833-3; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2010, J TRAUMA, V68, P353, DOI 10.1097/TA.0b013e3181c8269a; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; LINDEMANN JP, 1982, AM HEART J, V103, P746, DOI 10.1016/0002-8703(82)90482-3; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489; MCAINSH J, 1990, PHARMACOL THERAPEUT, V46, P163, DOI 10.1016/0163-7258(90)90092-G; MCLEOD AA, 1982, BRIT HEART J, V47, P221; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Neil-Dwyer G, 1990, Acta Neurochir Suppl (Wien), V47, P102; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Schroeppel TJ, 2014, J TRAUMA ACUTE CARE, V76, P504, DOI 10.1097/TA.0000000000000104; Schroeppel TJ, 2010, J TRAUMA, V69, P776, DOI 10.1097/TA.0b013e3181e981b8; Sharma D, 2011, J NEUROSURG ANESTH, V23, P363, DOI 10.1097/01.ana.0000405613.27980.ea; Singh Jaspal, 2011, J Emerg Trauma Shock, V4, P446, DOI 10.4103/0974-2700.86626; WEKSLER BB, 1977, BLOOD, V49, P185	32	13	13	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	FEB	2016	200	2					586	592		10.1016/j.jss.2015.08.020			7	Surgery	Surgery	CZ1BU	WOS:000366841500022	26365164				2021-06-18	
J	Hu, H; Zhou, Y; Wang, Q; Su, SS; Qiu, YM; Ge, JW; Wang, Z; Xiao, ZP				Hu, Hao; Zhou, Yan; Wang, Qian; Su, Shanshan; Qiu, Yongming; Ge, Jianwei; Wang, Zhen; Xiao, Zeping			Association of abnormal white matter integrity in the acute phase of motor vehicle accidents with post-traumatic stress disorder	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Motor vehicle accidents; Post-traumatic stress disorder; Diffusion tensor Imaging	TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; FUNCTIONAL CONNECTIVITY; PSYCHOMETRIC PROPERTIES; NETWORK CONNECTIVITY; COMBAT VETERANS; PTSD; COMORBIDITY; EXTINCTION; CINGULATE	Background: A small portion of the Motor vehicle accidents (MVA) survivors would develop post-traumatic stress disorder (PTSD), which would cause substantial social function loss. How to identify those high-risk MVA survivors in the acute phase of the trauma is the first step to prevent the onset of PTSD. In the present study, we studied white matter integrity of subjects post to MVA by diffusional tensor imaging (DTI). Methods: To investigate whether the integrity of the white matter was impaired in the acute phase of the MVA among survivors who later develop PTSD and whether it could predict the severity of PTSD while being diagnosed. MVA Survivors were recruited to get trauma-specific clinical assessments and received DTI scan within 2 days from the MVA. These survivors were divided into 2 groups, PTSD group and trauma control (TC) group based on the clinical follow-up interview. Tract-Based Spatial Statistics (TBSS) was carried out to investigate difference in white matter integrity between 2 groups within DTI parameter maps. White matter integrity was measured by using fractional anisotropy (FA), axial diffusivity (AD), mean diffusivity (MD), and radical diffusivity (RD). Results: Compared with TC group, PTSD group showed lower FA value in multiple regions of both hemispheres, mainly involving anterior thalamic radiation, cortico-spinal tract, forceps minor, uncinate, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, cingulum and superior longitudinal fasciculus. Increased RD was also detected in PTSD group in the posterior part of right hemisphere, involving forceps major, inferior fronto-occipital fasciculus, inferior longitudinal fasciculus, cingulum, hippocampus and superior longitudinal fasciculus. The baseline FA and RD values correlated with Clinician-Administered PTSD Scale scores at clinical follow up. Conclusion: MVA survivors who later developed PTSD had more abnormalities in white matter integrity in the acute phase than those non-PTSD MVA survivors. Imaging markers of white matter integrity might be helpful in early identification of MVA survivors at high risk of PTSD. Limitations: Larger sample size in our extensive study is needed to confer a robust inference and image data at follow up are needed to observe the longitudinal changes of white matter integrity. (C) 2015 Elsevier B.V. All rights reserved.	[Hu, Hao; Su, Shanshan; Wang, Zhen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Hu, Hao; Su, Shanshan; Wang, Zhen] Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China; [Zhou, Yan] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Wang, Qian] Shanghai Jiao Tong Univ, MedX Res Inst, Shanghai 200030, Peoples R China; [Qiu, Yongming; Ge, Jianwei] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China; [Xiao, Zeping] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Wang, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	wangzhen@smhc.org.cn; xiaozeping88@163.com	Wang, Qian/AAY-9494-2020	Wang, Qian/0000-0002-3490-3836	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371486]; Shanghai Rising-Star Program [13QA1403200]; Shanghai Key Laboratory of Psychotic Disorders [13dz2260500]	The research was supported by grants from the National Natural Science Foundation of China (No.81371486), the Shanghai Rising-Star Program (No.13QA1403200), and the Shanghai Key Laboratory of Psychotic Disorders (No.13dz2260500). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared no conflict of interest.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bierer LM, 2015, PSYCHONEUROENDOCRINO, V51, P567, DOI 10.1016/j.psyneuen.2014.11.007; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Brown VM, 2014, NEUROPSYCHOPHARMACOL, V39, P351, DOI 10.1038/npp.2013.197; Bruce SE, 2013, NEUROIMAGE-CLIN, V2, P43, DOI 10.1016/j.nicl.2012.11.003; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Chossegros L, 2011, ACCIDENT ANAL PREV, V43, P471, DOI 10.1016/j.aap.2010.10.004; Cohen, 1977, STAT POWER ANAL BEHA; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Felmingham KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103653; Freedman S.A., 2015, EUR J PSYCHOTRAUMATO, V6, P2508; Gray MJ, 2004, ASSESSMENT, V11, P330, DOI 10.1177/1073191104269954; Hall T, 2012, BIOL MOOD ANXIETY DI, V2, DOI 10.1186/2045-5380-2-21; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Jin C, 2014, PSYCHOL MED, V44, P1927, DOI 10.1017/S003329171300250X; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Jorm AF, 2005, AM J PSYCHIAT, V162, P699, DOI 10.1176/appi.ajp.162.4.699; Kennis M, 2015, NEUROPSYCHOPHARMACOL, V40, P2434, DOI 10.1038/npp.2015.94; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kitayama N, 2007, J NERV MENT DIS, V195, P1027, DOI 10.1097/NMD.0b013e31815c044f; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mirza KAH, 1998, BRIT J PSYCHIAT, V172, P443, DOI 10.1192/bjp.172.5.443; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Moser DA, 2015, SOC COGN AFFECT NEUR, V10, P645, DOI 10.1093/scan/nsu099; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Nardo D, 2011, PSYCHOL MED, V41, P2549, DOI 10.1017/S0033291711000912; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Qin LD, 2012, BRAIN RES, V1484, P50, DOI 10.1016/j.brainres.2012.09.029; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Rougemont-Bucking A, 2011, CNS NEUROSCI THER, V17, P227, DOI 10.1111/j.1755-5949.2010.00152.x; Saar-Ashkenazy R, 2014, J TRAUMA STRESS, V27, P18, DOI 10.1002/jts.21887; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Simmons AN, 2013, J AFFECT DISORDERS, V146, P426, DOI 10.1016/j.jad.2012.08.006; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sripada RK, 2012, PSYCHOSOM MED, V74, P904, DOI 10.1097/PSY.0b013e318273bf33; Stein MB, 2001, J AFFECT DISORDERS, V66, P133, DOI 10.1016/S0165-0327(00)00301-3; Sun YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083473; Tursich M, 2015, ACTA PSYCHIAT SCAND, V132, P29, DOI 10.1111/acps.12387; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zhang L, 2012, ACTA NEUROPSYCHIATR, V24, P34, DOI 10.1111/j.1601-5215.2011.00580.x; Zhang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121095; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833	60	13	13	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	JAN 15	2016	190						714	722		10.1016/j.jad.2015.09.044			9	Clinical Neurology; Psychiatry	Neurosciences & Neurology; Psychiatry	CY5QT	WOS:000366463000096	26600413				2021-06-18	
J	Stockslager, MA; Samuels, BC; Allingham, RR; Klesmith, ZA; Schwaner, SA; Forest, CR; Ethier, CR				Stockslager, Max A.; Samuels, Brian C.; Allingham, R. Rand; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross			System for Rapid, Precise Modulation of Intraocular Pressure, toward Minimally-Invasive In Vivo Measurement of Intracranial Pressure	PLOS ONE			English	Article							CEREBROSPINAL-FLUID PRESSURE; OPTIC-NERVE HEAD; OUTFLOW FACILITY; OCULAR RIGIDITY; LUMBAR PUNCTURE; GOLDMANN APPLANATION; UVEOSCLERAL OUTFLOW; GLAUCOMA; PULSATION; EYE	Pathologic changes in intracranial pressure (ICP) are commonly observed in a variety of medical conditions, including traumatic brain injury, stroke, brain tumors, and glaucoma. However, current ICP measurement techniques are invasive, requiring a lumbar puncture or surgical insertion of a cannula into the cerebrospinal fluid (CSF)-filled ventricles of the brain. A potential alternative approach to ICP measurement leverages the unique anatomy of the central retinal vein, which is exposed to both intraocular pressure (IOP) and ICP as it travels inside the eye and through the optic nerve; manipulating IOP while observing changes in the natural pulsations of the central retinal vein could potentially provide an accurate, indirect measure of ICP. As a step toward implementing this technique, we describe the design, fabrication, and characterization of a system that is capable of manipulating IOP in vivo with <0.1 mmHg resolution and settling times less than 2 seconds. In vitro tests were carried out to characterize system performance. Then, as a proof of concept, we used the system to manipulate IOP in tree shrews (Tupaia belangeri) while video of the retinal vessels was recorded and the caliber of a selected vein was quantified. Modulating IOP using our system elicited a rapid change in the appearance of the retinal vein of interest: IOP was lowered from 10 to 3 mmHg, and retinal vein caliber sharply increased as IOP decreased from 7 to 5 mmHg. Another important feature of this technology is its capability to measure ocular compliance and outflow facility in vivo, as demonstrated in tree shrews. Collectively, these proof-of-concept demonstrations support the utility of this system to manipulate IOP for a variety of useful applications in ocular biomechanics, and provide a framework for further study of the mechanisms of retinal venous pulsation.	[Stockslager, Max A.; Klesmith, Zoe A.; Schwaner, Stephen A.; Forest, Craig R.; Ethier, C. Ross] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Samuels, Brian C.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Allingham, R. Rand] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Ethier, C. Ross] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Ethier, C. Ross] Emory Univ, Atlanta, GA 30322 USA	Ethier, CR (corresponding author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.; Ethier, CR (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	ross.ethier@bme.gatech.edu		Samuels, Brian/0000-0003-3860-6879	National Institute of Health BRAIN Initiative Grant (NEI) [1-U01-MH106027-01]; National Institute of Health BRAIN Initiative Grant (NIMH) [1-U01-MH106027-01]; National Institutes of Health Single Cell Grant [1 R01 EY023173]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY023173, P30EY006360, T32EY007092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH106027] Funding Source: NIH RePORTER	CRE acknowledges the Georgia Research Alliance (gra.org). CRF acknowledges the National Institutes of Health BRAIN Initiative Grant (NEI and NIMH 1-U01-MH106027-01; nih.gov) and National Institutes of Health Single Cell Grant (1 R01 EY023173; nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SV, 2006, POSTGRAD MED J, V82, P713, DOI 10.1136/pgmj.2006.044792; Alm A, 2009, EXP EYE RES, V88, P760, DOI 10.1016/j.exer.2008.12.012; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Berdahl JP, 2008, INVEST OPHTH VIS SCI, V49, P5412, DOI 10.1167/iovs.08-2228; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Boussommier-Calleja A, 2012, INVEST OPHTH VIS SCI, V53, P5838, DOI 10.1167/iovs.12-9923; Brubaker RF, 2003, SURV OPHTHALMOL, V48, pS17, DOI 10.1016/S0039-6257(03)00003-1; Brubaker RF, 2001, J GLAUCOMA, V10, pS45, DOI 10.1097/00061198-200110001-00017; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Chen W, P 2009 2 INT C BIOM, DOI [10.1109/BMEI.2009.5305808, DOI 10.1109/BMEI.2009.5305808]; Cheung CMG, 2004, BRIT J OPHTHALMOL, V88, P582, DOI 10.1136/bjo.2003.027219; Cioboata M, 2014, J Med Life, V7 Spec No. 2, P5; De Moraes CGV., 2008, J OPTOM, V1, P43, DOI DOI 10.3921/JOPTOM.2008.43; Eilaghi A, 2010, ANN BIOMED ENG, V38, P1586, DOI 10.1007/s10439-009-9879-7; EISENLOHR JE, 1962, INVEST OPHTH VISUAL, V1, P63; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Golzan SM, 2012, ANN BIOMED ENG, V40, P1940, DOI 10.1007/s10439-012-0563-y; GRANT WM, 1950, ARCH OPHTHALMOL-CHIC, V44, P204; GRANT WM, 1951, AMA ARCH OPHTHALMOL, V46, P113; Gurol ME, 2008, CURR ATHEROSCLER REP, V10, P324, DOI 10.1007/s11883-008-0050-y; Harder B, 2007, BR J OPHTHALMOL, V91, P399; HARRINGTON H, 1982, J NEUROSURG, V57, P703, DOI 10.3171/jns.1982.57.5.0703; Heimann H., 2010, ESSENTIALS OPHTHALMO, P67; Honjo M., 2011, ARCH OPHTHALMOL-CHIC, V119, P1171; Jacks AS, 2003, J NEUROL NEUROSUR PS, V74, P7, DOI 10.1136/jnnp.74.1.7; Kahook MY, 2013, CHANDLER AND GRANT'S GLAUCOMA, FIFTH EDITION, P1; KAST R, 1985, J NEUROL, V232, P260, DOI 10.1007/BF00313790; Kramer LA, 2012, RADIOLOGY, V263, P819, DOI 10.1148/radiol.12111986; Kymionis GD, 2008, J REFRACT SURG, V24, P173, DOI 10.3928/1081597X-20080201-08; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Lei YA, 2011, INVEST OPHTH VIS SCI, V52, P1865, DOI 10.1167/iovs.10-6019; Levine DN, 1998, MICROVASC RES, V56, P154, DOI 10.1006/mvre.1998.2098; Mendelson AA, 2012, CAN J NEUROL SCI, V39, P571, DOI 10.1017/S0317167100015286; Morgan WH, 1999, THESIS U W AUSTR; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Pallikaris IG, 2005, INVEST OPHTH VIS SCI, V46, P409, DOI 10.1167/iovs.04-0162; Ramulu PY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1335, DOI 10.1001/archophthalmol.2010.224; RUBEN JB, 1985, INVEST OPHTH VIS SCI, V26, P153; Sherwood JM, 2015, PLOS ONE UNPUB; Shetty AK, 1999, PEDIATRICS, V103, P1284, DOI 10.1542/peds.103.6.1284; Villamarin A, 2012, INVEST OPHTH VIS SCI, V53, P2831, DOI 10.1167/iovs.11-8752; Wall M, 2010, NEUROL CLIN, V28, P593, DOI 10.1016/j.ncl.2010.03.003; Wang AS, 2013, J GLAUCOMA, V22, P127, DOI 10.1097/IJG.0b013e3182254ba3; Wang J, 2013, INVEST OPHTH VIS SCI, V54, P1706, DOI 10.1167/iovs.12-9841	44	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2016	11	1							e0147020	10.1371/journal.pone.0147020			15	Multidisciplinary Sciences	Science & Technology - Other Topics	DB6ME	WOS:000368628300052	26771837	DOAJ Gold, Green Published			2021-06-18	
J	Francis, HM; Fisher, A; Rushby, JA; McDonald, S				Francis, Heather M.; Fisher, Alana; Rushby, Jacqueline A.; McDonald, Skye			Reduced heart rate variability in chronic severe traumatic brain injury: Association with impaired emotional and social functioning, and potential for treatment using biofeedback	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Traumatic brain injury; Heart rate variability; Social cognition; Emotion	NEUROVISCERAL INTEGRATION; INDIVIDUAL-DIFFERENCES; COGNITIVE PERFORMANCE; NERVOUS-SYSTEM; EMPATHY; ALEXITHYMIA; RECOGNITION; DEPRESSION; BEHAVIOR; DAMAGE	Heart rate variability (HRV) may provide an index of capacity for social functioning and may be remediated by HRV biofeedback. Given reductions in HRV are found following traumatic brain injury (TBI), the present study aimed to determine whether lower HRV in TBI is associated with social function, and whether HRV biofeedback might be a useful remediation technique in this population. Resting state HRV and measures of social and emotional processing were collected in 30 individuals with severe TBI (3-34years post-injury) and 30 controls. This was followed by a single session of HRV biofeedback. HRV was positively associated with social cognition and empathy, and negatively associated with alexithymia for the TBI group. Both TBI and control groups showed significantly increased HRV on both time-domain (i.e., SDNN, rMSSD) and frequency-domain measures (LF, HF, LF:HF ratio) during biofeedback compared to baseline. These results suggest that decreased HRV is linked to social and emotional function following severe TBI, and may be a novel target for therapy using HRV biofeedback techniques.	[Francis, Heather M.; Fisher, Alana; Rushby, Jacqueline A.; McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia	Francis, HM (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	h.francis@unsw.edu.au	Fisher, Alana/T-1869-2019; Rushby, Jacqueline/D-1820-2010	Rushby, Jacqueline/0000-0002-5018-638X; Fisher, Alana/0000-0002-6027-659X; Francis, Heather/0000-0002-7223-7782	Australian National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [APP1013796]; Centre of Research Excellence in traumatic brain injury - NHMRCNational Health and Medical Research Council of Australia	JAR is supported by an Australian National Health and Medical Research Council (NHMRC) Postdoctoral Fellowship [Clinical Training; APP1013796]. The project was supported by other initiatives including a Centre of Research Excellence in traumatic brain injury funded by NHMRC. The researchers received no direct personal benefit of a financial or other kind.	ALBENTOSA M, 1994, AQUACULTURE, V126, P315, DOI 10.1016/0044-8486(94)90048-5; Alcala V., 2013, REV PSICOPATOLOGIA P, V18, P73, DOI [10.5944/rppc.vol.18.num.1.2013.12764, DOI 10.5944/RPPC.VOL.18.NUM.1.2013.12764]; Alvares GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070468; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bal E, 2010, J AUTISM DEV DISORD, V40, P358, DOI 10.1007/s10803-009-0884-3; Berger S, 2010, PROG NEURO-PSYCHOPH, V34, P406, DOI 10.1016/j.pnpbp.2010.01.009; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Daluwatte C, 2013, J AUTISM DEV DISORD, V43, P1910, DOI 10.1007/s10803-012-1741-3; Davis M.H, 1980, J PERS SOC PSYCHOL, V10, P85; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Diamond LM, 2013, INT J PSYCHOPHYSIOL, V88, P339, DOI 10.1016/j.ijpsycho.2012.08.008; Diamond LM, 2011, PERS SOC PSYCHOL B, V37, P731, DOI 10.1177/0146167211400620; Diamond LM, 2005, J SOC PERS RELAT, V22, P499, DOI 10.1177/0265407505054520; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287; Holt-Lunstad J, 2007, ANN BEHAV MED, V33, P278, DOI 10.1007/BF02879910; Karavidas MK, 2007, APPL PSYCHOPHYS BIOF, V32, P19, DOI 10.1007/s10484-006-9029-z; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.12.012, 10.1016/j.biopsych.2009.11.019]; Keren O, 2005, BRAIN INJURY, V19, P605, DOI 10.1080/02699050400024946; Kim S, 2013, BRAIN INJURY, V27, P209, DOI 10.3109/02699052.2012.729292; King ML, 1997, BRAIN INJURY, V11, P445; Kraus M. F., 1999, TRAUMATIC BRAIN INJU, V14; LACQUANITI LG, 1993, INT J CLIN MONIT COM, V10, P181, DOI 10.1007/BF01246453; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Lehrer PM, 2003, PSYCHOSOM MED, V65, P796, DOI 10.1097/01.PSY.0000089200.81962.19; Lovibond S.H., 1995, MANUAL DEPRESSION AN; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; MEHRABIAN A, 1972, J PERS, V40, P525, DOI 10.1111/j.1467-6494.1972.tb00078.x; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Prinsloo GE, 2011, APPL COGNITIVE PSYCH, V25, P792, DOI 10.1002/acp.1750; Quintana DS, 2012, INT J PSYCHOPHYSIOL, V86, P168, DOI 10.1016/j.ijpsycho.2012.08.012; Rapenne T, 2001, J NEUROSURG ANESTH, V13, P260, DOI 10.1097/00008506-200107000-00016; Riganello F, 2010, CLIN NEUROPHYSIOL, V121, P2024, DOI 10.1016/j.clinph.2010.05.010; Sanchez-Navarro JP, 2005, BEHAV NEUROSCI, V119, P87, DOI 10.1037/0735-7044.119.1.87; Siepmann M, 2008, APPL PSYCHOPHYS BIOF, V33, P195, DOI 10.1007/s10484-008-9064-z; Tate R., 2005, BRAIN IMPAIR, V6, P75, DOI DOI 10.1375/BRIM.2005.6.2.75; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; von Borries AKL, 2012, PSYCHIAT RES, V200, P761, DOI 10.1016/j.psychres.2012.06.026; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Wells R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046597; Williams C, 2009, ARCH CLIN NEUROPSYCH, V24, P478; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Zucker TL, 2009, APPL PSYCHOPHYS BIOF, V34, P135, DOI 10.1007/s10484-009-9085-2	58	13	14	0	46	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	JAN 2	2016	26	1					103	125		10.1080/09602011.2014.1003246			23	Neurosciences; Psychology	Neurosciences & Neurology; Psychology	CU7EM	WOS:000363699300005	25627984				2021-06-18	
J	Willenbring, BD; Lerner, EB; Brasel, K; Cushman, JT; Guse, CE; Shah, MN; Swor, R				Willenbring, Brian D.; Lerner, E. Brooke; Brasel, Karen; Cushman, Jeremy T.; Guse, Clare E.; Shah, Manish N.; Swor, Robert			EVALUATION OF A CONSENSUS-BASED CRITERION STANDARD DEFINITION OF TRAUMA CENTER NEED FOR USE IN FIELD TRIAGE RESEARCH	PREHOSPITAL EMERGENCY CARE			English	Article						wounds and injury; field triage; emergency medical services; trauma centers	INJURY SEVERITY SCORE; VALIDATION	Research on field triage of injured patients is limited by the lack of a widely used criterion standard for defining trauma center need. Injury Severity Score (ISS) >15 has been a commonly used outcome measure in research for determining trauma center need that has never been validated. A multidisciplinary team recently published a consensus-based criterion standard definition of trauma center need, but this measure has not yet been validated. The objective was to determine if the consensus-based criterion standard can be obtained by medical record review and compare patients identified as needing a trauma center by the consensus-based criterion standard vs. ISS >15. A subanalysis of data collected during a 2-year prospective cohort study of 4,528 adult trauma patients transported by EMS to a single trauma center was conducted. These data included ICD-9-CM codes, treatment times, and other patient care data. Presence of the consensus-based criterion standard was determined for each patient. ISS was calculated based on ICD-9-CM codes assigned for billing. The consensus-based criterion standard could be applied to 4,471 (98.7%) cases. ISS could be determined for 4,506 (99.5%) cases. Based on an ISS >15, 8.9% of cases were identified as needing a trauma center. Of those, only 48.2% met the consensus-based criterion standard. Almost all patients that did not meet the consensus-based criterion standard, but had an ISS >15 were diagnosed with chest (rib fractures (100/205 cases)/pneumothorax (57/205 cases), closed head (without surgical intervention 88/205 cases), vertebral (without spinal cord injury 45/205 cases), and/or extremity injuries (39/205 cases). There were 4,053 cases with an ISS <15. 5.0% of those with an ISS <15 met the consensus-based criterion standard with the majority requiring surgery (139/203 cases) or a blood transfusion (60/203 cases). The kappa coefficient of agreement for ISS and the consensus-based criterion standard was 0.43. We determined that the consensus-based criterion standard could be identified through a medical record review. Use of the consensus-based criterion standard for field triage research will more accurately identify injured patients who need the resources of a trauma center when compared to ISS.	[Willenbring, Brian D.; Lerner, E. Brooke; Guse, Clare E.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Brasel, Karen] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Cushman, Jeremy T.; Shah, Manish N.] Univ Rochester, Rochester, NY USA; [Swor, Robert] William Beaumont Hosp, Royal Oak, MI 48072 USA	Lerner, EB (corresponding author), Med Coll Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA.	eblerner@mcw.edu		Cushman, Jeremy/0000-0003-4767-3731; Shah, Manish/0000-0001-6331-1074	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [5R49CE001010]; Medical College of Wisconsin EMS philanthropy fund	This project was supported in part by grant 5R49CE001010 from the Centers for Disease Control and Prevention (CDC). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the CDC. Mr. Willenbring was awarded a travel stipend from the Medical College of Wisconsin EMS philanthropy fund to offset the costs of presenting this project at a national meeting in Tucson, AZ.	[Anonymous], 1986, Bull Am Coll Surg, V71, P4; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAXT WG, 1990, ANN EMERG MED, V19, P1396, DOI 10.1016/S0196-0644(05)82606-X; Holcomb JB, 2005, MIL MED, V170, P7, DOI 10.7205/MILMED.170.1.7; Hopson LR, 2003, J AM COLL SURGEONS, V196, P106, DOI 10.1016/S1072-7515(02)01668-X; Leach SR, 2008, PREHOSP EMERG CARE, V12, P467, DOI 10.1080/10903120802290836; Lerner EB, 2014, J TRAUMA ACUTE CARE, V76, P1157, DOI 10.1097/TA.0000000000000189; Lerner EB, 2011, PREHOSP EMERG CARE, V15, P518, DOI 10.3109/10903127.2011.598617; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Mackersie RC, 2004, J TRAUMA, V57, P49; Marx WH, 2004, J TRAUMA, V57, P46, DOI 10.1097/01.TA.0000135502.18989.61; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; RUTLEDGE R, 1995, J TRAUMA, V38, P590, DOI 10.1097/00005373-199504000-00022; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1	15	13	13	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1090-3127	1545-0066		PREHOSP EMERG CARE	Prehosp. Emerg. Care	JAN 2	2016	20	1					1	5		10.3109/10903127.2015.1056896			5	Emergency Medicine; Public, Environmental & Occupational Health	Emergency Medicine; Public, Environmental & Occupational Health	DA1DI	WOS:000367536100001	26270033				2021-06-18	
J	Astafiev, SV; Zinn, KL; Shulman, GL; Corbetta, M				Astafiev, Serguei V.; Zinn, Kristina L.; Shulman, Gordon L.; Corbetta, Maurizio			Exploring the physiological correlates of chronic mild traumatic brain injury symptoms	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; MRI; Diffusion tensor imaging; Behavioral assessments	WHITE-MATTER INJURY; DIFFUSION-TENSOR; FUNCTIONAL CONNECTIVITY; MILITARY PERSONNEL; VISUAL-CORTEX; AXONAL INJURY; HEAD-INJURY; MRI; MIGRAINE; ATTENTION	We report on the results of a multimodal imaging study involving behavioral assessments, evoked and resting-state BOLD fMRI, and DTI in chronic mTBI subjects. We found that larger task-evoked BOLD activity in the MT+/LO region in extra-striate visual cortex correlated with mTBI and PTSD symptoms, especially light sensitivity. Moreover, higher FA values near the left optic radiation (OR) were associated with both light sensitivity and higher BOLD activity in the MT+/LO region. The MT+/LO region was localized as a region of abnormal functional connectivity with central white matter regions previously found to have abnormal physiological signals during visual eye movement tracking (Astafiev et al., 2015). We conclude that mTBI symptoms and light sensitivity may be related to excessive responsiveness of visual cortex to sensory stimuli. This abnormal sensitivity may be related to chronic remodeling of white matter visual pathways acutely injured. (C) 2016 The Authors. Published by Elsevier Inc.	[Astafiev, Serguei V.; Zinn, Kristina L.; Shulman, Gordon L.; Corbetta, Maurizio] Washington Univ, Dept Neurol, 660 S Euclid Ave,Campus Box 8225, St Louis, MO 63110 USA	Astafiev, SV (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave,Campus Box 8225, St Louis, MO 63110 USA.	astafiev@npg.wustl.edu; zinnk@npg.wustl.edu; gordon@npg.wustl.edu; mau@npg.wustl.edu	Corbetta, maurizio/AAZ-5219-2020	Astafiev, Serguei/0000-0003-3736-7095; CORBETTA, MAURIZIO/0000-0001-8295-3304	James S. McDonnell Foundation grant; National Institute of Neurological Disorders (NINDS) grant [R01 NS095741]; Department of Neurology, Washington University in St. Louis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095741] Funding Source: NIH RePORTER	This work was supported by a James S. McDonnell Foundation grant to the Attention Dynamics Consortium in Traumatic Brain Injury (ADC-TBI) and by the National Institute of Neurological Disorders (NINDS) grant R01 NS095741. Serguei V. Astafiev, PhD was partially supported by funds from the Department of Neurology, Washington University in St. Louis.	Armstrong RC, 2015, NEUROPHARMACOLOGY; Ashina Sait, 2005, Curr Pain Headache Rep, V9, P415, DOI 10.1007/s11916-005-0021-8; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Aurora SK, 2003, CEPHALALGIA, V23, P258, DOI 10.1046/j.1468-2982.2003.00471.x; Baldassarre A, 2014, BRAIN, V137, P3267, DOI 10.1093/brain/awu297; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boes A. D., 2015, BRAIN; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Datta R, 2013, CEPHALALGIA, V33, P365, DOI 10.1177/0333102412474503; Davenport N. D., 2014, HUM BRAIN MAPP; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Ding ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082107; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Faul M.D., 2010, TRAUMATIC BRAIN INJU; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laitinen T. P., 2009, P INT SOC MAGN RESON; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Martin H, 2011, HEADACHE, V51, P1520, DOI 10.1111/j.1526-4610.2011.02013.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rigon A., 2015, J NEUROTRAUMA; Rocca M. A., 2015, HUM BRAIN MAPP; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Strangman GE, 2012, NEUROREHABILITATION, V31, P295, DOI 10.3233/NRE-2012-0797; Talairach J., 1988, COPLANAR STEREOTAXIC; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; Windischberger C, 2002, MAGN RESON IMAGING, V20, P575, DOI 10.1016/S0730-725X(02)00563-5; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	79	13	13	1	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	11						10	19		10.1016/j.nicl.2016.01.004			10	Neuroimaging	Neurosciences & Neurology	DQ9BD	WOS:000379504500002	26909324	DOAJ Gold, Green Published			2021-06-18	
J	Bruce, J; Echemendia, R; Tangeman, L; Meeuwisse, W; Comper, P; Hutchison, M; Aubry, M				Bruce, Jared; Echemendia, Ruben; Tangeman, Lindy; Meeuwisse, Willem; Comper, Paul; Hutchison, Michael; Aubry, Mark			Two baselines are better than one: Improving the reliability of computerized testing in sports neuropsychology	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Neuropsychology; practice; sports	TEST-RETEST RELIABILITY; NORMATIVE DATA; CONCUSSION; IMPACT; MANAGEMENT	Computerized neuropsychological tests are frequently used to assist in return-to-play decisions following sports concussion. However, due to concerns about test reliability, the Centers for Disease Control and Prevention recommends yearly baseline testing. The standard practice that has developed in baseline/postinjury comparisons is to examine the difference between the most recent baseline test and postconcussion performance. Drawing from classical test theory, the present study investigated whether temporal stability could be improved by taking an alternate approach that uses the aggregate of 2 baselines to more accurately estimate baseline cognitive ability. One hundred fifteen English-speaking professional hockey players with 3 consecutive Immediate Postconcussion Assessment and Testing (ImPACT) baseline tests were extracted from a clinical program evaluation database overseen by the National Hockey League and National Hockey League Players' Association. The temporal stability of ImPACT composite scores was significantly increased by aggregating test performance during Sessions 1 and 2 to predict performance during Session 3. Using this approach, the 2-factor Memory (r=.72) and Speed (r=.79) composites of ImPACT showed acceptable long-term reliability. Using the aggregate of 2 baseline scores significantly improves temporal stability and allows for more accurate predictions of cognitive change following concussion. Clinicians are encouraged to estimate baseline abilities by taking into account all of an athlete's previous baseline scores.	[Bruce, Jared; Echemendia, Ruben; Tangeman, Lindy] Univ Missouri, Dept Psychol, Kansas City, MO 64110 USA; [Echemendia, Ruben] Psychol & Neurobehav Associates, State Coll, PA USA; [Meeuwisse, Willem] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Comper, Paul; Hutchison, Michael] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada	Bruce, J (corresponding author), Univ Missouri, Coll Arts & Sci, Dept Psychol, 5030 Cherry St,Cherry Hall Room 324, Kansas City, MO 64110 USA.	brucejm@umkc.edu	Echemendia, Ruben/R-6939-2019		National Hockey League	Drs. Echemendia, Meeuwisse, Comper, Hutchison, and Aubry are members of the National Hockey League/National Hockey League Players Association Concussion Subcommittee and that Dr. Bruce is a paid consultant to the National Hockey League.	Anastasi A., 1998, PSYCHOL TESTING; Baumgartner T.A., 2001, MEAS PHYS EDUC EXERC, V5, P179, DOI [10.1207/S15327841MPEE0503_4, DOI 10.1207/S15327841MPEE0503_4]; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; BURLINGAME GM, 1995, J MENT HEALTH ADMIN, V22, P226, DOI 10.1007/BF02521118; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Field A. P, 2009, DISCOVERING STAT USI; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MacDonald J, 2015, CLIN J SPORT MED, V25, P367, DOI 10.1097/JSM.0000000000000139; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Spreen O., 2006, COMPENDIUM NEUROPSYC; Teesson M., 1994, MEASUREMENT CONSUMER; Traub RE., 2005, ED MEASUREMENT ISSUE, V16, P8, DOI DOI 10.1111/J.1745-3992.1997.TB00603.X	22	13	13	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2016	23	5					336	342		10.1080/23279095.2015.1064002			7	Clinical Neurology; Psychology	Neurosciences & Neurology; Psychology	DR8DX	WOS:000380129700004	26786726				2021-06-18	
J	Choe, MC; Blume, HK				Choe, Meeryo C.; Blume, Heidi K.			Pediatric Posttraumatic Headache: A Review	JOURNAL OF CHILD NEUROLOGY			English	Article						posttraumatic headache; traumatic brain injury; concussion; child; adolescent; migraine	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; SEX-DIFFERENCES; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; UNITED-STATES; US SOLDIERS; PREDICTORS; CHILDREN; RECOVERY	Head injuries are common in pediatrics, and headaches are the most common complaint following mild head trauma. Although moderate and severe traumatic brain injuries occur less frequently, headaches can complicate recovery. There is currently an intense spotlight on concussion and there has been a corresponding increase in the number of children seeking care for headache after mild traumatic brain injury or concussion. Understanding the natural history of, and recognition of factors that are associated with posttraumatic headache will help providers and families to limit disability and may prompt earlier intervention to address disabling headaches. While there are few studies on the treatment of posttraumatic headache, proper evaluation and management of posttraumatic headaches is essential to prevent further injury and to promote recovery. In this article, we will review the current definitions and epidemiology of pediatric posttraumatic headache and discuss current recommendations for the evaluation and management of this syndrome in children and adolescents.	[Choe, Meeryo C.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA 90095 USA; [Blume, Heidi K.] Univ Washington, Seattle Childrens Hosp, Ctr Integrat Brain Res, Div Pediat Neurol, Seattle, WA 98105 USA	Blume, HK (corresponding author), Univ Washington, Seattle Childrens Hosp, Ctr Integrat Brain Res, Div Pediat Neurol, 4800 Sandpoint Way,MS B-5552, Seattle, WA 98105 USA.	heidi.blume@seattlechildrens.org					Ashwal S, 2014, J CHILD NEUROL, V29, P1704, DOI 10.1177/0883073814538504; Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Berz K, 2013, PHYSICIAN SPORTSMED, V41, P58, DOI 10.3810/psm.2013.05.2015; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blume HK, 2012, PEDIATR REV, V33, P562, DOI 10.1542/pir.33-12-562; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; GAWEL MJ, 1993, HEADACHE, V33, P96, DOI 10.1111/j.1526-4610.1993.hed3302096.x; Gioia G, 2016, J CHILD NEUROL, V31; Granito VJ., 2002, J SPORT BEHAV, V25, P243; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Heyer G, 2013, ANN NEUROL S17, V74, P128; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Kirk C, 2008, DEV MED CHILD NEUROL, V50, P422, DOI 10.1111/j.1469-8749.2008.02063.x; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lambru G, 2012, CURR PAIN HEADACHE R, V16, P162, DOI 10.1007/s11916-012-0248-0; Landy SH, 1996, HEADACHE, V36, P44, DOI 10.1046/j.1526-4610.1996.3601044.x; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mansell J, 2005, J ATHL TRAINING, V40, P310; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Powers SW, 2003, PEDIATRICS, V112, pE1, DOI 10.1542/peds.112.1.e1; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Saggese JA, 1998, HEADACHE, V38, P554, DOI 10.1046/j.1526-4610.1998.3807554.x; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Wang SJ, 2007, NEUROLOGY, V68, P591, DOI 10.1212/01.wnl.0000252800.82704.62; Wells E, 2016, J CHILD NEUROL, V31, P86; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	64	13	13	0	15	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	JAN	2016	31	1			SI		76	85		10.1177/0883073814568152			10	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	CY8HW	WOS:000366650400008	25670632				2021-06-18	
J	Chong, SL; Chew, SY; Feng, JXY; Teo, PYL; Chin, ST; Liu, N; Ong, MEH				Chong, Shu-Ling; Chew, Su Yah; Feng, Jasmine Xun Yi; Teo, Penny Yun Lin; Chin, Sock Teng; Liu, Nan; Ong, Marcus Eng Hock			A prospective surveillance of paediatric head injuries in Singapore: a dual-centre study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; EMERGENCY-DEPARTMENT; POPULATION; CHILDREN; ACCIDENTS	Objective: To study the causes of head injuries among the paediatric population in Singapore, and the association between causes and mortality, as well as the need for airway or neurosurgical intervention. Design: This is a prospective observational study utilising data from the trauma surveillance system from January 2011 to March 2015. Setting: Paediatric emergency departments (EDs) of KK Women's and Children's Hospital and the National University Health System. Participants: We included children aged <16 years presenting to the paediatric EDs with head injuries who required a CT scan, admission for monitoring of persistent symptoms, or who died from the head injury. We excluded children who presented with minor mechanisms and those whose symptoms had spontaneously resolved. Primary and secondary outcome measures: Primary composite outcome was defined as death or the need for intubation or neurosurgical intervention. Secondary outcomes included length of hospital stay and type of neurosurgical intervention. Results: We analysed 1049 children who met the inclusion criteria. The mean age was 6.7 (SD 5.2) years. 260 (24.8%) had a positive finding on CT. 17 (1.6%) children died, 52 (5.0%) required emergency intubation in the ED and 58 (5.5%) underwent neurosurgery. The main causes associated with severe outcomes were motor vehicle crashes (OR 7.2, 95% CI 4.3 to 12.0) and non-accidental trauma (OR 5.8, 95% CI 1.8 to 18.6). This remained statistically significant when we stratified to children aged <2 years and performed a multivariable analysis adjusting for age and location of injury. For motor vehicle crashes, less than half of the children were using restraints. Conclusions: Motor vehicle crashes and non-accidental trauma causes are particularly associated with poor outcomes among children with paediatric head injury. Continued vigilance and compliance with injury prevention initiatives and legislature are vital.	[Chong, Shu-Ling] KK Womens & Childrens Hosp, Duke NUS Med Sch, Dept Emergency Med, Singapore, Singapore; [Chew, Su Yah] Natl Univ Hlth Syst, Natl Univ Singapore, Yong Loo Lin Sch Med, Khoo Teck Puat Natl Univ Childrens Med Inst,Dept, Singapore, Singapore; [Feng, Jasmine Xun Yi] KK Womens & Childrens Hosp, Dept Emergency Med, Singapore, Singapore; [Teo, Penny Yun Lin; Chin, Sock Teng] Natl Univ Hlth Syst, Dept Emergency Med, Singapore, Singapore; [Liu, Nan] Singapore Gen Hosp, Duke NUS Med Sch, Dept Emergency Med, Ctr Quantitat Med, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, HSSR, Duke NUS Med Sch, Singapore, Singapore	Chong, SL (corresponding author), KK Womens & Childrens Hosp, Duke NUS Med Sch, Dept Emergency Med, Singapore, Singapore.	Chong.Shu-Ling@kkh.com.sg	Liu, Nan/L-9529-2013	Liu, Nan/0000-0003-3610-4883	SingHealth DUKE-NUS Paediatrics Academic Clinical Programme	The head injury surveillance work in KK Women's and Children's Hospital is funded by the SingHealth DUKE-NUS Paediatrics Academic Clinical Programme.	Befeler AR, 2014, J NEUROSURG-PEDIATR, V14, P414, DOI 10.3171/2014.7.PEDS1433; Bray Liz, 2015, Nurs Child Young People, V27, P22, DOI 10.7748/ncyp.27.7.22.e618; Brown EA, 2016, J PEDIATR PSYCHOL, V41, P244, DOI 10.1093/jpepsy/jsv090; Chong SL, 2015, INJURY, V46, P1270, DOI 10.1016/j.injury.2015.04.002; Chong SL, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0015-0; Cusimano MD, 2016, J NEUROSURG-PEDIATR, V17, P3, DOI 10.3171/2015.2.PEDS14472; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058868; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P261, DOI 10.3171/2014.9.PEDS14149; Hinds T, 2015, CURR PROB PEDIATR AD, V45, P71, DOI 10.1016/j.cppeds.2015.02.002; Johnston BD, 2013, ACAD PEDIATR, V13, P499, DOI 10.1016/j.acap.2013.04.016; Kiley K, 2014, PEDIATR EMERG CARE, V30, P631, DOI 10.1097/PEC.0000000000000210; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Korley FK, 2015, J HEAD TRAUMA REHABI; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee LK, 2015, J TRAUMA ACUTE CARE, V79, pS55, DOI 10.1097/TA.0000000000000673; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Maguire SA, 2011, PEDIATRICS, V128, pE550, DOI 10.1542/peds.2010-2949; Nnadi MO, 2015, NEUROSCI J, V2015; Peden M., 2008, WORLD REPORT CHILD I; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Thiam DW, 2015, ANN ACAD MED SINGAP, V44, P335; Ward A, 2015, AM SURGEON, V81, P835	23	13	14	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	2							e010618	10.1136/bmjopen-2015-010618			6	Medicine, General & Internal	General & Internal Medicine	DT5HX	WOS:000381514500144	26908533	DOAJ Gold, Green Published			2021-06-18	
J	Chong, ZZ; Changyaleket, B; Xu, HL; Dull, RO; Schwartz, DE				Chong, Zhao Zhong; Changyaleket, Benjarat; Xu, Haoliang; Dull, Randy O.; Schwartz, David E.			Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases	CURRENT MEDICINAL CHEMISTRY			English	Article						RAGE; PI3K; MAPK; neurodegeneration; stroke; diabetes; biomarker	GLYCATION END-PRODUCTS; NEURON-SPECIFIC ENOLASE; NF-KAPPA-B; CEREBROSPINAL-FLUID S100B; NECROSIS-FACTOR-ALPHA; AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROTROPHIC PROTEIN S100B; FIBRILLARY ACIDIC PROTEIN; CALCIUM-BINDING PROTEIN; FOCAL CEREBRAL-ISCHEMIA	The calcium binding protein S100B has attracted great attention as a biomarker for a variety of diseases. S100B is mainly expressed in glial cells and functions through intracellular and extracellular signaling pathways. The biological roles of S100B have been closely associated with its concentrations and its physiological states. The released S100B can bind to the receptor of advanced glycation end products and induce the initiation of multiple cell signaling transductions. The regulation of S100B bioactivities has been suggested through phosphoinositide 3 kinase/Akt, p53, mitogen-activated protein kinases, transcriptional factors including nuclear factor-kappaB, and cyclic adenosine monophosphate. The levels of S100B in the blood may function to predict the progress or the prognosis of many kinds of diseases, such as cerebrovascular diseases, neurodegenerative diseases, motor neuron diseases, traumatic brain injury, schizophrenia, depression, diabetes mellitus, myocardial infarction, cancer, and infectious diseases. Given that the activity of S100B has been implicated in the pathological process of these diseases, S100B should not be simply regarded as a biomarker, it may also function as therapeutic target for these diseases. Further elucidation of the roles of S100B may formulate innovative therapeutic strategies for multiple diseases.	[Chong, Zhao Zhong; Changyaleket, Benjarat; Dull, Randy O.; Schwartz, David E.] Univ Illinois, Dept Anesthesiol, 835 S Wolcott St,Room E713,Bldg 935, Chicago, IL 60612 USA; [Xu, Haoliang] Univ Illinois, Dept Pathol, Chicago, IL USA	Chong, ZZ (corresponding author), Univ Illinois, Dept Anesthesiol, 835 S Wolcott St,Room E713,Bldg 935, Chicago, IL 60612 USA.	zzchong@uic.edu					Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Akdemir HU, 2014, HUM EXP TOXICOL, V33, P1113, DOI 10.1177/0960327114521049; Al-Jarrah M, 2007, NEUROSCIENCE, V149, P28, DOI 10.1016/j.neuroscience.2007.07.038; Al-Jarrah M, 2013, NEUROREHABILITATION, V32, P141, DOI 10.3233/NRE-130831; Al-Jarrah MD, 2011, NEUROREHABILITATION, V28, P359, DOI 10.3233/NRE-2011-0664; Aleksovska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106342; Alexanian AR, 1999, FASEB J, V13, P1611; Amiri M, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00065; Arcuri C, 2005, J BIOL CHEM, V280, P4402, DOI 10.1074/jbc.M406440200; Arfvidsson B, 2015, CLIN CHEM LAB MED, V53, P111, DOI 10.1515/cclm-2014-0283; Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Barateiro A., 2015, MOL NEUROBIOL; BARD JA, 1993, J BIOL CHEM, V268, P23422; Bartosik-Psujek H, 2011, ACTA NEUROL SCAND, V123, P252, DOI 10.1111/j.1600-0404.2010.01393.x; Batassini C, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/387028; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006; Bayazit H, 2016, EUR ADDICT RES, V22, P177, DOI 10.1159/000442046; Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bialowas-McGoey LA, 2008, GLIA, V56, P1780, DOI 10.1002/glia.20727; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bluhm B, 2015, CEREBELLUM, V14, P119, DOI 10.1007/s12311-014-0606-z; Boespflug A, 2013, EUR J DERMATOL, V23, P719, DOI 10.1684/ejd.2013.2133; Bowman G, 2006, NEUROCRIT CARE, V5, P222, DOI 10.1385/NCC:5:3:222; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; BRETT J, 1993, AM J PATHOL, V143, P1699; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cai XY, 2011, ATHEROSCLEROSIS, V217, P536, DOI 10.1016/j.atherosclerosis.2011.05.023; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Carvalho DZ, 2015, NEUROSCI LETT, V608, P57, DOI 10.1016/j.neulet.2015.10.010; Celikbilek A, 2014, NEUROSCI LETT, V558, P53, DOI 10.1016/j.neulet.2013.10.067; Changyaleket B, 2016, BRAIN RES, V1634, P171, DOI 10.1016/j.brainres.2015.12.061; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Cheng CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091426; Cheong KA, 2014, EXP DERMATOL, V23, P165, DOI 10.1111/exd.12332; Chong ZZ, 2015, CURR DRUG TARGETS, V16, P1107, DOI 10.2174/1389450116666150408103448; Chong ZZ, 2013, EXPERT OPIN THER TAR, V17, P707, DOI 10.1517/14728222.2013.780599; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; Chong ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045456; Chong ZZ, 2012, FUTUR CARDIOL, V8, P89, DOI [10.2217/fca.11.76, 10.2217/FCA.11.76]; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Chong ZZ, 2005, BRAIN RES REV, V49, P1, DOI 10.1016/j.brainresrev.2004.11.005; Chong ZZ, 2004, HISTOL HISTOPATHOL, V19, P495, DOI 10.14670/HH-19.495; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; CHYATTE D, 1984, J NEUROSURG, V60, P923, DOI 10.3171/jns.1984.60.5.0923; CHYATTE D, 1987, NEUROSURGERY, V21, P157, DOI 10.1227/00006123-198708000-00004; Cirillo C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/508342; Clatterbuck RE, 2003, J NEUROSURG, V99, P376, DOI 10.3171/jns.2003.99.2.0376; COCCHIA D, 1981, Neurochemistry International, V3, P123, DOI 10.1016/0197-0186(81)90030-9; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Dang XB, 2014, INT J CLIN EXP PATHO, V7, P3818; Darlot F, 2008, AM J PHYSIOL-RENAL, V295, pF1142, DOI 10.1152/ajprenal.00599.2007; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Di Legge S, 2003, NEUROL SCI, V24, P351, DOI 10.1007/s10072-003-0188-x; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Egberts F, 2008, ONKOLOGIE, V31, P380, DOI 10.1159/000135492; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; EVENHUIS HM, 1990, ARCH NEUROL-CHICAGO, V47, P263, DOI 10.1001/archneur.1990.00530030029011; Faye RS, 2008, MELANOMA RES, V18, P134, DOI 10.1097/CMR.0b013e3282f623d9; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Foerch C, 2004, STROKE, V35, P2160, DOI 10.1161/01.STR.0000138730.03264.ac; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Friel LA, 2007, J PERINAT MED, V35, P385, DOI 10.1515/JPM.2007.101; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Garg N, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.362; Gazzolo D, 2003, CLIN CHIM ACTA, V330, P131, DOI 10.1016/S0009-8981(03)00010-X; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Glaser N., 2015, BRAIN RES; Gomez-Tourino I, 2015, CLIN EXP IMMUNOL, V180, P207, DOI 10.1111/cei.12572; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Gribenko AV, 1998, J MOL BIOL, V283, P679, DOI 10.1006/jmbi.1998.2116; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Hackam DG, 2015, STROKE, V46, P852, DOI 10.1161/STROKEAHA.115.008680; Hanafy KA, 2010, J CLIN NEUROSCI, V17, P853, DOI 10.1016/j.jocn.2009.11.041; Hartman KG, 2013, FUTURE MED CHEM, V5, P97, DOI 10.4155/fmc.12.191; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hedlund PB, 2004, TRENDS PHARMACOL SCI, V25, P481, DOI 10.1016/j.tips.2004.07.002; Heidari K, 2015, BRAIN INJURY, V29, P33, DOI 10.3109/02699052.2014.948068; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hemachandra D., 2015, AUST NZ J PUBL HEAL, P1; Herson PS, 2014, FUTUR NEUROL, V9, P541, DOI 10.2217/FNL.14.44; HESTON LL, 1984, PSYCHIAT DEV, V2, P287; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; ISOBE T, 1977, BIOCHIM BIOPHYS ACTA, V494, P222, DOI 10.1016/0005-2795(77)90150-7; Jackson CE, 1998, SEMIN NEUROL, V18, P27, DOI 10.1055/s-2008-1040859; Jiang Y, 2012, J CLIN NEUROSCI, V19, P866, DOI 10.1016/j.jocn.2011.08.038; Jickling GC, 2015, STROKE, V46, P915, DOI 10.1161/STROKEAHA.114.005604; Joanna P, 2015, NEUROL NEUROCHIR POL, V49, P313, DOI 10.1016/j.pjnns.2015.07.006; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kaneda K, 2010, BRAIN RES BULL, V81, P173, DOI 10.1016/j.brainresbull.2009.10.020; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Katayama Y, 2007, STROKE, V38, P2373, DOI 10.1161/STROKEAHA.106.480038; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Koppal T, 2001, NEUROCHEM INT, V39, P401, DOI 10.1016/S0197-0186(01)00047-X; Korczyn AD, 2015, EXPERT REV NEUROTHER, V15, P227, DOI 10.1586/14737175.2015.1014806; Koulis C, 2015, DIABETES METAB, V41, P272, DOI 10.1016/j.diabet.2015.01.006; Landar A, 1997, BBA-PROTEIN STRUCT M, V1343, P117, DOI 10.1016/S0167-4838(97)00126-X; Lanzillotta A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00098; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2015, BBA-MOL BASIS DIS, V1852, P2706, DOI 10.1016/j.bbadis.2015.09.022; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Leis AA, 2012, MUSCLE NERVE, V45, P826, DOI 10.1002/mus.23241; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Li F, 2006, CURR NEUROVASC RES, V3, P187, DOI 10.2174/156720206778018758; Li YK, 1998, J NEUROCHEM, V71, P1421; Liang FR, 2013, J CLIN NEUROSCI, V20, P357, DOI 10.1016/j.jocn.2012.06.005; Lim Ee Tuan, 2004, J Negat Results Biomed, V3, P4, DOI 10.1186/1477-5751-3-4; Lin CL, 2005, SURG NEUROL, V64, P201, DOI 10.1016/j.surneu.2005.04.038; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Lin J, 2010, J BIOL CHEM, V285, P27487, DOI 10.1074/jbc.M110.155382; Liu JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050719; Liu JL, 2011, ARCH MED RES, V42, P1, DOI 10.1016/j.arcmed.2011.01.005; Loquai C, 2013, ONKOLOGIE, V36, P578, DOI 10.1159/000355159; Lu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022126; MACDONALD G, 1991, GENOMICS, V11, P317, DOI 10.1016/0888-7543(91)90138-5; Maiese K, 2008, EXPERT OPIN THER TAR, V12, P905, DOI [10.1517/14728222.12.7.905, 10.1517/14728222.12.7.905 ]; Maiese K, 2013, EXPERT OPIN DRUG DIS, V8, P35, DOI 10.1517/17460441.2013.736485; Marlatt NM, 2009, BIOCHEMISTRY-US, V48, P1954, DOI 10.1021/bi802086a; Masaoka N., 2015, J MATERN-FETAL NEO M, P1; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Miller BA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/384342; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mohammadzadeh F, 2013, LIFE SCI, V92, P639, DOI 10.1016/j.lfs.2012.09.011; Montaner J, 2012, J PROTEOMICS, V75, P4758, DOI 10.1016/j.jprot.2012.01.033; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Moutsatsou P, 2014, CLIN CHEM LAB MED, V52, P999, DOI 10.1515/cclm-2013-0978; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Netto CB, 2004, CLIN BIOCHEM, V37, P134, DOI 10.1016/j.clinbiochem.2003.09.010; Netto CBO, 2005, CLIN BIOCHEM, V38, P433, DOI 10.1016/j.clinbiochem.2004.12.014; Nishino A, 2010, NEUROL RES, V32, P873, DOI 10.1179/016164109X12608733393791; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Niven J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132688; Ohtaki N, 2007, J VIROL, V81, P5940, DOI 10.1128/JVI.02137-06; Ostendorp T, 2005, ACTA CRYSTALLOGR F, V61, P673, DOI 10.1107/S1744309105018014; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otto M, 1998, NEUROSCI LETT, V240, P171, DOI 10.1016/S0304-3940(97)00947-6; Park JW, 2013, YONSEI MED J, V54, P567, DOI 10.3349/ymj.2013.54.3.567; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pedersen A, 2008, PROG NEURO-PSYCHOPH, V32, P1789, DOI 10.1016/j.pnpbp.2008.07.017; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Petzold A, 2003, NEUROSCI LETT, V336, P167, DOI 10.1016/S0304-3940(02)01257-0; Piazza O, 2007, BRIT J ANAESTH, V99, P518, DOI 10.1093/bja/aem201; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Piazza O, 2013, INT J IMMUNOPATH PH, V26, P383, DOI 10.1177/039463201302600211; Piazza O, 2009, NEUROCHEM RES, V34, P1289, DOI 10.1007/s11064-008-9907-2; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Rohlwink UK, 2014, CLIN CHEM, V60, P823, DOI 10.1373/clinchem.2013.212472; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; Rose DZ, 2015, NEUROLOGY, V85, P1177, DOI 10.1212/WNL.0000000000001973; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothermundt M, 2007, PROG NEURO-PSYCHOPH, V31, P361, DOI 10.1016/j.pnpbp.2006.09.013; Sanchez-Pena P, 2008, CRIT CARE MED, V36, P2267, DOI 10.1097/CCM.0b013e3181809750; Sathe K, 2012, BRAIN, V135, P3336, DOI 10.1093/brain/aws250; Schaf DV, 2005, PARKINSONISM RELAT D, V11, P39, DOI 10.1016/j.parkreldis.2004.07.002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schmidt H, 2010, NEUROSCI LETT, V475, P104, DOI 10.1016/j.neulet.2010.03.059; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Schroeter ML, 2002, NEUROREPORT, V13, P1675, DOI 10.1097/00001756-200209160-00021; Scotto C, 1998, J BIOL CHEM, V273, P3901, DOI 10.1074/jbc.273.7.3901; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Shang YC, 2010, CELL SIGNAL, V22, P1317, DOI 10.1016/j.cellsig.2010.04.009; Shapiro LA, 2010, CARDIOVASC PSYCHIAT, V2010; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; Sorci G, 2004, J CELL PHYSIOL, V199, P274, DOI 10.1002/jcp.10462; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; Steinacker P, 2013, ACTA NEUROL SCAND, V128, P249, DOI 10.1111/ane.12113; Steiner J, 2006, J NEUROL NEUROSUR PS, V77, P1284, DOI 10.1136/jnnp.2006.093427; Steiner J, 2008, J PSYCHIATR RES, V42, P868, DOI 10.1016/j.jpsychires.2007.10.001; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Steiner J, 2009, BIOL PSYCHIAT, V65, P1107, DOI 10.1016/j.biopsych.2008.10.044; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Stroth N, 2015, EUR NEUROPSYCHOPHARM, V25, P2372, DOI 10.1016/j.euroneuro.2015.10.003; Sussmuth SD, 2003, NEUROSCI LETT, V353, P57, DOI 10.1016/j.neulet.2003.09.018; Takematsu M, 2014, CLIN TOXICOL, V52, P973, DOI 10.3109/15563650.2014.958614; Tanaka Y, 2008, BRAIN RES, V1227, P248, DOI 10.1016/j.brainres.2008.06.076; Tanaka Y, 2008, NEUROSCI LETT, V436, P40, DOI 10.1016/j.neulet.2008.02.056; Tanaka Y, 2007, BRAIN RES, V1154, P194, DOI 10.1016/j.brainres.2007.03.085; Tasker RC, 2015, CURR OPIN PEDIATR, V27, P694, DOI 10.1097/MOP.0000000000000287; Thelin E. P., 2015, EUR J TRAUMA EMERG S; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Tort ABL, 2004, LIFE SCI, V76, P379, DOI 10.1016/j.lfs.2004.09.003; Tsoporis JN, 2010, CIRC RES, V106, P93, DOI 10.1161/CIRCRESAHA.109.195834; Tsoporis JN, 2005, CIRCULATION, V111, P598, DOI 10.1161/01.CIR.0000154554.65287.F5; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; Tulner DM, 2009, NEUROPSYCHOBIOLOGY, V59, P87, DOI 10.1159/000209860; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; van Dieck J, 2010, FEBS LETT, V584, P3269, DOI 10.1016/j.febslet.2010.06.024; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Villarreal A, 2014, J NEUROCHEM, V131, P190, DOI 10.1111/jnc.12790; Villarreal A, 2011, J NEUROCHEM, V117, P321, DOI 10.1111/j.1471-4159.2011.07207.x; VLASSARA H, 1992, DIABETES, V41, P52, DOI 10.2337/diab.41.2.S52; Wafer LN, 2012, BIOCHEMISTRY-US, V51, P7189, DOI 10.1021/bi300865g; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Winocur G, 2001, NEUROBIOL LEARN MEM, V75, P230, DOI 10.1006/nlme.2000.3961; Wolff V, 2015, CEREBROVASC DIS, V39, P31, DOI 10.1159/000369776; Wolff V, 2013, STROKE, V44, P558, DOI 10.1161/STROKEAHA.112.671347; Yamagishi Sho-ichi, 2010, Front Biosci (Elite Ed), V2, P1184; Yamamoto KI, 2013, ONCOL REP, V29, P1073, DOI 10.3892/or.2012.2191; Yang K, 2009, CAN J PSYCHIAT, V54, P312, DOI 10.1177/070674370905400505; Yoneko M, 2010, METHOD FIND EXP CLIN, V32, P727, DOI 10.1358/mf.2010.32.10.1561078; Yoshimura C, 2013, BIOORGAN MED CHEM, V21, P1109, DOI 10.1016/j.bmc.2012.12.042; Zaccardi F, 2016, POSTGRAD MED J, V92, P63, DOI 10.1136/postgradmedj-2015-133281; Zarogoulidis P, 2015, J CANCER, V6, P9, DOI 10.7150/jca.10560; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhai JG, 2011, BEHAV BRAIN RES, V217, P363, DOI 10.1016/j.bbr.2010.11.004; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002; Zimmer Danna B, 2013, Methods Mol Biol, V963, P303, DOI 10.1007/978-1-62703-230-8_18; Zimmer DB, 1997, ENDOCRINOLOGY, V138, P5176, DOI 10.1210/en.138.12.5176	269	13	13	1	14	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2016	23	15					1571	1596		10.2174/0929867323666160406121117			26	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	DM6HK	WOS:000376451700005	27048377				2021-06-18	
J	D'Alessandro, A; Nemkov, T; Moore, HB; Moore, EE; Wither, M; Nydam, T; Slaughter, A; Silliman, CC; Banerjee, A; Hansen, KC				D'Alessandro, Angelo; Nemkov, Travis; Moore, Hunter B.; Moore, Ernest E.; Wither, Matthew; Nydam, Trevor; Slaughter, Annie; Silliman, Christopher C.; Banerjee, Anirban; Hansen, Kirk C.			Metabolomics of trauma-associated death: shared and fluid-specific features of human plasma vs lymph	BLOOD TRANSFUSION			English	Article						small molecule; mass spectrometry; correlation; quantitative changes; trauma	MESENTERIC LYMPH; LUNG INJURY; HYDROGEN-SULFIDE; SUCCINATE; ACID; METABOLISM	Background. Water-soluble components in mesenteric lymph have been implicated in the pathophysiology of acute lung injury and distal organ failure following trauma and haemorrhagic shock. Proteomics analyses have recently shown similarities and specificities of post-trauma/haemorrhagic shock lymph and plasma. We hypothesise that the metabolic phenotype of post-trauma/haemorrhagic shock mesenteric lymph and plasma share common metabolites, but are also characterised by unique features that differentiate these two fluids. Materials and methods. Matched samples were collected from 5 brain-dead organ donors who had suffered extreme trauma/haemorrhagic shock. Metabolomics analyses were performed through ultra-high performance liquid chromatography mass spectrometry. Results. Overall, 269 metabolites were identified in either fluid. Despite significant overlapping, metabolic phenotypes of matched lymph or plasma from the same patients could be used to discriminate sample fluid or biological patient/traumatic-injury origin. Metabolites showing relatively high levels in both fluids included markers of haemolysis and cell lysis secondary to tissue injury. Discussion. High positive correlations were observed between the quantitative levels of markers of systemic metabolic derangement following traumatic/haemorrhagic hypoxaemia, such as succinate, oxoproline, urate and fatty acids. These metabolites might contribute to coagulopathies of trauma and neutrophil priming driving acute lung injury. Future studies will investigate whether the observed compositional specificities mirror functional or pathological adaptations after trauma and haemorrhage.	[D'Alessandro, Angelo; Nemkov, Travis; Wither, Matthew; Hansen, Kirk C.] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Moore, Hunter B.; Moore, Ernest E.; Slaughter, Annie; Banerjee, Anirban] Univ Colorado Denver, Sch Med, Dept Surg, Aurora, CO USA; [Moore, Ernest E.; Nydam, Trevor] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Silliman, Christopher C.] Univ Colorado, Dept Paediat, 12801 East 17th Ave, Aurora, CO 80045 USA; [Silliman, Christopher C.] Bonfils Blood Ctr, Denver, CO USA	Hansen, KC (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 12801 East 17th Ave, Aurora, CO 80045 USA.	kirk.hansen@UCDenver.edu	D'Alessandro, Angelo/AAA-4695-2019	D'Alessandro, Angelo/0000-0002-2258-6490	National Institutes of Health, National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32-GM008315, P50-GM049222]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023015]; University of Colorado Comprehensive Cancer Center Core Support [P30 CA046934-17]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR023015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008315, P50GM049222] Funding Source: NIH RePORTER	This work was supported in part by grants from the National Institutes of Health, National Institute of General Medical Sciences grants: T32-GM008315 and P50-GM049222, National Center for Research Resources (Grant Number S10RR023015), and University of Colorado Comprehensive Cancer Center Core Support (P30 CA046934-17).	Aller MA, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-27; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Chinopoulos C, 2013, J NEUROSCI RES, V91, P1030, DOI 10.1002/jnr.23196; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clement CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009863; Cryer HG, 2014, J TRAUMA ACUTE CARE, V76, P592; CUTHBERTSON DP, 1982, SCOT MED J, V27, P158, DOI 10.1177/003693308202700210; D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975; D'Alessandro A, 2014, SHOCK, V42, P509, DOI 10.1097/SHK.0000000000000259; DAlessandro A, 2015, AM J PHYSL REGUL INT; de la Pena HC, 2000, ARCH MED RES, V31, P546, DOI 10.1016/S0188-4409(00)00238-1; Dzieciatkowska M, 2014, SHOCK, V42, P485, DOI 10.1097/SHK.0000000000000249; Hansen KC, 2015, INT IMMUNOL, V27, P219, DOI 10.1093/intimm/dxv012; Hasko G, 2006, CRIT CARE MED, V34, P1119, DOI 10.1097/01.CCM.0000206467.19509.C6; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Huang S, 2015, IJC HEART VASC, V7, P51, DOI 10.1016/j.ijcha.2015.01.010; Kinross J, 2009, CURR PHARM DESIGN, V15, P1537, DOI 10.2174/138161209788168119; Kinross JM, 2011, J PROTEOME RES, V10, P277, DOI 10.1021/pr1003278; Lee C, 2004, J TRAUMA, V57, P955, DOI 10.1097/01.ta.0000149495.44582.76; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Michel CC, 1997, EXP PHYSIOL, V82, P1; Mikhail J, 1999, AACN Clin Issues, V10, P85, DOI 10.1097/00044067-199902000-00008; Moore HB, 2014, J TRAUMA ACUTE CARE, V77, P811, DOI 10.1097/TA.0000000000000341; Morishita K, 2012, J TRAUMA ACUTE CARE, V72, P1541, DOI 10.1097/TA.0b013e318256df15; Nemkov T, 2015, AMINO ACIDS, V47, P2345, DOI 10.1007/s00726-015-2019-9; Peltz ED, 2015, J TRAUMA ACUTE CARE, V78, P742, DOI 10.1097/TA.0000000000000589; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Spath B, 2012, PLATELETS, V23, P60, DOI 10.3109/09537104.2011.590255; Synenki L, 2007, CRIT CARE MED, V35, P842, DOI 10.1097/01.CCM.0000257254.87984.69; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Whiteman M, 2009, J CELL MOL MED, V13, P488, DOI 10.1111/j.1582-4934.2009.00645.x; Zallen G, 1999, J SURG RES, V83, P83, DOI 10.1006/jsre.1999.5569; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4	36	13	13	0	8	SIMTI SERVIZI SRL	MILAN	VIA DESIDERIO 21, MILAN, 20131, ITALY	1723-2007			BLOOD TRANSFUS-ITALY	Blood Transf.		2016	14	3					185	194		10.2450/2016.0208-15			10	Hematology	Hematology	DP6PO	WOS:000378619800001	27177401				2021-06-18	
J	Dretsch, M; Bleiberg, J; Williams, K; Caban, J; Kelly, J; Grammer, G; DeGraba, T				Dretsch, Michael; Bleiberg, Joseph; Williams, Kathy; Caban, Jesus; Kelly, James; Grammer, Geoffrey; DeGraba, Thomas			Three Scoring Approaches to the Neurobehavioral Symptom Inventory for Measuring Clinical Change in Service Members Receiving Intensive Treatment for Combat-Related mTBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; neurobehavioral symptom inventory; postconcussive syndrome; neurorehabilitation; rehabilitation outcome assessment	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; SAMPLES	Objective: To examine the use of the Neurobehavioral Symptom Inventory to measure clinical changes over time in a population of US service members undergoing treatment of mild traumatic brain injury and comorbid psychological health conditions. Setting: A 4-week, 8-hour per day, intensive, outpatient, interdisciplinary, comprehensive treatment program at the National Intrepid Center of Excellence in Bethesda, Maryland. Participants: Three hundred fourteen active-duty service members being treated for combat-related comorbid mild traumatic brain injury and psychological health conditions. Design: Repeated-measures, retrospective analysis of a single-group using a pretest-posttest treatment design. Main Measures: Three Neurobehavioral Symptom Inventory scoring methods: (1) a total summated score, (2) the 3-factor method, and (3) the 4-factor method (with and without orphan items). Results: All 3 scoring methods yielded statistically significant within-subject changes between admission and discharge. The evaluation of effect sizes indicated that the 3 different Neurobehavioral Symptom Inventory scoring methods were comparable. Conclusion: Findings indicate that the different scoring methods all have potential for assessing clinical changes in symptoms for groups of patients undergoing treatment, with no clear advantage with any one method.	[Dretsch, Michael; Bleiberg, Joseph; Williams, Kathy; Caban, Jesus; Kelly, James; Grammer, Geoffrey; DeGraba, Thomas] Walter Reed Natl Mil Med Ctr, Dept Res, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA	Dretsch, M (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Res, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA.	Michael.n.dretsch.mil@mail.mil		Bleiberg, Joseph/0000-0003-0867-5494			[Anonymous], 2008, INVISIBLE WOUNDS WAR; [Anonymous], 2014, NEUR SYMPT INV NSI R; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	12	13	13	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					23	29		10.1097/HTR.0000000000000109			7	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000010	25699618				2021-06-18	
J	Eslami, M; Ghanbari, E; Sayyah, M; Etemadi, F; Choopani, S; Soleimani, M; Amiri, Z; Hadjighassem, M				Eslami, Mansoureh; Ghanbari, Elham; Sayyah, Mohammad; Etemadi, Fatemeh; Choopani, Samira; Soleimani, Mansoureh; Amiri, Zohreh; Hadjighassem, Mahmoudreza			Traumatic brain injury accelerates kindling epileptogenesis in rats	NEUROLOGICAL RESEARCH			English	Article						Controlled cortical impact; Epileptogenesis; Parieto-temporal cortex; PTZ kindling; Amygdala kindling	SEIZURES; DISEASE	Objectives: Traumatic brain injury (TBI) is a well-known cause of symptomatic epilepsy. In animal models of post-traumatic epilepsy (PTE), progression of trauma to epilepsy takes several weeks to months. Although this long process is similar to clinical PTE, it is costly and laborious. We used a combination of TBI and kindling as an accelerated animal model to develop epilepsy in much shorter period compared to that occurring in PTE. Methods: Traumatic brain injury was exerted to parieto-temporal cortex of anaesthetised rats by controlled cortical impact (CCI, 5 mm round tip, 4.5 mm/seconds velocity and 150 ms duration). Chemical kindling started 24 hours after CCI by intraperitoneal injection of 30 mg/kg pentylenetetrazole (PTZ) every other day until manifestation of three consecutive generalised seizures. Rapid electrical kindling of the amygdala began 1 week after TBI by exertion of 12 daily threshold stimuli (50 Hz mono-phasic square-wave stimulus of 1 ms per wave for 3 seconds) with 5 minutes interval between each stimulation until the rats became kindled. Results: Controlled cortical impact injury accelerated rate of both chemical and electrical kindling. Number of PTZ injections required for acquisition of generalised seizures decreased from 13.1 +/- 1.6 in sham-operated animals to 7.1 +/- 0.3 in traumatic rats (p < 0.05). The required number of stimuli to elicit electrically kindled focal and generalised seizures decreased from 24.0 +/- 3.9 and 80 +/- 6.5 in sham-operated animals to 6.6 +/- 0.9 and 53 +/- 6.5 in traumatic rats (p < 0.01), respectively. Limitations: Unlike the animal models of PTE in which recurrent seizures occur spontaneously after TBI, in our study, epilepsy is elicited by kindling stimulations. Discussion: Traumatic brain injury facilitates acquisition of epilepsy in both chemical and electrical kindling models. Combination of trauma and kindling can be considered as an inexpensive and time-saving animal model in PTE studies.	[Eslami, Mansoureh; Ghanbari, Elham; Sayyah, Mohammad; Etemadi, Fatemeh; Choopani, Samira] Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran; [Eslami, Mansoureh] Shaheed Beheshti Univ Med Sci, Paramed Fac, Dept Physiol, Tehran, Iran; [Eslami, Mansoureh] Sch Adv Technol Med, Dept Neurosci, Tehran, Iran; [Soleimani, Mansoureh] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Amiri, Zohreh] Shaheed Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Dept Basic Sci, Tehran, Iran; [Hadjighassem, Mahmoudreza] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci, Tehran, Iran	Sayyah, M (corresponding author), Pasteur Inst Iran, Dept Physiol & Pharmacol, Tehran, Iran.; Hadjighassem, M (corresponding author), Univ Tehran Med Sci, Sch Adv Technol Med, Dept Neurosci, Tehran, Iran.	sayyahm2@pasteur.ac.ir; mhaji63@yahoo.com	Sayyah, Mohammad/K-4871-2017; Hadjighassem, Mahmoudreza/AAD-8498-2019; Hadjighassem, Mahmoudreza/R-7811-2019	Sayyah, Mohammad/0000-0003-0603-2444; 	Pasteur institute of Iran [634]; Iran University of Medical Sciences [15734]	This work is supported by the Pasteur institute of Iran [grant number 634] and the Iran University of Medical Sciences [grant number 15734].	Ahmadi A, 2013, EXP BRAIN RES, V226, P107, DOI 10.1007/s00221-013-3415-6; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Evans RW, 2014, POSTTRAUMATIC SEIZUR; HAMM RJ, 1995, EXP NEUROL, V136, P143, DOI 10.1006/exnr.1995.1091; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Ko DY, POSTTRAUMATIC EPILEP; LOTHMAN EW, 1993, EPILEPSY RES, V14, P209, DOI 10.1016/0920-1211(93)90045-9; LOTHMAN EW, 1991, PROG NEUROBIOL, V37, P1, DOI 10.1016/0301-0082(91)90011-O; Pitkanen A, 2014, EPILEPSY BEHAV, V38, P19, DOI 10.1016/j.yebeh.2014.01.013; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Shandra AA, 2005, ADV BEHAV BIOL, V55, P49; Walker MC, 2002, BRAIN, V125, P1937, DOI 10.1093/brain/awf203; Zhang F., 2012, ANIM MODEL ACUTE NEU, V9, P93, DOI [10.1007/978-1-61779-782-8_9, DOI 10.1007/978-1-61779-782-8_9]	13	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	3					269	274		10.1179/1743132815Y.0000000086			6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	DM4SS	WOS:000376337600011	26315855				2021-06-18	
J	Hurtig, T; Ebeling, H; Jokelainen, J; Koivumaa-Honkanen, H; Taanila, A				Hurtig, Tuula; Ebeling, Hanna; Jokelainen, Jari; Koivumaa-Honkanen, Heli; Taanila, Anja			The Association Between Hospital-Treated Injuries and ADHD Symptoms in Childhood and Adolescence: A Follow-Up Study in the Northern Finland Birth Cohort 1986	JOURNAL OF ATTENTION DISORDERS			English	Article						ADHD symptoms/diagnosis; ADHD; injury; children; adolescents; epidemiological study; follow-up study	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY-DISORDER; TRAUMATIC BRAIN-INJURY; SCHOOL-AGE-CHILDREN; UNINTENTIONAL INJURY; INCREASED RISK; BEHAVIOR; COMORBIDITY; SEVERITY; VALIDITY	Objective: We examined the risk of hospital-treated injuries related to the symptoms/diagnosis of ADHD. Method: The study population (N = 6,111) was composed from the Northern Finland Birth Cohort 1986. At the age of 8, symptoms of hyperactivity and at the age of 15, symptoms of ADHD were assessed by the parents while the clinical diagnoses of ADHD were set in adolescence. Information on injuries was obtained from national register. Results: The risk for hospital-treated injuries during ages 0 to 7 was 1.7-fold increased among those with symptoms of hyperactivity assessed at age 8. Also, injuries during ages 7 to 15 years were more common among those with symptoms of ADHD at age 15 with respect to any injury, fractures, and intracranial injuries, and among those with the diagnosis of ADHD with respect to any injury. Conclusion: The present study shows an association between hospital-treated injuries and symptoms of ADHD in a large epidemiological sample of 0- to 15-year-old children.	[Hurtig, Tuula; Ebeling, Hanna; Jokelainen, Jari; Koivumaa-Honkanen, Heli; Taanila, Anja] Univ Oulu, Oulu 90014, Finland; [Hurtig, Tuula; Ebeling, Hanna; Taanila, Anja] Univ Hosp Oulu, Oulu, Finland; [Koivumaa-Honkanen, Heli] Univ Eastern Finland, Kuopio, Finland; [Koivumaa-Honkanen, Heli] Kuopio Univ Hosp, Kuopio, Finland; [Koivumaa-Honkanen, Heli] Lapland Hosp Dist, Rovaniemi, Finland; [Koivumaa-Honkanen, Heli] South Savonia Hosp Dist, Kuopio, Finland; [Koivumaa-Honkanen, Heli] North Karelia Cent Hosp, Joensuu, Finland	Hurtig, T (corresponding author), Univ Oulu, Inst Hlth Sci, POB 5000, Oulu 90014, Finland.	tuula.hurtig@oulu.fi	Koivumaa-Honkanen, Heli TJ/L-1274-2015	Jokelainen, Jari/0000-0003-4629-0560	Academy of FinlandAcademy of FinlandEuropean Commission; Emil Aaltonen Foundation; Paulo Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Academy of Finland (grants to T. Hurtig, PhD, and Professor A. Taanila), the Emil Aaltonen Foundation, and Paulo Foundation (grants to T. Hurtig, PhD) are acknowledged for their support.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1111/1469-7610.00424; Biederman J, 2002, J Atten Disord, V6 Suppl 1, pS7; Ebeling H, 2003, NORD J PSYCHIAT, V57, P345, DOI 10.1080/08039480310002679; Fritz KM, 2007, CURR OPIN PEDIATR, V19, P565, DOI 10.1097/MOP.0b013e3282ef498c; Garzon DL, 2008, ARCH PSYCHIAT NURS, V22, P288, DOI 10.1016/j.apnu.2007.12.006; Hay DA, 2007, BIOL PSYCHIAT, V61, P700, DOI 10.1016/j.biopsych.2006.04.040; Hoare P, 2003, EUR J EMERG MED, V10, P98, DOI 10.1097/01.mej.0000072631.17469.71; Hurtig T, 2007, EUR CHILD ADOLES PSY, V16, P362, DOI 10.1007/s00787-007-0607-2; Hurtig T, 2012, NORD J PSYCHIAT, V66, P320, DOI 10.3109/08039488.2011.644806; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kresanov K, 1998, EUR CHILD ADOLES PSY, V7, P85, DOI 10.1007/s007870050052; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Liisanantti JH, 2010, SUBST USE MISUSE, V45, P1340, DOI 10.3109/10826081003682859; Marcus SC, 2008, J ATTEN DISORD, V12, P64, DOI 10.1177/1087054707305168; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Maxson RT, 2009, J PEDIATR SURG, V44, P743, DOI 10.1016/j.jpedsurg.2008.08.003; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Pittsenbarger ZE, 2008, PEDIATR EMERG CARE, V24, P438, DOI 10.1097/PEC.0b013e31817de130; Polderman TJC, 2007, J CHILD PSYCHOL PSYC, V48, P1080, DOI 10.1111/j.1469-7610.2007.01783.x; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Rowe R, 2007, J CHILD PSYCHOL PSYC, V48, P71, DOI 10.1111/j.1469-7610.2006.01674.x; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Schwebel DC, 2006, J SAFETY RES, V37, P167, DOI 10.1016/j.jsr.2005.11.004; Smalley SL, 2007, J AM ACAD CHILD PSY, V46, P1575, DOI 10.1097/chi.0b013e3181573137; Swanson J, 2001, IDENTIFICATION EXTRE; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; VALENT F, 2004, ENV BURDEN DIS SERIE, V8; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	36	13	13	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	JAN	2016	20	1					3	10		10.1177/1087054713486699			8	Psychology, Developmental; Psychiatry	Psychology; Psychiatry	CZ6YZ	WOS:000367248400001	23665592				2021-06-18	
J	Iraji, A; Chen, HB; Wiseman, N; Zhang, T; Welch, R; O'Neil, B; Kulek, A; Ayaz, SI; Wang, X; Zuk, C; Haacke, EM; Liu, TM; Kou, ZF				Iraji, Armin; Chen, Hanbo; Wiseman, Natalie; Zhang, Tuo; Welch, Robert; O'Neil, Brian; Kulek, Andrew; Ayaz, Syed Imran; Wang, Xiao; Zuk, Conor; Haacke, E. Mark; Liu, Tianming; Kou, Zhifeng			Connectome-scale assessment of structural and functional connectivity in mild traumatic brain injury at the acute stage	NEUROIMAGE-CLINICAL			English	Article						Brain connectivity; Brain connectome; Magnetic resonance imaging; Neuroimaging; Traumatic brain injury	AMYLOID PRECURSOR PROTEIN; RESTING-STATE NETWORKS; WHITE-MATTER INJURY; WORKING-MEMORY; AXONAL DAMAGE; LOCALIZATION; INDIVIDUALS; DISRUPTION; ACTIVATION; HEMISPHERE	Mild traumatic brain injury (mTBI) accounts for over one million emergency visits each year in the United States. The large-scale structural and functional network connectivity changes of mTBI are still unknown. This study was designed to determine the connectome-scale brain network connectivity changes in mTBI at both structural and functional levels. 40 mTBI patients at the acute stage and 50 healthy controls were recruited. A novel approach called Dense Individualized and Common Connectivity-based Cortical Landmarks (DICCCOLs) was applied for connectome-scale analysis of both diffusion tensor imaging and resting state functional MRI data. Among 358 networks identified on DICCCOL analysis, 41 networks were identified as structurally discrepant between patient and control groups. The involved major white matter tracts include the corpus callosum, and superior and inferior longitudinal fasciculi. Functional connectivity analysis identified 60 connectomic signatures that differentiate patients from controls with 93.75% sensitivity and 100% specificity. Analysis of functional domains showed decreased intra-network connectivity within the emotion network and among emotion-cognition interactions, and increased interactions among action-emotion and action-cognition as well as within perception networks. This work suggests that mTBI may result in changes of structural and functional connectivity on a connectome scale at the acute stage. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.	[Iraji, Armin; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA; [Chen, Hanbo; Zhang, Tuo; Liu, Tianming] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA; [Wiseman, Natalie] Wayne State Univ, Dept Psychiat & Behav Neurosci, Detroit, MI 48207 USA; [Zhang, Tuo] Northwestern Polytech Univ, Sch Automat, Xian, Shaanxi, Peoples R China; [Welch, Robert; O'Neil, Brian; Kulek, Andrew; Ayaz, Syed Imran] Wayne State Univ, Dept Emergency Med, Detroit, MI USA; [Wang, Xiao; Zuk, Conor; Haacke, E. Mark; Kou, Zhifeng] Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA; [Wang, Xiao] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China	Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48201 USA.; Liu, TM (corresponding author), Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA.; Kou, ZF (corresponding author), Wayne State Univ, Dept Radiol, Detroit, MI 48201 USA.	tliu@cs.uga.edu; zhifeng_kou@wayne.edu		Wiseman, Natalie/0000-0003-0884-6425	International Society for Magnetic Resonance in Medicine; US Department of DefenseUnited States Department of Defense [W81XWH-11-1-0493]; National Institute of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090153]; Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F30HD084144]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F30HD084144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090153] Funding Source: NIH RePORTER	The authors would like to thank the following co-workers for their contribution: Mr. Zahid Latif, Mr. Yang Xuan andMr. Yashwanth Katkuri from Wayne State University MR Research Facility (MRRF) for their help of data acquisition; Ms. Anamika Chaudhary and Ms. Judith Farah from MRRF for their coordination; Detroit Receiving Hospital Emergency Medicine research team for subject screening and recruitment; and other colleagues in the Cortical Architecture Imaging and Discovery Laboratory in the University of Georgia for their assistance in image analysis. This work was supported by a Seed Grant from the International Society for Magnetic Resonance in Medicine (PI: Zhifeng Kou) and a research grant from the US Department of Defense (award number W81XWH-11-1-0493). Research reported in this publication was also partially supported by the National Institute of Neurological Disorders And Stroke of the National Institutes of Health under Award Number R21NS090153 and the Eunice Kennedy Shriver National Institute of Child Health and Human Development under Award Number F30HD084144. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blumbergs P. C., 1997, HEAD INJURY PATHOPHY, P39; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P1265, DOI 10.1002/hbm.20463; CDC, 2003, REP C MILD TRAUM BRA; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chen HB, 2015, LECT NOTES COMPUT SC, V9350, P194, DOI 10.1007/978-3-319-24571-3_24; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Iraji A, 2016, NEUROIMAGE, V134, P494, DOI 10.1016/j.neuroimage.2016.04.006; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI DOI 10.1097/00001199-199309000-00009; Kay T., 1993, J HEAD TRAUMA REHABI, V8, P86, DOI [10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kou ZF, 2014, NEURAL REGEN RES, V9, P693, DOI 10.4103/1673-5374.131568; Kou ZF, 2012, RSC DRUG DISCOV, V24, P19, DOI 10.1039/9781849734745-00019; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Li K., 2010, ADV NEURAL INFORM PR, P1369; Li KM, 2013, HUM BRAIN MAPP, V34, P2494, DOI 10.1002/hbm.22082; Li KM, 2012, NEUROINFORMATICS, V10, P225, DOI 10.1007/s12021-012-9142-5; Li KM, 2010, I S BIOMED IMAGING, P656, DOI 10.1109/ISBI.2010.5490089; Liu TM, 2008, NEUROIMAGE, V40, P991, DOI 10.1016/j.neuroimage.2007.12.027; Liu TM, 2007, NEUROIMAGE, V38, P114, DOI 10.1016/j.neuroimage.2007.07.002; Liu TM, 2011, BRAIN IMAGING BEHAV, V5, P189, DOI 10.1007/s11682-011-9123-6; Mayer AR, 2015, J NEUROTRAUM, V32, P1046, DOI 10.1089/neu.2014.3542; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Morgan AT, 2013, BRAIN, V136, P646, DOI 10.1093/brain/aws355; National Academy of Neuropsychology, 2002, MILD TRAUM BRAIN INJ; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Pelleg D., 2000, P 17 INT C MACHINE L, P727, DOI DOI 10.1007/3-540-44491-2_3; Penny D.W., 2011, STAT PARAMETRIC MAPP; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Sharp David J, 2015, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tivarus ME, 2012, BRAIN LANG, V123, P1, DOI 10.1016/j.bandl.2012.06.006; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yuan YX, 2013, NEUROINFORMATICS, V11, P47, DOI 10.1007/s12021-012-9165-y; Zhang T, 2012, CEREB CORTEX, V22, P854, DOI 10.1093/cercor/bhr152; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DJ, 2014, HUM BRAIN MAPP, V35, P2911, DOI 10.1002/hbm.22373; Zhu DJ, 2013, CEREB CORTEX, V23, P786, DOI 10.1093/cercor/bhs072; Zhu DJ, 2011, LECT NOTES COMPUT SC, V6801, P97, DOI 10.1007/978-3-642-22092-0_9; Zhu DJ, 2012, NEUROIMAGE, V59, P1382, DOI 10.1016/j.neuroimage.2011.08.037; Zoroya G., 2007, US TODAY	70	13	14	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	12						100	115		10.1016/j.nicl.2016.06.012			16	Neuroimaging	Neurosciences & Neurology	EF3AI	WOS:000390196400013	27408795	DOAJ Gold, Green Published			2021-06-18	
J	Knox, L; Douglas, JM; Bigby, C				Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine			Becoming a decision-making supporter for someone with acquired cognitive disability following traumatic brain injury	RESEARCH AND PRACTICE IN INTELLECTUAL AND DEVELOPMENTAL DISABILITIES			English	Article						Decision-making; supported decision-making; brain injury; qualitative	INDIVIDUALS; PARTNERS; AUTONOMY; TBI	Despite an increased awareness of society's obligation to ensure that people with cognitive disabilities have access to decision-making support, little is known about how this support should be provided. For people with traumatic brain injury, informal support mechanisms may provide the primary means of support but there is limited understanding of how this aids participation. As part of a larger project using constructivist grounded theory to explore processes used by adults with severe traumatic brain injury in making decisions after injury, the authors explored a single-case study, presented in this article. In particular, the study aimed to build an understanding of the evolution of decision-making support over time from multiple perspectives. Data consisted of seven in-depth, individual interviews with three participants: the central participant, Beau, and two participants whom he nominated as his decision-making supporters. Analysis of the data revealed several key themes relating to both the nature of the decision-making process and the factors that underpinned decision-making support. Relational factors included: (a) knowing who I am and what I value; (b) understanding the nature of the relationship; and (c) working with each other. Process factors included: (a) sharing a vision; (b) adjusting process to decisional circumstances; and (c) developing a supportive network. Findings emphasised that knowing the person well and sharing a focus on maximising autonomy contributed to positive decision-making support. However, the data also highlight potential challenges associated with the role of decision-making supporter and the importance of support for those who take on this role.	[Knox, Lucy; Douglas, Jacinta M.] La Trobe Univ, Dept Community & Allied Hlth, Melbourne, Vic, Australia; [Knox, Lucy; Douglas, Jacinta M.; Bigby, Christine] La Trobe Univ, Living Disabil Res Ctr, Melbourne, Vic, Australia; [Douglas, Jacinta M.] Summer Fdn, Box Hill, Vic, Australia	Knox, L (corresponding author), La Trobe Univ, Dept Community & Allied Hlth, Melbourne, Vic, Australia.; Knox, L (corresponding author), La Trobe Univ, Living Disabil Res Ctr, Melbourne, Vic, Australia.	L.Knox@latrobe.edu.au	; Bigby, Christine/I-8526-2015	Knox, Lucy/0000-0001-8331-6032; Bigby, Christine/0000-0001-7001-8976	university postgraduate scholarship; Victorian Brain Injury Recovery Association; East Kew Branch of the Community Bendigo Bank Research Scholarship	Sincere thanks are extended to the participants in this research, who generously shared their experiences. This research was supported by a university postgraduate scholarship and Victorian Brain Injury Recovery Association and East Kew Branch of the Community Bendigo Bank Research Scholarship awarded to the first author.	Australian Institute of Health and Welfare, 2007, DIS AUSTR ACQ BRAIN; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Browning M, 2014, RES PRACT INTELLECT, V1, P34, DOI 10.1080/23297018.2014.902726; Carney T, 2014, RES PRACT INTELLECT, V1, P46, DOI 10.1080/23297018.2014.902727; Charmaz K., 2014, CONSTRUCTING GROUNDE; Charmaz Kathy, 2008, HDB CONSTRUCTIONIST, V1, P397, DOI DOI 10.1016/J.DESTUD.2004.08.003; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corbin J, 2003, QUAL INQ, V9, P335, DOI 10.1177/1077800403009003001; Dey I., 1999, GROUNDING GROUNDED T; DOUGLAS J, 2004, EVIDENCE BASED PRACT; Fellows LK, 2012, J INT NEUROPSYCH SOC, V18, P937, DOI 10.1017/S1355617712001294; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hunt MR, 2011, DISABIL REHABIL, V33, P961, DOI 10.3109/09638288.2010.515703; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jumisko Eija, 2005, J Neurosci Nurs, V37, P42; Kennedy TJT, 2006, MED EDUC, V40, P101, DOI 10.1111/j.1365-2929.2005.02378.x; Knox L, 2016, NEUROPSYCHOL REHABIL, V26, P236, DOI 10.1080/09602011.2015.1019519; Knox L, 2015, BRAIN INJURY, V29, P745, DOI 10.3109/02699052.2015.1004753; Knox L, 2013, DISABIL REHABIL, V35, P1926, DOI 10.3109/09638288.2013.766270; Kohn NA, 2014, DISABIL HEALTH J, V7, pS40, DOI 10.1016/j.dhjo.2013.03.005; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; National Institute of Neurological Disorders and Stroke, 2011, NINDS TRAUM BRAIN IN; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; QSR International Pty Ltd, 2010, NVIVO QUAL DAT AN SO; Schipper K, 2011, NURS ETHICS, V18, P526, DOI 10.1177/0969733011403554; SLOAN S, 2007, BRAIN IMPAIR, V8, P251, DOI DOI 10.1375/BRIM.8.3.251; United Nations General Assembly, 2007, CONV RIGHTS PERS DIS	28	13	13	0	2	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2329-7018	2329-7026		RES PRACT INTELLECT	Res. Pract. Intellect. Dev. Disabil.		2016	3	1					12	21		10.1080/23297018.2015.1077341			10	Rehabilitation	Rehabilitation	FF1TE	WOS:000408681000003					2021-06-18	
J	Lei, BL; Wang, HC; Jeong, ST; Hsieh, JT; Majeed, M; Dawson, H; Sheng, HX; Warner, DS; James, ML				Lei, Beilei; Wang, Haichen; Jeong, Seongtae; Hsieh, Justin T.; Majeed, Mohammed; Dawson, Hana; Sheng, Huaxin; Warner, David S.; James, Michael L.			Progesterone Improves Neurobehavioral Outcome in Models of Intracerebral Hemorrhage	NEUROENDOCRINOLOGY			English	Article						Progesterone; Sex differences; Intracerebral hemorrhage; Neurobehavior; Recovery; Murine model; Collagenase; Autologous blood; Aged mice	TRAUMATIC BRAIN-INJURY; RAT; STROKE; ESTROGEN; EDEMA; TRIAL; NEUROPROTECTION; EXPRESSION; HEMATOMAS; MICROGLIA	In models of acute brain injury, progesterone improves recovery through several mechanisms including modulation of neuroinflammation. Secondary injury from neuroinflammation is a potential therapeutic target after intracerebral hemorrhage (ICH). For potential translation of progesterone as a clinical acute ICH therapeutic, the present study sought to define efficacy of exogenous progesterone administration in ICH-relevant experimental paradigms. Young and aged C57BL/6 male, female, and ovariectomized (OVX) mice underwent left intrastriatal collagenase (0.05-0.075 U) or autologous whole blood (35 mu I) injection. Progesterone at varying doses (4-16 mg/kg) was administered at 2, 5, 24, 48, and 72 h after injury. Rotarod and Morris water maze latencies were measured on days 1-7 and days 28-31 after injury, respectively. Hematoma volume, brain water content (cerebral edema), complementary immunohistochemistry, multiplex cytokine arrays, and inflammatory proteins were as-sessed at prespecified time points after injury. Progesterone (4 mg/kg) administration improved rotarod and water maze latencies (p < 0.01), and decreased cerebral edema (p < 0.05), microglial proliferation, and neuronal loss (p < 0.01) in young and aged male, young OVX, and aged female mice. Brain concentration of proinflammatory cytokines and Toll-like receptor-associated proteins were also decreased after progesterone (4 mg/kg) treatment (p < 0.01). Progesterone treated young female mice showed no detectable effects. Exogenous progesterone improved short- and long-term neurobehavioral recovery and modulated neuroinflammation in male and OVX mice after ICH. Future studies should validate these findings, and address timing and length of administration before translation to clinical trial. (C) 2015 S. Karger AG, Basel	[Lei, Beilei; Wang, Haichen; Jeong, Seongtae; Hsieh, Justin T.; Majeed, Mohammed; Sheng, Huaxin; Warner, David S.; James, Michael L.] Duke Univ, Multidisciplinary Neuroprotect Labs, Durham, NC USA; [Lei, Beilei; Sheng, Huaxin; Warner, David S.; James, Michael L.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Wang, Haichen; Dawson, Hana; James, Michael L.] Duke Univ, Dept Neurol, Durham, NC USA; [Jeong, Seongtae; Warner, David S.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Hsieh, Justin T.] Chonnam Natl Univ, Sch Med, Dept Anesthesiol & Pain Med, Gwanju, South Korea; [Hsieh, Justin T.] Duke Natl Univ Singapore, Singapore, Singapore	James, ML (corresponding author), DUMC 3094, Durham, NC 27710 USA.	michael.james@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210; Hsieh, Justin/0000-0002-9701-0998			Appelboom G, 2015, NEUROL RES, V37, P657, DOI 10.1179/1743132815Y.0000000047; Atif F, 2011, MOL MED, V17, P1084, DOI 10.2119/molmed.2010.00255; Baudry M, 2013, NEUROSCIENCE, V239, P280, DOI 10.1016/j.neuroscience.2012.10.051; Caligioni Claudia S, 2009, Curr Protoc Neurosci, VAppendix 4, p4I, DOI 10.1002/0471142301.nsa04is48; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen G, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93431; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chen Z, 2011, ACTA NEUROCHIR SUPPL, V111, P289, DOI 10.1007/978-3-7091-0693-8_48; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Deinsberger W, 1998, NEUROL RES, V20, P349, DOI 10.1080/01616412.1998.11740530; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Ganti L, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/219097; Gokhale S, 2015, STROKE, V46, P886, DOI 10.1161/STROKEAHA.114.007682; Grossman KJ, 2004, BRAIN RES, V1008, P29, DOI 10.1016/j.brainres.2004.02.022; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Habib P, 2013, J STEROID BIOCHEM, V138, P195, DOI 10.1016/j.jsbmb.2013.06.003; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Harrison DE, 2012, LIFESPAN BIOMARKER; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Hwang-Levine J, 2011, NEUROCHEM RES, V36, P1870, DOI 10.1007/s11064-011-0508-0; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; James ML, 2008, NEUROCRIT CARE, V9, P139, DOI 10.1007/s12028-007-9030-2; Jiang C, 2011, INT IMMUNOPHARMACOL, V11, P1925, DOI 10.1016/j.intimp.2011.08.001; Lapchak PA, 2013, TRANSL STROKE RES, V4, P279, DOI 10.1007/s12975-012-0209-2; Lee HY, 2010, STROKE, V41, P739, DOI 10.1161/STROKEAHA.109.573543; Lei BL, 2014, JOVE-J VIS EXP, DOI 10.3791/51439; Lei BL, 2012, TRANSL STROKE RES, V3, pS94, DOI 10.1007/s12975-012-0176-7; Manwani B, 2015, J CEREBR BLOOD F MET, V35, P221, DOI 10.1038/jcbfm.2014.186; Mayer SA, 2008, NEW ENGL J MED, V358, P2127, DOI 10.1056/NEJMoa0707534; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mirza MA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0251-6; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mracsko E, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00388; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P218; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Schwamm LH, 2014, NEW ENGL J MED, V371, P2522, DOI 10.1056/NEJMe1412951; Sheng SP, 2012, ANESTHESIOLOGY, V117, P1262, DOI 10.1097/ALN.0b013e3182746b81; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Soderpalm AHV, 2004, PSYCHONEUROENDOCRINO, V29, P339, DOI 10.1016/S0306-4530(03)00033-7; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Umeano O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081664; Wang Z, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/848309; Warner DS, 2014, JAMA NEUROL, V71, P1311, DOI 10.1001/jamaneurol.2014.1238; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Wood GA, 2007, REPRODUCTION, V133, P1035, DOI 10.1530/REP-06-0302; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yang J, 2015, STROKE, V46, P1009, DOI 10.1161/STROKEAHA.114.007154	50	13	13	0	2	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0028-3835	1423-0194		NEUROENDOCRINOLOGY	Neuroendocrinology		2016	103	6					665	677		10.1159/000442204			13	Endocrinology & Metabolism; Neurosciences	Endocrinology & Metabolism; Neurosciences & Neurology	DX6TV	WOS:000384516900004	26562172				2021-06-18	
J	Lin, YC; Xu, DZ; Li, XH; Liu, C; Liu, X; Huang, S; Huang, YW; Liu, XJ				Lin, Yuchang; Xu, Dezhi; Li, Xiaohong; Liu, Chun; Liu, Xia; Huang, Shen; Huang, Yuwei; Liu, Xiaojuan			Upregulation of Interferon Regulatory Factor 6 Promotes Neuronal Apoptosis After Traumatic Brain Injury in Adult Rats	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						IRF6; Traumatic brain injury; Neuronal apoptosis; Rat	FACTOR-I; TRANSCRIPTION FACTORS; CASPASE-3 ACTIVATION; REPERFUSION INJURY; ISCHEMIC-STROKE; IRF FAMILY; CELLS; ONCOGENESIS; OVEREXPRESSION; MECHANISMS	The interferon regulatory factor (IRF) family was first discovered as a set of transcriptional regulators of the type I interferon system in 1988. In mammals, the IRF family includes nine members that play important roles in the immune system, oncogenesis, and apoptosis. However, the distribution and the function of IRF6 in the central nervous system are limited. In this study, we established an adult rat traumatic brain injury (TBI) model. Compared to the sham brain cortex, Western blot and immunohistochemistry showed significant upregulation of IRF6 in the ipsilateral brain cortex after TBI. Immunofluorescence double-labeling showed that IRF6 completely co-localized with neurons, not astrocytes or oligodendrocytes. Furthermore, we detected that the neuronal apoptosis marker active caspase-3 co-localized with IRF6 in neurons. Additionally, IRF6 knockdown in PC12 cells in vitro resulted in a decrease in active caspase-3 expression and an increase in Bcl-2 and p-Akt expression. We conclude that IRF6 might promote neuronal apoptosis by inhibiting Akt phosphorylation after TBI.	[Lin, Yuchang; Xu, Dezhi] Nanjing Med Univ, Wuxi Hosp 2, Dept Neurosurg, Wuxi 214002, Jiangsu, Peoples R China; [Li, Xiaohong] Nantong Univ, Affiliated Hosp, Surg Comprehens Lab, Nantong 226001, Jiangsu, Peoples R China; [Liu, Chun] Nantong Univ, Lab Anim Ctr, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xia] Nantong Univ, Dept Pathophysiol, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Huang, Shen] Nantong Univ, Affiliated Hosp 2, Dept Osteol, Nantong 226001, Peoples R China; [Huang, Yuwei] Nantong Univ, Inst Nav Med, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xiaojuan] Nantong Univ, Dept Pathogen Biol, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Lin, Yuchang; Xu, Dezhi; Li, Xiaohong; Liu, Chun; Liu, Xia; Huang, Shen; Huang, Yuwei; Liu, Xiaojuan] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China	Liu, XJ (corresponding author), Nantong Univ, Dept Pathogen Biol, Coll Med, Nantong 226001, Jiangsu, Peoples R China.	prof_lxj@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401365, 81373223, 81200918, 81172879, 31200800]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by the National Natural Science Foundation of China (Nos. 81401365, 81373223, 81200918, 81172879 and 31200800) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alexander M, 2003, ACTA NEUROPATHOL, V105, P420, DOI 10.1007/s00401-002-0658-x; Banerjee S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003314; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Chen FF, 2013, ONCOL LETT, V5, P417, DOI 10.3892/ol.2012.1051; Chen WJ, 2010, CELL SIGNAL, V22, P883, DOI 10.1016/j.cellsig.2009.12.005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Hafeez A, 2014, AGING DIS, V5, P366, DOI 10.14336/AD.2014.0500366; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Jia D, 2014, INT J BIOL MACROMOL, V63, P177, DOI 10.1016/j.ijbiomac.2013.10.034; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Lallemand C, 2007, ONCOGENE, V26, P328, DOI 10.1038/sj.onc.1209795; Melis MHM, 2013, CELL DEATH DIFFER, V20, P765, DOI 10.1038/cdd.2013.8; Minones-Suarez L, 2012, PEDIATR DERMATOL, V29, P768, DOI 10.1111/j.1525-1470.2011.01575.x; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.153; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiang M, 2014, J NEUROCHEM, V129, P988, DOI 10.1111/jnc.12682; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475; Yu S, 2012, J CELL BIOCHEM, V113, P2671; Yun N, 2014, J BIOL CHEM, V289, P22183, DOI 10.1074/jbc.M114.552679; Zhang S, 2014, FASEB J, V28, P4394, DOI 10.1096/fj.14-253625; Zhang X, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-147; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Zhuang SG, 1999, EXP CELL RES, V250, P203, DOI 10.1006/excr.1999.4501; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	39	13	14	1	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JAN	2016	36	1					27	36		10.1007/s10571-015-0217-3			10	Cell Biology; Neurosciences	Cell Biology; Neurosciences & Neurology	DA3KF	WOS:000367694900003	26077898				2021-06-18	
J	Manzano, S; Holzinger, IB; Kellenberger, CJ; Lacroix, L; Klima-Lange, D; Hersberger, M; La Scala, G; Altermatt, S; Staubli, G				Manzano, Sergio; Holzinger, Iris Bachmann; Kellenberger, Christian J.; Lacroix, Laurence; Klima-Lange, Dagmar; Hersberger, Martin; La Scala, Giorgio; Altermatt, Stefan; Staubli, Georg			Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma	EMERGENCY MEDICINE JOURNAL			English	Article							COMPUTED-TOMOGRAPHY; UNITED-STATES; DECISION RULE; BRAIN-INJURY; CT; PREDICT; RISK; CHILDHOOD; SCANS	Objective To assess the accuracy of S001B serum level to detect intracranial injury in children with mild traumatic brain injury. Methods A multicenter prospective cohort study was carried out in the paediatric emergency departments of three tertiary hospitals in Switzerland between January 2009 and December 2011. Participants included children aged <16 years with a mild traumatic brain injury (GCS >= 13) for whom a head CT was requested by the attending physician. Venous blood was obtained within 6 h of the trauma in all children for S100B measurement before a head CT was performed. As the S100B value was not available during the acute care period, the patient's management was not altered. The main measures were protein S100B value and the CT result. Results 20/73 (27.4%) included children had an intracranial injury detected on CT. S100B receiver operating characteristics area under the curve was 0.73 (95% CI 0.60 to 0.86). With a 0.14 mu g/L cut-off point, S100B reached an excellent sensitivity of 95% (95% Cl 77% to 100%) and 100% (95% CI 81% to 100%) in all children and in children aged >2 years, respectively. The specificity, however, was 34% (95% CI 27% to 36%) and 37% (95% CI 30% to 37%), respectively. Conclusions S100B has an excellent sensitivity but poor specificity. It is therefore an accurate tool to help rule out an intracranial injury but cannot be used as the sole marker owing to its specificity. Used with clinical decision rules, S100B may help to reduce the number of unnecessary CT scans.	[Manzano, Sergio; Lacroix, Laurence] Univ Hosp Geneva, Pediat Emergency Dept, CH-1211 Geneva, Switzerland; [Holzinger, Iris Bachmann; Staubli, Georg] Univ Childrens Hosp, Pediat Emergency Dept, Zurich, Switzerland; [Holzinger, Iris Bachmann] Univ Childrens Hosp, Dept Diagnost Imaging, Zurich, Switzerland; [Klima-Lange, Dagmar] Ostschweizer Childrens Hosp, Dept Pediat Surg, St Gallen, Switzerland; [Hersberger, Martin] Univ Childrens Hosp, Div Clin Chem & Biochem, Zurich, Switzerland; [La Scala, Giorgio] Univ Hosp Geneva, Dept Pediat Surg, CH-1211 Geneva, Switzerland; [Altermatt, Stefan] Univ Childrens Hosp, Dept Pediat Surg, Geneva, Switzerland	Manzano, S (corresponding author), Univ Hosp Geneva, Pediat Emergency Dept, 6 Rue Willy Donze, CH-1211 Geneva, Switzerland.	sergio.manzano@hcuge.ch	La Scala, Giorgio/AAM-8031-2020; Manzano, Sergio/ABG-6281-2020	La Scala, Giorgio/0000-0003-1572-598X; Manzano, Sergio/0000-0001-9603-5520; Hersberger, Martin/0000-0002-4472-329X; Kellenberger, Christian/0000-0001-9122-2431; Lacroix, Laurence/0000-0002-6636-3344			Astrand R, 2011, CLIN CHIM ACTA, V412, P2190, DOI 10.1016/j.cca.2011.08.009; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger RP, 2002, J NEUROTRAUM, V19, P1405, DOI 10.1089/089771502320914633; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bouvier D, 2011, CLIN BIOCHEM, V44, P927, DOI 10.1016/j.clinbiochem.2011.05.004; Castellani C, 2009, ACTA PAEDIATR, V98, P1607, DOI 10.1111/j.1651-2227.2009.01423.x; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Filippidis AS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10185; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Hallen M, 2010, J TRAUMA, V69, P284, DOI 10.1097/TA.0b013e3181ca060b; Ingebrigtsen T, 1999, NEUROSURGERY, V45, P468, DOI 10.1097/00006123-199909000-00010; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kotlyar S, 2011, J EMERG MED, V41, P285, DOI 10.1016/j.jemermed.2010.05.040; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Leidel BA, 2012, UNFALLCHIRURG, V115, P903, DOI 10.1007/s00113-010-1946-x; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Muller B, 2011, EMERG MED J, V28, P938, DOI 10.1136/emj.2010.095372; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	34	13	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	JAN	2016	33	1					42	46		10.1136/emermed-2014-204513			5	Emergency Medicine	Emergency Medicine	DA0BP	WOS:000367462000010	26283067	Bronze			2021-06-18	
J	Mao, X; Miao, GZ; Tao, XG; Hao, SY; Zhang, H; Li, H; Hou, ZG; Tian, RF; Lu, T; Ma, J; Zhang, XD; Cheng, HW; Liu, BY				Mao, Xiang; Miao, Guozhuan; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Ma, Jun; Zhang, Xiaodong; Cheng, Hongwei; Liu, Baiyun			Saikosaponin a protects TBI rats after controlled cortical impact and the underlying mechanism	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						Saikosaponin a; controlled cortical impact; neuroprotection; inflammation; mitogen-activated protein kinase	NERVOUS-SYSTEM INJURIES; TRAUMATIC BRAIN-INJURY; RAW 264.7 CELLS; INFLAMMATION; PATHWAY; MAPK; LPS; ACTIVATION; DEFICITS; STROKE	The inflammatory response plays a significant role in neuronal cell death and functional deficits after Traumatic brain injury (TBI). Importantly, anti-inflammatory agents have neuroprotective effects. To date, however, no studies have investigated the neuroprotective effects of Saikosaponin a (SSa) after TBI. In the present study, rats with controlled cortical impact (CCI) were used to investigate the neuroprotective effects of SSa. The results showed that SSa reduced body weight loss, improved neurological functions andcognition, and reduced brain edema and blood brain barrier permeability after CCI. Moreover, SSa inhibited aquaporin-4 (AQP-4), matrix metalloprotein-9 (MMP-9), mitogen-activated protein kinase (MAPK), c-Jun N-terminal kinase (c-JNK), tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The reduction in the loss of occludin mediated by SSa may partially account for its neuroprotective effects. Together, our results suggest that SSa appears to counteract the inflammatory response and neurological function deficits after TBI and possibly via an anti-inflammatory response and inhibition of the MAPK signaling pathway.	[Mao, Xiang; Zhang, Hao; Zhang, Xiaodong; Cheng, Hongwei] Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Anhui, Peoples R China; [Mao, Xiang; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China; [Miao, Guozhuan; Zhang, Hao; Liu, Baiyun] Gen Hosp Armed Police Forces, Dept Neurotrauma, Beijing, Peoples R China; [Tao, Xiaogang; Hao, Shuyu; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Mao, Xiang; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] Beijing Inst Brain Disorders, Nerve Injury & Repair Ctr, Beijing, Peoples R China; [Mao, Xiang; Tao, Xiaogang; Hao, Shuyu; Zhang, Hao; Li, Huan; Hou, Zonggang; Tian, Runfa; Lu, Te; Liu, Baiyun] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Ma, Jun] Capital Med Univ, Beijing Tian Tan Hosp, Imaging Ctr Neurosci, Beijing, Peoples R China	Cheng, HW (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Neurosurg, Hefei, Anhui, Peoples R China.; Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Neurotrauma Lab, Beijing, Peoples R China.	chenghongweiamu@126.com; liubaiyun1212@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171144, 81471238, 81341059, 81371610]; Beijing Nova programBeijing Municipal Science & Technology Commission [2012033]; National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2013BAI09B03]	The authors report no conflict of interests related to this study or the findings specified in this paper. This study was supported by National Natural Science Foundation of China (No. 81171144, No. 81471238, No. 81341059, No. 81371610), Beijing Nova program (No. 2012033) and National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03).	Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JC, 2003, AM J CHINESE MED, V31, P363, DOI 10.1142/S0192415X03001065; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Fan WH, 2011, CHINESE J EXPT TRADI, V17, P181; KUMAZAWA Y, 1990, INT J IMMUNOPHARMACO, V12, P531, DOI 10.1016/0192-0561(90)90117-6; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Li Chang-zheng, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P839; Li ZY, 2014, PROG NEURO-PSYCHOPH, V53, P80, DOI 10.1016/j.pnpbp.2014.02.010; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Liu KH, 2005, FREE RADICAL BIO MED, V39, P71, DOI 10.1016/j.freeadbiomed.2005.03.033; Lu CN, 2012, INT IMMUNOPHARMACOL, V14, P121, DOI 10.1016/j.intimp.2012.06.010; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mao X, 2015, BRAIN INJURY, V29, P86, DOI 10.3109/02699052.2014.968621; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Noble LJ, 2002, J NEUROSCI, V22, P7526; QIAN L, 1995, PATHOL INT, V45, P207, DOI 10.1111/j.1440-1827.1995.tb03444.x; Shao JX, 2013, J NEUROIMMUNOL, V254, P83, DOI 10.1016/j.jneuroim.2012.09.012; Sharma S, 2006, EUR J PHARMACOL, V536, P256, DOI 10.1016/j.ejphar.2006.03.006; Shyu KG, 2004, LIFE SCI, V76, P813, DOI 10.1016/j.lfs.2004.10.003; Wang ZQ, 2012, J ETHNOPHARMACOL, V144, P145, DOI 10.1016/j.jep.2012.08.041; Yu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050694; Zeuthen T, 1997, BIOL CELL, V89, P307, DOI 10.1016/S0248-4900(97)83383-7; Zhu J, 2013, EXP THER MED, V5, P1345, DOI 10.3892/etm.2013.988	28	13	17	0	2	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2016	8	1					133	141					9	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	DE1EN	WOS:000370369600013	27069547				2021-06-18	
J	McKinlay, A; Linden, M; DePompei, R; Jonsson, CA; Anderson, V; Braga, L; Castelli, E; de Koning, P; Hawley, CA; Hermans, E; Kristiansen, I; Madden, A; Rumney, P; Savage, R; Wicks, B				McKinlay, Audrey; Linden, Mark; DePompei, Roberta; Jonsson, Catherine Aaro; Anderson, Vicki; Braga, Lucia; Castelli, Enrico; de Koning, Peter; Hawley, Carol A.; Hermans, Eric; Kristiansen, Ingela; Madden, Alison; Rumney, Peter; Savage, Ron; Wicks, Beth			Service provision for children and young people with acquired brain injury: Practice recommendations	BRAIN INJURY			English	Article						Rehabilitation; paediatric; recovery; education; neurotrauma	REPORTED PROBLEMS; RUGBY PLAYERS; MILD; SCHOOL; CHILDHOOD; NEEDS; TBI; ADOLESCENTS; TERM; REHABILITATION	Background: Providing appropriate rehabilitation services for Acquired Brain Injury (ABI) in childhood presents a number of challenges for caregivers, health and education professionals and the young person as they develop. Primary objective: To record the challenges and possible creative solutions generated by an international group of professionals to address the needs of children with ABI. Review of information: Recommendations were generated from children's special interest group meetings of the International Brain Injury Association (Turin, Italy, 2001; Stockholm, Sweden, 2003; Melbourne, Australia, 2005; Lisbon, Portugal, 2008) and through meetings of the International Paediatric Brain Injury Society (IPBIS), formed in 2009. Delegates participating in the workshops were representative of nations from around the world and included The Netherlands, New Zealand, Australia, the UK, Finland, Germany, South Africa, the US, Canada, Sweden, Brazil and Italy. Outcomes: The information presented is based on a retrospective review of those meetings and the summaries of the topics considered.	[McKinlay, Audrey] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Linden, Mark] Queens Univ Belfast, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland; [DePompei, Roberta] Univ Akron, Sch Speech & Language Pathol, Akron, OH 44325 USA; [Jonsson, Catherine Aaro] Ostersunds Hosp, Child & Youth Rehabil, Ostersund, Sweden; [Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Braga, Lucia] Rede Sarah Hosp Reabil, Salvador, BA, Brazil; [Castelli, Enrico] Osped Pediat Bambino Gesu, Rome, Italy; [de Koning, Peter] Heliomare Rehabil Ctr, Wijk Aan Zee, Netherlands; [Hawley, Carol A.] Univ Warwick, Fac Med, Coventry, W Midlands, England; [Hermans, Eric] Brain Project, Sittard, Netherlands; [Kristiansen, Ingela] Univ Uppsala Hosp, Dept Pediat Neurol, Uppsala, Sweden; [Madden, Alison] Goukam Hlth, Riversdale, South Africa; [Rumney, Peter] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada; [Savage, Ron] Sarah Jane Brain Fdn, New York, NY USA; [Wicks, Beth] Beth Wicks Consultancy, Nottingham, England	McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au	Braga, Lucia/AAQ-1030-2020; Hawley, Carol/AAG-3830-2019; Linden, Mark/L-7754-2019	Linden, Mark/0000-0002-3832-4102; McKinlay, Audrey/0000-0001-9846-8514			Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Armstrong Kira, 2002, Pediatr Rehabil, V5, P149, DOI 10.1080/1363849021000039353; Benz B, 1999, RESTOR NEUROL NEUROS, V14, P135; Blosser J, 2003, PEDIAT TRAUMATIC BRA; Bodde TRA, 2015, DEV NEUROPSYCHOL, V40, P254, DOI 10.1080/87565641.2015.1034864; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Clark Alex, 2008, Clin Child Psychol Psychiatry, V13, P565, DOI 10.1177/1359104508090607; Crothers IR, 2007, BRAIN INJURY, V21, P47, DOI 10.1080/02699050601149054; Deidrick KKM, 2005, PREV SCH FAIL, V49, P23, DOI 10.3200/PSFL.49.4.23-33; DeMatteo CA, 2010, PEDIATRICS, V125, P327, DOI 10.1542/peds.2008-2720; DiScala C, 1997, J HEAD TRAUMA REHAB, V12, P1, DOI 10.1097/00001199-199704000-00002; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Farmer JE, 1997, REHABIL PSYCHOL, V42, P273; Gan C, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P621; Gan C, 2010, NEUROREHABILITATION, V27, P5, DOI 10.3233/NRE-2010-0577; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Gillett J, 2004, NEUROREHABILITATION, V19, P207; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P1, DOI 10.1080/0269905021000010096; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hermans E, 2014, 10 WORLD C BRAIN INJ; Hermans E, 2012, NEUROREHABILITATION, V30, P213, DOI 10.3233/NRE-2012-0747; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Jordan J, 2013, BRAIN INJURY, V27, P1063, DOI 10.3109/02699052.2013.794962; Kelley PW, 2014, QUALITATIVE HLTH RES, V25, P426; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Linden MA, 2013, NEUROTRAUMA, V33; Linden MA, 2013, INT NEUROTRAUMA LETT, P33; Linden MA, 2013, BRAIN INJURY, V27, P92, DOI 10.3109/02699052.2012.722262; Max JE, 1998, BRAIN INJURY, V12, P41; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2012, MILD TRAUMATIC BRAIN, V18, P361; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P507, DOI 10.1097/HTR.0000000000000000; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Mock C, 2001, WESTERN J MED, V175, P372, DOI 10.1136/ewjm.175.6.372; Moore C, 2004, NZ MED J, V117, P1; Morris KC, 2001, BRAIN INJURY, V15, P239, DOI 10.1080/02699050010004068; Mukherjee S, 2000, EDUC RES, V42, P59, DOI 10.1080/001318800363917; Murray HM, 2006, BRAIN INJURY, V20, P575, DOI 10.1080/02699050600664590; National Institute for Health and Clinical Excellence, 2007, HEAD INJ TRIAG ASS I, V56; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Roscigno CI, 2013, BRAIN INJURY, V27, P1536, DOI 10.3109/02699052.2013.831122; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Savage Ronald C, 2005, Pediatr Rehabil, V8, P92; Sharmin N., 2014, J BIOMATER APPL, V0, P1; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Sullivan SJ, 2009, CLIN J SPORT MED, V19, P228, DOI 10.1097/JSM.0b013e3181a41e43; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Wade SL, 2004, J CONSULT CLIN PSYCH, V72, P776, DOI 10.1037/0022-006X.72.5.776; Wake-Dyster W, 2001, Aust Health Rev, V24, P34; Yeates Keith Owen, 2005, Pediatr Rehabil, V8, P5; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Ylvisaker M, 2001, J HEAD TRAUMA REHAB, V16, P76, DOI 10.1097/00001199-200102000-00009; Ylvisaker M, 1998, SCH REENTRY TRAUMATI, P369; Zemek R, 2014, PAED CHILD HEALT-CAN, V19, P474, DOI 10.1093/pch/19.9.475; Zirkle LG, 2008, CLIN ORTHOP RELAT R, V466, P2443, DOI 10.1007/s11999-008-0387-0	72	13	13	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1656	1664		10.1080/02699052.2016.1201592			9	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800020	27740853	Green Published			2021-06-18	
J	Mufson, EJ; Perez, SE; Nadeem, M; Mahady, L; Kanaan, NM; Abrahamson, EE; Ikonomovic, MD; Crawford, F; Alvarez, V; Stein, T; McKee, AC				Mufson, Elliott J.; Perez, Sylvia E.; Nadeem, Muhammad; Mahady, Laura; Kanaan, Nicholas M.; Abrahamson, Eric E.; Ikonomovic, Milos D.; Crawford, Fiona; Alvarez, Victor; Stein, Thor; McKee, Ann C.			Progression of tau pathology within cholinergic nucleus basalis neurons in chronic traumatic encephalopathy: A chronic effects of neurotrauma consortium study	BRAIN INJURY			English	Article						Cognition; head injury; memory; mild brain injury; traumatic brain injury	MILD COGNITIVE IMPAIRMENT; NERVE GROWTH-FACTOR; BETA-AMYLOID DEPOSITION; ALZHEIMERS-DISEASE; BRAIN-INJURY; HEAD-INJURY; ACETYLTRANSFERASE ACTIVITY; FOREBRAIN NEURONS; CASPASE CLEAVAGE; UP-REGULATION	Objective: To test the hypothesis that the nucleus basalis of Meynert (nbM), a cholinergic basal forebrain (CBF) cortical projection system, develops neurofibrillary tangles (NFTs) during the progressive pathological stages of chronic traumatic encephalopathy (CTE) in the brain of athletes.Method: To characterize NFT pathology, tau-antibodies marking early, intermediate and late stages of NFT development in CBF tissue obtained at autopsy from eighteen former athletes and veterans with a history of repetitive mild traumatic brain injury (TBI) were used.Results: Analysis revealed that cholinergic nbM neurons develop intracellular tau-immunoreactive changes progressively across the pathological stages of CTE. In particular, there was an increase in pre-tangle (phosphorylated pS422) and oligomeric (TOC1 and TNT1) forms of tau in stage IV compared to stage II CTE cases. The nbM neurons also displayed pathologic TDP-43 inclusions and diffuse extracellular and vascular amyloid- (A) deposits in CTE. A higher percentage of pS422/p75(NTR), pS422 and TNT1 labelled neurons were significantly correlated with age at symptom onset, interval between symptom onset and death and age at death.Conclusion: The development of NFTs within the cholinergic nbM neurons could contribute to an axonal disconnection in CTE. Further studies are needed to determine the mechanism driving NFT formation in the nbM neurons and its relation to chronic cognitive dysfunction in CTE.	[Mufson, Elliott J.; Perez, Sylvia E.; Nadeem, Muhammad; Mahady, Laura] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Kanaan, Nicholas M.] Michigan State Univ, Dept Translat Sci & Mol Med, Coll Human Med, Grand Rapids, MI USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] Univ Pittsburgh, Dept Neurol & Psychiat, Pittsburgh, PA USA; [Abrahamson, Eric E.; Ikonomovic, Milos D.] VA Pittsburgh Hlthcare Syst, Geriatr Res Educ & Clin Ctr, Pittsburgh, PA USA; [Crawford, Fiona] Roskamp Inst, Sarasota, FL USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, VA Boston HlthCare Syst, Alzheimer Dis Ctr, Boston, MA USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, CTE Program, Boston, MA USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA USA; [Alvarez, Victor; Stein, Thor; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA USA	Mufson, EJ (corresponding author), Barrow Neurol Inst, Alzheimers Dis Res Lab, 350 W Thomas St, Phoenix, AZ 85013 USA.	elliott.mufson@dignityhealth.org	Lang, Steven/AAE-8102-2021; Kanaan, Nicholas/J-3428-2016	Lang, Steven/0000-0003-1669-9146; Kanaan, Nicholas/0000-0002-4362-2593	US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); US Department of Veterans AffairsUS Department of Veterans Affairs [W81XWH-13-2-0095]; Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX001774]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U01NS086659-01]; National Institute of Aging, Boston University AD Center [P30AG13846, 0572063345-5]; Veterans Affairs Biorepository [CSP 501]; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Foundation; World Wrestling Entertainment; National Football League; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001774] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This material is based upon work supported by the US Army Medical Research and Material Command and from the US Department of Veterans Affairs [2] under Award No. W81XWH-13-2-0095. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. Any opinions, findings, conclusions or recommendations expressed in this publication are those of the authors and do not necessarily reflect the views of the US Government, or the US Department of Veterans Affairs, and no official endorsement should be inferred. This work was also supported by an award from the Department of Veterans Affairs No. I01 RX001774, National Institute of Neurological Disorders and Stroke, National Institute of Biomedical Imaging and Bioengineering (U01NS086659-01) and National Institute of Aging, Boston University AD Center (P30AG13846; supplement 0572063345-5), the Veterans Affairs Biorepository (CSP 501), the National Operating Committee on Standards for Athletic Equipment, the Concussion Legacy Foundation, the Andlinger Foundation and the World Wrestling Entertainment and the National Football League.	[Anonymous], 2003, J NEUROPSYCH CLIN N, V15, P383, DOI 10.1176/appi.neuropsych.15.3.383; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Binder LI, 2005, BBA-MOL BASIS DIS, V1739, P216, DOI 10.1016/j.bbadis.2004.08.014; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bourgeois JA, 2002, J NEUROPSYCH CLIN N, V14, P463, DOI 10.1176/appi.neuropsych.14.4.463; Budson A.E., 2016, MEMORY LOSS ALZHEIME; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Collins M, 2012, ACTA NEUROPATHOL, V124, P717, DOI 10.1007/s00401-012-1045-x; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; David X Cifu D-AR, 2015, FED PRACTICE, V32, P44; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; Dewar D, 1996, J NEUROTRAUM, V13, P181, DOI 10.1089/neu.1996.13.181; Donat CK, 2010, NEUROPATH APPL NEURO, V36, P225, DOI 10.1111/j.1365-2990.2009.01050.x; Doody RS, 2003, NEUROLOGIST, V9, P225, DOI 10.1097/01.nrl.0000087723.53475.48; Galvin JE, 2008, ALZ DIS ASSOC DIS, V22, P30, DOI 10.1097/WAD.0b013e3181630b81; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Garcia-Sierra F, 2003, J ALZHEIMERS DIS, V5, P65, DOI 10.3233/JAD-2003-5201; Ghoshal N, 2002, EXP NEUROL, V177, P475, DOI 10.1006/exnr.2002.8014; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; Ginsberg SD, 2011, J CHEM NEUROANAT, V42, P102, DOI 10.1016/j.jchemneu.2011.05.012; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grossberg G, 2004, AM J GERIAT PSYCHIAT, V12, P420, DOI 10.1176/appi.ajgp.12.4.420; Guillozet-Bongaarts AL, 2006, J NEUROCHEM, V97, P1005, DOI 10.1111/j.1471-4159.2006.03784.x; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Guillozet-Bongaarts AL, 2007, ACTA NEUROPATHOL, V113, P513, DOI 10.1007/s00401-007-0209-6; HEFTI F, 1986, ANN NEUROL, V20, P275, DOI 10.1002/ana.410200302; HEFTI F, 1983, ANN NEUROL, V13, P109, DOI 10.1002/ana.410130127; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Ikonomovic MD, 2006, METHOD ENZYMOL, V412, P123, DOI 10.1016/S0076-6879(06)12009-1; Johnson Gail V. W., 1998, Alzheimer's Disease Review, V3, P125; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kanaan NM, 2015, J NEUROPATHOLOGY EXP, V75, P19; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kaye NS, 2003, J NEUROPSYCHIATRY CL, V15; King A, 2011, NEUROPATHOLOGY, V31, P239, DOI 10.1111/j.1440-1789.2010.01171.x; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; KORDOWER JH, 1988, J COMP NEUROL, V277, P465, DOI 10.1002/cne.902770402; Lopez-Pousa S, 2000, REV NEUROLOGIA, V31, P724, DOI 10.33588/rn.3108.2000316; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mesulam M, 2004, ANN NEUROL, V55, P815, DOI 10.1002/ana.20100; Mesulam M, 2012, BIOL PSYCHIAT, V71, P760, DOI 10.1016/j.biopsych.2012.02.025; MESULAM MM, 1983, J COMP NEUROL, V214, P170, DOI 10.1002/cne.902140206; Mesulam NM, 1999, NEURON, V24, P521, DOI 10.1016/S0896-6273(00)81109-5; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; MUFSON EJ, 1989, J COMP NEUROL, V285, P196, DOI 10.1002/cne.902850204; MUFSON EJ, 1989, EXP NEUROL, V105, P221, DOI 10.1016/0014-4886(89)90124-6; Mufson EJ, 2012, ACTA NEUROPATHOL, V123, P13, DOI 10.1007/s00401-011-0884-1; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; Murdoch I, 2002, J NEUROTRAUM, V19, P279, DOI 10.1089/08977150252807018; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Perez Sylvia E, 2012, Int J Physiol Pathophysiol Pharmacol, V4, P115; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Sassin I, 2000, ACTA NEUROPATHOL, V100, P259, DOI 10.1007/s004019900178; SCHATTEMAN GC, 1988, J NEUROSCI, V8, P860; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Thomas A, 2001, CLIN NEUROPHARMACOL, V24, P31, DOI 10.1097/00002826-200101000-00007; Trovato M, 2006, BRAIN INJURY, V20, P339, DOI 10.1080/02699050500487811; Vana L, 2011, AM J PATHOL, V179, P2533, DOI 10.1016/j.ajpath.2011.07.044; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Walker W, 2004, BRAIN INJURY, V18, P739, DOI 10.1080/02699050310001646224; Ward SM, 2013, J ALZHEIMERS DIS, V37, P593, DOI 10.3233/JAD-131235; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341	83	13	14	0	11	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1399	1413		10.1080/02699052.2016.1219058			15	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100002	27834536	Green Accepted			2021-06-18	
S	Rowe, RK; Griffiths, DR; Lifshitz, J		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Rowe, Rachel K.; Griffiths, Daniel R.; Lifshitz, Jonathan			Midline (Central) Fluid Percussion Model of Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Traumatic brain injury (TBI); Concussion; Diffuse; Fluid percussion; Trauma; Rodent; Rat; Mouse; Experimental model; Righting reflex; Fencing response; Postoperative care	RAT	Research models of traumatic brain injury (TBI) hold significant validity towards the human condition, with each model replicating a subset of clinical features and symptoms. After 30 years of characterization and implementation, fluid percussion injury (FPI) is firmly recognized as a clinically relevant model of TBI, encompassing concussion through severe injury. The midline variation of FPI may best represent mild and diffuse clinical brain injury, because of the acute behavioral deficits, the late onset of subtle behavioral morbidities, and the absence of gross histopathology. This chapter outlines the procedures for midline (diffuse) FPI in adult male rats and mice. With these procedures, it becomes possible to generate brain-injured laboratory animals for studies of injury-induced pathophysiology and behavioral deficits, for which rational therapeutic interventions can be implemented.	[Rowe, Rachel K.; Griffiths, Daniel R.; Lifshitz, Jonathan] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Griffiths, Daniel R.; Lifshitz, Jonathan] Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85006 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA	Rowe, RK (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA.; Rowe, RK (corresponding author), Univ Arizona, Coll Med, Dept Child Hlth, Phoenix, AZ 85006 USA.; Rowe, RK (corresponding author), Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA.			Rowe, Rachel/0000-0002-9034-3159			Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Lifshitz J, 2008, ANIMAL MODELS ACUTE; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; Yamamoto T, 1988, J NEUROTRAUM, V5, P69, DOI 10.1089/neu.1988.5.69	8	13	13	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						211	230		10.1007/978-1-4939-3816-2_13	10.1007/978-1-4939-3816-2		20	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500015	27604721				2021-06-18	
J	Song, SJ; Kong, XY; Acosta, S; Sava, V; Borlongan, C; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Acosta, Sandra; Sava, Vasyl; Borlongan, Cesar; Sanchez-Ramos, Juan			Granulocyte-colony stimulating factor promotes brain repair following traumatic brain injury by recruitment of microglia and increasing neurotrophic factor expression	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Granulocyte-colony stimulating factor; traumatic brain injury; neuro-inflammation; neurogenesis; doublecortin; astrocytosis; microgliosis; chimeric mice; green fluorescent protein	REVERSES COGNITIVE IMPAIRMENT; BONE-MARROW-CELLS; FACTOR G-CSF; CELLULAR PROLIFERATION; FUNCTION RECOVERY; PURKINJE NEURONS; ISCHEMIC-STROKE; NEUROGENESIS; ADULT; TRANSPLANTATION	Purpose: The overall objective was to elucidate cellular mechanisms by which G-CSF enhances recovery from traumatic brain injury in a hippocampal-dependent learning task. Methods: Chimeric mice were prepared by transplanting bone marrow cells that express green fluorescent protein (GFP+) from a transgenic "green" mice into C57BL/6 mice. Two months later, the animals sustained mild controlled cortical impact (CCI) to the right frontal-parietal cortex, followed by G-CSF (100 [kg/kg) treatment for 3 consecutive days. The primary behavioral end-point was performance on the radial arm water maze (RAWM) assessed before and after CCI (days 7 and 14). Secondary endpoints included a), motor performance on a rotating cylinder (rotarod), b) measurement of microglial and astroglial response, c) hippocampal neurogenesis, and d) measures of neurotrophic factors (BDNF, GDNF) in brain homogenates. Results: G-CSF treatment resulted in significantly better performance on the rotorod at one week, and in the RAWM after one and two weeks. The cellular changes found 2 wks after CCI in the G-CSF group included increased numbers of hippocampal newborn neurons as well as astrocytosis and microgliosis in striatum and frontal cortex on both sides of brain. GFP+ cells that co-labeled with Ibal (microglial marker) comprised a significant proportion of striatal microglia in G-CSF treated animals, indicating the capacity of G-CSF to increase microglial recruitment to the site of injury. Neurotrophic factors GDNF and BDNF, elaborated by activated microglia and astrocytes, were increased in G-CSF treated mice. Conclusions: G-CSF serves as a neurotrophic factor that increases hippocampal neurogenesis (or enhances survival of new-born neurons), and activates astrocytes and microglia. In turn, these activated glia release a plethora of cytokines and neurotrophic factors that contribute, in a poorly understood cascade, to the brain's repair response. G-CSF also acts directly on bone marrow-derived cells to enhance recruitment of microglia to the site of CCI from circulating monocytes to the site of CCI.	[Song, Shijie; Kong, Xiaoyuan; Sava, Vasyl; Sanchez-Ramos, Juan] James A Haley VAH Res Serv, Tampa, FL USA; [Song, Shijie; Sava, Vasyl; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Kong, Xiaoyuan; Acosta, Sandra; Borlongan, Cesar] Univ S Florida, Dept Neurosurg, Tampa, FL USA	Sanchez-Ramos, J (corresponding author), 13220 Laurel Dr, Tampa, FL 33612 USA.	jsramos@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Sanchez-Ramos, Juan/A-1188-2009	Sanchez-Ramos, Juan/0000-0002-3391-7857	Veterans Administration Merit Review GrantUS Department of Veterans Affairs; Helen Ellis Research Endowment Funds; Veterans AffairsUS Department of Veterans Affairs [I01BX004037, I01BX001407] Funding Source: NIH RePORTER	Supported by Veterans Administration Merit Review Grant to S. Song and by the Helen Ellis Research Endowment Funds to J. Sanchez-Ramos.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Boku S, 2013, BIOCHEM BIOPH RES CO, V434, P779, DOI 10.1016/j.bbrc.2013.04.011; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Catlow BJ, 2013, EXP BRAIN RES, V228, P481, DOI 10.1007/s00221-013-3579-0; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen WF, 2011, PEDIATR RES, V70, P589, DOI 10.1203/PDR.0b013e3182324424; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cheng XW, 2011, CELL RES, V21, P338, DOI 10.1038/cr.2010.141; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; DOCZI TP, 1995, ACTA NEUROCHIR, V132, P87, DOI 10.1007/BF01404853; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Kempermann G., 2006, ADULT NEUROGENSIS ST; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sikoglu EM, 2014, BEHAV BRAIN RES, V259, P354, DOI 10.1016/j.bbr.2013.11.008; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Song SJ, 2014, J NEUROSCI RES, V92, P975, DOI 10.1002/jnr.23378; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Song Shijie, 2002, Methods Mol Biol, V198, P79; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	41	13	13	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	3					415	431		10.3233/RNN-150607			17	Neurosciences	Neurosciences & Neurology	DQ1EY	WOS:000378945500006	26923619				2021-06-18	
J	Stone, JR; Wilde, EA; Taylor, BA; Tate, DF; Levin, H; Bigler, ED; Scheibel, RS; Newsome, MR; Mayer, AR; Abildskov, T; Black, GM; Lennon, MJ; York, GE; Agarwal, R; DeVillasante, J; Ritter, JL; Walker, PB; Ahlers, ST; Tustison, NJ				Stone, James R.; Wilde, Elisabeth A.; Taylor, Brian A.; Tate, David F.; Levin, Harvey; Bigler, Erin D.; Scheibel, Randall S.; Newsome, Mary R.; Mayer, Andrew R.; Abildskov, Tracy; Black, Garrett M.; Lennon, Michael J.; York, Gerald E.; Agarwal, Rajan; DeVillasante, Jorge; Ritter, John L.; Walker, Peter B.; Ahlers, Stephen T.; Tustison, Nicholas J.			Supervised learning technique for the automated identification of white matter hyperintensities in traumatic brain injury	BRAIN INJURY			English	Article						Neuroimaging; brain imaging; magnetic resonance imaging; machine learning; random forest decision tree; deep learning; TBI	IMAGE REGISTRATION; AXONAL INJURY; MR-IMAGES; SEGMENTATION; LESIONS; METAANALYSIS; FORESTS; VOLUME; ANTS	Background: White matter hyperintensities (WMHs) are foci of abnormal signal intensity in white matter regions seen with magnetic resonance imaging (MRI). WMHs are associated with normal ageing and have shown prognostic value in neurological conditions such as traumatic brain injury (TBI). The impracticality of manually quantifying these lesions limits their clinical utility and motivates the utilization of machine learning techniques for automated segmentation workflows.Methods: This study develops a concatenated random forest framework with image features for segmenting WMHs in a TBI cohort. The framework is built upon the Advanced Normalization Tools (ANTs) and ANTsR toolkits. MR (3D FLAIR, T2- and T1-weighted) images from 24 service members and veterans scanned in the Chronic Effects of Neurotrauma Consortium's (CENC) observational study were acquired. Manual annotations were employed for both training and evaluation using a leave-one-out strategy. Performance measures include sensitivity, positive predictive value, score and relative volume difference.Results: Final average results were: sensitivity = 0.68 0.38, positive predictive value = 0.51 +/- 0.40, = 0.52 +/- 0.36, relative volume difference = 43 +/- 26%. In addition, three lesion size ranges are selected to illustrate the variation in performance with lesion size.Conclusion: Paired with correlative outcome data, supervised learning methods may allow for identification of imaging features predictive of diagnosis and prognosis in individual TBI patients.	[Stone, James R.; Tustison, Nicholas J.] Univ Virginia, Dept Radiol & Med Imaging, Box 800170,1215 Lee St, Charlottesville, VA 22908 USA; [Stone, James R.] Univ Virginia, Dept Neurol Surg, Charlottesville, VA USA; [Wilde, Elisabeth A.; Taylor, Brian A.; Levin, Harvey; Scheibel, Randall S.; Newsome, Mary R.; Agarwal, Rajan] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Wilde, Elisabeth A.; Taylor, Brian A.; Levin, Harvey; Scheibel, Randall S.; Newsome, Mary R.; Black, Garrett M.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Levin, Harvey] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Taylor, Brian A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Bigler, Erin D.; Abildskov, Tracy; Black, Garrett M.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Mayer, Andrew R.] Mind Res Network, Dept Translat Neurosci, Albuquerque, NM USA; [Mayer, Andrew R.] Univ New Mexico Hlth Ctr, Dept Neurol, Albuquerque, NM USA; [Lennon, Michael J.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [York, Gerald E.] Alaska Radiol Associates, Anchorage, AK USA; [DeVillasante, Jorge] USF Morsani Coll Med, Dept Radiol, Tampa, FL USA; [Ritter, John L.] San Antonio Mil Med Ctr, Dept Radiol, San Antonio, TX USA; [Ritter, John L.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Washington, DC USA; [Walker, Peter B.; Ahlers, Stephen T.] Naval Med Res Ctr, Silver Spring, MD USA	Stone, JR (corresponding author), Univ Virginia, Dept Radiol & Med Imaging, Box 800170,1215 Lee St, Charlottesville, VA 22908 USA.	jrs7r@virginia.edu	Tate, David F/I-3963-2013; Ritter, John/AAG-8899-2020	Tate, David F/0000-0003-0213-1920; Taylor, Brian/0000-0001-9745-1075; TUSTISON, NICHOLAS/0000-0001-9418-5103	Department of DefenseUnited States Department of Defense [W81XWH-13-2-0095]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01 CX001135, I01 RX 002174]; USUHS Grant [HU 0001-08-0001]; Veterans AffairsUS Department of Veterans Affairs [I01RX002174, I21RX001608] Funding Source: NIH RePORTER	This project was jointly supported by the Department of Defense (W81XWH-13-2-0095), the US Department of Veterans Affairs (I01 CX001135 and I01 RX 002174), as well as USUHS Grant HU 0001-08-0001. The authors report no financial disclosures or conflicts of interest. The views expressed here are those of the authors and do not necessarily reflect the official policy of position of the Department of the Navy, Department of Defense, nor the US Government. This work was prepared as a part of official duties; Title 17 USC 105 provides that copyright protection under this title is not available for any work of the US Government. Title 17 USC 101 defines a US Governmentwork as awork prepared by a military service member of employee of the US Government as part of that person's official duties.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Avants BB, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00044; Avants BB, 2011, NEUROINFORMATICS, V9, P381, DOI 10.1007/s12021-011-9109-y; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Bauer S., 2012, MICCAI BRATS WORK, P10; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Garcia-Lorenzo D, 2013, MED IMAGE ANAL, V17, P1, DOI 10.1016/j.media.2012.09.004; Geremia E, 2011, NEUROIMAGE, V57, P378, DOI 10.1016/j.neuroimage.2011.03.080; Kloppenborg RP, 2014, NEUROLOGY, V82, P2127, DOI 10.1212/WNL.0000000000000505; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; Liaw A., 2002, R NEWS, V2, P18, DOI DOI 10.1177/154405910408300516; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Maurer CR, 2003, IEEE T PATTERN ANAL, V25, P265, DOI 10.1109/TPAMI.2003.1177156; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Neema M, 2009, AM J NEURORADIOL, V30, P911, DOI 10.3174/ajnr.A1514; Nyul LG, 2000, IEEE T MED IMAGING, V19, P143, DOI 10.1109/42.836373; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Pustina D, 2016, HUM BRAIN MAPP, V37, P1405, DOI 10.1002/hbm.23110; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Smitherman E, 2016, J NEUROTRAUM, V33, P35, DOI 10.1089/neu.2014.3801; Tustison NJ, 2015, NEUROINFORMATICS, V13, P209, DOI 10.1007/s12021-014-9245-2; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Tustison NJ, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00039; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Van Ginneken B., 2007, 3D SEGMENTATION CLIN, P7; Viola P, 2005, INT J COMPUT VISION, V63, P153, DOI 10.1007/s11263-005-6644-8; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Yi Z, 2009, LECT NOTES COMPUT SC, V5762, P558; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zikic D., 2012, P MICCAI BRATS NIC F, P1	39	13	13	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	12					1458	1468		10.1080/02699052.2016.1222080			11	Neurosciences; Rehabilitation	Neurosciences & Neurology; Rehabilitation	ED1IO	WOS:000388599100008	27834541				2021-06-18	
J	Turhan, L; Batmaz, S; Kocbiyik, S; Soygur, AH				Turhan, Levent; Batmaz, Sedat; Kocbiyik, Sibel; Soygur, Arif Haldun			The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia	NORDIC JOURNAL OF PSYCHIATRY			English	Article						Immune system; schizophrenia; soluble tumour necrosis factor alpha receptor I; soluble tumour necrosis factor alpha receptor II; tumour necrosis factor alpha	NEGATIVE-SYNDROME-SCALE; INCREASED PLASMA-LEVELS; TRAUMATIC BRAIN-INJURY; TNF-ALPHA; BIPOLAR DISORDER; SERUM-LEVELS; GENE-EXPRESSION; NO ASSOCIATION; POPULATION; CYTOKINES	Background Immunological mechanisms may be responsible for the development and maintenance of schizophrenia symptoms. Aim The aim of this study is to measure tumour necrosis factor-alpha (TNF-alpha), soluble tumour necrosis factor-alpha receptor I (sTNF-alpha RI), and soluble tumour necrosis factor-alpha receptor II (sTNF-alpha RII) levels in patients with schizophrenia and healthy individuals, and to determine their relationship with the symptoms of schizophrenia. Methods Serum TNF-alpha, sTNF-alpha RI and sTNF-alpha RII levels were measured. The Positive and Negative Syndrome Scale (PANSS) was administered for patients with schizophrenia (n = 35), and the results were compared with healthy controls (n = 30). Hierarchical regression analyses were undertaken to predict the levels of TNF-alpha, sTNF-alpha RI and sTNF-alpha RII. Results No significant difference was observed in TNF-alpha levels, but sTNF-alpha RI and sTNF-alpha RII levels were lower in patients with schizophrenia. Serum sTNF-alpha RI and sTNF-alpha RII levels were found to be negatively correlated with the negative subscale score of the PANSS, and sTNF-alpha RI levels were also negatively correlated with the total score of the PANSS. Smoking, gender, body mass index were not correlated with TNF-alpha and sTNF-alpha receptor levels. Conclusions These results suggest that there may be a change in antiinflammatory response in patients with schizophrenia due to sTNF-alpha RI and sTNF-alpha RII levels. The study also supports low levels of TNF activity in schizophrenia patients with negative symptoms.	[Turhan, Levent] Kartal Lutfi Kirdar Training & Res Hosp, Psychiat Clin, Istanbul, Turkey; [Batmaz, Sedat] Gaziosmanpasa Univ, Sch Med, Dept Psychiat, Tokat, Turkey; [Kocbiyik, Sibel] Ataturk Training & Res Hosp, Psychiat Clin, Ankara, Turkey	Batmaz, S (corresponding author), Gaziosmanpasa Univ, Sch Med, Dept Psychiat, Tokat, Turkey.	sedat.batmaz@gop.edu.tr	Batmaz, Sedat/A-2157-2019	Batmaz, Sedat/0000-0003-0585-2184			American Psychiatric Association, 1995, DIAGN STAT MAN MENT; American Psychiatric Association (APA), 2000, DIAGNOSTIC AND STATI; Barbosa IG, 2011, EUR ARCH PSY CLIN N, V261, P139, DOI 10.1007/s00406-010-0116-z; Baune BT, 2008, AM J MED GENET B, V147B, P1056, DOI 10.1002/ajmg.b.30712; Baune BT, 2010, TRENDS NEUROSCI, V3, P263; Bette M, 2003, J COMP NEUROL, V465, P417, DOI 10.1002/cne.10877; Brietzke E, 2008, PROG NEURO-PSYCHOPH, V32, P1355, DOI 10.1016/j.pnpbp.2008.01.006; Camara ML, 2015, BEHAV BRAIN RES, V290, P51, DOI 10.1016/j.bbr.2015.04.040; Camara ML, 2013, PSYCHONEUROENDOCRINO, V38, P3102, DOI 10.1016/j.psyneuen.2013.09.010; Carpentier I, 2004, CURR MED CHEM, V11, P2205, DOI 10.2174/0929867043364694; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Coelho FM, 2008, NEUROIMMUNOMODULAT, V15, P140, DOI 10.1159/000148197; Corapcioglu A, 1999, STRUCTURED CLIN INTE; Czerski PM, 2008, NEUROPSYCHOBIOLOGY, V57, P88, DOI 10.1159/000135642; Dean B, 2013, MOL PSYCHIATR, V18, P767, DOI 10.1038/mp.2012.95; Debnath M, 2013, CYTOKINE, V61, P455, DOI 10.1016/j.cyto.2012.10.028; Di Nicola M, 2013, BRAIN BEHAV IMMUN, V31, P90, DOI 10.1016/j.bbi.2012.06.010; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Duan SW, 2004, NEUROSCI LETT, V366, P139, DOI 10.1016/j.neulet.2004.05.039; Dunjic-Kostic B, 2013, PSYCHIAT DANUB, V25, P55; Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; Erbagci AB, 2001, MEDIAT INFLAMM, V10, P109, DOI 10.1080/09629350120072761; Falcone Tatiana, 2015, Clin Schizophr Relat Psychoses, V9, P65, DOI 10.3371/CSRP.FACA.030813; First M.B., 1996, STRUCTURED CLIN INTE; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Francesconi LP, 2011, PSYCHIAT RES, V189, P305; GATANAGA T, 1990, P NATL ACAD SCI USA, V87, P8781, DOI 10.1073/pnas.87.22.8781; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; Haack M, 1999, J PSYCHIATR RES, V33, P407, DOI 10.1016/S0022-3956(99)00021-7; Hope S, 2013, SCHIZOPHR RES, V145, P36, DOI 10.1016/j.schres.2012.12.023; Hope S, 2009, BIPOLAR DISORD, V11, P726, DOI 10.1111/j.1399-5618.2009.00757.x; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim YK, 2009, NEUROPSYCHOBIOLOGY, V59, P123, DOI 10.1159/000213565; Kinney DK, 2010, MED HYPOTHESES, V74, P555, DOI 10.1016/j.mehy.2009.09.040; Kostakoglu E, 1999, TURK PSIKOL DERG, V14, P23; Kowalski J, 2001, SCHIZOPHR RES, V50, P169, DOI 10.1016/S0920-9964(00)00156-0; Kubistova A, 2012, PSYCHIAT DANUB, V24, pS153; Kunz M, 2011, REV BRAS PSIQUIATR, V33, P268, DOI [10.1590/S1516-44462011005000009, 10.1590/S1516-44462011000300010]; Lewis S., 2009, KAPLAN SADOCKS COMPR, P1433; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lu Lu-xian, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P1251; Lv MH, 2015, PSYCHOPHARMACOLOGY, V232, P165, DOI 10.1007/s00213-014-3650-y; Maddahi A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-107; Maschietto M, 2012, PSYCHIAT RES, V200, P1018, DOI 10.1016/j.psychres.2012.04.030; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Mills NT, 2015, TWIN RES HUM GENET, V18, P28, DOI 10.1017/thg.2014.70; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; Monteleone P, 1997, PSYCHIAT RES, V71, P11, DOI 10.1016/S0165-1781(97)00036-X; Morar B, 2007, AM J MED GENET B, V144B, P318, DOI 10.1002/ajmg.b.30451; Muller N, 2004, EUR ARCH PSY CLIN N, V254, P14, DOI 10.1007/s00406-004-0478-1; Naudin J, 1997, SCHIZOPHR RES, V26, P227, DOI 10.1016/S0920-9964(97)00059-5; Naz M, 2011, MOL BIOL REP, V38, P4709, DOI 10.1007/s11033-010-0606-0; Neijts M, 2013, TWIN RES HUM GENET, V16, P931, DOI 10.1017/thg.2013.58; Noto C, 2013, J PSYCHIATR RES, V47, P467, DOI 10.1016/j.jpsychires.2012.12.010; O'Brien SM, 2008, PSYCHIAT RES, V160, P256, DOI 10.1016/j.psychres.2007.11.014; Pae CU, 2003, PSYCHIAT CLIN NEUROS, V57, P399, DOI 10.1046/j.1440-1819.2003.01138.x; Pan W, 2002, EXP NEUROL, V174, P193, DOI 10.1006/exnr.2002.7871; Pandey GN, 2015, SCHIZOPHR RES, V164, P193, DOI 10.1016/j.schres.2015.02.004; Pedrini M, 2012, J PSYCHIATR RES, V46, P819, DOI 10.1016/j.jpsychires.2012.03.019; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Rodriguez M, 2009, BRAIN PATHOL, V19, P12, DOI 10.1111/j.1750-3639.2008.00151.x; Sacchetti E, 2007, BRAIN BEHAV IMMUN, V21, P450, DOI 10.1016/j.bbi.2006.11.009; Saviouk V, 2005, MOL PSYCHIATR, V10, P375, DOI 10.1038/sj.mp.4001582; Schwarz MJ, 2001, MED HYPOTHESES, V56, P483, DOI 10.1054/mehy.2000.1203; SECKINGER P, 1989, J BIOL CHEM, V264, P11966; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; SMITH RS, 1995, MED HYPOTHESES, V45, P135, DOI 10.1016/0306-9877(95)90062-4; Stahl S., 2013, STAHLS ESSENTIAL PSY, V4th ed.; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Takei Y, 2008, TRENDS MOL MED, V14, P381, DOI 10.1016/j.molmed.2008.07.002; Teixeira AL, 2015, HUM PSYCHOPHARM CLIN, V30, P52, DOI 10.1002/hup.2450; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; Watanabe Y, 2007, PSYCHIAT RES, V153, P1, DOI 10.1016/j.psychres.2006.03.009; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229	85	13	13	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0803-9488	1502-4725		NORD J PSYCHIAT	Nord. J. Psychiatr.		2016	70	5					342	350		10.3109/08039488.2015.1122079			9	Psychiatry	Psychiatry	DQ9LU	WOS:000379532200004	26754110				2021-06-18	
